Citrus Sinensis ID: 004689

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730------
Protein Sequence
MKRENIQSYVLCNCRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGSFGGTENFLSLDESIVRPSAR
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccEEEEEEEccccccccccHHHHHHHHcccccccEEEEEEccccccccEEEEEEcEEEcccccccEEEEEEEcccccccccccccccccccccccccccccccccccEEEEEEccccccccccccccHHHcEEcccccccccHHHHHHHHHHHccccccccccccccccccccEEEcccccccEEEEEcccccccEEccccccccccccEEEccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccEEEEEEEccccEEEEEEcccccccHHHHHHHHHHHHHHcccccccccEEEEcccccEEEEEcccccccHHHHccccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEccccccccccccccEEEcEEcccccccccccccccccccccccccHHHHHHHHHHccccccccccccccccHHHHHHHHHHccccccEEcccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccEEEccccccccEEcccccccccccccccccccEEEccccccccccccccHHHHHHcccccccccEEEEcccccccccEEEEEHHHHHHHccccccEEEEEEccccccccccccccccccccccccccccccccccEEEEEEEEccccccccHHHHHHHHEEEEEcccccccccHHHHHHHHccHHHHcccccccccccccccEEccccccccEEEEEEccccccccccHHHccccccEEEEcccccccccccccccccccEEEEcccccccccccHHHHccccccEEEEccccccccccHHHHHccccccccccccccccccccccccEEHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccHccccccEccHHHHHHHHHHHHHHcccccccEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHccccccEccccccHHHEEEcccccEEEccccccccccccccccccccccccccccHHHHHHccccHHHHHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHcccHHHcccccHcccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccHccccccc
Coil and Loop (DISEMBL)
mkreniqsyvlcncrypddpfdriwesdslkkANYLVDVAagtekvstklpidlrsdelppqkvMQTAVVgtngsltyrlnldgfpgfgwAVTYFAeiedldpdesrkfrlvlpgqpdvSKAIVNIQENaqgkyrvyepgytnlslpfvlsfkfgktydssrgpllnAMEINKYlerndgsidgVAIVSVISLYssadwaqeggdpclpvpwswlqcnsdpqpsitVIHLSsknltgnipsdltKLSSLVELWldgnsltgpipdfsgcpdlriihlednqltgplpsslmnlpnlRELYVQNnmlsgtvpssllSKNVVLNyagninlheggrgakhLNIIIGSSVGAAVLLLATVVSCLFMhkgkknnydkeqhrhslpvqrpvsslndapaeaahcftlSDIEDATKMLEKKigsggfgvvyygklkdgkEIAVKVLTsnsyqgkreftnEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHngtlkehlygtlthEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDlkssnilldkhmrakvsdfglskfavdgashvssivrgtvgyldpeyyisqqltdksdvySFGVILLELISgqeaisnekfgaNCRNIVQWAKLHIesgdiqgiidpslldeyDIQSMWKIEEKALMCvlphghmrpsiSEVLKDIQDAIVIEREAAaardgnsddmsrnslhsslnvgsfggtenflsldesivrpsar
Flexible Loop (DISEMBL)
MKRENIQSYVLCNCRYPDDPFDRIWESDSLKKANYLVDVAagtekvstklpidlrsdelppqkVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKknnydkeqhrhSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKvltsnsyqgkreFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAaardgnsddmsrNSLHSSLnvgsfggtenflsldesivrpsar
Low Complexity Region (SEG)
MKRENIQSYVLCNCRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGplpsslmnlpnlRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIgssvgaavlllatvvsCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQdaiviereaaaardGNSDDMSRNSLHSSLNVGSFGGTENFLSLDESIVRPSAR
Disordered region (IsUnstruct)
*****IQSYVLCNCRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPID**********VMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHK******************************AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE***********************************************
Disordered Region (DISOPRED)
MKRENIQSYVLCNCRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISL*S******EGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNV************************GSSVGAAVLLLATVVSCLFMHK********************************HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAV***************NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI*******************************************I*R****
Disordered Region (DISEMBL)
MKRENIQSYVLCNCRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAA***********RNSLHSSLNVGSFGGTENFLSLDE********
Disordered Region (DISPRO)
MKRENIQSYVLCNCRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKK**************************EAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAA*******************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKRENIQSYVLCNCRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGSFGGTENFLSLDESIVRPSAR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	736	2.2.26 [Sep-21-2011]
C0LGI2	929	Probable LRR receptor-lik	no	no	0.908	0.720	0.514	0.0
Q9FZB8	871	Probable LRR receptor-lik	no	no	0.879	0.742	0.351	1e-106
Q9ZQQ7	886	Putative leucine-rich rep	no	no	0.879	0.730	0.363	1e-102
Q8LKZ1	924	Nodulation receptor kinas	N/A	no	0.889	0.708	0.364	1e-101
Q9LIG2	899	Receptor-like protein kin	no	no	0.883	0.723	0.345	1e-101
Q9FZB1	872	Probable LRR receptor-lik	no	no	0.873	0.737	0.339	1e-101
Q9ZQR3	868	Leucine-rich repeat recep	no	no	0.820	0.695	0.369	1e-101
Q8L4H4	925	Nodulation receptor kinas	N/A	no	0.887	0.705	0.363	1e-100
C0LGG6	876	Probable LRR receptor-lik	no	no	0.851	0.715	0.351	1e-100
C0LGG4	890	Probable LRR receptor-lik	no	no	0.869	0.719	0.346	3e-99

>sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1

 Score =  697 bits (1798), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 354/688 (51%), Positives = 464/688 (67%), Gaps = 19/688 (2%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
           RYPDDP+DRIWESD  K+ NYLV VA GT +++T   I+  + E PP KVMQTAVVGT G
Sbjct: 204 RYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTREYPPMKVMQTAVVGTQG 263

Query: 75  SLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 134
            ++YRLNL+ FP    A  YFAEIE+L  +E+RKF+LV P  PD S A+VNI ENA G Y
Sbjct: 264 LISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDYSNAVVNIAENANGSY 323

Query: 135 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYL------ERNDGSIDGVAIV 188
            +YEP Y N++L FVL+F FGKT DS++GPLLNA+EI+KYL      +R+D S+    + 
Sbjct: 324 TLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISVKTDRSDVSV----LD 379

Query: 189 SVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSS 248
           ++ S+   +DWA EGGDPC+PV WSW+ C+S   P +T I LS KNL G IP  +  + +
Sbjct: 380 AIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEIPPGINYMEA 439

Query: 249 LVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG 308
           L ELWLD N LTG +PD S   +L+I+HLE+NQL+G LP  L +LPNL+EL ++NN   G
Sbjct: 440 LTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNLQELSIENNSFKG 499

Query: 309 TVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVL-----LLATVVSCLFM 363
            +PS+LL   V+  Y  N  L    +  KH   I+G S+ A  +       + V+ C   
Sbjct: 500 KIPSALLKGKVLFKYNNNPELQNEAQ-RKHFWQILGISIAAVAILLLLVGGSLVLLCALR 558

Query: 364 HKGKKNNYDK-EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFG 422
              + +  D  E  +  L     V   +      A+  +L  +E+AT    KK+G G FG
Sbjct: 559 KTKRADKGDSTETKKKGLVAYSAVRGGHLLDEGVAYFISLPVLEEATDNFSKKVGRGSFG 618

Query: 423 VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV 482
            VYYG++KDGKE+AVK+    S    R+F  EV LLSRIHHRNLV  +GYC+E  R +LV
Sbjct: 619 SVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYCEEADRRILV 678

Query: 483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 542
           YE+MHNG+L +HL+G+  ++  ++W+ RL+IA+DAAKG+EYLHTGC P+IIHRD+KSSNI
Sbjct: 679 YEYMHNGSLGDHLHGSSDYKP-LDWLTRLQIAQDAAKGLEYLHTGCNPSIIHRDVKSSNI 737

Query: 543 LLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVIL 602
           LLD +MRAKVSDFGLS+   +  +HVSS+ +GTVGYLDPEYY SQQLT+KSDVYSFGV+L
Sbjct: 738 LLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEKSDVYSFGVVL 797

Query: 603 LELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKAL 662
            EL+SG++ +S E FG    NIV WA+  I  GD+ GIIDP +     I+S+W++ E A 
Sbjct: 798 FELLSGKKPVSAEDFGPEL-NIVHWARSLIRKGDVCGIIDPCIASNVKIESVWRVAEVAN 856

Query: 663 MCVLPHGHMRPSISEVLKDIQDAIVIER 690
            CV   GH RP + EV+  IQDAI IER
Sbjct: 857 QCVEQRGHNRPRMQEVIVAIQDAIRIER 884

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1

 Score =  386 bits (992), Expect = e-106,   Method: Compositional matrix adjust.
 Identities = 257/732 (35%), Positives = 402/732 (54%), Gaps = 85/732 (11%)

Query: 5   NIQSYVLCNCRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKV 64
           N++ Y+     YPDD  DRIW+   L   ++ +        ++T L I++ +D   PQ+V
Sbjct: 194 NLKGYI----EYPDDVHDRIWK-QILPYQDWQI--------LTTNLQINVSNDYDLPQRV 240

Query: 65  MQTAVVGTNGSLT---YRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSK 121
           M+TAV     S T   +  NL+      +   +FAE++ L  +E+R+F +VL        
Sbjct: 241 MKTAVTPIKASTTTMEFPWNLEPPTSQFYLFLHFAELQSLQANETREFNVVL-------- 292

Query: 122 AIVNIQENAQGKYRVYEPGYTNLSLPFVLS----------FKFGKTYDSSRGPLLNAMEI 171
                  N    ++ Y P +  +   +  +           +  KT  S+  PL+NAME 
Sbjct: 293 -------NGNVTFKSYSPKFLEMQTVYSTAPKQCDGGKCLLQLVKTSRSTLPPLINAMEA 345

Query: 172 NKYLE--RNDGSIDGV-AIVSVISLY--SSADWAQEGGDPCLPVPWSW--LQCN----SD 220
              L+  + + ++D V AI ++ S Y  S   W    GDPC+P  + W  L CN    S 
Sbjct: 346 YTVLDFPQIETNVDEVIAIKNIQSTYGLSKTTWQ---GDPCVPKKFLWDGLNCNNSDDST 402

Query: 221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLED 279
           P P IT ++LSS  LTG I   +  L++L EL L  N+L+G +P+F +    L +I+L  
Sbjct: 403 P-PIITSLNLSSSGLTGIIVLTIQNLANLQELDLSNNNLSGGVPEFLADMKSLLVINLSG 461

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHL 339
           N L+G +P  L+    L+     N  L+ TV  S ++K+            EGGR  K +
Sbjct: 462 NNLSGVVPQKLIEKKMLKLNIEGNPKLNCTV-ESCVNKD-----------EEGGRQIKSM 509

Query: 340 NIIIGSSVGAAV-LLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAH 398
            I I +S+G+ V   +A ++ C+     +KNN   ++   S     P  S +  P     
Sbjct: 510 TIPIVASIGSVVAFTVALMIFCVV----RKNNPSNDEAPTS--CMLPADSRSSEPTIVTK 563

Query: 399 C--FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVT 456
              FT +++   T   +K +G GGFG+VYYG +   +++AVK+L+ +S QG ++F  EV 
Sbjct: 564 NKKFTYAEVLTMTNNFQKILGKGGFGIVYYGSVNGTEQVAVKMLSHSSAQGYKQFKAEVE 623

Query: 457 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 516
           LL R+HH+NLV  +GYC+E  +  L+YE+M NG L EH+ G       +NW  RL+IA +
Sbjct: 624 LLLRVHHKNLVGLVGYCEEGDKLALIYEYMANGDLDEHMSGK-RGGSILNWGTRLKIALE 682

Query: 517 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGT 575
           AA+G+EYLH GC P ++HRD+K++NILL++H   K++DFGLS+ F ++G +HVS++V GT
Sbjct: 683 AAQGLEYLHNGCKPLMVHRDVKTTNILLNEHFDTKLADFGLSRSFPIEGETHVSTVVAGT 742

Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 635
           +GYLDPEYY +  LT+KSDVYSFGV+LL +I+ Q  I   +     R+I +W    +  G
Sbjct: 743 IGYLDPEYYRTNWLTEKSDVYSFGVVLLVMITNQPVIDQNR---EKRHIAEWVGGMLTKG 799

Query: 636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE--REAA 693
           DI+ I DP+LL +Y+  S+WK  E A+ C+ P    RP++S+V+ ++++ +  E  RE +
Sbjct: 800 DIKSITDPNLLGDYNSGSVWKAVELAMSCMNPSSMTRPTMSQVVFELKECLASESSREVS 859

Query: 694 AARDGNSDDMSR 705
                    M+R
Sbjct: 860 MTFGTEVAPMAR 871

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZQQ7|Y2144_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14440 OS=Arabidopsis thaliana GN=At2g14440 PE=1 SV=1

 Score =  373 bits (957), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 260/715 (36%), Positives = 390/715 (54%), Gaps = 68/715 (9%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDEL-PPQKVMQTAVVGTN 73
           RYP+D +DR+W   S  +            +++T   +   SD   PPQ V++TA + TN
Sbjct: 210 RYPEDVYDRVWIPHSQPEWT----------QINTTRNVSGFSDGYNPPQDVIKTASIPTN 259

Query: 74  GS--LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQ 131
            S  LT+    +      +A  YFAEI+ L  +E+R+F++++ G        V   +   
Sbjct: 260 VSEPLTFTWMSESSDDETYAYLYFAEIQQLKANETRQFKILVNG--------VYYIDYIP 311

Query: 132 GKYRVYEPGYTNLSLPF---VLSFKFGKTYDSSRGPLLNAMEINKYLE--RNDGSIDGV- 185
            K+   E   T  +L     V   +  KT  S+  P +NA+EI   ++  ++D + D V 
Sbjct: 312 RKFEA-ETLITPAALKCGGGVCRVQLSKTPKSTLPPQMNAIEIFSVIQFPQSDTNTDEVI 370

Query: 186 AIVSVISLY--SSADWAQEGGDPCLPVPWSWL--QCN----SDPQPSITVIHLSSKNLTG 237
           AI ++ S Y  S   W    GDPC+P+ +SW+   CN    S P P I  + LSS  LTG
Sbjct: 371 AIKNIQSTYKVSRISWQ---GDPCVPIQFSWMGVSCNVIDISTP-PRIISLDLSSSGLTG 426

Query: 238 NIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNL 296
            I   +  L+ L EL L  N+LTG IP        LR + L +N LTG +P  L  +  L
Sbjct: 427 VITPSIQNLTMLRELDLSNNNLTGVIPPSLQNLTMLRELDLSNNNLTGEVPEFLATIKPL 486

Query: 297 RELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLAT 356
             ++++ N L G+VP +L  +    N  G + L  G    K   + I +S+    + +  
Sbjct: 487 LVIHLRGNNLRGSVPQALQDRE---NNDG-LKLLRGKHQPKSWLVAIVASISCVAVTIIV 542

Query: 357 VVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKI 416
           +V  +F+ + +K++  K        V RP   + +        F  S++++ T   E  +
Sbjct: 543 LV-LIFIFRRRKSSTRK--------VIRPSLEMKN------RRFKYSEVKEMTNNFEVVL 587

Query: 417 GSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 476
           G GGFGVVY+G L + +++AVKVL+ +S QG +EF  EV LL R+HH NLV  +GYC + 
Sbjct: 588 GKGGFGVVYHGFL-NNEQVAVKVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDKG 646

Query: 477 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRD 536
               L+YEFM NG LKEHL G       +NW  RL+IA ++A GIEYLH GC P ++HRD
Sbjct: 647 NDLALIYEFMENGNLKEHLSGK-RGGPVLNWPGRLKIAIESALGIEYLHIGCKPPMVHRD 705

Query: 537 LKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDV 595
           +KS+NILL     AK++DFGLS+ F V   +HVS+ V GT+GYLDPEYY    LT+KSDV
Sbjct: 706 VKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGYLDPEYYQKNWLTEKSDV 765

Query: 596 YSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMW 655
           YSFG++LLE+I+GQ  I   +   +   IV+WAK  + +GDI+ I+D +L  +YD  S W
Sbjct: 766 YSFGIVLLEIITGQPVIEQSR---DKSYIVEWAKSMLANGDIESIMDRNLHQDYDTSSSW 822

Query: 656 KIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHS 710
           K  E A++C+ P   +RP+++ V  ++ + + I       R     + S++S H+
Sbjct: 823 KALELAMLCINPSSTLRPNMTRVAHELNECLEIYN--LTKRRSQDQNSSKSSGHT 875

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LKZ1|NORK_PEA Nodulation receptor kinase OS=Pisum sativum GN=NORK PE=1 SV=1

 Score =  370 bits (949), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 255/700 (36%), Positives = 373/700 (53%), Gaps = 45/700 (6%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
           R+P D  DRIW++ S    +Y + ++     V      +L     PP +V+QTA+     
Sbjct: 203 RFPVDQNDRIWKATS--TPSYALPLSFNVSNV------ELNGKVTPPLQVLQTALTHPER 254

Query: 75  SLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 134
                + L+        + YF E+ D      R F + L    ++ K   ++ E      
Sbjct: 255 LEFVHVGLETDDYEYSVLLYFLELNDTLKAGQRVFDIYL--NSEIKKEGFDVLEGGSK-- 310

Query: 135 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEI---NKYLERNDGSIDGV--AIVS 189
             Y     N+S    L+    K   S  GPLLNA EI     +++  D +   V   +  
Sbjct: 311 --YSYTVLNISANGSLNITLVKASGSKFGPLLNAYEILQARPWIDETDQTDLEVIQKMRK 368

Query: 190 VISLYSSADWAQEG--GDPCLPVPWSWLQCN-SDPQPSITVIHLSSKNLTGNIPSDLTKL 246
            + L +  + A E   GDPC+  PW  + C+ S+    IT + LSS NL G IPS +T++
Sbjct: 369 ELLLQNQDNEALESWSGDPCMLFPWKGVACDGSNGSSVITKLDLSSSNLKGTIPSSVTEM 428

Query: 247 SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 306
           + L  L L  N   G IP F     L  + L  N LTG LP S+++LP+L  LY   N  
Sbjct: 429 TKLQILNLSHNHFDGYIPSFPPSSLLISVDLSYNDLTGQLPESIISLPHLNSLYFGCNQH 488

Query: 307 SGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVV---SCLFM 363
                 + L+ +++    G  N  +   G   +   IG+    ++L+   VV    C + 
Sbjct: 489 MRDDDEAKLNSSLINTDYGRCNAKKPKFGQVFM---IGAITSGSILITLAVVILFFCRYR 545

Query: 364 HK-------GKKNNYDKEQHRHSLPVQRP--VSSLNDAPAEAAHCFTLSDIEDATKMLEK 414
           HK       G K          SLP +    + S++  P      FTL  IE AT+  + 
Sbjct: 546 HKSITLEGFGGKTYPMATNIIFSLPSKDDFFIKSVSVKP------FTLEYIELATEKYKT 599

Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 474
            IG GGFG VY G L DG+E+AVKV ++ S QG REF NE+ LLS I H NLV  LGYC 
Sbjct: 600 LIGEGGFGSVYRGTLDDGQEVAVKVRSATSTQGTREFDNELNLLSAIQHENLVPLLGYCN 659

Query: 475 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIH 534
           E  + +LVY FM NG+L + LYG     + ++W  RL IA  AA+G+ YLHT    ++IH
Sbjct: 660 EYDQQILVYPFMSNGSLLDRLYGEPAKRKILDWPTRLSIALGAARGLAYLHTFPGRSVIH 719

Query: 535 RDLKSSNILLDKHMRAKVSDFGLSKFA-VDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           RD+KSSNILLD  M AKV+DFG SK+A  +G S+VS  VRGT GYLDPEYY +QQL++KS
Sbjct: 720 RDVKSSNILLDHSMCAKVADFGFSKYAPQEGDSYVSLEVRGTAGYLDPEYYKTQQLSEKS 779

Query: 594 DVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQS 653
           DV+SFGV+LLE++SG+E + N K      ++V+WAK +I +  +  I+DP +   Y  ++
Sbjct: 780 DVFSFGVVLLEIVSGREPL-NIKRPRVEWSLVEWAKPYIRASKVDEIVDPGIKGGYHAEA 838

Query: 654 MWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAA 693
           +W++ E AL C+ P+   RP + +++++++DA++IE  A+
Sbjct: 839 LWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENNAS 878

Involved in the perception of symbiotic fungi and bacteria and required for the calcium spiking. Part of the perception/transduction system leading to nodulation or mycorrhizal infection.

Pisum sativum (taxid: 3888)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LIG2|RLK6_ARATH Receptor-like protein kinase At3g21340 OS=Arabidopsis thaliana GN=At3g21340 PE=1 SV=1

 Score =  370 bits (949), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 253/732 (34%), Positives = 381/732 (52%), Gaps = 82/732 (11%)

Query: 13  NCRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAV--V 70
           N RYPDD  DR W            D    TE ++T L I+  +   PP+ VM +A   +
Sbjct: 209 NIRYPDDVNDRKWYP--------FFDAKEWTE-LTTNLNINSSNGYAPPEVVMASASTPI 259

Query: 71  GTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENA 130
            T G+  +   L       +   +FAEI+ L   ++R+F++ L               N 
Sbjct: 260 STFGTWNFSWLLPSSTTQFYVYMHFAEIQTLRSLDTREFKVTL---------------NG 304

Query: 131 QGKYRVYEPGYTNLSLPFVLS----------FKFGKTYDSSRGPLLNAMEINKYL---ER 177
           +  Y  Y P        F  +           +  KT  S+  PL+NA+E+   +   + 
Sbjct: 305 KLAYERYSPKTLATETIFYSTPQQCEDGTCLLELTKTPKSTLPPLMNALEVFTVIDFPQM 364

Query: 178 NDGSIDGVAIVSVISLY--SSADWAQEGGDPCLPVPWSW--LQCN----SDPQPSITVIH 229
                D  AI S+ S Y  S   W    GDPC+P  + W  L CN    S P P +T ++
Sbjct: 365 ETNPDDVAAIKSIQSTYGLSKISWQ---GDPCVPKQFLWEGLNCNNLDNSTP-PIVTSLN 420

Query: 230 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPS 288
           LSS +LTG I   +  L+ L EL L  N+LTG IP+F +    L +I+L  N   G +P 
Sbjct: 421 LSSSHLTGIIAQGIQNLTHLQELDLSNNNLTGGIPEFLADIKSLLVINLSGNNFNGSIPQ 480

Query: 289 SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIG--SS 346
            L+    L+ +   N  L       +    + +N AGN        GAK +N++I   +S
Sbjct: 481 ILLQKKGLKLILEGNANL-------ICPDGLCVNKAGN-------GGAKKMNVVIPIVAS 526

Query: 347 VGAAVLL---LATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLS 403
           V   V+L   LA              +     +     V R + S   A       FT S
Sbjct: 527 VAFVVVLGSALAFFFIFKKKKTSNSQDLGPSSYTQVSEV-RTIRSSESAIMTKNRRFTYS 585

Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           ++   T   E+ +G GGFG+VY+G + + +++AVK+L+ +S QG +EF  EV LL R+HH
Sbjct: 586 EVVTMTNNFERVLGKGGFGMVYHGTVNNTEQVAVKMLSHSSSQGYKEFKAEVELLLRVHH 645

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           +NLV  +GYC E     L+YE+M NG L+EH+ G       +NW  RL+I  ++A+G+EY
Sbjct: 646 KNLVGLVGYCDEGENLALIYEYMANGDLREHMSGK-RGGSILNWETRLKIVVESAQGLEY 704

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE 582
           LH GC P ++HRD+K++NILL++H+ AK++DFGLS+ F ++G +HVS++V GT GYLDPE
Sbjct: 705 LHNGCKPPMVHRDVKTTNILLNEHLHAKLADFGLSRSFPIEGETHVSTVVAGTPGYLDPE 764

Query: 583 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
           YY +  L +KSDVYSFG++LLE+I+ Q  I+  +      +I +W  L +  GDIQ I+D
Sbjct: 765 YYRTNWLNEKSDVYSFGIVLLEIITNQLVINQSR---EKPHIAEWVGLMLTKGDIQNIMD 821

Query: 643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDD 702
           P L  +YD  S+W+  E A+ C+ P    RP++S+V+ ++ + +  E     AR G S +
Sbjct: 822 PKLYGDYDSGSVWRAVELAMSCLNPSSARRPTMSQVVIELNECLSYEN----ARGGTSQN 877

Query: 703 M-SRNSLHSSLN 713
           M S +S+  S+N
Sbjct: 878 MNSESSIEVSMN 889

Probable receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FZB1|Y5188_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51880 OS=Arabidopsis thaliana GN=At1g51880 PE=2 SV=1

 Score =  369 bits (948), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 253/745 (33%), Positives = 386/745 (51%), Gaps = 102/745 (13%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
           RY +D  DR+W          +     G + +ST L +D  +    PQ V +TA V +N 
Sbjct: 207 RYDEDIHDRVW----------VRQFGNGLKSISTDLLVDTSNPYDVPQAVAKTACVPSNA 256

Query: 75  S--LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQG 132
           S  L +   LD      +   +FAEI+ L  ++ R+F +   G               Q 
Sbjct: 257 SQPLIFDWTLDNITSQSYVYMHFAEIQTLKDNDIREFNITYNG--------------GQN 302

Query: 133 KYRVYEPGYTNLSLPF----------VLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSI 182
            Y    P    +S  F            S  F KT +S+  PL+N +EI K L+  +   
Sbjct: 303 VYSYLRPEKFEISTLFDSKPLSSPDGSFSLSFTKTGNSTLPPLINGLEIYKVLDLLELET 362

Query: 183 DGVAIVSVISLYSSADWAQE---GGDPCLPVPWSW--LQC---NSDPQPSITVIHLSSKN 234
           D   + ++I++ ++ D +++    GDPC P  + W  L C   NSD QP I  ++L+   
Sbjct: 363 DQDEVSAMINIKATYDLSKKVSWQGDPCAPKSYQWEGLNCSYPNSD-QPRIISLNLAENK 421

Query: 235 LTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDN-QLTGPLPSSLMN 292
           LTG I  +++KL+ L+EL L  N L+G IP+F +    L++I+L  N  L   +P S+  
Sbjct: 422 LTGTITPEISKLTQLIELDLSKNDLSGEIPEFFADMKLLKLINLSGNLGLNSTIPDSIQQ 481

Query: 293 LPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVL 352
             + + L +   +LS TV     +K V L           G+  K   I I +SV A V 
Sbjct: 482 RLDSKSLIL---ILSKTV-----TKTVTLK----------GKSKKVPMIPIVASV-AGVF 522

Query: 353 LLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKML 412
            L  +++  F+ + K    +K  +   +  +R +              T  ++   T   
Sbjct: 523 ALLVILAIFFVVRRKNGESNKGTNPSIITKERRI--------------TYPEVLKMTNNF 568

Query: 413 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           E+ +G GGFG VY+G L+D  ++AVK+L+ +S QG +EF  EV LL R+HHRNLV  +GY
Sbjct: 569 ERVLGKGGFGTVYHGNLED-TQVAVKMLSHSSAQGYKEFKAEVELLLRVHHRNLVGLVGY 627

Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
           C +     L+YE+M NG LKE++ G       + W  R++IA +AA+G+EYLH GC P +
Sbjct: 628 CDDGDNLALIYEYMANGDLKENMSGK-RGGNVLTWENRMQIAVEAAQGLEYLHNGCTPPM 686

Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
           +HRD+K++NILL++   AK++DFGLS+ F VDG SHVS++V GT GYLDPEYY +  L++
Sbjct: 687 VHRDVKTTNILLNERYGAKLADFGLSRSFPVDGESHVSTVVAGTPGYLDPEYYRTNWLSE 746

Query: 592 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 651
           KSDVYSFGV+LLE+++ Q      +      +I +W    +  GDI+ I+DP L+ +YD 
Sbjct: 747 KSDVYSFGVVLLEIVTNQPVTDKTR---ERTHINEWVGSMLTKGDIKSILDPKLMGDYDT 803

Query: 652 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSS 711
              WKI E AL CV P  + RP+++ V+ ++ + + +E    A R G      R  +H+S
Sbjct: 804 NGAWKIVELALACVNPSSNRRPTMAHVVTELNECVALEN---ARRQG------REEMHTS 854

Query: 712 LNVGSFGGTENFLSLDESIVRPSAR 736
                  G  +F     S   P AR
Sbjct: 855 -------GYVDFSRSSASEFSPGAR 872

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZQR3|Y2451_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14510 OS=Arabidopsis thaliana GN=At2g14510 PE=2 SV=1

 Score =  369 bits (946), Expect = e-101,   Method: Compositional matrix adjust.
 Identities = 258/699 (36%), Positives = 375/699 (53%), Gaps = 95/699 (13%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDEL-PPQKVMQTAVVGTN 73
           RYP+D +DR+W   S  +            +++T   +   SD   PPQ V+QTA + TN
Sbjct: 209 RYPEDVYDRVWMPYSQPEWT----------QINTTRNVSGFSDGYNPPQGVIQTASIPTN 258

Query: 74  GS--LTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQ 131
           GS  LT+  NL+      +A  +FAEI+ L  +E+R+F+++  G   +            
Sbjct: 259 GSEPLTFTWNLESSDDETYAYLFFAEIQQLKVNETREFKILANGVDYID----------- 307

Query: 132 GKYRVYEPGYTNLSLPF-------VLSFKFGKTYDSSRGPLLNAMEINKYLE--RNDGSI 182
             Y  ++     LS P        V   +  KT  S+  PL+NA+EI   ++  ++D + 
Sbjct: 308 --YTPWKFEARTLSNPAPLKCEGGVCRVQLSKTPKSTLPPLMNAIEIFSVIQFPQSDTNT 365

Query: 183 DGV-AIVSVISLY--SSADWAQEGGDPCLPVPWSWL--QCN----SDPQPSITVIHLSSK 233
           D V AI  + S Y  S   W    GDPC+P  +SW+   CN    S P P I  + LS  
Sbjct: 366 DEVIAIKKIQSTYQLSRISWQ---GDPCVPKQFSWMGVSCNVIDISTP-PRIISLDLSLS 421

Query: 234 NLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPSSLMN 292
            LTG I   +  L+ L EL L  N+LTG +P+F +    L +IHL  N L G +P +L +
Sbjct: 422 GLTGVISPSIQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIHLRGNNLRGSVPQALQD 481

Query: 293 LPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKH--LNIIIGSSVGAA 350
               RE                  KN  L    + N+   G+      L  I+ S    A
Sbjct: 482 ----RE------------------KNDGLKLFVDPNITRRGKHQPKSWLVAIVASISCVA 519

Query: 351 VLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATK 410
           V ++  V+  +F+ + +K++  K        V RP   + +        F  S++++ T 
Sbjct: 520 VTIIVLVL--IFIFRRRKSSTRK--------VIRPSLEMKN------RRFKYSEVKEMTN 563

Query: 411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
             E  +G GGFGVVY+G L + +++AVKVL+ +S QG +EF  EV LL R+HH NLV  +
Sbjct: 564 NFEVVLGKGGFGVVYHGFL-NNEQVAVKVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLV 622

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
           GYC E     L+YEFM NG LKEHL G       +NW  RL+IA ++A GIEYLH GC P
Sbjct: 623 GYCDEGIDLALIYEFMENGNLKEHLSGK-RGGSVLNWSSRLKIAIESALGIEYLHIGCQP 681

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
            ++HRD+KS+NILL     AK++DFGLS+ F V   +HVS+ V GT+GYLDPEYY+   L
Sbjct: 682 PMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQAHVSTNVAGTLGYLDPEYYLKNWL 741

Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 649
           T+KSDVYSFG++LLE I+GQ  I   +   +   IV+WAK  + +GDI+ I+DP+L  +Y
Sbjct: 742 TEKSDVYSFGIVLLESITGQPVIEQSR---DKSYIVEWAKSMLANGDIESIMDPNLHQDY 798

Query: 650 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI 688
           D  S WK  E A++C+ P    RP+++ V  ++ + + I
Sbjct: 799 DSSSSWKALELAMLCINPSSTQRPNMTRVAHELNECLEI 837

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2

 Score =  367 bits (943), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 257/707 (36%), Positives = 376/707 (53%), Gaps = 54/707 (7%)

Query: 13  NCRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGT 72
           + R+PDD  DRIW+          + ++     V      DL+    PP +V+QTA+   
Sbjct: 201 DIRFPDDQNDRIWKRKETSTPTSALPLSFNVSNV------DLKDSVTPPLQVLQTALTHP 254

Query: 73  NGSLTYRLNL--DGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENA 130
                 RL    DG     +  + F    +L+         V  GQ      + N  E  
Sbjct: 255 E-----RLEFVHDGLETDDYEYSVFLHFLELNGT-------VRAGQRVFDIYLNN--EIK 300

Query: 131 QGKYRVYEPG----YT--NLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYL----ERNDG 180
           + K+ V   G    YT  N+S    L+    K   S  GPLLNA EI +      E N  
Sbjct: 301 KEKFDVLAGGSKNSYTALNISANGSLNITLVKASGSEFGPLLNAYEILQARSWIEETNQK 360

Query: 181 SIDGV-AIVSVISLYSSADWAQEG--GDPCLPVPWSWLQCNSDPQPSI-TVIHLSSKNLT 236
            ++ +  +   + L++  + A E   GDPC+  PW  + C+     SI T + LSS NL 
Sbjct: 361 DLEVIQKMREELLLHNQENEALESWSGDPCMIFPWKGITCDDSTGSSIITKLDLSSNNLK 420

Query: 237 GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNL 296
           G IPS +TK+++L  L L  N      P F     L  + L  N L+G LP S+++LP+L
Sbjct: 421 GAIPSIVTKMTNLQILNLSHNQFDMLFPSFPPSSLLISLDLSYNDLSGWLPESIISLPHL 480

Query: 297 RELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG---GRGAKHLNIIIGSSVGAAVLL 353
           + LY       G  PS        LN +  IN   G    +  K   + +  ++ +  LL
Sbjct: 481 KSLYF------GCNPSMSDEDTTKLN-SSLINTDYGRCKAKKPKFGQVFVIGAITSGSLL 533

Query: 354 LATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPV----SSLNDAPAEAAHC--FTLSDIED 407
           +   V  LF  + +  +   E    + P+   +     S +D   ++     FTL  IE 
Sbjct: 534 ITLAVGILFFCRYRHKSITLEGFGKTYPMATNIIFSLPSKDDFFIKSVSVKPFTLEYIEQ 593

Query: 408 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 467
           AT+  +  IG GGFG VY G L DG+E+AVKV +S S QG REF NE+ LLS I H NLV
Sbjct: 594 ATEQYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSSTSTQGTREFDNELNLLSAIQHENLV 653

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
             LGYC E  + +LVY FM NG+L + LYG  +  + ++W  RL IA  AA+G+ YLHT 
Sbjct: 654 PLLGYCNEYDQQILVYPFMSNGSLLDRLYGEASKRKILDWPTRLSIALGAARGLAYLHTF 713

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA-VDGASHVSSIVRGTVGYLDPEYYIS 586
              ++IHRD+KSSNILLD+ M AKV+DFG SK+A  +G S+VS  VRGT GYLDPEYY +
Sbjct: 714 PGRSVIHRDVKSSNILLDQSMCAKVADFGFSKYAPQEGDSYVSLEVRGTAGYLDPEYYKT 773

Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           QQL++KSDV+SFGV+LLE++SG+E + N K      ++V+WAK +I +  +  I+DP + 
Sbjct: 774 QQLSEKSDVFSFGVVLLEIVSGREPL-NIKRPRIEWSLVEWAKPYIRASKVDEIVDPGIK 832

Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAA 693
             Y  +++W++ E AL C+ P+   RP + +++++++DA++IE  A+
Sbjct: 833 GGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDALIIENNAS 879

Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection.

Medicago truncatula (taxid: 3880)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2

 Score =  365 bits (937), Expect = e-100,   Method: Compositional matrix adjust.
 Identities = 244/695 (35%), Positives = 382/695 (54%), Gaps = 68/695 (9%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
           RY +D  DRIW    L   N L+         ST+L +D  +    PQ V +TA V  N 
Sbjct: 203 RYDEDVHDRIW-IPFLDNKNSLL---------STELSVDTSNFYNVPQTVAKTAAVPLNA 252

Query: 75  SLTYRLN--LDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQG 132
           +   ++N  LD      +   +FAEIE+L+ +E+R+F +   G  +              
Sbjct: 253 TQPLKINWSLDDITSQSYIYMHFAEIENLEANETREFNITYNGGENWFSYF------RPP 306

Query: 133 KYR---VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLE--RNDGSIDGV-A 186
           K+R   VY P   + SL    +F F  T +S+  PL+N +EI + LE  + D   D V A
Sbjct: 307 KFRITTVYNPAAVS-SLDGNFNFTFSMTGNSTHPPLINGLEIYQVLELPQLDTYQDEVSA 365

Query: 187 IVSVISLYSSADWAQEGGDPCLPVPWSW--LQC---NSDPQPSITVIHLSSKNLTGNIPS 241
           ++++ ++Y  +  +   GDPC P  + W  L C   N  P P I  ++LS  NL+G I S
Sbjct: 366 MMNIKTIYGLSKRSSWQGDPCAPELYRWEGLNCSYPNFAP-PQIISLNLSGSNLSGTITS 424

Query: 242 DLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 300
           D++KL+ L EL L  N L+G IP  FS   +L +I+L  N+                   
Sbjct: 425 DISKLTHLRELDLSNNDLSGDIPFVFSDMKNLTLINLSGNK------------------- 465

Query: 301 VQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGA--AVLLLATVV 358
                L+ +VP +L  +  + N +  +   E G+ + ++ + I +SV +  AVL++  +V
Sbjct: 466 ----NLNRSVPETLQKR--IDNKSLTLIRDETGKNSTNV-VAIAASVASVFAVLVILAIV 518

Query: 359 SCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGS 418
             +   K + N     +   +  V+    S + +       FT S++   TK  E+ +G 
Sbjct: 519 FVVIRKKQRTNEASGPRSFTTGTVKSDARSSSSSIITKERKFTYSEVLKMTKNFERVLGK 578

Query: 419 GGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR 478
           GGFG VY+G L D  ++AVK+L+ +S QG +EF  EV LL R+HHR+LV  +GYC +   
Sbjct: 579 GGFGTVYHGNLDD-TQVAVKMLSHSSAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDN 637

Query: 479 SVLVYEFMHNGTLKEHLYGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL 537
             L+YE+M  G L+E++ G   H   + +W  R++IA +AA+G+EYLH GC P ++HRD+
Sbjct: 638 LALIYEYMEKGDLRENMSG--KHSVNVLSWETRMQIAVEAAQGLEYLHNGCRPPMVHRDV 695

Query: 538 KSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVY 596
           K +NILL++  +AK++DFGLS+ F VDG SHV ++V GT GYLDPEYY +  L++KSDVY
Sbjct: 696 KPTNILLNERSQAKLADFGLSRSFPVDGESHVMTVVAGTPGYLDPEYYRTNWLSEKSDVY 755

Query: 597 SFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWK 656
           SFGV+LLE+++ Q  ++  +      +I +W    + +GDI+ I+DP L ++YD   +WK
Sbjct: 756 SFGVVLLEIVTNQPVMNKNR---ERPHINEWVMFMLTNGDIKSIVDPKLNEDYDTNGVWK 812

Query: 657 IEEKALMCVLPHGHMRPSISEVLKDIQDAIVIERE 691
           + E AL CV P    RP++  V+ ++ + + +E E
Sbjct: 813 VVELALACVNPSSSRRPTMPHVVMELNECLALEIE 847

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGG4|Y1518_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51860 OS=Arabidopsis thaliana GN=At1g51860 PE=2 SV=2

 Score =  363 bits (931), Expect = 3e-99,   Method: Compositional matrix adjust.
 Identities = 256/738 (34%), Positives = 384/738 (52%), Gaps = 98/738 (13%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
           RY +D  DR+W S +  +          T  +ST LPID  +    PQ VM+TA V  N 
Sbjct: 208 RYDEDIHDRVWNSFTDDE----------TVWISTDLPIDTSNSYDMPQSVMKTAAVPKNA 257

Query: 75  SLTYRL--NLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQG 132
           S  + L   LD      +   +FAE+++L  +E+R+F               NI  N   
Sbjct: 258 SEPWLLWWTLDENTAQSYVYMHFAEVQNLTANETREF---------------NITYNGGL 302

Query: 133 KYRVY-EPGYTNLSLPF----------VLSFKFGKTYDSSRGPLLNAMEINKY-----LE 176
           ++  Y  P   ++S  F          + +F F  T +S+  PLLNA+EI        LE
Sbjct: 303 RWFSYLRPPNLSISTIFNPRAVSSSNGIFNFTFAMTGNSTLPPLLNALEIYTVVDILQLE 362

Query: 177 RNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSW--LQCN-SDPQPS-ITVIHLSS 232
            N   +   A++++   Y  +      GDPC P  + W  L C+  D + S I  ++L+ 
Sbjct: 363 TNKDEVS--AMMNIKETYGLSKKISWQGDPCAPQLYRWEGLNCSYPDSEGSRIISLNLNG 420

Query: 233 KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPSSLM 291
             LTG+I SD++KL+ L  L L  N L+G IP F +    L++I+L  N           
Sbjct: 421 SELTGSITSDISKLTLLTVLDLSNNDLSGDIPTFFAEMKSLKLINLSGN----------- 469

Query: 292 NLPNLRELYVQNNMLSGTVPSSLL----SKNVVLNYAGNINLHEGGRGAKHLNIIIGSSV 347
             PNL       N+ +  +P SL     SK++ L    N+ L       K   + I +SV
Sbjct: 470 --PNL-------NLTA--IPDSLQQRVNSKSLTLILGENLTLTPKKESKKVPMVAIAASV 518

Query: 348 GAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLP--------VQRPVSSLNDAPAEAAHC 399
            A V  L  +++  F+ K K    + + H+   P        V+    S N +       
Sbjct: 519 -AGVFALLVILAIFFVIKRK----NVKAHKSPGPPPLVTPGIVKSETRSSNPSIITRERK 573

Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 459
            T  ++   T   E+ +G GGFG VY+G L DG E+AVK+L+ +S QG +EF  EV LL 
Sbjct: 574 ITYPEVLKMTNNFERVLGKGGFGTVYHGNL-DGAEVAVKMLSHSSAQGYKEFKAEVELLL 632

Query: 460 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 519
           R+HHR+LV  +GYC +     L+YE+M NG L+E++ G       + W  R++IA +AA+
Sbjct: 633 RVHHRHLVGLVGYCDDGDNLALIYEYMANGDLRENMSGK-RGGNVLTWENRMQIAVEAAQ 691

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 578
           G+EYLH GC P ++HRD+K++NILL++   AK++DFGLS+ F +DG  HVS++V GT GY
Sbjct: 692 GLEYLHNGCRPPMVHRDVKTTNILLNERCGAKLADFGLSRSFPIDGECHVSTVVAGTPGY 751

Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 638
           LDPEYY +  L++KSDVYSFGV+LLE+++ Q  I   +      +I  W    +  GDI+
Sbjct: 752 LDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVIDKTR---ERPHINDWVGFMLTKGDIK 808

Query: 639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDG 698
            I+DP L+ +YD    WKI E AL CV P  + RP+++ V+ ++ D + +E    A R G
Sbjct: 809 SIVDPKLMGDYDTNGAWKIVELALACVNPSSNRRPTMAHVVMELNDCVALEN---ARRQG 865

Query: 699 NSDDMSRNSLHSSLNVGS 716
           + +  S  S+  SL+  S
Sbjct: 866 SEEMYSMGSVDYSLSSTS 883

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	736
224068652	924	predicted protein [Populus trichocarpa]	0.979	0.780	0.823	0.0
224138590	921	predicted protein [Populus trichocarpa]	0.978	0.781	0.817	0.0
356570730	936	PREDICTED: probable LRR receptor-like se	0.978	0.769	0.804	0.0
356503698	937	PREDICTED: probable LRR receptor-like se	0.978	0.768	0.793	0.0
297741494	924	unnamed protein product [Vitis vinifera]	0.979	0.780	0.796	0.0
225439769	927	PREDICTED: probable LRR receptor-like se	0.979	0.777	0.794	0.0
255568426	900	Nodulation receptor kinase precursor, pu	0.945	0.773	0.795	0.0
357510569	932	Leucine-rich repeat receptor-like protei	0.980	0.774	0.780	0.0
449440057	897	PREDICTED: probable LRR receptor-like se	0.945	0.775	0.762	0.0
147780497	879	hypothetical protein VITISV_001651 [Viti	0.948	0.794	0.743	0.0

>gi|224068652|ref|XP_002326166.1| predicted protein [Populus trichocarpa] gi|222833359|gb|EEE71836.1| predicted protein [Populus trichocarpa]

 Score = 1245 bits (3221), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 596/724 (82%), Positives = 658/724 (90%), Gaps = 3/724 (0%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
           RYPDDP+DRIWESDS+KKANYLVDVAAGT+KVST +PID+  DE PP++VMQTAVVGTNG
Sbjct: 202 RYPDDPYDRIWESDSVKKANYLVDVAAGTKKVSTDMPIDVNIDERPPERVMQTAVVGTNG 261

Query: 75  SLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 134
           SLTYRLNLDGFPGFGWAVTYFAEIEDLDP+ESRKFRLVLPG PD+SKAIVNI+ENAQGKY
Sbjct: 262 SLTYRLNLDGFPGFGWAVTYFAEIEDLDPEESRKFRLVLPGYPDMSKAIVNIEENAQGKY 321

Query: 135 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY 194
           R+YEPGYTNLSLPFVLSF+FGKT DSSRGPL+NAMEI+KYLE+NDG++DG  I  VI  +
Sbjct: 322 RLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLVNAMEIHKYLEKNDGTLDGYVISRVILSH 381

Query: 195 SSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWL 254
           S+ DWAQEGGDPCLPVPWSW+QCNSD +P I  + LSSKNL+GN+PS LT L+ LVELWL
Sbjct: 382 STEDWAQEGGDPCLPVPWSWVQCNSDARPRIVKLSLSSKNLSGNVPSGLTMLTGLVELWL 441

Query: 255 DGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           DGNSLTGPIPDF+GC  L IIHLE+NQLTG LPSSL+NLPNLRELYVQNN+LSGT+PS L
Sbjct: 442 DGNSLTGPIPDFTGCTGLEIIHLENNQLTGELPSSLLNLPNLRELYVQNNLLSGTIPSGL 501

Query: 315 LSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKE 374
            S+ V LNY+GNINL EG R  +H++IIIGSSVGAAVLL+AT+VSCLFMHKGKK + D+E
Sbjct: 502 -SRKVALNYSGNINLREGARRGRHMDIIIGSSVGAAVLLIATIVSCLFMHKGKKRHPDQE 560

Query: 375 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE 434
           Q R SLP+Q  VSSL +AP EAAHCFT  +IEDATK  EKKIGSGGFGVVYYGK+KDG+E
Sbjct: 561 QLRDSLPMQMVVSSLRNAPGEAAHCFTTFEIEDATKKFEKKIGSGGFGVVYYGKMKDGRE 620

Query: 435 IAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH 494
           IAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE+G+S+LVYEFMHNGTLKEH
Sbjct: 621 IAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEDGKSMLVYEFMHNGTLKEH 680

Query: 495 LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 554
           LYG L   + INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL+DK+MRAKV+D
Sbjct: 681 LYGPLKRGKSINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILVDKNMRAKVAD 740

Query: 555 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 614
           FGLSK AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLEL+SGQEAISN
Sbjct: 741 FGLSKLAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELMSGQEAISN 800

Query: 615 EKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS 674
           E FG NCRNIVQWAKLHIESGDIQGIIDPSL  EYDIQSMWKI EKALMCV PHGHMRPS
Sbjct: 801 ESFGVNCRNIVQWAKLHIESGDIQGIIDPSLCGEYDIQSMWKIAEKALMCVQPHGHMRPS 860

Query: 675 ISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDESIVR 732
           ISEVLK+IQDAI+IERE  AAR+  SD+MSRNS+HSSLN+GS   GG EN+L+LDESI +
Sbjct: 861 ISEVLKEIQDAILIEREVTAAREDISDEMSRNSVHSSLNLGSLDLGGAENYLALDESIAQ 920

Query: 733 PSAR 736
           P+AR
Sbjct: 921 PTAR 924

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224138590|ref|XP_002322852.1| predicted protein [Populus trichocarpa] gi|222867482|gb|EEF04613.1| predicted protein [Populus trichocarpa]

 Score = 1233 bits (3189), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 592/724 (81%), Positives = 657/724 (90%), Gaps = 4/724 (0%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
           RYPDDP+DRIWESDS+KKANYLVDVAAGT+KVST +PI++  DE PP+KVMQTAVVGTNG
Sbjct: 200 RYPDDPYDRIWESDSVKKANYLVDVAAGTKKVSTDMPINVNIDERPPEKVMQTAVVGTNG 259

Query: 75  SLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 134
           SLTYRLNLDGFPGFGWA TYFAEIEDLDP ESRKFRLVLPG PD+SKA+VNI+ENAQGKY
Sbjct: 260 SLTYRLNLDGFPGFGWACTYFAEIEDLDPTESRKFRLVLPGNPDMSKAVVNIEENAQGKY 319

Query: 135 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY 194
           R+YEPGYTNLSLPFVLSF+FGKT DSSRGPLLNAMEINKYLE+NDGS+DG  I  VI LY
Sbjct: 320 RLYEPGYTNLSLPFVLSFRFGKTSDSSRGPLLNAMEINKYLEKNDGSLDGDVISGVILLY 379

Query: 195 SSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWL 254
           S+ADWAQEGGDPC+PVPWSW+QCNS+ +P I  + LSSKNL+G++PSDLTKL+ LVELWL
Sbjct: 380 STADWAQEGGDPCMPVPWSWVQCNSEARPRIVKLSLSSKNLSGSVPSDLTKLTGLVELWL 439

Query: 255 DGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           DGNSLTGPIPDF+GC DL IIHLE+NQLTG LPSSL+NLPNLRELYVQNNMLSGT+PS L
Sbjct: 440 DGNSLTGPIPDFTGCTDLEIIHLENNQLTGELPSSLLNLPNLRELYVQNNMLSGTIPSGL 499

Query: 315 LSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKE 374
             + VVLNY+GNINLHEG R  +H+ IIIGSSVGAAVLL+ T+VSC+FM KGKK + D+E
Sbjct: 500 -GRKVVLNYSGNINLHEGARRGRHMGIIIGSSVGAAVLLITTLVSCMFMQKGKKRHPDQE 558

Query: 375 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE 434
           Q R SLPVQR VS+L++AP EAAH FT  +IEDATK  EKKIGSGGFGVVYYGK+KDG+E
Sbjct: 559 QLRDSLPVQRVVSTLSNAPGEAAHRFTSFEIEDATKKFEKKIGSGGFGVVYYGKMKDGRE 618

Query: 435 IAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH 494
           IAVKVLTSNS+QGKREF+NEV+LLSRIHHRNLVQFLG+CQE G+S+LVYEFMHNGTLKEH
Sbjct: 619 IAVKVLTSNSFQGKREFSNEVSLLSRIHHRNLVQFLGFCQEVGKSMLVYEFMHNGTLKEH 678

Query: 495 LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 554
           LYG L   + I+WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK+SNILLDK+MRAKV+D
Sbjct: 679 LYGPLKQGRSISWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKTSNILLDKNMRAKVAD 738

Query: 555 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 614
           FGLSK AVDGASHVSSIVRGTVGYLDPEYYISQQLT+KSDVYSFGVILLEL+SGQEAISN
Sbjct: 739 FGLSKLAVDGASHVSSIVRGTVGYLDPEYYISQQLTNKSDVYSFGVILLELMSGQEAISN 798

Query: 615 EKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS 674
           E FG NCRNIVQWAKLHIESGDIQGIIDPSL +E+DIQSMWKI EKAL CV PHGHMRPS
Sbjct: 799 ESFGVNCRNIVQWAKLHIESGDIQGIIDPSLCNEFDIQSMWKIAEKALTCVQPHGHMRPS 858

Query: 675 ISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDESIVR 732
           ISEVLK+IQDAI+IERE  AAR G SD+MSRNS+ SS N+GS   GGTEN L+LDESI R
Sbjct: 859 ISEVLKEIQDAILIEREVTAAR-GFSDEMSRNSVQSSFNLGSLDLGGTENCLALDESIAR 917

Query: 733 PSAR 736
           P+AR
Sbjct: 918 PTAR 921

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356570730|ref|XP_003553538.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max]

 Score = 1226 bits (3172), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 587/730 (80%), Positives = 650/730 (89%), Gaps = 10/730 (1%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
           RYPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST +PID+  DE+PP KVMQTAVVGTNG
Sbjct: 209 RYPDDPFDRIWESDSVKKANYLVDVAAGTEKISTTVPIDVNRDEMPPVKVMQTAVVGTNG 268

Query: 75  SLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 134
           SLTYRLNLDGFPG GWA TYFAEIEDLDPDESRKFRLVLPGQPD+SKA+VNI+ENAQGKY
Sbjct: 269 SLTYRLNLDGFPGTGWAFTYFAEIEDLDPDESRKFRLVLPGQPDISKAVVNIEENAQGKY 328

Query: 135 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY 194
           R+YEPG+TN+SLPFVLSF+FGKTYDSSRGPLLNAMEIN YLE+NDGS+DG  I +++S Y
Sbjct: 329 RLYEPGFTNISLPFVLSFRFGKTYDSSRGPLLNAMEINMYLEKNDGSLDGATISNILSHY 388

Query: 195 SSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWL 254
           S+ADW QEGGDPCLPVPWSW++CNSDPQP I  I LS+KNLTGNIP D+TKL  LVELWL
Sbjct: 389 SAADWLQEGGDPCLPVPWSWVRCNSDPQPRIVSILLSNKNLTGNIPLDITKLVGLVELWL 448

Query: 255 DGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           DGN LTGP PDF+GC DL+IIHLE+NQLTG LP+SL NLP+LRELYVQNNMLSGT+PS L
Sbjct: 449 DGNMLTGPFPDFTGCMDLKIIHLENNQLTGVLPTSLTNLPSLRELYVQNNMLSGTIPSEL 508

Query: 315 LSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKE 374
           LSK++VLNY+GNINLH   R   H+ +IIGSSVGA+VLLLAT++SCL+MHKGK+  +  E
Sbjct: 509 LSKDLVLNYSGNINLHRESRIKGHMYVIIGSSVGASVLLLATIISCLYMHKGKRRYH--E 566

Query: 375 QHR------HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK 428
           Q R       SLP QR  S  +D PAEAAHCF+ S+IE+AT   EKKIGSGGFGVVYYGK
Sbjct: 567 QGRILNSCIDSLPTQRLASWKSDDPAEAAHCFSYSEIENATNNFEKKIGSGGFGVVYYGK 626

Query: 429 LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 488
           LKDGKEIAVKVLTSNSYQGKREF+NEVTLLSRIHHRNLVQ LGYC++E  S+LVYEFMHN
Sbjct: 627 LKDGKEIAVKVLTSNSYQGKREFSNEVTLLSRIHHRNLVQLLGYCRDEENSMLVYEFMHN 686

Query: 489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 548
           GTLKEHLYG L H + INWIKRLEIAEDAAKGIEYLHTGCVP +IHRDLKSSNILLDKHM
Sbjct: 687 GTLKEHLYGPLVHGRSINWIKRLEIAEDAAKGIEYLHTGCVPVVIHRDLKSSNILLDKHM 746

Query: 549 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
           RAKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG
Sbjct: 747 RAKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 806

Query: 609 QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPH 668
           QEAISNE FG NCRNIVQWAKLHIESGDIQGIIDP L ++YD+QSMWKI EKALMCV PH
Sbjct: 807 QEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPLLRNDYDLQSMWKIAEKALMCVQPH 866

Query: 669 GHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSL 726
           GHMRPSISE LK+IQDAI IER+A A R+GNSDDMS+NS HSS+N+GS   GG E++LS+
Sbjct: 867 GHMRPSISEALKEIQDAISIERQAEALREGNSDDMSKNSFHSSMNMGSMDLGGAESYLSI 926

Query: 727 DESIVRPSAR 736
           DESI +P+AR
Sbjct: 927 DESIAQPTAR 936

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356503698|ref|XP_003520642.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max]

 Score = 1216 bits (3145), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 579/730 (79%), Positives = 648/730 (88%), Gaps = 10/730 (1%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
           RYPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST +PID+  DE+PP KVMQTAVVGTNG
Sbjct: 210 RYPDDPFDRIWESDSVKKANYLVDVAAGTEKISTTVPIDVNRDEMPPVKVMQTAVVGTNG 269

Query: 75  SLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 134
           SLTYRLNLDGFPG GWA TYFAEIEDLDP+ESRKFRLVLPGQPD+SKA+VNI+ENAQGKY
Sbjct: 270 SLTYRLNLDGFPGTGWAFTYFAEIEDLDPNESRKFRLVLPGQPDISKAVVNIEENAQGKY 329

Query: 135 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY 194
           R+YEPG+TN+SLPFVLSF+FGKTYDSSRGPLLNAMEIN YLE+NDGS+DG  I +++S Y
Sbjct: 330 RLYEPGFTNISLPFVLSFRFGKTYDSSRGPLLNAMEINMYLEKNDGSLDGATISNILSHY 389

Query: 195 SSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWL 254
           S+ DWAQEGGDPCLPVPWSW++CNSDPQP I  I LS+KNLTGNIP D+TKL  LVELWL
Sbjct: 390 SAEDWAQEGGDPCLPVPWSWVRCNSDPQPRIVSILLSNKNLTGNIPMDITKLVGLVELWL 449

Query: 255 DGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           DGN LTGP PDF+GC DL+IIHLE+NQLTG LP+SL NLP+LRELYVQNNMLSGT+PS L
Sbjct: 450 DGNMLTGPFPDFTGCMDLKIIHLENNQLTGVLPTSLTNLPSLRELYVQNNMLSGTIPSEL 509

Query: 315 LSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKE 374
           LSK++VLNY+GNINLH   R   H+ +IIGSSVGA+VLLLAT++SCL+M KGK+  +  E
Sbjct: 510 LSKDLVLNYSGNINLHRESRIKGHMYVIIGSSVGASVLLLATIISCLYMRKGKRRYH--E 567

Query: 375 QHR------HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK 428
           Q R       SLP QR  S  +D PAEAAHCF+  +IE+AT   E KIGSGGFG+VYYGK
Sbjct: 568 QGRILNNRIDSLPTQRLASWKSDDPAEAAHCFSFPEIENATNNFETKIGSGGFGIVYYGK 627

Query: 429 LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 488
           LKDGKEIAVKVLTSNSYQGKREF+NEVTLLSRIHHRNLVQ LGYC++E  S+LVYEFMHN
Sbjct: 628 LKDGKEIAVKVLTSNSYQGKREFSNEVTLLSRIHHRNLVQLLGYCRDEESSMLVYEFMHN 687

Query: 489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 548
           GTLKEHLYG L H + INWIKRLEIAEDAAKGIEYLHTGC+P +IHRDLKSSNILLDKHM
Sbjct: 688 GTLKEHLYGPLVHGRSINWIKRLEIAEDAAKGIEYLHTGCIPVVIHRDLKSSNILLDKHM 747

Query: 549 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
           RAKVSDFGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG
Sbjct: 748 RAKVSDFGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 807

Query: 609 QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPH 668
           QEAISNE FG NCRNIVQWAKLHIESGDIQGIIDP L ++YD+QSMWKI EKALMCV PH
Sbjct: 808 QEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPLLRNDYDLQSMWKIAEKALMCVQPH 867

Query: 669 GHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSL 726
           GHMRP+ISEV+K+IQDAI IER+A A R+GNSDDMS++S HSS+N+GS   GG E++LS+
Sbjct: 868 GHMRPTISEVIKEIQDAISIERQAEALREGNSDDMSKHSFHSSMNMGSMDLGGAESYLSI 927

Query: 727 DESIVRPSAR 736
           DESI +P+AR
Sbjct: 928 DESIAQPTAR 937

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297741494|emb|CBI32626.3| unnamed protein product [Vitis vinifera]

 Score = 1188 bits (3074), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 576/723 (79%), Positives = 642/723 (88%), Gaps = 2/723 (0%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
           RYPDDPFDRIWESDSLKKANYLVDVA GTEKVST++PID+  D  PP+KVMQTAVVG NG
Sbjct: 203 RYPDDPFDRIWESDSLKKANYLVDVAPGTEKVSTQMPIDVNKDSRPPEKVMQTAVVGRNG 262

Query: 75  SLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 134
           +L+YRLNLDGFPGFGWA TY AEIEDL P+E+RKFRL+LP  PD+SK  VNIQENAQGKY
Sbjct: 263 TLSYRLNLDGFPGFGWAFTYLAEIEDLGPEETRKFRLILPNMPDLSKPAVNIQENAQGKY 322

Query: 135 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY 194
           R+YEPGY N+SLPFVLSFKFGKT DSS+GPLLNAMEINKYLE+ DG +DG AI S++  Y
Sbjct: 323 RLYEPGYPNISLPFVLSFKFGKTSDSSQGPLLNAMEINKYLEKRDGCLDGSAIASIVLQY 382

Query: 195 SSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWL 254
           SS DWA+EGGDPCLPVPWSW+ CNSDPQP I  IHLS KNLTGNIP+DLTKLS LVELWL
Sbjct: 383 SSEDWAKEGGDPCLPVPWSWVACNSDPQPRIVSIHLSGKNLTGNIPTDLTKLSGLVELWL 442

Query: 255 DGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           DGN+L GPIPDF+G  +L+ IHLE+NQL+G LPSSL++L +L+ELYVQNNMLSG VPS L
Sbjct: 443 DGNALAGPIPDFTGLINLKTIHLENNQLSGELPSSLVDLQSLKELYVQNNMLSGKVPSGL 502

Query: 315 LSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKE 374
           L++N+  NY+GN NLH+G  G +H+ IIIGSSVGA VLL+AT+ SCLFMHKGKK  Y+++
Sbjct: 503 LNENLDFNYSGNDNLHKGSTGGRHIGIIIGSSVGAVVLLIATIASCLFMHKGKKRYYEQD 562

Query: 375 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE 434
           Q  H LP QR VSSLNDA  EAA+CF+LS+IEDAT+  EKKIGSGGFGVVYYGK+KDGKE
Sbjct: 563 QLGHGLPAQRIVSSLNDAATEAANCFSLSEIEDATRKFEKKIGSGGFGVVYYGKMKDGKE 622

Query: 435 IAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH 494
           IAVKVL +NSYQG REF+NEVTLLSRIHHRNLVQFLGYCQEEGRS+LVYEFMHNGTLKEH
Sbjct: 623 IAVKVLINNSYQGNREFSNEVTLLSRIHHRNLVQFLGYCQEEGRSMLVYEFMHNGTLKEH 682

Query: 495 LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 554
           LYG LT E+ I+WIKRLEIAEDAAKGIEYLHTGCVP+IIHRDLKSSNILLDK+M+AKVSD
Sbjct: 683 LYGPLTRERAISWIKRLEIAEDAAKGIEYLHTGCVPSIIHRDLKSSNILLDKYMKAKVSD 742

Query: 555 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 614
           FGLSK AVDG+SHVSS+VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN
Sbjct: 743 FGLSKLAVDGSSHVSSVVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 802

Query: 615 EKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS 674
           E FG NCRNIVQWAKLHIESGDIQGIIDPSL DEYDIQSMWKI EKALMCV PHG MRP 
Sbjct: 803 ESFGVNCRNIVQWAKLHIESGDIQGIIDPSLRDEYDIQSMWKIAEKALMCVQPHGSMRPP 862

Query: 675 ISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVG-SFGGTENFLSLDESIVRP 733
           ISEV+K+IQ+AI IER A AAR+GNS D SRNS+HSS+N+G   G TEN+LS DESI RP
Sbjct: 863 ISEVIKEIQEAISIERGAEAAREGNS-DASRNSIHSSINMGIDVGPTENYLSFDESIARP 921

Query: 734 SAR 736
           + R
Sbjct: 922 TPR 924

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225439769|ref|XP_002275389.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Vitis vinifera]

 Score = 1185 bits (3066), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 576/725 (79%), Positives = 642/725 (88%), Gaps = 4/725 (0%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
           RYPDDPFDRIWESDSLKKANYLVDVA GTEKVST++PID+  D  PP+KVMQTAVVG NG
Sbjct: 204 RYPDDPFDRIWESDSLKKANYLVDVAPGTEKVSTQMPIDVNKDSRPPEKVMQTAVVGRNG 263

Query: 75  SLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 134
           +L+YRLNLDGFPGFGWA TY AEIEDL P+E+RKFRL+LP  PD+SK  VNIQENAQGKY
Sbjct: 264 TLSYRLNLDGFPGFGWAFTYLAEIEDLGPEETRKFRLILPNMPDLSKPAVNIQENAQGKY 323

Query: 135 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY 194
           R+YEPGY N+SLPFVLSFKFGKT DSS+GPLLNAMEINKYLE+ DG +DG AI S++  Y
Sbjct: 324 RLYEPGYPNISLPFVLSFKFGKTSDSSQGPLLNAMEINKYLEKRDGCLDGSAIASIVLQY 383

Query: 195 SSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWL 254
           SS DWA+EGGDPCLPVPWSW+ CNSDPQP I  IHLS KNLTGNIP+DLTKLS LVELWL
Sbjct: 384 SSEDWAKEGGDPCLPVPWSWVACNSDPQPRIVSIHLSGKNLTGNIPTDLTKLSGLVELWL 443

Query: 255 DGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           DGN+L GPIPDF+G  +L+ IHLE+NQL+G LPSSL++L +L+ELYVQNNMLSG VPS L
Sbjct: 444 DGNALAGPIPDFTGLINLKTIHLENNQLSGELPSSLVDLQSLKELYVQNNMLSGKVPSGL 503

Query: 315 LSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKE 374
           L++N+  NY+GN NLH+G  G +H+ IIIGSSVGA VLL+AT+ SCLFMHKGKK  Y++ 
Sbjct: 504 LNENLDFNYSGNDNLHKGSTGGRHIGIIIGSSVGAVVLLIATIASCLFMHKGKKRYYEQG 563

Query: 375 QHR--HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDG 432
            H+  H LP QR VSSLNDA  EAA+CF+LS+IEDAT+  EKKIGSGGFGVVYYGK+KDG
Sbjct: 564 MHQLGHGLPAQRIVSSLNDAATEAANCFSLSEIEDATRKFEKKIGSGGFGVVYYGKMKDG 623

Query: 433 KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 492
           KEIAVKVL +NSYQG REF+NEVTLLSRIHHRNLVQFLGYCQEEGRS+LVYEFMHNGTLK
Sbjct: 624 KEIAVKVLINNSYQGNREFSNEVTLLSRIHHRNLVQFLGYCQEEGRSMLVYEFMHNGTLK 683

Query: 493 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 552
           EHLYG LT E+ I+WIKRLEIAEDAAKGIEYLHTGCVP+IIHRDLKSSNILLDK+M+AKV
Sbjct: 684 EHLYGPLTRERAISWIKRLEIAEDAAKGIEYLHTGCVPSIIHRDLKSSNILLDKYMKAKV 743

Query: 553 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 612
           SDFGLSK AVDG+SHVSS+VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI
Sbjct: 744 SDFGLSKLAVDGSSHVSSVVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 803

Query: 613 SNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR 672
           SNE FG NCRNIVQWAKLHIESGDIQGIIDPSL DEYDIQSMWKI EKALMCV PHG MR
Sbjct: 804 SNESFGVNCRNIVQWAKLHIESGDIQGIIDPSLRDEYDIQSMWKIAEKALMCVQPHGSMR 863

Query: 673 PSISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVG-SFGGTENFLSLDESIV 731
           P ISEV+K+IQ+AI IER A AAR+GNS D SRNS+HSS+N+G   G TEN+LS DESI 
Sbjct: 864 PPISEVIKEIQEAISIERGAEAAREGNS-DASRNSIHSSINMGIDVGPTENYLSFDESIA 922

Query: 732 RPSAR 736
           RP+ R
Sbjct: 923 RPTPR 927

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255568426|ref|XP_002525187.1| Nodulation receptor kinase precursor, putative [Ricinus communis] gi|223535484|gb|EEF37153.1| Nodulation receptor kinase precursor, putative [Ricinus communis]

 Score = 1185 bits (3065), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 577/725 (79%), Positives = 636/725 (87%), Gaps = 29/725 (4%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
           RYPDDPFDRIWESDS+KKANYLVDVAAGTEK+ST + ID+ +DE PP+KVMQTAVVGTNG
Sbjct: 202 RYPDDPFDRIWESDSVKKANYLVDVAAGTEKISTNMSIDVSNDERPPEKVMQTAVVGTNG 261

Query: 75  SLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 134
           SLTYRLNLDGFPGFGWAVTYFAEIEDL PDESRKFRL+LPG PD+SK IVNIQENAQGKY
Sbjct: 262 SLTYRLNLDGFPGFGWAVTYFAEIEDLAPDESRKFRLILPGFPDMSKPIVNIQENAQGKY 321

Query: 135 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY 194
           R+Y+PGY N+SLPFVLSF+FGKT DSSRGPLLNAMEINKYLE+NDGS+DG  I SVISLY
Sbjct: 322 RLYQPGYPNISLPFVLSFRFGKTSDSSRGPLLNAMEINKYLEKNDGSLDGEVIASVISLY 381

Query: 195 SSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWL 254
           +S DWAQEGGDPCLPVPWSWLQCNSD +P I  I LSSKNLTGNIPSDL KL  L E  L
Sbjct: 382 TSTDWAQEGGDPCLPVPWSWLQCNSDARPRIIKISLSSKNLTGNIPSDLPKLKGLAEFHL 441

Query: 255 DGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
                                  E+NQLTG LPSSLMNLP+LRELYVQNN+LSGTVPS L
Sbjct: 442 -----------------------ENNQLTGGLPSSLMNLPHLRELYVQNNLLSGTVPSGL 478

Query: 315 LSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKE 374
           L KN+ LNY+GN+++HEGGR  KH  IIIGSSVGAAVLL+AT+ SC F+ +GKK+N+D E
Sbjct: 479 LDKNLFLNYSGNLHVHEGGRREKHTGIIIGSSVGAAVLLIATIASCFFIRRGKKSNHDYE 538

Query: 375 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE 434
            HR   PVQR VS+LND PAE A+CFT S+IEDAT+ LEKKIGSGGFG+VYYGKLK+GKE
Sbjct: 539 HHRVPPPVQRLVSTLNDNPAEGAYCFTFSEIEDATRKLEKKIGSGGFGIVYYGKLKNGKE 598

Query: 435 IAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH 494
           IAVKVLT+NS+QGKREF+NEVTLLSRIHHRNLVQFLG+CQE+GRS+LVYE+MHNGTLKEH
Sbjct: 599 IAVKVLTNNSFQGKREFSNEVTLLSRIHHRNLVQFLGFCQEDGRSMLVYEYMHNGTLKEH 658

Query: 495 LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 554
           LYG  +  + INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK+SNILLDKHMRAKVSD
Sbjct: 659 LYG--SRGRSINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKTSNILLDKHMRAKVSD 716

Query: 555 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 614
           FGLSK A+DGASHVSS+VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLEL+SG+EAISN
Sbjct: 717 FGLSKLALDGASHVSSVVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELMSGKEAISN 776

Query: 615 EKFGANCRNIVQWAKLHIESGDIQGIIDPSL-LDEYDIQSMWKIEEKALMCVLPHGHMRP 673
           E FG NCRNIVQWAKLHIESGDIQG+ID S   DEYDIQSMWKI EKALMCV PHGHMRP
Sbjct: 777 E-FGTNCRNIVQWAKLHIESGDIQGVIDSSFDDDEYDIQSMWKIAEKALMCVQPHGHMRP 835

Query: 674 SISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDESIV 731
           SISEVLK+IQDAI IERE+ A R+GNSDDMSRNS+HSSLN+GS   GGTEN+LSLDES+ 
Sbjct: 836 SISEVLKEIQDAIAIERESVAVREGNSDDMSRNSVHSSLNLGSLELGGTENYLSLDESVA 895

Query: 732 RPSAR 736
           RP+AR
Sbjct: 896 RPTAR 900

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357510569|ref|XP_003625573.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula] gi|355500588|gb|AES81791.1| Leucine-rich repeat receptor-like protein kinase [Medicago truncatula]

 Score = 1177 bits (3045), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 565/724 (78%), Positives = 633/724 (87%), Gaps = 2/724 (0%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
           RYPDDPFDRIWESDS+KKANYLVDVA GTEKVST +PI +  D++PP KVMQTAVVGTNG
Sbjct: 209 RYPDDPFDRIWESDSVKKANYLVDVAVGTEKVSTNVPILVNRDDVPPVKVMQTAVVGTNG 268

Query: 75  SLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 134
           SLTYRLNLDGFPG  WAVTYFAEIEDL P+ESRKFRLVLPGQP++SKAIVNI+ENA GKY
Sbjct: 269 SLTYRLNLDGFPGNAWAVTYFAEIEDLSPNESRKFRLVLPGQPEISKAIVNIEENAFGKY 328

Query: 135 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY 194
           R+YEPG+TNLSLPFVLSFKF KT DSS+GPL+NAMEINKYLE+NDGS D  AI  V+S Y
Sbjct: 329 RLYEPGFTNLSLPFVLSFKFAKTPDSSKGPLVNAMEINKYLEKNDGSPDVEAISGVLSHY 388

Query: 195 SSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWL 254
           SSA+W QEGGDPCLPVPWSW++C+SDPQP I  I LS KNLTGNIPSD+TKL  LVELWL
Sbjct: 389 SSANWTQEGGDPCLPVPWSWIRCSSDPQPRIISILLSGKNLTGNIPSDITKLVGLVELWL 448

Query: 255 DGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           DGN LTGPIPDF+GC DL+IIHLE+NQ  G LP+SL NLP+LRELYVQNNMLSG VP  L
Sbjct: 449 DGNMLTGPIPDFTGCMDLKIIHLENNQFNGVLPASLANLPSLRELYVQNNMLSGEVPPHL 508

Query: 315 LSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKE 374
           LSK+++LNY+GN NLH+  R   H+ IIIGS+VGA+VLLLATV+SCL +HKGK+  Y+K+
Sbjct: 509 LSKDLILNYSGNTNLHKQSRIKSHMYIIIGSAVGASVLLLATVISCLVIHKGKRRYYEKD 568

Query: 375 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE 434
               ++P QRP S  +D PAEAAHCF+L++IE AT   EK+IGSGGFG+VYYGKLK+GKE
Sbjct: 569 HIVSAVPTQRPDSWKSDDPAEAAHCFSLAEIETATNNFEKRIGSGGFGIVYYGKLKEGKE 628

Query: 435 IAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH 494
           IAVKVL +NSYQGKREF+NEVTLLSRIHHRNLVQ +GYC+EE  S+LVYEFMHNGTLKEH
Sbjct: 629 IAVKVLRNNSYQGKREFSNEVTLLSRIHHRNLVQLIGYCREEENSILVYEFMHNGTLKEH 688

Query: 495 LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 554
           LYGTL H + INWIKRLEIAEDAAKGIEYLHTGCVP +IHRDLK+SNILLD+ MRAKVSD
Sbjct: 689 LYGTLEHGRSINWIKRLEIAEDAAKGIEYLHTGCVPVVIHRDLKTSNILLDRQMRAKVSD 748

Query: 555 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 614
           FGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN
Sbjct: 749 FGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 808

Query: 615 EKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS 674
           E FG +CRNIVQWAKLHIESGDIQGIIDP L   YD+QSMWKI EKALMCV PHG MRPS
Sbjct: 809 ESFGLHCRNIVQWAKLHIESGDIQGIIDPLLGSNYDLQSMWKIAEKALMCVQPHGDMRPS 868

Query: 675 ISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS--FGGTENFLSLDESIVR 732
           ISEVLK+IQDAI IE+EA   R+GNSD+ SRNS  SS+N+GS   G  E+FLS+DESI +
Sbjct: 869 ISEVLKEIQDAISIEKEAETLREGNSDEASRNSFQSSMNIGSMDLGRAESFLSIDESIAQ 928

Query: 733 PSAR 736
           P+AR
Sbjct: 929 PTAR 932

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449440057|ref|XP_004137801.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] gi|449524194|ref|XP_004169108.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus]

 Score = 1144 bits (2958), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 552/724 (76%), Positives = 626/724 (86%), Gaps = 28/724 (3%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
           RYPDDPFDR+WESDS++KANYLVDVAAGTEKVSTKLPID+  DE PPQKVMQTAVVG NG
Sbjct: 200 RYPDDPFDRMWESDSVRKANYLVDVAAGTEKVSTKLPIDVDRDERPPQKVMQTAVVGRNG 259

Query: 75  SLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 134
           SLTYRLNLDGFPGFGWAVTYFAEIEDL P ++RKFRLVLPG P++SKA+VNI+ENAQGKY
Sbjct: 260 SLTYRLNLDGFPGFGWAVTYFAEIEDLGPTDTRKFRLVLPGMPEISKAVVNIEENAQGKY 319

Query: 135 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY 194
           R+YEPG+TN++LPFVLSF+FGKT DSS GPLLNAMEINKYLE++DGS+DG  + SVIS +
Sbjct: 320 RLYEPGFTNITLPFVLSFRFGKTQDSSLGPLLNAMEINKYLEKSDGSLDGAVVASVISKF 379

Query: 195 SSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWL 254
            S+DW  EGGDPC+PVPWSWLQCNSDPQP I  I LS +NL+GNIP+D+ KLS LVE   
Sbjct: 380 PSSDW-DEGGDPCMPVPWSWLQCNSDPQPRIIKISLSKQNLSGNIPTDIAKLSGLVEF-- 436

Query: 255 DGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
                                HLE+NQLTG LPSSL +LPNLRELYVQNNMLSGTVPS L
Sbjct: 437 ---------------------HLENNQLTGELPSSLASLPNLRELYVQNNMLSGTVPSGL 475

Query: 315 LSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKE 374
           LSKN+V++Y+GNINLHEGG+   H+ II+GS +GA VLLLATVVSC F+HKG++  ++++
Sbjct: 476 LSKNLVVDYSGNINLHEGGK-KNHVYIIVGSVIGAVVLLLATVVSCYFLHKGRRRYHEQD 534

Query: 375 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE 434
               SL VQR VSS  DA  E AHCF++++I  ATK  E+KIGSGGFGVVYYGKL DGKE
Sbjct: 535 LPEESLAVQRFVSSKGDASKETAHCFSVNEIVQATKDFERKIGSGGFGVVYYGKLNDGKE 594

Query: 435 IAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH 494
           IAVKVLTSNS+QG+REF NEVTLLSRIHHRNLVQFLGYCQE+ RS+L+YEFMHNGTLKEH
Sbjct: 595 IAVKVLTSNSFQGRREFANEVTLLSRIHHRNLVQFLGYCQEQDRSMLIYEFMHNGTLKEH 654

Query: 495 LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 554
           LYG LT E+ I+WIKRLEIAEDAA+G+EYLHTGC+PAIIHRDLKSSNILLD+HM+AKVSD
Sbjct: 655 LYGPLTREKTISWIKRLEIAEDAARGVEYLHTGCIPAIIHRDLKSSNILLDRHMKAKVSD 714

Query: 555 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 614
           FGLSK AVDG SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN
Sbjct: 715 FGLSKLAVDGVSHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 774

Query: 615 EKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS 674
             FGANCRNIVQWAKLHIESGDIQGIIDPSL +EYDIQSMWKI EKALMCV  +GH+RPS
Sbjct: 775 VNFGANCRNIVQWAKLHIESGDIQGIIDPSLRNEYDIQSMWKIAEKALMCVQANGHLRPS 834

Query: 675 ISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGSFG--GTENFLSLDESIVR 732
           ISEVLK+IQD+I+IERE+ A ++GNSDDMSRNS+H SLN+GS    G EN++S DESI R
Sbjct: 835 ISEVLKEIQDSILIERESTATKEGNSDDMSRNSVH-SLNMGSLDLCGNENYVSFDESIAR 893

Query: 733 PSAR 736
           P+AR
Sbjct: 894 PTAR 897

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147780497|emb|CAN67050.1| hypothetical protein VITISV_001651 [Vitis vinifera]

 Score = 1130 bits (2923), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 560/753 (74%), Positives = 622/753 (82%), Gaps = 55/753 (7%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
           RYPDDPFDRIWESDSLKKANYLVDVA GTEKVST++PID+  D  PP+KVMQTAVVG NG
Sbjct: 151 RYPDDPFDRIWESDSLKKANYLVDVAPGTEKVSTQMPIDVNKDSRPPEKVMQTAVVGRNG 210

Query: 75  SLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 134
           +L+YRLNLDGFPGFGWA TY AEIEDL P+E+RKFRL+LP  PD+SK  VNIQENAQGKY
Sbjct: 211 TLSYRLNLDGFPGFGWAFTYLAEIEDLGPEETRKFRLILPNMPDLSKPAVNIQENAQGKY 270

Query: 135 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY 194
           R+YEPGY N+SLPFVLSFKFGKT DSS+GPLLNAMEINKYLE+ DG +DG AI S++  Y
Sbjct: 271 RLYEPGYPNISLPFVLSFKFGKTSDSSQGPLLNAMEINKYLEKRDGCLDGSAIASIVLQY 330

Query: 195 SSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWL 254
           SS DWA+EGGDPCLPVPWSW+ CNSDPQP I  IHLS KNLTGNIP+DLTKLS LVELWL
Sbjct: 331 SSEDWAKEGGDPCLPVPWSWVACNSDPQPRIVSIHLSGKNLTGNIPTDLTKLSGLVELWL 390

Query: 255 DGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           DGN+L GPIPDF+G  +L+ IHLE+NQL+G LPSSL++L +L+EL               
Sbjct: 391 DGNALAGPIPDFTGLINLKTIHLENNQLSGELPSSLVDLQSLKEL--------------- 435

Query: 315 LSKNVVLNYAGNINLHEGGRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKE 374
                   Y+GN NLH+G  G +H+ IIIGSSVGA VLL+AT+ SCLFMHKGKK  Y++ 
Sbjct: 436 --------YSGNDNLHKGSTGGRHIGIIIGSSVGAVVLLIATIASCLFMHKGKKRYYEQG 487

Query: 375 QH------------------------------RHSLPVQRPVSSLNDAPAEAAHCFTLSD 404
            H                               H LP QR VSSLNDA  EAA+CF+LS+
Sbjct: 488 MHVSNLEVCLFSSIEMSVSVTGFFYEFVSDQLGHGLPAQRIVSSLNDAATEAANCFSLSE 547

Query: 405 IEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 464
           IEDAT+  EKKIGSGGFGVVYYGK+KDGKEIAVKVL +NSYQG REF+NEVTLLSRIHHR
Sbjct: 548 IEDATRKFEKKIGSGGFGVVYYGKMKDGKEIAVKVLINNSYQGNREFSNEVTLLSRIHHR 607

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
           NLVQFLGYCQEEGRS+LVYEFMHNGTLKEHLYG LT E+ I+WIKRLEIAEDAAKGIEYL
Sbjct: 608 NLVQFLGYCQEEGRSMLVYEFMHNGTLKEHLYGPLTXERXISWIKRLEIAEDAAKGIEYL 667

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 584
           HTGCVP+IIHRDLKSSNILLDK+M+AKVSDFGLSK AVDG+SHVSS+VRGTVGYLDPEYY
Sbjct: 668 HTGCVPSIIHRDLKSSNILLDKYMKAKVSDFGLSKLAVDGSSHVSSVVRGTVGYLDPEYY 727

Query: 585 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 644
           ISQQLTDKSDVYSFGVILLELISGQEAISNE FG NCRNIVQWAKLHIESGDIQGIIDPS
Sbjct: 728 ISQQLTDKSDVYSFGVILLELISGQEAISNESFGVNCRNIVQWAKLHIESGDIQGIIDPS 787

Query: 645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAAAARDGNSDDMS 704
           L DEYDIQSMWKI EKALMCV PHG MRP ISEV+K+IQ+AI IER A AAR+GNS D S
Sbjct: 788 LRDEYDIQSMWKIAEKALMCVQPHGSMRPPISEVIKEIQEAISIERGAEAAREGNS-DAS 846

Query: 705 RNSLHSSLNVG-SFGGTENFLSLDESIVRPSAR 736
           RNS+HSS+N+G   G TEN+LS DESI RP+ R
Sbjct: 847 RNSIHSSINMGIDVGPTENYLSFDESIARPTPR 879

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	736
TAIR|locus:2057991	934	AT2G37050 [Arabidopsis thalian	0.979	0.771	0.693	1.6e-278
TAIR|locus:2008565	929	AT1G67720 [Arabidopsis thalian	0.972	0.770	0.476	1.6e-173
TAIR|locus:2126540	876	AT4G29990 [Arabidopsis thalian	0.584	0.490	0.370	1.1e-97
TAIR|locus:2066163	872	AT2G29000 [Arabidopsis thalian	0.574	0.485	0.395	8.8e-96
TAIR|locus:2055160	886	AT2G14440 [Arabidopsis thalian	0.377	0.313	0.485	2.3e-95
TAIR|locus:2078216	793	AT3G46370 [Arabidopsis thalian	0.380	0.353	0.473	2.3e-93
TAIR|locus:2066133	880	AT2G28960 [Arabidopsis thalian	0.576	0.481	0.382	7.9e-93
TAIR|locus:2174294	868	AT5G59670 [Arabidopsis thalian	0.380	0.322	0.480	2.1e-92
TAIR|locus:2078171	883	AT3G46400 [Arabidopsis thalian	0.581	0.484	0.358	3.4e-92
TAIR|locus:2078191	838	AT3G46420 [Arabidopsis thalian	0.370	0.325	0.467	1.9e-91

TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)]

 Score = 2677 (947.4 bits), Expect = 1.6e-278, P = 1.6e-278
 Identities = 506/730 (69%), Positives = 593/730 (81%)

Query:    15 RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
             RYPDDP+DRIWESD  KK NYLVDVAAGT +VST LPI+ R D+ PPQKVMQTAVVGTNG
Sbjct:   206 RYPDDPYDRIWESDLQKKPNYLVDVAAGTVRVSTTLPIESRVDDRPPQKVMQTAVVGTNG 265

Query:    75 SLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 134
             SLTYR+NLDGFPGFGWA TYFAEIEDL  DESRKFRLVLP QP+ SK++VNI+EN Q  Y
Sbjct:   266 SLTYRMNLDGFPGFGWAFTYFAEIEDLAEDESRKFRLVLPEQPEYSKSVVNIKENTQRPY 325

Query:   135 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY 194
             RVY PGY N++LPFVL+F+F KT DSSRGP+LNAMEI+KYL ++DGS+D   + +V SLY
Sbjct:   326 RVYAPGYPNITLPFVLNFRFAKTADSSRGPILNAMEISKYLRKSDGSVDATVMANVASLY 385

Query:   195 SSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWL 254
             SS +WAQEGGDPC P PWSW+QCNSDPQP +  I LSS NLTGNIPSDL KL+ LVELWL
Sbjct:   386 SSTEWAQEGGDPCSPSPWSWVQCNSDPQPRVVAIKLSSMNLTGNIPSDLVKLTGLVELWL 445

Query:   255 DGNSLTGPIPDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSGTVPSSL 314
             DGNS TGPIPDFS CP+L IIHLE+N+LTG            +ELY+QNN+L+GT+PS L
Sbjct:   446 DGNSFTGPIPDFSRCPNLEIIHLENNRLTGKIPSSLTKLPNLKELYLQNNVLTGTIPSDL 505

Query:   315 LSKNVVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFMHKGKKNNY--- 371
              +K+V+ N++GN+NL + G   K L +II                C+ M K KKNN    
Sbjct:   506 -AKDVISNFSGNLNLEKSGDKGKKLGVIIGASVGAFVLLIATIISCIVMCKSKKNNKLGK 564

Query:   372 -DKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK 430
                E     LP+QR  S+L++A  +AAHCFTL +IE+ATK  EK+IGSGGFG+VYYGK +
Sbjct:   565 TSAELTNRPLPIQRVSSTLSEAHGDAAHCFTLYEIEEATKKFEKRIGSGGFGIVYYGKTR 624

Query:   431 DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 490
             +GKEIAVKVL +NSYQGKREF NEVTLLSRIHHRNLVQFLGYCQEEG+++LVYEFMHNGT
Sbjct:   625 EGKEIAVKVLANNSYQGKREFANEVTLLSRIHHRNLVQFLGYCQEEGKNMLVYEFMHNGT 684

Query:   491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 550
             LKEHLYG +  ++RI+WIKRLEIAEDAA+GIEYLHTGCVPAIIHRDLK+SNILLDKHMRA
Sbjct:   685 LKEHLYGVVPRDRRISWIKRLEIAEDAARGIEYLHTGCVPAIIHRDLKTSNILLDKHMRA 744

Query:   551 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 610
             KVSDFGLSKFAVDG SHVSSIVRGTVGYLDPEYYISQQLT+KSDVYSFGVILLEL+SGQE
Sbjct:   745 KVSDFGLSKFAVDGTSHVSSIVRGTVGYLDPEYYISQQLTEKSDVYSFGVILLELMSGQE 804

Query:   611 AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL-DEYDIQSMWKIEEKALMCVLPHG 669
             AISNE FG NCRNIVQWAK+HI++GDI+GIIDP+L  D+Y +QSMWKI EKAL+CV PHG
Sbjct:   805 AISNESFGVNCRNIVQWAKMHIDNGDIRGIIDPALAEDDYSLQSMWKIAEKALLCVKPHG 864

Query:   670 HMRPSISEVLKDIQXXXXXXXXXXXXXXGNSDDMSRNSLHSS-LNVG--SFGGTENFLSL 726
             +MRPS+SEV KDIQ              G SD+ SR+S HSS LN+G     G+++++S+
Sbjct:   865 NMRPSMSEVQKDIQDAIRIEKEALAARGGISDEFSRSSAHSSSLNMGMLDLAGSQSYVSI 924

Query:   727 DESIVRPSAR 736
             DES+++P+AR
Sbjct:   925 DESVLQPTAR 934

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)]

 Score = 1686 (598.6 bits), Expect = 1.6e-173, P = 1.6e-173
 Identities = 349/732 (47%), Positives = 460/732 (62%)

Query:    15 RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG 74
             RYPDDP+DRIWESD  K+ NYLV VA GT +++T   I+  + E PP KVMQTAVVGT G
Sbjct:   204 RYPDDPYDRIWESDINKRPNYLVGVAPGTTRINTSKTINTLTREYPPMKVMQTAVVGTQG 263

Query:    75 SLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKY 134
              ++YRLNL+ FP    A  YFAEIE+L  +E+RKF+LV P  PD S A+VNI ENA G Y
Sbjct:   264 LISYRLNLEDFPANARAYAYFAEIEELGANETRKFKLVQPYFPDYSNAVVNIAENANGSY 323

Query:   135 RVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLE---RNDGSIDGVAIVSVI 191
              +YEP Y N++L FVL+F FGKT DS++GPLLNA+EI+KYL    + D S   V+++  I
Sbjct:   324 TLYEPSYMNVTLDFVLTFSFGKTKDSTQGPLLNAIEISKYLPISVKTDRS--DVSVLDAI 381

Query:   192 -SLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLV 250
              S+   +DWA EGGDPC+PV WSW+ C+S   P +T I LS KNL G IP  +  + +L 
Sbjct:   382 RSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEIPPGINYMEALT 441

Query:   251 ELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLSGTV 310
             ELWLD N LTG +PD S   +L+I+HLE+NQL+G            +EL ++NN   G +
Sbjct:   442 ELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNLQELSIENNSFKGKI 501

Query:   311 PSSLLSKNVVLNYAGNINLHEGGRGAKH----LNIIIXXXXXXXXXXXXXXXXCLFMHKG 366
             PS+LL   V+  Y  N  L    +  KH    L I I                   + K 
Sbjct:   502 PSALLKGKVLFKYNNNPELQNEAQ-RKHFWQILGISIAAVAILLLLVGGSLVLLCALRKT 560

Query:   367 KK-NNYDK-EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVV 424
             K+ +  D  E  +  L     V   +      A+  +L  +E+AT    KK+G G FG V
Sbjct:   561 KRADKGDSTETKKKGLVAYSAVRGGHLLDEGVAYFISLPVLEEATDNFSKKVGRGSFGSV 620

Query:   425 YYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 484
             YYG++KDGKE+AVK+    S    R+F  EV LLSRIHHRNLV  +GYC+E  R +LVYE
Sbjct:   621 YYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYCEEADRRILVYE 680

Query:   485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 544
             +MHNG+L +HL+G+  ++  ++W+ RL+IA+DAAKG+EYLHTGC P+IIHRD+KSSNILL
Sbjct:   681 YMHNGSLGDHLHGSSDYKP-LDWLTRLQIAQDAAKGLEYLHTGCNPSIIHRDVKSSNILL 739

Query:   545 DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLE 604
             D +MRAKVSDFGLS+   +  +HVSS+ +GTVGYLDPEYY SQQLT+KSDVYSFGV+L E
Sbjct:   740 DINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEKSDVYSFGVVLFE 799

Query:   605 LISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMC 664
             L+SG++ +S E FG    NIV WA+  I  GD+ GIIDP +     I+S+W++ E A  C
Sbjct:   800 LLSGKKPVSAEDFGPEL-NIVHWARSLIRKGDVCGIIDPCIASNVKIESVWRVAEVANQC 858

Query:   665 VLPHGHMRPSISEVLKDIQXXXXXXXXXXXXXXGNSDDMSRNSLHSSLNVGSFGGTENFL 724
             V   GH RP + EV+  IQ               +S   S+        + SF   E+  
Sbjct:   859 VEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSKAQSSRKTLLTSFLELES-P 917

Query:   725 SLDESIVRPSAR 736
              +  + + P+AR
Sbjct:   918 DISRNSLAPAAR 929

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007267 "cell-cell signaling" evidence=RCA

GO:0009616 "virus induced gene silencing" evidence=RCA

GO:0010267 "production of ta-siRNAs involved in RNA interference" evidence=RCA

GO:0035196 "production of miRNAs involved in gene silencing by miRNA" evidence=RCA

TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)]

 Score = 763 (273.6 bits), Expect = 1.1e-97, Sum P(2) = 1.1e-97
 Identities = 168/454 (37%), Positives = 263/454 (57%)

Query:   241 SDLTKLSSLVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXREL 299
             SD       + L L  + LTG I P F+    +  + L +N LTG             EL
Sbjct:   403 SDNNTSPKSIALNLSSSGLTGQIDPAFANLTSINKLDLSNNSLTGKVPDFLASLPNLTEL 462

Query:   300 YVQNNMLSGTVPSSLLSKN----VVLNYAGNINLHEGGR----GAKHLNIIIXXXXXXXX 351
              ++ N L+G++P+ LL K+    + L + GN +L +         K +  I+        
Sbjct:   463 NLEGNKLTGSIPAKLLEKSKDGSLSLRFGGNPDLCQSPSCQTTTKKKIGYIVPVVASLAG 522

Query:   352 XXXXXXXXCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAA-HCFTLSDIEDATK 410
                      L  H      + K   R ++   +P+  +N  P + A   F  S++ + T 
Sbjct:   523 LLIVLTALALIWH------FKKRSRRGTIS-NKPLG-VNTGPLDTAKRYFIYSEVVNITN 574

Query:   411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
               E+ +G GGFG VY+G L +G ++AVK+L+  S QG +EF  EV LL R+HH NL   +
Sbjct:   575 NFERVLGKGGFGKVYHGFL-NGDQVAVKILSEESTQGYKEFRAEVELLMRVHHTNLTSLI 633

Query:   471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
             GYC E+    L+YE+M NG L ++L G  +    ++W +RL+I+ DAA+G+EYLH GC P
Sbjct:   634 GYCNEDNHMALIYEYMANGNLGDYLSGKSS--LILSWEERLQISLDAAQGLEYLHYGCKP 691

Query:   531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
              I+HRD+K +NILL+++++AK++DFGLS+ F V+G+S VS++V GT+GYLDPEYY ++Q+
Sbjct:   692 PIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTVVAGTIGYLDPEYYATRQM 751

Query:   590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 649
              +KSDVYSFGV+LLE+I+G+ AI + +      ++       + +GDI+GI+D  L D +
Sbjct:   752 NEKSDVYSFGVVLLEVITGKPAIWHSR--TESVHLSDQVGSMLANGDIKGIVDQRLGDRF 809

Query:   650 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
             ++ S WKI E AL C       RP++S+V+ +++
Sbjct:   810 EVGSAWKITELALACASESSEQRPTMSQVVMELK 843

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2066163 AT2G29000 [Arabidopsis thaliana (taxid:3702)]

 Score = 767 (275.1 bits), Expect = 8.8e-96, Sum P(2) = 8.8e-96
 Identities = 174/440 (39%), Positives = 243/440 (55%)

Query:   249 LVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLS 307
             ++ L L    L G I P       L  + L  N+L+G              + +  N L 
Sbjct:   408 IISLDLSNRGLKGIIEPVLQNLTQLEKLDLSINRLSGEVPEFLANMKSLSNINLSWNNLK 467

Query:   308 GTVPSSLLSKN---VVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFMH 364
             G +P +L  K    + LN  GN NL  G    + +                     L + 
Sbjct:   468 GLIPPALEEKRKNGLKLNTQGNQNLCPGDECKRSIPKFPVTTVVSISAILLTVVVLLIVF 527

Query:   365 KGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVV 424
               KK    K +HR  LP+ +  S +          FT S++E  T   E+ IG GGFG+V
Sbjct:   528 IYKKKKTSKVRHR--LPITK--SEILTKKRR----FTYSEVEAVTNKFERVIGEGGFGIV 579

Query:   425 YYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 484
             Y+G L D +++AVK+L+ +S QG ++F  EV LL R+HH NLV  +GYC EE    LVYE
Sbjct:   580 YHGHLNDTEQVAVKLLSHSSTQGYKQFKAEVELLLRVHHTNLVNLVGYCNEEDHLALVYE 639

Query:   485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 544
             +  NG LK+HL G  +    +NW  RL IA + A+G+EYLH GC P +IHRD+K++NILL
Sbjct:   640 YAANGDLKQHLSGE-SSSAALNWASRLGIATETAQGLEYLHIGCEPPMIHRDVKTTNILL 698

Query:   545 DKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL 603
             D+H  AK++DFGLS+ F V   SHVS+ V GT GYLDPEYY +  LT+KSDVYS G++LL
Sbjct:   699 DEHFHAKLADFGLSRSFPVGVESHVSTNVAGTPGYLDPEYYRTNWLTEKSDVYSMGIVLL 758

Query:   604 ELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALM 663
             E+I+ Q  I   +      +I +W  L +  GDI+ I+DP L  EYD  S+WK  E A+ 
Sbjct:   759 EIITNQPVIQQVR---EKPHIAEWVGLMLTKGDIKSIMDPKLNGEYDSSSVWKALELAMS 815

Query:   664 CVLPHGHMRPSISEVLKDIQ 683
             CV P    RP++S+V+ +++
Sbjct:   816 CVNPSSGGRPTMSQVISELK 835

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2055160 AT2G14440 [Arabidopsis thaliana (taxid:3702)]

 Score = 695 (249.7 bits), Expect = 2.3e-95, Sum P(2) = 2.3e-95
 Identities = 138/284 (48%), Positives = 192/284 (67%)

Query:   400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 459
             F  S++++ T   E  +G GGFGVVY+G L + +++AVKVL+ +S QG +EF  EV LL 
Sbjct:   571 FKYSEVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLL 629

Query:   460 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 519
             R+HH NLV  +GYC +     L+YEFM NG LKEHL G       +NW  RL+IA ++A 
Sbjct:   630 RVHHVNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGKRGGPV-LNWPGRLKIAIESAL 688

Query:   520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 578
             GIEYLH GC P ++HRD+KS+NILL     AK++DFGLS+ F V   +HVS+ V GT+GY
Sbjct:   689 GIEYLHIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGY 748

Query:   579 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 638
             LDPEYY    LT+KSDVYSFG++LLE+I+GQ  I   +   +   IV+WAK  + +GDI+
Sbjct:   749 LDPEYYQKNWLTEKSDVYSFGIVLLEIITGQPVIEQSR---DKSYIVEWAKSMLANGDIE 805

Query:   639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
              I+D +L  +YD  S WK  E A++C+ P   +RP+++ V  ++
Sbjct:   806 SIMDRNLHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAHEL 849

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2078216 AT3G46370 [Arabidopsis thaliana (taxid:3702)]

 Score = 696 (250.1 bits), Expect = 2.3e-93, Sum P(2) = 2.3e-93
 Identities = 135/285 (47%), Positives = 191/285 (67%)

Query:   400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 459
             FT S++ + TK  +K +G GGFG VYYG L   +++AVKVL+ +S QG + F  EV LL 
Sbjct:   477 FTYSEVVEMTKNFQKTLGEGGFGTVYYGNLNGSEQVAVKVLSQSSSQGYKHFKAEVELLL 536

Query:   460 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 519
             R+HH NLV  +GYC E     L+YE M NG LK+HL G   +   + W  RL IA DAA 
Sbjct:   537 RVHHINLVSLVGYCDERNHLALIYECMSNGDLKDHLSGKKGNAV-LKWSTRLRIAVDAAL 595

Query:   520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 578
             G+EYLH GC P+I+HRD+KS+NILLD  + AK++DFGLS+ F +   S  S++V GT+GY
Sbjct:   596 GLEYLHYGCRPSIVHRDVKSTNILLDDQLMAKIADFGLSRSFKLGEESQASTVVAGTLGY 655

Query:   579 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 638
             LDPEYY + +L + SDVYSFG++LLE+I+ Q  I + +  A+   I +W  L ++ GD+ 
Sbjct:   656 LDPEYYRTCRLAEMSDVYSFGILLLEIITNQNVIDHAREKAH---ITEWVGLVLKGGDVT 712

Query:   639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
              I+DP+L  EY+ +S+W+  E A+ C  P    RP +S+V+ D++
Sbjct:   713 RIVDPNLDGEYNSRSVWRALELAMSCANPSSEHRPIMSQVVIDLK 757

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2066133 AT2G28960 [Arabidopsis thaliana (taxid:3702)]

 Score = 728 (261.3 bits), Expect = 7.9e-93, Sum P(2) = 7.9e-93
 Identities = 170/445 (38%), Positives = 241/445 (54%)

Query:   249 LVELWLDGNSLTGPI-PDFSGCPDLRIIHLEDNQLTGXXXXXXXXXXXXRELYVQNNMLS 307
             ++ L L    L G I P F    +LR + L +N  TG              + +  N L+
Sbjct:   410 IISLDLSSRGLKGVIAPAFQNLTELRKLDLSNNSFTGGVPEFLASMKSLSIINLNWNDLT 469

Query:   308 GTVPSSLLS--KN-VVLNYAGNINLHEGGRGAKHLN---II-IXXXXXXXXXXXXXXXXC 360
             G +P  LL   KN + L   GN  L        + N   I+ +                 
Sbjct:   470 GPLPKLLLDREKNGLKLTIQGNPKLCNDASCKNNNNQTYIVPVVASVASVLIIIAVLILI 529

Query:   361 LFMHKGKKNNYDK-EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSG 419
             L   K +    D     +H LP  RP S            FT S++E  T   E+ +G G
Sbjct:   530 LVFKKRRPTQVDSLPTVQHGLP-NRP-SIFTQTKR-----FTYSEVEALTDNFERVLGEG 582

Query:   420 GFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS 479
             GFGVVY+G L   + IAVK+L+ +S QG +EF  EV LL R+HH NLV  +GYC EE   
Sbjct:   583 GFGVVYHGILNGTQPIAVKLLSQSSVQGYKEFKAEVELLLRVHHVNLVSLVGYCDEESNL 642

Query:   480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 539
              L+YE+  NG LK+HL G       + W  RL+I  + A+G+EYLHTGC P ++HRD+K+
Sbjct:   643 ALLYEYAPNGDLKQHLSGERGGSP-LKWSSRLKIVVETAQGLEYLHTGCKPPMVHRDVKT 701

Query:   540 SNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 598
             +NILLD+H +AK++DFGLS+ F V G +HVS+ V GT GYLDPEYY + +L +KSDVYSF
Sbjct:   702 TNILLDEHFQAKLADFGLSRSFPVGGETHVSTAVAGTPGYLDPEYYRTNRLNEKSDVYSF 761

Query:   599 GVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIE 658
             G++LLE+I+ +  I   +      +I  W    +  GDI+ ++DP L  +Y+  S+WK  
Sbjct:   762 GIVLLEIITSRPVIQQTR---EKPHIAAWVGYMLTKGDIENVVDPRLNRDYEPTSVWKAL 818

Query:   659 EKALMCVLPHGHMRPSISEVLKDIQ 683
             E A+ CV P    RP++S+V  +++
Sbjct:   819 EIAMSCVNPSSEKRPTMSQVTNELK 843

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010043 "response to zinc ion" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2174294 AT5G59670 [Arabidopsis thaliana (taxid:3702)]

 Score = 699 (251.1 bits), Expect = 2.1e-92, Sum P(2) = 2.1e-92
 Identities = 137/285 (48%), Positives = 194/285 (68%)

Query:   400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 459
             FT S++   TK  ++ +G GGFG+VY+G +K  +++AVKVL+ +S QG +EF  EV LL 
Sbjct:   554 FTYSEVVQVTKNFQRVLGKGGFGMVYHGTVKGSEQVAVKVLSQSSTQGSKEFKAEVDLLL 613

Query:   460 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 519
             R+HH NLV  +GYC E     LVYEF+ NG LK+HL G       INW  RL IA +AA 
Sbjct:   614 RVHHTNLVSLVGYCCEGDYLALVYEFLPNGDLKQHLSGK-GGNSIINWSIRLRIALEAAL 672

Query:   520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 578
             G+EYLH GC P ++HRD+K++NILLD++ +AK++DFGLS+ F  +G S  S+ + GT+GY
Sbjct:   673 GLEYLHIGCTPPMVHRDVKTANILLDENFKAKLADFGLSRSFQGEGESQESTTIAGTLGY 732

Query:   579 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 638
             LDPE Y S +L +KSDVYSFG++LLE+I+ Q  I N+  G +  +I QW    +  GDI 
Sbjct:   733 LDPECYHSGRLGEKSDVYSFGIVLLEMITNQPVI-NQTSGDS--HITQWVGFQMNRGDIL 789

Query:   639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
              I+DP+L  +Y+I S W+  E A+ C  P    RPS+S+V+ +++
Sbjct:   790 EIMDPNLRKDYNINSAWRALELAMSCAYPSSSKRPSMSQVIHELK 834

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2078171 AT3G46400 [Arabidopsis thaliana (taxid:3702)]

 Score = 709 (254.6 bits), Expect = 3.4e-92, Sum P(2) = 3.4e-92
 Identities = 158/441 (35%), Positives = 242/441 (54%)

Query:   249 LVELWLDGNSLTGPIPDFSGCPDLRIIH---LEDNQLTGXXXXXXXXXXXXRELYVQNNM 305
             +  L L  + L G IP  SG  +  ++    L +N LTG              + ++ N 
Sbjct:   413 ITSLNLSSSGLVGTIP--SGIQNFTLLEKLDLSNNNLTGLVPEFLAKMETLLFIDLRKNK 470

Query:   306 LSGTVPSSLLS--KNVVLNYAGNINLHEGGRGAKHLNIIIXXXXXXXXXXXXXXXXCLFM 363
             L+G++P++L    K  +  +    N            ++I                 +F+
Sbjct:   471 LNGSIPNTLRDREKKGLQIFVDGDNTCLSCVPKNKFPMMIAALAASAIVVAILVLILIFV 530

Query:   364 HKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGV 423
                KK +   E    ++ +     S      +    F  S++ + TK  EK +G GGFG+
Sbjct:   531 FTKKKWSTHMEVILPTMDIMSKTISEQLIKTKRRR-FAYSEVVEMTKKFEKALGEGGFGI 589

Query:   424 VYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 483
             VY+G LK+ +++AVKVL+ +S QG + F  EV LL R+HH NLV  +GYC E+    L+Y
Sbjct:   590 VYHGYLKNVEQVAVKVLSQSSSQGYKHFKAEVELLLRVHHINLVSLVGYCDEKDHLALIY 649

Query:   484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 543
             E+M NG LK+HL G    +  + W  RL+IA D A G+EYLH GC P+++HRD+KS+NIL
Sbjct:   650 EYMPNGDLKDHLSGK-QGDSVLEWTTRLQIAVDVALGLEYLHYGCRPSMVHRDVKSTNIL 708

Query:   544 LDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVIL 602
             LD    AK++DFGLS+ F V   S +S++V GT GYLDPEYY + +L + SDVYSFG++L
Sbjct:   709 LDDQFMAKIADFGLSRSFKVGDESEISTVVAGTPGYLDPEYYRTSRLAEMSDVYSFGIVL 768

Query:   603 LELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKAL 662
             LE+I+ Q      + G    +I +W    +  GDI  I+DP+L  EY+ +S+W+  E A+
Sbjct:   769 LEIITNQRVFDQAR-GKI--HITEWVAFMLNRGDITRIVDPNLHGEYNSRSVWRAVELAM 825

Query:   663 MCVLPHGHMRPSISEVLKDIQ 683
              C  P    RP++S+V+ +++
Sbjct:   826 SCANPSSEYRPNMSQVVIELK 846

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2078191 AT3G46420 [Arabidopsis thaliana (taxid:3702)]

 Score = 679 (244.1 bits), Expect = 1.9e-91, Sum P(2) = 1.9e-91
 Identities = 130/278 (46%), Positives = 186/278 (66%)

Query:   407 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 466
             D T   ++ +G GGFGVVY+G L   +++AVK+L+ +S QG +EF  EV LL R+HH NL
Sbjct:   528 DMTNNFQRALGEGGFGVVYHGYLNGSEQVAVKLLSQSSVQGYKEFKAEVELLLRVHHINL 587

Query:   467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
             V  +GYC +     LVYE+M NG LK HL G   +   ++W  RL+IA DAA G+EYLH 
Sbjct:   588 VSLVGYCDDRNHLALVYEYMSNGDLKHHLSGR-NNGFVLSWSTRLQIAVDAALGLEYLHI 646

Query:   527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 585
             GC P+++HRD+KS+NILL +   AK++DFGLS+ F +   +H+S++V GT GYLDPEYY 
Sbjct:   647 GCRPSMVHRDVKSTNILLGEQFTAKMADFGLSRSFQIGDENHISTVVAGTPGYLDPEYYR 706

Query:   586 SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 645
             + +L +KSD+YSFG++LLE+I+ Q AI   +      +I  W    I  GDI  IIDP+L
Sbjct:   707 TSRLAEKSDIYSFGIVLLEMITSQHAIDRTRVK---HHITDWVVSLISRGDITRIIDPNL 763

Query:   646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
                Y+ +S+W+  E A+ C  P    RP++S+V+ D++
Sbjct:   764 QGNYNSRSVWRALELAMSCANPTSEKRPNMSQVVIDLK 801

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pg.C_280116 hypothetical protein (924 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	736
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-50
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-50
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-44
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-44
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-35
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-32
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-31
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-31
pfam12819	335	pfam12819, Malectin_like, Carbohydrate-binding pro	2e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-30
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	8e-30
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-29
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-29
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-28
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-27
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-27
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	9e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-24
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-24
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	4e-23
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-23
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-22
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-22
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-21
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-21
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-21
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-21
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	8e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-19
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-19
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-19
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	4e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	8e-19
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-19
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-18
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-18
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-17
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-17
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-16
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-16
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-16
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	6e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	8e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-15
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-14
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-14
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-13
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-13
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	7e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	9e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-12
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-12
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-11
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-11
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-11
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-10
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	6e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	8e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-09
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	8e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-08
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-08
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	5e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	8e-08
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-07
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-07
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	4e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-06
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.001
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.003

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  176 bits (450), Expect = 1e-50
 Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 13/206 (6%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGK-----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 465
           L KK+G G FG VY GKLK        E+AVK L  + S Q   EF  E  ++ ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +V+ LG C EE    +V E+M  G L  +L     +  +++    L  A   A+G+EYL 
Sbjct: 63  VVKLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLE 119

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
           +      IHRDL + N L+ +++  K+SDFGLS+   D   +     +  + ++ PE   
Sbjct: 120 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLK 176

Query: 586 SQQLTDKSDVYSFGVILLELIS-GQE 610
             + T KSDV+SFGV+L E+ + G++
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQ 202

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  176 bits (448), Expect = 2e-50
 Identities = 73/206 (35%), Positives = 111/206 (53%), Gaps = 12/206 (5%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGK-----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 465
           L KK+G G FG VY G LK        E+AVK L  + S Q   EF  E  ++ ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +V+ LG C EE   ++V E+M  G L ++L       + ++    L  A   A+G+EYL 
Sbjct: 63  IVKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLE 120

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
           +      IHRDL + N L+ +++  K+SDFGLS+   D   +     +  + ++ PE   
Sbjct: 121 SKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLK 177

Query: 586 SQQLTDKSDVYSFGVILLELIS-GQE 610
             + T KSDV+SFGV+L E+ + G+E
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEE 203

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  170 bits (434), Expect = 6e-49
 Identities = 75/204 (36%), Positives = 117/204 (57%), Gaps = 13/204 (6%)

Query: 416 IGSGGFGVVYYGK-LKDGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           +G GGFG VY  +  K GK++A+K++   +S     E   E+ +L +++H N+V+  G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAI 532
           ++E    LV E+   G+LK+ L     +E +++  + L I     +G+EYLH  G    I
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSNG----I 113

Query: 533 IHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ-LT 590
           IHRDLK  NILLD  + + K++DFGLSK      S + +IV GT  Y+ PE  + +   +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYS 172

Query: 591 DKSDVYSFGVILLELISGQEAISN 614
           +KSD++S GVIL EL   ++ I  
Sbjct: 173 EKSDIWSLGVILYELPELKDLIRK 196

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  164 bits (417), Expect = 5e-46
 Identities = 66/202 (32%), Positives = 112/202 (55%), Gaps = 15/202 (7%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 469
           + +K+G G FG VY  + K  GK +A+KV+     +  RE    E+ +L ++ H N+V+ 
Sbjct: 3   ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
               ++E +  LV E+   G L + L   G L+ ++   +++  +I       +EYLH+ 
Sbjct: 63  YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLR--QILS----ALEYLHSK 116

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               I+HRDLK  NILLD+    K++DFGL++  +D    +++ V GT  Y+ PE  + +
Sbjct: 117 G---IVHRDLKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGK 171

Query: 588 QLTDKSDVYSFGVILLELISGQ 609
                 D++S GVIL EL++G+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  160 bits (407), Expect = 1e-44
 Identities = 73/204 (35%), Positives = 114/204 (55%), Gaps = 16/204 (7%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           L +K+GSG FG VY  K K  GK +AVK+L   S   +  +    E+ +L R+ H N+V+
Sbjct: 3   LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
            +   +++    LV E+   G L ++L   G L+ ++      ++       +G+EYLH 
Sbjct: 63  LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQI------LRGLEYLH- 115

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                IIHRDLK  NILLD++   K++DFGL+K  +  +S +++ V GT  Y+ PE  + 
Sbjct: 116 --SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLG 172

Query: 587 QQL-TDKSDVYSFGVILLELISGQ 609
                 K DV+S GVIL EL++G+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  160 bits (406), Expect = 2e-44
 Identities = 71/209 (33%), Positives = 107/209 (51%), Gaps = 22/209 (10%)

Query: 414 KKIGSGGFGVVYYGKLKDGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQ 468
           KK+G G FG VY GKLK       E+AVK L  + S + +++F  E  ++ ++ H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIEY 523
            LG C EE    LV E+M  G L ++L           +  ++    L  A   AKG+EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-----IVRGTVGY 578
           L +      +HRDL + N L+ + +  K+SDFGLS+   D   +         +R    +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173

Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELIS 607
           + PE       T KSDV+SFGV+L E+ +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  159 bits (404), Expect = 4e-44
 Identities = 69/204 (33%), Positives = 108/204 (52%), Gaps = 13/204 (6%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-----IAVKVLT-SNSYQGKREFTNEVTLLSRIHHRN 465
           L KK+G G FG VY G LK   E     +AVK L    S + + EF  E +++ ++ H N
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +V+ LG C +     +V E+M  G L + L     H +++     L++A   AKG+EYL 
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYY 584
           +      +HRDL + N L+ +++  K+SDFGLS+    D         +  + ++ PE  
Sbjct: 120 SKN---FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESL 176

Query: 585 ISQQLTDKSDVYSFGVILLELISG 608
              + T KSDV+SFGV+L E+ + 
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  151 bits (382), Expect = 1e-37
 Identities = 139/485 (28%), Positives = 234/485 (48%), Gaps = 54/485 (11%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
             +  + LS   L+G IP +L+    LV L L  N L+G IP  FS  P L  + L  NQ
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS--LLSKNVVLNYAGNINLHEGG------ 333
           L+G +P +L N+ +L ++ + +N L G++PS+   L+ N     AGNI+L  G       
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINAS-AVAGNIDLCGGDTTSGLP 617

Query: 334 -----RGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDK--EQHRHSLPVQRPV 386
                R        I  ++GA  L+LA V       +G+ N   K  E    +  +Q   
Sbjct: 618 PCKRVRKTPSWWFYITCTLGA-FLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD 676

Query: 387 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNS 444
           S       + +   T++DI  + K  E  I  G  G  Y GK +K+G +  VK +   NS
Sbjct: 677 S-------KVSKSITINDILSSLKE-ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS 728

Query: 445 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 504
                  ++E+  + ++ H N+V+ +G C+ E  + L++E++    L E L         
Sbjct: 729 IP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------- 776

Query: 505 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAV 562
           ++W +R +IA   AK + +LH  C PA++  +L    I++D       ++S  GL     
Sbjct: 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGL--LCT 834

Query: 563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 622
           D    +SS       Y+ PE   ++ +T+KSD+Y FG+IL+EL++G+   ++ +FG +  
Sbjct: 835 DTKCFISS------AYVAPETRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFGVH-G 886

Query: 623 NIVQWAKLHIESGDIQGIIDPSLLDEYDI--QSMWKIEEKALMCVLPHGHMRPSISEVLK 680
           +IV+WA+       +   IDPS+  +  +    + ++   AL C       RP  ++VLK
Sbjct: 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946

Query: 681 DIQDA 685
            ++ A
Sbjct: 947 TLESA 951

Length = 968

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  134 bits (341), Expect = 1e-35
 Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 17/204 (8%)

Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           + +G G FG VY    KD G+ +AVK   L+ +S +       E+ +LS + H N+V++ 
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 471 G-YCQEEGRSVLVY-EFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           G    EE  ++ ++ E++  G+L   L  +G L        I++        +G+ YLH+
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKY--TRQILEGLAYLHS 119

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYI 585
                I+HRD+K +NIL+D     K++DFG +K   D      +  VRGT  ++ PE   
Sbjct: 120 NG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 586 SQQLTDKSDVYSFGVILLELISGQ 609
            ++    +D++S G  ++E+ +G+
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  132 bits (335), Expect = 8e-35
 Identities = 69/200 (34%), Positives = 111/200 (55%), Gaps = 15/200 (7%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +KIG GGFG VY  +  + GKE+A+KV+   S + K +  NE+ +L +  H N+V++ G 
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 473 CQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
             ++    +V EF   G+LK+       TLT E +I ++ +     +  KG+EYLH+   
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLLKSTNQTLT-ESQIAYVCK-----ELLKGLEYLHSN-- 117

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             IIHRD+K++NILL      K+ DFGLS    D  +  + +  GT  ++ PE    +  
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPY 174

Query: 590 TDKSDVYSFGVILLELISGQ 609
             K+D++S G+  +EL  G+
Sbjct: 175 DYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  125 bits (315), Expect = 3e-32
 Identities = 62/198 (31%), Positives = 107/198 (54%), Gaps = 7/198 (3%)

Query: 411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
              K++GSG FGVV+ GK +   ++A+K++   +   + +F  E  ++ ++ H NLVQ  
Sbjct: 7   TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLY 65

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
           G C ++    +V E+M NG L  +L      + ++     L++  D  + +EYL +    
Sbjct: 66  GVCTKQRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESNGF- 121

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
             IHRDL + N L+ +    KVSDFGL+++ +D     S   +  V +  PE +   + +
Sbjct: 122 --IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 591 DKSDVYSFGVILLELISG 608
            KSDV+SFGV++ E+ S 
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  123 bits (311), Expect = 1e-31
 Identities = 68/195 (34%), Positives = 111/195 (56%), Gaps = 9/195 (4%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K++G+G FGVV YGK +   ++A+K++   S   + EF  E  ++ ++ H  LVQ  G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
            ++    +V E+M NG L  +L     H +R    + LE+ +D  +G+ YL +      I
Sbjct: 69  TKQRPIYIVTEYMSNGCLLNYLR---EHGKRFQPSQLLEMCKDVCEGMAYLES---KQFI 122

Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQLTDK 592
           HRDL + N L+D     KVSDFGLS++ +D   + SS+  +  V +  PE  +  + + K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSSK 181

Query: 593 SDVYSFGVILLELIS 607
           SDV++FGV++ E+ S
Sbjct: 182 SDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  123 bits (311), Expect = 2e-31
 Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 16/204 (7%)

Query: 414 KKIGSGGFGVVYYGKL-----KDGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 467
           K++G G FG V   +        G+++AVK L  S   Q + +F  E+ +L  + H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 468 QFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           ++ G C++ G     L+ E++ +G+L+++L     H  +IN  + L  +    KG++YL 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLG 126

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV--DGASHVSSIVRGTVGYLDPEY 583
           +      IHRDL + NIL++     K+SDFGL+K         +V       + +  PE 
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183

Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
             + + +  SDV+SFGV L EL +
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|221790 pfam12819, Malectin_like, Carbohydrate-binding protein of the ER

 Score =  122 bits (308), Expect = 2e-30
 Identities = 53/165 (32%), Positives = 78/165 (47%), Gaps = 19/165 (11%)

Query: 15  RYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSD---ELPPQKVMQTAVVG 71
           RYPDD +DRIWE             + G  ++ST L +D+ S+    +PP  V+QTAV  
Sbjct: 185 RYPDDVYDRIWEPFF---------SSPGWSQISTSLSVDISSNNAPYIPPSAVLQTAVTP 235

Query: 72  TNGSLTYRLNLD-GFPGFG-WAVTYFAEIEDLDPDESRKFRLVLPGQPDVSKAIVNIQEN 129
           TN S       D   P F  +   +FAEI+ L   E+R+F + + G+       V+ +  
Sbjct: 236 TNASAPLNFTWDLVDPNFEYYVYLHFAEIQSL---ETREFDIYINGKTVYGD--VSPKYL 290

Query: 130 AQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKY 174
                 +Y     N+S   +L+     T  S+  PLLNA+EI K 
Sbjct: 291 GTDTGALYLDFPVNVSGGGLLNISLVPTSGSTLPPLLNALEIFKV 335

Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. The domain is found on a number of plant receptor kinases. Length = 335

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  119 bits (301), Expect = 3e-30
 Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 48/284 (16%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-TSNSYQGKREFT-NEVTLLSRIHHRNLVQ 468
           + K+IG G FG VY  +   DGK   +K +  SN  + +RE   NEV +L +++H N+++
Sbjct: 4   IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHL------YGTLTHEQRINWIKRLEIAEDAAKGIE 522
           +    +E+G+  +V E+   G L + +            EQ ++W  +L         ++
Sbjct: 64  YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALK 117

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YLH+     I+HRD+K  NI L  +   K+ DFG+SK          ++V GT  YL PE
Sbjct: 118 YLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE 173

Query: 583 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE------SGD 636
              ++    KSD++S G +L EL + +     E        I+   K          S +
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL---KGQYPPIPSQYSSE 230

Query: 637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 680
           ++ ++  SLL         K  E+           RPSI+++L+
Sbjct: 231 LRNLVS-SLL--------QKDPEE-----------RPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  118 bits (297), Expect = 8e-30
 Identities = 65/199 (32%), Positives = 108/199 (54%), Gaps = 13/199 (6%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L ++IGSG FG+V+ G   + +++A+K +       + +F  E  ++ ++ H  LVQ  G
Sbjct: 8   LVQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
            C E     LV+EFM +G L ++L    G  + E        L +  D  +G+ YL +  
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQE------TLLGMCLDVCEGMAYLESSN 120

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
           V   IHRDL + N L+ ++   KVSDFG+++F +D     S+  +  V +  PE +   +
Sbjct: 121 V---IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK 177

Query: 589 LTDKSDVYSFGVILLELIS 607
            + KSDV+SFGV++ E+ S
Sbjct: 178 YSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 1e-29
 Identities = 74/202 (36%), Positives = 103/202 (50%), Gaps = 20/202 (9%)

Query: 416 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 471
           +G G FG V   + KD GK  A+KVL       ++E      E  +LSRI+H  +V+ L 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK-LH 59

Query: 472 YC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 527
           Y  Q E +  LV E+   G L  HL   G  + E+R     R   AE     +EYLH+ G
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFS-EERA----RFYAAE-IVLALEYLHSLG 113

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               II+RDLK  NILLD     K++DFGL+K      S  ++   GT  YL PE  + +
Sbjct: 114 ----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGK 168

Query: 588 QLTDKSDVYSFGVILLELISGQ 609
                 D +S GV+L E+++G+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  119 bits (299), Expect = 3e-29
 Identities = 70/212 (33%), Positives = 110/212 (51%), Gaps = 19/212 (8%)

Query: 411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRI-HHRNL 466
            + +K+G G FG VY  +  D K +A+KVL     +  +    F  E+ +L+ + H  N+
Sbjct: 3   RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+   + Q+EG   LV E++  G+L++ L   +  +  ++  + L I       +EYLH+
Sbjct: 61  VKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALEYLHS 119

Query: 527 GCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVS-----SIVRGTVGYLD 580
                IIHRD+K  NILLD+     K+ DFGL+K   D  S  S     S   GT GY+ 
Sbjct: 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 581 PEYYISQQL---TDKSDVYSFGVILLELISGQ 609
           PE  +   L   +  SD++S G+ L EL++G 
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  115 bits (290), Expect = 9e-29
 Identities = 66/192 (34%), Positives = 103/192 (53%), Gaps = 11/192 (5%)

Query: 416 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE 475
           IG G FG V  G  + G+++AVK L  +S    + F  E ++++ + H NLVQ LG   +
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 476 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHR 535
                +V E+M  G+L ++L         I   ++L  A D  +G+EYL        +HR
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHR 126

Query: 536 DLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDV 595
           DL + N+L+ + + AKVSDFGL+K     AS      +  V +  PE    ++ + KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDV 182

Query: 596 YSFGVILLELIS 607
           +SFG++L E+ S
Sbjct: 183 WSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  115 bits (289), Expect = 1e-28
 Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 7/203 (3%)

Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 2   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 60

Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q +N +  L +A   +  +E
Sbjct: 61  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAME 118

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 119 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 175

Query: 583 YYISQQLTDKSDVYSFGVILLEL 605
                + + KSDV++FGV+L E+
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  114 bits (288), Expect = 1e-28
 Identities = 61/196 (31%), Positives = 103/196 (52%), Gaps = 6/196 (3%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE+K+GSG FG V+ G  K+   +A+K+L S+    +++F  EV  L R+ H++L+    
Sbjct: 10  LERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
            C       ++ E M  G+L   L       Q +     +++A   A+G+ YL       
Sbjct: 70  VCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEE---QN 124

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            IHRDL + NIL+ + +  KV+DFGL++   +   ++SS  +    +  PE       + 
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFST 183

Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L E+ +
Sbjct: 184 KSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 6e-28
 Identities = 68/197 (34%), Positives = 105/197 (53%), Gaps = 8/197 (4%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGY 472
           +KIG G FG VY G LK   E+AVK   S      KR+F  E  +L +  H N+V+ +G 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
           C ++    +V E +  G+L   L      + R+   K L+++ DAA G+EYL +      
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKNC--- 114

Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VGYLDPEYYISQQLTD 591
           IHRDL + N L+ ++   K+SDFG+S+    G   VS  ++   + +  PE     + T 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 592 KSDVYSFGVILLELISG 608
           +SDV+S+G++L E  S 
Sbjct: 175 ESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 2e-27
 Identities = 57/204 (27%), Positives = 103/204 (50%), Gaps = 15/204 (7%)

Query: 411 MLEKKIGSGGFGVVYYG-KLKDGKEIAVK--VLTSNSYQGKREFTNEVTLLSRIHHRNLV 467
            L   IG G FGVVY G  L+ G  +A+K   L     +  +    E+ LL  + H N+V
Sbjct: 3   QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +++G  +      ++ E+  NG+L++ +  +G         ++ ++       +G+ YLH
Sbjct: 63  KYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV------LQGLAYLH 116

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
                 +IHRD+K++NIL  K    K++DFG++   ++  S   + V GT  ++ PE   
Sbjct: 117 E---QGVIHRDIKAANILTTKDGVVKLADFGVAT-KLNDVSKDDASVVGTPYWMAPEVIE 172

Query: 586 SQQLTDKSDVYSFGVILLELISGQ 609
               +  SD++S G  ++EL++G 
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  111 bits (281), Expect = 2e-27
 Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 21/203 (10%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +KIG G  G VY       GKE+A+K +     Q K    NE+ ++    H N+V +   
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYD- 82

Query: 473 CQEEGRSV-LVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               G  + +V E+M  G+L + +       +E +I ++ R E+ +    G+EYLH+   
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCR-EVLQ----GLEYLHSQ-- 135

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD---GASHVSSIVRGTVGYLDPEYYIS 586
             +IHRD+KS NILL K    K++DFG   FA       S  +S+V GT  ++ PE    
Sbjct: 136 -NVIHRDIKSDNILLSKDGSVKLADFG---FAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190

Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
           +    K D++S G++ +E+  G+
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  109 bits (275), Expect = 7e-27
 Identities = 64/197 (32%), Positives = 107/197 (54%), Gaps = 13/197 (6%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K++GSG FGVV+ GK +   ++A+K +   +   + +F  E  ++ ++ H  LVQ  G C
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 474 QEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
            ++    +V EFM NG L  +L    G L+ +        L + +D  +G+EYL      
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML------LSMCQDVCEGMEYLERN--- 119

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
           + IHRDL + N L+      KVSDFG++++ +D     SS  +  V +  PE +   + +
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179

Query: 591 DKSDVYSFGVILLELIS 607
            KSDV+SFGV++ E+ +
Sbjct: 180 SKSDVWSFGVLMWEVFT 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 2e-26
 Identities = 59/205 (28%), Positives = 108/205 (52%), Gaps = 16/205 (7%)

Query: 411 MLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRN 465
            +EK IG G FG V  G+L    K   ++A+K L + S   +R +F  E +++ +  H N
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +++  G   +    +++ E+M NG+L + L     ++ +    + + +    A G++YL 
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGSLDKFLR---ENDGKFTVGQLVGMLRGIASGMKYLS 123

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLDPE 582
                  +HRDL + NIL++ ++  KVSDFGLS+      S  +   +G    + +  PE
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSR--RLEDSEATYTTKGGKIPIRWTAPE 178

Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
               ++ T  SDV+SFG+++ E++S
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  108 bits (272), Expect = 2e-26
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 20/203 (9%)

Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKV--LTSNSYQGK---REFTNEVTLLSRIHHRNLVQF 469
           +GSG FG VY G  L DG   AVK   L  +   G+   ++   E+ LLS++ H N+VQ+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           LG  +EE    +  E +  G+L + L  YG+        + +++        G+EYLH  
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI------LLGLEYLHDR 121

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
                +HRD+K +NIL+D +   K++DFG++K  V+ +   S   +G+  ++ PE    Q
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQ 176

Query: 588 QLTD-KSDVYSFGVILLELISGQ 609
                 +D++S G  +LE+ +G+
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 3e-26
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 14/208 (6%)

Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           +I+  +  L +K+G+G FG V+ G   +   +AVK L   +   K +F  E  ++ ++ H
Sbjct: 2   EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRH 60

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG----TLTHEQRINWIKRLEIAEDAAK 519
             L+Q    C  E    +V E M  G+L E+L G     L   Q I      ++A   A 
Sbjct: 61  PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI------DMAAQVAS 114

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 579
           G+ YL        IHRDL + N+L+ ++   KV+DFGL++   +         +  + + 
Sbjct: 115 GMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT 171

Query: 580 DPEYYISQQLTDKSDVYSFGVILLELIS 607
            PE  +  + + KSDV+SFG++L E+++
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  108 bits (271), Expect = 5e-26
 Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 27/217 (12%)

Query: 412 LEKKIGSGGFGVVYYGKL-----KDGKEI-AVKVLT-SNSYQGKREFTNEVTLLSRIHHR 464
           L++++G G FG V+ G+      ++ KE+ AVK L  + S   +++F  E  LL+   H 
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------YGTLTHEQRINWIKRLEIA 514
           N+V+F G C E    ++V+E+M +G L + L              +    +   + L+IA
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 515 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 574
              A G+ YL +      +HRDL + N L+   +  K+ DFG+S+   D  +     V G
Sbjct: 129 VQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGG 182

Query: 575 T----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
                + ++ PE  + ++ T +SDV+SFGV+L E+ +
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 7e-26
 Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 6/196 (3%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE+K+G+G FG V+ G      ++AVK L   +      F  E  ++ ++ H  LVQ   
Sbjct: 10  LERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
            C EE    +V E+M  G+L + L      + R+   + +++A   A+G+ YL +     
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQIAEGMAYLES---RN 123

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            IHRDL + NIL+ +++  K++DFGL++   D         +  + +  PE     + T 
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTI 183

Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L E+++
Sbjct: 184 KSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  107 bits (269), Expect = 7e-26
 Identities = 62/201 (30%), Positives = 102/201 (50%), Gaps = 15/201 (7%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLG 471
           K +G G  GVVY  + K  GK  A+K +  +   + +++   E+  L       +V+  G
Sbjct: 7   KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL---EIAEDAAKGIEYLHTGC 528
              +EG   +V E+M  G+L + L       +++  I       IA    KG++YLHT  
Sbjct: 67  AFYKEGEISIVLEYMDGGSLADLL-------KKVGKIPEPVLAYIARQILKGLDYLHT-- 117

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              IIHRD+K SN+L++     K++DFG+SK   +     ++ V GTV Y+ PE    + 
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGES 176

Query: 589 LTDKSDVYSFGVILLELISGQ 609
            +  +D++S G+ LLE   G+
Sbjct: 177 YSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  105 bits (264), Expect = 4e-25
 Identities = 71/219 (32%), Positives = 110/219 (50%), Gaps = 47/219 (21%)

Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ +L  + H N+V+
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 469 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + G C   GR    LV E++  G+L+++L     H +R++  K L  A    KG+EYL +
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYLGS 126

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRDL + NIL++   R K+ DFGL+K                V   D EYY  
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTK----------------VLPQDKEYYKV 167

Query: 587 QQ-------------LTD-----KSDVYSFGVILLELIS 607
           ++             LT+      SDV+SFGV+L EL +
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  104 bits (262), Expect = 9e-25
 Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 39/227 (17%)

Query: 411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREF-TNEVTLLSRI-HHR 464
              K IG G F  V   K K   KE A+K+L        + K ++   E  +L+R+  H 
Sbjct: 4   KFGKIIGEGSFSTVVLAKEKETNKEYAIKIL-DKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 522
            +++     Q+E     V E+  NG L +++  YG+L  E+   +      AE     +E
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD-EKCTRFY----AAE-ILLALE 116

Query: 523 YLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF----------AVDGASHVSSI 571
           YLH+ G    IIHRDLK  NILLDK M  K++DFG +K             D  +  S I
Sbjct: 117 YLHSKG----IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 572 VR---------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
            +         GT  Y+ PE    +     SD+++ G I+ ++++G+
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  104 bits (261), Expect = 1e-24
 Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 34/231 (14%)

Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLT-SNSYQGKREFT 452
             LS +        +++G G FG VY G+L           +A+K L  +   + ++EF 
Sbjct: 2   IPLSAVR-----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR 56

Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE---------- 502
            E  L+S + H N+V  LG C +E  + +++E++ +G L E L     H           
Sbjct: 57  QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116

Query: 503 --QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 560
               ++    L IA   A G+EYL +      +HRDL + N L+ + +  K+SDFGLS+ 
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR- 172

Query: 561 AVDGASH----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             D  S     V S     V ++ PE  +  + T +SD++SFGV+L E+ S
Sbjct: 173 --DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  101 bits (254), Expect = 4e-24
 Identities = 59/217 (27%), Positives = 100/217 (46%), Gaps = 15/217 (6%)

Query: 416 IGSGGFG-VVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +G G FG    Y + +D   +  K   LT  S + +R+  NE+ +LS + H N++ +  +
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 473 CQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
             ++   ++  E+ + GTL +      G L  E+ + W             + Y+H    
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY-----LFQIVSAVSYIHKA-- 120

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             I+HRD+K+ NI L K    K+ DFG+SK      S   ++V GT  Y+ PE     + 
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178

Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
             KSD+++ G +L EL++ +              IVQ
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  100 bits (250), Expect = 1e-23
 Identities = 67/200 (33%), Positives = 107/200 (53%), Gaps = 18/200 (9%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           KKIG G FG +Y  K K D +   +K   LT    + K     EV LL+++ H N+V F 
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 526
              QE GR  +V E+   G L + +    G L  E +I +W  ++ +      G++++H 
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHD 119

Query: 527 GCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
                I+HRD+KS NI L K+ M AK+ DFG+++  ++ +  ++    GT  YL PE   
Sbjct: 120 ---RKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTCVGTPYYLSPEICQ 175

Query: 586 SQQLTDKSDVYSFGVILLEL 605
           ++   +K+D++S G +L EL
Sbjct: 176 NRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  100 bits (249), Expect = 2e-23
 Identities = 66/196 (33%), Positives = 106/196 (54%), Gaps = 13/196 (6%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L + IG G FG V  G+   G+++AVK +  +     + F  E  +++++HH+NLV+ LG
Sbjct: 10  LGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLG 66

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
                G  + V E M  G L   L         ++ I+ L+ + D A+G+EYL +     
Sbjct: 67  VILHNGLYI-VMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLES---KK 120

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
           ++HRDL + NIL+ +   AKVSDFGL++    G  +    V+ T     PE    ++ + 
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA----PEALKHKKFSS 176

Query: 592 KSDVYSFGVILLELIS 607
           KSDV+S+GV+L E+ S
Sbjct: 177 KSDVWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 99.5 bits (248), Expect = 4e-23
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 21/205 (10%)

Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLT--SNSYQGKRE---FTNEVTLLSRIHHRNLV 467
           K +G G FG VY     D G+E+AVK +    +S + K+E      E+ LL  + H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 468 QFLGYCQEEGRSVLVY-EFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
           Q+ G C  +  ++ ++ E+M  G++K+ L  YG LT      + +  +I E    G+EYL
Sbjct: 68  QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR--QILE----GVEYL 120

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLDPE 582
           H+     I+HRD+K +NIL D     K+ DFG SK      S  + +  V GT  ++ PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177

Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
               +    K+DV+S G  ++E+++
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 98.9 bits (246), Expect = 4e-23
 Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 13/197 (6%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L + IG G FG V  G  + G ++AVK + +++    + F  E ++++++ H NLVQ LG
Sbjct: 10  LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 66

Query: 472 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
              EE   + +V E+M  G+L ++L         +     L+ + D  + +EYL      
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN--- 121

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
             +HRDL + N+L+ +   AKVSDFGL+K     AS      +  V +  PE    ++ +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 177

Query: 591 DKSDVYSFGVILLELIS 607
            KSDV+SFG++L E+ S
Sbjct: 178 TKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 97.8 bits (244), Expect = 9e-23
 Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 19/203 (9%)

Query: 414 KKIGSGGFGVVYYG--KLKDGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQ 468
           K++G G FG V  G   +K GKE+  AVK L       GK+EF  E ++++++ H  +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
            +G C+ E   +LV E    G L ++L       + I      E+A   A G+ YL +  
Sbjct: 61  LIGVCKGEP-LMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES-- 113

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPE--YY 584
               +HRDL + N+LL    +AK+SDFG+S+    G+ +  +   G   + +  PE   Y
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + + KSDV+S+GV L E  S
Sbjct: 173 --GKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 98.4 bits (245), Expect = 1e-22
 Identities = 66/209 (31%), Positives = 114/209 (54%), Gaps = 23/209 (11%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 466
           +E+ IG+G FG V  G+LK  GK    +A+K L S  + + +R+F +E +++ +  H N+
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           +   G   +    +++ EFM NG L   L     ++ +   I+ + +    A G++YL  
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLSE 124

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS---HVSSI-----VRGTVGY 578
                 +HRDL + NIL++ ++  KVSDFGLS+F  D  S   + SS+     +R T   
Sbjct: 125 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA-- 179

Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELIS 607
             PE    ++ T  SDV+S+G+++ E++S
Sbjct: 180 --PEAIAYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 96.9 bits (241), Expect = 2e-22
 Identities = 62/210 (29%), Positives = 114/210 (54%), Gaps = 13/210 (6%)

Query: 405 IEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQGKREFTNEVTLLS 459
           I+ +   +EK IG+G FG V  G+LK    +EI V + T     + + +R+F +E +++ 
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60

Query: 460 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 519
           +  H N++   G   +    ++V E+M NG+L   L     H+ +   I+ + +    A 
Sbjct: 61  QFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR---KHDGQFTVIQLVGMLRGIAS 117

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVG 577
           G++YL        +HRDL + NIL++ ++  KVSDFGLS+   D   A++ +   +  + 
Sbjct: 118 GMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIR 174

Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +  PE    ++ T  SDV+S+G+++ E++S
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 96.5 bits (240), Expect = 3e-22
 Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 7/196 (3%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L KK+G+G FG V+ G      ++A+K L   S      F  E  L+ ++ H  LV+   
Sbjct: 10  LVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYA 68

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              +E    ++ E+M NG+L + L      +  IN  K +++A   A+G+ ++       
Sbjct: 69  VVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTIN--KLIDMAAQIAEGMAFIE---RKN 122

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            IHRDL+++NIL+ + +  K++DFGL++   D         +  + +  PE       T 
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182

Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L E+++
Sbjct: 183 KSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 96.0 bits (239), Expect = 4e-22
 Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 9/218 (4%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +  KIG G FGVV+    K D +  A+K   L+  + + + E  +E  +L+++    +++
Sbjct: 4   ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
           +     ++G+  +V E+  NG L + L          + + R  I      G+ +LH+  
Sbjct: 64  YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLHSK- 120

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              I+HRD+KS N+ LD +   K+ D G++K   D  +  ++IV GT  YL PE    + 
Sbjct: 121 --KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDKP 177

Query: 589 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
             +KSDV++ GV+L E  +G+        GA    I++
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 95.9 bits (238), Expect = 5e-22
 Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 7/196 (3%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H  LVQ   
Sbjct: 10  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 68

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE    +V E+M  G+L + L G +    R+  +  +++A   A G+ Y+       
Sbjct: 69  VVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVER---MN 122

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T 
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L EL +
Sbjct: 183 KSDVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 95.7 bits (238), Expect = 6e-22
 Identities = 77/278 (27%), Positives = 131/278 (47%), Gaps = 37/278 (13%)

Query: 416 IGSGGFGVVYYGKLKDGKEIAVKVL---TSNSYQGKREFTN---EVTLLSRIHHRNLVQF 469
           +G G +G VY G    G+ IAVK +   TSN    ++E+     EV LL  + H N+VQ+
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           LG C ++    +  EF+  G++   L  +G L       + K++        G+ YLH  
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI------LDGVAYLHNN 121

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSS----IVRGTVGYLDPE 582
           CV   +HRD+K +N++L  +   K+ DFG + + A  G     S     + GT  ++ PE
Sbjct: 122 CV---VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 583 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
                    KSD++S G  + E+ +G+  +++    A        A  +I  G  +G++ 
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--------AMFYI--GAHRGLM- 227

Query: 643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 680
           P L D +   ++    +    C+    H RPS  ++L+
Sbjct: 228 PRLPDSFSAAAI----DFVTSCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 96.0 bits (239), Expect = 8e-22
 Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 12/199 (6%)

Query: 415 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           ++G G  G V   +LK+   I A+K + T  +   +++   E+ +        +V++ G 
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67

Query: 473 CQEEGRSVL--VYEFMHNGTLKEHLYG-TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
             +E  S +    E+   G+L + +Y        RI      +IAE   KG+ YLH+   
Sbjct: 68  FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS--- 123

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             IIHRD+K SNILL +  + K+ DFG+S   V   + ++    GT  Y+ PE    +  
Sbjct: 124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFTGTSFYMAPERIQGKPY 180

Query: 590 TDKSDVYSFGVILLELISG 608
           +  SDV+S G+ LLE+   
Sbjct: 181 SITSDVWSLGLTLLEVAQN 199

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 73/252 (28%), Positives = 106/252 (42%), Gaps = 40/252 (15%)

Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 471
           I  G +G V+  K K   +I A+KV+       K +      E  +LS+     +V+   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 472 YCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
             Q +    LV E++  G L       G+L  +     + R+ IAE     +EYLH+   
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDED-----VARIYIAE-IVLALEYLHSN-- 112

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV--------DGASHVSSIVRGTVGYLDP 581
             IIHRDLK  NIL+D +   K++DFGLSK  +        D       IV GT  Y+ P
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAP 170

Query: 582 EYYISQQLTDKSDVYSFGVILLELISG----QEAISNEKFGANCRNIVQWAKLHIESGDI 637
           E  + Q  +   D +S G IL E + G          E F             +I +G I
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ------------NILNGKI 218

Query: 638 QGIIDPSLLDEY 649
           +   D  + DE 
Sbjct: 219 EWPEDVEVSDEA 230

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 94.2 bits (234), Expect = 2e-21
 Identities = 77/278 (27%), Positives = 125/278 (44%), Gaps = 40/278 (14%)

Query: 414 KKIGSGGFGVVYYGKLKDG------KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 467
           + +G G FG+V+  + K        K+I V+ +T +     +   NE  +L  + H N++
Sbjct: 6   RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           ++     E+   ++V E+   GTL E++      ++  + +    I     + +  LH  
Sbjct: 63  EYYENFLEDKALMIVMEYAPGGTLAEYI-----QKRCNSLLDEDTILHFFVQILLALHHV 117

Query: 528 CVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
               I+HRDLK+ NILLDKH M  K+ DFG+SK  +  +   +  V GT  Y+ PE    
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISK--ILSSKSKAYTVVGTPCYISPELCEG 175

Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID---P 643
           +    KSD+++ G +L EL S + A       AN   +V    L I SG    I D   P
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFE----AANLPALV----LKIMSGTFAPISDRYSP 227

Query: 644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
            L     I SM  +              RP +S+++  
Sbjct: 228 DL--RQLILSMLNL----------DPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 20/206 (9%)

Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFL 470
            KIG G FG VY    L  G+ +AVK +       K  +E  +E+ +L  + H NLV++ 
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRIN-WIKRLEIAEDAAKGIEYLHTGC 528
           G      +  +  E+   GTL+E L +G +  E  I  +  +L       +G+ YLH+  
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL------LEGLAYLHSH- 118

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLDPEYYI 585
              I+HRD+K +NI LD +   K+ DFG +    +  + +   V+   G   Y+ PE   
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 586 SQQLTDK---SDVYSFGVILLELISG 608
             +       +D++S G ++LE+ +G
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATG 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 94.3 bits (234), Expect = 2e-21
 Identities = 59/202 (29%), Positives = 113/202 (55%), Gaps = 13/202 (6%)

Query: 413 EKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLV 467
           +K IG+G FG V+ G LK  G++   +A+K L     + +R +F +E +++ +  H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           +  G   +   ++++ E+M NG L ++L     H+   +  + + +    A G++YL   
Sbjct: 70  RLEGVVTKFKPAMIITEYMENGALDKYLR---DHDGEFSSYQLVGMLRGIAAGMKYLSD- 125

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVGYLDPEYYI 585
                +HRDL + NIL++ ++  KVSDFGLS+   D    ++ +S  +  + +  PE   
Sbjct: 126 --MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 586 SQQLTDKSDVYSFGVILLELIS 607
            ++ T  SDV+SFG+++ E++S
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 68/295 (23%), Positives = 128/295 (43%), Gaps = 58/295 (19%)

Query: 416 IGSGGFGVVYYGKLK----DGKE--IAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQ 468
           +G G FG V+  K K    +G E  + VK L     +  + EF  E+ +  ++ H+N+V+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-----QRINWIKRLEIAEDAAKGIEY 523
            LG C+E     ++ E+   G LK+ L  T + +       ++  +++ +    A G+++
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVRGTVGYLDP 581
           L        +HRDL + N L+      KVS   LSK  +  +     ++++   + +L P
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI--PLRWLAP 187

Query: 582 EYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLHIESGDI 637
           E       + KSDV+SFGV++ E+ +  E     +S+E+               +++G +
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR-----------LQAGKL 236

Query: 638 QGIIDPSLLDEYDIQSMWKIEEKA------LM--CVLPHGHMRPSISEVLKDIQD 684
           +                  + E        LM  C   +   RPS SE++  + +
Sbjct: 237 E----------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 94.1 bits (234), Expect = 3e-21
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 17/202 (8%)

Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DG++I  AVK L      +   +F  E  ++    H N++  L
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAAKGIEYLHTGC 528
           G C   EG  ++V  +M +G L+  +      E     +K L       AKG+EYL +  
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFI----RSETHNPTVKDLIGFGLQVAKGMEYLAS-- 116

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYI 585
               +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   
Sbjct: 117 -KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175

Query: 586 SQQLTDKSDVYSFGVILLELIS 607
           +Q+ T KSDV+SFGV+L EL++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 20/204 (9%)

Query: 414 KKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G      E     +A+KVL    S +  +E  +E  +++ + H ++V
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYL 524
           + LG C    +  L+ + M  G L +++      +  +  +NW          AKG+ YL
Sbjct: 73  RLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEY 583
                  ++HRDL + N+L+      K++DFGL+K   VD   + +   +  + ++  E 
Sbjct: 126 EE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
            + +  T KSDV+S+GV + EL++
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 93.7 bits (233), Expect = 4e-21
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 26/221 (11%)

Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE----------FTNEVTLLSRIHHR 464
           IG G +G VY    +  G+ +AVK +   +    R             +E+  L  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 522
           N+VQ+LG+   E    +  E++  G++   L  YG    EQ + +       E   +G+ 
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRF-EEQLVRFF-----TEQVLEGLA 122

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDP 581
           YLH+     I+HRDLK+ N+L+D     K+SDFG+SK + D   +  ++ ++G+V ++ P
Sbjct: 123 YLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179

Query: 582 EYYISQQ--LTDKSDVYSFGVILLELISGQEAISN-EKFGA 619
           E   S     + K D++S G ++LE+ +G+   S+ E   A
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 93.2 bits (231), Expect = 4e-21
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 9/197 (4%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           ++IG G FG V+ G+L+ D   +AVK          K +F  E  +L +  H N+V+ +G
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
            C ++    +V E +  G     L    T   R+   + +++ E+AA G+EYL +     
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKHC-- 115

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VGYLDPEYYISQQLT 590
            IHRDL + N L+ +    K+SDFG+S+   DG    +  ++   V +  PE     + +
Sbjct: 116 -IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174

Query: 591 DKSDVYSFGVILLELIS 607
            +SDV+SFG++L E  S
Sbjct: 175 SESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 94.0 bits (233), Expect = 4e-21
 Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 21/214 (9%)

Query: 411 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 464
           +L++++G G FG V+  +       +D   +AVK L   S   +++F  E  LL+ + H 
Sbjct: 8   VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----GTLTHE----QRINWIKRLEIAE 515
           ++V+F G C E    ++V+E+M +G L + L        L  E      +   + L IA+
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVR 573
             A G+ YL +      +HRDL + N L+ +++  K+ DFG+S+  ++ D    V     
Sbjct: 128 QIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD-YYRVGGHTM 183

Query: 574 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             + ++ PE  + ++ T +SDV+S GV+L E+ +
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 18/213 (8%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
            ++G+G  GVV     +  GK +AVK   L  N    K+    E+ +L + +   +V F 
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ-ILRELDILHKCNSPYIVGFY 65

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL---EIAEDAAKGIEYLHTG 527
           G     G   +  E+M  G+L + L      ++    I      +IA    KG+ YLH  
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILGKIAVAVLKGLTYLHE- 118

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               IIHRD+K SNIL++   + K+ DFG+S   V+  +       GT  Y+ PE     
Sbjct: 119 -KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGN 174

Query: 588 QLTDKSDVYSFGVILLELISGQEAISNEKFGAN 620
             + KSD++S G+ L+EL +G+     E    +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 93.5 bits (232), Expect = 6e-21
 Identities = 62/222 (27%), Positives = 110/222 (49%), Gaps = 34/222 (15%)

Query: 411 MLEKKIGSGGFGVVYYGK------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 464
           +L++++G G FG V+  +       KD   +AVK L   +   +++F  E  LL+ + H 
Sbjct: 8   VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 67

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIKRLE 512
           ++V+F G C +    ++V+E+M +G L + L                  +  +   + L 
Sbjct: 68  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127

Query: 513 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-------FAVDGA 565
           IA   A G+ YL +      +HRDL + N L+  ++  K+ DFG+S+       + V G 
Sbjct: 128 IASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG- 183

Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            H    +R    ++ PE  + ++ T +SDV+SFGVIL E+ +
Sbjct: 184 -HTMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 93.4 bits (232), Expect = 6e-21
 Identities = 64/224 (28%), Positives = 106/224 (47%), Gaps = 35/224 (15%)

Query: 413 EKKIGSGGFGVVYYGK---LKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRN 465
            + IG G FG V+  +   L   +    +AVK+L    S   + +F  E  L++   H N
Sbjct: 10  VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQ------------------RINW 507
           +V+ LG C       L++E+M  G L E L       Q                   ++ 
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVD-- 563
            ++L IA+  A G+ YL        +HRDL + N L+ ++M  K++DFGLS+  ++ D  
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186

Query: 564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            AS   +I    + ++ PE     + T +SDV+++GV+L E+ S
Sbjct: 187 KASENDAI---PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 92.6 bits (230), Expect = 7e-21
 Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 28/211 (13%)

Query: 416 IGSGGFGVVYYG-KLKDGKEIAVK--VLTSNSYQGKRE-------FTNEVTLLSRIHHRN 465
           IGSG FG VY G     G+ +AVK   L S S   K            E+ LL  + H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           +VQ+LG   +     +  E++  G++   L  YG        N+++++       KG+ Y
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGLNY 121

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK------FAVDGASHVSSIVRGTVG 577
           LH      IIHRD+K +NIL+D     K+SDFG+SK       +        S+ +G+V 
Sbjct: 122 LHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL-QGSVF 177

Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELISG 608
           ++ PE       T K+D++S G +++E+++G
Sbjct: 178 WMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 93.0 bits (231), Expect = 8e-21
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 18/204 (8%)

Query: 414 KKIGSGGFGVVY---YGKLKD--GKEIAVKVLTS-NSYQGKREFTNEVTLLSRIHHRNLV 467
           + +G G FG V    Y    D  G+ +AVK L      Q    +  E+ +L  ++H N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 468 QFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           ++ G C E+G     L+ E++  G+L+++L      + ++N  + L  A+   +G+ YLH
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLH 124

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPEY 583
           +      IHRDL + N+LLD     K+ DFGL+K   +G  +  V       V +   E 
Sbjct: 125 S---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVEC 181

Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
               + +  SDV+SFGV L EL++
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 92.3 bits (229), Expect = 9e-21
 Identities = 81/293 (27%), Positives = 126/293 (43%), Gaps = 60/293 (20%)

Query: 411 MLEKKIGSGGFGVVYYGK---------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI 461
           +L++++G G FG VY  K         LK  KEI V  L  N      +   E  LLS++
Sbjct: 3   ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKL 59

Query: 462 HHRNLVQFLG-------------YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 508
            H  +V+F               YC+       + E  H G        TL+  Q   W 
Sbjct: 60  DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK-------TLSENQVCEWF 112

Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
            +L +      G+ Y+H      I+HRDLK+ NI L  ++  K+ DFG+S+  + G+  +
Sbjct: 113 IQLLL------GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDL 161

Query: 569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 628
           ++   GT  Y+ PE    Q    KSD++S G IL E+     A   + F +    IV+  
Sbjct: 162 ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE-- 219

Query: 629 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
                 G       PSL + Y  + +  I +  L        +RPS +E+L++
Sbjct: 220 ------GPT-----PSLPETYS-RQLNSIMQSMLN---KDPSLRPSAAEILRN 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 59/202 (29%), Positives = 86/202 (42%), Gaps = 23/202 (11%)

Query: 416 IGSGGFGVVYYGKLKDGKEI-------AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           IG G FG V   + +D K++         K +   S +      NE  +L  ++H  LV 
Sbjct: 8   IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVL---NERRILQELNHPFLVN 64

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
                Q+E    LV + +  G L+ HL      + EQ      +  I E     +EYLH+
Sbjct: 65  LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ-----VKFWICE-IVLALEYLHS 118

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                IIHRD+K  NILLD+     ++DF ++          S    GT GY+ PE    
Sbjct: 119 ---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTS--TSGTPGYMAPEVLCR 173

Query: 587 QQLTDKSDVYSFGVILLELISG 608
           Q  +   D +S GV   E + G
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRG 195

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 60/209 (28%), Positives = 94/209 (44%), Gaps = 30/209 (14%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN--EVTLLSRIHHRNLVQFL 470
            KIG G +GVVY  + K   EI A+K +           T   E+ LL  ++H N+++ L
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 522
              + +G   LV+EFM        LY  +   QR        + E   K        G+ 
Sbjct: 65  DVFRHKGDLYLVFEFMD-----TDLYKLIKDRQR-------GLPESLIKSYLYQLLQGLA 112

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDP 581
           + H+     I+HRDLK  N+L++     K++DFGL++ F      +   +V  T  Y  P
Sbjct: 113 FCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV--TRWYRAP 167

Query: 582 E-YYISQQLTDKSDVYSFGVILLELISGQ 609
           E     +  +   D++S G I  EL+S +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 19/211 (9%)

Query: 412 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHR 464
           L + +G G FG VY G  +    D  E+ V V T   S S Q + +F  E  ++S+ +H+
Sbjct: 10  LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQ 69

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGI 521
           N+V+ +G   E     ++ E M  G LK  L       +R   +     L  A D AKG 
Sbjct: 70  NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 522 EYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGT--V 576
           +YL        IHRD+ + N LL        AK++DFG+++  +  AS+     R    +
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-DIYRASYYRKGGRAMLPI 185

Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            ++ PE ++    T K+DV+SFGV+L E+ S
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 7/196 (3%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L KK+G+G FG V+ G      ++AVK L   +      F  E  ++ ++ H  LVQ   
Sbjct: 10  LIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYA 68

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE    +V E+M  G+L + L       + +     +++A   A G+ Y+       
Sbjct: 69  VVSEE-PIYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER---MN 122

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            IHRDL+S+NIL+   +  K++DFGL++   D         +  + +  PE  +  + T 
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L EL++
Sbjct: 183 KSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 30/214 (14%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLV 467
           + IG G FG V   + K DGK +  K +    Y     + K++  +EV +L  + H N+V
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEI---DYGNMTEKEKQQLVSEVNILRELKHPNIV 62

Query: 468 QFLGYCQEEGRSVL--VYEFMHNGTL--------KEHLYGTLTHEQRINWIKRLEIAEDA 517
           ++     +     L  V E+   G L        KE  Y  +  E     + +L +A   
Sbjct: 63  RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY--IEEEFIWRILTQLLLA--- 117

Query: 518 AKGIEYLHTGCVP--AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 575
              +   H    P   ++HRDLK +NI LD +   K+ DFGL+K     +S   + V GT
Sbjct: 118 ---LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GT 173

Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
             Y+ PE        +KSD++S G ++ EL +  
Sbjct: 174 PYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 91.6 bits (227), Expect = 2e-20
 Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 23/216 (10%)

Query: 411 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 464
           +L+ ++G G FG V+  +       +D   +AVK L   S   +++F  E  LL+ + H+
Sbjct: 8   VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQ 67

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----------GTLTHEQRINWIKRLEI 513
           ++V+F G C E    ++V+E+M +G L   L            G      ++   + L I
Sbjct: 68  HIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSI 571
           A   A G+ YL +      +HRDL + N L+ + +  K+ DFG+S+  ++ D    V   
Sbjct: 128 ASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGR 183

Query: 572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               + ++ PE  + ++ T +SD++SFGV+L E+ +
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 90.7 bits (226), Expect = 5e-20
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 29/209 (13%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQG-----KREFTNEVTLLSRIHHRNL 466
            +IG G +G VY  +  K G+ +A+K +   N  +G      RE    + LL ++ H N+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIRE----IKLLQKLRHPNI 60

Query: 467 VQFLGYCQEEGR-SV-LVYEFM-H--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
           V+       +G+ S+ +V+E+M H   G L        T  Q   ++K+L       +G+
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEV-KFTESQIKCYMKQL------LEGL 113

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 580
           +YLH+     I+HRD+K SNIL++     K++DFGL+  +    ++  ++ V  T+ Y  
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRP 169

Query: 581 PEYYI-SQQLTDKSDVYSFGVILLELISG 608
           PE  + + +   + D++S G IL EL  G
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 90.6 bits (226), Expect = 5e-20
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 34/211 (16%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKV---------LTSNSYQGKREFTNEVTLLSRIHH 463
           +K+G G +GVVY  +  K G+ +A+K          + S + +       E++LL  + H
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-------EISLLKELKH 57

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKG 520
            N+V+ L     E +  LV+E+     LK   +   G L+     N IK   I     +G
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS----PNLIKS--IMYQLLRG 110

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYL 579
           + Y H+     I+HRDLK  NIL+++    K++DFGL++ F +   ++   +V  T+ Y 
Sbjct: 111 LAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYR 165

Query: 580 DPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
            PE  +  +    + D++S G I  E+I+G+
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 5e-20
 Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 41/222 (18%)

Query: 412 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHR 464
           L +++G G FG+VY G  K          +A+K +  N+   +R EF NE +++   +  
Sbjct: 10  LIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH 69

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLE 512
           ++V+ LG       +++V E M  G LK +L             G  T ++ I       
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM----- 124

Query: 513 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-------FAVDGA 565
            A + A G+ YL        +HRDL + N ++ + +  K+ DFG+++       +   G 
Sbjct: 125 -AAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             +   VR    ++ PE       T KSDV+SFGV+L E+ +
Sbjct: 181 GLLP--VR----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 89.7 bits (222), Expect = 7e-20
 Identities = 54/201 (26%), Positives = 103/201 (51%), Gaps = 7/201 (3%)

Query: 407 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 466
           ++ K++ KK+G+G FG V+ G   +  ++AVK L   +    + F  E  L+  + H  L
Sbjct: 6   ESIKLV-KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKL 63

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+      +E    ++ E+M  G+L + L        ++   K ++ +   A+G+ Y+  
Sbjct: 64  VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER 121

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 IHRDL+++N+L+ + +  K++DFGL++   D         +  + +  PE    
Sbjct: 122 ---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 178

Query: 587 QQLTDKSDVYSFGVILLELIS 607
              T KSDV+SFG++L E+++
Sbjct: 179 GSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 90.0 bits (223), Expect = 8e-20
 Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 16/204 (7%)

Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLV 467
           + +G G FG V    Y    D  G+++AVK L   S      +   E+ +L  ++H N+V
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 468 QFLGYCQEEG-RSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           ++ G C E+G   + L+ EF+ +G+LKE+L         IN  ++L+ A    KG++YL 
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLG 126

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPEY 583
           +      +HRDL + N+L++   + K+ DFGL+K       +  V   +   V +  PE 
Sbjct: 127 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
            I  +    SDV+SFGV L EL++
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 89.3 bits (221), Expect = 8e-20
 Identities = 60/194 (30%), Positives = 99/194 (51%), Gaps = 9/194 (4%)

Query: 416 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQ 474
           +G G FG V+ G LKD   +AVK    +  Q  K +F +E  +L +  H N+V+ +G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 475 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAII 533
           +     +V E +  G     L      +  +   + ++ A DAA G+ YL +  C    I
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLESKNC----I 115

Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRDL + N L+ ++   K+SDFG+S+   DG    S + +  + +  PE     + + +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175

Query: 594 DVYSFGVILLELIS 607
           DV+S+G++L E  S
Sbjct: 176 DVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 7/204 (3%)

Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           +I   +  LEKK+G+G FG V+        ++AVK +   S      F  E  ++  + H
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQH 60

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
             LV+      +E   ++  EFM  G+L + L      +Q +   K ++ +   A+G+ +
Sbjct: 61  DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAF 117

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 118 IEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174

Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
                 T KSDV+SFG++L+E+++
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 89.9 bits (223), Expect = 2e-19
 Identities = 65/206 (31%), Positives = 106/206 (51%), Gaps = 24/206 (11%)

Query: 414 KKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKREF--TNEVTLLSRIHHRNLV 467
           K +G G FG V+  +   G +     A+KVL   + + +       E  +L+ ++H  +V
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL-----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           +     Q EG+  L+ +F+  G L     KE ++   T E       +  +AE  A  ++
Sbjct: 62  KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF---TEED-----VKFYLAE-LALALD 112

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     II+RDLK  NILLD+    K++DFGLSK ++D      S   GTV Y+ PE
Sbjct: 113 HLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPE 168

Query: 583 YYISQQLTDKSDVYSFGVILLELISG 608
               +  T  +D +SFGV++ E+++G
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)

Query: 412 LEKKIGSGGFGVVYYGKLK--DGK--EIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRN 465
           L K +G G FG V  G+L   DG   ++AVK   L  ++Y    EF +E   +    H N
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPN 62

Query: 466 LVQFLGYC------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI--KRLEIAEDA 517
           +++ +G C      Q+  + +++  FM +G L   L  +              L+   D 
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-IVRGTV 576
           A G+EYL        IHRDL + N +L + M   V+DFGLSK    G  +    I +  V
Sbjct: 123 ALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 609
            ++  E    +  T KSDV++FGV + E+ + GQ
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 63/206 (30%), Positives = 91/206 (44%), Gaps = 16/206 (7%)

Query: 414 KKIGSGGFGVVYYGKLKD--GKEI--AVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQ 468
           KK+G G FGVV  G+     GK I  AVK L S+       +F  E  ++  + H NL++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAAKGIEYLHTG 527
             G        ++V E    G+L + L            I  L + A   A G+ YL + 
Sbjct: 61  LYGVVLTH-PLMMVTELAPLGSLLDRLR---KDALGHFLISTLCDYAVQIANGMRYLES- 115

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV--GYLDPEYYI 585
                IHRDL + NILL    + K+ DFGL +       H        V   +  PE   
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173

Query: 586 SQQLTDKSDVYSFGVILLELIS-GQE 610
           ++  +  SDV+ FGV L E+ + G+E
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEE 199

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 87.9 bits (218), Expect = 2e-19
 Identities = 75/278 (26%), Positives = 128/278 (46%), Gaps = 44/278 (15%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           KK+G G +G VY  K L D +  A+K   L S S + + +  NE+ +L+ ++H N++ + 
Sbjct: 6   KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65

Query: 471 GYCQEEGRSVLVYEFMHNGTL-----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
               +  +  +V E+   G L     K      L  EQ I W   +++     +G++ LH
Sbjct: 66  EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI-WRIFIQLL----RGLQALH 120

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
                 I+HRDLKS+NILL  +   K+ D G+SK       +++    GT  Y+ PE + 
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWK 174

Query: 586 SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL----HIESGDIQGII 641
            +  + KSD++S G +L E+ +        +   + R  VQ  K      I S D+Q  I
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPF-EARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI 233

Query: 642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 679
                             ++++ V P   +RP+  ++L
Sbjct: 234 ------------------RSMLQVKP--KLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 88.9 bits (220), Expect = 2e-19
 Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 28/222 (12%)

Query: 411 MLEKKIGSGGFGVVYYGKLKDGKE---------------IAVKVLTSNSYQGKR-EFTNE 454
            L++K+G G FG V+  + +   E               +AVK+L ++  +  R +F  E
Sbjct: 8   RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKE 67

Query: 455 VTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIK 509
           + ++SR+ + N+++ LG C  +    ++ E+M NG L + L       T TH   I  + 
Sbjct: 68  IKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127

Query: 510 R---LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
               L +A   A G++YL +      +HRDL + N L+  H   K++DFG+S+    G  
Sbjct: 128 IANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Query: 567 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           + +       + ++  E  +  + T  SDV++FGV L E+ +
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 88.1 bits (218), Expect = 4e-19
 Identities = 74/230 (32%), Positives = 111/230 (48%), Gaps = 46/230 (20%)

Query: 406 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRI 461
           ED     E  IG G FG V    +K DG ++  A+K+L    S    R+F  E+ +L ++
Sbjct: 2   EDIK--FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKL 59

Query: 462 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTL-----------------KEH-LYGTLTHE 502
            HH N++  LG C+  G   +  E+   G L                 KEH    TLT +
Sbjct: 60  GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119

Query: 503 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 562
           Q       L+ A D A G++YL        IHRDL + N+L+ +++ +K++DFGLS+   
Sbjct: 120 QL------LQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGE- 169

Query: 563 DGASHVSSIVRGTVGYLDPEYYISQQL-----TDKSDVYSFGVILLELIS 607
                    V+ T+G L   +   + L     T KSDV+SFGV+L E++S
Sbjct: 170 ------EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 87.8 bits (217), Expect = 4e-19
 Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 26/221 (11%)

Query: 408 ATKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTS-NSYQGKREFTNEVTLLSRI 461
           A + +E+ +G   FG +Y G L        + +A+K L   N+ Q   EF  E +L++ +
Sbjct: 6   AVRFMEE-LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL 64

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-------------EQRINWI 508
           HH N+V  LG   +E    +++E+++ G L E L     H             +  ++  
Sbjct: 65  HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124

Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGAS 566
             L IA   A G+EYL +      +H+DL + NIL+ + +  K+SD GLS+  ++ D   
Sbjct: 125 DFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD-YY 180

Query: 567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            V       + ++ PE  +  + +  SD++SFGV+L E+ S
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 86.8 bits (215), Expect = 8e-19
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 29/208 (13%)

Query: 416 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 474
           +G G +G+VY  + L     IA+K +     +  +    E+ L S + HRN+VQ+LG   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 475 EEGRSVLVYEFMHNGTLKEHL---YGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
           E G   +  E +  G+L   L   +G L  +EQ I +  + +I E    G++YLH     
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QILE----GLKYLHDN--- 127

Query: 531 AIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
            I+HRD+K  N+L++ +    K+SDFG SK  + G +  +    GT+ Y+ PE      +
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSK-RLAGINPCTETFTGTLQYMAPE------V 180

Query: 590 TDK--------SDVYSFGVILLELISGQ 609
            DK        +D++S G  ++E+ +G+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 88.1 bits (219), Expect = 9e-19
 Identities = 67/253 (26%), Positives = 95/253 (37%), Gaps = 49/253 (19%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT----NEVTLLSRIHHRNLVQ 468
           K IG G FG V+  + KD  ++ A+KVL   S   KR        E  +L+      +V+
Sbjct: 7   KVIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADADSPWIVK 65

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
                Q+E    LV E+M  G L   L        E       R  IAE     ++ +H 
Sbjct: 66  LYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-----TARFYIAELVL-ALDSVHK 119

Query: 527 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGAS------------------ 566
            G     IHRD+K  NIL+D     K++DFGL  K                         
Sbjct: 120 LGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 567 ----------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 616
                       +S V GT  Y+ PE         + D +S GVIL E++ G     ++ 
Sbjct: 176 RRRDHKQRRVRANSTV-GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234

Query: 617 FGANCRNIVQWAK 629
                  I+ W +
Sbjct: 235 LQETYNKIINWKE 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 86.4 bits (214), Expect = 9e-19
 Identities = 71/223 (31%), Positives = 104/223 (46%), Gaps = 30/223 (13%)

Query: 416 IGSGGFGVVYYGKLKD----GKE---IAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLV 467
           +GSG FG VY G   D    G     +AVK L   +  Q K+EF  E  L+S  +H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYG---TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           + LG C       ++ E M  G L  +L            +   + L+I  D AKG  YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 525 HTGCVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKFAVDGASHVSSIVRG----T 575
                   IHRDL + N L+     D     K+ DFGL++   D          G     
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKSDYYRKEGEGLLP 176

Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQE---AISN 614
           V ++ PE  +  + T +SDV+SFGV++ E+++ GQ+   A++N
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN 219

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 86.7 bits (214), Expect = 1e-18
 Identities = 66/214 (30%), Positives = 103/214 (48%), Gaps = 32/214 (14%)

Query: 416 IGSGGFGVVYYGKLK-DGKEI--AVKVLTS-NSYQGKREFTNEVTLLSRI-HHRNLVQFL 470
           IG G FG V   ++K DG  +  A+K +    S    R+F  E+ +L ++ HH N++  L
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR------------LEIAEDAA 518
           G C+  G   L  E+  +G L + L  +   E    +               L  A D A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           +G++YL        IHRDL + NIL+ ++  AK++DFGLS+            V+ T+G 
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMGR 172

Query: 579 LDPEYYISQQL-----TDKSDVYSFGVILLELIS 607
           L   +   + L     T  SDV+S+GV+L E++S
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 76/274 (27%), Positives = 131/274 (47%), Gaps = 34/274 (12%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFL 470
           KKIG G FG     K K DGK+  +K +  +    K   E   EV +LS + H N+VQ+ 
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 526
              +E G   +V ++   G L + +    G L  E +I +W  ++ +A      ++++H 
Sbjct: 66  ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHD 119

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                I+HRD+KS NI L K    K+ DFG+++  ++    ++    GT  YL PE   +
Sbjct: 120 ---RKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEICEN 175

Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           +   +KSD+++ G +L E+ + + A        N +N+V    L I  G    +   S  
Sbjct: 176 RPYNNKSDIWALGCVLYEMCTLKHAFE----AGNMKNLV----LKIIRGSYPPV---SSH 224

Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 680
             YD++++     K       +   RPS++ +L+
Sbjct: 225 YSYDLRNLVSQLFKR------NPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 87.0 bits (215), Expect = 1e-18
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 32/214 (14%)

Query: 416 IGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGK---REFTNEVTLLSRI-HHRNLVQFL 470
           IG G FG V   ++ KDG  +   +     Y  K   R+F  E+ +L ++ HH N++  L
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE------------QRINWIKRLEIAEDAA 518
           G C+  G   L  E+  +G L + L  +   E              ++  + L  A D A
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           +G++YL        IHRDL + NIL+ ++  AK++DFGLS+            V+ T+G 
Sbjct: 135 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMGR 184

Query: 579 LDPEYYISQQL-----TDKSDVYSFGVILLELIS 607
           L   +   + L     T  SDV+S+GV+L E++S
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 61/225 (27%), Positives = 110/225 (48%), Gaps = 31/225 (13%)

Query: 411 MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTSNSYQGK-REFTNEVTLLSRIHH 463
           +L K +G G FG V        K       +AVK+L  N+   + R+  +E  LL +++H
Sbjct: 3   VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH 62

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------------YGTLTH--EQ 503
            ++++  G C ++G  +L+ E+   G+L+  L                     L +  E+
Sbjct: 63  PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122

Query: 504 RINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 563
            +     +  A   ++G++YL       ++HRDL + N+L+ +  + K+SDFGLS+   +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179

Query: 564 GASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             S+V  S  R  V ++  E       T +SDV+SFGV+L E+++
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 9/197 (4%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L+ K+G G FG V+ G      ++A+K L   +      F  E  ++ ++ H  LV    
Sbjct: 10  LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
              EE    +V EFM  G+L + L  G   +   +   + +++A   A G+ Y+      
Sbjct: 69  VVSEE-PIYIVTEFMGKGSLLDFLKEGDGKY---LKLPQLVDMAAQIADGMAYIER---M 121

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
             IHRDL+++NIL+  ++  K++DFGL++   D         +  + +  PE  +  + T
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 591 DKSDVYSFGVILLELIS 607
            KSDV+SFG++L EL++
Sbjct: 182 IKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 87.2 bits (216), Expect = 2e-18
 Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 21/204 (10%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 471
            +IGSG  G VY    +  G+  A+KV+  N     +R+   E+ +L  ++H N+V+   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
                G   ++ EFM  G+L+      +  EQ +      ++A     GI YLH      
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGT---HIADEQFLA-----DVARQILSGIAYLHR---RH 188

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
           I+HRD+K SN+L++     K++DFG+S+         +S V GT+ Y+ PE  I+  L  
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE-RINTDLNH 246

Query: 592 ------KSDVYSFGVILLELISGQ 609
                   D++S GV +LE   G+
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 85.6 bits (212), Expect = 3e-18
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 12/204 (5%)

Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
            KIG G  G+V        G+++AVK +     Q +    NEV ++    H N+V+    
Sbjct: 25  VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
                   +V EF+  G L + +  T  +E++I       +     K + +LH      +
Sbjct: 85  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLAVLKALSFLHA---QGV 136

Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD- 591
           IHRD+KS +ILL    R K+SDFG             S+V GT  ++ PE  IS+     
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPE-VISRLPYGT 194

Query: 592 KSDVYSFGVILLELISGQEAISNE 615
           + D++S G++++E++ G+    NE
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 84.9 bits (210), Expect = 3e-18
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 27/219 (12%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT----SNSYQGK--REFTNEVTLLSRIHHRNL 466
           +++G+G F   Y  + +K G  +AVK +T    ++S Q +       E+ L++R++H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
           ++ LG   E+    L  E+M  G++   L  YG       IN+ ++L       +G+ YL
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYL 119

Query: 525 HTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLS-KFAVD--GASHVSSIVRGTVGYLD 580
           H      IIHRD+K +N+L+D    R +++DFG + + A    GA      + GT+ ++ 
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176

Query: 581 PEYYISQQLTDKSDVYSFGVILLELISGQ-----EAISN 614
           PE    +Q     DV+S G +++E+ + +     E  SN
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 61/200 (30%), Positives = 90/200 (45%), Gaps = 15/200 (7%)

Query: 416 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 471
           +G GGFG V   ++K  GK  A K L     + ++      NE  +L ++  R +V  L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVS-LA 59

Query: 472 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTGCV 529
           Y  E    + LV   M+ G LK H+Y      +      R    A     G+E+LH    
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIY---NVGEPGFPEARAIFYAAQIICGLEHLHQ--- 113

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             I++RDLK  N+LLD H   ++SD GL+     G         GT GY+ PE    +  
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVY 171

Query: 590 TDKSDVYSFGVILLELISGQ 609
               D ++ G  L E+I+G+
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 85.5 bits (211), Expect = 3e-18
 Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 17/208 (8%)

Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           +G GGFG V   +++  GK  A K L        +G+    NE  +L +++ R +V  L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVS-LA 66

Query: 472 YCQEEGRSV-LVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
           Y  E   ++ LV   M+ G LK H+Y  G    E+     + +  A +   G+E LH   
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG----RAVFYAAEICCGLEDLHQ-- 120

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              I++RDLK  NILLD H   ++SD GL+    +G +    +  GTVGY+ PE   +++
Sbjct: 121 -ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNER 177

Query: 589 LTDKSDVYSFGVILLELISGQEAISNEK 616
            T   D ++ G +L E+I+GQ      K
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 85.4 bits (211), Expect = 4e-18
 Identities = 64/224 (28%), Positives = 112/224 (50%), Gaps = 34/224 (15%)

Query: 411 MLEKKIGSGGFGVVY----YGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRI 461
           +L K +G G FG V     YG  K   +    +AVK+L  N + +   +  +E+ L+  I
Sbjct: 15  VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLI 74

Query: 462 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------------GTLTHEQRINWI 508
             H+N++  LG C +EG   ++ E+   G L+E L              T   E+++++ 
Sbjct: 75  GKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134

Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
             +  A   A+G+EYL +      IHRDL + N+L+ +    K++DFGL++    G   +
Sbjct: 135 DLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDI 187

Query: 569 -----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
                +S  R  V ++ PE    +  T +SDV+SFG+++ E+ +
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 84.3 bits (208), Expect = 6e-18
 Identities = 74/291 (25%), Positives = 132/291 (45%), Gaps = 45/291 (15%)

Query: 414 KKIGSGGFGVVY----YGKLKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNL 466
           +++G G FG+VY     G +KD  E  V + T N     RE   F NE +++   +  ++
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI------KRLEIAEDAAKG 520
           V+ LG   +   ++++ E M  G LK +L       +           K +++A + A G
Sbjct: 72  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TVGY 578
           + YL+       +HRDL + N ++ +    K+ DFG+++  +    +     +G   V +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRW 187

Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLHIES 634
           + PE       T  SDV+SFGV+L E+ +  E     +SNE+                  
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV----------------- 230

Query: 635 GDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 684
             ++ +++  LLD+ D    M  + E   MC   +  MRPS  E++  I++
Sbjct: 231 --LRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 83.6 bits (207), Expect = 9e-18
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 32/277 (11%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIA---VKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 467
           +EKKIG G F VVY    L DG+ +A   V++      + +++   E+ LL ++ H N++
Sbjct: 6   IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVI 65

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIE 522
           ++L    E     +V E    G L   +        L  E+ I W   +++       +E
Sbjct: 66  KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQLCS----ALE 120

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           ++H+     I+HRD+K +N+ +      K+ D GL +F     +   S+V GT  Y+ PE
Sbjct: 121 HMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176

Query: 583 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
                    KSD++S G +L E+ + Q     +K   N  ++ +     IE  D      
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCK----KIEKCDYP---- 226

Query: 643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 679
           P   D Y  +    + +    C+ P    RP IS VL
Sbjct: 227 PLPADHYSEE----LRDLVSRCINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 84.3 bits (208), Expect = 9e-18
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 10/202 (4%)

Query: 415 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           KIG G  G+V     K  GK++AVK +     Q +    NEV ++   HH N+V      
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
                  +V EF+  G L + +  T  +E++I       +     + + YLH      +I
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHN---QGVI 140

Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRD+KS +ILL    R K+SDFG             S+V GT  ++ PE         + 
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199

Query: 594 DVYSFGVILLELISGQEAISNE 615
           D++S G++++E+I G+    NE
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNE 221

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 84.5 bits (209), Expect = 9e-18
 Identities = 65/229 (28%), Positives = 102/229 (44%), Gaps = 53/229 (23%)

Query: 402 LSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKR------EFT 452
           L   +D  K+    ++IG G FG VY+ +     E+ A+K +   SY GK+      +  
Sbjct: 7   LFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKM---SYSGKQSNEKWQDII 63

Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF----------MHNGTLKEHLYGTLTHE 502
            EV  L ++ H N +++ G    E  + LV E+          +H   L+E         
Sbjct: 64  KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQE--------- 114

Query: 503 QRINWIKRLEIA---EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 559
                   +EIA     A +G+ YLH+      IHRD+K+ NILL +    K++DFG + 
Sbjct: 115 --------VEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSAS 163

Query: 560 FAVDGASHVSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLEL 605
                 S V     GT  ++ PE  ++    Q   K DV+S G+  +EL
Sbjct: 164 LVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 57/201 (28%), Positives = 105/201 (52%), Gaps = 16/201 (7%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           + +K+G G +G VY    K+ G+ +A+KV+        +E   E+++L +     +V++ 
Sbjct: 7   ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYY 64

Query: 471 GYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           G   +     +V E+   G+   + +    TLT E+ I  I          KG+EYLH+ 
Sbjct: 65  GSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLT-EEEIAAILY-----QTLKGLEYLHSN 118

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
                IHRD+K+ NILL++  +AK++DFG+S    D  +  ++++ GT  ++ PE     
Sbjct: 119 ---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEI 174

Query: 588 QLTDKSDVYSFGVILLELISG 608
              +K+D++S G+  +E+  G
Sbjct: 175 GYNNKADIWSLGITAIEMAEG 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 86.8 bits (215), Expect = 1e-17
 Identities = 102/381 (26%), Positives = 162/381 (42%), Gaps = 57/381 (14%)

Query: 22  DRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNG--SLTYR 79
           DR W       +    D A  TE V  K      +    P+ + Q+A+V T+    L+Y 
Sbjct: 217 DRFWNRMQTFGSG--SDQAISTENVIKKA---SNAPNFYPESLYQSALVSTDTQPDLSYT 271

Query: 80  LNLDGFPGFGWAV-TYFAEIED-LDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVY 137
           +++D  P   ++V  +FAEI++ +  +  R F +++ G  D +   V+I + +  +Y   
Sbjct: 272 MDVD--PNRNYSVWLHFAEIDNSITAEGKRVFDVLING--DTAFKDVDIVKMSGERY--- 324

Query: 138 EPGYTNLSLP---FVLSFKFGKTYDSSRGP--LLNAMEINKYLERNDGSIDGVA-----I 187
               T L L     V            +G   ++NA+E+ + +     ++         +
Sbjct: 325 ----TALVLNKTVAVSGRTLTIVLQPKKGTHAIINAIEVFEIITAESKTLLEEVSALQTL 380

Query: 188 VSVISLYSSADWAQEGGDPCLPV--PWSWLQCNSDPQPS---ITVIHLSSKNLTGNIPSD 242
            S + L     W    GDPC+P   PWS   C  D       I  + L ++ L G IP+D
Sbjct: 381 KSSLGLPLRFGW---NGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPND 437

Query: 243 LTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 301
           ++KL  L  + L GNS+ G IP        L ++ L  N   G +P SL  L +LR L +
Sbjct: 438 ISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497

Query: 302 QNNMLSGTVPSSL---LSKNVVLNYAGNINL------HEGGR----GAKHLNIIIGSSVG 348
             N LSG VP++L   L      N+  N  L         G     GAK     IG + G
Sbjct: 498 NGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVGAK-----IGIAFG 552

Query: 349 AAVLLLATVVSCLFMHKGKKN 369
            +V  L  V+  +   K ++N
Sbjct: 553 VSVAFLFLVICAMCWWKRRQN 573

Length = 623

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 83.2 bits (205), Expect = 2e-17
 Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 12/218 (5%)

Query: 401 TLSDIEDATKMLEK--KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTL 457
           T+  I D  K   +  KIG G  G V+    +  G+E+A+K +       K    NE+ +
Sbjct: 10  TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69

Query: 458 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 517
           +  + + N+V FL          +V E++  G+L + +  T   E +I  + R     + 
Sbjct: 70  MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR-----EC 124

Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
            + +E+LH      +IHRD+KS N+LL      K++DFG         S  S++V GT  
Sbjct: 125 LQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY 180

Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
           ++ PE    +    K D++S G++ +E++ G+    NE
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 59/205 (28%), Positives = 92/205 (44%), Gaps = 23/205 (11%)

Query: 415 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLG 471
            +G G +GVV   + K   EI A+K    S   +  ++    EV +L ++ H N+V    
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHL----YGTLTHE-QRINWIKRLEIAEDAAKGIEYLHT 526
             + +GR  LV+E++   TL E L     G      +   W           + I Y H+
Sbjct: 68  AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIW--------QLLQAIAYCHS 118

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI 585
                IIHRD+K  NIL+ +    K+ DFG ++      AS ++  V  T  Y  PE  +
Sbjct: 119 H---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLV 174

Query: 586 SQQLTDKS-DVYSFGVILLELISGQ 609
                 K  DV++ G I+ EL+ G+
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 64/215 (29%), Positives = 102/215 (47%), Gaps = 25/215 (11%)

Query: 407 DATKMLEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGK-REFTNEVTLLSRIHHR 464
           D  +++E  IG G   VVY        E +A+K +     Q    E   EV  +S+ +H 
Sbjct: 1   DDYELIEV-IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHP 59

Query: 465 NLVQFLGYCQ-EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA---EDAAK 519
           N+V++  Y     G  + LV  ++  G+L       +        +    IA   ++  K
Sbjct: 60  NVVKY--YTSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATVLKEVLK 113

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR----GT 575
           G+EYLH+      IHRD+K+ NILL +    K++DFG+S    DG    +  VR    GT
Sbjct: 114 GLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD-RTRKVRKTFVGT 169

Query: 576 VGYLDPEYYISQQ--LTDKSDVYSFGVILLELISG 608
             ++ PE  + Q      K+D++SFG+  +EL +G
Sbjct: 170 PCWMAPE-VMEQVHGYDFKADIWSFGITAIELATG 203

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 31/212 (14%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           L ++IGSG +G VY  + +  G+ +A+KV+             E+++L    H N+V + 
Sbjct: 7   LIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYF 66

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLY----GTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           G      +  +V E+   G+L++ +Y    G L+ E +I ++ R     +  KG+ YLH 
Sbjct: 67  GSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLS-ELQIAYVCR-----ETLKGLAYLHE 119

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-----GTVGYLDP 581
                 IHRD+K +NILL +    K++DFG+S      A   ++I +     GT  ++ P
Sbjct: 120 TGK---IHRDIKGANILLTEDGDVKLADFGVS------AQLTATIAKRKSFIGTPYWMAP 170

Query: 582 EYYISQQLTD----KSDVYSFGVILLELISGQ 609
           E   + +       K D+++ G+  +EL   Q
Sbjct: 171 E-VAAVERKGGYDGKCDIWALGITAIELAELQ 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 82.6 bits (204), Expect = 3e-17
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 12/218 (5%)

Query: 401 TLSDIEDATKMLEK--KIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTL 457
           T+  + D  K   +  KIG G  G VY    +  G+E+A+K +       K    NE+ +
Sbjct: 10  TIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILV 69

Query: 458 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 517
           +    H N+V +L          +V E++  G+L + +  T   E +I  + R     + 
Sbjct: 70  MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----EC 124

Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
            + +E+LH+  V   IHRD+KS NILL      K++DFG         S  S++V GT  
Sbjct: 125 LQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY 180

Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
           ++ PE    +    K D++S G++ +E++ G+    NE
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 30/278 (10%)

Query: 411 MLEKKIGSGGFGVVYYGK-LKDGKEIAVK---VLTSNSYQGKREFTNEVTLLSRIHHRNL 466
            +EKKIG G F  VY    L D K +A+K   +      + +++   E+ LL +++H N+
Sbjct: 5   QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNV 64

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE----QRINWIKRLEIAEDAAKGIE 522
           +++L    E+    +V E    G L + +      +    +R  W   +++       +E
Sbjct: 65  IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS----AVE 120

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           ++H+     ++HRD+K +N+ +      K+ D GL +F     +   S+V GT  Y+ PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176

Query: 583 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
                    KSD++S G +L E+ + Q     +K   N  ++ Q     IE  D      
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSLCQ----KIEQCDY----- 225

Query: 643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 680
           P L  E+  +   K+ E   MC+ P    RP I  V +
Sbjct: 226 PPLPTEHYSE---KLRELVSMCIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 82.6 bits (205), Expect = 3e-17
 Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 33/208 (15%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSY--QGKREFT-NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   + K   +  A+K+L+        + E   NE  +L  I H  LV  
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 521
            G  Q++    LV E++  G L  HL              R    E  A+         +
Sbjct: 67  YGSFQDDSNLYLVMEYVPGGELFSHL----------RKSGRFP--EPVARFYAAQVVLAL 114

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           EYLH+     I++RDLK  N+LLD     K++DFG +K        +     GT  YL P
Sbjct: 115 EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAP 167

Query: 582 EYYISQQLTDKS-DVYSFGVILLELISG 608
           E  I  +   K+ D ++ G+++ E+++G
Sbjct: 168 E-IILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 25/210 (11%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSN--SYQGKREFTN---EVTLLSRIHHRN 465
           L K +G G FG VY     D G+E+AVK +  +  S +  +E      E+ LL  + H  
Sbjct: 6   LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER 65

Query: 466 LVQFLGYCQEEGRSVL--VYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGI 521
           +VQ+ G  ++     L    E M  G++K+ L  YG LT      + +++       +G+
Sbjct: 66  IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------LEGV 119

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVG 577
            YLH+     I+HRD+K +NIL D     K+ DFG SK      + G    S  V GT  
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPY 174

Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           ++ PE    +    K+D++S G  ++E+++
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 14/210 (6%)

Query: 404 DIEDATKMLEK--KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR 460
           D  D   +LE   KIG G  G+V   + K  G+++AVK++     Q +    NEV ++  
Sbjct: 15  DQGDPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD 74

Query: 461 IHHRNLVQ-FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 519
             H+N+V+ +  Y   E   VL+ EF+  G L +     +  + R+N  +   + E   +
Sbjct: 75  YQHQNVVEMYKSYLVGEELWVLM-EFLQGGALTD-----IVSQTRLNEEQIATVCESVLQ 128

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 579
            + YLH+     +IHRD+KS +ILL    R K+SDFG             S+V GT  ++
Sbjct: 129 ALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWM 184

Query: 580 DPEYYISQQLTDKSDVYSFGVILLELISGQ 609
            PE         + D++S G++++E++ G+
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 82.0 bits (202), Expect = 4e-17
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 25/208 (12%)

Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKVLT--SNSYQGKREFTN---EVTLLSRIHHRNLV 467
           K +G G FG VY    +  G+E+A K +     S +  +E +    E+ LL  + H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 468 QFLGYCQEEGRSVLV--YEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           Q+ G  ++     L    E+M  G++K+ L  YG LT      + +++       +G+ Y
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSY 121

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVGYL 579
           LH+     I+HRD+K +NIL D     K+ DFG SK      + G    S  V GT  ++
Sbjct: 122 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--VTGTPYWM 176

Query: 580 DPEYYISQQLTDKSDVYSFGVILLELIS 607
            PE    +    K+DV+S G  ++E+++
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 81.5 bits (201), Expect = 4e-17
 Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 16/205 (7%)

Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
            ++GSG FG V    Y   K  K +AVK+L   +N    K E   E  ++ ++ +  +V+
Sbjct: 1   GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
            +G C+ E   +LV E    G L + L       + +      E+    + G++YL    
Sbjct: 61  MIGICEAESW-MLVMELAELGPLNKFL----QKNKHVTEKNITELVHQVSMGMKYLEET- 114

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYIS 586
               +HRDL + N+LL     AK+SDFGLSK      ++  +   G   V +  PE    
Sbjct: 115 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172

Query: 587 QQLTDKSDVYSFGVILLELIS-GQE 610
            + + KSDV+SFGV++ E  S GQ+
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 17/202 (8%)

Query: 419 GGFGVVYYGKLKDGK-----EIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQFLGY 472
           G FG ++YG L D K     E+ VK +  ++ + +      E  LL  + H+N++  L  
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 473 CQEEGRSVLV-YEFMHNGTLKEHL----YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           C E+G    V Y +M+ G LK  L     G   + Q ++  + + +A   A G+ YLH  
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK- 135

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVRGTVGYLDPEYYI 585
               +IH+D+ + N ++D+ ++ K++D  LS+  F +D      +  R  V ++  E  +
Sbjct: 136 --RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR-PVKWMALESLV 192

Query: 586 SQQLTDKSDVYSFGVILLELIS 607
           +++ +  SDV+SFGV+L EL++
Sbjct: 193 NKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 81.8 bits (202), Expect = 6e-17
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 22/207 (10%)

Query: 414 KKIGSGGFGVVY----YGKLKDGK--EIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 465
           K +G+G FG V     YG  K     ++AVK+L   ++  +RE   +E+ ++S + +H N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +V  LG C   G  +++ E+   G L   L      E  +     L  +   AKG+ +L 
Sbjct: 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLA 158

Query: 526 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT----VGYLD 580
           +  C    IHRDL + N+LL      K+ DFGL++   D  +  + +V+G     V ++ 
Sbjct: 159 SKNC----IHRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYVVKGNARLPVKWMA 211

Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
           PE   +   T +SDV+S+G++L E+ S
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 81.0 bits (200), Expect = 8e-17
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 13/199 (6%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  +    G+ +A+K   L + +         E++LL  ++H N+V+ L
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+  V 
Sbjct: 66  DVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCHSHRV- 121

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
             +HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 122 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 177

Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 178 YSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 81.7 bits (201), Expect = 1e-16
 Identities = 66/220 (30%), Positives = 107/220 (48%), Gaps = 25/220 (11%)

Query: 406 EDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKR------EFTNEVTL 457
           ED  K+    ++IG G FG VY+ +  D +   V  +   SY GK+      +   EV  
Sbjct: 21  EDPEKLFTDLREIGHGSFGAVYFAR--DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78

Query: 458 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 517
           L RI H N +++ G    E  + LV E+   G+  + L     H++ +  ++   I   A
Sbjct: 79  LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGA 134

Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
            +G+ YLH+     +IHRD+K+ NILL +  + K++DFG +  A    S V     GT  
Sbjct: 135 LQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPY 186

Query: 578 YLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISN 614
           ++ PE  ++    Q   K DV+S G+  +EL   +  + N
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 10/202 (4%)

Query: 415 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           KIG G  G+V    +K  GK +AVK +     Q +    NEV ++    H N+V+     
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
                  +V EF+  G L + +  T  +E++I       +     K +  LH      +I
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGVI 138

Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRD+KS +ILL    R K+SDFG             S+V GT  ++ PE         + 
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197

Query: 594 DVYSFGVILLELISGQEAISNE 615
           D++S G++++E++ G+    NE
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 25/210 (11%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTN---EVTLLSRIHHRN 465
           L K +G G FG VY     D G+E+AVK +    +S +  +E      E+ LL  + H  
Sbjct: 6   LGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR 65

Query: 466 LVQFLGYCQ--EEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGI 521
           +VQ+ G  +  EE +  +  E+M  G++K+ L  YG LT      + +++       +G+
Sbjct: 66  IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI------LQGV 119

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDGASHVSSIVRGTVG 577
            YLH+     I+HRD+K +NIL D     K+ DFG SK      + G    S  V GT  
Sbjct: 120 SYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--VTGTPY 174

Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           ++ PE    +    K+DV+S    ++E+++
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 80.7 bits (200), Expect = 1e-16
 Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 23/205 (11%)

Query: 413 EKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN-----EVTLLSRIHHRNL 466
            KK+G G + VVY  +  + G+ +A+K +     +  ++  N     E+ LL  + H N+
Sbjct: 5   GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG----TLTHEQRINWIKRLEIAEDAAKGIE 522
           +  L     +    LV+EFM   T  E +       LT     +++          +G+E
Sbjct: 65  IGLLDVFGHKSNINLVFEFME--TDLEKVIKDKSIVLTPADIKSYMLMT------LRGLE 116

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YLH      I+HRDLK +N+L+      K++DFGL++        ++  V  T  Y  PE
Sbjct: 117 YLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPE 172

Query: 583 -YYISQQLTDKSDVYSFGVILLELI 606
             + ++      D++S G I  EL+
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 81.3 bits (201), Expect = 1e-16
 Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 27/225 (12%)

Query: 415 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGK---REFTNEVTLLSRIHHRNLVQFL 470
           ++G GG+G V+  K KD  EI A+K +  +        R    E  +L+      LV+ L
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
              Q++    L  E++  G  +  L   G L+ +       R  +AE     ++ LH   
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH-----ARFYMAEMFE-AVDALHE-- 119

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
               IHRDLK  N L+D     K++DFGLSK  V   ++ +S+V G+  Y+ PE    + 
Sbjct: 120 -LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANSVV-GSPDYMAPEVLRGKG 174

Query: 589 LTDKSDVYSFGVILLELISGQEAIS----NEKFGANCRNIVQWAK 629
                D +S G +L E + G    S    NE +     N+  W +
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW----ENLKYWKE 215

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 19/209 (9%)

Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 471
           +G GGFG V   +++  GK  A K L     + ++      NE  +L +++ R +V  L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 66

Query: 472 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 527
           Y  E   ++ LV   M+ G LK H+Y        E+R  +      A +   G+E LH  
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY-----AAEITCGLEDLHR- 120

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               I++RDLK  NILLD +   ++SD GL+    +G +    +  GTVGY+ PE   ++
Sbjct: 121 --ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKNE 176

Query: 588 QLTDKSDVYSFGVILLELISGQEAISNEK 616
           + T   D +  G ++ E+I G+      K
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)

Query: 415 KIGSGGFGVVYYGKLKDGK---EIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFL 470
           ++GSG FG V  G  K  K   ++A+KVL + + +  R E   E  ++ ++ +  +V+ +
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
           G C+ E   +LV E    G L + L G    +  I     +E+    + G++YL      
Sbjct: 62  GVCEAEAL-MLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEG---K 114

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             +HRDL + N+LL     AK+SDFGLSK   A D      S  +  + +  PE    ++
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 589 LTDKSDVYSFGVILLELIS-GQE 610
            + +SDV+S+G+ + E  S GQ+
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQK 197

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 20/205 (9%)

Query: 412 LEKKIGSGGFGVVY---YGKLKDGK-EIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 466
           L + IG G FG VY   Y   ++ K  +AVK   + +    RE F  E  ++ +  H ++
Sbjct: 10  LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI---AEDAAKGIEY 523
           V+ +G    E    +V E    G L+ +L      +     +    +   +   +  + Y
Sbjct: 70  VKLIGVI-TENPVWIVMELAPLGELRSYL------QVNKYSLDLASLILYSYQLSTALAY 122

Query: 524 LH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           L     V    HRD+ + N+L+      K+ DFGLS++  D + + +S  +  + ++ PE
Sbjct: 123 LESKRFV----HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178

Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
               ++ T  SDV+ FGV + E++ 
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 80.2 bits (197), Expect = 2e-16
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 10/203 (4%)

Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +KIG G  G VY    +  G+E+A++ +       K    NE+ ++    + N+V +L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
                   +V E++  G+L + +  T   E +I  + R     +  + +E+LH+     +
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN---QV 137

Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           IHRD+KS NILL      K++DFG         S  S++V GT  ++ PE    +    K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196

Query: 593 SDVYSFGVILLELISGQEAISNE 615
            D++S G++ +E+I G+    NE
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNE 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 80.2 bits (197), Expect = 2e-16
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 10/203 (4%)

Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +KIG G  G VY    +  G+E+A+K +       K    NE+ ++    + N+V +L  
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
                   +V E++  G+L + +  T   E +I  + R     +  + +++LH+     +
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALDFLHSN---QV 136

Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           IHRD+KS NILL      K++DFG         S  S++V GT  ++ PE    +    K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195

Query: 593 SDVYSFGVILLELISGQEAISNE 615
            D++S G++ +E++ G+    NE
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 80.1 bits (197), Expect = 3e-16
 Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 28/220 (12%)

Query: 412 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 461
           L K +G G FG V           K K+   +AVK+L  ++ +    +  +E+ ++  I 
Sbjct: 19  LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 78

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L                  ++++ +  
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +      A+G+EYL +      IHRDL + N+L+ ++   K++DFGL++  V+   +  
Sbjct: 139 LVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR-DVNNIDYYK 194

Query: 570 SIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               G   V ++ PE    +  T +SDV+SFGV++ E+ +
Sbjct: 195 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 22/213 (10%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 469
           L + IG G +G VY  +  K G+ +A+K++       + E   E  +L +  +H N+  F
Sbjct: 10  LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATF 68

Query: 470 LG-YCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGI 521
            G + ++          LV E    G++ + + G     +R+   WI    I  +  +G+
Sbjct: 69  YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILRETLRGL 126

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
            YLH   V   IHRD+K  NILL K+   K+ DFG+S   +D      +   GT  ++ P
Sbjct: 127 AYLHENKV---IHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLGRRNTFIGTPYWMAP 182

Query: 582 EYYISQQLTD-----KSDVYSFGVILLELISGQ 609
           E     +  D     +SDV+S G+  +EL  G+
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 79.7 bits (196), Expect = 3e-16
 Identities = 62/224 (27%), Positives = 113/224 (50%), Gaps = 34/224 (15%)

Query: 411 MLEKKIGSGGFGVVYYG------KLKDGK--EIAVKVLTSNSYQGK-REFTNEVTLLSRI 461
           +L K +G G FG V         K K  +  ++AVK+L S++ +    +  +E+ ++  I
Sbjct: 21  VLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 80

Query: 462 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWI 508
             H+N++  LG C ++G   ++ E+   G L+E+L              T   E+++++ 
Sbjct: 81  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
             +  A   A+G+EYL +      IHRDL + N+L+ +    K++DFGL++       H+
Sbjct: 141 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 193

Query: 569 SSIVRGTVG-----YLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               + T G     ++ PE    +  T +SDV+SFGV+L E+ +
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 15/201 (7%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 468
           K IG G FG V   K K DGK  AVKVL   +   K+E          LL  + H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                Q   +   V ++++ G L  HL      E+     +    A + A  + YLH+  
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLHS-- 114

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              II+RDLK  NILLD      ++DFGL K  ++ +   S+   GT  YL PE  + +Q
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPE-VLRKQ 171

Query: 589 LTDKS-DVYSFGVILLELISG 608
             D++ D +  G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 79.2 bits (195), Expect = 4e-16
 Identities = 66/209 (31%), Positives = 100/209 (47%), Gaps = 19/209 (9%)

Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           +G GGFG V   +++  GK  A K L        +G+    NE  +L +++ + +V  L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN-LA 66

Query: 472 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 527
           Y  E   ++ LV   M+ G LK H+Y        E+R      L  A +   G+E LH  
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA-----LFYAAEILCGLEDLHR- 120

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
                ++RDLK  NILLD +   ++SD GL+    +G S    +  GTVGY+ PE   +Q
Sbjct: 121 --ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNNQ 176

Query: 588 QLTDKSDVYSFGVILLELISGQEAISNEK 616
           + T   D +  G ++ E+I GQ      K
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 79.4 bits (196), Expect = 4e-16
 Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 40/225 (17%)

Query: 412 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 463
           L K +G G FG V   +            +AVK+L  ++ +    +  +E+ ++  I  H
Sbjct: 16  LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 75

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRL 511
           +N++  LG C +EG   +V E+  +G L++ L                  E+ +     +
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 512 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS---------KFAV 562
             A   A+G+E+L +      IHRDL + N+L+ +    K++DFGL+         +   
Sbjct: 136 SFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192

Query: 563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +G        R  V ++ PE    +  T +SDV+SFGV+L E+ +
Sbjct: 193 NG--------RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 54/207 (26%), Positives = 105/207 (50%), Gaps = 17/207 (8%)

Query: 416 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHH---RNLVQFL 470
           IG G +G VY GK +  G+ +A+K++  ++      +   EV LLS++      N+ ++ 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 471 GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G    +G  + ++ E+   G+++  +      E+ I+ I R     +    ++Y+H    
Sbjct: 69  G-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIHKV-- 120

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K++NIL+      K+ DFG++      +S  S+ V GT  ++ PE     + 
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178

Query: 590 TD-KSDVYSFGVILLELISGQEAISNE 615
            D K+D++S G+ + E+ +G    S+ 
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDV 205

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.4 bits (194), Expect = 6e-16
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN-EVTLLSRIHHRNLVQF 469
           L + IG G FG VY    K   + +A+KV+     + + E    E+  LS+     + ++
Sbjct: 5   LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
            G   +  +  ++ E+   G+  + L  G L  E  I +I R     +   G+EYLH   
Sbjct: 65  YGSFLKGSKLWIIMEYCGGGSCLDLLKPGKL-DETYIAFILR-----EVLLGLEYLHEEG 118

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
               IHRD+K++NILL +    K++DFG+S       S  ++ V GT  ++ PE  I Q 
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPE-VIKQS 173

Query: 589 LTD-KSDVYSFGVILLELISG 608
             D K+D++S G+  +EL  G
Sbjct: 174 GYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 78.0 bits (192), Expect = 7e-16
 Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 19/214 (8%)

Query: 412 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTS--NSYQGKREFTNEVTLLSRIHHRN 465
           L + +G G FG V   +LK      +++AVK+L +   S     EF  E   +    H N
Sbjct: 3   LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPN 62

Query: 466 LVQFLG---YCQEEGR---SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR--LEIAEDA 517
           +++ +G     + +GR    +++  FM +G L   L  +   E+      +  +    D 
Sbjct: 63  VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122

Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTV 576
           A G+EYL +      IHRDL + N +L+++M   V+DFGLSK    G  +      +  V
Sbjct: 123 ASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPV 179

Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 609
            +L  E       T  SDV++FGV + E+++ GQ
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 78.2 bits (192), Expect = 8e-16
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 18/213 (8%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEI---AVKVLTSN--SYQGKREFTNEVTLLSRIHHRNL 466
           L K +G G FG V  G+L     I   AVK +     +     +F +E   +    H N+
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 467 VQFLGYC----QEEG--RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL--EIAEDAA 518
           ++ +G C    + EG    V++  FM +G L   L  +   +       ++  +   D A
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-IVRGTVG 577
            G+EYL +    + IHRDL + N +L+++M   V+DFGLSK   +G  +    I +  V 
Sbjct: 123 SGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELIS-GQ 609
           ++  E    +  T KSDV+SFGV + E+ + GQ
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 78.5 bits (193), Expect = 8e-16
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 25/210 (11%)

Query: 415 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKR------EFTNEVTLLSRIHHRNLV 467
           +IG G FG VY+       E+ AVK +   SY GK+      +   EV  L ++ H N +
Sbjct: 28  EIGHGSFGAVYFATNSHTNEVVAVKKM---SYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           ++ G   +E  + LV E+   G+  + L     H++ +  ++   I   A +G+ YLH+ 
Sbjct: 85  EYKGCYLKEHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH 140

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               +IHRD+K+ NILL +  + K++DFG +  +    S V     GT  ++ PE  ++ 
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192

Query: 588 ---QLTDKSDVYSFGVILLELISGQEAISN 614
              Q   K DV+S G+  +EL   +  + N
Sbjct: 193 DEGQYDGKVDVWSLGITCIELAERKPPLFN 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 17/202 (8%)

Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFLG 471
           +IG G  G+V+  K  + G+ +A+K +     +G    +   E+  L    H  +V+ L 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYLHTGC 528
                   VLV E+M +      L   L  E+R      +K         KG+ Y+H   
Sbjct: 67  VFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSY--MRMLLKGVAYMHAN- 118

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE-YYISQ 587
              I+HRDLK +N+L+      K++DFGL++   +    + S    T  Y  PE  Y ++
Sbjct: 119 --GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176

Query: 588 QLTDKSDVYSFGVILLELISGQ 609
           +     D+++ G I  EL++G 
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 77.3 bits (190), Expect = 9e-16
 Identities = 53/201 (26%), Positives = 96/201 (47%), Gaps = 16/201 (7%)

Query: 411 MLEKKIGSGGFG--VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
            + + +G G FG  ++      D K    ++    S     +   E  LL+++ H N+V 
Sbjct: 3   NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYL 524
           F    + +G   +V E+   G L + +    G L  E  I  W  ++ +      G++++
Sbjct: 63  FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 584
           H      ++HRD+KS NI L ++ + K+ DFG ++      ++  + V GT  Y+ PE +
Sbjct: 117 HE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIW 172

Query: 585 ISQQLTDKSDVYSFGVILLEL 605
            +    +KSD++S G IL EL
Sbjct: 173 ENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 23/203 (11%)

Query: 416 IGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRI---HHRNLVQF 469
           IG G +G VY  + L  G+ +A+K V    S +G    T  E+ LL ++    H N+V+ 
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66

Query: 470 LGYCQ----EEGRSV-LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           L  C     +    + LV+E +     T            + I  + R ++     +G++
Sbjct: 67  LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR-QLL----RGVD 121

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     I+HRDLK  NIL+    + K++DFGL++      +  S +V  T+ Y  PE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176

Query: 583 YYISQQLTDKSDVYSFGVILLEL 605
             +        D++S G I  EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 68/275 (24%), Positives = 127/275 (46%), Gaps = 35/275 (12%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           + +G G +G V   + + DGK+  +K L   + S + ++    E  LLS++ H N+V + 
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 471 GYCQ-EEGRSVLVYEFMHNG----TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
              + E+G   +V  F   G     LKE     L   Q + W  ++ +A      ++YLH
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLH 119

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
                 I+HRDLK+ N+ L +    KV D G+++  ++    ++S + GT  Y+ PE + 
Sbjct: 120 E---KHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPELFS 175

Query: 586 SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 645
           ++    KSDV++ G  + E+ + + A + +   +    I++  KL            P +
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKL------------PPM 222

Query: 646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 680
             +Y  +    I    ++   P    RPS+  +L+
Sbjct: 223 PKDYSPELGELI--ATMLSKRP--EKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 77.9 bits (192), Expect = 1e-15
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 27/214 (12%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT-----NEVTLLSR------I 461
           K +G G FG V   +LK   E  A+K L       K++        E T++ R       
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKAL-------KKDVVLEDDDVECTMVERRVLALAW 53

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H  L       Q +     V E+++ G L  H+  +   ++        EI      G+
Sbjct: 54  EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEII----CGL 109

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           ++LH      II+RDLK  N+LLDK    K++DFG+ K  ++G    S+   GT  Y+ P
Sbjct: 110 QFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAP 165

Query: 582 EYYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
           E    Q+  +  D +SFGV+L E++ GQ     E
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 14/206 (6%)

Query: 407 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHH 463
           D TK+  +KIG G +GVVY G+  K G+ +A+K +   S +     T   E++LL  + H
Sbjct: 1   DYTKI--EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH 58

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
            N+V       +E R  L++EF+ +  LK++L  +L   Q ++            +GI +
Sbjct: 59  PNIVCLQDVLMQESRLYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILF 116

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE 582
            H+     ++HRDLK  N+L+D     K++DFGL++ F +    +   +V  T+ Y  PE
Sbjct: 117 CHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPE 171

Query: 583 YYI-SQQLTDKSDVYSFGVILLELIS 607
             + S + +   D++S G I  E+ +
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 77.4 bits (191), Expect = 2e-15
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 24/209 (11%)

Query: 413 EK--KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQG-KREFTNEVTLLSRIHHRNLV 467
           EK  +IG G +G+VY  +     EI    KV   N   G       E+TLL  + H N+V
Sbjct: 10  EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69

Query: 468 QFLGYCQEEGRSV----LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
           +        G+ +    LV E+      +L +++    +  Q    +K L +     +G+
Sbjct: 70  ELKEVVV--GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQ----VKCLML--QLLRGL 121

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           +YLH      IIHRDLK SN+LL      K++DFGL++     A  ++  V  T+ Y  P
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAP 177

Query: 582 EYYI-SQQLTDKSDVYSFGVILLELISGQ 609
           E  +     T   D+++ G IL EL++ +
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 471
             +G+G  G V   K +  G  +A KV+   +    +++   E+ ++       +V F G
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               E    +  EFM  G+L       G +  E         +IA    +G+ YL+   V
Sbjct: 71  AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVE------ILGKIAVAVVEGLTYLYN--V 122

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             I+HRD+K SNIL++   + K+ DFG+S   ++    ++    GT  Y+ PE     + 
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IADTFVGTSTYMSPERIQGGKY 179

Query: 590 TDKSDVYSFGVILLELISGQ 609
           T KSDV+S G+ ++EL  G+
Sbjct: 180 TVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 30/237 (12%)

Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 471
           +G GGFG V   +++  GK  A K L     + ++ +     E  +L+++H R +V    
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
             Q +    LV   M+ G L+ H+Y            +          G+E+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
           II+RDLK  N+LLD     ++SD GL+    DG S       GT G++ PE    ++   
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYDF 176

Query: 592 KSDVYSFGVILLELISGQ-------EAISN---------------EKFGANCRNIVQ 626
             D ++ GV L E+I+ +       E + N               +KF    ++  +
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 77.0 bits (189), Expect = 3e-15
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 26/221 (11%)

Query: 395 EAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---- 449
           + A  F   D E     L ++IG G FG VY+ + +++ + +A+K +   SY GK+    
Sbjct: 3   DVAELFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEK 58

Query: 450 --EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
             +   EV  L ++ H N +Q+ G    E  + LV E+   G+  + L     H++ +  
Sbjct: 59  WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQE 114

Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 567
           ++   +   A +G+ YLH+     +IHRD+K+ NILL +    K+ DFG +         
Sbjct: 115 VEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF 171

Query: 568 VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLEL 605
           V     GT  ++ PE  ++    Q   K DV+S G+  +EL
Sbjct: 172 V-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 76.3 bits (187), Expect = 3e-15
 Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 12/208 (5%)

Query: 404 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 461
           D E+    LEK IG G FG V+ G   +  K +A+K++     + + E    E+T+LS+ 
Sbjct: 1   DPEELFTKLEK-IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
               + ++ G   ++ +  ++ E++  G+  + L      E +I  I R     +  KG+
Sbjct: 60  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGL 114

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           +YLH+      IHRD+K++N+LL +H   K++DFG++    D     ++ V GT  ++ P
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 170

Query: 582 EYYISQQLTDKSDVYSFGVILLELISGQ 609
           E         K+D++S G+  +EL  G+
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 64/204 (31%), Positives = 93/204 (45%), Gaps = 21/204 (10%)

Query: 416 IGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTN-EVTLLSRIHHR--NLVQF 469
           IGSG  G VY  +  K G  +AVK +  T N  + KR   + +V L S   H    +V+ 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIVKC 79

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY   +    +  E M   T  + L   +      + + ++ +A    K + YL     
Sbjct: 80  YGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA--IVKALHYLKEK-- 133

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K SNILLD     K+ DFG+S   VD  +   S   G   Y+ PE       
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS--AGCAAYMAPERIDPPDP 191

Query: 590 TDK----SDVYSFGVILLELISGQ 609
             K    +DV+S G+ L+EL +GQ
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 76.1 bits (187), Expect = 4e-15
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 22/205 (10%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG V+ G  + +G  I    A+K +   S  Q  +E T+ +  +  + H  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 468 QFLGYCQEEGRSV-LVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C   G S+ LV +    G+L +H+     +L  ++ +NW  ++      AKG+ Y
Sbjct: 73  RLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYY 124

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPE 582
           L       ++HR+L + NILL      +++DFG++     D   +  S  +  + ++  E
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181

Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
             +  + T +SDV+S+GV + E++S
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 76.5 bits (188), Expect = 4e-15
 Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 17/203 (8%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR------IHHRNL 466
           K +G G FG V+  +LK   +  A+K L  +      +   E T++ +        H  L
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFL 58

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
                  Q +     V E+++ G L  H+        + +  +    A +   G+++LH+
Sbjct: 59  THLYCTFQTKENLFFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHS 114

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                I++RDLK  NILLD     K++DFG+ K  + G +   +   GT  Y+ PE  + 
Sbjct: 115 ---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLG 170

Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
           Q+     D +SFGV+L E++ GQ
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 5e-15
 Identities = 69/234 (29%), Positives = 99/234 (42%), Gaps = 33/234 (14%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR-----NLV 467
           K I  G FG VY  K +  G   A+KVL  +    K + TN V     I         + 
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYVA 60

Query: 468 QFLGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +     Q +    LV E+++ G   +L + L G L  +    W K+  IAE    G+E L
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPED----WAKQY-IAE-VVLGVEDL 113

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 584
           H      IIHRD+K  N+L+D+    K++DFGLS+         +    GT  YL PE  
Sbjct: 114 HQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETI 165

Query: 585 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 638
           +       SD +S G ++ E + G        F A   + V +    I S  I 
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPP-----FHAETPDAV-FDN--ILSRRIN 211

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 76.1 bits (187), Expect = 7e-15
 Identities = 65/206 (31%), Positives = 100/206 (48%), Gaps = 23/206 (11%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV----- 467
           K +G G FG V   +LK  G+  AVK L  +      +   E T++ +   R L      
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDV--ECTMVEK---RVLALAWEN 55

Query: 468 QFLG--YC--QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
            FL   YC  Q +     V EF++ G L  H+      + R +  +    A +   G+++
Sbjct: 56  PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHI----QDKGRFDLYRATFYAAEIVCGLQF 111

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH+     II+RDLK  N++LD+    K++DFG+ K  V G +  S+   GT  Y+ PE 
Sbjct: 112 LHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEI 167

Query: 584 YISQQLTDKSDVYSFGVILLELISGQ 609
               + T   D +SFGV+L E++ GQ
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 75.5 bits (185), Expect = 9e-15
 Identities = 57/201 (28%), Positives = 104/201 (51%), Gaps = 14/201 (6%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+ +    A+K+L   +  +   EF +E  +++ + H +LV
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           + LG C       LV + M +G L ++++    H+  I     L      AKG+ YL   
Sbjct: 73  RLLGVCLSPTIQ-LVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLEE- 127

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYIS 586
               ++HRDL + N+L+      K++DFGL++    D   + +   +  + ++  E    
Sbjct: 128 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185

Query: 587 QQLTDKSDVYSFGVILLELIS 607
           ++ T +SDV+S+GV + EL++
Sbjct: 186 RKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.0 bits (184), Expect = 9e-15
 Identities = 65/209 (31%), Positives = 99/209 (47%), Gaps = 19/209 (9%)

Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           +G GGFG V   +++  GK  A K L        +G+    NE  +L +++ R +V  L 
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVS-LA 66

Query: 472 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTG 527
           Y  E   ++ LV   M+ G LK H+Y        EQR      +  A +   G+E L   
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRA-----IFYAAELCCGLEDLQR- 120

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               I++RDLK  NILLD     ++SD GL+    +G +    +  GTVGY+ PE   ++
Sbjct: 121 --ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNE 176

Query: 588 QLTDKSDVYSFGVILLELISGQEAISNEK 616
           + T   D +  G ++ E+I GQ      K
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 59/208 (28%), Positives = 109/208 (52%), Gaps = 22/208 (10%)

Query: 410 KMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLV 467
           K LEK +G G +  VY G+ +   EI A+K +  ++ +G       E++L+  + H N+V
Sbjct: 3   KQLEK-LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIE 522
           +       E + +LV+E+M +  LK+++      G L      ++  +L       KGI 
Sbjct: 62  RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL------LKGIA 114

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDP 581
           + H      ++HRDLK  N+L++K    K++DFGL++ F +   +  + +V  T+ Y  P
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAP 169

Query: 582 EYYI-SQQLTDKSDVYSFGVILLELISG 608
           +  + S+  +   D++S G I+ E+I+G
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 67/271 (24%), Positives = 118/271 (43%), Gaps = 22/271 (8%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVK---VLTSNSYQGKREFTNEVTLLSRIHHRNLV 467
           +EKKIG G F  VY    L DG  +A+K   +      + + +   E+ LL +++H N++
Sbjct: 6   IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           ++     E+    +V E    G L   +      ++ I      +        +E++H+ 
Sbjct: 66  KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS- 124

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               ++HRD+K +N+ +      K+ D GL +F     +   S+V GT  Y+ PE     
Sbjct: 125 --RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 181

Query: 588 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 647
               KSD++S G +L E+ + Q     +K      N+    K  IE  D      P L  
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCK-KIEQCDY-----PPLPS 230

Query: 648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEV 678
           ++  + + ++     MC+ P    RP I+ V
Sbjct: 231 DHYSEELRQLVN---MCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 56/204 (27%), Positives = 105/204 (51%), Gaps = 20/204 (9%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + DG+ +    A+KVL  N S +  +E  +E  +++ +    + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYL 524
           + LG C       LV + M  G L +++      +  +  +NW  ++      AKG+ YL
Sbjct: 73  RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA-VDGASHVSSIVRGTVGYLDPEY 583
                  ++HRDL + N+L+      K++DFGL++   +D   + +   +  + ++  E 
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182

Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
            + ++ T +SDV+S+GV + EL++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 1e-14
 Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 19/199 (9%)

Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 474
           +G G FG VY  + K+     A K++   S +   +F  E+ +LS   H N+V       
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 475 EEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
            E +  ++ EF   G L      L   LT E +I ++ R        + + +LH+     
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLT-EPQIRYVCR-----QMLEALNFLHSH---K 123

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
           +IHRDLK+ NILL      K++DFG+S           + + GT  ++ PE    +   D
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKD 182

Query: 592 -----KSDVYSFGVILLEL 605
                K+D++S G+ L+EL
Sbjct: 183 NPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 28/202 (13%)

Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           +G G  G VY    L   + +AVKV+  + + + +++  +E+ +L +     ++ F G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 474 QEEGRSVLVYEFMHNGTLK------EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
             E R  +  EFM  G+L       EH+ G               IA    KG+ YL + 
Sbjct: 69  FVENRISICTEFMDGGSLDVYRKIPEHVLG--------------RIAVAVVKGLTYLWS- 113

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               I+HRD+K SN+L++   + K+ DFG+S   V+    ++    GT  Y+ PE    +
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGE 168

Query: 588 QLTDKSDVYSFGVILLELISGQ 609
           Q    SDV+S G+  +EL  G+
Sbjct: 169 QYGIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 74/225 (32%), Positives = 109/225 (48%), Gaps = 28/225 (12%)

Query: 401 TLSDIEDATKMLEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 459
           +L D  D  +++E  IG G +G VY     KDG   AVK+L   S     E   E  +L 
Sbjct: 16  SLGDPTDTWEIIET-IGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQ 73

Query: 460 RI-HHRNLVQFLG--YCQEE---GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 513
            + +H N+V+F G  Y  ++   G+  LV E  + G++ E + G L   QR++      I
Sbjct: 74  SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133

Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 573
              A  G+++LH      IIHRD+K +NILL      K+ DFG+S      A   S+ +R
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS------AQLTSTRLR 184

Query: 574 -----GTVGYLDPEYYISQQLTDKS-----DVYSFGVILLELISG 608
                GT  ++ PE    +Q  D S     DV+S G+  +EL  G
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 57/231 (24%), Positives = 112/231 (48%), Gaps = 37/231 (16%)

Query: 411 MLEKKIGSGGFGVVYYGKLKDGKE-----------------IAVKVLTSNSYQGKR-EFT 452
           + ++K+G G FG V+  ++ + ++                 +AVK+L  ++ +  R +F 
Sbjct: 8   LFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFL 67

Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-------- 504
            EV +LSR+   N+++ LG C +E    ++ E+M NG L + L      ++         
Sbjct: 68  KEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127

Query: 505 -------INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 557
                  I++   L +A   A G++YL +      +HRDL + N L+ +++  K++DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGM 184

Query: 558 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           S+    G  + +       + ++  E  +  + T  SDV++FGV L E++ 
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 77.6 bits (191), Expect = 2e-14
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 26/200 (13%)

Query: 432 GKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFL--GYCQEEGRSVLVYEFM 486
           G E+A+K+L +++ + + +   F  E  L +R++H N+V  L  G     G    V+E++
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 487 HNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL 544
              TL+E L   G L   +    + ++  A   A      H      I+HRDLK  NI++
Sbjct: 62  PGRTLREVLAADGALPAGETGRLMLQVLDALACA------HNQ---GIVHRDLKPQNIMV 112

Query: 545 ---DKHMRAKVSDFGLSKFAVD-GASHVSSIVR-----GTVGYLDPEYYISQQLTDKSDV 595
                   AKV DFG+         + V+++ R     GT  Y  PE    + +T  SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172

Query: 596 YSFGVILLELISGQEAISNE 615
           Y++G+I LE ++GQ  +   
Sbjct: 173 YAWGLIFLECLTGQRVVQGA 192

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 56/197 (28%), Positives = 101/197 (51%), Gaps = 13/197 (6%)

Query: 415 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           ++G G FG VY  K K+ G   A KV+ + S +   ++  E+ +L+  +H  +V+ LG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
             +G+  ++ EF   G +   +   L  ++ +   +   I     + ++YLH+     II
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVICRQMLEALQYLHS---MKII 132

Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 591
           HRDLK+ N+LL      K++DFG+S   V       S + GT  ++ PE  + + + D  
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTP 191

Query: 592 ---KSDVYSFGVILLEL 605
              K+D++S G+ L+E+
Sbjct: 192 YDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 75.0 bits (184), Expect = 2e-14
 Identities = 65/200 (32%), Positives = 89/200 (44%), Gaps = 13/200 (6%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 468
           K IG G FG V   K K DG   AVKVL   +   K+E  + +     LL  + H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                Q   +   V ++++ G L  HL      E+     +    A + A  I YLH+  
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLHS-- 114

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              II+RDLK  NILLD      ++DFGL K  V+     S+   GT  YL PE    + 
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEP 172

Query: 589 LTDKSDVYSFGVILLELISG 608
                D +  G +L E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 61/236 (25%)

Query: 414 KKIGSGGFGVVYYGK--------LKDGKE---------IAVKVLTSN-SYQGKREFTNEV 455
           +K+G G FG V+  +         K   E         +AVKVL  + S   + +F  EV
Sbjct: 11  EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70

Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR----- 510
            +LSR+   N+ + LG C  +    ++ E+M NG L + L     H    + +       
Sbjct: 71  KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQ---KHVAETSGLACNSKSL 127

Query: 511 -----LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK------ 559
                L +A   A G+ YL +      +HRDL + N L+ K+   K++DFG+S+      
Sbjct: 128 SFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 560 -FAVDGASHV-------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            + V G + +        S++ G             + T KSDV++FGV L E+++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLG-------------KFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 65/224 (29%), Positives = 96/224 (42%), Gaps = 33/224 (14%)

Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN----- 453
           FT  D++D       +IG G FG V     K  G  +AVK + S     ++E        
Sbjct: 1   FTAEDLKD-----LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV--DEKEQKRLLMDL 53

Query: 454 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-- 511
           +V + S      +V+F G    EG   +  E M      +  Y  +    +    + +  
Sbjct: 54  DVVMRSS-DCPYIVKFYGALFREGDCWICMELMD--ISLDKFYKYVYEVLKSVIPEEILG 110

Query: 512 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 571
           +IA    K + YL       IIHRD+K SNILLD++   K+ DFG+S   VD      SI
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SI 162

Query: 572 VR----GTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISG 608
            +    G   Y+ PE            +SDV+S G+ L E+ +G
Sbjct: 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 66/201 (32%), Positives = 89/201 (44%), Gaps = 15/201 (7%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 468
           K IG G FG V   K K DGK  AVKVL       ++E          LL  + H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTG 527
                Q   +   V +F++ G L  HL    +  E R     R   AE  A  + YLH+ 
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR----ARFYAAE-IASALGYLHS- 114

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               I++RDLK  NILLD      ++DFGL K  +  +   ++   GT  YL PE    Q
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC-GTPEYLAPEVIRKQ 171

Query: 588 QLTDKSDVYSFGVILLELISG 608
              +  D +  G +L E++ G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 13/204 (6%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQFLG 471
           ++IG G FG VY G     KE+ A+K++     + + E    E+T+LS+     + ++ G
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              +  +  ++ E++  G+  + L      E  I  I R     +  KG++YLH+     
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLHS---ER 121

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            IHRD+K++N+LL +    K++DFG++    D     ++ V GT  ++ PE  I Q   D
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE-VIKQSAYD 179

Query: 592 -KSDVYSFGVILLELISGQEAISN 614
            K+D++S G+  +EL  G+   S+
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSD 203

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 73.6 bits (180), Expect = 3e-14
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 20/206 (9%)

Query: 416 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYC 473
           +G+G +G VY G+ +K G+  A+KV+     + + E   E+ +L +  HHRN+  + G  
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 474 QEEG------RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
            ++       +  LV EF   G++ + +  T  +  +  WI    I  +  +G+ +LH  
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH 130

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               +IHRD+K  N+LL ++   K+ DFG+S   +D      +   GT  ++ PE     
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIACD 186

Query: 588 QLTD-----KSDVYSFGVILLELISG 608
           +  D     KSD++S G+  +E+  G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 73.8 bits (182), Expect = 4e-14
 Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 38/218 (17%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT---SNSYQGKREFTNEVTLLSRI-HHRNL 466
           + +K+G G +G+V+    +  KE+ A+K +     N+   +R F  E+  L  +  H N+
Sbjct: 11  ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNI 69

Query: 467 VQFLG-YCQEEGRSV-LVYEFM----HN----GTLKEHLYGTLTHEQRINWIKRLEIAED 516
           V+ L     E  + + LV+E+M    H       L++       H++ I +         
Sbjct: 70  VKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED------VHKRYIMY--------Q 115

Query: 517 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGT 575
             K ++Y+H+G    +IHRDLK SNILL+   R K++DFGL++  +    +  + ++   
Sbjct: 116 LLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY 172

Query: 576 VG---YLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 609
           V    Y  PE  + S + T   D++S G IL E++ G+
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 73.6 bits (180), Expect = 4e-14
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 12/206 (5%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 469
           K +G G FG V   + K  GK  A+K+L       K E  + +T   +L    H  L   
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q + R   V E+++ G L  HL    + E+  +  +      +    ++YLH+G  
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLHSG-- 114

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             I++RDLK  N++LDK    K++DFGL K  +  A+ + +   GT  YL PE       
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDY 172

Query: 590 TDKSDVYSFGVILLELISGQEAISNE 615
               D +  GV++ E++ G+    N+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQ 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 73.7 bits (181), Expect = 5e-14
 Identities = 70/225 (31%), Positives = 95/225 (42%), Gaps = 48/225 (21%)

Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREF--------- 451
           LSD E     + + +G+G FG V   K K  G+  A+K L       KRE          
Sbjct: 17  LSDFE-----MGETLGTGSFGRVRIAKHKGTGEYYAIKCLK------KREILKMKQVQHV 65

Query: 452 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 511
             E ++L  + H  +V  +   Q+E R   + EF+  G L  HL             K  
Sbjct: 66  AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR------------KAG 113

Query: 512 EIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 563
               D AK          EYLH+     II+RDLK  N+LLD     KV+DFG +K   D
Sbjct: 114 RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170

Query: 564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
               +     GT  YL PE   S+      D ++ GV+L E I+G
Sbjct: 171 RTFTLC----GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 74/293 (25%), Positives = 136/293 (46%), Gaps = 45/293 (15%)

Query: 412 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 464
           L +++G G FG+VY G  +D         +AVK +  S S + + EF NE +++      
Sbjct: 10  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN-------WIKRLEIAEDA 517
           ++V+ LG   +   +++V E M +G LK +L  +L  E   N         + +++A + 
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 575
           A G+ YL+       +HRDL + N ++      K+ DFG+++  +    +     +G   
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 184

Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 631
           V ++ PE       T  SD++SFGV+L E+ S  E     +SNE+               
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-------------- 230

Query: 632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 684
                ++ ++D   LD+ D     ++ +   MC   +  MRP+  E++  ++D
Sbjct: 231 -----LKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 73.5 bits (180), Expect = 6e-14
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 28/220 (12%)

Query: 412 LEKKIGSGGFGVVYYG------KLKDGK--EIAVKVLTSNSY-QGKREFTNEVTLLSRI- 461
           L K +G G FG V         K K  K   +AVK+L  ++  +   +  +E+ ++  I 
Sbjct: 16  LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL---------YGTLT---HEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L         Y   T    E+++ +  
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +  A   A+G+EYL +      IHRDL + N+L+ +    K++DFGL++  V    +  
Sbjct: 136 LVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLAR-DVHNIDYYK 191

Query: 570 SIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               G   V ++ PE    +  T +SDV+SFGV+L E+ +
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 72.9 bits (179), Expect = 6e-14
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 14/201 (6%)

Query: 413 EKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQF 469
            +KIG G +GVVY  + +   E IA+K +           T   E++LL  + H N+V+ 
Sbjct: 7   VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
                 E R  LV+E++ +  LK+H+  +    +    IK         +GI Y H+   
Sbjct: 67  QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTY--LYQILRGIAYCHSH-- 121

Query: 530 PAIIHRDLKSSNILLDKHMRA-KVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-S 586
             ++HRDLK  N+L+D+   A K++DFGL++ F +   +    +V  T+ Y  PE  + S
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGS 178

Query: 587 QQLTDKSDVYSFGVILLELIS 607
           +  +   D++S G I  E+++
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 22/222 (9%)

Query: 402 LSDIEDATKMLE--KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLL 458
           LS + D   + E  + +G+G +G VY G+ +K G+  A+KV+     + + E   E+ +L
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINML 66

Query: 459 SRI-HHRNLVQFLGY------CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 511
            +  HHRN+  + G          + +  LV EF   G++ + +  T  +  + +WI   
Sbjct: 67  KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY- 125

Query: 512 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 571
            I  +  +G+ +LH      +IHRD+K  N+LL ++   K+ DFG+S   +D      + 
Sbjct: 126 -ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNT 180

Query: 572 VRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISG 608
             GT  ++ PE     +  D     +SD++S G+  +E+  G
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 72.7 bits (178), Expect = 7e-14
 Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 14/201 (6%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEI----AVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++    A+K L  + S +  +E  +E  +++ + + ++ 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           + LG C       L+ + M  G L +++     H+  I     L      AKG+ YL   
Sbjct: 73  RLLGICLTSTVQ-LITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLEE- 127

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYIS 586
               ++HRDL + N+L+      K++DFGL+K    D   + +   +  + ++  E  + 
Sbjct: 128 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH 185

Query: 587 QQLTDKSDVYSFGVILLELIS 607
           +  T +SDV+S+GV + EL++
Sbjct: 186 RIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 21/205 (10%)

Query: 416 IGSGGFGVVYYGKLKDG-------KEIAVKVLTSNSYQGKRE-------FTNEVTLL-SR 460
           +GSG FG VY  + K+        KEI V        + KRE         +EVT++  +
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNP--AFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 461 IHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 520
           + H N+V++     E  R  +V + +    L EH       +QR    +   I       
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           + YLH      I+HRDL  +NI+L +  +  ++DFGL+K      S ++S+V GT+ Y  
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV-GTILYSC 181

Query: 581 PEYYISQQLTDKSDVYSFGVILLEL 605
           PE   ++   +K+DV++FG IL ++
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 74.1 bits (182), Expect = 2e-13
 Identities = 44/120 (36%), Positives = 68/120 (56%), Gaps = 8/120 (6%)

Query: 212 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGC 269
           W  + CN+  +  +  I LS KN++G I S + +L  +  + L  N L+GPIPD  F+  
Sbjct: 60  WQGITCNNSSR--VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117

Query: 270 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 327
             LR ++L +N  TG +P    ++PNL  L + NNMLSG +P+ +   S   VL+  GN+
Sbjct: 118 SSLRYLNLSNNNFTGSIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175

Length = 968

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 22/204 (10%)

Query: 416 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 469
           IG GGFG VY  +  D GK  A+K L        QG+    NE  +LS +   +   +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 470 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + Y      +   + + M+ G L  HL  +G  +  +   +      A +   G+E++H 
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY------AAEIILGLEHMHN 115

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
             V   ++RDLK +NILLD+H   ++SD GL+        H S    GT GY+ PE    
Sbjct: 116 RFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169

Query: 587 QQLTDKS-DVYSFGVILLELISGQ 609
               D S D +S G +L +L+ G 
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGH 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 71.8 bits (177), Expect = 2e-13
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 39/219 (17%)

Query: 411 MLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNL 466
            L K IGSG +GVV      + G+++A+K ++    +    KR    E+ LL  + H N+
Sbjct: 3   ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENI 61

Query: 467 VQ----FLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAK- 519
           +           E+   V +V E M           T  H      IK    + +D  + 
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELME----------TDLH----KVIKSPQPLTDDHIQY 107

Query: 520 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 572
                  G++YLH+     +IHRDLK SNIL++ +   K+ DFGL++           + 
Sbjct: 108 FLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 573 RGTVG--YLDPEYYISQQLTDKS-DVYSFGVILLELISG 608
              V   Y  PE  +S     K+ D++S G I  EL++ 
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 31/210 (14%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN-----EVTLLS-RI----- 461
           K +G G FG V   +LK   E+ AVKVL       K++        E T+   R+     
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVL-------KKDVILQDDDVECTMTEKRVLALAG 53

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAK 519
            H  L Q     Q + R   V E+++ G L  H+   G     +   +      A +   
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY------AAEIVL 107

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 579
           G+++LH      II+RDLK  N+LLD     K++DFG+ K  + G    S+   GT  Y+
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYI 163

Query: 580 DPEYYISQQLTDKSDVYSFGVILLELISGQ 609
            PE    Q      D ++ GV+L E+++GQ
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 18/203 (8%)

Query: 416 IGSGGFGVVYYGKLK---DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           +G G +GVV   K++    G  +AVK +  T NS + KR   +    +  +     V F 
Sbjct: 9   LGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLY-GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G    EG   +  E M   T  +  Y         I      +IA    K +EYLH+   
Sbjct: 67  GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL- 123

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY---IS 586
            ++IHRD+K SN+L++++ + K+ DFG+S + VD  S   +I  G   Y+ PE     ++
Sbjct: 124 -SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD--SVAKTIDAGCKPYMAPERINPELN 180

Query: 587 QQLTD-KSDVYSFGVILLELISG 608
           Q+  D KSDV+S G+ ++EL +G
Sbjct: 181 QKGYDVKSDVWSLGITMIELATG 203

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.3 bits (172), Expect = 3e-13
 Identities = 52/211 (24%), Positives = 101/211 (47%), Gaps = 15/211 (7%)

Query: 404 DIEDATKMLEKKIGSGGFGVVYYG--KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLL 458
           ++++ +  +E+ +G+G FG +  G  KL   +E+ V + T     S + +R F  E   L
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60

Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
            +  H N+V+  G        ++V E+M NG L   L     HE ++   + + +    A
Sbjct: 61  GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLA 117

Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TV 576
            G++YL        +H+ L +  +L++  +  K+S F   +   D +  + + + G   V
Sbjct: 118 SGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPV 172

Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            +  PE       +  SDV+SFG+++ E++S
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 70.3 bits (173), Expect = 4e-13
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN--EVTLLSRI-HHRNLVQF 469
           K++G G FG VY  + K+  E+ A+K +    +    E  N  EV  L ++  H N+V+ 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPNIVKL 63

Query: 470 LGYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
               +E      V+E+M       +K+      +     + I ++       +G+ ++H 
Sbjct: 64  KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQI------LQGLAHIHK 117

Query: 527 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 559
            G      HRDLK  N+L+      K++DFGL++
Sbjct: 118 HG----FFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 24/211 (11%)

Query: 412 LEKKIGSGGFGVVYY----GKLKDGKEIAVKVLTSNSYQGKR---EFT-NEVTLLSRIHH 463
           L + +G+G +G V+     G    GK  A+KVL   +   K    E T  E  +L  +  
Sbjct: 4   LLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRR 63

Query: 464 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK---RLEIAEDAAK 519
              +  L Y  Q + +  L+ ++++ G L  HLY      QR ++ +   R+ IAE    
Sbjct: 64  CPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY------QREHFTESEVRVYIAE-IVL 116

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 579
            +++LH      II+RD+K  NILLD      ++DFGLSK  +      +    GT+ Y+
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173

Query: 580 DPEYYISQQL--TDKSDVYSFGVILLELISG 608
            PE             D +S GV+  EL++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 70.3 bits (172), Expect = 5e-13
 Identities = 65/216 (30%), Positives = 98/216 (45%), Gaps = 14/216 (6%)

Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 471
           IG G FG V   + +D + I A+K +       + E T+   E T+L++++   +V    
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAKGIEYLHTGCVP 530
             Q   +  LV  F++ G L  HL      E R +  + R   AE     +E LH   V 
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHL----QREGRFDLSRARFYTAE-LLCALENLHKFNV- 114

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
             I+RDLK  NILLD      + DFGL K  +      ++   GT  YL PE  +    T
Sbjct: 115 --IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYT 171

Query: 591 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
              D ++ GV+L E+++G     +E      R I+Q
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 54/208 (25%), Positives = 105/208 (50%), Gaps = 12/208 (5%)

Query: 404 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 461
           D E+    LE+ IG G FG V+ G   +  + +A+K++     + + E    E+T+LS+ 
Sbjct: 1   DPEELFTKLER-IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
               + ++ G   +  +  ++ E++  G+  + L      E +I       + ++  KG+
Sbjct: 60  DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI-----ATMLKEILKGL 114

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           +YLH+      IHRD+K++N+LL +    K++DFG++    D     ++ V GT  ++ P
Sbjct: 115 DYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 170

Query: 582 EYYISQQLTDKSDVYSFGVILLELISGQ 609
           E         K+D++S G+  +EL  G+
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 69.6 bits (170), Expect = 5e-13
 Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 22/211 (10%)

Query: 416 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 469
           IG GGFG VY  +  D GK  A+K L        QG+    NE  +LS +   +   +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 470 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + Y      +   + + M+ G L  HL  +G  + ++   +      A +   G+E++H 
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY------ATEIILGLEHMHN 115

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
             V   ++RDLK +NILLD+H   ++SD GL+        H S    GT GY+ PE    
Sbjct: 116 RFV---VYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169

Query: 587 QQLTDKS-DVYSFGVILLELISGQEAISNEK 616
               D S D +S G +L +L+ G       K
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 69.4 bits (170), Expect = 7e-13
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 27/221 (12%)

Query: 399 CFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK---REFTNEV 455
           C    DI+  T +L   I       +Y G   + KE+ ++         K       NE+
Sbjct: 14  CIESDDIDKYTSVL---IKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEI 69

Query: 456 TLLSRIHHRNLVQFLGY----CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 511
             L RI   N+++  G+      +  R  L+ E+   G L+E L      E+ +++  +L
Sbjct: 70  KNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKL 125

Query: 512 EIAEDAAKGIEYLHTGC-VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVS 569
           ++A D  KG+  L+     P   +++L S + L+ ++ + K+   GL K  +     +V+
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182

Query: 570 SIVRGTVGYLDPEYY--ISQQLTDKSDVYSFGVILLELISG 608
            +V     Y   +    I  + T K D+YS GV+L E+ +G
Sbjct: 183 FMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218

Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 69.3 bits (170), Expect = 7e-13
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 20/203 (9%)

Query: 415 KIGSGGFGVVYYGKLKD-GKEIAVK--VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           KIG G +GVV+  + ++ G+ +A+K  V + +    K+    E+ +L ++ H NLV  + 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 472 YCQEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 527
             + + +  LV+E+  +  L E   +  G   H      IK+  I     + + + H   
Sbjct: 68  VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHL-----IKK--IIWQTLQAVNFCHKHN 120

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
           C    IHRD+K  NIL+ K  + K+ DFG ++         +  V  T  Y  PE  +  
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGD 175

Query: 588 -QLTDKSDVYSFGVILLELISGQ 609
            Q     DV++ G +  EL++GQ
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 69.9 bits (171), Expect = 7e-13
 Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 15/206 (7%)

Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQFLG 471
           +G G FG V   +LK  G+  AVKVL  +      +    +T   +LS   +   +  L 
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 472 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
            C Q   R   V EF++ G L  H+  +    +R +  +    A +    + +LH     
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEITSALMFLHD---K 115

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQL 589
            II+RDLK  N+LLD     K++DFG+ K  + +G +  +S   GT  Y+ PE       
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEMLY 173

Query: 590 TDKSDVYSFGVILLELISGQEAISNE 615
               D ++ GV+L E++ G      E
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFEAE 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 8e-13
 Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 58/231 (25%)

Query: 412 LEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGK-------REFTNEVTLLSRI 461
           +E  IG G +G VY  K K   DGKE A+K    +  Q         RE    + LL  +
Sbjct: 4   IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLREL 59

Query: 462 HHRNLVQFLGYCQEEG-RSV-LVYEFMHNGTLKEH-LYGTLTHEQRINWIKRLEIAEDAA 518
            H N+V  +    E   +SV L++++       EH L+  +   ++    KR+ I     
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQA---KRVSIPPSMV 110

Query: 519 K--------GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSK------- 559
           K        G+ YLH+     ++HRDLK +NIL+     +    K+ D GL++       
Sbjct: 111 KSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167

Query: 560 --FAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELIS 607
               +D        V  T+ Y  PE  + ++  T   D+++ G I  EL++
Sbjct: 168 PLADLDP-------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 68.8 bits (168), Expect = 9e-13
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 26/210 (12%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEIA---VKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
            +IG+G FG V  G+   G   A   VK L  S +   +  F  EV     ++H N++Q 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE-IAEDAAKGIEYLHTGC 528
           LG C E    +LV EF   G LK +L        ++     L+ +A + A G+ +LH   
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLS------KFAVDGASHVSSIVRGTVGYLDPE 582
               IH DL   N  L   +  K+ D+GL+       + +    H   +      +L PE
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL-----RWLAPE 172

Query: 583 YYISQQ-------LTDKSDVYSFGVILLEL 605
               +         T KS+++S GV + EL
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 71.4 bits (175), Expect = 1e-12
 Identities = 43/106 (40%), Positives = 64/106 (60%), Gaps = 3/106 (2%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 282
           S+  + L+S  L G IP +L ++ SL  ++L  N+L+G IP +  G   L  + L  N L
Sbjct: 189 SLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 326
           TGP+PSSL NL NL+ L++  N LSG +P S+  L K + L+ + N
Sbjct: 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294

Length = 968

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 20/217 (9%)

Query: 407 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHH 463
           D+ + LEK +G G +  VY GK K +GK +A+KV+     +G   FT   E +LL  + H
Sbjct: 5   DSYEKLEK-LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKH 62

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 520
            N+V        +    LV+E++H      + +H  G      ++   + L       +G
Sbjct: 63  ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLL-------RG 115

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           + Y+H      I+HRDLK  N+L+      K++DFGL++ A    SH  S    T+ Y  
Sbjct: 116 LSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRP 171

Query: 581 PEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEK 616
           P+  + S + +   D++  G I +E+I G  A    K
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)

Query: 415 KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLG 471
           KIG G +G V+  K ++  EI    +V   +  +G       E+ LL  + H+N+V+   
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 472 YCQEEGRSVLVYEFMHNGTLK--EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               + +  LV+E+      K  +   G +  E   +++ +L       KG+ + H+   
Sbjct: 67  VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL------LKGLAFCHS--- 117

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             ++HRDLK  N+L++K+   K++DFGL++ F +    + + +V  T+ Y  P+     +
Sbjct: 118 HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAK 175

Query: 589 LTDKS-DVYSFGVILLELISG 608
           L   S D++S G I  EL + 
Sbjct: 176 LYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 69.6 bits (170), Expect = 1e-12
 Identities = 70/218 (32%), Positives = 99/218 (45%), Gaps = 18/218 (8%)

Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRN---LVQ 468
           IG G FG VY  + KD + I A+KVL+      K+E  +   E  +L R        +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK-RLEIAEDAAKGIEYLHTG 527
                Q +    LV ++M  G L  HL      E R +  + +  IAE     +E+LH  
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHL----QKEGRFSEDRAKFYIAE-LVLALEHLHKY 115

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               I++RDLK  NILLD      + DFGLSK A    +  ++   GT  YL PE  + +
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDE 171

Query: 588 Q-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
           +  T   D +S GV++ E+  G      E      RNI
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 69.3 bits (170), Expect = 1e-12
 Identities = 58/208 (27%), Positives = 86/208 (41%), Gaps = 30/208 (14%)

Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLL----------SRI 461
           +G G FG V   + K   E+ A+K L       K+      +EV  L          +  
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKAL-------KKGDIIARDEVESLMCEKRIFETANSE 59

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H  LV      Q E     V E+   G L  H+     H    +  + +  A     G+
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-----HTDVFSEPRAVFYAACVVLGL 114

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           +YLH      I++RDLK  N+LLD     K++DFGL K  + G    +S   GT  +L P
Sbjct: 115 QYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM-GFGDRTSTFCGTPEFLAP 170

Query: 582 EYYISQQLTDKSDVYSFGVILLELISGQ 609
           E       T   D +  GV++ E++ G+
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGE 198

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 60/203 (29%), Positives = 89/203 (43%), Gaps = 18/203 (8%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 469
           K +G G FG V   + K  GK  A+K+L       K E  + +T   +L    H  L   
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
               Q   R   V E+ + G L  HL      + ++      R   AE     + YLH+ 
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAE-IVSALGYLHSC 114

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYIS 586
               +++RDLK  N++LDK    K++DFGL K  + DGA+       GT  YL PE    
Sbjct: 115 ---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLED 169

Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
                  D +  GV++ E++ G+
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 29/205 (14%)

Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFLG 471
           KIG G +GVVY  +    G+ +A+K +   +       T   E++LL  ++H N+V+ L 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLD 65

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEY 523
               E +  LV+EF+    LK+++          +      +     K        GI Y
Sbjct: 66  VVHSENKLYLVFEFLDL-DLKKYM----------DSSPLTGLDPPLIKSYLYQLLQGIAY 114

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE 582
            H+     ++HRDLK  N+L+D+    K++DFGL++ F V   ++   +V  T+ Y  PE
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 169

Query: 583 YYI-SQQLTDKSDVYSFGVILLELI 606
             + S+Q +   D++S G I  E++
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMV 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 37/212 (17%)

Query: 416 IGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQF 469
           IG G +G VY  + KD  E+    KV   N  +G   F      E+ +L +++HRN+V  
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNHRNIVNL 71

Query: 470 ----------LGYCQEEGRSVLVYEFM-HN--GTLKEHLYGTLTHEQRINWIKRLEIAED 516
                     L + +++G   LV+E+M H+  G L+  L    + +   +++K+L     
Sbjct: 72  KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV-HFSEDHIKSFMKQL----- 125

Query: 517 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRG 574
             +G+ Y H       +HRD+K SNILL+   + K++DFGL++   + +   + + ++  
Sbjct: 126 -LEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-- 179

Query: 575 TVGYLDPEYYISQQLTDKS-DVYSFGVILLEL 605
           T+ Y  PE  + ++    + DV+S G IL EL
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 19/202 (9%)

Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLVQ 468
           +IG G +G VY  +    G  +A+K V    +  G    T  EV LL R+    H N+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 469 FLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
            +  C       E +  LV+E + +  L+ +L            IK  ++     +G+++
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIK--DLMRQFLRGLDF 123

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH  C   I+HRDLK  NIL+    + K++DFGL++      +    +V  T+ Y  PE 
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEV 178

Query: 584 YISQQLTDKSDVYSFGVILLEL 605
            +        D++S G I  E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 51/204 (25%), Positives = 97/204 (47%), Gaps = 22/204 (10%)

Query: 415 KIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
            +G G +G+V   K K+ G+ +A+K    + +    K+    E+ +L ++ H NLV  + 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 472 YCQEEGRSVLVYEFMHNGTLK--EHLYGTLTHE--QRINWIKRLEIAEDAAKGIEYLHTG 527
             + + R  LV+EF+ +  L   E     L     ++  +           +GIE+ H+ 
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLF--------QILRGIEFCHSH 119

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYIS 586
               IIHRD+K  NIL+ +    K+ DFG ++  A  G  +   +   T  Y  PE  + 
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV--ATRWYRAPELLVG 174

Query: 587 QQLTDKS-DVYSFGVILLELISGQ 609
                ++ D+++ G ++ E+++G+
Sbjct: 175 DTKYGRAVDIWAVGCLVTEMLTGE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 62/201 (30%), Positives = 88/201 (43%), Gaps = 15/201 (7%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 468
           K IG G FG V   + K + K  AVKVL   +   K+E     +    LL  + H  LV 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTG 527
                Q   +   V ++++ G L  HL       +R     R    A + A  + YLH+ 
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHL-----QRERCFLEPRARFYAAEIASALGYLHS- 114

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               I++RDLK  NILLD      ++DFGL K  ++     S+   GT  YL PE    Q
Sbjct: 115 --LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQ 171

Query: 588 QLTDKSDVYSFGVILLELISG 608
                 D +  G +L E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 21/206 (10%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +K+G G +  VY G  + +G+ +A+KV++  + +G   FT   E +LL  + H N+V   
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLH 69

Query: 471 GYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
                +     V+E+MH      + +H  G   +  R+   + L       +G+ Y+H  
Sbjct: 70  DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL-------RGLAYIHG- 121

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI- 585
               I+HRDLK  N+L+      K++DFGL++  ++   ++ S +V  T+ Y  P+  + 
Sbjct: 122 --QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLG 177

Query: 586 SQQLTDKSDVYSFGVILLELISGQEA 611
           +   +   D++  G I +E++ GQ A
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 69.9 bits (171), Expect = 3e-12
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 1/99 (1%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
           P +  + +S+ NL G I S    + SL  L L  N   G +PD  G   L  + L  NQ 
Sbjct: 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQF 487

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS-KNVV 320
           +G +P  L +L  L +L +  N LSG +P  L S K +V
Sbjct: 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV 526

Length = 968

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.5 bits (168), Expect = 3e-12
 Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 60/234 (25%)

Query: 404 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVK-------VLTSNSYQGKREFTNEV 455
           D+    K +E  IGSG +GVV      + GK++A+K       V T      KR    E+
Sbjct: 2   DVGSRYKPIEN-IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTL----AKRTL-REL 55

Query: 456 TLLSRIHHRNLV---QFLGYCQEEGRSV-LVYEFM----H-----NGTLKEH-----LYG 497
            +L    H N++     L     + + V +V + M    H     +  L E      LY 
Sbjct: 56  KILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQ 115

Query: 498 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG- 556
            L                   +G++Y+H+  V   IHRDLK SN+L+++    ++ DFG 
Sbjct: 116 LL-------------------RGLKYIHSANV---IHRDLKPSNLLVNEDCELRIGDFGM 153

Query: 557 ---LSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELI 606
              LS    +    ++  V  T  Y  PE  +S  + T   D++S G I  E++
Sbjct: 154 ARGLSSSPTEHKYFMTEYV-ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 39/180 (21%)

Query: 399 CFTLSDIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFT--NEV 455
           C  L D E     +  K+G G FG VY   ++K G+ +A+K +  ++ +     T   E+
Sbjct: 4   CSKLRDYE-----ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREI 58

Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSV--------LVYEFM--------HNGTLKEHLYGTL 499
            +L ++ H N+V  +    E             +V  +M         N ++K      L
Sbjct: 59  KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK------L 112

Query: 500 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 559
           T  Q   ++ +L       +GI YLH      I+HRD+K++NIL+D     K++DFGL++
Sbjct: 113 TESQIKCYMLQL------LEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 54/197 (27%), Positives = 94/197 (47%), Gaps = 13/197 (6%)

Query: 415 KIGSGGFGVVYYGKLKDGKEIAV-KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           ++G G FG VY  + K+   +A  KV+ + S +   ++  E+ +L+   H N+V+ L   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
             E    ++ EF   G +   +   L  E+ +   +   + +   + + YLH      II
Sbjct: 72  YYENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHEN---KII 125

Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 591
           HRDLK+ NIL       K++DFG+S           S + GT  ++ PE  + +   D  
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 184

Query: 592 ---KSDVYSFGVILLEL 605
              K+DV+S G+ L+E+
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 68.0 bits (166), Expect = 3e-12
 Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 29/222 (13%)

Query: 412 LEKKIGSGGFGVVYY----GKLKDGKE-------------IAVKVLTSNSYQGKR-EFTN 453
            ++K+G G FG V+     G  K   +             +AVK+L  ++ +  R +F  
Sbjct: 9   FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 454 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-------GTLTHEQRIN 506
           E+ ++SR+   N+++ L  C       ++ E+M NG L + L                I+
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 507 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
           +   + +A   A G++YL +      +HRDL + N L+ K+   K++DFG+S+    G  
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185

Query: 567 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           + +       + ++  E  +  + T  SDV++FGV L E+++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 26/210 (12%)

Query: 414 KKIGSGGFGVVYYGKLKDG---KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQF 469
           K+IG+G FG V  G++  G    ++ VK L  + S Q + +F  E      + H NL+Q 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE-IAEDAAKGIEYLHTGC 528
           LG C E    +LV EF   G LK +L      E        L+ +A + A G+ +LH   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
               IH DL   N LL   +  K+ D+GLS        +V+           P  +I+ +
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV-----PLRWIAPE 172

Query: 589 LTDK-------------SDVYSFGVILLEL 605
           L D+             S+V+S GV + EL
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 66.6 bits (162), Expect = 6e-12
 Identities = 53/200 (26%), Positives = 99/200 (49%), Gaps = 16/200 (8%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           L ++IGSG +G VY  + +  G+  A+KV+     +       E+ ++    H N+V + 
Sbjct: 13  LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72

Query: 471 GYCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
           G      +  +  EF   G+L++  H+ G L+ E +I ++ R     +  +G+ YLH+  
Sbjct: 73  GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLS-ESQIAYVSR-----ETLQGLYYLHS-- 124

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
               +HRD+K +NILL  +   K++DFG+S       +   S + GT  ++ PE    ++
Sbjct: 125 -KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVER 182

Query: 589 ---LTDKSDVYSFGVILLEL 605
                   D+++ G+  +EL
Sbjct: 183 KGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 67.4 bits (165), Expect = 6e-12
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 27/208 (12%)

Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K IGSG  G+V   Y      G+ +A+K L+    N    KR +  E+ L+  ++H+N++
Sbjct: 22  KPIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNII 78

Query: 468 QFLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
             L         EE + V LV E M +  L + +   L HE R++++    +      GI
Sbjct: 79  GLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHE-RMSYLLYQMLC-----GI 131

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           ++LH+     IIHRDLK SNI++      K+ DFGL++ A         +V  T  Y  P
Sbjct: 132 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAP 186

Query: 582 EYYISQQLTDKSDVYSFGVILLELISGQ 609
           E  +     +  D++S G I+ E+I G 
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 67.4 bits (164), Expect = 6e-12
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 23/205 (11%)

Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           K IGSG  G+V        G  +AVK L+    N    KR +  E+ LL  ++H+N++  
Sbjct: 27  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 85

Query: 470 LGY-----CQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           L         EE + V LV E M +  L + ++  L HE R++++    +      GI++
Sbjct: 86  LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHE-RMSYLLYQMLC-----GIKH 138

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH+     IIHRDLK SNI++      K+ DFGL++ A         +V  T  Y  PE 
Sbjct: 139 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEV 193

Query: 584 YISQQLTDKSDVYSFGVILLELISG 608
            +     +  D++S G I+ EL+ G
Sbjct: 194 ILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 68.3 bits (167), Expect = 9e-12
 Identities = 36/89 (40%), Positives = 54/89 (60%), Gaps = 1/89 (1%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 282
           S+  I+L   NL+G IP ++  L+SL  L L  N+LTGPIP       +L+ + L  N+L
Sbjct: 213 SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL 272

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVP 311
           +GP+P S+ +L  L  L + +N LSG +P
Sbjct: 273 SGPIPPSIFSLQKLISLDLSDNSLSGEIP 301

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 68.0 bits (166), Expect = 1e-11
 Identities = 38/92 (41%), Positives = 50/92 (54%), Gaps = 1/92 (1%)

Query: 222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDN 280
             ++TV+ LS+ NLTG IP  L    +L +L L  NSL G IP     C  LR + L+DN
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 312
             +G LPS    LP +  L + NN L G + S
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446

Length = 968

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 33/209 (15%)

Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSN----------SYQGKREFTNEVTLLSRIHHR 464
           +G G FG V   + K   E+ A+K+L  +          +   KR     + L  +    
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV----LALPGKPPF- 62

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---GI 521
            L Q     Q   R   V E+++ G L  H+       Q++   K       AA+   G+
Sbjct: 63  -LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGKFKEPHAVFYAAEIAIGL 114

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
            +LH+     II+RDLK  N++LD     K++DFG+ K  + G     +   GT  Y+ P
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAP 170

Query: 582 EYYISQQLTDKS-DVYSFGVILLELISGQ 609
           E  I+ Q   KS D ++FGV+L E+++GQ
Sbjct: 171 E-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 63/226 (27%), Positives = 109/226 (48%), Gaps = 18/226 (7%)

Query: 401 TLSDIEDATKMLEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 459
           +  D  D  +++E  IG G +G V+     K+G + AVK+L    +    E   E  +L 
Sbjct: 12  SFPDPSDTWEIIET-IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILK 69

Query: 460 RIH-HRNLVQFLG-YCQEEGRS----VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 513
            +  H N+V+F G Y +++ ++     LV E  + G++ + + G L   +R+       I
Sbjct: 70  ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129

Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 573
             +A  G+++LH   V   IHRD+K +NILL      K+ DFG+S   +       +   
Sbjct: 130 LHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSA-QLTSTRLRRNTSV 185

Query: 574 GTVGYLDPEYYISQQLTDKS-----DVYSFGVILLELISGQEAISN 614
           GT  ++ PE    +Q  D +     DV+S G+  +EL  G   +++
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 25/225 (11%)

Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKRE-FTNEVT 456
           +I  +T    +++G   FG VY G L      +  + +A+K L   +    RE F +E  
Sbjct: 1   EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60

Query: 457 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH------------EQR 504
           + SR+ H N+V  LG   +E    +++ +  +  L E L     H            +  
Sbjct: 61  MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 505 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAV 562
           +     + I    A G+E+L +  V   +H+DL + N+L+   +  K+SD GL +  +A 
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHV---VHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177

Query: 563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           D    + + +   + ++ PE  +  + +  SD++S+GV+L E+ S
Sbjct: 178 DYYKLMGNSLL-PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 66.4 bits (162), Expect = 1e-11
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 34/219 (15%)

Query: 414 KKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKREFTN----EVTLLSRIHHRN 465
           K +G GG+G V+  +   G +     A+KVL   +    ++ T     E  +L  + H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAK----- 519
           +V  +   Q  G+  L+ E++  G L  HL             +R  I  ED A      
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHL-------------EREGIFMEDTACFYLSE 108

Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 576
               +E+LH      II+RDLK  NILLD     K++DFGL K ++   + V+    GT+
Sbjct: 109 ISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTI 164

Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
            Y+ PE  +        D +S G ++ ++++G    + E
Sbjct: 165 EYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 66.7 bits (162), Expect = 1e-11
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)

Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 80

Query: 469 FLGY-----CQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++    +      GI+
Sbjct: 81  LLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 133

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 134 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 188

Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 15/199 (7%)

Query: 414 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQF 469
           K +G+G FG V+  + +  +   A+KV+        + ++   NE  +L  + H  +++ 
Sbjct: 7   KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
                ++    ++ E++  G     L+  L +  R +    L  A +    +EYLH+   
Sbjct: 67  FWTEHDQRFLYMLMEYVPGG----ELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS--- 119

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             I++RDLK  NILLDK    K++DFG +K   D    +     GT  YL PE   S+  
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQSKGH 175

Query: 590 TDKSDVYSFGVILLELISG 608
               D ++ G+++ E++ G
Sbjct: 176 NKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 18/201 (8%)

Query: 412 LEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           L +++GSG +G VY    L  G+  AVK++             E+ ++    H N+V + 
Sbjct: 13  LIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYF 72

Query: 471 GYCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
           G      +  +  E+   G+L++  H+ G L+ E +I ++ R     +  +G+ YLH+  
Sbjct: 73  GSYLSREKLWICMEYCGGGSLQDIYHVTGPLS-ELQIAYVCR-----ETLQGLAYLHS-- 124

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               +HRD+K +NILL  +   K++DFG+ +K     A   S I  GT  ++ PE    +
Sbjct: 125 -KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI--GTPYWMAPEVAAVE 181

Query: 588 Q---LTDKSDVYSFGVILLEL 605
           +        D+++ G+  +EL
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 28/207 (13%)

Query: 415 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 468
           +I  G +GVVY  + K   EI A+K L     + ++E    T+  E+ +L ++ H N+V 
Sbjct: 12  RIEEGTYGVVYRARDKKTGEIVALKKL---KMEKEKEGFPITSLREINILLKLQHPNIVT 68

Query: 469 F----LGYCQEEGRSVLVYEFMHNG--TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
                +G   +  +  +V E++ +   +L E +       +    + +L        G+ 
Sbjct: 69  VKEVVVGSNLD--KIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQL------LSGVA 120

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH      I+HRDLK+SN+LL+     K+ DFGL++         + +V  T+ Y  PE
Sbjct: 121 HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPE 176

Query: 583 YYISQQL-TDKSDVYSFGVILLELISG 608
             +  +  +   D++S G I  EL++ 
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 65.5 bits (159), Expect = 3e-11
 Identities = 65/227 (28%), Positives = 110/227 (48%), Gaps = 31/227 (13%)

Query: 400 FTLSDIEDATKMLEKK------IGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQG 447
           F   +I D+T  + K+      IGSG  G+V   Y   L+  + +A+K L+    N    
Sbjct: 10  FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67

Query: 448 KREFTNEVTLLSRIHHRNLVQFLGY-----CQEEGRSVLVYEFMHNGTLKEHLYGTLTHE 502
           KR +  E+ L+  ++H+N++  L         EE + V +   + +  L + +   L HE
Sbjct: 68  KRAY-RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE 126

Query: 503 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV 562
            R++++    +      GI++LH+     IIHRDLK SNI++      K+ DFGL++ A 
Sbjct: 127 -RMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA- 176

Query: 563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
            G S + +    T  Y  PE  +     +  D++S G I+ E+I G 
Sbjct: 177 -GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 4e-11
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 35/215 (16%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQF 469
               IG G +G+V     K  G ++A+K ++   +Q   + T  E+ +L R  H N++  
Sbjct: 9   NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGI 68

Query: 470 LGYCQ----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 519
           L   +    E    V +V E M     +  LY           IK   ++ D  +     
Sbjct: 69  LDIIRPPSFESFNDVYIVQELM-----ETDLYKL---------IKTQHLSNDHIQYFLYQ 114

Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--G 574
              G++Y+H+  V   +HRDLK SN+LL+ +   K+ DFGL++ A     H   +     
Sbjct: 115 ILRGLKYIHSANV---LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171

Query: 575 TVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 608
           T  Y  PE  ++ +   K+ D++S G IL E++S 
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN 206

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 65.1 bits (159), Expect = 4e-11
 Identities = 67/260 (25%), Positives = 101/260 (38%), Gaps = 58/260 (22%)

Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEV----TLLSRIHHRNLVQ 468
           K IG G FG V   + KD G   A+K L   S   ++E    V     +L+   +  +V+
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEADNPWVVK 65

Query: 469 FLGYC--QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
              Y   Q+E    L+ E++  G +   L    T T E+      R  IAE     I+ +
Sbjct: 66  L--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE-----TRFYIAE-TILAIDSI 117

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK---------------------FAVD 563
           H       IHRD+K  N+LLD     K+SDFGL                       F   
Sbjct: 118 HK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174

Query: 564 GASHVSSIVR----------------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            +  +SS  +                GT  Y+ PE ++      + D +S GVI+ E++ 
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234

Query: 608 GQEAISNEKFGANCRNIVQW 627
           G     ++      R I+ W
Sbjct: 235 GYPPFCSDNPQETYRKIINW 254

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 64.3 bits (156), Expect = 6e-11
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 13/207 (6%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 469
           K +G G FG V   K K  G+  A+K+L       K E  + +T   +L    H  L   
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q   R   V E+ + G L  HL    + E+  +  +      +    ++YLH+   
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSE-- 114

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQ 588
             +++RDLK  N++LDK    K++DFGL K  + DGA+  +    GT  YL PE      
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC--GTPEYLAPEVLEDND 172

Query: 589 LTDKSDVYSFGVILLELISGQEAISNE 615
                D +  GV++ E++ G+    N+
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQ 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 63.4 bits (155), Expect = 6e-11
 Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 52/217 (23%)

Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN--EVTLLSRI-HHRNLVQFL 470
           KIG G F  V   +  K GK  A+K +    ++   +  N  E+  L R+  H N+++ +
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 471 G--YCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--EQRI-NWIKRLEIAEDAAKGIEYLH 525
              + ++ GR  LV+E M +  L E + G      E+R+ +++ +L       K ++++H
Sbjct: 65  EVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL------LKSLDHMH 117

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY-- 583
                 I HRD+K  NIL+      K++DFG             S  RG   Y  P Y  
Sbjct: 118 RN---GIFHRDIKPENILIKDD-ILKLADFG-------------SC-RGI--YSKPPYTE 157

Query: 584 YISQQ--------LTD-----KSDVYSFGVILLELIS 607
           YIS +        LTD     K D+++ G +  E++S
Sbjct: 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 63.9 bits (155), Expect = 7e-11
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 12/206 (5%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 469
           K +G G FG V   + K  G+  A+K+L       K E  + VT   +L    H  L   
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q   R   V E+ + G L  HL    + E+     +      +    +EYLH+  V
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRDV 116

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
              ++RD+K  N++LDK    K++DFGL K  +   + + +   GT  YL PE       
Sbjct: 117 ---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDY 172

Query: 590 TDKSDVYSFGVILLELISGQEAISNE 615
               D +  GV++ E++ G+    N+
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQ 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 62.6 bits (153), Expect = 1e-10
 Identities = 53/205 (25%), Positives = 86/205 (41%), Gaps = 29/205 (14%)

Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 471
           +G GGFG V   K+K   +  A+K +         +     +E  +L   +H  +V+   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEY 523
             +++    ++ E+   G L   L              R    E  A+          EY
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILR------------DRGLFDEYTARFYIACVVLAFEY 108

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH      II+RDLK  N+LLD +   K+ DFG +K    G    +    GT  Y+ PE 
Sbjct: 109 LHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC--GTPEYVAPEI 163

Query: 584 YISQQLTDKSDVYSFGVILLELISG 608
            +++      D +S G++L EL++G
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTG 188

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 41/229 (17%)

Query: 412 LEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKRE------------FT--NEVT 456
               +G G +G V        GK +A+K +                      FT   E+ 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 457 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 516
           +++ I H N++  +    E     LV + M +   K         E ++  I  L+I   
Sbjct: 73  IMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCI-LLQIL-- 129

Query: 517 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGAS--------- 566
              G+  LH       +HRDL  +NI ++     K++DFGL+ ++     S         
Sbjct: 130 --NGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 567 -----HVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 609
                  S +V  T+ Y  PE  + +++     D++S G I  EL++G+
Sbjct: 185 QRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 13/206 (6%)

Query: 416 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLG 471
           +G GGFG V   ++K+ GK  A K L     +   G++    E  +L +++   +V  L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVN-LA 59

Query: 472 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
           Y  E    + LV   M+ G LK H+Y        +  +  +  +     GI +LH+    
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERV--IHYSAQITCGILHLHS---M 114

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
            I++RD+K  N+LLD     ++SD GL+    DG +       GT GY+ PE    +  +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA--GTNGYMAPEILKEEPYS 172

Query: 591 DKSDVYSFGVILLELISGQEAISNEK 616
              D ++ G  + E+++G+    + K
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFKDHK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 63.6 bits (155), Expect = 1e-10
 Identities = 58/213 (27%), Positives = 99/213 (46%), Gaps = 29/213 (13%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG----KREFTNEVTLLSRIHHRNL 466
            ++ IG G FGVV+     +DGK +A+K +  N +Q     KR F  E+ +L    H N+
Sbjct: 4   PDRPIGYGAFGVVWSVTDPRDGKRVALKKMP-NVFQNLVSCKRVF-RELKMLCFFKHDNV 61

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------- 519
           +  L   Q          ++    ++  L+  +   Q +        + D  K       
Sbjct: 62  LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPL--------SSDHVKVFLYQIL 113

Query: 520 -GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVG 577
            G++YLH+     I+HRD+K  N+L++ +   K+ DFGL++    D + H++  V  T  
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169

Query: 578 YLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 609
           Y  PE  + S+  T   D++S G I  EL+  +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 9/167 (5%)

Query: 447 GKREFT-NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 505
           G+R  T  E  +L  I+H +++Q  G       + L+         K  LY  L  ++ I
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP-----RYKTDLYCYLAAKRNI 179

Query: 506 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
                L I     + I+YLH      IIHRD+K+ NI ++      + DFG + F VD  
Sbjct: 180 AICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236

Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI 612
           ++      GT+    PE           D++S G++L E+ +  +++
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283

Length = 391

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 49/149 (32%), Positives = 75/149 (50%), Gaps = 13/149 (8%)

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEY 523
           +V F G    +G   +  E M  G+L +     L    RI  N + ++ IA    +G+ Y
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQ----VLKKAGRIPENILGKISIA--VLRGLTY 114

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           L       I+HRD+K SNIL++     K+ DFG+S   +D  S  +S V GT  Y+ PE 
Sbjct: 115 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPER 169

Query: 584 YISQQLTDKSDVYSFGVILLELISGQEAI 612
                 T +SD++S G+ L+E+  G+  I
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 16/206 (7%)

Query: 416 IGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 472
           +G G +GVV   + K+ KEI    K   S   +  +E T  E+ +L  +   N+V+    
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68

Query: 473 CQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            +  G+  LV+E++    L+   E   G    + R ++I +L       K I + H    
Sbjct: 69  FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-SYIYQL------IKAIHWCHKN-- 119

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             I+HRD+K  N+L+  +   K+ DFG ++   +G++   +    T  Y  PE  +    
Sbjct: 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY 178

Query: 590 TDKSDVYSFGVILLELISGQEAISNE 615
               D++S G IL EL  GQ     E
Sbjct: 179 GKAVDMWSVGCILGELSDGQPLFPGE 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 15/202 (7%)

Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 472
           ++G+G  GVV   + K    I  + L     +   + +   E+ +L   +   +V F G 
Sbjct: 12  ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVP 530
              +G   +  E M  G+L +     L   +RI    + ++ IA    +G+ YL      
Sbjct: 72  FYSDGEISICMEHMDGGSLDQ----VLKEAKRIPEEILGKVSIA--VLRGLAYLREK--H 123

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
            I+HRD+K SNIL++     K+ DFG+S   +D  S  +S V GT  Y+ PE       +
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYS 180

Query: 591 DKSDVYSFGVILLELISGQEAI 612
            +SD++S G+ L+EL  G+  I
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 35/216 (16%)

Query: 412 LEKKIGSGGFGVVYY----GKLKDGKEIAVKVLTSNSYQGKREFTNEVT-----LLSRIH 462
           L K +G+G +G V+          GK  A+KVL   +   ++  T E T     +L  + 
Sbjct: 4   LLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLEHVR 62

Query: 463 HRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 519
               +  L Y  Q E +  L+ +++  G +  HLY      QR N+      +ED  +  
Sbjct: 63  QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY------QRDNF------SEDEVRFY 110

Query: 520 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 573
                  +E+LH      I++RD+K  NILLD      ++DFGLSK  +      +    
Sbjct: 111 SGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC 167

Query: 574 GTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 608
           GT+ Y+ PE    +    K+ D +S G+++ EL++G
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 23/210 (10%)

Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSR--IHHRN----LVQ 468
           +G G FG V   + K   E+ A+K+L  +      +   E T++ +  +  ++    L Q
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--ECTMVEKRVLALQDKPPFLTQ 65

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
                Q   R   V E+++ G L  H+   G     Q + +      A + + G+ +LH 
Sbjct: 66  LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISVGLFFLHR 119

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 585
                II+RDLK  N++LD     K++DFG+ K   VDG +  +    GT  Y+ PE   
Sbjct: 120 ---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIA 174

Query: 586 SQQLTDKSDVYSFGVILLELISGQEAISNE 615
            Q      D +++GV+L E+++GQ     E
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 28/208 (13%)

Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQ 468
           K++GSG +G V      + G+++A+K L S  +Q     KR +  E+TLL  + H N++ 
Sbjct: 21  KQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAY-RELTLLKHMQHENVIG 78

Query: 469 FLGY--CQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L        G       LV  +M     K  + G    E ++ ++           G++
Sbjct: 79  LLDVFTSAVSGDEFQDFYLVMPYMQTDLQK--IMGHPLSEDKVQYL-----VYQMLCGLK 131

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK  N+ +++    K+ DFGL++ A   A     +V  T  Y  PE
Sbjct: 132 YIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVV--TRWYRAPE 184

Query: 583 YYIS-QQLTDKSDVYSFGVILLELISGQ 609
             ++        D++S G I+ E+++G+
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 24/218 (11%)

Query: 407 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIHH 463
           DA + LEK IG G +G VY  +    GK +A+K        +G       E++LL  +  
Sbjct: 1   DAYEKLEK-IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSE 59

Query: 464 RN-LVQFLGYCQEEGRS-----VLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIA 514
              +V+ L     E ++      LV+E++ +  LK+ +               IK     
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMY- 117

Query: 515 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSK-FAVDGASHVSSIV 572
               KG+ + H      ++HRDLK  N+L+DK     K++D GL + F++   S+   IV
Sbjct: 118 -QLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173

Query: 573 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 609
             T+ Y  PE  + S   +   D++S G I  E+   Q
Sbjct: 174 --TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 13/201 (6%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 468
           K +G G FG V   +LK   E+ A+KVL  +      +     T +  L     H  L  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                Q + R   V E+++ G L   +       ++ +  +    A +    + +LH   
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQI----QRSRKFDEPRSRFYAAEVTLALMFLHRH- 115

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              +I+RDLK  NILLD     K++DFG+ K  +      ++   GT  Y+ PE     +
Sbjct: 116 --GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEILQELE 172

Query: 589 LTDKSDVYSFGVILLELISGQ 609
                D ++ GV++ E+++GQ
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 63.6 bits (154), Expect = 3e-10
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 36/227 (15%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-----KREFTNEVTLLSRIHHRNLVQ 468
           KKIG+G FG V+  K K  +E       + SY+G     K +   EV ++  + H+N+V+
Sbjct: 19  KKIGNGRFGEVFLVKHKRTQEFFC--WKAISYRGLKEREKSQLVIEVNVMRELKHKNIVR 76

Query: 469 FLGYCQEEGRSVL--VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++     +    L  + EF   G L  ++        +I     ++I       + Y H 
Sbjct: 77  YIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136

Query: 527 ----GCVPAIIHRDLKSSNILLDKHMR-----------------AKVSDFGLSK-FAVDG 564
                    ++HRDLK  NI L   +R                 AK+ DFGLSK   ++ 
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES 196

Query: 565 ASHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQ 609
            +H  S V GT  Y  PE  +  ++   DKSD+++ G I+ EL SG+
Sbjct: 197 MAH--SCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.7 bits (152), Expect = 3e-10
 Identities = 48/164 (29%), Positives = 81/164 (49%), Gaps = 20/164 (12%)

Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE 512
           +E+  L+   H  +V+     + + + +L+ E+   G L + +      +QR+   + L 
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI------KQRLK--EHLP 165

Query: 513 IAEDAAKGIEY--------LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 564
             E     + Y        +H+     ++HRDLKS+NI L      K+ DFG SK   D 
Sbjct: 166 FQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222

Query: 565 AS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            S  V+S   GT  YL PE +  ++ + K+D++S GVIL EL++
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.6 bits (149), Expect = 4e-10
 Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 25/211 (11%)

Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLS-RIHHRN-----LVQ 468
           +G G FG V   + K   E+ A+K+L  +      +   E T++  R+   +     L Q
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV--ECTMVEKRVLALSGKPPFLTQ 65

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR---LEIAEDAAKGIEYLH 525
                Q   R   V E+++ G L   +       Q++   K    +  A + A G+ +LH
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDLMYQI-------QQVGRFKEPHAVFYAAEIAIGLFFLH 118

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYY 584
           +     II+RDLK  N++LD     K++DFG+ K  + DG +  +    GT  Y+ PE  
Sbjct: 119 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPEII 173

Query: 585 ISQQLTDKSDVYSFGVILLELISGQEAISNE 615
             Q      D ++FGV+L E+++GQ     E
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 60.9 bits (148), Expect = 6e-10
 Identities = 51/163 (31%), Positives = 82/163 (50%), Gaps = 32/163 (19%)

Query: 415 KIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGKREFT----NEVTLLSRIHHRNLVQ 468
           KIG G FG V+  + K  K+I    KVL  N  +G   F      E+ +L  + H N+V 
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVVN 75

Query: 469 FLGYCQEE--------GRSVLVYEFMHNGTLKEH-LYGTLTHEQ---RINWIKRLEIAED 516
            +  C+ +        G   LV+EF       EH L G L+++     ++ IK+  + + 
Sbjct: 76  LIEICRTKATPYNRYKGSFYLVFEFC------EHDLAGLLSNKNVKFTLSEIKK--VMKM 127

Query: 517 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 559
              G+ Y+H      I+HRD+K++NIL+ K    K++DFGL++
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 61.8 bits (150), Expect = 6e-10
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQ 468
           + + +GSG  G V   K + DG+  AVKV+         K     EV  L      ++V+
Sbjct: 36  ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVK 95

Query: 469 FLGYCQEE------------GRSVLVYEFMHNGTLKEHLYGT-------LTHEQRINWIK 509
               C E+                LV ++ + G L++ +            HE  + +I+
Sbjct: 96  ----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151

Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHV 568
            L         + ++H+     +IHRD+KS+NILL  +   K+ DFG SK +A   +  V
Sbjct: 152 VL-------LAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDV 201

Query: 569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
                GT  Y+ PE +  +  + K+D++S GV+L EL++
Sbjct: 202 GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240

Length = 496

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 61.3 bits (149), Expect = 6e-10
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 34/212 (16%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 469
           K IG G FG V   + K  K++ A+K+L+      + +   F  E  +++  +   +VQ 
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 521
               Q++    +V E+M  G L             +N +   +I E  A+         +
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDL-------------VNLMSNYDIPEKWARFYTAEVVLAL 155

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 580
           + +H+      IHRD+K  N+LLDK    K++DFG   K   +G     + V GT  Y+ 
Sbjct: 156 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYIS 211

Query: 581 PEYYISQ----QLTDKSDVYSFGVILLELISG 608
           PE   SQ        + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 61.2 bits (148), Expect = 7e-10
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 34/212 (16%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 469
           K IG G FG V   + K  +++    L S     KR     F  E  +++  +   +VQ 
Sbjct: 49  KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 521
               Q++    +V E+M  G L             +N +   ++ E  AK         +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWAKFYTAEVVLAL 155

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 580
           + +H+     +IHRD+K  N+LLDKH   K++DFG   K    G     + V GT  Y+ 
Sbjct: 156 DAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYIS 211

Query: 581 PEYYISQ----QLTDKSDVYSFGVILLELISG 608
           PE   SQ        + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)

Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 472
           ++G+G  GVV+    K    I  + L     +   + +   E+ +L   +   +V F G 
Sbjct: 12  ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71

Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
              +G   +  E M  G+L + L       ++I  + ++ IA    KG+ YL       I
Sbjct: 72  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLREK--HKI 125

Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           +HRD+K SNIL++     K+ DFG+S   +D  S  +S V GT  Y+ PE       + +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSVQ 182

Query: 593 SDVYSFGVILLELISGQEAI 612
           SD++S G+ L+E+  G+  I
Sbjct: 183 SDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 60.8 bits (148), Expect = 8e-10
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 43/214 (20%)

Query: 416 IGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V           +A+K L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKL-SRPFQSAIHAKRTY-RELRLLKHMDHENVIGLL 80

Query: 471 -----GYCQEEGRSV-LVYEFMH---NGTLKEHLYGTLTHEQRINWIKRL--EIAEDAAK 519
                    E+ + V LV   M    N  +K      L+ +     I+ L  +I     +
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQ---KLSDDH----IQFLVYQIL----R 129

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG-- 577
           G++Y+H+     IIHRDLK SNI +++    K+ DFGL       A H    + G V   
Sbjct: 130 GLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL-------ARHTDDEMTGYVATR 179

Query: 578 -YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 609
            Y  PE  ++        D++S G I+ EL++G+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.7 bits (147), Expect = 9e-10
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 37/213 (17%)

Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQ 468
           K++GSG +G V      + G ++A+K L    +Q     KR +  E+ LL  + H N++ 
Sbjct: 21  KQVGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAY-RELRLLKHMKHENVIG 78

Query: 469 FLG-YCQEEGRS-----VLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 520
            L  +  +          LV  FM    G L +H       E RI ++          KG
Sbjct: 79  LLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---EKLSEDRIQFL-----VYQMLKG 130

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV---G 577
           ++Y+H      IIHRDLK  N+ +++    K+ DFGL       A    S + G V    
Sbjct: 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL-------ARQTDSEMTGYVVTRW 180

Query: 578 YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 609
           Y  PE  ++    T   D++S G I+ E+++G+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 61.4 bits (149), Expect = 1e-09
 Identities = 37/100 (37%), Positives = 54/100 (54%), Gaps = 3/100 (3%)

Query: 230 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPS 288
           L    L+G IP  +  L  L+ L L  NSL+G IP+      +L I+HL  N  TG +P 
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326

Query: 289 SLMNLPNLRELYVQNNMLSGTVPSSLLSKN--VVLNYAGN 326
           +L +LP L+ L + +N  SG +P +L   N   VL+ + N
Sbjct: 327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 61.4 bits (149), Expect = 1e-09
 Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 1/92 (1%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 282
           ++ ++HL S N TG IP  LT L  L  L L  N  +G IP +     +L ++ L  N L
Sbjct: 309 NLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNL 368

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           TG +P  L +  NL +L + +N L G +P SL
Sbjct: 369 TGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400

Length = 968

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 38/211 (18%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ- 468
           + +G G FG+V   +    G+ +A+K +    S     KR +  E+ LL  + H N++  
Sbjct: 16  QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISL 74

Query: 469 ---FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE------IAEDAAK 519
              F+   ++      +Y           L GT  H  R+   + LE            +
Sbjct: 75  SDIFISPLED------IY-------FVTELLGTDLH--RLLTSRPLEKQFIQYFLYQILR 119

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 579
           G++Y+H+  V   +HRDLK SNIL++++   K+ DFGL++        ++  V  T  Y 
Sbjct: 120 GLKYVHSAGV---VHRDLKPSNILINENCDLKICDFGLARIQ---DPQMTGYV-STRYYR 172

Query: 580 DPEYYISQQLTD-KSDVYSFGVILLELISGQ 609
            PE  ++ Q  D + D++S G I  E++ G+
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)

Query: 412 LEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSYQGKREFT----NEVTLLSRIHH 463
           L K +G+G +G V+  +       GK  A+KVL   +   K + T     E  +L  I  
Sbjct: 4   LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 63

Query: 464 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK---RLEIAEDAAK 519
              +  L Y  Q + +  L+ ++++ G L  HL       QR  + +   ++   E    
Sbjct: 64  SPFLVTLHYAFQTDTKLHLILDYINGGELFTHL------SQRERFKEQEVQIYSGE-IVL 116

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 578
            +E+LH      II+RD+K  NILLD +    ++DFGLSK F  D      S   GT+ Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFC-GTIEY 172

Query: 579 LDPEYYISQQLT-DKS-DVYSFGVILLELISG 608
           + P+         DK+ D +S GV++ EL++G
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 49/205 (23%), Positives = 93/205 (45%), Gaps = 18/205 (8%)

Query: 416 IGSGGFGVVYYGKLKDGK--------EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 467
           +G G F  ++ G  ++          E+ +KVL  +       F    +++S++ H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
              G C     S++V E++  G+L  +L     ++  IN   +LE+A+  A  + +L   
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLK---KNKNLINISWKLEVAKQLAWALHFLED- 118

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVGYLDPE-Y 583
               + H ++ + N+LL +    K  +    K +  G S       I+   + ++ PE  
Sbjct: 119 --KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176

Query: 584 YISQQLTDKSDVYSFGVILLELISG 608
              Q L+  +D +SFG  L E+ SG
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 46/191 (24%), Positives = 86/191 (45%), Gaps = 21/191 (10%)

Query: 454 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-INWIKRLE 512
           E  LL  ++H ++++          + +V            LY  LT   R +   + L 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLP-----HYSSDLYTYLTKRSRPLPIDQALI 161

Query: 513 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 572
           I +   +G+ YLH      IIHRD+K+ NI ++   +  + D G ++F V   + +   +
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216

Query: 573 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI------SNEKFGANCRN--- 623
            GTV    PE     +   K+D++S G++L E+++    I      + E++  +C +   
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLL 276

Query: 624 -IVQWAKLHIE 633
            I+   K+H E
Sbjct: 277 KIISTLKVHPE 287

Length = 357

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 21/203 (10%)

Query: 415 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGY 472
           K+G G +  V+ G+ K     +A+K +     +G       EV+LL  + H N+V     
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 473 CQEEGRSVLVYEFMHNGTLKEHL--YGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGC 528
              E    LV+E++ +  LK++L   G L   H  +I   + L       +G+ Y H   
Sbjct: 72  IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL-------RGLSYCHK-- 121

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI-S 586
              I+HRDLK  N+L+++    K++DFGL++  +V   ++ + +V  T+ Y  P+  + S
Sbjct: 122 -RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGS 178

Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
            + +   D++  G IL E+ +G+
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 26/208 (12%)

Query: 415 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFLGY 472
           ++G G +G VY    +  G  +A+K +     + K  +   E+ +L +     +V F G 
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67

Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL---HTGCV 529
              EG   +  E+M  G+L + LY      + I       I     KG+++L   H    
Sbjct: 68  FFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--- 123

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLDPEYYIS 586
             IIHRD+K +N+L++ + + K+ DFG+S       + V+S+ +  +G   Y+ PE   S
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTNIGCQSYMAPERIKS 175

Query: 587 QQLTD------KSDVYSFGVILLELISG 608
                      +SDV+S G+ +LE+  G
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALG 203

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 60.6 bits (147), Expect = 2e-09
 Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 1/93 (1%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG-CPDLRIIHLEDNQ 281
           P++  + LS+  L+G IP+D+   SSL  L L GN L G IP+       L  + L  NQ
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           L G +P  L  + +L+ +Y+  N LSG +P  +
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI 232

Length = 968

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 60.7 bits (147), Expect = 2e-09
 Identities = 54/171 (31%), Positives = 79/171 (46%), Gaps = 29/171 (16%)

Query: 405 IEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           IE+    + K I  G FG VY G K  + K  AVKV+       K +  N+  +      
Sbjct: 3   IEEFV--IVKPISRGAFGKVYLGRKKNNSKLYAVKVVK------KADMINKNMVHQVQAE 54

Query: 464 RNLV-----QF---LGYCQEEGRSV-LVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLE 512
           R+ +      F   L Y  +   +V LV E++  G +K   H+YG    E  + +I  + 
Sbjct: 55  RDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVA 114

Query: 513 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 563
           +A D      YLH      IIHRDLK  N+L+      K++DFGLSK  ++
Sbjct: 115 LALD------YLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 57.9 bits (140), Expect = 6e-09
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 37/219 (16%)

Query: 414 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNLVQ 468
           K I +G +G VY  + K+ ++  A+K +   +     Q ++ F  E  +L+   +  +V 
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVS 65

Query: 469 FLGYCQEEGRSVL--VYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
              +C  E +  L  V E++  G   TL +++ G L  +     + R+  AE     +EY
Sbjct: 66  M--FCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVD-----MARMYFAE-TVLALEY 116

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--------------AVDGASHVS 569
           LH      I+HRDLK  N+L+      K++DFGLSK                 D    + 
Sbjct: 117 LHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
             V GT  Y+ PE  + Q      D ++ G+IL E + G
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 57.7 bits (139), Expect = 8e-09
 Identities = 66/264 (25%), Positives = 105/264 (39%), Gaps = 71/264 (26%)

Query: 412 LEKKIGSGGFGVVY------YGKLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 463
           L K +G G FG V         K      +AVK+L   +   + +   +E+ +L  I +H
Sbjct: 11  LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNH 70

Query: 464 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHL---------YGTLTHEQRINWIKRLEI 513
            N+V  LG C +  G  +++ EF   G L   L         Y   + +QR  +   +E 
Sbjct: 71  LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130

Query: 514 A------------------------------------------ED-------AAKGIEYL 524
           +                                          ED        A+G+E+L
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEY 583
            +      IHRDL + NILL ++   K+ DFGL++       +V     R  + ++ PE 
Sbjct: 191 AS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES 247

Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
              +  T +SDV+SFGV+L E+ S
Sbjct: 248 IFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 57.7 bits (139), Expect = 8e-09
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 37/211 (17%)

Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 82

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS    E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 83  DVFTP-ARS---LEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 134

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YL 579
           Y+H+     IIHRDLK SN+ +++    K+ DFGL       A H    + G V    Y 
Sbjct: 135 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL-------ARHTDDEMTGYVATRWYR 184

Query: 580 DPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
            PE  ++    +++ D++S G I+ EL++G+
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 57.6 bits (139), Expect = 1e-08
 Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 6/92 (6%)

Query: 518 AKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGT 575
           A+G+E+L +  C    IHRDL + NILL ++   K+ DFGL++       +V     R  
Sbjct: 183 ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           + ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 51/202 (25%), Positives = 100/202 (49%), Gaps = 19/202 (9%)

Query: 415 KIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGY 472
           K+G G +  VY G+ K     +A+K +     +G       EV+LL  + H N+V     
Sbjct: 13  KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72

Query: 473 CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRIN-WIKRLEIAEDAAKGIEYLHTGCV 529
              E    LV+E++ +  LK++L   G   +   +  ++ +L       +G+ Y H    
Sbjct: 73  IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQL------LRGLNYCHR--- 122

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI-SQ 587
             ++HRDLK  N+L+++    K++DFGL++  ++   ++ + +V  T+ Y  P+  + S 
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGST 180

Query: 588 QLTDKSDVYSFGVILLELISGQ 609
             + + D++  G I  E+ +G+
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 54/226 (23%)

Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIH-HRNL 466
           K++G G +G+V      +  + + +A+K +T   S     KR    E+ LL     H+N+
Sbjct: 6   KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-RELKLLRHFRGHKNI 64

Query: 467 V-----------QFLG-YCQEEGRSVLVYEFMHNGT------LKEHLYGTLTHEQRINWI 508
                        F   Y  EE     +++ + +G        +  +Y  L         
Sbjct: 65  TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILC-------- 116

Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----FAVDG 564
                      G++Y+H+  V   +HRDLK  N+L++     K+ DFGL++       + 
Sbjct: 117 -----------GLKYIHSANV---LHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN 162

Query: 565 ASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
           A  ++  V  T  Y  PE  +S Q   K+ DV+S G IL EL+  +
Sbjct: 163 AGFMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 29/207 (14%)

Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQFLG 471
           IG G +  V   +LK   +I A+KV+         +      E  +  +      +  L 
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 472 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 522
            C Q   R  LV E+++ G L  H+       QR       ++ E+ A+         + 
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHM-----QRQR-------KLPEEHARFYAAEICIALN 110

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH      II+RDLK  N+LLD     K++D+G+ K  + G    +S   GT  Y+ PE
Sbjct: 111 FLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-GPGDTTSTFCGTPNYIAPE 166

Query: 583 YYISQQLTDKSDVYSFGVILLELISGQ 609
               ++     D ++ GV++ E+++G+
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 25/218 (11%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 469
           K IG G FG V   KLK+  ++ A+K+L       + E   F  E  +L    ++ +   
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 470 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
               Q+E    LV ++   G   TL       L  +    ++  + IA D+   + Y   
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+K  NIL+D +   +++DFG     ++  +  SS+  GT  Y+ PE  I 
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE--IL 175

Query: 587 QQLTD-------KSDVYSFGVILLELISGQEAISNEKF 617
           Q + D       + D +S GV + E++ G+     E  
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 50.6 bits (122), Expect = 3e-08
 Identities = 25/61 (40%), Positives = 33/61 (54%), Gaps = 3/61 (4%)

Query: 248 SLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 305
           +L  L L  N LT  IPD  F G P+L+++ L  N LT   P +   LP+LR L +  N 
Sbjct: 1   NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 306 L 306
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 57.1 bits (138), Expect = 3e-08
 Identities = 57/237 (24%), Positives = 92/237 (38%), Gaps = 41/237 (17%)

Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKV----LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           + IG GG G VY        + +A+K     L+ N    KR F  E  + + + H  +V 
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKR-FLREAKIAADLIHPGIVP 66

Query: 469 FLGYCQEEGRSVLVY---EFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAA 518
               C +      VY    ++   TLK  L              ++ +    L I     
Sbjct: 67  VYSICSD---GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123

Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-------------AVDGA 565
             IEY+H+     ++HRDLK  NILL       + D+G + F                  
Sbjct: 124 ATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 566 SHVS-----SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 617
            + S      IV GT  Y+ PE  +    ++ +D+Y+ GVIL ++++       +K 
Sbjct: 181 CYSSMTIPGKIV-GTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236

Length = 932

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 34/91 (37%), Positives = 52/91 (57%), Gaps = 4/91 (4%)

Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTV 576
           AKG+E+L +      IHRDL + NILL ++   K+ DFGL++       +V     R  +
Sbjct: 189 AKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245

Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 52/204 (25%), Positives = 103/204 (50%), Gaps = 21/204 (10%)

Query: 414 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLG 471
           +K+G G +  V+ G+ K  +  +A+K +     +G       EV+LL  + H N+V    
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTG 527
               +    LV+E++ +  LK+++   G +   H  +I   + L       +G+ Y H  
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQIL-------RGLAYCHR- 122

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI- 585
               ++HRDLK  N+L+++    K++DFGL++  +V   ++ + +V  T+ Y  P+  + 
Sbjct: 123 --RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLG 178

Query: 586 SQQLTDKSDVYSFGVILLELISGQ 609
           S + + + D++  G I  E+ SG+
Sbjct: 179 SSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 17/201 (8%)

Query: 415 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFLG 471
           K+G G +  VY G+ K  G+ +A+K +     +G   FT   E +LL  + H N+V    
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               +    LV+E++    LK+++   G       +    RL + +   +G+ Y H    
Sbjct: 71  IIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNV----RLFLFQ-LLRGLAYCHQ--- 121

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
             ++HRDLK  N+L+ +    K++DFGL++ A    S   S    T+ Y  P+  + S +
Sbjct: 122 RRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 589 LTDKSDVYSFGVILLELISGQ 609
            +   D++  G I  E+ +G+
Sbjct: 181 YSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 15/204 (7%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEIA---VKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQF 469
           ++IG+G FG V   ++     +A   VK L +N S + + EF  +      + H N++Q 
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           LG C E    +LV+E+   G LK +L     H +    +    +A + A G+ ++H    
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK--- 117

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGL--SKFAVD---GASHVSSIVRGTVGYLDPEYY 584
              +H DL   N  L   +  KV D+G+  S++  D           +R     L  E++
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177

Query: 585 ---ISQQLTDKSDVYSFGVILLEL 605
              I+ + T  S+V++ GV L EL
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 24/208 (11%)

Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTS---NSYQGKREFTNEVTLLSRIHHRNLVQF 469
           K IG G +G+V   K  +  +++A+K + +   N    KR    E+ LL  + H N++  
Sbjct: 11  KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL-REIKLLRHLDHENVIAI 69

Query: 470 LGYCQEEGRSV-----LVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIE 522
                   R       +VYE M +  L + +    TL+ +    ++ +L       +G++
Sbjct: 70  KDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQL------LRGLK 122

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     ++HRDLK SN+LL+ +   K+ DFGL++   +    ++  V  T  Y  PE
Sbjct: 123 YIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPE 178

Query: 583 YYIS-QQLTDKSDVYSFGVILLELISGQ 609
             ++  + T   DV+S G I  EL+  +
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 5e-08
 Identities = 67/274 (24%), Positives = 98/274 (35%), Gaps = 77/274 (28%)

Query: 414 KKIGSGGFGVV-YYGKLKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 469
           K IG G FG V    K   GK  A+K L  +    K +  +   E  +L+      +V  
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
               Q+     L+ EF+  G L   L  Y T + +     + R  +AE            
Sbjct: 67  YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-----VTRFYMAE------------ 109

Query: 528 CVPAI--------IHRDLKSSNILLDKHMRAKVSDFGLS------------------KFA 561
           CV AI        IHRD+K  NIL+D+    K+SDFGLS                  K  
Sbjct: 110 CVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169

Query: 562 VDGASHVSSIV----------------------------RGTVGYLDPEYYISQQLTDKS 593
            +   + +S+                              GT  Y+ PE ++ Q    + 
Sbjct: 170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229

Query: 594 DVYSFGVILLELISGQEAISNEKFGANCRNIVQW 627
           D +S G I+ E + G     +E      R I+ W
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINW 263

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 55.1 bits (132), Expect = 6e-08
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)

Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQFL 470
           IG G +  V   +LK  + I A+KV+         +     T +       +H  LV   
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 522
              Q E R   V E+++ G L  H+       QR       ++ E+ A+         + 
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHM-----QRQR-------KLPEEHARFYSAEISLALN 110

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YLH      II+RDLK  N+LLD     K++D+G+ K  +      S+   GT  Y+ PE
Sbjct: 111 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE 166

Query: 583 YYISQQLTDKSDVYSFGVILLELISGQ 609
               +      D ++ GV++ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 54.8 bits (132), Expect = 7e-08
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 29/207 (14%)

Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNLVQFL 470
           IG G +  V   +LK  + I A+KV+         +     T +    +  +H  LV   
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 522
              Q E R   V EF+  G L  H+       QR       ++ E+ A+         + 
Sbjct: 63  SCFQTESRLFFVIEFVSGGDLMFHM-----QRQR-------KLPEEHARFYSAEISLALN 110

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH      II+RDLK  N+LLD     K++D+G+ K  +      +S   GT  Y+ PE
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGDTTSTFCGTPNYIAPE 166

Query: 583 YYISQQLTDKSDVYSFGVILLELISGQ 609
               +      D ++ GV++ E+++G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.9 bits (132), Expect = 8e-08
 Identities = 35/102 (34%), Positives = 56/102 (54%), Gaps = 12/102 (11%)

Query: 511 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
           L  +   AKG+ +L +  C    IHRDL + NILL      K+ DFGL++   D  +  +
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR---DIRNDSN 269

Query: 570 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            +V+G     V ++ PE   +   T +SDV+S+G++L E+ S
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 54.6 bits (131), Expect = 8e-08
 Identities = 62/254 (24%), Positives = 97/254 (38%), Gaps = 49/254 (19%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 469
           K IG G FG V   + KD   I A+K+L       K +  +   E  +L       +V+ 
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
               Q++    L+ EF+  G +   L    TL+ E    +I    +A DA   + +    
Sbjct: 67  FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF---- 122

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------------------SKFAVDGAS 566
                IHRD+K  N+LLD     K+SDFGL                     S F+    +
Sbjct: 123 -----IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 567 -------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 613
                         ++    GT  Y+ PE ++        D +S GVI+ E++ G     
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 614 NEKFGANCRNIVQW 627
           +E      R ++ W
Sbjct: 238 SETPQETYRKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 54.9 bits (132), Expect = 1e-07
 Identities = 31/88 (35%), Positives = 48/88 (54%), Gaps = 1/88 (1%)

Query: 230 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPS 288
           LS  +L+G IP  + +L +L  L L  N+ TG IP   +  P L+++ L  N+ +G +P 
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350

Query: 289 SLMNLPNLRELYVQNNMLSGTVPSSLLS 316
           +L    NL  L +  N L+G +P  L S
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCS 378

Length = 968

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 16/200 (8%)

Query: 414 KKIGSGGFGVVYYGKLKDGK--EIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQ 468
           + +G+G FG V     K+     +A+K    +    +++     +E  +L+ I+H   V 
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
             G  ++E    LV EF+  G      +  L   +R         A       EYL +  
Sbjct: 96  LYGSFKDESYLYLVLEFVIGG----EFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS-- 149

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              I++RDLK  N+LLDK    K++DFG +K  VD  ++    + GT  Y+ PE  ++  
Sbjct: 150 -LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYT---LCGTPEYIAPEILLNVG 204

Query: 589 LTDKSDVYSFGVILLELISG 608
               +D ++ G+ + E++ G
Sbjct: 205 HGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 1e-07
 Identities = 63/236 (26%), Positives = 90/236 (38%), Gaps = 55/236 (23%)

Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG----KREFTNEVTLLSRIHHRNLVQ 468
           K +G G  G V+  +LK  GK  A+KVL           KR  T E  +L+ + H  L  
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLT-EQEILATLDHPFLPT 65

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 520
                Q E    LV ++   G     L+  L  +      K L   E+ A+         
Sbjct: 66  LYASFQTETYLCLVMDYCPGG----ELFRLLQRQPG----KCLS--EEVARFYAAEVLLA 115

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR------- 573
           +EYLH      I++RDLK  NILL +     +SDF LSK +      VS  +R       
Sbjct: 116 LEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172

Query: 574 ---------------------GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
                                GT  Y+ PE           D ++ G++L E++ G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 61/254 (24%), Positives = 97/254 (38%), Gaps = 49/254 (19%)

Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 469
           K IG G FG V   + KD G   A+K+L       K +  +   E  +L       +V+ 
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
               Q++    L+ EF+  G +   L    TLT E+   +I    +A D+   + +    
Sbjct: 67  FYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF---- 122

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------------------SKFAVDGAS 566
                IHRD+K  N+LLD     K+SDFGL                     S F     +
Sbjct: 123 -----IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 567 -------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS 613
                         ++    GT  Y+ PE ++        D +S GVI+ E++ G     
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 614 NEKFGANCRNIVQW 627
           +E      + ++ W
Sbjct: 238 SETPQETYKKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 34/102 (33%), Positives = 57/102 (55%), Gaps = 12/102 (11%)

Query: 511 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
           L      A+G+E+L +  CV    HRDL + N+LL +    K+ DFGL++  +  +++VS
Sbjct: 240 LSFTYQVARGMEFLASKNCV----HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295

Query: 570 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
              +G+    V ++ PE       T  SDV+S+G++L E+ S
Sbjct: 296 ---KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 20/203 (9%)

Query: 415 KIGSGGFGVVYYGK-LKDG-KEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLV 467
           +IG G +G V+  + LK+G + +A+K V      +G    T  EV +L  +    H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 468 QFLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           +    C       E +  LV+E + +  L  +L            IK  ++     +G++
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLD 124

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     ++HRDLK  NIL+    + K++DFGL++      +  S +V  T+ Y  PE
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 179

Query: 583 YYISQQLTDKSDVYSFGVILLEL 605
             +        D++S G I  E+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 52.7 bits (126), Expect = 4e-07
 Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 34/212 (16%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 469
           K IG G FG V   + K  +++    L S     KR     F  E  +++  +   +VQ 
Sbjct: 49  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 521
               Q++    +V E+M  G L             +N +   ++ E  A+         +
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWARFYTAEVVLAL 155

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 580
           + +H+      IHRD+K  N+LLDK    K++DFG   K   +G     + V GT  Y+ 
Sbjct: 156 DAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 211

Query: 581 PEYYISQ----QLTDKSDVYSFGVILLELISG 608
           PE   SQ        + D +S GV L E++ G
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 42/222 (18%)

Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           + +G G  G+V+     D  K +AVK +     Q  +    E+ ++ R+ H N+V+    
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK---- 66

Query: 473 CQEEGRSVLVYEFM-HNGTLKEHLYGTLTHEQRI------------NWIKRLEIAEDAAK 519
                    VYE +  +G+      G+LT    +            N +++  ++E+ A+
Sbjct: 67  ---------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117

Query: 520 --------GIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSS 570
                   G++Y+H+  V   +HRDLK +N+ ++ + +  K+ DFGL++      SH   
Sbjct: 118 LFMYQLLRGLKYIHSANV---LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174

Query: 571 IVRGTVG--YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 609
           +  G V   Y  P   +S    T   D+++ G I  E+++G+
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.4 bits (125), Expect = 4e-07
 Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 41/213 (19%)

Query: 416 IGSGGFGVV---YYGKLKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           +GSG +G V   Y  +L+  +++AVK L S  +Q     R    E+ LL  + H N++  
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKL-SRPFQSLIHARRTYRELRLLKHMKHENVIGL 79

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKE----HLYGTLTHEQRINWIKRLEIAEDAA------- 518
           L              F    +++     +L   L      N +K  +++++         
Sbjct: 80  LDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL 127

Query: 519 -KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
            +G++Y+H+     IIHRDLK SN+ +++    ++ DFGL++ A D    ++  V  T  
Sbjct: 128 LRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGYV-ATRW 180

Query: 578 YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
           Y  PE  ++    +++ D++S G I+ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 4e-07
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 27/211 (12%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 469
           K IG G FG V   K+K+  ++ A+K+L       + E   F  E  +L     R +   
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 470 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
               Q+E    LV ++   G   TL       L  +    ++  + +A D+   + Y   
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY--- 123

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYYI 585
                 +HRD+K  N+LLDK+   +++DFG   +   DG    S++  GT  Y+ PE  I
Sbjct: 124 ------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ-SNVAVGTPDYISPE--I 174

Query: 586 SQQLTD-------KSDVYSFGVILLELISGQ 609
            Q + D       + D +S GV + E++ G+
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.7 bits (126), Expect = 5e-07
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 25/213 (11%)

Query: 416 IGSGGFGVVYYGKLKDGKE-IAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           IG+G FGVVY     D  E +A+K VL    Y+ +     E+ ++  ++H N++    Y 
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-----ELLIMKNLNHINIIFLKDYY 128

Query: 474 QEEG-----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE----DAAKGIEYL 524
             E      +++ +   M       H Y  + H  R N    L + +       + + Y+
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKY--MKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           H+     I HRDLK  N+L+D +    K+ DFG +K  + G   VS I   +  Y  PE 
Sbjct: 187 HS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC--SRFYRAPEL 241

Query: 584 YI-SQQLTDKSDVYSFGVILLELISGQEAISNE 615
            + +   T   D++S G I+ E+I G    S +
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274

Length = 440

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 52.1 bits (125), Expect = 5e-07
 Identities = 50/181 (27%), Positives = 66/181 (36%), Gaps = 50/181 (27%)

Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL---------SKF 560
           R  IAE     IE +H       IHRD+K  NIL+D+    K++DFGL         SK+
Sbjct: 104 RFYIAE-LTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159

Query: 561 AVDGASH----------VSSIVR-----------------------GTVGYLDPEYYISQ 587
              G  H           S I R                       GT  Y+ PE  +  
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219

Query: 588 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-LHIESGDIQGIIDPSLL 646
             T   D +S GVIL E++ GQ     +        ++ W   LHI S   Q  +     
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPS---QAKLSREAS 276

Query: 647 D 647
           D
Sbjct: 277 D 277

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.5 bits (123), Expect = 6e-07
 Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 25/210 (11%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 469
           K IG G FG V   K+K  + I A+K+L       + E   F  E  +L     + +   
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66

Query: 470 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
               Q+E    LV ++   G   TL       L  +    +I  + +A  +   + Y   
Sbjct: 67  HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY--- 123

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+K  N+LLD +   +++DFG         +  SS+  GT  Y+ PE  I 
Sbjct: 124 ------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE--IL 175

Query: 587 QQLTD-------KSDVYSFGVILLELISGQ 609
           Q + D       + D +S GV + E++ G+
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 43/233 (18%)

Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKLK----------------DGKEIAVKVLTSNSY 445
           L DI      ++K IG GGFG VY  +                  + + I ++ L  N+ 
Sbjct: 6   LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNI 65

Query: 446 QGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE 502
                  +++ L   IH   H  + ++ G C    R  + Y F+    L E L    T E
Sbjct: 66  YDI----DKIALWKNIHNIDHLGIPKYYG-CGSFKRCRMYYRFI----LLEKLVEN-TKE 115

Query: 503 --QRI-NWIKRL--EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 557
             +RI    K+L   I +D    +EY+H      I H D+K  NI++D + R  + D+G+
Sbjct: 116 IFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGI 172

Query: 558 SKFAVDGASHVS------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLE 604
           +   +    H+        + RGT+ Y   + +    +T + D+ S G  +L+
Sbjct: 173 ASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 33/102 (32%), Positives = 59/102 (57%), Gaps = 12/102 (11%)

Query: 511 LEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
           L  +   A+G+++L +  C    IHRD+ + N+LL     AK+ DFGL++  ++ +++V 
Sbjct: 215 LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV- 269

Query: 570 SIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             V+G     V ++ PE       T +SDV+S+G++L E+ S
Sbjct: 270 --VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 52/226 (23%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLV 467
           +++ IG G +GVV        G+++A+K +  + ++   + T    E+ LL  + H ++V
Sbjct: 4   IQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIV 62

Query: 468 Q----FLGYCQEEGRSV-LVYEFMH---------NGTL-KEH----LYGTLTHEQRINWI 508
           +     L   + E + + +V+E M          N  L  EH    LY  L         
Sbjct: 63  EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL--------- 113

Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASH 567
                     + ++Y+HT  V    HRDLK  NIL +   + K+ DFGL++ A  D  + 
Sbjct: 114 ----------RALKYIHTANV---FHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160

Query: 568 V--SSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQ 609
           +  +  V  T  Y  PE   S   + T   D++S G I  E+++G+
Sbjct: 161 IFWTDYV-ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 37/219 (16%)

Query: 415 KIGSGGFGVVYYGKLKDG---KEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLV-- 467
           K+G G +G VY  K KDG   KE A+K +  T  S    R    E+ LL  + H N++  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR----EIALLRELKHPNVIAL 63

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEH-LYGTLT-HEQRINWIKRLEIAEDAAK------ 519
           Q +     + +  L++++       EH L+  +  H       K +++     K      
Sbjct: 64  QKVFLSHSDRKVWLLFDY------AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117

Query: 520 --GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSI-- 571
             GI YLH   V   +HRDLK +NIL+     +  R K++D G ++        ++ +  
Sbjct: 118 LDGIHYLHANWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174

Query: 572 VRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 609
           V  T  Y  PE  + ++  T   D+++ G I  EL++ +
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 49.7 bits (118), Expect = 4e-06
 Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 26/228 (11%)

Query: 389 LNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK 448
           ++D PA A     +  +  +T+  E      G      GK K  + IA +V      +  
Sbjct: 153 IDDLPAGAFGKIFICALRASTEEAEA---RRGVNSTNQGKPKCERLIAKRV--KAGSRAA 207

Query: 449 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV--------YEFMHNGTLKEHLYGTLT 500
            +  NE+  L R++H N+++     + E  + ++        Y FM++          L 
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267

Query: 501 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG-LSK 559
             + I  +K+L  A      +EY+H      +IHRD+K  NI L+   +  + DFG    
Sbjct: 268 QTRAI--MKQLLCA------VEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316

Query: 560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           F  +  +     V GTV    PE        + +D++S G+ILL+++S
Sbjct: 317 FEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 16/150 (10%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV--QFLG 471
           K +  G    VY    KD     +K+  S      RE   EV +L  +  + L   + L 
Sbjct: 4   KLLKGGLTNRVYLLGTKDED-YVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLA 60

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
             + +G S L+ E++   TL E     ++ E++ +      IAE  A+ +  LH   +  
Sbjct: 61  SGESDGWSYLLMEWIEGETLDE-----VSEEEKED------IAEQLAELLAKLHQLPLLV 109

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFA 561
           + H DL   NIL+D      + D+  + + 
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYG 139

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 48.3 bits (116), Expect = 5e-06
 Identities = 28/80 (35%), Positives = 40/80 (50%), Gaps = 8/80 (10%)

Query: 532 IIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
           IIH D+K  N+L D+   R  + D+GL K          S   GT+ Y  PE  I     
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPE-KIKGHNY 183

Query: 591 DKS-DVYSFGVILLELISGQ 609
           D S D ++ GV+  EL++G+
Sbjct: 184 DVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 22/207 (10%)

Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLG 471
           +G G FG V   + K   +I A+KV+  +    +     F  E  +LS  +   + Q   
Sbjct: 9   VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
             Q++    LV E+   G L   L  Y     E       +  +AE     +  +H+   
Sbjct: 69  AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYLAEL----VLAIHSVHQ 120

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-GTVGYLDPEYYISQQ 588
              +HRD+K  N+L+D+    K++DFG S   +     V+S +  GT  Y+ PE   +  
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179

Query: 589 LTDKS------DVYSFGVILLELISGQ 609
              K       D +S GVI  E+I G+
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 48.5 bits (115), Expect = 7e-06
 Identities = 52/210 (24%), Positives = 94/210 (44%), Gaps = 19/210 (9%)

Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG-Y 472
           K+G G +G VY  K KDGK+     L      G       E+ LL  + H N++     +
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 473 CQEEGRSV-LVYEFMHNG---TLKEHLYGTLTHEQRINWIKRL--EIAEDAAKGIEYLHT 526
                R V L++++  +     +K H   +  +++ +   + +   +      GI YLH 
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFH-RASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126

Query: 527 GCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLD 580
             V   +HRDLK +NIL+     +  R K++D G ++        ++ +  V  T  Y  
Sbjct: 127 NWV---LHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 581 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 609
           PE  + ++  T   D+++ G I  EL++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.5 bits (115), Expect = 9e-06
 Identities = 30/95 (31%), Positives = 56/95 (58%), Gaps = 12/95 (12%)

Query: 518 AKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT- 575
           A G+E+L +  CV    HRDL + N+L+ +    K+ DFGL++  +  ++++S   +G+ 
Sbjct: 249 ANGMEFLASKNCV----HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS---KGST 301

Query: 576 ---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
              + ++ PE   +   T  SDV+SFG++L E+ +
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 47.7 bits (114), Expect = 9e-06
 Identities = 48/211 (22%), Positives = 82/211 (38%), Gaps = 30/211 (14%)

Query: 417 GSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGY 472
                 +V+  K K     +AVK   +     K +      E+    ++ H N++ ++  
Sbjct: 9   CFEDLMIVHLAKHKPTNTLVAVKK-INLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67

Query: 473 CQEEGRSVLVYEFMHNGT----LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-G 527
              +    +V   M  G+    LK H    L  E  I +I +     D    ++Y+H+ G
Sbjct: 68  FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-ELAIAFILK-----DVLNALDYIHSKG 121

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG------YLDP 581
                IHR +K+S+ILL    +  +S    S   +        +            +L P
Sbjct: 122 F----IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177

Query: 582 EYYISQQL---TDKSDVYSFGVILLELISGQ 609
           E  + Q L    +KSD+YS G+   EL +G 
Sbjct: 178 EV-LQQNLQGYNEKSDIYSVGITACELANGH 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 2/85 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++  + LS  N   ++P ++  LS+L EL L  NS+   +   S   +L  + L +N+L
Sbjct: 186 SNLNNLDLSG-NKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKL 244

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLS 307
              LP S+ NL NL  L + NN +S
Sbjct: 245 E-DLPESIGNLSNLETLDLSNNQIS 268

Length = 394

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.4 bits (110), Expect = 4e-05
 Identities = 47/195 (24%), Positives = 81/195 (41%), Gaps = 25/195 (12%)

Query: 452 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 511
            +E  LL R+ H  ++  L      G + LV     +      LY  L    R+  +   
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-----DLYTYLG--ARLRPLGLA 260

Query: 512 EIAEDAAK---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
           ++   A +    I+Y+H      IIHRD+K+ N+L++      + DFG + FA    S  
Sbjct: 261 QVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFA--RGSWS 315

Query: 569 SSIVRGTVGYLD---PEYYISQQLTDKSDVYSFGVILLE-------LISGQEAISNEKFG 618
           +    G  G +D   PE       T   D++S G+++ E       L S         + 
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYD 375

Query: 619 ANCRNIVQWAKLHIE 633
           A    I++ A++H++
Sbjct: 376 AQILRIIRQAQVHVD 390

Length = 461

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 41/220 (18%)

Query: 416 IGSGGFGVVYYGKLKD---------GKEIAV--KVLTSNSYQGKREFTNEVTLLSRIHHR 464
           +G G F  +Y G L+          G+E++V  KVL S+ ++    F    +L+S++ H+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-HRDSLAFFETASLMSQLSHK 61

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN----WIKRLEIAEDAAKG 520
           +LV+  G C  +  +++V E++  G L   L     H ++ N    W  +L++A+  A  
Sbjct: 62  HLVKLYGVCVRDE-NIMVEEYVKFGPLDVFL-----HREKNNVSLHW--KLDVAKQLASA 113

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKH-------MRAKVSDFGLSKFAVDGASHVSSIVR 573
           + YL       ++H ++   NIL+ ++          K+SD G+    +     V  I  
Sbjct: 114 LHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-- 168

Query: 574 GTVGYLDPEYY--ISQQLTDKSDVYSFGVILLELISGQEA 611
               ++ PE        LT  +D +SFG  LLE+ S  E 
Sbjct: 169 ---PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 45.6 bits (108), Expect = 7e-05
 Identities = 27/88 (30%), Positives = 47/88 (53%), Gaps = 8/88 (9%)

Query: 412 LEKKIGSGGFGVVY------YGKLKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 463
             K +G+G FG V        GK  +   +AVK+L ++++  +RE   +E+ +LS +  H
Sbjct: 42  FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQH 101

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTL 491
           +N+V  LG C   G  +++ E+   G L
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDL 129

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 45.6 bits (108), Expect = 7e-05
 Identities = 58/230 (25%), Positives = 96/230 (41%), Gaps = 28/230 (12%)

Query: 387 SSLNDAPAEAAHCFTLSDIEDATKM---LEKKIGSGGFGVVY----YGKLKDGKEIAVKV 439
           S   D   E     + SD     +M   +   +  G  G V+    +G  +  K++ VK 
Sbjct: 68  SPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKA 126

Query: 440 LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL-GYCQEEGRSVLVYEFMHNGTLKEHLYGT 498
           +T     G +    E+ +L  I HR ++  +  Y  +    +++ ++  +        G 
Sbjct: 127 VT-----GGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGP 181

Query: 499 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 558
           L  EQ I   +RL  A      + YLH      IIHRD+K+ NI LD+   A + DFG +
Sbjct: 182 LPLEQAITIQRRLLEA------LAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA 232

Query: 559 KFAVDGASHVSSIVRGTVGYLD---PEYYISQQLTDKSDVYSFGVILLEL 605
                 A   +    G  G L+   PE         K+D++S G++L E+
Sbjct: 233 --CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 39/146 (26%), Positives = 60/146 (41%), Gaps = 15/146 (10%)

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 522
           N+V    Y   E    LV +    G L  H+  +  +  E    W   + +A DA     
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
            LH      I+ RDL  +NILLD     +++ F      V+ +    ++      Y  PE
Sbjct: 101 -LHR---EGIVCRDLNPNNILLDDRGHIQLTYFS-RWSEVEDSCDGEAVENM---YCAPE 152

Query: 583 YYISQQLTDKSDVYSFGVILLELISG 608
                + T+  D +S G IL EL++G
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 73/296 (24%), Positives = 103/296 (34%), Gaps = 105/296 (35%)

Query: 412 LEKKIGSGGFGVVYYG-----KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN- 465
           L KK+G G FGVVY       + K   +  +K   +  Y     + NE     R    N 
Sbjct: 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK--KATEYGAVEIWMNERV---RRACPNS 190

Query: 466 ----LVQFLGYCQEEGRSV--LVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEI 513
               +  FL     +      LV+ +    TL      KE  Y     E  +     L  
Sbjct: 191 CADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNV---EPYL-----LGK 242

Query: 514 AEDAAKGIEY------------------LH-TGCVPAIIHRDLKSSNILLDKHMRA-KVS 553
            +D  KG+E                   LH TG    I+HRD+K  NI+  +   + K+ 
Sbjct: 243 VQDLPKGLERENKIIQTIMRQILFALDGLHSTG----IVHRDVKPQNIIFSEGSGSFKII 298

Query: 554 DFGLSKFAVDGASHVSSIVRGTVGY------LDP------EYYISQQ------------- 588
           D G    A D        +R  + Y      LDP      +Y +S Q             
Sbjct: 299 DLGA---AAD--------LRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATAL 347

Query: 589 --------LTDKSDVYSFGVILLE-----LISGQEAIS-NEKFGANCRNIVQWAKL 630
                   L D+ D+YS G+I L+     L S    I  N +   N  ++V W KL
Sbjct: 348 SPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL 403

Length = 566

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.1 bits (101), Expect = 4e-04
 Identities = 60/248 (24%), Positives = 93/248 (37%), Gaps = 61/248 (24%)

Query: 414 KKIGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 469
           K +G G FG V    K+      A+K L       + +  +   E  +L+   +  +V+ 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++     V +++  G +   L       + +    R  IAE     IE +H    
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIAE-LTLAIESVHK--- 119

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGL---------SKFAVDGASHVS----------- 569
              IHRD+K  NIL+D     K++DFGL         SK+   G SH+            
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG-SHIRQDSMEPSDLWD 178

Query: 570 ----------------------------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI 601
                                       S+V GT  Y+ PE  + +  T   D +S GVI
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLV-GTPNYIAPEVLLRKGYTQLCDWWSVGVI 237

Query: 602 LLELISGQ 609
           L E++ GQ
Sbjct: 238 LFEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 41.8 bits (98), Expect = 7e-04
 Identities = 49/191 (25%), Positives = 84/191 (43%), Gaps = 21/191 (10%)

Query: 431 DGKEIAV--KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN 488
           +G+E+ V  KVL  +       F    +L+S++ H +L    G C     +++V EF+ +
Sbjct: 41  NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100

Query: 489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 548
           G L   L         + W  ++ +A+  A  + YL       ++H ++ + NILL +  
Sbjct: 101 GPLDVCLRKEKGR-VPVAW--KITVAQQLASALSYLED---KNLVHGNVCAKNILLARLG 154

Query: 549 RA-------KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGV 600
            A       K+SD G+S  A+     V  I      ++ PE       L+  +D +SFG 
Sbjct: 155 LAEGTSPFIKLSDPGVSFTALSREERVERI-----PWIAPECVPGGNSLSTAADKWSFGT 209

Query: 601 ILLELISGQEA 611
            LLE+    E 
Sbjct: 210 TLLEICFDGEV 220

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.0 bits (96), Expect = 0.001
 Identities = 35/114 (30%), Positives = 58/114 (50%), Gaps = 15/114 (13%)

Query: 414 KKIGSGGFGVVY----YGKLKDGK--EIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 465
           K +G+G FG V     YG  K      +AVK+L  +++  +RE   +E+ +LS + +H N
Sbjct: 41  KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHIN 100

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI--KRLEIAEDA 517
           +V  LG C   G ++++ E+   G L   L       +R ++I  K  + AE A
Sbjct: 101 IVNLLGACTVGGPTLVITEYCCYGDLLNFL-----RRKRDSFICPKHEDHAEAA 149

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 33/112 (29%)

Query: 517 AAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV--- 572
           A +G+ YLH  G     IHR++K+S+IL        +S  GL   ++ G SH+ S+V   
Sbjct: 110 ALRGLNYLHQNGY----IHRNIKASHIL--------ISGDGL--VSLSGLSHLYSLVRNG 155

Query: 573 -RGTVGYLDPEYYIS-----------QQLTD---KSDVYSFGVILLELISGQ 609
            +  V Y  P++  S           Q L     KSD+YS G+   EL +G+
Sbjct: 156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 40/149 (26%), Positives = 55/149 (36%), Gaps = 51/149 (34%)

Query: 533 IHRDLKSSNILLDKHMRAKVSDFGL---------SKFAVDGASHVS-------------- 569
           IHRD+K  NIL+D+    K++DFGL         SK+   G  HV               
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG-DHVRQDSMDFSNEWGDPA 181

Query: 570 -------------------------SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLE 604
                                    S+V GT  Y+ PE  +    T   D +S GVIL E
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLV-GTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240

Query: 605 LISGQEAISNEKFGANCRNIVQW-AKLHI 632
           ++ GQ     +        ++ W   LHI
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSLHI 269

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	736
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
PLN03150	623	hypothetical protein; Provisional	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.98
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.98
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
PF12819	347	Malectin_like: Carbohydrate-binding protein of the	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.77
PRK10345	210	hypothetical protein; Provisional	99.75
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.75
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.72
smart00090	237	RIO RIO-like kinase.	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.69
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.67
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.62
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.59
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.58
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.54
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.49
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.47
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.41
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.4
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.3
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.29
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.27
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.25
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.22
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.21
PLN03150	623	hypothetical protein; Provisional	99.2
KOG1243	690	consensus Protein kinase [General function predict	99.18
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.16
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.11
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.09
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.08
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.99
KOG3087	229	consensus Serine/threonine protein kinase [General	98.98
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.93
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.91
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.87
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	98.85
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.82
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.72
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.71
COG4248	637	Uncharacterized protein with protein kinase and he	98.7
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.69
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.68
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.67
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.65
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.6
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.6
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.59
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.56
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.48
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.44
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.44
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.44
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.41
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.41
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.39
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.29
PRK09902	216	hypothetical protein; Provisional	98.27
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.27
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.22
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.19
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.08
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.08
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.08
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.07
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.07
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.05
PF01636	239	APH: Phosphotransferase enzyme family This family	98.04
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.04
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.02
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.0
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.98
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	97.95
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	97.94
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.91
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.89
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	97.86
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.85
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.85

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.8e-56  Score=543.02  Aligned_cols=506  Identities=26%  Similarity=0.406  Sum_probs=364.3

Q ss_pred             cccceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHH--HHHH--cCCCCcCCCCCCCCCCCCCceEEecC
Q 004689          145 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVS--VISL--YSSADWAQEGGDPCLPVPWSWLQCNS  219 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~--l~~~--~~~~~w~~~~~dpc~~~~~~~v~c~~  219 (736)
                      .++.+..++++.|.++..+|. +..+..++.|.++.|.+.+.....  ...+  +.+..-...+..|-          ..
T Consensus       426 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~----------~~  495 (968)
T PLN00113        426 KLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPR----------KL  495 (968)
T ss_pred             cCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccCh----------hh
Confidence            356778899999998876665 566677777877777653210000  0000  00111110001110          11


Q ss_pred             CCCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccce
Q 004689          220 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE  298 (736)
Q Consensus       220 ~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~  298 (736)
                      ..+++|+.|+|++|.++|.+|..+.+|++|++|+|++|.++|.+| .+.++++|+.|+|++|+++|.+|..+.++++|+.
T Consensus       496 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~  575 (968)
T PLN00113        496 GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQ  575 (968)
T ss_pred             hhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCE
Confidence            235689999999999999999999999999999999999999998 6899999999999999999999999999999999


Q ss_pred             eecccccCcCCCCccc-ccccccccccCCcccccCCC-----------CCccceEEEeehhhHHHHHHHHhheeeeeecC
Q 004689          299 LYVQNNMLSGTVPSSL-LSKNVVLNYAGNINLHEGGR-----------GAKHLNIIIGSSVGAAVLLLATVVSCLFMHKG  366 (736)
Q Consensus       299 L~l~~N~l~g~~P~~~-~~~~~~l~~~~n~~~c~~~~-----------~~~~~~iii~~~~~~~~~~l~~~~~~~~~~rr  366 (736)
                      |++++|+++|.+|..- +.......+.||+.+|++..           +.....++++++++++++++++++++++++++
T Consensus       576 l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  655 (968)
T PLN00113        576 VNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGR  655 (968)
T ss_pred             EeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhh
Confidence            9999999999999753 33445567899999997531           11112233333333333332333322222222


Q ss_pred             CCCcCcccccccCCCCCCCCCCCCCCCcccccccCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc
Q 004689          367 KKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY  445 (736)
Q Consensus       367 k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~  445 (736)
                       ++...+.. ..    .................++..++... ....+.||+|+||.||+|+.. ++..||||++.....
T Consensus       656 -~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~  728 (968)
T PLN00113        656 -NNLELKRV-EN----EDGTWELQFFDSKVSKSITINDILSS-LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS  728 (968)
T ss_pred             -hccccccc-cc----ccccccccccccccchhhhHHHHHhh-CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc
Confidence             21111100 00    00000000000011122344444432 234578999999999999874 789999998864321


Q ss_pred             ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHH
Q 004689          446 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH  525 (736)
Q Consensus       446 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH  525 (736)
                          ...+|++++++++|||||+++++|.+.+..++||||+++|+|.++++       .++|..+.+++.|+++||+|||
T Consensus       729 ----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH  797 (968)
T PLN00113        729 ----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLH  797 (968)
T ss_pred             ----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhc
Confidence                23457899999999999999999999999999999999999999984       3789999999999999999999


Q ss_pred             hCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHH
Q 004689          526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLEL  605 (736)
Q Consensus       526 ~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~el  605 (736)
                      ..+.++|+||||||+||+++.++.+++. ||.+......     ....||+.|+|||++.+..++.++|||||||++|||
T Consensus       798 ~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el  871 (968)
T PLN00113        798 CRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIEL  871 (968)
T ss_pred             cCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHH
Confidence            7766799999999999999999888876 6665432111     123588999999999999999999999999999999


Q ss_pred             HhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc--CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          606 ISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE--YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       606 ltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      ++|+.||+...  .....+++|++..........++|+.+...  .+.++..++.+++.+|++.+|++||+|+||++.|+
T Consensus       872 ~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  949 (968)
T PLN00113        872 LTGKSPADAEF--GVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE  949 (968)
T ss_pred             HhCCCCCCccc--CCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHH
Confidence            99999995432  234578888887766666677778777543  34566778999999999999999999999999998


Q ss_pred             HHH
Q 004689          684 DAI  686 (736)
Q Consensus       684 ~~~  686 (736)
                      ++.
T Consensus       950 ~~~  952 (968)
T PLN00113        950 SAS  952 (968)
T ss_pred             Hhh
Confidence            774

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-54  Score=461.77  Aligned_cols=287  Identities=49%  Similarity=0.859  Sum_probs=253.8

Q ss_pred             cccccCHHHHHHHHHHhh--ccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeee
Q 004689          396 AAHCFTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC  473 (736)
Q Consensus       396 ~~~~~~~~~i~~~~~~~~--~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~  473 (736)
                      ....|++.++..+|.+|.  ++||+|+||.||+|.+.+++.||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            456799999999999995  799999999999999999999999988765433156699999999999999999999999


Q ss_pred             eeCC-eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEE
Q 004689          474 QEEG-RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV  552 (736)
Q Consensus       474 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl  552 (736)
                      .+.+ +.+||||||++|+|.++|+.....  .++|..|++||.++|+||+|||..+.+.||||||||+|||||+++++||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9998 599999999999999999875433  7899999999999999999999999889999999999999999999999


Q ss_pred             EeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh
Q 004689          553 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       553 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      +|||+|+.......+......||.+|+|||++..+..+.|+|||||||+|+||+||++|.+... +.....++.|++..+
T Consensus       219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLL  297 (361)
T ss_pred             cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHH
Confidence            9999997654312222211179999999999999999999999999999999999999887654 344556999999999


Q ss_pred             hcCCcceeccCccC-CcCCH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          633 ESGDIQGIIDPSLL-DEYDI-QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       633 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      .++++.+++|+.+. +.+.. +++.++..+|.+|++.+|.+||+|.||+++|+.+
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            99999999999998 66665 6889999999999999999999999999999654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=393.30  Aligned_cols=253  Identities=35%  Similarity=0.572  Sum_probs=210.5

Q ss_pred             hhccccccCceEEEEEEECCCcE-EEEEEeccCCccc--chhhhhHHHHHhhcCCCceeeEeeeeeeCC-eEEEEEEecC
Q 004689          412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGYCQEEG-RSVLVYEFMH  487 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~~~~-vAvK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~~lV~e~~~  487 (736)
                      +.+.||+|+||+||+|.++ |+. ||||++.......  .+.|.+|+.+|.+++|||||+++|+|.+.. ..++|||||+
T Consensus        45 ~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            4566999999999999999 555 9999997653322  458999999999999999999999999988 7999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCc-eecCCCCCCCEEEcCCC-cEEEEeecCCccccCCC
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-IIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~-iiHrDikp~NILl~~~~-~~kl~DFGla~~~~~~~  565 (736)
                      +|+|.++++..  ....+++..+++++.|||+||.|||++   + ||||||||+|||++.++ ++||+|||+++......
T Consensus       124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            99999999764  457799999999999999999999998   7 99999999999999997 99999999998654332


Q ss_pred             CcceecccccccccCccccc--cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          566 SHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~--~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                       ...+...||+.|||||++.  ...|+.|+||||||++||||+||+.||.+...    ..+...   ....         
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~~~~---v~~~---------  261 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQVASA---VVVG---------  261 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHHHHH---HHhc---------
Confidence             2223357999999999999  56999999999999999999999999987652    111111   1111         


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ..+...+......+..++..||+.||..||++.||+..|+.+..
T Consensus       262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence            11222233355678889999999999999999999999998755

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-45  Score=369.59  Aligned_cols=256  Identities=29%  Similarity=0.402  Sum_probs=211.1

Q ss_pred             cCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccC-CcccchhhhhHHHHHhhcCCCceeeEeeeeeeCC
Q 004689          400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG  477 (736)
Q Consensus       400 ~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  477 (736)
                      ++..|++     ....||+|..|+|||++++ +++-+|+|++..+ .....+++.+|++++++++||+||+++|.|..+.
T Consensus        76 i~~~dle-----~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   76 ISLSDLE-----RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             cCHHHhh-----hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            5556665     3467999999999999987 6788999999544 3345678999999999999999999999999988


Q ss_pred             -eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeec
Q 004689          478 -RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG  556 (736)
Q Consensus       478 -~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFG  556 (736)
                       ...++||||.+|+|++.+..    .+++++....+|+.++++||.|||+.  .+||||||||+||||+..|++||||||
T Consensus       151 ~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFG  224 (364)
T KOG0581|consen  151 EEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFG  224 (364)
T ss_pred             ceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccc
Confidence             49999999999999999853    36789999999999999999999974  399999999999999999999999999


Q ss_pred             CCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccc-cccccccHHHHHHHhhhcC
Q 004689          557 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK-FGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       557 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~-~~~~~~~l~~~~~~~~~~~  635 (736)
                      .++.+.+.   ...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+.... .......+..++-..    
T Consensus       225 VS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~----  297 (364)
T KOG0581|consen  225 VSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE----  297 (364)
T ss_pred             ccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC----
Confidence            99877654   4566789999999999999999999999999999999999999997641 111222333322211    


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .     .|++..+   ....++..++..|++.||.+||+++|+++|
T Consensus       298 p-----pP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  298 P-----PPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             C-----CCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            1     1222222   234468999999999999999999999887

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-45  Score=388.20  Aligned_cols=260  Identities=27%  Similarity=0.424  Sum_probs=221.2

Q ss_pred             HHHHHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       404 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      ++......+.+.||+|-||+||.|.++....||+|.++.. ......|.+|+++|++++|+|||+++++|..++.++|||
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            4555666788999999999999999997779999999765 334677889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      |||+.|+|.++|..  ..+..+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+|+...+
T Consensus       281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence            99999999999975  3466789999999999999999999998   999999999999999999999999999996655


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      +.........-+..|.|||.+..+.++.|||||||||+||||+| |+.|+.++...+.        ...+..|       
T Consensus       356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev--------~~~le~G-------  420 (468)
T KOG0197|consen  356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV--------LELLERG-------  420 (468)
T ss_pred             CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH--------HHHHhcc-------
Confidence            55545554555789999999999999999999999999999999 9999987763221        1222222       


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                        .+-..+..++..+.+++..|++.+|++|||++.+...|+++.
T Consensus       421 --yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  421 --YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             --CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence              122234456678999999999999999999999988888774

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=369.45  Aligned_cols=197  Identities=31%  Similarity=0.555  Sum_probs=177.1

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccC--CcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.||+|+||+||+|+++ ++.+||||.+...  .....+.+..|+.+|+.++|||||.|++++..++..+||||||.
T Consensus        13 ~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~   92 (429)
T KOG0595|consen   13 ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCN   92 (429)
T ss_pred             eehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCC
Confidence            34566999999999999987 6899999998766  34445668899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC------CcEEEEeecCCccc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH------MRAKVSDFGLSKFA  561 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~------~~~kl~DFGla~~~  561 (736)
                      ||+|.++|+.    .+.+++.....++.|+|.||++||++   +||||||||.||||+..      -.+||+|||+|+.+
T Consensus        93 gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   93 GGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            9999999954    45799999999999999999999999   99999999999999875      56899999999987


Q ss_pred             cCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccc
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK  616 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~  616 (736)
                      ..  .....+.+|++.|||||++..++|+.|+|+||+|+++|||++|+.||+...
T Consensus       166 ~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  166 QP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             Cc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            64  344567889999999999999999999999999999999999999998655

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-45  Score=373.74  Aligned_cols=254  Identities=26%  Similarity=0.395  Sum_probs=205.3

Q ss_pred             HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc-------cchhhhhHHHHHhhcCCCceeeEeeeeeeCCe
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR  478 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  478 (736)
                      ..+|.+.+.||+|+||.|-+|..+ +|+.||||++++....       ......+|+++|++++|||||++++++..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            345566899999999999999754 7999999999765221       12345799999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC---CcEEEEee
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDF  555 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~---~~~kl~DF  555 (736)
                      .|+||||++||+|.+++-.    ...+.+..-..++.|++.|+.|||++   ||+||||||+|||+..+   ..+||+||
T Consensus       251 ~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             eEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999999853    34455556678999999999999998   99999999999999876   78999999


Q ss_pred             cCCccccCCCCcceecccccccccCccccccCc---CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh
Q 004689          556 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       556 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      |+|+...  ....+.+.|||+.|.|||++.+..   +..++|+||+|||||-+++|.+||.+...+..   +    ..++
T Consensus       324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s---l----~eQI  394 (475)
T KOG0615|consen  324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS---L----KEQI  394 (475)
T ss_pred             chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc---H----HHHH
Confidence            9999765  445667789999999999998654   33478999999999999999999987664321   1    1223


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      ..|++..      .+....+...+.++++.+|+..||++||++.|++++=
T Consensus       395 ~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp  438 (475)
T KOG0615|consen  395 LKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP  438 (475)
T ss_pred             hcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence            3333321      1112234456789999999999999999999999873

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-44  Score=386.08  Aligned_cols=248  Identities=25%  Similarity=0.411  Sum_probs=211.1

Q ss_pred             HHHHhhccccccCceEEEEEEE-CCCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      .+|...+.||+|||+.||.++. .+|+.||+|++.+..   ......+.+|++|.+.|+|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4566688999999999999988 789999999998653   233566889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      |+|.+|+|.+++.    ....+++..+..++.||+.||.|||+.   +|+|||||..|+|++++.++||+|||+|..+..
T Consensus        98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            9999999999884    356799999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      . .+...+.+|||.|+|||++....++..+||||+|||||-||.|++||+.....+.+..|..        .+   ..  
T Consensus       171 ~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~--------~~---Y~--  236 (592)
T KOG0575|consen  171 D-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL--------NE---YS--  236 (592)
T ss_pred             c-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh--------cC---cc--
Confidence            3 2444567899999999999999999999999999999999999999997764443333322        11   00  


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                           .+.....+..+|+..+++++|.+|||+++|+.+
T Consensus       237 -----~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  237 -----MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -----cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                 011223357789999999999999999999876

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-45  Score=357.92  Aligned_cols=259  Identities=27%  Similarity=0.415  Sum_probs=210.2

Q ss_pred             HHHHhhccccccCceEEEEEEE-CCCcEEEEEEeccC--CcccchhhhhHHHHHhhcCCCceeeEee-eeeeCCe-EEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLG-YCQEEGR-SVLV  482 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~-~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~-~~~~~~~-~~lV  482 (736)
                      +.+.+.++||+|.||+|||+.. .+|..||.|.+.-.  ......+...|+.+|++++|||||++++ -+.++.. +++|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3456789999999999999964 58999999988633  2334567889999999999999999998 4444444 8999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~--iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      ||||..|+|...+.....+.+.+++..+++++.|++.||.++|++. +.  |+||||||.||+++.+|.+||+|||++++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999888778888999999999999999999999932 24  89999999999999999999999999998


Q ss_pred             ccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      +....+ .....+|||.||+||.+.+.+|+.++||||+||++|||+.-+.||.+...-    ++..    .+.+|+...+
T Consensus       178 l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~----~L~~----KI~qgd~~~~  248 (375)
T KOG0591|consen  178 LSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL----SLCK----KIEQGDYPPL  248 (375)
T ss_pred             hcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH----HHHH----HHHcCCCCCC
Confidence            765543 344567999999999999999999999999999999999999999877532    2221    2333433211


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                           .   +.-....+.+++..|+..||+.||+.-.+++.+..
T Consensus       249 -----p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  249 -----P---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             -----c---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                 1   12234468899999999999999996555555443

>PLN03150 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-43  Score=408.21  Aligned_cols=317  Identities=26%  Similarity=0.425  Sum_probs=241.6

Q ss_pred             ccccccccc-cccccCCCCCC--CcccccCccccccccccccCceeeeccccccCC--CCCCCCcHHHHhhceeccCC--
Q 004689            2 KRENIQSYV-LCNCRYPDDPF--DRIWESDSLKKANYLVDVAAGTEKVSTKLPIDL--RSDELPPQKVMQTAVVGTNG--   74 (736)
Q Consensus         2 ~~~~~~~~~-~~~~ryp~D~~--dR~W~~~~~~~~~~~~~~~~~~~~~st~~~i~~--~~~~~pP~~v~~ta~t~~~~--   74 (736)
                      .|-|+|... ..++|||||+|  ||+|.|+..     +.  ...+.++++...|..  ..++.+|++|||||.++.++  
T Consensus       194 ~R~n~G~~~~~~~~d~~~D~~~~dR~W~~d~~-----~~--~~~~~~~st~~~I~~~~~~~~~~P~~VyqTA~~~~~~~~  266 (623)
T PLN03150        194 KRLSCGAGKSKFDEDYSGDHWGGDRFWNRMQT-----FG--SGSDQAISTENVIKKASNAPNFYPESLYQSALVSTDTQP  266 (623)
T ss_pred             EEEEecCcccccccCCCCCcccCccccCcCcc-----cC--CCcccccccccccccccCCCccChHHHhhhhccccCCCC
Confidence            588888653 33699999999  999998642     11  222566777777762  34567899999999988764  


Q ss_pred             ceEEEEcCCCCCCcceEEEEEeeccC-CCCCCceEEEEEeCCCcCCccccccccccccCcceeccCccccccccceeEEE
Q 004689           75 SLTYRLNLDGFPGFGWAVTYFAEIED-LDPDESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFK  153 (736)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~~~Fae~~~-~~~~~~R~F~i~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~l~  153 (736)
                      .+++.++++ ....+++++||+|++. ....++|+|||++||+.+.+.  .++.......+.+....+.........++.
T Consensus       267 ~lty~~~v~-~~~~Y~VrLhFaEi~~~~~~~~~R~F~V~ing~~~~~~--~di~~~~g~~~~~~~~~~~v~~~~g~l~is  343 (623)
T PLN03150        267 DLSYTMDVD-PNRNYSVWLHFAEIDNSITAEGKRVFDVLINGDTAFKD--VDIVKMSGERYTALVLNKTVAVSGRTLTIV  343 (623)
T ss_pred             ceEEEeecC-CCCCEEEEEEEEeccCccCCCceEEEEEEECCEEeecc--cChhhhcCCcccceEEEeEEeecCCeEEEE
Confidence            355555532 3456778889999985 556789999999999876543  222222222222221111111112445566


Q ss_pred             eeccCCCCCCCccchhhhhhhhccCC--CCchHHHHHHHHHHcCCC---CcCCCCCCCCCCC--CCceEEecCCCC---C
Q 004689          154 FGKTYDSSRGPLLNAMEINKYLERND--GSIDGVAIVSVISLYSSA---DWAQEGGDPCLPV--PWSWLQCNSDPQ---P  223 (736)
Q Consensus       154 l~~~~~s~lpP~in~~e~~~~l~~~~--~~~~~~al~~l~~~~~~~---~w~~~~~dpc~~~--~~~~v~c~~~~~---~  223 (736)
                      |..+.  .-+|+|||+|++++.....  ...|+.||+.+|+.+...   +|.   +|||.|.  +|.||.|+.+..   .
T Consensus       344 l~p~~--~s~pilNaiEI~~~~~~~~~t~~~~~~aL~~~k~~~~~~~~~~W~---g~~C~p~~~~w~Gv~C~~~~~~~~~  418 (623)
T PLN03150        344 LQPKK--GTHAIINAIEVFEIITAESKTLLEEVSALQTLKSSLGLPLRFGWN---GDPCVPQQHPWSGADCQFDSTKGKW  418 (623)
T ss_pred             EeeCC--CCcceeeeeeeeeccccccccCchHHHHHHHHHHhcCCcccCCCC---CCCCCCcccccccceeeccCCCCce
Confidence            66654  4479999999999965444  667999999999988742   775   8999875  799999964322   3


Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      .++.|+|++|+|+|.+|..|.+|++|+.|+|++|+|+|.+| .+++|++|+.|+|++|+|+|.+|..+++|++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            59999999999999999999999999999999999999999 69999999999999999999999999999999999999


Q ss_pred             cccCcCCCCcccccc---cccccccCCcccccCC
Q 004689          303 NNMLSGTVPSSLLSK---NVVLNYAGNINLHEGG  333 (736)
Q Consensus       303 ~N~l~g~~P~~~~~~---~~~l~~~~n~~~c~~~  333 (736)
                      +|+|+|.+|..+...   ...+.+.+|+.+|+.+
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            999999999987542   3467899999999864

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-44  Score=389.52  Aligned_cols=266  Identities=25%  Similarity=0.447  Sum_probs=224.1

Q ss_pred             HHHHHHHHhhccccccCceEEEEEEEC----CCcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCe
Q 004689          404 DIEDATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR  478 (736)
Q Consensus       404 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  478 (736)
                      ||......++++||.|.||+||+|+++    ....||||.++....+ ..++|..|+.||.++.||||++|.|+......
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P  704 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP  704 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence            455555567899999999999999886    2456999999876443 46789999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCC
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS  558 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla  558 (736)
                      .++|+|||++|+|+.||+..   ..++.+.+...|+.+||.||.||.+.   ++|||||.++||||+.+..+|++|||++
T Consensus       705 vMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence            99999999999999999754   46699999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCCcceecccc--cccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcC
Q 004689          559 KFAVDGASHVSSIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       559 ~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      +.+.++.....++.-|  ..+|.|||.+..++++.++||||||+||||.++ |.+||.++..++..    .    .    
T Consensus       779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI----k----a----  846 (996)
T KOG0196|consen  779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI----K----A----  846 (996)
T ss_pred             eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH----H----H----
Confidence            9876665333333223  468999999999999999999999999999988 99999988743221    1    1    


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREA  692 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~  692 (736)
                           ++...+-..+++++..|.+|++.|++.|-.+||.+.||+..|.+++..+..-
T Consensus       847 -----Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL  898 (996)
T KOG0196|consen  847 -----IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL  898 (996)
T ss_pred             -----HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence                 1222233346778889999999999999999999999999999987554433

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-42  Score=386.59  Aligned_cols=260  Identities=28%  Similarity=0.460  Sum_probs=218.2

Q ss_pred             HHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  480 (736)
                      ....+.+.||+|+||+||+|+..      +..-||||.++..... ...+|++|+++|..++|||||+|+|.|.+++.++
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~  565 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC  565 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence            33346788999999999999754      3456999999877554 6789999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccc------c----ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcE
Q 004689          481 LVYEFMHNGTLKEHLYGTLT------H----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA  550 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~  550 (736)
                      +|+|||..|||.+||.....      .    ...++..+.+.||.|||.||+||-++   .+|||||..+|+||.++..|
T Consensus       566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEE
Confidence            99999999999999965421      1    22388999999999999999999998   99999999999999999999


Q ss_pred             EEEeecCCccccCCCCccee-cccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHH
Q 004689          551 KVSDFGLSKFAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWA  628 (736)
Q Consensus       551 kl~DFGla~~~~~~~~~~~~-~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~  628 (736)
                      ||+|||+++.....+.+... ...=..+||+||.+..++++.++|||||||||||+++ |+.||.+....    +.    
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~----EV----  714 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ----EV----  714 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH----HH----
Confidence            99999999976555444322 2334689999999999999999999999999999999 99999877632    22    


Q ss_pred             HHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          629 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       629 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ...++.|++.         ..+..++.++..|+..||+..|++||+++||-..|+....
T Consensus       715 Ie~i~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  715 IECIRAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             HHHHHcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            2334445442         2345567789999999999999999999999999998753

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.2e-42  Score=339.15  Aligned_cols=269  Identities=21%  Similarity=0.258  Sum_probs=205.1

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      ..++|+|+||+|||++.+ +|+-||||++....  ..-++-..+|+++|++++|||+|.|+++|.....++||+|||+.-
T Consensus         7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT   86 (396)
T KOG0593|consen    7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT   86 (396)
T ss_pred             hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence            357999999999999987 58999999986442  223455789999999999999999999999999999999999885


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      -|.++-    .....++.....+++.|++.|+.|+|++   ++|||||||+||||+.++.+||||||+|+.+.. .....
T Consensus        87 vL~eLe----~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~Y  158 (396)
T KOG0593|consen   87 VLHELE----RYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDNY  158 (396)
T ss_pred             HHHHHH----hccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccchh
Confidence            554433    2234578888999999999999999999   999999999999999999999999999997753 33344


Q ss_pred             ecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh-------h-cCCccee
Q 004689          570 SIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI-------E-SGDIQGI  640 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~-------~-~~~~~~~  640 (736)
                      +..+.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+-|.+.+.-+..-.|+......+       . +.-+..+
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            55678999999999998 7899999999999999999999999987663211111211111111       1 1112222


Q ss_pred             ccCccCCcC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHHHHHH
Q 004689          641 IDPSLLDEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDAIVIE  689 (736)
Q Consensus       641 ~d~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~~~~~  689 (736)
                      .=|....--     -......+++++..|++.||.+|++-+|++.+  ++..+.++
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er~  294 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIERE  294 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHHH
Confidence            111111110     11223368899999999999999999999876  55555544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=346.44  Aligned_cols=245  Identities=28%  Similarity=0.420  Sum_probs=201.1

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.++||+|+||+||.++.+ +++-+|+|++++....   ..+...+|..||.+++||+||+++-.|.+.+.+|||+||+.
T Consensus        29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~  108 (357)
T KOG0598|consen   29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN  108 (357)
T ss_pred             eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence            5789999999999999766 6888999999876433   34567899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      ||.|..+|    ++++.+++..+.-++.+|+.||.|||++   +||||||||+|||+|.+|+++|+|||+++..... ..
T Consensus       109 GGeLf~hL----~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~  180 (357)
T KOG0598|consen  109 GGELFYHL----QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GD  180 (357)
T ss_pred             CccHHHHH----HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC-CC
Confidence            99999999    4567789998899999999999999998   9999999999999999999999999999854332 23


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      .+.+++||+.|||||++.+..|+.++|.||+|+++|||++|.+||...........+..        +++      ...+
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~--------~k~------~~~p  246 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILK--------GKL------PLPP  246 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhc--------CcC------CCCC
Confidence            34457899999999999999999999999999999999999999987653322222211        220      0011


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCC----CHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRP----SISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RP----t~~ev~~~  681 (736)
                      .+   ...+..+++...+..||++|.    +..+|-+|
T Consensus       247 ~~---ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  247 GY---LSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             cc---CCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence            11   122467788899999999996    45555444

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.2e-40  Score=319.34  Aligned_cols=261  Identities=21%  Similarity=0.291  Sum_probs=203.8

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +|...++||+|.||.||+|+.. +|+.||||+++.....  -.....+|+..|+.++|+||+.++++|...+...||+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            3445688999999999999764 7999999998755322  245678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      |+. +|+..+++   ....+....+..++.++++|++|||++   .|+||||||+|+|++.+|.+||+|||+|+.+....
T Consensus        83 m~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   83 MPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            976 89888864   345688889999999999999999998   99999999999999999999999999999876544


Q ss_pred             CcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee----
Q 004689          566 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI----  640 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~----  640 (736)
                      ...... +-|.+|+|||.+.+ +.|+..+||||.|||+.||+-|.+-|.+.+.   .+++...++ .+.......+    
T Consensus       156 ~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD---idQL~~If~-~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  156 RIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD---IDQLSKIFR-ALGTPTPDQWPEMT  230 (318)
T ss_pred             cccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch---HHHHHHHHH-HcCCCCcccCcccc
Confidence            333222 57999999999986 6799999999999999999999988876652   222222222 1111111111    


Q ss_pred             -----ccCc-----cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          641 -----IDPS-----LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       641 -----~d~~-----l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                           .+=.     .....-..+....++++..++..||.+|+++.|.+++
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                 0000     0000112233456999999999999999999999876

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-40  Score=348.24  Aligned_cols=258  Identities=25%  Similarity=0.337  Sum_probs=202.4

Q ss_pred             hhccccccCceEEEEEEE-CCCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeC--CeEEEEEEec
Q 004689          412 LEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFM  486 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV~e~~  486 (736)
                      ..++||+|.||.||+|+. .+|+.||+|+++-..  ........+||.||++|.||||++|.+...+.  ...|||+|||
T Consensus       121 ki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYM  200 (560)
T KOG0600|consen  121 KIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYM  200 (560)
T ss_pred             HHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecc
Confidence            346899999999999975 479999999987554  33456678999999999999999999998776  6899999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      +. +|..++..   ..-.|+..++..++.|++.||+|||++   +|+|||||.+|||||.+|.+||+|||+|+++.....
T Consensus       201 dh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  201 DH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS  273 (560)
T ss_pred             cc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence            87 78777742   345789999999999999999999999   999999999999999999999999999998766665


Q ss_pred             cceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhc--------CCc
Q 004689          567 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES--------GDI  637 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~--------~~~  637 (736)
                      ...+..+-|++|+|||++.+ ..|+.++|+||.||||.||+.|++.|.+...-   .++....+.. ..        .++
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv---eQl~kIfklc-GSP~e~~W~~~kL  349 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV---EQLHKIFKLC-GSPTEDYWPVSKL  349 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH---HHHHHHHHHh-CCCChhccccccC
Confidence            55666678999999999987 58999999999999999999999999876521   1222211111 10        011


Q ss_pred             c--eeccC------ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 Q--GIIDP------SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~--~~~d~------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .  ..+.+      ++.+. -.......++|+..++..||.+|.|+.++++.
T Consensus       350 P~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             CcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            1  01111      11110 00112357889999999999999999998754

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=354.92  Aligned_cols=264  Identities=27%  Similarity=0.495  Sum_probs=210.8

Q ss_pred             HHHHHHHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeE
Q 004689          402 LSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       402 ~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  479 (736)
                      ..||......+.+.||+|.||+||+|+|.  ..||||++......  ..+.|++|+.++++-+|.||+-+.|||..+.. 
T Consensus       386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-  462 (678)
T KOG0193|consen  386 EWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-  462 (678)
T ss_pred             ccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence            34555555667889999999999999996  57999999876433  45679999999999999999999999999888 


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      .+|+.+|+|.+|+.+||..   +.+|...+.+.||.|+|+|+.|||.+   +|||||||..|||+.+++.|||+|||++.
T Consensus       463 AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  463 AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccccee
Confidence            9999999999999999854   46788999999999999999999998   99999999999999999999999999985


Q ss_pred             cccC-CCCcceecccccccccCcccccc---CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC
Q 004689          560 FAVD-GASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       560 ~~~~-~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      .-.. ..........|...|||||++..   .+|+..+||||||||+|||++|..||.........        .+...|
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi--------fmVGrG  608 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII--------FMVGRG  608 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE--------EEeccc
Confidence            3211 11122223447889999999974   47899999999999999999999999843311111        111222


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      .+.    +++. .....+.+++.+|+..|+..++++||.+.+|+..|++++.
T Consensus       609 ~l~----pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  609 YLM----PDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ccC----ccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            111    1110 1123456678899999999999999999999999988764

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-40  Score=347.70  Aligned_cols=246  Identities=26%  Similarity=0.351  Sum_probs=204.3

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEe
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      .|++.||+|+|++|++|+.. ++++||||++.+.-   .....-...|-.+|.+| .||.|++|+-.|.++..+|+|+||
T Consensus        76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~  155 (604)
T KOG0592|consen   76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY  155 (604)
T ss_pred             chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence            47889999999999999865 68999999987542   22234467888999999 899999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.++|..    .+.|++....-++.+|+.||+|||++   |||||||||+|||+|.+|++||+|||.|+.+.+..
T Consensus       156 A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  156 APNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             cCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            999999999953    46789999999999999999999998   99999999999999999999999999998764322


Q ss_pred             Cc----------c--eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh
Q 004689          566 SH----------V--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE  633 (736)
Q Consensus       566 ~~----------~--~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~  633 (736)
                      ..          .  ...++||..|.+||++.....+..+|+|+|||+||+|+.|++||.+...--.++.|+..      
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l------  302 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL------  302 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh------
Confidence            11          1  14478999999999999999999999999999999999999999876632222222221      


Q ss_pred             cCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          634 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       634 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                              |=.+.+.++    ..+.+|+.+.+..||.+|+|..||.+|
T Consensus       303 --------~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  303 --------DYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             --------cccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence                    111122223    457889999999999999999999887

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-41  Score=348.50  Aligned_cols=268  Identities=21%  Similarity=0.262  Sum_probs=207.6

Q ss_pred             HHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcC-CCceeeEeeeeeeCC-eEEE
Q 004689          406 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEG-RSVL  481 (736)
Q Consensus       406 ~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~-~~~l  481 (736)
                      ...+|.+.++||.|.||.||+|+.. +|..||||.++..-. .++..=.+|+..|++++ |||||+|.+++.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            3456778899999999999999765 689999999976532 23334468999999998 999999999998887 9999


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      |||||+. +|.+++.++   .+.+++..+..|+.||++||+|+|.+   |+.|||+||+|||+.....+||+|||+|+..
T Consensus        88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence            9999975 899998754   56799999999999999999999999   9999999999999999899999999999977


Q ss_pred             cCCCCcceecccccccccCccccc-cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC----
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD----  636 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~----  636 (736)
                      ......+  ..+.|.+|+|||++. .+-|+.+.|||++|||++|+.+-++-|.+...-+..-.|.+-......+.+    
T Consensus       161 ~SkpPYT--eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  161 RSKPPYT--EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             ccCCCcc--hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            6554433  345799999999986 577999999999999999999999999876632222222221111100000    


Q ss_pred             -cceecc---CccCC----cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          637 -IQGIID---PSLLD----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       637 -~~~~~d---~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                       +...+.   |...+    ..-.....+..+++.+|++.||.+|||+.|.+++-
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence             000110   01000    00112456789999999999999999999999873

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-40  Score=340.48  Aligned_cols=254  Identities=26%  Similarity=0.364  Sum_probs=201.3

Q ss_pred             HHhhccccccCceEEEEEEECC-CcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCC--eEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~lV~e~~  486 (736)
                      +...+.||+|+||+||++...+ |...|||.+........+.+.+|+.+|++++|||||+.+|.....+  .+++.|||+
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~   98 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA   98 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence            3456889999999999998764 8999999886553333566899999999999999999999855444  689999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeecCCccccC--
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVD--  563 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~-~~~~kl~DFGla~~~~~--  563 (736)
                      ++|+|.+++.+..   ..+++..+..+..|+++||+|||++   +|+||||||+|||++. ++.+||+|||+++....  
T Consensus        99 ~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   99 PGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             CCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999996432   2699999999999999999999998   9999999999999999 79999999999986553  


Q ss_pred             CCCcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      ..........||+.|||||++..+ ....++||||+||++.||+||+.||....      ....+......++..     
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~------~~~~~~~~ig~~~~~-----  241 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF------EEAEALLLIGREDSL-----  241 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc------chHHHHHHHhccCCC-----
Confidence            222333457799999999999863 33459999999999999999999997531      112222222222211     


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                      |    ..+.....+..+++.+|+..+|++|||+.+++++.-.
T Consensus       242 P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  242 P----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             C----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            1    1222233457889999999999999999999988654

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.9e-40  Score=353.52  Aligned_cols=262  Identities=26%  Similarity=0.407  Sum_probs=203.1

Q ss_pred             HHHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeC-C
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-G  477 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~-~  477 (736)
                      ...+.+.++||+|+||.||+|.+.      +++.||||+++.... .....+.+|+.+++++ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            345667889999999999999742      356799999875432 2345688999999999 899999999988764 4


Q ss_pred             eEEEEEEecCCCCHHHHhhccccc--------------------------------------------------------
Q 004689          478 RSVLVYEFMHNGTLKEHLYGTLTH--------------------------------------------------------  501 (736)
Q Consensus       478 ~~~lV~e~~~~gsL~~~l~~~~~~--------------------------------------------------------  501 (736)
                      ..++||||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            578999999999999998642110                                                        


Q ss_pred             --ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc-ceecccccccc
Q 004689          502 --EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGY  578 (736)
Q Consensus       502 --~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y  578 (736)
                        ...+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++........ ......+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              12477888899999999999999998   9999999999999999999999999999865333222 12233467889


Q ss_pred             cCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHH
Q 004689          579 LDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI  657 (736)
Q Consensus       579 ~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  657 (736)
                      +|||++.+..++.++|||||||++|||++ |..||.+....+   .+.    ..+..+....     .    +......+
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~---~~~----~~~~~~~~~~-----~----~~~~~~~l  306 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE---EFC----QRLKDGTRMR-----A----PENATPEI  306 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH---HHH----HHHhcCCCCC-----C----CCCCCHHH
Confidence            99999999999999999999999999997 999997644211   111    1112221110     1    11223458


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          658 EEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       658 ~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      .+++.+|++.||++||++.||++.|++++.
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=334.90  Aligned_cols=261  Identities=25%  Similarity=0.377  Sum_probs=207.4

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCccc-chhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      ..|.+.+.||.|.-++||+|+.. .++.||||++.-..... -..+.+|+..|+.++||||++++..|..+..+++||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            34567889999999999999754 68999999997654443 47789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      |.+|++.+.+.....  ..+++..+..|.+++++||.|||.+   |.||||||+.||||+.+|.|||+|||.+-.+.+..
T Consensus       106 Ma~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999987654  3489999999999999999999999   99999999999999999999999999986544322


Q ss_pred             Cc---ceecccccccccCcccccc--CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          566 SH---VSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       566 ~~---~~~~~~gt~~Y~aPE~~~~--~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      ..   ...+.+||++|||||++..  ..|+.|+||||||+...||.+|..||.....-   ..+..-    + ++.....
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm---kvLl~t----L-qn~pp~~  252 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM---KVLLLT----L-QNDPPTL  252 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH---HHHHHH----h-cCCCCCc
Confidence            11   1145689999999999643  67999999999999999999999999865511   111111    1 1222111


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .-..+..+........+.+++..|++.||.+|||+.+++++
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            10011111122233478899999999999999999999865

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-39  Score=348.13  Aligned_cols=249  Identities=25%  Similarity=0.428  Sum_probs=203.7

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccC----Cc-ccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN----SY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~----~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~  480 (736)
                      ..|.+.+.||+|.||+|+.|.+. ++..||+|++...    .. .....+.+|+.++++++ ||||+++++++......+
T Consensus        17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~   96 (370)
T KOG0583|consen   17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY   96 (370)
T ss_pred             CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence            34567789999999999999765 6899999977653    11 23456778999999998 999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeecCCc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSK  559 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~-~~~kl~DFGla~  559 (736)
                      +||||+.+|+|.+++..    ..++.+..+..++.|+++|++|||++   +|+||||||+|||++.+ +++||+|||++.
T Consensus        97 ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   97 IVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             EEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999953    46788889999999999999999998   99999999999999999 999999999998


Q ss_pred             cccCCCCcceecccccccccCccccccCc-CC-CcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYISQQ-LT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~-~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                      ... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.....    +..    .+..+.+
T Consensus       170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~----l~~----ki~~~~~  240 (370)
T KOG0583|consen  170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN----LYR----KIRKGEF  240 (370)
T ss_pred             ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH----HHH----HHhcCCc
Confidence            663 3334456678999999999999877 86 78999999999999999999998744211    111    1222221


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .      +.....   ..++..++.+|+..+|.+|+++.+|+++
T Consensus       241 ~------~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  241 K------IPSYLL---SPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             c------CCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence            0      001110   3468899999999999999999999843

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=347.63  Aligned_cols=245  Identities=27%  Similarity=0.408  Sum_probs=206.7

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      -.+||+|+.|.||.|... +++.||||++.......++-+.+|+.+|+..+|+|||.+++.|...+.++.|||||++|+|
T Consensus       278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL  357 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL  357 (550)
T ss_pred             hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence            367999999999999654 6889999999877777777899999999999999999999999999999999999999999


Q ss_pred             HHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceec
Q 004689          492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI  571 (736)
Q Consensus       492 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  571 (736)
                      .+.+..     ..+++.++..|+.++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+..... ...+
T Consensus       358 TDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR~T  428 (550)
T KOG0578|consen  358 TDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KRST  428 (550)
T ss_pred             hhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cccc
Confidence            998843     3488999999999999999999999   999999999999999999999999999876655444 4455


Q ss_pred             ccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCH
Q 004689          572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI  651 (736)
Q Consensus       572 ~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  651 (736)
                      .+||+.|||||++....|+.+.||||||++++||+-|++||-.+..       .+-.+.....|...      +.  ...
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-------lrAlyLIa~ng~P~------lk--~~~  493 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------LRALYLIATNGTPK------LK--NPE  493 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-------HHHHHHHhhcCCCC------cC--Ccc
Confidence            6799999999999999999999999999999999999999975431       11122222233221      11  112


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          652 QSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       652 ~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .....+.+++.+|+..|+++||++.|+++|
T Consensus       494 klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  494 KLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            233468899999999999999999999987

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=375.17  Aligned_cols=265  Identities=29%  Similarity=0.439  Sum_probs=216.3

Q ss_pred             HHHHHHHhhccccccCceEEEEEEECC--Cc----EEEEEEeccC-CcccchhhhhHHHHHhhcCCCceeeEeeeeeeCC
Q 004689          405 IEDATKMLEKKIGSGGFGVVYYGKLKD--GK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG  477 (736)
Q Consensus       405 i~~~~~~~~~~IG~G~fG~Vy~~~~~~--~~----~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  477 (736)
                      +......+.+.||+|.||.||+|...+  |.    .||||.++.. +.+...+|.+|..+|+.++|||||+++|+|.+.+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            444445567899999999999998653  33    4899988765 4556788999999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcccc---cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 004689          478 RSVLVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD  554 (736)
Q Consensus       478 ~~~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~D  554 (736)
                      ..++++|||++|+|..+|++...   ....+.....+.++.|||+|+.||+++   ++|||||.++|+||+....+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence            99999999999999999975421   244588899999999999999999998   999999999999999999999999


Q ss_pred             ecCCccccCCCCcceecc-cccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhh
Q 004689          555 FGLSKFAVDGASHVSSIV-RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       555 FGla~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      ||+|+.+.+......... .-...|||||.+..+.++.|+|||||||+|||++| |..||...+..    .+..   ...
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~----~v~~---~~~  918 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF----EVLL---DVL  918 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH----HHHH---HHH
Confidence            999996555443333222 23468999999999999999999999999999999 89999876521    1111   122


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                      +.|++          +.+..++..+.+++..||+.+|++||++..|++.+..+....
T Consensus       919 ~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  919 EGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             hCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence            23322          234455667889999999999999999999999988876653

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=343.25  Aligned_cols=248  Identities=29%  Similarity=0.449  Sum_probs=204.8

Q ss_pred             cCHHHHHHHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeE
Q 004689          400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       400 ~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  479 (736)
                      +.+++|.+.     +-||+|+.|.||+|++. ++.||||+++.-       -+.+|.-|++|+||||+.+.|+|.....+
T Consensus       121 iPFe~IsEL-----eWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcy  187 (904)
T KOG4721|consen  121 IPFEEISEL-----EWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCY  187 (904)
T ss_pred             CCHHHhhhh-----hhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCcee
Confidence            344555443     34899999999999998 799999987522       24678899999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      |+|||||..|-|...|+    .++.+.......+..+||.||.|||.+   .|||||||.-||||+.+..+||+|||-++
T Consensus       188 CIiMEfCa~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  188 CIIMEFCAQGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             EEeeeccccccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchH
Confidence            99999999999999994    456677778889999999999999998   99999999999999999999999999998


Q ss_pred             cccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ...+.  .+...++||..|||||++...+.++|+||||||||||||+||..||.+.....+.     |..   ...    
T Consensus       261 e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII-----wGV---GsN----  326 (904)
T KOG4721|consen  261 ELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-----WGV---GSN----  326 (904)
T ss_pred             hhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE-----Eec---cCC----
Confidence            76554  2333467999999999999999999999999999999999999999765421111     100   011    


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                          .+.--.+..++.-+.-|+..|++-.|..||++++|+.||+..
T Consensus       327 ----sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  327 ----SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             ----cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence                111223455666788999999999999999999999999754

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=352.66  Aligned_cols=256  Identities=30%  Similarity=0.440  Sum_probs=206.7

Q ss_pred             HhhccccccCceEEEEEEECC--C---cEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLKD--G---KEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~--~---~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      .+.++||+|+||.||+|++..  +   ..||||..+...   .....+|.+|+++|++++|||||+++|++.....+++|
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv  239 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV  239 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence            356899999999999998763  2   238999988532   34467899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      ||+|.||+|.++|...   ...++..+++.++.++|.||+|||++   +++||||.++|+|++.++.+||+|||+++...
T Consensus       240 mEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  240 MELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             EEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            9999999999999643   23689999999999999999999998   99999999999999999999999999987543


Q ss_pred             CCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      .... ......-+..|+|||.+....|+.++|||||||++||+++ |..||.+....    .+..++.   ..+.     
T Consensus       314 ~~~~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~---~~~~-----  380 (474)
T KOG0194|consen  314 QYVM-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----EVKAKIV---KNGY-----  380 (474)
T ss_pred             ceee-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----HHHHHHH---hcCc-----
Confidence            1111 1111234689999999999999999999999999999999 89999877632    2333321   1111     


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                          +-..+...+..+..+..+|+..+|++||+|.+|.+.|+.+....
T Consensus       381 ----r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  381 ----RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             ----cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence                11122244556778888999999999999999999999886543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-38  Score=335.06  Aligned_cols=245  Identities=22%  Similarity=0.317  Sum_probs=197.9

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCccc---chhhhhHHHHHhhcCCCceeeEeeeeee----CCeEEEEEEec
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVYEFM  486 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lV~e~~  486 (736)
                      ..||+|++|.||+|.+. |+.||||+++......   .+.+.+|+.+|++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            56999999999999985 8999999987653332   3567899999999999999999999876    35689999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .+|+|.+++..    ...+++...+.++.|++.||.|||+.  .+++||||||+|||++.++.+||+|||+++...... 
T Consensus       105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            99999999853    34688999999999999999999984  278899999999999999999999999987543322 


Q ss_pred             cceecccccccccCcccccc--CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          567 HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                         ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......    .+..   .....+. .      
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~----~~~~---~i~~~~~-~------  240 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK----EIYD---LIINKNN-S------  240 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH----HHHH---HHHhcCC-C------
Confidence               22358899999999976  68999999999999999999999999865421    1111   1111111 0      


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                        ...+......+.+++.+|++.||++|||++||++.|+..
T Consensus       241 --~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        241 --LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             --CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence              011112344688999999999999999999999999875

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.2e-39  Score=340.27  Aligned_cols=245  Identities=27%  Similarity=0.377  Sum_probs=206.7

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      |.+-+.||+|.||+||||+.+ +.+.||+|.+.+...  ...+.+.+|++|++.++|||||.++++|+...+.++|.||+
T Consensus         4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a   83 (808)
T KOG0597|consen    4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA   83 (808)
T ss_pred             hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence            344578999999999999766 678899999875432  23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .| +|..+|    .....+++..+..++.++..||.|||+.   +|+|||+||.|||++..+.+|+||||+|+-... ..
T Consensus        84 ~g-~L~~il----~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t  154 (808)
T KOG0597|consen   84 VG-DLFTIL----EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT  154 (808)
T ss_pred             hh-hHHHHH----HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence            87 999998    4567799999999999999999999998   999999999999999999999999999986654 34


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      ...+...|||.|||||++.++.|+..+|+||+||++||+++|++||....       +.+-++....+.-          
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-------i~~Lv~~I~~d~v----------  217 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-------ITQLVKSILKDPV----------  217 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-------HHHHHHHHhcCCC----------
Confidence            45566789999999999999999999999999999999999999997544       3333333322211          


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       .++......+..++...+..||..|.+-.+++.|
T Consensus       218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence             1223444568889999999999999999999877

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-39  Score=345.15  Aligned_cols=246  Identities=24%  Similarity=0.369  Sum_probs=207.8

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+++.||.|+-|.|-.|++. +|+.+|||++.+....   ....+++|+.+|+.+.||||+++++++++..++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            456788999999999999876 7999999999765322   245688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|-|.+++.    .++.++...+.+++.||..|+.|+|..   +|+|||+||+|+|||..+++||+|||+|.+-..  
T Consensus        94 v~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~--  164 (786)
T KOG0588|consen   94 VPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP--  164 (786)
T ss_pred             cCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence            99999999994    467789999999999999999999998   999999999999999999999999999976443  


Q ss_pred             CcceecccccccccCccccccCcCC-CcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                      .....+.||.+.|.|||++.+..|. .++||||+|||||.||+|+.||+++.    .+.|..    ..+.|.++      
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN----ir~LLl----KV~~G~f~------  230 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN----IRVLLL----KVQRGVFE------  230 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc----HHHHHH----HHHcCccc------
Confidence            3344567899999999999999886 68999999999999999999998654    222222    23334332      


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                          .+.....+..+|+.+|+..||++|.|++||.+|-
T Consensus       231 ----MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  231 ----MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             ----CCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence                1122334578899999999999999999999884

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=8.3e-39  Score=333.89  Aligned_cols=257  Identities=22%  Similarity=0.344  Sum_probs=204.1

Q ss_pred             HHHHHHhhccccccCceEEEEEEEC----CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEE
Q 004689          406 EDATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       406 ~~~~~~~~~~IG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  480 (736)
                      ....+.+.+.||+|+||.||+|.+.    .+..||+|+++.... .....+.+|+.++++++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            3455667889999999999999764    356899999876532 22456889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+|++|||.+..
T Consensus        83 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          83 IVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            999999999999998542   34688999999999999999999998   999999999999999999999999998764


Q ss_pred             ccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      .............++..|+|||++.+..++.++|||||||++||+++ |..||......    .+...    +.++... 
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----~~~~~----~~~~~~~-  227 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----DVIKA----VEDGFRL-  227 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHH----HHCCCCC-
Confidence            32222111222335678999999999999999999999999999875 99999765421    12221    1121110 


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                              ..+......+.+++..|++.+|.+||+++||.+.|+++
T Consensus       228 --------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 --------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                    01122334688899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.5e-38  Score=338.70  Aligned_cols=263  Identities=25%  Similarity=0.392  Sum_probs=201.8

Q ss_pred             HHHHhhccccccCceEEEEEEECC-----------------CcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLKD-----------------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQF  469 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~~-----------------~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l  469 (736)
                      ..+.+.++||+|+||.||+|.+.+                 +..||+|++..... ....++.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            445677899999999999997542                 33699999875432 234578899999999999999999


Q ss_pred             eeeeeeCCeEEEEEEecCCCCHHHHhhcccc---------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceec
Q 004689          470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT---------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIH  534 (736)
Q Consensus       470 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiH  534 (736)
                      ++++.+.+..++||||+.+|+|.+++.....               ....+++...+.++.|++.||.|||+.   +|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence            9999999999999999999999998854311               113467888999999999999999998   9999


Q ss_pred             CCCCCCCEEEcCCCcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh--CCCc
Q 004689          535 RDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEA  611 (736)
Q Consensus       535 rDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt--G~~p  611 (736)
                      |||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999755332221 1223346789999999998899999999999999999987  5567


Q ss_pred             CcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          612 ISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       612 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      |......    .+...+............      ...+......+.+++.+|++.+|++|||+.||.+.|+
T Consensus       242 ~~~~~~~----~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDE----QVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHH----HHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            7654321    222332222221110000      0011123356889999999999999999999998886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-39  Score=309.56  Aligned_cols=255  Identities=25%  Similarity=0.395  Sum_probs=213.7

Q ss_pred             cccCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeee
Q 004689          398 HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYC  473 (736)
Q Consensus       398 ~~~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~  473 (736)
                      ..+++++++     +++.||+|-||.||.|+.+ ++--||+|++.+..   .+...++.+|++|-..++||||+++++||
T Consensus        17 ~~~~l~dfe-----igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f   91 (281)
T KOG0580|consen   17 KTWTLDDFE-----IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF   91 (281)
T ss_pred             cccchhhcc-----ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe
Confidence            446666654     7899999999999999876 56679999997653   33467899999999999999999999999


Q ss_pred             eeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE
Q 004689          474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS  553 (736)
Q Consensus       474 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~  553 (736)
                      .+....||++||..+|.|...|.+.  ...+++......+..|+|.||.|+|..   .+|||||||+|+|++..+..|++
T Consensus        92 hd~~riyLilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiA  166 (281)
T KOG0580|consen   92 HDSKRIYLILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIA  166 (281)
T ss_pred             eccceeEEEEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeecc
Confidence            9999999999999999999999643  245577888889999999999999998   99999999999999999999999


Q ss_pred             eecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh
Q 004689          554 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE  633 (736)
Q Consensus       554 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~  633 (736)
                      |||.+....   .....+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||......+.+..|..       
T Consensus       167 dfGwsV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k-------  236 (281)
T KOG0580|consen  167 DFGWSVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK-------  236 (281)
T ss_pred             CCCceeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH-------
Confidence            999986432   4455677899999999999999999999999999999999999999987664444433332       


Q ss_pred             cCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          634 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       634 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                          .++.+|       ........+++..|+..+|.+|.+..||+++-.
T Consensus       237 ----~~~~~p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  237 ----VDLKFP-------STISGGAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             ----ccccCC-------cccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence                111112       222345789999999999999999999998753

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2e-38  Score=335.34  Aligned_cols=287  Identities=22%  Similarity=0.275  Sum_probs=221.3

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCccc---chhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +...||+|+||.||.|+-+ +|..+|+|++++.....   ...+..|-.+|....+|+||+|+..|.+.+++||||||++
T Consensus       145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP  224 (550)
T KOG0605|consen  145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP  224 (550)
T ss_pred             hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence            4578999999999999866 68999999998764433   3456789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC----
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD----  563 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~----  563 (736)
                      ||++..+|.    ..+.|+...+..++.+++.|++.||+.   |+|||||||+|+|||..|++||+||||+.-+..    
T Consensus       225 GGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  225 GGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             CccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence            999999994    456788888889999999999999998   999999999999999999999999999842210    


Q ss_pred             -----------C---------C-----Ccc-----------------eecccccccccCccccccCcCCCcchhHHHHHH
Q 004689          564 -----------G---------A-----SHV-----------------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI  601 (736)
Q Consensus       564 -----------~---------~-----~~~-----------------~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvv  601 (736)
                                 .         .     ...                 ....+|||-|||||++.+..|+..+|.||+|||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I  377 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI  377 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence                       0         0     000                 112459999999999999999999999999999


Q ss_pred             HHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCC---HHHH
Q 004689          602 LLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEV  678 (736)
Q Consensus       602 l~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~ev  678 (736)
                      |||||.|.+||......+.+..|+.|........+              .....+..+|+.+|+. ||++|..   +.||
T Consensus       378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI  442 (550)
T KOG0605|consen  378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLGSKGAEEI  442 (550)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence            99999999999999988899999999765422111              1111467889999999 9999986   4444


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCCCCCCCccccccccCCCCCCCCccccccccc
Q 004689          679 LKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGSFGGTENFLSLDESIV  731 (736)
Q Consensus       679 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~s~~~~~~~~~~~~~~~  731 (736)
                      .+|=           .-+...+...-....+.....-+-.+|+.|=.+++...
T Consensus       443 K~HP-----------fF~~v~W~~l~~~~apfvP~v~~~~DT~yFddF~e~~~  484 (550)
T KOG0605|consen  443 KKHP-----------FFKGVDWDHLREMPAPFVPQVNSELDTQYFDDFPEEDS  484 (550)
T ss_pred             hcCC-----------ccccCCcchhhcCCCCCCCCCCCcccccccccCccccc
Confidence            3331           01122222222233455555555566666654444433

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.5e-38  Score=348.54  Aligned_cols=260  Identities=25%  Similarity=0.376  Sum_probs=202.7

Q ss_pred             HHHHHhhccccccCceEEEEEEE------CCCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCe
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR  478 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~------~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~  478 (736)
                      ...+.+.+.||+|+||.||+|++      .++..||||+++.... .....+.+|+.+++.+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            34456789999999999999964      2456899999875432 2345688999999999 89999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcccc----------------------------------------------------------
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLT----------------------------------------------------------  500 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------------  500 (736)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999999864211                                                          


Q ss_pred             -------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          501 -------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       501 -------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                                   ....+++..++.++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                         012478888999999999999999998   9999999999999999999999999999765433221


Q ss_pred             -ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          568 -VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       568 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                       ......++..|+|||++.+..++.++|||||||++|||++ |..||......   ..+..+.    ..+...       
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~---~~~~~~~----~~~~~~-------  336 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD---SKFYKMI----KEGYRM-------  336 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch---HHHHHHH----HhCccC-------
Confidence             1122335678999999999999999999999999999998 88888754321   1122221    111100       


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                        ..+.....++.+++..|++.||++||++.||++.|++.
T Consensus       337 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         337 --LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence              00111124688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.4e-39  Score=327.83  Aligned_cols=256  Identities=27%  Similarity=0.371  Sum_probs=201.9

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCC-----eEEEEEEec
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVYEFM  486 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~lV~e~~  486 (736)
                      .+++|.|+||.||+|... +++.||||+.-.+    .+.-.+|+++|+++.|||||+|+-+|....     ...+|||||
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym  104 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM  104 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence            478999999999999876 4689999987533    334467999999999999999998885432     346899999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeecCCccccCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~-~~~kl~DFGla~~~~~~~  565 (736)
                      +. +|.+.++.....+.+++...+.-+..|+.+||.|||+.   +|+||||||.|+|+|.+ |.+||||||.|+....+.
T Consensus       105 P~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  105 PE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             hH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            86 89999876655667788888889999999999999997   99999999999999987 999999999999887776


Q ss_pred             CcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh--hc-------C
Q 004689          566 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI--ES-------G  635 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~--~~-------~  635 (736)
                      ...+..+  |..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.+..   .+++..++..=  ..       .
T Consensus       181 pniSYic--SRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~---dQL~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  181 PNISYIC--SRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV---DQLVEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             CceeEEE--eccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH---HHHHHHHHHhCCCCHHHHhhcCc
Confidence            6666655  889999999986 68999999999999999999999999886632   23333332210  00       1


Q ss_pred             CcceeccCccCCc-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          636 DIQGIIDPSLLDE-----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       636 ~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...+.-.+.+...     +......+.++++.+++..+|.+|.++.|++.+
T Consensus       256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            1111112222221     223344568999999999999999999999876

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.2e-38  Score=332.96  Aligned_cols=250  Identities=26%  Similarity=0.365  Sum_probs=198.7

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      ...+.||+|+||.||+|... +++.||+|++.....   .....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05631           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM   82 (285)
T ss_pred             eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence            34578999999999999864 789999999865432   22345778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++....... 
T Consensus        83 ~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          83 NGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             CCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            9999998875421  23588899999999999999999998   99999999999999999999999999997643322 


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                       ......||..|+|||++.+..++.++|||||||++|||++|+.||...........+.    .......          
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~----~~~~~~~----------  221 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD----RRVKEDQ----------  221 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH----HHhhccc----------
Confidence             1233468999999999999999999999999999999999999998654211111111    1111110          


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  681 (736)
                      ..+.......+.+++.+|++.||.+||+     +++++++
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            0111222345788999999999999997     7888775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-38  Score=336.52  Aligned_cols=270  Identities=25%  Similarity=0.397  Sum_probs=221.7

Q ss_pred             CHHHHHHHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCccc-chhhhhHHHHHhhcCCCceeeEeeeeeeCCeE
Q 004689          401 TLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       401 ~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  479 (736)
                      .+.|+....-.|.++||+|.||.|..+....+..||||+++...... .++|.+|+++|.+++||||++|+|+|..++.+
T Consensus       531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi  610 (807)
T KOG1094|consen  531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL  610 (807)
T ss_pred             chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence            44566666667789999999999999999877999999999876554 47899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ++|+|||++|+|.+++.....+  .+.-....+|+.|||.||+||.+.   .++||||.++|||++.++++||+|||+++
T Consensus       611 cmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR  685 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSR  685 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccc
Confidence            9999999999999999654322  244455677999999999999998   99999999999999999999999999999


Q ss_pred             cccCCCCcce-ecccccccccCccccccCcCCCcchhHHHHHHHHHHHh--CCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          560 FAVDGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       560 ~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt--G~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      .+..+..+.. ...+-+.+|||+|.+.-++++.++|||+||+.|||+++  ...||.....    +++++-.......+.
T Consensus       686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~----e~vven~~~~~~~~~  761 (807)
T KOG1094|consen  686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD----EQVVENAGEFFRDQG  761 (807)
T ss_pred             ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH----HHHHHhhhhhcCCCC
Confidence            7666555433 23445789999999999999999999999999999876  7789876552    344444444433322


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      ....+      ..+.-+..++.++++.|+..+.++||+++++...|++.
T Consensus       762 ~~~~l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  762 RQVVL------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cceec------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            22211      12344566789999999999999999999999999875

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.1e-38  Score=345.82  Aligned_cols=262  Identities=26%  Similarity=0.412  Sum_probs=203.3

Q ss_pred             HHHHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCC
Q 004689          406 EDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG  477 (736)
Q Consensus       406 ~~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~  477 (736)
                      ....+.+.+.||+|+||.||+|...      ++..||||+++.... .....+.+|+++++.+ +|+||++++++|....
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            3445667899999999999998742      345799999875432 2245688999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcccc---------------------------------------------------------
Q 004689          478 RSVLVYEFMHNGTLKEHLYGTLT---------------------------------------------------------  500 (736)
Q Consensus       478 ~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------  500 (736)
                      ..++||||+.+|+|.+++.....                                                         
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            99999999999999999853210                                                         


Q ss_pred             ---------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc-cee
Q 004689          501 ---------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSS  570 (736)
Q Consensus       501 ---------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~  570 (736)
                               ....+++..+++++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++........ ...
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                     112477888999999999999999998   9999999999999999999999999999754332221 122


Q ss_pred             cccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcC
Q 004689          571 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY  649 (736)
Q Consensus       571 ~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  649 (736)
                      ...++..|+|||++.+..++.++|||||||++|||++ |+.||.......   .+..    ....+.     ......  
T Consensus       273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~----~~~~~~-----~~~~~~--  338 (374)
T cd05106         273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYK----MVKRGY-----QMSRPD--  338 (374)
T ss_pred             CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHH----HHHccc-----CccCCC--
Confidence            2335678999999998899999999999999999997 999997543211   1111    111110     000011  


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          650 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       650 ~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                        ....++.+++.+|++.+|++||++.+|++.|++++
T Consensus       339 --~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 --FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             --CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence              11346889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=333.77  Aligned_cols=244  Identities=25%  Similarity=0.382  Sum_probs=201.7

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      .+.||+|.||.||||... +++.||+|++.-.... ...++.+|+.+|..++++||.++++.+..+..++++||||.+|+
T Consensus        18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs   97 (467)
T KOG0201|consen   18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS   97 (467)
T ss_pred             chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence            478999999999999865 6889999999765433 35678899999999999999999999999999999999999999


Q ss_pred             HHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCccee
Q 004689          491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS  570 (736)
Q Consensus       491 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  570 (736)
                      +.+.|..    ...+++....-++.++..||.|||.+   +.+|||||+.|||+..+|.+||+|||.+-......... .
T Consensus        98 v~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~  169 (467)
T KOG0201|consen   98 VLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-K  169 (467)
T ss_pred             hhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-c
Confidence            9999843    33346666677889999999999999   99999999999999999999999999997655444333 6


Q ss_pred             cccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCC
Q 004689          571 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD  650 (736)
Q Consensus       571 ~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  650 (736)
                      +++||+.|||||++....|+.|+||||||++.+||.+|.+|+.+.........             +..-..|.+.+.+ 
T Consensus       170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------------Ipk~~PP~L~~~~-  235 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------------IPKSAPPRLDGDF-  235 (467)
T ss_pred             cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------------ccCCCCCcccccc-
Confidence            67899999999999998999999999999999999999999986652111000             1111223333333 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          651 IQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       651 ~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                         ...+.+++..|+..+|+.||++.+++++
T Consensus       236 ---S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  236 ---SPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ---CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence               3458899999999999999999999876

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-38  Score=326.29  Aligned_cols=255  Identities=25%  Similarity=0.439  Sum_probs=205.5

Q ss_pred             HHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      ...+.+.+.||+|+||.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            34566788999999999999998878899999986543 23567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .+++|.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++.......
T Consensus        84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            9999999986432  34688999999999999999999998   999999999999999999999999999986543322


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      .......++..|+|||++.+..++.++||||||+++|||++ |+.||......    .+..    .+..+..        
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~----~~~~~~~--------  222 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA----EVLQ----QVDQGYR--------  222 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHH----HHHcCCC--------
Confidence            22222223468999999998899999999999999999999 99998754311    1111    1111100        


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                       ..........+.+++.+|++.+|.+||+++++++.|++
T Consensus       223 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 -MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence             01111223568899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.1e-37  Score=328.91  Aligned_cols=265  Identities=21%  Similarity=0.252  Sum_probs=199.9

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      |.+.+.||+|+||+||+|+.+ +++.||+|++.....  .....+.+|++++++++||||+++++++..++..++||||+
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07848           3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV   82 (287)
T ss_pred             ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence            445688999999999999986 578899999875422  23456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      +++.+.....    ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        83 ~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          83 EKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            9887765442    234588888999999999999999998   999999999999999999999999999986543333


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHH--------HHHhhhcCCcc
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW--------AKLHIESGDIQ  638 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~--------~~~~~~~~~~~  638 (736)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+...        ...........
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            2333456899999999999888999999999999999999999999765421111111110        00000111111


Q ss_pred             eeccCccCCc------CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          639 GIIDPSLLDE------YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       639 ~~~d~~l~~~------~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....+.....      +.......+.+++.+|++.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            1100110000      001123458999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=311.46  Aligned_cols=239  Identities=26%  Similarity=0.365  Sum_probs=196.4

Q ss_pred             cCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCccc---chhhhhHHHHHhhcCCCceeeEeeeeee
Q 004689          400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQE  475 (736)
Q Consensus       400 ~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~  475 (736)
                      +++.|++     +.+.||.|+||+|..++.+ +|..+|+|++.+.....   .+...+|..+|+.+.||+++++++.|.+
T Consensus        41 ~~l~dfe-----~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d  115 (355)
T KOG0616|consen   41 YSLQDFE-----RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD  115 (355)
T ss_pred             cchhhhh-----heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence            4555543     5578999999999999987 57789999997654332   3446789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEee
Q 004689          476 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF  555 (736)
Q Consensus       476 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DF  555 (736)
                      .+.++|||||++||.|..+++    ..++++...+.-++.||+.||+|||+.   +|++||+||+|||+|.+|.+||+||
T Consensus       116 ~~~lymvmeyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF  188 (355)
T KOG0616|consen  116 NSNLYMVMEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF  188 (355)
T ss_pred             CCeEEEEEeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence            999999999999999999995    356799999999999999999999998   9999999999999999999999999


Q ss_pred             cCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC
Q 004689          556 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       556 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      |+|+....    .+.+.||||.|+|||++.+..|..++|.|||||++|||+.|.+||.....-+.++.|        -++
T Consensus       189 GFAK~v~~----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI--------~~~  256 (355)
T KOG0616|consen  189 GFAKRVSG----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI--------LEG  256 (355)
T ss_pred             cceEEecC----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH--------HhC
Confidence            99987643    356778999999999999999999999999999999999999999876632222222        222


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCC
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR  672 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R  672 (736)
                      ++          .++.-....+.+|+...++.|-.+|
T Consensus       257 ~v----------~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  257 KV----------KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cc----------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            21          1122222346677777777777777

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-38  Score=322.33  Aligned_cols=250  Identities=21%  Similarity=0.389  Sum_probs=213.0

Q ss_pred             HHHHHHhhccccccCceEEEEEEE-CCCcEEEEEEeccCCcccchh---hhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          406 EDATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       406 ~~~~~~~~~~IG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~---~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      ...+|.|.+.||+|.||.|-+|.. ..|+.||||.+++....++.+   +.+|++||..++||||+.++.+|+..+..++
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            345677889999999999999975 679999999998876665544   6789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||..+|.|.+++    ...+.+++.....++.||.+|+.|+|.+   +++|||||.+|||+|.++++||+|||++.++
T Consensus       131 vMEYaS~GeLYDYi----Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly  203 (668)
T KOG0611|consen  131 VMEYASGGELYDYI----SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY  203 (668)
T ss_pred             EEEecCCccHHHHH----HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence            99999999999999    4567899999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCcceecccccccccCccccccCcCC-CcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      .+.  ....+++|++-|.+||++.+.+|. +.+|-||+||+||-|+.|.-||++.+..    .+++    ++..|...+ 
T Consensus       204 ~~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk----~lvr----QIs~GaYrE-  272 (668)
T KOG0611|consen  204 ADK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK----RLVR----QISRGAYRE-  272 (668)
T ss_pred             ccc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH----HHHH----HhhcccccC-
Confidence            543  344668899999999999998886 7899999999999999999999976632    3333    233333322 


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                                .+.+....-|+.+|+..+|++|.|+.+|+.+..
T Consensus       273 ----------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  273 ----------PETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             ----------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                      112223566899999999999999999999863

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.4e-38  Score=338.97  Aligned_cols=242  Identities=24%  Similarity=0.321  Sum_probs=195.9

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.||+|+||.||+|+.. +|+.||+|+++....   .....+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999875 688999999875421   22345778999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~  152 (323)
T cd05571          81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM  152 (323)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence            99988853    34678889999999999999999998   99999999999999999999999999987532221 222


Q ss_pred             ecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcC
Q 004689          570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY  649 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  649 (736)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+....    ..+..      .+    
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~~----~~~~~------~~----  214 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELI----LMEEI------RF----  214 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH----HHHHHH----HcCCC------CC----
Confidence            3456999999999999999999999999999999999999999754321    111111    11111      11    


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          650 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       650 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                      +......+.+++.+|++.||++||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            112234578899999999999999     79999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.1e-37  Score=323.24  Aligned_cols=249  Identities=29%  Similarity=0.505  Sum_probs=200.9

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.+.+.||+|+||.||+|.++++..+|+|.+.... ....++.+|++++++++||||+++++++...+..++||||+++|
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   84 (256)
T cd05114           6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG   84 (256)
T ss_pred             cEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence            34567899999999999999888899999876432 23467889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        85 ~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05114          85 CLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS  158 (256)
T ss_pred             cHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence            999988643   23588999999999999999999998   999999999999999999999999999876543322222


Q ss_pred             ecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      ....++..|+|||++.+..++.++||||||+++|||++ |+.||.....    ..+.....    .+..  ...+.    
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~~~~~i~----~~~~--~~~~~----  224 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEVVEMIS----RGFR--LYRPK----  224 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHH----CCCC--CCCCC----
Confidence            23345678999999998889999999999999999999 8999975442    12222211    1110  01111    


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                         .....+.+++.+|++.+|.+||++.|+++.|
T Consensus       225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               1224588999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-38  Score=339.67  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=201.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||.||+|+.. +++.||||+++....   .....+.+|+++++.++||||+++++++...+..++||||
T Consensus         3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   82 (333)
T cd05600           3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY   82 (333)
T ss_pred             cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence            345688999999999999876 588999999875421   2345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....  
T Consensus        83 ~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          83 VPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999999843    34578888999999999999999998   999999999999999999999999999975433  


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                        ......||+.|+|||++.+..++.++|||||||++|||++|..||......+....+..|...          +....
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------~~~~~  221 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----------LQRPV  221 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc----------ccCCC
Confidence              223456999999999999999999999999999999999999999765432222222222110          00000


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...........+.+++.+|+..+|.+||+++|++++
T Consensus       222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000001223457889999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=7.8e-38  Score=325.18  Aligned_cols=254  Identities=24%  Similarity=0.436  Sum_probs=204.5

Q ss_pred             HHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      ..+.+.++||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++|+||+++++++...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            3445678999999999999998888899999876433 235678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++...  ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.........
T Consensus        85 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          85 KGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            99999998643  234578888899999999999999998   9999999999999999999999999999865443222


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      ......++..|+|||++....++.++|||||||++|||++ |..||......    .+..+..    .+...    + ..
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~~----~~~~~----~-~~  226 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----DVMSALQ----RGYRM----P-RM  226 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----HHHHHHH----cCCCC----C-CC
Confidence            2223346778999999988889999999999999999998 99999754311    1222211    11100    0 01


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                      .    .....+.+++.+|+..+|++||+++++.+.|++
T Consensus       227 ~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         227 E----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             C----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1    123458899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-37  Score=324.72  Aligned_cols=254  Identities=30%  Similarity=0.446  Sum_probs=203.8

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.+.||+|+||.||+|... .++.||+|++.... ....++.+|++++++++||||+++++++..+...++||||++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   85 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence            3456788999999999999875 58889999986442 234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++....  ...+++..++.++.|++.||+|||+.   +++||||||+||++++++.+||+|||++.........
T Consensus        86 ~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          86 YGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999985432  34588999999999999999999998   9999999999999999999999999999765443222


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      ......++..|+|||++.+..++.++|||||||++|||++ |..||......    .+..   . +..+         ..
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~---~-~~~~---------~~  223 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYE---L-LEKG---------YR  223 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH---H-HHCC---------CC
Confidence            2222334678999999998999999999999999999998 99998754321    1111   1 1111         00


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      ...+......+.+++.+|++.+|++||++.++++.|+.+
T Consensus       224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            111122235688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-38  Score=325.95  Aligned_cols=253  Identities=25%  Similarity=0.335  Sum_probs=197.3

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCccc--------------chhhhhHHHHHhhcCCCceeeEeeee
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG--------------KREFTNEVTLLSRIHHRNLVQFLGYC  473 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~--------------~~~~~~E~~il~~l~HpnIv~l~~~~  473 (736)
                      .|.+.+.||+|.||.|-+|+.. +++.||||++.+.....              .+...+|+.+|++++|||||+|+++.
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            4556788999999999999865 68999999996542111              13578899999999999999999998


Q ss_pred             eeC--CeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEE
Q 004689          474 QEE--GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK  551 (736)
Q Consensus       474 ~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~k  551 (736)
                      .+.  +..|||+|||..|.+...=    .....+...++++++.++..||+|||.+   +||||||||+|+||+++|++|
T Consensus       178 DDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  178 DDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             cCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEE
Confidence            765  5789999999999875432    2223388999999999999999999999   999999999999999999999


Q ss_pred             EEeecCCccccCCCC----cceecccccccccCccccccCc----CCCcchhHHHHHHHHHHHhCCCcCccccccccccc
Q 004689          552 VSDFGLSKFAVDGAS----HVSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRN  623 (736)
Q Consensus       552 l~DFGla~~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~----~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~  623 (736)
                      |+|||.+..+..+..    ......+|||.|+|||.+.++.    .+.+.||||+||+||.|+.|+.||.+...-+.+..
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K  330 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK  330 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence            999999976532211    1223367999999999998733    34678999999999999999999987653222222


Q ss_pred             HHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          624 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       624 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                      |+.                ..+.-....+.-..+.+|+.+++..||++|.+..+|..|..-
T Consensus       331 Ivn----------------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  331 IVN----------------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             Hhc----------------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence            211                111111112344568899999999999999999999988743

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2e-37  Score=322.01  Aligned_cols=254  Identities=27%  Similarity=0.437  Sum_probs=208.5

Q ss_pred             HHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      ..+.+.++||.|+||.||+|...+++.+|+|++..........+.+|+.+++.++||||+++++++......++||||++
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME   85 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence            44667889999999999999998899999999887655556778999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||.+.........
T Consensus        86 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          86 KGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             cCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            99999999653  234578999999999999999999998   9999999999999999999999999999765433222


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                       .....++..|+|||.+....++.++||||||+++|+|++ |+.||.....    ..+......   ...          
T Consensus       161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~----~~~~~~~~~---~~~----------  222 (261)
T cd05148         161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN----HEVYDQITA---GYR----------  222 (261)
T ss_pred             -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH----HHHHHHHHh---CCc----------
Confidence             123346778999999988899999999999999999998 8999975441    112222111   100          


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                      ...+......+.+++.+|++.+|.+|||++++++.|+.
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            01112223468899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.9e-37  Score=325.71  Aligned_cols=257  Identities=26%  Similarity=0.475  Sum_probs=205.5

Q ss_pred             HHHHHhhccccccCceEEEEEEECC------CcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~~------~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  479 (736)
                      ...+.+.+.||+|+||.||+|...+      ++.||||+++..... ....+.+|++++++++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3456678899999999999998643      478999998755433 356789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhccc----------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTL----------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR  549 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~  549 (736)
                      ++||||+++|+|.+++....          .....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            99999999999999996431          2234578889999999999999999998   9999999999999999999


Q ss_pred             EEEEeecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHH
Q 004689          550 AKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQW  627 (736)
Q Consensus       550 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~  627 (736)
                      +||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||......    .+...
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~----~~~~~  236 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----EVIEC  236 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH
Confidence            99999999875432221 11223346788999999999999999999999999999998 99998754421    22222


Q ss_pred             HHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          628 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       628 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      .    ..+....         .+......+.+++.+|++.+|++||++.||++.|+
T Consensus       237 ~----~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 I----TQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             H----HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            1    1222111         11122346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-37  Score=350.97  Aligned_cols=252  Identities=22%  Similarity=0.310  Sum_probs=203.2

Q ss_pred             HHhhccccccCceEEEEEEEC-C-CcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-D-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~  148 (478)
T PTZ00267         69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS  148 (478)
T ss_pred             EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence            566889999999999999765 3 57788887755444444567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC-
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-  566 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~-  566 (736)
                      +|+|.+++.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus       149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~  225 (478)
T PTZ00267        149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL  225 (478)
T ss_pred             CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence            9999998876544455688889999999999999999998   999999999999999999999999999986543322 


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+..   ... .+....       
T Consensus       226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~----~~~~---~~~-~~~~~~-------  290 (478)
T PTZ00267        226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR----EIMQ---QVL-YGKYDP-------  290 (478)
T ss_pred             ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH---HHH-hCCCCC-------
Confidence            2234456999999999999999999999999999999999999999754321    1111   111 111110       


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        .+......+.+++..|++.+|++||++.+++++
T Consensus       291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             --CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence              111122458899999999999999999998754

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.7e-37  Score=327.95  Aligned_cols=264  Identities=21%  Similarity=0.286  Sum_probs=196.9

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.++||+|+||+||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+.
T Consensus         7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (288)
T cd07871           7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD   86 (288)
T ss_pred             ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence            455688999999999999876 688999999865432 234467799999999999999999999999999999999997


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      + +|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        87 ~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-  158 (288)
T cd07871          87 S-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-  158 (288)
T ss_pred             c-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence            5 898887532   23478888899999999999999998   999999999999999999999999999875432221 


Q ss_pred             ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh--------cCCcc
Q 004689          568 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE--------SGDIQ  638 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~--------~~~~~  638 (736)
                      ......|++.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+.........        .....
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            2233458999999999875 56899999999999999999999999765432221111111000000        00011


Q ss_pred             eeccCccCCcC----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          639 GIIDPSLLDEY----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       639 ~~~d~~l~~~~----~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....+......    ......+..+++..|++.||.+|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            11111110000    00112357899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-38  Score=331.93  Aligned_cols=243  Identities=23%  Similarity=0.325  Sum_probs=197.7

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.+.||+|+||.||+|... +++.||+|++.....   .....+.+|++++++++||||+++++++.+....++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   82 (291)
T cd05612           3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY   82 (291)
T ss_pred             ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence            345688999999999999876 688999999864321   2345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +.+|+|.+++..    ...+++.....++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..... 
T Consensus        83 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          83 VPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            999999999853    34578888899999999999999998   9999999999999999999999999998765332 


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+.+    .+..+..      .+
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~----~~~~----~i~~~~~------~~  217 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF----GIYE----KILAGKL------EF  217 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH----HHHhCCc------CC
Confidence               12346899999999999888999999999999999999999999765421    1111    1111111      01


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  681 (736)
                      ...    ....+.+++.+|++.||.+||+     ++|++++
T Consensus       218 ~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         218 PRH----LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             Ccc----CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            111    1235789999999999999995     8888776

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=330.32  Aligned_cols=261  Identities=25%  Similarity=0.390  Sum_probs=219.1

Q ss_pred             HHHHHHhhccccccCceEEEEEEECC---C--cEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeE
Q 004689          406 EDATKMLEKKIGSGGFGVVYYGKLKD---G--KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       406 ~~~~~~~~~~IG~G~fG~Vy~~~~~~---~--~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  479 (736)
                      ..+...+.++||.|-||.||+|.+.+   |  -.||||..+.+. ....+.|..|+.+|+.++||||++|+|+|.+. ..
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence            33444457899999999999997642   3  358889888753 44567899999999999999999999999765 57


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ++|||.++-|.|..+|..   ....++......++.|++.||+|||+.   .++||||..+||||.....+||+|||+++
T Consensus       466 WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence            999999999999999963   356788889999999999999999998   99999999999999999999999999999


Q ss_pred             cccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      ...+...+..+...-+..|||||.+.-++++.++|||-|||.|||++. |..||.+....+....+        ++|+  
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i--------EnGe--  609 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI--------ENGE--  609 (974)
T ss_pred             hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe--------cCCC--
Confidence            988877776666566789999999999999999999999999999988 99999887644333222        2222  


Q ss_pred             eeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 004689          639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER  690 (736)
Q Consensus       639 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~  690 (736)
                             +...+..++..+..|+.+||+.+|.+||.+.|+...|.+++..+.
T Consensus       610 -------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek  654 (974)
T KOG4257|consen  610 -------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK  654 (974)
T ss_pred             -------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence                   222345566779999999999999999999999999999887543

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-38  Score=334.14  Aligned_cols=240  Identities=23%  Similarity=0.325  Sum_probs=193.1

Q ss_pred             ccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       416 IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      ||+|+||.||+|... +++.||+|++....   ......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999876 57899999986432   22345677899999999999999999999999999999999999999


Q ss_pred             HHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceec
Q 004689          492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI  571 (736)
Q Consensus       492 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  571 (736)
                      .+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~  152 (312)
T cd05585          81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT  152 (312)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence            999853    34588889999999999999999998   99999999999999999999999999987543222 22334


Q ss_pred             ccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCH
Q 004689          572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI  651 (736)
Q Consensus       572 ~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  651 (736)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......       ........ +..      .    ++.
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~-------~~~~~~~~-~~~------~----~~~  214 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN-------EMYRKILQ-EPL------R----FPD  214 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH-------HHHHHHHc-CCC------C----CCC
Confidence            56999999999999999999999999999999999999999754421       11111111 111      0    111


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 004689          652 QSMWKIEEKALMCVLPHGHMRPS---ISEVLKD  681 (736)
Q Consensus       652 ~~~~~l~~l~~~cl~~dP~~RPt---~~ev~~~  681 (736)
                      .....+.+++.+|++.||++||+   +.|++.+
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            12245788999999999999985   5666554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.7e-37  Score=325.11  Aligned_cols=248  Identities=24%  Similarity=0.333  Sum_probs=196.7

Q ss_pred             ccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       416 IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      ||+|+||+||++... +++.||+|++......   ....+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999875 6889999998654222   224567899999999999999999999999999999999999999


Q ss_pred             HHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceec
Q 004689          492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI  571 (736)
Q Consensus       492 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  571 (736)
                      .+++.........+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            988865444456789999999999999999999998   999999999999999999999999999975543322 2233


Q ss_pred             ccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCH
Q 004689          572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI  651 (736)
Q Consensus       572 ~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  651 (736)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.   .... .+..          .++.
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~-~~~~----------~~~~  222 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---QRIL-NDSV----------TYPD  222 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH---Hhhc-ccCC----------CCcc
Confidence            468999999999999999999999999999999999999997543211111111   1110 1100          1112


Q ss_pred             HHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          652 QSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       652 ~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                      .....+.+++..|++.||++||     ++++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            2334578999999999999999     67777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.8e-37  Score=326.55  Aligned_cols=255  Identities=28%  Similarity=0.485  Sum_probs=203.3

Q ss_pred             HHhhccccccCceEEEEEEECC------CcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~------~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      +.+.+.||+|+||.||+|....      ...||+|.+..... .....+.+|++++++++||||+++++++...+..+++
T Consensus         7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   86 (283)
T cd05048           7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML   86 (283)
T ss_pred             cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence            3467889999999999998642      25799999865432 2345688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhccccc------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcE
Q 004689          483 YEFMHNGTLKEHLYGTLTH------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA  550 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~  550 (736)
                      |||+++|+|.+++......            ...+++...+.++.|++.||.|||+.   +++||||||+||++++++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~  163 (283)
T cd05048          87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTV  163 (283)
T ss_pred             EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcE
Confidence            9999999999998643211            14578889999999999999999998   99999999999999999999


Q ss_pred             EEEeecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHH
Q 004689          551 KVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWA  628 (736)
Q Consensus       551 kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~  628 (736)
                      ||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+....    .+... 
T Consensus       164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----~~~~~-  238 (283)
T cd05048         164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----EVIEM-  238 (283)
T ss_pred             EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH-
Confidence            9999999975433221 12233456889999999998899999999999999999998 99999765421    22222 


Q ss_pred             HHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          629 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       629 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                         +..+....         .+.....++.+++.+|++.+|.+||++.||+++|+.
T Consensus       239 ---i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         239 ---IRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence               11221111         122234568999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=346.12  Aligned_cols=258  Identities=23%  Similarity=0.323  Sum_probs=209.1

Q ss_pred             HHHhhccccccCceEEEEEEECCC-cEEEEEEeccCCcccchhhhhHHHHHhhcC-CCceeeEeee-eee------CCeE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDG-KEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGY-CQE------EGRS  479 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~-~~~------~~~~  479 (736)
                      ...+++.|.+|||+.||.|+...+ .+||+|++-.......+.+.+|+++|++|+ |+|||.+++. ...      .-+.
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev  117 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV  117 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence            345678999999999999998765 999999998777777788999999999996 9999999993 221      1356


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      +|.||||.+|.|-|++..+...  +|.+.++++|+.|+++|+++||.. .++|||||||-+||||+.+++.||||||.+.
T Consensus       118 llLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  118 LLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            8999999999999999766543  399999999999999999999995 5689999999999999999999999999986


Q ss_pred             cccCCCCcce--------ecccccccccCccccc---cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHH
Q 004689          560 FAVDGASHVS--------SIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA  628 (736)
Q Consensus       560 ~~~~~~~~~~--------~~~~gt~~Y~aPE~~~---~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~  628 (736)
                      ..........        -...-|+.|+|||++.   +...++|+|||+|||+||-|+....||++...           
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-----------  263 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-----------  263 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-----------
Confidence            4322221100        1123689999999984   67899999999999999999999999986531           


Q ss_pred             HHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          629 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       629 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                               ..+++....--........+.+||..||+++|.+||++.||++.+.++...+
T Consensus       264 ---------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  264 ---------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             ---------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence                     1122222211112456678999999999999999999999999998887654

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5e-38  Score=326.80  Aligned_cols=249  Identities=34%  Similarity=0.544  Sum_probs=193.1

Q ss_pred             hhccccccCceEEEEEEEC-----CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          412 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-----~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.||.|.||.||+|.+.     .+..|+||+++.... .....+.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999877     357899999965432 2367899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.++|...  ....+++..++.|+.|+++||.|||+.   +++|+||+++||+++.++.+||+|||++.......
T Consensus        83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999754  235689999999999999999999998   99999999999999999999999999997653222


Q ss_pred             C-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          566 S-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       566 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      . .......+...|+|||.+....++.++||||||+++|||++ |+.||.....    ..+....    .++...     
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~----~~~~~~~----~~~~~~-----  224 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN----EEIIEKL----KQGQRL-----  224 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH----HHHHHHH----HTTEET-----
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccc----cccccc-----
Confidence            2 22233457789999999999889999999999999999999 7788865431    1222211    222111     


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                          ..+......+.+++..|++.+|++||++.+|++.|
T Consensus       225 ----~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 ----PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ----TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ----eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                11112234588999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.6e-37  Score=332.14  Aligned_cols=261  Identities=23%  Similarity=0.313  Sum_probs=200.5

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+.+.+.||+|+||.||+++.. ++..||+|++..... .....+.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   85 (331)
T cd06649           6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM   85 (331)
T ss_pred             cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence            3445678999999999999876 678899999875422 23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++..    ...+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||++....... 
T Consensus        86 ~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  158 (331)
T cd06649          86 DGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  158 (331)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence            99999999853    34578888999999999999999985  269999999999999999999999999987553321 


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC---Ccc-----
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG---DIQ-----  638 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~---~~~-----  638 (736)
                        .....||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+..........+   ...     
T Consensus       159 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         159 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK----ELEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             --cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHhcccccccccCCccccCcc
Confidence              22346899999999999989999999999999999999999999654311    1111110000000   000     


Q ss_pred             ----------------------e----eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          639 ----------------------G----IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       639 ----------------------~----~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                                            +    +...............++.+++.+|++.||++|||++|++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                  0    0000000000111234688999999999999999999999885

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.7e-38  Score=337.07  Aligned_cols=243  Identities=27%  Similarity=0.358  Sum_probs=197.9

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus        20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   99 (329)
T PTZ00263         20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF   99 (329)
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence            456789999999999999876 58899999986542   12345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +.+|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263        100 VVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             CCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence            999999999853    34578888888999999999999998   99999999999999999999999999997653321


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                          ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....    .+.    ..+.++.+.      +
T Consensus       173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~----~~i~~~~~~------~  234 (329)
T PTZ00263        173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----RIY----EKILAGRLK------F  234 (329)
T ss_pred             ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----HHH----HHHhcCCcC------C
Confidence                2346999999999999999999999999999999999999999754311    111    111122111      1


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  681 (736)
                      ...    ....+.+++..|++.||.+||+     +++++++
T Consensus       235 p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        235 PNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            111    1235788999999999999997     6888766

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-37  Score=334.03  Aligned_cols=242  Identities=24%  Similarity=0.330  Sum_probs=194.7

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.||+|+||.||+++.. +|+.||+|+++...   ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36899999999999875 68999999987542   122345678999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +|..++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~  152 (323)
T cd05595          81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM  152 (323)
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence            99888743    34688999999999999999999998   99999999999999999999999999987532221 122


Q ss_pred             ecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcC
Q 004689          570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY  649 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  649 (736)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+..   .. ..+..      .+    
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~---~~-~~~~~------~~----  214 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFE---LI-LMEEI------RF----  214 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----HHHH---HH-hcCCC------CC----
Confidence            3356999999999999999999999999999999999999999754321    1111   11 01110      11    


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          650 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       650 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                      +......+.+++.+|++.||++||     ++.+++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            111234578899999999999998     89998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=338.07  Aligned_cols=238  Identities=26%  Similarity=0.354  Sum_probs=200.0

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCccc---chhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEe
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      .+.++||+|.||+|+++..+ +++.+|||++++...-.   .+....|.+|+... +||.++.|+.+|...+++++||||
T Consensus       371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey  450 (694)
T KOG0694|consen  371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY  450 (694)
T ss_pred             EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence            36789999999999999887 57889999999875433   34567788888877 599999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +.||++..+.     ..+.+++..+.-++..|+.||.|||++   +|||||||.+|||||.+|++||+|||+++..... 
T Consensus       451 ~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-  521 (694)
T KOG0694|consen  451 VAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-  521 (694)
T ss_pred             cCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC-
Confidence            9999944333     456799999999999999999999999   9999999999999999999999999999854322 


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      ...+.+.+|||.|||||++.+..|+.++|.|||||+|||||.|+.||.+++..+...+|+.           .+      
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~-----------d~------  584 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN-----------DE------  584 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-----------CC------
Confidence            2356678999999999999999999999999999999999999999998775444444432           01      


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI  675 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  675 (736)
                       .-|+.-...+...++.+.+..+|++|..+
T Consensus       585 -~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 -VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             -CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence             12333444568889999999999999976

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-37  Score=319.13  Aligned_cols=249  Identities=28%  Similarity=0.468  Sum_probs=199.9

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.+.+.||+|+||.||+|.++++..+|+|++..... ....+.+|++++++++||||+++++++...+..++||||++++
T Consensus         6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05059           6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG   84 (256)
T ss_pred             cchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence            456788999999999999988778899999864332 3456888999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++...+......
T Consensus        85 ~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          85 CLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            999998643   23688999999999999999999998   999999999999999999999999999876543322222


Q ss_pred             ecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      ....++..|+|||++.+..++.++|||||||++|||++ |+.||......    .+...    ...+.     ..    .
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~----~~~~~-----~~----~  221 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----EVVES----VSAGY-----RL----Y  221 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----HHHHH----HHcCC-----cC----C
Confidence            22234568999999998899999999999999999999 88898754321    11111    11110     00    1


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      .+.....++.+++.+|+..+|++||++.|+++.|
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            1112344689999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-37  Score=321.12  Aligned_cols=254  Identities=26%  Similarity=0.442  Sum_probs=203.0

Q ss_pred             HHHhhccccccCceEEEEEEECC----CcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      .+.+.+.||+|+||.||+|.+..    ...||||+++.... .....+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   84 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT   84 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence            34567899999999999998752    45799999865432 23456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||+++....
T Consensus        85 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          85 EYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999998643   23688999999999999999999998   999999999999999999999999999986642


Q ss_pred             CCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          564 GAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       564 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      ... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......    .+....    ..+...   
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~----~~~~~~---  227 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ----DVIKAV----EDGYRL---  227 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH----HHHHHH----HcCCCC---
Confidence            222 12222345678999999998899999999999999999998 99998654321    122211    111100   


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                            ..+......+.+++.+|++.+|++||++.||+++|+++
T Consensus       228 ------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 ------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                  00112234688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.1e-37  Score=339.70  Aligned_cols=260  Identities=24%  Similarity=0.390  Sum_probs=203.2

Q ss_pred             HHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCcc-cchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~  479 (736)
                      ..+.+.++||+|+||.||+|...      .+..||||+++..... ....+.+|+++|+++. ||||++++++|.+....
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            34557789999999999999753      2347999998754322 3456889999999996 99999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcccc-----------------------------------------------------------
Q 004689          480 VLVYEFMHNGTLKEHLYGTLT-----------------------------------------------------------  500 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~-----------------------------------------------------------  500 (736)
                      ++||||+++|+|.+++.....                                                           
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            999999999999998864311                                                           


Q ss_pred             ---------------------------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC
Q 004689          501 ---------------------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH  547 (736)
Q Consensus       501 ---------------------------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~  547 (736)
                                                       ....+++..++.++.|+++||.|||+.   +|+||||||+|||++.+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~  273 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQG  273 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCC
Confidence                                             012477888899999999999999998   99999999999999999


Q ss_pred             CcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHH
Q 004689          548 MRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIV  625 (736)
Q Consensus       548 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~  625 (736)
                      +.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.......   .+.
T Consensus       274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~---~~~  350 (400)
T cd05105         274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS---TFY  350 (400)
T ss_pred             CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH---HHH
Confidence            99999999999765332222 1223346788999999998899999999999999999997 999987543111   111


Q ss_pred             HHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          626 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       626 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      .    ....+..     .    ..+......+.+++.+|++.+|++||++.+|.+.|++++
T Consensus       351 ~----~~~~~~~-----~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         351 N----KIKSGYR-----M----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             H----HHhcCCC-----C----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            1    1111110     0    011122346889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.2e-37  Score=332.10  Aligned_cols=242  Identities=25%  Similarity=0.360  Sum_probs=195.6

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999875 68999999987542   223356778999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~  152 (328)
T cd05593          81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM  152 (328)
T ss_pred             CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence            99988843    34688999999999999999999998   99999999999999999999999999987532221 122


Q ss_pred             ecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcC
Q 004689          570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY  649 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  649 (736)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+..   ... .+.      ..+..  
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~----~~~~---~~~-~~~------~~~p~--  216 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFE---LIL-MED------IKFPR--  216 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH----HHHH---Hhc-cCC------ccCCC--
Confidence            3456999999999999889999999999999999999999999754421    1111   111 111      01111  


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          650 DIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       650 ~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                        .....+.+++.+|++.||++||     ++.|++++
T Consensus       217 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 --TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             --CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence              1233578899999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.1e-37  Score=332.36  Aligned_cols=262  Identities=26%  Similarity=0.413  Sum_probs=203.5

Q ss_pred             HHHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeee-CC
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQE-EG  477 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~-~~  477 (736)
                      ...+.+.+.||+|+||.||+|...      +++.||+|+++.... .....+..|+++++++ +|+||++++++|.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            345778899999999999999642      347899999874432 2234577899999999 89999999998864 45


Q ss_pred             eEEEEEEecCCCCHHHHhhcccc---------------------------------------------------------
Q 004689          478 RSVLVYEFMHNGTLKEHLYGTLT---------------------------------------------------------  500 (736)
Q Consensus       478 ~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------  500 (736)
                      ..+++|||+.+|+|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            68899999999999998854211                                                         


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc-eeccccccccc
Q 004689          501 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYL  579 (736)
Q Consensus       501 ~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~  579 (736)
                      ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......... .....++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence            013578999999999999999999998   99999999999999999999999999998654332222 22344677899


Q ss_pred             CccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHH
Q 004689          580 DPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIE  658 (736)
Q Consensus       580 aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  658 (736)
                      |||++.+..++.++|||||||++|||++ |..||.+....+   .+.    ..+..+...         ..+.....++.
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~~---------~~~~~~~~~~~  306 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFC----RRLKEGTRM---------RAPEYATPEIY  306 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHH----HHHhccCCC---------CCCccCCHHHH
Confidence            9999999999999999999999999998 999987533111   111    111121110         00112234688


Q ss_pred             HHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          659 EKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       659 ~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      +++.+|++.+|++||++.||+++|++++.
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.5e-37  Score=319.37  Aligned_cols=256  Identities=25%  Similarity=0.429  Sum_probs=203.6

Q ss_pred             HHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      ...+.+.++||+|+||.||+|++.++..||+|+++... .....+.+|++++++++||||+++++++.+ ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            34567789999999999999998877789999987533 234578899999999999999999998754 5578999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .+|+|.+++....  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.++.......
T Consensus        83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          83 SKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            9999999996432  33578889999999999999999998   999999999999999999999999999976543332


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      .......++..|+|||+..+..++.++|||||||++|||++ |..||......    .+..    ....+..        
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~~~----~~~~~~~--------  221 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLD----QVERGYR--------  221 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HHHH----HHhcCCC--------
Confidence            22223346778999999988899999999999999999999 88888654311    1111    1111100        


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                       .....+....+.+++.+|++.+|++||++.++++.|++..
T Consensus       222 -~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         222 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             -CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence             0112233456889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.4e-37  Score=330.13  Aligned_cols=256  Identities=23%  Similarity=0.389  Sum_probs=200.3

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCc----EEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~----~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      ..+...+.||+|+||.||+|++. ++.    .||+|+++... .....++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            44556789999999999999864 333    48999986543 23356788999999999999999999999865 4679


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      |+||+.+|+|.+++...   ...+++...+.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence            99999999999998643   34578888999999999999999998   9999999999999999999999999999865


Q ss_pred             cCCCCcc-eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          562 VDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       562 ~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ....... .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....    .+...    ...+... 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~----~~~~~----~~~~~~~-  230 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSI----LEKGERL-  230 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH----HhCCCCC-
Confidence            4332221 122334678999999999999999999999999999998 99999754311    11111    1111100 


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                              ..+......+.+++.+|+..+|.+||++.+++..|..+..
T Consensus       231 --------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         231 --------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             --------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                    0011123457899999999999999999999999987753

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=7.2e-37  Score=317.86  Aligned_cols=254  Identities=26%  Similarity=0.445  Sum_probs=202.7

Q ss_pred             HHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      ...+.+.++||+|+||.||+|...++..+|+|.+..... ....+.+|+.++++++|+|++++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence            345677889999999999999988888999999875433 34568999999999999999999998854 5678999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .+++|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++........
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05070          83 SKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence            999999998643  234578999999999999999999998   999999999999999999999999999976543322


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      .......++..|+|||++.+..++.++||||||+++|||++ |..||.....    ..+.....    .+.         
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~~----~~~---------  220 (260)
T cd05070         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN----REVLEQVE----RGY---------  220 (260)
T ss_pred             ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHH----cCC---------
Confidence            22222335678999999988889999999999999999999 8889875431    11222111    110         


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                      ....+......+.+++.+|+..+|.+|||+.++.+.|++
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            001112223468999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.6e-37  Score=319.63  Aligned_cols=250  Identities=30%  Similarity=0.484  Sum_probs=200.8

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.+.+.||+|+||+||+|+..++..+|+|.+.... .....+.+|++++++++||||+++++++......++||||+.+|
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05113           6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG   84 (256)
T ss_pred             eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence            44668899999999999998877789999886443 23467899999999999999999999999988999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +|.+++...   ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++..........
T Consensus        85 ~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          85 CLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             cHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            999998542   23588999999999999999999998   999999999999999999999999999876544332222


Q ss_pred             ecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      ....++..|+|||++.+..++.++|||||||++|||++ |..||......    .+....    ..+...         .
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~----~~~~~~---------~  221 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----ETVEKV----SQGLRL---------Y  221 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHH----hcCCCC---------C
Confidence            22345678999999988889999999999999999998 99998654321    111111    111110         0


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      ........+.+++.+|++.+|.+||++.+|++.|+
T Consensus       222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            01112356889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.6e-37  Score=323.95  Aligned_cols=260  Identities=27%  Similarity=0.468  Sum_probs=206.1

Q ss_pred             HHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      ..+.+.+.||+|+||.||++...      ++..+|+|.+..........+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            34456789999999999999752      345689998876554445678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhccc---------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEE
Q 004689          482 VYEFMHNGTLKEHLYGTL---------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV  552 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl  552 (736)
                      ||||+++++|.+++....         .....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence            999999999999986432         1223589999999999999999999998   9999999999999999999999


Q ss_pred             EeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHH
Q 004689          553 SDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL  630 (736)
Q Consensus       553 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~  630 (736)
                      +|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......    .+..    
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~----~~~~----  233 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIE----  233 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH----
Confidence            999999755332211 1222345788999999998899999999999999999998 89998654321    1111    


Q ss_pred             hhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          631 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       631 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      .+..+....     ....    ....+.+++.+|++.+|.+|||+.||.+.|+++..
T Consensus       234 ~i~~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         234 CITQGRVLQ-----RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHHcCCcCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            112222111     1111    22458999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.9e-37  Score=324.88  Aligned_cols=258  Identities=26%  Similarity=0.463  Sum_probs=206.6

Q ss_pred             HHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      +.+.+.||+|+||.||+|...      ++..+++|.+..........+.+|++++++++||||+++++++......++||
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (291)
T cd05094           7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF   86 (291)
T ss_pred             eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence            445788999999999999753      35568999987655545567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccc------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEE
Q 004689          484 EFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK  551 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~k  551 (736)
                      ||+++++|.+++.....            ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+|
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~  163 (291)
T cd05094          87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVK  163 (291)
T ss_pred             ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence            99999999999864321            223588999999999999999999998   999999999999999999999


Q ss_pred             EEeecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHH
Q 004689          552 VSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAK  629 (736)
Q Consensus       552 l~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~  629 (736)
                      |+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......    .+.+.  
T Consensus       164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~~--  237 (291)
T cd05094         164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EVIEC--  237 (291)
T ss_pred             ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH--
Confidence            999999975433221 12223446789999999999999999999999999999999 99998654421    12221  


Q ss_pred             HhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          630 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       630 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                        ...+....         ........+.+++.+|++.+|++||++++|++.|+++..
T Consensus       238 --~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         238 --ITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             --HhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence              12222111         111223468899999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.3e-37  Score=310.90  Aligned_cols=260  Identities=21%  Similarity=0.260  Sum_probs=198.9

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCc-eeeEeeeeeeCC------eEEEE
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRN-LVQFLGYCQEEG------RSVLV  482 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~------~~~lV  482 (736)
                      .++||+|+||+||+|+.+ +|+.||+|+++-....  ......+|+.+|+.++|+| |++|++++...+      ..++|
T Consensus        16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv   95 (323)
T KOG0594|consen   16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV   95 (323)
T ss_pred             HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence            456999999999999865 7889999998765432  3455789999999999999 999999998877      78999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      +||+.. +|..++.........++...+..++.|+++||+|||++   +|+||||||.||||++.|.+||+|||+|+...
T Consensus        96 fe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~  171 (323)
T KOG0594|consen   96 FEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFS  171 (323)
T ss_pred             EEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhc
Confidence            999965 89999865432224567778899999999999999999   99999999999999999999999999998543


Q ss_pred             CCCCcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhc----CCc
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES----GDI  637 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~----~~~  637 (736)
                      -.. ...+..++|.+|+|||++.+. .|+...||||+||+++||++++.-|.+...   ...+....+ .+..    .+.
T Consensus       172 ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~-~lGtP~e~~Wp  246 (323)
T KOG0594|consen  172 IPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFR-LLGTPNEKDWP  246 (323)
T ss_pred             CCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHH-HcCCCCccCCC
Confidence            222 223445689999999999875 799999999999999999999999987763   122222211 1111    111


Q ss_pred             cee----ccCccCCcC-----CHHH---HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 QGI----IDPSLLDEY-----DIQS---MWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~~~----~d~~l~~~~-----~~~~---~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...    .+.......     ....   .....+++.+|++.+|.+|.+++.+++|
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            100    000000000     0001   1367899999999999999999999887

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.8e-37  Score=304.28  Aligned_cols=256  Identities=22%  Similarity=0.250  Sum_probs=197.6

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeee--CCeEEEEEEec
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFM  486 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV~e~~  486 (736)
                      ..++|++|.||.||+|+.+ +++-||+|+++.....  -.-...+|+.+|.+++|||||.+-.+...  -+..|+|||||
T Consensus        80 ~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~  159 (419)
T KOG0663|consen   80 KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYV  159 (419)
T ss_pred             HHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHH
Confidence            4578999999999999876 6888999998755321  12345789999999999999999887753  35689999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      +. +|...+...   .+++...++.-++.|+++|++|||..   .|+|||||++|+|+++.|.+||+|||+|+.+.....
T Consensus       160 Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k  232 (419)
T KOG0663|consen  160 EH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK  232 (419)
T ss_pred             Hh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence            87 888888654   36788889999999999999999998   999999999999999999999999999998766543


Q ss_pred             cceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          567 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      . .+..+-|.+|+|||.+.+ ..|+.+.|+||+|||+.||+++++-|.+...-   .++-..+.. +  |...+.+.|.+
T Consensus       233 ~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~---dQl~~If~l-l--GtPte~iwpg~  305 (419)
T KOG0663|consen  233 P-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI---DQLDKIFKL-L--GTPSEAIWPGY  305 (419)
T ss_pred             c-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH---HHHHHHHHH-h--CCCccccCCCc
Confidence            3 334457999999999986 57999999999999999999999999876522   122222211 1  11111111111


Q ss_pred             -------------------CCcCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 -------------------LDEYDIQ-SMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 -------------------~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                                         ...+... ....-++|+...+..||.+|-|+.|.+++
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence                               1111111 12345788889999999999999998876

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-36  Score=324.22  Aligned_cols=261  Identities=23%  Similarity=0.316  Sum_probs=194.8

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.++...++||||+.
T Consensus         7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   86 (303)
T cd07869           7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH   86 (303)
T ss_pred             ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence            455789999999999999876 688999999875432 223457789999999999999999999999999999999996


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                       ++|.+++...   ...++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... .
T Consensus        87 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  158 (303)
T cd07869          87 -TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-H  158 (303)
T ss_pred             -cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-c
Confidence             6787777532   34578888999999999999999998   99999999999999999999999999987543221 2


Q ss_pred             ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC---cc-----
Q 004689          568 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD---IQ-----  638 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~---~~-----  638 (736)
                      ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....   ...............   ..     
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI---QDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHHHHHHHhCCCChhhccchhhc
Confidence            2233568999999999875 45888999999999999999999999764311   111111111100000   00     


Q ss_pred             eeccCccCCcC---CH-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          639 GIIDPSLLDEY---DI-------QSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       639 ~~~d~~l~~~~---~~-------~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..+++.....+   ..       .....+.+++.+|++.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            00000000000   00       012357789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-36  Score=320.79  Aligned_cols=265  Identities=24%  Similarity=0.376  Sum_probs=200.8

Q ss_pred             HhhccccccCceEEEEEEE-----CCCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeC--CeEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV  482 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~-----~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV  482 (736)
                      .+.+.||+|+||+||++..     .+++.||+|+++.... .....+.+|++++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            5678899999999988653     3578899999875432 2355688999999999999999999988653  467899


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      |||+++|+|.+++..     ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccC
Confidence            999999999999853     3589999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCc--ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          563 DGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       563 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      .....  ......++..|+|||.+....++.++|||||||++|||++|..|+......  ...+..+.........+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhhhh
Confidence            32221  112233567899999998888999999999999999999999998643210  11111111100001111111


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      ++.......+.....++.+++..|++.+|++||++++|++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            121111112223345789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.5e-37  Score=332.40  Aligned_cols=250  Identities=24%  Similarity=0.308  Sum_probs=196.5

Q ss_pred             HhhccccccCceEEEEEEEC----CCcEEEEEEeccCC----cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l  481 (736)
                      .+.+.||+|+||.||+++..    +++.||+|++....    ......+..|+.+++++ +||||+++++++...+..++
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (332)
T cd05614           3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL   82 (332)
T ss_pred             eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence            45688999999999999753    57899999986432    12234577899999999 59999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+.+|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        83 v~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          83 ILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            9999999999999853    34588889999999999999999998   9999999999999999999999999999765


Q ss_pred             cCCCCcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      ............||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+    ...+..      
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~----~~~~~~------  225 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV----SRRILK------  225 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH----HHHHhc------
Confidence            43333333345699999999999865 4788999999999999999999999754321111111    111111      


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                      .++.+...    ....+.+++.+|++.||++||     ++.+++++
T Consensus       226 ~~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 CDPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            11111111    233578899999999999999     77788776

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=7.6e-37  Score=317.69  Aligned_cols=256  Identities=25%  Similarity=0.416  Sum_probs=205.5

Q ss_pred             HHHHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          405 IEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       405 i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      +....+++.++||+|+||.||+|...+++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..+++||
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            45567778899999999999999988899999999875433 3467889999999999999999999874 456899999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+.+|+|.+++...  ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            99999999988543  234688899999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      .........++..|+|||++....++.++|||||||++|||++ |+.||......    .+....    ..+..     .
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~----~~~~~-----~  222 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP----EVIQNL----ERGYR-----M  222 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH----HHHHHH----HcCCC-----C
Confidence            2222223346778999999998889999999999999999999 99999755421    122211    11110     0


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                      ...    .....++.+++.+|+..+|++||+++++.+.|+.
T Consensus       223 ~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 PRP----DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            011    1123468999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.9e-36  Score=326.84  Aligned_cols=202  Identities=27%  Similarity=0.407  Sum_probs=172.9

Q ss_pred             HHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          406 EDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       406 ~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      ....|.+.++||+|+||.||+|... ++..+|+|++..... .....+.+|++++++++||||++++++|..++..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            3445667889999999999999876 678899998865422 23456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+.+|+|.+++..    ...+++.....++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||++.....
T Consensus        83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          83 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            99999999999853    34578888899999999999999974  2799999999999999999999999999875432


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccc
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK  616 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~  616 (736)
                      .   ......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence            2   1223468999999999998889999999999999999999999997543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-37  Score=319.17  Aligned_cols=258  Identities=28%  Similarity=0.429  Sum_probs=195.2

Q ss_pred             hhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhh--cCCCceeeEeeeeeeCC----eEEEEEEe
Q 004689          412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQEEG----RSVLVYEF  485 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~~~----~~~lV~e~  485 (736)
                      +.+.||+|+||.||||++. ++.||||++..   +.+..|.+|-.|.+.  ++|+||++++++-....    .++||++|
T Consensus       214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f  289 (534)
T KOG3653|consen  214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF  289 (534)
T ss_pred             hHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence            4578999999999999998 69999999863   345667777777665  58999999999886655    88999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCC------CCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~------~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      .+.|+|.++|.     ...++|....+|+.-+++||+|||+..      .++|+|||||++||||.+|+++.|+|||+|.
T Consensus       290 h~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  290 HPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             ccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            99999999995     345899999999999999999999854      3789999999999999999999999999998


Q ss_pred             cccCCCCc-ceecccccccccCccccccC-cCC-----CcchhHHHHHHHHHHHhCCCcCccccccc-------------
Q 004689          560 FAVDGASH-VSSIVRGTVGYLDPEYYISQ-QLT-----DKSDVYSFGVILLELISGQEAISNEKFGA-------------  619 (736)
Q Consensus       560 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~-~~~-----~~~DVwSlGvvl~elltG~~p~~~~~~~~-------------  619 (736)
                      .+..+... .....+||.+|||||++.+. .+.     .+.||||+|.|||||++....+.....++             
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            66543322 23346799999999999763 222     46899999999999999765443111000             


Q ss_pred             ccccHHHHHHHhhhcCCcceeccCccCCcC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          620 NCRNIVQWAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       620 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      ...++...+...    +    ..|.+.... ....+.-+.+.+..|++.||+.|.|+.=|.+.+.++.
T Consensus       445 t~e~mq~~VV~k----K----~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  445 TLEEMQELVVRK----K----QRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             CHHHHHHHHHhh----c----cCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence            011111111111    0    111111110 1134556888999999999999999999998888774

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1e-36  Score=331.66  Aligned_cols=244  Identities=25%  Similarity=0.390  Sum_probs=189.5

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.++||+|+||+||+|+.. +++.||||++..... .....+.+|+++++.++|+||+++++++...+..++||||+++|
T Consensus        78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  157 (353)
T PLN00034         78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG  157 (353)
T ss_pred             hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence            5578999999999999876 689999999865432 23456889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +|.+..        ......+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus       158 ~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~  225 (353)
T PLN00034        158 SLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PC  225 (353)
T ss_pred             cccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cc
Confidence            986532        234566778999999999999998   999999999999999999999999999976533221 12


Q ss_pred             ecccccccccCcccccc-----CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          570 SIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~-----~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                      ....||..|+|||++..     ...+.++|||||||++|||++|+.||......+ ...+..   .... ..     .+ 
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~---~~~~-~~-----~~-  294 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMC---AICM-SQ-----PP-  294 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHH---HHhc-cC-----CC-
Confidence            33469999999998853     234468999999999999999999997433111 111111   1000 00     00 


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                         ........++.+++..|++.||++||++.|++++
T Consensus       295 ---~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        295 ---EAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               1111223458899999999999999999999886

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6e-37  Score=323.79  Aligned_cols=264  Identities=21%  Similarity=0.278  Sum_probs=193.7

Q ss_pred             HHhhccccccCceEEEEEEEC--CCcEEEEEEeccCCcc--cchhhhhHHHHHhhc---CCCceeeEeeeee-----eCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRI---HHRNLVQFLGYCQ-----EEG  477 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~--~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l---~HpnIv~l~~~~~-----~~~  477 (736)
                      |.+.+.||+|+||+||+|+..  +++.||+|+++.....  ....+.+|+.+++.+   +||||++++++|.     ...
T Consensus         3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~   82 (290)
T cd07862           3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET   82 (290)
T ss_pred             cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence            456688999999999999863  4678999998654322  233566788877766   6999999999885     345


Q ss_pred             eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecC
Q 004689          478 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL  557 (736)
Q Consensus       478 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGl  557 (736)
                      ..++||||+. ++|.+++....  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          83 KLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             cEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            6899999996 68988885432  34578899999999999999999998   999999999999999999999999999


Q ss_pred             CccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          558 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       558 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                      ++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+.+...........
T Consensus       157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            9754332  22334568999999999988899999999999999999999999998654322222222211100000000


Q ss_pred             c------eeccCccCC---cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 Q------GIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~------~~~d~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .      ..+.+....   .........+.+++.+|++.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0      000000000   0001122457799999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-36  Score=334.33  Aligned_cols=259  Identities=20%  Similarity=0.282  Sum_probs=194.7

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .|.+.+.||+|+||.||+|... +++.||+|...      ...+.+|++++++++||||+++++++......++|+|++.
T Consensus        93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence            4566789999999999999875 68899999743      2346789999999999999999999999999999999985


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                       ++|.+++..    ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++........
T Consensus       167 -~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        167 -TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             -CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence             688887743    34688899999999999999999998   9999999999999999999999999999754333223


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccc-cccc---ccHHHHHHHh---hhc------
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-GANC---RNIVQWAKLH---IES------  634 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~-~~~~---~~l~~~~~~~---~~~------  634 (736)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....   ..+.......   ..+      
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            33445799999999999999999999999999999999999988753321 1000   0111100000   000      


Q ss_pred             CCcceec---------cCccCCcC--CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          635 GDIQGII---------DPSLLDEY--DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       635 ~~~~~~~---------d~~l~~~~--~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..+...+         .+......  .......+.+++.+|++.||++|||++|++++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0000000         00000000  01223468899999999999999999999875

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-37  Score=326.03  Aligned_cols=249  Identities=25%  Similarity=0.362  Sum_probs=207.9

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCe-EEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR-SVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-~~lV~e~  485 (736)
                      |...+.+|+|+||.++..+++ +++.+++|.+.-...  ...+...+|+.++++++|||||.+.+.|.+++. .++||+|
T Consensus         6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y   85 (426)
T KOG0589|consen    6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY   85 (426)
T ss_pred             hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence            445688999999999999876 578899999875432  234467899999999999999999999999888 9999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      |+||+|.+.+....  +.-+++..+++++.|++.|+.|||++   +|+|||||+.|||++.+..|||+|||+|+......
T Consensus        86 ~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   86 CEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             cCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            99999999997543  45688999999999999999999988   99999999999999999999999999999776554


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                       ....+..||+.||.||++.+.+|..|+|||||||++|||++-+++|...+.......+.+.        .    + ..+
T Consensus       161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~--------~----~-~Pl  226 (426)
T KOG0589|consen  161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRG--------L----Y-SPL  226 (426)
T ss_pred             -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhc--------c----C-CCC
Confidence             2445567999999999999999999999999999999999999999876643222222111        0    1 111


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          +.....++..++..|+..+|+.||++.+++.+
T Consensus       227 ----p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  227 ----PSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                22334468899999999999999999999987

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.6e-37  Score=330.21  Aligned_cols=242  Identities=26%  Similarity=0.366  Sum_probs=193.8

Q ss_pred             ccccccCceEEEEEEE----CCCcEEEEEEeccCC----cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          414 KKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~----~~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.||+|+||.||+++.    .+++.||||+++...    ......+.+|+++|+.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999975    357899999987532    12234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +.+|+|.+++..    ...+.+..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            999999998843    34567788888999999999999998   99999999999999999999999999987533222


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|+.||......       ..... +..+..      .+
T Consensus       155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~~-~~~~~~------~~  219 (323)
T cd05584         155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTIDK-ILKGKL------NL  219 (323)
T ss_pred             C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHHH-HHcCCC------CC
Confidence            2 223356999999999999888999999999999999999999999765421       11111 111111      01


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                      ..    .....+.+++.+|++.+|++||     ++.+++++
T Consensus       220 ~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         220 PP----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CC----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            11    1223578999999999999999     88888775

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=9.7e-37  Score=328.47  Aligned_cols=250  Identities=22%  Similarity=0.299  Sum_probs=196.1

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||.||+|+.. +++.||+|+++....   .....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999876 578999999875422   2234577888888776 899999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|..++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~  152 (329)
T cd05618          81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT  152 (329)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence            999888743    34688999999999999999999998   99999999999999999999999999987532221 12


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccccc-ccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA-NCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+....+..+..          
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------
Confidence            234569999999999999999999999999999999999999996432111 112223333333222221          


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCC------HHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPS------ISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~ev~~~  681 (736)
                      ..+......+.+++.+|++.||++||+      +.+++++
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            111122345789999999999999998      5677665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.1e-36  Score=314.97  Aligned_cols=247  Identities=29%  Similarity=0.434  Sum_probs=195.5

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      +.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999875 68999999876432 23346789999999999999999999999999999999999999999


Q ss_pred             HHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce-e
Q 004689          492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS-S  570 (736)
Q Consensus       492 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~  570 (736)
                      .+++...   ...+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++........... .
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            9998532   34578999999999999999999998   999999999999999999999999999875432211111 1


Q ss_pred             cccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcC
Q 004689          571 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY  649 (736)
Q Consensus       571 ~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  649 (736)
                      ...++..|+|||.+.++.++.++|||||||++|||++ |..||......    ..    ......+.         ....
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~----~~----~~~~~~~~---------~~~~  217 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ----QT----REAIEQGV---------RLPC  217 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH----HH----HHHHHcCC---------CCCC
Confidence            1123467999999998889999999999999999998 88888644311    11    11111110         0111


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          650 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       650 ~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      +......+.+++.+|++.+|++||++.||.+.|+
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1122346889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=330.53  Aligned_cols=260  Identities=27%  Similarity=0.396  Sum_probs=215.8

Q ss_pred             HHHHHHHhhccccccCceEEEEEEECC-CcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          405 IEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       405 i~~~~~~~~~~IG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      ++.......++||-|.||.||.|.|+. .-.||||.++.+.. ...+|.+|+.+|+.++|||+|+|+|+|..+...|+|+
T Consensus       264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT  342 (1157)
T KOG4278|consen  264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT  342 (1157)
T ss_pred             ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence            333333347899999999999999974 56799999976543 4678999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      |||..|+|.++|++..  +..++....+.|+.||++||+||..+   .+|||||.++|+||.++..+||+|||+++++..
T Consensus       343 EfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  343 EFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             ecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            9999999999997653  44567777889999999999999998   999999999999999999999999999998765


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      +.........-...|.|||-+....++.|+|||+|||+|||+.| |..||.+.+..        .+...++.        
T Consensus       418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS--------qVY~LLEk--------  481 (1157)
T KOG4278|consen  418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYGLLEK--------  481 (1157)
T ss_pred             CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH--------HHHHHHhc--------
Confidence            54433333344678999999999999999999999999999999 99999876521        22233222        


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                       ..+-+.+..++.++.+|+..||+..|.+||++.|+.+.++.++.
T Consensus       482 -gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  482 -GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             -cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence             22223345567789999999999999999999999999987754

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.7e-37  Score=332.94  Aligned_cols=244  Identities=23%  Similarity=0.265  Sum_probs=197.3

Q ss_pred             HHHhhccccccCceEEEEEEECC--CcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~--~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      .+.+.+.||+|+||.||+|.+..  +..||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~  110 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL  110 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence            35567899999999999998653  3689999986432   222346788999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+.+|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       111 Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        111 EFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999999853    34588888999999999999999998   999999999999999999999999999976532


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++|..||.......    +    ...+..+..      
T Consensus       184 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~----~~~i~~~~~------  245 (340)
T PTZ00426        184 R----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL----I----YQKILEGII------  245 (340)
T ss_pred             C----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH----H----HHHHhcCCC------
Confidence            2    233569999999999998889999999999999999999999997654111    1    111111111      


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                      .+...    ....+.+++.+|++.+|++|+     +++|++++
T Consensus       246 ~~p~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 YFPKF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCCC----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            01111    123477899999999999995     89998877

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.3e-36  Score=313.07  Aligned_cols=258  Identities=25%  Similarity=0.383  Sum_probs=205.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.+.||+|+||.||+|+.. +++.||||.++...   ......+.+|+++++.++||||+++++++...+..++|+||
T Consensus         4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08228           4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence            445788999999999999875 68999999876432   22234688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++.........++......++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999988854333344578888999999999999999998   99999999999999999999999999987654322


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      . ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||.....     ....+.... .....     +. 
T Consensus       161 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~~-~~~~~-----~~-  227 (267)
T cd08228         161 T-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQKI-EQCDY-----PP-  227 (267)
T ss_pred             H-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHHH-hcCCC-----CC-
Confidence            1 12234588999999999988899999999999999999999999864431     112222211 11111     11 


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                        .........+.+++.+|++.+|++||++.+|++.|+++
T Consensus       228 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 --LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             --CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence              11112335688999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.1e-36  Score=328.05  Aligned_cols=250  Identities=22%  Similarity=0.309  Sum_probs=197.3

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||.||+|+.. +++.||+|+++....   .....+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999999876 688999999975422   2234577899999988 799999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~  152 (329)
T cd05588          81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT  152 (329)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence            999988742    35689999999999999999999998   9999999999999999999999999998743221 122


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccc-cccHHHHHHHhhhcCCcceeccCccCC
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+....+..+...      +  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~--  224 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------I--  224 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------C--
Confidence            2345699999999999999999999999999999999999999974332111 112223333333222211      1  


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCC------HHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPS------ISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~ev~~~  681 (736)
                        +......+.+++.+|++.||.+||+      +.+++++
T Consensus       225 --p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         225 --PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             --CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence              1112345788999999999999997      6787765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.7e-37  Score=327.86  Aligned_cols=241  Identities=26%  Similarity=0.387  Sum_probs=189.6

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||.||+|+.. +++.||+|+++....   .....+..|..++... +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 578899999875421   2233455666777654 899999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++..    ...++...+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  152 (316)
T cd05592          81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK  152 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence            999988843    34588888999999999999999998   99999999999999999999999999997543322 22


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....    .+..   . +....      +    .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~----~~~~---~-i~~~~------~----~  214 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED----ELFD---S-ILNDR------P----H  214 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH----HHHH---H-HHcCC------C----C
Confidence            33456999999999999989999999999999999999999999765421    1111   1 11110      0    1


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLK  680 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~~  680 (736)
                      ++......+.+++..|++.+|.+||++. ++.+
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            1111234577899999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.5e-37  Score=320.52  Aligned_cols=256  Identities=24%  Similarity=0.422  Sum_probs=200.1

Q ss_pred             HHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  480 (736)
                      ..+.+.+.||+|+||.||+|.+.      ++..||+|++..... ....++.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            34566789999999999999753      246799998864322 23456889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhccccc------ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 004689          481 LVYEFMHNGTLKEHLYGTLTH------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD  554 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~D  554 (736)
                      +||||+.+|+|.+++......      ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECC
Confidence            999999999999998643211      23457888899999999999999998   999999999999999999999999


Q ss_pred             ecCCccccCCCCcc-eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhh
Q 004689          555 FGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       555 FGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      ||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||.....    ......    .
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~----~~~~~~----~  234 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----EQVLRF----V  234 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH----H
Confidence            99987543322211 122345788999999998899999999999999999999 6888865431    111111    1


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      .++....         .+......+.+++.+|++.+|++||++.|+++.|+
T Consensus       235 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         235 MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1111111         11122346889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.1e-36  Score=320.62  Aligned_cols=256  Identities=22%  Similarity=0.382  Sum_probs=201.3

Q ss_pred             HHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  480 (736)
                      ..+.+.+.||+|+||.||+|...      +++.||+|+++..... ....+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            34567789999999999999864      2478999998754322 2356889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhccc------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC
Q 004689          481 LVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM  548 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~  548 (736)
                      +++||+.+++|.+++....            .....+++..+..++.|++.||.|||+.   +|+||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence            9999999999999985321            1123578888999999999999999998   999999999999999999


Q ss_pred             cEEEEeecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHH
Q 004689          549 RAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQ  626 (736)
Q Consensus       549 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~  626 (736)
                      .+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+...    ..+..
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~  237 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDVIE  237 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Confidence            999999999875433221 11223346789999999988889999999999999999998 8888865431    11222


Q ss_pred             HHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          627 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       627 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      .    +..+...         ..+......+.+++..|++.+|.+||++++|++.|+
T Consensus       238 ~----i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         238 M----IRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             H----HHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            1    1122111         111223345889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-36  Score=320.98  Aligned_cols=257  Identities=26%  Similarity=0.440  Sum_probs=202.8

Q ss_pred             HhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      ++.+.||+|+||.||+|...      ....+|+|.+..... .....+.+|+.+++.++||||+++++.+...+..++++
T Consensus         3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (290)
T cd05045           3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV   82 (290)
T ss_pred             cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence            45688999999999999753      235789998865432 23456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhccc--------------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEE
Q 004689          484 EFMHNGTLKEHLYGTL--------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL  543 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NIL  543 (736)
                      ||+.+|+|.+++....                    .....+++..++.++.|++.||.|||+.   +++||||||+|||
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil  159 (290)
T cd05045          83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL  159 (290)
T ss_pred             EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence            9999999999986421                    1123578899999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCccccccccc
Q 004689          544 LDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC  621 (736)
Q Consensus       544 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~  621 (736)
                      +++++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....    
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----  235 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP----  235 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH----
Confidence            999999999999999754332221 1223346778999999988889999999999999999998 9999865431    


Q ss_pred             ccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          622 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       622 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ..+..+..    .+.         ....+......+.+++..|++.+|++||++.|+++.|++++.
T Consensus       236 ~~~~~~~~----~~~---------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         236 ERLFNLLK----TGY---------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHHHHHh----CCC---------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            12222211    110         001111223468899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-36  Score=328.02  Aligned_cols=264  Identities=25%  Similarity=0.431  Sum_probs=205.9

Q ss_pred             HHHHHHHhhccccccCceEEEEEEEC--------CCcEEEEEEeccCC-cccchhhhhHHHHHhhc-CCCceeeEeeeee
Q 004689          405 IEDATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ  474 (736)
Q Consensus       405 i~~~~~~~~~~IG~G~fG~Vy~~~~~--------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  474 (736)
                      +...++.+.+.||+|+||.||+|+..        .+..||+|+++... ......+.+|+++++++ +||||++++++|.
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            33456678899999999999999752        12368999887542 22346788999999999 8999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHhhccc------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCE
Q 004689          475 EEGRSVLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI  542 (736)
Q Consensus       475 ~~~~~~lV~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NI  542 (736)
                      ..+..++++||+.+|+|.+++....            .....+++..++.++.|++.||+|||+.   +++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence            9999999999999999999986432            1234588899999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEEeecCCccccCCCCcc-eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccc
Q 004689          543 LLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGAN  620 (736)
Q Consensus       543 Ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~  620 (736)
                      |++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......  
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--  243 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--  243 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence            99999999999999997553322111 122234578999999999999999999999999999998 88888654321  


Q ss_pred             cccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          621 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       621 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                           ...... ..+...         .........+.+++.+|++.+|++||++.|+++.|+++...
T Consensus       244 -----~~~~~~-~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         244 -----ELFKLL-KEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             -----HHHHHH-HcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence                 111111 111111         11112234688999999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.6e-36  Score=313.06  Aligned_cols=247  Identities=27%  Similarity=0.414  Sum_probs=198.4

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCHH
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK  492 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~  492 (736)
                      ++||+|+||.||+|...+++.+|+|++..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            36899999999999988889999999865432 22346889999999999999999999999999999999999999999


Q ss_pred             HHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceecc
Q 004689          493 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV  572 (736)
Q Consensus       493 ~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  572 (736)
                      +++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            988532   23578899999999999999999998   999999999999999999999999999875433322222223


Q ss_pred             cccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCH
Q 004689          573 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI  651 (736)
Q Consensus       573 ~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  651 (736)
                      .++..|+|||++.+..++.++|||||||++||+++ |..||......    ....    ....+...         ....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~~----~~~~~~~~---------~~~~  217 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QARE----QVEKGYRM---------SCPQ  217 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHH----HHHcCCCC---------CCCC
Confidence            45678999999998889999999999999999998 99999754321    1111    11111100         1111


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          652 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       652 ~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      .....+.+++.+|++.+|++||++.|+++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            23356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=9.7e-37  Score=321.12  Aligned_cols=256  Identities=24%  Similarity=0.425  Sum_probs=200.6

Q ss_pred             HHHhhccccccCceEEEEEEE-----CCCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      .+.+.+.||+|+||.||+|..     .++..||+|.+.... ......+.+|++++++++||||+++++++......++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   85 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML   85 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence            345678999999999999975     246789999987433 22335688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcccc-------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc
Q 004689          483 YEFMHNGTLKEHLYGTLT-------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR  549 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~  549 (736)
                      |||+.+|+|.+++.....             ....+++...+.++.|++.||.|||+.   +++||||||+|||++.++.
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCc
Confidence            999999999999853211             123478888999999999999999998   9999999999999999999


Q ss_pred             EEEEeecCCccccCCC-CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHH
Q 004689          550 AKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQW  627 (736)
Q Consensus       550 ~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~  627 (736)
                      +||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..||.....    ..+...
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~----~~~~~~  238 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----QEVIEM  238 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH
Confidence            9999999997553322 122233346778999999988889999999999999999998 8889865431    122221


Q ss_pred             HHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          628 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       628 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                      ..    .+....         .+.....++.+++.+|++.+|++||++.+|.++|..
T Consensus       239 ~~----~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 VR----KRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HH----cCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11    111110         111123457889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=302.30  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=202.8

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccC--CcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      .|.+.+.||+|.|+.||+..+. +|+.+|+|++..+  ...+.+++.+|+.|-+.++||||++|.+.+.+.+..++|+|+
T Consensus        12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~   91 (355)
T KOG0033|consen   12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL   91 (355)
T ss_pred             hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence            4556678999999999999665 7899999988644  334567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeecCCcccc
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAV  562 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~---~~~~kl~DFGla~~~~  562 (736)
                      |.|++|..-+-.    +..+++..+-..+.||+.+|.|+|.+   +|+|||+||+|+++..   ..-+||+|||+|....
T Consensus        92 m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   92 VTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999876632    34467777778899999999999999   9999999999999964   3469999999998776


Q ss_pred             CCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                        ........+|||+|||||++...+|+..+|||+.||+||-|+.|..||.+.+....++.|.        .|+..  ++
T Consensus       165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~--------~g~yd--~~  232 (355)
T KOG0033|consen  165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK--------AGAYD--YP  232 (355)
T ss_pred             --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh--------ccccC--CC
Confidence              3344556789999999999999999999999999999999999999999865433332222        22211  22


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +.......    .+..+|+.+|+..||.+|.|+.|.+.+
T Consensus       233 ~~~w~~is----~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  233 SPEWDTVT----PEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             CcccCcCC----HHHHHHHHHHhccChhhhccHHHHhCC
Confidence            22222222    346789999999999999999998765

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.7e-37  Score=332.25  Aligned_cols=242  Identities=24%  Similarity=0.326  Sum_probs=194.3

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.||+|+||.||++... +++.||+|+++....   .....+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999865 688999999875421   22345678999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      +|.+++..    ...+++..+..++.|++.||.|||+ .   +|+||||||+|||++.++.+||+|||+++....... .
T Consensus        81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~  152 (325)
T cd05594          81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T  152 (325)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence            99988743    3468899999999999999999997 5   999999999999999999999999999875322221 2


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+....    ..+..      .+.. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~----~~~~~i----~~~~~------~~p~-  217 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELI----LMEEI------RFPR-  217 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH----HHHHHH----hcCCC------CCCC-
Confidence            23346999999999999999999999999999999999999999754421    111111    11110      1111 


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                         .....+.+++.+|++.||++|+     ++.+++++
T Consensus       218 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         218 ---TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             ---CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence               1234578899999999999996     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=9.3e-37  Score=322.84  Aligned_cols=259  Identities=25%  Similarity=0.425  Sum_probs=204.4

Q ss_pred             HHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  479 (736)
                      ..+.+.+.||+|+||.||+|...      ....+|+|++..... .....+.+|+++++++ +|+||+++++++...+..
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            34456789999999999999864      236799999875422 2335688899999999 899999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhccc------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC
Q 004689          480 VLVYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH  547 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~  547 (736)
                      +++|||+++|+|.+++....            .....+++..++.++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~  168 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTED  168 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCC
Confidence            99999999999999986431            2345688999999999999999999998   99999999999999999


Q ss_pred             CcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHH
Q 004689          548 MRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIV  625 (736)
Q Consensus       548 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~  625 (736)
                      +.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+    +.
T Consensus       169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----~~  244 (293)
T cd05053         169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----LF  244 (293)
T ss_pred             CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH----HH
Confidence            99999999999865433221 1122335678999999988899999999999999999998 989987544211    11


Q ss_pred             HHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          626 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       626 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      .    ....+..         ...+......+.+++.+|+..+|++|||+.|+++.|++++
T Consensus       245 ~----~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 K----LLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             H----HHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            1    1111110         1112223446889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.9e-36  Score=333.40  Aligned_cols=262  Identities=24%  Similarity=0.385  Sum_probs=203.4

Q ss_pred             HHHHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCcc-cchhhhhHHHHHhhcC-CCceeeEeeeeeeCC
Q 004689          406 EDATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIH-HRNLVQFLGYCQEEG  477 (736)
Q Consensus       406 ~~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~  477 (736)
                      ....+.+.+.||+|+||.||+|++.      .++.||+|+++..... ....+.+|+.+|.++. ||||++++++|...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3344556789999999999999864      3468999999754322 2346889999999997 999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcccc---------------------------------------------------------
Q 004689          478 RSVLVYEFMHNGTLKEHLYGTLT---------------------------------------------------------  500 (736)
Q Consensus       478 ~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------  500 (736)
                      ..++||||+.+|+|.++++....                                                         
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            99999999999999999964311                                                         


Q ss_pred             -------------------------------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEE
Q 004689          501 -------------------------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL  543 (736)
Q Consensus       501 -------------------------------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NIL  543 (736)
                                                           ....+++...+.++.|++.||+|||+.   +++||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence                                                 112367778889999999999999998   9999999999999


Q ss_pred             EcCCCcEEEEeecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCccccccccc
Q 004689          544 LDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC  621 (736)
Q Consensus       544 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~  621 (736)
                      ++.++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||......+  
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--  349 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--  349 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--
Confidence            99999999999999975432221 11222357889999999998889999999999999999998 888986543111  


Q ss_pred             ccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          622 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       622 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                           .....+..+..         ...+.....++.+++.+|+..+|.+||+++||++.|++++
T Consensus       350 -----~~~~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 -----QFYNAIKRGYR---------MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -----HHHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                 01111111110         0111122346889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=337.01  Aligned_cols=250  Identities=24%  Similarity=0.320  Sum_probs=200.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||+||+|+.. +++.||||+++....   .....+.+|++++..++||||+++++++.+++..++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (350)
T cd05573           3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY   82 (350)
T ss_pred             ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence            345688999999999999876 689999999875421   2345688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++...    ..++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          83 MPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            9999999998542    5688889999999999999999998   99999999999999999999999999997654332


Q ss_pred             ----------------------------CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccc
Q 004689          566 ----------------------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF  617 (736)
Q Consensus       566 ----------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~  617 (736)
                                                  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                        1122345699999999999999999999999999999999999999976542


Q ss_pred             ccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 004689          618 GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-ISEVLKD  681 (736)
Q Consensus       618 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~ev~~~  681 (736)
                      ......+..|.      ..+.  + +   .  .......+.+++.+|+. +|.+||+ ++|++++
T Consensus       236 ~~~~~~i~~~~------~~~~--~-p---~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 QETYNKIINWK------ESLR--F-P---P--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHHHHhccC------Cccc--C-C---C--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            21111111110      0000  0 0   0  00123457889999997 9999999 9999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.7e-37  Score=328.65  Aligned_cols=242  Identities=22%  Similarity=0.333  Sum_probs=193.7

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999876 57899999987542   12234567788888876 799999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|...+..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~  152 (321)
T cd05591          81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT  152 (321)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence            999988843    34688889999999999999999998   99999999999999999999999999987532222 22


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+...   . ..+..   .       
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~----~~~~~---i-~~~~~---~-------  214 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED----DLFES---I-LHDDV---L-------  214 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH----HHHHH---H-HcCCC---C-------
Confidence            23456999999999999989999999999999999999999999765421    11111   1 11111   0       


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRP-------SISEVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RP-------t~~ev~~~  681 (736)
                      ++......+.+++..|++.||++||       ++.+++++
T Consensus       215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            0111124578899999999999999       88888766

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.8e-37  Score=337.05  Aligned_cols=249  Identities=21%  Similarity=0.291  Sum_probs=191.8

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.+.||+|+||+||+|+.. +++.||||++.....   .....+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~   84 (381)
T cd05626           5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP   84 (381)
T ss_pred             EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence            4578999999999999875 678999999875422   223568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC-
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-  566 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~-  566 (736)
                      +|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++....... 
T Consensus        85 gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          85 GGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            9999999853    34578888888999999999999998   999999999999999999999999999753210000 


Q ss_pred             ---------------------------------------------cceecccccccccCccccccCcCCCcchhHHHHHH
Q 004689          567 ---------------------------------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI  601 (736)
Q Consensus       567 ---------------------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvv  601 (736)
                                                                   .......||+.|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                         00123469999999999998899999999999999


Q ss_pred             HHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhh--ccCCCCCCCCCHHHHH
Q 004689          602 LLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVL  679 (736)
Q Consensus       602 l~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--cl~~dP~~RPt~~ev~  679 (736)
                      +|||++|+.||......+....+..|.      ..+.  +.+  ....+    .++.+++.+  |...++..||++.|++
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~~------~~~~--~~~--~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         238 LFEMLVGQPPFLAPTPTETQLKVINWE------NTLH--IPP--QVKLS----PEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             HHHHHhCCCCCcCCCHHHHHHHHHccc------cccC--CCC--CCCCC----HHHHHHHHHHccCcccccCCCCHHHHh
Confidence            999999999997654211111111110      0000  000  01122    234556654  6677777899999999


Q ss_pred             HH
Q 004689          680 KD  681 (736)
Q Consensus       680 ~~  681 (736)
                      ++
T Consensus       304 ~h  305 (381)
T cd05626         304 AH  305 (381)
T ss_pred             cC
Confidence            87

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=8.7e-37  Score=334.05  Aligned_cols=251  Identities=22%  Similarity=0.272  Sum_probs=197.1

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .+.+.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.++...++|||
T Consensus        44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05596          44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME  123 (370)
T ss_pred             HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence            4456788999999999999876 68899999986432   1223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++|+|.+++..     ..++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       124 y~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         124 YMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             CCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999998853     2467777888999999999999998   9999999999999999999999999999765433


Q ss_pred             CCcceecccccccccCccccccC----cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      .........||+.|+|||++.+.    .++.++|||||||++|||++|+.||.........       ........... 
T Consensus       196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-------~~i~~~~~~~~-  267 (370)
T cd05596         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY-------SKIMDHKNSLT-  267 (370)
T ss_pred             CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH-------HHHHcCCCcCC-
Confidence            22233445799999999998653    4788999999999999999999999865421111       11111100000 


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~  681 (736)
                          ...  .......+.+++..|++.+|.+  ||++.|++++
T Consensus       268 ----~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         268 ----FPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             ----CCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                001  0112345788999999999987  9999999887

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=320.34  Aligned_cols=250  Identities=26%  Similarity=0.356  Sum_probs=199.0

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      ...++||+|+||+||++... +++.||+|++.....   .....+.+|+.++++++||||+++++++..++..++||||+
T Consensus         3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (285)
T cd05605           3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM   82 (285)
T ss_pred             eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence            45678999999999999875 688999999865432   22345778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++........
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          83 NGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             CCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            999999888643  234588999999999999999999998   999999999999999999999999999876433221


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                        .....|++.|+|||++.+..++.++||||+||++|||++|+.||.+.....    ....+...+..+.          
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~----------  221 (285)
T cd05605         158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KREEVERRVKEDQ----------  221 (285)
T ss_pred             --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHHHHHHHhhhcc----------
Confidence              123468999999999998889999999999999999999999997644211    1111111111111          


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                      ..++......+.+++.+|++.||++||     ++++++++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            111222334578999999999999999     78888766

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.1e-37  Score=328.26  Aligned_cols=242  Identities=26%  Similarity=0.386  Sum_probs=192.6

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||+||+|+.+ +++.||||++....   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999876 57899999987532   12234567788888876 699999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~  152 (320)
T cd05590          81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT  152 (320)
T ss_pred             chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence            999988843    34688889999999999999999998   99999999999999999999999999987532221 22


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+...    +..+...          
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~----i~~~~~~----------  214 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED----DLFEA----ILNDEVV----------  214 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHH----HhcCCCC----------
Confidence            23456999999999999989999999999999999999999999765421    11111    1111110          


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~------~ev~~~  681 (736)
                      ++......+.+++..|++.||++||++      ++++++
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            011122357889999999999999998      666654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.9e-36  Score=313.37  Aligned_cols=258  Identities=24%  Similarity=0.368  Sum_probs=205.9

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.+.||+|+||.||+|... +++.+|||.+.....   ....++.+|+.+++.++||||+++++++..++..+++|||
T Consensus         4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   83 (267)
T cd08229           4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL   83 (267)
T ss_pred             hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence            456788999999999999864 789999998764322   2235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            999999998865433445689999999999999999999998   99999999999999999999999999987654322


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      .. .....|+..|+|||++.+..++.++||||||+++|||++|..||.....     ......... ...     ..+..
T Consensus       161 ~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~-~~~-----~~~~~  228 (267)
T cd08229         161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKI-EQC-----DYPPL  228 (267)
T ss_pred             cc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhhh-hcC-----CCCCC
Confidence            21 2234588999999999888899999999999999999999999965431     111111111 111     11111


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      .   .......+.+++.+|++.+|++||||.+|++.++++
T Consensus       229 ~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         229 P---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             C---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            1   112334688999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=296.71  Aligned_cols=265  Identities=21%  Similarity=0.294  Sum_probs=210.5

Q ss_pred             HHHHHHHhhccccccCceEEEEEE-ECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCC-----e
Q 004689          405 IEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----R  478 (736)
Q Consensus       405 i~~~~~~~~~~IG~G~fG~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~  478 (736)
                      |.+.+|.+.+.||+|||+-||.++ ..+++.+|+|++...+.++.+...+|++..++++||||+++++++..+.     .
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            345677889999999999999997 4478899999988777777788999999999999999999999885443     4


Q ss_pred             EEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCC
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS  558 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla  558 (736)
                      .|++++|...|+|.+.+.....++..+++.+.+.|+.++++||++||+. .++++||||||.|||+.+.+.+++.|||.+
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence            8999999999999999987766677899999999999999999999997 346999999999999999999999999998


Q ss_pred             ccccCC----CCc----ceecccccccccCccccc---cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHH
Q 004689          559 KFAVDG----ASH----VSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW  627 (736)
Q Consensus       559 ~~~~~~----~~~----~~~~~~gt~~Y~aPE~~~---~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~  627 (736)
                      +...-.    ...    ......-|..|+|||.+.   +...++++|||||||+||+|+.|..||+..-..         
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---------  247 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---------  247 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------
Confidence            643211    100    001122488999999985   346789999999999999999999999754311         


Q ss_pred             HHHhhhcCCcceecc-CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          628 AKLHIESGDIQGIID-PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       628 ~~~~~~~~~~~~~~d-~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                            .|.+.-.+. +.+.-..+......+.+++..|++.||.+||++.+++.+++.+
T Consensus       248 ------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  248 ------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                  122221111 1111111122455789999999999999999999999998875

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.2e-36  Score=344.06  Aligned_cols=253  Identities=24%  Similarity=0.330  Sum_probs=201.7

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCC--------
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--------  477 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--------  477 (736)
                      .|.+.+.||+|+||+||+|+.. +++.||||++....  ......+.+|+.++..++|+||+++++.+....        
T Consensus        33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~  112 (496)
T PTZ00283         33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL  112 (496)
T ss_pred             CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence            5567889999999999999765 68999999986543  223456788999999999999999988765332        


Q ss_pred             eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecC
Q 004689          478 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL  557 (736)
Q Consensus       478 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGl  557 (736)
                      ..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       113 ~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGl  189 (496)
T PTZ00283        113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGF  189 (496)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEeccc
Confidence            36899999999999999976554556788999999999999999999998   999999999999999999999999999


Q ss_pred             CccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          558 SKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       558 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      ++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....       ........ .+.
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~~-~~~  261 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKTL-AGR  261 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHh-cCC
Confidence            986543221 223345699999999999999999999999999999999999999975432       11111111 111


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...         .+......+.+++..|++.+|.+||++.+++++
T Consensus       262 ~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        262 YDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            110         111223458899999999999999999999865

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.2e-36  Score=312.14  Aligned_cols=258  Identities=26%  Similarity=0.377  Sum_probs=207.4

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.+.||+|+||.||+|... +++.||+|.++...   ......+.+|++++++++|+||+++++++...+..++||||
T Consensus         4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   83 (267)
T cd08224           4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL   83 (267)
T ss_pred             eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence            446788999999999999887 78999999886432   22245788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++.........+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            999999999865444456688999999999999999999998   99999999999999999999999999987553322


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      .. .....|+..|+|||++.+..++.++|||||||++|||++|+.||....     ..+.+.... ...+....      
T Consensus       161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~-~~~~~~~~------  227 (267)
T cd08224         161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKK-IEKCDYPP------  227 (267)
T ss_pred             cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-----ccHHHHHhh-hhcCCCCC------
Confidence            21 223458899999999998889999999999999999999999986443     122222111 11111110      


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                        .........+.+++.+|+..+|++||++.+|++.|+++
T Consensus       228 --~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         228 --LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             --CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence              00112334688999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.2e-36  Score=326.73  Aligned_cols=260  Identities=20%  Similarity=0.279  Sum_probs=193.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeC-----CeEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL  481 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~l  481 (736)
                      |.+.++||+|+||.||+|... +++.||||++....  ......+.+|++++++++||||+++++++...     ...++
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            345688999999999999875 68999999986432  22345688999999999999999999988543     24799


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+. ++|.+++..    ...+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        82 v~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          82 VFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            999995 688888742    34588999999999999999999998   9999999999999999999999999999754


Q ss_pred             cCCCC--cceecccccccccCcccccc--CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh-----
Q 004689          562 VDGAS--HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI-----  632 (736)
Q Consensus       562 ~~~~~--~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~-----  632 (736)
                      .....  .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.......    .........     
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~----~~~~~~~~~~~~~~  229 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH----QLDLITDLLGTPSP  229 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH----HHHHHHHHhCCCCH
Confidence            32211  12233568999999999875  678999999999999999999999997543211    111110000     


Q ss_pred             ------hcCCcceec---cCccCCcC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          633 ------ESGDIQGII---DPSLLDEY---DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       633 ------~~~~~~~~~---d~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                            ........+   .+......   .......+.+++.+|++.+|++||+++|++++
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                  000000000   00000000   00112357899999999999999999999976

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-37  Score=337.28  Aligned_cols=249  Identities=23%  Similarity=0.340  Sum_probs=194.9

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+.+.||+|+||+||+|+.. +++.||||++....   ......+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus         4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~   83 (364)
T cd05599           4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL   83 (364)
T ss_pred             eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence            34688999999999999876 68899999987532   122345778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          84 PGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            99999999853    34588899999999999999999998   999999999999999999999999999864321110


Q ss_pred             c-------------------------------------ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCC
Q 004689          567 H-------------------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ  609 (736)
Q Consensus       567 ~-------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~  609 (736)
                      .                                     .....+||+.|+|||++....++.++|||||||++|||++|.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            0                                     011245999999999999999999999999999999999999


Q ss_pred             CcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 004689          610 EAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEVLKD  681 (736)
Q Consensus       610 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~ev~~~  681 (736)
                      .||......+....+..|.      ..+.  +.    .  .......+.+++.+|+. +|.+|++   +.|++++
T Consensus       237 ~Pf~~~~~~~~~~~i~~~~------~~~~--~~----~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         237 PPFCSDNPQETYRKIINWK------ETLQ--FP----D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCHHHHHHHHHcCC------CccC--CC----C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9997654222111111110      0000  00    0  00112346678888886 8999998   9998876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.4e-36  Score=313.54  Aligned_cols=246  Identities=29%  Similarity=0.433  Sum_probs=194.7

Q ss_pred             cccccCceEEEEEEEC---CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          415 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       415 ~IG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      .||+|+||.||+|.++   ++..+|+|+++....  ....++.+|+.+++.+.||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999999753   578899999864432  234568899999999999999999998864 4678999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc-
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-  568 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~-  568 (736)
                      +|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......... 
T Consensus        81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99999843    34588899999999999999999998   99999999999999999999999999998654333221 


Q ss_pred             -eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          569 -SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       569 -~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                       .....++..|+|||.+....++.++|||||||++|||++ |+.||......    .+...    +..+...        
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~----i~~~~~~--------  217 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN----EVTQM----IESGERM--------  217 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH----HHCCCCC--------
Confidence             112234678999999988889999999999999999998 99999754311    12221    1222111        


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                       ..+.....++.+++.+|++.+|++||++.+|++.|++.
T Consensus       218 -~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         218 -ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             -CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence             11112234578999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.9e-36  Score=313.45  Aligned_cols=253  Identities=25%  Similarity=0.410  Sum_probs=200.9

Q ss_pred             HHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      ..+.+.+.||+|+||.||+|....+..+|+|.+.... .....+.+|++++++++|||++++++++.. ...+++|||+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            3456778999999999999998877789999876443 234568899999999999999999998854 56789999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+|||+++........
T Consensus        84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          84 KGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            999999986432  33478899999999999999999998   9999999999999999999999999999765433222


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      ......++..|+|||+..+..++.++|||||||++|||++ |..||.+....    ....+..    .+..     .   
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~----~~~~-----~---  222 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----EVLEQVE----RGYR-----M---  222 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH----cCCC-----C---
Confidence            2222346778999999988889999999999999999999 89998754421    1222111    1100     0   


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                       ..+......+.+++.+|+..+|++||++++|.+.|++
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             0111233568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-36  Score=315.74  Aligned_cols=255  Identities=26%  Similarity=0.426  Sum_probs=199.8

Q ss_pred             HhhccccccCceEEEEEEECC----CcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCe------
Q 004689          411 MLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------  478 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~------  478 (736)
                      .+.+.||+|+||.||+|....    +..||+|+++....  .....+.+|+++++.++||||+++++++.....      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            356889999999999998652    36799999875422  223568899999999999999999998866554      


Q ss_pred             EEEEEEecCCCCHHHHhhcccc--cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeec
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG  556 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFG  556 (736)
                      .++++||+++|+|.+++.....  ....+++.....++.|++.||.|||+.   +++||||||+||++++++.+||+|||
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg  158 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFG  158 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCcc
Confidence            7999999999999999854321  234688899999999999999999998   99999999999999999999999999


Q ss_pred             CCccccCCCCcc-eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhc
Q 004689          557 LSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIES  634 (736)
Q Consensus       557 la~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~  634 (736)
                      +++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.+....    .+.++..    .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~----~~~~~~~----~  230 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH----EIYDYLR----H  230 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH----c
Confidence            998654332221 122335678999999988899999999999999999999 88888654321    2222221    1


Q ss_pred             CCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          635 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       635 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      +...     .    .+......+.+++.+|++.||.+||++.||++.|+++
T Consensus       231 ~~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GNRL-----K----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCCC-----C----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1111     0    1122344689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-36  Score=332.09  Aligned_cols=199  Identities=26%  Similarity=0.371  Sum_probs=171.0

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+.+.||+|+||+||+|... +++.||+|+++....   .....+.+|+.++.+++||||+++++++.+....++||||+
T Consensus         4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~   83 (363)
T cd05628           4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL   83 (363)
T ss_pred             eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence            34678999999999999875 588999999875421   22346788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          84 PGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            99999999853    35688899999999999999999998   999999999999999999999999999875422100


Q ss_pred             ----------------------------------cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcC
Q 004689          567 ----------------------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI  612 (736)
Q Consensus       567 ----------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~  612 (736)
                                                        ......+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence                                              0112346999999999999999999999999999999999999999


Q ss_pred             cccc
Q 004689          613 SNEK  616 (736)
Q Consensus       613 ~~~~  616 (736)
                      ....
T Consensus       237 ~~~~  240 (363)
T cd05628         237 CSET  240 (363)
T ss_pred             CCCC
Confidence            7654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-36  Score=339.91  Aligned_cols=263  Identities=22%  Similarity=0.277  Sum_probs=192.8

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeC--------CeE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--------GRS  479 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--------~~~  479 (736)
                      .|.+.+.||+|+||.||+|... +++.||||++...    .....+|+.+|+.++||||+++++++...        ...
T Consensus        67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            3556789999999999999875 6889999987533    23345799999999999999999876432        246


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeecCC
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLS  558 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~-~~kl~DFGla  558 (736)
                      ++||||+++ +|.+++.........+++..+..++.|++.||.|||+.   +|+||||||+|||++.++ .+||+|||++
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            799999985 77777754444456788999999999999999999998   999999999999999664 7999999999


Q ss_pred             ccccCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHh----hh
Q 004689          559 KFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH----IE  633 (736)
Q Consensus       559 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~----~~  633 (736)
                      +.......  .....||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....+....+.+.....    +.
T Consensus       219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~  296 (440)
T PTZ00036        219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK  296 (440)
T ss_pred             hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            86543222  223458999999999875 468999999999999999999999998654222211221110000    00


Q ss_pred             --cCCcce-----eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          634 --SGDIQG-----IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       634 --~~~~~~-----~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        ......     .....+...++.....++.+++.+|++.||.+|||+.|++++
T Consensus       297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence              000000     000011111111223468899999999999999999999877

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=311.07  Aligned_cols=261  Identities=23%  Similarity=0.368  Sum_probs=198.4

Q ss_pred             HhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhc--CCCceeeEeeeeeeCC----eEEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI--HHRNLVQFLGYCQEEG----RSVLVYE  484 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~~~~~~~~----~~~lV~e  484 (736)
                      .+.+.||+|.||+||+|+++ |+.||||++...   +++.+.+|.+|++.+  +|+||+.+++.-..+.    +++||++
T Consensus       214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTd  289 (513)
T KOG2052|consen  214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTD  289 (513)
T ss_pred             EEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeee
Confidence            45788999999999999999 999999998643   356677888888775  9999999998775443    6799999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHh-----CCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-----~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      |.+.|+|.|+|.     ...++....++++..+|.||+|||.     ++.|.|.|||||+.||||..++.+.|+|+|+|.
T Consensus       290 YHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  290 YHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             cccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            999999999994     3568888999999999999999997     345899999999999999999999999999997


Q ss_pred             cccCCC---CcceecccccccccCccccccCc------CCCcchhHHHHHHHHHHHhC----------CCcCcccccccc
Q 004689          560 FAVDGA---SHVSSIVRGTVGYLDPEYYISQQ------LTDKSDVYSFGVILLELISG----------QEAISNEKFGAN  620 (736)
Q Consensus       560 ~~~~~~---~~~~~~~~gt~~Y~aPE~~~~~~------~~~~~DVwSlGvvl~elltG----------~~p~~~~~~~~~  620 (736)
                      ......   .......+||.+|||||++...-      --..+||||||.|+||+...          +.||.+.-..+ 
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D-  443 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD-  443 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC-
Confidence            554332   22334578999999999996531      22468999999999999864          34554322110 


Q ss_pred             cccHHHHHHHhhhcCCcceeccCccCC-cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          621 CRNIVQWAKLHIESGDIQGIIDPSLLD-EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       621 ~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                       .+..+- +...    ..+-+.|.+.. ..+.+.+..+.+++..|+..+|..|-|+-.|-+.|.++..
T Consensus       444 -Ps~eeM-rkVV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  444 -PSFEEM-RKVV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             -CCHHHH-hcce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence             111110 0000    00111111111 1245778889999999999999999999999999988763

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.7e-36  Score=324.68  Aligned_cols=242  Identities=25%  Similarity=0.386  Sum_probs=191.0

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||+||+|+.. +++.||||+++...   ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999876 57899999987542   12234456678888764 899999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  152 (316)
T cd05619          81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK  152 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence            999998853    34578888899999999999999998   99999999999999999999999999987432221 12


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+.+.+.    .+.      +..   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~~i~----~~~------~~~---  215 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE----ELFQSIR----MDN------PCY---  215 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH----HHHHHHH----hCC------CCC---
Confidence            23456999999999999989999999999999999999999999754421    1222111    111      111   


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~~~  681 (736)
                       +......+.+++.+|++.+|++||++. ++.++
T Consensus       216 -~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         216 -PRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             -CccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence             111223578899999999999999997 66543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.6e-36  Score=312.32  Aligned_cols=247  Identities=27%  Similarity=0.431  Sum_probs=194.7

Q ss_pred             cccccCceEEEEEEEC---CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          415 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       415 ~IG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      .||+|+||.||+|.+.   .+..||+|++..... .....+.+|+.++++++||||+++++++.. ...++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999999764   355799999865432 224568899999999999999999998864 56799999999999


Q ss_pred             HHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce-
Q 004689          491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS-  569 (736)
Q Consensus       491 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-  569 (736)
                      |.+++...   ...+++..+++++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.......... 
T Consensus        81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            99998532   34688999999999999999999998   999999999999999999999999999975433322211 


Q ss_pred             -ecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          570 -SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       570 -~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                       ....++..|+|||.+....++.++|||||||++||+++ |..||......    .+..    .+..+..         .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~----~~~~~~~---------~  217 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----EVMS----FIEQGKR---------L  217 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----HHHH----HHHCCCC---------C
Confidence             11223578999999988889999999999999999996 99999765421    1111    1111111         1


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      ..+.....++.+++.+|+..+|++||++.+|.+.|+..
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            11222345688899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-36  Score=313.68  Aligned_cols=255  Identities=26%  Similarity=0.449  Sum_probs=204.8

Q ss_pred             HHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      ...+.+.+.||+|+||.||+|..++++.||||.+.... ....++.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            34556778999999999999998888899999987543 23567899999999999999999999999989999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||+++.......
T Consensus        84 ~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          84 SKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             CCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            9999999996532  34688999999999999999999998   999999999999999999999999999876543222


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      .......++..|+|||.+.+..++.++|||||||+++||++ |+.||......    ........    + ..    .  
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~~~~~----~-~~----~--  223 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR----EVLEQVER----G-YR----M--  223 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHc----C-CC----C--
Confidence            22222335678999999998889999999999999999999 99999654311    11111111    1 00    0  


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                        ..+......+.+++.+|++.+|++||+++++.+.|+.
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 --PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              0011123468899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.1e-37  Score=332.54  Aligned_cols=251  Identities=21%  Similarity=0.219  Sum_probs=198.6

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.+.||+|+||+||+|... +++.||+|+++....   .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (330)
T cd05601           3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY   82 (330)
T ss_pred             ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence            345688999999999999876 688999999875422   2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          83 QPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            9999999998543   24688888999999999999999998   99999999999999999999999999998654433


Q ss_pred             CcceecccccccccCccccc------cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          566 SHVSSIVRGTVGYLDPEYYI------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~------~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ........||+.|+|||++.      ...++.++|||||||++|||++|+.||........       ............
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~~~i~~~~~~~~  229 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-------YNNIMNFQRFLK  229 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-------HHHHHcCCCccC
Confidence            33334456999999999986      45678899999999999999999999976542111       111111111000


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .     ..  .......+.+++..|+. +|.+||++.+++++
T Consensus       230 ~-----~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         230 F-----PE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             C-----CC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            0     00  01123457788889997 99999999999876

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.7e-36  Score=321.33  Aligned_cols=264  Identities=23%  Similarity=0.431  Sum_probs=206.8

Q ss_pred             HHHHHHhhccccccCceEEEEEEEC--------CCcEEEEEEeccCC-cccchhhhhHHHHHhhc-CCCceeeEeeeeee
Q 004689          406 EDATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE  475 (736)
Q Consensus       406 ~~~~~~~~~~IG~G~fG~Vy~~~~~--------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~  475 (736)
                      ....+.+.+.||+|+||.||+|+..        ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3445567789999999999999742        24579999886442 23346788999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcccc------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEE
Q 004689          476 EGRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL  543 (736)
Q Consensus       476 ~~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NIL  543 (736)
                      ....++||||+.+|+|.+++.....            ....+++..++.++.|+++||.|||+.   +++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence            9999999999999999999965321            124578889999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCccccccccc
Q 004689          544 LDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC  621 (736)
Q Consensus       544 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~  621 (736)
                      ++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......   
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---  246 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---  246 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---
Confidence            999999999999999865432222 1222346778999999988889999999999999999998 78888654311   


Q ss_pred             ccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          622 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       622 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                          ..... +..+...         ..+......+.+++.+|++.+|.+||++.||++.|++++...
T Consensus       247 ----~~~~~-~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         247 ----ELFKL-LKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             ----HHHHH-HHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence                11111 1111110         011223456888999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.5e-36  Score=326.34  Aligned_cols=244  Identities=24%  Similarity=0.335  Sum_probs=192.1

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHH---hhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLL---SRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il---~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      .+.+.||+|+||.||+|... +++.||||+++...   ......+..|+.++   +.++||||+++++++...+..++||
T Consensus         2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~   81 (324)
T cd05589           2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM   81 (324)
T ss_pred             eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence            34678999999999999876 68999999987542   12234466666655   5668999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+++|+|...+.     ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        82 E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          82 EYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             cCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            9999999988874     24589999999999999999999998   999999999999999999999999999874322


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+..   . +..+..      
T Consensus       154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~----~~~~---~-i~~~~~------  218 (324)
T cd05589         154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE----EVFD---S-IVNDEV------  218 (324)
T ss_pred             CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH----HHHH---H-HHhCCC------
Confidence            21 2223456999999999999999999999999999999999999999765421    1111   1 111111      


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                      .    ++......+.+++.+|++.||.+||     ++.+++++
T Consensus       219 ~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         219 R----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             C----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            0    1111234578899999999999999     56676665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-36  Score=319.74  Aligned_cols=262  Identities=26%  Similarity=0.394  Sum_probs=198.8

Q ss_pred             HHHhhccccccCceEEEEEEEC-----CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeee--CCeEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVL  481 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-----~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~l  481 (736)
                      .+.+.+.||+|+||.||+|..+     ++..||+|++........+.+.+|++++++++||||+++++++..  ....++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   84 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL   84 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence            3445688999999999999753     578999999876554455678999999999999999999998753  346899


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        85 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          85 VMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            99999999999998532   23588999999999999999999998   9999999999999999999999999999865


Q ss_pred             cCCCCcc--eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccc-------ccc-ccHHHHHHHh
Q 004689          562 VDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG-------ANC-RNIVQWAKLH  631 (736)
Q Consensus       562 ~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~-------~~~-~~l~~~~~~~  631 (736)
                      .......  .....++..|+|||++.+..++.++|||||||++|||++|..++......       ... ..+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            4332211  11122445699999999888999999999999999999988765432210       000 0001111111


Q ss_pred             hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      ...+.         ...........+.+++.+|++.+|++|||+.||++.|+.+
T Consensus       239 ~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         239 LKNNG---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HhcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            11110         0011112234688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.3e-36  Score=325.56  Aligned_cols=242  Identities=26%  Similarity=0.358  Sum_probs=191.2

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||.||+|+.. +++.||+|+++...   ......+..|..++... +||||+++++++.+.+..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999876 68899999987542   12234566778887754 899999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  152 (316)
T cd05620          81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR  152 (316)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence            999988843    34578888999999999999999998   99999999999999999999999999987432211 22


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+.+..    ..+.      +.+.. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~----~~~~~~----~~~~------~~~~~-  217 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED----ELFESI----RVDT------PHYPR-  217 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHH----HhCC------CCCCC-
Confidence            33456999999999999999999999999999999999999999755421    111111    1110      11111 


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~~~  681 (736)
                         ....++.+++.+|++.||++||++. ++.++
T Consensus       218 ---~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         218 ---WITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             ---CCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence               1223578899999999999999984 66543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.7e-36  Score=321.82  Aligned_cols=262  Identities=24%  Similarity=0.432  Sum_probs=204.8

Q ss_pred             HHHHHhhccccccCceEEEEEEEC--------CCcEEEEEEeccCC-cccchhhhhHHHHHhhc-CCCceeeEeeeeeeC
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE  476 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~--------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~  476 (736)
                      ...+.+.+.||+|+||.||+|...        +...+|+|++.... .....++.+|+++++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            345677899999999999999753        23569999987542 22345688899999999 799999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhcccc------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE
Q 004689          477 GRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL  544 (736)
Q Consensus       477 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl  544 (736)
                      +..++||||+.+|+|.+++.....            ....+++..++.++.|++.||+|||+.   +++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence            999999999999999999965321            123588999999999999999999998   99999999999999


Q ss_pred             cCCCcEEEEeecCCccccCCCCcc-eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccc
Q 004689          545 DKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCR  622 (736)
Q Consensus       545 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~  622 (736)
                      +.++.+||+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||......    
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~----  249 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----  249 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence            999999999999987553221111 112234578999999998889999999999999999998 88888654311    


Q ss_pred             cHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          623 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       623 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                      .+..    ....+...         ..+......+.+++.+|+..+|.+||+|.+|++.|++++..
T Consensus       250 ~~~~----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         250 ELFK----LLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHHH----HHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            1111    11111111         11112234688899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.4e-36  Score=332.10  Aligned_cols=251  Identities=22%  Similarity=0.282  Sum_probs=193.9

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .+.+.+.||+|+||.||+++.. +++.+|+|++....   ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus        44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E  123 (370)
T cd05621          44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME  123 (370)
T ss_pred             HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence            3455678999999999999876 57889999986432   1223457889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++|+|.+++..     ..++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       124 y~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         124 YMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             CCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            9999999998843     2477888889999999999999998   9999999999999999999999999999865433


Q ss_pred             CCcceecccccccccCccccccC----cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      .........||+.|+|||++.+.    .++.++||||+||++|||++|+.||......+.       ............ 
T Consensus       196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~-------~~~i~~~~~~~~-  267 (370)
T cd05621         196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT-------YSKIMDHKNSLN-  267 (370)
T ss_pred             CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCcccC-
Confidence            32233456799999999999754    378899999999999999999999976542111       111111100000 


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCC--CCCCHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGH--MRPSISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~--~RPt~~ev~~~  681 (736)
                          ...  .......+.+++..|+..++.  .||++.|++++
T Consensus       268 ----~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         268 ----FPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ----CCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                000  111233466788888875554  38999999887

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.6e-36  Score=315.00  Aligned_cols=253  Identities=25%  Similarity=0.424  Sum_probs=200.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CC---cEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DG---KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~---~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      +...+.||+|+||.||+|... ++   ..+|+|.+.... ......+..|++++++++||||+++++++...+..++|||
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (268)
T cd05063           7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE   86 (268)
T ss_pred             ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence            345688999999999999875 23   369999886542 2234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        87 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          87 YMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999998532   34688999999999999999999998   9999999999999999999999999998755433


Q ss_pred             CCccee--cccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          565 ASHVSS--IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       565 ~~~~~~--~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      ......  ....+..|+|||++....++.++|||||||++|||++ |+.||......    .+...   . ..+.     
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~----~~~~~---i-~~~~-----  227 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH----EVMKA---I-NDGF-----  227 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH----HHHHH---H-hcCC-----
Confidence            222211  1223467999999998889999999999999999997 99999654311    11111   1 1110     


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                          ...........+.+++.+|++.+|++||++.+|++.|+++
T Consensus       228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                0011112335688999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.6e-36  Score=314.51  Aligned_cols=254  Identities=28%  Similarity=0.434  Sum_probs=196.6

Q ss_pred             hhccccccCceEEEEEEECCCc---EEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeC------CeEE
Q 004689          412 LEKKIGSGGFGVVYYGKLKDGK---EIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSV  480 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~~~---~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~~~  480 (736)
                      +.+.||+|+||.||+|......   .+|+|.++...  ......+.+|+++++.++||||+++++++...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            4678999999999999876432   58999886542  22345688899999999999999999987432      2468


Q ss_pred             EEEEecCCCCHHHHhhccc--ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCC
Q 004689          481 LVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS  558 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla  558 (736)
                      ++|||+.+|+|.+++....  .....+++.....++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence            9999999999998874221  1234578999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          559 KFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       559 ~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      +........ ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......    .+..    .+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~----~~~~~~  231 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS----EIYD----YLRQGN  231 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH----HHHcCC
Confidence            865432221 1122346778999999999899999999999999999999 78888654311    1111    122222


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      ...         ........+.+++.+|++.+|++|||+.+|++.|+++
T Consensus       232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111         1112234588999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-36  Score=323.57  Aligned_cols=250  Identities=28%  Similarity=0.388  Sum_probs=209.3

Q ss_pred             HHHHhhccccccCceEEEEEEECC-CcEEEEEEeccCCccc---chhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQG---KREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~---~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV  482 (736)
                      ..|.+.+.||+|.||.||+++.+. |+.+|+|++.+.....   ...+.+|+++|+++. |||||.+.+.+++....++|
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv  114 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV  114 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence            455667899999999999998874 9999999998765443   358899999999998 99999999999999999999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC----CcEEEEeecCC
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLS  558 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~----~~~kl~DFGla  558 (736)
                      ||++.||.|.+.+...     .+++..+..++.|++.|+.|||+.   +|+||||||+|+|+...    +.+|++|||++
T Consensus       115 mEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  115 MELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            9999999999999654     288999999999999999999998   99999999999999754    57999999999


Q ss_pred             ccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          559 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       559 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      .....  .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+........        .+..+++ 
T Consensus       187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------~i~~~~~-  255 (382)
T KOG0032|consen  187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------AILRGDF-  255 (382)
T ss_pred             eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------HHHcCCC-
Confidence            87655  445566789999999999999999999999999999999999999998776332222        2222322 


Q ss_pred             eeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       639 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       -++..    +-........+++..|+..||.+|+|+.++++|
T Consensus       256 -~f~~~----~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 -DFTSE----PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             -CCCCC----CccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence             11111    112223457889999999999999999999996

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.1e-36  Score=315.90  Aligned_cols=252  Identities=24%  Similarity=0.406  Sum_probs=196.1

Q ss_pred             HhhccccccCceEEEEEEEC-CCc----EEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~----~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .+.+.||+|+||+||+|.+. +++    .+++|.+..... ....++..|+.+++++.||||+++++++.. ...++++|
T Consensus        10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e   88 (279)
T cd05111          10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQ   88 (279)
T ss_pred             eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEE
Confidence            45678999999999999874 344    477777653322 223567788889999999999999998864 45678999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+.+|+|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++.....
T Consensus        89 ~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          89 LSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             eCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999998632   34588999999999999999999998   9999999999999999999999999999865332


Q ss_pred             CC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          565 AS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       565 ~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      .. .......++..|+|||++.++.++.++|||||||++|||++ |..||.+....    .+.+.    +..+....  .
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~~----~~~~~~~~--~  232 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPDL----LEKGERLA--Q  232 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH----HHCCCcCC--C
Confidence            22 22233457789999999998899999999999999999998 99999765421    11121    12222111  1


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      +.       .....+.+++.+|+..+|++||++.|+++.|..+.
T Consensus       233 ~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         233 PQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             CC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            11       11234678899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=308.79  Aligned_cols=257  Identities=23%  Similarity=0.333  Sum_probs=194.2

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccC--CcccchhhhhHHHHHhhcCCCceeeEeeeeee-----CCeEEEEEE
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-----EGRSVLVYE  484 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~lV~e  484 (736)
                      .+.||+|+||.|+.|... +|+.||||++...  .....+...+|+.+|+.++|+||+.+.+++..     -...|+|+|
T Consensus        27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e  106 (359)
T KOG0660|consen   27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE  106 (359)
T ss_pred             cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence            478999999999999875 7899999988632  33345667899999999999999999998865     346799999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      +|+ -+|...++    ..+.+......-++.|+++||.|+|+.   +|+|||+||+|+|++.+...||+|||+|+.....
T Consensus       107 lMe-tDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~  178 (359)
T KOG0660|consen  107 LME-TDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF  178 (359)
T ss_pred             HHh-hHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeecccc
Confidence            994 48888774    344588888889999999999999998   9999999999999999999999999999976432


Q ss_pred             -CCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC-------
Q 004689          565 -ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG-------  635 (736)
Q Consensus       565 -~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~-------  635 (736)
                       .....+..+.|.+|.|||++.. ..|+.+.||||.||++.||++|++-|.+.+.-.    ...-+...+...       
T Consensus       179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~----Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH----QLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH----HHHHHHHhcCCCCHHHHHH
Confidence             1223345568999999999864 789999999999999999999999998754211    111111111100       


Q ss_pred             ----CcceeccCcc-CCcCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          636 ----DIQGIIDPSL-LDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       636 ----~~~~~~d~~l-~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          .....+...- ....+     .......++|+.+|+..||.+|+|++|.+++
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                0000000000 00000     1122357899999999999999999999887

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.6e-36  Score=326.07  Aligned_cols=245  Identities=24%  Similarity=0.321  Sum_probs=193.2

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCC-CceeeEeeeeeeCCeEEEEEEe
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      .+.+.||+|+||.||+|+.. +++.||||++....   ......+..|++++..+.| ++|+++++++...+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (324)
T cd05587           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY   82 (324)
T ss_pred             eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence            45688999999999999876 57889999987542   2234457789999999976 5688899999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          83 VNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            999999988843    34578889999999999999999998   99999999999999999999999999986432211


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+...+    .....        
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i----~~~~~--------  218 (324)
T cd05587         156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----ELFQSI----MEHNV--------  218 (324)
T ss_pred             -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHH----HcCCC--------
Confidence             1223456999999999999999999999999999999999999999755421    111111    11110        


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~ev~~~  681 (736)
                        .++.....++.+++.+|+..+|.+||+.     .++.++
T Consensus       219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         219 --SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              1111123457889999999999999976     566554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-36  Score=319.71  Aligned_cols=264  Identities=22%  Similarity=0.352  Sum_probs=199.9

Q ss_pred             HHHHHhhccccccCceEEEEEEECC---------------CcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEe
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLKD---------------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFL  470 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~~---------------~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~  470 (736)
                      ...+.+.+.||+|+||.||++....               ...||+|+++.... .....+.+|++++++++||||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            4456678899999999999987542               23489999875422 2345688999999999999999999


Q ss_pred             eeeeeCCeEEEEEEecCCCCHHHHhhcccc--------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCE
Q 004689          471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLT--------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI  542 (736)
Q Consensus       471 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NI  542 (736)
                      +++...+..++||||+.+++|.+++.....        ....+++..++.++.|++.||+|||+.   +++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence            999999999999999999999999854211        112467888999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh--CCCcCccccccc
Q 004689          543 LLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGA  619 (736)
Q Consensus       543 Ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt--G~~p~~~~~~~~  619 (736)
                      +++.++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++|||++  |..||...... 
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-  239 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-  239 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH-
Confidence            9999999999999998754332211 1122345778999999998889999999999999999998  55677643321 


Q ss_pred             ccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          620 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       620 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                         .+................      ...+......+.+++.+|++.+|++||+|++|++.|+
T Consensus       240 ---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 ---QVIENTGEFFRNQGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ---HHHHHHHHhhhhcccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence               122211111111110000      0011112346899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.8e-36  Score=324.84  Aligned_cols=242  Identities=26%  Similarity=0.374  Sum_probs=193.9

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||+||+|... +++.||||+++...   ......+..|.++++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 57899999987542   22234567888898888 799999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~  152 (318)
T cd05570          81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT  152 (318)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence            999988843    34688999999999999999999998   99999999999999999999999999986432221 12


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+..    .+.....          .
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~----~~~~----~i~~~~~----------~  214 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED----ELFQ----SILEDEV----------R  214 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH----HHHH----HHHcCCC----------C
Confidence            23346899999999999999999999999999999999999999754421    1111    1111111          0


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~ev~~~  681 (736)
                      ++......+.+++.+|++.||.+||++     .+++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            111123457899999999999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-36  Score=316.74  Aligned_cols=257  Identities=25%  Similarity=0.418  Sum_probs=203.3

Q ss_pred             HHHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  479 (736)
                      ...+.+.+.||+|+||.||+|...      .+..||+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            344556789999999999999864      246899999865432 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhccccc------ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTH------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS  553 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~  553 (736)
                      ++||||+++|+|.+++......      ...+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence            9999999999999998654322      23478889999999999999999998   99999999999999999999999


Q ss_pred             eecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHh
Q 004689          554 DFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH  631 (736)
Q Consensus       554 DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~  631 (736)
                      |||+++....... .......++..|+|||.+.+..++.++|||||||++||+++ |..||.....    ..+..+..  
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~~~~~--  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----EEVLKFVI--  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH----HHHHHHHh--
Confidence            9999875543221 12223446889999999988889999999999999999998 8999865432    12222211  


Q ss_pred             hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                        .+....         .+......+.+++.+|++.+|++|||+.++++.|+
T Consensus       236 --~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 --DGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             --cCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence              111111         11112456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.6e-36  Score=316.18  Aligned_cols=260  Identities=25%  Similarity=0.369  Sum_probs=205.3

Q ss_pred             HHHHHhhccccccCceEEEEEEECC-----CcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeee-CCeE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRS  479 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~~-----~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~  479 (736)
                      ...+.+.+.||+|+||.||+|.+.+     +..|++|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            3455667899999999999998765     6889999886542 2234568899999999999999999998766 4678


Q ss_pred             EEEEEecCCCCHHHHhhccccc----ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEee
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTH----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF  555 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DF  555 (736)
                      ++++||+.+|+|.+++......    ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998653221    15688999999999999999999998   9999999999999999999999999


Q ss_pred             cCCccccCCCCcc-eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhh
Q 004689          556 GLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE  633 (736)
Q Consensus       556 Gla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~  633 (736)
                      |+++......... .....++..|+|||++.+..++.++|||||||++||+++ |+.||.....    ..+..+...   
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~---  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP----FEMAAYLKD---  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH----HHHHHHHHc---
Confidence            9998553332221 122346778999999988889999999999999999999 9999975431    122222221   


Q ss_pred             cCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          634 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       634 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      ...+.          ........+.+++.+|+..+|++||++.||++.|+++.
T Consensus       235 ~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         235 GYRLA----------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             CCCCC----------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            11100          01112346889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.2e-36  Score=318.80  Aligned_cols=258  Identities=27%  Similarity=0.421  Sum_probs=200.2

Q ss_pred             HHhhccccccCceEEEEEEECC-Cc--EEEEEEeccCC-cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~-~~--~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      +.+.+.||+|+||.||+|...+ +.  .+++|.++... ....+.+.+|+++++++ +||||+++++++...+..++|+|
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e   83 (297)
T cd05089           4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE   83 (297)
T ss_pred             ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence            4467899999999999998753 33  47888876432 23345688999999999 79999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccc------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEE
Q 004689          485 FMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV  552 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl  552 (736)
                      |+++|+|.+++.....            ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence            9999999999964321            113578899999999999999999998   9999999999999999999999


Q ss_pred             EeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHh
Q 004689          553 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH  631 (736)
Q Consensus       553 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~  631 (736)
                      +|||++.......  .......+..|+|||++.+..++.++|||||||++|||++ |..||......    .+..   ..
T Consensus       161 ~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~----~~~~---~~  231 (297)
T cd05089         161 ADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA----ELYE---KL  231 (297)
T ss_pred             CCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH---HH
Confidence            9999986422111  1111223567999999998889999999999999999998 99999755421    1111   11


Q ss_pred             hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                       ..+.     ..    ..+......+.+++.+|++.+|.+||++.+|++.|++++...
T Consensus       232 -~~~~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         232 -PQGY-----RM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             -hcCC-----CC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence             1110     00    111112345789999999999999999999999999887644

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.6e-36  Score=320.28  Aligned_cols=259  Identities=27%  Similarity=0.440  Sum_probs=200.6

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCc--EEEEEEeccCC-cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGK--EIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~--~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      .+.+.+.||+|+||.||+|.+. ++.  .+|+|.++... ......+.+|++++.++ +||||+++++++...+..++||
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~   87 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI   87 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence            4456789999999999999875 444  45777765432 22345788899999999 8999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccc------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEE
Q 004689          484 EFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK  551 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~k  551 (736)
                      ||+++|+|.+++.....            ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+|
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~k  164 (303)
T cd05088          88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK  164 (303)
T ss_pred             EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEE
Confidence            99999999999864321            123578999999999999999999998   999999999999999999999


Q ss_pred             EEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHH
Q 004689          552 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL  630 (736)
Q Consensus       552 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~  630 (736)
                      |+|||+++......  ......++..|+|||++.+..++.++|||||||++|||++ |..||......    .....   
T Consensus       165 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~---  235 (303)
T cd05088         165 IADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEK---  235 (303)
T ss_pred             eCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH----HHHHH---
Confidence            99999986321111  1111224678999999988889999999999999999998 99999754321    11111   


Q ss_pred             hhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          631 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       631 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                       ...+.         ....+......+.+++.+|++.+|++||++.++++.|++++..+
T Consensus       236 -~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         236 -LPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             -HhcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence             11110         00011112345789999999999999999999999999886544

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=7.9e-36  Score=311.20  Aligned_cols=254  Identities=20%  Similarity=0.313  Sum_probs=198.9

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      ..+.+.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            34567789999999999999874 68899999987554444556888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus        89 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          89 GGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            99999998853    34578889999999999999999998   999999999999999999999999999975532221


Q ss_pred             cceecccccccccCccccc---cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          567 HVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                       ......|+..|+|||.+.   ...++.++|||||||++|||++|+.||......+....+        ....+   ..+
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~--------~~~~~---~~~  229 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--------SKSNF---QPP  229 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee--------ecCCC---CCC
Confidence             122345889999999985   345788999999999999999999998644311110000        00000   001


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      ....  .......+.+++.+|++.+|++||++++|+++|
T Consensus       230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1110  112234688999999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.8e-36  Score=317.28  Aligned_cols=254  Identities=26%  Similarity=0.430  Sum_probs=200.6

Q ss_pred             HHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      ..+.++||+|+||.||++...      ++..+|+|.+..........+.+|+++++.++|+||+++++++......+++|
T Consensus         7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (280)
T cd05092           7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF   86 (280)
T ss_pred             ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence            345789999999999999642      35679999887655455667999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccc-----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEE
Q 004689          484 EFMHNGTLKEHLYGTLT-----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV  552 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl  552 (736)
                      ||+.+|+|.+++.....           ....+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL  163 (280)
T cd05092          87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKI  163 (280)
T ss_pred             ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEE
Confidence            99999999999864321           113578899999999999999999998   9999999999999999999999


Q ss_pred             EeecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHH
Q 004689          553 SDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL  630 (736)
Q Consensus       553 ~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~  630 (736)
                      +|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||......    ......  
T Consensus       164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~--  237 (280)
T cd05092         164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT----EAIECI--  237 (280)
T ss_pred             CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH----HHHHHH--
Confidence            99999875432221 11222335788999999999999999999999999999998 89998654321    111111  


Q ss_pred             hhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          631 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       631 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                        ..+...         ..+......+.+++.+|++.||.+||+++||.+.|+
T Consensus       238 --~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         238 --TQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             --HcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence              111100         001112345789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.5e-36  Score=315.92  Aligned_cols=255  Identities=27%  Similarity=0.412  Sum_probs=198.9

Q ss_pred             HHHhhccccccCceEEEEEEECC------CcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~------~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      .+.+.+.||+|+||.||+|.+..      +..||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..++
T Consensus         7 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   86 (277)
T cd05036           7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFI   86 (277)
T ss_pred             HcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEE
Confidence            34457899999999999998753      56789998764432 234568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcccc---cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC---cEEEEee
Q 004689          482 VYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDF  555 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~---~~kl~DF  555 (736)
                      ||||+.+|+|.+++.....   ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++   .+||+||
T Consensus        87 v~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~df  163 (277)
T cd05036          87 LLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADF  163 (277)
T ss_pred             EEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccC
Confidence            9999999999999865321   123588999999999999999999998   999999999999998764   5999999


Q ss_pred             cCCccccCCCCcc-eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhh
Q 004689          556 GLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE  633 (736)
Q Consensus       556 Gla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~  633 (736)
                      |+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......    .+...   ...
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~----~~~~~---~~~  236 (277)
T cd05036         164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ----EVMEF---VTG  236 (277)
T ss_pred             ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH---HHc
Confidence            9998653222111 112223568999999998999999999999999999997 99999765421    12111   111


Q ss_pred             cCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          634 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       634 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      ...          ...+......+.+++.+|++.+|++||++.+|+++|+
T Consensus       237 ~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         237 GGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111          1111222356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.8e-36  Score=324.13  Aligned_cols=237  Identities=28%  Similarity=0.356  Sum_probs=187.2

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHH-HHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||+||+|+.. +++.||+|++.....   .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36899999999999876 689999999865321   12233444444 56788999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~  152 (323)
T cd05575          81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT  152 (323)
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence            999988843    34678888899999999999999998   99999999999999999999999999987532222 22


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......       +...... .+..      .+...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-------~~~~~i~-~~~~------~~~~~  218 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA-------EMYDNIL-NKPL------RLKPN  218 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH-------HHHHHHH-cCCC------CCCCC
Confidence            33456999999999999999999999999999999999999999765421       1111111 1111      11111


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSIS  676 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~  676 (736)
                      .    ...+.+++.+|++.||.+||+++
T Consensus       219 ~----~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         219 I----SVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             C----CHHHHHHHHHHhhcCHHhCCCCC
Confidence            2    34578899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.3e-37  Score=327.46  Aligned_cols=238  Identities=26%  Similarity=0.350  Sum_probs=191.1

Q ss_pred             ccccccCceEEEEEEE----CCCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          414 KKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~----~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.||+|+||.||+++.    .+|+.||+|++.....  .....+..|++++++++||||+++++++..++..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875    3578999999875422  223456789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            9999998843    34588999999999999999999998   999999999999999999999999999875433322 


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......    ....   . +.....          
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~----~~~~---~-i~~~~~----------  215 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK----ETMT---M-ILKAKL----------  215 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH----HHHH---H-HHcCCC----------
Confidence            223456999999999999888999999999999999999999999754311    1111   1 111111          


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISE  677 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  677 (736)
                      ..+......+.+++.+|++.||++||++.+
T Consensus       216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         216 GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            011112235788999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-36  Score=312.14  Aligned_cols=251  Identities=27%  Similarity=0.454  Sum_probs=195.5

Q ss_pred             ccccccCceEEEEEEECC-Cc--EEEEEEeccCC-cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~-~~--~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||.||+|...+ +.  .+|+|.++... ......+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999998763 43  46888876432 23345788999999999 899999999999999999999999999


Q ss_pred             CCHHHHhhcccc------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeec
Q 004689          489 GTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG  556 (736)
Q Consensus       489 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFG  556 (736)
                      |+|.+++.....            ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999864321            123578899999999999999999998   99999999999999999999999999


Q ss_pred             CCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcC
Q 004689          557 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       557 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      ++......  ........+..|+|||++....++.++|||||||++|||++ |..||......    .+.+.    ...+
T Consensus       158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~----~~~~  227 (270)
T cd05047         158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEK----LPQG  227 (270)
T ss_pred             Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH----HHHHH----HhCC
Confidence            98632111  11111224567999999988889999999999999999997 99999654321    11111    1111


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      ...         .........+.+++.+|++.+|.+||++.++++.|++++
T Consensus       228 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         228 YRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCC---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            100         011112345789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.8e-36  Score=322.20  Aligned_cols=249  Identities=22%  Similarity=0.277  Sum_probs=194.8

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||.||+|... +++.||+|+++....   .....+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999876 578899999975422   2234577899999888 699999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|..++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~  152 (327)
T cd05617          81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT  152 (327)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence            999988742    34688999999999999999999998   99999999999999999999999999987432211 22


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+..........      .    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~------~----  221 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP-DMNTEDYLFQVILEKPI------R----  221 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc-ccccHHHHHHHHHhCCC------C----
Confidence            234569999999999999999999999999999999999999996433111 11122222222222111      0    


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~------~ev~~~  681 (736)
                      .+......+.+++.+|++.||++||++      .++.++
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            111122357889999999999999984      566655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.2e-36  Score=317.28  Aligned_cols=263  Identities=23%  Similarity=0.381  Sum_probs=200.2

Q ss_pred             HHHHhhccccccCceEEEEEEEC-----------------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-----------------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQF  469 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-----------------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l  469 (736)
                      ..+.+.+.||+|+||.||++...                 +...||+|++..... ....++.+|++++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            34567789999999999998532                 234689999875432 234578899999999999999999


Q ss_pred             eeeeeeCCeEEEEEEecCCCCHHHHhhccccc-------ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCE
Q 004689          470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI  542 (736)
Q Consensus       470 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NI  542 (736)
                      ++++...+..++||||+.+|+|.+++......       ...+++...+.++.|++.||+|||+.   +++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence            99999999999999999999999998653211       23477889999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEEeecCCccccCCCCcc-eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh--CCCcCccccccc
Q 004689          543 LLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGA  619 (736)
Q Consensus       543 Ll~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt--G~~p~~~~~~~~  619 (736)
                      |++.++.++|+|||+++......... .....++..|++||...++.++.++|||||||++|||++  |..||......+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            99999999999999997553322211 122234678999999888889999999999999999998  667876543221


Q ss_pred             ccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          620 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       620 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                          +................. +     .+......+.+++.+|++.+|.+||++.||++.|+
T Consensus       242 ----~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 ----VIENTGEFFRDQGRQVYL-P-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             ----HHHHHHHHHhhccccccC-C-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                111111111111100000 0     01122356889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=334.63  Aligned_cols=249  Identities=25%  Similarity=0.329  Sum_probs=192.3

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+.+.||+|+||+||++... +++.||||++....   ......+.+|++++++++||||+++++++.+....++||||+
T Consensus         4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~   83 (377)
T cd05629           4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL   83 (377)
T ss_pred             eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence            45688999999999999865 68899999986432   122356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        84 ~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          84 PGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            99999999853    34578888888999999999999998   999999999999999999999999999863211000


Q ss_pred             ------------c----------------------------------ceecccccccccCccccccCcCCCcchhHHHHH
Q 004689          567 ------------H----------------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGV  600 (736)
Q Consensus       567 ------------~----------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGv  600 (736)
                                  .                                  ......||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence                        0                                  001246999999999999999999999999999


Q ss_pred             HHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCC---CCCHHH
Q 004689          601 ILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM---RPSISE  677 (736)
Q Consensus       601 vl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~---RPt~~e  677 (736)
                      ++|||++|..||......+....+..|..      .+ .     +...  ......+.+++.+|+. +|.+   |+++.|
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~------~~-~-----~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYRKIINWRE------TL-Y-----FPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHHHHHccCC------cc-C-----CCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            99999999999976542211112221100      00 0     0000  0112357788888887 6665   569999


Q ss_pred             HHHH
Q 004689          678 VLKD  681 (736)
Q Consensus       678 v~~~  681 (736)
                      ++++
T Consensus       302 ~l~h  305 (377)
T cd05629         302 IKSH  305 (377)
T ss_pred             HhcC
Confidence            9887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.4e-36  Score=312.03  Aligned_cols=254  Identities=23%  Similarity=0.398  Sum_probs=203.1

Q ss_pred             HHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      ...+.+.+.||+|+||.||+|...++..+|+|.+.... .....+.+|++++++++|+||+++++++.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            44566788999999999999998878889999886432 234678899999999999999999999887 7789999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||.+........
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          83 AKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            999999998643  234578888999999999999999998   999999999999999999999999999875543322


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      .......++..|+|||++....++.++|+|||||++||+++ |+.||......    .+..+..    .+...       
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~~----~~~~~-------  222 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRALE----RGYRM-------  222 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHh----CCCCC-------
Confidence            22223346678999999998889999999999999999999 89999754321    1222211    11110       


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                        .........+.+++.+|++.+|++||+++++.+.|+.
T Consensus       223 --~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             --CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              0111223458899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.2e-35  Score=312.12  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=193.1

Q ss_pred             ccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       416 IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      ||+|+||.||+++.+ +|+.||+|.+.....   .....+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999875 689999999864322   1234456799999999999999999999999999999999999999


Q ss_pred             HHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceec
Q 004689          492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI  571 (736)
Q Consensus       492 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  571 (736)
                      .+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~  153 (277)
T cd05607          81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ  153 (277)
T ss_pred             HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence            9888543  234578888999999999999999998   99999999999999999999999999987654322  2233


Q ss_pred             ccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCH
Q 004689          572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI  651 (736)
Q Consensus       572 ~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  651 (736)
                      ..|+..|+|||++.+..++.++||||+||++|||++|+.||........   ......... ...+..    . ...   
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~---~~~~~~~~~-~~~~~~----~-~~~---  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA---KEELKRRTL-EDEVKF----E-HQN---  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh---HHHHHHHhh-cccccc----c-ccc---
Confidence            4689999999999988899999999999999999999999975431111   111111111 111100    0 011   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          652 QSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       652 ~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                       ...++.+++.+|++.||++||+++|+++.+
T Consensus       222 -~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         222 -FTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             -CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence             223578999999999999999997776443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.3e-36  Score=317.42  Aligned_cols=263  Identities=25%  Similarity=0.399  Sum_probs=203.4

Q ss_pred             HHHHhhccccccCceEEEEEEECC-----------------CcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLKD-----------------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQF  469 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~~-----------------~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l  469 (736)
                      ..+.+.+.||+|+||.||+|...+                 +..||+|++..... .....+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            345667899999999999987642                 24689999875532 235578899999999999999999


Q ss_pred             eeeeeeCCeEEEEEEecCCCCHHHHhhcccc-------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCE
Q 004689          470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI  542 (736)
Q Consensus       470 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NI  542 (736)
                      ++++..++..++++||+.+++|.+++.....       ....+++..++.++.|++.||+|||+.   +++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhce
Confidence            9999999999999999999999999865431       122588999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEEeecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh--CCCcCccccccc
Q 004689          543 LLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS--GQEAISNEKFGA  619 (736)
Q Consensus       543 Ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt--G~~p~~~~~~~~  619 (736)
                      +++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++  |..||.....  
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~--  239 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD--  239 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh--
Confidence            999999999999999875433221 12233446789999999988889999999999999999998  6677764432  


Q ss_pred             ccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          620 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       620 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                        ..+.+...............      ..+.....++.+++..|++.+|++||++.||++.|+
T Consensus       240 --~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 --QQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             --HHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence              12222222222111111111      111122346899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.4e-36  Score=329.08  Aligned_cols=261  Identities=24%  Similarity=0.308  Sum_probs=195.0

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCC-----eEEEEE
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVY  483 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~lV~  483 (736)
                      +.+.||+|+||.||+|... +++.||||++....  ....+.+.+|+++++.++||||+++++++....     ..++|+
T Consensus         4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~   83 (372)
T cd07853           4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT   83 (372)
T ss_pred             ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence            4678999999999999864 68999999986432  223456889999999999999999999998776     789999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+. ++|.+.+.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        84 e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          84 ELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             eccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9997 57877763    234688999999999999999999998   999999999999999999999999999976543


Q ss_pred             CCCcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHH---------------H
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------------W  627 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~---------------~  627 (736)
                      ..........+|+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.+               .
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            333333334589999999998864 578999999999999999999999976542111111111               0


Q ss_pred             HHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          628 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       628 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....+..........+.+. ........++.+++.+|++.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLY-TLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHhCCCCCCchHHhc-ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            0111100000000000000 0011123467899999999999999999999876

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.5e-36  Score=318.68  Aligned_cols=257  Identities=25%  Similarity=0.391  Sum_probs=202.2

Q ss_pred             HHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  479 (736)
                      ..+.+.+.||+|+||.||+|...      ++..||||+++.... .....+.+|+++++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            34556889999999999999742      355799999875432 2235688999999999 799999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ++||||+.+|+|.+++....  ...+++.....++.|++.||.|||+.   +|+|+||||+|||++.++.++++|||+++
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~  189 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR  189 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccc
Confidence            99999999999999986432  23378999999999999999999998   99999999999999999999999999997


Q ss_pred             cccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          560 FAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       560 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                      ........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+   .+..    ....+..
T Consensus       190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~  262 (302)
T cd05055         190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KFYK----LIKEGYR  262 (302)
T ss_pred             cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HHHH----HHHcCCc
Confidence            55433221 1222346788999999998889999999999999999998 999987544211   1111    1111110


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                               .........++.+++.+|++.+|++||++.||++.|+++
T Consensus       263 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 ---------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                     000111234688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.5e-36  Score=323.40  Aligned_cols=245  Identities=24%  Similarity=0.308  Sum_probs=193.6

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEe
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      .+.+.||+|+||.||+|... +++.||||+++....   .....+..|..++..+ +|++|+++++++...+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~   82 (323)
T cd05616           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY   82 (323)
T ss_pred             eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence            35678999999999999876 578999999875422   1223456788888777 589999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          83 VNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            999999988843    34578889999999999999999998   99999999999999999999999999987532221


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+...+.    ....        
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~----~~~~~i~----~~~~--------  218 (323)
T cd05616         156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQSIM----EHNV--------  218 (323)
T ss_pred             -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH----HHHHHHH----hCCC--------
Confidence             1223456999999999999999999999999999999999999999765421    1222111    1111        


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~ev~~~  681 (736)
                        .++.....++.+++.+|++.+|.+|++.     .++.++
T Consensus       219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         219 --AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             --CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence              1111223457899999999999999984     666554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.3e-36  Score=312.73  Aligned_cols=254  Identities=26%  Similarity=0.452  Sum_probs=201.4

Q ss_pred             HHHhhccccccCceEEEEEEEC----CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      .+.+.+.||+|+||.||+|...    .+..+|+|.++.... .....+.+|+.++++++||||+++++++..++..++||
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT   84 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence            4456789999999999999864    234799998865432 23457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++.....
T Consensus        85 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          85 EYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999998643   24578899999999999999999998   999999999999999999999999999986544


Q ss_pred             CCCcceec--ccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          564 GASHVSSI--VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       564 ~~~~~~~~--~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      ........  ..++..|+|||++.+..++.++|||||||++||+++ |..||......    .+....    .++..   
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~----~~~~~~----~~~~~---  227 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ----DVIKAI----EEGYR---  227 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH----HHHHHH----hCCCc---
Confidence            33222211  223568999999998899999999999999999887 99999754421    122211    11110   


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                        ..    ........+.+++.+|++.+|.+||+|.++++.|+++
T Consensus       228 --~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 --LP----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             --CC----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence              00    0112234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.3e-36  Score=309.34  Aligned_cols=249  Identities=31%  Similarity=0.542  Sum_probs=199.9

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.+.+.||+|+||.||+|.+.+++.+|+|++..... ...++.+|++++++++||||+++++++......++||||++++
T Consensus         6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (256)
T cd05112           6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG   84 (256)
T ss_pred             eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence            345688999999999999887788999998864432 3457889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++..........
T Consensus        85 ~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          85 CLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             cHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            999988532   23578888999999999999999998   999999999999999999999999999875543322222


Q ss_pred             ecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      ....++..|+|||++.+..++.++|||||||++|||++ |..||......    .+...    +..+.  ....+..   
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~~----~~~~~--~~~~~~~---  225 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS----EVVET----INAGF--RLYKPRL---  225 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH----HHHHH----HhCCC--CCCCCCC---
Confidence            22335678999999998899999999999999999998 99998754311    11111    11110  1111111   


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                          ....+.+++.+|++.+|++||++.||++.|
T Consensus       226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence                234688999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=6.3e-36  Score=324.11  Aligned_cols=263  Identities=27%  Similarity=0.419  Sum_probs=201.6

Q ss_pred             HHHHHHhhccccccCceEEEEEEE------CCCcEEEEEEeccCCcc-cchhhhhHHHHHhhc-CCCceeeEeeeeeeC-
Q 004689          406 EDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-  476 (736)
Q Consensus       406 ~~~~~~~~~~IG~G~fG~Vy~~~~------~~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~-  476 (736)
                      ....+.+.+.||+|+||.||+|..      .+++.||||+++..... ....+.+|+.++.++ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            344677889999999999999974      24678999998754322 235678899999999 789999999988654 


Q ss_pred             CeEEEEEEecCCCCHHHHhhcccc--------------------------------------------------------
Q 004689          477 GRSVLVYEFMHNGTLKEHLYGTLT--------------------------------------------------------  500 (736)
Q Consensus       477 ~~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------  500 (736)
                      ...++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            567899999999999999864210                                                        


Q ss_pred             -------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc-ceecc
Q 004689          501 -------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIV  572 (736)
Q Consensus       501 -------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~  572 (736)
                             ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                   012367888899999999999999998   9999999999999999999999999998764332221 11223


Q ss_pred             cccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCH
Q 004689          573 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI  651 (736)
Q Consensus       573 ~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  651 (736)
                      .++..|+|||.+.+..++.++|||||||++|||++ |..||.......   .+.    .....+....     ....   
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~~~-----~~~~---  306 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFC----RRLKEGTRMR-----APDY---  306 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH---HHH----HHHhccCCCC-----CCCC---
Confidence            45678999999998899999999999999999997 899986543211   111    1111221110     0011   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          652 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       652 ~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                       ...++.+++..|++.+|++||++.||+++|+.++.
T Consensus       307 -~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         307 -TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             -CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             12357899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.1e-36  Score=313.85  Aligned_cols=254  Identities=26%  Similarity=0.476  Sum_probs=200.8

Q ss_pred             HHHhhccccccCceEEEEEEECC-C---cEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKD-G---KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~-~---~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      .+.+.+.||+|+||.||+|.... +   ..||||++.... ......|..|+.++++++||||+++++++.++...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            45678899999999999998753 3   369999986542 223467899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++....
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          85 EFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             ecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence            999999999998543   34588999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCcce-e-cc--cccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          564 GASHVS-S-IV--RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       564 ~~~~~~-~-~~--~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      ...... . ..  ..+..|+|||++.+..++.++|||||||++|||++ |..||.....    ..+..++...   ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~~~~~i~~~---~~~~  231 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVINAIEQD---YRLP  231 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HHHHHHHHcC---CcCC
Confidence            322111 1 11  12457999999999999999999999999999886 9999975431    1222322111   0000


Q ss_pred             eeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       639 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                                ...+....+.+++..|++.+|.+||++++|+..|+++
T Consensus       232 ----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         232 ----------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                      0112234578999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.2e-36  Score=332.72  Aligned_cols=199  Identities=24%  Similarity=0.317  Sum_probs=168.5

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+.++||+|+||+||+|+.. +++.||+|++.....   .....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~   83 (382)
T cd05625           4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI   83 (382)
T ss_pred             EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence            34678999999999999875 678899999865421   22356888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC-
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-  565 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~-  565 (736)
                      ++|+|.+++..    ...++......++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus        84 ~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          84 PGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            99999998853    24577888888999999999999998   99999999999999999999999999975321000 


Q ss_pred             ---------------------------------------------CcceecccccccccCccccccCcCCCcchhHHHHH
Q 004689          566 ---------------------------------------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGV  600 (736)
Q Consensus       566 ---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGv  600 (736)
                                                                   ........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         00012346999999999999999999999999999


Q ss_pred             HHHHHHhCCCcCcccc
Q 004689          601 ILLELISGQEAISNEK  616 (736)
Q Consensus       601 vl~elltG~~p~~~~~  616 (736)
                      ++|||++|+.||....
T Consensus       237 il~elltG~~Pf~~~~  252 (382)
T cd05625         237 ILYEMLVGQPPFLAQT  252 (382)
T ss_pred             HHHHHHhCCCCCCCCC
Confidence            9999999999997654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.6e-36  Score=315.77  Aligned_cols=260  Identities=23%  Similarity=0.411  Sum_probs=201.0

Q ss_pred             HHHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  479 (736)
                      ...+.+.++||+|+||.||+|..+      .+..||+|.+..... .....+.+|+.++++++||||+++++++......
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT   84 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            345667889999999999999754      245799998764432 2234578899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhccccc------ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTH------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS  553 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~  553 (736)
                      ++||||+.+|+|.+++......      ...+.+..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence            9999999999999999643211      23346677889999999999999998   99999999999999999999999


Q ss_pred             eecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHh
Q 004689          554 DFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH  631 (736)
Q Consensus       554 DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~  631 (736)
                      |||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||......    .+..   ..
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~----~~~~---~~  234 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE----QVLK---FV  234 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH---HH
Confidence            99998754332211 1122345778999999998899999999999999999999 78888653311    1111   11


Q ss_pred             hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      . .+....         .+......+.+++.+|++.+|++||++.++++.|++.+
T Consensus       235 ~-~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         235 M-DGGYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             H-cCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            1 111110         11112346899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=9.4e-37  Score=334.88  Aligned_cols=250  Identities=22%  Similarity=0.277  Sum_probs=191.8

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||.||+|+.. +++.||||++.....   .....+.+|+++|++++||||+++++.+.+++..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~   82 (376)
T cd05598           3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY   82 (376)
T ss_pred             ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence            345688999999999999875 588999999864321   2235578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC-
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG-  564 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~-  564 (736)
                      +++|+|.+++..    ...++......++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..+... 
T Consensus        83 ~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          83 IPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999999853    34577888888999999999999998   9999999999999999999999999997422100 


Q ss_pred             -----------------------------------------CCcceecccccccccCccccccCcCCCcchhHHHHHHHH
Q 004689          565 -----------------------------------------ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILL  603 (736)
Q Consensus       565 -----------------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~  603 (736)
                                                               .........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                     000012346999999999999999999999999999999


Q ss_pred             HHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCC---CHHHHHH
Q 004689          604 ELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP---SISEVLK  680 (736)
Q Consensus       604 elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP---t~~ev~~  680 (736)
                      ||++|+.||......+....+..|..      .+   ..+. ....    ...+.+++.+|+ .+|.+|+   ++.|+++
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~~------~~---~~~~-~~~~----s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWET------TL---HIPS-QAKL----SREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccCc------cc---cCCC-CCCC----CHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            99999999976542211111111100      00   0000 0111    223556666665 4999999   8999987


Q ss_pred             H
Q 004689          681 D  681 (736)
Q Consensus       681 ~  681 (736)
                      +
T Consensus       301 h  301 (376)
T cd05598         301 H  301 (376)
T ss_pred             C
Confidence            7

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=308.45  Aligned_cols=247  Identities=30%  Similarity=0.439  Sum_probs=196.4

Q ss_pred             ccccccCceEEEEEEECC----CcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      ++||+|+||.||+|.+..    +..+|+|.+..... ....++.+|+++++.+.||||+++++++.. ...++||||+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence            469999999999997542    26899999875543 235678899999999999999999998764 467999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++...    ..+++..++.++.|++.||+|||..   +++||||||+|||++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999999532    3688999999999999999999998   99999999999999999999999999998654333222


Q ss_pred             ee--cccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          569 SS--IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       569 ~~--~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      ..  ...++..|+|||.+.+..++.++|||||||++|||++ |..||.....    ..+..+..    .+...       
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~~~----~~~~~-------  217 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAMLE----SGERL-------  217 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHHHH----cCCcC-------
Confidence            11  1224568999999998899999999999999999998 9999975442    12222222    11110       


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                        ..+......+.+++.+|+..+|++||++.+|++.|+++
T Consensus       218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence              01112234688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=8e-36  Score=308.71  Aligned_cols=248  Identities=25%  Similarity=0.403  Sum_probs=201.0

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.||+|+||.||+|... +++.|++|.+....  ......+.+|++++++++||||+++++++...+..++||||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd08529           3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE   82 (256)
T ss_pred             eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence            34678999999999999876 68899999986432  2345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++........
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          83 NGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             CCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            99999998653  234688889999999999999999998   9999999999999999999999999998765433222


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                       .....|++.|+|||++.+..++.++|+|||||++|||++|+.||......    .+...    ...+....        
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~----~~~~~~~~--------  220 (256)
T cd08529         158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG----ALILK----IIRGVFPP--------  220 (256)
T ss_pred             -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----HHcCCCCC--------
Confidence             23345889999999999988999999999999999999999999755411    11111    11111111        


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       ........+.+++.+|++.+|++||++.+++++
T Consensus       221 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         221 -VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence             111233468999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=308.95  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=197.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc-----cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      +.+.+.||+|+||.||+|... +++.||+|.+......     ....+.+|++++++++||||+++++++...+..++|+
T Consensus         4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   83 (263)
T cd06625           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM   83 (263)
T ss_pred             ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence            345689999999999999865 6899999988643211     2346888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+++++|.+++..    ...++......++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++....
T Consensus        84 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          84 EYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            99999999998853    34577888899999999999999998   999999999999999999999999999875433


Q ss_pred             CCCcce--ecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          564 GASHVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       564 ~~~~~~--~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      ......  ....|+..|+|||++.+..++.++|||||||++|||++|+.||......    ....   .......     
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~---~~~~~~~-----  224 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIF---KIATQPT-----  224 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HHHH---HHhccCC-----
Confidence            221111  2345788999999999988999999999999999999999999654311    1111   1111110     


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          ....+......+.+++..|+..+|.+||++.|++++
T Consensus       225 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         225 ----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                011112233457889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-36  Score=308.63  Aligned_cols=248  Identities=30%  Similarity=0.471  Sum_probs=201.9

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.+.+.||+|+||.||+|... ++.||+|.+..... ....+.+|+.++++++|+||+++++++......++||||+++
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            4456789999999999999876 89999999876543 456788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      ++|.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||.++.......  
T Consensus        85 ~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--  157 (256)
T cd05039          85 GSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--  157 (256)
T ss_pred             CcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence            99999985432  23589999999999999999999998   999999999999999999999999999976532221  


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                        ...++..|+|||++....++.++||||||+++|||++ |..||.....    ..+...    ...+...         
T Consensus       158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~~~~----~~~~~~~---------  218 (256)
T cd05039         158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPH----VEKGYRM---------  218 (256)
T ss_pred             --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHH----HhcCCCC---------
Confidence              2235678999999998889999999999999999997 9999865431    112221    1111100         


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                      ..+......+.+++.+|+..+|++||++.|+++.|+.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            0111223568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.5e-36  Score=324.85  Aligned_cols=240  Identities=26%  Similarity=0.329  Sum_probs=187.2

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHH-HHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEV-TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~-~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||+||+|+.. +++.||+|++.....   .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999876 577899999865321   1223344444 456788999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++..    ...+.......++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~  152 (325)
T cd05602          81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT  152 (325)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence            999998853    34577778888999999999999998   99999999999999999999999999987533222 22


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+    +...   .. ....      ...  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~---i~-~~~~------~~~--  216 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE----MYDN---IL-NKPL------QLK--  216 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH----HHHH---HH-hCCc------CCC--
Confidence            334569999999999999999999999999999999999999997654211    1111   11 1111      011  


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVL  679 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~  679 (736)
                        ......+.+++.+|++.+|.+||++.+.+
T Consensus       217 --~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         217 --PNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             --CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence              11234578899999999999999877433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.2e-35  Score=317.92  Aligned_cols=261  Identities=25%  Similarity=0.438  Sum_probs=203.4

Q ss_pred             HHHHHhhccccccCceEEEEEEEC--------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeC
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE  476 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~--------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~  476 (736)
                      ...+.+.+.||+|+||.||+|+..        ....+|+|+++.... .....+..|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            345557899999999999999752        245789998875422 2345688899999999 699999999999999


Q ss_pred             CeEEEEEEecCCCCHHHHhhcccc------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE
Q 004689          477 GRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL  544 (736)
Q Consensus       477 ~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl  544 (736)
                      +..++||||+.+|+|.+++.....            ....+++.....++.|++.||.|||+.   +++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence            999999999999999999965321            224588999999999999999999998   99999999999999


Q ss_pred             cCCCcEEEEeecCCccccCCCCcc-eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccc
Q 004689          545 DKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCR  622 (736)
Q Consensus       545 ~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~  622 (736)
                      +.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......    
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----  243 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE----  243 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH----
Confidence            999999999999997654322111 112234568999999998889999999999999999999 88888654321    


Q ss_pred             cHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          623 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       623 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      .+..    ....+...         ..+.....++.+++.+|++.+|++||++.|+++.|+++..
T Consensus       244 ~~~~----~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         244 ELFK----LLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HHHH----HHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            1111    11111111         1111223467889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=327.97  Aligned_cols=245  Identities=25%  Similarity=0.406  Sum_probs=199.9

Q ss_pred             cccccCceEEEEEEECC-CcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCHHH
Q 004689          415 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE  493 (736)
Q Consensus       415 ~IG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~~  493 (736)
                      +||+|.||+||.|+..+ ...+|||-+..........+.+|+.+.++++|.|||+++|.|.+++..-+.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999998774 55789999987766667778999999999999999999999999999999999999999999


Q ss_pred             Hhhccccccccc--CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeecCCccccCCCCccee
Q 004689          494 HLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSS  570 (736)
Q Consensus       494 ~l~~~~~~~~~l--~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~  570 (736)
                      +|+..   -+.+  ++.+.--+.+||++||.|||.+   .|||||||-.||||+. .|.+||+|||-++.+.. ....+.
T Consensus       662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TE  734 (1226)
T KOG4279|consen  662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTE  734 (1226)
T ss_pred             HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccc
Confidence            99643   2334  5666777889999999999998   9999999999999975 68999999999986533 334556


Q ss_pred             cccccccccCcccccc--CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          571 IVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       571 ~~~gt~~Y~aPE~~~~--~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      ++.||..|||||++..  +.|+.++|||||||.+.||.||++||.....+...    .     ++-|-+  .+    .+.
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA----M-----FkVGmy--Kv----HP~  799 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA----M-----FKVGMY--KV----HPP  799 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh----h-----hhhcce--ec----CCC
Confidence            6779999999999975  46999999999999999999999999765432211    1     111110  01    122


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .+.+...+...++++|+.++|.+||+++++++.
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            344555678899999999999999999998754

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.1e-36  Score=310.21  Aligned_cols=252  Identities=31%  Similarity=0.475  Sum_probs=199.3

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccch--hhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKR--EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~--~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      ++.+.||+|+||+||+++.. +++.||+|++.........  ...+|+.++++++||||+++++++......++||||+.
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~   81 (260)
T PF00069_consen    2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP   81 (260)
T ss_dssp             EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred             EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence            45688999999999999987 4568999999866443222  33559999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++.    ....+++..++.++.|+++||.+||+.   +|+|+||||+||+++.++.++|+|||.+... .....
T Consensus        82 ~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~  153 (260)
T PF00069_consen   82 GGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNE  153 (260)
T ss_dssp             TEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTS
T ss_pred             ccccccccc----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-ccccc
Confidence            999999995    356689999999999999999999998   9999999999999999999999999998754 12222


Q ss_pred             ceecccccccccCccccc-cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          568 VSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~-~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      ......++..|+|||++. +..++.++||||+|+++|+|++|..||......+....+..-.......         ...
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~  224 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS---------SSQ  224 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH---------HTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc---------ccc
Confidence            334456899999999998 8889999999999999999999999998652111111111111100000         000


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .  .......+.+++..|++.||++||++.+++++
T Consensus       225 ~--~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  225 Q--SREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             S--HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             c--cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0  00112579999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.7e-36  Score=311.53  Aligned_cols=256  Identities=22%  Similarity=0.359  Sum_probs=201.9

Q ss_pred             HHHHhhccccccCceEEEEEEECC----CcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      ..+.+.+.||+|+||.||+|...+    ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            345567899999999999998653    2468999886554 3345578899999999999999999999876 456899


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      |||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++...
T Consensus        85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence            9999999999998542   23588999999999999999999998   99999999999999999999999999997654


Q ss_pred             CCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      ...........++..|+|||.+....++.++|||||||++||+++ |..||......    ....+.    ..+...   
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~~----~~~~~~---  227 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGRI----ENGERL---  227 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHH----HcCCcC---
Confidence            433222223335678999999988889999999999999999986 99999765421    111111    111110   


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                        ..    .......+.+++.+|+..+|.+|||+.++++.|+++..
T Consensus       228 --~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         228 --PM----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             --CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence              01    11223468889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-35  Score=307.53  Aligned_cols=250  Identities=31%  Similarity=0.502  Sum_probs=202.8

Q ss_pred             ccccccCceEEEEEEECC----CcEEEEEEeccCCccc-chhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||.||+|....    +..||+|+++...... ...+.+|+++++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998764    7889999987654332 56788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhccccc-----ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          489 GTLKEHLYGTLTH-----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       489 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ++|.+++......     ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999654221     36789999999999999999999998   999999999999999999999999999986544


Q ss_pred             CCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          564 GAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       564 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      ... .......++..|+|||.+....++.++||||+||++|||++ |..||......    .+.+...    .+...   
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~~----~~~~~---  226 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE----EVLEYLR----KGYRL---  226 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHH----cCCCC---
Confidence            321 12233457889999999988889999999999999999999 69999765321    1222111    11110   


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                            ..+......+.+++.+|+..+|.+||++.|++++|+
T Consensus       227 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 ------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  111122356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.8e-36  Score=313.14  Aligned_cols=254  Identities=25%  Similarity=0.414  Sum_probs=198.6

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCc----EEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~----~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      .+.+.++||+|+||+||+|++. +++    .||+|+++.... .....+.+|+.+++.++||||+++++++... ..+++
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~   86 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLV   86 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEE
Confidence            3445688999999999999864 444    489999875432 2356788999999999999999999999764 46799


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      +||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++...
T Consensus        87 ~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          87 TQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            9999999999998642   34588999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCcc-eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          563 DGASHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       563 ~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      ...... .....++..|+|||...+..++.++|||||||++|||++ |..||.....    ..+..+..    .+.... 
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~----~~~~~~-  231 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDLLE----KGERLP-  231 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHH----CCCcCC-
Confidence            322211 112235678999999998899999999999999999998 8999865431    12222221    111100 


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                              ........+.+++.+|++.||++||++.++++.|+.+.
T Consensus       232 --------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         232 --------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             --------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                    01122346789999999999999999999999887663

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.4e-35  Score=309.81  Aligned_cols=254  Identities=26%  Similarity=0.346  Sum_probs=191.2

Q ss_pred             ccccccCceEEEEEEECC---CcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          414 KKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~---~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.||+|+||.||+|...+   +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653   45799998865432 23457888999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc-
Q 004689          490 TLKEHLYGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-  567 (736)
Q Consensus       490 sL~~~l~~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-  567 (736)
                      +|.+++..... .....++..+..++.|++.||.|||+.   +++||||||+||+++.++++||+|||+++........ 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999965322 223456777888999999999999998   9999999999999999999999999998754332211 


Q ss_pred             ceecccccccccCccccccC-------cCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          568 VSSIVRGTVGYLDPEYYISQ-------QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~-------~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ......|+..|+|||++...       .++.++|||||||++|||++ |+.||......    ....+.   .. +....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~~~~~~---~~-~~~~~  229 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----QVLTYT---VR-EQQLK  229 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----HHHHHH---hh-cccCC
Confidence            12234578899999998642       35789999999999999996 99999754321    111111   11 11111


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      ..++.+...    ....+.+++..|+ .+|++|||++||++.|+
T Consensus       230 ~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 LPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            222222211    1234677888898 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.4e-35  Score=307.30  Aligned_cols=248  Identities=27%  Similarity=0.409  Sum_probs=198.7

Q ss_pred             ccccccCceEEEEEEECC--C--cEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLKD--G--KEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~--~--~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||.||+|.+.+  +  ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998753  2  3699999876655 445678999999999999999999999988 889999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc-
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-  567 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-  567 (736)
                      |+|.+++.....  ..+++...+.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++........ 
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999865422  4688999999999999999999998   9999999999999999999999999999865432221 


Q ss_pred             -ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          568 -VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       568 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                       ......++..|+|||++.+..++.++|||||||++|||++ |..||......    .+......   .+...       
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~---~~~~~-------  220 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS----QILKKIDK---EGERL-------  220 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHh---cCCcC-------
Confidence             1123457789999999998899999999999999999999 99999654321    12111111   11100       


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                        ..+......+.+++.+|++.+|++||++.+|++.|.
T Consensus       221 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 --ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence              001122346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.3e-37  Score=297.27  Aligned_cols=246  Identities=26%  Similarity=0.388  Sum_probs=200.1

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcc----c----chhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEE
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ----G----KREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~----~----~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      .+.||+|..++|.++.++ +|++.|+|++......    .    .+.-..|+.||+++ .||+|+++.++++.+...++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            568999999999998765 6899999998643221    1    12345699999998 699999999999999999999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      +|.|+.|.|.|+|.    ....+++....+|+.|+..|++|||..   .|+||||||+|||++++.++||+|||+|+.+.
T Consensus       102 Fdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen  102 FDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             hhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccC
Confidence            99999999999994    456789999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCcceecccccccccCcccccc------CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      .+.  .....+|||+|+|||.+..      ..|+...|+|++||+||-|+.|.+||...+.      ++  ....+.+|+
T Consensus       175 ~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------ml--MLR~ImeGk  244 (411)
T KOG0599|consen  175 PGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------ML--MLRMIMEGK  244 (411)
T ss_pred             Cch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------HH--HHHHHHhcc
Confidence            543  3456789999999999864      3688899999999999999999999987652      11  122233443


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .. +-.|. +    .+....+.+|+.+|++.||.+|.|++|+++|
T Consensus       245 yq-F~spe-W----adis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  245 YQ-FRSPE-W----ADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             cc-cCCcc-h----hhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            31 11110 0    1223457899999999999999999999987

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.1e-36  Score=325.45  Aligned_cols=238  Identities=28%  Similarity=0.354  Sum_probs=187.3

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHH-HHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||+||+|+.. +|+.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999999875 68999999986542   122334455554 56778999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|..++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~  152 (325)
T cd05604          81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT  152 (325)
T ss_pred             CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence            99988874    245688889999999999999999998   99999999999999999999999999987432221 12


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+    +.   .... .+.+      .+...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~----~~---~~~~-~~~~------~~~~~  218 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE----MY---DNIL-HKPL------VLRPG  218 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH----HH---HHHH-cCCc------cCCCC
Confidence            234569999999999999999999999999999999999999997654211    11   1111 1111      01111


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISE  677 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  677 (736)
                          ....+.+++..|++.+|.+||++++
T Consensus       219 ----~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         219 ----ASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             ----CCHHHHHHHHHHhccCHHhcCCCCC
Confidence                2235778999999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.1e-36  Score=315.29  Aligned_cols=264  Identities=26%  Similarity=0.393  Sum_probs=201.9

Q ss_pred             HHHHHhhccccccCceEEEEEEE-----CCCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeC--Ce
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GR  478 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~  478 (736)
                      ...+.+.+.||+|+||.||++..     .++..||+|.++... ......+.+|++++++++||||+++.+++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            34566778899999999999974     257889999986543 22345788999999999999999999998765  56


Q ss_pred             EEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCC
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS  558 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla  558 (736)
                      .++||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence            89999999999999998532   23578999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCCc--ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccc-------ccccccHHHHHH
Q 004689          559 KFAVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-------GANCRNIVQWAK  629 (736)
Q Consensus       559 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~-------~~~~~~l~~~~~  629 (736)
                      +........  ......|+..|+|||++.+..++.++|||||||++|||++++.|......       +...........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV  236 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence            865433221  12234567789999999888899999999999999999998766432110       000011111111


Q ss_pred             HhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          630 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       630 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      .....+...         .........+.+++.+|++.+|++||+++++++.|+++
T Consensus       237 ~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         237 RVLEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            111111110         01112335689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=313.03  Aligned_cols=247  Identities=24%  Similarity=0.357  Sum_probs=207.8

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      .|.+++.||+|.|+.|-+|++- +|..||||++.+....  ....+.+|++.|+.++|||||+|+++......+|||+|.
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            3556788999999999999865 8999999999876433  456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc-CCCcEEEEeecCCccccCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~-~~~~~kl~DFGla~~~~~~  564 (736)
                      -.+|+|.++|.   +....+.+....+++.||+.|+.|+|+.   .+|||||||+||.+- .-|-+||.|||++..+..+
T Consensus        99 GD~GDl~DyIm---KHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   99 GDGGDLFDYIM---KHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             cCCchHHHHHH---hhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            99999999996   3466789999999999999999999998   999999999999765 5689999999999866554


Q ss_pred             CCcceecccccccccCccccccCcCC-CcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      .  ..++.+|++.|-|||++.+..|+ +++||||+||+||.|++|+.||+.....+....|                +|-
T Consensus       173 ~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI----------------mDC  234 (864)
T KOG4717|consen  173 K--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI----------------MDC  234 (864)
T ss_pred             c--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh----------------hcc
Confidence            3  34567899999999999999998 5789999999999999999999876643332222                222


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..  ..+.....++.+|+..|+..||++|.+.+||+..
T Consensus       235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            11  1234456678999999999999999999998754

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.5e-36  Score=328.38  Aligned_cols=253  Identities=22%  Similarity=0.252  Sum_probs=195.5

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      ..+.+.+.||+|+||.||+++.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.++...++||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            45566789999999999999876 57889999986432   122345778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+++|+|.+++..     ..++...+..++.|++.||.|||+.   +|+||||||+|||++.++++||+|||+++....
T Consensus       123 Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~  194 (371)
T cd05622         123 EYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  194 (371)
T ss_pred             cCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence            99999999998853     3477778888999999999999998   999999999999999999999999999986543


Q ss_pred             CCCcceecccccccccCccccccC----cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ..........||+.|+|||++.+.    .++.++|||||||++|||++|+.||......       ..............
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~~  267 (371)
T cd05622         195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNHKNSLT  267 (371)
T ss_pred             CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcCCCccc
Confidence            333333456799999999998753    3788999999999999999999999765421       11111111111111


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKDI  682 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~L  682 (736)
                      +.+       .......+.+++..|+..++.+  ||++.|++++.
T Consensus       268 ~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         268 FPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            100       0112335778889999844433  78999998875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.5e-35  Score=308.77  Aligned_cols=248  Identities=26%  Similarity=0.353  Sum_probs=194.8

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.++||+|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++++...+..++||||+++
T Consensus         4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   83 (279)
T cd06619           4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG   83 (279)
T ss_pred             hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence            45678999999999999864 68899999986542 22345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      ++|..+.        .+++.....++.|++.||.|||+.   +|+|+||||+|||++.++.++|+|||++......   .
T Consensus        84 ~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~  149 (279)
T cd06619          84 GSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I  149 (279)
T ss_pred             CChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence            9996542        356778889999999999999998   9999999999999999999999999998754332   1


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||..............+....... .     .+.+.. 
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~-  222 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-D-----PPVLPV-  222 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-C-----CCCCCC-
Confidence            223468999999999998899999999999999999999999997533211111111111111111 0     011100 


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        .....++.+++.+|++.+|++||+++|++++
T Consensus       223 --~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         223 --GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              1122357899999999999999999999887

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3e-36  Score=323.55  Aligned_cols=237  Identities=27%  Similarity=0.346  Sum_probs=186.2

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHH-HHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEV-TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~-~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||.||+|+.. +++.||+|++.....   .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999876 578999999865321   1223444554 467889999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|..++..    ...+....+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~  152 (321)
T cd05603          81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET  152 (321)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence            999888742    34577888888999999999999998   99999999999999999999999999987532222 22


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+..   ... .+.+          .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~---~i~-~~~~----------~  214 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS----QMYD---NIL-HKPL----------Q  214 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH----HHHH---HHh-cCCC----------C
Confidence            33456999999999999889999999999999999999999999765411    1111   111 1110          1


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSIS  676 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~  676 (736)
                      .+......+.+++.+|++.+|.+||+..
T Consensus       215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         215 LPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            1112234578999999999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.7e-35  Score=313.94  Aligned_cols=249  Identities=24%  Similarity=0.350  Sum_probs=199.6

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.+.||||+++++++......++||||++
T Consensus        21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~  100 (296)
T cd06654          21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA  100 (296)
T ss_pred             ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence            3445678999999999999864 688999999876655556678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++..     ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.........
T Consensus       101 ~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654         101 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             CCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            9999998843     3478888999999999999999998   9999999999999999999999999998754332211


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                       .....|++.|+|||.+.+..++.++|||||||++|||++|+.||......   ..+..    ....+..      .+  
T Consensus       173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~---~~~~~----~~~~~~~------~~--  236 (296)
T cd06654         173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL---RALYL----IATNGTP------EL--  236 (296)
T ss_pred             -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH---HhHHH----HhcCCCC------CC--
Confidence             22345889999999999888999999999999999999999999754311   11111    1111100      00  


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..+......+.+++.+|+..+|++||++.||+++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            0111223457889999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.2e-35  Score=327.68  Aligned_cols=259  Identities=21%  Similarity=0.257  Sum_probs=192.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.+.+.||+|+||.||+|.+. .++.||||...      ...+.+|+++|++++|+||+++++++...+..++|||++. 
T Consensus       171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-  243 (461)
T PHA03211        171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-  243 (461)
T ss_pred             eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence            445688999999999999876 47889999632      2346789999999999999999999999999999999995 


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC-c
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-H  567 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~-~  567 (736)
                      ++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... .
T Consensus       244 ~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        244 SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            6888887532   23689999999999999999999998   999999999999999999999999999986533222 1


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccc----cccHHHHHHHhhh-cCCcceecc
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN----CRNIVQWAKLHIE-SGDIQGIID  642 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~----~~~l~~~~~~~~~-~~~~~~~~d  642 (736)
                      ......||+.|+|||++.+..++.++|||||||++|||++|..++........    ...+.+.+...-. ...+.....
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            22345699999999999999999999999999999999998876533221100    1112221111000 000000000


Q ss_pred             Cc------------cCCcCCH-------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PS------------LLDEYDI-------QSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~------------l~~~~~~-------~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .+            ....+..       .....+.+++.+|++.||.+|||+.|++++
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00            0000000       111257889999999999999999999876

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-35  Score=304.08  Aligned_cols=247  Identities=33%  Similarity=0.465  Sum_probs=197.6

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCHH
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK  492 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~  492 (736)
                      ++||+|+||.||+|...+++.||+|++...... ....+.+|++++++++|+||+++++++......++||||+.+++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            469999999999999877999999998765433 4567889999999999999999999999999999999999999999


Q ss_pred             HHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce-ec
Q 004689          493 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS-SI  571 (736)
Q Consensus       493 ~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~  571 (736)
                      +++...   ...+++.....++.+++.||.|||++   +++||||||+||+++.++.+||+|||+++.......... ..
T Consensus        81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            998542   23578888899999999999999998   999999999999999999999999999875432221111 12


Q ss_pred             ccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCC
Q 004689          572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD  650 (736)
Q Consensus       572 ~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  650 (736)
                      ..++..|+|||.+.++.++.++|+|||||++|||++ |..||......    ......    ..+.         ....+
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----~~~~~~----~~~~---------~~~~~  217 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----QTRERI----ESGY---------RMPAP  217 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH----HHHHHH----hcCC---------CCCCC
Confidence            234667999999988899999999999999999999 88888654311    111111    1110         00011


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          651 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       651 ~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      ......+.+++.+|+..+|.+||++.||++.|+
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            122346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.7e-36  Score=317.83  Aligned_cols=264  Identities=20%  Similarity=0.291  Sum_probs=195.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|++++++++||||+++++++..++..++||||+.
T Consensus         8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   87 (309)
T cd07872           8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD   87 (309)
T ss_pred             eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence            445688999999999999876 678899999875432 233457789999999999999999999999999999999997


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      + +|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... .
T Consensus        88 ~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  159 (309)
T cd07872          88 K-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-K  159 (309)
T ss_pred             C-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc-c
Confidence            5 888877532   34578888899999999999999998   99999999999999999999999999987543222 1


Q ss_pred             ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHH-------hhhc-CCcc
Q 004689          568 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HIES-GDIQ  638 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~-------~~~~-~~~~  638 (736)
                      ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+......       .+.. ....
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            2223457899999999865 56889999999999999999999999765432211111110000       0000 0000


Q ss_pred             eeccCccCCc----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          639 GIIDPSLLDE----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       639 ~~~d~~l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..-.+.....    ........+.+++.+|++.||.+|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            0000000000    001122357899999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.5e-35  Score=307.16  Aligned_cols=247  Identities=29%  Similarity=0.446  Sum_probs=197.2

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeee-eCCeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~lV~e~~~  487 (736)
                      .+.+.+.||+|+||.||+|... +..||+|.++...  ....+.+|+.++++++|+|++++++++. ..+..++||||++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            4556789999999999999876 8889999986432  2456889999999999999999999764 5567899999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++....  ...+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||+++......  
T Consensus        84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          84 KGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999986432  23478889999999999999999998   99999999999999999999999999987543222  


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                        ....++..|+|||++.+..++.++|||||||++|||++ |+.||.....    ..+..+.    ..+...     .  
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~----~~~~~~-----~--  219 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRV----EKGYKM-----D--  219 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH----hcCCCC-----C--
Confidence              12235678999999988889999999999999999998 9999865431    1222221    111110     1  


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                        ........+.+++.+|++.+|++|||+.++++.|+.
T Consensus       220 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         220 --APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             --CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence              111223468899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.5e-36  Score=320.75  Aligned_cols=239  Identities=23%  Similarity=0.310  Sum_probs=189.9

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEEe
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      ++.+.||+|+||+||+|... +++.||+|++.....   .....+..|..+++.+. |++|+++++++...+..++||||
T Consensus         3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey   82 (323)
T cd05615           3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY   82 (323)
T ss_pred             eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence            45688999999999999876 688999999875421   22345677888888885 57888899999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          83 VNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            999999998843    34688999999999999999999998   99999999999999999999999999987532221


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+.....    ....        
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~----~~~~~i~----~~~~--------  218 (323)
T cd05615         156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED----ELFQSIM----EHNV--------  218 (323)
T ss_pred             -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHH----hCCC--------
Confidence             1223356999999999999989999999999999999999999999765421    1222111    1111        


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSI  675 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  675 (736)
                        .++......+.+++.+|++.+|.+|++.
T Consensus       219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              0111122457889999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=9.1e-36  Score=314.54  Aligned_cols=256  Identities=25%  Similarity=0.429  Sum_probs=200.9

Q ss_pred             HHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      .+.+.+.||+|+||.||+|...      ++..||+|++.... .....++.+|+.++++++||||+++++++..+...++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l   85 (288)
T cd05050           6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL   85 (288)
T ss_pred             hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence            3456788999999999999864      46789999987543 2334668899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhccc------------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEE
Q 004689          482 VYEFMHNGTLKEHLYGTL------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL  543 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NIL  543 (736)
                      ||||+.+|+|.+++....                  .....+++..++.++.|++.||+|||+.   +++||||||+||+
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil  162 (288)
T cd05050          86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCL  162 (288)
T ss_pred             EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheE
Confidence            999999999999996431                  1123478888999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEEeecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCccccccccc
Q 004689          544 LDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC  621 (736)
Q Consensus       544 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~  621 (736)
                      ++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....   
T Consensus       163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~---  239 (288)
T cd05050         163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE---  239 (288)
T ss_pred             ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence            99999999999999875432221 11122235678999999998899999999999999999998 88888644311   


Q ss_pred             ccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          622 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       622 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                       .+..    .+..+.....         +.....++.+++.+|++.+|++||++.|+++.|++
T Consensus       240 -~~~~----~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 -EVIY----YVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             -HHHH----HHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence             1221    1222222110         11123468899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6e-35  Score=305.12  Aligned_cols=254  Identities=24%  Similarity=0.336  Sum_probs=190.2

Q ss_pred             ccccccCceEEEEEEECCCc---EEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          414 KKIGSGGFGVVYYGKLKDGK---EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~---~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.||+|+||.||+|...++.   .+++|.+.... ......+.+|+.+++.++||||++++++|......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            35999999999999755433   45667665433 233567899999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC-Ccc
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SHV  568 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~-~~~  568 (736)
                      +|.+++..........+......++.|++.||+|||+.   +++||||||+|||++.++.+||+|||++....... ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999975433334566777888999999999999998   99999999999999999999999999986422111 112


Q ss_pred             eecccccccccCcccccc-------CcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          569 SSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~-------~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      .....|+..|+|||++..       ..++.++|||||||++|||++ |..||......       ......+.+ .....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~-~~~~~  229 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-------EVLNHVIKD-QQVKL  229 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhh-ccccc
Confidence            233457899999999853       245789999999999999997 56677543311       111111221 22233


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      .++.+...++    ..+.+++..|+ .+|.+||+++||++.|.
T Consensus       230 ~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            4444433333    34677888899 67999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.5e-35  Score=312.59  Aligned_cols=264  Identities=23%  Similarity=0.312  Sum_probs=193.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhc---CCCceeeEeeeeee-----CCe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRI---HHRNLVQFLGYCQE-----EGR  478 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l---~HpnIv~l~~~~~~-----~~~  478 (736)
                      |.+.+.||+|+||+||+|... +++.||+|.++.....  ....+.+|+++++++   +||||+++++++..     ...
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            345678999999999999876 6889999998754222  234566788887766   69999999998864     345


Q ss_pred             EEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCC
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS  558 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla  558 (736)
                      .++||||+.+ +|.+++....  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        82 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          82 VTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             EEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence            7999999984 8888875432  24588999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          559 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       559 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      +......  ......||..|+|||++.+..++.++||||+||++|||++|++||......+....+..+...........
T Consensus       156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            7653321  12234589999999999988999999999999999999999999976542222222222111000000000


Q ss_pred             ------eeccCccC---CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          639 ------GIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       639 ------~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                            ..+.+...   ..........+.+++.+|++.||++|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                  00000000   00011223457899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.6e-35  Score=342.19  Aligned_cols=260  Identities=22%  Similarity=0.318  Sum_probs=201.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.++||+|+||.||+|... +++.||+|++......   ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY   83 (932)
T PRK13184          4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY   83 (932)
T ss_pred             eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence            445689999999999999876 5899999998754222   245688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccc-------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCC
Q 004689          486 MHNGTLKEHLYGTLT-------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS  558 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla  558 (736)
                      +++|+|.+++.....       ....+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence            999999999864211       123456778889999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCC-----------------cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccccccc
Q 004689          559 KFAVDGAS-----------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC  621 (736)
Q Consensus       559 ~~~~~~~~-----------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~  621 (736)
                      +.......                 .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~---  237 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR---  237 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh---
Confidence            75521100                 0112246999999999999999999999999999999999999999754311   


Q ss_pred             ccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHH
Q 004689          622 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIV  687 (736)
Q Consensus       622 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~~~~  687 (736)
                       .+...  ...        .++.-.. ...+....+.+++.+|++.||++|| +++++.+.|+..+.
T Consensus       238 -ki~~~--~~i--------~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        238 -KISYR--DVI--------LSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             -hhhhh--hhc--------cChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence             11110  000        0000000 0012234578899999999999996 67788888887754

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.8e-35  Score=306.69  Aligned_cols=239  Identities=21%  Similarity=0.371  Sum_probs=187.3

Q ss_pred             ccccccCceEEEEEEECC-------------CcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEE
Q 004689          414 KKIGSGGFGVVYYGKLKD-------------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~-------------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  480 (736)
                      +.||+|+||.||+|.+..             ...||+|++..........+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998542             2358899876544444556888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc-------EEEE
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-------AKVS  553 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~-------~kl~  553 (736)
                      +||||+++|+|..++...   ...+++..++.++.|+++||+|||+.   +|+||||||+|||++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            999999999999887532   34588889999999999999999998   9999999999999987664       8999


Q ss_pred             eecCCccccCCCCcceecccccccccCccccc-cCcCCCcchhHHHHHHHHHHH-hCCCcCcccccccccccHHHHHHHh
Q 004689          554 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELI-SGQEAISNEKFGANCRNIVQWAKLH  631 (736)
Q Consensus       554 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DVwSlGvvl~ell-tG~~p~~~~~~~~~~~~l~~~~~~~  631 (736)
                      |||++......     ....|+..|+|||.+. +..++.++|||||||++|||+ .|..|+......    ....    .
T Consensus       155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~~~----~  221 (262)
T cd05077         155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA----EKER----F  221 (262)
T ss_pred             CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh----HHHH----H
Confidence            99998654221     2235788999999987 467899999999999999998 588887644311    0100    0


Q ss_pred             hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                       ..+... .         .......+.+++.+|++.||.+||++.+|++.|
T Consensus       222 -~~~~~~-~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         222 -YEGQCM-L---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -HhcCcc-C---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence             111110 0         011134578999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.6e-35  Score=312.99  Aligned_cols=197  Identities=23%  Similarity=0.377  Sum_probs=160.0

Q ss_pred             hccccccCceEEEEEEEC---CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeee--CCeEEEEEEecC
Q 004689          413 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMH  487 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV~e~~~  487 (736)
                      .++||+|+||+||+|+..   +++.||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999865   46789999986432  23457889999999999999999998854  456789999986


Q ss_pred             CCCHHHHhhccc-----ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE----cCCCcEEEEeecCC
Q 004689          488 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS  558 (736)
Q Consensus       488 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl----~~~~~~kl~DFGla  558 (736)
                      + +|.+++....     .....++...+..++.|++.||.|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            4 7877764221     1123578888999999999999999998   99999999999999    45678999999999


Q ss_pred             ccccCCCCc--ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCccc
Q 004689          559 KFAVDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNE  615 (736)
Q Consensus       559 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~  615 (736)
                      +........  ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            865432211  2234568999999999976 45889999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.9e-35  Score=305.98  Aligned_cols=250  Identities=29%  Similarity=0.454  Sum_probs=191.5

Q ss_pred             ccccccCceEEEEEEEC----CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeee-eCCeEEEEEEecC
Q 004689          414 KKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVYEFMH  487 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~lV~e~~~  487 (736)
                      +.||+|+||.||+|.+.    +...||+|.+.... ......+.+|+.+++.++||||+++++++. .+...++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999864    24579999875432 233457888999999999999999999875 4556789999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++...   ...+.+..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++........
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999998643   23356777888999999999999998   9999999999999999999999999998754332111


Q ss_pred             ---ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhC-CCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          568 ---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       568 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                         ......++..|+|||++.+..++.++|||||||++|||++| ..||.....    ..+...   . ..+...     
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~---~-~~~~~~-----  221 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS----FDITVY---L-LQGRRL-----  221 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH---H-hcCCCC-----
Confidence               11223467789999999888999999999999999999995 555654321    122221   1 111100     


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      .    .+......+.+++..|++.+|++||++.||++.|+++.
T Consensus       222 ~----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         222 L----QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             C----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            0    01111245889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.1e-35  Score=311.56  Aligned_cols=249  Identities=27%  Similarity=0.377  Sum_probs=196.6

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      ..+.||+|+||.||++... +++.||||.+......   ....+.+|+.++++++|+||+++++.+...+..++||||++
T Consensus         4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05630           4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN   83 (285)
T ss_pred             eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence            4578999999999999876 6889999998654322   23456789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++........ 
T Consensus        84 g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          84 GGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             CCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            99999988542  224588889999999999999999998   999999999999999999999999999875433221 


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                       .....|+..|+|||++.+..++.++|||||||++|||++|+.||..............    .....      ......
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~----~~~~~------~~~~~~  226 (285)
T cd05630         158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----LVKEV------QEEYSE  226 (285)
T ss_pred             -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh----hhhhh------hhhcCc
Confidence             1234689999999999988999999999999999999999999976432111111111    00000      001111


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  681 (736)
                      .    ....+.+++..|++.||++|||     ++|++++
T Consensus       227 ~----~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         227 K----FSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             c----CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            1    2235788999999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.3e-35  Score=309.41  Aligned_cols=239  Identities=23%  Similarity=0.380  Sum_probs=186.5

Q ss_pred             cccccCceEEEEEEECC-------------------------CcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeE
Q 004689          415 KIGSGGFGVVYYGKLKD-------------------------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF  469 (736)
Q Consensus       415 ~IG~G~fG~Vy~~~~~~-------------------------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l  469 (736)
                      +||+|+||.||+|.+..                         ...||+|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997521                         13588998865443344568889999999999999999


Q ss_pred             eeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-
Q 004689          470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-  548 (736)
Q Consensus       470 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~-  548 (736)
                      +++|.+....++||||+++|+|..++..   ....+++..+..++.|+++||+|||+.   +|+||||||+|||++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            9999999999999999999999988853   234678889999999999999999998   999999999999998643 


Q ss_pred             ------cEEEEeecCCccccCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHH-hCCCcCcccccccc
Q 004689          549 ------RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELI-SGQEAISNEKFGAN  620 (736)
Q Consensus       549 ------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~ell-tG~~p~~~~~~~~~  620 (736)
                            .+|++|||++......     ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......  
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--  228 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS--  228 (274)
T ss_pred             ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH--
Confidence                  3899999987643221     12347888999998875 56889999999999999995 689988754321  


Q ss_pred             cccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          621 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       621 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                        ....+....   ..        ....    ....+.+++.+|++.+|++||++.+|++.|.
T Consensus       229 --~~~~~~~~~---~~--------~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         229 --EKERFYEKK---HR--------LPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HHHHHHHhc---cC--------CCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              111111100   00        0111    1135788999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=332.49  Aligned_cols=255  Identities=26%  Similarity=0.396  Sum_probs=207.6

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CC----cEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DG----KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~----~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      ......++||+|+||+||||.+- +|    .+||+|++.... .+...++.+|+.+|.++.|||+++|+|+|..+. ..|
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            33344688999999999999763 33    468999987653 445678999999999999999999999998776 789


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      |++||+.|+|.++++.   ++..+-....+.++.|||+||.|||.+   +++||||.++||||..-..+||.|||+++..
T Consensus       775 vtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             HHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            9999999999999975   355677788899999999999999998   9999999999999999999999999999976


Q ss_pred             cCCCCcce-ecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          562 VDGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       562 ~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ........ ....-.+.|||-|.+....|+.++|||||||.+||++| |..|+++....+        +...++.|.   
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------I~dlle~ge---  917 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------IPDLLEKGE---  917 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------hhHHHhccc---
Confidence            55443332 22334678999999999999999999999999999999 999998776321        122222221   


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                            +-.-+..+...+..++.+||..|+..||+++++...+.++.
T Consensus       918 ------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  918 ------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             ------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence                  11223445567899999999999999999999998887654

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6e-35  Score=307.31  Aligned_cols=250  Identities=23%  Similarity=0.341  Sum_probs=197.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.+.+.||+|+||.||+|... ++..+|+|.+..........+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            556788999999999999876 4778899988655544456788899999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|..++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... ..
T Consensus        87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~  159 (282)
T cd06643          87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR  159 (282)
T ss_pred             CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence            9999887532   34588999999999999999999998   99999999999999999999999999987543222 12


Q ss_pred             eecccccccccCccccc-----cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          569 SSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~-----~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      .....|+..|+|||++.     +..++.++|||||||++|||++|+.||......   ..+....    . ........ 
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~----~-~~~~~~~~-  230 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---RVLLKIA----K-SEPPTLAQ-  230 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH---HHHHHHh----h-cCCCCCCC-
Confidence            23345899999999984     345778999999999999999999998754311   1111111    1 10000000 


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                            +......+.+++.+|++.+|.+||++.+++++
T Consensus       231 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         231 ------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  11122458899999999999999999998765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.4e-35  Score=308.36  Aligned_cols=247  Identities=24%  Similarity=0.380  Sum_probs=198.8

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+...+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4455678999999999999865 57889999986443 223456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .+++|.+++..     ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999998842     4578888999999999999999998   999999999999999999999999999876543221


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.|+......    ....    ....+.     .+.+ 
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~----~~~~~~-----~~~~-  221 (277)
T cd06642         157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM----RVLF----LIPKNS-----PPTL-  221 (277)
T ss_pred             -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh----hHHh----hhhcCC-----CCCC-
Confidence             122345889999999999888999999999999999999999998643311    1111    111111     1111 


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                         .......+.+++.+|++.+|.+||+|.+|+++
T Consensus       222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 ---EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ---CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence               12234568899999999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.7e-35  Score=308.98  Aligned_cols=250  Identities=29%  Similarity=0.428  Sum_probs=196.7

Q ss_pred             ccccccCceEEEEEEECC-------CcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          414 KKIGSGGFGVVYYGKLKD-------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~-------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.||+|+||.||+|+..+       ++.+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999998652       2579999876543 23356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccc---cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-----cEEEEeecC
Q 004689          486 MHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-----RAKVSDFGL  557 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~-----~~kl~DFGl  557 (736)
                      +++|+|.+++.....   ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.+.     .++++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999965322   224478899999999999999999998   999999999999999887     899999999


Q ss_pred             CccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcC
Q 004689          558 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       558 a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      ++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||......    ......    ..+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~----~~~~~~----~~~  229 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ----EVLQHV----TAG  229 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH----HHHHHH----hcC
Confidence            8754332211 1122345788999999999999999999999999999998 99998654311    111111    111


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      ...         .........+.+++.+|+..+|.+||++++|.+.|+
T Consensus       230 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         230 GRL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             Ccc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            100         111123356789999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.3e-35  Score=311.25  Aligned_cols=249  Identities=27%  Similarity=0.355  Sum_probs=196.1

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      ..+.||+|+||+||+|... +++.||+|.+......   ....+.+|++++++++|+||+++.+++..++..++||||+.
T Consensus         4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   83 (285)
T cd05632           4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN   83 (285)
T ss_pred             EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence            3468999999999999875 6889999998654322   23457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++....  ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........ 
T Consensus        84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05632          84 GGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-  157 (285)
T ss_pred             CccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence            999998886432  34589999999999999999999998   999999999999999999999999999875432221 


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                       .....|+..|+|||++.+..++.++|+|||||++|||++|..||........    ..........+.      .    
T Consensus       158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~~------~----  222 (285)
T cd05632         158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLETE------E----  222 (285)
T ss_pred             -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhccc------c----
Confidence             2234689999999999988999999999999999999999999975432111    111111111111      0    


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  681 (736)
                      .+.......+.+++..|++.+|++||+     +.+++++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            111112235788999999999999999     6666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-36  Score=322.54  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=204.9

Q ss_pred             hhccccccCceEEEEEEEC--CCc--EEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          412 LEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~--~~~--~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      +-++||+|.||.|++|.|.  .|+  .||||.++..... .-.+|.+|+.+|.+|+|||+++|+|+..+ ....||+|.+
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            5578999999999999886  343  5899999876544 46789999999999999999999999988 6789999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      +.|+|.+.|+.  .....|.......++.|||.||.||.++   ++|||||..+|+||.....+||+|||+.+-+.....
T Consensus       193 plGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  193 PLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             ccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            99999999986  3455678888899999999999999998   999999999999999999999999999987655444


Q ss_pred             cce--ecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          567 HVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       567 ~~~--~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      +..  ....-...|+|||.+..+.++.++|||+|||.+|||+| |..||.+....    .|.             +.+|.
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----qIL-------------~~iD~  330 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----QIL-------------KNIDA  330 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----HHH-------------Hhccc
Confidence            321  11223568999999999999999999999999999999 88999877632    111             12222


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      .-+-..+..+.+.+.+++..||..+|++|||+..|.+.+
T Consensus       331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            222233455677899999999999999999999997554

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6e-35  Score=307.73  Aligned_cols=259  Identities=24%  Similarity=0.317  Sum_probs=204.6

Q ss_pred             HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      ...+.+.+.||+|+||+||++... +++.||+|++.... ......+.+|+++++.++||||+++++++......++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            345667789999999999999875 58899999886543 2335678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++++|.+++..    ...+++.....++.+++.||.|||+.  .+++||||||+||+++.++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999988743    34578889999999999999999974  28999999999999999999999999998644222


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccc----cccccHHHHHHHhhhcCCccee
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG----ANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~----~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      .   .....|+..|+|||++.+..++.++|||||||++|||++|+.||......    .....+..+......+..    
T Consensus       158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  230 (284)
T cd06620         158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP----  230 (284)
T ss_pred             c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC----
Confidence            1   12346899999999998888999999999999999999999999754422    111223333333222110    


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                        +.+.   .......+.+++.+|++.||.+||++.||+++..
T Consensus       231 --~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         231 --PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             --CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence              1111   1113346889999999999999999999998743

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.9e-35  Score=305.97  Aligned_cols=250  Identities=24%  Similarity=0.376  Sum_probs=194.3

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeeeC------CeEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE------GRSV  480 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~------~~~~  480 (736)
                      .+.+.+.||+|+||.||+|... +++.||+|++.... .....+..|+.+++++ +||||+++++++...      ...+
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (272)
T cd06637           7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW   85 (272)
T ss_pred             hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence            3455678999999999999875 57889999986543 3345788999999998 799999999998753      4679


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+.+|+|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        86 iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          86 LVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            999999999999998642  234588889999999999999999998   999999999999999999999999999875


Q ss_pred             ccCCCCcceecccccccccCccccc-----cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      ..... .......|+..|+|||++.     ...++.++|||||||++|||++|+.||......      .....  ....
T Consensus       161 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~------~~~~~--~~~~  231 (272)
T cd06637         161 LDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFL--IPRN  231 (272)
T ss_pred             ccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH------HHHHH--HhcC
Confidence            43222 1223456899999999986     335788999999999999999999999644311      11111  0111


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ......        .......+.+++.+|+..+|.+||++.||+++
T Consensus       232 ~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         232 PAPRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             CCCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            111111        11123457899999999999999999999764

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.5e-35  Score=304.82  Aligned_cols=252  Identities=22%  Similarity=0.337  Sum_probs=197.7

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.+.||+|+||.||+|+.. +++.||+|+++.........+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~   89 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG   89 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence            4567789999999999999865 688999999876544444567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++..    ...+++.....++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....... .
T Consensus        90 ~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~  161 (267)
T cd06645          90 GGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A  161 (267)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence            9999998843    34688899999999999999999998   99999999999999999999999999987543322 1


Q ss_pred             ceecccccccccCccccc---cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          568 VSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~---~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                      ......|+..|+|||++.   ...++.++|||||||++|||++|..||.......   .+...     ......   .+.
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~---~~~~~-----~~~~~~---~~~  230 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLM-----TKSNFQ---PPK  230 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh---hHHhh-----hccCCC---CCc
Confidence            223346899999999974   4568889999999999999999999986443111   01010     001100   011


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....  ......+.+++.+|++.+|++||++++|+++
T Consensus       231 ~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         231 LKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            1110  0112357889999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-35  Score=318.91  Aligned_cols=189  Identities=22%  Similarity=0.346  Sum_probs=161.3

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .|.+.+.||+|+||.||+|... +++.||+|+...      .....|+.++++++||||+++++++......++|+|++.
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  140 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS  140 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence            4566789999999999999876 567899997432      234579999999999999999999999999999999995


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                       ++|.+++..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......  
T Consensus       141 -~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  211 (357)
T PHA03209        141 -SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--  211 (357)
T ss_pred             -CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence             688888753   234688999999999999999999998   99999999999999999999999999987533221  


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI  612 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~  612 (736)
                      ......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            223346899999999999999999999999999999999965554

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.4e-35  Score=310.02  Aligned_cols=262  Identities=25%  Similarity=0.405  Sum_probs=202.9

Q ss_pred             HHHhhccccccCceEEEEEEEC-----CCcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeee--CCeEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSV  480 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-----~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~  480 (736)
                      .+.+.+.||+|+||.||+|.+.     +++.+|||++...... ....+.+|+++++.++||||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            3456688999999999999864     3678999998755432 45679999999999999999999999877  55789


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++..
T Consensus        85 lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            999999999999998643   23589999999999999999999998   999999999999999999999999999986


Q ss_pred             ccCCCCcc--eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccccccc-------ccHHHHHHHh
Q 004689          561 AVDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC-------RNIVQWAKLH  631 (736)
Q Consensus       561 ~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~-------~~l~~~~~~~  631 (736)
                      ........  .....++..|+|||.+.+..++.++|||||||+++||++|..|+.........       ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            64322211  11233566799999998889999999999999999999999998653311100       0011111111


Q ss_pred             hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      +..+.         ....+.....++.+++.+|++.+|++||+|.||+++|+.+
T Consensus       239 ~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11111         0011112235688999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.7e-35  Score=306.63  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=187.5

Q ss_pred             cccccCceEEEEEEECC---CcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          415 KIGSGGFGVVYYGKLKD---GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       415 ~IG~G~fG~Vy~~~~~~---~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      .||+|+||.||+|...+   ...+|+|.+..... .....+.+|+++++.++||||+++++++......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997543   34688887754332 224567899999999999999999999999999999999999999


Q ss_pred             HHHHhhccccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC-cc
Q 004689          491 LKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HV  568 (736)
Q Consensus       491 L~~~l~~~~~~-~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~-~~  568 (736)
                      |.+++...... ....++.....++.|++.||+|||+.   +|+||||||+|||++.++++||+|||++........ ..
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            99999654322 23356777889999999999999998   999999999999999999999999999864322211 11


Q ss_pred             eecccccccccCcccccc-------CcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          569 SSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~-------~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||......    ....   ....++. ...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~~~---~~~~~~~-~~~  230 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE----QVLK---QVVREQD-IKL  230 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH----HHHH---HHhhccC-ccC
Confidence            122346778999999753       356789999999999999999 77888654311    1111   1111111 111


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      .++.+...    ....+.+++..|+ .||++||+++||++.|.
T Consensus       231 ~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            12222212    2234566777887 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-35  Score=300.62  Aligned_cols=249  Identities=24%  Similarity=0.307  Sum_probs=204.6

Q ss_pred             hhccccccCceEEEEEEECC-CcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.+.||.|.-|+||++++++ +..+|+|++.+....   .....+.|-+||+.+.||.++.|++.++.+...||+||||+
T Consensus        81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp  160 (459)
T KOG0610|consen   81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP  160 (459)
T ss_pred             HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence            56789999999999999874 578999999876433   23457789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC----
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD----  563 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~----  563 (736)
                      ||+|...++.  +....++...+.-++.+++-||+|||..   |||+|||||+||||.++|++.|+||.++..+..    
T Consensus       161 GGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~  235 (459)
T KOG0610|consen  161 GGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL  235 (459)
T ss_pred             CccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence            9999998865  3567799999999999999999999998   999999999999999999999999998742210    


Q ss_pred             -----------------------------CCC----------------------cceecccccccccCccccccCcCCCc
Q 004689          564 -----------------------------GAS----------------------HVSSIVRGTVGYLDPEYYISQQLTDK  592 (736)
Q Consensus       564 -----------------------------~~~----------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~  592 (736)
                                                   ...                      ..+..++||-.|+|||++.+...+.+
T Consensus       236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA  315 (459)
T KOG0610|consen  236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA  315 (459)
T ss_pred             eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence                                         000                      01123569999999999999999999


Q ss_pred             chhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCC
Q 004689          593 SDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR  672 (736)
Q Consensus       593 ~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R  672 (736)
                      +|.|+|||++|||+.|..||.+....+...+++..   .           ....+  .......+.+||.+.+..||.+|
T Consensus       316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~---~-----------l~Fp~--~~~vs~~akDLIr~LLvKdP~kR  379 (459)
T KOG0610|consen  316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ---P-----------LKFPE--EPEVSSAAKDLIRKLLVKDPSKR  379 (459)
T ss_pred             hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC---C-----------CcCCC--CCcchhHHHHHHHHHhccChhhh
Confidence            99999999999999999999987755444444331   0           00111  12445678899999999999999


Q ss_pred             CC----HHHHHHH
Q 004689          673 PS----ISEVLKD  681 (736)
Q Consensus       673 Pt----~~ev~~~  681 (736)
                      ..    +.||.+|
T Consensus       380 lg~~rGA~eIK~H  392 (459)
T KOG0610|consen  380 LGSKRGAAEIKRH  392 (459)
T ss_pred             hccccchHHhhcC
Confidence            98    8888776

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.4e-35  Score=305.88  Aligned_cols=247  Identities=26%  Similarity=0.393  Sum_probs=193.6

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      ...||+|+||.||+|... ++..||+|.+..........+.+|+.++++++|+||+++++++..++..++|+||+.+++|
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   92 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL   92 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence            357999999999999865 5778999988766555566789999999999999999999999999999999999999999


Q ss_pred             HHHhhccccccccc--CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeecCCccccCCCCcc
Q 004689          492 KEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       492 ~~~l~~~~~~~~~l--~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      .+++....   ..+  +...+..++.|++.||+|||+.   +|+||||||+||+++. ++.++|+|||++........ .
T Consensus        93 ~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~  165 (268)
T cd06624          93 SALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-C  165 (268)
T ss_pred             HHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-c
Confidence            99986432   223  6777888999999999999998   9999999999999986 67999999999875433222 1


Q ss_pred             eecccccccccCccccccC--cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          569 SSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~--~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      .....|++.|+|||++...  .++.++||||||+++|||++|+.||......    ....+......       ..+   
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~----~~~~~~~~~~~-------~~~---  231 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP----QAAMFKVGMFK-------IHP---  231 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh----hhhHhhhhhhc-------cCC---
Confidence            2223588999999998754  3788999999999999999999998643211    11111111100       001   


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       ..+.....++.+++.+|++.+|.+||++.|++++
T Consensus       232 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         232 -EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             -CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence             1112223457889999999999999999999865

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.4e-35  Score=321.94  Aligned_cols=262  Identities=19%  Similarity=0.248  Sum_probs=198.4

Q ss_pred             HHHHHHhhccccccCceEEEEEEEC---CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          406 EDATKMLEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       406 ~~~~~~~~~~IG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      ....|.+.+.||+|+||.||++...   .+..||+|.+...     ....+|+++|++++||||+++++++......++|
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            3445677889999999999999754   3578999987532     3456899999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      ||++. ++|.+++.    ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       165 ~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        165 MPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             ehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence            99986 68888873    345689999999999999999999998   99999999999999999999999999997554


Q ss_pred             CCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc--e
Q 004689          563 DGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ--G  639 (736)
Q Consensus       563 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~--~  639 (736)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+....+ .+......  .
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~  315 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQ  315 (392)
T ss_pred             cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCC
Confidence            3322 222345699999999999999999999999999999999999999976543221112211111 11000000  0


Q ss_pred             -----------eccCccCCcCC-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 -----------IIDPSLLDEYD-------IQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 -----------~~d~~l~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                                 .+.......+.       ......+.+++.+|+..||++||++.|++.+
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                       00000000000       0112357788999999999999999999887

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-35  Score=315.73  Aligned_cols=253  Identities=22%  Similarity=0.271  Sum_probs=192.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||+||+++.. +++.||+|++....   ......+.+|+.++..++|+||+++++++.+++..++||||
T Consensus         3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   82 (331)
T cd05597           3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY   82 (331)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence            345688999999999999876 58899999986432   12234578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          83 YVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             CCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            9999999998532   34578888999999999999999998   99999999999999999999999999987554433


Q ss_pred             CcceecccccccccCcccccc-----CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          566 SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      ........||+.|+|||++..     ..++.++|||||||++|||++|+.||......       +............. 
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~-  228 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKEHFQ-  228 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCccc-
Confidence            333334569999999999863     45788999999999999999999999754421       11111111111000 


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhcc--CCCCCCCCCHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCV--LPHGHMRPSISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl--~~dP~~RPt~~ev~~~  681 (736)
                      +.+. ...    ....+.+++.+|+  ..++..||++++++++
T Consensus       229 ~~~~-~~~----~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 FPPD-VTD----VSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCc-cCC----CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0000 011    1223555666555  4455558999999988

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.6e-35  Score=316.03  Aligned_cols=257  Identities=20%  Similarity=0.304  Sum_probs=193.4

Q ss_pred             hhcccccc--CceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          412 LEKKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       412 ~~~~IG~G--~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      +.++||+|  +||+||++..+ +|+.||+|++.....  .....+.+|+++++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  78999999875 689999999875432  22356778999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++....  ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.++++||+..........
T Consensus        82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999985432  23488899999999999999999998   999999999999999999999999986543221111


Q ss_pred             c------ceecccccccccCcccccc--CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          567 H------VSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       567 ~------~~~~~~gt~~Y~aPE~~~~--~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      .      ......++..|+|||++.+  ..++.++|||||||++|||++|+.||........   +....     .+...
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~-----~~~~~  228 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKL-----NGTVP  228 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHh-----cCCcc
Confidence            0      1112346788999999976  4688999999999999999999999975432110   00000     00000


Q ss_pred             eecc-------------------Ccc-----------------CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          639 GIID-------------------PSL-----------------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       639 ~~~d-------------------~~l-----------------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..++                   ...                 ...+.......+.+++.+|++.||++|||+.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            0000                   000                 000111223468899999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-34  Score=303.77  Aligned_cols=247  Identities=22%  Similarity=0.363  Sum_probs=200.6

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+...+.||.|+||.||+|... +++.||+|++.... ......+.+|+.+++++.||||+++++++.++...++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            3445678999999999999875 58899999987543 233456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++..     ..+++.....++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999998842     3477888899999999999999998   999999999999999999999999999976543221


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                       ......++..|+|||++.+..++.++|+|||||++|||++|..||.......    ...    ....+.         .
T Consensus       157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~----~~~~~~---------~  218 (277)
T cd06640         157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLF----LIPKNN---------P  218 (277)
T ss_pred             -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hhh----hhhcCC---------C
Confidence             2223457889999999988889999999999999999999999997544111    100    001111         1


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..........+.+++.+|++.+|++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            12223445678899999999999999999999877

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8.4e-36  Score=325.35  Aligned_cols=248  Identities=23%  Similarity=0.343  Sum_probs=191.1

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.+.||+|+||.||++... +++.||+|+++...   ......+.+|+.++..++||||+++++++.+.+..++||||++
T Consensus         5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~   84 (360)
T cd05627           5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP   84 (360)
T ss_pred             EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence            4578999999999999876 58899999987532   2224567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC-
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-  566 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~-  566 (736)
                      +|+|.+++..    ...++...+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        85 gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          85 GGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             CccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            9999999853    34688888999999999999999998   999999999999999999999999999864321100 


Q ss_pred             ---------------------------------cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCc
Q 004689          567 ---------------------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS  613 (736)
Q Consensus       567 ---------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~  613 (736)
                                                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence                                             01123469999999999999999999999999999999999999997


Q ss_pred             ccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHH
Q 004689          614 NEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEVLKD  681 (736)
Q Consensus       614 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~ev~~~  681 (736)
                      ..........+..|        .....+.+.    ..  ...++.+++.+|+ .+|.+|++   +.|+.++
T Consensus       238 ~~~~~~~~~~i~~~--------~~~~~~p~~----~~--~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         238 SETPQETYRKVMNW--------KETLVFPPE----VP--ISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCHHHHHHHHHcC--------CCceecCCC----CC--CCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            65422211111111        000001111    00  1224566666655 49999985   6777666

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.7e-35  Score=301.82  Aligned_cols=249  Identities=26%  Similarity=0.401  Sum_probs=200.4

Q ss_pred             HHHhhccccccCceEEEEEEECC-CcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.+.||+|+||.||+|...+ ++.+|+|.+.....  ..++.+|++++++++||||+++++++......++++||+.
T Consensus         4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   81 (256)
T cd06612           4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG   81 (256)
T ss_pred             cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence            34567889999999999999874 78999999865432  5689999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++...   ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++........ 
T Consensus        82 ~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          82 AGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            99999998532   35688999999999999999999998   999999999999999999999999999876543321 


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......   ....     ......     +.+  
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~---~~~~-----~~~~~~-----~~~--  219 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR---AIFM-----IPNKPP-----PTL--  219 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---hhhh-----hccCCC-----CCC--
Confidence            2233458899999999998899999999999999999999999997543111   0000     000000     000  


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..+......+.+++.+|++.+|.+||++.||+++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            0111223468899999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.6e-35  Score=304.68  Aligned_cols=247  Identities=27%  Similarity=0.425  Sum_probs=196.5

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCccc---------chhhhhHHHHHhhcCCCceeeEeeeeeeCCeEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---------KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~---------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  480 (736)
                      .+...||+|+||.||+|... +++.||+|.+.......         ...+.+|+.++++++||||+++++++...+..+
T Consensus         3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (267)
T cd06628           3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN   82 (267)
T ss_pred             cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence            45678999999999999865 57899999886543221         145788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+++++|.+++..    ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++.
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          83 IFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             EEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            99999999999999843    34578888889999999999999998   999999999999999999999999999876


Q ss_pred             ccCCCCc-----ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC
Q 004689          561 AVDGASH-----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       561 ~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      .......     ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......   .+.    . ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~----~-~~~~  227 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---AIF----K-IGEN  227 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---HHH----H-Hhcc
Confidence            5422111     1122458899999999998889999999999999999999999997543110   110    0 0011


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                           ..+.+    +......+.+++.+|++.+|.+||++.||+++
T Consensus       228 -----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         228 -----ASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             -----CCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                 11111    12233467889999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.3e-35  Score=309.31  Aligned_cols=250  Identities=23%  Similarity=0.331  Sum_probs=199.9

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      ..|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++..+...++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            34556788999999999999864 78999999987655445566889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|+|||++........
T Consensus        99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            99999998843     3478888999999999999999998   999999999999999999999999999875433222


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      . .....|++.|+|||.+.+..++.++|||||||++|+|++|..||.......   .+..    ....+. ..       
T Consensus       171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~---~~~~----~~~~~~-~~-------  234 (297)
T cd06656         171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYL----IATNGT-PE-------  234 (297)
T ss_pred             C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch---heee----eccCCC-CC-------
Confidence            1 223458899999999998889999999999999999999999996543110   0000    000000 00       


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...+......+.+++.+|+..+|++||++++|+++
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00111223457789999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.5e-35  Score=318.80  Aligned_cols=262  Identities=23%  Similarity=0.294  Sum_probs=192.5

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCC------eE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RS  479 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------~~  479 (736)
                      .|.+.+.||+|+||.||++... +++.||||++....  ......+.+|+.+++.++||||+++++++....      ..
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  101 (359)
T cd07876          22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV  101 (359)
T ss_pred             ceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence            4556789999999999999875 58899999986432  223456778999999999999999999986443      57


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ++||||+.+ +|.+.+.      ..++...+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       102 ~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876         102 YLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             EEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence            999999975 5665553      2367778888999999999999998   99999999999999999999999999997


Q ss_pred             cccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccH---------------
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI---------------  624 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l---------------  624 (736)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+               
T Consensus       172 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         172 TACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             ccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            54322  1223346899999999999999999999999999999999999999754321100000               


Q ss_pred             HHHHHHhhhc-CC-----cceeccCccCC---cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          625 VQWAKLHIES-GD-----IQGIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       625 ~~~~~~~~~~-~~-----~~~~~d~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      .......... ..     +.+....-...   .........+.+++.+|++.||++|||+.|++++-
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            0001111000 00     00000000000   00111234578999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-35  Score=304.98  Aligned_cols=247  Identities=25%  Similarity=0.381  Sum_probs=199.7

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||.|+||.||+|... +++.||+|++.... ......+.+|+++++.++|+||+++++++.++...++|+||++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG   82 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence            456688999999999999876 68899999986543 2334568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++...     .+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||+++....... 
T Consensus        83 ~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  153 (274)
T cd06609          83 GGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-  153 (274)
T ss_pred             CCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence            99999998532     688999999999999999999998   999999999999999999999999999976644322 


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||......    ...    ..+..+...     .+..
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----~~~----~~~~~~~~~-----~~~~  220 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM----RVL----FLIPKNNPP-----SLEG  220 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH----HHH----HHhhhcCCC-----CCcc
Confidence            223345889999999999888999999999999999999999999754311    111    111111111     1111


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .   .....+.+++.+|+..+|++||++++++++
T Consensus       221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            1   023357889999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.7e-35  Score=305.08  Aligned_cols=253  Identities=25%  Similarity=0.399  Sum_probs=198.2

Q ss_pred             HhhccccccCceEEEEEEECC--CcEEEEEEeccCCc----------ccchhhhhHHHHHhh-cCCCceeeEeeeeeeCC
Q 004689          411 MLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNSY----------QGKREFTNEVTLLSR-IHHRNLVQFLGYCQEEG  477 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~--~~~vAvK~l~~~~~----------~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~~~  477 (736)
                      .+.+.||+|+||.||+|....  ++.+|+|.+.....          ....++..|+.++.+ ++||||+++++++..++
T Consensus         3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   82 (269)
T cd08528           3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND   82 (269)
T ss_pred             hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence            456789999999999999864  68899998753321          112346678887765 69999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecC
Q 004689          478 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL  557 (736)
Q Consensus       478 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGl  557 (736)
                      ..++||||+++++|.+++.........+++..++.++.|++.||.|||+.  .+++|+||||+||+++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccc
Confidence            99999999999999998865434455688999999999999999999963  2899999999999999999999999999


Q ss_pred             CccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          558 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       558 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                      +.......  ......|+..|+|||++.+..++.++||||||+++|||++|+.||......    ....   . ..++..
T Consensus       161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~----~~~~---~-~~~~~~  230 (269)
T cd08528         161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML----SLAT---K-IVEAVY  230 (269)
T ss_pred             eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH----HHHH---H-HhhccC
Confidence            97654332  223456899999999999888999999999999999999999998644311    1111   1 111111


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      ...    ...    .....+.+++.+|++.||++||++.||.++++
T Consensus       231 ~~~----~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         231 EPL----PEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CcC----Ccc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            110    001    12245888999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=7.4e-35  Score=310.92  Aligned_cols=259  Identities=23%  Similarity=0.317  Sum_probs=197.1

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.+.||+|+||.||++... ++..+|+|.+..... ....++.+|++++++++||||+++++++..++..++||||+++
T Consensus         4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~   83 (308)
T cd06615           4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDG   83 (308)
T ss_pred             eEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence            45678999999999999876 578899998864422 2245688999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      ++|.+++..    ...+++..+..++.|+++||.|||+.  .+++||||||+|||++.++.+||+|||++.......   
T Consensus        84 ~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---  154 (308)
T cd06615          84 GSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---  154 (308)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence            999999853    24578888999999999999999974  289999999999999999999999999987543321   


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc----------
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ----------  638 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~----------  638 (736)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......    ....+...........          
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK----ELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh----hHHHhhcCccccccccCCcccccCCC
Confidence            22346899999999998888999999999999999999999998643311    1111111100000000          


Q ss_pred             ----------eeccCcc---CCcCC-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          639 ----------GIIDPSL---LDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       639 ----------~~~d~~l---~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                                +..+...   ....+ ......+.+++.+|+..+|++||++.||+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                      0000000   00000 01223588999999999999999999998874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=5e-35  Score=311.48  Aligned_cols=253  Identities=25%  Similarity=0.416  Sum_probs=196.6

Q ss_pred             HhhccccccCceEEEEEEEC-CCc----EEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~----~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      ...+.||+|+||.||+|.+. ++.    .||+|.+..... .....+.+|+.++++++||||++++++|... ..++++|
T Consensus        10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e   88 (303)
T cd05110          10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ   88 (303)
T ss_pred             eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence            34578999999999999864 343    478888765432 2234688999999999999999999998764 4679999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        89 ~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~  162 (303)
T cd05110          89 LMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD  162 (303)
T ss_pred             hcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCc
Confidence            99999999998532   33578888999999999999999998   9999999999999999999999999999865432


Q ss_pred             CCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          565 ASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       565 ~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      ... ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+...    ..+..+..    .+....   
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~~~~~~~----~~~~~~---  231 (303)
T cd05110         163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----REIPDLLE----KGERLP---  231 (303)
T ss_pred             ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHH----CCCCCC---
Confidence            221 1222345778999999998899999999999999999997 8999875431    12222221    111100   


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                            ........+.+++..|+..+|++||+++++++.|+++..
T Consensus       232 ------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         232 ------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             ------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                  011122457889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.8e-35  Score=306.70  Aligned_cols=254  Identities=24%  Similarity=0.380  Sum_probs=199.9

Q ss_pred             HhhccccccCceEEEEEEEC------CCcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      .+.+.||+|+||.||+|+.+      +.+.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||
T Consensus         8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   87 (275)
T cd05046           8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMIL   87 (275)
T ss_pred             eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEE
Confidence            34678999999999999864      3467999988654332 3456899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhccccc-----ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCC
Q 004689          484 EFMHNGTLKEHLYGTLTH-----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS  558 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla  558 (736)
                      ||+++|+|.+++......     ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++++|||++
T Consensus        88 e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~  164 (275)
T cd05046          88 EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLS  164 (275)
T ss_pred             EecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccc
Confidence            999999999998644311     12589999999999999999999998   9999999999999999999999999998


Q ss_pred             ccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          559 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       559 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                      +..............++..|+|||.+.+..++.++|||||||++|||++ |..||.....    ..+....    ..+..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~----~~~~~~~----~~~~~  236 (275)
T cd05046         165 KDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD----EEVLNRL----QAGKL  236 (275)
T ss_pred             cccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch----HHHHHHH----HcCCc
Confidence            7543322222233456788999999988888999999999999999999 7788864331    1222221    11111


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      ...        ........+.+++.+|++.+|++||++.|+++.|.
T Consensus       237 ~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         237 ELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            110        01122346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-34  Score=302.31  Aligned_cols=249  Identities=25%  Similarity=0.400  Sum_probs=196.9

Q ss_pred             HhhccccccCceEEEEEEECCCcEEEEEEeccCCc------ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .+.+.||+|+||.||+|...+++.+|+|.+.....      .....+.+|++++++++|+||+++++++.+....++|+|
T Consensus         3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (265)
T cd06631           3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME   82 (265)
T ss_pred             cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence            34678999999999999988899999998864321      112458889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++++|.+++..    ...+++..+..++.|++.||+|||+.   +|+|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          83 FVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            9999999999853    23578888889999999999999998   9999999999999999999999999998754211


Q ss_pred             C-----CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          565 A-----SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       565 ~-----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      .     ........|+..|+|||++.+..++.++|||||||++|||++|+.||.......      .........+.   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~~---  226 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------AMFYIGAHRGL---  226 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH------HHHHhhhccCC---
Confidence            1     111223458999999999998889999999999999999999999997543111      10000000011   


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        .+.+...    ....+.+++.+|++.+|.+||++.|++++
T Consensus       227 --~~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         227 --MPRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             --CCCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              1112222    23457889999999999999999998763

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.8e-34  Score=303.85  Aligned_cols=251  Identities=23%  Similarity=0.342  Sum_probs=198.2

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .|.+.++||+|+||.||+|+.. +++.||+|++..........+.+|+.+++.++||||+++++++..++..++||||++
T Consensus        13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   92 (292)
T cd06644          13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP   92 (292)
T ss_pred             hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence            4567788999999999999876 488999999876655556678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|..++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++++||+|||++....... .
T Consensus        93 ~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~  165 (292)
T cd06644          93 GGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q  165 (292)
T ss_pred             CCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence            99998877432   34588999999999999999999998   99999999999999999999999999986533221 1


Q ss_pred             ceecccccccccCccccc-----cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          568 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      ......++..|+|||++.     ...++.++|||||||++|||++|..||.....       ....... ......... 
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~-~~~~~~~~~-  236 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLKI-AKSEPPTLS-  236 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-------HHHHHHH-hcCCCccCC-
Confidence            223345889999999985     34567899999999999999999999865431       1111111 111110000 


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                            .+......+.+++.+|++.+|++||++.||+++
T Consensus       237 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         237 ------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                  011223457889999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7e-35  Score=302.22  Aligned_cols=238  Identities=24%  Similarity=0.424  Sum_probs=188.2

Q ss_pred             ccccccCceEEEEEEECCCc-----------EEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          414 KKIGSGGFGVVYYGKLKDGK-----------EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~-----------~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      +.||+|+||.||+|.+.+..           .+++|++...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46899999999999886433           4788877644333 5778899999999999999999999988 778999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-------cEEEEee
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-------RAKVSDF  555 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~-------~~kl~DF  555 (736)
                      |||+.+|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++       .+||+||
T Consensus        79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence            9999999999998643   22678889999999999999999998   999999999999999887       7999999


Q ss_pred             cCCccccCCCCcceecccccccccCccccccC--cCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhh
Q 004689          556 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       556 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      |++.....     .....++..|+|||++...  .++.++|||||||++|||++ |..|+......    ....+..   
T Consensus       153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~----~~~~~~~---  220 (259)
T cd05037         153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS----EKERFYQ---  220 (259)
T ss_pred             Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch----hHHHHHh---
Confidence            99875433     1223467889999999876  78999999999999999999 56677544311    1111111   


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      ....         ..   ......+.+++.+|+..+|.+||++.||++.|+
T Consensus       221 ~~~~---------~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQHR---------LP---MPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCCC---------CC---CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0000         00   001156889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-35  Score=308.85  Aligned_cols=265  Identities=21%  Similarity=0.261  Sum_probs=199.6

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      +.+.+.||+|+||.||+|... +++.||+|+++...  ......+.+|++++++++|+||+++++++..++..++||||+
T Consensus         3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   82 (288)
T cd07833           3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV   82 (288)
T ss_pred             eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence            445688999999999999876 57899999886542  223467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .++.+..+..    ....+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.+||+|||++........
T Consensus        83 ~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          83 ERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             CCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            9877766553    234478899999999999999999998   999999999999999999999999999886544433


Q ss_pred             cceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHH--------hhhcCCc
Q 004689          567 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL--------HIESGDI  637 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~--------~~~~~~~  637 (736)
                      .......++..|+|||++.+. .++.++||||||+++|||++|+.||......+....+......        .......
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            233345688999999999887 8899999999999999999999999754321111111110000        0000000


Q ss_pred             c-----eeccCcc-CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 Q-----GIIDPSL-LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~-----~~~d~~l-~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .     ...++.. ...++.....++.+++.+|+..+|++||++++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            0     0000000 001111224678999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.8e-35  Score=307.15  Aligned_cols=240  Identities=24%  Similarity=0.404  Sum_probs=187.8

Q ss_pred             ccccccCceEEEEEEECC--------CcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          414 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.||+|+||.||+|....        ..+||+|.+..........+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999997642        235888887654444456788899999999999999999999998999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc--------EEEEeecC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--------AKVSDFGL  557 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~--------~kl~DFGl  557 (736)
                      +.+|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.        ++++|||+
T Consensus        81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999998643   23578888999999999999999998   9999999999999987765        69999998


Q ss_pred             CccccCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCC-CcCcccccccccccHHHHHHHhhhcC
Q 004689          558 SKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       558 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~-~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      +.....     .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+......    ....    .... 
T Consensus       155 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~----~~~~----~~~~-  220 (258)
T cd05078         155 SITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ----KKLQ----FYED-  220 (258)
T ss_pred             ccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH----HHHH----HHHc-
Confidence            864432     122457889999999986 45889999999999999999995 555432210    0011    0000 


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      .          ...+.....++.+++.+|++.+|++|||++++++.|+
T Consensus       221 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 R----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             c----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0          0111112246889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.4e-35  Score=302.75  Aligned_cols=248  Identities=22%  Similarity=0.360  Sum_probs=198.6

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.+.||+|+||.||++... +++.+|+|.++... ......+.+|+.+++.++||||+++++++......++||||+++
T Consensus         3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (255)
T cd08219           3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG   82 (255)
T ss_pred             eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence            45688999999999999876 68899999986432 23345688899999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++...  ....++......++.|++.||.|||+.   +++|+||||+||+++.++.++++|||.+........ .
T Consensus        83 ~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  156 (255)
T cd08219          83 GDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y  156 (255)
T ss_pred             CcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence            9999988532  234578888999999999999999998   999999999999999999999999999875533221 2


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....|++.|+|||++.+..++.++|+||||+++|+|++|..||......    ..   .. ....+....     +   
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~---~~-~~~~~~~~~-----~---  220 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK----NL---IL-KVCQGSYKP-----L---  220 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH----HH---HH-HHhcCCCCC-----C---
Confidence            23345899999999999888999999999999999999999999754311    11   11 111222111     1   


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       +......+.+++.+|++.+|++||++.+|+..
T Consensus       221 -~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 -PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             -CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence             11122357889999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-34  Score=310.03  Aligned_cols=197  Identities=24%  Similarity=0.382  Sum_probs=159.6

Q ss_pred             hccccccCceEEEEEEEC---CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeee--eCCeEEEEEEecC
Q 004689          413 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ--EEGRSVLVYEFMH  487 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~lV~e~~~  487 (736)
                      ..+||+|+||+||+|+..   ++..||+|.+....  ....+.+|++++++++||||+++++++.  .+...++||||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999865   35789999886432  2345788999999999999999999885  3567899999987


Q ss_pred             CCCHHHHhhccc-----ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE----cCCCcEEEEeecCC
Q 004689          488 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS  558 (736)
Q Consensus       488 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl----~~~~~~kl~DFGla  558 (736)
                      + +|.+++....     .....+++..+..++.|++.||.|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 7777764221     1223578888999999999999999998   99999999999999    56679999999999


Q ss_pred             ccccCCCCc--ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCccc
Q 004689          559 KFAVDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNE  615 (736)
Q Consensus       559 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~  615 (736)
                      +........  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            865433221  2233468999999999876 45889999999999999999999999643

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.2e-35  Score=303.17  Aligned_cols=253  Identities=24%  Similarity=0.344  Sum_probs=200.4

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeee--CCeEEEEEEe
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEF  485 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV~e~  485 (736)
                      .+.+.||.|+||.||++... +++.||+|++....  ......+..|++++++++||||+++++++..  ....+++|||
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~   82 (265)
T cd08217           3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY   82 (265)
T ss_pred             eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence            45678999999999999865 67899999986542  2234568889999999999999999998753  4567999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCC--CCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~--~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      +++++|.+++.........+++...+.++.|++.||.|||..+  ..+++|+||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~  162 (265)
T cd08217          83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH  162 (265)
T ss_pred             ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccC
Confidence            9999999999665444567899999999999999999999321  23999999999999999999999999999986544


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      .... .....|++.|+|||++.+..++.++||||||+++++|++|+.||.....    ..+.+.    ...+...     
T Consensus       163 ~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~----~~~~~~~-----  228 (265)
T cd08217         163 DSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ----LQLASK----IKEGKFR-----  228 (265)
T ss_pred             Cccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH----HHHHHH----HhcCCCC-----
Confidence            3321 2234589999999999988899999999999999999999999975431    112221    1112111     


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          ..+......+.+++.+|++.+|++||++++|+++
T Consensus       229 ----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 ----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                1122233568899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5.4e-35  Score=318.36  Aligned_cols=261  Identities=22%  Similarity=0.301  Sum_probs=193.0

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeC------CeE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS  479 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~~  479 (736)
                      .|.+.+.||+|+||.||++... .++.||||++.....  .....+.+|+.+++.++||||+++++++...      ...
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   97 (355)
T cd07874          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV   97 (355)
T ss_pred             ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence            4455788999999999999865 688999999865422  2345677899999999999999999988543      356


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ++||||+.+ +|.+.+.      ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        98 ~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~  167 (355)
T cd07874          98 YLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_pred             EEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccc
Confidence            999999975 5666653      2477888889999999999999998   99999999999999999999999999997


Q ss_pred             cccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHH-------------
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ-------------  626 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~-------------  626 (736)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+..             
T Consensus       168 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             cCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            54332  122334689999999999998999999999999999999999999976442111111100             


Q ss_pred             --HHHHhhhc-CCcceeccCcc-----CC---cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          627 --WAKLHIES-GDIQGIIDPSL-----LD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       627 --~~~~~~~~-~~~~~~~d~~l-----~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        ........ ........+..     ..   .........+.+++.+|++.||++|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence              00000000 00000000000     00   0111123467899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.1e-35  Score=311.02  Aligned_cols=260  Identities=22%  Similarity=0.319  Sum_probs=195.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++++++||||+++++++..+...++||||+.
T Consensus         8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~   87 (301)
T cd07873           8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD   87 (301)
T ss_pred             eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence            445688999999999999876 678999999864432 223457789999999999999999999999999999999997


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                       ++|.+++...   ...+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||++........ 
T Consensus        88 -~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (301)
T cd07873          88 -KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  159 (301)
T ss_pred             -cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence             5888887532   34578888999999999999999998   999999999999999999999999999875432221 


Q ss_pred             ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh---cCCcceecc-
Q 004689          568 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE---SGDIQGIID-  642 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~---~~~~~~~~d-  642 (736)
                      ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||......+    ....+.....   ......+++ 
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~  235 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE----QLHFIFRILGTPTEETWPGILSN  235 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHcCCCChhhchhhhcc
Confidence            1223347899999999875 457889999999999999999999997654221    1111111100   000000000 


Q ss_pred             --------CccCCc----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 --------PSLLDE----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 --------~~l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                              +.....    ........+.+++.+|++.||.+|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                    000000    001123357899999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.4e-35  Score=320.23  Aligned_cols=261  Identities=22%  Similarity=0.289  Sum_probs=192.9

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeC------CeE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS  479 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~~  479 (736)
                      .|.+.+.||+|+||.||+|... .++.||||++....  ......+.+|+.+++.++||||+++++++...      ...
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~  104 (364)
T cd07875          25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV  104 (364)
T ss_pred             ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence            4556789999999999999865 58899999986532  22345677899999999999999999987543      357


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ++||||+.+ +|.+.+.      ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       105 ~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         105 YIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             EEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            999999975 6766663      2367788889999999999999998   99999999999999999999999999997


Q ss_pred             cccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHH-------------
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ-------------  626 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~-------------  626 (736)
                      ......  ......||..|+|||++.+..++.++|||||||++|||++|+.||......+....+..             
T Consensus       175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (364)
T cd07875         175 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  252 (364)
T ss_pred             ccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            543321  22334689999999999999999999999999999999999999976442111111110             


Q ss_pred             --HHHHhhhc-CCcc-----eeccCccC---CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          627 --WAKLHIES-GDIQ-----GIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       627 --~~~~~~~~-~~~~-----~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        ........ ....     ........   ..........+.+++.+|++.||.+|||+.|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence              00000000 0000     00000000   00011123467899999999999999999999887

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-35  Score=305.34  Aligned_cols=256  Identities=24%  Similarity=0.403  Sum_probs=201.6

Q ss_pred             HHHHhhccccccCceEEEEEEECC-Cc----EEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLKD-GK----EIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~~-~~----~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      ..+.+.+.||+|+||.||+|...+ ++    .+|+|++..... .....+.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            345567899999999999998652 32    589998865543 234578899999999999999999999987 78899


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            99999999999998643   33488999999999999999999997   9999999999999999999999999999865


Q ss_pred             cCCCCcce-ecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          562 VDGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       562 ~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ........ ....++..|+|||.+....++.++|+|||||++||+++ |+.||.....    ..+.....    .+... 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~----~~~~~-  230 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA----VEIPDLLE----KGERL-  230 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH----HHHHHHHh----CCCCC-
Confidence            43322211 12224578999999988889999999999999999998 9999976542    12222111    11110 


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                              ..+......+.+++.+|+..+|.+||++.++++.|+++..
T Consensus       231 --------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         231 --------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             --------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                    0011122357889999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.4e-35  Score=318.02  Aligned_cols=253  Identities=21%  Similarity=0.240  Sum_probs=193.1

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||+||+++.. +++.||+|++....   ......+.+|..++..++|+||+++++++.+.+..++||||
T Consensus         3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey   82 (331)
T cd05624           3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY   82 (331)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence            345688999999999999876 57889999986432   12234578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          83 YVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             CCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999998532   24578888889999999999999998   99999999999999999999999999997654433


Q ss_pred             CcceecccccccccCcccccc-----CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          566 SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||......+       .......... .-.
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-------~~~~i~~~~~-~~~  228 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-------TYGKIMNHEE-RFQ  228 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-------HHHHHHcCCC-ccc
Confidence            333334569999999999875     467889999999999999999999997544211       1111111110 000


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~  681 (736)
                      +.+.. .    .....+.+++.+|+..++.+  |+++++++++
T Consensus       229 ~p~~~-~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 FPSHI-T----DVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CCCcc-c----cCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            11111 1    12235677888887765543  5688888876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.6e-34  Score=304.20  Aligned_cols=264  Identities=22%  Similarity=0.278  Sum_probs=197.4

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      |.+.+.||+|+||.||+|+.. +++.||+|++.....  ...+.+.+|+.++++++||||+++++++......++||||+
T Consensus         3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~   82 (286)
T cd07847           3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC   82 (286)
T ss_pred             eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence            345678999999999999886 588999998864321  22356789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      +++.|..++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus        83 ~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          83 DHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             CccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            99888877632    34588999999999999999999998   999999999999999999999999999976543321


Q ss_pred             cceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHh-------hhcCC-c
Q 004689          567 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------IESGD-I  637 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~~~~~-~  637 (736)
                       ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+.......       ..... .
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence             1223347889999999876 567899999999999999999999997654221111111111000       00000 0


Q ss_pred             ceeccCccCCcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 QGIIDPSLLDEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~~~~d~~l~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .....+......+.     .....+.+++.+|++.+|++||++.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            00001111000011     113467899999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.8e-35  Score=306.21  Aligned_cols=265  Identities=23%  Similarity=0.253  Sum_probs=194.4

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.||+|+||.||+|+.. +++.||+|+++....  .....+.+|+.++++++||||+++++++.++...++||||+.
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (285)
T cd07861           3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS   82 (285)
T ss_pred             eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence            34578999999999999876 688999999864422  223567889999999999999999999999999999999997


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                       ++|.+++.... ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....... .
T Consensus        83 -~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~  156 (285)
T cd07861          83 -MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-R  156 (285)
T ss_pred             -CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-c
Confidence             68888875432 235688999999999999999999998   99999999999999999999999999987543221 1


Q ss_pred             ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh----hc----CCcc
Q 004689          568 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI----ES----GDIQ  638 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~----~~----~~~~  638 (736)
                      ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+........    ..    ....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            1222357899999998865 4578899999999999999999999975432111101100000000    00    0000


Q ss_pred             eeccCccCC---cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          639 GIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       639 ~~~d~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..++.....   ........++.+++.+|++.||++|||+++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            000000000   0001123457799999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.5e-34  Score=299.43  Aligned_cols=249  Identities=23%  Similarity=0.378  Sum_probs=198.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeee-CCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||.||++... +++.||+|.+.....  .....+.+|++++++++|+|++++++.+.. +...+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            346788999999999999876 578899999864322  234568889999999999999999998764 4467899999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++++|.+++...  ....+++..+..++.|++.|+++||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          82 CEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             cCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            9999999998643  234588999999999999999999998   99999999999999999999999999987653322


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      . ......|++.|+|||++.+..++.++|||||||+++||++|+.||.....       ....... ..+.+.       
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~-~~~~~~-------  220 (257)
T cd08223         157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYRI-IEGKLP-------  220 (257)
T ss_pred             C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHH-HhcCCC-------
Confidence            2 22334589999999999999999999999999999999999999875431       1111111 112211       


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        ..+......+.+++.+|++.+|++||++.+++++
T Consensus       221 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             --CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence              1112233468899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-34  Score=305.12  Aligned_cols=253  Identities=25%  Similarity=0.371  Sum_probs=195.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeee-----eCCeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ-----EEGRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~-----~~~~~~lV  482 (736)
                      +.+.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +||||+++++++.     .+...++|
T Consensus        20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv   98 (286)
T cd06638          20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV   98 (286)
T ss_pred             eeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence            345678999999999999875 57899999876432 2245678899999999 6999999999884     34568999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      |||+++++|.+++.........+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++...
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~  175 (286)
T cd06638          99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  175 (286)
T ss_pred             EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence            999999999998865444456688889999999999999999998   99999999999999999999999999987553


Q ss_pred             CCCCcceecccccccccCcccccc-----CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                      ... .......|++.|+|||++..     ..++.++|||||||++|||++|+.||......   ..+...     .....
T Consensus       176 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~~~-----~~~~~  246 (286)
T cd06638         176 STR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RALFKI-----PRNPP  246 (286)
T ss_pred             cCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHhhc-----cccCC
Confidence            322 12233458999999999853     45788999999999999999999999754311   111110     00100


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      ....++.       .....+.+++.+|++.+|++||++.||++++
T Consensus       247 ~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         247 PTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             CcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            1111111       1123588999999999999999999998864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-34  Score=300.09  Aligned_cols=249  Identities=31%  Similarity=0.501  Sum_probs=199.4

Q ss_pred             hhccccccCceEEEEEEECC-----CcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          412 LEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~-----~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.||+|+||.||++...+     +..||+|++...... ....+..|+++++.++|+||+++++++.+.+..+++|||
T Consensus         3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~   82 (258)
T smart00219        3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY   82 (258)
T ss_pred             ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence            45789999999999998763     378999998755433 456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++++|.+++....  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+++......
T Consensus        83 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       83 MEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             cCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999986432  12289999999999999999999998   99999999999999999999999999998665442


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                      ........+++.|+|||.+.+..++.++||||+||+++||++ |..||.....    ..+.+..    ..+....     
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~----~~~~~~~----~~~~~~~-----  224 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN----EEVLEYL----KKGYRLP-----  224 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH----hcCCCCC-----
Confidence            222222337889999999988889999999999999999998 7888865331    1222211    1111110     


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                          .......++.+++.+|+..+|++|||+.|+++.|
T Consensus       225 ----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 ----KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                0111334688899999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=303.62  Aligned_cols=251  Identities=24%  Similarity=0.342  Sum_probs=199.4

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.+.||.|+||.||+|... +++.+|+|++..........+..|++++++++||||+++++++..+...++||||++
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD   85 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence            4667788999999999999875 688999999876554445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++...   ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++........ 
T Consensus        86 ~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (280)
T cd06611          86 GGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-  158 (280)
T ss_pred             CCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence            99999988532   34588999999999999999999998   999999999999999999999999999865433221 


Q ss_pred             ceecccccccccCccccc-----cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          568 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      ......|+..|+|||++.     ...++.++|||||||++|||++|+.||......   ..+..     +..+...... 
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~~~~-----~~~~~~~~~~-  229 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RVLLK-----ILKSEPPTLD-  229 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HHHHH-----HhcCCCCCcC-
Confidence            222345899999999975     345678999999999999999999999754311   11111     1111110000 


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                            .+......+.+++..|++.+|.+||++.+|+++
T Consensus       230 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         230 ------QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ------CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                  011122357889999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-34  Score=307.87  Aligned_cols=248  Identities=24%  Similarity=0.370  Sum_probs=199.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.+.+.||.|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++......++|+||+.+
T Consensus        21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  100 (296)
T cd06655          21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG  100 (296)
T ss_pred             EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCC
Confidence            344578999999999999864 6899999998765544556788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      ++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......... 
T Consensus       101 ~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-  171 (296)
T cd06655         101 GSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-  171 (296)
T ss_pred             CcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence            999998842     3578999999999999999999998   9999999999999999999999999998754332221 


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||......   ..+    ......+ ....       .
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~---~~~----~~~~~~~-~~~~-------~  236 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RAL----YLIATNG-TPEL-------Q  236 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhcC-Cccc-------C
Confidence            22345889999999999888999999999999999999999999764411   011    1111111 0000       0


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .+......+.+++.+|+..+|++||++.+|+++
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            011122357789999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-34  Score=305.58  Aligned_cols=261  Identities=23%  Similarity=0.294  Sum_probs=199.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      |.+.+.||+|+||.||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++......++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            345678999999999999875 68999999987553  223457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                       +++|.+++...   ...+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.++|+|||++........
T Consensus        82 -~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          82 -PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             -CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence             99999988543   24588999999999999999999998   999999999999999999999999999886544332


Q ss_pred             cceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC---------C
Q 004689          567 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG---------D  636 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~---------~  636 (736)
                      .......|+..|+|||++.+. .++.++||||+||+++||++|.++|.......    ...+........         .
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE----QLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH----HHHHHHHHcCCCChHHHhhccC
Confidence            222334689999999998754 46899999999999999999988876543211    111111111000         0


Q ss_pred             c---ceeccCccC----CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 I---QGIIDPSLL----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~---~~~~d~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +   ..+..+...    .....+....+.+++.+|++.+|++||++++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0   000000000    00001223678899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=318.42  Aligned_cols=241  Identities=26%  Similarity=0.315  Sum_probs=186.1

Q ss_pred             ccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhc---CCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRI---HHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       416 IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l---~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      ||+|+||+||+|+.. +++.||||++......   ....+..|..++.+.   +||||+++++++......++||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999876 5899999998643221   122344566676665   699999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++.    ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~  152 (330)
T cd05586          81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT  152 (330)
T ss_pred             ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence            99998884    345688899999999999999999998   99999999999999999999999999987532222 22


Q ss_pred             eecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          569 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......    .+.    ..+..+..      .+..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~----~~~----~~i~~~~~------~~~~  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ----QMY----RNIAFGKV------RFPK  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH----HHH----HHHHcCCC------CCCC
Confidence            2345699999999998754 5889999999999999999999999754321    111    11111111      0100


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCC----CHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRP----SISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RP----t~~ev~~~  681 (736)
                      .   .....+.+++.+|++.+|.+||    ++.|++++
T Consensus       219 ~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         219 N---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             c---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            0   1123567899999999999998    56666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7e-35  Score=339.83  Aligned_cols=255  Identities=25%  Similarity=0.341  Sum_probs=196.5

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeee--CCeEEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLV  482 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV  482 (736)
                      ..|.+.+.||+|+||+||+|... ++..||+|++....  ......+..|+.++++++|||||+++++|..  ....++|
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV   92 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL   92 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence            34567789999999999999876 56788999886442  2234568899999999999999999998854  4568999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCC----CceecCCCCCCCEEEcC------------
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV----PAIIHRDLKSSNILLDK------------  546 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~----~~iiHrDikp~NILl~~------------  546 (736)
                      |||+.+|+|.++|.........+++..++.|+.||+.||.|||+.+.    .+|+||||||+||||+.            
T Consensus        93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~  172 (1021)
T PTZ00266         93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA  172 (1021)
T ss_pred             EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence            99999999999997654444578999999999999999999998521    25999999999999964            


Q ss_pred             -----CCcEEEEeecCCccccCCCCcceecccccccccCcccccc--CcCCCcchhHHHHHHHHHHHhCCCcCccccccc
Q 004689          547 -----HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGA  619 (736)
Q Consensus       547 -----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~  619 (736)
                           .+.+||+|||++.......  ......||+.|+|||++.+  ..++.++|||||||+||||++|+.||.....  
T Consensus       173 ~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~--  248 (1021)
T PTZ00266        173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN--  248 (1021)
T ss_pred             cccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc--
Confidence                 2358999999997653322  2234569999999999864  4588999999999999999999999975431  


Q ss_pred             ccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          620 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       620 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          ....... +..+.       .+..   ......+.+++..|++.+|.+||++.|++++
T Consensus       249 ----~~qli~~-lk~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        249 ----FSQLISE-LKRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             ----HHHHHHH-HhcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence                1111111 11111       0000   0112458899999999999999999999854

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=7.8e-35  Score=328.57  Aligned_cols=262  Identities=19%  Similarity=0.266  Sum_probs=188.4

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCC------CceeeEeeeeeeC-CeE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH------RNLVQFLGYCQEE-GRS  479 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H------pnIv~l~~~~~~~-~~~  479 (736)
                      ..|.+.++||+|+||+||+|... .++.||||+++... .....+..|+++++.++|      .+++++++++... .+.
T Consensus       129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~  207 (467)
T PTZ00284        129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM  207 (467)
T ss_pred             CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence            34556789999999999999875 57889999986432 223456678888877755      4588999988754 578


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-----------
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-----------  548 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~-----------  548 (736)
                      ++|||++ +++|.+++..    ...+++..+..++.|++.||.|||++  .+|+||||||+|||++.++           
T Consensus       208 ~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~  280 (467)
T PTZ00284        208 CIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRAL  280 (467)
T ss_pred             EEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccccccc
Confidence            8999987 6788888743    34688999999999999999999973  2899999999999998765           


Q ss_pred             -----cEEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccccccccc
Q 004689          549 -----RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN  623 (736)
Q Consensus       549 -----~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~  623 (736)
                           .+||+|||.+....    .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....
T Consensus       281 ~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        281 PPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             CCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                 49999999875322    222345799999999999999999999999999999999999999976442111111


Q ss_pred             HHH--------HHHH--------hhh-cCCcceeccCccC----C---cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 004689          624 IVQ--------WAKL--------HIE-SGDIQGIIDPSLL----D---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVL  679 (736)
Q Consensus       624 l~~--------~~~~--------~~~-~~~~~~~~d~~l~----~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~  679 (736)
                      +..        |...        ... .+.+....++...    .   .........+.+|+..|++.||++|||++|++
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            110        1000        000 0000000010000    0   00001124577999999999999999999999


Q ss_pred             HH
Q 004689          680 KD  681 (736)
Q Consensus       680 ~~  681 (736)
                      +|
T Consensus       437 ~H  438 (467)
T PTZ00284        437 TH  438 (467)
T ss_pred             cC
Confidence            86

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.2e-34  Score=300.01  Aligned_cols=246  Identities=29%  Similarity=0.481  Sum_probs=195.6

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.+.+.||+|+||.||+|.. +++.||+|+++...  ....+.+|+.++++++||||+++++++... ..++||||+.+
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~   82 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK   82 (254)
T ss_pred             HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence            355678999999999999975 47889999986432  245688999999999999999999998765 46899999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++...  ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......   
T Consensus        83 ~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          83 GNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            9999998643  234578889999999999999999998   99999999999999999999999999987543221   


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                       .....+..|+|||++.+..++.++|||||||++|||++ |+.||......    .+..    ....+...         
T Consensus       155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~~~~----~~~~~~~~---------  216 (254)
T cd05083         155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK----EVKE----CVEKGYRM---------  216 (254)
T ss_pred             -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH----HHHH----HHhCCCCC---------
Confidence             11234678999999988899999999999999999998 99998755421    1111    11111110         


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                      .........+.+++.+|++.+|++||++++|++.|++
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            0111223467899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-34  Score=313.04  Aligned_cols=252  Identities=22%  Similarity=0.257  Sum_probs=191.9

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+.++||+|+||+||+++.+ +++.+|+|++....   ......+.+|+.++..++|+||+++++++.+.+..++||||+
T Consensus         4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~   83 (332)
T cd05623           4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY   83 (332)
T ss_pred             eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence            45688999999999999876 47789999986432   122345788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .+|+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++........
T Consensus        84 ~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          84 VGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            999999999532   34578888899999999999999998   999999999999999999999999999875443333


Q ss_pred             cceecccccccccCccccc-----cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          567 HVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      .......||+.|+|||++.     ...++.++|||||||++|||++|+.||......       ............. .+
T Consensus       158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~~~~-~~  229 (332)
T cd05623         158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKERF-QF  229 (332)
T ss_pred             ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH-------HHHHHHhCCCccc-cC
Confidence            3333456999999999986     346788999999999999999999999755421       1111111111000 00


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLP--HGHMRPSISEVLKD  681 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~--dP~~RPt~~ev~~~  681 (736)
                      . ...    ......+.+++.+|+..  ++..||++.|++++
T Consensus       230 p-~~~----~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         230 P-AQV----TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             C-Ccc----ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0 000    11223466677776644  44457899999888

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.9e-34  Score=298.69  Aligned_cols=249  Identities=22%  Similarity=0.316  Sum_probs=200.6

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.||.|+||.||.++.. +++.+++|.+....  .....++.+|++++++++|+||+++++++.+.+..+++|||++
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (256)
T cd08221           3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN   82 (256)
T ss_pred             eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence            45678999999999999765 58899999876442  3334568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++....  ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........ 
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          83 GGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             CCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            999999986432  34578899999999999999999998   999999999999999999999999999876543332 


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      ......|++.|+|||++.+..++.++||||||+++|||++|..||......       +..... ..+.....       
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~~~~~~-~~~~~~~~-------  221 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-------NLVVKI-VQGNYTPV-------  221 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHH-HcCCCCCC-------
Confidence            223345899999999998888899999999999999999999999754311       111111 11221111       


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                        ......++.+++.+|++.+|.+||+++|+++++
T Consensus       222 --~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         222 --VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             --ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence              112234588899999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4e-35  Score=318.69  Aligned_cols=261  Identities=22%  Similarity=0.258  Sum_probs=201.9

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcC-C-----CceeeEeeeeeeCCeEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-H-----RNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-H-----pnIv~l~~~~~~~~~~~  480 (736)
                      .+|.+.+.||+|.||.|-+|... +++.||||+++... .-.++...|+.+|..++ |     -|+|++++||.-.++.|
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            36667899999999999999755 69999999997543 33566778999999996 4     48999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC--CcEEEEeecCC
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLS  558 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~--~~~kl~DFGla  558 (736)
                      ||+|.+. -+|.++|...  ....++...+..|+.||+.||..||+.   +|||+||||+||||.+-  ..+||+|||.|
T Consensus       265 iVfELL~-~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  265 IVFELLS-TNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeehhhh-hhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccc
Confidence            9999885 5999999754  345688999999999999999999998   99999999999999764  47999999999


Q ss_pred             ccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHH-------HHHh
Q 004689          559 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW-------AKLH  631 (736)
Q Consensus       559 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~-------~~~~  631 (736)
                      ++......    +...+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+....+....|++-       ....
T Consensus       339 c~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  339 CFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             cccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            86543322    344688999999999999999999999999999999999888876532222222211       1100


Q ss_pred             hhcCCcceeccC--------------------------------ccCC--------cCCHHHHHHHHHHHhhccCCCCCC
Q 004689          632 IESGDIQGIIDP--------------------------------SLLD--------EYDIQSMWKIEEKALMCVLPHGHM  671 (736)
Q Consensus       632 ~~~~~~~~~~d~--------------------------------~l~~--------~~~~~~~~~l~~l~~~cl~~dP~~  671 (736)
                      .  .+....++.                                ....        .........+++++.+|+..||.+
T Consensus       415 ~--~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  415 A--KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             c--cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence            0  000111111                                0000        011133467899999999999999


Q ss_pred             CCCHHHHHHH
Q 004689          672 RPSISEVLKD  681 (736)
Q Consensus       672 RPt~~ev~~~  681 (736)
                      |+|..|.++|
T Consensus       493 R~tp~qal~H  502 (586)
T KOG0667|consen  493 RITPAQALNH  502 (586)
T ss_pred             cCCHHHHhcC
Confidence            9999999987

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.7e-35  Score=307.30  Aligned_cols=264  Identities=22%  Similarity=0.323  Sum_probs=197.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      +.+.+.||+|+||.||+|... +++.||+|++......  ....+.+|+++++.++||||+++++++..+...++|+||+
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (286)
T cd07846           3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV   82 (286)
T ss_pred             eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence            345678999999999999886 5899999987654322  2456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .+++|.++...    ...+++..+..++.|+++||+|||+.   +++||||+|+||++++++.++|+|||++....... 
T Consensus        83 ~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-  154 (286)
T cd07846          83 DHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  154 (286)
T ss_pred             CccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence            99998877632    23488999999999999999999998   99999999999999999999999999987653332 


Q ss_pred             cceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh-------hcCCc-
Q 004689          567 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI-------ESGDI-  637 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~-------~~~~~-  637 (736)
                      .......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+..+.....       ....+ 
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence            22223457899999999875 4578899999999999999999999875442111111111111100       00000 


Q ss_pred             ceeccCccCCcC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 QGIIDPSLLDEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~~~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .....+......     .......+.+++.+|++.+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            000000000000     01223568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-34  Score=303.49  Aligned_cols=252  Identities=25%  Similarity=0.376  Sum_probs=197.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +++.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||++
T Consensus         3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (286)
T cd06622           3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD   82 (286)
T ss_pred             hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence            456789999999999999876 78999999886542 2224568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++.... ....+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|||++.......  
T Consensus        83 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--  157 (286)
T cd06622          83 AGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--  157 (286)
T ss_pred             CCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence            999998885431 234688999999999999999999974  289999999999999999999999999987543221  


Q ss_pred             ceecccccccccCccccccC------cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          568 VSSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~------~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                       .....|+..|+|||.+.+.      .++.++|+|||||++|||++|+.||......    ........ ...+..    
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~-~~~~~~----  227 (286)
T cd06622         158 -AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA----NIFAQLSA-IVDGDP----  227 (286)
T ss_pred             -cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh----hHHHHHHH-HhhcCC----
Confidence             2233578899999998654      3578999999999999999999999654311    11111111 111111    


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       +.    .+......+.+++.+|++.+|++||++.+++++
T Consensus       228 -~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         228 -PT----LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -CC----CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence             11    112234457889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-34  Score=298.97  Aligned_cols=252  Identities=23%  Similarity=0.367  Sum_probs=200.8

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.+.+.||+|+||.||+|... +++.+|+|++..........+.+|++++++++||||+++++++......+++|||+.+
T Consensus         5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~   84 (262)
T cd06613           5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG   84 (262)
T ss_pred             eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence            445688999999999999875 5788999998766555567789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      ++|.+++...   ...++...+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++....... ..
T Consensus        85 ~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~  157 (262)
T cd06613          85 GSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-AK  157 (262)
T ss_pred             CcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-hc
Confidence            9999988532   24688889999999999999999998   99999999999999999999999999987543321 12


Q ss_pred             eecccccccccCccccccC---cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          569 SSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~---~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      .....++..|+|||.+.+.   .++.++|||||||++|||++|+.||.......   ....     .....+.   .+.+
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~---~~~~-----~~~~~~~---~~~~  226 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR---ALFL-----ISKSNFP---PPKL  226 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHH-----HHhccCC---Cccc
Confidence            2234588899999999776   88899999999999999999999997543111   1111     0111000   0011


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        .........+.+++.+|+..+|.+||++.+|+.+
T Consensus       227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              1122334568899999999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.9e-34  Score=300.89  Aligned_cols=247  Identities=25%  Similarity=0.391  Sum_probs=189.2

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-----ccchhhhhHHHHHhhcCCCceeeEeeeeee--CCeEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLV  482 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV  482 (736)
                      ...+.||+|+||.||+|... +++.||+|++.....     .....+.+|+.++++++||||+++++++..  ....+++
T Consensus         5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~   84 (266)
T cd06651           5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF   84 (266)
T ss_pred             cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence            34678999999999999875 588999998864321     123457889999999999999999998865  3577899


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      +||+++++|.+++..    ...+++...+.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        85 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          85 MEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            999999999999853    23478888899999999999999998   99999999999999999999999999987543


Q ss_pred             CCC--CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          563 DGA--SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       563 ~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      ...  ........++..|+|||++.+..++.++|||||||++|||++|+.||.....      ... ........     
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~-~~~~~~~~-----  225 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAA-IFKIATQP-----  225 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHH-HHHHhcCC-----
Confidence            211  1111234588999999999988899999999999999999999999975431      111 11111111     


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..+.+    +......+.+++ .|+..+|++||+++||+++
T Consensus       226 ~~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         226 TNPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             CCCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            01111    111122344555 7888999999999999764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-34  Score=311.67  Aligned_cols=258  Identities=24%  Similarity=0.305  Sum_probs=190.7

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeC------CeE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS  479 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~~  479 (736)
                      .|.+.+.||+|+||+||+|... +++.||||++.....  .....+.+|+.++++++||||+++++++...      ...
T Consensus        16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   95 (343)
T cd07878          16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV   95 (343)
T ss_pred             hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence            4556788999999999999865 678999999865321  2234577899999999999999999987543      356


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      +++++++ +++|.+.+.     ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~  166 (343)
T cd07878          96 YLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR  166 (343)
T ss_pred             EEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccce
Confidence            8999987 778888763     24588899999999999999999998   99999999999999999999999999997


Q ss_pred             cccCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHH-------h
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------H  631 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~-------~  631 (736)
                      .....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+......       .
T Consensus       167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (343)
T cd07878         167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK  242 (343)
T ss_pred             ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            54332    223458999999999876 56889999999999999999999999754321111111110000       0


Q ss_pred             hhcCCcceeccCccCCcCCH--------HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDI--------QSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~--------~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +........+ ..+. ..+.        .....+.+++.+|++.||.+|||+.|++++
T Consensus       243 ~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         243 ISSEHARKYI-QSLP-HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             cchhhHHHHh-hccc-cccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000000 0000 0000        011246789999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.5e-34  Score=297.14  Aligned_cols=252  Identities=27%  Similarity=0.376  Sum_probs=195.6

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc----------cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ----------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~----------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  479 (736)
                      ...+.||+|+||.||+|... +++.||+|.++.....          ..+.+.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   83 (272)
T cd06629           4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL   83 (272)
T ss_pred             eecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence            34678999999999999765 6889999987532111          113577899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ++||||+.+|+|.+++...    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||+++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          84 SIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             EEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            9999999999999998543    4678888899999999999999998   99999999999999999999999999987


Q ss_pred             cccCCCCc-ceecccccccccCccccccCc--CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          560 FAVDGASH-VSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       560 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~--~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      ........ ......|+..|+|||++....  ++.++||||||+++||+++|..||.....      ..... .... ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~-~~~~-~~  228 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMF-KLGN-KR  228 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHH-Hhhc-cc
Confidence            54332211 123345889999999987654  88999999999999999999999964331      11111 1111 11


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....++.....    .....+.+++..|+..+|.+||++++|+++
T Consensus       229 ~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 SAPPIPPDVSM----NLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCCcCCccccc----cCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            11111111111    223568889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.1e-34  Score=301.43  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=196.4

Q ss_pred             hhccccccCceEEEEEEEC----CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCC------eE
Q 004689          412 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RS  479 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------~~  479 (736)
                      +.+.||+|+||.||+|.+.    +++.||||++....  .....++.+|++++++++||||+++++++....      ..
T Consensus         3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   82 (273)
T cd05074           3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP   82 (273)
T ss_pred             chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence            4678999999999999764    36889999987542  223456889999999999999999999886432      24


Q ss_pred             EEEEEecCCCCHHHHhhccc--ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecC
Q 004689          480 VLVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL  557 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGl  557 (736)
                      ++++||+.+|+|.+++....  .....+++...+.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence            78899999999998875322  1223578888999999999999999998   999999999999999999999999999


Q ss_pred             CccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcC
Q 004689          558 SKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       558 a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      ++........ ......+++.|++||.+....++.++|||||||++|||++ |+.||.....    ..+..+...   ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~---~~  232 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYNYLIK---GN  232 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHHHHHc---CC
Confidence            8855332211 1122345678999999988889999999999999999999 8888865432    122222111   11


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      .+.          .+......+.+++.+|++.+|.+||++.|+++.|+++
T Consensus       233 ~~~----------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 RLK----------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             cCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            110          0112234689999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.3e-34  Score=306.70  Aligned_cols=244  Identities=25%  Similarity=0.388  Sum_probs=196.1

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCHH
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK  492 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~  492 (736)
                      ..||+|+||.||++... ++..||||.+..........+.+|+.++++++||||+++++.+...+..++||||+++++|.
T Consensus        28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~  107 (292)
T cd06658          28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT  107 (292)
T ss_pred             hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence            56999999999999875 68899999986554444567889999999999999999999999999999999999999999


Q ss_pred             HHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceecc
Q 004689          493 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV  572 (736)
Q Consensus       493 ~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  572 (736)
                      +++..     ..+++.....++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++........ .....
T Consensus       108 ~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~  178 (292)
T cd06658         108 DIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSL  178 (292)
T ss_pred             HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCcee
Confidence            98742     3478889999999999999999998   999999999999999999999999999875433222 12234


Q ss_pred             cccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHH
Q 004689          573 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ  652 (736)
Q Consensus       573 ~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  652 (736)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.||......    .........         +.+.+...  ..
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~~---------~~~~~~~~--~~  243 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----QAMRRIRDN---------LPPRVKDS--HK  243 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhc---------CCCccccc--cc
Confidence            5899999999998888999999999999999999999999754311    111111110         11111111  11


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          653 SMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       653 ~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....+.+++..|+..+|.+|||++|++++
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            22357788999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-34  Score=299.03  Aligned_cols=246  Identities=27%  Similarity=0.405  Sum_probs=196.5

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-----ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      ...+.||+|+||.||+|... +++.|++|.+.....     +..+.+.+|+++++.++|+||+++++++......++++|
T Consensus         3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   82 (258)
T cd06632           3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE   82 (258)
T ss_pred             cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence            34578999999999999876 789999999865431     234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++......
T Consensus        83 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          83 LVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             ecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            9999999999853    23578888999999999999999998   9999999999999999999999999998765332


Q ss_pred             CCcceecccccccccCccccccCc-CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      .  ......|+..|++||.+.... ++.++|+|||||++|+|++|+.||.....   ...+..    ........     
T Consensus       156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~~~----~~~~~~~~-----  221 (258)
T cd06632         156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFK----IGRSKELP-----  221 (258)
T ss_pred             c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHHHH----HHhcccCC-----
Confidence            2  223345889999999997766 89999999999999999999999965431   011111    11101111     


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          ..+......+.+++.+|++.+|.+||++.+++++
T Consensus       222 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         222 ----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             ----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                1111223457889999999999999999999764

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.6e-34  Score=299.23  Aligned_cols=247  Identities=25%  Similarity=0.404  Sum_probs=198.5

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.++++++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4456678999999999999865 678999998764332 23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .+++|.+++..     ..+++.....++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++....... 
T Consensus        85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06641          85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence            99999998842     3578889999999999999999998   99999999999999999999999999987553322 


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      .......|+..|+|||++.+..++.++|+|||||++|||++|..||.....    .....    ....+..     +.+ 
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~----~~~~~~~-----~~~-  221 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MKVLF----LIPKNNP-----PTL-  221 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----HHHHH----HHhcCCC-----CCC-
Confidence            122234588999999999888889999999999999999999999864331    11111    1111111     111 


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                         .......+.+++.+|++.+|.+||++.+++++
T Consensus       222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         222 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ---CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               11223457889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.1e-34  Score=303.35  Aligned_cols=260  Identities=20%  Similarity=0.237  Sum_probs=192.4

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.||+|+||.||+|+.. +|+.||+|+++....  .....+.+|++++++++||||+++++++.+....++|+||+.
T Consensus         3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (284)
T cd07839           3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD   82 (284)
T ss_pred             eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence            45678999999999999876 688999999865422  223567889999999999999999999999999999999997


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                       ++|.+++...   ...+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++....... 
T Consensus        83 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-  154 (284)
T cd07839          83 -QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-  154 (284)
T ss_pred             -CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence             5787776532   34588999999999999999999998   999999999999999999999999999875432221 


Q ss_pred             ceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC------Cccee
Q 004689          568 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG------DIQGI  640 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~------~~~~~  640 (736)
                      ......++..|+|||++.+. .++.++|||||||++|||++|..|+.......   ...+.........      .+...
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH---HHHHHHHHHhCCCChHHhHHhhhc
Confidence            12233578999999998764 47899999999999999999998864322111   0001000000000      00000


Q ss_pred             ccCccCC---------cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          641 IDPSLLD---------EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~---------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .+.....         ........++.+++.+|++.||.+|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            0000000         0011123467899999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.9e-34  Score=304.69  Aligned_cols=244  Identities=23%  Similarity=0.360  Sum_probs=196.2

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCHH
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK  492 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~  492 (736)
                      ..||+|+||.||+|... +++.||+|++..........+.+|+.+++.++||||+++++++..++..++|+||+++++|.
T Consensus        27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~  106 (297)
T cd06659          27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT  106 (297)
T ss_pred             hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence            47999999999999875 68999999986554444567889999999999999999999999999999999999999999


Q ss_pred             HHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceecc
Q 004689          493 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV  572 (736)
Q Consensus       493 ~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  572 (736)
                      +++.     ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........ .....
T Consensus       107 ~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~  177 (297)
T cd06659         107 DIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSL  177 (297)
T ss_pred             HHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccce
Confidence            8773     24578889999999999999999998   999999999999999999999999999875433221 22334


Q ss_pred             cccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHH
Q 004689          573 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ  652 (736)
Q Consensus       573 ~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  652 (736)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.||......    ......    ........     .  ....
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~----~~~~~~~~-----~--~~~~  242 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----QAMKRL----RDSPPPKL-----K--NAHK  242 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH----hccCCCCc-----c--ccCC
Confidence            5899999999999888999999999999999999999999754311    111111    11110000     0  0011


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          653 SMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       653 ~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....+.+++..|++.+|++||++.+++++
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            12357889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3e-34  Score=297.21  Aligned_cols=249  Identities=25%  Similarity=0.379  Sum_probs=199.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      |.+.+.||+|+||.||++... +++.||+|.+....  .....++.+|+.++++++||||+++++++...+..++|+||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            345688999999999999865 68899999986432  223457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .+++|.+++....  ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          82 EGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999999885321  23578888999999999999999998   999999999999999999999999999875433221


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                       ......|++.|+|||++.+..++.++|||||||+++||++|+.||.....       ...+.... .+....       
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~-~~~~~~-------  220 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKII-RGSYPP-------  220 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHh-cCCCCC-------
Confidence             12234588999999999988899999999999999999999999865431       11111111 111110       


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        .+......+.+++.+|++.+|.+||++.+|+++
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence              111223458899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.4e-34  Score=297.96  Aligned_cols=251  Identities=26%  Similarity=0.410  Sum_probs=198.4

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      |.+.+.||+|+||.||+|... +++.||+|+++.....  ....+.+|++++++++|+||+++++++...+..++|+||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            345688999999999999865 6889999998765432  4567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++++|.+++..    ...+++..+..++.|+++||.|||+.   +++|+||+|+||+++.++.+||+|||++........
T Consensus        82 ~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          82 SGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            99999999853    33477888899999999999999998   999999999999999999999999999876544332


Q ss_pred             ccee---cccccccccCccccccCc---CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          567 HVSS---IVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       567 ~~~~---~~~gt~~Y~aPE~~~~~~---~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      ....   ...++..|+|||++.+..   ++.++||||||+++||+++|+.||......   ..+...    ...+.    
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~~~~~~----~~~~~----  223 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---FQIMFH----VGAGH----  223 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---HHHHHH----HhcCC----
Confidence            2211   345789999999998766   889999999999999999999999654211   011111    11111    


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       .+.+...  ......+.+++.+|++.+|.+||++.|++.+
T Consensus       224 -~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         224 -KPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             -CCCCCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             0111111  1123457789999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.8e-34  Score=302.23  Aligned_cols=263  Identities=21%  Similarity=0.253  Sum_probs=196.3

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc-----cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .+.+.||+|+||.||+|... +++.||||.++.....     ....+..|++++++++|+||+++++++.+.+..++|||
T Consensus         3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   82 (298)
T cd07841           3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE   82 (298)
T ss_pred             eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence            34678999999999999875 6899999998755432     23456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+ +|+|.+++....   ..+++..+..++.|+++||.|||+.   +++|+||||+||+++.++.+||+|||+++.....
T Consensus        83 ~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          83 FM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             cc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            99 899999985421   3688999999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh-----cCCcc
Q 004689          565 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE-----SGDIQ  638 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~-----~~~~~  638 (736)
                      ... .....+++.|+|||.+.+ ..++.++|||||||++|||++|..+|......+....+.........     .....
T Consensus       156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            221 122346889999998864 46788999999999999999998877654321111111111000000     00000


Q ss_pred             eeccCccCCcCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          639 GIIDPSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       639 ~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...........+     ......+.+++.+|++.+|++||++.||+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            111100011111     1223568899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.5e-34  Score=301.40  Aligned_cols=252  Identities=27%  Similarity=0.384  Sum_probs=195.6

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeeeC-----CeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-----GRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~-----~~~~lV  482 (736)
                      +.+.+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++++ +|||++++++++...     ...++|
T Consensus        24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv  102 (291)
T cd06639          24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV  102 (291)
T ss_pred             eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence            345678999999999999875 68899999986432 2245677899999999 899999999998653     358999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      |||+++|+|.+++.........+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus       103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~  179 (291)
T cd06639         103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT  179 (291)
T ss_pred             EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence            999999999998865444455688999999999999999999998   99999999999999999999999999987543


Q ss_pred             CCCCcceecccccccccCccccccC-----cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                      .... ......|+..|+|||++...     .++.++|||||||++|||++|+.||......   ..+..+     ..+..
T Consensus       180 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~---~~~~~~-----~~~~~  250 (291)
T cd06639         180 STRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV---KTLFKI-----PRNPP  250 (291)
T ss_pred             cccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH---HHHHHH-----hcCCC
Confidence            3221 12234588999999998643     3678999999999999999999999754311   111111     11111


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..+.+       .......+.+++.+|++.+|++||++.|++++
T Consensus       251 ~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         251 PTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             CCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11111       11223458899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-33  Score=297.29  Aligned_cols=257  Identities=24%  Similarity=0.321  Sum_probs=200.0

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeee--CCeEEEEEEecC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMH  487 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV~e~~~  487 (736)
                      ..+.||.|++|.||+|... +++.+|+|.+..... .....+.+|++++++++||||++++++|..  ....++||||++
T Consensus         5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~   84 (287)
T cd06621           5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE   84 (287)
T ss_pred             EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecC
Confidence            3578999999999999875 578999999875432 335678899999999999999999998864  346899999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++.........++......++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........ 
T Consensus        85 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-  160 (287)
T cd06621          85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA-  160 (287)
T ss_pred             CCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc-
Confidence            9999998765444455688889999999999999999998   999999999999999999999999999875432221 


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccc-cccccHHHHHHHhhhcCCcceeccCccC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG-ANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                        ....++..|+|||.+.+..++.++|||||||++|||++|+.||...... .....+..+....    .... +.....
T Consensus       161 --~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~  233 (287)
T cd06621         161 --GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPE-LKDEPG  233 (287)
T ss_pred             --ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchh-hccCCC
Confidence              2335788999999999889999999999999999999999999765321 1111222332211    1000 110100


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        ........+.+++.+|+..+|.+|||+.||+++
T Consensus       234 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         234 --NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             --CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence              011234568899999999999999999999885

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.1e-34  Score=300.44  Aligned_cols=265  Identities=21%  Similarity=0.225  Sum_probs=196.7

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeC--CeEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVY  483 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV~  483 (736)
                      .+.+.+.||+|+||.||+|... +++.+|+|.++.....  ....+.+|+.++++++||||+++++++...  ...++||
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            3456788999999999999886 5889999998754322  223567899999999999999999999877  8899999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+. ++|.+.+...   ...+++.....++.|++.||+|||+.   +++|+||||+||+++.++.+||+|||++.....
T Consensus        86 e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          86 EYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             hhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            9997 4898887542   23588999999999999999999998   999999999999999999999999999876544


Q ss_pred             CCCcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHH---------H--h
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK---------L--H  631 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~---------~--~  631 (736)
                      ... ......+++.|+|||.+.+. .++.++|+|||||++|||++|..||...........+.....         .  .
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (293)
T cd07843         159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSEL  237 (293)
T ss_pred             Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhcc
Confidence            321 12234578899999998754 468899999999999999999999975542211111111100         0  0


Q ss_pred             --hhcCCcceeccCccCCcCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          632 --IESGDIQGIIDPSLLDEYDIQ-SMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       632 --~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        .............+...+... ....+.+++..|++.+|++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             chhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence              000000011111111111111 24457899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.1e-34  Score=296.38  Aligned_cols=251  Identities=28%  Similarity=0.402  Sum_probs=200.5

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.+.||+|+||.||++... +++.+|+|.+..... ....++.+|++++++++||||+++++++......++++||+.+
T Consensus         4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (265)
T cd06605           4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG   83 (265)
T ss_pred             hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence            35678999999999999886 688999999876532 3456788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      ++|.+++....   ..++......++.|++.||+|||+ .   +++|+||||+||+++.++.++|+|||.+.........
T Consensus        84 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  157 (265)
T cd06605          84 GSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK  157 (265)
T ss_pred             CcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence            99999985432   567888889999999999999999 7   9999999999999999999999999998755322211


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                         ...|+..|+|||++.+..++.++|||||||++|+|++|+.||......  .....+..........      +.+..
T Consensus       158 ---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~------~~~~~  226 (265)
T cd06605         158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEPP------PRLPS  226 (265)
T ss_pred             ---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCCC------CCCCh
Confidence               156889999999999989999999999999999999999999754311  1122222222211111      11111


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .   .....+.+++..|+..+|++||++.|++.+
T Consensus       227 ~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         227 G---KFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             h---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            1   133458899999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-34  Score=301.79  Aligned_cols=261  Identities=21%  Similarity=0.299  Sum_probs=192.8

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.+.+.||+|+||.||+|... +++.||+|.+...... ....+.+|++++++++||||+++++++.+....++||||+.
T Consensus         7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07844           7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD   86 (291)
T ss_pred             eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence            345678999999999999876 6889999998654322 23456789999999999999999999999999999999998


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      + +|.+++...   ...+++.....++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++...... .
T Consensus        87 ~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~  158 (291)
T cd07844          87 T-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-K  158 (291)
T ss_pred             C-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-c
Confidence            5 899888543   23578888999999999999999998   99999999999999999999999999986432211 1


Q ss_pred             ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhc---CCc------
Q 004689          568 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---GDI------  637 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---~~~------  637 (736)
                      ......++..|+|||++.+ ..++.++||||+||++|||++|+.||.......   .........+..   ...      
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE---DQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH---HHHHHHHHhcCCCChhhhhhhhhc
Confidence            1122346889999999875 458899999999999999999999996543110   001100000000   000      


Q ss_pred             ceec--------cCccCCcC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 QGII--------DPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~~~~--------d~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....        ...+.... .......+.+++.+|++.+|++||++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            0000        00000000 01112467899999999999999999998763

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.5e-34  Score=295.30  Aligned_cols=255  Identities=25%  Similarity=0.368  Sum_probs=201.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.+.+.||.|+||+||+|... ++..+|+|++.... ......+.+|+++++.++|+||+++++.+..++..++|+|+++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~   82 (267)
T cd06610           3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS   82 (267)
T ss_pred             ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence            345678999999999999865 67889999986543 2245678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++..... ...+++.....++.|++.||+|||+.   +++||||||+||++++++.++|+|||++.........
T Consensus        83 ~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          83 GGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             CCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            9999999864321 24578889999999999999999998   9999999999999999999999999998765433222


Q ss_pred             ---ceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          568 ---VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       568 ---~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                         ......|+..|+|||++... .++.++|+|||||++|||++|+.||......+   .+.+....    .      .+
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~~----~------~~  225 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VLMLTLQN----D------PP  225 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hHHHHhcC----C------CC
Confidence               22334689999999999876 78899999999999999999999997554211   11111111    0      01


Q ss_pred             ccCCcC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .+.... .......+.+++.+|+..+|++||++.|++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            111110 01223567899999999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.5e-34  Score=297.09  Aligned_cols=247  Identities=24%  Similarity=0.337  Sum_probs=190.1

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-----ccchhhhhHHHHHhhcCCCceeeEeeeeeeC--CeEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV  482 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV  482 (736)
                      .+.+.||+|+||.||+|... ++..||+|.+.....     .....+.+|++++++++||||+++++++.+.  ...+++
T Consensus         5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v   84 (265)
T cd06652           5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF   84 (265)
T ss_pred             eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence            34688999999999999875 588999998753321     1134678899999999999999999988763  467899


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      |||+++++|.+++..    ...+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++...
T Consensus        85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          85 MEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            999999999998853    23467788889999999999999998   99999999999999999999999999987543


Q ss_pred             CCCC--cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          563 DGAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       563 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      ....  .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......      ... .......     
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~-~~~~~~~-----  225 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM------AAI-FKIATQP-----  225 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH------HHH-HHHhcCC-----
Confidence            2111  1122345889999999998888999999999999999999999999754311      111 1111000     


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..    ...+......+.+++.+|+. +|++||+++||+++
T Consensus       226 ~~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         226 TN----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             CC----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            01    11122333457778888884 89999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-34  Score=306.01  Aligned_cols=250  Identities=23%  Similarity=0.282  Sum_probs=196.5

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+.+.||+|+||.||+|... +++.||+|.+......   ..+.+.+|+++++.++||||+++++.+......++||||+
T Consensus         4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   83 (316)
T cd05574           4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC   83 (316)
T ss_pred             EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence            34578999999999999876 4899999998755332   3456888999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .+++|.+++...  ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          84 PGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             CCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            999999988532  235688889999999999999999998   999999999999999999999999999864422111


Q ss_pred             c----------------------------ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccc
Q 004689          567 H----------------------------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG  618 (736)
Q Consensus       567 ~----------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~  618 (736)
                      .                            ......||..|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence            0                            111235889999999999888999999999999999999999999755421


Q ss_pred             cccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCC----HHHHHHH
Q 004689          619 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS----ISEVLKD  681 (736)
Q Consensus       619 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~ev~~~  681 (736)
                      ..   +..    .. ....      ....  .......+.+++.+|++.+|++||+    ++|++++
T Consensus       239 ~~---~~~----~~-~~~~------~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         239 ET---FSN----IL-KKEV------TFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             HH---HHH----Hh-cCCc------cCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            11   100    10 0000      0000  1113456899999999999999999    5555543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-35  Score=308.84  Aligned_cols=240  Identities=27%  Similarity=0.433  Sum_probs=196.1

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.||.|+||.||-|+.. +.+.||||++.-...+   .-.++.+|+.+|++++|||++.+-|||..+...+||||||-| 
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG-  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG-  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc-
Confidence            56999999999999865 6788999998755333   345789999999999999999999999999999999999964 


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +-.|.+.   .....+....+..|+.+.+.||+|||+.   +.||||||+.|||+++.|.|||+|||.|....+     .
T Consensus       111 SAsDlle---VhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----A  179 (948)
T KOG0577|consen  111 SASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----A  179 (948)
T ss_pred             cHHHHHH---HHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-----h
Confidence            6667664   2356688888999999999999999998   999999999999999999999999999875432     3


Q ss_pred             ecccccccccCccccc---cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          570 SIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~---~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      ..++|||.|||||++.   .+.|+-++||||+|++..||.-.++|+..+.-        .-+..++...+-     |-+.
T Consensus       180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--------MSALYHIAQNes-----PtLq  246 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNES-----PTLQ  246 (948)
T ss_pred             hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--------HHHHHHHHhcCC-----CCCC
Confidence            4567999999999996   47899999999999999999999999876551        111122222211     1111


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                         ..+....+..++..|++.-|.+|||..+++++
T Consensus       247 ---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  247 ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             ---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence               23455678999999999999999999988765

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=7.2e-34  Score=294.09  Aligned_cols=248  Identities=27%  Similarity=0.392  Sum_probs=197.6

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      |.+.+.||+|+||.||++... +++.+|+|.+....  ......+.+|++++++++||||+++++.+..++..++||||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            345678999999999999875 68899999986542  223457889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeecCCccccCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~-~~~kl~DFGla~~~~~~~  565 (736)
                      ++++|.+++....  ...+++..+..++.|++.||.|||++   +++|+||||+||+++.+ +.+||+|||++.......
T Consensus        82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          82 PGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999986432  34478889999999999999999998   99999999999999865 468999999997654322


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                        ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......    .......    .+....+     
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~~~----~~~~~~~-----  221 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----ALVLKIM----SGTFAPI-----  221 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH----HHHHHHH----hcCCCCC-----
Confidence              122345889999999999888999999999999999999999999755421    1111111    1111111     


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          .......+.+++..|++.+|.+|||+.|++++
T Consensus       222 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         222 ----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ----CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                11123458899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-34  Score=298.39  Aligned_cols=253  Identities=26%  Similarity=0.399  Sum_probs=197.3

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeeeCC------eEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG------RSV  480 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~------~~~  480 (736)
                      .|.+.+.||+|+||.||+|... +++.+++|++..... ....+.+|+.+++++ .|+||+++++++....      ..+
T Consensus         7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   85 (275)
T cd06608           7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW   85 (275)
T ss_pred             heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence            4556789999999999999885 578899999875443 346789999999999 7999999999997644      489


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+++++|.+++.........+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++..
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            99999999999998865433345788999999999999999999998   999999999999999999999999999875


Q ss_pred             ccCCCCcceecccccccccCcccccc-----CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      ...... ......|+..|+|||++..     ..++.++|||||||++|||++|+.||......   ..+..     +..+
T Consensus       163 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~-----~~~~  233 (275)
T cd06608         163 LDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFK-----IPRN  233 (275)
T ss_pred             cccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHH-----hhcc
Confidence            433222 2233458999999998854     34678899999999999999999999643311   11111     1111


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...     .+.  ........+.+++.+|+..||++|||+.|++++
T Consensus       234 ~~~-----~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         234 PPP-----TLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             CCC-----CCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            111     111  111233468899999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=296.34  Aligned_cols=247  Identities=25%  Similarity=0.390  Sum_probs=196.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcC---CCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      |.+.+.||+|+||.||+|.+. +++.||+|.+.... .....++.+|+.++++++   |||++++++++......++|||
T Consensus         3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e   82 (277)
T cd06917           3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME   82 (277)
T ss_pred             hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence            345678999999999999874 68999999986542 233456888999999996   9999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++++|.+++..     ..+++...+.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          83 YAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             cCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            9999999998743     2588899999999999999999998   9999999999999999999999999998765443


Q ss_pred             CCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          565 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      ... .....|+..|+|||++.+ ..++.++|||||||++|+|++|..||......       .+.. .....     ..+
T Consensus       155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~~~~-~~~~~-----~~~  220 (277)
T cd06917         155 SSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-------RAMM-LIPKS-----KPP  220 (277)
T ss_pred             ccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-------hhhh-ccccC-----CCC
Confidence            322 233458999999999875 45688999999999999999999999754321       1111 11111     111


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .+...   .....+.+++.+|++.+|++||++.|++++
T Consensus       221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            11111   123468899999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7e-34  Score=296.44  Aligned_cols=251  Identities=24%  Similarity=0.399  Sum_probs=197.1

Q ss_pred             HhhccccccCceEEEEEEE-CCCcEEEEEEeccCCcc------cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      ...+.||+|+||.||+|.. .+++.||+|++......      ....+.+|+.++++++|+||+++++++.+.+..++|+
T Consensus         3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~   82 (268)
T cd06630           3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV   82 (268)
T ss_pred             cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence            3457899999999999986 46899999998643211      2356889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeecCCcccc
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAV  562 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~-~~kl~DFGla~~~~  562 (736)
                      ||+.+++|.+++..    ...+++.....++.|++.||.|||+.   +++|+||||+||+++.++ .+||+|||.+....
T Consensus        83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          83 EWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             eccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999999853    34578889999999999999999998   999999999999998775 59999999987654


Q ss_pred             CCCC---cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          563 DGAS---HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       563 ~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ....   .......|+..|+|||++.+..++.++||||+||++++|++|..||......    ..............   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~---  228 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS----NHLALIFKIASATT---  228 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc----chHHHHHHHhccCC---
Confidence            3211   1122345889999999998888999999999999999999999999644321    11111111110000   


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                            ....+......+.+++.+|+..+|.+||++.|++++
T Consensus       229 ------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         229 ------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             ------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence                  111222334568889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.1e-34  Score=302.03  Aligned_cols=262  Identities=21%  Similarity=0.266  Sum_probs=193.7

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      ..+.||+|+||.||+|+.. +++.||||++.....  .....+.+|++++++++||||+++++++.+.+..++||||+. 
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-   82 (284)
T cd07860           4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-   82 (284)
T ss_pred             eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence            4578999999999999875 688999998865432  223568899999999999999999999999999999999996 


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      ++|.+++...  ....+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++........ .
T Consensus        83 ~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~  156 (284)
T cd07860          83 QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-T  156 (284)
T ss_pred             cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-c
Confidence            6888887543  235688999999999999999999998   999999999999999999999999999875433221 1


Q ss_pred             eecccccccccCccccccCc-CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh----------h--cC
Q 004689          569 SSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI----------E--SG  635 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~-~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~----------~--~~  635 (736)
                      .....++..|+|||++.+.. ++.++|||||||++|||++|+.||...........+.++.....          .  ..
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP  236 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence            12234788999999887644 68899999999999999999999975442111111111110000          0  00


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .........+.. ........+.+++.+|++.||.+||+++|++++
T Consensus       237 ~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         237 SFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            000000000000 000112356789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.2e-34  Score=300.75  Aligned_cols=251  Identities=26%  Similarity=0.386  Sum_probs=192.2

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHH-HhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTL-LSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~i-l~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.||+|+||.||+|... +|+.||+|+++.... ....++..|+.+ ++..+||||+++++++..++..+++|||++
T Consensus         4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~   83 (283)
T cd06617           4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD   83 (283)
T ss_pred             eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc
Confidence            35678999999999999876 689999999875432 233455566665 566789999999999999999999999997


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                       |+|.+++.........+++..++.++.|++.||.|||++  .+++||||||+||+++.++.+||+|||++.......  
T Consensus        84 -~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  158 (283)
T cd06617          84 -TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV--  158 (283)
T ss_pred             -ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccccc--
Confidence             688888765444456789999999999999999999985  289999999999999999999999999987653321  


Q ss_pred             ceecccccccccCcccccc----CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          568 VSSIVRGTVGYLDPEYYIS----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~----~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      ......|+..|+|||.+.+    ..++.++|+|||||++|||++|+.||.....  ....+..    ... +..     +
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~----~~~-~~~-----~  226 (283)
T cd06617         159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQ----VVE-EPS-----P  226 (283)
T ss_pred             ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHH----HHh-cCC-----C
Confidence            1222458899999998865    4568899999999999999999999964321  1111111    111 110     1


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .+..   ......+.+++.+|+..+|.+||++.+|+++
T Consensus       227 ~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         227 QLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             CCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1100   1123458899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8e-34  Score=302.45  Aligned_cols=252  Identities=21%  Similarity=0.265  Sum_probs=195.5

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+.+.||+|+||.||++... +++.||+|.+.....   .....+.+|+++++.++||||+++++.+..++..++||||+
T Consensus         4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   83 (305)
T cd05609           4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV   83 (305)
T ss_pred             eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence            34678999999999999876 578999999875432   22346788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC-
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-  565 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~-  565 (736)
                      ++++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++...... 
T Consensus        84 ~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          84 EGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            99999999843    34578888899999999999999998   99999999999999999999999999986321100 


Q ss_pred             -------------CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh
Q 004689          566 -------------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       566 -------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                                   ........|+..|+|||++....++.++|+|||||++|||++|..||.+....    .+..   .. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----~~~~---~~-  228 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----ELFG---QV-  228 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH---HH-
Confidence                         00111235788999999998888999999999999999999999999754311    1111   11 


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                      ..+..   ..+....    .....+.+++.+|++.+|++||++.++.+.|+.
T Consensus       229 ~~~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         229 ISDDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             Hhccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            11111   0011111    123357899999999999999997666665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-34  Score=323.98  Aligned_cols=271  Identities=19%  Similarity=0.260  Sum_probs=187.1

Q ss_pred             HHHHHhhccccccCceEEEEEEECC--CcEEEEEEe--------------cc---CCcccchhhhhHHHHHhhcCCCcee
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLKD--GKEIAVKVL--------------TS---NSYQGKREFTNEVTLLSRIHHRNLV  467 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~~--~~~vAvK~l--------------~~---~~~~~~~~~~~E~~il~~l~HpnIv  467 (736)
                      ...|.+.+.||+|+||+||++..+.  +...+.|.+              .+   ........+.+|+.+|++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            3456778899999999999987542  222222211              00   0111234578999999999999999


Q ss_pred             eEeeeeeeCCeEEEEEEecCCCCHHHHhhccc-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 004689          468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL-THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK  546 (736)
Q Consensus       468 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~  546 (736)
                      ++++++...+..++|+|++. ++|.+++.... .............++.|++.||.|||++   +|+||||||+|||++.
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~  302 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC  302 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence            99999999999999999985 57777764322 1122334556778999999999999998   9999999999999999


Q ss_pred             CCcEEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHH
Q 004689          547 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ  626 (736)
Q Consensus       547 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~  626 (736)
                      ++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|..++...........+..
T Consensus       303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~  382 (501)
T PHA03210        303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK  382 (501)
T ss_pred             CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence            99999999999986654433333446799999999999999999999999999999999998754332221111112211


Q ss_pred             HHHHhh-hcCCc-------ceeccCccC----CcC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          627 WAKLHI-ESGDI-------QGIIDPSLL----DEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       627 ~~~~~~-~~~~~-------~~~~d~~l~----~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...... ....+       ...++....    ...     .......+.+++.+|++.||.+|||+.|++++
T Consensus       383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            111000 00000       000000000    000     00112346778899999999999999999876

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-35  Score=314.52  Aligned_cols=246  Identities=29%  Similarity=0.434  Sum_probs=192.2

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEE---EEecc-CCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCe--EEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAV---KVLTS-NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR--SVLVY  483 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAv---K~l~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~--~~lV~  483 (736)
                      ++..+||+|+|-+||||.+. +|.+||=   |.-.. .+......|..|+.+|+.|+||||++++.++.+...  ..+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            45678999999999999875 5777753   32111 122234678999999999999999999999987655  78999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeecCCcccc
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAV  562 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~-~~~kl~DFGla~~~~  562 (736)
                      |.|..|+|..|+.+    .++.+......++.||++||.|||++ .|+|||||||.+||||+.+ |.|||+|.|+|....
T Consensus       123 EL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  123 ELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            99999999999853    45678888999999999999999996 5799999999999999875 899999999998653


Q ss_pred             CCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      .  ++. ..+.|||.|||||++. ..|.+.+||||||+.|+||+|+..||....      +-.+..+.. ..|.-...+.
T Consensus       198 ~--s~a-ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~------n~AQIYKKV-~SGiKP~sl~  266 (632)
T KOG0584|consen  198 K--SHA-KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT------NPAQIYKKV-TSGIKPAALS  266 (632)
T ss_pred             c--ccc-ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC------CHHHHHHHH-HcCCCHHHhh
Confidence            3  222 2367999999999987 789999999999999999999999998655      222222222 2222111111


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          .--    ..++.+++.+|+.. ..+|||+.|++++
T Consensus       267 ----kV~----dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  267 ----KVK----DPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             ----ccC----CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                011    12478899999999 8899999999865

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=9.8e-34  Score=300.06  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=199.0

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.++++++||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~   99 (293)
T cd06647          20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA   99 (293)
T ss_pred             hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence            4455688999999999999764 678999999865444445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++..     ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++........ 
T Consensus       100 ~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-  170 (293)
T cd06647         100 GGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (293)
T ss_pred             CCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence            9999998853     3467888899999999999999998   999999999999999999999999998875433222 


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      ......|++.|+|||++....++.++|||||||++||+++|+.||...........+       ...+..      ..  
T Consensus       171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~-------~~~~~~------~~--  235 (293)
T cd06647         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------ATNGTP------EL--  235 (293)
T ss_pred             ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh-------hcCCCC------CC--
Confidence            222345889999999998888999999999999999999999999754421110000       000000      00  


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .........+.+++..|+..+|++||++++++.+
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0111223457889999999999999999999877

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-34  Score=299.58  Aligned_cols=262  Identities=23%  Similarity=0.276  Sum_probs=194.3

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.+.||.|++|.||+|... +|+.||+|++.....  .....+.+|++++++++|||++++++++.+.+..+++|||++ 
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-   81 (283)
T cd07835           3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-   81 (283)
T ss_pred             hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence            4578999999999999875 689999999875432  223567889999999999999999999999999999999995 


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      ++|.+++....  ...+++..++.++.|+++||+|||+.   +++||||+|+||+++.++.++|+|||+++........ 
T Consensus        82 ~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-  155 (283)
T cd07835          82 LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-  155 (283)
T ss_pred             cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence            68998885432  23688999999999999999999998   9999999999999999999999999998754322111 


Q ss_pred             eecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC--------C---
Q 004689          569 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG--------D---  636 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~--------~---  636 (736)
                      .....++..|+|||++.+. .++.++|||||||++|||++|+.||...........+.++........        .   
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            1223468899999988764 578899999999999999999999975442111111111100000000        0   


Q ss_pred             -cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 -IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 -~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       ......+.. ..........+.+++.+|++.+|++||+++|++++
T Consensus       236 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         236 TFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             000000000 00011122467899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-34  Score=303.61  Aligned_cols=267  Identities=21%  Similarity=0.263  Sum_probs=195.2

Q ss_pred             HhhccccccCceEEEEEEECC---CcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeC--CeEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV  482 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~---~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV  482 (736)
                      .+.+.||+|+||.||+|....   ++.||+|.+....   ......+.+|++++++++||||+++++++...  ...++|
T Consensus         3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   82 (316)
T cd07842           3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL   82 (316)
T ss_pred             eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence            456789999999999998753   7899999987643   22345677899999999999999999999888  789999


Q ss_pred             EEecCCCCHHHHhhcccccc-cccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC----CCcEEEEeecC
Q 004689          483 YEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK----HMRAKVSDFGL  557 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~----~~~~kl~DFGl  557 (736)
                      |||+++ +|.+.+....... ..++...+..++.|++.||.|||+.   +|+||||||+||+++.    ++.+||+|||+
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            999975 6766664332222 3688889999999999999999998   9999999999999999    89999999999


Q ss_pred             CccccCCCC--cceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccc------cccHHHHH
Q 004689          558 SKFAVDGAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGAN------CRNIVQWA  628 (736)
Q Consensus       558 a~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~------~~~l~~~~  628 (736)
                      ++.......  .......++..|+|||++.+ ..++.++|||||||+++||++|+.||........      ...+...+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            986543322  12233467899999998876 4578999999999999999999999976543210      00111111


Q ss_pred             HHhh-----------hcCCcceeccCccCCcCC---------H--HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          629 KLHI-----------ESGDIQGIIDPSLLDEYD---------I--QSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       629 ~~~~-----------~~~~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...-           .........+......++         .  ....++.+++.+|++.||++|||+.|++++
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0000           000000000000000111         0  223468899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.2e-33  Score=297.41  Aligned_cols=250  Identities=25%  Similarity=0.388  Sum_probs=192.3

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeee------CCeEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE------EGRSV  480 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~------~~~~~  480 (736)
                      .+.+.+.||+|+||.||+|... +++.+|+|++.... .....+..|+.+++++ +||||+++++++..      ....+
T Consensus        17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~   95 (282)
T cd06636          17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW   95 (282)
T ss_pred             hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence            4456689999999999999875 57899999986543 2345678899999998 79999999999853      45789


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      ++|||+.+|+|.+++....  ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||++..
T Consensus        96 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          96 LVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            9999999999999885432  23477888889999999999999998   999999999999999999999999999875


Q ss_pred             ccCCCCcceecccccccccCccccc-----cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      ...... ......|+..|+|||.+.     ...++.++|||||||++|||++|..||........   +..     ....
T Consensus       171 ~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~---~~~-----~~~~  241 (282)
T cd06636         171 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA---LFL-----IPRN  241 (282)
T ss_pred             hhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh---hhh-----HhhC
Confidence            432211 123345899999999986     34578899999999999999999999965431110   100     0000


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .     .+...   .......+.+++.+|++.||.+||++.|++++
T Consensus       242 ~-----~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         242 P-----PPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             C-----CCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            0     00110   01123468899999999999999999999763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=7.3e-34  Score=300.46  Aligned_cols=243  Identities=26%  Similarity=0.362  Sum_probs=196.9

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||.||++... +++.||+|++.....   .....+.+|++++++++||||+++++++......++||||
T Consensus         3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (290)
T cd05580           3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY   82 (290)
T ss_pred             eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence            345688999999999999876 589999999865321   2245688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++++|.+++..    ...++...+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||+++..... 
T Consensus        83 ~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          83 VPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            999999999853    35688889999999999999999998   9999999999999999999999999998765433 


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                         .....|++.|+|||.+.+...+.++||||||+++|||++|+.||......    ....    ....+..      .+
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~----~~~~~~~------~~  217 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI----QIYE----KILEGKV------RF  217 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----HHHH----HHhcCCc------cC
Confidence               22345899999999998888899999999999999999999999754411    1111    1111111      11


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                      ...    ....+.+++.+|+..+|.+||     +++|++++
T Consensus       218 ~~~----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         218 PSF----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             Ccc----CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            111    134578899999999999999     77777655

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.8e-33  Score=292.42  Aligned_cols=249  Identities=29%  Similarity=0.408  Sum_probs=202.7

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.+.||+|++|.||+|+.. +++.||+|++..... .....+.+|+..+++++|+||+++++++......++||||+++
T Consensus         4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (264)
T cd06623           4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG   83 (264)
T ss_pred             eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence            45688999999999999887 589999999876543 3456789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      ++|.+++...    ..++....+.++.|+++||+|||+ .   +++||||+|+||+++.++.++|+|||.+.........
T Consensus        84 ~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          84 GSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999998532    568889999999999999999999 8   9999999999999999999999999998765433322


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                       .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... .....+..+..    ....     +.   
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~----~~~~-----~~---  222 (264)
T cd06623         157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAIC----DGPP-----PS---  222 (264)
T ss_pred             -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHHHHh----cCCC-----CC---
Confidence             2234588999999999988899999999999999999999999976542 11112222221    1111     01   


Q ss_pred             cCCHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          648 EYDIQ-SMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       648 ~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       .+.. ....+.+++..|+..+|++||++.|++++
T Consensus       223 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 -LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             1111 33568899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2e-33  Score=296.44  Aligned_cols=245  Identities=25%  Similarity=0.356  Sum_probs=196.9

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      .+.||+|++|.||+|... +++.+|+|++..........+.+|+.+++.++||||+++++++...+..++++||+.+++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L  103 (285)
T cd06648          24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL  103 (285)
T ss_pred             ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence            368999999999999864 6889999988654444455688999999999999999999999999999999999999999


Q ss_pred             HHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceec
Q 004689          492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI  571 (736)
Q Consensus       492 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  571 (736)
                      .+++..     ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++........ ....
T Consensus       104 ~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~  174 (285)
T cd06648         104 TDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS  174 (285)
T ss_pred             HHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence            998853     3578888999999999999999998   999999999999999999999999998875433221 2223


Q ss_pred             ccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCH
Q 004689          572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI  651 (736)
Q Consensus       572 ~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  651 (736)
                      ..|+..|+|||.+.+..++.++|||||||++|||++|+.||.....       ....... ..+..     +....  ..
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~~-~~~~~-----~~~~~--~~  239 (285)
T cd06648         175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRI-RDNLP-----PKLKN--LH  239 (285)
T ss_pred             ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHH-HhcCC-----CCCcc--cc
Confidence            4589999999999888899999999999999999999999865431       1111111 11110     01100  11


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          652 QSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       652 ~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .....+.+++.+|++.+|++||++.+++++
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            123468999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2e-33  Score=299.60  Aligned_cols=246  Identities=26%  Similarity=0.380  Sum_probs=193.7

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .+.+.+.||+|+||+||+|... +++.||+|++.....   .....+.+|+++++.++||||++++++|......++|+|
T Consensus        16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e   95 (307)
T cd06607          16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME   95 (307)
T ss_pred             hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence            3556788999999999999875 688999998864332   223468899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+. |++.+.+...   ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++......
T Consensus        96 ~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          96 YCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             hhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            997 5776666422   24588999999999999999999998   9999999999999999999999999998754322


Q ss_pred             CCcceecccccccccCccccc---cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          565 ASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                           ....|+..|+|||++.   ...++.++||||||+++|||++|+.||.......       .... ......    
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~~-~~~~~~----  231 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYH-IAQNDS----  231 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHHH-HhcCCC----
Confidence                 2245788999999884   3568889999999999999999999987543111       0111 111110    


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                       +.+   ........+.+++.+|++.+|++||++.+|+.+.
T Consensus       232 -~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         232 -PTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             -CCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence             000   0112344688999999999999999999998863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.4e-34  Score=308.20  Aligned_cols=246  Identities=25%  Similarity=0.423  Sum_probs=204.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      |.+...||+|.|++|..|++. ++.+||||++.+....  ....+.+|+++|+.++|||||+++.+......+|+||||+
T Consensus        58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya  137 (596)
T KOG0586|consen   58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA  137 (596)
T ss_pred             eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence            445789999999999999876 7999999999766433  2345889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .+|.+++++..    ..++....+..++.|+.+|++|||++   .|+|||||++||||+.+.++||+|||++.++.  ..
T Consensus       138 ~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~  208 (596)
T KOG0586|consen  138 SGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--YG  208 (596)
T ss_pred             cCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--cc
Confidence            99999999953    34455578888999999999999999   99999999999999999999999999998765  34


Q ss_pred             cceecccccccccCccccccCcCC-CcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      ....+.+|++.|.|||++.+..|. +++|+||+|+++|-|+.|..||++....+...                    +.+
T Consensus       209 ~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~--------------------rvl  268 (596)
T KOG0586|consen  209 LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP--------------------RVL  268 (596)
T ss_pred             ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc--------------------hhe
Confidence            455677899999999999987764 78999999999999999999999776433221                    112


Q ss_pred             CCcCCH--HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          646 LDEYDI--QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       646 ~~~~~~--~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                      .+.+..  -...++.+++.+++-.+|.+|+++++|.++-..
T Consensus       269 ~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~  309 (596)
T KOG0586|consen  269 RGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR  309 (596)
T ss_pred             eeeecccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence            222111  111246788999999999999999999887543

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=297.70  Aligned_cols=263  Identities=22%  Similarity=0.295  Sum_probs=196.5

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeC--CeEEEEEEec
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFM  486 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV~e~~  486 (736)
                      +.+.||+|+||.||+|... +++.+|+|++....  ......+.+|++++++++|||++++++++...  +..++|+||+
T Consensus         3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   82 (287)
T cd07840           3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM   82 (287)
T ss_pred             eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence            4578999999999999876 47899999997653  22345688899999999999999999999888  8899999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++ +|.+++...   ...+++..++.++.|++.||+|||+.   +++|+||||+||++++++.+||+|||++........
T Consensus        83 ~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          83 DH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            75 888887532   24688999999999999999999998   999999999999999999999999999986544332


Q ss_pred             cceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC--Ccce----
Q 004689          567 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG--DIQG----  639 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~--~~~~----  639 (736)
                      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+...........  ....    
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence            22333457889999998765 4678999999999999999999999976542211111111100000000  0000    


Q ss_pred             -------eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 -------IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 -------~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                             .....+...+.......+.+++.+|++.+|.+||++++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                   000000000111124568999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-33  Score=296.67  Aligned_cols=265  Identities=21%  Similarity=0.292  Sum_probs=196.4

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.+.||+|++|.||+|+.. +++.||||+++..... ....+.+|++++++++||||+++++++...+..++||||+++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   82 (284)
T cd07836           3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK   82 (284)
T ss_pred             eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence            34678999999999999986 6889999998755332 345677899999999999999999999999999999999985


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                       +|.+++.... ....+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|+|||++........ .
T Consensus        83 -~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  156 (284)
T cd07836          83 -DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T  156 (284)
T ss_pred             -cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence             8888875432 234589999999999999999999998   999999999999999999999999999875433211 1


Q ss_pred             eecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHh-------hh-cCCcce
Q 004689          569 SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------IE-SGDIQG  639 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~~-~~~~~~  639 (736)
                      .....++..|++||++.+ ..++.++|||||||++|||++|+.||......+....+.+.....       +. ...+..
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP  236 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence            223347889999999865 457889999999999999999999997654322211221111000       00 000000


Q ss_pred             eccCcc---CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 IIDPSL---LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 ~~d~~l---~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .+....   ...........+.+++.+|++.+|.+||++.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            000000   000011123457899999999999999999999763

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.4e-33  Score=294.54  Aligned_cols=261  Identities=21%  Similarity=0.294  Sum_probs=191.7

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.+++.++|+||+++++++..+...++|+||+.
T Consensus         7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~   86 (291)
T cd07870           7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH   86 (291)
T ss_pred             eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence            345678999999999999865 6889999998654322 23457789999999999999999999999999999999996


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                       ++|.+++...   ...+.+..+..++.|++.||.|||+.   +|+|+||||+||+++.++++||+|||+++....... 
T Consensus        87 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  158 (291)
T cd07870          87 -TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-  158 (291)
T ss_pred             -CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence             6777766432   23467778888999999999999998   999999999999999999999999999875432211 


Q ss_pred             ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh-------------
Q 004689          568 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE-------------  633 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~-------------  633 (736)
                      ......+++.|+|||++.+ ..++.++|||||||++|||++|..||......  ...+.+ ....+.             
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV--FEQLEK-IWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH--HHHHHH-HHHHcCCCChhhhhhhhhc
Confidence            1223347899999999875 45788999999999999999999999754321  111111 000000             


Q ss_pred             cCCcceeccCccCCcC-----CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          634 SGDIQGIIDPSLLDEY-----DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       634 ~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .....+..........     .......+.+++.+|+..||++|||+.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            0000000000000000     00113467889999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.1e-33  Score=288.91  Aligned_cols=247  Identities=30%  Similarity=0.470  Sum_probs=200.8

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      +.+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+||+++++++......++++||+.+++
T Consensus         4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~   83 (253)
T cd05122           4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGS   83 (253)
T ss_pred             eeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCc
Confidence            4578999999999999886 688999999876554456788999999999999999999999999999999999999999


Q ss_pred             HHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCccee
Q 004689          491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS  570 (736)
Q Consensus       491 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  570 (736)
                      |.+++...   ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||.+........  ..
T Consensus        84 L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~  155 (253)
T cd05122          84 LKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN  155 (253)
T ss_pred             HHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence            99988543   14689999999999999999999997   999999999999999999999999999876544332  23


Q ss_pred             cccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCC
Q 004689          571 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD  650 (736)
Q Consensus       571 ~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  650 (736)
                      ...|+..|+|||++.+..++.++||||||+++++|++|+.||......       ....... ........+       .
T Consensus       156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~-~~~~~~~~~-------~  220 (253)
T cd05122         156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-------KALFKIA-TNGPPGLRN-------P  220 (253)
T ss_pred             ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-------HHHHHHH-hcCCCCcCc-------c
Confidence            456889999999999888999999999999999999999999754311       1111110 011111111       1


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          651 IQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       651 ~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ......+.+++.+|++.+|++|||+.|++++
T Consensus       221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1113468899999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.9e-33  Score=298.90  Aligned_cols=247  Identities=26%  Similarity=0.380  Sum_probs=193.9

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .+...+.||+|+||.||+|+.. ++..||+|++......   ....+.+|++++++++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3455678999999999999865 6889999998644222   23468889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+. |+|.+.+...   ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++......
T Consensus       106 ~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         106 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            997 4777776422   34588999999999999999999998   9999999999999999999999999998654321


Q ss_pred             CCcceecccccccccCccccc---cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          565 ASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                           ....|+..|+|||++.   .+.++.++|||||||++|||++|+.||.......   .+..+    ...+..    
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~~~----~~~~~~----  242 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHI----AQNESP----  242 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH---HHHHH----HhccCC----
Confidence                 2335889999999974   4568899999999999999999999986543110   11111    111110    


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                           ..........+.+++.+|++.+|.+||++.+|++++.
T Consensus       243 -----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         243 -----TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             -----CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence                 0001122345889999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.9e-33  Score=295.17  Aligned_cols=244  Identities=27%  Similarity=0.366  Sum_probs=190.8

Q ss_pred             ccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       416 IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      ||+|+||+||++... +|+.||+|++.....   .....+..|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999765 688999999865422   2244567899999999999999999999999999999999999999


Q ss_pred             HHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceec
Q 004689          492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI  571 (736)
Q Consensus       492 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  571 (736)
                      .+++....  ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||++.......  ....
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~  153 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG  153 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence            99986432  24688999999999999999999998   99999999999999999999999999987553321  1223


Q ss_pred             ccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCH
Q 004689          572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI  651 (736)
Q Consensus       572 ~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  651 (736)
                      ..++..|+|||++.+..++.++|||||||++++|++|+.||...........+..    ....      ...    ..+.
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~------~~~----~~~~  219 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR----RTLE------MAV----EYPD  219 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh----cccc------ccc----cCCc
Confidence            4578899999999888899999999999999999999999975442111111111    0000      000    1111


Q ss_pred             HHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 004689          652 QSMWKIEEKALMCVLPHGHMRP-----SISEVLK  680 (736)
Q Consensus       652 ~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~  680 (736)
                      .....+.+++.+|++.+|.+||     ++.++++
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            1234578999999999999999     5555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.5e-33  Score=295.56  Aligned_cols=249  Identities=27%  Similarity=0.404  Sum_probs=199.6

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.+.+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+++++.++|+||+++++++......++|+||+++
T Consensus        21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   99 (286)
T cd06614          21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG   99 (286)
T ss_pred             chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCC
Confidence            334578999999999999887 688999999875543 456788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      ++|.+++....   ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++........ .
T Consensus       100 ~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~  172 (286)
T cd06614         100 GSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K  172 (286)
T ss_pred             CcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence            99999986431   3689999999999999999999998   999999999999999999999999999865433221 2


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....++..|++||++.+..++.++|||||||++|||++|+.||......   ......     .........+      
T Consensus       173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~~~-----~~~~~~~~~~------  238 (286)
T cd06614         173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALFLI-----TTKGIPPLKN------  238 (286)
T ss_pred             hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH-----HhcCCCCCcc------
Confidence            22334788999999998888999999999999999999999998754311   011111     1111111100      


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       .......+.+++.+|++.+|.+||++.+|+++
T Consensus       239 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         239 -PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             11123468899999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.2e-33  Score=296.26  Aligned_cols=253  Identities=26%  Similarity=0.349  Sum_probs=192.7

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      ..+.||+|+||.||++... +++.||+|.+..... .....+.+|+.++.++. ||||+++++++..+...+++|||+..
T Consensus         8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~   87 (288)
T cd06616           8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI   87 (288)
T ss_pred             HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence            4568999999999999876 589999999875432 33456889999999996 99999999999999999999999864


Q ss_pred             CCHHHHhhcc-cccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          489 GTLKEHLYGT-LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       489 gsL~~~l~~~-~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                       ++.++.... ......+++.....++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||+++....... 
T Consensus        88 -~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  163 (288)
T cd06616          88 -SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA-  163 (288)
T ss_pred             -CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc-
Confidence             555433211 11235688999999999999999999974  2899999999999999999999999999875433221 


Q ss_pred             ceecccccccccCccccccC---cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          568 VSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~---~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                       .....|+..|+|||++.+.   .++.++|||||||++|||++|+.||....      ........... +.     .+.
T Consensus       164 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~-~~-----~~~  230 (288)
T cd06616         164 -KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVK-GD-----PPI  230 (288)
T ss_pred             -cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcC-CC-----CCc
Confidence             1223588999999999765   68899999999999999999999996543      11111111111 11     111


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +...........+.+++.+|++.+|++||++++|+++
T Consensus       231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111112234568899999999999999999999876

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.3e-33  Score=307.38  Aligned_cols=261  Identities=22%  Similarity=0.298  Sum_probs=193.6

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccC--CcccchhhhhHHHHHhhcCCCceeeEeeeeeeC------CeE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS  479 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~~  479 (736)
                      .|...+.||+|+||.||+|... +++.||+|++...  .......+.+|+.++++++||||+++++++...      ...
T Consensus        17 ~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   96 (353)
T cd07850          17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV   96 (353)
T ss_pred             ceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence            4455688999999999999875 6899999998643  222334677899999999999999999988643      357


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ++||||+. ++|.+.+..      .++...+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        97 ~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          97 YLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             EEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            99999996 488877732      277888889999999999999998   99999999999999999999999999997


Q ss_pred             cccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHH-------------
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ-------------  626 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~-------------  626 (736)
                      .......  .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+..             
T Consensus       167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (353)
T cd07850         167 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL  244 (353)
T ss_pred             eCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            6533221  2234578999999999999999999999999999999999999975432111111100             


Q ss_pred             --HHHHhhhcC------CcceeccCcc----CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          627 --WAKLHIESG------DIQGIIDPSL----LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       627 --~~~~~~~~~------~~~~~~d~~l----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        .........      .+.+.+...+    ...........+.+++.+|++.||++||++.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              000000000      0001111111    011111234567899999999999999999999876

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.8e-33  Score=295.39  Aligned_cols=265  Identities=21%  Similarity=0.217  Sum_probs=192.6

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcC-CCceeeEeeeeeeCCe-----EEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR-----SVL  481 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~-----~~l  481 (736)
                      .+.+.||+|+||.||+|... +++.||+|+++.....  ....+.+|+.++++++ ||||+++++++...+.     .++
T Consensus         4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l   83 (295)
T cd07837           4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL   83 (295)
T ss_pred             eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence            45678999999999999876 6899999987654322  2356788999999995 6999999999987665     899


Q ss_pred             EEEecCCCCHHHHhhccccc-ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeecCCc
Q 004689          482 VYEFMHNGTLKEHLYGTLTH-EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSK  559 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~-~~~~kl~DFGla~  559 (736)
                      ||||+++ +|.+++...... ...+++..++.++.|++.||.|||+.   +|+||||||+||+++. ++.+||+|||+++
T Consensus        84 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          84 VFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccce
Confidence            9999985 788887643322 34689999999999999999999998   9999999999999998 8999999999987


Q ss_pred             cccCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      ....... ......+++.|+|||++.+ ..++.++|||||||++|||++|..||...........+....... ......
T Consensus       160 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  237 (295)
T cd07837         160 AFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP-TEQVWP  237 (295)
T ss_pred             ecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC-ChhhCc
Confidence            5432211 1122346889999998865 457899999999999999999999997654221111111110000 000000


Q ss_pred             ee---cc----CccCC----cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          639 GI---ID----PSLLD----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       639 ~~---~d----~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..   .+    +....    ........++.+++.+|+..+|.+||++.|++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00   00    00000    0001123468899999999999999999999764

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1e-33  Score=292.78  Aligned_cols=248  Identities=23%  Similarity=0.364  Sum_probs=201.5

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.++||+|+||.||++... +++.+|+|.+....  ......+.+|++++++++|+||+++++++......++|+||++
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd08530           3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP   82 (256)
T ss_pred             eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence            35678999999999999765 67899999987543  2234567789999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++.........+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||+++.....   
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---  156 (256)
T cd08530          83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN---  156 (256)
T ss_pred             CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence            9999999865443446688999999999999999999998   9999999999999999999999999999765443   


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      ......|+..|++||.+.+..++.++|+||||+++|||++|+.||......    .+..    ....+...         
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~~~~----~~~~~~~~---------  219 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----DLRY----KVQRGKYP---------  219 (256)
T ss_pred             CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH----HHhcCCCC---------
Confidence            122245789999999999988999999999999999999999999755421    1111    11111111         


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .........+.+++.+|++.+|++||++.|++++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            1112334568999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.6e-33  Score=301.78  Aligned_cols=261  Identities=21%  Similarity=0.278  Sum_probs=192.7

Q ss_pred             cccccc--CceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G--~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      ..||+|  +||+||+|.+. +++.||+|++.....  ...+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  99999999875 789999999865432  2235688899999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc-
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-  567 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-  567 (736)
                      |+|.+++....  ...+++..+..++.|++.||+|||+.   +++||||||+|||++.++.++++||+.+......... 
T Consensus        84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            99999886542  23578888899999999999999998   9999999999999999999999999865322111110 


Q ss_pred             -----ceecccccccccCccccccC--cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHh---------
Q 004689          568 -----VSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH---------  631 (736)
Q Consensus       568 -----~~~~~~gt~~Y~aPE~~~~~--~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~---------  631 (736)
                           ......++..|+|||++.+.  .++.++|||||||++|||++|+.||........   +.......         
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM---LLQKLKGPPYSPLDITT  235 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH---HHHHhcCCCCCCccccc
Confidence                 01112356779999999763  578999999999999999999999975432111   11100000         


Q ss_pred             -----------------------hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          632 -----------------------IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       632 -----------------------~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                                             ...+......+..+...........+.+++.+|++.||++|||++|++++-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence                                   000000011111111112233456789999999999999999999998774

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-35  Score=287.04  Aligned_cols=245  Identities=21%  Similarity=0.350  Sum_probs=203.8

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      .+..+||+|+||.||+|.++ .|+.+|||.+....  +..++.+|+.||+++..|++|+++|.+.....+++|||||..|
T Consensus        36 Di~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG  113 (502)
T KOG0574|consen   36 DIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG  113 (502)
T ss_pred             HHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence            45678999999999999876 68999999876443  3567889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +..+.++.+   ...+.+..+..++...++||+|||..   .-||||||+.|||++.+|.+||+|||.|-.+.+.. ...
T Consensus       114 SiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AKR  186 (502)
T KOG0574|consen  114 SISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AKR  186 (502)
T ss_pred             cHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-Hhh
Confidence            999998643   56788999999999999999999997   78999999999999999999999999987554432 234


Q ss_pred             ecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcC
Q 004689          570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY  649 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  649 (736)
                      .++.||+.|||||++..-.|..++||||+|+...||..|++||.+-..-...        ..+....         .+.+
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------FMIPT~P---------PPTF  249 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------FMIPTKP---------PPTF  249 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--------EeccCCC---------CCCC
Confidence            5677999999999999999999999999999999999999999765421110        0111111         1122


Q ss_pred             --CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          650 --DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       650 --~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        +.+...++-+++..|+-..|++|-|+.+++++
T Consensus       250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence              23445578999999999999999999999876

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.1e-33  Score=290.26  Aligned_cols=250  Identities=27%  Similarity=0.438  Sum_probs=203.5

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.||+|+||.||++... +++.+|+|++.....  .....+.+|+++++.++|||++++++.+......++|+||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~   82 (258)
T cd08215           3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD   82 (258)
T ss_pred             eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence            34578999999999999876 688999999875533  345678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++.........+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~  158 (258)
T cd08215          83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-D  158 (258)
T ss_pred             CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-c
Confidence            9999999976543456789999999999999999999998   99999999999999999999999999987654432 2


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      ......|++.|+|||...+..++.++||||+|+++++|++|+.||......       +...... .....     .+  
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~~~~~~~-~~~~~-----~~--  223 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL-------ELALKIL-KGQYP-----PI--  223 (258)
T ss_pred             eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH-------HHHHHHh-cCCCC-----CC--
Confidence            233346899999999998888999999999999999999999999654311       1111111 11111     11  


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        +......+.+++.+|+..+|++||++.|++++
T Consensus       224 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         224 --PSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             --CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              11223458899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.9e-33  Score=293.30  Aligned_cols=242  Identities=25%  Similarity=0.318  Sum_probs=186.0

Q ss_pred             cccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhh---cCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          415 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSR---IHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       415 ~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~---l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .||+|+||.||++... +++.+|+|.+......   ....+.+|..+++.   .+||||+.+++++...+..++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 5889999988654321   12234455544443   379999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++........ 
T Consensus        81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-  152 (279)
T cd05633          81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-  152 (279)
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence            9999988853    34589999999999999999999998   999999999999999999999999999875433221 


Q ss_pred             ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          568 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                        ....|+..|+|||.+.+ ..++.++|||||||++|||++|..||....... ...+..   ....       ....+ 
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~---~~~~-------~~~~~-  218 (279)
T cd05633         153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDR---MTLT-------VNVEL-  218 (279)
T ss_pred             --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-HHHHHH---Hhhc-------CCcCC-
Confidence              22458999999999864 568899999999999999999999997543211 111111   0000       11111 


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                         +.....++.+++.+|+..||++||     +++|++++
T Consensus       219 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         219 ---PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ---ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence               112234678899999999999999     59988876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.6e-33  Score=288.83  Aligned_cols=242  Identities=23%  Similarity=0.309  Sum_probs=194.1

Q ss_pred             ccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       416 IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      ||.|+||.||+|+.. +++.+|+|++.....   .....+.+|+++++.++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999876 488999999875432   2345688999999999999999999999999999999999999999


Q ss_pred             HHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceec
Q 004689          492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI  571 (736)
Q Consensus       492 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  571 (736)
                      .+++..    ...++...+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++......  ....
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            999854    23478888999999999999999998   99999999999999999999999999998654432  2223


Q ss_pred             ccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCH
Q 004689          572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI  651 (736)
Q Consensus       572 ~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  651 (736)
                      ..|+..|++||.+....++.++|+||||+++|||++|..||.....     +.......... +        .....++.
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~-~--------~~~~~~~~  217 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-----DPMEIYNDILK-G--------NGKLEFPN  217 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-----CHHHHHHHHhc-c--------CCCCCCCc
Confidence            4688999999999888899999999999999999999999975541     11111111111 0        00111122


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 004689          652 QSMWKIEEKALMCVLPHGHMRPS-----ISEVLK  680 (736)
Q Consensus       652 ~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~  680 (736)
                      .....+.+++.+|++.+|++||+     ++|+++
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            22456899999999999999999     566554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.4e-33  Score=294.62  Aligned_cols=257  Identities=20%  Similarity=0.227  Sum_probs=191.7

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcC-CCceeeEeeeeeeC--CeEEEEEEe
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEE--GRSVLVYEF  485 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~--~~~~lV~e~  485 (736)
                      .+.+.||+|+||.||+|... +++.||+|+++.... .......+|+.+++++. |+||+++++++.+.  +..++||||
T Consensus         2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~   81 (282)
T cd07831           2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL   81 (282)
T ss_pred             ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence            34578999999999999865 688999999875422 22234457888999885 99999999999887  889999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +. |+|.+.+...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++. +.+||+|||+++......
T Consensus        82 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          82 MD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             CC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            97 5888777532   24689999999999999999999998   9999999999999999 999999999997654332


Q ss_pred             CcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh-----------
Q 004689          566 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE-----------  633 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~-----------  633 (736)
                      ..  ....++..|+|||++.. ..++.++|||||||++|||++|..||......+    .+.+......           
T Consensus       154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD----QIAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH----HHHHHHHHcCCCCHHHHHhhc
Confidence            21  22357899999997754 557889999999999999999999997654221    1122111110           


Q ss_pred             cCCcceeccCccCCc----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          634 SGDIQGIIDPSLLDE----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       634 ~~~~~~~~d~~l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .........+...+.    ........+.+++.+|++.+|++||++++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            000000000000000    011234678999999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=297.51  Aligned_cols=243  Identities=26%  Similarity=0.342  Sum_probs=197.4

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      -++||+||||.||-++.+ +|+-+|.|.+.+..   ...+....+|-.+|.+++.+.||.+--.|+..+.++||+..|.|
T Consensus       190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG  269 (591)
T KOG0986|consen  190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG  269 (591)
T ss_pred             eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence            478999999999999876 68999999886543   33455678899999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.-+|+..-  ...+++..+.-++.+|+.||++||+.   +||+||+||+|||+|+.|+++|+|.|+|..+..+....
T Consensus       270 GDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~  344 (591)
T KOG0986|consen  270 GDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR  344 (591)
T ss_pred             CceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence            99999997653  36799999999999999999999998   99999999999999999999999999998776655443


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                        ..+||.+|||||++....|+...|.||+||++|||+.|+.||...........+-+.+...              ...
T Consensus       345 --~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~--------------~~e  408 (591)
T KOG0986|consen  345 --GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLED--------------PEE  408 (591)
T ss_pred             --cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcc--------------hhh
Confidence              3479999999999999999999999999999999999999997655221111121111110              112


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSIS  676 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~  676 (736)
                      |+.....+...+....++.||.+|..-+
T Consensus       409 y~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  409 YSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             cccccCHHHHHHHHHHHccCHHHhccCC
Confidence            3333334466777778889999887533

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.7e-33  Score=291.42  Aligned_cols=248  Identities=28%  Similarity=0.418  Sum_probs=197.7

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.||+|+||.||+|... +|..+|+|.+....  ......+.+|++++++++|+||+++++++......++|+||+.
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (257)
T cd08225           3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD   82 (257)
T ss_pred             eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence            34678999999999999876 57899999986542  2234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeecCCccccCCCC
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~-~~kl~DFGla~~~~~~~~  566 (736)
                      +++|.+++...  ....+++..+..++.|+++||.|||+.   +++|+||||+||++++++ .+||+|||.+........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          83 GGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999998643  223578999999999999999999998   999999999999999885 469999999876543222


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                       ......|++.|+|||++.+..++.++|||||||++|||++|..||....       ..++..... .+....     . 
T Consensus       158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~-~~~~~~-----~-  222 (257)
T cd08225         158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVLKIC-QGYFAP-----I-  222 (257)
T ss_pred             -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHh-cccCCC-----C-
Confidence             2233458999999999988889999999999999999999999986443       112222211 111111     0 


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                         .......+.+++.+|+..+|++||++.||+++
T Consensus       223 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         223 ---SPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ---CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence               11122458899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-34  Score=300.50  Aligned_cols=253  Identities=27%  Similarity=0.340  Sum_probs=199.8

Q ss_pred             HHHHHHhhccccccCceEEEEEEECCCcEEEEEEeccC--CcccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEE
Q 004689          406 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       406 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      ....|.+.++||+||.+.||++...+.+-+|+|++.-.  +.+....|.+|+..|.++ .|.+||+|++|-..++.+|||
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            34556677899999999999999888888999876432  334456799999999999 599999999999999999999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      |||- ..+|...|....   ..++-..+..+..|++.|+.++|.+   ||||.||||.|+|+-. |.+||+|||+|.-+.
T Consensus       439 mE~G-d~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ  510 (677)
T ss_pred             eecc-cccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence            9965 459999986432   2223226677899999999999999   9999999999999864 689999999998765


Q ss_pred             CCCC-cceecccccccccCccccccCc-----------CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHH
Q 004689          563 DGAS-HVSSIVRGTVGYLDPEYYISQQ-----------LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL  630 (736)
Q Consensus       563 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~-----------~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~  630 (736)
                      .+.+ -.....+||+.||+||.+....           .+.++||||+||+||+|+.|+.||....      +  .|.+ 
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------n--~~aK-  581 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------N--QIAK-  581 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------H--HHHH-
Confidence            4443 3445678999999999985432           4578999999999999999999996432      1  2222 


Q ss_pred             hhhcCCcceeccCccCCcCC-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          631 HIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       631 ~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                            +..+.||.-.-+|+ ....+++.+++..|++.||.+||+..|++++
T Consensus       582 ------l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  582 ------LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ------HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                  34455664433332 2334459999999999999999999999987

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-34  Score=304.38  Aligned_cols=250  Identities=23%  Similarity=0.351  Sum_probs=200.4

Q ss_pred             HHhhccccccCceEEEEEEECCCc-EEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~-~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.+...||-|+||.||+|..++.. -.|.|++...+.+...+|.-|++||..+.||+||+|++.|.-++.++++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            445567899999999999877433 3466888777777778899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |-++..+..   -+..+...++.-++.|++.||.|||++   .|||||||+.|||++-+|.++|+|||.+-.... ....
T Consensus       114 GAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qk  186 (1187)
T KOG0579|consen  114 GAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQK  186 (1187)
T ss_pred             chHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhh
Confidence            999887743   356788899999999999999999998   999999999999999999999999999743211 1223


Q ss_pred             eecccccccccCccccc-----cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          569 SSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~-----~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      ...+.|||+|||||+..     ..+|+.++||||||+.|.||..+.+|-....       . ..+...+.......++.|
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-------p-MRVllKiaKSePPTLlqP  258 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-------P-MRVLLKIAKSEPPTLLQP  258 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------h-HHHHHHHhhcCCCcccCc
Confidence            34567999999999985     3689999999999999999999998875433       1 112222222222223222


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                             ......+.+++.+|+..+|..||++.++++|
T Consensus       259 -------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  259 -------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             -------chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                   2334568899999999999999999999865

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.3e-33  Score=292.97  Aligned_cols=245  Identities=24%  Similarity=0.310  Sum_probs=198.0

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+.+.||.|+||.||+|... +++.||+|++.....   ...+.+.+|++++++++||||+++++++..+...++|+||+
T Consensus         3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   82 (258)
T cd05578           3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL   82 (258)
T ss_pred             eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence            45688999999999999876 589999999875432   23467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .+++|.+++...    ..++......++.|+++||.|||+.   +++|+||+|+||++++++.++|+|||++....... 
T Consensus        83 ~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          83 LGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            999999998532    4678889999999999999999998   99999999999999999999999999987554332 


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                       ......|+..|+|||++.+..++.++|+||||+++|+|++|..||......     ...+........          .
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~----------~  218 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQETA----------D  218 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhccc----------c
Confidence             223345889999999999888999999999999999999999999865421     111111111110          0


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSI--SEVL  679 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~--~ev~  679 (736)
                      ...+......+.+++.+|++.+|.+||+.  +|++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            11122223568899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.4e-33  Score=301.68  Aligned_cols=264  Identities=20%  Similarity=0.208  Sum_probs=194.1

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCccc--------------chhhhhHHHHHhhcCCCceeeEeeee
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG--------------KREFTNEVTLLSRIHHRNLVQFLGYC  473 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~--------------~~~~~~E~~il~~l~HpnIv~l~~~~  473 (736)
                      +..+.+.||+|+||+||+|... +++.||||+++......              ...+.+|++++++++||||+++++++
T Consensus        10 y~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   89 (335)
T PTZ00024         10 YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVY   89 (335)
T ss_pred             hhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEE
Confidence            3345678999999999999865 68999999986542221              12467899999999999999999999


Q ss_pred             eeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE
Q 004689          474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS  553 (736)
Q Consensus       474 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~  553 (736)
                      ...+..++||||+. |+|.+++..    ...++......++.|++.||.|||+.   +++||||||+||+++.++.+||+
T Consensus        90 ~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         90 VEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             ecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence            99999999999997 688888742    34588889999999999999999998   99999999999999999999999


Q ss_pred             eecCCccccCCC-------------CcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCccccccc
Q 004689          554 DFGLSKFAVDGA-------------SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGA  619 (736)
Q Consensus       554 DFGla~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~  619 (736)
                      |||+++......             ........++..|+|||++.+. .++.++|||||||++|||++|+.||......+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999987543110             1111223468899999998764 47889999999999999999999997654221


Q ss_pred             ccccHHHHHHHhhhcCCccee--------ccCccCC---cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          620 NCRNIVQWAKLHIESGDIQGI--------IDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       620 ~~~~l~~~~~~~~~~~~~~~~--------~d~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....+......... ......        .......   .........+.+++..|++.+|++||+++|++.+
T Consensus       242 ~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        242 QLGRIFELLGTPNE-DNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHHHHHHhCCCch-hhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            11111111110000 000000        0000000   0001123457899999999999999999999864

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.8e-33  Score=292.20  Aligned_cols=245  Identities=26%  Similarity=0.360  Sum_probs=195.0

Q ss_pred             ccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       416 IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      ||+|+||.||++... +++.+|+|++.....   .....+.+|++++++++||||+++++.+......++++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999987 489999999875533   2345688899999999999999999999999999999999999999


Q ss_pred             HHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC-----
Q 004689          492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-----  566 (736)
Q Consensus       492 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~-----  566 (736)
                      .+++...    ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++........     
T Consensus        81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            9998532    3688999999999999999999998   999999999999999999999999999875432211     


Q ss_pred             --cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          567 --HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       567 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                        .......++..|+|||......++.++||||||+++|||++|..||......    .+..   .. ..+....     
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~---~~-~~~~~~~-----  220 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE----EIFQ---NI-LNGKIEW-----  220 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHH---HH-hcCCcCC-----
Confidence              1223345788999999998888999999999999999999999999754411    1111   11 1111100     


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                       ..  .......+.+++.+|++.+|.+|||+.+|.+.|+
T Consensus       221 -~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         221 -PE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -Cc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence             00  0001356889999999999999999966666554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7.3e-33  Score=295.57  Aligned_cols=264  Identities=22%  Similarity=0.248  Sum_probs=193.1

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeC--CeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV~e  484 (736)
                      +.+.+.||+|+||.||+|... +|+.||+|+++.....  ....+.+|+.++++++|+||+++++++...  +..++|||
T Consensus         9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   88 (309)
T cd07845           9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME   88 (309)
T ss_pred             eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence            445678999999999999875 5899999998654322  123466899999999999999999998754  56899999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+.+ +|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        89 ~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          89 YCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             cCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9974 788887532   24588999999999999999999998   9999999999999999999999999999765432


Q ss_pred             CCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHh-------hhcCC
Q 004689          565 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------IESGD  636 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~~~~~  636 (736)
                      .. ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+..+....       .....
T Consensus       162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence            21 1222346788999999875 557899999999999999999999997654222211121111000       00000


Q ss_pred             cceec--cCccCCcC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 IQGII--DPSLLDEY---DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~~~~~--d~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....+  ........   .......+.+++.+|++.||++|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00000  00000000   00123457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.8e-33  Score=295.41  Aligned_cols=265  Identities=22%  Similarity=0.254  Sum_probs=191.7

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      +.+.+.||+|++|+||+|... +++.||+|++.....  .....+.+|++++++++||||+++++++......++||||+
T Consensus         4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (294)
T PLN00009          4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL   83 (294)
T ss_pred             eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence            345678999999999999876 688999998864422  22356788999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeecCCccccCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~-~~~~kl~DFGla~~~~~~~  565 (736)
                      . ++|.+++....  ...+++.....++.|++.||+|||+.   +++||||||+||+++. ++.+||+|||++.......
T Consensus        84 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         84 D-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             c-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            6 57877774321  23357778888999999999999998   9999999999999985 5679999999997543321


Q ss_pred             CcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC-----Ccce
Q 004689          566 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG-----DIQG  639 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~-----~~~~  639 (736)
                      . ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+..+........     .+..
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            1 1123357899999999876 4578999999999999999999999976542211111111100000000     0000


Q ss_pred             ec--cCccCC----cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 II--DPSLLD----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 ~~--d~~l~~----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..  -+....    ........++.+++.+|++.+|++||++.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00  000000    0011123457889999999999999999999875

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.4e-33  Score=294.90  Aligned_cols=244  Identities=25%  Similarity=0.364  Sum_probs=195.3

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCHH
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK  492 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~  492 (736)
                      .+||+|+||.||+|... +++.||||++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            57999999999999875 68899999986544444567889999999999999999999999999999999999999999


Q ss_pred             HHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceecc
Q 004689          493 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV  572 (736)
Q Consensus       493 ~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~  572 (736)
                      +++..     ..+++.....++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++....... ......
T Consensus       106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~  176 (292)
T cd06657         106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL  176 (292)
T ss_pred             HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence            87742     3478888999999999999999998   99999999999999999999999999986543322 122334


Q ss_pred             cccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHH
Q 004689          573 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ  652 (736)
Q Consensus       573 ~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  652 (736)
                      .|+..|+|||++.+..++.++|+||+||++|||++|..||......    ..........         .+.+...  ..
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~----~~~~~~~~~~---------~~~~~~~--~~  241 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIRDNL---------PPKLKNL--HK  241 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhhC---------CcccCCc--cc
Confidence            5889999999998888899999999999999999999998754311    1111111110         0111000  11


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          653 SMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       653 ~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....+.+++.+|++.+|.+||++.+++++
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            22347789999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-33  Score=306.14  Aligned_cols=269  Identities=23%  Similarity=0.367  Sum_probs=201.2

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCC------eEEEEEE
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSVLVYE  484 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------~~~lV~e  484 (736)
                      .+.||+|+||.||+|+.+ +|+.||||.++..... ......+|+++|++++|||||+++++-++..      ..++|||
T Consensus        18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE   97 (732)
T KOG4250|consen   18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME   97 (732)
T ss_pred             hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence            467999999999999965 7999999999865433 2445678999999999999999999876544      5689999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC--CC--cEEEEeecCCcc
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HM--RAKVSDFGLSKF  560 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~--~~--~~kl~DFGla~~  560 (736)
                      ||.+|||...|.+. .....++....+.++.+++.||.|||++   +|+||||||.||++-.  +|  .-||+|||.|+.
T Consensus        98 yC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   98 YCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             ecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            99999999999654 3456799999999999999999999998   9999999999999843  23  479999999998


Q ss_pred             ccCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ..+..  .....+||..|++||++.. ..|+..+|.|||||++||+.||..||.....+.... -+.|....-+.....-
T Consensus       174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~-~~~~~~~tkkp~~v~i  250 (732)
T KOG4250|consen  174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK-EIMWHIITKKPSGVAI  250 (732)
T ss_pred             CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc-hhhhhhhccCCCceeE
Confidence            76654  4566789999999999984 889999999999999999999999997654332111 1222221111111111


Q ss_pred             eccCccCC------------cCCHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHHHHHH
Q 004689          640 IIDPSLLD------------EYDIQSMWKIEEKALMCVLPHGHMRP--SISEVLKDIQDAIVI  688 (736)
Q Consensus       640 ~~d~~l~~------------~~~~~~~~~l~~l~~~cl~~dP~~RP--t~~ev~~~L~~~~~~  688 (736)
                      ..++...+            .........+-.....++..+|++|.  ...+....+..++..
T Consensus       251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence            12222211            11123334455666677778888888  666666666666543

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.7e-33  Score=286.38  Aligned_cols=248  Identities=25%  Similarity=0.383  Sum_probs=200.5

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeC--CeEEEEEEec
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEFM  486 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV~e~~  486 (736)
                      ..+.||+|++|.||+|... +++.|++|++.....  .....+.+|++++++++||||+++++++...  ...++++||+
T Consensus         4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~   83 (260)
T cd06606           4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV   83 (260)
T ss_pred             eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence            4578999999999999887 689999999875542  3356788999999999999999999999988  8899999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .+++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+........
T Consensus        84 ~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          84 SGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            999999998532    3789999999999999999999998   999999999999999999999999999876544332


Q ss_pred             c-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          567 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       567 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      . ......++..|+|||.+.+...+.++||||||+++++|++|..||....      ..............         
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~---------  221 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG------NPMAALYKIGSSGE---------  221 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHhccccCC---------
Confidence            1 1233458899999999988889999999999999999999999997554      11111111110011         


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....+......+.+++.+|++.+|.+||++.|++++
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            111122224568899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.7e-33  Score=293.52  Aligned_cols=250  Identities=24%  Similarity=0.331  Sum_probs=194.1

Q ss_pred             HhhccccccCceEEEEEEE----CCCcEEEEEEeccCCc----ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~----~~~~~vAvK~l~~~~~----~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l  481 (736)
                      .+.+.||+|+||.||++..    .+|+.||+|+++....    ...+.+.+|+++++++ +|+||+++++++..+...++
T Consensus         3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (290)
T cd05613           3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL   82 (290)
T ss_pred             eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence            3567899999999999976    3688999999875422    2235678899999999 59999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+++++|.+++..    ...+++.....++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++...
T Consensus        83 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          83 ILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            9999999999999853    34577888888999999999999998   9999999999999999999999999999765


Q ss_pred             cCCCCcceecccccccccCccccccC--cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ............|+..|+|||++.+.  .++.++||||||+++|+|++|..||......   ..............    
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~~~~~----  228 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK---NSQAEISRRILKSE----  228 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc---ccHHHHHHHhhccC----
Confidence            43322223345589999999998753  4678999999999999999999999643211   11222222221111    


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                         +    .++......+.+++.+|++.+|++||     +.++++.+
T Consensus       229 ---~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         229 ---P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             ---C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence               0    01112234578999999999999997     67777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-33  Score=288.48  Aligned_cols=244  Identities=23%  Similarity=0.275  Sum_probs=187.4

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHH-hhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLL-SRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il-~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||.||+|... +++.||+|+++.....   ....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999875 5889999998654321   122344555444 445899999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      ++|.+++..    ...++...+..++.|++.||.|||+.   +++||||+|+||+++.++.+||+|||+++....     
T Consensus        82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            999998843    24578888999999999999999998   999999999999999999999999999875432     


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....|+..|+|||.+.+..++.++||||||+++|||++|..||......    .+..   . ...+...  ......  
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~---~-~~~~~~~--~~~~~~--  217 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD----AVFD---N-ILSRRIN--WPEEVK--  217 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHH---H-HHhcccC--CCCccc--
Confidence            22335889999999998888999999999999999999999999754321    1111   1 1111110  000111  


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                        ......+.+++.+|++.+|++||++.++.+.|.
T Consensus       218 --~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         218 --EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             --ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence              112345889999999999999998766655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.2e-33  Score=293.86  Aligned_cols=265  Identities=23%  Similarity=0.282  Sum_probs=194.6

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCC-------
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-------  477 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-------  477 (736)
                      ..+.+.+.||+|+||.||+|... +++.||+|+++....  .....+.+|++++++++||||+++++++.+..       
T Consensus         7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            44556789999999999999986 588999999875432  22346778999999999999999999987654       


Q ss_pred             ---eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 004689          478 ---RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD  554 (736)
Q Consensus       478 ---~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~D  554 (736)
                         ..++|+||+++ ++.+.+...   ...+++..+..++.|++.||.|||+.   +|+||||||+||++++++.+||+|
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCc
Confidence               78999999986 676666432   34688999999999999999999998   999999999999999999999999


Q ss_pred             ecCCccccCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh
Q 004689          555 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE  633 (736)
Q Consensus       555 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~  633 (736)
                      ||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+.........
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  239 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP  239 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            99997654333222223346788999998865 45788999999999999999999999754321111111111100000


Q ss_pred             cCCccee--------ccC------ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          634 SGDIQGI--------IDP------SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       634 ~~~~~~~--------~d~------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       .....+        .++      ....... .....+.+++..|++.+|.+||++++|+++
T Consensus       240 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         240 -AVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             -hhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             000000        000      0000000 123568899999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.3e-33  Score=293.45  Aligned_cols=253  Identities=22%  Similarity=0.285  Sum_probs=196.4

Q ss_pred             HhhccccccCceEEEEEEEC----CCcEEEEEEeccCC----cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l  481 (736)
                      .+.+.||+|+||.||+++..    +++.||||+++...    ......+.+|++++.++ +||||+++++.+..+...++
T Consensus         3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l   82 (288)
T cd05583           3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL   82 (288)
T ss_pred             eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence            34678999999999999753    57889999986432    12235678899999999 59999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+.+|+|.+++..    ...+++.....++.|+++||.|||+.   +++||||||+||+++.++.++|+|||+++..
T Consensus        83 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          83 ILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            9999999999998853    34578888899999999999999998   9999999999999999999999999998765


Q ss_pred             cCCCCcceecccccccccCccccccCc--CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ............|+..|+|||.+.+..  .+.++||||||+++|||++|..||.......   ............     
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~-----  227 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRRILKS-----  227 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc---hHHHHHHHHHcc-----
Confidence            443322233345899999999987654  7889999999999999999999996432111   111111111111     


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                        .+.....    ....+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       228 --~~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 --KPPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             --CCCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence              0111111    22357889999999999999999888777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.5e-33  Score=293.91  Aligned_cols=258  Identities=19%  Similarity=0.214  Sum_probs=181.7

Q ss_pred             HHHHHHHhhccccccCceEEEEEEECC----CcEEEEEEeccCCcccc-----------hhhhhHHHHHhhcCCCceeeE
Q 004689          405 IEDATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSYQGK-----------REFTNEVTLLSRIHHRNLVQF  469 (736)
Q Consensus       405 i~~~~~~~~~~IG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~~~~-----------~~~~~E~~il~~l~HpnIv~l  469 (736)
                      +....|.+.++||+|+||+||+|...+    +..+|+|+.........           .....+...+..+.|+|++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            334456778899999999999998764    34566665432211100           011223344556689999999


Q ss_pred             eeeeeeCC----eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc
Q 004689          470 LGYCQEEG----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD  545 (736)
Q Consensus       470 ~~~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~  545 (736)
                      ++++....    ..++++|++.. ++.+.+..    ....++..+..++.|++.||+|||+.   +|+||||||+|||++
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~  160 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD  160 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence            99776543    34677776643 55555532    22346777889999999999999998   999999999999999


Q ss_pred             CCCcEEEEeecCCccccCCCC------cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccccc
Q 004689          546 KHMRAKVSDFGLSKFAVDGAS------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA  619 (736)
Q Consensus       546 ~~~~~kl~DFGla~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~  619 (736)
                      .++.++|+|||+|+.......      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            999999999999976532211      11123469999999999999999999999999999999999999998663221


Q ss_pred             ccccH--HHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          620 NCRNI--VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       620 ~~~~l--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      .....  .++. ..+..+++.           .......+.+++..|+..+|++||++.++.+.|
T Consensus       241 ~~~~~~~~~~~-~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        241 NLIHAAKCDFI-KRLHEGKIK-----------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHhHHHHH-HHhhhhhhc-----------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            11111  1111 111222110           011235688999999999999999999999876

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-33  Score=304.33  Aligned_cols=259  Identities=23%  Similarity=0.316  Sum_probs=191.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeC-----CeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~lV  482 (736)
                      |.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++...     ...++|
T Consensus         7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv   86 (336)
T cd07849           7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV   86 (336)
T ss_pred             eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence            456789999999999999865 68999999986432 22345577899999999999999999987644     357999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      +||+.+ +|.+.+.     ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        87 ~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          87 QELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             ehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            999974 7777763     24588889999999999999999998   99999999999999999999999999987543


Q ss_pred             CCCCc--ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC---C
Q 004689          563 DGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG---D  636 (736)
Q Consensus       563 ~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~---~  636 (736)
                      .....  ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||.+....    .............   .
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~----~~~~~~~~~~~~~~~~~  233 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL----HQLNLILGVLGTPSQED  233 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHcCCCCHHH
Confidence            32211  1123468999999998764 56889999999999999999999999754321    1111111111100   0


Q ss_pred             cceeccCcc---------CCcCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 IQGIIDPSL---------LDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~~~~~d~~l---------~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +..+.+...         ....+     .....++.+++.+|++.+|++||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000         00000     1123458899999999999999999999887

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.5e-32  Score=296.97  Aligned_cols=265  Identities=24%  Similarity=0.338  Sum_probs=193.5

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccC--CcccchhhhhHHHHHhhc-CCCceeeEeeeeeeC--CeEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE--GRSVL  481 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~~l  481 (736)
                      ..+.+.+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.+++++ +||||+++++++...  ...++
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            34566789999999999999876 5889999988543  122334577899999999 999999999998643  46899


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+. ++|.+++..     ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus        87 v~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~  157 (337)
T cd07852          87 VFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL  157 (337)
T ss_pred             Eecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence            999997 589888743     2578888889999999999999998   9999999999999999999999999999755


Q ss_pred             cCCCC----cceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHH------
Q 004689          562 VDGAS----HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL------  630 (736)
Q Consensus       562 ~~~~~----~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~------  630 (736)
                      .....    .......|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+......      
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07852         158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI  237 (337)
T ss_pred             ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            33221    12223458999999998865 56788999999999999999999999754321111111111000      


Q ss_pred             -hhhcCCcceeccC----ccC--CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          631 -HIESGDIQGIIDP----SLL--DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       631 -~~~~~~~~~~~d~----~l~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       .+.......+++.    ...  ..........+.+++.+|++.+|++||++.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence             0000000000100    000  00001123468899999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-33  Score=276.70  Aligned_cols=258  Identities=25%  Similarity=0.383  Sum_probs=200.0

Q ss_pred             HHHHHhhccccccCceEEEEEE-ECCCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~-~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      +.+..-.+.||+|+|+.|--+. ..+|.++|||++.+..........+|++++.++ .|+||++|+++|+++...|||||
T Consensus        77 d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE  156 (463)
T KOG0607|consen   77 DMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE  156 (463)
T ss_pred             HHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe
Confidence            3333346889999999998885 558999999999888777778889999999998 59999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC---CcEEEEeecCCccc
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFA  561 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~---~~~kl~DFGla~~~  561 (736)
                      -|.||+|..+|.    +..-+++..+.++..+|+.||.+||.+   ||.|||+||+|||-.+.   .-+|||||.+..-.
T Consensus       157 Km~GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~  229 (463)
T KOG0607|consen  157 KMRGGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGI  229 (463)
T ss_pred             cccCchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccccccc
Confidence            999999999995    445688999999999999999999998   99999999999999754   35899999887432


Q ss_pred             c--CC----CCcceecccccccccCccccc-----cCcCCCcchhHHHHHHHHHHHhCCCcCccccc-------cccccc
Q 004689          562 V--DG----ASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKF-------GANCRN  623 (736)
Q Consensus       562 ~--~~----~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~-------~~~~~~  623 (736)
                      .  ..    .+....+.+|+..|||||+..     ...|+.+.|.||+|||||-|++|.+||.+.-.       ++.++.
T Consensus       230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~  309 (463)
T KOG0607|consen  230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV  309 (463)
T ss_pred             ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH
Confidence            1  11    112223467999999999873     34688999999999999999999999986432       222221


Q ss_pred             HHHHHHHhhhcCCcceeccCccCCcCCHH----HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          624 IVQWAKLHIESGDIQGIIDPSLLDEYDIQ----SMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       624 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~----~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      =.+-.-..+++|+.          +++.+    ...+..+++...+..++..|.++.+++.+
T Consensus       310 CQ~~LFesIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  310 CQNKLFESIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             HHHHHHHHHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            11222223444432          12222    12345677777788999999999998874

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-33  Score=285.17  Aligned_cols=245  Identities=25%  Similarity=0.415  Sum_probs=198.6

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.||+|++|.||+|... +++.||+|.+.....  .....+.+|++++++++|||++++++++...+..+++|||++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (254)
T cd06627           3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE   82 (254)
T ss_pred             eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence            45678999999999999876 578999999876543  334578899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          83 NGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             CCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            9999998853    25688999999999999999999998   9999999999999999999999999999865443322


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                       .....|+..|+|||...+..++.++||||+|+++|+|++|+.||.....     ....|...   ....     +.   
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~~~~---~~~~-----~~---  218 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALFRIV---QDDH-----PP---  218 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHh---ccCC-----CC---
Confidence             2334589999999999888889999999999999999999999875431     01111111   1111     11   


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK  680 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~  680 (736)
                       .+......+.+++.+|+..+|++||++.|++.
T Consensus       219 -~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         219 -LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             11122346789999999999999999999875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-32  Score=287.44  Aligned_cols=248  Identities=23%  Similarity=0.324  Sum_probs=192.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-----cccchhhhhHHHHHhhcCCCceeeEeeeeeeC--CeEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVL  481 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~l  481 (736)
                      +.+.+.||+|+||.||+|... +++.||+|++....     ......+.+|++++++++|+||+++++++.+.  ...++
T Consensus         4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (264)
T cd06653           4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI   83 (264)
T ss_pred             eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence            345789999999999999865 58999999875321     12234688899999999999999999998654  46789


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ++||+++++|.+++..    ...+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||+++..
T Consensus        84 v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          84 FVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            9999999999998853    23477888899999999999999998   9999999999999999999999999999754


Q ss_pred             cCCC--CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          562 VDGA--SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       562 ~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ....  ........|+..|+|||++.+..++.++|+|||||++|||++|+.||......   ..+.    .....+.   
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~~~~~~~---  226 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AAIF----KIATQPT---  226 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HHHH----HHHcCCC---
Confidence            3211  11112345899999999999888999999999999999999999999754311   1111    1111110   


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                            ....+......+.+++.+|+. +|..||+..+++.+
T Consensus       227 ------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         227 ------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             ------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence                  011122233458889999999 47999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=9.1e-33  Score=294.40  Aligned_cols=264  Identities=19%  Similarity=0.248  Sum_probs=190.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeCC--------e
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--------R  478 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--------~  478 (736)
                      |.+.+.||+|+||.||+|... +++.||||.+......  ....+.+|++++++++||||+++++++....        .
T Consensus        14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   93 (310)
T cd07865          14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS   93 (310)
T ss_pred             eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence            456788999999999999876 6889999988644222  2334568999999999999999999987654        4


Q ss_pred             EEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCC
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS  558 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla  558 (736)
                      .++||||+.+ +|.+.+...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++
T Consensus        94 ~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          94 FYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             EEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCc
Confidence            5999999975 787777432   23588999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCCc---ceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhc
Q 004689          559 KFAVDGASH---VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES  634 (736)
Q Consensus       559 ~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~  634 (736)
                      .........   ......++..|+|||++.+. .++.++||||||+++|||++|+.||......... ............
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~-~~~~~~~~~~~~  245 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL-TLISQLCGSITP  245 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCh
Confidence            755332211   12234578899999988764 4788999999999999999999998754421111 111111100000


Q ss_pred             CCcc-----eeccC-ccCCcC---------CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          635 GDIQ-----GIIDP-SLLDEY---------DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       635 ~~~~-----~~~d~-~l~~~~---------~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....     +..+. ......         .......+.+++.+|+..||++|||++|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            0000     00000 000000         00012346789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-33  Score=320.69  Aligned_cols=264  Identities=27%  Similarity=0.428  Sum_probs=210.3

Q ss_pred             HHHHHHHhhccccccCceEEEEEEEC----C----CcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeee
Q 004689          405 IEDATKMLEKKIGSGGFGVVYYGKLK----D----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQ  474 (736)
Q Consensus       405 i~~~~~~~~~~IG~G~fG~Vy~~~~~----~----~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  474 (736)
                      +......+.+.||+|.||.|++|...    .    ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|+|.
T Consensus       293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t  372 (609)
T KOG0200|consen  293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT  372 (609)
T ss_pred             echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence            33333356679999999999999743    1    45699999876543 3456799999999999 6999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHhhccc----------ccc--cccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCE
Q 004689          475 EEGRSVLVYEFMHNGTLKEHLYGTL----------THE--QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI  542 (736)
Q Consensus       475 ~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~--~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NI  542 (736)
                      .++..++|+||+..|+|.++|+...          ...  ..+.....+.++.|||.|++||++.   +++||||.++||
T Consensus       373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV  449 (609)
T KOG0200|consen  373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV  449 (609)
T ss_pred             cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence            9999999999999999999997554          011  2388899999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEEeecCCccccCCCCcceecccc--cccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCccccccc
Q 004689          543 LLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGA  619 (736)
Q Consensus       543 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~  619 (736)
                      |++.+..+||+|||+|+...+..........|  ...|||||.+....|+.++|||||||+||||+| |..||.+...  
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--  527 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--  527 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--
Confidence            99999999999999998665544443333333  346999999999999999999999999999999 8899976321  


Q ss_pred             ccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          620 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       620 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                       ...+.+    .+++|.-.         ..+..+..++.+++..|++.+|++||++.|+.+.|+..+.
T Consensus       528 -~~~l~~----~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  528 -TEELLE----FLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             -HHHHHH----HHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence             112222    33333321         1223334568899999999999999999999999998643

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.1e-33  Score=289.49  Aligned_cols=250  Identities=26%  Similarity=0.386  Sum_probs=195.4

Q ss_pred             HHhhccccccCceEEEEEEECC-CcEEEEEEeccCC-----cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      |.+.+.||+|+||.||++.... +..+++|+++...     .....++..|+.++++++||||+++++++.+....++||
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            4567889999999999998753 4556666665322     122335677999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||||+||+++. +.+||+|||+++....
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~  157 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG  157 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence            99999999998865444456789999999999999999999998   9999999999999975 5699999999876543


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      ... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....       ......... .+..     +
T Consensus       158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~~-~~~~-----~  223 (260)
T cd08222         158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRIV-EGPT-----P  223 (260)
T ss_pred             Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHH-cCCC-----C
Confidence            222 2233458899999999988888999999999999999999999986433       111111111 1111     1


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          ..+......+.+++.+|+..+|++||++.|++++
T Consensus       224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         224 ----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             ----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                1122334568899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-32  Score=288.26  Aligned_cols=258  Identities=22%  Similarity=0.275  Sum_probs=196.2

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.+.||+|++|.||+|... +++.+|+|.+......  ....+.+|++++++++|+||+++++++..+...++|+||+++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   82 (283)
T cd05118           3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT   82 (283)
T ss_pred             cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence            4567999999999999875 6889999998654322  345788899999999999999999999999999999999975


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                       +|.+++...   ...+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||.+....... ..
T Consensus        83 -~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~  154 (283)
T cd05118          83 -DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP  154 (283)
T ss_pred             -CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence             888877532   24688999999999999999999998   99999999999999999999999999987654432 11


Q ss_pred             eecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC---Ccceecc--
Q 004689          569 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG---DIQGIID--  642 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d--  642 (736)
                      .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+.    ......   ......+  
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF----RTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----HHcCCCchHhcccchhhh
Confidence            2223478899999999876 78899999999999999999999997544211111111    110000   0000000  


Q ss_pred             ----CccC-------CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 ----PSLL-------DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ----~~l~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          ....       .........++.+++..|++.||.+||++.+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                0000       00011234578999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-32  Score=288.65  Aligned_cols=263  Identities=21%  Similarity=0.277  Sum_probs=195.3

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEEecC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.||+|+||+||+|... +++.||||++..... .......+|+..+++++ ||||+++++++..++..++||||+ 
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   80 (283)
T cd07830           2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-   80 (283)
T ss_pred             eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence            35678999999999999986 478899999865432 22334567999999998 999999999999999999999999 


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++....  ...+++..++.++.|++.+|.|||+.   +++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          81 EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence            889998885432  34689999999999999999999998   9999999999999999999999999999765432221


Q ss_pred             ceecccccccccCccccc-cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHH---------HHHHhhhcCCc
Q 004689          568 VSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDI  637 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~-~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~---------~~~~~~~~~~~  637 (736)
                        ....|+..|+|||++. ...++.++|+||||++++||++|+.||......+....+..         |..........
T Consensus       156 --~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         156 --TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             --CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence              2345788999999885 45678999999999999999999999975542211111111         11111000011


Q ss_pred             ceeccCccC---CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 QGIIDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...+.....   ..........+.+++.+|++.+|++||+++|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000000   00001113568899999999999999999999764

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.7e-32  Score=293.38  Aligned_cols=262  Identities=18%  Similarity=0.253  Sum_probs=192.0

Q ss_pred             hhccccccCceEEEEEEECCCcEEEEEEeccC--CcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.+.+|.|+++.||++.. +++.||||++...  .......+.+|++++++++||||+++++++...+..+++|||+++|
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            345555666666666655 5899999998754  2334467899999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC---
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS---  566 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~---  566 (736)
                      +|.+++....  ...++......++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+........   
T Consensus        85 ~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          85 SCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            9999986432  23578888899999999999999998   999999999999999999999999998864422111   


Q ss_pred             ---cceecccccccccCcccccc--CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh----h----
Q 004689          567 ---HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI----E----  633 (736)
Q Consensus       567 ---~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~----~----  633 (736)
                         .......++..|+|||++..  ..++.++|||||||++|||++|+.||.......   .+.+......    .    
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ---MLLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhccCccccccCch
Confidence               11122347789999999875  458899999999999999999999997543111   1111111000    0    


Q ss_pred             ---cCCcce----eccCccC----CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          634 ---SGDIQG----IIDPSLL----DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       634 ---~~~~~~----~~d~~l~----~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                         ......    ..++...    ..........+.+++..|++.+|++|||++|++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence               000000    0000000    011122335688999999999999999999999873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.2e-32  Score=287.37  Aligned_cols=242  Identities=24%  Similarity=0.304  Sum_probs=186.2

Q ss_pred             cccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHH---HhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          415 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTL---LSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       415 ~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~i---l~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .||+|+||.||+|... +++.||+|.+......   ....+..|..+   ++...||||+++++++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999865 5889999998754322   12223444443   444579999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++..    ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......  
T Consensus        81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            9999988842    34689999999999999999999998   99999999999999999999999999987543222  


Q ss_pred             ceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          568 VSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                       .....|+..|+|||++.++ .++.++||||+||++|||++|+.||........    ... ......      .+..+.
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~----~~~-~~~~~~------~~~~~~  219 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEI-DRMTLT------MAVELP  219 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch----HHH-HHHhhc------cCCCCC
Confidence             1234689999999999754 689999999999999999999999976532111    110 000000      111111


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                      ..    ....+.+++.+|+..+|.+||     ++.+++++
T Consensus       220 ~~----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         220 DS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             Cc----CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            11    234688999999999999999     99998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.5e-33  Score=276.99  Aligned_cols=270  Identities=21%  Similarity=0.258  Sum_probs=196.4

Q ss_pred             HHHhhccccccCceEEEEEEEC---C--CcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeee-CCeEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK---D--GKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSV  480 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~---~--~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~  480 (736)
                      .|+....||+|.||.||+|...   +  .+++|+|+++.....  -.....+|+.+++.++||||+.|..++.. +...+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~  104 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW  104 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence            3445678999999999999543   2  347999998765322  23457799999999999999999999977 78899


Q ss_pred             EEEEecCCCCHHHHhhcc-cccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC----CcEEEEee
Q 004689          481 LVYEFMHNGTLKEHLYGT-LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDF  555 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~----~~~kl~DF  555 (736)
                      |++||.+. +|.+.++-. ......++...+..|+.||+.|+.|||++   -|+||||||.||||..+    |.+||+||
T Consensus       105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecc
Confidence            99999987 788877432 23346789999999999999999999998   89999999999999887    89999999


Q ss_pred             cCCccccCCCCcc--eecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCccccccccc-----ccHHHH
Q 004689          556 GLSKFAVDGASHV--SSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANC-----RNIVQW  627 (736)
Q Consensus       556 Gla~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~-----~~l~~~  627 (736)
                      |+++.+.+.-...  ...++-|.+|+|||.+.+ ..|+.+.|||+.||++.||++-++-|.+....-..     .+-+..
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r  260 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR  260 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence            9999776543322  234567999999999987 57999999999999999999998888654311000     011111


Q ss_pred             HHHhhhcCCcceeccCccCCc------------CCH----H-------HHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          628 AKLHIESGDIQGIIDPSLLDE------------YDI----Q-------SMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       628 ~~~~~~~~~~~~~~d~~l~~~------------~~~----~-------~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      +-..+....-..+-+-...++            ++.    .       .....++|..+++..||.+|.|++|.+++.
T Consensus       261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            111111111000000000000            000    0       001267899999999999999999998763

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.6e-32  Score=293.01  Aligned_cols=248  Identities=24%  Similarity=0.364  Sum_probs=193.0

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      .++...+.||+|+||.||+|+.. +++.+|+|.+.....   ....++.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34555678999999999999875 578899998864321   22346778999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+. |++.+.+...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        95 e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          95 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            9996 5787776422   34578889999999999999999998   999999999999999999999999999875432


Q ss_pred             CCCcceecccccccccCccccc---cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          564 GASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      .     ....|+..|+|||++.   ...++.++|||||||++|||++|..||.......   .+..+     ..+...  
T Consensus       168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~-----~~~~~~--  232 (308)
T cd06634         168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHI-----AQNESP--  232 (308)
T ss_pred             c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHHHH-----hhcCCC--
Confidence            2     2235789999999975   3567889999999999999999999986543110   01111     111110  


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                         ...   .......+.+++.+|++.+|++||++.+|+++..
T Consensus       233 ---~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         233 ---ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             ---CcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence               000   1122345789999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-33  Score=300.66  Aligned_cols=264  Identities=23%  Similarity=0.298  Sum_probs=198.6

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCC-----eEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVL  481 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~l  481 (736)
                      +.+.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+.+++.++||||+++++++....     ..++
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            345688999999999999876 48999999987543  334567889999999999999999999998775     7899


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+. ++|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||++...
T Consensus        82 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          82 VTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             Eecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            999998 478888743    33788999999999999999999998   9999999999999999999999999999865


Q ss_pred             cCCCC--cceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh------
Q 004689          562 VDGAS--HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI------  632 (736)
Q Consensus       562 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~------  632 (736)
                      .....  .......++..|+|||++.+. .++.++|+|||||++|+|++|+.||......+....+........      
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            44321  112234578999999999887 889999999999999999999999976542211111111100000      


Q ss_pred             -hcCCcceeccC-ccCC-----cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          633 -ESGDIQGIIDP-SLLD-----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       633 -~~~~~~~~~d~-~l~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       ........+.. ....     .........+.+++.+|++.+|.+||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             00000000000 0000     0011123467899999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-32  Score=288.02  Aligned_cols=262  Identities=22%  Similarity=0.283  Sum_probs=193.2

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhc---CCCceeeEeeeeeeCCe-----EE
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRI---HHRNLVQFLGYCQEEGR-----SV  480 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l---~HpnIv~l~~~~~~~~~-----~~  480 (736)
                      +.+.||+|+||.||+|..+ +++.||+|+++.....  ....+.+|+.+++++   .||||+++++++...+.     .+
T Consensus         3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   82 (287)
T cd07838           3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT   82 (287)
T ss_pred             EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence            4578999999999999987 4899999998744222  234566788877766   59999999999988776     89


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      ++|||+.+ +|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||+|||++..
T Consensus        83 l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          83 LVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             EEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence            99999974 8888875432  23588999999999999999999998   999999999999999999999999999876


Q ss_pred             ccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCc---
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI---  637 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~---  637 (736)
                      ......  .....++..|+|||++.+..++.++|+|||||++|||++|..||......+....+.+...........   
T Consensus       157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence            533221  122347889999999998889999999999999999999999987654222111111111000000000   


Q ss_pred             ---ceeccCccCC---cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 ---QGIIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ---~~~~d~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                         ...+......   .........+.+++.+|++.||.+||++.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence               0000000000   0011233567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=6.5e-33  Score=299.43  Aligned_cols=261  Identities=19%  Similarity=0.278  Sum_probs=194.1

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeee----CCeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lV  482 (736)
                      +.+.+.||+|+||.||+|... +++.||+|++.....  .....+.+|+.++++++||||+++++++..    ....++|
T Consensus         7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv   86 (334)
T cd07855           7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV   86 (334)
T ss_pred             eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence            445678999999999999865 689999999875422  234567789999999999999999998753    3568999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      |||+. |+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        87 ~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          87 MDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             Eehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99996 688888743    34588999999999999999999998   99999999999999999999999999987543


Q ss_pred             CCCC---cceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh-----
Q 004689          563 DGAS---HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE-----  633 (736)
Q Consensus       563 ~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~-----  633 (736)
                      ....   .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........    .........     
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~----~~~~~~~~g~~~~~  234 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ----LKLILSVLGSPSEE  234 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH----HHHHHHHhCCChhH
Confidence            3221   11223468999999999865 5688999999999999999999999976542110    111111000     


Q ss_pred             ------cCCcceeccC-ccCCcCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          634 ------SGDIQGIIDP-SLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       634 ------~~~~~~~~d~-~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                            ...+....+. .......     ......+.+++..|++.+|++||++.+++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence                  0000000000 0000011     12245689999999999999999999998863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.5e-33  Score=301.10  Aligned_cols=262  Identities=21%  Similarity=0.310  Sum_probs=193.1

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeC-----CeEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL  481 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~l  481 (736)
                      |.+.+.||+|+||+||+|+.. +++.||||.+....  ......+.+|+.+++.++||||+++++++...     ...++
T Consensus         7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l   86 (337)
T cd07858           7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI   86 (337)
T ss_pred             eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence            445678999999999999865 68999999986532  22344577899999999999999999988644     35799


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      |+||+. ++|.+++..    ...++......++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        87 v~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          87 VYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            999996 688887742    34688999999999999999999998   9999999999999999999999999999765


Q ss_pred             cCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHH-------hhh
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HIE  633 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~-------~~~  633 (736)
                      .... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...........+.+....       ...
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence            3322 22233457899999998865 56889999999999999999999999754321111111110000       000


Q ss_pred             cCCcceec-------cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          634 SGDIQGII-------DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       634 ~~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .+.....+       ++.... .......++.+++.+|++.+|++||+++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         238 NEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             chhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            00000000       000000 011223567899999999999999999999988

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.2e-32  Score=290.36  Aligned_cols=242  Identities=25%  Similarity=0.393  Sum_probs=189.9

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      ..+.||+|+||+||+|+.. +++.||+|++......   ....+.+|+++++.++|||++++++++.+....++||||+.
T Consensus        25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  104 (313)
T cd06633          25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL  104 (313)
T ss_pred             cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence            3467999999999999875 6889999998654322   23457889999999999999999999999999999999996


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                       |++.+.+...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.....    
T Consensus       105 -~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         105 -GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             -CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence             5777776432   34588999999999999999999998   999999999999999999999999999864321    


Q ss_pred             ceecccccccccCccccc---cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          568 VSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~---~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                       .....|+..|+|||++.   ...++.++|||||||++|||++|..||......    .....   ... .......   
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~----~~~~~---~~~-~~~~~~~---  241 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYH---IAQ-NDSPTLQ---  241 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHH---HHh-cCCCCCC---
Confidence             12345889999999984   456888999999999999999999998754311    11111   111 1111110   


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                           .......+.+++.+|++.+|.+||++.+++++
T Consensus       242 -----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         242 -----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 11112357889999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.2e-32  Score=282.27  Aligned_cols=235  Identities=20%  Similarity=0.307  Sum_probs=182.5

Q ss_pred             ccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecCCCCHHH
Q 004689          416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE  493 (736)
Q Consensus       416 IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~~  493 (736)
                      ||+|+||.||++... ++..+|+|++......   .  .|+.....+ +||||+++++++...+..++||||+++|+|.+
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~   98 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---A--IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD   98 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---h--hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHH
Confidence            599999999999865 6788999997643211   1  133333323 79999999999999999999999999999999


Q ss_pred             HhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeecCCccccCCCCcceecc
Q 004689          494 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIV  572 (736)
Q Consensus       494 ~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~~  572 (736)
                      ++..    ...+++..+..++.|+++||.|||+.   +++||||||+||+++.++ .++|+|||+++......     ..
T Consensus        99 ~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~  166 (267)
T PHA03390         99 LLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CY  166 (267)
T ss_pred             HHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cC
Confidence            9853    23789999999999999999999998   999999999999999998 99999999987543221     23


Q ss_pred             cccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHH
Q 004689          573 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQ  652 (736)
Q Consensus       573 ~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  652 (736)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.||......  ......+....  .... .     ...    .
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~--~~~~-~-----~~~----~  232 (267)
T PHA03390        167 DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE--ELDLESLLKRQ--QKKL-P-----FIK----N  232 (267)
T ss_pred             CCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc--hhhHHHHHHhh--cccC-C-----ccc----c
Confidence            5889999999999889999999999999999999999999744321  11122222211  0000 0     011    2


Q ss_pred             HHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 004689          653 SMWKIEEKALMCVLPHGHMRPS-ISEVLKD  681 (736)
Q Consensus       653 ~~~~l~~l~~~cl~~dP~~RPt-~~ev~~~  681 (736)
                      ....+.+++..|++.+|.+||+ ++|++++
T Consensus       233 ~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        233 VSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             cCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence            2345788999999999999996 6888754

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-33  Score=277.86  Aligned_cols=244  Identities=25%  Similarity=0.327  Sum_probs=195.9

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccch---hhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~---~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.++||+|.||.|-.++-+ +++-+|+|++++...-.+.   .-..|-++|+..+||.+..|--.|...+++|+||||+.
T Consensus       172 fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyan  251 (516)
T KOG0690|consen  172 FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYAN  251 (516)
T ss_pred             HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEcc
Confidence            5689999999999999866 6899999999876543333   34568899999999999999989999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      ||.|.-+|.    ..+.+++....-+..+|..||.|||++   +||.||+|.+|.|+|.+|++||+|||+++.-.. ...
T Consensus       252 GGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~-~g~  323 (516)
T KOG0690|consen  252 GGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK-YGD  323 (516)
T ss_pred             CceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc-ccc
Confidence            999988883    456788888888899999999999998   999999999999999999999999999974322 233


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      .+.+++|||.|+|||++....|+.++|.|.+|||||||++|+.||..........-|..      .+-            
T Consensus       324 t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------ed~------------  385 (516)
T KOG0690|consen  324 TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------EDL------------  385 (516)
T ss_pred             eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh------hhc------------
Confidence            45678899999999999999999999999999999999999999986653222211111      111            


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                      .++.....+...|....+..||.+|.     .++||.++
T Consensus       386 kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  386 KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            11212222456677788899999997     35666554

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=326.88  Aligned_cols=245  Identities=25%  Similarity=0.381  Sum_probs=192.9

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      ..+||.|.||.||-|... +|.-.|+|-++....  .......+|..++..++|||+|+.+|+-...+..++.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            467999999999999755 677889998765432  33456889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc--
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--  567 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~--  567 (736)
                      +|.+.+.    .++..++.....+..|++.|++|||++   |||||||||.||+++.+|.+|++|||.|..+......  
T Consensus      1320 sLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1320 SLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             cHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence            9999983    334455666667889999999999998   9999999999999999999999999999876544211  


Q ss_pred             -ceecccccccccCcccccc---CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHh-hhcCCcceecc
Q 004689          568 -VSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-IESGDIQGIID  642 (736)
Q Consensus       568 -~~~~~~gt~~Y~aPE~~~~---~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~d  642 (736)
                       ......||+.|||||++.+   .....++||||+|||+.||+||++||...+.        +|.... ..-|.      
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--------e~aIMy~V~~gh------ 1458 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--------EWAIMYHVAAGH------ 1458 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--------hhHHHhHHhccC------
Confidence             1234569999999999975   3466789999999999999999999976542        222221 11111      


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                         .++.+.....+=.+++.+|+..||++|.++.|++++
T Consensus      1459 ---~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 ---KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ---CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence               122222333445688999999999999988877554

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=9.5e-33  Score=289.50  Aligned_cols=247  Identities=25%  Similarity=0.335  Sum_probs=197.9

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      |.+.+.||+|+||.||+|... +++.||+|++....   ......+.+|++++++++ ||||+++++++...+..++|||
T Consensus         3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd05581           3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE   82 (280)
T ss_pred             ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence            345678999999999999876 68999999986532   223456888999999998 9999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++++|||++......
T Consensus        83 ~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          83 YAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            9999999999853    33689999999999999999999998   9999999999999999999999999998755432


Q ss_pred             CC-------------------cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHH
Q 004689          565 AS-------------------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV  625 (736)
Q Consensus       565 ~~-------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~  625 (736)
                      ..                   .......|+..|+|||......++.++||||||++++++++|+.||......    ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~  231 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----LTF  231 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH----HHH
Confidence            21                   1122345789999999998888999999999999999999999999755411    111


Q ss_pred             HHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCH----HHHHHH
Q 004689          626 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI----SEVLKD  681 (736)
Q Consensus       626 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~ev~~~  681 (736)
                      +.   .. ...          ...+......+.+++.+|++.+|.+||++    +|++++
T Consensus       232 ~~---~~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         232 QK---IL-KLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HH---HH-hcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            11   11 000          01111223458899999999999999999    777653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=287.64  Aligned_cols=262  Identities=24%  Similarity=0.270  Sum_probs=196.3

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.+.||+|+||.||+|+.. +++.||+|++....  ......+..|+.++++++|+||+++++++...+..++|+||+. 
T Consensus         3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-   81 (282)
T cd07829           3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-   81 (282)
T ss_pred             eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence            3467999999999999876 48999999987653  2234567889999999999999999999999999999999998 


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      ++|.+++....   ..+++..+..++.|++.||.|||+.   +|+||||+|+||++++++.+||+|||+++....... .
T Consensus        82 ~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  154 (282)
T cd07829          82 MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T  154 (282)
T ss_pred             cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence            58999885421   4588999999999999999999998   999999999999999999999999999876543222 1


Q ss_pred             eecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhc-----CCc---ce
Q 004689          569 SSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES-----GDI---QG  639 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~-----~~~---~~  639 (736)
                      .....++..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.+........     ..+   ..
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            2223467889999998776 78899999999999999999999997654221111111110000000     000   00


Q ss_pred             eccCccCC---cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 IIDPSLLD---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 ~~d~~l~~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .+......   .........+.+++..|+..+|++||++.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            00000000   0001113468999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.98  E-value=1.7e-32  Score=292.44  Aligned_cols=266  Identities=21%  Similarity=0.274  Sum_probs=190.6

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeC--------C
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEE--------G  477 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--------~  477 (736)
                      .+.+.++||+|+||.||+|... +++.+|+|++......  ....+.+|++++++++||||+++++++...        .
T Consensus         9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   88 (311)
T cd07866           9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG   88 (311)
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence            3446788999999999999876 6889999988654322  234577899999999999999999987543        3


Q ss_pred             eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecC
Q 004689          478 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL  557 (736)
Q Consensus       478 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGl  557 (736)
                      ..++|+||+.+ +|...+..   ....+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        89 ~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          89 SVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             eEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence            46999999875 67666643   234689999999999999999999998   999999999999999999999999999


Q ss_pred             CccccCCCCc----------ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHH
Q 004689          558 SKFAVDGASH----------VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ  626 (736)
Q Consensus       558 a~~~~~~~~~----------~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~  626 (736)
                      ++........          ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            8754322111          1123457889999998865 4588999999999999999999999975442211111111


Q ss_pred             HHHHhhh-----cCCcceeccCccCCcCC-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          627 WAKLHIE-----SGDIQGIIDPSLLDEYD-------IQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       627 ~~~~~~~-----~~~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .......     ...+....+.......+       ......+.+++.+|++.+|++|||+.|++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            0000000     00000000000000000       1112467899999999999999999998764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=5.1e-33  Score=282.15  Aligned_cols=258  Identities=24%  Similarity=0.326  Sum_probs=203.8

Q ss_pred             HHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeC-CeE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEE-GRS  479 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~  479 (736)
                      .+.++...+-+|.||.||+|.+.      +.++|.||.++....+ ....+..|...+..+.|||+.++.+++.++ ...
T Consensus       284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P  363 (563)
T KOG1024|consen  284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP  363 (563)
T ss_pred             hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence            33344567899999999999665      3456778877654332 345577888889999999999999998754 567


Q ss_pred             EEEEEecCCCCHHHHhhccc----ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEee
Q 004689          480 VLVYEFMHNGTLKEHLYGTL----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF  555 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DF  555 (736)
                      +.+|.++.-|+|..+|....    ...+.+...+...++.|++.|++|||++   ++||.||..+|++|++..++||+|=
T Consensus       364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDs  440 (563)
T KOG1024|consen  364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDS  440 (563)
T ss_pred             eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccc
Confidence            88999999999999996221    2345577788889999999999999998   9999999999999999999999999


Q ss_pred             cCCccccCCCCcce-ecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhh
Q 004689          556 GLSKFAVDGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIE  633 (736)
Q Consensus       556 Gla~~~~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~  633 (736)
                      .+++.......+.. .....+..||+||.+....|+.++|||||||+||||+| |+.|+..-+.-    .+..    .+.
T Consensus       441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf----Em~~----ylk  512 (563)
T KOG1024|consen  441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF----EMEH----YLK  512 (563)
T ss_pred             hhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH----HHHH----HHh
Confidence            99997665554433 22345789999999999999999999999999999999 99998654421    1111    112


Q ss_pred             cCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          634 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       634 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      +|         .+-.-+..++.++..++.-||...|++||+..|++.-|.+.
T Consensus       513 dG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  513 DG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             cc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            22         11222455677899999999999999999999999999876

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.98  E-value=6.9e-32  Score=286.25  Aligned_cols=251  Identities=25%  Similarity=0.335  Sum_probs=190.3

Q ss_pred             HHhhccccccCceEEEEEEECC-CcEEEEEEeccCCc-ccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      +.+.+.||+|+||.||+|...+ ++.||||+++.... .....+..|+.++.+.. ||||+++++++.+....++||||+
T Consensus        17 ~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   96 (296)
T cd06618          17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM   96 (296)
T ss_pred             heeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence            3467899999999999999874 88999999875432 23345666777776664 999999999999999999999998


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      . +++.+++...   ...+++..+..++.|++.||.|||+.  .+|+||||+|+||+++.++.+||+|||++........
T Consensus        97 ~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          97 S-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             C-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            5 4676665332   23688888999999999999999973  2899999999999999999999999999876543222


Q ss_pred             cceecccccccccCccccccCc----CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~----~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      .  ....++..|+|||++.+..    ++.++||||||+++|||++|+.||......  ...+.    ...... ....  
T Consensus       171 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~----~~~~~~-~~~~--  239 (296)
T cd06618         171 K--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLT----KILQEE-PPSL--  239 (296)
T ss_pred             c--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHH----HHhcCC-CCCC--
Confidence            2  2234788999999987553    788999999999999999999999653211  11111    111111 0000  


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                         ..  ......++.+++.+|++.+|.+||++.+++++-
T Consensus       240 ---~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         240 ---PP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             ---CC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence               00  001234588999999999999999999998774

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.98  E-value=1.3e-32  Score=313.65  Aligned_cols=245  Identities=25%  Similarity=0.365  Sum_probs=184.3

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeee----------------
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----------------  475 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----------------  475 (736)
                      +.||+||||.|||++.+ ||+.||||++.-.. ......+.+|+.+|++++|||||+++..+.+                
T Consensus       485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~  564 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE  564 (1351)
T ss_pred             HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence            57999999999999987 89999999987653 2335668899999999999999998732200                


Q ss_pred             --------------------------------------------------------------------------------
Q 004689          476 --------------------------------------------------------------------------------  475 (736)
Q Consensus       476 --------------------------------------------------------------------------------  475 (736)
                                                                                                      
T Consensus       565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~  644 (1351)
T KOG1035|consen  565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD  644 (1351)
T ss_pred             hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence                                                                                            


Q ss_pred             ---------------C--------CeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 004689          476 ---------------E--------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI  532 (736)
Q Consensus       476 ---------------~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~i  532 (736)
                                     +        ..+|+-||||+.-.|.+++....-..   .....++++.+|+.||.|+|++   ||
T Consensus       645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH~~---gi  718 (1351)
T KOG1035|consen  645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIHDQ---GI  718 (1351)
T ss_pred             chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHHhC---ce
Confidence                           0        13478889999877777775432110   3456789999999999999998   99


Q ss_pred             ecCCCCCCCEEEcCCCcEEEEeecCCcccc-----------------CCCCcceecccccccccCccccccC---cCCCc
Q 004689          533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAV-----------------DGASHVSSIVRGTVGYLDPEYYISQ---QLTDK  592 (736)
Q Consensus       533 iHrDikp~NILl~~~~~~kl~DFGla~~~~-----------------~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~  592 (736)
                      |||||||.|||++++..|||+|||+|+...                 .......+..+||.-|+|||++.+.   .|+.|
T Consensus       719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K  798 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK  798 (1351)
T ss_pred             eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence            999999999999999999999999997621                 0111133456799999999999764   59999


Q ss_pred             chhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCC
Q 004689          593 SDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR  672 (736)
Q Consensus       593 ~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R  672 (736)
                      +|+||+|||++||+.   ||...-       -..-+...++.+.+...      .++.......-..++.+++++||.+|
T Consensus       799 iDmYSLGIVlFEM~y---PF~TsM-------ERa~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kR  862 (1351)
T KOG1035|consen  799 IDMYSLGIVLFEMLY---PFGTSM-------ERASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKR  862 (1351)
T ss_pred             hhhHHHHHHHHHHhc---cCCchH-------HHHHHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccC
Confidence            999999999999985   353211       01112233445554433      12233344456789999999999999


Q ss_pred             CCHHHHHH
Q 004689          673 PSISEVLK  680 (736)
Q Consensus       673 Pt~~ev~~  680 (736)
                      ||+.|++.
T Consensus       863 PtA~eLL~  870 (1351)
T KOG1035|consen  863 PTATELLN  870 (1351)
T ss_pred             CCHHHHhh
Confidence            99999875

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1e-31  Score=291.09  Aligned_cols=261  Identities=22%  Similarity=0.323  Sum_probs=189.2

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeC------CeEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVL  481 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~~~l  481 (736)
                      .+.+.||+|+||.||+|... +++.||||++.....  .....+.+|++++++++||||+++++++...      ...++
T Consensus        18 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~l   97 (342)
T cd07879          18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYL   97 (342)
T ss_pred             EEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEE
Confidence            34678999999999999865 689999999865321  2234578899999999999999999998654      34689


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      |+||+.. +|...+      ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        98 v~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          98 VMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             Eeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            9999864 676654      23478888999999999999999998   9999999999999999999999999998754


Q ss_pred             cCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHH-------HHhhh
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA-------KLHIE  633 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~~  633 (736)
                      ...    .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+....       .....
T Consensus       168 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07879         168 DAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE  243 (342)
T ss_pred             CCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence            221    122357889999999876 468899999999999999999999997643211111111000       00000


Q ss_pred             cCCcceecc--Ccc-CCcC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHH
Q 004689          634 SGDIQGIID--PSL-LDEY---DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA  685 (736)
Q Consensus       634 ~~~~~~~~d--~~l-~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~  685 (736)
                      .........  +.. ....   .......+.+++.+|++.||++||++.|++++  ++..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            000000000  000 0000   00122357899999999999999999999976  6654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=6.2e-32  Score=292.76  Aligned_cols=263  Identities=20%  Similarity=0.253  Sum_probs=189.9

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeC-----------
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----------  476 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----------  476 (736)
                      ++.+.+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...           
T Consensus         6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (342)
T cd07854           6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL   85 (342)
T ss_pred             ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence            3445688999999999999875 6889999998765555556788999999999999999999876543           


Q ss_pred             ---CeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEE
Q 004689          477 ---GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKV  552 (736)
Q Consensus       477 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~-~~~~kl  552 (736)
                         ...++||||+. ++|.+++.     ...+++.....++.|++.||.|||+.   +|+||||||+||+++. ++.+|+
T Consensus        86 ~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          86 TELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence               35789999997 58888773     23578889999999999999999998   9999999999999974 567899


Q ss_pred             EeecCCccccCCCCc--ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHH-
Q 004689          553 SDFGLSKFAVDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA-  628 (736)
Q Consensus       553 ~DFGla~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~-  628 (736)
                      +|||+++........  ......|+..|+|||++.. ..++.++|||||||++|||++|+.||......+....+..-. 
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999998754322111  1122357889999998754 567889999999999999999999997543211100000000 


Q ss_pred             ------HHhhhcCCcceecc-CccCCcCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          629 ------KLHIESGDIQGIID-PSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       629 ------~~~~~~~~~~~~~d-~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                            ...... .+..... .......+     .....++.+++..|++.||++||++.|++++
T Consensus       237 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         237 VVREEDRNELLN-VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CCChHHhhhhhh-hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence                  000000 0000000 00000000     1122457899999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.98  E-value=2.1e-32  Score=266.07  Aligned_cols=247  Identities=25%  Similarity=0.357  Sum_probs=189.9

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      ...||.|..|.|++++.+ +|.-+|||.+..... +..+.+...+.++.+.+ +|.||+.+|||..+....+.||.|.. 
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence            456999999999999877 578899999976643 33455667777766654 89999999999999999999998853 


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      .++.++...   ...+++.-.-++...+.+||.||.++  .+|+|||+||+|||+|+.|++|+||||++-.+.+...+  
T Consensus       176 C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh--  248 (391)
T KOG0983|consen  176 CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH--  248 (391)
T ss_pred             HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeeccccc--
Confidence            344444322   34477777778888999999999998  49999999999999999999999999999877654443  


Q ss_pred             ecccccccccCcccccc---CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          570 SIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~---~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      +...|-+.|||||.+.-   ..|+.++||||||+.++||.||+.||.+.+..   ......+.   .+.      .|.+.
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td---Fe~ltkvl---n~e------PP~L~  316 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD---FEVLTKVL---NEE------PPLLP  316 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc---HHHHHHHH---hcC------CCCCC
Confidence            34568999999999964   46889999999999999999999999875521   11111111   111      12222


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +..  .....+.+++..|+..|+.+||...+++++
T Consensus       317 ~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  317 GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            211  122358889999999999999999999876

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=9e-32  Score=277.36  Aligned_cols=236  Identities=29%  Similarity=0.358  Sum_probs=191.1

Q ss_pred             ccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       416 IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      ||+|+||.||++... +++.+|+|++......   ....+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999876 5889999998765332   244688999999999999999999999999999999999999999


Q ss_pred             HHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceec
Q 004689          492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI  571 (736)
Q Consensus       492 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  571 (736)
                      .+++..    ...+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~  152 (250)
T cd05123          81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT  152 (250)
T ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence            999853    23588999999999999999999997   99999999999999999999999999987654332 12233


Q ss_pred             ccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCH
Q 004689          572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI  651 (736)
Q Consensus       572 ~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  651 (736)
                      ..|+..|++||...+...+.++|+||||+++||+++|+.||.....    ..+.+.+.    .+..          ..+.
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~----~~~~----------~~~~  214 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKIL----KDPL----------RFPE  214 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHh----cCCC----------CCCC
Confidence            4588999999999888889999999999999999999999965442    11111111    1110          1111


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHH
Q 004689          652 QSMWKIEEKALMCVLPHGHMRPSISE  677 (736)
Q Consensus       652 ~~~~~l~~l~~~cl~~dP~~RPt~~e  677 (736)
                      .....+.+++.+|+..||++||++.+
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            11346789999999999999999944

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.98  E-value=1.5e-31  Score=287.96  Aligned_cols=259  Identities=19%  Similarity=0.267  Sum_probs=190.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeee-CCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||.||+|... +++.||+|++....  ......+.+|++++++++||||+++.+++.. ....++|+||
T Consensus        12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~   91 (328)
T cd07856          12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL   91 (328)
T ss_pred             eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence            445689999999999999865 78999999875432  2234567889999999999999999998865 5678999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      + +++|.+++..     ..++......++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||++...... 
T Consensus        92 ~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-  161 (328)
T cd07856          92 L-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-  161 (328)
T ss_pred             h-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCC-
Confidence            8 5688887742     3467777888999999999999998   9999999999999999999999999998743221 


Q ss_pred             CcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHH--------HHHhhhcCC
Q 004689          566 SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW--------AKLHIESGD  636 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~--------~~~~~~~~~  636 (736)
                         .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.++        .........
T Consensus       162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd07856         162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT  238 (328)
T ss_pred             ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence               122357889999998866 56899999999999999999999999754321111111111        000000000


Q ss_pred             cceeccCccCCcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...+..-......+.     .....+.+++.+|++.+|++||++.+++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000000011111     123568899999999999999999999776

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.3e-33  Score=312.68  Aligned_cols=282  Identities=22%  Similarity=0.248  Sum_probs=213.6

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccC---CcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .+.+.++||+|+||.|..++++ +++.||+|++.+.   .......|.+|-.+|.....+-|+.|+-.|.++.++|+|||
T Consensus        76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd  155 (1317)
T KOG0612|consen   76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD  155 (1317)
T ss_pred             hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence            3446789999999999999886 5788999999763   23345668899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      ||+||+|..+|..    ..+++..-+.-++.++.-||.-||+.   |+|||||||+|||+|..|++||+|||.+-.+..+
T Consensus       156 Y~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  156 YMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             cccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence            9999999999853    33688888888999999999999998   9999999999999999999999999988666555


Q ss_pred             CCcceecccccccccCcccccc-----CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          565 ASHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ....+...+|||-|++||++..     +.|+..+|.||+||++|||+.|..||..+...+.+..|.......    .+.+
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l----~FP~  304 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESL----SFPD  304 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhc----CCCc
Confidence            5556667789999999999963     568999999999999999999999998776544444444421100    0100


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCC---HHHHHHHHHHHHHHHHHHhhhcCCCCCCCCCCccccccccCC
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS---ISEVLKDIQDAIVIEREAAAARDGNSDDMSRNSLHSSLNVGS  716 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~ev~~~L~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~s  716 (736)
                                .........+|+.+-+. +|+.|..   +.++-.|---           ....|.-...+..+..+..+|
T Consensus       305 ----------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF-----------~g~~W~~iR~~~pP~vPevss  362 (1317)
T KOG0612|consen  305 ----------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFF-----------EGIDWDNIRESVPPVVPEVSS  362 (1317)
T ss_pred             ----------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccc-----------cCCChhhhhhcCCCCCCcCCC
Confidence                      01122345555555443 4566776   7776655210           011122223445556677777


Q ss_pred             CCCCCCc
Q 004689          717 FGGTENF  723 (736)
Q Consensus       717 ~~~~~~~  723 (736)
                      ..+|.+|
T Consensus       363 d~DTsnF  369 (1317)
T KOG0612|consen  363 DDDTSNF  369 (1317)
T ss_pred             CCccccc
Confidence            8888888

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=287.81  Aligned_cols=245  Identities=25%  Similarity=0.395  Sum_probs=194.8

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccC--CcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      ++.||+|.||+||-|+++ +|+.||||++.+.  ....+.++.+|++||+.++||.||.+-.-|+..++.++|||-+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            789999999999999876 7999999999765  334467899999999999999999999999999999999999965 


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC---CcEEEEeecCCccccCCCC
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~---~~~kl~DFGla~~~~~~~~  566 (736)
                      +..+.+..  .+..+++.....-++.||+.||.|||.+   +|+|+||||+|||+.+.   -++||||||+|+.+...  
T Consensus       648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--  720 (888)
T KOG4236|consen  648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--  720 (888)
T ss_pred             hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence            55555433  3467788888888999999999999998   99999999999999765   47999999999987543  


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      .....++||+.|+|||++....|...-|+||.||++|--++|..||..+.      +|-+.+.    +..+  ++.+.-+
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE------dIndQIQ----NAaF--MyPp~PW  788 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE------DINDQIQ----NAAF--MYPPNPW  788 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc------chhHHhh----cccc--ccCCCch
Confidence            34456789999999999999999999999999999999999999997553      2222111    1111  1112212


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .+    .....++++...++..-.+|-+.++-+.+
T Consensus       789 ~e----is~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  789 SE----ISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             hh----cCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            22    22345677777788777888888776544

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=7.8e-32  Score=290.75  Aligned_cols=263  Identities=22%  Similarity=0.267  Sum_probs=188.6

Q ss_pred             HhhccccccCceEEEEEEEC-C--CcEEEEEEeccCC--cccchhhhhHHHHHhhc-CCCceeeEeeeeeeC----CeEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-D--GKEIAVKVLTSNS--YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE----GRSV  480 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~--~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~----~~~~  480 (736)
                      .+.+.||+|+||.||++... .  +..||+|++....  ......+.+|+++++++ +||||+++++++...    ...+
T Consensus         3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~   82 (332)
T cd07857           3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY   82 (332)
T ss_pred             eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence            45678999999999999876 3  6789999986432  12245678899999999 599999999875432    4568


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +++||+. ++|.+.+..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          83 LYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            8888886 688888742    35688999999999999999999998   999999999999999999999999999975


Q ss_pred             ccCCCCc---ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHH------
Q 004689          561 AVDGASH---VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL------  630 (736)
Q Consensus       561 ~~~~~~~---~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~------  630 (736)
                      .......   ......||..|+|||++.+ ..++.++||||+||++|+|++|+.||...........+......      
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            4322211   1123468999999998865 56889999999999999999999999754321111111110000      


Q ss_pred             -hhhcCCccee---ccCccC---CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          631 -HIESGDIQGI---IDPSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       631 -~~~~~~~~~~---~d~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       .+........   ....-.   ..........+.+++.+|++.+|++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             0000000000   000000   00001123468899999999999999999998765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.2e-31  Score=288.63  Aligned_cols=258  Identities=22%  Similarity=0.304  Sum_probs=189.6

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCC------eEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV  480 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------~~~  480 (736)
                      |.+.+.||+|+||.||+|... +++.||||++.....  .....+.+|++++++++||||+++++++....      ..+
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07880          17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY   96 (343)
T ss_pred             eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence            445678999999999999865 689999999854321  22345788999999999999999999887543      458


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+ +++|.+++.     ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        97 lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          97 LVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             EEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence            999998 678988774     23588899999999999999999998   999999999999999999999999999875


Q ss_pred             ccCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHH--------HHHHh
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ--------WAKLH  631 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~--------~~~~~  631 (736)
                      .....    ....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+..        +....
T Consensus       168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         168 TDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             cccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            43221    22357899999999876 4688999999999999999999999975432111111111        00000


Q ss_pred             hhcCCcceecc--CccC-C---cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          632 IESGDIQGIID--PSLL-D---EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       632 ~~~~~~~~~~d--~~l~-~---~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       ..........  +... .   .........+.+++.+|++.||++|||+.+++++
T Consensus       244 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         244 -QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             -cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0000000000  0000 0   0001122357899999999999999999999865

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.1e-32  Score=278.86  Aligned_cols=242  Identities=24%  Similarity=0.314  Sum_probs=193.4

Q ss_pred             HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchh---hhhHHHHHhhc-CCCceeeEeeeeeeCCeEEE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~---~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~l  481 (736)
                      ....+|..+||+|+||.|-+|..+ +.+-+|||+++++..-...+   -..|-++|... +-|.+++++.+|..-+++++
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            344567899999999999999766 45679999998774332222   33566777665 57899999999999999999


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+.||+|.-++    ++-.++.++.+.-+|.+||-||-+||++   +||+||||..|||++.+|++||+|||+++.-
T Consensus       428 VMEyvnGGDLMyhi----QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHI----QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             EEEEecCchhhhHH----HHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence            99999999998887    3456677788888999999999999998   9999999999999999999999999999743


Q ss_pred             cCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      .- ...++.+.+|||.|+|||++...+|+..+|.|||||+||||+.|++||++.+..+..+.|.+.              
T Consensus       501 i~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh--------------  565 (683)
T KOG0696|consen  501 IF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH--------------  565 (683)
T ss_pred             cc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc--------------
Confidence            22 233456688999999999999999999999999999999999999999987744443333321              


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCC
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS  674 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt  674 (736)
                        .  -.|+.....+...+...-+...|.+|..
T Consensus       566 --n--vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  566 --N--VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             --c--CcCcccccHHHHHHHHHHhhcCCccccC
Confidence              1  1233333445666777778888888864

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-33  Score=270.26  Aligned_cols=264  Identities=27%  Similarity=0.360  Sum_probs=197.7

Q ss_pred             ccccCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeee
Q 004689          397 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYC  473 (736)
Q Consensus       397 ~~~~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~  473 (736)
                      .+.|+-.++++.     ..||.|+||+|+|..++ .|+..|||+++.... .+..++..|.+...+- +.||||+++|.+
T Consensus        58 ~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~  132 (361)
T KOG1006|consen   58 LHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL  132 (361)
T ss_pred             ccccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence            345555555433     35899999999999876 689999999987754 4456788888765554 789999999999


Q ss_pred             eeCCeEEEEEEecCCCCHHHHhhc-ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEE
Q 004689          474 QEEGRSVLVYEFMHNGTLKEHLYG-TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV  552 (736)
Q Consensus       474 ~~~~~~~lV~e~~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl  552 (736)
                      -.++..++.||.|.- +|..+-.. .......+++.-.-.|..-...||.||.+.  ..|||||+||+|||++..|.+||
T Consensus       133 F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKL  209 (361)
T KOG1006|consen  133 FSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKL  209 (361)
T ss_pred             hcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEee
Confidence            999999999999953 55433211 122345677777777888889999999987  58999999999999999999999


Q ss_pred             EeecCCccccCCCCcceecccccccccCcccccc--CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHH
Q 004689          553 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL  630 (736)
Q Consensus       553 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~  630 (736)
                      ||||++-.+.+.  ...+.-.|-..|||||.+..  ..|+.++||||+|++|+|+.||+.|+....      ++.+....
T Consensus       210 CDFGIcGqLv~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~------svfeql~~  281 (361)
T KOG1006|consen  210 CDFGICGQLVDS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD------SVFEQLCQ  281 (361)
T ss_pred             ecccchHhHHHH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH------HHHHHHHH
Confidence            999998655432  22334468899999999964  358999999999999999999999997654      12222222


Q ss_pred             hhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          631 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       631 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      . -.|+...+..+    .-..+....+...+..|+..|-..||...++.++
T Consensus       282 V-v~gdpp~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  282 V-VIGDPPILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             H-HcCCCCeecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            2 22332222211    1123344568889999999999999999998765

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.4e-31  Score=290.42  Aligned_cols=257  Identities=22%  Similarity=0.292  Sum_probs=187.9

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeC------CeEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVL  481 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~~~l  481 (736)
                      .+.+.||+|+||.||+|... +++.||+|++....  ......+.+|+.++++++||||+++++++...      ...++
T Consensus        20 ~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l   99 (345)
T cd07877          20 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL   99 (345)
T ss_pred             EEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEE
Confidence            34578999999999999764 68899999986532  22245677899999999999999999988643      34678


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      +++++ +++|.+.+..     ..+++..+..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       100 v~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877         100 VTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             Eehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccccc
Confidence            88876 7789887742     3588899999999999999999998   9999999999999999999999999998754


Q ss_pred             cCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHH-------Hhhh
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LHIE  633 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~-------~~~~  633 (736)
                      ...    .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.....       ..+.
T Consensus       171 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T cd07877         171 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  246 (345)
T ss_pred             ccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence            322    223457899999999876 5688899999999999999999999965432111111111100       0000


Q ss_pred             cCCc-------ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          634 SGDI-------QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       634 ~~~~-------~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....       ......... .........+.+++..|++.+|.+||++.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         247 SESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             cHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0000       000000000 0000123357899999999999999999999877

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=3.1e-31  Score=310.12  Aligned_cols=143  Identities=31%  Similarity=0.413  Sum_probs=126.4

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.++||+|+||+||+|... +++.||||+++.....   ....+..|+.+++.++||||+++++++......++||||
T Consensus         6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy   85 (669)
T cd05610           6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY   85 (669)
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence            345688999999999999876 6889999998754322   235688899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      +.+++|.+++..    ...+.+..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          86 LIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999853    23577888899999999999999998   99999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=6.4e-32  Score=292.79  Aligned_cols=259  Identities=22%  Similarity=0.303  Sum_probs=191.4

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCe------EE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------SV  480 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~------~~  480 (736)
                      |.+.+.||+|+||.||+|+.. +++.||||++....  ......+.+|+.++++++||||+++++++...+.      .+
T Consensus        17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   96 (343)
T cd07851          17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY   96 (343)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence            345688999999999999886 57899999886432  2233557789999999999999999998876554      89


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +|+||+ +++|.+++..     ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        97 lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          97 LVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             EEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence            999998 5699888743     4588999999999999999999998   999999999999999999999999999875


Q ss_pred             ccCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHH-------Hhh
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LHI  632 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~-------~~~  632 (736)
                      ....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.+...       ..+
T Consensus       168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            4332    223357889999999865 4678999999999999999999999975442111111111000       000


Q ss_pred             hcCCcceecc---CccCCcC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          633 ESGDIQGIID---PSLLDEY---DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       633 ~~~~~~~~~d---~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ........+.   ......+   ......++.+++.+|++.+|++|||+.||+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            0000000000   0000000   00123468899999999999999999999876

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=264.49  Aligned_cols=243  Identities=24%  Similarity=0.274  Sum_probs=195.1

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeee----CCeEEEEEEec
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE----EGRSVLVYEFM  486 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~----~~~~~lV~e~~  486 (736)
                      .++||-|-.|.|-.+.++ +++.+|+|++..     .....+|+++.-.. .|||||.++++|..    ...+.+|||.|
T Consensus        67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m  141 (400)
T KOG0604|consen   67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM  141 (400)
T ss_pred             hhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence            478999999999999776 788999999852     23456888886555 69999999998864    45778999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeecCCccccC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~---~~~~kl~DFGla~~~~~  563 (736)
                      +||.|...+.++.  .+.+.+.++..|+.||+.|+.|||+.   .|.||||||+|+|.+.   +..+||+|||+|+....
T Consensus       142 eGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  142 EGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             cchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            9999999986542  45589999999999999999999998   9999999999999975   45799999999986543


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                        .....+.+-|+.|.|||++-..+|+...|+||+||+||-|++|.+||.....    ..+.--.+..+..|..      
T Consensus       217 --~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg----~aispgMk~rI~~gqy------  284 (400)
T KOG0604|consen  217 --PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKRRIRTGQY------  284 (400)
T ss_pred             --CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC----ccCChhHHhHhhccCc------
Confidence              2233455679999999999999999999999999999999999999986652    2233333334444432      


Q ss_pred             ccCCcCC----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYD----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          +|+    ....+...+++...+..+|.+|.|+.|++.+
T Consensus       285 ----~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  285 ----EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ----cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                122    1234457788999999999999999999876

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=4.6e-31  Score=270.63  Aligned_cols=220  Identities=21%  Similarity=0.176  Sum_probs=175.0

Q ss_pred             cCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCHHHHhhc
Q 004689          419 GGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG  497 (736)
Q Consensus       419 G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~  497 (736)
                      |.||.||++... +++.||+|+++...     .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999875 68899999986542     234455555566799999999999999999999999999999998853


Q ss_pred             ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceeccccccc
Q 004689          498 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG  577 (736)
Q Consensus       498 ~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~  577 (736)
                          ...+++.....++.|++.||.|||+.   +|+||||||+||+++.++.++++|||.+......    .....++..
T Consensus        79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~  147 (237)
T cd05576          79 ----FLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM  147 (237)
T ss_pred             ----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence                23588999999999999999999998   9999999999999999999999999987654322    122346778


Q ss_pred             ccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHH
Q 004689          578 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI  657 (736)
Q Consensus       578 Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  657 (736)
                      |+|||.+.+..++.++||||+||++|||++|..|+......     +        .     ......+...    ....+
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~--------~-----~~~~~~~~~~----~~~~~  205 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I--------N-----THTTLNIPEW----VSEEA  205 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c--------c-----cccccCCccc----CCHHH
Confidence            99999998888999999999999999999999887533210     0        0     0000011111    22457


Q ss_pred             HHHHhhccCCCCCCCCCHH
Q 004689          658 EEKALMCVLPHGHMRPSIS  676 (736)
Q Consensus       658 ~~l~~~cl~~dP~~RPt~~  676 (736)
                      .+++.+|++.||++||++.
T Consensus       206 ~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         206 RSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHHccCCHHHhcCCC
Confidence            8899999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=290.04  Aligned_cols=238  Identities=21%  Similarity=0.326  Sum_probs=191.2

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEec
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .|.+...+|.|+|+.|-++.+. +++..+||++...    ..+-.+|+.++... +||||+++.+.+.+..+.++|||.+
T Consensus       323 ~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l  398 (612)
T KOG0603|consen  323 SYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELL  398 (612)
T ss_pred             hhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhc
Confidence            3456677999999999999765 6889999998654    34456778776666 7999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE-cCCCcEEEEeecCCccccCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL-DKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl-~~~~~~kl~DFGla~~~~~~~  565 (736)
                      .+|-+.+.+...     ......+..|+.+++.|+.|||++   |++|||+||+|||+ ++.++++|+|||.++..... 
T Consensus       399 ~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  399 DGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             cccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            999888877432     122256667999999999999998   99999999999999 58899999999999866444 


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                         ....+-|..|.|||++....|++++|+||||++||+|++|+.||.....+   ..+    ...+..++.        
T Consensus       470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei----~~~i~~~~~--------  531 (612)
T KOG0603|consen  470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEI----HTRIQMPKF--------  531 (612)
T ss_pred             ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHH----HHhhcCCcc--------
Confidence               22234688999999999999999999999999999999999999865522   112    122222222        


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          +........+|+.+|++.||.+||+|.|+..+
T Consensus       532 ----s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  532 ----SECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             ----ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence                22333457899999999999999999999765

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=6.6e-33  Score=266.60  Aligned_cols=263  Identities=21%  Similarity=0.299  Sum_probs=191.5

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEecc-CC-cccchhhhhHHHHHhhcCCCceeeEeeeeee--------CCeEE
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTS-NS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EGRSV  480 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~-~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--------~~~~~  480 (736)
                      -..+||+|.||+||+|+.+ +|+.||+|++-- +. ..-.....+|+.+|..++|+|++.+++.|..        ....+
T Consensus        21 k~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~y  100 (376)
T KOG0669|consen   21 KLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFY  100 (376)
T ss_pred             HHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceee
Confidence            3468999999999999876 577889976532 22 2223456789999999999999999998853        23579


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||.+|+. +|...|...   ..+++..++.+++.++..||.|+|+.   .|+|||+|+.|+||+.++.+||+|||+++.
T Consensus       101 lVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen  101 LVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             eeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence            99999986 787777532   36788899999999999999999998   999999999999999999999999999975


Q ss_pred             ccCCC---CcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHh-----
Q 004689          561 AVDGA---SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-----  631 (736)
Q Consensus       561 ~~~~~---~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~-----  631 (736)
                      +....   ....+..+-|.+|++||.+.+ +.|+++.|||+.||||.||++|.+-+.+........-|..-...+     
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            43222   122334456999999999987 679999999999999999999999888765322111111100000     


Q ss_pred             --hhcCCcceec--cCccCCcCC--HHHH------HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          632 --IESGDIQGII--DPSLLDEYD--IQSM------WKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       632 --~~~~~~~~~~--d~~l~~~~~--~~~~------~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        ..+-.+...+  .|--.+.+.  .+..      .+.++|+..++..||.+|+++++++.+
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence              0000111111  110011111  1111      256789999999999999999998865

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-31  Score=241.00  Aligned_cols=258  Identities=20%  Similarity=0.285  Sum_probs=188.4

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      -++||+|.||+||+|+.. +++-||+|.++-+.  ........+|+.+|+.++|.|||++++....+..+.+|+|||.. 
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-   85 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-   85 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-
Confidence            368999999999999866 57789999987543  22356688999999999999999999999999999999999964 


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +|..+....   .+.++......++.|+++||.++|++   .+.|||+||.|.|++.+|+.|++|||+++-++-... ..
T Consensus        86 dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr-cy  158 (292)
T KOG0662|consen   86 DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-CY  158 (292)
T ss_pred             HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE-ee
Confidence            676665322   45578888899999999999999998   999999999999999999999999999986543322 22


Q ss_pred             ecccccccccCccccccC-cCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHH--hhhcCC---cceecc
Q 004689          570 SIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL--HIESGD---IQGIID  642 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~--~~~~~~---~~~~~d  642 (736)
                      ...+-|.+|.+|.++.+. -|+...|+||.||++.|+.. |++.|.+.+..   .++.+.++.  ...+..   +..+-|
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd---dqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH---HHHHHHHHHhCCCccccCCccccCCC
Confidence            233469999999999874 58889999999999999998 66667665422   233332222  122211   111122


Q ss_pred             CccCCcCCHHHH---------HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PSLLDEYDIQSM---------WKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~---------~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      =...+.|+....         ..=.++....+.-+|..|.++++.+++
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            112222221111         112355555566688888888877654

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=289.68  Aligned_cols=250  Identities=25%  Similarity=0.377  Sum_probs=203.1

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeee-----eCCeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ-----EEGRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~-----~~~~~~lV  482 (736)
                      ..|.+.||.|.+|.||+++.. +++-+|+|++.... ....+.+.|.++|+.. .|||++.++|++.     .++.++||
T Consensus        21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV   99 (953)
T KOG0587|consen   21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV   99 (953)
T ss_pred             cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence            346789999999999999865 68889999987554 3456788899999888 6999999999985     35689999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      ||||.+|+..|++.+..  ..++.|..+.-|+.+++.||.|||..   .++|||||-.|||++.++.+||+|||.+....
T Consensus       100 MEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen  100 MEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             eeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            99999999999998776  77899999999999999999999998   99999999999999999999999999987543


Q ss_pred             CCCCcceecccccccccCccccccC-----cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                      .. .....+..||+.|||||++...     .|+..+|+||+|++..||.-|.+|+-++....        +...+...  
T Consensus       175 sT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--------aLF~IpRN--  243 (953)
T KOG0587|consen  175 ST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIPRN--  243 (953)
T ss_pred             cc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--------hhccCCCC--
Confidence            32 3344567799999999999753     36678999999999999999999997665210        11111111  


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                           |...-..+.....++.+++..|+..|-++||++.+++++
T Consensus       244 -----PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  244 -----PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             -----CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                 111112234556789999999999999999999998765

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=272.76  Aligned_cols=260  Identities=24%  Similarity=0.338  Sum_probs=197.4

Q ss_pred             HHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCccc-------chhhhhHHHHHhhcCCCceeeEeeeee-e
Q 004689          405 IEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIHHRNLVQFLGYCQ-E  475 (736)
Q Consensus       405 i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-------~~~~~~E~~il~~l~HpnIv~l~~~~~-~  475 (736)
                      ....+|.+.++||+|||+.||+|..- ..+-||||+-..+..+.       .+...+|..|.+.+.||.||++++|+. +
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            44567777899999999999999754 57789999865443221       123568999999999999999999997 4


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEE
Q 004689          476 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKV  552 (736)
Q Consensus       476 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~---~~~~kl  552 (736)
                      .+..|-|+|||+|.+|+-+|.    ..+.+++..+..|+.||+.||.||.+. .++|||-||||.|||+-.   .|.+||
T Consensus       540 tdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI  614 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI  614 (775)
T ss_pred             cccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence            567899999999999999884    456688999999999999999999996 469999999999999954   588999


Q ss_pred             EeecCCccccCCCCc------ceecccccccccCccccccC----cCCCcchhHHHHHHHHHHHhCCCcCcccccccccc
Q 004689          553 SDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQ----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCR  622 (736)
Q Consensus       553 ~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~----~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~  622 (736)
                      .|||+++.+.++...      .+....||.+|++||.+.-+    ..+.|+||||+||++|+++.|+.||......   +
T Consensus       615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---Q  691 (775)
T KOG1151|consen  615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---Q  691 (775)
T ss_pred             eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---H
Confidence            999999977544322      23456799999999998643    5788999999999999999999999865421   2


Q ss_pred             cHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          623 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       623 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .|.+.       ..+.....-....  -+....+...++.+|++..-++|....+++.+
T Consensus       692 dILqe-------NTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  692 DILQE-------NTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             HHHhh-------hchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            22221       1111111100000  01122346788999999999999888777643

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=4.3e-30  Score=262.22  Aligned_cols=238  Identities=27%  Similarity=0.424  Sum_probs=192.2

Q ss_pred             CceEEEEEEEC-CCcEEEEEEeccCCccc-chhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCHHHHhhc
Q 004689          420 GFGVVYYGKLK-DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG  497 (736)
Q Consensus       420 ~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~  497 (736)
                      +||.||+|... +++.+|+|++....... ...+.+|++.+++++|+||+++++++......++++||+.+++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 48999999987655444 67899999999999999999999999999999999999999999998853


Q ss_pred             ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceeccccccc
Q 004689          498 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG  577 (736)
Q Consensus       498 ~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~  577 (736)
                      .    ..+++..+..++.+++.++.|||+.   +++|+||+|+||+++.++.++|+|||.+.......  ......++..
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence            2    2278889999999999999999998   99999999999999999999999999997654432  2234458899


Q ss_pred             ccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHH
Q 004689          578 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI  657 (736)
Q Consensus       578 Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  657 (736)
                      |++||......++.++||||||+++++|++|..||....   ....+.++..    .+.....       ........++
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~---~~~~~~~~~~----~~~~~~~-------~~~~~~~~~~  217 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD---QLLELFKKIG----KPKPPFP-------PPEWKISPEA  217 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHh----ccCCCCc-------cccccCCHHH
Confidence            999999998889999999999999999999999997532   1112222211    1111000       0000023468


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHH
Q 004689          658 EEKALMCVLPHGHMRPSISEVLK  680 (736)
Q Consensus       658 ~~l~~~cl~~dP~~RPt~~ev~~  680 (736)
                      .+++.+|+..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            89999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=277.59  Aligned_cols=244  Identities=22%  Similarity=0.279  Sum_probs=198.3

Q ss_pred             hccccccCceEEEEEEECCCc-EEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          413 EKKIGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~~~~-~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      ...||-||||.|-+++.+... .+|+|++++....   ..+.+..|-.||..++.|.||+++..|.+..+.|+.||-|-|
T Consensus       425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG  504 (732)
T KOG0614|consen  425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG  504 (732)
T ss_pred             hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence            356999999999999887433 3899988765433   234567899999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |.|+..|+    .++.++..+..-++..+.+|++|||++   +||+|||||+|.+++.+|-+||.|||+|+.+..+  ..
T Consensus       505 GElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~K  575 (732)
T KOG0614|consen  505 GELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--RK  575 (732)
T ss_pred             chhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC--Cc
Confidence            99999995    456677778888899999999999998   9999999999999999999999999999977553  34


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      +.+++||+.|.|||++.....+.++|.||+|+++|||++|.+||.+.+.-..+..|..-+...                .
T Consensus       576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i----------------~  639 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI----------------E  639 (732)
T ss_pred             eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh----------------h
Confidence            567899999999999999999999999999999999999999998776322222222211110                2


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  681 (736)
                      ++....+...+++.+.+..+|.+|..     +.+|-+|
T Consensus       640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  640 FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            23333445677888888899999986     5666555

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=5.2e-30  Score=292.65  Aligned_cols=256  Identities=23%  Similarity=0.265  Sum_probs=167.4

Q ss_pred             HHhhccccccCceEEEEEEEC-C----CcEEEEEEeccCCcccchhhhhHHHHH---hhcCCCceeeEeee------eee
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-D----GKEIAVKVLTSNSYQGKREFTNEVTLL---SRIHHRNLVQFLGY------CQE  475 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~----~~~vAvK~l~~~~~~~~~~~~~E~~il---~~l~HpnIv~l~~~------~~~  475 (736)
                      +.+.+.||+|+||.||+|++. +    +..||||++.....       .|+.+.   +...+.++..++..      +..
T Consensus       134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-------~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-------VEIWMNERVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-------hHHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence            446789999999999999876 4    68999998753221       122222   22222333322221      245


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcccc----------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCC
Q 004689          476 EGRSVLVYEFMHNGTLKEHLYGTLT----------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS  539 (736)
Q Consensus       476 ~~~~~lV~e~~~~gsL~~~l~~~~~----------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp  539 (736)
                      ....++||||+.+++|.+++.....                .........+..++.|++.||.|||+.   +|+||||||
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP  283 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKP  283 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCH
Confidence            6678999999999999998854210                000112234557899999999999998   999999999


Q ss_pred             CCEEEcC-CCcEEEEeecCCccccCCCCcceecccccccccCccccccC----------------------cCCCcchhH
Q 004689          540 SNILLDK-HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ----------------------QLTDKSDVY  596 (736)
Q Consensus       540 ~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~~~~~DVw  596 (736)
                      +|||++. ++.+||+|||+|+..............||+.|+|||.+...                      .++.++|||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            9999986 58999999999986544444444556789999999965322                      234567999


Q ss_pred             HHHHHHHHHHhCCCcCccccc------ccccccHHHHHHHhhhcCCcceeccCccCCcCC--HHHHHHHHHHHhhccCCC
Q 004689          597 SFGVILLELISGQEAISNEKF------GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD--IQSMWKIEEKALMCVLPH  668 (736)
Q Consensus       597 SlGvvl~elltG~~p~~~~~~------~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~l~~~cl~~d  668 (736)
                      ||||+||||+++..+++....      ......+..|.......      ..+.+...+.  ........+|+.+|++.|
T Consensus       364 SlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        364 SAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             HHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            999999999998766542210      00011222332221110      0000000010  001123458999999999


Q ss_pred             CCCCCCHHHHHHH
Q 004689          669 GHMRPSISEVLKD  681 (736)
Q Consensus       669 P~~RPt~~ev~~~  681 (736)
                      |++|||++|+++|
T Consensus       438 P~kR~ta~e~L~H  450 (566)
T PLN03225        438 GRQRISAKAALAH  450 (566)
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999987

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-30  Score=242.01  Aligned_cols=199  Identities=27%  Similarity=0.406  Sum_probs=168.0

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhh-cCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSR-IHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      ...||+|+||.|-+.++. +|+-.|+|.++..- .+..++...|+.+..+ ..+|.+|.++|...+....++.||.|.- 
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-  129 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-  129 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-
Confidence            356999999999888775 78999999987653 3345566778777554 4799999999999999999999999964 


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +|..+-......+..+++...-+|+..+.+||.|||++  ..++|||+||+|||++.+|++|+||||++-.+.+...  .
T Consensus       130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA--k  205 (282)
T KOG0984|consen  130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA--K  205 (282)
T ss_pred             hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhH--H
Confidence            78777666667788899999999999999999999998  5899999999999999999999999999987655332  2


Q ss_pred             ecccccccccCcccccc----CcCCCcchhHHHHHHHHHHHhCCCcCcccc
Q 004689          570 SIVRGTVGYLDPEYYIS----QQLTDKSDVYSFGVILLELISGQEAISNEK  616 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~----~~~~~~~DVwSlGvvl~elltG~~p~~~~~  616 (736)
                      +...|-..|||||.+..    ..|+-++||||+|+.+.||.+++.||+...
T Consensus       206 t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  206 TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            23458889999999853    378999999999999999999999998654

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2.1e-29  Score=280.69  Aligned_cols=259  Identities=22%  Similarity=0.333  Sum_probs=176.9

Q ss_pred             HHhhccccccCceEEEEEEE-----------------CCCcEEEEEEeccCCcccch--------------hhhhHHHHH
Q 004689          410 KMLEKKIGSGGFGVVYYGKL-----------------KDGKEIAVKVLTSNSYQGKR--------------EFTNEVTLL  458 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~-----------------~~~~~vAvK~l~~~~~~~~~--------------~~~~E~~il  458 (736)
                      +.+.++||+|+||+||+|..                 ..++.||||++.........              ....|+.++
T Consensus       147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l  226 (507)
T PLN03224        147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC  226 (507)
T ss_pred             ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence            44578999999999999964                 23567999998654322222              233467777


Q ss_pred             hhcCCCce-----eeEeeeeee--------CCeEEEEEEecCCCCHHHHhhcccc--------------------ccccc
Q 004689          459 SRIHHRNL-----VQFLGYCQE--------EGRSVLVYEFMHNGTLKEHLYGTLT--------------------HEQRI  505 (736)
Q Consensus       459 ~~l~HpnI-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~~l  505 (736)
                      .+++|.++     ++++++|..        .+..+|||||+++|+|.++++....                    ....+
T Consensus       227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~  306 (507)
T PLN03224        227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR  306 (507)
T ss_pred             HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence            77776654     677888753        3567999999999999999864321                    11234


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceecccccccccCccccc
Q 004689          506 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI  585 (736)
Q Consensus       506 ~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~  585 (736)
                      ++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..............+|+.|+|||.+.
T Consensus       307 ~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        307 DINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence            6778889999999999999998   9999999999999999999999999999754332222222233588999999985


Q ss_pred             cCc--------------------C--CCcchhHHHHHHHHHHHhCCC-cCccccc-c----cccccHHHHHHHhhhcCCc
Q 004689          586 SQQ--------------------L--TDKSDVYSFGVILLELISGQE-AISNEKF-G----ANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       586 ~~~--------------------~--~~~~DVwSlGvvl~elltG~~-p~~~~~~-~----~~~~~l~~~~~~~~~~~~~  637 (736)
                      ...                    +  ..+.||||+||+++||++|.. |+..... .    .....+..|...  .....
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~~~~~  461 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--KGQKY  461 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--cccCC
Confidence            432                    1  134699999999999999875 6653211 0    011122223221  11111


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCC---CCCCCHHHHHHH
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHG---HMRPSISEVLKD  681 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP---~~RPt~~ev~~~  681 (736)
                          +-...    ........+++.+++..+|   .+|+|+.|+++|
T Consensus       462 ----~~~~~----d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        462 ----DFSLL----DRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             ----Ccccc----cccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence                00001    1122346778888888755   789999999876

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-30  Score=284.43  Aligned_cols=244  Identities=27%  Similarity=0.379  Sum_probs=187.6

Q ss_pred             hccccccCce-EEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          413 EKKIGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       413 ~~~IG~G~fG-~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      .+++|.|+-| .||+|... |++||||++-..   ......+|+..|+.- .|||||++++.-.+++..|+..|.|.. +
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-s  588 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-S  588 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-h
Confidence            4678999988 57999987 899999987533   234567899999988 699999999999999999999999975 9


Q ss_pred             HHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---C--CcEEEEeecCCccccCCC
Q 004689          491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---H--MRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       491 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~---~--~~~kl~DFGla~~~~~~~  565 (736)
                      |.+++...........-...+.+..|+++||+|||+.   +||||||||.||||+.   +  .+++|+|||+++....+.
T Consensus       589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            9999975311111112144567889999999999997   9999999999999976   2  579999999999776555


Q ss_pred             Ccc--eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhC-CCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          566 SHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       566 ~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      ...  .....||-+|+|||++....-+.++||||+|||+|+.++| ..||.+...  ...+|+.-      +..+..+  
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~~------~~~L~~L--  735 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILTG------NYTLVHL--  735 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhcC------ccceeee--
Confidence            433  3456799999999999988888899999999999999995 899975431  11122210      0111111  


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                         ...  .++  +..+|+.+|++++|..||++.+|+.|
T Consensus       736 ---~~~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  736 ---EPL--PDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             ---ccC--chH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence               111  111  67899999999999999999999865

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-30  Score=264.34  Aligned_cols=273  Identities=19%  Similarity=0.255  Sum_probs=205.2

Q ss_pred             cccCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCC--C----ceeeEe
Q 004689          398 HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--R----NLVQFL  470 (736)
Q Consensus       398 ~~~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H--p----nIv~l~  470 (736)
                      ..+...|....+|.+...+|+|.||.|-.+... .+..||||+++.-... .+...-|+++|+++.+  |    -+|.+.
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~  157 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMR  157 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence            346677887888888999999999999999655 4688999998754322 3445679999999942  2    278888


Q ss_pred             eeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC----
Q 004689          471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK----  546 (736)
Q Consensus       471 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~----  546 (736)
                      +||.-.++.|+|+|.+ |-++.++|...  ....++...+..|+.|+++++++||+.   +++|-||||+|||+.+    
T Consensus       158 ~wFdyrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~  231 (415)
T KOG0671|consen  158 DWFDYRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF  231 (415)
T ss_pred             hhhhccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence            9999999999999987 55899999643  356788899999999999999999998   9999999999999932    


Q ss_pred             ----------------CCcEEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCC
Q 004689          547 ----------------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE  610 (736)
Q Consensus       547 ----------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~  610 (736)
                                      +..+||+|||.|++.....    ...+.|..|+|||++.+-..+..+||||+||||.|+.+|..
T Consensus       232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             EEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence                            3458999999998643322    44568999999999999999999999999999999999999


Q ss_pred             cCcccccccc-----------cccHHHHH--HHhhhcCCc-----------ceeccCccCC----cCCHHHHHHHHHHHh
Q 004689          611 AISNEKFGAN-----------CRNIVQWA--KLHIESGDI-----------QGIIDPSLLD----EYDIQSMWKIEEKAL  662 (736)
Q Consensus       611 p~~~~~~~~~-----------~~~l~~~~--~~~~~~~~~-----------~~~~d~~l~~----~~~~~~~~~l~~l~~  662 (736)
                      .|+.-..-+.           ...++...  ......+.+           ....+++...    .....+..++.+|+.
T Consensus       308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~  387 (415)
T KOG0671|consen  308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR  387 (415)
T ss_pred             ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence            8875442111           11111111  111111111           1111111110    112455667999999


Q ss_pred             hccCCCCCCCCCHHHHHHH
Q 004689          663 MCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       663 ~cl~~dP~~RPt~~ev~~~  681 (736)
                      .|+..||.+|+|++|++.+
T Consensus       388 ~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  388 RMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHccCccccccHHHHhcC
Confidence            9999999999999999875

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.6e-29  Score=267.89  Aligned_cols=209  Identities=25%  Similarity=0.367  Sum_probs=174.6

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCccc---chhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.||-|+||+|.+++.. +...+|+|.+++.+.-.   ....+.|-.||.....+-||+|+-.|.+++.+|+||+|++||
T Consensus       635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG  714 (1034)
T KOG0608|consen  635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG  714 (1034)
T ss_pred             eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence            45999999999999654 56678999987654322   334678999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc--------
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA--------  561 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~--------  561 (736)
                      ++..+|...    +-|.+..+.-++.+++.|+++.|..   |+|||||||+|||||.+|++||.||||+.-+        
T Consensus       715 DmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  715 DMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             cHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            999998532    3456666677888999999999998   9999999999999999999999999997421        


Q ss_pred             -cCCCCcc---------------------------------eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh
Q 004689          562 -VDGASHV---------------------------------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS  607 (736)
Q Consensus       562 -~~~~~~~---------------------------------~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt  607 (736)
                       ..+ .+.                                 ....+||+.|+|||++....|+.-+|.||.|||||||+.
T Consensus       788 Yq~g-dH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  788 YQEG-DHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV  866 (1034)
T ss_pred             ccCC-CccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence             110 000                                 112459999999999999999999999999999999999


Q ss_pred             CCCcCcccccccccccHHHHHHH
Q 004689          608 GQEAISNEKFGANCRNIVQWAKL  630 (736)
Q Consensus       608 G~~p~~~~~~~~~~~~l~~~~~~  630 (736)
                      |+.||-.....+....+..|...
T Consensus       867 g~~pf~~~tp~~tq~kv~nw~~~  889 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQYKVINWRNF  889 (1034)
T ss_pred             CCCCccCCCCCcceeeeeehhhc
Confidence            99999988877777788888553

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-29  Score=251.38  Aligned_cols=245  Identities=22%  Similarity=0.298  Sum_probs=193.2

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEec
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      +.++||+|+|+.|-.++++ +.+-+|+|++++.-   .++....+.|-.+..+. +||.+|.|+.+|..+.++++|.||+
T Consensus       254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv  333 (593)
T KOG0695|consen  254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV  333 (593)
T ss_pred             eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence            4578999999999999876 57789999987653   22334456677666665 7999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      +||+|.-++    +..+++++..+.-+..+|.-||.|||++   |||.||+|..|||+|.+|++||.|+|+++.-. ...
T Consensus       334 ~ggdlmfhm----qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l-~~g  405 (593)
T KOG0695|consen  334 NGGDLMFHM----QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-GPG  405 (593)
T ss_pred             cCcceeeeh----hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC-CCC
Confidence            999998777    3456799999999999999999999999   99999999999999999999999999987532 233


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      ..+.+++|||.|+|||++.+..|...+|.|++||+|+||+.|+.||+-........+-.++....+-+.++.        
T Consensus       406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir--------  477 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR--------  477 (593)
T ss_pred             cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--------
Confidence            455678899999999999999999999999999999999999999986543333334444444443333221        


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCC
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPS  674 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt  674 (736)
                      -  +.....+...+...-+..||.+|..
T Consensus       478 i--prslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  478 I--PRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             c--cceeehhhHHHHHHhhcCCcHHhcC
Confidence            1  1111123455667778889988753

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=1.7e-28  Score=233.31  Aligned_cols=257  Identities=19%  Similarity=0.323  Sum_probs=195.1

Q ss_pred             HHHhhccccccCceEEEEEEE-CCCcEEEEEEeccCCcccchhhhhHHHHHhhcC-CCceeeEeeeeeeCC--eEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEG--RSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~--~~~lV~e  484 (736)
                      .|++.+++|+|.|++||.|.. .+++.++||+++..   ..+.+.+|+.||+.+. ||||++|+++..++.  ...||+|
T Consensus        39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE  115 (338)
T KOG0668|consen   39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE  115 (338)
T ss_pred             hHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence            456789999999999999974 46788999998743   3567899999999996 999999999997654  5689999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeecCCccccC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVD  563 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~-~~~kl~DFGla~~~~~  563 (736)
                      |+.+.+....-       +.+.-..+...+.++++||.|+|+.   ||+|||+||.|+++|.. ...+|+|+|+|.+...
T Consensus       116 ~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  116 YVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             hhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            99997765543       4466667778899999999999998   99999999999999975 5699999999987655


Q ss_pred             CCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhc------CC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES------GD  636 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~------~~  636 (736)
                      +...  ...+.+..|..||.+.. ..|+..-|+|||||++..|+..+.||....  +...+++..++-.-.+      .+
T Consensus       186 ~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~--dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  186 GKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH--DNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             Ccee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC--CCHHHHHHHHHHhChHHHHHHHHH
Confidence            4433  23456888999999875 568889999999999999999999997543  2334555544322110      01


Q ss_pred             cceeccCccCC---cCC-------------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          637 IQGIIDPSLLD---EYD-------------IQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       637 ~~~~~d~~l~~---~~~-------------~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      ..--+|++..+   .+.             .-...+.++++...+..|-.+|||++|.+.+-
T Consensus       262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp  323 (338)
T KOG0668|consen  262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP  323 (338)
T ss_pred             HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence            11113333211   110             00124578889999999999999999998873

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.7e-28  Score=252.86  Aligned_cols=280  Identities=20%  Similarity=0.307  Sum_probs=202.8

Q ss_pred             CCcccccccCHHHHHH-HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcC-----C-
Q 004689          392 APAEAAHCFTLSDIED-ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----H-  463 (736)
Q Consensus       392 ~~~~~~~~~~~~~i~~-~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-----H-  463 (736)
                      ....+.|+...+|... .+|.+.++||-|-|++||++... ..+.||+|+.+.... -.+....||.+|++++     | 
T Consensus        61 Y~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~  139 (590)
T KOG1290|consen   61 YRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDP  139 (590)
T ss_pred             hhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCC
Confidence            3345667777888777 88888999999999999999754 577899999875432 2455678999999993     3 


Q ss_pred             --CceeeEeeeeee----CCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCC
Q 004689          464 --RNLVQFLGYCQE----EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL  537 (736)
Q Consensus       464 --pnIv~l~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDi  537 (736)
                        ..||+|++.|..    +.+.|||+|++ |.+|..+|...  ..+.++...+.+|+.||+.||.|||++|  +|||-||
T Consensus       140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDl  214 (590)
T KOG1290|consen  140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDL  214 (590)
T ss_pred             CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCC
Confidence              469999999964    56899999988 44777777543  3567899999999999999999999997  9999999


Q ss_pred             CCCCEEEcCC----------------------------------------------------------------------
Q 004689          538 KSSNILLDKH----------------------------------------------------------------------  547 (736)
Q Consensus       538 kp~NILl~~~----------------------------------------------------------------------  547 (736)
                      ||+|||+..+                                                                      
T Consensus       215 KPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~  294 (590)
T KOG1290|consen  215 KPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGI  294 (590)
T ss_pred             CcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccc
Confidence            9999999200                                                                      


Q ss_pred             --------------------------------------------------------------------------------
Q 004689          548 --------------------------------------------------------------------------------  547 (736)
Q Consensus       548 --------------------------------------------------------------------------------  547 (736)
                                                                                                      
T Consensus       295 ~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~  374 (590)
T KOG1290|consen  295 EEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTI  374 (590)
T ss_pred             cccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccc
Confidence                                                                                            


Q ss_pred             ----------------CcEEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCc
Q 004689          548 ----------------MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA  611 (736)
Q Consensus       548 ----------------~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p  611 (736)
                                      .+|||+|||-|+....    ..+.-..|..|+|||++.+..|+..+||||++|+++||+||...
T Consensus       375 ~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyL  450 (590)
T KOG1290|consen  375 ASNPLVNPDIPLPECDIRVKIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYL  450 (590)
T ss_pred             ccccccCCCCCCCccceeEEEeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCcee
Confidence                            0134444444433211    11112258899999999999999999999999999999999988


Q ss_pred             Ccccc---cccccccHHHHHH-------Hhhhc-----------CCcceeccCccCC---------cCCHHHHHHHHHHH
Q 004689          612 ISNEK---FGANCRNIVQWAK-------LHIES-----------GDIQGIIDPSLLD---------EYDIQSMWKIEEKA  661 (736)
Q Consensus       612 ~~~~~---~~~~~~~l~~~~~-------~~~~~-----------~~~~~~~d~~l~~---------~~~~~~~~~l~~l~  661 (736)
                      |+...   .......|...+.       .....           |.+..+-.-..++         +++.++..++.+++
T Consensus       451 FePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL  530 (590)
T KOG1290|consen  451 FEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFL  530 (590)
T ss_pred             ecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHH
Confidence            86432   2222222222111       11111           2222221111111         34577788999999


Q ss_pred             hhccCCCCCCCCCHHHHHHH
Q 004689          662 LMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       662 ~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .-|++.+|++|||+.+.+++
T Consensus       531 ~PmLef~PeKR~tA~~cl~h  550 (590)
T KOG1290|consen  531 SPMLEFDPEKRPTAAQCLKH  550 (590)
T ss_pred             HHHHhcCccccccHHHHhcC
Confidence            99999999999999999876

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.3e-30  Score=249.55  Aligned_cols=263  Identities=22%  Similarity=0.287  Sum_probs=190.6

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccC--CcccchhhhhHHHHHhhcCCCceeeEeeeeeeCC-----eEEEEEE
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-----RSVLVYE  484 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~lV~e  484 (736)
                      .+.||-|+||.||..++. +|+.||.|++...  ...+.+.+.+|+.+|..++|.|++..+++.....     ..|+++|
T Consensus        58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE  137 (449)
T KOG0664|consen   58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE  137 (449)
T ss_pred             CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence            467999999999999765 7999999988643  2234567889999999999999999988765442     4467778


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      .|.. +|...+    ...+.++...+.-+..||++||.|||+.   +|+||||||.|.|++.+...||||||+++....+
T Consensus       138 LmQS-DLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  138 LMQS-DLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHh-hhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchh
Confidence            7753 555544    4566788888888999999999999998   9999999999999999999999999999976555


Q ss_pred             CCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccc---------------cHHHHH
Q 004689          565 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR---------------NIVQWA  628 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~---------------~l~~~~  628 (736)
                      .....+..+-|..|+|||++.+ +.|+.+.||||.||++.||+..+..|.....-+..+               .-.+-+
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            4444555567999999999987 679999999999999999998888776443111000               111112


Q ss_pred             HHhhhcCCcceeccCccCCcCC-HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          629 KLHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       629 ~~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      +.++-.+....---+.+..-.+ ...-.+-..+.+.++..||.+|.+..+.+.++.
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            2222111111000011111001 112234567788899999999999999887764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=3.5e-27  Score=234.54  Aligned_cols=211  Identities=35%  Similarity=0.609  Sum_probs=182.2

Q ss_pred             ccccCceEEEEEEECC-CcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCHHH
Q 004689          416 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE  493 (736)
Q Consensus       416 IG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~~  493 (736)
                      ||+|.+|.||++.... ++++++|++...... ....+.+|++.++.++|++++++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999998864 899999998755432 34678999999999999999999999999999999999999999999


Q ss_pred             HhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeecCCccccCCCCcceecc
Q 004689          494 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSIV  572 (736)
Q Consensus       494 ~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~  572 (736)
                      ++....   ..+++..+..++.++++++.+||+.   +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence            985321   3578889999999999999999998   9999999999999999 89999999999875543321 12234


Q ss_pred             cccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCH
Q 004689          573 RGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI  651 (736)
Q Consensus       573 ~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  651 (736)
                      .+...|++||..... .++.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            578899999999877 888999999999999999                                              


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          652 QSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       652 ~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                         ..+.+++..|++.+|.+||++.++++++
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence               3578899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=8e-28  Score=239.83  Aligned_cols=249  Identities=25%  Similarity=0.336  Sum_probs=187.7

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccC--CcccchhhhhHHHHHhhcCCCceeeEeeeeeeC------CeEEEEEE
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVLVYE  484 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~~~lV~e  484 (736)
                      ..+|.|.- .|..|.+. .+++||+|++...  .....+...+|..++..++|+||++++.++.-.      ...|+|||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            46788877 56555433 6899999987543  233456678899999999999999999998644      35689999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      +|. ++|...+.      ..++-.+...|..|++.|+.|||+.   +|+||||||+||++..++.+||.|||+|+.....
T Consensus       102 ~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~  171 (369)
T KOG0665|consen  102 LMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD  171 (369)
T ss_pred             hhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc
Confidence            996 48888775      2355667788999999999999998   9999999999999999999999999999754322


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCc-------
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI-------  637 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~-------  637 (736)
                        ...+..+.|..|.|||++.+..|.+.+||||.||++.||++|..-|.+..      .+-+|.+-.-..|..       
T Consensus       172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d------~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD------HIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch------HHHHHHHHHHHhcCCCHHHHHH
Confidence              34455668999999999999999999999999999999999998887543      333443332111111       


Q ss_pred             --------------------ceeccCcc-CC--cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 --------------------QGIIDPSL-LD--EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 --------------------~~~~d~~l-~~--~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                                          .+.+...+ ..  +.+........+++.+|+-.+|++|-+++++++|
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                                01110000 00  0111223457889999999999999999999987

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=1.7e-28  Score=257.08  Aligned_cols=279  Identities=18%  Similarity=0.271  Sum_probs=211.3

Q ss_pred             cccccccCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcC------CCce
Q 004689          394 AEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH------HRNL  466 (736)
Q Consensus       394 ~~~~~~~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~------HpnI  466 (736)
                      +++.-.+.++++.+..|.+....|+|-|++|.+|... .|..||||+++.+... .+.=..|++||++|+      --+.
T Consensus       418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hc  496 (752)
T KOG0670|consen  418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHC  496 (752)
T ss_pred             ccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHH
Confidence            4666778899999999999889999999999999865 4789999999876543 233457999999995      3478


Q ss_pred             eeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 004689          467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK  546 (736)
Q Consensus       467 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~  546 (736)
                      ++|+..|...+++|||+|-+. .+|.+.|... .....|....+..++.|+.-||.+|...   +|+|.||||.||||++
T Consensus       497 lrl~r~F~hknHLClVFE~Ls-lNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE  571 (752)
T KOG0670|consen  497 LRLFRHFKHKNHLCLVFEPLS-LNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNE  571 (752)
T ss_pred             HHHHHHhhhcceeEEEehhhh-chHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEecc
Confidence            999999999999999999764 5888988654 3456688888999999999999999997   9999999999999997


Q ss_pred             C-CcEEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHH
Q 004689          547 H-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV  625 (736)
Q Consensus       547 ~-~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~  625 (736)
                      . ..+||||||.|.........   ...-+..|.|||++.+-.|+...|+||.||.||||.||+..|.+.....+..-..
T Consensus       572 ~k~iLKLCDfGSA~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m  648 (752)
T KOG0670|consen  572 SKNILKLCDFGSASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM  648 (752)
T ss_pred             CcceeeeccCcccccccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence            6 46899999999765443221   1123567999999999999999999999999999999999998765432211111


Q ss_pred             HH----HHHhhhcCCcc---------------------------eeccC------ccCC-----cCCHHHHHHHHHHHhh
Q 004689          626 QW----AKLHIESGDIQ---------------------------GIIDP------SLLD-----EYDIQSMWKIEEKALM  663 (736)
Q Consensus       626 ~~----~~~~~~~~~~~---------------------------~~~d~------~l~~-----~~~~~~~~~l~~l~~~  663 (736)
                      +.    -..+++.|.+.                           ..+.|      .+..     +-.......+.+|+..
T Consensus       649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk  728 (752)
T KOG0670|consen  649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK  728 (752)
T ss_pred             HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence            10    00111111110                           00111      0111     1123445678899999


Q ss_pred             ccCCCCCCCCCHHHHHHH
Q 004689          664 CVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       664 cl~~dP~~RPt~~ev~~~  681 (736)
                      |+..||++|.|..|.++|
T Consensus       729 ml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  729 MLILDPEKRITVNQALKH  746 (752)
T ss_pred             HhccChhhcCCHHHHhcC
Confidence            999999999999998765

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=9.9e-28  Score=254.43  Aligned_cols=192  Identities=22%  Similarity=0.421  Sum_probs=164.4

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--------cchhhhhHHHHHhhcC---CCceeeEeeeeeeCCeE
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--------~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~  479 (736)
                      ..+.+|+|+||.|+.|.++ +..+|+||.+.+...-        .......|++||..++   |+||++++++|++++.+
T Consensus       565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y  644 (772)
T KOG1152|consen  565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY  644 (772)
T ss_pred             eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence            3578999999999999887 4678999998765321        1223667999999997   99999999999999999


Q ss_pred             EEEEEec-CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCC
Q 004689          480 VLVYEFM-HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS  558 (736)
Q Consensus       480 ~lV~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla  558 (736)
                      ||+||-. ++-+|.+++    .....+++..+..|+.|++.|+++||++   +|+|||||-+||.++.+|-+||+|||.|
T Consensus       645 yl~te~hg~gIDLFd~I----E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  645 YLETEVHGEGIDLFDFI----EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             EEEecCCCCCcchhhhh----hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccch
Confidence            9999975 455888888    4567799999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCCcceecccccccccCccccccCcCCC-cchhHHHHHHHHHHHhCCCcCc
Q 004689          559 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-KSDVYSFGVILLELISGQEAIS  613 (736)
Q Consensus       559 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~-~~DVwSlGvvl~elltG~~p~~  613 (736)
                      .+...+.   ...++||..|.|||++.+..|-- .-|||++|++||-++....||.
T Consensus       718 a~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  718 AYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            7765443   34567999999999999888764 5699999999999998888875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=2.4e-26  Score=232.22  Aligned_cols=197  Identities=35%  Similarity=0.543  Sum_probs=170.1

Q ss_pred             hhccccccCceEEEEEEECC-CcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.+.||+|++|.||++...+ ++.+|+|.+...... ....+.+|++.+++++|+|++++++++......++++||+.++
T Consensus         3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~   82 (225)
T smart00221        3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG   82 (225)
T ss_pred             eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence            45789999999999999875 889999998765443 4668889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +|.+++.....   .+++.....++.+++.++.+||+.   +++|+||+|.||+++.++.++|+|||.+...........
T Consensus        83 ~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       83 DLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            99999854321   178889999999999999999998   999999999999999999999999999886544321122


Q ss_pred             ecccccccccCcccc-ccCcCCCcchhHHHHHHHHHHHhCCCcCcc
Q 004689          570 SIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELISGQEAISN  614 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~-~~~~~~~~~DVwSlGvvl~elltG~~p~~~  614 (736)
                      ....++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            334578899999998 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=6.1e-27  Score=252.36  Aligned_cols=250  Identities=22%  Similarity=0.338  Sum_probs=196.8

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      .+..++|.|.||.||||+.. +++..|+|+++-.......-..+|+-+++..+||||+.++|.+......+++||||.+|
T Consensus        18 ellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg   97 (829)
T KOG0576|consen   18 ELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG   97 (829)
T ss_pred             hheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence            35578999999999999865 68899999998776667777889999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +|.+.-+.    ...+.+.+..-++++..+||+|||+.   +=+|||||-.||++++.|.+|++|||.+-.+.... ...
T Consensus        98 slQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati-~Kr  169 (829)
T KOG0576|consen   98 SLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATI-AKR  169 (829)
T ss_pred             cccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhh-hhh
Confidence            99987643    35577888888999999999999998   88999999999999999999999999985443221 223


Q ss_pred             ecccccccccCccccc---cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          570 SIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~---~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      ..+.||+.|||||+..   .+.|...+|||++|+...|+---++|..+..        ...+...+....    +++-..
T Consensus       170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--------pmr~l~LmTkS~----~qpp~l  237 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--------PMRALFLMTKSG----FQPPTL  237 (829)
T ss_pred             hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--------hHHHHHHhhccC----CCCCcc
Confidence            4467999999999974   5679999999999999999988777754332        111122221111    111111


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .+ .......+-+++..|+..+|++||+++.++++
T Consensus       238 kD-k~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  238 KD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             cC-CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            11 11223457789999999999999999987754

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=8e-25  Score=213.28  Aligned_cols=252  Identities=20%  Similarity=0.304  Sum_probs=181.1

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeee-eeeCCeEEEEEEe
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGY-CQEEGRSVLVYEF  485 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~-~~~~~~~~lV~e~  485 (736)
                      .|.+.+.+|+|.||.+-++.++ +.+.+++|.+... ....++|.+|..-=-.| .|.||+.-++. |...+.+++++||
T Consensus        25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~  103 (378)
T KOG1345|consen   25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF  103 (378)
T ss_pred             hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence            4567889999999999999987 5678999987643 33467788887654444 58999988764 5677788999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC--CCcEEEEeecCCccccC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~--~~~~kl~DFGla~~~~~  563 (736)
                      ++.|+|.+.+.     ...+-+....+++.|+++|+.|||++   .+||||||.+||||-.  ..++||||||+++..+.
T Consensus       104 aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  104 APRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             CccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            99999998873     24566777889999999999999998   9999999999999943  35899999999864322


Q ss_pred             CCCcceecccccccccCccccccC-----cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQ-----QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      .    .....-+..|.+||.....     ...+.+|+|.||++++.+++|+.||+...  ..+....+|..-  ..+...
T Consensus       176 t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~--~~d~~Y~~~~~w--~~rk~~  247 (378)
T KOG1345|consen  176 T----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS--IMDKPYWEWEQW--LKRKNP  247 (378)
T ss_pred             e----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh--ccCchHHHHHHH--hcccCc
Confidence            1    1222346679999987542     35577899999999999999999998543  223344444332  222221


Q ss_pred             eeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       639 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                           ++...+.. ...++..+-.+-+.++|++|=...++.++-.
T Consensus       248 -----~~P~~F~~-fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  248 -----ALPKKFNP-FSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             -----cCchhhcc-cCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence                 11111111 1123556666778899998855556555443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=9.6e-26  Score=270.16  Aligned_cols=196  Identities=18%  Similarity=0.271  Sum_probs=139.3

Q ss_pred             hcCC-CceeeEeeee-------eeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 004689          460 RIHH-RNLVQFLGYC-------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA  531 (736)
Q Consensus       460 ~l~H-pnIv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~  531 (736)
                      .++| +||++++++|       ......++++|++ +++|.++|...   ...+++..++.++.||++||.|||++   +
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            4556 6888888887       2334567888887 56999999532   34589999999999999999999998   9


Q ss_pred             eecCCCCCCCEEEcCC-------------------CcEEEEeecCCccccCCC---------------Ccceeccccccc
Q 004689          532 IIHRDLKSSNILLDKH-------------------MRAKVSDFGLSKFAVDGA---------------SHVSSIVRGTVG  577 (736)
Q Consensus       532 iiHrDikp~NILl~~~-------------------~~~kl~DFGla~~~~~~~---------------~~~~~~~~gt~~  577 (736)
                      |+||||||+||||+..                   +.+|++|||+++......               ........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            9999999999999654                   455666666664321100               000112358899


Q ss_pred             ccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHH
Q 004689          578 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI  657 (736)
Q Consensus       578 Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l  657 (736)
                      |||||++.+..++.++|||||||+||||++|..|+....     ..+......         .+.+..     .....+.
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~---------~~~~~~-----~~~~~~~  241 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHR---------VLPPQI-----LLNWPKE  241 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHh---------hcChhh-----hhcCHHH
Confidence            999999999999999999999999999999988765321     011111000         011110     1112335


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHHH
Q 004689          658 EEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       658 ~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..++..|++++|.+||+|.||+++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhc
Confidence            678889999999999999999764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.92  E-value=3.1e-25  Score=229.48  Aligned_cols=258  Identities=22%  Similarity=0.318  Sum_probs=190.2

Q ss_pred             HHhhccccccCceEEEEEEEC----CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      +...++||+|.|++||+|.+.    ..+.||+|.+...+  ....+.+|+++|..+ .+.||+++.+++...+..++|+|
T Consensus        38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp  115 (418)
T KOG1167|consen   38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP  115 (418)
T ss_pred             hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence            345789999999999999754    36789999886443  345688999999999 58999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeecCCcccc-
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAV-  562 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~-~~~kl~DFGla~~~~-  562 (736)
                      |++.....++..       .++...+..++..+..||.++|..   |||||||||+|+|.+.. +.-.|.|||+|.... 
T Consensus       116 ~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~  185 (418)
T KOG1167|consen  116 YFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG  185 (418)
T ss_pred             ccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHh
Confidence            999988888763       356778888999999999999998   99999999999999865 778999999986110 


Q ss_pred             ----------------C--C--------------CCc----------ceecccccccccCcccccc-CcCCCcchhHHHH
Q 004689          563 ----------------D--G--------------ASH----------VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFG  599 (736)
Q Consensus       563 ----------------~--~--------------~~~----------~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlG  599 (736)
                                      .  +              ...          ......||++|.|||++.. ...+.++||||.|
T Consensus       186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G  265 (418)
T KOG1167|consen  186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence                            0  0              000          0112459999999999975 5678999999999


Q ss_pred             HHHHHHHhCCCcCcccccccccccHHHHHH---------HhhhcCC--cce----------------e-ccCccCCc---
Q 004689          600 VILLELISGQEAISNEKFGANCRNIVQWAK---------LHIESGD--IQG----------------I-IDPSLLDE---  648 (736)
Q Consensus       600 vvl~elltG~~p~~~~~~~~~~~~l~~~~~---------~~~~~~~--~~~----------------~-~d~~l~~~---  648 (736)
                      |+++-+++++.||......  ...+.+.+.         .....|.  +.+                + ........   
T Consensus       266 VI~Lslls~~~PFf~a~dd--~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n  343 (418)
T KOG1167|consen  266 VILLSLLSRRYPFFKAKDD--ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN  343 (418)
T ss_pred             ceeehhhccccccccCccc--cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence            9999999999999654321  112221111         0111122  111                0 00000000   


Q ss_pred             -----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          649 -----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       649 -----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                           ........++++..+|+..||.+|-|+++.+++
T Consensus       344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                 011112357899999999999999999999877

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=7.7e-24  Score=206.46  Aligned_cols=168  Identities=20%  Similarity=0.171  Sum_probs=126.4

Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++...   ...+++..++.++.|+++||.|||++   +      ||+|||++.++.+|+  ||+++......   
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            6888888532   34589999999999999999999997   4      999999999999999  99987653322   


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                         ..||+.|||||++.+..++.++|||||||++|||++|+.||......  ...+..+.... ....      +.-. .
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~-~~~~------~~~~-~  130 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGM-PADD------PRDR-S  130 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHh-ccCC------cccc-c
Confidence               25899999999999999999999999999999999999999654311  11111111111 1100      0000 0


Q ss_pred             CCHHHH--HHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          649 YDIQSM--WKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       649 ~~~~~~--~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      ......  ..+.+++.+|+..+|.+||++.|+++++....
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            011111  25899999999999999999999999998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=4.1e-22  Score=213.68  Aligned_cols=261  Identities=21%  Similarity=0.256  Sum_probs=196.1

Q ss_pred             HHHhhccccccCceEEEEEEECCC--cEEEEEEeccCCcccchhhhhHHHHHhhcCC----CceeeEeeee-eeCCeEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDG--KEIAVKVLTSNSYQGKREFTNEVTLLSRIHH----RNLVQFLGYC-QEEGRSVL  481 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~--~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H----pnIv~l~~~~-~~~~~~~l  481 (736)
                      .+.+.++||+|+||.||++.....  ..+|+|+...........+..|+.++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            566789999999999999987653  4789998765543333378899999999973    6888999888 47778899


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-----CcEEEEeec
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-----MRAKVSDFG  556 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~-----~~~kl~DFG  556 (736)
                      ||+.+ |.+|.++.....  .+.++..+.+.|+.|++.+|++||+.   |++||||||.|+++...     ..+.|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99976 679998764432  57899999999999999999999998   99999999999999865     469999999


Q ss_pred             CCc--ccc-CCCC---cc---eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHH
Q 004689          557 LSK--FAV-DGAS---HV---SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW  627 (736)
Q Consensus       557 la~--~~~-~~~~---~~---~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~  627 (736)
                      +++  ... ....   ..   .....||..|+++....+...+.+.|+||++.++.|++.|..||...........+...
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~  252 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD  252 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence            998  321 1111   11   23456999999999999999999999999999999999999999765422221111111


Q ss_pred             HHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          628 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       628 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                      ....        ....     ........+.++...+-..+...+|....+...|+.....
T Consensus       253 ~~~~--------~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  253 PRKL--------LTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             hhhh--------cccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            1111        0110     1111223455666666668899999999999999887653

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=9.1e-24  Score=205.61  Aligned_cols=247  Identities=20%  Similarity=0.308  Sum_probs=189.6

Q ss_pred             HhhccccccCceEEEEEEECCCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      ++..+|.+...|+.|+|++. |..+++|++....  ....++|.+|.-.|+.+.||||+.++|.|..+.+..++..||+.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            45667899999999999998 7788889886543  23457899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE--eecCCccccCCCC
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS--DFGLSKFAVDGAS  566 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~--DFGla~~~~~~~~  566 (736)
                      |+|...|++..  .-..+..++.+++.++|+|++|||+. .+-|..--+.+..|++|++.+++|+  |--++.   .   
T Consensus       272 gslynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf---q---  342 (448)
T KOG0195|consen  272 GSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---Q---  342 (448)
T ss_pred             hHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee---e---
Confidence            99999998653  44567778899999999999999996 3233344689999999999988874  322211   1   


Q ss_pred             cceecccccccccCccccccCcCC---CcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLT---DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~---~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                        .....-.+.||+||.++..+-+   .++|+|||++++|||.|...||.+-..-+....+      .          -.
T Consensus       343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------a----------le  404 (448)
T KOG0195|consen  343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------A----------LE  404 (448)
T ss_pred             --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh------h----------hc
Confidence              0112246889999999876543   5789999999999999999999865521111111      1          01


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      .++...++.....+.+|+.-|+..||.+||.++.|+-.|+++
T Consensus       405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            222233333344577888999999999999999999999876

>PF12819 Malectin_like: Carbohydrate-binding protein of the ER; InterPro: IPR024788 Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan []

Probab=99.89  E-value=3.4e-23  Score=222.31  Aligned_cols=160  Identities=31%  Similarity=0.378  Sum_probs=117.6

Q ss_pred             ccccccccccccccCCCCCCCcccccCccccccccccccCceeeeccccccC---CCCCCCCcHHHHhhceeccCCc--e
Q 004689            2 KRENIQSYVLCNCRYPDDPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPID---LRSDELPPQKVMQTAVVGTNGS--L   76 (736)
Q Consensus         2 ~~~~~~~~~~~~~ryp~D~~dR~W~~~~~~~~~~~~~~~~~~~~~st~~~i~---~~~~~~pP~~v~~ta~t~~~~~--~   76 (736)
                      .|-|+|.... .||||||+|||+|+|+.         ..+.|+++++..+|+   ..+.+.||++|||||+++.+.+  +
T Consensus       181 ~R~n~G~~~~-~iryp~D~~dR~W~~~~---------~~~~~~~ist~~~i~~~~~~~~~~~P~~V~~TA~~~~~~s~~~  250 (347)
T PF12819_consen  181 YRLNVGGSSS-FIRYPDDTYDRIWQPYS---------SSPGWSNISTTSNININSSNNPYDAPSAVYQTARTPSNSSDPL  250 (347)
T ss_pred             EeecCCCccc-ccCCCCCcceeeccccc---------cCccccccccceeeecccCCccCcChHHHHHhhhcccccccce
Confidence            5888866543 49999999999999742         245688898877775   3457899999999999998886  8


Q ss_pred             EEEEcCCCCCCcceEEEEEeeccCCCCC-CceEEEEEeCCCcCCcccccc-ccccccCcceeccCccccccccceeEEEe
Q 004689           77 TYRLNLDGFPGFGWAVTYFAEIEDLDPD-ESRKFRLVLPGQPDVSKAIVN-IQENAQGKYRVYEPGYTNLSLPFVLSFKF  154 (736)
Q Consensus        77 ~~~~~~~~~~~~~~~~~~Fae~~~~~~~-~~R~F~i~~n~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~l~l  154 (736)
                      .+.|.+.+....+|++|||+|++..... ++|+|||||||+.+.++ +.+ .....  ....+.............++.|
T Consensus       251 nltw~~~~~~~~y~v~lHFaEi~~~~~~~~~R~F~IyiN~~~~~~~-~~~~~~~~~--~~~~~~d~~~~~~~~~~~~isL  327 (347)
T PF12819_consen  251 NLTWSFVDPGFSYYVRLHFAEIQSLSPNNNQREFDIYINGQTAYSD-VSPPYLGAD--TVPYYSDYVVNVPDSGFLNISL  327 (347)
T ss_pred             EEEeccCCCCccEEEEEEEeecccccCCCCeEEEEEEECCeEccCc-cCcccccCc--ceEeecceEEEecCCCEEEEEE
Confidence            9999986666678888999999997544 47999999999988652 222 22211  1111111111222234567899


Q ss_pred             eccCCCCCCCccchhhhhhh
Q 004689          155 GKTYDSSRGPLLNAMEINKY  174 (736)
Q Consensus       155 ~~~~~s~lpP~in~~e~~~~  174 (736)
                      ..+..|++||+|||+|+|++
T Consensus       328 ~~t~~S~lppiLNalEIy~v  347 (347)
T PF12819_consen  328 GPTPDSTLPPILNALEIYKV  347 (347)
T ss_pred             EeCCCCCcCceeEeeeeEeC
Confidence            99999999999999999864

This entry represents a malectin-like domain found in a number of plant receptor kinases.

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.3e-22  Score=217.34  Aligned_cols=161  Identities=19%  Similarity=0.180  Sum_probs=124.5

Q ss_pred             HHHhhccccccCceEEEEEEEC--CCcEEEEEEeccCCc-----ccchhhhhHHHHHhhcCCCceee-EeeeeeeCCeEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIHHRNLVQ-FLGYCQEEGRSV  480 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~--~~~~vAvK~l~~~~~-----~~~~~~~~E~~il~~l~HpnIv~-l~~~~~~~~~~~  480 (736)
                      .|.+.+.||+|+||+||+|.+.  +++.||||++.....     .....+.+|+++|++++|+|+++ ++++    +..+
T Consensus        19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~   94 (365)
T PRK09188         19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDG   94 (365)
T ss_pred             CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcE
Confidence            3556789999999999999875  467789998753311     12456899999999999999985 4432    4579


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCC-CCCCEEEcCCCcEEEEeecCCc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL-KSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDi-kp~NILl~~~~~~kl~DFGla~  559 (736)
                      +||||+++++|... .    ...      ...++.++++||.|||+.   +|+|||| ||+|||++.++++||+|||+|+
T Consensus        95 LVmE~~~G~~L~~~-~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         95 LVRGWTEGVPLHLA-R----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             EEEEccCCCCHHHh-C----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence            99999999999632 1    111      135788999999999998   9999999 9999999999999999999998


Q ss_pred             cccCCCCcc-------eecccccccccCccccccC
Q 004689          560 FAVDGASHV-------SSIVRGTVGYLDPEYYISQ  587 (736)
Q Consensus       560 ~~~~~~~~~-------~~~~~gt~~Y~aPE~~~~~  587 (736)
                      .........       .....+++.|+|||++...
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            654432111       1345688999999999653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=1.9e-20  Score=198.67  Aligned_cols=260  Identities=28%  Similarity=0.417  Sum_probs=195.3

Q ss_pred             HhhccccccCceEEEEEEECCCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCC-ceeeEeeeeeeCCeEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHR-NLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~Hp-nIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+.+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +|+++.+++......+++++++
T Consensus         3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            34578999999999999887  88999998765433   356789999999999988 7999999997777789999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeecCCccccCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~-~~kl~DFGla~~~~~~~  565 (736)
                      .++++.+++...... ..+.......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.++......
T Consensus        81 ~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          81 DGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999766432211 3678888899999999999999998   899999999999999998 79999999997544333


Q ss_pred             Cc-----ceecccccccccCcccccc---CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          566 SH-----VSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       566 ~~-----~~~~~~gt~~Y~aPE~~~~---~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                      ..     ......||..|++||.+.+   ..+....|+||+|++++++++|..||...................    ..
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~----~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL----PT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc----CC
Confidence            22     2355679999999999987   578889999999999999999999966543110011111111111    10


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      . .................+.+++..|+..+|..|.++.+....
T Consensus       233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            0 000001111001223467889999999999999999988775

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=1.8e-20  Score=180.15  Aligned_cols=260  Identities=22%  Similarity=0.284  Sum_probs=192.4

Q ss_pred             HHHHHhhccccccCceEEEEEEE-CCCcEEEEEEeccCCcccchhhhhHHHHHhhcCC-CceeeEeeeeeeCCeEEEEEE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lV~e  484 (736)
                      ...|.+.++||.|+||.+|.|.. .+|.+||||+-+...  ...++..|..+.+.++| ..|..+..|..+..+-.+||+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            34566789999999999999975 479999999865433  34568889999999976 677788888888999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC---CcEEEEeecCCccc
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFA  561 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~---~~~kl~DFGla~~~  561 (736)
                      .. |-+|+++..-   -.+.++..+.+-++.|++.-++|+|.+   +++||||||+|.|..-+   ..+.++|||+|+..
T Consensus        92 LL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   92 LL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             cc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence            87 5688887631   145688889999999999999999998   99999999999999643   56899999999865


Q ss_pred             cCCCCc------ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC
Q 004689          562 VDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       562 ~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      .+..+.      ......||.+|.+-....+...+.+.|+-|+|.||..+.-|..||++.......+     ....+.+.
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q-----KyEkI~Ek  239 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ-----KYEKISEK  239 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH-----HHHHHHHh
Confidence            443322      1233569999999887777788899999999999999999999998765221111     11122222


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      ++...+. .+...++    .++...+.-|-..--++-|...-+-+.+.-+
T Consensus       240 K~s~~ie-~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL  284 (341)
T KOG1163|consen  240 KMSTPIE-VLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL  284 (341)
T ss_pred             hcCCCHH-HHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence            2221111 1222333    3466777788888888888877666555443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=4.3e-20  Score=185.25  Aligned_cols=261  Identities=20%  Similarity=0.266  Sum_probs=192.0

Q ss_pred             HHhhccccccCceEEEEEEE-CCCcEEEEEEeccCCcccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.+.++||+|.||+++.|+. -++++||||.-...  ...-++..|.+..+.|. .++|...+-+..++.+..||+|.+ 
T Consensus        30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             ceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            45689999999999999974 47999999975432  23567889999999984 699999988888888999999987 


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-----CcEEEEeecCCcccc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-----MRAKVSDFGLSKFAV  562 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~-----~~~kl~DFGla~~~~  562 (736)
                      |-+|+|+..-   -+++++..+++.+|.|+..-++|+|++   .+|.|||||+|.||..-     ..+.++|||+|+...
T Consensus       107 GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  107 GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            5688877632   256799999999999999999999998   99999999999999743     358999999999776


Q ss_pred             CCCCcc------eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          563 DGASHV------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       563 ~~~~~~------~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      +..+..      ....-||.+||+-....+++.+.+.|+-|+|-|+...|-|..||.+-+-+..-+.     ...+.+.+
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k-----YeKIGe~K  255 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK-----YEKIGETK  255 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH-----HHHhcccc
Confidence            554432      2234599999999999999999999999999999999999999997653211111     11111111


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                      -..-++. +...+ +++....+..   .-..+-.+-|..+-+...+.+++...
T Consensus       256 r~T~i~~-Lc~g~-P~efa~Yl~y---vR~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  256 RSTPIEV-LCEGF-PEEFATYLRY---VRRLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             ccCCHHH-HHhcC-HHHHHHHHHH---HHhcCcccCCCHHHHHHHHHHHHHhc
Confidence            1111110 11112 2233333333   33445567788888888777776653

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=2.3e-20  Score=183.91  Aligned_cols=139  Identities=19%  Similarity=0.192  Sum_probs=107.6

Q ss_pred             hccccccCceEEEEEEECCCcEEEEEEeccCCccc---------chhh-----------------hhHHHHHhhcCCCce
Q 004689          413 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG---------KREF-----------------TNEVTLLSRIHHRNL  466 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~---------~~~~-----------------~~E~~il~~l~HpnI  466 (736)
                      ...||+|+||.||+|...+|+.||||+++......         ...|                 ..|++++.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            36799999999999998889999999997542111         1122                 349999999988776


Q ss_pred             eeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHH-HhCCCCceecCCCCCCCEEEc
Q 004689          467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCVPAIIHRDLKSSNILLD  545 (736)
Q Consensus       467 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~L-H~~~~~~iiHrDikp~NILl~  545 (736)
                      .....+..  ...++||||++++++...+.    ....++......++.|++.+|.|| |+.   +|+||||||+|||++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence            44333222  22389999999987765432    234578888999999999999999 677   999999999999998


Q ss_pred             CCCcEEEEeecCCccc
Q 004689          546 KHMRAKVSDFGLSKFA  561 (736)
Q Consensus       546 ~~~~~kl~DFGla~~~  561 (736)
                       ++.++|+|||+|...
T Consensus       153 -~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 -DGKLYIIDVSQSVEH  167 (190)
T ss_pred             -CCcEEEEEccccccC
Confidence             478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=3.5e-21  Score=219.56  Aligned_cols=253  Identities=23%  Similarity=0.258  Sum_probs=182.8

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccC--Cccc----chhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQG----KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~--~~~~----~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .+.++|.|++|.|+..... ..+..+.|..+..  ....    ...+..|+.+-..++|||++..+..+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4678999999977777543 3333444433210  1111    1125668888888999999988888777666666699


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC-
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD-  563 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~-  563 (736)
                      ||+. +|..++..    ...+....+..++.|+..|+.|||+.   ||.|||+|++|++++.+|.+||+|||.+..+.- 
T Consensus       402 ~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  402 YCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             cccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            9999 99998843    24577788889999999999999998   999999999999999999999999999875422 


Q ss_pred             CC--CcceecccccccccCccccccCcCCCc-chhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          564 GA--SHVSSIVRGTVGYLDPEYYISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       564 ~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      ..  .......+|+..|+|||++.+..|.+. .||||.|+++..|.+|+.||......+...      ......++....
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~~~  547 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRNIF  547 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhccccccccc
Confidence            22  255666789999999999999999875 699999999999999999997655322110      000000000000


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                         .-..........+...++.++++.+|.+|-|+++|++.
T Consensus       548 ---~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  548 ---EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ---cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence               00000112334457789999999999999999999764

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=1.5e-20  Score=187.51  Aligned_cols=174  Identities=14%  Similarity=0.171  Sum_probs=134.5

Q ss_pred             HHHHHHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchh---------hhhHHHHHhhcCCCceeeEeeee
Q 004689          403 SDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---------FTNEVTLLSRIHHRNLVQFLGYC  473 (736)
Q Consensus       403 ~~i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~---------~~~E~~il~~l~HpnIv~l~~~~  473 (736)
                      .++.+..++..+.+|.|+||.||.+.. ++..+|||+++.........         +++|+..+.+++||+|..+.+++
T Consensus        26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~  104 (232)
T PRK10359         26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY  104 (232)
T ss_pred             HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence            455666777789999999999999766 57789999997553332222         68899999999999999998886


Q ss_pred             eeC--------CeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc
Q 004689          474 QEE--------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD  545 (736)
Q Consensus       474 ~~~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~  545 (736)
                      ...        +..++||||++|.+|.+...        ++.    ....+++.+|..||+.   +++|||+||+||+++
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~  169 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVS  169 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEe
Confidence            533        35789999999999987631        121    2456899999999998   999999999999999


Q ss_pred             CCCcEEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHH
Q 004689          546 KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI  606 (736)
Q Consensus       546 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ell  606 (736)
                      .++ ++|+|||...........             ..+.....|..++|+||||+.+..+.
T Consensus       170 ~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        170 KNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            988 999999987644221111             01344556778999999999887654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=1.2e-20  Score=213.85  Aligned_cols=243  Identities=21%  Similarity=0.276  Sum_probs=177.3

Q ss_pred             HhhccccccCceEEEEEEECCCcEEEEEEeccCC-cccchhhhhHHHH--HhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS-YQGKREFTNEVTL--LSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~~E~~i--l~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.||++.|=+|.+|++++|. |+||++-+.. .-..+.|.++++-  ...++|||.+++..+-..+...|||-+|..
T Consensus        26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk  104 (1431)
T KOG1240|consen   26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK  104 (1431)
T ss_pred             eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence            35678999999999999999776 9999986654 3344555554433  444589999999888777777888888886


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc--cCCC
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA--VDGA  565 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~--~~~~  565 (736)
                      + +|.|.|    ..+.-+...+...|+.|++.||..+|..   +|+|||||.+||||+.-..+.|+||..-+..  ..+.
T Consensus       105 h-nLyDRl----STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN  176 (1431)
T KOG1240|consen  105 H-NLYDRL----STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN  176 (1431)
T ss_pred             h-hhhhhh----ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence            5 677766    4566677888889999999999999998   9999999999999999999999999865532  2222


Q ss_pred             Ccc----eecccccccccCccccccC-----------cCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHH
Q 004689          566 SHV----SSIVRGTVGYLDPEYYISQ-----------QLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAK  629 (736)
Q Consensus       566 ~~~----~~~~~gt~~Y~aPE~~~~~-----------~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~  629 (736)
                      ...    ..+...-.+|+|||.+...           ..+++.||||+|||++||++ |+++|.-.       ++..+..
T Consensus       177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------QL~aYr~  249 (1431)
T KOG1240|consen  177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------QLLAYRS  249 (1431)
T ss_pred             cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------HHHhHhc
Confidence            111    1222344689999988541           15678899999999999999 67777532       2222211


Q ss_pred             Hh-hh-cCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          630 LH-IE-SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       630 ~~-~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .. .. +--+..+-|            ..+..++..|++.||.+|.+++++++.
T Consensus       250 ~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  250 GNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             cCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence            10 00 000011111            147789999999999999999999987

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=2.6e-19  Score=176.86  Aligned_cols=140  Identities=20%  Similarity=0.203  Sum_probs=109.6

Q ss_pred             hccccccCceEEEEEEECCCcEEEEEEeccCCccc--------------------------chhhhhHHHHHhhcCCCce
Q 004689          413 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--------------------------KREFTNEVTLLSRIHHRNL  466 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~--------------------------~~~~~~E~~il~~l~HpnI  466 (736)
                      ...||+|+||.||+|...+|+.||||+++......                          ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            36799999999999998789999999987652210                          0123578899999999987


Q ss_pred             eeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEEc
Q 004689          467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLD  545 (736)
Q Consensus       467 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiHrDikp~NILl~  545 (736)
                      .....+...  ..++||||++++++.....    ....++......++.|++.++.+||+ .   ||+||||||+|||++
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            544443332  2489999999886543321    12346777888999999999999999 7   999999999999999


Q ss_pred             CCCcEEEEeecCCcccc
Q 004689          546 KHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       546 ~~~~~kl~DFGla~~~~  562 (736)
                       ++.++|+|||++....
T Consensus       153 -~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 -DGKPYIIDVSQAVELD  168 (190)
T ss_pred             -CCCEEEEEcccceecC
Confidence             8899999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=3.5e-19  Score=194.15  Aligned_cols=216  Identities=25%  Similarity=0.401  Sum_probs=166.0

Q ss_pred             HhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCC
Q 004689          458 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL  537 (736)
Q Consensus       458 l~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDi  537 (736)
                      |+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+..   ...++++.....+..+++.||.|||+.  +...|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence            4678999999999999999999999999999999999974   456789999999999999999999997  23389999


Q ss_pred             CCCCEEEcCCCcEEEEeecCCccccCC-CCcceecccccccccCccccccC-------cCCCcchhHHHHHHHHHHHhCC
Q 004689          538 KSSNILLDKHMRAKVSDFGLSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQ-------QLTDKSDVYSFGVILLELISGQ  609 (736)
Q Consensus       538 kp~NILl~~~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~-------~~~~~~DVwSlGvvl~elltG~  609 (736)
                      ++.|++++....+|++|||+....... .........-..-|.|||.+...       ..+.+.||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999998765321 11111112235679999999763       1466799999999999999999


Q ss_pred             CcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          610 EAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       610 ~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      .||...........++.+++.    + -...+.|.+....  +....+..++..|+..+|.+||++++|-..++.+
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~----~-~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKK----G-GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             CccccccccCChHHHHHHHHh----c-CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            999875544333455555443    1 1112222222211  3333689999999999999999999998877655

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=1.7e-18  Score=169.09  Aligned_cols=185  Identities=14%  Similarity=0.138  Sum_probs=138.7

Q ss_pred             hccccccCceEEEEEEECCCcEEEEEEeccCCcccc----hhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEEecC
Q 004689          413 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK----REFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~----~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      ...|++|+||+||.+.. .+.+++.+.+........    ..+.+|+++|+++. |+++++++++    +..+++|||+.
T Consensus         7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            46799999999998766 578888877765543222    24789999999995 5889999886    34699999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCC-CCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL-KSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDi-kp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      |.+|.+.+.    .       ....++.|++.+|.++|+.   ||+|||| ||+|||++.++.++|+|||++........
T Consensus        82 G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         82 GAAMYQRPP----R-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             CccHHhhhh----h-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            999865431    1       1134678999999999998   9999999 79999999999999999999985433221


Q ss_pred             c----c--------eecccccccccCccccccC-cCC-CcchhHHHHHHHHHHHhCCCcCcccc
Q 004689          567 H----V--------SSIVRGTVGYLDPEYYISQ-QLT-DKSDVYSFGVILLELISGQEAISNEK  616 (736)
Q Consensus       567 ~----~--------~~~~~gt~~Y~aPE~~~~~-~~~-~~~DVwSlGvvl~elltG~~p~~~~~  616 (736)
                      .    .        ......++.|++|+...-. ..+ ...+.++-|+-+|.++|+..+...+.
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            0    0        1122367778888754321 222 46688999999999999998876544

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.77  E-value=2e-19  Score=195.60  Aligned_cols=225  Identities=25%  Similarity=0.311  Sum_probs=174.7

Q ss_pred             cccccCceEEEEEE----ECCCcEEEEEEeccCCcc--cchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEEecC
Q 004689          415 KIGSGGFGVVYYGK----LKDGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       415 ~IG~G~fG~Vy~~~----~~~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+|+|.||.|+.++    .+.|+-+|+|++++....  .......|..++..++ ||.+|++.-.+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999763    345778999988765322  1224566888888886 9999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|.|...+.    ....+...........++-+++++|+.   +|+|||+|++||+++.+|++++.|||+++........
T Consensus        81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            999988874    345566777777888999999999998   9999999999999999999999999999876443322


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                           +||..|||||++.  ....++|-||||++++||++|..||....        .   +..++           ...
T Consensus       154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~--------~---~~Il~-----------~~~  204 (612)
T KOG0603|consen  154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDT--------M---KRILK-----------AEL  204 (612)
T ss_pred             -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHH--------H---HHHhh-----------hcc
Confidence                 7999999999998  67789999999999999999999997511        1   11110           001


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSI  675 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~  675 (736)
                      ..+.+.......+...+...+|..|.-.
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            1223333345566677777778777754

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=8.8e-18  Score=167.21  Aligned_cols=134  Identities=18%  Similarity=0.258  Sum_probs=104.2

Q ss_pred             hccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhc-----CCCceeeEeeeeeeCC---e-EEEEE
Q 004689          413 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-----HHRNLVQFLGYCQEEG---R-SVLVY  483 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~---~-~~lV~  483 (736)
                      .+.||+|+||.||.  +.+....+||++........+.+.+|+.+++.+     .||||++++|++.++.   . ..+|+
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            36899999999996  443344479988765444567799999999999     5799999999998764   3 33789


Q ss_pred             Ee--cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHH-HHHHhCCCCceecCCCCCCCEEEcC----CCcEEEEeec
Q 004689          484 EF--MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI-EYLHTGCVPAIIHRDLKSSNILLDK----HMRAKVSDFG  556 (736)
Q Consensus       484 e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L-~~LH~~~~~~iiHrDikp~NILl~~----~~~~kl~DFG  556 (736)
                      ||  +.+|+|.+++...     .++..  ..++.+++.++ +|||++   +|+||||||+|||++.    +.+++|+||+
T Consensus        85 e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         85 DFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             cCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            99  5589999999532     24444  34577777777 999998   9999999999999974    3489999954


Q ss_pred             CC
Q 004689          557 LS  558 (736)
Q Consensus       557 la  558 (736)
                      -+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            33

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.75  E-value=1.3e-17  Score=171.43  Aligned_cols=230  Identities=19%  Similarity=0.212  Sum_probs=144.8

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcC----------CCceeeEeeee-----
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIH----------HRNLVQFLGYC-----  473 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~----------HpnIv~l~~~~-----  473 (736)
                      .+.||.|+++.||.+++. +++++|||+.......   ..+++++|......+.          |-.++..++..     
T Consensus        17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~   96 (288)
T PF14531_consen   17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred             ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence            578999999999999987 5899999988644322   2345666665554432          21222222211     


Q ss_pred             ----eeC---C-----eEEEEEEecCCCCHHHHhhc---ccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCC
Q 004689          474 ----QEE---G-----RSVLVYEFMHNGTLKEHLYG---TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK  538 (736)
Q Consensus       474 ----~~~---~-----~~~lV~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDik  538 (736)
                          ...   .     ..+++|+-+ .++|.+.+..   .......+....++.+..|+.+.+++||+.   |++|+|||
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccc
Confidence                111   1     236778877 4588777532   222223455666777889999999999998   99999999


Q ss_pred             CCCEEEcCCCcEEEEeecCCccccCCCCcceecccccccccCccccccC--------cCCCcchhHHHHHHHHHHHhCCC
Q 004689          539 SSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ--------QLTDKSDVYSFGVILLELISGQE  610 (736)
Q Consensus       539 p~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--------~~~~~~DVwSlGvvl~elltG~~  610 (736)
                      |+|++++.+|.++|+||+.....+..   .. ....+..|.+||.....        .++.+.|.|++|+++|.|.+|..
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~---~~-~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTR---YR-CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEE---EE-GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCce---ee-ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999999999999876533221   11 12346789999987542        47788999999999999999999


Q ss_pred             cCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCC
Q 004689          611 AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR  672 (736)
Q Consensus       611 p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R  672 (736)
                      ||...........                .+.     ... +.+..+..|+..+++.+|.+|
T Consensus       249 Pf~~~~~~~~~~~----------------~f~-----~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW----------------DFS-----RCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG----------------GGT-----TSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc----------------cch-----hcC-CcCHHHHHHHHHHccCCcccC
Confidence            9986542211100                111     122 445678899999999999887

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=7.4e-17  Score=187.53  Aligned_cols=249  Identities=20%  Similarity=0.225  Sum_probs=176.5

Q ss_pred             HHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcC---CCceeeEeeeeeeCCeEEEEE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      ...+-+.+.||+|+||.||+|...+|+.||+|+=+....+.   |--=.+++.+|+   -+-|+.+...+.-.+..+||+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~  773 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS  773 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence            33445678899999999999998889999999976554432   222234444554   234444555555566778999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-------CCcEEEEeec
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------HMRAKVSDFG  556 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~-------~~~~kl~DFG  556 (736)
                      ||.+.|+|.+++.    ..+.+++.-...+..|+++.+++||..   +|||+||||+|.||..       ..-++|+|||
T Consensus       774 ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG  846 (974)
T KOG1166|consen  774 EYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG  846 (974)
T ss_pred             eccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence            9999999999984    556788888999999999999999998   9999999999999953       3458999999


Q ss_pred             CCccccCC-CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC
Q 004689          557 LSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       557 la~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      .+-.+.-- ........++|-.+-.+|+..++..+.++|.|.++-+++-||.|+.-=                   ...|
T Consensus       847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------------------~~~g  907 (974)
T KOG1166|consen  847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------------------VKNG  907 (974)
T ss_pred             cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------------------hcCC
Confidence            98543211 123445567899999999999999999999999999999999996421                   0111


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                      .. ..++..+..-...+...++..+++-   +|-..=|...++...+++++..
T Consensus       908 ~~-~~~~~~~~Ry~~~~~W~~~F~~lLN---~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  908 SS-WMVKTNFPRYWKRDMWNKFFDLLLN---PDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             cc-eeccccchhhhhHHHHHHHHHHHhC---cCcccchhHHHHHHHHHHHHHH
Confidence            11 1111111111122223344444443   6666667788888888877653

>smart00090 RIO RIO-like kinase

Probab=99.71  E-value=5.7e-17  Score=165.29  Aligned_cols=140  Identities=22%  Similarity=0.252  Sum_probs=108.0

Q ss_pred             HHhhccccccCceEEEEEE--ECCCcEEEEEEeccCCcc------------------------cchhhhhHHHHHhhcCC
Q 004689          410 KMLEKKIGSGGFGVVYYGK--LKDGKEIAVKVLTSNSYQ------------------------GKREFTNEVTLLSRIHH  463 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~--~~~~~~vAvK~l~~~~~~------------------------~~~~~~~E~~il~~l~H  463 (736)
                      +.+.+.||+|+||.||+|.  ..+|+.||+|+++.....                        ....+..|++++.++.+
T Consensus        30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~  109 (237)
T smart00090       30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE  109 (237)
T ss_pred             HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence            4567899999999999998  558999999998754211                        01235689999999975


Q ss_pred             Cc--eeeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCc-eecCCCCCC
Q 004689          464 RN--LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-IIHRDLKSS  540 (736)
Q Consensus       464 pn--Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~-iiHrDikp~  540 (736)
                      ..  +.+++++    ...++||||+++++|......    ...+.......++.|++.++.+||+.   + ++||||||+
T Consensus       110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~  178 (237)
T smart00090      110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY  178 (237)
T ss_pred             cCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence            33  3444443    234899999999888665421    22344556678999999999999998   8 999999999


Q ss_pred             CEEEcCCCcEEEEeecCCccc
Q 004689          541 NILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       541 NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||+++ ++.++|+|||.+...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999998754

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=9.8e-17  Score=161.28  Aligned_cols=134  Identities=25%  Similarity=0.427  Sum_probs=113.0

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCcc--------cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.||+|++|.||+|.. .|..+++|+.......        ....+.+|++++..++|++|.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999988 5788999987643221        123577899999999999998877777777888999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      ++|++|.+.+...       .. .+..++.+++.+|.+||+.   +++|||++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988432       11 6788999999999999998   999999999999999 78999999998864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.69  E-value=1.5e-16  Score=158.43  Aligned_cols=130  Identities=26%  Similarity=0.450  Sum_probs=106.5

Q ss_pred             cccccCceEEEEEEECCCcEEEEEEeccCCcc--------cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       415 ~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .||+|+||.||+|.+. +..|++|+.......        ....+.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            4899999999999964 789999986543211        1245678999999999887666555666667779999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +|++|.+.+...    ..       .++.+++.+|.+||+.   +++|||++|.||+++ ++.++++|||+++.
T Consensus        80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999887421    10       6889999999999998   999999999999999 88999999999864

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.67  E-value=3.5e-16  Score=160.56  Aligned_cols=197  Identities=19%  Similarity=0.223  Sum_probs=137.5

Q ss_pred             CCCceeeEeeeeee---------------------------CCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHH
Q 004689          462 HHRNLVQFLGYCQE---------------------------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA  514 (736)
Q Consensus       462 ~HpnIv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  514 (736)
                      +|||||++.++|.+                           +..+|+||.-... +|.+++..     +..+.....-|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence            59999999887643                           2356888876654 88888843     335566677789


Q ss_pred             HHHHHHHHHHHhCCCCceecCCCCCCCEEEc--CC--CcEEEEeecCCccccCC---CCc--ceecccccccccCccccc
Q 004689          515 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KH--MRAKVSDFGLSKFAVDG---ASH--VSSIVRGTVGYLDPEYYI  585 (736)
Q Consensus       515 ~qia~~L~~LH~~~~~~iiHrDikp~NILl~--~~--~~~kl~DFGla~~~~~~---~~~--~~~~~~gt~~Y~aPE~~~  585 (736)
                      .|+++|+.|||++   ||.|||+|++|||+.  +|  -...|+|||++--....   -..  ..-..-|.-.-||||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999998   999999999999994  33  46889999987421110   001  111234778899999987


Q ss_pred             cCc------CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHH
Q 004689          586 SQQ------LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEE  659 (736)
Q Consensus       586 ~~~------~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  659 (736)
                      ..+      -..|+|.|+.|-+.||++....||....  +..-+...+     ++.++     |.+    +..+...+.+
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG--em~L~~r~Y-----qe~qL-----Pal----p~~vpp~~rq  488 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG--EMLLDTRTY-----QESQL-----PAL----PSRVPPVARQ  488 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc--hheechhhh-----hhhhC-----CCC----cccCChHHHH
Confidence            543      2368999999999999999999997633  111122221     11111     112    2233345788


Q ss_pred             HHhhccCCCCCCCCCHHHHHHHHH
Q 004689          660 KALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       660 l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                      ++...++.||.+|++.+-....|.
T Consensus       489 lV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  489 LVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHhcCCccccCCccHHHhHHH
Confidence            899999999999999877666654

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.67  E-value=3.5e-16  Score=155.69  Aligned_cols=135  Identities=21%  Similarity=0.238  Sum_probs=106.6

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCcc----------------------cchhhhhHHHHHhhcCCCc--
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ----------------------GKREFTNEVTLLSRIHHRN--  465 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~----------------------~~~~~~~E~~il~~l~Hpn--  465 (736)
                      +.+.+.||+|+||.||+|...+|+.||||+++.....                      ....+..|+.++.++.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            5567889999999999999888999999987643210                      0113567889999998874  


Q ss_pred             eeeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc
Q 004689          466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD  545 (736)
Q Consensus       466 Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~  545 (736)
                      +...++.    ...++||||+++++|......          .....++.+++.++.++|+.   +|+||||||+||+++
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~  159 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVD  159 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEc
Confidence            4444432    345899999999998765420          23456889999999999997   999999999999999


Q ss_pred             CCCcEEEEeecCCccc
Q 004689          546 KHMRAKVSDFGLSKFA  561 (736)
Q Consensus       546 ~~~~~kl~DFGla~~~  561 (736)
                      .+++++|+|||++...
T Consensus       160 ~~~~~~liDfg~~~~~  175 (198)
T cd05144         160 DDEKIYIIDWPQMVST  175 (198)
T ss_pred             CCCcEEEEECCccccC
Confidence            9999999999998543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=4.5e-16  Score=178.30  Aligned_cols=132  Identities=23%  Similarity=0.342  Sum_probs=108.7

Q ss_pred             hhccccccCceEEEEEEECCCcEEEEEEeccCC-c-------ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS-Y-------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~-~-------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      ..+.||+|+||+||+|.+.. ..+++|+..... .       .....+.+|+++++.++|++++....++......++||
T Consensus       337 ~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~  415 (535)
T PRK09605        337 PDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM  415 (535)
T ss_pred             ccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence            46789999999999998864 445555432211 1       11245788999999999999998888888777889999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      ||+++++|.+++.            ....++.+++++|.|||+.   +++||||||+|||+ .++.++|+|||+++.
T Consensus       416 E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        416 EYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            9999999998873            3467899999999999998   99999999999999 678999999999875

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.65  E-value=3e-17  Score=175.53  Aligned_cols=175  Identities=28%  Similarity=0.373  Sum_probs=129.3

Q ss_pred             CeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeec
Q 004689          477 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG  556 (736)
Q Consensus       477 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFG  556 (736)
                      .+.++.|++|..++|.++|.+.. .....++...+.++.|++.|++|   +   +.+|+|+||.||+...+.++||+|||
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence            35789999999999999996443 23456777889999999999999   5   89999999999999999999999999


Q ss_pred             CCccccCCC-----CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHH
Q 004689          557 LSKFAVDGA-----SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKL  630 (736)
Q Consensus       557 la~~~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~  630 (736)
                      +........     ....+...||..||+||.+.+..|+.++||||||++|+|++. =..++....           +-.
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-----------t~~  470 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-----------TLT  470 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-----------hhh
Confidence            986544333     223345669999999999999999999999999999999997 233332111           011


Q ss_pred             hhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 004689          631 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV  678 (736)
Q Consensus       631 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev  678 (736)
                      -++.|.+    ++....+++.     -..+..+++.+.|.+||+..++
T Consensus       471 d~r~g~i----p~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  471 DIRDGII----PPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hhhcCCC----ChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence            1122222    2222223332     2467889999999999954443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.62  E-value=1.8e-16  Score=180.46  Aligned_cols=203  Identities=25%  Similarity=0.301  Sum_probs=138.6

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      .+.|..|+||.||..+++ ..+++|+|+=+.+-      +.+-  ++.....|.+|                     |+-
T Consensus        88 IklisngAygavylvrh~~trqrfa~kiNkq~l------ilRn--ilt~a~npfvv---------------------gDc  138 (1205)
T KOG0606|consen   88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQNL------ILRN--ILTFAGNPFVV---------------------GDC  138 (1205)
T ss_pred             eEeeccCCCCceeeeeccccccchhhcccccch------hhhc--cccccCCccee---------------------chh
Confidence            578999999999999887 46778886522111      1110  33333444443                     333


Q ss_pred             HHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC------
Q 004689          492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA------  565 (736)
Q Consensus       492 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~------  565 (736)
                      ...+..    .+.++.        +++.+++|||+.   +|+|||+||+|.+|+.-|++|+.|||+++......      
T Consensus       139 ~tllk~----~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e  203 (1205)
T KOG0606|consen  139 ATLLKN----IGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE  203 (1205)
T ss_pred             hhhccc----CCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence            333321    122322        237789999998   99999999999999999999999999986421100      


Q ss_pred             --------CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          566 --------SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       566 --------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                              ......++||+.|+|||++....|+..+|.|++|+++||.+-|+.||.++...+....++.......+    
T Consensus       204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE----  279 (1205)
T KOG0606|consen  204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE----  279 (1205)
T ss_pred             cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc----
Confidence                    01123468999999999999999999999999999999999999999988644444343332221111    


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCC
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS  674 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt  674 (736)
                                 .+.....+..+++...++.+|..|--
T Consensus       280 -----------~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  280 -----------EDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             -----------cCcCCCHHHHHHHHHHHHhChHhhcc
Confidence                       12222334677777888888888863

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.59  E-value=5.5e-15  Score=145.53  Aligned_cols=136  Identities=21%  Similarity=0.265  Sum_probs=96.9

Q ss_pred             hccccccCceEEEEEEECCCcEEEEEEeccCCccc--chh----------------------hhhHHHHHhhcCCCc--e
Q 004689          413 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KRE----------------------FTNEVTLLSRIHHRN--L  466 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~--~~~----------------------~~~E~~il~~l~Hpn--I  466 (736)
                      .+.||+|+||.||+|...++++||||+++......  ...                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999998889999999987542211  111                      134556666664432  4


Q ss_pred             eeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEEc
Q 004689          467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLD  545 (736)
Q Consensus       467 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiHrDikp~NILl~  545 (736)
                      .+.+++    ...++||||++++.+.........    .. .....++.+++.++.++|. .   +|+||||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence            444443    235899999999654321110000    01 4567889999999999999 6   999999999999999


Q ss_pred             CCCcEEEEeecCCccc
Q 004689          546 KHMRAKVSDFGLSKFA  561 (736)
Q Consensus       546 ~~~~~kl~DFGla~~~  561 (736)
                       ++.++++|||.+...
T Consensus       150 -~~~~~liDfg~a~~~  164 (187)
T cd05119         150 -DGKVYIIDVPQAVEI  164 (187)
T ss_pred             -CCcEEEEECcccccc
Confidence             899999999998643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.58  E-value=1.3e-14  Score=136.52  Aligned_cols=134  Identities=24%  Similarity=0.285  Sum_probs=113.3

Q ss_pred             hccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCC--CceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          413 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      .+.||+|.++.||++... +..+++|.......  ...+.+|+.+++.++|  .++.+++++....+..+++|||+.++.
T Consensus         3 ~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           3 IKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             ceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            367999999999999986 48899999765432  4578999999999976  589999999888888999999999877


Q ss_pred             HHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       491 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +...           +......++.++++++++||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus        80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            6543           4455667889999999999996545799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.54  E-value=6.1e-14  Score=143.32  Aligned_cols=135  Identities=18%  Similarity=0.224  Sum_probs=104.8

Q ss_pred             hcccc-ccCceEEEEEEECCCcEEEEEEeccCC-------------cccchhhhhHHHHHhhcCCCce--eeEeeeeeeC
Q 004689          413 EKKIG-SGGFGVVYYGKLKDGKEIAVKVLTSNS-------------YQGKREFTNEVTLLSRIHHRNL--VQFLGYCQEE  476 (736)
Q Consensus       413 ~~~IG-~G~fG~Vy~~~~~~~~~vAvK~l~~~~-------------~~~~~~~~~E~~il~~l~HpnI--v~l~~~~~~~  476 (736)
                      ...|| .||.|+||++... +..++||.+....             ......+.+|++++.+++|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            35788 8999999999886 7889999875311             1123457889999999998875  6777765433


Q ss_pred             C----eEEEEEEecCC-CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEE
Q 004689          477 G----RSVLVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK  551 (736)
Q Consensus       477 ~----~~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~k  551 (736)
                      .    ..++|||++++ .+|.+++..     ..++..    .+.+++.+|.+||+.   ||+||||||.|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence            2    23599999997 689888743     223332    356899999999998   999999999999999999999


Q ss_pred             EEeecCCcc
Q 004689          552 VSDFGLSKF  560 (736)
Q Consensus       552 l~DFGla~~  560 (736)
                      |+|||.+..
T Consensus       183 LIDfg~~~~  191 (239)
T PRK01723        183 LIDFDRGEL  191 (239)
T ss_pred             EEECCCccc
Confidence            999998864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=3.3e-15  Score=170.75  Aligned_cols=253  Identities=20%  Similarity=0.272  Sum_probs=182.3

Q ss_pred             HhhccccccCceEEEEEEECC--CcEEEEEEeccCC--cccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEEe
Q 004689          411 MLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~--~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      .+.+.||+|.|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++.....+..+++++|
T Consensus        23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~  102 (601)
T KOG0590|consen   23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY  102 (601)
T ss_pred             cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence            345669999999998886543  3445666554332  222334556777777776 99999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHH-hCCCCceecCCCCCCCEEEcCCC-cEEEEeecCCccccC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD  563 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH-~~~~~~iiHrDikp~NILl~~~~-~~kl~DFGla~~~~~  563 (736)
                      ..+|++.+.+..  ......+....-.++.|+..++.|+| ..   ++.||||||+|.+++..+ ..+++|||+|.....
T Consensus       103 s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen  103 SDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccccccccccc--CCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999887731  11113444556678999999999999 66   999999999999999999 999999999986544


Q ss_pred             --CCCcceecccc-cccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          564 --GASHVSSIVRG-TVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       564 --~~~~~~~~~~g-t~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                        +........+| ++.|+|||...+. -..+..|+||.|+++.-+++|..|+.......  .....|....   +.   
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~---~~---  249 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNK---GR---  249 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeecccc---cc---
Confidence              44444455678 9999999999885 44578899999999999999999997654221  1112221111   00   


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       .......    .......++..+++..+|..|.+.+++...
T Consensus       250 -~~~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  250 -FTQLPWN----SISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             -cccCccc----cCChhhhhcccccccCCchhcccccccccc
Confidence             0000111    112235667778888999999999887543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.47  E-value=6.7e-14  Score=140.93  Aligned_cols=202  Identities=23%  Similarity=0.334  Sum_probs=145.2

Q ss_pred             HhhcCCCceeeEeeeeeeC-----CeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 004689          458 LSRIHHRNLVQFLGYCQEE-----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI  532 (736)
Q Consensus       458 l~~l~HpnIv~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~i  532 (736)
                      |-++-|.|||+++.|+.+.     .+..++.|||..|++.++|++.......+......+++.||..||.|||+ |.|.|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCcc
Confidence            4455799999999998654     35789999999999999998887777788888899999999999999999 67899


Q ss_pred             ecCCCCCCCEEEcCCCcEEEEeecCCcccc---CCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCC
Q 004689          533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAV---DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ  609 (736)
Q Consensus       533 iHrDikp~NILl~~~~~~kl~DFGla~~~~---~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~  609 (736)
                      +|+++..+-|++..++-+|++--.-.....   ...........|-++|.+||+-.....+.++|||+||+..+||..|.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            999999999999999988875321111000   00011112233678999999988888888999999999999998876


Q ss_pred             Cc-CcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          610 EA-ISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       610 ~p-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .- -...........+..-+         .. +...           .-...+..|++..|..||+|++++.|
T Consensus       280 iq~tnseS~~~~ee~ia~~i---------~~-len~-----------lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  280 IQSTNSESKVEVEENIANVI---------IG-LENG-----------LQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             eccCCCcceeehhhhhhhhe---------ee-ccCc-----------cccCcCcccccCCCCCCcchhhhhcC
Confidence            43 22222111111111100         00 0000           11246678999999999999998876

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.41  E-value=7.1e-13  Score=147.12  Aligned_cols=140  Identities=23%  Similarity=0.271  Sum_probs=99.3

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCccc----------------------------------------chhhhh
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG----------------------------------------KREFTN  453 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~----------------------------------------~~~~~~  453 (736)
                      +.||.|++|.||+|++++|+.||||+.+......                                        +-+|..
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            5799999999999999999999999986532110                                        013555


Q ss_pred             HHHHHhhcC-----CCceeeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHH-HHHHHHhC
Q 004689          454 EVTLLSRIH-----HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-GIEYLHTG  527 (736)
Q Consensus       454 E~~il~~l~-----HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~-~L~~LH~~  527 (736)
                      |++.+.+++     ++++.-..-|....+..+|||||++|++|.+......   ...   .+..++..++. .+..+|..
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHhC
Confidence            666666662     3443222222233445799999999999988763211   111   23446666665 46788987


Q ss_pred             CCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       528 ~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                         |++|+|+||.||+++.+++++++|||++....
T Consensus       277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               99999999999999999999999999987553

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.40  E-value=2e-13  Score=168.36  Aligned_cols=108  Identities=34%  Similarity=0.568  Sum_probs=100.1

Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      ++|+.|+|++|+++|.+|..+.++++|+.|+|++|++++.+| .+.+|++|++|+|++|.++|.+|..++++++|+.|+|
T Consensus       475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  554 (968)
T PLN00113        475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL  554 (968)
T ss_pred             ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence            589999999999999999999999999999999999999998 7899999999999999999999999999999999999


Q ss_pred             ccccCcCCCCccccc--ccccccccCCcccc
Q 004689          302 QNNMLSGTVPSSLLS--KNVVLNYAGNINLH  330 (736)
Q Consensus       302 ~~N~l~g~~P~~~~~--~~~~l~~~~n~~~c  330 (736)
                      ++|+++|.+|..+..  .+..+++.+|...+
T Consensus       555 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~  585 (968)
T PLN00113        555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHG  585 (968)
T ss_pred             CCCcccccCChhHhcCcccCEEeccCCccee
Confidence            999999999998744  45778888887664

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.30  E-value=1e-13  Score=149.34  Aligned_cols=164  Identities=23%  Similarity=0.302  Sum_probs=105.0

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      +++.+..|+|+.|.+..|||.+..+-.|+-|.+++|++....|.+|-++-.+.....+++.-.    ..-+.-+.+.+.+
T Consensus       148 nLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT----l~N~Ptsld~l~N  223 (1255)
T KOG0444|consen  148 NLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT----LDNIPTSLDDLHN  223 (1255)
T ss_pred             hhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch----hhcCCCchhhhhh
Confidence            577889999999999999999999999999999999998877777666555432211111111    0011112233456


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      |..+|||.|+|. .+|+.+.+|.+|+.|+||+|+|+..--..+...+|++|+||.|+|+ .+|+.+..|++|+.|++.+|
T Consensus       224 L~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~N  301 (1255)
T KOG0444|consen  224 LRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNN  301 (1255)
T ss_pred             hhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccC
Confidence            666666666666 5666666666666666666666654444455556666666666666 56666666666666666666


Q ss_pred             cCc-CCCCccc
Q 004689          305 MLS-GTVPSSL  314 (736)
Q Consensus       305 ~l~-g~~P~~~  314 (736)
                      +|+ .-||+++
T Consensus       302 kL~FeGiPSGI  312 (1255)
T KOG0444|consen  302 KLTFEGIPSGI  312 (1255)
T ss_pred             cccccCCccch
Confidence            553 2345444

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.29  E-value=2.1e-13  Score=125.31  Aligned_cols=172  Identities=22%  Similarity=0.314  Sum_probs=120.9

Q ss_pred             ccccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchH-----HHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEec
Q 004689          144 LSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDG-----VAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN  218 (736)
Q Consensus       144 ~~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~-----~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~  218 (736)
                      ++++..+.|+|+-|.++.+||-|..+..+++|.+.+|+++.     ..|..++-+- +.... -+.-|      .|    
T Consensus        30 f~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~ln-vgmnr-l~~lp------rg----   97 (264)
T KOG0617|consen   30 FNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILN-VGMNR-LNILP------RG----   97 (264)
T ss_pred             cchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhhee-cchhh-hhcCc------cc----
Confidence            34556677899999999999999999999999999988753     1222222110 00000 00111      11    


Q ss_pred             CCCCCceEEEEccCCCCCc-cCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccc
Q 004689          219 SDPQPSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR  297 (736)
Q Consensus       219 ~~~~~~l~~L~L~~n~l~g-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~  297 (736)
                      .+.+|.|+.|||+.|+|.. .+|..|..|+.|.-|+|+.|.|.-.+|++++|++|+.|.|..|.+- ++|..++.|++|+
T Consensus        98 fgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lr  176 (264)
T KOG0617|consen   98 FGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLR  176 (264)
T ss_pred             cCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHH
Confidence            2346778888888888763 5777888888888888888888877778888888888888888888 7888888888888


Q ss_pred             eeecccccCcCCCCcccccc-----cccccccCCccc
Q 004689          298 ELYVQNNMLSGTVPSSLLSK-----NVVLNYAGNINL  329 (736)
Q Consensus       298 ~L~l~~N~l~g~~P~~~~~~-----~~~l~~~~n~~~  329 (736)
                      +|.+.+|+++ .+|+++...     ........|||.
T Consensus       177 elhiqgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  177 ELHIQGNRLT-VLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             HHhcccceee-ecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            8888888888 777776432     133444555554

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.27  E-value=1.9e-11  Score=118.15  Aligned_cols=129  Identities=20%  Similarity=0.164  Sum_probs=96.3

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCcee-eEeeeeeeCCeEEEEEEecCCCCHH
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QFLGYCQEEGRSVLVYEFMHNGTLK  492 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv-~l~~~~~~~~~~~lV~e~~~~gsL~  492 (736)
                      +.|+.|.++.||+++.. ++.|++|+...... ....+..|+.+++.+.+.+++ +++.+.  ....++||||+++.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence            46899999999999876 78899998754322 234578899999999765554 444443  23457999999998775


Q ss_pred             HHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCC--CCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          493 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       493 ~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~--~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      +..         .   ....++.+++++|+.||+..  ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus        80 ~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          80 TED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            420         0   11235678999999999973  12369999999999999 6789999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.25  E-value=8.2e-12  Score=136.78  Aligned_cols=253  Identities=21%  Similarity=0.212  Sum_probs=179.6

Q ss_pred             HHHHHHHHhhccccc--cCceEEEEEEE---CCCcEEEEEEeccC--CcccchhhhhHHHHHhhc-CCCceeeEeeeeee
Q 004689          404 DIEDATKMLEKKIGS--GGFGVVYYGKL---KDGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE  475 (736)
Q Consensus       404 ~i~~~~~~~~~~IG~--G~fG~Vy~~~~---~~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~  475 (736)
                      +..+....+.+.+|.  |.+|.||.+..   .++..+|+|.-+..  .......=.+|+...+++ .|+|.++....+..
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc
Confidence            445555566788999  99999999976   36788999873322  222233334566666666 59999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHH----HHHHHHhCCCCceecCCCCCCCEEEcCC-CcE
Q 004689          476 EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----GIEYLHTGCVPAIIHRDLKSSNILLDKH-MRA  550 (736)
Q Consensus       476 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~----~L~~LH~~~~~~iiHrDikp~NILl~~~-~~~  550 (736)
                      .+..++-+|++. .+|.++.+...   ..++....+....+..+    ||.++|+.   .++|-|+||.||+...+ ..+
T Consensus       190 ~~~lfiqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~  262 (524)
T KOG0601|consen  190 SGILFIQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSC  262 (524)
T ss_pred             CCcceeeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccccee
Confidence            999999999886 67877765432   23455556667777777    99999998   99999999999999999 899


Q ss_pred             EEEeecCCccccCCCCc----ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHH
Q 004689          551 KVSDFGLSKFAVDGASH----VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ  626 (736)
Q Consensus       551 kl~DFGla~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~  626 (736)
                      +++|||+...+.+..-.    ......|...|++||... +.++.+.|+|++|.+..|..+|..........       .
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~  334 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS-------S  334 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-------C
Confidence            99999998776554422    222335889999999764 46788999999999999999987665433110       1


Q ss_pred             HHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          627 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       627 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      |..  ++.+.        +..++......++......+++.+|..|++...+..+
T Consensus       335 W~~--~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  335 WSQ--LRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             ccc--ccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            111  11111        1122222222345558889999999999988877553

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.22  E-value=3.9e-11  Score=134.84  Aligned_cols=138  Identities=20%  Similarity=0.238  Sum_probs=90.3

Q ss_pred             ccccccCceEEEEEEECC-CcEEEEEEeccCCcc----------------------------------------cchhhh
Q 004689          414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQ----------------------------------------GKREFT  452 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~----------------------------------------~~~~~~  452 (736)
                      +.||+|++|.||+|++++ |++||||+.+.....                                        .+-++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            579999999999999987 999999999754110                                        011344


Q ss_pred             hHHHHHhhcC----CCceeeEeeeee-eCCeEEEEEEecCCCCHHHHh--hcccccccccCHHHHHHHHHHHHHHHHHHH
Q 004689          453 NEVTLLSRIH----HRNLVQFLGYCQ-EEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH  525 (736)
Q Consensus       453 ~E~~il~~l~----HpnIv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~qia~~L~~LH  525 (736)
                      +|+..+.+++    +.+.+.+-.++. -....+|||||++|+.+.+.-  .........+.......++.|       ++
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VF  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HH
Confidence            5555555552    333333333332 245678999999999998742  111001112222222223333       34


Q ss_pred             hCCCCceecCCCCCCCEEEcCCC----cEEEEeecCCccc
Q 004689          526 TGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGLSKFA  561 (736)
Q Consensus       526 ~~~~~~iiHrDikp~NILl~~~~----~~kl~DFGla~~~  561 (736)
                      ..   |++|+|+||.||+++.++    +++++|||++...
T Consensus       278 ~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        278 RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence            45   999999999999999988    9999999998655

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.21  E-value=3.1e-12  Score=137.50  Aligned_cols=197  Identities=18%  Similarity=0.171  Sum_probs=123.0

Q ss_pred             CceEEEEEeCCCcCCcc------ccccccccccCcceeccCc-cccccccceeEEEeeccCCCCCCCc-cchhhhhhhhc
Q 004689          105 ESRKFRLVLPGQPDVSK------AIVNIQENAQGKYRVYEPG-YTNLSLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLE  176 (736)
Q Consensus       105 ~~R~F~i~~n~~~~~~~------~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~  176 (736)
                      ..|+.|.+-|....-+.      +.+...-.+..+-+..+.+ +.+  ++++..|.|++|.++++|+- +..+..|+.|.
T Consensus       150 alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~--lnsL~tlkLsrNrittLp~r~Fk~L~~L~~Ld  227 (873)
T KOG4194|consen  150 ALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDS--LNSLLTLKLSRNRITTLPQRSFKRLPKLESLD  227 (873)
T ss_pred             hhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccc--cchheeeecccCcccccCHHHhhhcchhhhhh
Confidence            46888888887632111      1122222333444444443 233  44899999999999999998 55599999999


Q ss_pred             cCCCCch---HHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceEEEEccCCCCCccCCccccccccccccc
Q 004689          177 RNDGSID---GVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELW  253 (736)
Q Consensus       177 ~~~~~~~---~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~  253 (736)
                      ++.|.+.   +.+.+.|.++-.+.--.   .|----....+.+|     .++++|+|+.|+++..--.++.+|+.|+.|+
T Consensus       228 LnrN~irive~ltFqgL~Sl~nlklqr---N~I~kL~DG~Fy~l-----~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~  299 (873)
T KOG4194|consen  228 LNRNRIRIVEGLTFQGLPSLQNLKLQR---NDISKLDDGAFYGL-----EKMEHLNLETNRLQAVNEGWLFGLTSLEQLD  299 (873)
T ss_pred             ccccceeeehhhhhcCchhhhhhhhhh---cCcccccCcceeee-----cccceeecccchhhhhhcccccccchhhhhc
Confidence            9999873   44444444443321111   11100011223345     3677788888887755556777788888888


Q ss_pred             ccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCCCCc
Q 004689          254 LDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS  312 (736)
Q Consensus       254 Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~  312 (736)
                      ||.|.|...-+ +++-+.+|+.|+|++|+|+...|.+|..|.+|+.|+|++|.++ .+-+
T Consensus       300 lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e  358 (873)
T KOG4194|consen  300 LSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-HLAE  358 (873)
T ss_pred             cchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH-HHHh
Confidence            88888777666 5777777778888888777655666666666666666666655 4433

>PLN03150 hypothetical protein; Provisional

Probab=99.20  E-value=2.7e-11  Score=140.65  Aligned_cols=91  Identities=31%  Similarity=0.460  Sum_probs=82.1

Q ss_pred             CCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCc-cccce
Q 004689          221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNL-PNLRE  298 (736)
Q Consensus       221 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l-~~L~~  298 (736)
                      .+++|+.|+|++|+|+|.+|..++.|++|+.|+|++|+|+|.+| .+++|++|++|+|++|+|+|.+|..++.+ .++..
T Consensus       440 ~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~  519 (623)
T PLN03150        440 KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRAS  519 (623)
T ss_pred             CCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCce
Confidence            35799999999999999999999999999999999999999999 68999999999999999999999998875 46788


Q ss_pred             eecccccCcCCCC
Q 004689          299 LYVQNNMLSGTVP  311 (736)
Q Consensus       299 L~l~~N~l~g~~P  311 (736)
                      +++++|...+..|
T Consensus       520 l~~~~N~~lc~~p  532 (623)
T PLN03150        520 FNFTDNAGLCGIP  532 (623)
T ss_pred             EEecCCccccCCC
Confidence            9999998654444

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.18  E-value=2.6e-10  Score=126.15  Aligned_cols=166  Identities=19%  Similarity=0.232  Sum_probs=123.2

Q ss_pred             ECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHH
Q 004689          429 LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI  508 (736)
Q Consensus       429 ~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~  508 (736)
                      ..++.+|.|+..+...........+-+..|+.++||||++++..+..++..|+|+|-+.  .|...+...       .-.
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence            34688899988775554444557788899999999999999999999999999999875  566666321       234


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceecccccccccCccccccCc
Q 004689          509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ  588 (736)
Q Consensus       509 ~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~  588 (736)
                      .....+.||+.||.+||..|  +++|++|.-.-|+|+..|+.||++|-++........ ......---.|..|+.+....
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence            45567889999999999775  899999999999999999999999987653221111 111111122455666543221


Q ss_pred             CCCcchhHHHHHHHHHHHhC
Q 004689          589 LTDKSDVYSFGVILLELISG  608 (736)
Q Consensus       589 ~~~~~DVwSlGvvl~elltG  608 (736)
                        -..|.|.|||+++|++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              346999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.16  E-value=3.8e-10  Score=110.58  Aligned_cols=135  Identities=19%  Similarity=0.186  Sum_probs=96.6

Q ss_pred             ccccccCceEEEEEEECC-------CcEEEEEEeccCCcc----------c------------chh----hhhHHHHHhh
Q 004689          414 KKIGSGGFGVVYYGKLKD-------GKEIAVKVLTSNSYQ----------G------------KRE----FTNEVTLLSR  460 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~-------~~~vAvK~l~~~~~~----------~------------~~~----~~~E~~il~~  460 (736)
                      ..||.|--+.||.|...+       +..+|||+.+.....          .            ...    .++|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997553       479999987532100          0            011    2379999999


Q ss_pred             cCC--CceeeEeeeeeeCCeEEEEEEecCCCCHHH-HhhcccccccccCHHHHHHHHHHHHHHHHHH-HhCCCCceecCC
Q 004689          461 IHH--RNLVQFLGYCQEEGRSVLVYEFMHNGTLKE-HLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCVPAIIHRD  536 (736)
Q Consensus       461 l~H--pnIv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~qia~~L~~L-H~~~~~~iiHrD  536 (736)
                      +..  -++.+++++    ...++||||+.++.+.. .+.+     ..++......+..+++.+|..| |..   +++|||
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            853  456666654    45689999998754322 1211     1233445567788999999999 777   999999


Q ss_pred             CCCCCEEEcCCCcEEEEeecCCccc
Q 004689          537 LKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       537 ikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      +++.|||++ ++.+.|+|||.+...
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeC
Confidence            999999997 468999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.11  E-value=5.5e-12  Score=116.06  Aligned_cols=109  Identities=25%  Similarity=0.365  Sum_probs=86.7

Q ss_pred             CCCCCceEEEEccCCCCCccCCcccccccccccccccccccCC-CCC-CCCCCCCCcEEEcCCCCCCCCCCccccCcccc
Q 004689          219 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNL  296 (736)
Q Consensus       219 ~~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~-~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L  296 (736)
                      .++++.|+.|+++-|.|. .+|..|+.++.|+.|||..|++.. .+| .|-.++.|+.|+|++|.|. .+|..+++|++|
T Consensus        75 issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~l  152 (264)
T KOG0617|consen   75 ISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNL  152 (264)
T ss_pred             hhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcce
Confidence            455778888888888888 788888888888888888888887 456 6788888888888888888 788888888888


Q ss_pred             ceeecccccCcCCCCcccc--cccccccccCCcccc
Q 004689          297 RELYVQNNMLSGTVPSSLL--SKNVVLNYAGNINLH  330 (736)
Q Consensus       297 ~~L~l~~N~l~g~~P~~~~--~~~~~l~~~~n~~~c  330 (736)
                      +.|.+..|++- ++|.++.  ..+..+..+||.-..
T Consensus       153 qil~lrdndll-~lpkeig~lt~lrelhiqgnrl~v  187 (264)
T KOG0617|consen  153 QILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTV  187 (264)
T ss_pred             eEEeeccCchh-hCcHHHHHHHHHHHHhcccceeee
Confidence            88888888887 7888774  334556667775443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.09  E-value=9.8e-10  Score=103.94  Aligned_cols=131  Identities=24%  Similarity=0.403  Sum_probs=102.3

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCccc--------chhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--------KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~--------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      ..+++|+-+.+|.+.+. |.++++|.-..+....        .....+|+.++.+++--.|...+-|..+.....++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35789999999999876 5567777543332111        23466799999999776666666677777888999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      ++|-.|.+.+...           ...++..+-.-+.-||..   +|+|+|+.++||++..+. +.++|||++.+
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999998888432           245677788888899998   999999999999998775 99999999863

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.08  E-value=1.1e-09  Score=110.71  Aligned_cols=142  Identities=18%  Similarity=0.335  Sum_probs=107.9

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCC--CceeeEeeeeeeC---CeEEEEEEecC
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHH--RNLVQFLGYCQEE---GRSVLVYEFMH  487 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~---~~~~lV~e~~~  487 (736)
                      +.||.|.++.||++...+|+.+++|+...... .....+..|+++++.+++  .++.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            46899999999999887678999998754322 235678999999999975  4457777777654   35689999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC---------------------------------------  528 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~---------------------------------------  528 (736)
                      |+++.+.+..     ..++......++.+++++|..||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888765421     23556666677778888888887521                                       


Q ss_pred             --------------CCceecCCCCCCCEEEcC--CCcEEEEeecCCcc
Q 004689          529 --------------VPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKF  560 (736)
Q Consensus       529 --------------~~~iiHrDikp~NILl~~--~~~~kl~DFGla~~  560 (736)
                                    ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          246899999999999998  66789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.99  E-value=1.1e-10  Score=126.42  Aligned_cols=150  Identities=19%  Similarity=0.219  Sum_probs=118.8

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCc-----hHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCC
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSI-----DGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSD  220 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~-----~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~  220 (736)
                      .+.+..|.|..+.+..+|..+.++..|+.|.++-|.+     +...|..|++...-.+--.+          +|+.-+.-
T Consensus        31 Mt~~~WLkLnrt~L~~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKn----------sGiP~diF  100 (1255)
T KOG0444|consen   31 MTQMTWLKLNRTKLEQVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKN----------SGIPTDIF  100 (1255)
T ss_pred             hhheeEEEechhhhhhChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhcccccc----------CCCCchhc
Confidence            4577889999999999999999999999988887765     33444555544432222222          23333344


Q ss_pred             CCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCcccccee
Q 004689          221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL  299 (736)
Q Consensus       221 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L  299 (736)
                      .+..|+.||||+|+|+ ..|..+..-+++..|+||+|+|..++. -|.+|+.|-.||||+|+|. .+|+.+..|..|+.|
T Consensus       101 ~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL  178 (1255)
T KOG0444|consen  101 RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTL  178 (1255)
T ss_pred             ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhh
Confidence            5678999999999999 899999999999999999999986654 4789999999999999999 888889999999999


Q ss_pred             ecccccCc
Q 004689          300 YVQNNMLS  307 (736)
Q Consensus       300 ~l~~N~l~  307 (736)
                      .|++|.|.
T Consensus       179 ~Ls~NPL~  186 (1255)
T KOG0444|consen  179 KLSNNPLN  186 (1255)
T ss_pred             hcCCChhh
Confidence            99999764

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.98  E-value=4.5e-09  Score=98.91  Aligned_cols=141  Identities=26%  Similarity=0.303  Sum_probs=105.6

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCc--------ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      ..|-+|+-+.|+++.+. |+...||.-.....        -......+|+++|.+++--.|.-..-++.+...-.++|||
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            56789999999999987 78777775432211        1235577899999999766666666667777777899999


Q ss_pred             cCC-CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC---cEEEEeecCCcc
Q 004689          486 MHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKF  560 (736)
Q Consensus       486 ~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~---~~kl~DFGla~~  560 (736)
                      +++ -++.+++.......  ........++..+-+.+.-||..   +|+|+||..+||++..++   .+.++|||++..
T Consensus        92 ~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   92 IDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             ccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            976 47888876544221  22222357888899999999999   999999999999997664   358999999853

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.93  E-value=2.9e-10  Score=128.79  Aligned_cols=170  Identities=28%  Similarity=0.325  Sum_probs=122.7

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhh--hhhhccCCC------CchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEe
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEI--NKYLERNDG------SIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC  217 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~--~~~l~~~~~------~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c  217 (736)
                      +.++.+|+|.+|++..+|+..-+...  +..|.-+.+      +.+...+..|.-++. .+..  =+|-|    |.-+.|
T Consensus       309 ~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~Lyl-anN~--Ltd~c----~p~l~~  381 (1081)
T KOG0618|consen  309 LKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYL-ANNH--LTDSC----FPVLVN  381 (1081)
T ss_pred             cceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHH-hcCc--ccccc----hhhhcc
Confidence            56777888888888888874222111  112211111      112222222332222 2222  16777    444444


Q ss_pred             cCCCCCceEEEEccCCCCCccCCc-ccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCcccc
Q 004689          218 NSDPQPSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNL  296 (736)
Q Consensus       218 ~~~~~~~l~~L~L~~n~l~g~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L  296 (736)
                          ..+|+.|+|+.|.|. .+|+ .+.+|..|++|+||+|+|+..+..+.+|..|++|...+|+|. ..| .+.++++|
T Consensus       382 ----~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL  454 (1081)
T KOG0618|consen  382 ----FKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQL  454 (1081)
T ss_pred             ----ccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcc
Confidence                468999999999999 6777 567999999999999999987768999999999999999999 788 89999999


Q ss_pred             ceeecccccCc-CCCCcccc-cccccccccCCccc
Q 004689          297 RELYVQNNMLS-GTVPSSLL-SKNVVLNYAGNINL  329 (736)
Q Consensus       297 ~~L~l~~N~l~-g~~P~~~~-~~~~~l~~~~n~~~  329 (736)
                      +.+|||.|+|+ +.+|..+. ..++.+++.||.++
T Consensus       455 ~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  455 KVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             eEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            99999999996 55677666 67789999999865

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.91  E-value=1.2e-09  Score=119.97  Aligned_cols=241  Identities=21%  Similarity=0.198  Sum_probs=168.0

Q ss_pred             hhccccccCceEEEEEEEC--CCcEEEEEEeccCCcccc--hhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEec
Q 004689          412 LEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~--~~~~vAvK~l~~~~~~~~--~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      +...||.|.|+.|++...+  ++..+++|.+........  ..-..|+.+...+ .|.++++....+......++--|||
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~  348 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC  348 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence            3567999999999988644  577899998765543322  2234566666666 5888888887777777777889999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeecCCccccCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~-~~~kl~DFGla~~~~~~~  565 (736)
                      +++++...+    .-...++...++++..|++.++.++|+.   .++|+|+||+||++..+ +..+++|||++..+.-. 
T Consensus       349 ~~~s~~l~~----~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-  420 (524)
T KOG0601|consen  349 EGGSSSLRS----VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-  420 (524)
T ss_pred             cCcchhhhh----HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee-
Confidence            999887765    2234566777888999999999999997   99999999999999986 88899999988532111 


Q ss_pred             Ccceeccccccccc--CccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          566 SHVSSIVRGTVGYL--DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~--aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                         .....++-++.  +++......+..+.|++|||.-+.|..+|..--....         +|..  +..+.+.     
T Consensus       421 ---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---------~~~~--i~~~~~p-----  481 (524)
T KOG0601|consen  421 ---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---------QSLT--IRSGDTP-----  481 (524)
T ss_pred             ---cccccccccccccchhhccccccccccccccccccccccccCcccCcccc---------ccee--eeccccc-----
Confidence               01111233344  5555556778899999999999999998864322111         1110  1111111     


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                      .+.    . ....+..++..++.+++..||...+...+.+.
T Consensus       482 ~~~----~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  482 NLP----G-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             CCC----c-hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence            111    1 11456778888999999999999888776554

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.87  E-value=2.8e-08  Score=106.82  Aligned_cols=169  Identities=21%  Similarity=0.307  Sum_probs=131.0

Q ss_pred             eEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeee----eCCeEEEEEEecCC-CCHHHHh
Q 004689          422 GVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ----EEGRSVLVYEFMHN-GTLKEHL  495 (736)
Q Consensus       422 G~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~----~~~~~~lV~e~~~~-gsL~~~l  495 (736)
                      .+.||+... ||..|++|+++.+..+.......-++.++++.|+|+|++.+++.    .+..+++||+|.++ ++|.+.-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            588999765 89999999996665554444556789999999999999999886    45678999999876 5777765


Q ss_pred             hccc-----------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          496 YGTL-----------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       496 ~~~~-----------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      +...           .....+++...|.++.|++.||.++|+.   |+.-+-|.+++|+++.+.+++|+..|+......+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            4322           2234567889999999999999999998   9999999999999999999999888876554333


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCc
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA  611 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p  611 (736)
                      ..               |.+.+   -.+-|.=.||.+++-|.||..-
T Consensus       447 ~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  447 PT---------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            21               11111   1356888999999999999643

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=98.85  E-value=3.8e-09  Score=114.14  Aligned_cols=158  Identities=21%  Similarity=0.241  Sum_probs=103.7

Q ss_pred             ccccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCch---HHHH---HHHHHHcCC-CCcCCCCCCCCCCCCCceEE
Q 004689          144 LSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSID---GVAI---VSVISLYSS-ADWAQEGGDPCLPVPWSWLQ  216 (736)
Q Consensus       144 ~~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~---~~al---~~l~~~~~~-~~w~~~~~dpc~~~~~~~v~  216 (736)
                      .+++++..+.+.+|.++.+|-.....-+++.|.+..|-+.   ..+|   .++..+ .+ .+-...-..||.|..     
T Consensus        99 ~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrsl-DLSrN~is~i~~~sfp~~-----  172 (873)
T KOG4194|consen   99 YNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSL-DLSRNLISEIPKPSFPAK-----  172 (873)
T ss_pred             hcCCcceeeeeccchhhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhh-hhhhchhhcccCCCCCCC-----
Confidence            4677888899999999999988888888888888887553   2222   222222 22 222223356665432     


Q ss_pred             ecCCCCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccc
Q 004689          217 CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPN  295 (736)
Q Consensus       217 c~~~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~  295 (736)
                            .+++.|+|++|.++..--..|.+|.+|..|.|+.|+++..++ .|.+|++|+.|+|..|+|.-.---.|.+|++
T Consensus       173 ------~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~S  246 (873)
T KOG4194|consen  173 ------VNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPS  246 (873)
T ss_pred             ------CCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchh
Confidence                  467777888887775555677777777777777777777666 6777777777777777776221234556666


Q ss_pred             cceeecccccCcCCCCccc
Q 004689          296 LRELYVQNNMLSGTVPSSL  314 (736)
Q Consensus       296 L~~L~l~~N~l~g~~P~~~  314 (736)
                      |+.|.|..|+++ .+-++.
T Consensus       247 l~nlklqrN~I~-kL~DG~  264 (873)
T KOG4194|consen  247 LQNLKLQRNDIS-KLDDGA  264 (873)
T ss_pred             hhhhhhhhcCcc-cccCcc
Confidence            666666666665 444443

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=2.2e-08  Score=97.81  Aligned_cols=125  Identities=26%  Similarity=0.329  Sum_probs=80.3

Q ss_pred             EEEEEEECCCcEEEEEEeccCCcc---------------------c-----chhhhhHHHHHhhcCCC--ceeeEeeeee
Q 004689          423 VVYYGKLKDGKEIAVKVLTSNSYQ---------------------G-----KREFTNEVTLLSRIHHR--NLVQFLGYCQ  474 (736)
Q Consensus       423 ~Vy~~~~~~~~~vAvK~l~~~~~~---------------------~-----~~~~~~E~~il~~l~Hp--nIv~l~~~~~  474 (736)
                      .||.|...+|..+|||+.+.....                     .     .....+|++.|.++...  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            489999988999999997532100                     0     12356799999999765  456666543 


Q ss_pred             eCCeEEEEEEecC--CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHH-HHhCCCCceecCCCCCCCEEEcCCCcEE
Q 004689          475 EEGRSVLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY-LHTGCVPAIIHRDLKSSNILLDKHMRAK  551 (736)
Q Consensus       475 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~-LH~~~~~~iiHrDikp~NILl~~~~~~k  551 (736)
                         ..++||||++  |..+.......      +.......++.+++..+.. +|..   ||+|+|+.+.||+++++ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               3479999998  54554332111      1122345567777776666 4676   99999999999999988 999


Q ss_pred             EEeecCCccc
Q 004689          552 VSDFGLSKFA  561 (736)
Q Consensus       552 l~DFGla~~~  561 (736)
                      ++|||.+...
T Consensus       147 iIDf~qav~~  156 (188)
T PF01163_consen  147 IIDFGQAVDS  156 (188)
T ss_dssp             E--GTTEEET
T ss_pred             EEecCcceec
Confidence            9999988643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.80  E-value=6.3e-10  Score=115.25  Aligned_cols=165  Identities=19%  Similarity=0.176  Sum_probs=105.7

Q ss_pred             eeEEEeeccCCCCCCCccchhhhhhhhccCCCCc-----hHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCC
Q 004689          149 VLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSI-----DGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP  223 (736)
Q Consensus       149 l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~-----~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~  223 (736)
                      +..++...|+++++|+-+..+-.+..+....|.+     +..+|..+|.           -|||. .-..-+.-+.+.+.
T Consensus       139 l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~-----------ld~~~-N~L~tlP~~lg~l~  206 (565)
T KOG0472|consen  139 LEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKH-----------LDCNS-NLLETLPPELGGLE  206 (565)
T ss_pred             hhhhhccccccccCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHh-----------cccch-hhhhcCChhhcchh
Confidence            3444555566666666655555555554444433     3333333332           24441 00000111223345


Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCC-CCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      +|.-|+|..|++. .+| +|..+..|++|+++.|++.-.+.+. .+|.+|.+|||..|++. ..|+.+.-|.+|..||+|
T Consensus       207 ~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlS  283 (565)
T KOG0472|consen  207 SLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLS  283 (565)
T ss_pred             hhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhccc
Confidence            6777788888887 677 6888888888888888887554454 47888888888888888 788888888888888898


Q ss_pred             cccCcCCCCccccc-ccccccccCCccc
Q 004689          303 NNMLSGTVPSSLLS-KNVVLNYAGNINL  329 (736)
Q Consensus       303 ~N~l~g~~P~~~~~-~~~~l~~~~n~~~  329 (736)
                      +|.++ .+|.++.+ .+..+.+.|||--
T Consensus       284 NN~is-~Lp~sLgnlhL~~L~leGNPlr  310 (565)
T KOG0472|consen  284 NNDIS-SLPYSLGNLHLKFLALEGNPLR  310 (565)
T ss_pred             CCccc-cCCcccccceeeehhhcCCchH
Confidence            88888 77777744 3456667788644

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.72  E-value=2.6e-09  Score=123.01  Aligned_cols=204  Identities=21%  Similarity=0.220  Sum_probs=141.2

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.+-+|.++.++.+.-. .|.-.++|+.....   ....+....+-.++-..+||-++...--+.......|+++|..++
T Consensus       810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~  889 (1205)
T KOG0606|consen  810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG  889 (1205)
T ss_pred             ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence            46788999998877543 23333444332211   111223334444444456677777666666677889999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC------
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD------  563 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~------  563 (736)
                      +|...|+..-    ..+..-.......+..+++|||..   .+.|+|++|.|++...+++.+++|||.......      
T Consensus       890 ~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~  962 (1205)
T KOG0606|consen  890 DLPSKLHNSG----CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD  962 (1205)
T ss_pred             CchhhhhcCC----CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence            9999886432    222222333455677889999997   689999999999999999999999984321100      


Q ss_pred             C--C----------------C------cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccccc
Q 004689          564 G--A----------------S------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA  619 (736)
Q Consensus       564 ~--~----------------~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~  619 (736)
                      .  .                .      .......||+.|.+||...+......+|.|++|++++|.++|..||......+
T Consensus       963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen  963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred             cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence            0  0                0      00122458999999999999999999999999999999999999998776544


Q ss_pred             ccccH
Q 004689          620 NCRNI  624 (736)
Q Consensus       620 ~~~~l  624 (736)
                      ..+++
T Consensus      1043 ~f~ni 1047 (1205)
T KOG0606|consen 1043 IFENI 1047 (1205)
T ss_pred             hhhcc
Confidence            44333

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.71  E-value=6e-09  Score=82.31  Aligned_cols=58  Identities=43%  Similarity=0.580  Sum_probs=28.0

Q ss_pred             ccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          248 SLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       248 ~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      +|++|+|++|+|+...+ .|.++++|++|+|++|.|+...|..|.++++|+.|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34444444444444443 34445555555555555544444445555555555555554

...

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.70  E-value=8.9e-07  Score=93.16  Aligned_cols=299  Identities=13%  Similarity=0.128  Sum_probs=169.2

Q ss_pred             hccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeee------eee-CCeEEEEEE
Q 004689          413 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGY------CQE-EGRSVLVYE  484 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~------~~~-~~~~~lV~e  484 (736)
                      .+.||+|+-+.+|-.--  -...+.|+..........+.   ++.|... .||-+-.-+.|      ..+ ....-+.|+
T Consensus        16 gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          16 GRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            56799999999995421  12235577664433222222   2223333 45543331111      112 223567788


Q ss_pred             ecCCCCHHHHhhcc---cccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          485 FMHNGTLKEHLYGT---LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       485 ~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      .+.+.---..+++.   .+......|...++.+..+|.+.+-||..   |.+-+|+.++|+|+.+++.+.|.|-..-...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence            77664221222221   12234478999999999999999999998   8899999999999999999999985432222


Q ss_pred             cCCCCcceecccccccccCccccc-----cCcCCCcchhHHHHHHHHHHHhC-CCcCcccccccccccHHHHHHHhhhcC
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DVwSlGvvl~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      .++  ....-.+|...|.+||.-.     +..-+...|-|.+||++++++.| +.||.+-........-.+   ..+..|
T Consensus       168 ~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~g  242 (637)
T COG4248         168 ANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAHG  242 (637)
T ss_pred             cCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhcc
Confidence            222  2223346899999999865     23456778999999999999986 899976432111000000   000111


Q ss_pred             CcceeccCc--cC---CcCCHH-HHHHHHHHHhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhhcCC-CCCCCCCC
Q 004689          636 DIQGIIDPS--LL---DEYDIQ-SMWKIEEKALMCVLP--HGHMRPSISEVLKDIQDAIVIEREAAAARDG-NSDDMSRN  706 (736)
Q Consensus       636 ~~~~~~d~~--l~---~~~~~~-~~~~l~~l~~~cl~~--dP~~RPt~~ev~~~L~~~~~~~~~~~~~~~~-~~~~~~~~  706 (736)
                      .+...-|.+  +.   ...+.+ -...+..+-.+|+..  .+.-||+++-.+..|..+......=.....+ .......+
T Consensus       243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H~y~~hl~~C  322 (637)
T COG4248         243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMHVYPVHLTDC  322 (637)
T ss_pred             eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccccccCCCCCC
Confidence            111111100  00   011111 112355566677764  3678999999999888765443222211111 23344555


Q ss_pred             ccccccccCCCCCCCCcc
Q 004689          707 SLHSSLNVGSFGGTENFL  724 (736)
Q Consensus       707 s~~~~~~~~s~~~~~~~~  724 (736)
                      ++..-.+.|...+.++.|
T Consensus       323 PwCa~~~~g~~~~~~e~i  340 (637)
T COG4248         323 PWCALDNQGVIYFGEEVI  340 (637)
T ss_pred             chhhhcccCccccCccee
Confidence            555555555544444433

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.69  E-value=2e-08  Score=117.18  Aligned_cols=74  Identities=34%  Similarity=0.397  Sum_probs=44.7

Q ss_pred             ccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCCCCcccc--cccccccccC
Q 004689          248 SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAG  325 (736)
Q Consensus       248 ~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~~--~~~~~l~~~~  325 (736)
                      +|+.|+|++|+|++.++.   .++|+.|+|++|+|+ .+|...   .+|+.|+|++|+|+ .+|..+.  ..+..+.+.+
T Consensus       383 ~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~  454 (788)
T PRK15387        383 GLKELIVSGNRLTSLPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG  454 (788)
T ss_pred             ccceEEecCCcccCCCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence            456666666666643222   245666777777776 355432   35667777777777 7777663  3345667777


Q ss_pred             Cccc
Q 004689          326 NINL  329 (736)
Q Consensus       326 n~~~  329 (736)
                      |+..
T Consensus       455 N~Ls  458 (788)
T PRK15387        455 NPLS  458 (788)
T ss_pred             CCCC
Confidence            7543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.68  E-value=2.5e-07  Score=95.84  Aligned_cols=140  Identities=14%  Similarity=0.100  Sum_probs=98.8

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCcc-----------cchhhhhHHHHHhhcCCCc--eeeEeeeeee-----
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-----------GKREFTNEVTLLSRIHHRN--LVQFLGYCQE-----  475 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~-----------~~~~~~~E~~il~~l~Hpn--Iv~l~~~~~~-----  475 (736)
                      +.+-.-....|.+..+. |+.|.||........           ....+.+|...+.++...+  ..+++++...     
T Consensus        28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            33444444557777664 789999976433211           1113778999998885433  3344555543     


Q ss_pred             CCeEEEEEEecCCC-CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-------C
Q 004689          476 EGRSVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------H  547 (736)
Q Consensus       476 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~-------~  547 (736)
                      ....++|+|++++- +|.+++....  ...........++.+++..+.-||..   ||+|+|++++|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence            23578999999886 7888874221  12334556678999999999999998   9999999999999985       4


Q ss_pred             CcEEEEeecCCc
Q 004689          548 MRAKVSDFGLSK  559 (736)
Q Consensus       548 ~~~kl~DFGla~  559 (736)
                      ..+.++||+.++
T Consensus       182 ~~~~LIDl~r~~  193 (268)
T PRK15123        182 LKLSVIDLHRAQ  193 (268)
T ss_pred             ceEEEEECCccc
Confidence            689999999875

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.67  E-value=1.5e-08  Score=80.08  Aligned_cols=60  Identities=37%  Similarity=0.578  Sum_probs=54.6

Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCC
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL  282 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l  282 (736)
                      |+|+.|+|++|+|+..-+..|.++++|++|+|++|+++...| .|.+|++|++|+|++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            579999999999995555688999999999999999998888 689999999999999986

...

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.65  E-value=1.3e-08  Score=97.92  Aligned_cols=101  Identities=33%  Similarity=0.529  Sum_probs=39.1

Q ss_pred             ceEEEEccCCCCCccCCcccc-cccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccc-cCccccceeec
Q 004689          224 SITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSL-MNLPNLRELYV  301 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~l  301 (736)
                      +++.|+|.+|+|+ .+ +.++ .|++|+.|||++|+|+. ++.+..|+.|++|+|++|.|+ .+.+.+ ..+++|+.|+|
T Consensus        20 ~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L   95 (175)
T PF14580_consen   20 KLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYL   95 (175)
T ss_dssp             ------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--EEE-
T ss_pred             ccccccccccccc-cc-cchhhhhcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEEC
Confidence            7899999999999 45 4576 68999999999999996 467888999999999999999 565555 46899999999


Q ss_pred             ccccCcCCCCc----ccccccccccccCCccc
Q 004689          302 QNNMLSGTVPS----SLLSKNVVLNYAGNINL  329 (736)
Q Consensus       302 ~~N~l~g~~P~----~~~~~~~~l~~~~n~~~  329 (736)
                      ++|++. .+-.    .-+..+..+++.|||..
T Consensus        96 ~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   96 SNNKIS-DLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             TTS----SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             cCCcCC-ChHHhHHHHcCCCcceeeccCCccc
Confidence            999997 3322    22455678899999865

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.60  E-value=2.8e-07  Score=92.58  Aligned_cols=135  Identities=21%  Similarity=0.250  Sum_probs=96.5

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCc---------------c-------cchhhhhHHHHHhhcCCC--c
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY---------------Q-------GKREFTNEVTLLSRIHHR--N  465 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~---------------~-------~~~~~~~E~~il~~l~Hp--n  465 (736)
                      +.+...||.|--+.||.|...+|.++|||.-+....               .       +....++|.++|.++.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            356789999999999999999999999997432100               0       112356899999998644  5


Q ss_pred             eeeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc
Q 004689          466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD  545 (736)
Q Consensus       466 Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~  545 (736)
                      +.+.+++    ++..+||||++|-.|...-         ++....-.++..|+.-+..+-..   ||+|+|+.+-||+++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence            6666553    4568999999986554321         11222334455555555555555   999999999999999


Q ss_pred             CCCcEEEEeecCCcc
Q 004689          546 KHMRAKVSDFGLSKF  560 (736)
Q Consensus       546 ~~~~~kl~DFGla~~  560 (736)
                      ++|.+.++||-.+..
T Consensus       237 ~dg~~~vIDwPQ~v~  251 (304)
T COG0478         237 EDGDIVVIDWPQAVP  251 (304)
T ss_pred             cCCCEEEEeCccccc
Confidence            999999999976643

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.60  E-value=7e-08  Score=113.19  Aligned_cols=94  Identities=28%  Similarity=0.475  Sum_probs=51.9

Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN  303 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~  303 (736)
                      +|+.|+|++|+|+ .+|..+.  ++|+.|+|++|+|++.++.+.  ++|+.|++++|.|++ +|..+.  ++|+.|+|++
T Consensus       284 sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~  355 (754)
T PRK15370        284 ELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSK  355 (754)
T ss_pred             CCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCC
Confidence            5777777777777 4555443  356666666666664332221  455566666666652 454442  4566666666


Q ss_pred             ccCcCCCCcccccccccccccCC
Q 004689          304 NMLSGTVPSSLLSKNVVLNYAGN  326 (736)
Q Consensus       304 N~l~g~~P~~~~~~~~~l~~~~n  326 (736)
                      |+|+ .+|..+...+..+.+.+|
T Consensus       356 N~L~-~LP~~lp~~L~~LdLs~N  377 (754)
T PRK15370        356 NQIT-VLPETLPPTITTLDVSRN  377 (754)
T ss_pred             CCCC-cCChhhcCCcCEEECCCC
Confidence            6665 455555444445555554

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.59  E-value=3.5e-09  Score=109.85  Aligned_cols=154  Identities=21%  Similarity=0.264  Sum_probs=91.4

Q ss_pred             ccccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCch--HHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEec--C
Q 004689          144 LSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSID--GVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN--S  219 (736)
Q Consensus       144 ~~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~--~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~--~  219 (736)
                      .++..+..+....|..+.+||.|..+|.++.+.-+-|.+.  ..++-++.+...+. ..          ....+.|.  .
T Consensus        65 ~nL~~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~-~s----------~n~~~el~~~i  133 (565)
T KOG0472|consen   65 KNLACLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLD-CS----------SNELKELPDSI  133 (565)
T ss_pred             hcccceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhh-cc----------ccceeecCchH
Confidence            3566788899999999999999999999888777666552  12222222222110 00          01112221  1


Q ss_pred             CCCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCcccccee
Q 004689          220 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL  299 (736)
Q Consensus       220 ~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L  299 (736)
                      ..+-.+..|+..+|+++ ++|++++++.+|..|++.+|++...+|+.-+++.|++||...|.+. .+|+.++.|.+|..|
T Consensus       134 ~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~L  211 (565)
T KOG0472|consen  134 GRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELL  211 (565)
T ss_pred             HHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHH
Confidence            11234555666666666 5666666666666666666666666665444666666666666665 566666666666666


Q ss_pred             ecccccCcCCCC
Q 004689          300 YVQNNMLSGTVP  311 (736)
Q Consensus       300 ~l~~N~l~g~~P  311 (736)
                      ||..|.+. .+|
T Consensus       212 yL~~Nki~-~lP  222 (565)
T KOG0472|consen  212 YLRRNKIR-FLP  222 (565)
T ss_pred             Hhhhcccc-cCC
Confidence            66666665 555

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.56  E-value=1.4e-07  Score=110.06  Aligned_cols=52  Identities=31%  Similarity=0.380  Sum_probs=31.3

Q ss_pred             CCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCCCCcccccccccccccCCc
Q 004689          270 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI  327 (736)
Q Consensus       270 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~~~~~~~l~~~~n~  327 (736)
                      .+|+.|+|++|+|+ .+|..   .++|+.|++++|.|+ .+|.. ...+..+.+.+|.
T Consensus       382 ~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l-~~~L~~L~Ls~Nq  433 (788)
T PRK15387        382 SGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPML-PSGLLSLSVYRNQ  433 (788)
T ss_pred             cccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcc-hhhhhhhhhccCc
Confidence            35667777777777 35543   246777788888877 56653 2334445555553

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.48  E-value=3.5e-08  Score=109.95  Aligned_cols=151  Identities=19%  Similarity=0.325  Sum_probs=103.5

Q ss_pred             HHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC--------cceecccccccccCcccccc
Q 004689          515 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--------HVSSIVRGTVGYLDPEYYIS  586 (736)
Q Consensus       515 ~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~--------~~~~~~~gt~~Y~aPE~~~~  586 (736)
                      .+++.||.|+|..  .++||++|.|++|.++..+..||+.|+.+........        .......-...|.|||++..
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            3456899999998  6999999999999999999999999998754322111        11112234678999999999


Q ss_pred             CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccC
Q 004689          587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVL  666 (736)
Q Consensus       587 ~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~  666 (736)
                      ...+.++|+||+||++|-+..|..+...............             ..+..-.-.++.+.+.++.+-+.+.+.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------------~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------------NLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-------------cccccccccccccCcHHHHHHHHHHhc
Confidence            8889999999999999999955444322221111111111             011111112334445678888889999


Q ss_pred             CCCCCCCCHHHHHH
Q 004689          667 PHGHMRPSISEVLK  680 (736)
Q Consensus       667 ~dP~~RPt~~ev~~  680 (736)
                      .++..||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998877654

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.44  E-value=1.7e-08  Score=109.08  Aligned_cols=102  Identities=25%  Similarity=0.331  Sum_probs=74.4

Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN  303 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~  303 (736)
                      -|..|-+++|+|+ .+|+.|+.+..|..||.+.|.+...++.+++|.+|+.|++..|++. .+|+.+..| .|..||+++
T Consensus       144 pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfSc  220 (722)
T KOG0532|consen  144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSC  220 (722)
T ss_pred             cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeeccc
Confidence            4777888888888 7888888778888888888888877777788887777777777777 666666655 367777777


Q ss_pred             ccCcCCCCccccc--ccccccccCCccc
Q 004689          304 NMLSGTVPSSLLS--KNVVLNYAGNINL  329 (736)
Q Consensus       304 N~l~g~~P~~~~~--~~~~l~~~~n~~~  329 (736)
                      |+++ .||-.+..  .++.+.+..||-.
T Consensus       221 Nkis-~iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  221 NKIS-YLPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             Ccee-ecchhhhhhhhheeeeeccCCCC
Confidence            7777 77776633  3455666666554

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.44  E-value=1.7e-06  Score=86.48  Aligned_cols=106  Identities=26%  Similarity=0.312  Sum_probs=82.2

Q ss_pred             chhhhhHHHHHhhcCCC--ceeeEeeeeeeC----CeEEEEEEecCCC-CHHHHhhcccccccccCHHHHHHHHHHHHHH
Q 004689          448 KREFTNEVTLLSRIHHR--NLVQFLGYCQEE----GRSVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKG  520 (736)
Q Consensus       448 ~~~~~~E~~il~~l~Hp--nIv~l~~~~~~~----~~~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~  520 (736)
                      .....+|...+.++...  .+.+.+++....    ...++|+|++++- +|.+++....    ..+......++.+++..
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL  130 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence            44677898888888533  345566666543    2458999999874 7888885321    14455667899999999


Q ss_pred             HHHHHhCCCCceecCCCCCCCEEEcCCC---cEEEEeecCCcc
Q 004689          521 IEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKF  560 (736)
Q Consensus       521 L~~LH~~~~~~iiHrDikp~NILl~~~~---~~kl~DFGla~~  560 (736)
                      +.-||..   ||+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999998   999999999999999887   899999997764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=6.2e-07  Score=100.46  Aligned_cols=144  Identities=23%  Similarity=0.270  Sum_probs=95.1

Q ss_pred             HHHhh-ccccccCceEEEEEEECCCcEEEEEEeccCCccc----------------------------------------
Q 004689          409 TKMLE-KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG----------------------------------------  447 (736)
Q Consensus       409 ~~~~~-~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~----------------------------------------  447 (736)
                      ...|+ +.|+.++-|.||+|++++|+.||||+.+..-...                                        
T Consensus       125 F~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~  204 (517)
T COG0661         125 FSEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE  204 (517)
T ss_pred             HHHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence            33443 6799999999999999999999999976431110                                        


Q ss_pred             chhhhhHHHHHhhcC-----CCceeeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHH-H
Q 004689          448 KREFTNEVTLLSRIH-----HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG-I  521 (736)
Q Consensus       448 ~~~~~~E~~il~~l~-----HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~-L  521 (736)
                      +-++..|+..+.+++     .+++.-.-=|.+-.+..+|+|||++|-.+.+...-.   ...++..   .++..++++ +
T Consensus       205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k---~ia~~~~~~f~  278 (517)
T COG0661         205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRK---ELAELLVRAFL  278 (517)
T ss_pred             HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHH---HHHHHHHHHHH
Confidence            012445555555552     344433333344456679999999998888774211   1233422   233333332 2


Q ss_pred             HHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       522 ~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ..+-..   |++|.|.+|.||+++.++++.+.|||+....
T Consensus       279 ~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         279 RQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             HHHHhc---CccccCCCccceEEecCCcEEEEcCcceecC
Confidence            233333   8999999999999999999999999998654

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.41  E-value=4e-07  Score=106.85  Aligned_cols=98  Identities=28%  Similarity=0.369  Sum_probs=77.0

Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      .+|+.|+|++|+++ .+|..+.  ++|+.|+|++|+|+..+..+.  ++|+.|+|++|+|+ .+|..+.  ++|+.|+++
T Consensus       241 ~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls  312 (754)
T PRK15370        241 DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISCLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQ  312 (754)
T ss_pred             ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccCccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhc
Confidence            36899999999998 7888775  589999999999996443453  58999999999999 5676554  478999999


Q ss_pred             cccCcCCCCcccccccccccccCCccc
Q 004689          303 NNMLSGTVPSSLLSKNVVLNYAGNINL  329 (736)
Q Consensus       303 ~N~l~g~~P~~~~~~~~~l~~~~n~~~  329 (736)
                      +|+|+ .+|..+...+..+.+..|...
T Consensus       313 ~N~Lt-~LP~~l~~sL~~L~Ls~N~Lt  338 (754)
T PRK15370        313 SNSLT-ALPETLPPGLKTLEAGENALT  338 (754)
T ss_pred             CCccc-cCCccccccceeccccCCccc
Confidence            99998 688777766777777777543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.41  E-value=3.4e-08  Score=109.34  Aligned_cols=125  Identities=29%  Similarity=0.379  Sum_probs=98.6

Q ss_pred             CCCCCCCCCCce---EEecCCC----------CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCC
Q 004689          203 GGDPCLPVPWSW---LQCNSDP----------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSG  268 (736)
Q Consensus       203 ~~dpc~~~~~~~---v~c~~~~----------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~  268 (736)
                      +||-|...+|.-   ..|+++.          ++.|+.|||++|+++. . ..|-.|++|++|||+.|.|+-.+- ...+
T Consensus       154 ggd~~ns~~Wn~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~-v-~~Lr~l~~LkhLDlsyN~L~~vp~l~~~g  231 (1096)
T KOG1859|consen  154 GGDISNSPVWNKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTK-V-DNLRRLPKLKHLDLSYNCLRHVPQLSMVG  231 (1096)
T ss_pred             ccccccchhhhhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhh-h-HHHHhcccccccccccchhccccccchhh
Confidence            467776555554   5777665          3688999999999993 3 378899999999999999996544 4566


Q ss_pred             CCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCCC---CcccccccccccccCCcccccC
Q 004689          269 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTV---PSSLLSKNVVLNYAGNINLHEG  332 (736)
Q Consensus       269 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~---P~~~~~~~~~l~~~~n~~~c~~  332 (736)
                      |+ |+.|.|.+|-++..  -.+.+|++|+.|||++|-|++.-   |-+.+..+..+.+.|||..|.+
T Consensus       232 c~-L~~L~lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  232 CK-LQLLNLRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             hh-heeeeecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            77 99999999999833  24889999999999999988654   4444555678899999999986

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.39  E-value=1.5e-07  Score=90.63  Aligned_cols=84  Identities=25%  Similarity=0.383  Sum_probs=42.6

Q ss_pred             CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCC-CCCCCCcEEEcCCCCCCCC-CCccccCcccccee
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDNQLTGP-LPSSLMNLPNLREL  299 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L  299 (736)
                      +.+|+.|+|++|+|+ .+. .+..|++|++|+|++|+|+...+.+ ..|++|++|+|++|+|... --..+..|++|+.|
T Consensus        41 l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L  118 (175)
T PF14580_consen   41 LDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL  118 (175)
T ss_dssp             -TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred             hcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence            358999999999999 554 5889999999999999999765555 4699999999999999842 12468889999999


Q ss_pred             ecccccCc
Q 004689          300 YVQNNMLS  307 (736)
Q Consensus       300 ~l~~N~l~  307 (736)
                      +|.+|.++
T Consensus       119 ~L~~NPv~  126 (175)
T PF14580_consen  119 SLEGNPVC  126 (175)
T ss_dssp             E-TT-GGG
T ss_pred             eccCCccc
Confidence            99999998

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.29  E-value=6.6e-08  Score=104.71  Aligned_cols=154  Identities=18%  Similarity=0.252  Sum_probs=116.4

Q ss_pred             ceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchH----HHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCC
Q 004689          148 FVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDG----VAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP  223 (736)
Q Consensus       148 ~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~----~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~  223 (736)
                      ++..+.|.-|.+-.+|+.|..++.+.+|.++.|++..    .-..-||-++. .+.    ..-|+|-+       ....+
T Consensus        99 ~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lpLkvli~-sNN----kl~~lp~~-------ig~~~  166 (722)
T KOG0532|consen   99 SLESLILYHNCIRTIPEAICNLEALTFLDLSSNQLSHLPDGLCDLPLKVLIV-SNN----KLTSLPEE-------IGLLP  166 (722)
T ss_pred             HHHHHHHHhccceecchhhhhhhHHHHhhhccchhhcCChhhhcCcceeEEE-ecC----ccccCCcc-------cccch
Confidence            4555677778888888888888888887777766532    11111221111 111    12233221       12346


Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN  303 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~  303 (736)
                      .|..||.+.|.+. .+|+.++.|++|+.|.+..|++...++++. .-.|..||+|.|+++ .||-.|.+|+.|++|-|.+
T Consensus       167 tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~Len  243 (722)
T KOG0532|consen  167 TLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLEN  243 (722)
T ss_pred             hHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeecc
Confidence            8999999999999 899999999999999999999999988888 556899999999999 9999999999999999999


Q ss_pred             ccCcCCCCcccccc
Q 004689          304 NMLSGTVPSSLLSK  317 (736)
Q Consensus       304 N~l~g~~P~~~~~~  317 (736)
                      |.|. +.|..+..+
T Consensus       244 NPLq-SPPAqIC~k  256 (722)
T KOG0532|consen  244 NPLQ-SPPAQICEK  256 (722)
T ss_pred             CCCC-CChHHHHhc
Confidence            9999 778776443

>PRK09902 hypothetical protein; Provisional

Probab=98.27  E-value=1.9e-05  Score=77.77  Aligned_cols=137  Identities=18%  Similarity=0.173  Sum_probs=100.9

Q ss_pred             ccccCceEEEEEEECCCcEEEEEEeccC---C---cccchhhhhHHHHHhhcCC--CceeeEeeeee-e----CCeEEEE
Q 004689          416 IGSGGFGVVYYGKLKDGKEIAVKVLTSN---S---YQGKREFTNEVTLLSRIHH--RNLVQFLGYCQ-E----EGRSVLV  482 (736)
Q Consensus       416 IG~G~fG~Vy~~~~~~~~~vAvK~l~~~---~---~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~-~----~~~~~lV  482 (736)
                      -|+||-+.|++-.+. |+.+-+|.-...   +   +.....|.+|...|.++..  -.+.+.+ ++. .    .-+.+||
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            477999999998776 557888875421   1   2345679999999999953  2345555 332 1    1245899


Q ss_pred             EEecCC-CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc--EEEEeecCCc
Q 004689          483 YEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLSK  559 (736)
Q Consensus       483 ~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~--~kl~DFGla~  559 (736)
                      +|-+.+ -+|.+++....  ..+.+...+..+..++++.+.-||..   |+.|+|+.+.||+++.++.  ++++||--++
T Consensus       104 Te~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997764 58888874321  22345666778999999999999998   9999999999999986666  9999998765

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.27  E-value=3.1e-08  Score=112.74  Aligned_cols=170  Identities=19%  Similarity=0.266  Sum_probs=122.4

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchH-----HHHHHH-HHHcCCCCcCCCCCCCCCCCCCceEEec
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDG-----VAIVSV-ISLYSSADWAQEGGDPCLPVPWSWLQCN  218 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~-----~al~~l-~~~~~~~~w~~~~~dpc~~~~~~~v~c~  218 (736)
                      ..+.+..+..+.|.++.+||-...+..+..|.+..|.+--     .+.... -..+..+.. .-..-||.         .
T Consensus       285 ~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n-~l~~lp~~---------~  354 (1081)
T KOG0618|consen  285 RITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSN-KLSTLPSY---------E  354 (1081)
T ss_pred             hhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhc-cccccccc---------c
Confidence            4556677777888888888888877777777777665511     111111 001111111 01122331         1


Q ss_pred             CCCCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccc
Q 004689          219 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR  297 (736)
Q Consensus       219 ~~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~  297 (736)
                      ....+.|+.|.|.+|.|+...-+-|.+.++|+.|+|++|+|...+. .+.++..|++|+||+|.|+ .+|..+.+++.|+
T Consensus       355 e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~  433 (1081)
T KOG0618|consen  355 ENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLH  433 (1081)
T ss_pred             chhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhH
Confidence            1234689999999999999888889999999999999999996655 5899999999999999999 8999999999999


Q ss_pred             eeecccccCcCCCCccc-ccccccccccCC
Q 004689          298 ELYVQNNMLSGTVPSSL-LSKNVVLNYAGN  326 (736)
Q Consensus       298 ~L~l~~N~l~g~~P~~~-~~~~~~l~~~~n  326 (736)
                      .|...+|+|. .+|... +..++.++++.|
T Consensus       434 tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N  462 (1081)
T KOG0618|consen  434 TLRAHSNQLL-SFPELAQLPQLKVLDLSCN  462 (1081)
T ss_pred             HHhhcCCcee-echhhhhcCcceEEecccc
Confidence            9999999999 888433 233455566555

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.22  E-value=1.5e-05  Score=80.88  Aligned_cols=138  Identities=16%  Similarity=0.223  Sum_probs=85.4

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCc--eeeEeeeeeeCCeEEEEEEecCCCC-
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGYCQEEGRSVLVYEFMHNGT-  490 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~e~~~~gs-  490 (736)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +.+.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            46899999999984   25568889875432  3445789999999986443  4677788777778889999999864 


Q ss_pred             HHHHh---------------------hcccccccccCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCceecCC
Q 004689          491 LKEHL---------------------YGTLTHEQRINWIKRLE-IAE----------DAAK-GIEYLHTG-CVPAIIHRD  536 (736)
Q Consensus       491 L~~~l---------------------~~~~~~~~~l~~~~~~~-i~~----------qia~-~L~~LH~~-~~~~iiHrD  536 (736)
                      +...+                     |......  ........ +..          .+.. ...+|... ..+.++|+|
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            21111                     1100000  01000000 000          0111 12222211 124678999


Q ss_pred             CCCCCEEEcCCCcEEEEeecCCc
Q 004689          537 LKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       537 ikp~NILl~~~~~~kl~DFGla~  559 (736)
                      +.|.||++++++ +.|+||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999888 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.19  E-value=1.3e-05  Score=80.07  Aligned_cols=137  Identities=22%  Similarity=0.249  Sum_probs=91.9

Q ss_pred             cccccCceEEEEEEECCCcEEEEEEeccCCcccc------------------------hhhhhHHHHHhhcC--CCceee
Q 004689          415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK------------------------REFTNEVTLLSRIH--HRNLVQ  468 (736)
Q Consensus       415 ~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~------------------------~~~~~E~~il~~l~--HpnIv~  468 (736)
                      .|+.|.-+.||+|...++..+|||+.+.......                        ....+|+.-|+++.  +-.+.+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            5777888899999888899999999864322111                        11345777777763  334444


Q ss_pred             EeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC
Q 004689          469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM  548 (736)
Q Consensus       469 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~  548 (736)
                      .+++.    ...|||||+...-.   -...+. ...+.......+..++++.+.-|-..+  ++||+||..-|||+. ++
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~---pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~  203 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGL---PAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DG  203 (268)
T ss_pred             ceeec----CCeEEEEeccCCCC---CCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CC
Confidence            44443    34799999965411   111111 112222245667778888888887742  999999999999999 88


Q ss_pred             cEEEEeecCCcccc
Q 004689          549 RAKVSDFGLSKFAV  562 (736)
Q Consensus       549 ~~kl~DFGla~~~~  562 (736)
                      .+.++|||.|....
T Consensus       204 ~p~iID~~QaV~~~  217 (268)
T COG1718         204 EPYIIDVSQAVTID  217 (268)
T ss_pred             eEEEEECccccccC
Confidence            99999999986543

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.08  E-value=1.1e-06  Score=91.62  Aligned_cols=210  Identities=20%  Similarity=0.171  Sum_probs=138.2

Q ss_pred             CceEEEEEeCCCcCCccccccccccccCcceeccCccccccccceeEEEe-eccCCCCCCCc-cchhhhhhhhccCCCCc
Q 004689          105 ESRKFRLVLPGQPDVSKAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKF-GKTYDSSRGPL-LNAMEINKYLERNDGSI  182 (736)
Q Consensus       105 ~~R~F~i~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~l~l-~~~~~s~lpP~-in~~e~~~~l~~~~~~~  182 (736)
                      +.|..|++=|+..+-.   ++.+.              .  +.++.+|.+ +.|.+..+|-- ++++-.++.|.++-+.+
T Consensus        92 ~LRrLdLS~N~Is~I~---p~AF~--------------G--L~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i  152 (498)
T KOG4237|consen   92 RLRRLDLSKNNISFIA---PDAFK--------------G--LASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHI  152 (498)
T ss_pred             hhceecccccchhhcC---hHhhh--------------h--hHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhh
Confidence            4599999999886511   11111              1  223334444 45889999855 88888888888887655


Q ss_pred             ---hHHHHHHHHHH-----cCC----------------CCc----CCCCCCCC----------CCCCCceEEecCCC---
Q 004689          183 ---DGVAIVSVISL-----YSS----------------ADW----AQEGGDPC----------LPVPWSWLQCNSDP---  221 (736)
Q Consensus       183 ---~~~al~~l~~~-----~~~----------------~~w----~~~~~dpc----------~~~~~~~v~c~~~~---  221 (736)
                         -..|+.+++..     +..                ...    +..-.||-          .|+..+|..|...-   
T Consensus       153 ~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~  232 (498)
T KOG4237|consen  153 NCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLY  232 (498)
T ss_pred             cchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHH
Confidence               45666666655     220                000    00011221          23456777775321   


Q ss_pred             ------------CCceEEE--Ecc-CCCCCccCCc-ccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCC
Q 004689          222 ------------QPSITVI--HLS-SKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTG  284 (736)
Q Consensus       222 ------------~~~l~~L--~L~-~n~l~g~~p~-~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g  284 (736)
                                  ...++.+  .++ .....+..|. .|..|++|+.|+|++|+++++-+ .|.++.+|++|.|..|+|.-
T Consensus       233 ~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~  312 (498)
T KOG4237|consen  233 YKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEF  312 (498)
T ss_pred             HHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHH
Confidence                        1122222  233 3334445554 57899999999999999999888 79999999999999999985


Q ss_pred             CCCccccCccccceeecccccCcCCCCcccc--cccccccccCCcccccCC
Q 004689          285 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNINLHEGG  333 (736)
Q Consensus       285 ~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~~--~~~~~l~~~~n~~~c~~~  333 (736)
                      .--..|.++..|+.|+|.+|+|+...|..+-  ..+..+++-+||+.|++.
T Consensus       313 v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~  363 (498)
T KOG4237|consen  313 VSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCR  363 (498)
T ss_pred             HHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccc
Confidence            4455788999999999999999944454442  234678899999999983

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.08  E-value=3.7e-05  Score=79.05  Aligned_cols=140  Identities=18%  Similarity=0.161  Sum_probs=86.4

Q ss_pred             ccccCc-eEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEEecCCCCHHH
Q 004689          416 IGSGGF-GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE  493 (736)
Q Consensus       416 IG~G~f-G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~~  493 (736)
                      |-.|.. ..||+.... +..+.||+.....   ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            445555 789999765 4788899875432   346778999998884 4446677887776677899999999987764


Q ss_pred             Hh-------------------hcccccccccC--HHHHHHHHH--------------------HHHHHHHHHHh----CC
Q 004689          494 HL-------------------YGTLTHEQRIN--WIKRLEIAE--------------------DAAKGIEYLHT----GC  528 (736)
Q Consensus       494 ~l-------------------~~~~~~~~~l~--~~~~~~i~~--------------------qia~~L~~LH~----~~  528 (736)
                      ..                   +........+.  .........                    .+...+..|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            32                   11100000000  000000000                    01111222211    11


Q ss_pred             CCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       529 ~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      .+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            2579999999999999998778899999764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.08  E-value=6.5e-07  Score=93.27  Aligned_cols=99  Identities=23%  Similarity=0.396  Sum_probs=79.8

Q ss_pred             EEecCCCC--------CceEEEEccCCCCCccCCc-ccccccccccccccccccCCCCC-CCCCCCCCcEEEc-CCCCCC
Q 004689          215 LQCNSDPQ--------PSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHL-EDNQLT  283 (736)
Q Consensus       215 v~c~~~~~--------~~l~~L~L~~n~l~g~~p~-~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~L-s~N~l~  283 (736)
                      |.|+...+        +..+.|.|..|+|+ .||+ .|..|++|+.||||+|+|+.+-| +|.+|.+|..|-| ++|+|+
T Consensus        51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~  129 (498)
T KOG4237|consen   51 VDCRGKGLTEVPANLPPETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT  129 (498)
T ss_pred             EEccCCCcccCcccCCCcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence            78876653        56789999999999 5555 78899999999999999999888 7999999876654 559999


Q ss_pred             CCCCccccCccccceeecccccCcCCCCcccc
Q 004689          284 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL  315 (736)
Q Consensus       284 g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~~  315 (736)
                      ...-..|++|..|+.|.+.-|++. .++...+
T Consensus       130 ~l~k~~F~gL~slqrLllNan~i~-Cir~~al  160 (498)
T KOG4237|consen  130 DLPKGAFGGLSSLQRLLLNANHIN-CIRQDAL  160 (498)
T ss_pred             hhhhhHhhhHHHHHHHhcChhhhc-chhHHHH
Confidence            444458899999999999888888 5555443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.07  E-value=8.8e-07  Score=97.76  Aligned_cols=182  Identities=16%  Similarity=0.169  Sum_probs=131.4

Q ss_pred             hccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCc-eeeEeeeeeeCCeEEEEEEecCCC-C
Q 004689          413 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEGRSVLVYEFMHNG-T  490 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~e~~~~g-s  490 (736)
                      -+-+++|+++.+||.+-...+....+.+...     ....-++++|.+++||| .+..++-+..+...+++++++.+| +
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs  321 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRS  321 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcc
Confidence            3557899999999987553444445554322     34556899999999999 777777777788889999999887 2


Q ss_pred             HHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCccee
Q 004689          491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS  570 (736)
Q Consensus       491 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  570 (736)
                      -...+   ......+...+...++..-++++++||+.   .=+|+|    ||+..+ +..+..||+....+....  ...
T Consensus       322 ~~~~~---~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~  388 (829)
T KOG0576|consen  322 SALEM---TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR  388 (829)
T ss_pred             ccccC---ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence            21111   11222344444555667778899999996   447888    777665 679999999876554432  334


Q ss_pred             cccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcC
Q 004689          571 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI  612 (736)
Q Consensus       571 ~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~  612 (736)
                      ...+|+.++|||+.....+..+.|+|+.|+--.++--|-+|-
T Consensus       389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            456899999999999999999999999998777777776654

>PLN03210 Resistant to P

Probab=98.07  E-value=5.8e-06  Score=103.43  Aligned_cols=107  Identities=23%  Similarity=0.319  Sum_probs=89.7

Q ss_pred             CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      +.+|+.|+|++|+|. .+|..+..|++|+.|+|++|...+.+|.++.+++|++|+|++|.....+|.++++|++|+.|++
T Consensus       610 ~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L  688 (1153)
T PLN03210        610 PENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM  688 (1153)
T ss_pred             ccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence            358999999999998 7888899999999999999887778888999999999999998777789999999999999999


Q ss_pred             ccccCcCCCCccc-ccccccccccCCccc
Q 004689          302 QNNMLSGTVPSSL-LSKNVVLNYAGNINL  329 (736)
Q Consensus       302 ~~N~l~g~~P~~~-~~~~~~l~~~~n~~~  329 (736)
                      ++|..-+.+|..+ +..+..+.+.|+..+
T Consensus       689 ~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L  717 (1153)
T PLN03210        689 SRCENLEILPTGINLKSLYRLNLSGCSRL  717 (1153)
T ss_pred             CCCCCcCccCCcCCCCCCCEEeCCCCCCc
Confidence            9976555888765 344556667766433

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=98.05  E-value=9.8e-06  Score=101.38  Aligned_cols=89  Identities=18%  Similarity=0.213  Sum_probs=48.8

Q ss_pred             CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      +++|+.|+|++|..-..+|..|.+|++|+.|+|++|...+.+|...++++|+.|+|++|...+.+|..   .++|+.|+|
T Consensus       656 l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L  732 (1153)
T PLN03210        656 ATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDI---STNISWLDL  732 (1153)
T ss_pred             CCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccc---cCCcCeeec
Confidence            34566666666544445666666666666666665544444443335666666666665544445432   234556666


Q ss_pred             ccccCcCCCCccc
Q 004689          302 QNNMLSGTVPSSL  314 (736)
Q Consensus       302 ~~N~l~g~~P~~~  314 (736)
                      ++|.++ .+|..+
T Consensus       733 ~~n~i~-~lP~~~  744 (1153)
T PLN03210        733 DETAIE-EFPSNL  744 (1153)
T ss_pred             CCCccc-cccccc
Confidence            666655 555443

syringae 6; Provisional

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.04  E-value=5.4e-05  Score=76.68  Aligned_cols=143  Identities=19%  Similarity=0.236  Sum_probs=84.5

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCC--ceeeEeeeee---eCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR--NLVQFLGYCQ---EEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~~~~~---~~~~~~lV~e~~~~  488 (736)
                      +.|+.|..+.||+....+ ..+++|+....  .....+..|..+++.+...  -+.+++.++.   .....+++|+++++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            468999999999999886 69999996543  3456788999999888533  3456666443   33457899999999


Q ss_pred             CCHHH----------------Hh---hcccccccccCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 004689          489 GTLKE----------------HL---YGTLTHEQRINWIK---------RLEI------------AEDAAK-GIEYLHT-  526 (736)
Q Consensus       489 gsL~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~qia~-~L~~LH~-  526 (736)
                      ..+..                .+   +.............         ....            ...+.+ .+..+++ 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            88877                11   11100000011000         0000            112222 3333332 


Q ss_pred             ---CCCCceecCCCCCCCEEEc-CCCcEEEEeecCCc
Q 004689          527 ---GCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSK  559 (736)
Q Consensus       527 ---~~~~~iiHrDikp~NILl~-~~~~~kl~DFGla~  559 (736)
                         .....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               1234799999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.04  E-value=2.5e-05  Score=87.36  Aligned_cols=140  Identities=19%  Similarity=0.213  Sum_probs=89.3

Q ss_pred             hccccccCceEEEEEEECCCcEEEEEEeccCCccc-------------------------------------chhhhhHH
Q 004689          413 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-------------------------------------KREFTNEV  455 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~-------------------------------------~~~~~~E~  455 (736)
                      .+.||.-+.|.||+|++++|+.||||+-+..-...                                     +-+|.+|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            36799999999999999999999999854321100                                     11344555


Q ss_pred             HHHhhc----CCCc------eeeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHH
Q 004689          456 TLLSRI----HHRN------LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH  525 (736)
Q Consensus       456 ~il~~l----~Hpn------Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH  525 (736)
                      +-..++    .|-+      |.+++  ..-....+|+||||+|..+.|.-.-   .+..++...   ++..+.++...  
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~---i~~~l~~~~~~--  315 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHD---ILNKLVEAYLE--  315 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHH---HHcCCCHHH---HHHHHHHHHHH--
Confidence            544443    3444      22222  2233467999999999877765321   123344433   33333333221  


Q ss_pred             hCCCCceecCCCCCCCEEEcC----CCcEEEEeecCCcccc
Q 004689          526 TGCVPAIIHRDLKSSNILLDK----HMRAKVSDFGLSKFAV  562 (736)
Q Consensus       526 ~~~~~~iiHrDikp~NILl~~----~~~~kl~DFGla~~~~  562 (736)
                      .--..|++|+|-.|.||+++.    ++++.+-|||+...+.
T Consensus       316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            111138999999999999994    6789999999987553

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.02  E-value=1.2e-06  Score=93.67  Aligned_cols=139  Identities=18%  Similarity=0.231  Sum_probs=88.7

Q ss_pred             ccceeEEEeeccCCCC-CCCccchhhh---hhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCC
Q 004689          146 LPFVLSFKFGKTYDSS-RGPLLNAMEI---NKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDP  221 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~-lpP~in~~e~---~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~  221 (736)
                      .+.+..|.++.+.+.. .++.+..+..   ++.|.++.+.....++..+...+..                        .
T Consensus        80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~------------------------~  135 (319)
T cd00116          80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKD------------------------L  135 (319)
T ss_pred             cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHh------------------------C
Confidence            4567777777777663 3334544444   6666666666554444433322110                        0


Q ss_pred             CCceEEEEccCCCCCcc----CCcccccccccccccccccccCCC----CC-CCCCCCCCcEEEcCCCCCCCC----CCc
Q 004689          222 QPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGP----IP-DFSGCPDLRIIHLEDNQLTGP----LPS  288 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p-~~~~l~~L~~L~Ls~N~l~g~----~p~  288 (736)
                      .++|+.|+|++|.+++.    ++..+..+++|++|+|++|.+++.    ++ .+..+++|++|+|++|.+++.    ++.
T Consensus       136 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~  215 (319)
T cd00116         136 PPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAE  215 (319)
T ss_pred             CCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHH
Confidence            14788888888888843    333455667888888888888852    11 345567888888888888743    344


Q ss_pred             cccCccccceeecccccCcC
Q 004689          289 SLMNLPNLRELYVQNNMLSG  308 (736)
Q Consensus       289 ~~~~l~~L~~L~l~~N~l~g  308 (736)
                      .+..+++|+.|++++|.+++
T Consensus       216 ~~~~~~~L~~L~ls~n~l~~  235 (319)
T cd00116         216 TLASLKSLEVLNLGDNNLTD  235 (319)
T ss_pred             HhcccCCCCEEecCCCcCch
Confidence            56677888888888888875

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.00  E-value=4.6e-07  Score=90.98  Aligned_cols=85  Identities=25%  Similarity=0.291  Sum_probs=55.6

Q ss_pred             CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCC-CccccCccccceee
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPL-PSSLMNLPNLRELY  300 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~  300 (736)
                      +++|+.||||+|.|+ .+-.+=.+|-+++.|.|+.|.+.. +..+..|-+|..||+++|+|...- -..+|+|+.|+.|.
T Consensus       328 L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~-LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~  405 (490)
T KOG1259|consen  328 LPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET-LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLR  405 (490)
T ss_pred             cccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhh-hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHh
Confidence            456666666666666 444444456666666666666552 234555667788888888877321 24678888888888


Q ss_pred             cccccCcC
Q 004689          301 VQNNMLSG  308 (736)
Q Consensus       301 l~~N~l~g  308 (736)
                      |-+|.+.+
T Consensus       406 L~~NPl~~  413 (490)
T KOG1259|consen  406 LTGNPLAG  413 (490)
T ss_pred             hcCCCccc
Confidence            88888874

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.98  E-value=4.5e-06  Score=60.75  Aligned_cols=36  Identities=47%  Similarity=0.720  Sum_probs=19.2

Q ss_pred             CCcEEEcCCCCCCCCCCccccCccccceeecccccCc
Q 004689          271 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS  307 (736)
Q Consensus       271 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  307 (736)
                      +|++|+|++|+|+ .+|+.+++|++|+.|++++|+++
T Consensus         2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            4555555555555 44545555555555555555555

...

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=97.95  E-value=6.4e-06  Score=91.11  Aligned_cols=171  Identities=26%  Similarity=0.343  Sum_probs=121.2

Q ss_pred             cccceeEEEeeccCCCCCCCccchhh-hhhhhccCCCCchHH--HHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCC
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAME-INKYLERNDGSIDGV--AIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDP  221 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e-~~~~l~~~~~~~~~~--al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~  221 (736)
                      .++.+..+.+..|.++.+||.+.... .++.|....+++.-.  .+..++.+..+.   ....+      +..+.-....
T Consensus       114 ~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~---l~~N~------l~~l~~~~~~  184 (394)
T COG4886         114 ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLD---LSFND------LSDLPKLLSN  184 (394)
T ss_pred             cccceeEEecCCcccccCccccccchhhcccccccccchhhhhhhhhccccccccc---cCCch------hhhhhhhhhh
Confidence            34678889999999999999999994 899999999888643  333333332221   00011      1111111113


Q ss_pred             CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      .+.|+.|++++|+++ .+|..+..+..|++|++++|.+...+..+.+++.|..|.+.+|++. .+|..++.+++|+.|++
T Consensus       185 ~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~  262 (394)
T COG4886         185 LSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDL  262 (394)
T ss_pred             hhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccchhccccccceecc
Confidence            568888999999998 7888777778899999999976666667888888888888888888 55778888888999999


Q ss_pred             ccccCcCCCCccc--ccccccccccCCcc
Q 004689          302 QNNMLSGTVPSSL--LSKNVVLNYAGNIN  328 (736)
Q Consensus       302 ~~N~l~g~~P~~~--~~~~~~l~~~~n~~  328 (736)
                      ++|.++ .++. +  ......+.+.+|..
T Consensus       263 s~n~i~-~i~~-~~~~~~l~~L~~s~n~~  289 (394)
T COG4886         263 SNNQIS-SISS-LGSLTNLRELDLSGNSL  289 (394)
T ss_pred             cccccc-cccc-ccccCccCEEeccCccc
Confidence            999988 6655 3  23345566666643

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=97.94  E-value=1.6e-06  Score=87.22  Aligned_cols=86  Identities=22%  Similarity=0.330  Sum_probs=66.6

Q ss_pred             CCCCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccce
Q 004689          219 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE  298 (736)
Q Consensus       219 ~~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~  298 (736)
                      ...-..|+.||||+|.++ .+-++.--++.++.|+||+|++... .++..|.+|+.||||+|.|+ .+..+-..|-+.+.
T Consensus       280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt  356 (490)
T KOG1259|consen  280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT  356 (490)
T ss_pred             cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee-hhhhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence            344456888999999988 7888888888999999999988844 34788889999999999888 55555556666777


Q ss_pred             eecccccCc
Q 004689          299 LYVQNNMLS  307 (736)
Q Consensus       299 L~l~~N~l~  307 (736)
                      |.|+.|.+.
T Consensus       357 L~La~N~iE  365 (490)
T KOG1259|consen  357 LKLAQNKIE  365 (490)
T ss_pred             eehhhhhHh
Confidence            777777765

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.91  E-value=5.6e-05  Score=74.80  Aligned_cols=113  Identities=19%  Similarity=0.258  Sum_probs=72.5

Q ss_pred             CCcEEEEEEeccCCcccchh---------hhhHHHHHhhcCC---CceeeEeeeee-----eCCeEEEEEEecCCCCHHH
Q 004689          431 DGKEIAVKVLTSNSYQGKRE---------FTNEVTLLSRIHH---RNLVQFLGYCQ-----EEGRSVLVYEFMHNGTLKE  493 (736)
Q Consensus       431 ~~~~vAvK~l~~~~~~~~~~---------~~~E~~il~~l~H---pnIv~l~~~~~-----~~~~~~lV~e~~~~gsL~~  493 (736)
                      +|+.+++|..+......++.         ..+++..+.+++.   .....++.+..     -....+++|||++|..|.+
T Consensus        53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d  132 (229)
T PF06176_consen   53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND  132 (229)
T ss_pred             CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence            47888888876543222222         2334444444432   22223222222     2234578999999988766


Q ss_pred             HhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          494 HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       494 ~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ...        ++.    .++..+.+++.-||..   |++|+|..|.|++++.++ ++++||+..+
T Consensus       133 ~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  133 IED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             chh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECcccc
Confidence            531        121    2455677889999998   999999999999999654 9999998754

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.89  E-value=0.00014  Score=71.10  Aligned_cols=123  Identities=22%  Similarity=0.343  Sum_probs=88.1

Q ss_pred             HHhhccccccCc-eEEEEEEECCCcEEEEEEecc---CCc------------------ccchhhhhHHHHHhhcC---CC
Q 004689          410 KMLEKKIGSGGF-GVVYYGKLKDGKEIAVKVLTS---NSY------------------QGKREFTNEVTLLSRIH---HR  464 (736)
Q Consensus       410 ~~~~~~IG~G~f-G~Vy~~~~~~~~~vAvK~l~~---~~~------------------~~~~~~~~E~~il~~l~---Hp  464 (736)
                      ..+.+.||.|.- |.||+++.. |+.+|+|+++.   ...                  .....|..|++...+++   +.
T Consensus        39 I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e  117 (207)
T PF13095_consen   39 IEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGRE  117 (207)
T ss_pred             EeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcccc
Confidence            346788999999 999999997 88999999321   100                  11235788999888884   45


Q ss_pred             ce--eeEeeeeeeC------------------CeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHH
Q 004689          465 NL--VQFLGYCQEE------------------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL  524 (736)
Q Consensus       465 nI--v~l~~~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~L  524 (736)
                      ++  |+.+||..-.                  ....+|.||+....             .+.    .+-+.++.+-|..+
T Consensus       118 ~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~~~  180 (207)
T PF13095_consen  118 GLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLKIL  180 (207)
T ss_pred             CceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHHHH
Confidence            66  8999987322                  12356777766532             111    22345677788899


Q ss_pred             HhCCCCceecCCCCCCCEEEcCCCcEEEEeecCC
Q 004689          525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS  558 (736)
Q Consensus       525 H~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla  558 (736)
                      |..   ||+-+|+|+.|..     .-||+|||.+
T Consensus       181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHC---CeeeccCcccccc-----CCEEEecccC
Confidence            998   9999999999996     5789999864

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=97.86  E-value=1.4e-06  Score=93.17  Aligned_cols=165  Identities=21%  Similarity=0.197  Sum_probs=97.4

Q ss_pred             CCCCccchhhhhhhhccCCCCchHHHHHHHHHHcC----C--CCcCCCCCCCCCCCCCceEEecCCCCCceEEEEccCCC
Q 004689          161 SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYS----S--ADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKN  234 (736)
Q Consensus       161 ~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~----~--~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~~L~L~~n~  234 (736)
                      ..+..+..++.++.|.+..+.+...++..+...+.    +  -+|......- .+..|.-+.+.....++|+.|+|++|.
T Consensus        14 ~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~~~~~~~l~~~~~L~~L~l~~~~   92 (319)
T cd00116          14 RATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGLQSLLQGLTKGCGLQELDLSDNA   92 (319)
T ss_pred             chHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHHHHHHHHHHhcCceeEEEccCCC
Confidence            33455566666667777777664444444333322    1  1232110000 000122222222335689999999999


Q ss_pred             CCccCCcccccccc---cccccccccccCCC----CC-CCCCC-CCCcEEEcCCCCCCCC----CCccccCccccceeec
Q 004689          235 LTGNIPSDLTKLSS---LVELWLDGNSLTGP----IP-DFSGC-PDLRIIHLEDNQLTGP----LPSSLMNLPNLRELYV  301 (736)
Q Consensus       235 l~g~~p~~~~~l~~---L~~L~Ls~N~l~~~----~p-~~~~l-~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~l  301 (736)
                      +.+..+..+..+.+   |++|+|++|++++.    +. .+..+ ++|+.|+|++|.+++.    ++..+..+++|+.|++
T Consensus        93 ~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l  172 (319)
T cd00116          93 LGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNL  172 (319)
T ss_pred             CChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEEC
Confidence            88777777776666   99999999988842    11 34556 8889999999998843    3445667778999999


Q ss_pred             ccccCcCCC----Ccccc--cccccccccCC
Q 004689          302 QNNMLSGTV----PSSLL--SKNVVLNYAGN  326 (736)
Q Consensus       302 ~~N~l~g~~----P~~~~--~~~~~l~~~~n  326 (736)
                      ++|.+++..    +..+.  ..+..+.+.+|
T Consensus       173 ~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n  203 (319)
T cd00116         173 ANNGIGDAGIRALAEGLKANCNLEVLDLNNN  203 (319)
T ss_pred             cCCCCchHHHHHHHHHHHhCCCCCEEeccCC
Confidence            999887532    22221  23455666665

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.85  E-value=5.6e-06  Score=60.27  Aligned_cols=37  Identities=32%  Similarity=0.543  Sum_probs=24.7

Q ss_pred             cccccccccccccCCCCCCCCCCCCCcEEEcCCCCCC
Q 004689          247 SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT  283 (736)
Q Consensus       247 ~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~  283 (736)
                      ++|++|+|++|+|+...|.+++|++|++|+|++|+|+
T Consensus         1 ~~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    1 KNLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             TT-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS
T ss_pred             CcceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC
Confidence            3567777777777755445777777777777777776

...

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.85  E-value=0.00014  Score=68.89  Aligned_cols=128  Identities=23%  Similarity=0.339  Sum_probs=87.4

Q ss_pred             hhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceee-EeeeeeeCCeEEEEEEecCCCC
Q 004689          412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ-FLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~-l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      ..+.||+|.+|.||+|.+. |.++|+|+-+.++  ....++.|+++|..+.-.++.+ ++.|-.+    .+.|||+.|-.
T Consensus        26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~   98 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcc
Confidence            3567999999999999998 7799999866544  3567999999999998776654 4444333    34599999988


Q ss_pred             HHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCC-CCCEEEcCCCcEEEEeecCCcc
Q 004689          491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK-SSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       491 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDik-p~NILl~~~~~~kl~DFGla~~  560 (736)
                      |.+.-...       +..+..    .++..---|-..   ||-|+.|. |...+|..+..+.|+||.-|++
T Consensus        99 L~~~~~~~-------~rk~l~----~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIGG-------DRKHLL----RVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhcc-------cHHHHH----HHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            87654211       122222    333332233443   88899886 4444444555999999998863

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	736
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-57
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-56
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-49
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-48
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-33
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-33
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-33
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-32
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-31
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-31
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-26
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-26
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-26
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-26
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-26
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-26
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-26
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-26
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-26
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-26
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-26
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-26
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-25
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-25
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-25
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-25
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-25
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-25
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-25
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-25
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-24
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-24
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-24
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-24
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-24
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-24
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-24
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-24
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-24
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		9e-24
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-23
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-23
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-23
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-23
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-23
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-23
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-23
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-23
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-23
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-23
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-23
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-23
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-23
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-23
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-23
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-23
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-22
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-22
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-22
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-21
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-21
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-21
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-21
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-21
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-21
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-21
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-21
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-21
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-21
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-21
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		7e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-21
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-21
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		8e-21
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		8e-21
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-21
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-20
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-20
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-20
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-20
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-20
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-20
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-20
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-20
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-20
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-20
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-20
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-19
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-19
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-19
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-19
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-19
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-19
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-19
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-19
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		9e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-18
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-18
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-18
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-18
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-18
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-18
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-18
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-17
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-17
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-17
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-17
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-17
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-17
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-17
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-17
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-16
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-16
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-16
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-16
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-16
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-16
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-16
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-16
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-16
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-16
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-16
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-16
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-16
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-16
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-16
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-16
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-16
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-16
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-16
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-16
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		6e-16
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-15
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-15
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-15
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-15
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-15
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-15
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-15
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-15
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-14
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-14
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-14
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-14
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-14
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-14
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		4e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		5e-14
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-14
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-14
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		8e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		9e-14
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		9e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-13
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-13
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-13
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-13
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-13
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-13
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-13
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-13
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-13
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-13
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-13
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-13
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-13
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-13
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-13
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-13
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-13
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-13
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-13
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		5e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		6e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		6e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		6e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-13
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-13
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-13
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		6e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		8e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-13
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-13
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-12
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-12
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-12
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-12
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-12
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-12
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-12
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-12
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-12
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		6e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		6e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		6e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-12
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-12
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		7e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-12
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-12
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		7e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-12
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		8e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		9e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-11
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-11
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-11
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-11
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		4e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-11
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		5e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		6e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		7e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		7e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-11
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		8e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		8e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		8e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		9e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		9e-11
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-10
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-10
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-10
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-10
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		6e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		8e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-10
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		8e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		8e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-09
3soa_A	444	Full-Length Human Camkii Length = 444		2e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-09
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-09
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-09
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-09
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-09
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-09
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-09
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-09
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-09
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-09
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-09
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-09
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		4e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-09
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		4e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-09
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-09
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-09
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-09
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-09
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-09
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-09
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-09
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-09
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-09
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-09
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		5e-09
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-09
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-09
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-09
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		6e-09
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-09
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-09
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-08
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		6e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		7e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		9e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		5e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		6e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		8e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		8e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		8e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		9e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		9e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-06
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		3e-06
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		3e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		3e-06
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		4e-06
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-06
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		4e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-06
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		4e-06
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-06
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-06
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-06
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-06
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		5e-06
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		6e-06
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		7e-06

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  221 bits (562), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 125/305 (40%), Positives = 189/305 (61%), Gaps = 13/305 (4%)
Query: 384 RPVSSLNDAPAEA------AHCFTLSDIEDATKMLEKK--IGSGGFGVVYYGKLKDGKEI 435
           +  +S+NDA + +      ++   L D+E+AT   + K  IG G FG VY G L+DG ++
Sbjct: 7   KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 436 AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL 495
           A+K  T  S QG  EF  E+  LS   H +LV  +G+C E    +L+Y++M NG LK HL
Sbjct: 67  ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 496 YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 555
           YG+      ++W +RLEI   AA+G+ YLHT    AIIHRD+KS NILLD++   K++DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183
Query: 556 GLSKFAVD-GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 614
           G+SK   + G +H+  +V+GT+GY+DPEY+I  +LT+KSDVYSFGV+L E++  + AI  
Sbjct: 184 GISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV- 242
Query: 615 EKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS 674
           +       N+ +WA     +G ++ I+DP+L D+   +S+ K  + A+ C+      RPS
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 675 ISEVL 679
           + +VL
Sbjct: 303 MGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  218 bits (555), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 124/305 (40%), Positives = 188/305 (61%), Gaps = 13/305 (4%)
Query: 384 RPVSSLNDAPAEA------AHCFTLSDIEDATKMLEKK--IGSGGFGVVYYGKLKDGKEI 435
           +  +S+NDA + +      ++   L D+E+AT   + K  IG G FG VY G L+DG ++
Sbjct: 7   KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 436 AVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL 495
           A+K  T  S QG  EF  E+  LS   H +LV  +G+C E    +L+Y++M NG LK HL
Sbjct: 67  ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 496 YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 555
           YG+      ++W +RLEI   AA+G+ YLHT    AIIHRD+KS NILLD++   K++DF
Sbjct: 127 YGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183
Query: 556 GLSKFAVD-GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISN 614
           G+SK   +   +H+  +V+GT+GY+DPEY+I  +LT+KSDVYSFGV+L E++  + AI  
Sbjct: 184 GISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV- 242
Query: 615 EKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS 674
           +       N+ +WA     +G ++ I+DP+L D+   +S+ K  + A+ C+      RPS
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS 302
Query: 675 ISEVL 679
           + +VL
Sbjct: 303 MGDVL 307

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  194 bits (493), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 112/314 (35%), Positives = 177/314 (56%), Gaps = 14/314 (4%)
Query: 383 QRPVSSLNDAPAEA---AHC-----FTLSDIEDATKMLEKK--IGSGGFGVVYYGKLKDG 432
           ++P     D PAE     H      F+L +++ A+     K  +G GGFG VY G+L DG
Sbjct: 3   KKPQDHFFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG 62
Query: 433 KEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL 491
             +AVK L     QG + +F  EV ++S   HRNL++  G+C      +LVY +M NG++
Sbjct: 63  TLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 122
Query: 492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAK 551
              L      +  ++W KR  IA  +A+G+ YLH  C P IIHRD+K++NILLD+   A 
Sbjct: 123 ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 182
Query: 552 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 611
           V DFGL+K       HV   VRGT+G++ PEY  + + ++K+DV+ +GV+LLELI+GQ A
Sbjct: 183 VGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRA 242
Query: 612 ISNEKFGANCRNI--VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHG 669
               +  AN  ++  + W K  ++   ++ ++D  L   Y  + + ++ + AL+C     
Sbjct: 243 FDLARL-ANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSP 301
Query: 670 HMRPSISEVLKDIQ 683
             RP +SEV++ ++
Sbjct: 302 MERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  189 bits (481), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 105/289 (36%), Positives = 168/289 (58%), Gaps = 6/289 (2%)
Query: 400 FTLSDIEDATKMLEKK--IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTNEVT 456
           F+L +++ A+     K  +G GGFG VY G+L DG  +AVK L     QG + +F  EV 
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 457 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 516
           ++S   HRNL++  G+C      +LVY +M NG++   L      +  ++W KR  IA  
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 517 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 576
           +A+G+ YLH  C P IIHRD+K++NILLD+   A V DFGL+K       HV   VRG +
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXI 199
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI--VQWAKLHIES 634
           G++ PEY  + + ++K+DV+ +GV+LLELI+GQ A    +  AN  ++  + W K  ++ 
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL-ANDDDVMLLDWVKGLLKE 258
Query: 635 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
             ++ ++D  L   Y  + + ++ + AL+C       RP +SEV++ ++
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  140 bits (353), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 86/232 (37%), Positives = 136/232 (58%), Gaps = 19/232 (8%)
Query: 398 HCFTLSDIEDATKMLEK--------KIGSGGFGVVYYGKLKDGKEIAVKVLTS----NSY 445
           H F+  ++++ T   ++        K+G GGFGVVY G + +   +AVK L +     + 
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 446 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 505
           + K++F  E+ ++++  H NLV+ LG+  +     LVY +M NG+L + L   L     +
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPL 130
Query: 506 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
           +W  R +IA+ AA GI +LH       IHRD+KS+NILLD+   AK+SDFGL++ +   A
Sbjct: 131 SWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 566 SHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 616
             V  S + GT  Y+ PE  +  ++T KSD+YSFGV+LLE+I+G  A+   +
Sbjct: 188 QTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  139 bits (350), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 85/232 (36%), Positives = 135/232 (58%), Gaps = 19/232 (8%)
Query: 398 HCFTLSDIEDATKMLEK--------KIGSGGFGVVYYGKLKDGKEIAVKVLTS----NSY 445
           H F+  ++++ T   ++        K+G GGFGVVY G + +   +AVK L +     + 
Sbjct: 7   HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 65
Query: 446 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 505
           + K++F  E+ ++++  H NLV+ LG+  +     LVY +M NG+L + L   L     +
Sbjct: 66  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPL 124
Query: 506 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
           +W  R +IA+ AA GI +LH       IHRD+KS+NILLD+   AK+SDFGL++ +   A
Sbjct: 125 SWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 181
Query: 566 SHVSSI-VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 616
             V    + GT  Y+ PE  +  ++T KSD+YSFGV+LLE+I+G  A+   +
Sbjct: 182 QXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 232

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  139 bits (349), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 85/232 (36%), Positives = 135/232 (58%), Gaps = 19/232 (8%)
Query: 398 HCFTLSDIEDATKMLEK--------KIGSGGFGVVYYGKLKDGKEIAVKVLTS----NSY 445
           H F+  ++++ T   ++        K+G GGFGVVY G + +   +AVK L +     + 
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 446 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 505
           + K++F  E+ ++++  H NLV+ LG+  +     LVY +M NG+L + L   L     +
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLDGTPPL 130
Query: 506 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
           +W  R +IA+ AA GI +LH       IHRD+KS+NILLD+   AK+SDFGL++ +   A
Sbjct: 131 SWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 566 SHVSSI-VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 616
             V    + GT  Y+ PE  +  ++T KSD+YSFGV+LLE+I+G  A+   +
Sbjct: 188 QTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  136 bits (343), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 79/205 (38%), Positives = 117/205 (57%), Gaps = 6/205 (2%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKR--EFTNEVTLLSRIHHRNLVQF 469
           +++KIG+G FG V+  +   G ++AVK+L    +  +R  EF  EV ++ R+ H N+V F
Sbjct: 41  IKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           +G   +     +V E++  G+L   L+ +   EQ ++  +RL +A D AKG+ YLH    
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHNRN- 157
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
           P I+HRDLKS N+L+DK    KV DFGLS+         S    GT  ++ PE    +  
Sbjct: 158 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKA-SXFLXSKXAAGTPEWMAPEVLRDEPS 216
Query: 590 TDKSDVYSFGVILLELISGQEAISN 614
            +KSDVYSFGVIL EL + Q+   N
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGN 241

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  135 bits (339), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 79/206 (38%), Positives = 122/206 (59%), Gaps = 8/206 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKR--EFTNEVTLLSRIHHRNLVQF 469
           +++KIG+G FG V+  +   G ++AVK+L    +  +R  EF  EV ++ R+ H N+V F
Sbjct: 41  IKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           +G   +     +V E++  G+L   L+ +   EQ ++  +RL +A D AKG+ YLH    
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHNRN- 157
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-IVRGTVGYLDPEYYISQQ 588
           P I+HR+LKS N+L+DK    KV DFGLS+  +  ++ +SS    GT  ++ PE    + 
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 589 LTDKSDVYSFGVILLELISGQEAISN 614
             +KSDVYSFGVIL EL + Q+   N
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGN 241

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  134 bits (337), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 85/232 (36%), Positives = 132/232 (56%), Gaps = 19/232 (8%)
Query: 398 HCFTLSDIEDATKMLEK--------KIGSGGFGVVYYGKLKDGKEIAVKVLTS----NSY 445
           H F+  ++++ T   ++        K G GGFGVVY G + +   +AVK L +     + 
Sbjct: 4   HSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 62
Query: 446 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 505
           + K++F  E+ + ++  H NLV+ LG+  +     LVY +  NG+L + L   L     +
Sbjct: 63  ELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL-SCLDGTPPL 121
Query: 506 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
           +W  R +IA+ AA GI +LH       IHRD+KS+NILLD+   AK+SDFGL++ +   A
Sbjct: 122 SWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 566 SHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 616
             V  S + GT  Y  PE  +  ++T KSD+YSFGV+LLE+I+G  A+   +
Sbjct: 179 QXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 229

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/217 (35%), Positives = 123/217 (56%), Gaps = 15/217 (6%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRI 461
           +I D    + ++IGSG FG VY GK     ++AVK+L  T+ + Q  + F NEV +L + 
Sbjct: 9   EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 66
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H N++ F+GY  +   ++ V ++    +L  HL+     E +   IK ++IA   A+G+
Sbjct: 67  RHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 122
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD-GASHVSSIVRGTVGYLD 580
           +YLH     +IIHRDLKS+NI L + +  K+ DFGL+        SH    + G++ ++ 
Sbjct: 123 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 581 PEYYISQQ---LTDKSDVYSFGVILLELISGQEAISN 614
           PE    Q     + +SDVY+FG++L EL++GQ   SN
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 216

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/217 (35%), Positives = 123/217 (56%), Gaps = 15/217 (6%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRI 461
           +I D    + ++IGSG FG VY GK     ++AVK+L  T+ + Q  + F NEV +L + 
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H N++ F+GY  +   ++ V ++    +L  HL+     E +   IK ++IA   A+G+
Sbjct: 62  RHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 117
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD-GASHVSSIVRGTVGYLD 580
           +YLH     +IIHRDLKS+NI L + +  K+ DFGL+        SH    + G++ ++ 
Sbjct: 118 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 581 PEYYISQQ---LTDKSDVYSFGVILLELISGQEAISN 614
           PE    Q     + +SDVY+FG++L EL++GQ   SN
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/217 (35%), Positives = 123/217 (56%), Gaps = 15/217 (6%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRI 461
           +I D    + ++IGSG FG VY GK     ++AVK+L  T+ + Q  + F NEV +L + 
Sbjct: 6   EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 63
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H N++ F+GY  +   ++ V ++    +L  HL+     E +   IK ++IA   A+G+
Sbjct: 64  RHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 119
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD-GASHVSSIVRGTVGYLD 580
           +YLH     +IIHRDLKS+NI L + +  K+ DFGL+        SH    + G++ ++ 
Sbjct: 120 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 176
Query: 581 PEYYISQQ---LTDKSDVYSFGVILLELISGQEAISN 614
           PE    Q     + +SDVY+FG++L EL++GQ   SN
Sbjct: 177 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 213

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  118 bits (296), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/217 (35%), Positives = 123/217 (56%), Gaps = 15/217 (6%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRI 461
           +I D    + ++IGSG FG VY GK     ++AVK+L  T+ + Q  + F NEV +L + 
Sbjct: 9   EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 66
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H N++ F+GY  +   ++ V ++    +L  HL+     E +   IK ++IA   A+G+
Sbjct: 67  RHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 122
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD-GASHVSSIVRGTVGYLD 580
           +YLH     +IIHRDLKS+NI L + +  K+ DFGL+        SH    + G++ ++ 
Sbjct: 123 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 179
Query: 581 PEYYISQQ---LTDKSDVYSFGVILLELISGQEAISN 614
           PE    Q     + +SDVY+FG++L EL++GQ   SN
Sbjct: 180 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 216

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/217 (35%), Positives = 123/217 (56%), Gaps = 15/217 (6%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRI 461
           +I D    + ++IGSG FG VY GK     ++AVK+L  T+ + Q  + F NEV +L + 
Sbjct: 31  EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 88
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H N++ F+GY  +   ++ V ++    +L  HL+     E +   IK ++IA   A+G+
Sbjct: 89  RHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 144
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD-GASHVSSIVRGTVGYLD 580
           +YLH     +IIHRDLKS+NI L + +  K+ DFGL+        SH    + G++ ++ 
Sbjct: 145 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 201
Query: 581 PEYYISQQ---LTDKSDVYSFGVILLELISGQEAISN 614
           PE    Q     + +SDVY+FG++L EL++GQ   SN
Sbjct: 202 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 238

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/217 (35%), Positives = 123/217 (56%), Gaps = 15/217 (6%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRI 461
           +I D    + ++IGSG FG VY GK     ++AVK+L  T+ + Q  + F NEV +L + 
Sbjct: 32  EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 89
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H N++ F+GY  +  +  +V ++    +L  HL+     E +   IK ++IA   A+G+
Sbjct: 90  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 145
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD-GASHVSSIVRGTVGYLD 580
           +YLH     +IIHRDLKS+NI L + +  K+ DFGL+        SH    + G++ ++ 
Sbjct: 146 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 202
Query: 581 PEYYISQQ---LTDKSDVYSFGVILLELISGQEAISN 614
           PE    Q     + +SDVY+FG++L EL++GQ   SN
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 239

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  117 bits (294), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 77/217 (35%), Positives = 122/217 (56%), Gaps = 15/217 (6%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRI 461
           +I D    + ++IGSG FG VY GK     ++AVK+L  T+ + Q  + F NEV +L + 
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H N++ F+GY      ++ V ++    +L  HL+     E +   IK ++IA   A+G+
Sbjct: 62  RHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 117
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD-GASHVSSIVRGTVGYLD 580
           +YLH     +IIHRDLKS+NI L + +  K+ DFGL+        SH    + G++ ++ 
Sbjct: 118 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 581 PEYYISQQ---LTDKSDVYSFGVILLELISGQEAISN 614
           PE    Q     + +SDVY+FG++L EL++GQ   SN
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 77/217 (35%), Positives = 125/217 (57%), Gaps = 15/217 (6%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRI 461
           +I D    + ++IGSG FG VY GK     ++AVK+L  T+ + Q  + F NEV +L + 
Sbjct: 4   EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H N++ F+GY  +   ++ V ++    +L  HL+     E +   IK ++IA   A+G+
Sbjct: 62  RHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 117
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLD 580
           +YLH     +IIHRDLKS+NI L + +  K+ DFGL ++ +    SH    + G++ ++ 
Sbjct: 118 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 174
Query: 581 PEYYISQQ---LTDKSDVYSFGVILLELISGQEAISN 614
           PE    Q     + +SDVY+FG++L EL++GQ   SN
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  117 bits (293), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 77/217 (35%), Positives = 125/217 (57%), Gaps = 15/217 (6%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRI 461
           +I D    + ++IGSG FG VY GK     ++AVK+L  T+ + Q  + F NEV +L + 
Sbjct: 24  EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 81
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H N++ F+GY  +   ++ V ++    +L  HL+     E +   IK ++IA   A+G+
Sbjct: 82  RHVNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 137
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLD 580
           +YLH     +IIHRDLKS+NI L + +  K+ DFGL ++ +    SH    + G++ ++ 
Sbjct: 138 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 194
Query: 581 PEYYISQQ---LTDKSDVYSFGVILLELISGQEAISN 614
           PE    Q     + +SDVY+FG++L EL++GQ   SN
Sbjct: 195 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 231

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  117 bits (293), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 77/217 (35%), Positives = 125/217 (57%), Gaps = 15/217 (6%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRI 461
           +I D    + ++IGSG FG VY GK     ++AVK+L  T+ + Q  + F NEV +L + 
Sbjct: 32  EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 89
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H N++ F+GY  +  +  +V ++    +L  HL+     E +   IK ++IA   A+G+
Sbjct: 90  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGM 145
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLD 580
           +YLH     +IIHRDLKS+NI L + +  K+ DFGL ++ +    SH    + G++ ++ 
Sbjct: 146 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 202
Query: 581 PEYYISQQ---LTDKSDVYSFGVILLELISGQEAISN 614
           PE    Q     + +SDVY+FG++L EL++GQ   SN
Sbjct: 203 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 239

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  116 bits (290), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 76/217 (35%), Positives = 122/217 (56%), Gaps = 15/217 (6%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRI 461
           +I D    + ++IGSG FG VY GK     ++AVK+L  T+ + Q  + F NEV +L + 
Sbjct: 8   EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 65
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H N++ F+GY  +  +  +V ++    +L  HL+ +   E +    K ++IA   A+G+
Sbjct: 66  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGM 121
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD-GASHVSSIVRGTVGYLD 580
           +YLH     +IIHRDLKS+NI L +    K+ DFGL+        SH    + G++ ++ 
Sbjct: 122 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 178
Query: 581 PEYYISQQ---LTDKSDVYSFGVILLELISGQEAISN 614
           PE    Q     + +SDVY+FG++L EL++GQ   SN
Sbjct: 179 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 215

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  115 bits (288), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 76/217 (35%), Positives = 124/217 (57%), Gaps = 15/217 (6%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRI 461
           +I D    + ++IGSG FG VY GK     ++AVK+L  T+ + Q  + F NEV +L + 
Sbjct: 20  EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H N++ F+GY  +  +  +V ++    +L  HL+ +   E +    K ++IA   A+G+
Sbjct: 78  RHVNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGM 133
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLD 580
           +YLH     +IIHRDLKS+NI L +    K+ DFGL ++ +    SH    + G++ ++ 
Sbjct: 134 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 581 PEYYISQQ---LTDKSDVYSFGVILLELISGQEAISN 614
           PE    Q     + +SDVY+FG++L EL++GQ   SN
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  115 bits (287), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 76/217 (35%), Positives = 123/217 (56%), Gaps = 15/217 (6%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRI 461
           +I D    + ++IGSG FG VY GK     ++AVK+L  T+ + Q  + F NEV +L + 
Sbjct: 20  EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H N++ F+GY     +  +V ++    +L  HL+ +   E +    K ++IA   A+G+
Sbjct: 78  RHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGM 133
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLD 580
           +YLH     +IIHRDLKS+NI L +    K+ DFGL ++ +    SH    + G++ ++ 
Sbjct: 134 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 581 PEYYISQQ---LTDKSDVYSFGVILLELISGQEAISN 614
           PE    Q     + +SDVY+FG++L EL++GQ   SN
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  114 bits (285), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 75/216 (34%), Positives = 121/216 (56%), Gaps = 23/216 (10%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL-----TSNSYQGKREFTNEVTLL 458
           +IE +  ML  +IGSG FG VY GK     ++AVK+L     T   +Q    F NEV +L
Sbjct: 32  EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQA---FRNEVAVL 86
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
            +  H N++ F+GY  ++  ++ V ++    +L +HL+     E +    + ++IA   A
Sbjct: 87  RKTRHVNILLFMGYMTKDNLAI-VTQWCEGSSLYKHLH---VQETKFQMFQLIDIARQTA 142
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS--KFAVDGASHVSSIVRGTV 576
           +G++YLH      IIHRD+KS+NI L + +  K+ DFGL+  K    G+  V     G+V
Sbjct: 143 QGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT-GSV 198
Query: 577 GYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQ 609
            ++ PE    Q     + +SDVYS+G++L EL++G+
Sbjct: 199 LWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 138/277 (49%), Gaps = 12/277 (4%)
Query: 385 PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS 444
           P+ S N AP+ A   +   +I+       K++G+G FGVV YGK +   ++A+K++   S
Sbjct: 2   PLGSKN-APSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS 60
Query: 445 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 504
              + EF  E  ++  + H  LVQ  G C ++    ++ E+M NG L  +L        R
Sbjct: 61  -MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHR 116
Query: 505 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 564
               + LE+ +D  + +EYL +      +HRDL + N L++     KVSDFGLS++ +D 
Sbjct: 117 FQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
Query: 565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS----GQEAISNEKFGAN 620
               S   +  V +  PE  +  + + KSD+++FGV++ E+ S      E  +N +   +
Sbjct: 174 EETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233
Query: 621 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 657
               ++  + H+ S  +  I+     ++ D +  +KI
Sbjct: 234 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKI 270

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  114 bits (284), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           ++IGSG FG+V+ G   +  ++A+K +   S   + +F  E  ++ ++ H  LVQ  G C
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
            E+    LV+EFM +G L ++L    T          L +  D  +G+ YL   CV   I
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV---I 145
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRDL + N L+ ++   KVSDFG+++F +D     S+  +  V +  PE +   + + KS
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 594 DVYSFGVILLELIS 607
           DV+SFGV++ E+ S
Sbjct: 206 DVWSFGVLMWEVFS 219

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 138/277 (49%), Gaps = 12/277 (4%)
Query: 385 PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS 444
           P+ S N AP+ A   +   +I+       K++G+G FGVV YGK +   ++A+K++   S
Sbjct: 2   PLGSKN-APSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS 60
Query: 445 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 504
              + EF  E  ++  + H  LVQ  G C ++    ++ E+M NG L  +L        R
Sbjct: 61  -MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL---REMRHR 116
Query: 505 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 564
               + LE+ +D  + +EYL +      +HRDL + N L++     KVSDFGLS++ +D 
Sbjct: 117 FQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
Query: 565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS----GQEAISNEKFGAN 620
               S   +  V +  PE  +  + + KSD+++FGV++ E+ S      E  +N +   +
Sbjct: 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233
Query: 621 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKI 657
               ++  + H+ S  +  I+     ++ D +  +KI
Sbjct: 234 IAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKI 270

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  113 bits (283), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           ++IGSG FG+V+ G   +  ++A+K +   +   + +F  E  ++ ++ H  LVQ  G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
            E+    LV+EFM +G L ++L    T          L +  D  +G+ YL   CV   I
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV---I 123
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRDL + N L+ ++   KVSDFG+++F +D     S+  +  V +  PE +   + + KS
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 594 DVYSFGVILLELIS 607
           DV+SFGV++ E+ S
Sbjct: 184 DVWSFGVLMWEVFS 197

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  113 bits (283), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           ++IGSG FG+V+ G   +  ++A+K +   +   + +F  E  ++ ++ H  LVQ  G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
            E+    LV+EFM +G L ++L    T          L +  D  +G+ YL   CV   I
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV---I 125
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRDL + N L+ ++   KVSDFG+++F +D     S+  +  V +  PE +   + + KS
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 594 DVYSFGVILLELIS 607
           DV+SFGV++ E+ S
Sbjct: 186 DVWSFGVLMWEVFS 199

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  113 bits (283), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           ++IGSG FG+V+ G   +  ++A+K +   +   + +F  E  ++ ++ H  LVQ  G C
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
            E+    LV+EFM +G L ++L    T          L +  D  +G+ YL   CV   I
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV---I 128
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRDL + N L+ ++   KVSDFG+++F +D     S+  +  V +  PE +   + + KS
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 594 DVYSFGVILLELIS 607
           DV+SFGV++ E+ S
Sbjct: 189 DVWSFGVLMWEVFS 202

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  111 bits (278), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 105/194 (54%), Gaps = 7/194 (3%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           ++IGSG FG+V+ G   +  ++A+K +   +   + +F  E  ++ ++ H  LVQ  G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
            E+    LV EFM +G L ++L    T          L +  D  +G+ YL   CV   I
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV---I 126
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRDL + N L+ ++   KVSDFG+++F +D     S+  +  V +  PE +   + + KS
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 594 DVYSFGVILLELIS 607
           DV+SFGV++ E+ S
Sbjct: 187 DVWSFGVLMWEVFS 200

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  110 bits (274), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 128/248 (51%), Gaps = 11/248 (4%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K++G+G FGVV YGK +   ++A+K++   S   + EF  E  ++  + H  LVQ  G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
            ++    ++ E+M NG L  +L   + H  R    + LE+ +D  + +EYL +      +
Sbjct: 74  TKQRPIFIITEYMANGCLLNYL-REMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFL 127
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRDL + N L++     KVSDFGLS++ +D     S   +  V +  PE  +  + + KS
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 594 DVYSFGVILLELIS----GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 649
           D+++FGV++ E+ S      E  +N +   +    ++  + H+ S  +  I+     ++ 
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKA 247
Query: 650 DIQSMWKI 657
           D +  +KI
Sbjct: 248 DERPTFKI 255

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ +L  + H N+V+
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 469 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + G C   GR    L+ EF+  G+L+E+L     H++RI+ IK L+      KG+EYL T
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYY 584
                 IHRDL + NIL++   R K+ DFGL+K          V       + +  PE  
Sbjct: 136 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + +  SDV+SFGV+L EL +
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  110 bits (274), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 107/194 (55%), Gaps = 7/194 (3%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K++G+G FGVV YGK +   ++A+K++   S   + EF  E  ++  + H  LVQ  G C
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
            ++    ++ E+M NG L  +L   + H  R    + LE+ +D  + +EYL +      +
Sbjct: 73  TKQRPIFIITEYMANGCLLNYL-REMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFL 126
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRDL + N L++     KVSDFGLS++ +D     S   +  V +  PE  +  + + KS
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 186
Query: 594 DVYSFGVILLELIS 607
           D+++FGV++ E+ S
Sbjct: 187 DIWAFGVLMWEIYS 200

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 107/194 (55%), Gaps = 7/194 (3%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K++G+G FGVV YGK +   ++A+K++   S   + EF  E  ++  + H  LVQ  G C
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
            ++    ++ E+M NG L  +L   + H  R    + LE+ +D  + +EYL +      +
Sbjct: 74  TKQRPIFIITEYMANGCLLNYL-REMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFL 127
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRDL + N L++     KVSDFGLS++ +D     S   +  V +  PE  +  + + KS
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 594 DVYSFGVILLELIS 607
           D+++FGV++ E+ S
Sbjct: 188 DIWAFGVLMWEIYS 201

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 71/248 (28%), Positives = 128/248 (51%), Gaps = 11/248 (4%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K++G+G FGVV YGK +   ++A+K++   S   + EF  E  ++  + H  LVQ  G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
            ++    ++ E+M NG L  +L   + H  R    + LE+ +D  + +EYL +      +
Sbjct: 69  TKQRPIFIITEYMANGCLLNYL-REMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFL 122
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRDL + N L++     KVSDFGLS++ +D     S   +  V +  PE  +  + + KS
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 594 DVYSFGVILLELIS----GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 649
           D+++FGV++ E+ S      E  +N +   +    ++  + H+ S  +  I+     ++ 
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKA 242
Query: 650 DIQSMWKI 657
           D +  +KI
Sbjct: 243 DERPTFKI 250

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  109 bits (273), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 63/194 (32%), Positives = 107/194 (55%), Gaps = 7/194 (3%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K++G+G FGVV YGK +   ++A+K++   S   + EF  E  ++  + H  LVQ  G C
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
            ++    ++ E+M NG L  +L   + H  R    + LE+ +D  + +EYL +      +
Sbjct: 80  TKQRPIFIITEYMANGCLLNYL-REMRH--RFQTQQLLEMCKDVCEAMEYLES---KQFL 133
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRDL + N L++     KVSDFGLS++ +D     S   +  V +  PE  +  + + KS
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 193
Query: 594 DVYSFGVILLELIS 607
           D+++FGV++ E+ S
Sbjct: 194 DIWAFGVLMWEIYS 207

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  109 bits (272), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 106/194 (54%), Gaps = 7/194 (3%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           ++IGSG FG+V+ G   +  ++A+K +   +   + +F  E  ++ ++ H  LVQ  G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
            E+    LV+EFM +G L ++L    T          L +  D  +G+ YL      ++I
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEA---SVI 125
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRDL + N L+ ++   KVSDFG+++F +D     S+  +  V +  PE +   + + KS
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 594 DVYSFGVILLELIS 607
           DV+SFGV++ E+ S
Sbjct: 186 DVWSFGVLMWEVFS 199

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  108 bits (271), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 79/232 (34%), Positives = 121/232 (52%), Gaps = 25/232 (10%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGK-------REFTN 453
           L  + D     EK+IG GGFG+V+ G+L KD   +A+K L     +G+       +EF  
Sbjct: 13  LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 454 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 513
           EV ++S ++H N+V+  G      R  +V EF+  G L   L   L     I W  +L +
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL---LDKAHPIKWSVKLRL 127
Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKFAVDGASHV 568
             D A GIEY+     P I+HRDL+S NI L     +  + AKV+DFGLS+ +V    H 
Sbjct: 128 MLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV----HS 182
Query: 569 SSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFG 618
            S + G   ++ PE   +++   T+K+D YSF +IL  +++G+       +G
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  108 bits (271), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 114/197 (57%), Gaps = 9/197 (4%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L K++GSG FGVV  GK K   ++AVK++   S   + EF  E   + ++ H  LV+F G
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
            C +E    +V E++ NG L  +L    +H + +   + LE+  D  +G+ +L +     
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESH---Q 124
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQLT 590
            IHRDL + N L+D+ +  KVSDFG++++ +D   +VSS+  +  V +  PE +   + +
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD-QYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 591 DKSDVYSFGVILLELIS 607
            KSDV++FG+++ E+ S
Sbjct: 184 SKSDVWAFGILMWEVFS 200

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 78/232 (33%), Positives = 120/232 (51%), Gaps = 25/232 (10%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGK-------REFTN 453
           L  + D     EK+IG GGFG+V+ G+L KD   +A+K L     +G+       +EF  
Sbjct: 13  LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 454 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 513
           EV ++S ++H N+V+  G      R  +V EF+  G L   L   L     I W  +L +
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL---LDKAHPIKWSVKLRL 127
Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKFAVDGASHV 568
             D A GIEY+     P I+HRDL+S NI L     +  + AKV+DFG S+ +V    H 
Sbjct: 128 MLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV----HS 182
Query: 569 SSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFG 618
            S + G   ++ PE   +++   T+K+D YSF +IL  +++G+       +G
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 113/215 (52%), Gaps = 15/215 (6%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVT 456
           ++  E+      +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ 
Sbjct: 22  MTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 81
Query: 457 LLSRIHHRNLVQFLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA 514
           +L  + H N+V++ G C   GR    L+ E++  G+L+++L     H++RI+ IK L+  
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYT 138
Query: 515 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIV 572
               KG+EYL T      IHRDL + NIL++   R K+ DFGL+K          V    
Sbjct: 139 SQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195
Query: 573 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
              + +  PE     + +  SDV+SFGV+L EL +
Sbjct: 196 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 113/215 (52%), Gaps = 15/215 (6%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVT 456
           ++  E+      +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ 
Sbjct: 22  MTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 81
Query: 457 LLSRIHHRNLVQFLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA 514
           +L  + H N+V++ G C   GR    L+ E++  G+L+++L     H++RI+ IK L+  
Sbjct: 82  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYT 138
Query: 515 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIV 572
               KG+EYL T      IHRDL + NIL++   R K+ DFGL+K          V    
Sbjct: 139 SQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG 195
Query: 573 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
              + +  PE     + +  SDV+SFGV+L EL +
Sbjct: 196 ESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  107 bits (266), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ +L  + H N+V+
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 469 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + G C   GR    L+ E++  G+L+++L     H++RI+ IK L+      KG+EYL T
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 136
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYY 584
                 IHRDL + NIL++   R K+ DFGL+K          V       + +  PE  
Sbjct: 137 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + +  SDV+SFGV+L EL +
Sbjct: 194 TESKFSVASDVWSFGVVLYELFT 216

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ +L  + H N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 469 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + G C   GR    L+ E++  G+L+++L     H++RI+ IK L+      KG+EYL T
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 163
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYY 584
                 IHRDL + NIL++   R K+ DFGL+K          V       + +  PE  
Sbjct: 164 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + +  SDV+SFGV+L EL +
Sbjct: 221 TESKFSVASDVWSFGVVLYELFT 243

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ +L  + H N+V+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 469 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + G C   GR    L+ E++  G+L+++L     H++RI+ IK L+      KG+EYL T
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 135
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYY 584
                 IHRDL + NIL++   R K+ DFGL+K          V       + +  PE  
Sbjct: 136 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + +  SDV+SFGV+L EL +
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ +L  + H N+V+
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 469 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + G C   GR    L+ E++  G+L+++L     H++RI+ IK L+      KG+EYL T
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 137
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYY 584
                 IHRDL + NIL++   R K+ DFGL+K          V       + +  PE  
Sbjct: 138 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + +  SDV+SFGV+L EL +
Sbjct: 195 TESKFSVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ +L  + H N+V+
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 469 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + G C   GR    L+ E++  G+L+++L     H++RI+ IK L+      KG+EYL T
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 139
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYY 584
                 IHRDL + NIL++   R K+ DFGL+K          V       + +  PE  
Sbjct: 140 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + +  SDV+SFGV+L EL +
Sbjct: 197 TESKFSVASDVWSFGVVLYELFT 219

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ +L  + H N+V+
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 469 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + G C   GR    L+ E++  G+L+++L     H++RI+ IK L+      KG+EYL T
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 131
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYY 584
                 IHRDL + NIL++   R K+ DFGL+K          V       + +  PE  
Sbjct: 132 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + +  SDV+SFGV+L EL +
Sbjct: 189 TESKFSVASDVWSFGVVLYELFT 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ +L  + H N+V+
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 469 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + G C   GR    L+ E++  G+L+++L     H++RI+ IK L+      KG+EYL T
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 138
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYY 584
                 IHRDL + NIL++   R K+ DFGL+K          V       + +  PE  
Sbjct: 139 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + +  SDV+SFGV+L EL +
Sbjct: 196 TESKFSVASDVWSFGVVLYELFT 218

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 78/232 (33%), Positives = 120/232 (51%), Gaps = 25/232 (10%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGK-------REFTN 453
           L  + D     EK+IG GGFG+V+ G+L KD   +A+K L     +G+       +EF  
Sbjct: 13  LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 454 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 513
           EV ++S ++H N+V+  G      R  +V EF+  G L   L   L     I W  +L +
Sbjct: 73  EVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL---LDKAHPIKWSVKLRL 127
Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKFAVDGASHV 568
             D A GIEY+     P I+HRDL+S NI L     +  + AKV+DF LS+ +V    H 
Sbjct: 128 MLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV----HS 182
Query: 569 SSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFG 618
            S + G   ++ PE   +++   T+K+D YSF +IL  +++G+       +G
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ +L  + H N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 469 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + G C   GR    L+ E++  G+L+++L     H++RI+ IK L+      KG+EYL T
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYY 584
                 IHRDL + NIL++   R K+ DFGL+K          V       + +  PE  
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + +  SDV+SFGV+L EL +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 108/203 (53%), Gaps = 15/203 (7%)
Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ +L  + H N+V+
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 469 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + G C   GR    L+ E++  G+L+++L     H +RI+ IK L+      KG+EYL T
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQA---HAERIDHIKLLQYTSQICKGMEYLGT 135
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYY 584
                 IHRDL + NIL++   R K+ DFGL+K          V       + +  PE  
Sbjct: 136 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + +  SDV+SFGV+L EL +
Sbjct: 193 TESKFSVASDVWSFGVVLYELFT 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  106 bits (265), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ +L  + H N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 469 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + G C   GR    L+ E++  G+L+++L     H++RI+ IK L+      KG+EYL T
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYY 584
                 IHRDL + NIL++   R K+ DFGL+K          V       + +  PE  
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + +  SDV+SFGV+L EL +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ +L  + H N+V+
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 469 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + G C   GR    L+ E++  G+L+++L     H++RI+ IK L+      KG+EYL T
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 130
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYY 584
                 IHRDL + NIL++   R K+ DFGL+K          V       + +  PE  
Sbjct: 131 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + +  SDV+SFGV+L EL +
Sbjct: 188 TESKFSVASDVWSFGVVLYELFT 210

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  106 bits (264), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ +L  + H N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 469 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + G C   GR    L+ E++  G+L+++L     H++RI+ IK L+      KG+EYL T
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 132
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYY 584
                 IHRDL + NIL++   R K+ DFGL+K          V       + +  PE  
Sbjct: 133 ---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + +  SDV+SFGV+L EL +
Sbjct: 190 TESKFSVASDVWSFGVVLYELFT 212

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  105 bits (262), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 110/203 (54%), Gaps = 15/203 (7%)
Query: 414 KKIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +++G G FG V    Y  L+D  G+ +AVK L  ++ +  R+F  E+ +L  + H N+V+
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 469 FLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + G C   GR    L+ E++  G+L+++L     H++RI+ IK L+      KG+EYL T
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYLGT 133
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPEYY 584
                 IHR+L + NIL++   R K+ DFGL+K       +  V       + +  PE  
Sbjct: 134 ---KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 190
Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + +  SDV+SFGV+L EL +
Sbjct: 191 TESKFSVASDVWSFGVVLYELFT 213

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  102 bits (255), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 23/221 (10%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS----YQGKREFTNEVTL 457
           L +I+ A   LE+ IG GGFG VY      G E+AVK    +      Q       E  L
Sbjct: 1   LLEIDFAELTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 458 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGT-LTHEQRINWIKRLEIAED 516
            + + H N++   G C +E    LV EF   G L   L G  +  +  +NW      A  
Sbjct: 60  FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQ 113
Query: 517 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--------AKVSDFGLSKFAVDGASHV 568
            A+G+ YLH   +  IIHRDLKSSNIL+ + +          K++DFGL++   +     
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTT 170
Query: 569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
                G   ++ PE   +   +  SDV+S+GV+L EL++G+
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 117/224 (52%), Gaps = 14/224 (6%)
Query: 391 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SY 445
           + P  A   FT  +IE +   +EK IGSG  G V YG+L+   +    +A+K L +  + 
Sbjct: 33  EEPGRAGRSFT-REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE 91
Query: 446 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 505
           + +R+F +E +++ +  H N+++  G       +++V E+M NG+L   L    TH+ + 
Sbjct: 92  RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQF 148
Query: 506 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
             ++ + +      G+ YL        +HRDL + N+L+D ++  KVSDFGLS+   D  
Sbjct: 149 TIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
Query: 566 SHVSSIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               +   G   + +  PE    +  +  SDV+SFGV++ E+++
Sbjct: 206 DAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 121/224 (54%), Gaps = 14/224 (6%)
Query: 391 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SY 445
           + P  A   FT  +IE +   +EK IGSG  G V YG+L+   +    +A+K L +  + 
Sbjct: 33  EEPGRAGRSFT-REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE 91
Query: 446 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 505
           + +R+F +E +++ +  H N+++  G       +++V E+M NG+L   L    TH+ + 
Sbjct: 92  RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQF 148
Query: 506 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD-- 563
             ++ + +      G+ YL        +HRDL + N+L+D ++  KVSDFGLS+   D  
Sbjct: 149 TIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
Query: 564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            A++ ++  +  + +  PE    +  +  SDV+SFGV++ E+++
Sbjct: 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 120/225 (53%), Gaps = 14/225 (6%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQG 447
           P +  H F   +++     ++K +G+G FG V  G+LK    KEI+V + T     + + 
Sbjct: 31  PTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           +R+F  E +++ +  H N+++  G   +    ++V E+M NG+L   L     H+ +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTV 146
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--A 565
           I+ + +    A G++YL        +HRDL + NIL++ ++  KVSDFGLS+   D   A
Sbjct: 147 IQLVGMLRGIASGMKYLSDM---GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 610
           ++ +   +  + +  PE    ++ T  SDV+S+G++L E++S  E
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 248

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 120/225 (53%), Gaps = 14/225 (6%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQG 447
           P +  H F   +++     ++K +G+G FG V  G+LK    KEI+V + T     + + 
Sbjct: 31  PTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           +R+F  E +++ +  H N+++  G   +    ++V E+M NG+L   L     H+ +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTV 146
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--A 565
           I+ + +    A G++YL        +HRDL + NIL++ ++  KVSDFGLS+   D   A
Sbjct: 147 IQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 610
           ++ +   +  + +  PE    ++ T  SDV+S+G++L E++S  E
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 248

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 120/225 (53%), Gaps = 14/225 (6%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQG 447
           P +  H F   +++     ++K +G+G FG V  G+LK    KEI+V + T     + + 
Sbjct: 31  PTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           +R+F  E +++ +  H N+++  G   +    ++V E+M NG+L   L     H+ +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTV 146
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--A 565
           I+ + +    A G++YL        +HRDL + NIL++ ++  KVSDFGLS+   D   A
Sbjct: 147 IQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 610
           ++ +   +  + +  PE    ++ T  SDV+S+G++L E++S  E
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 248

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 120/225 (53%), Gaps = 14/225 (6%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQG 447
           P +  H F   +++     ++K +G+G FG V  G+LK    KEI+V + T     + + 
Sbjct: 31  PTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           +R+F  E +++ +  H N+++  G   +    ++V E+M NG+L   L     H+ +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTV 146
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--A 565
           I+ + +    A G++YL        +HRDL + NIL++ ++  KVSDFGLS+   D   A
Sbjct: 147 IQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 610
           ++ +   +  + +  PE    ++ T  SDV+S+G++L E++S  E
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 248

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 120/225 (53%), Gaps = 14/225 (6%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQG 447
           P +  H F   +++     ++K +G+G FG V  G+LK    KEI+V + T     + + 
Sbjct: 31  PTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           +R+F  E +++ +  H N+++  G   +    ++V E+M NG+L   L     H+ +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTV 146
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--A 565
           I+ + +    A G++YL        +HRDL + NIL++ ++  KVSDFGLS+   D   A
Sbjct: 147 IQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 610
           ++ +   +  + +  PE    ++ T  SDV+S+G++L E++S  E
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 248

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 120/225 (53%), Gaps = 14/225 (6%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQG 447
           P +  H F   +++     ++K +G+G FG V  G+LK    KEI+V + T     + + 
Sbjct: 29  PTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 87
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           +R+F  E +++ +  H N+++  G   +    ++V E+M NG+L   L     H+ +   
Sbjct: 88  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTV 144
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--A 565
           I+ + +    A G++YL        +HRDL + NIL++ ++  KVSDFGLS+   D   A
Sbjct: 145 IQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 201
Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 610
           ++ +   +  + +  PE    ++ T  SDV+S+G++L E++S  E
Sbjct: 202 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 246

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 68
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q +N +  L +A   +  +E
Sbjct: 69  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAME 126
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 127 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 183
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 72
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q +N +  L +A   +  +E
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAME 130
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 131 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 187
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 117/212 (55%), Gaps = 14/212 (6%)
Query: 407 DATKM-LEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQGKREFTNEVTLLSR 460
           DAT + ++K +G+G FG V  G+LK    KEI+V + T     + + +R+F  E +++ +
Sbjct: 31  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 90
Query: 461 IHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 520
             H N+++  G   +    ++V E+M NG+L   L     H+ +   I+ + +    A G
Sbjct: 91  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASG 147
Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVGY 578
           ++YL        +HRDL + NIL++ ++  KVSDFGLS+   D   A++ +   +  + +
Sbjct: 148 MKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 204
Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELISGQE 610
             PE    ++ T  SDV+S+G++L E++S  E
Sbjct: 205 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 236

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 72
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q +N +  L +A   +  +E
Sbjct: 73  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAME 130
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 131 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  100 bits (248), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 72
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q +N +  L +A   +  +E
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAME 130
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 131 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 13  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 71
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q +N +  L +A   +  +E
Sbjct: 72  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAME 129
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 130 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 117/212 (55%), Gaps = 14/212 (6%)
Query: 407 DATKM-LEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQGKREFTNEVTLLSR 460
           DAT + ++K +G+G FG V  G+LK    KEI+V + T     + + +R+F  E +++ +
Sbjct: 14  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 461 IHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 520
             H N+++  G   +    ++V E+M NG+L   L     H+ +   I+ + +    A G
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASG 130
Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVGY 578
           ++YL        +HRDL + NIL++ ++  KVSDFGLS+   D   A++ +   +  + +
Sbjct: 131 MKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 187
Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELISGQE 610
             PE    ++ T  SDV+S+G++L E++S  E
Sbjct: 188 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 219

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 120/225 (53%), Gaps = 14/225 (6%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQG 447
           P +  H F   +++     ++K +G+G FG V  G+LK    KEI+V + T     + + 
Sbjct: 31  PTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           +R+F  E +++ +  H N+++  G   +    ++V E+M NG+L   L     H+ +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTV 146
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--A 565
           I+ + +    A G++YL        +HRDL + NIL++ ++  KVSDFGL++   D   A
Sbjct: 147 IQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEA 203
Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 610
           ++ +   +  + +  PE    ++ T  SDV+S+G++L E++S  E
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 248

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 10  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 68
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q +N +  L +A   +  +E
Sbjct: 69  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAME 126
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 127 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 183
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 184 SLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 99.8 bits (247), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 72
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q +N +  L +A   +  +E
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAME 130
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 131 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 69
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q +N +  L +A   +  +E
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAME 127
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 128 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPE 184
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q +N +  L +A   +  +E
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAME 125
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q +N +  L +A   +  +E
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAME 125
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 126 YLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 118/222 (53%), Gaps = 14/222 (6%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQG 447
           P +  H F   +++     ++K +G+G FG V  G+LK    KEI+V + T     + + 
Sbjct: 31  PTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           +R+F  E +++ +  H N+++  G   +    ++V E M NG+L   L     H+ +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR---KHDAQFTV 146
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--A 565
           I+ + +    A G++YL        +HRDL + NIL++ ++  KVSDFGLS+   D   A
Sbjct: 147 IQLVGMLRGIASGMKYLSDM---GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           ++ +   +  + +  PE    ++ T  SDV+S+G++L E++S
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 69
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q +N +  L +A   +  +E
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAME 127
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 128 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G FG VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 7   EMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 65
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q ++ +  L +A   +  +E
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAME 123
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 124 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 119/225 (52%), Gaps = 14/225 (6%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQG 447
           P +  H F   +++     ++K +G+G FG V  G+LK    KEI+V + T     + + 
Sbjct: 31  PTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           +R+F  E +++ +  H N+++  G   +    ++V E+M NG+L   L     H+ +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTV 146
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--A 565
           I+ + +    A G++YL        +HRDL + NIL++ ++  KVSDFGL +   D   A
Sbjct: 147 IQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203
Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 610
           ++ +   +  + +  PE    ++ T  SDV+S+G++L E++S  E
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 248

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 22  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 80
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q +N +  L +A   +  +E
Sbjct: 81  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAME 138
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 139 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 196 SLAYNKFSIKSDVWAFGVLLWEIAT 220

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 99.0 bits (245), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 11  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 69
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q +N +  L +A   +  +E
Sbjct: 70  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAME 127
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 128 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 184
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 185 SLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 99.0 bits (245), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 119/225 (52%), Gaps = 14/225 (6%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQG 447
           P +  H F   +++     ++K +G+G FG V  G+LK    KEI+V + T     + + 
Sbjct: 31  PTQTVHEFA-KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ 89
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           +R+F  E +++ +  H N+++  G   +    ++V E M NG+L   L     H+ +   
Sbjct: 90  RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR---KHDAQFTV 146
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--A 565
           I+ + +    A G++YL        +HRDL + NIL++ ++  KVSDFGLS+   D   A
Sbjct: 147 IQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 203
Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 610
           ++ +   +  + +  PE    ++ T  SDV+S+G++L E++S  E
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 248

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 114/222 (51%), Gaps = 14/222 (6%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKE---IAVKVL-TSNSYQG 447
           P  A H F   +++ +   +E+ IG+G FG V  G+LK  GK    +A+K L    + + 
Sbjct: 29  PNRAVHQFA-KELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQ 87
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           +R+F  E +++ +  H N+V   G        ++V EFM NG L   L     H+ +   
Sbjct: 88  RRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLR---KHDGQFTV 144
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 567
           I+ + +    A G+ YL        +HRDL + NIL++ ++  KVSDFGLS+   D    
Sbjct: 145 IQLVGMLRGIAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEA 201
Query: 568 VSSIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           V +   G   V +  PE    ++ T  SDV+S+G+++ E++S
Sbjct: 202 VYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H  LVQ   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE   +++ E+M  G+L + L G +    R+  +  +++A   A G+ Y+       
Sbjct: 81  VVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVERM---N 134
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L EL +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 115/209 (55%), Gaps = 14/209 (6%)
Query: 407 DATKM-LEKKIGSGGFGVVYYGKLK--DGKEIAVKVLT---SNSYQGKREFTNEVTLLSR 460
           DAT + ++K +G+G FG V  G+LK    KEI+V + T     + + +R+F  E +++ +
Sbjct: 14  DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 461 IHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 520
             H N+++  G   +    ++V E M NG+L   L     H+ +   I+ + +    A G
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASG 130
Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVGY 578
           ++YL        +HRDL + NIL++ ++  KVSDFGLS+   D   A++ +   +  + +
Sbjct: 131 MKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 187
Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELIS 607
             PE    ++ T  SDV+S+G++L E++S
Sbjct: 188 TSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ +I H  LVQ   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYA 80
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE    +V E+M  G+L + L G +    R+  +  +++A   A G+ Y+       
Sbjct: 81  VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVERM---N 134
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L EL +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 65
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q ++ +  L +A   +  +E
Sbjct: 66  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAME 123
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 124 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 120/222 (54%), Gaps = 14/222 (6%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKE---IAVKVL-TSNSYQG 447
           P +A H F   +IE +   +E+ IG+G FG V  G+LK  GK    +A+K L    + + 
Sbjct: 8   PNQAVHEFA-KEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQ 66
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           +R+F  E +++ +  H N++   G   +    ++V E+M NG+L   L     ++ +   
Sbjct: 67  RRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLK---KNDGQFTV 123
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--A 565
           I+ + +    + G++YL        +HRDL + NIL++ ++  KVSDFGLS+   D   A
Sbjct: 124 IQLVGMLRGISAGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA 180
Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           ++ +   +  + +  PE    ++ T  SDV+S+G+++ E++S
Sbjct: 181 AYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 255 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 313
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q +N +  L +A   +  +E
Sbjct: 314 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAME 371
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHR+L + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 372 YLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 428
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 429 SLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H  LVQ   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE   +++ E+M  G+L + L G +    R+   + +++A   A G+ Y+       
Sbjct: 81  VVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERM---N 134
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L EL +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           +I   +  LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 61
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
             LVQ      EE    +V E+M  G+L + L G +    R+   + +++A   A G+ Y
Sbjct: 62  EKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAY 118
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE 
Sbjct: 119 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 175
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
            +  + T KSDV+SFG++L EL +
Sbjct: 176 ALYGRFTIKSDVWSFGILLTELTT 199

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H  LVQ   
Sbjct: 13  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 71
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE    +V E+M  G+L + L G +    R+   + +++A   A G+ Y+       
Sbjct: 72  VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERM---N 125
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T 
Sbjct: 126 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L EL +
Sbjct: 186 KSDVWSFGILLTELTT 201

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 9/200 (4%)
Query: 411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQ 468
           +L ++IG G FG V+ G+L+ D   +AVK          K +F  E  +L +  H N+V+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
            +G C ++    +V E +  G     L    T   R+     L++  DAA G+EYL + C
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VGYLDPEYYISQ 587
               IHRDL + N L+ +    K+SDFG+S+   DG    S  +R   V +  PE     
Sbjct: 234 C---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 588 QLTDKSDVYSFGVILLELIS 607
           + + +SDV+SFG++L E  S
Sbjct: 291 RYSSESDVWSFGILLWETFS 310

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q ++ +  L +A   +  +E
Sbjct: 68  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAME 125
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 126 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 14  EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 72
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q ++ +  L +A   +  +E
Sbjct: 73  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAME 130
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 131 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 187
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 188 SLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q ++ +  L +A   +  +E
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAME 125
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 126 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 121/224 (54%), Gaps = 16/224 (7%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSN-SYQG 447
           P EA   F   +I+ +   +E+ IG+G FG V  G LK  GK    +A+K L S  + + 
Sbjct: 19  PNEAVREFA-KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ 77
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           +R+F +E +++ +  H N++   G   +    +++ EFM NG+L   L     ++ +   
Sbjct: 78  RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDGQFTV 134
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 567
           I+ + +    A G++YL        +HRDL + NIL++ ++  KVSDFGLS+F  D  S 
Sbjct: 135 IQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 191
Query: 568 --VSSIVRGTVG--YLDPEYYISQQLTDKSDVYSFGVILLELIS 607
              +S + G +   +  PE    ++ T  SDV+S+G+++ E++S
Sbjct: 192 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H  LVQ   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE    +V E+M  G+L + L G +    R+  +  +++A   A G+ Y+       
Sbjct: 81  VVSEEP-IYIVCEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVERM---N 134
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L EL +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q ++ +  L +A   +  +E
Sbjct: 68  HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAME 125
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 126 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H  LVQ   
Sbjct: 12  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 70
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE   + V E+M  G+L + L G      R+   + +++A   A G+ Y+       
Sbjct: 71  VVSEEPIXI-VTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQIASGMAYVERM---N 124
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T 
Sbjct: 125 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI 184
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L EL +
Sbjct: 185 KSDVWSFGILLTELTT 200

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H  LVQ   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE    +V E+M  G L + L G +    R+   + +++A   A G+ Y+       
Sbjct: 81  VVSEEP-IYIVMEYMSKGCLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERM---N 134
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L EL +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 7   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 65
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q ++ +  L +A   +  +E
Sbjct: 66  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAME 123
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 124 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPE 180
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 181 SLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 9   EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 67
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q ++ +  L +A   +  +E
Sbjct: 68  HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAME 125
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 126 YLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 182
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H  LVQ   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE    +V E+M  G+L + L G +    R+  +  +++A   A G+ Y+       
Sbjct: 81  VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVERM---N 134
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L EL +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 102/200 (51%), Gaps = 9/200 (4%)
Query: 411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQ 468
           +L ++IG G FG V+ G+L+ D   +AVK          K +F  E  +L +  H N+V+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
            +G C ++    +V E +  G     L    T   R+     L++  DAA G+EYL + C
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESKC 233
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VGYLDPEYYISQ 587
               IHRDL + N L+ +    K+SDFG+S+   DG    S  +R   V +  PE     
Sbjct: 234 C---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 588 QLTDKSDVYSFGVILLELIS 607
           + + +SDV+SFG++L E  S
Sbjct: 291 RYSSESDVWSFGILLWETFS 310

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 21/202 (10%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           +E+ +G G FGVV   K +  K++A+K + S S   ++ F  E+  LSR++H N+V+  G
Sbjct: 13  VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYG 69
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGT-----LTHEQRINWIKRLEIAEDAAKGIEYLHT 526
            C       LV E+   G+L   L+G       T    ++W  +       ++G+ YLH+
Sbjct: 70  ACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ------CSQGVAYLHS 121
Query: 527 GCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
               A+IHRDLK  N+LL       K+ DFG    A D  +H+++  +G+  ++ PE + 
Sbjct: 122 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGT---ACDIQTHMTN-NKGSAAWMAPEVFE 177
Query: 586 SQQLTDKSDVYSFGVILLELIS 607
               ++K DV+S+G+IL E+I+
Sbjct: 178 GSNYSEKCDVFSWGIILWEVIT 199

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H  LVQ   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE    +V E+M  G L + L G +    R+  +  +++A   A G+ Y+       
Sbjct: 81  VVSEEP-IYIVTEYMSKGCLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAYVERM---N 134
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T 
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L EL +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG++YL +   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKYLASK-- 151
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 152 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           Q+ T KSDV+SFGV+L EL++          GA     V    + +     + ++ P   
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTR---------GAPPYPDVNTFDITVYLLQGRRLLQP--- 258
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
            EY    ++++    L C  P   MRPS SE++  I
Sbjct: 259 -EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 290

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG++YL +   
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKYLASK-- 170
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 171 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           Q+ T KSDV+SFGV+L EL++          GA     V    + +     + ++ P   
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTR---------GAPPYPDVNTFDITVYLLQGRRLLQP--- 277
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
            EY    ++++    L C  P   MRPS SE++  I
Sbjct: 278 -EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 309

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG++YL +   
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKYLASK-- 144
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 145 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           Q+ T KSDV+SFGV+L EL++          GA     V    + +     + ++ P   
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTR---------GAPPYPDVNTFDITVYLLQGRRLLQP--- 251
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
            EY    ++++    L C  P   MRPS SE++  I
Sbjct: 252 -EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 283

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG++YL +   
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKYLASK-- 171
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 172 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           Q+ T KSDV+SFGV+L EL++          GA     V    + +     + ++ P   
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTR---------GAPPYPDVNTFDITVYLLQGRRLLQP--- 278
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
            EY    ++++    L C  P   MRPS SE++  I
Sbjct: 279 -EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 310

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 109/202 (53%), Gaps = 21/202 (10%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           +E+ +G G FGVV   K +  K++A+K + S S   ++ F  E+  LSR++H N+V+  G
Sbjct: 12  VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGT-----LTHEQRINWIKRLEIAEDAAKGIEYLHT 526
            C       LV E+   G+L   L+G       T    ++W  +       ++G+ YLH+
Sbjct: 69  ACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ------CSQGVAYLHS 120
Query: 527 GCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
               A+IHRDLK  N+LL       K+ DFG    A D  +H+++  +G+  ++ PE + 
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGT---ACDIQTHMTN-NKGSAAWMAPEVFE 176
Query: 586 SQQLTDKSDVYSFGVILLELIS 607
               ++K DV+S+G+IL E+I+
Sbjct: 177 GSNYSEKCDVFSWGIILWEVIT 198

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 122/227 (53%), Gaps = 16/227 (7%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSN-SYQG 447
           P EA   F   +I+ +   +E+ IG+G FG V  G+LK  GK+   +A+K L    + + 
Sbjct: 2   PNEAVREFA-KEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ 60
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           +REF +E +++ +  H N+++  G        +++ EFM NG L   L     ++ +   
Sbjct: 61  RREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTV 117
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS- 566
           I+ + +    A G+ YL      + +HRDL + NIL++ ++  KVSDFGLS+F  + +S 
Sbjct: 118 IQLVGMLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSD 174
Query: 567 --HVSSI-VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 610
               SS+  +  + +  PE    ++ T  SD +S+G+++ E++S  E
Sbjct: 175 PTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGE 221

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG++YL +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKYLASK-- 152
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 153 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           Q+ T KSDV+SFGV+L EL++          GA     V    + +     + ++ P   
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTR---------GAPPYPDVNTFDITVYLLQGRRLLQP--- 259
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
            EY    ++++    L C  P   MRPS SE++  I
Sbjct: 260 -EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 291

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           +I   +  LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H
Sbjct: 7   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 65
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
             LVQ      EE    +V E+M  G+L + L G      R+   + +++A   A G+ Y
Sbjct: 66  EKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQIASGMAY 122
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE 
Sbjct: 123 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 179
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
            +  + T KSDV+SFG++L EL +
Sbjct: 180 ALYGRFTIKSDVWSFGILLTELTT 203

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H  LVQ   
Sbjct: 22  LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE    +V E+M  G+L + L G +    R+   + +++A   A G+ Y+       
Sbjct: 81  VVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLP--QLVDMAAQIASGMAYVERM---N 134
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL ++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T 
Sbjct: 135 YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L EL +
Sbjct: 195 KSDVWSFGILLTELTT 210

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG++YL +   
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKYLASK-- 149
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 150 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           Q+ T KSDV+SFGV+L EL++          GA     V    + +     + ++ P   
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTR---------GAPPYPDVNTFDITVYLLQGRRLLQP--- 256
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
            EY    ++++    L C  P   MRPS SE++  I
Sbjct: 257 -EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 288

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG++YL +   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKYLASK-- 151
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 152 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           Q+ T KSDV+SFGV+L EL++          GA     V    + +     + ++ P   
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTR---------GAPPYPDVNTFDITVYLLQGRRLLQP--- 258
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
            EY    ++++    L C  P   MRPS SE++  I
Sbjct: 259 -EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 290

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG++YL +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKYLASK-- 152
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 153 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           Q+ T KSDV+SFGV+L EL++          GA     V    + +     + ++ P   
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTR---------GAPPYPDVNTFDITVYLLQGRRLLQP--- 259
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
            EY    ++++    L C  P   MRPS SE++  I
Sbjct: 260 -EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 291

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG++YL +   
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKYLASK-- 147
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 148 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           Q+ T KSDV+SFGV+L EL++          GA     V    + +     + ++ P   
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTR---------GAPPYPDVNTFDITVYLLQGRRLLQP--- 254
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
            EY    ++++    L C  P   MRPS SE++  I
Sbjct: 255 -EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 286

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ + + EF  E  ++  I 
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIK 274
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    ++ EFM  G L ++L     + Q ++ +  L +A   +  +E
Sbjct: 275 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAME 332
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHR+L + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 333 YLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 389
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV++FGV+L E+ +
Sbjct: 390 SLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 95.9 bits (237), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 137/279 (49%), Gaps = 37/279 (13%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG++YL +   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKYLAS--- 149
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 587 QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG--IIDP 643
           Q+ T KSDV+SFGV+L EL++ G     +     N  +I  +         +QG  ++ P
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAPPYPD----VNTFDITVYL--------LQGRRLLQP 257
Query: 644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
               EY    ++++    L C  P   MRPS SE++  I
Sbjct: 258 ----EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 289

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           +I   +  LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 69
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
             LVQ      EE    +V E+M+ G+L + L G      R+   + ++++   A G+ Y
Sbjct: 70  EKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLP--QLVDMSAQIASGMAY 126
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE 
Sbjct: 127 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEA 183
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
            +  + T KSDV+SFG++L EL +
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTT 207

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           +I   +  LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 321
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
             LVQ      EE    +V E+M  G+L + L G      R+  +  +++A   A G+ Y
Sbjct: 322 EKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAY 378
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE 
Sbjct: 379 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 435
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
            +  + T KSDV+SFG++L EL +
Sbjct: 436 ALYGRFTIKSDVWSFGILLTELTT 459

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 138/279 (49%), Gaps = 37/279 (13%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG+++L +   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKFLAS--- 152
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++  +D    + H  +  +  V ++  E   +
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 587 QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG--IIDP 643
           Q+ T KSDV+SFGV+L EL++ G     +     N  +I  +         +QG  ++ P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPD----VNTFDITVYL--------LQGRRLLQP 260
Query: 644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
               EY    ++++    L C  P   MRPS SE++  I
Sbjct: 261 ----EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 292

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           +I   +  LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 69
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
             LVQ      EE    +V E+M+ G+L + L G      R+  +  ++++   A G+ Y
Sbjct: 70  EKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGETGKYLRLPQL--VDMSAQIASGMAY 126
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE 
Sbjct: 127 VERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEA 183
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
            +  + T KSDV+SFG++L EL +
Sbjct: 184 ALYGRFTIKSDVWSFGILLTELTT 207

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           +I   +  LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H
Sbjct: 181 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGN-MSPEAFLQEAQVMKKLRH 239
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
             LVQ      EE    +V E+M  G+L + L G +    R+  +  +++A   A G+ Y
Sbjct: 240 EKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQL--VDMAAQIASGMAY 296
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        +HRDL+++NIL+ +++  KV+DFGL +   D         +  + +  PE 
Sbjct: 297 VERM---NYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEA 353
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
            +  + T KSDV+SFG++L EL +
Sbjct: 354 ALYGRFTIKSDVWSFGILLTELTT 377

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG+++L +   
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKFLASK-- 211
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 212 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           Q+ T KSDV+SFGV+L EL++          GA     V    + +     + ++ P   
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTR---------GAPPYPDVNTFDITVYLLQGRRLLQP--- 318
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
            EY    ++++    L C  P   MRPS SE++  I
Sbjct: 319 -EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 350

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H  LVQ   
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE    +V E+M  G+L + L G      R+  +  +++A   A G+ Y+       
Sbjct: 247 VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVERM---N 300
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T 
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L EL +
Sbjct: 361 KSDVWSFGILLTELTT 376

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H  LVQ   
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE    +V E+M  G+L + L G      R+  +  +++A   A G+ Y+       
Sbjct: 247 VVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVERM---N 300
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T 
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L EL +
Sbjct: 361 KSDVWSFGILLTELTT 376

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 122/228 (53%), Gaps = 15/228 (6%)
Query: 388 SLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--DGKE---IAVKVLTS 442
           ++   P +A   FT ++I  +    +K IG+G FG VY G LK   GK+   +A+K L +
Sbjct: 25  AMGSDPNQAVLKFT-TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA 83
Query: 443 NSYQGKR-EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH 501
              + +R +F  E  ++ +  H N+++  G   +    +++ E+M NG L + L      
Sbjct: 84  GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EK 140
Query: 502 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 561
           +   + ++ + +    A G++YL        +HRDL + NIL++ ++  KVSDFGLS+  
Sbjct: 141 DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197
Query: 562 VDG--ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            D   A++ +S  +  + +  PE    ++ T  SDV+SFG+++ E+++
Sbjct: 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 115/208 (55%), Gaps = 15/208 (7%)
Query: 412 LEKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 466
           +E+ IG+G FG V  G+LK  GK+   +A+K L    + + +REF +E +++ +  H N+
Sbjct: 18  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++  G        +++ EFM NG L   L     ++ +   I+ + +    A G+ YL  
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLR---LNDGQFTVIQLVGMLRGIASGMRYLAE 134
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS---HVSSI-VRGTVGYLDPE 582
               + +HRDL + NIL++ ++  KVSDFGLS+F  + +S   + SS+  +  + +  PE
Sbjct: 135 M---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 583 YYISQQLTDKSDVYSFGVILLELISGQE 610
               ++ T  SD +S+G+++ E++S  E
Sbjct: 192 AIAFRKFTSASDAWSYGIVMWEVMSFGE 219

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG+++L +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKFLASK-- 152
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 153 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           Q+ T KSDV+SFGV+L EL++          GA     V    + +     + ++ P   
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTR---------GAPPYPDVNTFDITVYLLQGRRLLQP--- 259
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
            EY    ++++    L C  P   MRPS SE++  I
Sbjct: 260 -EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 291

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG+++L +   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKFLASK-- 150
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 151 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           Q+ T KSDV+SFGV+L EL++          GA     V    + +     + ++ P   
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTR---------GAPPYPDVNTFDITVYLLQGRRLLQP--- 257
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
            EY    ++++    L C  P   MRPS SE++  I
Sbjct: 258 -EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 289

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 31/276 (11%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG+++L +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKFLAS--- 151
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           Q+ T KSDV+SFGV+L EL++          GA     V    + +     + ++ P   
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTR---------GAPPYPDVNTFDITVYLLQGRRLLQP--- 259
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
            EY    ++++    L C  P   MRPS SE++  I
Sbjct: 260 -EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 136/278 (48%), Gaps = 35/278 (12%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG+++L +   
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKFLASK-- 157
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 158 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG--IIDPS 644
           Q+ T KSDV+SFGV+L EL++       +    N  +I  +         +QG  ++ P 
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAPPYPD---VNTFDITVYL--------LQGRRLLQP- 264
Query: 645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
              EY    ++++    L C  P   MRPS SE++  I
Sbjct: 265 ---EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 296

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H  LVQ   
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE    +V E+M  G+L + L G      R+  +  +++A   A G+ Y+       
Sbjct: 247 VVSEEP-IYIVGEYMSKGSLLDFLKGETGKYLRLPQL--VDMAAQIASGMAYVERM---N 300
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T 
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L EL +
Sbjct: 361 KSDVWSFGILLTELTT 376

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 137/279 (49%), Gaps = 37/279 (13%)
Query: 416 IGSGGFGVVYYGKL--KDGKEI--AVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLVQFL 470
           IG G FG VY+G L   DGK+I  AVK L   +  G+  +F  E  ++    H N++  L
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C + EG  ++V  +M +G L+  +    TH   +     +      AKG+++L +   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVK--DLIGFGLQVAKGMKFLAS--- 152
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSIVRGTVGYLDPEYYIS 586
              +HRDL + N +LD+    KV+DFGL++   D    + H  +  +  V ++  E   +
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 587 QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG--IIDP 643
           Q+ T KSDV+SFGV+L EL++ G     +     N  +I  +         +QG  ++ P
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAPPYPD----VNTFDITVYL--------LQGRRLLQP 260
Query: 644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
               EY    ++++    L C  P   MRPS SE++  I
Sbjct: 261 ----EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRI 292

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 120/222 (54%), Gaps = 14/222 (6%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSN-SYQG 447
           P +A   F   +I+ +   +EK IG G FG V  G+LK  GK    +A+K L +  + + 
Sbjct: 15  PNQAVREFA-KEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ 73
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           +R+F +E +++ +  H N++   G   +    +++ E+M NG+L   L     ++ R   
Sbjct: 74  RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTV 130
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--A 565
           I+ + +      G++YL      + +HRDL + NIL++ ++  KVSDFG+S+   D   A
Sbjct: 131 IQLVGMLRGIGSGMKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA 187
Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           ++ +   +  + +  PE    ++ T  SDV+S+G+++ E++S
Sbjct: 188 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 110/217 (50%), Gaps = 24/217 (11%)
Query: 411 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 464
           +L++++G G FG V+  +       KD   +AVK L   +   +++F  E  LL+ + H 
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------TLTHEQ------RINWIKRLE 512
           ++V+F G C +    ++V+E+M +G L + L         L   Q       +   + L 
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 513 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSS 570
           IA   A G+ YL +      +HRDL + N L+  ++  K+ DFG+S+  ++ D    V  
Sbjct: 138 IASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-YYRVGG 193
Query: 571 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
                + ++ PE  + ++ T +SDV+SFGVIL E+ +
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 111/214 (51%), Gaps = 21/214 (9%)
Query: 411 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 464
           +L++++G G FG V+  +       +D   +AVK L   S   +++F  E  LL+ + H 
Sbjct: 16  VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 75
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----GTLTHE----QRINWIKRLEIAE 515
           ++V+F G C E    ++V+E+M +G L + L        L  E      +   + L IA+
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSIVR 573
             A G+ YL +      +HRDL + N L+ +++  K+ DFG+S+  ++ D    V     
Sbjct: 136 QIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD-YYRVGGHTM 191
Query: 574 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             + ++ PE  + ++ T +SDV+S GV+L E+ +
Sbjct: 192 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 7/205 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           ++E     ++ K+G G +G VY G  K     +AVK L  ++ +   EF  E  ++  I 
Sbjct: 28  EMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 86
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H NLVQ LG C  E    +V E+M  G L ++L     + + +  +  L +A   +  +E
Sbjct: 87  HPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL--RECNREEVTAVVLLYMATQISSAME 144
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YL        IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE
Sbjct: 145 YLEK---KNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 201
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                  + KSDV++FGV+L E+ +
Sbjct: 202 SLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           ++   T  L +++G+G FG V+ G      ++AVK L   S      F  E  L+ ++ H
Sbjct: 18  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 76
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LV+      +E   ++  E+M NG+L + L      +  IN  K L++A   A+G+ +
Sbjct: 77  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 133
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 134 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 190
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
                 T KSDV+SFG++L E+++
Sbjct: 191 INYGTFTIKSDVWSFGILLTEIVT 214

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           ++   T  L +++G+G FG V+ G      ++AVK L   S      F  E  L+ ++ H
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 73
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LV+      +E   ++  E+M NG+L + L      +  IN  K L++A   A+G+ +
Sbjct: 74  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 130
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 131 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 187
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
                 T KSDV+SFG++L E+++
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           ++   T  L +++G+G FG V+ G      ++AVK L   S      F  E  L+ ++ H
Sbjct: 11  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 69
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LV+      +E   ++  E+M NG+L + L      +  IN  K L++A   A+G+ +
Sbjct: 70  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 126
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 127 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 183
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
                 T KSDV+SFG++L E+++
Sbjct: 184 INYGTFTIKSDVWSFGILLTEIVT 207

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           ++   T  L +++G+G FG V+ G      ++AVK L   S      F  E  L+ ++ H
Sbjct: 17  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 75
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LV+      +E   ++  E+M NG+L + L      +  IN  K L++A   A+G+ +
Sbjct: 76  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 132
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 133 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 189
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
                 T KSDV+SFG++L E+++
Sbjct: 190 INYGTFTIKSDVWSFGILLTEIVT 213

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           ++   T  L +++G+G FG V+ G      ++AVK L   S      F  E  L+ ++ H
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LV+      +E   ++  E+M NG+L + L      +  IN  K L++A   A+G+ +
Sbjct: 68  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 124
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
                 T KSDV+SFG++L E+++
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 112/230 (48%), Gaps = 27/230 (11%)
Query: 416 IGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 474
           +G G FG  +     + G+ + +K L     + +R F  EV ++  + H N+++F+G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 475 EEGRSVLVYEFMHNGTLKEHLYGTL-THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
           ++ R   + E++  GTL+    G + + + +  W +R+  A+D A G+ YLH+     II
Sbjct: 78  KDKRLNFITEYIKGGTLR----GIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NII 130
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-------------VRGTVGYLD 580
           HRDL S N L+ ++    V+DFGL++  VD  +    +             V G   ++ 
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISGQEAISN-----EKFGANCRNIV 625
           PE    +   +K DV+SFG++L E+I    A  +       FG N R  +
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 116/211 (54%), Gaps = 13/211 (6%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSN-SYQGKREFTNEVTLL 458
           +I+ +   +EK IG G FG V  G+LK  GK    +A+K L +  + + +R+F +E +++
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
            +  H N++   G   +    +++ E+M NG+L   L     ++ R   I+ + +     
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIG 120
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTV 576
            G++YL      + +HRDL + NIL++ ++  KVSDFG+S+   D   A++ +   +  +
Sbjct: 121 SGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 177
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            +  PE    ++ T  SDV+S+G+++ E++S
Sbjct: 178 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 116/211 (54%), Gaps = 13/211 (6%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSN-SYQGKREFTNEVTLL 458
           +I+ +   +EK IG G FG V  G+LK  GK    +A+K L +  + + +R+F +E +++
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
            +  H N++   G   +    +++ E+M NG+L   L     ++ R   I+ + +     
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLR---KNDGRFTVIQLVGMLRGIG 126
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTV 576
            G++YL      + +HRDL + NIL++ ++  KVSDFG+S+   D   A++ +   +  +
Sbjct: 127 SGMKYLSD---MSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPI 183
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            +  PE    ++ T  SDV+S+G+++ E++S
Sbjct: 184 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           ++   T  L +++G+G FG V+ G      ++AVK L   S      F  E  L+ ++ H
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LV+      +E   ++  E+M NG+L + L      +  IN  K L++A   A+G+ +
Sbjct: 68  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 124
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 181
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
                 T KSDV+SFG++L E+++
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           ++   T  L +++G+G FG V+ G      ++AVK L   S      F  E  L+ ++ H
Sbjct: 10  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 68
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LV+      +E   ++  E+M NG+L + L      +  IN  K L++A   A+G+ +
Sbjct: 69  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 125
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 126 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEA 182
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
                 T KSDV+SFG++L E+++
Sbjct: 183 INYGTFTIKSDVWSFGILLTEIVT 206

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           +I   +  L K++G+G FG V+ G      ++A+K L   +      F  E  ++ ++ H
Sbjct: 5   EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKH 63
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
             LVQ      EE    +V E+M+ G+L + L        ++     +++A   A G+ Y
Sbjct: 64  DKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKDGEGRALKLP--NLVDMAAQVAAGMAY 120
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHRDL+S+NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 121 IERM---NYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEA 177
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
            +  + T KSDV+SFG++L EL++
Sbjct: 178 ALYGRFTIKSDVWSFGILLTELVT 201

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 116/213 (54%), Gaps = 15/213 (7%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKE---IAVKVLTSN-SYQGKREFTNEVTLL 458
           +I+ +   +E+ IG+G FG V  G LK  GK    +A+K L S  + + +R+F +E +++
Sbjct: 3   EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 62
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
            +  H N++   G   +    +++ EFM NG+L   L     ++ +   I+ + +    A
Sbjct: 63  GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIA 119
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGT- 575
            G++YL        +HR L + NIL++ ++  KVSDFGLS+F  D  S    +S + G  
Sbjct: 120 AGMKYLADM---NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 176
Query: 576 -VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            + +  PE    ++ T  SDV+S+G+++ E++S
Sbjct: 177 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           ++   T  L +++G+G FG V+ G      ++AVK L   S      F  E  L+ ++ H
Sbjct: 19  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 77
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LV+      +E   ++  E+M NG+L + L      +  IN  K L++A   A+G+ +
Sbjct: 78  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 134
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 135 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 191
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
                 T KSDV+SFG++L E+++
Sbjct: 192 INYGTFTIKSDVWSFGILLTEIVT 215

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           ++   T  L +++G+G FG V+ G      ++AVK L   S      F  E  L+ ++ H
Sbjct: 15  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 73
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LV+      +E   ++  E+M NG+L + L      +  IN  K L++A   A+G+ +
Sbjct: 74  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 130
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 131 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 187
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
                 T KSDV+SFG++L E+++
Sbjct: 188 INYGTFTIKSDVWSFGILLTEIVT 211

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           ++   T  L +++G+G FG V+ G      ++AVK L   S      F  E  L+ ++ H
Sbjct: 9   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LV+      +E   ++  E+M NG+L + L      +  IN  K L++A   A+G+ +
Sbjct: 68  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 124
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
                 T KSDV+SFG++L E+++
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           ++   T  L +++G+G FG V+ G      ++AVK L   S      F  E  L+ ++ H
Sbjct: 14  EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 72
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LV+      +E   ++  E+M NG+L + L      +  IN  K L++A   A+G+ +
Sbjct: 73  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 129
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 130 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 186
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
                 T KSDV+SFG++L E+++
Sbjct: 187 INYGTFTIKSDVWSFGILLTEIVT 210

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 411 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 464
           +L+ ++G G FG V+  +       +D   +AVK L   S   +++F  E  LL+ + H+
Sbjct: 15  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 74
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----------GTLTHEQRINWIKRLEI 513
           ++V+F G C E    ++V+E+M +G L   L            G       +   + L +
Sbjct: 75  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSI 571
           A   A G+ YL  G     +HRDL + N L+ + +  K+ DFG+S+  ++ D    V   
Sbjct: 135 ASQVAAGMVYL-AGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGR 190
Query: 572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               + ++ PE  + ++ T +SDV+SFGV+L E+ +
Sbjct: 191 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 411 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 464
           +L+ ++G G FG V+  +       +D   +AVK L   S   +++F  E  LL+ + H+
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----------GTLTHEQRINWIKRLEI 513
           ++V+F G C E    ++V+E+M +G L   L            G       +   + L +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSI 571
           A   A G+ YL  G     +HRDL + N L+ + +  K+ DFG+S+  ++ D    V   
Sbjct: 164 ASQVAAGMVYL-AGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGR 219
Query: 572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               + ++ PE  + ++ T +SDV+SFGV+L E+ +
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 23/216 (10%)
Query: 411 MLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 464
           +L+ ++G G FG V+  +       +D   +AVK L   S   +++F  E  LL+ + H+
Sbjct: 21  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 80
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-----------GTLTHEQRINWIKRLEI 513
           ++V+F G C E    ++V+E+M +G L   L            G       +   + L +
Sbjct: 81  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGASHVSSI 571
           A   A G+ YL  G     +HRDL + N L+ + +  K+ DFG+S+  ++ D    V   
Sbjct: 141 ASQVAAGMVYL-AGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD-YYRVGGR 196
Query: 572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               + ++ PE  + ++ T +SDV+SFGV+L E+ +
Sbjct: 197 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           ++   T  L +++G+G FG V+ G      ++AVK L   S      F  E  L+ ++ H
Sbjct: 4   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 62
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LV+      +E   ++  E+M NG+L + L      +  IN  K L++A   A+G+ +
Sbjct: 63  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 119
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 120 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 176
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
                 T KSDV+SFG++L E+++
Sbjct: 177 INYGTFTIKSDVWSFGILLTEIVT 200

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 13/197 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L + IG G FG V  G  + G ++AVK + +++    + F  E ++++++ H NLVQ LG
Sbjct: 10  LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 66
Query: 472 Y-CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
              +E+G   +V E+M  G+L ++L         +     L+ + D  + +EYL      
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN--- 121
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
             +HRDL + N+L+ +   AKVSDFGL+K     AS      +  V +  PE    ++ +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 591 DKSDVYSFGVILLELIS 607
            KSDV+SFG++L E+ S
Sbjct: 178 TKSDVWSFGILLWEIYS 194

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           ++   T  L +++G+G  G V+ G      ++AVK L   S      F  E  L+ ++ H
Sbjct: 9   EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LV+      +E   ++  E+M NG+L + L      +  IN  K L++A   A+G+ +
Sbjct: 68  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 124
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 125 IEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEA 181
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
                 T KSDV+SFG++L E+++
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVT 205

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 13/197 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L + IG G FG V  G  + G ++AVK + +++    + F  E ++++++ H NLVQ LG
Sbjct: 25  LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 81
Query: 472 Y-CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
              +E+G   +V E+M  G+L ++L         +     L+ + D  + +EYL      
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN--- 136
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
             +HRDL + N+L+ +   AKVSDFGL+K     AS      +  V +  PE    ++ +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 591 DKSDVYSFGVILLELIS 607
            KSDV+SFG++L E+ S
Sbjct: 193 TKSDVWSFGILLWEIYS 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 13/197 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L + IG G FG V  G  + G ++AVK + +++    + F  E ++++++ H NLVQ LG
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 472 Y-CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
              +E+G   +V E+M  G+L ++L         +     L+ + D  + +EYL      
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN--- 308
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
             +HRDL + N+L+ +   AKVSDFGL+K     AS      +  V +  PE    ++ +
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 591 DKSDVYSFGVILLELIS 607
            KSDV+SFG++L E+ S
Sbjct: 365 TKSDVWSFGILLWEIYS 381

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           ++   T  L +++G+G FG V+ G      ++AVK L   S      F  E  L+ ++ H
Sbjct: 5   EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 63
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LV+      +E   ++  E+M NG+L + L      +  IN  K L++A   A+G+ +
Sbjct: 64  QRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTIN--KLLDMAAQIAEGMAF 120
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +        IHR+L+++NIL+   +  K++DFGL++   D         +  + +  PE 
Sbjct: 121 IEER---NYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 177
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
                 T KSDV+SFG++L E+++
Sbjct: 178 INYGTFTIKSDVWSFGILLTEIVT 201

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 110/205 (53%), Gaps = 18/205 (8%)
Query: 414 KKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLV 467
           + +G G FG V   +        G+++AVK L   S      +   E+ +L  ++H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 468 QFLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           ++ G C E+G +   L+ EF+ +G+LKE+L     ++ +IN  ++L+ A    KG++YL 
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV---RGTVGYLDPE 582
           +      +HRDL + N+L++   + K+ DFGL+K A++      ++       V +  PE
Sbjct: 144 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDDRDSPVFWYAPE 199
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
             +  +    SDV+SFGV L EL++
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 110/205 (53%), Gaps = 18/205 (8%)
Query: 414 KKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRIHHRNLV 467
           + +G G FG V   +        G+++AVK L   S      +   E+ +L  ++H N+V
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 468 QFLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           ++ G C E+G +   L+ EF+ +G+LKE+L     ++ +IN  ++L+ A    KG++YL 
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLG 131
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV---RGTVGYLDPE 582
           +      +HRDL + N+L++   + K+ DFGL+K A++      ++       V +  PE
Sbjct: 132 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEXXTVKDDRDSPVFWYAPE 187
Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
             +  +    SDV+SFGV L EL++
Sbjct: 188 CLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 104/197 (52%), Gaps = 13/197 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L + IG G FG V  G  + G ++AVK + +++    + F  E ++++++ H NLVQ LG
Sbjct: 16  LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 72
Query: 472 Y-CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
              +E+G   +V E+M  G+L ++L         +     L+ + D  + +EYL      
Sbjct: 73  VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN--- 127
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
             +HRDL + N+L+ +   AKVSDFGL+K     AS      +  V +  PE       +
Sbjct: 128 NFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREAAFS 183
Query: 591 DKSDVYSFGVILLELIS 607
            KSDV+SFG++L E+ S
Sbjct: 184 TKSDVWSFGILLWEIYS 200

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/227 (31%), Positives = 113/227 (49%), Gaps = 31/227 (13%)
Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG--- 471
           IGSGGFG V+  K + DGK   +K +  N+ + +RE    V  L+++ H N+V + G   
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGCWD 74
Query: 472 --------YCQEEGRS-----VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
                     +   RS      +  EF   GTL++ +       ++++ +  LE+ E   
Sbjct: 75  GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQIT 132
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVG 577
           KG++Y+H+     +I+RDLK SNI L    + K+ DFGL +    DG    S   +GT+ 
Sbjct: 133 KGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS---KGTLR 186
Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN 623
           Y+ PE   SQ    + D+Y+ G+IL EL+     A    KF  + R+
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRD 233

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 99/196 (50%), Gaps = 6/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L KK+G+G FG V+ G   +  ++AVK L   +    + F  E  L+  + H  LV+   
Sbjct: 16  LVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYA 74
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              +E    ++ EFM  G+L + L        ++   K ++ +   A+G+ Y+       
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIER---KN 129
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            IHRDL+++N+L+ + +  K++DFGL++   D         +  + +  PE       T 
Sbjct: 130 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTI 189
Query: 592 KSDVYSFGVILLELIS 607
           KS+V+SFG++L E+++
Sbjct: 190 KSNVWSFGILLYEIVT 205

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LEKK+G+G FG V+        ++AVK +   S      F  E  ++  + H  LV+   
Sbjct: 19  LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA 77
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              +E   ++  EFM  G+L + L      +Q +   K ++ +   A+G+ ++       
Sbjct: 78  VVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQR---N 131
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE       T 
Sbjct: 132 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 191
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L+E+++
Sbjct: 192 KSDVWSFGILLMEIVT 207

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 98/196 (50%), Gaps = 6/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L K++G+G FG V+ G   +  ++AVK L   +    + F  E  L+  + H  LV+   
Sbjct: 17  LVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYA 75
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
               E    ++ E+M  G+L + L        ++   K ++ +   A+G+ Y+       
Sbjct: 76  VVTREEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---N 130
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            IHRDL+++N+L+ + +  K++DFGL++   D         +  + +  PE       T 
Sbjct: 131 YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTI 190
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L E+++
Sbjct: 191 KSDVWSFGILLYEIVT 206

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 415 KIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           ++G G FG V    Y  L D  G  +AVK L  +    +R+F  E+ +L  +H   +V++
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 470 LGYCQEEGRSVL--VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
            G     GR  L  V E++ +G L++ L     H  R++  + L  +    KG+EYL + 
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR 134
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASH-VSSIVRGTVGYLDPEYYI 585
                +HRDL + NIL++     K++DFGL+K   +D   + V    +  + +  PE   
Sbjct: 135 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 191
Query: 586 SQQLTDKSDVYSFGVILLELIS 607
               + +SDV+SFGV+L EL +
Sbjct: 192 DNIFSRQSDVWSFGVVLYELFT 213

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 415 KIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           ++G G FG V    Y  L D  G  +AVK L  +    +R+F  E+ +L  +H   +V++
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 470 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
            G     GR    LV E++ +G L++ L     H  R++  + L  +    KG+EYL + 
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR 130
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV--DGASHVSSIVRGTVGYLDPEYYI 585
                +HRDL + NIL++     K++DFGL+K          V    +  + +  PE   
Sbjct: 131 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLS 187
Query: 586 SQQLTDKSDVYSFGVILLELIS 607
               + +SDV+SFGV+L EL +
Sbjct: 188 DNIFSRQSDVWSFGVVLYELFT 209

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 83/321 (25%), Positives = 148/321 (46%), Gaps = 49/321 (15%)
Query: 386 VSSLNDAPAEAAHCFTLSDIEDATK--MLEKKIGSGGFGVVY----YGKLKDGKEIAVKV 439
           ++S+N     AA  +   + E A +   + +++G G FG+VY     G +KD  E  V +
Sbjct: 1   MASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI 60
Query: 440 LTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY 496
            T N     RE   F NE +++   +  ++V+ LG   +   ++++ E M  G LK +L 
Sbjct: 61  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120
Query: 497 GTLTHEQRINWI-------KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 549
            +L  E   N +       K +++A + A G+ YL+       +HRDL + N ++ +   
Sbjct: 121 -SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 176
Query: 550 AKVSDFGLSKFAVDGASHVSSIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            K+ DFG+++  +    +     +G   V ++ PE       T  SDV+SFGV+L E+ +
Sbjct: 177 VKIGDFGMTR-DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
Query: 608 GQE----AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKAL 662
             E     +SNE+                    ++ +++  LLD+ D    M  + E   
Sbjct: 236 LAEQPYQGLSNEQV-------------------LRFVMEGGLLDKPDNCPDM--LFELMR 274
Query: 663 MCVLPHGHMRPSISEVLKDIQ 683
           MC   +  MRPS  E++  I+
Sbjct: 275 MCWQYNPKMRPSFLEIISSIK 295

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 114/240 (47%), Gaps = 44/240 (18%)
Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG--- 471
           IGSGGFG V+  K + DGK   ++ +  N+ + +RE    V  L+++ H N+V + G   
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVHYNGCWD 75
Query: 472 -----------------YCQEEGRS---------VLVYEFMHNGTLKEHLYGTLTHEQRI 505
                            Y  E  ++          +  EF   GTL++ +       +++
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKL 133
Query: 506 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDG 564
           + +  LE+ E   KG++Y+H+     +IHRDLK SNI L    + K+ DFGL +    DG
Sbjct: 134 DKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 190
Query: 565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN 623
               S   +GT+ Y+ PE   SQ    + D+Y+ G+IL EL+     A    KF  + R+
Sbjct: 191 KRTRS---KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRD 247

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 415 KIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           ++G G FG V    Y  L D  G  +AVK L  +    +R+F  E+ +L  +H   +V++
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 470 LGYCQEEGRSVL--VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
            G     GR  L  V E++ +G L++ L     H  R++  + L  +    KG+EYL + 
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR 133
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASH-VSSIVRGTVGYLDPEYYI 585
                +HRDL + NIL++     K++DFGL+K   +D   + V    +  + +  PE   
Sbjct: 134 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 190
Query: 586 SQQLTDKSDVYSFGVILLELIS 607
               + +SDV+SFGV+L EL +
Sbjct: 191 DNIFSRQSDVWSFGVVLYELFT 212

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 415 KIGSGGFGVV---YYGKLKD--GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           ++G G FG V    Y  L D  G  +AVK L  +    +R+F  E+ +L  +H   +V++
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 470 LGYCQEEGRSVL--VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
            G     GR  L  V E++ +G L++ L     H  R++  + L  +    KG+EYL + 
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASH-VSSIVRGTVGYLDPEYYI 585
                +HRDL + NIL++     K++DFGL+K   +D   + V    +  + +  PE   
Sbjct: 147 ---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 586 SQQLTDKSDVYSFGVILLELIS 607
               + +SDV+SFGV+L EL +
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFT 225

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 7/196 (3%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LEKK+G+G FG V+        ++AVK +   S      F  E  ++  + H  LV+   
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              +E   ++  EFM  G+L + L      +Q +   K ++ +   A+G+ ++       
Sbjct: 251 VVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQR---N 304
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE       T 
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L+E+++
Sbjct: 365 KSDVWSFGILLMEIVT 380

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 143/311 (45%), Gaps = 49/311 (15%)
Query: 396 AAHCFTLSDIEDATK--MLEKKIGSGGFGVVY----YGKLKDGKEIAVKVLTSNSYQGKR 449
           AA  F   + E A +   + +++G G FG+VY     G +KD  E  V + T N     R
Sbjct: 2   AADVFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 61
Query: 450 E---FTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN 506
           E   F NE +++   +  ++V+ LG   +   ++++ E M  G LK +L  +L  E   N
Sbjct: 62  ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENN 120
Query: 507 WI-------KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 559
            +       K +++A + A G+ YL+       +HRDL + N ++ +    K+ DFG+++
Sbjct: 121 PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177
Query: 560 FAVDGASHVSSIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AIS 613
             +    +     +G   V ++ PE       T  SDV+SFGV+L E+ +  E     +S
Sbjct: 178 -DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 236
Query: 614 NEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMR 672
           NE+                    ++ +++  LLD+ D    M  + E   MC   +  MR
Sbjct: 237 NEQV-------------------LRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMR 275
Query: 673 PSISEVLKDIQ 683
           PS  E++  I+
Sbjct: 276 PSFLEIISSIK 286

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE-------FTNEVTLLSRIHHRNLV 467
           K+G GG   VY   L +   + +KV     +   RE       F  EV   S++ H+N+V
Sbjct: 18  KLGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
             +   +E+    LV E++   TL E++  +G L+ +  IN+  ++        GI++ H
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQI------LDGIKHAH 128
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
                 I+HRD+K  NIL+D +   K+ DFG++K   + +   ++ V GTV Y  PE   
Sbjct: 129 DM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAK 185
Query: 586 SQQLTDKSDVYSFGVILLELISGQEAISNE 615
            +   + +D+YS G++L E++ G+   + E
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGE 215

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 110/232 (47%), Gaps = 25/232 (10%)
Query: 398 HCF-----TLSDIEDATK---MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTS- 442
           +CF     ++SD+++  +    L + +G G FG VY G++          ++AVK L   
Sbjct: 53  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 112
Query: 443 NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL--- 499
            S Q + +F  E  ++S+ +H+N+V+ +G   +     ++ E M  G LK  L  T    
Sbjct: 113 CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 172
Query: 500 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFG 556
           +    +  +  L +A D A G +YL        IHRD+ + N LL        AK+ DFG
Sbjct: 173 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 229
Query: 557 LSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +++     G           V ++ PE ++    T K+D +SFGV+L E+ S
Sbjct: 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/320 (25%), Positives = 147/320 (45%), Gaps = 49/320 (15%)
Query: 387 SSLNDAPAEAAHCFTLSDIEDATK--MLEKKIGSGGFGVVY----YGKLKDGKEIAVKVL 440
           +S+N     AA  +   + E A +   + +++G G FG+VY     G +KD  E  V + 
Sbjct: 24  ASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK 83
Query: 441 TSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG 497
           T N     RE   F NE +++   +  ++V+ LG   +   ++++ E M  G LK +L  
Sbjct: 84  TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR- 142
Query: 498 TLTHEQRINWI-------KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 550
           +L  E   N +       K +++A + A G+ YL+       +HRDL + N ++ +    
Sbjct: 143 SLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 199
Query: 551 KVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
           K+ DFG+++  +    +     +G   V ++ PE       T  SDV+SFGV+L E+ + 
Sbjct: 200 KIGDFGMTR-DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 258
Query: 609 QE----AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALM 663
            E     +SNE+                    ++ +++  LLD+ D    M  + E   M
Sbjct: 259 AEQPYQGLSNEQV-------------------LRFVMEGGLLDKPDNCPDM--LFELMRM 297
Query: 664 CVLPHGHMRPSISEVLKDIQ 683
           C   +  MRPS  E++  I+
Sbjct: 298 CWQYNPKMRPSFLEIISSIK 317

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 110/232 (47%), Gaps = 25/232 (10%)
Query: 398 HCF-----TLSDIEDATK---MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTS- 442
           +CF     ++SD+++  +    L + +G G FG VY G++          ++AVK L   
Sbjct: 30  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 89
Query: 443 NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL--- 499
            S Q + +F  E  ++S+ +H+N+V+ +G   +     ++ E M  G LK  L  T    
Sbjct: 90  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 149
Query: 500 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFG 556
           +    +  +  L +A D A G +YL        IHRD+ + N LL        AK+ DFG
Sbjct: 150 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 206
Query: 557 LSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +++     G           V ++ PE ++    T K+D +SFGV+L E+ S
Sbjct: 207 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 115/231 (49%), Gaps = 22/231 (9%)
Query: 397 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFT 452
           +H  T S + D  ++ E  +G GG   V+  + L+D +++AVKVL ++  +       F 
Sbjct: 2   SHMTTPSHLSDRYELGEI-LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRS----VLVYEFMHNGTLKE--HLYGTLTHEQRIN 506
            E    + ++H  +V      + E  +     +V E++   TL++  H  G +T ++ I 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI- 119
Query: 507 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
                E+  DA + + + H      IIHRD+K +NIL+      KV DFG+++   D  +
Sbjct: 120 -----EVIADACQALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGN 171
Query: 567 HV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
            V  ++ V GT  YL PE      +  +SDVYS G +L E+++G+   + +
Sbjct: 172 SVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK---REFTNEVTLLSRI-HHRNLVQFL 470
           IG G FG V   ++K DG  +   +     Y  K   R+F  E+ +L ++ HH N++  L
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE------------QRINWIKRLEIAEDAA 518
           G C+  G   L  E+  +G L + L  +   E              ++  + L  A D A
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           +G++YL        IHRDL + NIL+ ++  AK++DFGLS+            V+ T+G 
Sbjct: 143 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMGR 192
Query: 579 LDPEYYISQQL-----TDKSDVYSFGVILLELIS 607
           L   +   + L     T  SDV+S+GV+L E++S
Sbjct: 193 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 112/232 (48%), Gaps = 25/232 (10%)
Query: 398 HCF-----TLSDIEDATK---MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTS- 442
           +CF     ++SD+++  +    L + +G G FG VY G++          ++AVK L   
Sbjct: 27  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 86
Query: 443 NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL--- 499
            S Q + +F  E  ++S+++H+N+V+ +G   +     ++ E M  G LK  L  T    
Sbjct: 87  CSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 146
Query: 500 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFG 556
           +    +  +  L +A D A G +YL        IHRD+ + N LL        AK+ DFG
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 557 LSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +++     + +         V ++ PE ++    T K+D +SFGV+L E+ S
Sbjct: 204 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK---REFTNEVTLLSRI-HHRNLVQFL 470
           IG G FG V   ++K DG  +   +     Y  K   R+F  E+ +L ++ HH N++  L
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE------------QRINWIKRLEIAEDAA 518
           G C+  G   L  E+  +G L + L  +   E              ++  + L  A D A
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           +G++YL        IHRDL + NIL+ ++  AK++DFGLS+            V+ T+G 
Sbjct: 153 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMGR 202
Query: 579 LDPEYYISQQL-----TDKSDVYSFGVILLELIS 607
           L   +   + L     T  SDV+S+GV+L E++S
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 134/296 (45%), Gaps = 53/296 (17%)
Query: 412 LEKKIGSGGFGVVY----YGKLKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHR 464
           + +++G G FG+VY     G +KD  E  V + T N     RE   F NE +++   +  
Sbjct: 14  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 73
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI-------KRLEIAEDA 517
           ++V+ LG   +   ++++ E M  G LK +L  +L  E   N +       K +++A + 
Sbjct: 74  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPSLSKMIQMAGEI 132
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
           A G+ YL+       +HRDL + N ++ +    K+ DFG+++             +G  G
Sbjct: 133 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXRKGGKG 185
Query: 578 -----YLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWA 628
                ++ PE       T  SDV+SFGV+L E+ +  E     +SNE+            
Sbjct: 186 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----------- 234
Query: 629 KLHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
                   ++ +++  LLD+ D    M  + E   MC   +  MRPS  E++  I+
Sbjct: 235 --------LRFVMEGGLLDKPDNCPDM--LLELMRMCWQYNPKMRPSFLEIISSIK 280

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 134/296 (45%), Gaps = 53/296 (17%)
Query: 412 LEKKIGSGGFGVVY----YGKLKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHR 464
           + +++G G FG+VY     G +KD  E  V + T N     RE   F NE +++   +  
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI-------KRLEIAEDA 517
           ++V+ LG   +   ++++ E M  G LK +L  +L  E   N +       K +++A + 
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPSLSKMIQMAGEI 141
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
           A G+ YL+       +HRDL + N ++ +    K+ DFG+++             +G  G
Sbjct: 142 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXRKGGKG 194
Query: 578 -----YLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWA 628
                ++ PE       T  SDV+SFGV+L E+ +  E     +SNE+            
Sbjct: 195 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV----------- 243
Query: 629 KLHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
                   ++ +++  LLD+ D    M  + E   MC   +  MRPS  E++  I+
Sbjct: 244 --------LRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 136/293 (46%), Gaps = 47/293 (16%)
Query: 412 LEKKIGSGGFGVVY----YGKLKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHR 464
           + +++G G FG+VY     G +KD  E  V + T N     RE   F NE +++   +  
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI-------KRLEIAEDA 517
           ++V+ LG   +   ++++ E M  G LK +L  +L  E   N +       K +++A + 
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPSLSKMIQMAGEI 140
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 575
           A G+ YL+       +HRDL + N ++ +    K+ DFG+++  +    +     +G   
Sbjct: 141 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 196
Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 631
           V ++ PE       T  SDV+SFGV+L E+ +  E     +SNE+               
Sbjct: 197 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------- 242
Query: 632 IESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
                ++ +++  LLD+ D    M  + E   MC   +  MRPS  E++  I+
Sbjct: 243 -----LRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 25/232 (10%)
Query: 398 HCF-----TLSDIEDATK---MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTS- 442
           +CF     ++SD+++  +    L + +G G FG VY G++          ++AVK L   
Sbjct: 12  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71
Query: 443 NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL--- 499
            S Q + +F  E  ++S+ +H+N+V+ +G   +     ++ E M  G LK  L  T    
Sbjct: 72  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 131
Query: 500 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFG 556
           +    +  +  L +A D A G +YL        IHRD+ + N LL        AK+ DFG
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 557 LSKFAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +++     + +         V ++ PE ++    T K+D +SFGV+L E+ S
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 113/233 (48%), Gaps = 27/233 (11%)
Query: 398 HCF-----TLSDIEDATK---MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTS- 442
           +CF     ++SD+++  +    L + +G G FG VY G++          ++AVK L   
Sbjct: 27  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 86
Query: 443 NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL--- 499
            S Q + +F  E  ++S+ +H+N+V+ +G   +     ++ E M  G LK  L  T    
Sbjct: 87  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 146
Query: 500 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFG 556
           +    +  +  L +A D A G +YL        IHRD+ + N LL        AK+ DFG
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 557 LSKFAVDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +++  +  AS+          V ++ PE ++    T K+D +SFGV+L E+ S
Sbjct: 204 MAR-DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 113/233 (48%), Gaps = 27/233 (11%)
Query: 398 HCF-----TLSDIEDATK---MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTS- 442
           +CF     ++SD+++  +    L + +G G FG VY G++          ++AVK L   
Sbjct: 4   YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 63
Query: 443 NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL--- 499
            S Q + +F  E  ++S+ +H+N+V+ +G   +     ++ E M  G LK  L  T    
Sbjct: 64  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 123
Query: 500 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFG 556
           +    +  +  L +A D A G +YL        IHRD+ + N LL        AK+ DFG
Sbjct: 124 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 180
Query: 557 LSKFAVDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +++  +  AS+          V ++ PE ++    T K+D +SFGV+L E+ S
Sbjct: 181 MAR-DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 136/293 (46%), Gaps = 47/293 (16%)
Query: 412 LEKKIGSGGFGVVY----YGKLKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHR 464
           + +++G G FG+VY     G +KD  E  V + T N     RE   F NE +++   +  
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI-------KRLEIAEDA 517
           ++V+ LG   +   ++++ E M  G LK +L  +L  E   N +       K +++A + 
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPSLSKMIQMAGEI 134
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 575
           A G+ YL+       +HRDL + N ++ +    K+ DFG+++  +    +     +G   
Sbjct: 135 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 190
Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 631
           V ++ PE       T  SDV+SFGV+L E+ +  E     +SNE+               
Sbjct: 191 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------- 236
Query: 632 IESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
                ++ +++  LLD+ D    M  + E   MC   +  MRPS  E++  I+
Sbjct: 237 -----LRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 25/232 (10%)
Query: 398 HCF-----TLSDIEDATK---MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTS- 442
           +CF     ++SD+++  +    L + +G G FG VY G++          ++AVK L   
Sbjct: 12  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71
Query: 443 NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL--- 499
            S Q + +F  E  ++S+ +H+N+V+ +G   +     ++ E M  G LK  L  T    
Sbjct: 72  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 131
Query: 500 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFG 556
           +    +  +  L +A D A G +YL        IHRD+ + N LL        AK+ DFG
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 557 LSKFAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +++     + +         V ++ PE ++    T K+D +SFGV+L E+ S
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 115/231 (49%), Gaps = 22/231 (9%)
Query: 397 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFT 452
           +H  T S + D  ++ E  +G GG   V+  + L+D +++AVKVL ++  +       F 
Sbjct: 2   SHMTTPSHLSDRYELGEI-LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRS----VLVYEFMHNGTLKE--HLYGTLTHEQRIN 506
            E    + ++H  +V      + E  +     +V E++   TL++  H  G +T ++ I 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI- 119
Query: 507 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
                E+  DA + + + H      IIHRD+K +NI++      KV DFG+++   D  +
Sbjct: 120 -----EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 567 HVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
            V+  + V GT  YL PE      +  +SDVYS G +L E+++G+   + +
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 115/231 (49%), Gaps = 22/231 (9%)
Query: 397 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFT 452
           +H  T S + D  ++ E  +G GG   V+  + L+D +++AVKVL ++  +       F 
Sbjct: 2   SHMTTPSHLSDRYELGEI-LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRS----VLVYEFMHNGTLKE--HLYGTLTHEQRIN 506
            E    + ++H  +V      + E  +     +V E++   TL++  H  G +T ++ I 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI- 119
Query: 507 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
                E+  DA + + + H      IIHRD+K +NI++      KV DFG+++   D  +
Sbjct: 120 -----EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 567 HVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
            V+  + V GT  YL PE      +  +SDVYS G +L E+++G+   + +
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 111/232 (47%), Gaps = 25/232 (10%)
Query: 398 HCF-----TLSDIEDATK---MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTS- 442
           +CF     ++SD+++  +    L + +G G FG VY G++          ++AVK L   
Sbjct: 29  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 88
Query: 443 NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL--- 499
            S Q + +F  E  ++S+ +H+N+V+ +G   +     ++ E M  G LK  L  T    
Sbjct: 89  CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 148
Query: 500 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFG 556
           +    +  +  L +A D A G +YL        IHRD+ + N LL        AK+ DFG
Sbjct: 149 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 205
Query: 557 LSKFAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +++     + +         V ++ PE ++    T K+D +SFGV+L E+ S
Sbjct: 206 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 136/293 (46%), Gaps = 47/293 (16%)
Query: 412 LEKKIGSGGFGVVY----YGKLKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHR 464
           + +++G G FG+VY     G +KD  E  V + T N     RE   F NE +++   +  
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI-------KRLEIAEDA 517
           ++V+ LG   +   ++++ E M  G LK +L  +L  E   N +       K +++A + 
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPSLSKMIQMAGEI 141
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 575
           A G+ YL+       +HRDL + N ++ +    K+ DFG+++  +    +     +G   
Sbjct: 142 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 197
Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 631
           V ++ PE       T  SDV+SFGV+L E+ +  E     +SNE+               
Sbjct: 198 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------- 243
Query: 632 IESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
                ++ +++  LLD+ D    M  + E   MC   +  MRPS  E++  I+
Sbjct: 244 -----LRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 136/293 (46%), Gaps = 47/293 (16%)
Query: 412 LEKKIGSGGFGVVY----YGKLKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHR 464
           + +++G G FG+VY     G +KD  E  V + T N     RE   F NE +++   +  
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI-------KRLEIAEDA 517
           ++V+ LG   +   ++++ E M  G LK +L  +L  E   N +       K +++A + 
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPSLSKMIQMAGEI 140
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 575
           A G+ YL+       +HRDL + N ++ +    K+ DFG+++  +    +     +G   
Sbjct: 141 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 196
Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 631
           V ++ PE       T  SDV+SFGV+L E+ +  E     +SNE+               
Sbjct: 197 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------- 242
Query: 632 IESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
                ++ +++  LLD+ D    M  + E   MC   +  MRPS  E++  I+
Sbjct: 243 -----LRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 113/233 (48%), Gaps = 27/233 (11%)
Query: 398 HCF-----TLSDIEDATK---MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTS- 442
           +CF     ++SD+++  +    L + +G G FG VY G++          ++AVK L   
Sbjct: 27  YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 86
Query: 443 NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL--- 499
            S Q + +F  E  ++S+ +H+N+V+ +G   +     ++ E M  G LK  L  T    
Sbjct: 87  YSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP 146
Query: 500 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFG 556
           +    +  +  L +A D A G +YL        IHRD+ + N LL        AK+ DFG
Sbjct: 147 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 203
Query: 557 LSKFAVDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +++  +  AS+          V ++ PE ++    T K+D +SFGV+L E+ S
Sbjct: 204 MAR-DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 19/237 (8%)
Query: 392 APAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG--- 447
            P  +   +TL D +     + + +G G FG VY  + +  K I A+KVL     +    
Sbjct: 1   GPLGSKRQWTLEDFD-----IGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGV 55
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           + +   EV + S + H N+++  GY  +  R  L+ E+   GT+    Y  L    R + 
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDE 111
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 567
            +      + A  + Y H+     +IHRD+K  N+LL  +   K++DFG S   V   S 
Sbjct: 112 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS---VHAPSS 165
Query: 568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
             + + GT+ YL PE    +   +K D++S GV+  E + G        +    R I
Sbjct: 166 RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRI 222

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 412 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 461
           L K +G G FG V           K K+   +AVK+L  ++ +    +  +E+ ++  I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L                  E+++ +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +      A+G+EYL +      IHRDL + N+L+ ++   K++DFGL++  ++   +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYK 214
Query: 570 SIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +   G   V ++ PE    +  T +SDV+SFGV++ E+ +
Sbjct: 215 NTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +KIG G  G VY    +  G+E+A++ +       K    NE+ ++    + N+V +L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
                   +V E++  G+L + +  T   E +I  + R     +  + +E+LH+     +
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN---QV 137
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           IHRD+KS NILL      K++DFG         S  S++V GT  ++ PE    +    K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 593 SDVYSFGVILLELISGQEAISNE 615
            D++S G++ +E+I G+    NE
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNE 219

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 110/229 (48%), Gaps = 20/229 (8%)
Query: 396 AAHCFTLSDIEDATK---MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTS-NSY 445
           A    ++SD+++  +    L + +G G FG VY G++          ++AVK L    S 
Sbjct: 16  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE 75
Query: 446 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL---THE 502
           Q + +F  E  ++S+++H+N+V+ +G   +     ++ E M  G LK  L  T    +  
Sbjct: 76  QDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP 135
Query: 503 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSK 559
             +  +  L +A D A G +YL        IHRD+ + N LL        AK+ DFG+++
Sbjct: 136 SSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192
Query: 560 FAVDGASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
                + +         V ++ PE ++    T K+D +SFGV+L E+ S
Sbjct: 193 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 112/218 (51%), Gaps = 31/218 (14%)
Query: 410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLV 467
           ++LE K   G FG V+  +L + + +AVK+      Q K+ + NE  V  L  + H N++
Sbjct: 27  QLLEVK-ARGRFGCVWKAQLLN-EYVAVKIF---PIQDKQSWQNEYEVYSLPGMKHENIL 81
Query: 468 QFLGYCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           QF+G  ++ G SV     L+  F   G+L + L   +     ++W +   IAE  A+G+ 
Sbjct: 82  QFIG-AEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLA 135
Query: 523 YLHT-------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRG 574
           YLH        G  PAI HRD+KS N+LL  ++ A ++DFGL+ KF    ++  +    G
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVG 195
Query: 575 TVGYLDPEYY-----ISQQLTDKSDVYSFGVILLELIS 607
           T  Y+ PE         +    + D+Y+ G++L EL S
Sbjct: 196 TRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 15/240 (6%)
Query: 415 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           KIG G  G+V     K  GK++AVK +     Q +    NEV ++   HH N+V      
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
                  +V EF+  G L + +  T  +E++I       +     + + YLH      +I
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQ---GVI 163
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRD+KS +ILL    R K+SDFG              +V GT  ++ PE         + 
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV-GTPYWMAPEVISRLPYGTEV 222
Query: 594 DVYSFGVILLELISGQEAISNEKFGANCRNIV-----QWAKLHIESGDIQGIIDPSLLDE 648
           D++S G++++E+I G+    NE      R I      +   LH  S  ++G +D  L+ E
Sbjct: 223 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVRE 282

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 412 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 461
           L K +G G FG V           K K+   +AVK+L  ++ +    +  +E+ ++  I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L                  E+++ +  
Sbjct: 99  KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +      A+G+EYL +      IHRDL + N+L+ ++   K++DFGL++  ++   +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYK 214
Query: 570 SIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               G   V ++ PE    +  T +SDV+SFGV++ E+ +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/321 (25%), Positives = 147/321 (45%), Gaps = 49/321 (15%)
Query: 386 VSSLNDAPAEAAHCFTLSDIEDATK--MLEKKIGSGGFGVVY----YGKLKDGKEIAVKV 439
           ++S+N     AA  +   + E A +   + +++G G FG+VY     G +KD  E  V +
Sbjct: 1   MASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI 60
Query: 440 LTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY 496
            T N     RE   F NE +++   +  ++V+ LG   +   ++++ E M  G LK +L 
Sbjct: 61  KTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR 120
Query: 497 GTLTHEQRINWI-------KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR 549
            +L      N +       K +++A + A G+ YL+       +HRDL + N ++ +   
Sbjct: 121 -SLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 176
Query: 550 AKVSDFGLSKFAVDGASHVSSIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            K+ DFG+++  +    +     +G   V ++ PE       T  SDV+SFGV+L E+ +
Sbjct: 177 VKIGDFGMTR-DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
Query: 608 GQE----AISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKAL 662
             E     +SNE+                    ++ +++  LLD+ D    M  + E   
Sbjct: 236 LAEQPYQGLSNEQV-------------------LRFVMEGGLLDKPDNCPDM--LFELMR 274
Query: 663 MCVLPHGHMRPSISEVLKDIQ 683
           MC   +  MRPS  E++  I+
Sbjct: 275 MCWQYNPKMRPSFLEIISSIK 295

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 412 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 461
           L K +G G FG V           K K+   +AVK+L  ++ +    +  +E+ ++  I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIG 98
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L                  E+++ +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +      A+G+EYL +      IHRDL + N+L+ ++   K++DFGL++  ++   +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYK 214
Query: 570 SIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               G   V ++ PE    +  T +SDV+SFGV++ E+ +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 412 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 461
           L K +G G FG V           K K+   +AVK+L  ++ +    +  +E+ ++  I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L                  E+++ +  
Sbjct: 99  KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +      A+G+EYL +      IHRDL + N+L+ ++   K++DFGL++  ++   +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYK 214
Query: 570 SIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               G   V ++ PE    +  T +SDV+SFGV++ E+ +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 412 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 461
           L K +G G FG V           K K+   +AVK+L  ++ +    +  +E+ ++  I 
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L                  E+++ +  
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +      A+G+EYL +      IHRDL + N+L+ ++   K++DFGL++  ++   +  
Sbjct: 205 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYK 260
Query: 570 SIVRG--TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               G   V ++ PE    +  T +SDV+SFGV++ E+ +
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 10/203 (4%)
Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +KIG G  G VY    +  G+E+A++ +       K    NE+ ++    + N+V +L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
                   +V E++  G+L + +  T   E +I  + R     +  + +E+LH+     +
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN---QV 137
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           IHRD+KS NILL      K++DFG         S  S +V GT  ++ PE    +    K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV-GTPYWMAPEVVTRKAYGPK 196
Query: 593 SDVYSFGVILLELISGQEAISNE 615
            D++S G++ +E+I G+    NE
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNE 219

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/225 (32%), Positives = 110/225 (48%), Gaps = 37/225 (16%)
Query: 414 KKIGSGGFGVVY----YGKLKDGK--EIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 465
           K +GSG FG V     YG  K G   ++AVK+L   +   +RE   +E+ +++++  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--EQRINW--IKRLEIAED----- 516
           +V  LG C   G   L++E+   G L  +L        E  I +   KRLE  ED     
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 517 ----------AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
                      AKG+E+L      + +HRDL + N+L+      K+ DFGL++   D  S
Sbjct: 171 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLAR---DIMS 224
Query: 567 HVSSIVRGT----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             + +VRG     V ++ PE       T KSDV+S+G++L E+ S
Sbjct: 225 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 412 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 461
           L K +G G FG V           K K+   +AVK+L  ++ +    +  +E+ ++  I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L                  E+++ +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA--VDGASH 567
            +      A+G+EYL +      IHRDL + N+L+ ++   K++DFGL++    +D    
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            ++  R  V ++ PE    +  T +SDV+SFGV++ E+ +
Sbjct: 216 TTN-GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 19/237 (8%)
Query: 392 APAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG--- 447
            P  +   +TL D +     + + +G G FG VY  + +  K I A+KVL     +    
Sbjct: 1   GPLGSKRQWTLEDFD-----IGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGV 55
Query: 448 KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINW 507
           + +   EV + S + H N+++  GY  +  R  L+ E+   GT+    Y  L    R + 
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSRFDE 111
Query: 508 IKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 567
            +      + A  + Y H+     +IHRD+K  N+LL  +   K++DFG S   V   S 
Sbjct: 112 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWS---VHAPSS 165
Query: 568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
               + GT+ YL PE    +   +K D++S GV+  E + G        +    R I
Sbjct: 166 RRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRI 222

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 396 AAHCFTLSDIEDATK---MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTS-NSY 445
           A    ++SD+++  +    L + +G G FG VY G++          ++AVK L    S 
Sbjct: 16  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE 75
Query: 446 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL---THE 502
           Q + +F  E  ++S+ +H+N+V+ +G   +     ++ E M  G LK  L  T    +  
Sbjct: 76  QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP 135
Query: 503 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSK 559
             +  +  L +A D A G +YL        IHRD+ + N LL        AK+ DFG+++
Sbjct: 136 SSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192
Query: 560 FAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
                + +         V ++ PE ++    T K+D +SFGV+L E+ S
Sbjct: 193 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 396 AAHCFTLSDIEDATK---MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTS-NSY 445
           A    ++SD+++  +    L + +G G FG VY G++          ++AVK L    S 
Sbjct: 22  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE 81
Query: 446 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL---THE 502
           Q + +F  E  ++S+ +H+N+V+ +G   +     ++ E M  G LK  L  T    +  
Sbjct: 82  QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP 141
Query: 503 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSK 559
             +  +  L +A D A G +YL        IHRD+ + N LL        AK+ DFG+++
Sbjct: 142 SSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198
Query: 560 FAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
                + +         V ++ PE ++    T K+D +SFGV+L E+ S
Sbjct: 199 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 10/203 (4%)
Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +KIG G  G VY    +  G+E+A++ +       K    NE+ ++    + N+V +L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
                   +V E++  G+L + +  T   E +I  + R     +  + +E+LH+     +
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN---QV 138
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           IHRD+KS NILL      K++DFG         S  S +V GT  ++ PE    +    K
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPK 197
Query: 593 SDVYSFGVILLELISGQEAISNE 615
            D++S G++ +E+I G+    NE
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNE 220

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 10/203 (4%)
Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +KIG G  G VY    +  G+E+A++ +       K    NE+ ++    + N+V +L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
                   +V E++  G+L + +  T   E +I  + R     +  + +E+LH+     +
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN---QV 137
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           IHRD+KS NILL      K++DFG         S  S +V GT  ++ PE    +    K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV-GTPYWMAPEVVTRKAYGPK 196
Query: 593 SDVYSFGVILLELISGQEAISNE 615
            D++S G++ +E+I G+    NE
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNE 219

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK---REFTNEVTLLSRI-HHRNLVQFL 470
           IG G FG V   ++K DG  +   +     Y  K   R+F  E+ +L ++ HH N++  L
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE------------QRINWIKRLEIAEDAA 518
           G C+  G   L  E+  +G L + L  +   E              ++  + L  A D A
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           +G++YL        IHR+L + NIL+ ++  AK++DFGLS+            V+ T+G 
Sbjct: 150 RGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTMGR 199
Query: 579 LDPEYYISQQL-----TDKSDVYSFGVILLELIS 607
           L   +   + L     T  SDV+S+GV+L E++S
Sbjct: 200 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 412 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 461
           L K +G G FG V           K K+   +AVK+L  ++ +    +  +E+ ++  I 
Sbjct: 26  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 85
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L                  E+++ +  
Sbjct: 86  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +      A+G+EYL +      IHRDL + N+L+ ++   K++DFGL++  ++   +  
Sbjct: 146 LVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLAR-DINNIDYYK 201
Query: 570 SIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               G   V ++ PE    +  T +SDV+SFGV++ E+ +
Sbjct: 202 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 109/220 (49%), Gaps = 28/220 (12%)
Query: 412 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 461
           L K +G G FG V           K K+   +AVK+L  ++ +    +  +E+ ++  I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L                  E+++ +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA--VDGASH 567
            +      A+G+EYL +      IHRDL + N+L+ ++   K++DFGL++    +D    
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKK 215
Query: 568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            ++  R  V ++ PE    +  T +SDV+SFGV++ E+ +
Sbjct: 216 TTN-GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 113/221 (51%), Gaps = 28/221 (12%)
Query: 411 MLEKKIGSGGFGVVYYGKL----KDG----KEIAVKVLTSNSYQGK-REFTNEVTLLSRI 461
           +L K +G G FG V   +     KD      ++AVK+L S++ +    +  +E+ ++  I
Sbjct: 31  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 462 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWI 508
             H+N++  LG C ++G   ++ E+   G L+E+L              +   E++++  
Sbjct: 91  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--FAVDGAS 566
             +  A   A+G+EYL +      IHRDL + N+L+ +    K++DFGL++    +D   
Sbjct: 151 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXK 207
Query: 567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             ++  R  V ++ PE    +  T +SDV+SFGV+L E+ +
Sbjct: 208 KTTN-GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 412 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 461
           L K +G G FG V           K K+   +AVK+L  ++ +    +  +E+ ++  I 
Sbjct: 28  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 87
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L                  E+++ +  
Sbjct: 88  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +      A+G+EYL +      IHRDL + N+L+ ++   K++DFGL++  ++   +  
Sbjct: 148 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYK 203
Query: 570 SIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               G   V ++ PE    +  T +SDV+SFGV++ E+ +
Sbjct: 204 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 19/230 (8%)
Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGK---REFTNEV 455
           FT+ D +     + + +G G FG VY  + K  K I A+KVL  +  + +    +   E+
Sbjct: 11  FTIDDFD-----IVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65
Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 515
            + S + H N+++   Y  +  R  L+ EF   G L    Y  L    R +  +     E
Sbjct: 66  EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFME 121
Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 575
           + A  + Y H      +IHRD+K  N+L+      K++DFG S   V   S     + GT
Sbjct: 122 ELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRXMCGT 175
Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 625
           + YL PE    +   +K D++  GV+  E + G     +       R IV
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 412 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 461
           L K +G G FG V           K K+   +AVK+L  ++ +    +  +E+ ++  I 
Sbjct: 31  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 90
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L                  E+++ +  
Sbjct: 91  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +      A+G+EYL +      IHRDL + N+L+ ++   K++DFGL++  ++   +  
Sbjct: 151 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYK 206
Query: 570 SIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               G   V ++ PE    +  T +SDV+SFGV++ E+ +
Sbjct: 207 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 396 AAHCFTLSDIEDATK---MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTS-NSY 445
           A    ++SD+++  +    L + +G G FG VY G++          ++AVK L    S 
Sbjct: 16  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE 75
Query: 446 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL---THE 502
           Q + +F  E  ++S+ +H+N+V+ +G   +     ++ E M  G LK  L  T    +  
Sbjct: 76  QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP 135
Query: 503 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSK 559
             +  +  L +A D A G +YL        IHRD+ + N LL        AK+ DFG+++
Sbjct: 136 SSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192
Query: 560 FAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
                + +         V ++ PE ++    T K+D +SFGV+L E+ S
Sbjct: 193 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 19/230 (8%)
Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGK---REFTNEV 455
           FT+ D +     + + +G G FG VY  + K  K I A+KVL  +  + +    +   E+
Sbjct: 12  FTIDDFD-----IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 66
Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 515
            + S + H N+++   Y  +  R  L+ EF   G L    Y  L    R +  +     E
Sbjct: 67  EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFME 122
Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 575
           + A  + Y H      +IHRD+K  N+L+      K++DFG S   V   S     + GT
Sbjct: 123 ELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRXMCGT 176
Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 625
           + YL PE    +   +K D++  GV+  E + G     +       R IV
Sbjct: 177 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 226

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 412 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 461
           L K +G G FG V           K K+   +AVK+L  ++ +    +  +E+ ++  I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L                  E+++ +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +      A+G+EYL +      IHRDL + N+L+ ++   +++DFGL++  ++   +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLAR-DINNIDYYK 214
Query: 570 SIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               G   V ++ PE    +  T +SDV+SFGV++ E+ +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 20/229 (8%)
Query: 396 AAHCFTLSDIEDATK---MLEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTS-NSY 445
           A    ++SD+++  +    L + +G G FG VY G++          ++AVK L    S 
Sbjct: 42  AGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE 101
Query: 446 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL---THE 502
           Q + +F  E  ++S+ +H+N+V+ +G   +     ++ E M  G LK  L  T    +  
Sbjct: 102 QDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQP 161
Query: 503 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSK 559
             +  +  L +A D A G +YL        IHRD+ + N LL        AK+ DFG+++
Sbjct: 162 SSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218
Query: 560 FAVDGASHVSS-IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
                + +         V ++ PE ++    T K+D +SFGV+L E+ S
Sbjct: 219 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 135/293 (46%), Gaps = 47/293 (16%)
Query: 412 LEKKIGSGGFGVVY----YGKLKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHR 464
           + +++G G FG+VY     G +KD  E  V + T N     RE   F NE +++   +  
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI-------KRLEIAEDA 517
           ++V+ LG   +   ++++ E M  G LK +L  +L  E   N +       K +++A + 
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENNPVLAPPSLSKMIQMAGEI 134
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 575
           A G+ YL+       +HRDL + N  + +    K+ DFG+++  +    +     +G   
Sbjct: 135 ADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 190
Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 631
           V ++ PE       T  SDV+SFGV+L E+ +  E     +SNE+               
Sbjct: 191 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------- 236
Query: 632 IESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
                ++ +++  LLD+ D    M  + E   MC   +  MRPS  E++  I+
Sbjct: 237 -----LRFVMEGGLLDKPDNCPDM--LLELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 414 KKIGSGGFGVV---YYGKLKDG--KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 467
           + +G G FG V    Y    DG  + +AVK L +++  Q +  +  E+ +L  ++H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 468 QFLGYCQEEGRSVL--VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           ++ G C++ G + L  V E++  G+L+++L         I   + L  A+   +G+ YLH
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR----GTVGYLDP 581
                  IHRDL + N+LLD     K+ DFGL+K   +G  H    VR      V +  P
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG--HEXYRVREDGDSPVFWYAP 206
Query: 582 EYYISQQLTDKSDVYSFGVILLELIS 607
           E     +    SDV+SFGV L EL++
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 125/248 (50%), Gaps = 28/248 (11%)
Query: 414 KKIGSGGFG-VVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           +KIG G FG  +     +DG++  +K +  +  S + + E   EV +L+ + H N+VQ+ 
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 526
              +E G   +V ++   G L + +    G L  E +I +W  ++ +A      ++++H 
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA------LKHVHD 143
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                I+HRD+KS NI L K    ++ DFG+++  ++    ++    GT  YL PE   +
Sbjct: 144 R---KILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACIGTPYYLSPEICEN 199
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           +   +KSD+++ G +L EL + + A        + +N+V    L I SG    +   SL 
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFE----AGSMKNLV----LKIISGSFPPV---SLH 248
Query: 647 DEYDIQSM 654
             YD++S+
Sbjct: 249 YSYDLRSL 256

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 17/200 (8%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTN-EVTLLSRIHHRNLVQF 469
           + +G+G FG V+  + + +G+  A+KVL         + E TN E  +LS + H  +++ 
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHTGC 528
            G  Q+  +  ++ +++  G     L+  L   QR  N + +   AE     +EYLH+  
Sbjct: 72  WGTFQDAQQIFMIMDYIEGG----ELFSLLRKSQRFPNPVAKFYAAE-VCLALEYLHSK- 125
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              II+RDLK  NILLDK+   K++DFG +K+  D    V+  + GT  Y+ PE   ++ 
Sbjct: 126 --DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDYIAPEVVSTKP 179
Query: 589 LTDKSDVYSFGVILLELISG 608
                D +SFG+++ E+++G
Sbjct: 180 YNKSIDWWSFGILIYEMLAG 199

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 100 YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 153
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 154 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMH 209
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 244

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 43/228 (18%)
Query: 414 KKIGSGGFGVVYYGK------LKDGKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 466
           + IG G FG V+  +       +    +AVK+L    S   + +F  E  L++   + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKE-------HLYGTLTHEQ-------------RIN 506
           V+ LG C       L++E+M  G L E       H   +L+H                ++
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 507 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK------- 559
             ++L IA   A G+ YL        +HRDL + N L+ ++M  K++DFGLS+       
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +  DG   +       + ++ PE     + T +SDV+++GV+L E+ S
Sbjct: 230 YKADGNDAIP------IRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +KIG G  G VY    +  G+E+A++ +       K    NE+ ++    + N+V +L  
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
                   +V E++  G+L + +  T   E +I  + R     +  + +E+LH+     +
Sbjct: 87  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN---QV 138
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           IHR++KS NILL      K++DFG         S  S++V GT  ++ PE    +    K
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 197
Query: 593 SDVYSFGVILLELISGQEAISNE 615
            D++S G++ +E+I G+    NE
Sbjct: 198 VDIWSLGIMAIEMIEGEPPYLNE 220

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 414 KKIGSGGFGVV---YYGKLKDG--KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 467
           + +G G FG V    Y    DG  + +AVK L ++   Q +  +  E+ +L  ++H +++
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 468 QFLGYCQEEGRSVL--VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           ++ G C+++G   L  V E++  G+L+++L         I   + L  A+   +G+ YLH
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TVGYLDPEY 583
           +      IHR+L + N+LLD     K+ DFGL+K   +G  +      G   V +  PE 
Sbjct: 135 SQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
               +    SDV+SFGV L EL++
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 106/204 (51%), Gaps = 20/204 (9%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + DG+ +    A+KVL  N S +  +E  +E  +++ +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYL 524
           + LG C       LV + M  G L +H+    G L  +  +NW  ++      AKG+ YL
Sbjct: 83  RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKGMSYL 135
Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA-VDGASHVSSIVRGTVGYLDPEY 583
                  ++HRDL + N+L+      K++DFGL++   +D   + +   +  + ++  E 
Sbjct: 136 EDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 192
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
            + ++ T +SDV+S+GV + EL++
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 112/224 (50%), Gaps = 34/224 (15%)
Query: 411 MLEKKIGSGGFGVVYYGKL----KDG----KEIAVKVLTSNSYQGK-REFTNEVTLLSRI 461
           +L K +G G FG V   +     KD      ++AVK+L S++ +    +  +E+ ++  I
Sbjct: 31  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 462 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWI 508
             H+N++  LG C ++G   ++ E+   G L+E+L              +   E++++  
Sbjct: 91  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
             +  A   A+G+EYL +      IHRDL + N+L+ +    K++DFGL++       H+
Sbjct: 151 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 203
Query: 569 SSIVRGT-----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               + T     V ++ PE    +  T +SDV+SFGV+L E+ +
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/293 (25%), Positives = 135/293 (46%), Gaps = 47/293 (16%)
Query: 412 LEKKIGSGGFGVVY----YGKLKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHR 464
           + +++G G FG+VY     G +KD  E  V + T N     RE   F NE +++   +  
Sbjct: 19  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 78
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI-------KRLEIAEDA 517
           ++V+ LG   +   ++++ E M  G LK +L  +L      N +       K +++A + 
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPAMANNPVLAPPSLSKMIQMAGEI 137
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 575
           A G+ YL+       +HRDL + N ++ +    K+ DFG+++  +    +     +G   
Sbjct: 138 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 193
Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 631
           V ++ PE       T  SDV+SFGV+L E+ +  E     +SNE+               
Sbjct: 194 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-------------- 239
Query: 632 IESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
                ++ +++  LLD+ D    M  + E   MC   +  MRPS  E++  I+
Sbjct: 240 -----LRFVMEGGLLDKPDNCPDM--LFELMRMCWQYNPKMRPSFLEIISSIK 285

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 107/231 (46%), Gaps = 19/231 (8%)
Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGK---REFTNEV 455
           FT+ D E     + + +G G FG VY  + K    I A+KVL  +  + +    +   E+
Sbjct: 20  FTIDDFE-----IGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREI 74
Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 515
            + + +HH N+++   Y  +  R  L+ E+   G L + L  + T +++    +   I E
Sbjct: 75  EIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQ----RTATIME 130
Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 575
           + A  + Y H      +IHRD+K  N+LL      K++DFG S   V   S     + GT
Sbjct: 131 ELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS---VHAPSLRRKTMCGT 184
Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
           + YL PE    +   +K D++  GV+  EL+ G     +       R IV+
Sbjct: 185 LDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVK 235

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 105/233 (45%), Gaps = 19/233 (8%)
Query: 396 AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREF 451
           A   + L D E     + + +G G FG VY  + K+ K I A+KVL     +    + + 
Sbjct: 1   AKRQWALEDFE-----IGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQL 55
Query: 452 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 511
             EV + S + H N+++  GY  +  R  L+ E+   GT+    Y  L    + +  +  
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTV----YRELQKLSKFDEQRTA 111
Query: 512 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 571
               + A  + Y H+     +IHRD+K  N+LL      K++DFG S   V   S   + 
Sbjct: 112 TYITELANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAA 165
Query: 572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
           + GT+ YL PE    +   +K D++S GV+  E + G+       +    + I
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRI 218

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 112/224 (50%), Gaps = 34/224 (15%)
Query: 411 MLEKKIGSGGFGVVYYGKL----KDG----KEIAVKVLTSNSYQGK-REFTNEVTLLSRI 461
           +L K +G G FG V   +     KD      ++AVK+L S++ +    +  +E+ ++  I
Sbjct: 16  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 75
Query: 462 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWI 508
             H+N++  LG C ++G   ++ E+   G L+E+L              +   E++++  
Sbjct: 76  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
             +  A   A+G+EYL +      IHRDL + N+L+ +    K++DFGL++       H+
Sbjct: 136 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 188
Query: 569 SSIVRGT-----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               + T     V ++ PE    +  T +SDV+SFGV+L E+ +
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEI----AVKVLTSNSYQGKREFTN--EVTLLSRIHHRN 465
           L K +G G FG V+  K   G +     A+KVL   + + +       E  +L  ++H  
Sbjct: 28  LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPF 87
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEY 523
           +V+     Q EG+  L+ +F+  G L   L      T E    ++  L +A      +++
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA------LDH 141
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH+     II+RDLK  NILLD+    K++DFGLSK ++D      S   GTV Y+ PE 
Sbjct: 142 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEV 197
Query: 584 YISQQLTDKSDVYSFGVILLELISG 608
              +  T  +D +SFGV++ E+++G
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 412 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 461
           L K +G G FG V           K K+   +AVK+L  ++ +    +  +E+ ++  I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 509
            H+N++  LG C ++G   ++  +   G L+E+L                  E+++ +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +      A+G+EYL +      IHRDL + N+L+ ++   K++DFGL++  ++   +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYK 214
Query: 570 SIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               G   V ++ PE    +  T +SDV+SFGV++ E+ +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 414 KKIGSGGFGVV---YYGKLKDG--KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 467
           + +G G FG V    Y    DG  + +AVK L ++   Q +  +  E+ +L  ++H +++
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 468 QFLGYCQEEGRSVL--VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           ++ G C+++G   L  V E++  G+L+++L         I   + L  A+   +G+ YLH
Sbjct: 80  KYKGCCEDQGEKSLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLH 134
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TVGYLDPEY 583
                  IHR+L + N+LLD     K+ DFGL+K   +G  +      G   V +  PE 
Sbjct: 135 AQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 191
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
               +    SDV+SFGV L EL++
Sbjct: 192 LKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 411 MLEKKIGSGGFGVVYYGKLK--DGKEIAVKV----LTSNSYQGKREFTNEVTLLSRIHHR 464
           +L K +G G FG V  G LK  DG  + V V    L ++S +   EF +E   +    H 
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 465 NLVQFLGYCQEEG-----RSVLVYEFMHNGTLKEHL-YGTL-THEQRINWIKRLEIAEDA 517
           N+++ LG C E       + +++  FM  G L  +L Y  L T  + I     L+   D 
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS-IVRGTV 576
           A G+EYL        +HRDL + N +L   M   V+DFGLSK    G  +    I +  V
Sbjct: 157 ALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            ++  E    +  T KSDV++FGV + E+ +
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 112/224 (50%), Gaps = 34/224 (15%)
Query: 411 MLEKKIGSGGFGVVYYGKL----KDG----KEIAVKVLTSNSYQGK-REFTNEVTLLSRI 461
           +L K +G G FG V   +     KD      ++AVK+L S++ +    +  +E+ ++  I
Sbjct: 20  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 79
Query: 462 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWI 508
             H+N++  LG C ++G   ++ E+   G L+E+L              +   E++++  
Sbjct: 80  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
             +  A   A+G+EYL +      IHRDL + N+L+ +    K++DFGL++       H+
Sbjct: 140 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 192
Query: 569 SSIVRGT-----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               + T     V ++ PE    +  T +SDV+SFGV+L E+ +
Sbjct: 193 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 74  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 127
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMH 183
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 112/224 (50%), Gaps = 34/224 (15%)
Query: 411 MLEKKIGSGGFGVVYYGKL----KDG----KEIAVKVLTSNSYQGK-REFTNEVTLLSRI 461
           +L K +G G FG V   +     KD      ++AVK+L S++ +    +  +E+ ++  I
Sbjct: 31  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 462 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWI 508
             H+N++  LG C ++G   ++ E+   G L+E+L              +   E++++  
Sbjct: 91  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
             +  A   A+G+EYL +      IHRDL + N+L+ +    K++DFGL++       H+
Sbjct: 151 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 203
Query: 569 SSIVRGT-----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               + T     V ++ PE    +  T +SDV+SFGV+L E+ +
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 112/224 (50%), Gaps = 34/224 (15%)
Query: 411 MLEKKIGSGGFGVVYYGKL----KDG----KEIAVKVLTSNSYQGK-REFTNEVTLLSRI 461
           +L K +G G FG V   +     KD      ++AVK+L S++ +    +  +E+ ++  I
Sbjct: 24  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 83
Query: 462 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWI 508
             H+N++  LG C ++G   ++ E+   G L+E+L              +   E++++  
Sbjct: 84  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
             +  A   A+G+EYL +      IHRDL + N+L+ +    K++DFGL++       H+
Sbjct: 144 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 196
Query: 569 SSIVRGT-----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               + T     V ++ PE    +  T +SDV+SFGV+L E+ +
Sbjct: 197 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 112/224 (50%), Gaps = 34/224 (15%)
Query: 411 MLEKKIGSGGFGVVYYGKL----KDG----KEIAVKVLTSNSYQGK-REFTNEVTLLSRI 461
           +L K +G G FG V   +     KD      ++AVK+L S++ +    +  +E+ ++  I
Sbjct: 23  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 82
Query: 462 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWI 508
             H+N++  LG C ++G   ++ E+   G L+E+L              +   E++++  
Sbjct: 83  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
             +  A   A+G+EYL +      IHRDL + N+L+ +    K++DFGL++       H+
Sbjct: 143 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 195
Query: 569 SSIVRGT-----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               + T     V ++ PE    +  T +SDV+SFGV+L E+ +
Sbjct: 196 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 91  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 144
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 145 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMH 200
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 201 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 235

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 112/224 (50%), Gaps = 34/224 (15%)
Query: 411 MLEKKIGSGGFGVVYYGKL----KDG----KEIAVKVLTSNSYQGK-REFTNEVTLLSRI 461
           +L K +G G FG V   +     KD      ++AVK+L S++ +    +  +E+ ++  I
Sbjct: 31  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 462 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWI 508
             H+N++  LG C ++G   ++ E+   G L+E+L              +   E++++  
Sbjct: 91  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
             +  A   A+G+EYL +      IHRDL + N+L+ +    K++DFGL++       H+
Sbjct: 151 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 203
Query: 569 SSIVRGT-----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               + T     V ++ PE    +  T +SDV+SFGV+L E+ +
Sbjct: 204 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 19/233 (8%)
Query: 396 AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREF 451
           A   + L D E     + + +G G FG VY  + K  K I A+KVL     +    + + 
Sbjct: 1   AKRQWALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 55
Query: 452 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 511
             EV + S + H N+++  GY  +  R  L+ E+   GT+    Y  L    + +  +  
Sbjct: 56  RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTA 111
Query: 512 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 571
               + A  + Y H+  V   IHRD+K  N+LL      K++DFG S   V   S   + 
Sbjct: 112 TYITELANALSYCHSKRV---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAA 165
Query: 572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
           + GT+ YL PE    +   +K D++S GV+  E + G+       +    + I
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEI----AVKVLTSNSYQGKREFTN--EVTLLSRIHHRN 465
           L K +G G FG V+  K   G +     A+KVL   + + +       E  +L  ++H  
Sbjct: 29  LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPF 88
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEY 523
           +V+     Q EG+  L+ +F+  G L   L      T E    ++  L +A D      +
Sbjct: 89  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD------H 142
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH+     II+RDLK  NILLD+    K++DFGLSK ++D      S   GTV Y+ PE 
Sbjct: 143 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEV 198
Query: 584 YISQQLTDKSDVYSFGVILLELISG 608
              +  T  +D +SFGV++ E+++G
Sbjct: 199 VNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEI----AVKVLTSNSYQGKREFTN--EVTLLSRIHHRN 465
           L K +G G FG V+  K   G +     A+KVL   + + +       E  +L  ++H  
Sbjct: 28  LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPF 87
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEY 523
           +V+     Q EG+  L+ +F+  G L   L      T E    ++  L +A D      +
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD------H 141
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH+     II+RDLK  NILLD+    K++DFGLSK ++D      S   GTV Y+ PE 
Sbjct: 142 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEV 197
Query: 584 YISQQLTDKSDVYSFGVILLELISG 608
              +  T  +D +SFGV++ E+++G
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 73  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 126
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 127 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMH 182
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 183 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 217

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 415 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ-FLGY 472
           KIG G  G+V   + K  G+++AVK++     Q +    NEV ++    H N+V+ +  Y
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
              E   VL+ EF+  G L +     +  + R+N  +   + E   + + YLH      +
Sbjct: 112 LVGEELWVLM-EFLQGGALTD-----IVSQVRLNEEQIATVCEAVLQALAYLHAQ---GV 162
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           IHRD+KS +ILL    R K+SDFG              +V GT  ++ PE         +
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV-GTPYWMAPEVISRSLYATE 221
Query: 593 SDVYSFGVILLELISGQ 609
            D++S G++++E++ G+
Sbjct: 222 VDIWSLGIMVIEMVDGE 238

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 77  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 130
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 114/231 (49%), Gaps = 22/231 (9%)
Query: 397 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFT 452
           +H  T S + D  ++ E  +G GG   V+  + L+  +++AVKVL ++  +       F 
Sbjct: 2   SHMTTPSHLSDRYELGEI-LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRS----VLVYEFMHNGTLKE--HLYGTLTHEQRIN 506
            E    + ++H  +V      + E  +     +V E++   TL++  H  G +T ++ I 
Sbjct: 61  REAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI- 119
Query: 507 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
                E+  DA + + + H      IIHRD+K +NI++      KV DFG+++   D  +
Sbjct: 120 -----EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 567 HVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
            V+  + V GT  YL PE      +  +SDVYS G +L E+++G+   + +
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 79  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 132
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 133 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 17/196 (8%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LEKK+G+G FG V+        ++AVK +   S      F  E  ++  + H  LV+   
Sbjct: 186 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA 244
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              +E   ++  EFM  G+L + L      +Q +   K ++ +   A+G+ ++       
Sbjct: 245 VVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQR---N 298
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            IHRDL+++NIL+   +  K++DFGL++             +  + +  PE       T 
Sbjct: 299 YIHRDLRAANILVSASLVCKIADFGLARVG----------AKFPIKWTAPEAINFGSFTI 348
Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L+E+++
Sbjct: 349 KSDVWSFGILLMEIVT 364

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 112/224 (50%), Gaps = 34/224 (15%)
Query: 411 MLEKKIGSGGFGVVYYGKL----KDG----KEIAVKVLTSNSYQGK-REFTNEVTLLSRI 461
           +L K +G G FG V   +     KD      ++AVK+L S++ +    +  +E+ ++  I
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 462 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWI 508
             H+N++  LG C ++G   ++ E+   G L+E+L              +   E++++  
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
             +  A   A+G+EYL +      IHRDL + N+L+ +    K++DFGL++       H+
Sbjct: 192 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 244
Query: 569 SSIVRGT-----VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               + T     V ++ PE    +  T +SDV+SFGV+L E+ +
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 74  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 127
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTXLCGTLDYLPPEMIEGRMH 183
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 107/220 (48%), Gaps = 28/220 (12%)
Query: 412 LEKKIGSGGFGVVYYG--------KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI- 461
           L K +G G FG V           K K+   +AVK+L  ++ +    +  +E+ ++  I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG------------TLTHEQRINWIK 509
            H+N++  LG C ++G   ++  +   G L+E+L                  E+++ +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +      A+G+EYL +      IHRDL + N+L+ ++   K++DFGL++  ++   +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYYK 214
Query: 570 SIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               G   V ++ PE    +  T +SDV+SFGV++ E+ +
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+  V
Sbjct: 78  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRV 133
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
              IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 134 ---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMH 187
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 188 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 222

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 100 YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 153
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S     + GT+ YL PE    +  
Sbjct: 154 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYLPPEMIEGRMH 209
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 210 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 244

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 77  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 130
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRMH 186
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 412 LEKKIGSGGFGVVYY----GKLKDGKEIAVKVLTSNSYQGKREFTN--EVTLLSRIHHRN 465
           L K +G G FG V+      +   G   A+KVL   + + +       E  +L+ ++H  
Sbjct: 32  LLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPF 91
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEY 523
           +V+     Q EG+  L+ +F+  G L   L      T E    ++  L      A G+++
Sbjct: 92  VVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL------ALGLDH 145
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH+     II+RDLK  NILLD+    K++DFGLSK A+D      S   GTV Y+ PE 
Sbjct: 146 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC-GTVEYMAPEV 201
Query: 584 YISQQLTDKSDVYSFGVILLELISG 608
              Q  +  +D +S+GV++ E+++G
Sbjct: 202 VNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 77  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 130
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 79  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 132
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 133 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEXIEGRXH 188
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 74  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 127
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTELCGTLDYLPPEMIEGRMH 183
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   G     +Y  L    + +  +      + A  + Y H+   
Sbjct: 79  YGYFHDATRVYLILEYAPRG----EVYKELQKLSKFDEQRTATYITELANALSYCHSK-- 132
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 133 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMH 188
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 75  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 128
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S     + GT+ YL PE    +  
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIEGRMH 184
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 134/288 (46%), Gaps = 45/288 (15%)
Query: 412 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 464
           L +++G G FG+VY G  +D         +AVK +  S S + + EF NE +++      
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN-------WIKRLEIAEDA 517
           ++V+ LG   +   +++V E M +G LK +L  +L  E   N         + +++A + 
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 575
           A G+ YL+       +HRDL + N ++      K+ DFG+++   + A +     +G   
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKG-GKGLLP 195
Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 631
           V ++ PE       T  SD++SFGV+L E+ S  E     +SNE+               
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-------------- 241
Query: 632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 679
                ++ ++D   LD+ D     ++ +   MC   +  MRP+  E++
Sbjct: 242 -----LKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   G     +Y  L    + +  +      + A  + Y H+  V
Sbjct: 79  YGYFHDATRVYLILEYAPRG----EVYKELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
              IHRD+K  N+LL      K++DFG S   V   S     + GT+ YL PE    +  
Sbjct: 135 ---IHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLXGTLDYLPPEMIEGRMH 188
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 116/237 (48%), Gaps = 22/237 (9%)
Query: 387 SSLNDAPAEAAHCFTLSDIEDATKMLE--KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSN 443
           S  +D+PA +     LS + D   + E  + +G+G +G VY G+ +K G+  A+KV+   
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 444 SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG------RSVLVYEFMHNGTLKEHLY 496
             + + E   E+ +L +  HHRN+  + G   ++       +  LV EF   G++ + + 
Sbjct: 61  GDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 497 GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG 556
            T  +  +  WI    I  +  +G+ +LH      +IHRD+K  N+LL ++   K+ DFG
Sbjct: 120 NTKGNTLKEEWIAY--ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 557 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISG 608
           +S   +D      +   GT  ++ PE     +  D     KSD++S G+  +E+  G
Sbjct: 175 VSA-QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 76  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 129
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S     + GT+ YL PE    +  
Sbjct: 130 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMH 185
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 220

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 114/231 (49%), Gaps = 22/231 (9%)
Query: 397 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFT 452
           +H  T S + D  ++ E  +G GG   V+  + L+  +++AVKVL ++  +       F 
Sbjct: 2   SHMTTPSHLSDRYELGEI-LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRS----VLVYEFMHNGTLKE--HLYGTLTHEQRIN 506
            E    + ++H  +V      + E  +     +V E++   TL++  H  G +T ++ I 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI- 119
Query: 507 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
                E+  DA + + + H      IIHRD+K +NI++      KV DFG+++   D  +
Sbjct: 120 -----EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 567 HVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
            V+  + V GT  YL PE      +  +SDVYS G +L E+++G+   + +
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 222

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 74  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 127
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLG 471
           +G GGFG V   +++  GK  A K L     +   G+    NE  +L +++ R +V  L 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 250
Query: 472 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI--AEDAAKGIEYLHTGC 528
           Y  E   ++ LV   M+ G LK H+Y    H  +  + +   +  A +   G+E LH   
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIY----HMGQAGFPEARAVFYAAEICCGLEDLHR-- 304
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              I++RDLK  NILLD H   ++SD GL+    +G +    +  GTVGY+ PE   +++
Sbjct: 305 -ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNER 361
Query: 589 LTDKSDVYSFGVILLELISGQEAISNEK 616
            T   D ++ G +L E+I+GQ      K
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLG 471
           +G GGFG V   +++  GK  A K L     +   G+    NE  +L +++ R +V  L 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 250
Query: 472 YCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI--AEDAAKGIEYLHTGC 528
           Y  E   ++ LV   M+ G LK H+Y    H  +  + +   +  A +   G+E LH   
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIY----HMGQAGFPEARAVFYAAEICCGLEDLHR-- 304
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              I++RDLK  NILLD H   ++SD GL+    +G +    +  GTVGY+ PE   +++
Sbjct: 305 -ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNER 361
Query: 589 LTDKSDVYSFGVILLELISGQEAISNEK 616
            T   D ++ G +L E+I+GQ      K
Sbjct: 362 YTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 74  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 127
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMH 183
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 79  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 132
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 133 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMH 188
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 189 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 223

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 71  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 124
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 125 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMH 180
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 181 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 215

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 75  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 128
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S   + + GT+ YL PE    +  
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMH 184
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 74  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 127
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S     + GT+ YL PE    +  
Sbjct: 128 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMH 183
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 184 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 218

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+  V
Sbjct: 75  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
              IHRD+K  N+LL      K++DFG S       S   + + GT+ YL PE    +  
Sbjct: 131 ---IHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTLDYLPPEMIEGRMH 184
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 219

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 115/251 (45%), Gaps = 34/251 (13%)
Query: 414 KKIGSGGFGVVYYGKLKDG-KEIAVKVLTSNSYQGKR-------------EFTNEVTLLS 459
           +K+GSG +G V   K K+G  E A+KV+  + +   R             E  NE++LL 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 460 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 519
            + H N+++     +++    LV EF   G L E     + +  + +      I +    
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQ----IINRHKFDECDAANIMKQILS 157
Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKFAVDGASHVSSIVRGTV 576
           GI YLH      I+HRD+K  NILL+     +  K+ DFGLS F          +  GT 
Sbjct: 158 GICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL--GTA 212
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI---VQWAKLHIE 633
            Y+ PE  + ++  +K DV+S GVI+  L+ G         G N ++I   V+  K + +
Sbjct: 213 YYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFG----GQNDQDIIKKVEKGKYYFD 267
Query: 634 SGDIQGIIDPS 644
             D + I D +
Sbjct: 268 FNDWKNISDEA 278

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 77  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 130
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S     + GT+ YL PE    +  
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMH 186
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 132/291 (45%), Gaps = 51/291 (17%)
Query: 412 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 464
           L +++G G FG+VY G  +D         +AVK +  S S + + EF NE +++      
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN-------WIKRLEIAEDA 517
           ++V+ LG   +   +++V E M +G LK +L  +L  E   N         + +++A + 
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
           A G+ YL+       +HRDL + N ++      K+ DFG+++             +G  G
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKG 192
Query: 578 -----YLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWA 628
                ++ PE       T  SD++SFGV+L E+ S  E     +SNE+            
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV----------- 241
Query: 629 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 679
                   ++ ++D   LD+ D     ++ +   MC   + +MRP+  E++
Sbjct: 242 --------LKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 104/223 (46%), Gaps = 35/223 (15%)
Query: 412 LEKKIGSGGFGVVY----YG--KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 463
           L K +G G FG V     +G  K    + +AVK+L   +   + R   +E+ +L  I HH
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 464 RNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED------ 516
            N+V  LG C + G  ++V  EF   G L  +L       +R  ++   E  ED      
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----RSKRNEFVPYKEAPEDLYKDFL 147
Query: 517 -----------AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
                       AKG+E+L +      IHRDL + NILL +    K+ DFGL++      
Sbjct: 148 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 204
Query: 566 SHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            +V     R  + ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 205 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 77  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 130
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K++DFG S   V   S     + GT+ YL PE    +  
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYLPPEMIEGRMH 186
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFLG 471
           +K+G G +GVVY  K   G+ +A+K +  ++       T   E++LL  +HH N+V  + 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 472 YCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
               E    LV+EFM       L E+  G    + +I   + L       +G+ + H   
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL-------RGVAHCHQH- 138
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-S 586
              I+HRDLK  N+L++     K++DFGL++ F +   S+   +V  T+ Y  P+  + S
Sbjct: 139 --RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGS 194
Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
           ++ +   D++S G I  E+I+G+
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFLG 471
           +K+G G +GVVY  K   G+ +A+K +  ++       T   E++LL  +HH N+V  + 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 472 YCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
               E    LV+EFM       L E+  G    + +I   + L       +G+ + H   
Sbjct: 87  VIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLL-------RGVAHCHQH- 138
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-S 586
              I+HRDLK  N+L++     K++DFGL++ F +   S+   +V  T+ Y  P+  + S
Sbjct: 139 --RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGS 194
Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
           ++ +   D++S G I  E+I+G+
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 114/231 (49%), Gaps = 22/231 (9%)
Query: 397 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFT 452
           +H  T S + D  ++ E  +G GG   V+  + L+  +++AVKVL ++  +       F 
Sbjct: 19  SHMTTPSHLSDRYELGEI-LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 77
Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRS----VLVYEFMHNGTLKE--HLYGTLTHEQRIN 506
            E    + ++H  +V      + E  +     +V E++   TL++  H  G +T ++ I 
Sbjct: 78  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI- 136
Query: 507 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
                E+  DA + + + H      IIHRD+K +NI++      KV DFG+++   D  +
Sbjct: 137 -----EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 188
Query: 567 HVS--SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
            V+  + V GT  YL PE      +  +SDVYS G +L E+++G+   + +
Sbjct: 189 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 239

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 115/225 (51%), Gaps = 31/225 (13%)
Query: 411 MLEKKIGSGGFGVV-----YYGKLKDG-KEIAVKVLTSNSYQGK-REFTNEVTLLSRIHH 463
           +L K +G G FG V     ++ K + G   +AVK+L  N+   + R+  +E  +L +++H
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGT------------------LTH--EQ 503
            ++++  G C ++G  +L+ E+   G+L+  L  +                  L H  E+
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 504 RINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 563
            +     +  A   ++G++YL       ++HRDL + NIL+ +  + K+SDFGLS+   +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 564 GASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             S+V  S  R  V ++  E       T +SDV+SFGV+L E+++
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 76  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 129
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K+++FG S   V   S   + + GT+ YL PE    +  
Sbjct: 130 -RVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMH 185
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 186 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 220

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 109/208 (52%), Gaps = 17/208 (8%)
Query: 410 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLV 467
           K LEK +G+G +  VY G  K  G  +A+K +  +S +G       E++L+  + H N+V
Sbjct: 8   KQLEK-LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIV 66
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHL----YGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           +       E +  LV+EFM N  LK+++     G       +N +K  +      +G+ +
Sbjct: 67  RLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQW--QLLQGLAF 123
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE 582
            H      I+HRDLK  N+L++K  + K+ DFGL++ F +   +  S +V  T+ Y  P+
Sbjct: 124 CHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRAPD 178
Query: 583 YYI-SQQLTDKSDVYSFGVILLELISGQ 609
             + S+  +   D++S G IL E+I+G+
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 115/225 (51%), Gaps = 31/225 (13%)
Query: 411 MLEKKIGSGGFGVV-----YYGKLKDG-KEIAVKVLTSNSYQGK-REFTNEVTLLSRIHH 463
           +L K +G G FG V     ++ K + G   +AVK+L  N+   + R+  +E  +L +++H
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGT------------------LTH--EQ 503
            ++++  G C ++G  +L+ E+   G+L+  L  +                  L H  E+
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 504 RINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 563
            +     +  A   ++G++YL      +++HRDL + NIL+ +  + K+SDFGLS+   +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEM---SLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 564 GASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             S V  S  R  V ++  E       T +SDV+SFGV+L E+++
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 99/212 (46%), Gaps = 20/212 (9%)
Query: 406 EDATKMLEKK--IGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 461
           ED  K+ E K  +G+G F  V   + K  GK  AVK +   + +GK     NE+ +L +I
Sbjct: 18  EDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKI 77
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAK 519
            H N+V      +      LV + +  G L + +   G  T +     I+++        
Sbjct: 78  KHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQV------LD 131
Query: 520 GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 576
            + YLH      I+HRDLK  N+L    D+  +  +SDFGLSK  ++G   V S   GT 
Sbjct: 132 AVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK--MEGKGDVMSTACGTP 186
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
           GY+ PE    +  +   D +S GVI   L+ G
Sbjct: 187 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 14/215 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQF 469
           + +G G FG VY  + K  K I A+KVL     +    + +   EV + S + H N+++ 
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            GY  +  R  L+ E+   GT+    Y  L    + +  +      + A  + Y H+   
Sbjct: 77  YGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK-- 130
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +IHRD+K  N+LL      K+++FG S   V   S   + + GT+ YL PE    +  
Sbjct: 131 -RVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMH 186
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            +K D++S GV+  E + G+       +    + I
Sbjct: 187 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 221

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 131/291 (45%), Gaps = 51/291 (17%)
Query: 412 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 464
           L +++G G FG+VY G  +D         +AVK +  S S + + EF NE +++      
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN-------WIKRLEIAEDA 517
           ++V+ LG   +   +++V E M +G LK +L  +L  E   N         + +++A + 
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
           A G+ YL+       +HRDL + N ++      K+ DFG+++             +G  G
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKG 192
Query: 578 -----YLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWA 628
                ++ PE       T  SD++SFGV+L E+ S  E     +SNE+            
Sbjct: 193 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV----------- 241
Query: 629 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 679
                   ++ ++D   LD+ D     ++ +   MC   +  MRP+  E++
Sbjct: 242 --------LKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 131/291 (45%), Gaps = 51/291 (17%)
Query: 412 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 464
           L +++G G FG+VY G  +D         +AVK +  S S + + EF NE +++      
Sbjct: 18  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 77
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN-------WIKRLEIAEDA 517
           ++V+ LG   +   +++V E M +G LK +L  +L  E   N         + +++A + 
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAEI 136
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
           A G+ YL+       +HRDL + N ++      K+ DFG+++             +G  G
Sbjct: 137 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKG 189
Query: 578 -----YLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWA 628
                ++ PE       T  SD++SFGV+L E+ S  E     +SNE+            
Sbjct: 190 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV----------- 238
Query: 629 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 679
                   ++ ++D   LD+ D     ++ +   MC   +  MRP+  E++
Sbjct: 239 --------LKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIV 280

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 133/288 (46%), Gaps = 45/288 (15%)
Query: 412 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 464
           L +++G G FG+VY G  +D         +AVK +  S S + + EF NE +++      
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN-------WIKRLEIAEDA 517
           ++V+ LG   +   +++V E M +G LK +L  +L  E   N         + +++A + 
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 575
           A G+ YL+       +HRDL + N ++      K+ DFG+++  +    +     +G   
Sbjct: 140 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 195
Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 631
           V ++ PE       T  SD++SFGV+L E+ S  E     +SNE+               
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-------------- 241
Query: 632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 679
                ++ ++D   LD+ D     ++ +   MC   +  MRP+  E++
Sbjct: 242 -----LKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIV 283

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 17/202 (8%)
Query: 416 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 474
           +G G +G+VY G+ L +   IA+K +     +  +    E+ L   + H+N+VQ+LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 475 EEGRSVLVYEFMHNGTLKEHL---YGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
           E G   +  E +  G+L   L   +G L  +EQ I +  + +I E    G++YLH     
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILE----GLKYLHDN--- 141
Query: 531 AIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--Q 587
            I+HRD+K  N+L++ +    K+SDFG SK  + G +  +    GT+ Y+ PE      +
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSK-RLAGINPCTETFTGTLQYMAPEIIDKGPR 200
Query: 588 QLTDKSDVYSFGVILLELISGQ 609
                +D++S G  ++E+ +G+
Sbjct: 201 GYGKAADIWSLGCTIIEMATGK 222

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 15/234 (6%)
Query: 415 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           KIG G  G+V    ++  GK +AVK +     Q +    NEV ++    H N+V+     
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
                  +V EF+  G L + +  T  +E++I       +     + +  LH      +I
Sbjct: 218 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLHAQ---GVI 269
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRD+KS +ILL    R K+SDFG              +V GT  ++ PE         + 
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 328
Query: 594 DVYSFGVILLELISGQEAISNEKFGANCRNI-----VQWAKLHIESGDIQGIID 642
           D++S G++++E++ G+    NE      + I      +   LH  S  ++G +D
Sbjct: 329 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 382

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 107/227 (47%), Gaps = 37/227 (16%)
Query: 407 DATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHR 464
           D  K+LE  IG G +G VY G L D + +AVKV    S+  ++ F NE  +  +  + H 
Sbjct: 13  DNLKLLEL-IGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVPLMEHD 67
Query: 465 NLVQFL---GYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 519
           N+ +F+        +GR   +LV E+  NG+L ++L    +     +W+    +A    +
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTR 122
Query: 520 GIEYLHTGC------VPAIIHRDLKSSNILLDKHMRAKVSDFGLS------KFAVDGASH 567
           G+ YLHT         PAI HRDL S N+L+       +SDFGLS      +    G   
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 568 VSSIVR-GTVGYLDPEYYI-------SQQLTDKSDVYSFGVILLELI 606
            ++I   GT+ Y+ PE           +    + D+Y+ G+I  E+ 
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 123/266 (46%), Gaps = 28/266 (10%)
Query: 380 LPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVK 438
           +P      SL D   + A  F   D E     L ++IG G FG VY+ + +++ + +A+K
Sbjct: 29  MPAGGRAGSLKDP--DVAELFFKDDPEKLFSDL-REIGHGSFGAVYFARDVRNSEVVAIK 85
Query: 439 VLTSNSYQGKR------EFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK 492
            +   SY GK+      +   EV  L ++ H N +Q+ G    E  + LV E+   G+  
Sbjct: 86  KM---SYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSAS 141
Query: 493 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV 552
           + L     H++ +  ++   +   A +G+ YLH+     +IHRD+K+ NILL +    K+
Sbjct: 142 DLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKL 195
Query: 553 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ---QLTDKSDVYSFGVILLELISGQ 609
            DFG +         V     GT  ++ PE  ++    Q   K DV+S G+  +EL   +
Sbjct: 196 GDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
Query: 610 EAISNEKFGANCRNIVQWAKLHIESG 635
             + N    +   +I Q     ++SG
Sbjct: 251 PPLFNMNAMSALYHIAQNESPALQSG 276

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 115/230 (50%), Gaps = 18/230 (7%)
Query: 385 PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEI----AVKV 439
           P++    AP +A     L  +++      K +GSG FG VY G  + +G+ +    A+K+
Sbjct: 19  PLTPSGTAPNQAQ----LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKI 74
Query: 440 LTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGT 498
           L   +  +   EF +E  +++ + H +LV+ LG C       LV + M +G L E+++  
Sbjct: 75  LNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLEYVH-- 131
Query: 499 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 558
             H+  I     L      AKG+ YL       ++HRDL + N+L+      K++DFGL+
Sbjct: 132 -EHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA 187
Query: 559 KFAV-DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +    D   + +   +  + ++  E    ++ T +SDV+S+GV + EL++
Sbjct: 188 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 133/288 (46%), Gaps = 45/288 (15%)
Query: 412 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 464
           L +++G G FG+VY G  +D         +AVK +  S S + + EF NE +++      
Sbjct: 20  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 79
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN-------WIKRLEIAEDA 517
           ++V+ LG   +   +++V E M +G LK +L  +L  E   N         + +++A + 
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAEI 138
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 575
           A G+ YL+       +HRDL + N ++      K+ DFG+++  +    +     +G   
Sbjct: 139 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 194
Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 631
           V ++ PE       T  SD++SFGV+L E+ S  E     +SNE+               
Sbjct: 195 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-------------- 240
Query: 632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 679
                ++ ++D   LD+ D     ++ +   MC   +  MRP+  E++
Sbjct: 241 -----LKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIV 282

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 411 MLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRN 465
           +L + +G G FG VY G   +  G++I V V T     +   K +F +E  ++  + H +
Sbjct: 27  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 86
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--EQRINWIKRLEI---AEDAAKG 520
           +V+ +G  +EE   ++         ++ + YG L H  E+  N +K L +   +    K 
Sbjct: 87  IVKLIGIIEEEPTWII---------MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 137
Query: 521 IEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 579
           + YL +  CV    HRD+   NIL+      K+ DFGLS++  D   + +S+ R  + ++
Sbjct: 138 MAYLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 193
Query: 580 DPEYYISQQLTDKSDVYSFGVILLELIS 607
            PE    ++ T  SDV+ F V + E++S
Sbjct: 194 SPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 114/225 (50%), Gaps = 31/225 (13%)
Query: 411 MLEKKIGSGGFGVV-----YYGKLKDG-KEIAVKVLTSNSYQGK-REFTNEVTLLSRIHH 463
           +L K +G G FG V     ++ K + G   +AVK+L  N+   + R+  +E  +L +++H
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGT------------------LTH--EQ 503
            ++++  G C ++G  +L+ E+   G+L+  L  +                  L H  E+
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 504 RINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 563
            +     +  A   ++G++YL       ++HRDL + NIL+ +  + K+SDFGLS+   +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 564 GASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             S V  S  R  V ++  E       T +SDV+SFGV+L E+++
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 414 KKIGSGGFGVVYYGKLKDGKE-----IAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G      E     +A+K+L   +  +   EF +E  +++ + H +LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYL 524
           + LG C       LV + M +G L E+++     +  +  +NW  ++      AKG+ YL
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 133
Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEY 583
                  ++HRDL + N+L+      K++DFGL++    D   + +   +  + ++  E 
Sbjct: 134 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALEC 190
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
              ++ T +SDV+S+GV + EL++
Sbjct: 191 IHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 31/219 (14%)
Query: 412 LEKKIGSGGFGVVY----YG--KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 463
           L K +G G FG V     +G  K    + +AVK+L   +   + R   +E+ +L  I HH
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 464 RNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED------ 516
            N+V  LG C + G  ++V  EF   G L  +L       +R  ++   ++ +D      
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----RSKRNEFVPYKDLYKDFLTLEH 145
Query: 517 -------AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV- 568
                   AKG+E+L +      IHRDL + NILL +    K+ DFGL++       +V 
Sbjct: 146 LICYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 202
Query: 569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               R  + ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 414 KKIGSGGFGVV---YYGKLKDG--KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 467
           + +G G FG V    Y    DG  + +AVK L      Q +  +  E+ +L  ++H ++V
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 74
Query: 468 QFLGYCQEEG-RSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           ++ G C+++G +SV LV E++  G+L+++L         +   + L  A+   +G+ YLH
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQLLLFAQQICEGMAYLH 129
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TVGYLDPEY 583
                  IHR L + N+LLD     K+ DFGL+K   +G  +      G   V +  PE 
Sbjct: 130 A---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 186
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
               +    SDV+SFGV L EL++
Sbjct: 187 LKECKFYYASDVWSFGVTLYELLT 210

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 411 MLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRN 465
           +L + +G G FG VY G   +  G++I V V T     +   K +F +E  ++  + H +
Sbjct: 11  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 70
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--EQRINWIKRLEI---AEDAAKG 520
           +V+ +G  +EE   ++         ++ + YG L H  E+  N +K L +   +    K 
Sbjct: 71  IVKLIGIIEEEPTWII---------MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 121
Query: 521 IEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 579
           + YL +  CV    HRD+   NIL+      K+ DFGLS++  D   + +S+ R  + ++
Sbjct: 122 MAYLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 177
Query: 580 DPEYYISQQLTDKSDVYSFGVILLELIS 607
            PE    ++ T  SDV+ F V + E++S
Sbjct: 178 SPESINFRRFTTASDVWMFAVCMWEILS 205

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 17/202 (8%)
Query: 416 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 474
           +G G +G+VY G+ L +   IA+K +     +  +    E+ L   + H+N+VQ+LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 475 EEGRSVLVYEFMHNGTLKEHL---YGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
           E G   +  E +  G+L   L   +G L  +EQ I +  + +I E    G++YLH     
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILE----GLKYLHDN--- 127
Query: 531 AIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--Q 587
            I+HRD+K  N+L++ +    K+SDFG SK  + G +  +    GT+ Y+ PE      +
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSK-RLAGINPCTETFTGTLQYMAPEIIDKGPR 186
Query: 588 QLTDKSDVYSFGVILLELISGQ 609
                +D++S G  ++E+ +G+
Sbjct: 187 GYGKAADIWSLGCTIIEMATGK 208

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 18/204 (8%)
Query: 414 KKIGSGGFGVV---YYGKLKDG--KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLV 467
           + +G G FG V    Y    DG  + +AVK L      Q +  +  E+ +L  ++H ++V
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIV 73
Query: 468 QFLGYCQEEG-RSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           ++ G C+++G +SV LV E++  G+L+++L         +   + L  A+   +G+ YLH
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-----PRHCVGLAQLLLFAQQICEGMAYLH 128
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--TVGYLDPEY 583
                  IHR L + N+LLD     K+ DFGL+K   +G  +      G   V +  PE 
Sbjct: 129 A---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 185
Query: 584 YISQQLTDKSDVYSFGVILLELIS 607
               +    SDV+SFGV L EL++
Sbjct: 186 LKECKFYYASDVWSFGVTLYELLT 209

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 15/234 (6%)
Query: 415 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           KIG G  G+V    ++  GK +AVK +     Q +    NEV ++    H N+V+     
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
                  +V EF+  G L + +  T  +E++I       +     + +  LH      +I
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLHAQ---GVI 147
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRD+KS +ILL    R K+SDFG              +V GT  ++ PE         + 
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 206
Query: 594 DVYSFGVILLELISGQEAISNEKFGANCRNI-----VQWAKLHIESGDIQGIID 642
           D++S G++++E++ G+    NE      + I      +   LH  S  ++G +D
Sbjct: 207 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 260

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 24/208 (11%)
Query: 411 MLEKKIGSGGFGVVYYGKLKD--GKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRN 465
           +L + +G G FG VY G   +  G++I V V T     +   K +F +E  ++  + H +
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--EQRINWIKRLEI---AEDAAKG 520
           +V+ +G  +EE   ++         ++ + YG L H  E+  N +K L +   +    K 
Sbjct: 75  IVKLIGIIEEEPTWII---------MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA 125
Query: 521 IEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 579
           + YL +  CV    HRD+   NIL+      K+ DFGLS++  D   + +S+ R  + ++
Sbjct: 126 MAYLESINCV----HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 580 DPEYYISQQLTDKSDVYSFGVILLELIS 607
            PE    ++ T  SDV+ F V + E++S
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 15/234 (6%)
Query: 415 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           KIG G  G+V    ++  GK +AVK +     Q +    NEV ++    H N+V+     
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
                  +V EF+  G L + +  T  +E++I       +     + +  LH      +I
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLHAQ---GVI 192
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRD+KS +ILL    R K+SDFG              +V GT  ++ PE         + 
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 251
Query: 594 DVYSFGVILLELISGQEAISNEKFGANCRNI-----VQWAKLHIESGDIQGIID 642
           D++S G++++E++ G+    NE      + I      +   LH  S  ++G +D
Sbjct: 252 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 305

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 31/219 (14%)
Query: 412 LEKKIGSGGFGVVY----YG--KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 463
           L K +G G FG V     +G  K    + +AVK+L   +   + R   +E+ +L  I HH
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 464 RNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED------ 516
            N+V  LG C + G  ++V  EF   G L  +L       +R  ++   ++ +D      
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----RSKRNEFVPYKDLYKDFLTLEH 145
Query: 517 -------AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV- 568
                   AKG+E+L +      IHRDL + NILL +    K+ DFGL++       +V 
Sbjct: 146 LIXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVR 202
Query: 569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
               R  + ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 15/234 (6%)
Query: 415 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           KIG G  G+V    ++  GK +AVK +     Q +    NEV ++    H N+V+     
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
                  +V EF+  G L + +  T  +E++I       +     + +  LH      +I
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLHAQ---GVI 149
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRD+KS +ILL    R K+SDFG              +V GT  ++ PE         + 
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 208
Query: 594 DVYSFGVILLELISGQEAISNEKFGANCRNI-----VQWAKLHIESGDIQGIID 642
           D++S G++++E++ G+    NE      + I      +   LH  S  ++G +D
Sbjct: 209 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 262

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 15/234 (6%)
Query: 415 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           KIG G  G+V    ++  GK +AVK +     Q +    NEV ++    H N+V+     
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
                  +V EF+  G L + +  T  +E++I       +     + +  LH      +I
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLHAQ---GVI 138
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRD+KS +ILL    R K+SDFG              +V GT  ++ PE         + 
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 197
Query: 594 DVYSFGVILLELISGQEAISNEKFGANCRNI-----VQWAKLHIESGDIQGIID 642
           D++S G++++E++ G+    NE      + I      +   LH  S  ++G +D
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 251

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 134/288 (46%), Gaps = 45/288 (15%)
Query: 412 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 464
           L +++G G FG+VY G  +D         +AVK +  S S + + EF NE +++      
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 80
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN-------WIKRLEIAEDA 517
           ++V+ LG   +   +++V E M +G LK +L  +L  E   N         + +++A + 
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 575
           A G+ YL+       +HR+L + N ++      K+ DFG+++  +    +     +G   
Sbjct: 140 ADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 195
Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 631
           V ++ PE       T  SD++SFGV+L E+ S  E     +SNE+               
Sbjct: 196 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-------------- 241
Query: 632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 679
                ++ ++D   LD+ D     ++ +   MC   + +MRP+  E++
Sbjct: 242 -----LKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPNMRPTFLEIV 283

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQ 468
           ++ +G G FG V   K K  G+E AVKV++    + K +      EV LL ++ H N+++
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
              + +++G   LV E    G     L+  +   +R + +    I      GI Y+H   
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN- 145
Query: 529 VPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
              I+HRDLK  N+LL+   K    ++ DFGLS            I  GT  Y+ PE  +
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPE-VL 200
Query: 586 SQQLTDKSDVYSFGVILLELISG 608
                +K DV+S GVIL  L+SG
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSG 223

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 25/209 (11%)
Query: 413 EKKIGSGGFGVVYYGKLKDGKE----IAVKVLTS-NSYQGKREFTNEVTLLSRIHHRNLV 467
           ++ IG G FGVVY+G+  D  +     A+K L+     Q    F  E  L+  ++H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 468 QFLG-YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAAKGIEYLH 525
             +G     EG   ++  +M +G L + +       QR   +K L       A+G+EYL 
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLA 141
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-------FAVDGASHVSSIVRGTVGY 578
                  +HRDL + N +LD+    KV+DFGL++       ++V    H    V+ T   
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL- 197
Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELIS 607
              E   + + T KSDV+SFGV+L EL++
Sbjct: 198 ---ESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 134/288 (46%), Gaps = 45/288 (15%)
Query: 412 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 464
           L +++G G FG+VY G  +D         +AVK +  S S + + EF NE +++      
Sbjct: 22  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 81
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRIN-------WIKRLEIAEDA 517
           ++V+ LG   +   +++V E M +G LK +L  +L  E   N         + +++A + 
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR-SLRPEAENNPGRPPPTLQEMIQMAAEI 140
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG--T 575
           A G+ YL+       +HR+L + N ++      K+ DFG+++  +    +     +G   
Sbjct: 141 ADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR-DIYETDYYRKGGKGLLP 196
Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE----AISNEKFGANCRNIVQWAKLH 631
           V ++ PE       T  SD++SFGV+L E+ S  E     +SNE+               
Sbjct: 197 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-------------- 242
Query: 632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 679
                ++ ++D   LD+ D     ++ +   MC   + +MRP+  E++
Sbjct: 243 -----LKFVMDGGYLDQPD-NCPERVTDLMRMCWQFNPNMRPTFLEIV 284

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 15/234 (6%)
Query: 415 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           KIG G  G+V    ++  GK +AVK +     Q +    NEV ++    H N+V+     
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
                  +V EF+  G L + +  T  +E++I       +     + +  LH      +I
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLHAQ---GVI 142
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS 593
           HRD+KS +ILL    R K+SDFG              +V GT  ++ PE         + 
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 201
Query: 594 DVYSFGVILLELISGQEAISNEKFGANCRNI-----VQWAKLHIESGDIQGIID 642
           D++S G++++E++ G+    NE      + I      +   LH  S  ++G +D
Sbjct: 202 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 255

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           KK+GSG +G V   + K    E A+K++  TS S     +   EV +L  + H N+++  
Sbjct: 43  KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
            + +++    LV E    G     L+  + H  + N +    I +    G+ YLH     
Sbjct: 103 DFFEDKRNYYLVMECYKGG----ELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK---H 155
Query: 531 AIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
            I+HRDLK  N+LL   +K    K+ DFGLS    +       +  GT  Y+ PE  + +
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPE-VLRK 212
Query: 588 QLTDKSDVYSFGVILLELISG 608
           +  +K DV+S GVIL  L++G
Sbjct: 213 KYDEKCDVWSIGVILFILLAG 233

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 112/232 (48%), Gaps = 25/232 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR------EFTNEVTLLSRIHHRNL 466
           ++IG G FG VY+ + +++ + +A+K +   SY GK+      +   EV  L ++ H N 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           +Q+ G    E  + LV E+   G+  + L     H++ +  ++   +   A +G+ YLH+
Sbjct: 78  IQYRGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +IHRD+K+ NILL +    K+ DFG +         V     GT  ++ PE  ++
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILA 185
Query: 587 Q---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 635
               Q   K DV+S G+  +EL   +  + N    +   +I Q     ++SG
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSG 237

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 25/217 (11%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKV-----LTSNSYQGKREFTNEV 455
           ++D+      L K IG G F  V   + +  GKE+AVK+     L S+S Q   +   EV
Sbjct: 1   MADLHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREV 57
Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA- 514
            ++  ++H N+V+     + E    LV E+   G + ++L   + H     W+K  E   
Sbjct: 58  RIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL---VAH----GWMKEKEARA 110
Query: 515 --EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 572
                   ++Y H      I+HRDLK+ N+LLD  M  K++DFG S     G        
Sbjct: 111 KFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK--LDTF 165
Query: 573 RGTVGYLDPEYYISQQLTD-KSDVYSFGVILLELISG 608
            G+  Y  PE +  ++    + DV+S GVIL  L+SG
Sbjct: 166 CGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQ 468
           ++ +G G FG V   K K  G+E AVKV++    + K +      EV LL ++ H N+++
Sbjct: 54  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 113
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
              + +++G   LV E    G     L+  +   +R + +    I      GI Y+H   
Sbjct: 114 LYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN- 168
Query: 529 VPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
              I+HRDLK  N+LL+   K    ++ DFGLS            I  GT  Y+ PE  +
Sbjct: 169 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPE-VL 223
Query: 586 SQQLTDKSDVYSFGVILLELISG 608
                +K DV+S GVIL  L+SG
Sbjct: 224 HGTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQ 468
           ++ +G G FG V   K K  G+E AVKV++    + K +      EV LL ++ H N+++
Sbjct: 55  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 114
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
              + +++G   LV E    G     L+  +   +R + +    I      GI Y+H   
Sbjct: 115 LYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN- 169
Query: 529 VPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
              I+HRDLK  N+LL+   K    ++ DFGLS            I  GT  Y+ PE  +
Sbjct: 170 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPE-VL 224
Query: 586 SQQLTDKSDVYSFGVILLELISG 608
                +K DV+S GVIL  L+SG
Sbjct: 225 HGTYDEKCDVWSTGVILYILLSG 247

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQ 468
           ++ +G G FG V   K K  G+E AVKV++    + K +      EV LL ++ H N+++
Sbjct: 37  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 96
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
              + +++G   LV E    G     L+  +   +R + +    I      GI Y+H   
Sbjct: 97  LYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN- 151
Query: 529 VPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
              I+HRDLK  N+LL+   K    ++ DFGLS            I  GT  Y+ PE  +
Sbjct: 152 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPE-VL 206
Query: 586 SQQLTDKSDVYSFGVILLELISG 608
                +K DV+S GVIL  L+SG
Sbjct: 207 HGTYDEKCDVWSTGVILYILLSG 229

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 110/215 (51%), Gaps = 24/215 (11%)
Query: 414 KKIGSGGFG-VVYYGKLKDGKE-----IAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 465
           K +G+G FG VV       GKE     +AVK+L S ++  ++E   +E+ ++S +  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLK-----------EHLYG-TLTHEQRINWIKRLEI 513
           +V  LG C   G  +++ E+   G L            E+ Y  +   E++++    L  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHF 171
Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIV 572
           +   A+G+ +L +      IHRD+ + N+LL     AK+ DFGL++  ++ +++ V    
Sbjct: 172 SSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 228
Query: 573 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           R  V ++ PE       T +SDV+S+G++L E+ S
Sbjct: 229 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 104/223 (46%), Gaps = 36/223 (16%)
Query: 412 LEKKIGSGGFGVVY----YG--KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 463
           L K +G G FG V     +G  K    + +AVK+L   +   + R   +E+ +L  I HH
Sbjct: 32  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 91
Query: 464 RNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHL---------YGT--------LTHEQRI 505
            N+V  LG C + G  ++V  EF   G L  +L         Y T        LT E  I
Sbjct: 92  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLI 151
Query: 506 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
            +      +   AKG+E+L +      IHRDL + NILL +    K+ DFGL++      
Sbjct: 152 CY------SFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 566 SHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             V     R  + ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 103/223 (46%), Gaps = 35/223 (15%)
Query: 412 LEKKIGSGGFGVVY----YG--KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 463
           L K +G G FG V     +G  K    + +AVK+L   +   + R   +E+ +L  I HH
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 464 RNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED------ 516
            N+V  LG C + G  ++V  EF   G L  +L       +R  ++      ED      
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----RSKRNEFVPYKVAPEDLYKDFL 145
Query: 517 -----------AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
                       AKG+E+L +      IHRDL + NILL +    K+ DFGL++      
Sbjct: 146 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 566 SHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            +V     R  + ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 414 KKIGSGGFG-VVYYGKLKDGKE-----IAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 465
           K +G+G FG VV       GKE     +AVK+L S ++  ++E   +E+ ++S +  H N
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY----GTLTHE--QRINWIKRLEIAEDAAK 519
           +V  LG C   G  +++ E+   G L   L       L  E  + +     L  +   A+
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 163
Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGY 578
           G+ +L +      IHRD+ + N+LL     AK+ DFGL++  ++ +++ V    R  V +
Sbjct: 164 GMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 220
Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELIS 607
           + PE       T +SDV+S+G++L E+ S
Sbjct: 221 MAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 405 IEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSR--- 460
           IED   +L K +G G FG V+  + K   +  A+K L  +      +   E T++ +   
Sbjct: 16  IEDF--ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVL 71
Query: 461 ---IHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 517
                H  L       Q +     V E+++ G L  H+        + +  +    A + 
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEI 127
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
             G+++LH+     I++RDLK  NILLDK    K++DFG+ K  + G +  +    GT  
Sbjct: 128 ILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC-GTPD 183
Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
           Y+ PE  + Q+     D +SFGV+L E++ GQ
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 415 KIGSGGFGVVYYGKLKDGK---EIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFL 470
           ++G G FG V  G  +  K   ++A+KVL   + +    E   E  ++ ++ +  +V+ +
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
           G CQ E   +LV E    G L + L G     + I      E+    + G++YL      
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEE---K 129
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             +HRDL + N+LL     AK+SDFGLSK   A D      S  +  + +  PE    ++
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 589 LTDKSDVYSFGVILLELIS-GQEAISNEK 616
            + +SDV+S+GV + E +S GQ+     K
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 19/212 (8%)
Query: 405 IEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSR--- 460
           IED    L K +G G FG V+  + K   +  A+K L  +      +   E T++ +   
Sbjct: 17  IEDFE--LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVL 72
Query: 461 ---IHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 517
                H  L       Q +     V E+++ G L  H+        + +  +    A + 
Sbjct: 73  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEI 128
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
             G+++LH+     I++RDLK  NILLDK    K++DFG+ K  + G +  +    GT  
Sbjct: 129 ILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC-GTPD 184
Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
           Y+ PE  + Q+     D +SFGV+L E++ GQ
Sbjct: 185 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 103/223 (46%), Gaps = 35/223 (15%)
Query: 412 LEKKIGSGGFGVVY----YG--KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 463
           L K +G G FG V     +G  K    + +AVK+L   +   + R   +E+ +L  I HH
Sbjct: 68  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 127
Query: 464 RNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED------ 516
            N+V  LG C + G  ++V  EF   G L  +L       +R  ++      ED      
Sbjct: 128 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----RSKRNEFVPYKVAPEDLYKDFL 182
Query: 517 -----------AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
                       AKG+E+L +      IHRDL + NILL +    K+ DFGL++      
Sbjct: 183 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 239
Query: 566 SHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            +V     R  + ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 240 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 414 KKIGSGGFG-VVYYGKLKDGKE-----IAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 465
           K +G+G FG VV       GKE     +AVK+L S ++  ++E   +E+ ++S +  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY----GTLTHE--QRINWIKRLEIAEDAAK 519
           +V  LG C   G  +++ E+   G L   L       L  E  + +     L  +   A+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 171
Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGY 578
           G+ +L +      IHRD+ + N+LL     AK+ DFGL++  ++ +++ V    R  V +
Sbjct: 172 GMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 228
Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELIS 607
           + PE       T +SDV+S+G++L E+ S
Sbjct: 229 MAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 102/222 (45%), Gaps = 35/222 (15%)
Query: 412 LEKKIGSGGFGVVY----YG--KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 463
           L K +G G FG V     +G  K    + +AVK+L   +   + R   +E+ +L  I HH
Sbjct: 33  LGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 92
Query: 464 RNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHLYGT----------------LTHEQRIN 506
            N+V  LG C + G  ++V  EF   G L  +L                   LT E  I 
Sbjct: 93  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIX 152
Query: 507 WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
           +      +   AKG+E+L +      IHRDL + NILL +    K+ DFGL++       
Sbjct: 153 Y------SFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 567 HV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            V     R  + ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 103/223 (46%), Gaps = 35/223 (15%)
Query: 412 LEKKIGSGGFGVVY----YG--KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 463
           L K +G G FG V     +G  K    + +AVK+L   +   + R   +E+ +L  I HH
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 464 RNLVQFLGYCQEEGRSVLVY-EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED------ 516
            N+V  LG C + G  ++V  EF   G L  +L       +R  ++      ED      
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-----RSKRNEFVPYKVAPEDLYKDFL 136
Query: 517 -----------AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
                       AKG+E+L +      IHRDL + NILL +    K+ DFGL++      
Sbjct: 137 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 566 SHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            +V     R  + ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 35/223 (15%)
Query: 412 LEKKIGSGGFGVVY----YG--KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 463
           L K +G G FG V     +G  K    + +AVK+L   +   + R   +E+ +L  I HH
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 464 RNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED------ 516
            N+V  LG C + G  ++V  EF   G L  +L       +R  ++      ED      
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----RSKRNEFVPYKVAPEDLYKDFL 145
Query: 517 -----------AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
                       AKG+E+L +      IHRDL + NILL +    K+ DFGL++      
Sbjct: 146 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 566 SHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             V     R  + ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 110/223 (49%), Gaps = 32/223 (14%)
Query: 410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLV 467
           ++LE K   G FG V+  +L +   +AVK+      Q K+ + +E  + S   + H NL+
Sbjct: 18  QLLEIK-ARGRFGCVWKAQLMN-DFVAVKIF---PLQDKQSWQSEREIFSTPGMKHENLL 72
Query: 468 QFLGYCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           QF+   ++ G ++     L+  F   G+L ++L G +     I W +   +AE  ++G+ 
Sbjct: 73  QFIA-AEKRGSNLEVELWLITAFHDKGSLTDYLKGNI-----ITWNELCHVAETMSRGLS 126
Query: 523 YLHT--------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVR 573
           YLH         G  P+I HRD KS N+LL   + A ++DFGL+ +F        +    
Sbjct: 127 YLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV 186
Query: 574 GTVGYLDPEYY-----ISQQLTDKSDVYSFGVILLELISGQEA 611
           GT  Y+ PE         +    + D+Y+ G++L EL+S  +A
Sbjct: 187 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKA 229

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 112/231 (48%), Gaps = 21/231 (9%)
Query: 381 PVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKV 439
           PVQ  +  + +  A+    FT          LEK IG G FG V+ G   +  K +A+K+
Sbjct: 5   PVQSGLPGMQNLKADPEELFT---------KLEK-IGKGSFGEVFKGIDNRTQKVVAIKI 54
Query: 440 L-TSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGT 498
           +    +     +   E+T+LS+     + ++ G   ++ +  ++ E++  G+  + L   
Sbjct: 55  IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG 114
Query: 499 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 558
              E +I  I R     +  KG++YLH+      IHRD+K++N+LL +H   K++DFG++
Sbjct: 115 PLDETQIATILR-----EILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVA 166
Query: 559 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
               D     +  V GT  ++ PE         K+D++S G+  +EL  G+
Sbjct: 167 GQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 14/209 (6%)
Query: 415 KIGSGGFGVVYYGKLKDGK---EIAVKVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFL 470
           ++G G FG V  G  +  K   ++A+KVL   + +    E   E  ++ ++ +  +V+ +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
           G CQ E   +LV E    G L + L G     + I      E+    + G++YL      
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK--- 455
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             +HR+L + N+LL     AK+SDFGLSK   A D      S  +  + +  PE    ++
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 589 LTDKSDVYSFGVILLELIS-GQEAISNEK 616
            + +SDV+S+GV + E +S GQ+     K
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMK 544

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 103/223 (46%), Gaps = 35/223 (15%)
Query: 412 LEKKIGSGGFGVVY----YG--KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 463
           L K +G G FG V     +G  K    + +AVK+L   +   + R   +E+ +L  I HH
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 464 RNLVQFLGYCQEEGRSVLVY-EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED------ 516
            N+V  LG C + G  ++V  EF   G L  +L       +R  ++      ED      
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-----RSKRNEFVPYKVAPEDLYKDFL 136
Query: 517 -----------AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
                       AKG+E+L +      IHRDL + NILL +    K+ DFGL++      
Sbjct: 137 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 566 SHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            +V     R  + ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 35/223 (15%)
Query: 412 LEKKIGSGGFGVVY----YG--KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 463
           L K +G G FG V     +G  K    + +AVK+L   +   + R   +E+ +L  I HH
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 464 RNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED------ 516
            N+V  LG C + G  ++V  EF   G L  +L       +R  ++      ED      
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----RSKRNEFVPYKVAPEDLYKDFL 145
Query: 517 -----------AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
                       AKG+E+L +      IHRDL + NILL +    K+ DFGL++      
Sbjct: 146 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 566 SHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             V     R  + ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 110/211 (52%), Gaps = 15/211 (7%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLL 458
           L D+E+  K+  +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL
Sbjct: 3   LVDMENFQKV--EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 60
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
             ++H N+V+ L     E +  LV+EF+H   LK+ +  +      +  IK         
Sbjct: 61  KELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLL 117
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVG 577
           +G+ + H+     ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ 
Sbjct: 118 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLW 172
Query: 578 YLDPEYYI-SQQLTDKSDVYSFGVILLELIS 607
           Y  PE  +  +  +   D++S G I  E+++
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRNLV 467
           KK+GSG +G V   K K  G E A+K++     T+ S  G     +EV +L ++ H N++
Sbjct: 27  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSG--ALLDEVAVLKQLDHPNIM 84
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           +   + +++    LV E    G     L+  +   Q+ + +    I +    G  YLH  
Sbjct: 85  KLYEFFEDKRNYYLVMEVYRGG----ELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH 140
Query: 528 CVPAIIHRDLKSSNILLDKHMR---AKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 584
               I+HRDLK  N+LL+   R    K+ DFGLS     G      +  GT  Y+ PE  
Sbjct: 141 ---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL--GTAYYIAPE-V 194
Query: 585 ISQQLTDKSDVYSFGVILLELISG 608
           + ++  +K DV+S GVIL  L+ G
Sbjct: 195 LRKKYDEKCDVWSCGVILYILLCG 218

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIH 462
           +L   +G G FG V  GK +  G ++AVK+L     +        +RE  N    L    
Sbjct: 19  ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQN----LKLFR 74
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H ++++            +V E++  G L    +  +    R++  +   + +    G++
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD 130
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y H   V   +HRDLK  N+LLD HM AK++DFGLS    DG     S   G+  Y  PE
Sbjct: 131 YCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC--GSPNYAAPE 185
Query: 583 YYISQQLT--DKSDVYSFGVILLELISG 608
             IS +L    + D++S GVIL  L+ G
Sbjct: 186 -VISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 107/212 (50%), Gaps = 12/212 (5%)
Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVL-TSNSYQGKREFTNEVTL 457
           F   D E+    LEK IG G FG V+ G   +  K +A+K++    +     +   E+T+
Sbjct: 20  FQSMDPEELFTKLEK-IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITV 78
Query: 458 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 517
           LS+     + ++ G   ++ +  ++ E++  G+  + L      E +I  I R     + 
Sbjct: 79  LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EI 133
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
            KG++YLH+      IHRD+K++N+LL +H   K++DFG++    D     ++ V GT  
Sbjct: 134 LKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPF 189
Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
           ++ PE         K+D++S G+  +EL  G+
Sbjct: 190 WMAPEVIKQSAYDSKADIWSLGITAIELARGE 221

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/256 (24%), Positives = 116/256 (45%), Gaps = 39/256 (15%)
Query: 416 IGSGGFGVVYYGK-LKDGKEIAVKVLTSNS-YQGK--REFTNEVTLLSRIHHRNLVQFLG 471
           +G G F  VY  + +  G E+A+K++   + Y+    +   NEV +  ++ H ++++   
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE---IAEDAAKGIEYLHTGC 528
           Y ++     LV E  HNG +  +L      + R+      E          G+ YLH+  
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYL------KNRVKPFSENEARHFMHQIITGMLYLHSH- 131
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
              I+HRDL  SN+LL ++M  K++DFGL ++  +    H +  + GT  Y+ PE     
Sbjct: 132 --GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRS 187
Query: 588 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 647
               +SDV+S G +   L+ G+                       ++  ++  ++  +L 
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPP--------------------FDTDTVKNTLNKVVLA 227
Query: 648 EYDIQSMWKIEEKALM 663
           +Y++ S   IE K L+
Sbjct: 228 DYEMPSFLSIEAKDLI 243

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 21/219 (9%)
Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVK-----VLTSNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +G G FG V        G+++A+K     VL  +  QG+ E   E++ L  + H +++
Sbjct: 10  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHII 67
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           +     + +   ++V E+  N      L+  +    +++  +     +     +EY H  
Sbjct: 68  KLYDVIKSKDEIIMVIEYAGN-----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               I+HRDLK  N+LLD+H+  K++DFGLS    DG    +S   G+  Y  PE  IS 
Sbjct: 123 ---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAPE-VISG 176
Query: 588 QLT--DKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
           +L    + DV+S GVIL  ++  +    +E      +NI
Sbjct: 177 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI 215

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 21/219 (9%)
Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVK-----VLTSNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +G G FG V        G+++A+K     VL  +  QG+ E   E++ L  + H +++
Sbjct: 14  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHII 71
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           +     + +   ++V E+  N      L+  +    +++  +     +     +EY H  
Sbjct: 72  KLYDVIKSKDEIIMVIEYAGN-----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 126
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               I+HRDLK  N+LLD+H+  K++DFGLS    DG    +S   G+  Y  PE  IS 
Sbjct: 127 ---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAPE-VISG 180
Query: 588 QLT--DKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
           +L    + DV+S GVIL  ++  +    +E      +NI
Sbjct: 181 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI 219

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           L K IG G F  V   + +  G+E+A+K++  T  +    ++   EV ++  ++H N+V+
Sbjct: 19  LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
                + E    L+ E+   G + ++L  +G +  ++  +  +++         ++Y H 
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYCHQ 132
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYYI 585
                I+HRDLK+ N+LLD  M  K++DFG S +F V G         G   Y  PE + 
Sbjct: 133 ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPELFQ 186
Query: 586 SQQLTD-KSDVYSFGVILLELISG 608
            ++    + DV+S GVIL  L+SG
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRNLV 467
           KK+GSG +G V   K K  G E A+K++     T+ S  G     +EV +L ++ H N++
Sbjct: 10  KKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA--LLDEVAVLKQLDHPNIM 67
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           +   + +++    LV E    G     L+  +   Q+ + +    I +    G  YLH  
Sbjct: 68  KLYEFFEDKRNYYLVMEVYRGG----ELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK- 122
Query: 528 CVPAIIHRDLKSSNILLDKHMR---AKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 584
               I+HRDLK  N+LL+   R    K+ DFGLS     G      +  GT  Y+ PE  
Sbjct: 123 --HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL--GTAYYIAPE-V 177
Query: 585 ISQQLTDKSDVYSFGVILLELISG 608
           + ++  +K DV+S GVIL  L+ G
Sbjct: 178 LRKKYDEKCDVWSCGVILYILLCG 201

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 35/223 (15%)
Query: 412 LEKKIGSGGFGVVY----YG--KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 463
           L K +G G FG V     +G  K    + +AVK+L   +   + R   +E+ +L  I HH
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 464 RNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED------ 516
            N+V  LG C + G  ++V  EF   G L  +L       +R  ++      ED      
Sbjct: 82  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----RSKRNEFVPYKVAPEDLYKDFL 136
Query: 517 -----------AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
                       AKG+E+L +      IHRDL + NILL +    K+ DFGL++      
Sbjct: 137 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 566 SHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             V     R  + ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           L K IG G F  V   + +  G+E+A+K++  T  +    ++   EV ++  ++H N+V+
Sbjct: 16  LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 75
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
                + E    L+ E+   G + ++L  +G +  ++  +  +++         ++Y H 
Sbjct: 76  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYCHQ 129
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYYI 585
                I+HRDLK+ N+LLD  M  K++DFG S +F V G         G+  Y  PE + 
Sbjct: 130 ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC---GSPPYAAPELFQ 183
Query: 586 SQQLTD-KSDVYSFGVILLELISG 608
            ++    + DV+S GVIL  L+SG
Sbjct: 184 GKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/239 (30%), Positives = 117/239 (48%), Gaps = 25/239 (10%)
Query: 399 CFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLT----SNSYQG--KREF 451
            F   D+ED  +M E+ +GSG F +V   + K  GKE A K +     S+S +G  + E 
Sbjct: 4   TFRQEDVEDHYEMGEE-LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEI 62
Query: 452 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIK 509
             EV +L  I H N++      + +   VL+ E +  G L + L    +LT ++   ++K
Sbjct: 63  EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK 122
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGA 565
           ++        G+ YLH+     I H DLK  NI LLDK++   R K+ DFG++   ++  
Sbjct: 123 QI------LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAG 172
Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
           +   +I  GT  ++ PE    + L  ++D++S GVI   L+SG      E       NI
Sbjct: 173 NEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI 230

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 118/271 (43%), Gaps = 22/271 (8%)
Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVK---VLTSNSYQGKREFTNEVTLLSRIHHRNLV 467
           +EKKIG G F  VY    L DG  +A+K   +      + + +   E+ LL +++H N++
Sbjct: 36  IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 95
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           ++     E+    +V E    G L   +      ++ I      +        +E++H+ 
Sbjct: 96  KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               ++HRD+K +N+ +      K+ D GL +F     +   S+V GT  Y+ PE     
Sbjct: 156 ---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 211
Query: 588 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 647
               KSD++S G +L E+ + Q     +K      N+    K  IE  D   +  PS  D
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCK-KIEQCDYPPL--PS--D 261
Query: 648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEV 678
            Y  +    + +   MC+ P    RP ++ V
Sbjct: 262 HYSEE----LRQLVNMCINPDPEKRPDVTYV 288

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           L+K IG G F  V   + +  G+E+AVK++  T  +    ++   EV ++  ++H N+V+
Sbjct: 19  LQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                + E    LV E+   G + ++L      +++    K  +I       ++Y H   
Sbjct: 79  LFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS----AVQYCHQ-- 132
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
              I+HRDLK+ N+LLD  M  K++DFG S +F V           G+  Y  PE +  +
Sbjct: 133 -KYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC---GSPPYAAPELFQGK 188
Query: 588 QLTD-KSDVYSFGVILLELISG 608
           +    + DV+S GVIL  L+SG
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSG 210

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 102/223 (45%), Gaps = 35/223 (15%)
Query: 412 LEKKIGSGGFGVVY----YG--KLKDGKEIAVKVLTSNSYQGK-REFTNEVTLLSRI-HH 463
           L K +G G FG V     +G  K    + +AVK+L   +   + R   +E+ +L  I HH
Sbjct: 22  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 81
Query: 464 RNLVQFLGYCQEEGRSVLVY-EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED------ 516
            N+V  LG C + G  ++V  EF   G L  +L       +R  ++      ED      
Sbjct: 82  LNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL-----RSKRNEFVPYKVAPEDLYKDFL 136
Query: 517 -----------AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
                       AKG+E+L +      IHRDL + NILL +    K+ DFGL++      
Sbjct: 137 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 566 SHV-SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             V     R  + ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQ 468
           ++ +G G FG V   K K  G+E AVKV++    + K +      EV LL ++ H N+ +
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXK 90
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
              + +++G   LV E    G     L+  +   +R + +    I      GI Y H   
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARIIRQVLSGITYXHKN- 145
Query: 529 VPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
              I+HRDLK  N+LL+   K    ++ DFGLS            I  GT  Y+ PE  +
Sbjct: 146 --KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI--GTAYYIAPE-VL 200
Query: 586 SQQLTDKSDVYSFGVILLELISG 608
                +K DV+S GVIL  L+SG
Sbjct: 201 HGTYDEKCDVWSTGVILYILLSG 223

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 21/219 (9%)
Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVK-----VLTSNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +G G FG V        G+++A+K     VL  +  QG+ E   E++ L  + H +++
Sbjct: 19  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHII 76
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           +     + +   ++V E+  N      L+  +    +++  +     +     +EY H  
Sbjct: 77  KLYDVIKSKDEIIMVIEYAGN-----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 131
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               I+HRDLK  N+LLD+H+  K++DFGLS    DG    +S   G+  Y  PE  IS 
Sbjct: 132 ---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAPE-VISG 185
Query: 588 QLTD--KSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
           +L    + DV+S GVIL  ++  +    +E      +NI
Sbjct: 186 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI 224

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 21/219 (9%)
Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVK-----VLTSNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +G G FG V        G+++A+K     VL  +  QG+ E   E++ L  + H +++
Sbjct: 20  KTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHII 77
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           +     + +   ++V E+  N      L+  +    +++  +     +     +EY H  
Sbjct: 78  KLYDVIKSKDEIIMVIEYAGN-----ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 132
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               I+HRDLK  N+LLD+H+  K++DFGLS    DG    +S   G+  Y  PE  IS 
Sbjct: 133 ---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAPE-VISG 186
Query: 588 QLTD--KSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
           +L    + DV+S GVIL  ++  +    +E      +NI
Sbjct: 187 KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI 225

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 465
           L K IG G F  V   + +  GKE+AVK+     L S+S Q   +   EV ++  ++H N
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVLNHPN 74
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +V+     + E    LV E+   G + ++L      +++    K  +I       ++Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS----AVQYCH 130
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
                 I+HRDLK+ N+LLD  M  K++DFG S     G + + +   G+  Y  PE + 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFC-GSPPYAAPELFQ 185
Query: 586 SQQLTD-KSDVYSFGVILLELISG 608
            ++    + DV+S GVIL  L+SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/243 (30%), Positives = 114/243 (46%), Gaps = 15/243 (6%)
Query: 372 DKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVV---YYGK 428
           DK   R +LP+   V     A  E      +        + +K++GSG FG V   YY  
Sbjct: 334 DKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQM 393
Query: 429 LKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM 486
            K  K +AVK+L   +N    K E   E  ++ ++ +  +V+ +G C+ E   +LV E  
Sbjct: 394 KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMA 452
Query: 487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK 546
             G L ++L     H +  N I   E+    + G++YL        +HRDL + N+LL  
Sbjct: 453 ELGPLNKYLQQN-RHVKDKNII---ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVT 505
Query: 547 HMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLE 604
              AK+SDFGLSK      ++  +   G   V +  PE     + + KSDV+SFGV++ E
Sbjct: 506 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 565
Query: 605 LIS 607
             S
Sbjct: 566 AFS 568

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/249 (31%), Positives = 117/249 (46%), Gaps = 27/249 (10%)
Query: 372 DKEQHRHSLPVQRPV--SSLNDA----PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVV- 424
           DK   R +LP+   V  S   D     P E      L  +ED      K++GSG FG V 
Sbjct: 333 DKGPQREALPMDTEVFESPFADPEEIRPKEVYLDRKLLTLED------KELGSGNFGTVK 386
Query: 425 --YYGKLKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 480
             YY   K  K +AVK+L   +N    K E   E  ++ ++ +  +V+ +G C+ E   +
Sbjct: 387 KGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WM 445
Query: 481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 540
           LV E    G L ++L     H +  N I   E+    + G++YL        +HRDL + 
Sbjct: 446 LVMEMAELGPLNKYLQQN-RHVKDKNII---ELVHQVSMGMKYLEES---NFVHRDLAAR 498
Query: 541 NILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYISQQLTDKSDVYSF 598
           N+LL     AK+SDFGLSK      ++  +   G   V +  PE     + + KSDV+SF
Sbjct: 499 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 558
Query: 599 GVILLELIS 607
           GV++ E  S
Sbjct: 559 GVLMWEAFS 567

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 465
           L K IG G F  V   + +  GKE+AVK+     L S+S Q   +   EV ++  ++H N
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVLNHPN 74
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +V+     + E    LV E+   G + ++L      +++    K  +I       ++Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS----AVQYCH 130
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
                 I+HRDLK+ N+LLD  M  K++DFG S     G + + +   G+  Y  PE + 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFC-GSPPYAAPELFQ 185
Query: 586 SQQLTD-KSDVYSFGVILLELISG 608
            ++    + DV+S GVIL  L+SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVL-TSNSYQGKREFTNEVTLLSRI 461
           D E+    LEK IG G FG V+ G   +  K +A+K++    +     +   E+T+LS+ 
Sbjct: 4   DPEELFTKLEK-IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 62
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
               + ++ G   ++ +  ++ E++  G+  + L      E +I  I R     +  KG+
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGL 117
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           +YLH+      IHRD+K++N+LL +H   K++DFG++    D     ++ V GT  ++ P
Sbjct: 118 DYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 173
Query: 582 EYYISQQLTDKSDVYSFGVILLELISGQ 609
           E         K+D++S G+  +EL  G+
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 414 KKIGSGGFG-VVYYGKLKDGKE-----IAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 465
           K +G+G FG VV       GKE     +AVK+L S ++  ++E   +E+ ++S +  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY----------GTLTHEQRINWIKRLEIAE 515
           +V  LG C   G  +++ E+   G L   L                   ++    L  + 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRG 574
             A+G+ +L +      IHRD+ + N+LL     AK+ DFGL++  ++ +++ V    R 
Sbjct: 172 QVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 575 TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            V ++ PE       T +SDV+S+G++L E+ S
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 413 EKKIGSGGFGVV---YYGKLKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLV 467
           +K++GSG FG V   YY   K  K +AVK+L   +N    K E   E  ++ ++ +  +V
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           + +G C+ E   +LV E    G L ++L     H +  N I   E+    + G++YL   
Sbjct: 92  RMIGICEAES-WMLVMEMAELGPLNKYLQQN-RHVKDKNII---ELVHQVSMGMKYLEES 146
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYI 585
                +HRDL + N+LL     AK+SDFGLSK      ++  +   G   V +  PE   
Sbjct: 147 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 203
Query: 586 SQQLTDKSDVYSFGVILLELIS 607
             + + KSDV+SFGV++ E  S
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 413 EKKIGSGGFGVV---YYGKLKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLV 467
           +K++GSG FG V   YY   K  K +AVK+L   +N    K E   E  ++ ++ +  +V
Sbjct: 32  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           + +G C+ E   +LV E    G L ++L     H +  N I   E+    + G++YL   
Sbjct: 92  RMIGICEAES-WMLVMEMAELGPLNKYLQQN-RHVKDKNII---ELVHQVSMGMKYLEES 146
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYI 585
                +HRDL + N+LL     AK+SDFGLSK      ++  +   G   V +  PE   
Sbjct: 147 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 203
Query: 586 SQQLTDKSDVYSFGVILLELIS 607
             + + KSDV+SFGV++ E  S
Sbjct: 204 YYKFSSKSDVWSFGVLMWEAFS 225

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 465
           L K IG G F  V   + +  GKE+AVK+     L S+S Q   +   EV ++  ++H N
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVLNHPN 74
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +V+     + E    LV E+   G + ++L      +++    K  +I       ++Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS----AVQYCH 130
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
                 I+HRDLK+ N+LLD  M  K++DFG S     G + + +   G   Y  PE + 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDAFC-GAPPYAAPELFQ 185
Query: 586 SQQLTD-KSDVYSFGVILLELISG 608
            ++    + DV+S GVIL  L+SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 76  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----ALEYLHGK-- 129
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 130 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 188
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 189 ACKSSDLWALGCIIYQLVAG 208

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 413 EKKIGSGGFGVV---YYGKLKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLV 467
           +K++GSG FG V   YY   K  K +AVK+L   +N    K E   E  ++ ++ +  +V
Sbjct: 30  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           + +G C+ E   +LV E    G L ++L     H +  N I   E+    + G++YL   
Sbjct: 90  RMIGICEAES-WMLVMEMAELGPLNKYLQQN-RHVKDKNII---ELVHQVSMGMKYLEES 144
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYI 585
                +HRDL + N+LL     AK+SDFGLSK      ++  +   G   V +  PE   
Sbjct: 145 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 201
Query: 586 SQQLTDKSDVYSFGVILLELIS 607
             + + KSDV+SFGV++ E  S
Sbjct: 202 YYKFSSKSDVWSFGVLMWEAFS 223

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 19/200 (9%)
Query: 415 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           ++G G FG VY  K K+ G   A KV+ + S +   ++  E+ +L+   H  +V+ LG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 474 QEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
             +G+  ++ EF   G +      L   LT E +I  + R        + + +LH+    
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLT-EPQIQVVCR-----QMLEALNFLHSK--- 128
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
            IIHRDLK+ N+L+      +++DFG+S   +       S + GT  ++ PE  + + + 
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMK 187
Query: 591 D-----KSDVYSFGVILLEL 605
           D     K+D++S G+ L+E+
Sbjct: 188 DTPYDYKADIWSLGITLIEM 207

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVS----ALEYLHGK-- 151
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 152 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 210
Query: 589 LTDKSDVYSFGVILLELISG 608
            +  SD+++ G I+ +L++G
Sbjct: 211 ASKSSDLWALGCIIYQLVAG 230

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 75  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----ALEYLHGK-- 128
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 129 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 187
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 188 ACKSSDLWALGCIIYQLVAG 207

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 103 YFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK-- 156
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 157 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 215
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 216 ACKSSDLWALGCIIYQLVAG 235

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK-- 149
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 150 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKS 208
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 209 ACKSSDLWALGCIIYQLVAG 228

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 26/214 (12%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQF 469
           L++ IGSG   VV        KE +A+K +     Q    E   E+  +S+ HH N+V +
Sbjct: 14  LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY 73
Query: 470 LGYCQEEGRSVLVYEFMHNGTL----------KEHLYGTLTHEQRINWIKRLEIAEDAAK 519
                 +    LV + +  G++           EH  G L  E  I  I R     +  +
Sbjct: 74  YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILR-----EVLE 127
Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR----GT 575
           G+EYLH       IHRD+K+ NILL +    +++DFG+S F   G     + VR    GT
Sbjct: 128 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 576 VGYLDPEYYISQQLTD-KSDVYSFGVILLELISG 608
             ++ PE     +  D K+D++SFG+  +EL +G
Sbjct: 185 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 100
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 101 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK-- 154
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 155 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 213
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 214 ACKSSDLWALGCIIYQLVAG 233

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 413 EKKIGSGGFGVV---YYGKLKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLV 467
           +K++GSG FG V   YY   K  K +AVK+L   +N    K E   E  ++ ++ +  +V
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           + +G C+ E   +LV E    G L ++L     H +  N I   E+    + G++YL   
Sbjct: 82  RMIGICEAES-WMLVMEMAELGPLNKYLQQN-RHVKDKNII---ELVHQVSMGMKYLEES 136
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYI 585
                +HRDL + N+LL     AK+SDFGLSK      ++  +   G   V +  PE   
Sbjct: 137 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 586 SQQLTDKSDVYSFGVILLELIS 607
             + + KSDV+SFGV++ E  S
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 413 EKKIGSGGFGVV---YYGKLKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLV 467
           +K++GSG FG V   YY   K  K +AVK+L   +N    K E   E  ++ ++ +  +V
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           + +G C+ E   +LV E    G L ++L     H +  N I   E+    + G++YL   
Sbjct: 76  RMIGICEAES-WMLVMEMAELGPLNKYLQQN-RHVKDKNII---ELVHQVSMGMKYLEES 130
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYI 585
                +HRDL + N+LL     AK+SDFGLSK      ++  +   G   V +  PE   
Sbjct: 131 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 187
Query: 586 SQQLTDKSDVYSFGVILLELIS 607
             + + KSDV+SFGV++ E  S
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK-- 152
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 153 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 211
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 212 ACKSSDLWALGCIIYQLVAG 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK-- 151
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 152 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 211 ACKSSDLWALGCIIYQLVAG 230

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 19/200 (9%)
Query: 415 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           ++G G FG VY  K K+ G   A KV+ + S +   ++  E+ +L+   H  +V+ LG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 474 QEEGRSVLVYEFMHNGTLKE---HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
             +G+  ++ EF   G +      L   LT E +I  + R        + + +LH+    
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLT-EPQIQVVCR-----QMLEALNFLHSK--- 136
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
            IIHRDLK+ N+L+      +++DFG+S   +       S + GT  ++ PE  + + + 
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMK 195
Query: 591 D-----KSDVYSFGVILLEL 605
           D     K+D++S G+ L+E+
Sbjct: 196 DTPYDYKADIWSLGITLIEM 215

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 413 EKKIGSGGFGVV---YYGKLKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLV 467
           +K++GSG FG V   YY   K  K +AVK+L   +N    K E   E  ++ ++ +  +V
Sbjct: 10  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           + +G C+ E   +LV E    G L ++L     H +  N I   E+    + G++YL   
Sbjct: 70  RMIGICEAES-WMLVMEMAELGPLNKYLQQN-RHVKDKNII---ELVHQVSMGMKYLEES 124
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYI 585
                +HRDL + N+LL     AK+SDFGLSK      ++  +   G   V +  PE   
Sbjct: 125 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 181
Query: 586 SQQLTDKSDVYSFGVILLELIS 607
             + + KSDV+SFGV++ E  S
Sbjct: 182 YYKFSSKSDVWSFGVLMWEAFS 203

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK-- 151
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 152 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 211 ACKSSDLWALGCIIYQLVAG 230

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 109/222 (49%), Gaps = 31/222 (13%)
Query: 414 KKIGSGGFG-VVYYGKLKDGKE-----IAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 465
           K +G+G FG VV       GKE     +AVK+L S ++  ++E   +E+ ++S +  H N
Sbjct: 37  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 96
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTL-------KEHLYG-TLTHEQRINWIKR------- 510
           +V  LG C   G  +++ E+   G L        E + G +L   Q    + +       
Sbjct: 97  IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLE 156
Query: 511 ----LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
               L  +   A+G+ +L +      IHRD+ + N+LL     AK+ DFGL++  ++ ++
Sbjct: 157 LRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 213
Query: 567 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           + V    R  V ++ PE       T +SDV+S+G++L E+ S
Sbjct: 214 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 26/214 (12%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQF 469
           L++ IGSG   VV        KE +A+K +     Q    E   E+  +S+ HH N+V +
Sbjct: 19  LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78
Query: 470 LGYCQEEGRSVLVYEFMHNGTL----------KEHLYGTLTHEQRINWIKRLEIAEDAAK 519
                 +    LV + +  G++           EH  G L  E  I  I R     +  +
Sbjct: 79  YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILR-----EVLE 132
Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR----GT 575
           G+EYLH       IHRD+K+ NILL +    +++DFG+S F   G     + VR    GT
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 576 VGYLDPEYYISQQLTD-KSDVYSFGVILLELISG 608
             ++ PE     +  D K+D++SFG+  +EL +G
Sbjct: 190 PCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK-- 151
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 152 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 211 ACKSSDLWALGCIIYQLVAG 230

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 12/208 (5%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVL-TSNSYQGKREFTNEVTLLSRI 461
           D E+    LEK IG G FG V+ G   +  K +A+K++    +     +   E+T+LS+ 
Sbjct: 4   DPEELFTKLEK-IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 62
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
               + ++ G   ++ +  ++ E++  G+  + L      E +I  I R     +  KG+
Sbjct: 63  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGL 117
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           +YLH+      IHRD+K++N+LL +H   K++DFG++    D     +  V GT  ++ P
Sbjct: 118 DYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAP 173
Query: 582 EYYISQQLTDKSDVYSFGVILLELISGQ 609
           E         K+D++S G+  +EL  G+
Sbjct: 174 EVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 105/223 (47%), Gaps = 42/223 (18%)
Query: 414 KKIGSGGFG-VVYYGKLKDGKE-----IAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 465
           K +G+G FG VV       GKE     +AVK+L S ++  ++E   +E+ ++S +  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR----------LEIAE 515
           +V  LG C   G  +++ E+   G L             +N+++R            IA 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDL-------------LNFLRRKSRVLETDPAFAIAN 158
Query: 516 DAAKGIEYLHTGCVPA----------IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA 565
             A   + LH     A           IHRD+ + N+LL     AK+ DFGL++  ++ +
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 566 SH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           ++ V    R  V ++ PE       T +SDV+S+G++L E+ S
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 465
           L K IG G F  V   + +  GKE+AV++     L S+S Q   +   EV ++  ++H N
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQ---KLFREVRIMKVLNHPN 74
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +V+     + E    LV E+   G + ++L      +++    K  +I       ++Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS----AVQYCH 130
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
                 I+HRDLK+ N+LLD  M  K++DFG S     G + + +   G+  Y  PE + 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFC-GSPPYAAPELFQ 185
Query: 586 SQQLTD-KSDVYSFGVILLELISG 608
            ++    + DV+S GVIL  L+SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK-- 149
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 150 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 209 ACKSSDLWALGCIIYQLVAG 228

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 413 EKKIGSGGFGVV---YYGKLKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLV 467
           +K++GSG FG V   YY   K  K +AVK+L   +N    K E   E  ++ ++ +  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           + +G C+ E   +LV E    G L ++L     H +  N I   E+    + G++YL   
Sbjct: 72  RMIGICEAES-WMLVMEMAELGPLNKYLQQN-RHVKDKNII---ELVHQVSMGMKYLEES 126
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYI 585
                +HRDL + N+LL     AK+SDFGLSK      ++  +   G   V +  PE   
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 586 SQQLTDKSDVYSFGVILLELIS 607
             + + KSDV+SFGV++ E  S
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFS 205

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK-- 149
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 150 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 209 ACKSSDLWALGCIIYQLVAG 228

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 73  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----ALEYLHGK-- 126
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 127 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 185
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 186 ACKSSDLWALGCIIYQLVAG 205

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----ALEYLHGK-- 127
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 128 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 186
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 187 ACKSSDLWALGCIIYQLVAG 206

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK-- 151
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 152 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 211 ACKSSDLWALGCIIYQLVAG 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHG--- 150
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 211 AXKSSDLWALGCIIYQLVAG 230

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+  V 
Sbjct: 76  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSHRV- 131
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 132 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGXKY 187
Query: 590 TDKS-DVYSFGVILLELIS 607
              + D++S G I  E+++
Sbjct: 188 YSTAVDIWSLGCIFAEMVT 206

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIH 462
           +L   +G G FG V  G+ +  G ++AVK+L     +        KRE  N    L    
Sbjct: 14  VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQN----LKLFR 69
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H ++++            +V E++  G L    +  +    R+  ++   + +     ++
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y H   V   +HRDLK  N+LLD HM AK++DFGLS    DG    +S   G+  Y  PE
Sbjct: 126 YCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAAPE 180
Query: 583 YYISQQLT--DKSDVYSFGVILLELISGQEAISNE 615
             IS +L    + D++S GVIL  L+ G     +E
Sbjct: 181 -VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK-- 152
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 153 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 211
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 212 ACKSSDLWALGCIIYQLVAG 231

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 414 KKIGSGGFGVVY----YGKLKD--GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 465
           K +G+G FG V     YG +K      +AVK+L  +++  +RE   +E+ +LS + +H N
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI----------------- 508
           +V  LG C   G ++++ E+   G L   L       +R ++I                 
Sbjct: 112 IVNLLGACTIGGPTLVITEYCCYGDLLNFL-----RRKRDSFICSKTSPAIMEDDELALD 166
Query: 509 --KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
               L  +   AKG+ +L +      IHRDL + NILL      K+ DFGL++   + ++
Sbjct: 167 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSN 223
Query: 567 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           + V    R  V ++ PE   +   T +SDV+S+G+ L EL S
Sbjct: 224 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+  V 
Sbjct: 69  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSHRV- 124
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 125 --LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGXKY 180
Query: 590 TDKS-DVYSFGVILLELIS 607
              + D++S G I  E+++
Sbjct: 181 YSTAVDIWSLGCIFAEMVT 199

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 76  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 129
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 130 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 187
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 188 YSTAVDIWSLGCIFAEMVT 206

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 109/211 (51%), Gaps = 15/211 (7%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLL 458
           L  +E+  K+  +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL
Sbjct: 3   LGSMENFQKV--EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 60
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
             ++H N+V+ L     E +  LV+EF+H   LK+ +  +      +  IK         
Sbjct: 61  KELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLL 117
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVG 577
           +G+ + H+     ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ 
Sbjct: 118 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 172
Query: 578 YLDPEYYI-SQQLTDKSDVYSFGVILLELIS 607
           Y  PE  +  +  +   D++S G I  E+++
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 416 IGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGYC 473
           +G+G F  V   + K  ++ +A+K +   + +GK     NE+ +L +I H N+V      
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
           +  G   L+ + +  G L + +     + +R       ++ +     ++YLH      I+
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD----AVKYLHD---LGIV 138
Query: 534 HRDLKSSNIL---LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
           HRDLK  N+L   LD+  +  +SDFGLSK    G+  V S   GT GY+ PE    +  +
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYS 196
Query: 591 DKSDVYSFGVILLELISGQEAISNE 615
              D +S GVI   L+ G     +E
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDE 221

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 27/211 (12%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           K+IG G +G V+ GK + G+++AVKV  T+      RE     T+L R  H N++ F+  
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMR--HENILGFIAA 99
Query: 473 ----CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                    +  L+ ++  NG+L ++L  T    + +     L++A  +  G+ +LHT  
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSM-----LKLAYSSVSGLCHLHTEI 154
Query: 529 V-----PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS---SIVRGTVGYLD 580
                 PAI HRDLKS NIL+ K+    ++D GL+   +   + V    +   GT  Y+ 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 581 PEYYISQ------QLTDKSDVYSFGVILLEL 605
           PE           Q    +D+YSFG+IL E+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 109/211 (51%), Gaps = 15/211 (7%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLL 458
           L  +E+  K+  +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL
Sbjct: 2   LGSMENFQKV--EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
             ++H N+V+ L     E +  LV+EF+H   LK+ +  +      +  IK         
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLL 116
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVG 577
           +G+ + H+     ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ 
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 171
Query: 578 YLDPEYYI-SQQLTDKSDVYSFGVILLELIS 607
           Y  PE  +  +  +   D++S G I  E+++
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 80  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----ALEYLHGK-- 133
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 134 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 192
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 193 ACKSSDLWALGCIIYQLVAG 212

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 68  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 121
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 179
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 180 YSTAVDIWSLGCIFAEMVT 198

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 413 EKKIGSGGFGVV---YYGKLKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLV 467
           +K++GSG FG V   YY   K  K +AVK+L   +N    K E   E  ++ ++ +  +V
Sbjct: 16  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           + +G C+ E   +LV E    G L ++L     H +  N I   E+    + G++YL   
Sbjct: 76  RMIGICEAES-WMLVMEMAELGPLNKYLQQN-RHVKDKNII---ELVHQVSMGMKYLEES 130
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYI 585
                +HRDL + N+LL     AK+SDFGLSK      +   +   G   V +  PE   
Sbjct: 131 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECIN 187
Query: 586 SQQLTDKSDVYSFGVILLELIS 607
             + + KSDV+SFGV++ E  S
Sbjct: 188 YYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLSFCHSH--- 122
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 180
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 181 YSTAVDIWSLGCIFAEMVT 199

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 465
           L K IG G F  V   + +  GKE+AV++     L S+S Q   +   EV ++  ++H N
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQ---KLFREVRIMKVLNHPN 74
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +V+     + E    LV E+   G + ++L      +++    K  +I       ++Y H
Sbjct: 75  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS----AVQYCH 130
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
                 I+HRDLK+ N+LLD  M  K++DFG S     G + +     G+  Y  PE + 
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDEFC-GSPPYAAPELFQ 185
Query: 586 SQQLTD-KSDVYSFGVILLELISG 608
            ++    + DV+S GVIL  L+SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 416 IGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGYC 473
           +G+G F  V   + K  ++ +A+K +   + +GK     NE+ +L +I H N+V      
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
           +  G   L+ + +  G L + +     + +R       ++ +     ++YLH      I+
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD----AVKYLHD---LGIV 138
Query: 534 HRDLKSSNIL---LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
           HRDLK  N+L   LD+  +  +SDFGLSK    G+  V S   GT GY+ PE    +  +
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYS 196
Query: 591 DKSDVYSFGVILLELISGQEAISNE 615
              D +S GVI   L+ G     +E
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDE 221

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 127/278 (45%), Gaps = 42/278 (15%)
Query: 415 KIGSGGFGVVYYGKLKDGK------EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +IG G F  VY G   +        E+  + LT +  Q    F  E   L  + H N+V+
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVR 89
Query: 469 FLGYCQE--EGRS--VLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIE 522
           F    +   +G+   VLV E   +GTLK +L      + ++  +W +++       KG++
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGLQ 143
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           +LHT   P IIHRDLK  NI +       K+ D GL+   +  AS   +++ GT  +  P
Sbjct: 144 FLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA--TLKRASFAKAVI-GTPEFXAP 199
Query: 582 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 641
           E Y  ++  +  DVY+FG   LE  + +   S       C+N  Q  +  + SG     +
Sbjct: 200 EXY-EEKYDESVDVYAFGXCXLEXATSEYPYS------ECQNAAQIYR-RVTSG-----V 246
Query: 642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 679
            P+  D+  I  + +I E    C+  +   R SI ++L
Sbjct: 247 KPASFDKVAIPEVKEIIEG---CIRQNKDERYSIKDLL 281

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 122
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 180
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 181 YSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 68  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 121
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 179
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 180 YSTAVDIWSLGCIFAEMVT 198

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 71  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 124
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 182
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 183 YSTAVDIWSLGCIFAEMVT 201

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 122
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 180
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 181 YSTAVDIWSLGCIFAEMVT 199

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 70  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 123
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 181
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 182 YSTAVDIWSLGCIFAEMVT 200

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQD-LKDFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 122
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 123 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 180
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 181 YSTAVDIWSLGCIFAEMVT 199

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 71  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 124
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 125 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 182
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 183 YSTAVDIWSLGCIFAEMVT 201

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 416 IGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGYC 473
           +G+G F  V   + K  ++ +A+K +   + +GK     NE+ +L +I H N+V      
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
           +  G   L+ + +  G L + +     + +R       ++ +     ++YLH      I+
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD----AVKYLHD---LGIV 138
Query: 534 HRDLKSSNIL---LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
           HRDLK  N+L   LD+  +  +SDFGLSK    G+  V S   GT GY+ PE    +  +
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYS 196
Query: 591 DKSDVYSFGVILLELISGQEAISNE 615
              D +S GVI   L+ G     +E
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDE 221

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 70
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 71  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 124
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 125 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 182
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 183 YSTAVDIWSLGCIFAEMVT 201

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 414 KKIGSGGFGVVY----YGKLKD--GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 465
           K +G+G FG V     YG +K      +AVK+L  +++  +RE   +E+ +LS + +H N
Sbjct: 45  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 104
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI----------------- 508
           +V  LG C   G ++++ E+   G L   L       +R ++I                 
Sbjct: 105 IVNLLGACTIGGPTLVITEYCCYGDLLNFL-----RRKRDSFICSKTSPAIMEDDELALD 159
Query: 509 --KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
               L  +   AKG+ +L +      IHRDL + NILL      K+ DFGL++   + ++
Sbjct: 160 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 216
Query: 567 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           + V    R  V ++ PE   +   T +SDV+S+G+ L EL S
Sbjct: 217 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 122
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 180
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 181 YSTAVDIWSLGCIFAEMVT 199

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 122
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 180
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 181 YSTAVDIWSLGCIFAEMVT 199

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 414 KKIGSGGFGVVY----YGKLKD--GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 465
           K +G+G FG V     YG +K      +AVK+L  +++  +RE   +E+ +LS + +H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI----------------- 508
           +V  LG C   G ++++ E+   G L   L       +R ++I                 
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFL-----RRKRDSFICSKTSPAIMEDDELALD 143
Query: 509 --KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
               L  +   AKG+ +L +      IHRDL + NILL      K+ DFGL++   + ++
Sbjct: 144 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 567 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           + V    R  V ++ PE   +   T +SDV+S+G+ L EL S
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 72  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 125
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 183
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 184 YSTAVDIWSLGCIFAEMVT 202

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 68  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 121
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 179
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 180 YSTAVDIWSLGCIFAEMVT 198

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 68  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 121
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 179
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 180 YSTAVDIWSLGCIFAEMVT 198

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK-- 148
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 149 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 207
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 208 ACKSSDLWALGCIIYQLVAG 227

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 416 IGSGGFGVVYYGKLKDGKE-IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGYC 473
           +G+G F  V   + K  ++ +A+K +   + +GK     NE+ +L +I H N+V      
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
           +  G   L+ + +  G L + +     + +R       ++ +     ++YLH      I+
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD----AVKYLHD---LGIV 138
Query: 534 HRDLKSSNIL---LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
           HRDLK  N+L   LD+  +  +SDFGLSK    G+  V S   GT GY+ PE    +  +
Sbjct: 139 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPYS 196
Query: 591 DKSDVYSFGVILLELISGQEAISNE 615
              D +S GVI   L+ G     +E
Sbjct: 197 KAVDCWSIGVIAYILLCGYPPFYDE 221

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 122
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 180
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 181 YSTAVDIWSLGCIFAEMVT 199

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K IGSG  G+V   Y   L+  + +A+K L+    N    KR +  E+ L+  ++H+N++
Sbjct: 30  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNII 86
Query: 468 QFLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
             L         EE + V +   + +  L + +   L HE+    + ++ +      GI+
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV------GIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELISG 608
             +     +  D++S GVI+ E+I G
Sbjct: 196 VILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K   E+    K+      +G       E++LL  ++H N+V+ L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 122
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 180
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 181 YSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K   E+    K+      +G       E++LL  ++H N+V+ L
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 68  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 121
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 179
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 180 YSTAVDIWSLGCIFAEMVT 198

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIH 462
           +L   +G G FG V  G+ +  G ++AVK+L     +        KRE  N    L    
Sbjct: 14  VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQN----LKLFR 69
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H ++++            +V E++  G L    +  +    R+  ++   + +     ++
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y H   V   +HRDLK  N+LLD HM AK++DFGLS    DG     S   G+  Y  PE
Sbjct: 126 YCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC--GSPNYAAPE 180
Query: 583 YYISQQLTD--KSDVYSFGVILLELISGQEAISNE 615
             IS +L    + D++S GVIL  L+ G     +E
Sbjct: 181 -VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 23/205 (11%)
Query: 414 KKIGSGGFGVVY--YGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + + + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 30  KPIGSGAQGIVVAAYDAILE-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNIIG 87
Query: 469 FLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
            L         EE + V +   + +  L + +   L HE+    + ++ +      GI++
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV------GIKH 141
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEV 196
Query: 584 YISQQLTDKSDVYSFGVILLELISG 608
            +     +  D++S GVI+ E+I G
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 70  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 123
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 181
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 182 YSTAVDIWSLGCIFAEMVT 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 70  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 123
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 181
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 182 YSTAVDIWSLGCIFAEMVT 200

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 414 KKIGSGGFGVVY----YGKLKD--GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 465
           K +G+G FG V     YG +K      +AVK+L  +++  +RE   +E+ +LS + +H N
Sbjct: 52  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 111
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI----------------- 508
           +V  LG C   G ++++ E+   G L   L       +R ++I                 
Sbjct: 112 IVNLLGACTIGGPTLVITEYCCYGDLLNFL-----RRKRDSFICSKTSPAIMEDDELALD 166
Query: 509 --KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
               L  +   AKG+ +L +      IHRDL + NILL      K+ DFGL++   + ++
Sbjct: 167 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 223
Query: 567 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           + V    R  V ++ PE   +   T +SDV+S+G+ L EL S
Sbjct: 224 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 38/279 (13%)
Query: 411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNL 466
           M  + +G GGF   Y     D KE+    +   S       K + + E+ +   + + ++
Sbjct: 45  MRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHV 104
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKE-HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           V F G+ +++    +V E     +L E H       E    +  R  I     +G++YLH
Sbjct: 105 VGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLH 159
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYY 584
                 +IHRDLK  N+ L+  M  K+ DFGL +K   DG       + GT  Y+ PE  
Sbjct: 160 NN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKTLCGTPNYIAPEVL 214
Query: 585 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 644
             +  + + D++S G IL  L+ G+       F  +C   ++   + I+           
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPP-----FETSC---LKETYIRIKK---------- 256
Query: 645 LLDEYDIQSMWKIEEKALMCVLPHGH--MRPSISEVLKD 681
             +EY +         AL+  + H    +RPS++E+L D
Sbjct: 257 --NEYSVPRHINPVASALIRRMLHADPTLRPSVAELLTD 293

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 69  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 122
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 123 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 180
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 181 YSTAVDIWSLGCIFAEMVT 199

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK+ +  +      +  IK         +G+ + H+    
Sbjct: 70  DVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 123
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 124 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 181
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 182 YSTAVDIWSLGCIFAEMVT 200

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 414 KKIGSGGFGVVY----YGKLKD--GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRN 465
           K +G+G FG V     YG +K      +AVK+L  +++  +RE   +E+ +LS + +H N
Sbjct: 47  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 106
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI----------------- 508
           +V  LG C   G ++++ E+   G L   L       +R ++I                 
Sbjct: 107 IVNLLGACTIGGPTLVITEYCCYGDLLNFL-----RRKRDSFICSKTSPAIMEDDELALD 161
Query: 509 --KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
               L  +   AKG+ +L +      IHRDL + NILL      K+ DFGL++   + ++
Sbjct: 162 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 218
Query: 567 H-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           + V    R  V ++ PE   +   T +SDV+S+G+ L EL S
Sbjct: 219 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F      + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK-- 149
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 150 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 209 ACKSSDLWALGCIIYQLVAG 228

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 38/279 (13%)
Query: 411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNL 466
           M  + +G GGF   Y     D KE+    +   S       K + + E+ +   + + ++
Sbjct: 45  MRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHV 104
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKE-HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           V F G+ +++    +V E     +L E H       E    +  R  I     +G++YLH
Sbjct: 105 VGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLH 159
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYY 584
                 +IHRDLK  N+ L+  M  K+ DFGL +K   DG       + GT  Y+ PE  
Sbjct: 160 NN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKXLCGTPNYIAPEVL 214
Query: 585 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 644
             +  + + D++S G IL  L+ G+       F  +C   ++   + I+           
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPP-----FETSC---LKETYIRIKK---------- 256
Query: 645 LLDEYDIQSMWKIEEKALMCVLPHGH--MRPSISEVLKD 681
             +EY +         AL+  + H    +RPS++E+L D
Sbjct: 257 --NEYSVPRHINPVASALIRRMLHADPTLRPSVAELLTD 293

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+H   LK  +  +      +  IK         +G+ + H+    
Sbjct: 72  DVIHTENKLYLVFEFLHQD-LKTFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 125
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 183
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 184 YSTAVDIWSLGCIFAEMVT 202

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF---TNEVTLLSRIHHRNLVQF 469
           K +G G F  V   + L   +E A+K+L       + +    T E  ++SR+ H   V+ 
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++ +      +  NG L +++    + ++        EI       +EYLH    
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV----SALEYLHGK-- 148
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    + 
Sbjct: 149 -GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 207
Query: 589 LTDKSDVYSFGVILLELISG 608
               SD+++ G I+ +L++G
Sbjct: 208 ACKSSDLWALGCIIYQLVAG 227

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN------SYQGKREFTNEVTLLSRIHHRNL 466
           + +G GGFG V+  ++K  GK  A K L          YQG      E  +L+++H R +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFI 247
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V      + +    LV   M+ G ++ H+Y            + +        G+E+LH 
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                II+RDLK  N+LLD     ++SD GL+     G +       GT G++ PE  + 
Sbjct: 308 ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLG 363
Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
           ++     D ++ GV L E+I+ +
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 17/204 (8%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV--QFLG 471
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V  ++  
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTH----EQRINWIKRLEIAEDAAKGIEYLHTG 527
           Y   E + V VY  +    + E +Y    H    +Q +  I          + + Y+H+ 
Sbjct: 83  YSSGEKKDV-VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 528 CVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY-YI 585
               I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +  Y  PE  + 
Sbjct: 142 ---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPELIFG 196
Query: 586 SQQLTDKSDVYSFGVILLELISGQ 609
           +   T   DV+S G +L EL+ GQ
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN------SYQGKREFTNEVTLLSRIHHRNL 466
           + +G GGFG V+  ++K  GK  A K L          YQG      E  +L+++H R +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFI 247
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V      + +    LV   M+ G ++ H+Y            + +        G+E+LH 
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                II+RDLK  N+LLD     ++SD GL+     G +       GT G++ PE  + 
Sbjct: 308 ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLG 363
Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
           ++     D ++ GV L E+I+ +
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 14/201 (6%)
Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLTSN------SYQGKREFTNEVTLLSRIHHRNLVQ 468
           +G GGFG V+  ++K  GK  A K L          YQG      E  +L+++H R +V 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFIVS 249
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                + +    LV   M+ G ++ H+Y            + +        G+E+LH   
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-- 307
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              II+RDLK  N+LLD     ++SD GL+     G +       GT G++ PE  + ++
Sbjct: 308 -RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEE 365
Query: 589 LTDKSDVYSFGVILLELISGQ 609
                D ++ GV L E+I+ +
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN------SYQGKREFTNEVTLLSRIHHRNL 466
           + +G GGFG V+  ++K  GK  A K L          YQG      E  +L+++H R +
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA---MVEKKILAKVHSRFI 247
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V      + +    LV   M+ G ++ H+Y            + +        G+E+LH 
Sbjct: 248 VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                II+RDLK  N+LLD     ++SD GL+     G +       GT G++ PE  + 
Sbjct: 308 ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLG 363
Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
           ++     D ++ GV L E+I+ +
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 38/279 (13%)
Query: 411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNL 466
           M  + +G GGF   Y     D KE+    +   S       K + + E+ +   + + ++
Sbjct: 45  MRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHV 104
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKE-HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           V F G+ +++    +V E     +L E H       E    +  R  I     +G++YLH
Sbjct: 105 VGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLH 159
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYY 584
                 +IHRDLK  N+ L+  M  K+ DFGL +K   DG       + GT  Y+ PE  
Sbjct: 160 NN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVL 214
Query: 585 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 644
             +  + + D++S G IL  L+ G+       F  +C   ++   + I+           
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPP-----FETSC---LKETYIRIKK---------- 256
Query: 645 LLDEYDIQSMWKIEEKALMCVLPHGH--MRPSISEVLKD 681
             +EY +         AL+  + H    +RPS++E+L D
Sbjct: 257 --NEYSVPRHINPVASALIRRMLHADPTLRPSVAELLTD 293

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 116/235 (49%), Gaps = 25/235 (10%)
Query: 403 SDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLT----SNSYQG--KREFTNEV 455
           S +ED  +M E+ +GSG F +V   + K  GKE A K +     S+S +G  + E   EV
Sbjct: 1   SMVEDHYEMGEE-LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59
Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEI 513
            +L  I H N++      + +   VL+ E +  G L + L    +LT ++   ++K++  
Sbjct: 60  NILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI-- 117
Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVS 569
                 G+ YLH+     I H DLK  NI LLDK++   R K+ DFG++   ++  +   
Sbjct: 118 ----LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFK 169
Query: 570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
           +I  GT  ++ PE    + L  ++D++S GVI   L+SG      E       NI
Sbjct: 170 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI 223

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV 467
           T +  + +GSG F  V+  K +  GK  A+K +  +         NE+ +L +I H N+V
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIV 69
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
                 +      LV + +  G L + +     + ++   +    + +     ++YLH  
Sbjct: 70  TLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL----VIQQVLSAVKYLHEN 125
Query: 528 CVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 584
               I+HRDLK  N+L    +++ +  ++DFGLSK   +G   + S   GT GY+ PE  
Sbjct: 126 ---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVL 179
Query: 585 ISQQLTDKSDVYSFGVILLELISG 608
             +  +   D +S GVI   L+ G
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCG 203

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 38/279 (13%)
Query: 411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNL 466
           M  + +G GGF   Y     D KE+    +   S       K + + E+ +   + + ++
Sbjct: 29  MRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHV 88
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKE-HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           V F G+ +++    +V E     +L E H       E    +  R  I     +G++YLH
Sbjct: 89  VGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTI-----QGVQYLH 143
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYY 584
                 +IHRDLK  N+ L+  M  K+ DFGL +K   DG       + GT  Y+ PE  
Sbjct: 144 NN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER--KKDLCGTPNYIAPEVL 198
Query: 585 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 644
             +  + + D++S G IL  L+ G+       F  +C   ++   + I+           
Sbjct: 199 CKKGHSFEVDIWSLGCILYTLLVGKPP-----FETSC---LKETYIRIKK---------- 240
Query: 645 LLDEYDIQSMWKIEEKALMCVLPHGH--MRPSISEVLKD 681
             +EY +         AL+  + H    +RPS++E+L D
Sbjct: 241 --NEYSVPRHINPVASALIRRMLHADPTLRPSVAELLTD 277

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 416 IGSGGFGVVYYGKLK-DGKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           +G GGFGVV+  K K D    A+K +   N    + +   EV  L+++ H  +V++    
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 474 QEEGRS---------VLVY---EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            E+  +         V +Y   +      LK+ + G  T E+R   +  L I    A+ +
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC-LHIFLQIAEAV 131
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--------------ASH 567
           E+LH+     ++HRDLK SNI        KV DFGL   A+D               A H
Sbjct: 132 EFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVT-AMDQDEEEQTVLTPMPAYARH 187
Query: 568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELI 606
              +  GT  Y+ PE       + K D++S G+IL EL+
Sbjct: 188 TGQV--GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 24/222 (10%)
Query: 414 KKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQF 469
           K IGSG FGV    + K  KE +AVK +   +      +RE  N  +L     H N+V+F
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL----RHPNIVRF 81
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
                      ++ E+   G L E +   G  + ++   + ++L        G+ Y H+ 
Sbjct: 82  KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------LSGVSYCHSM 135
Query: 528 CVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
               I HRDLK  N LLD     R K+ DFG SK +V  +   S++  GT  Y+ PE  +
Sbjct: 136 ---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLL 190
Query: 586 SQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
            Q+   K +DV+S GV L  ++ G     + +   + R  +Q
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ 232

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 33/219 (15%)
Query: 409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI--HHRNL 466
           T +L++ IG G FG V+ GK + G+E+AVK+ +S     +R +  E  +   +   H N+
Sbjct: 43  TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 98
Query: 467 VQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYG-TLTHEQRINWIKRLEIAEDAAKGI 521
           + F+    ++  +     LV ++  +G+L ++L   T+T E  I      ++A   A G+
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGL 152
Query: 522 EYLHTGCV-----PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV---- 572
            +LH   V     PAI HRDLKS NIL+ K+    ++D GL+    D A+    I     
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHR 211
Query: 573 RGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLEL 605
            GT  Y+ PE           +   ++D+Y+ G++  E+
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 416 IGSGGFGVVYYGKLKD---GKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +G G FG V   K KD    +E AVKV+   S + K   T   EV LL ++ H N+++  
Sbjct: 30  LGKGSFGEVL--KCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
              ++     +V E    G     L+  +   +R +      I +    GI Y+H     
Sbjct: 88  EILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK---H 140
Query: 531 AIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
            I+HRDLK  NILL   +K    K+ DFGLS            I  GT  Y+ PE  +  
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPE-VLRG 197
Query: 588 QLTDKSDVYSFGVILLELISG 608
              +K DV+S GVIL  L+SG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K IGSG  G+V   Y   L+  + +A+K L+    N    KR +  E+ L+  ++H+N++
Sbjct: 30  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNII 86
Query: 468 QFLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
             L         EE + V +   + +  L + +   L HE+    + ++ +      GI+
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLV------GIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELISG 608
             +     +  D++S G I+ E+I G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 33/219 (15%)
Query: 409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI--HHRNL 466
           T +L++ IG G FG V+ GK + G+E+AVK+ +S     +R +  E  +   +   H N+
Sbjct: 5   TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 60
Query: 467 VQFLGYCQEEGRSV----LVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGI 521
           + F+    ++  +     LV ++  +G+L ++L   T+T E  I      ++A   A G+
Sbjct: 61  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGL 114
Query: 522 EYLHTGCV-----PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV---- 572
            +LH   V     PAI HRDLKS NIL+ K+    ++D GL+    D A+    I     
Sbjct: 115 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHR 173
Query: 573 RGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLEL 605
            GT  Y+ PE           +   ++D+Y+ G++  E+
Sbjct: 174 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 416 IGSGGFGVVYYGKLKD---GKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +G G FG V   K KD    +E AVKV+   S + K   T   EV LL ++ H N+++  
Sbjct: 30  LGKGSFGEVL--KCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
              ++     +V E    G     L+  +   +R +      I +    GI Y+H     
Sbjct: 88  EILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH--- 140
Query: 531 AIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
            I+HRDLK  NILL   +K    K+ DFGLS            I  GT  Y+ PE  +  
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPE-VLRG 197
Query: 588 QLTDKSDVYSFGVILLELISG 608
              +K DV+S GVIL  L+SG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 25/211 (11%)
Query: 411 MLEK-----KIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIH 462
           M+EK     KIG G +GVV+  + +D G+ +A+K    + +    K+    E+ +L ++ 
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE---HLYGTLTH-EQRINWIKRLEIAEDAA 518
           H NLV  L   + + R  LV+E+  +  L E   +  G   H  + I W           
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITW--------QTL 112
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           + + + H       IHRD+K  NIL+ KH   K+ DFG ++     + +    V  T  Y
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWY 168
Query: 579 LDPEYYI-SQQLTDKSDVYSFGVILLELISG 608
             PE  +   Q     DV++ G +  EL+SG
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 415 KIGSGGFGVVYYGKLKDGKEIAV-KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           ++G G FG VY  + K+   +A  KV+ + S +   ++  E+ +L+   H N+V+ L   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
             E    ++ EF   G +   +   L  E+ +   +   + +     + YLH      II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KII 157
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 591
           HRDLK+ NIL       K++DFG+S           S + GT  ++ PE  + +   D  
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 216
Query: 592 ---KSDVYSFGVILLEL 605
              K+DV+S G+ L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 415 KIGSGGFGVVYYGKLKDGKEIAV-KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           ++G G FG VY  + K+   +A  KV+ + S +   ++  E+ +L+   H N+V+ L   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
             E    ++ EF   G +   +   L  E+ +   +   + +     + YLH      II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KII 157
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 591
           HRDLK+ NIL       K++DFG+S           S + GT  ++ PE  + +   D  
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI-GTPYWMAPEVVMCETSKDRP 216
Query: 592 ---KSDVYSFGVILLEL 605
              K+DV+S G+ L+E+
Sbjct: 217 YDYKADVWSLGITLIEM 233

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 33/219 (15%)
Query: 409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI--HHRNL 466
           T +L++ IG G FG V+ GK + G+E+AVK+ +S     +R +  E  +   +   H N+
Sbjct: 4   TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 59
Query: 467 VQFLGYCQEEGRSV----LVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGI 521
           + F+    ++  +     LV ++  +G+L ++L   T+T E  I      ++A   A G+
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGL 113
Query: 522 EYLHTGCV-----PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV---- 572
            +LH   V     PAI HRDLKS NIL+ K+    ++D GL+    D A+    I     
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHR 172
Query: 573 RGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLEL 605
            GT  Y+ PE           +   ++D+Y+ G++  E+
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 33/219 (15%)
Query: 409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI--HHRNL 466
           T +L++ IG G FG V+ GK + G+E+AVK+ +S     +R +  E  +   +   H N+
Sbjct: 30  TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 85
Query: 467 VQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYG-TLTHEQRINWIKRLEIAEDAAKGI 521
           + F+    ++  +     LV ++  +G+L ++L   T+T E  I      ++A   A G+
Sbjct: 86  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGL 139
Query: 522 EYLHTGCV-----PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV---- 572
            +LH   V     PAI HRDLKS NIL+ K+    ++D GL+    D A+    I     
Sbjct: 140 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHR 198
Query: 573 RGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLEL 605
            GT  Y+ PE           +   ++D+Y+ G++  E+
Sbjct: 199 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 33/219 (15%)
Query: 409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI--HHRNL 466
           T +L++ IG G FG V+ GK + G+E+AVK+ +S     +R +  E  +   +   H N+
Sbjct: 10  TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 65
Query: 467 VQFLGYCQEEGRSV----LVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGI 521
           + F+    ++  +     LV ++  +G+L ++L   T+T E  I      ++A   A G+
Sbjct: 66  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGL 119
Query: 522 EYLHTGCV-----PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV---- 572
            +LH   V     PAI HRDLKS NIL+ K+    ++D GL+    D A+    I     
Sbjct: 120 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHR 178
Query: 573 RGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLEL 605
            GT  Y+ PE           +   ++D+Y+ G++  E+
Sbjct: 179 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 55/227 (24%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQ 468
           L + +G G +G V+ G L  G+ +AVK+ +S   Q    + E  N V L     H N++ 
Sbjct: 12  LVECVGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLL----RHDNILG 66
Query: 469 FLG----------------YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE 512
           F+                 +  E G    +Y+F+   TL+ HL               L 
Sbjct: 67  FIASDMTSRNSSTQLWLITHYHEHGS---LYDFLQRQTLEPHL--------------ALR 109
Query: 513 IAEDAAKGIEYLH-----TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 567
           +A  AA G+ +LH     T   PAI HRD KS N+L+  +++  ++D GL+     G+ +
Sbjct: 110 LAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDY 169
Query: 568 V---SSIVRGTVGYLDPEYYISQQLTD------KSDVYSFGVILLEL 605
           +   ++   GT  Y+ PE    Q  TD       +D+++FG++L E+
Sbjct: 170 LDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 109/219 (49%), Gaps = 33/219 (15%)
Query: 409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI--HHRNL 466
           T +L++ IG G FG V+ GK + G+E+AVK+ +S     +R +  E  +   +   H N+
Sbjct: 7   TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 62
Query: 467 VQFLGYCQEEGRSV----LVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGI 521
           + F+    ++  +     LV ++  +G+L ++L   T+T E  I      ++A   A G+
Sbjct: 63  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI------KLALSTASGL 116
Query: 522 EYLHTGCV-----PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV---- 572
            +LH   V     PAI HRDLKS NIL+ K+    ++D GL+    D A+    I     
Sbjct: 117 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA-VRHDSATDTIDIAPNHR 175
Query: 573 RGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLEL 605
            GT  Y+ PE           +   ++D+Y+ G++  E+
Sbjct: 176 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 416 IGSGGFGVVYYGKLKD---GKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +G G FG V   K KD    +E AVKV+   S + K   T   EV LL ++ H N+++  
Sbjct: 30  LGKGSFGEVL--KCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
              ++     +V E    G     L+  +   +R +      I +    GI Y+H     
Sbjct: 88  EILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH--- 140
Query: 531 AIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
            I+HRDLK  NILL   +K    K+ DFGLS            I  GT  Y+ PE  +  
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPE-VLRG 197
Query: 588 QLTDKSDVYSFGVILLELISG 608
              +K DV+S GVIL  L+SG
Sbjct: 198 TYDEKCDVWSAGVILYILLSG 218

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+     
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR----- 111
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 112 -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 165 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--S 219
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K IGSG  G+V   Y   L+  + +A+K L+    N    KR +  E+ L+  ++H+N++
Sbjct: 30  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNII 86
Query: 468 QFLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
             L         EE + V +   + +  L + +   L HE R++++    +      GI+
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHE-RMSYLLYQMLC-----GIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELISG 608
             +     +  D++S G I+ E+I G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 111/235 (47%), Gaps = 28/235 (11%)
Query: 405 IEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH- 462
            ED  K+  + +G G +  V     L++GKE AVK++   +   +     EV  L +   
Sbjct: 10  FEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQG 69
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           ++N+++ + + +++ R  LV+E +  G++  H    +  ++  N  +   +  D A  ++
Sbjct: 70  NKNILELIEFFEDDTRFYLVFEKLQGGSILAH----IQKQKHFNEREASRVVRDVAAALD 125
Query: 523 YLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGL-SKFAVDGASHVSSIVR----- 573
           +LHT     I HRDLK  NIL    +K    K+ DF L S   ++ +    +        
Sbjct: 126 FLHT---KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC 182
Query: 574 GTVGYLDPEYYISQQLTDKS-------DVYSFGVILLELISGQEAISNEKFGANC 621
           G+  Y+ PE  + +  TD++       D++S GV+L  ++SG         GA+C
Sbjct: 183 GSAEYMAPE--VVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGH-CGADC 234

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 465
           L K IG G F  V   + +  GKE+AVK+     L S+S Q   +   EV +   ++H N
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIXKVLNHPN 74
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +V+     + E    LV E+   G + ++L      +++    K  +I       ++Y H
Sbjct: 75  IVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS----AVQYCH 130
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
                 I+HRDLK+ N+LLD     K++DFG S     G + + +   G   Y  PE + 
Sbjct: 131 QKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFG-NKLDAFC-GAPPYAAPELFQ 185
Query: 586 SQQLTD-KSDVYSFGVILLELISG 608
            ++    + DV+S GVIL  L+SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 113/233 (48%), Gaps = 30/233 (12%)
Query: 388 SLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT----- 441
           S+ +AP +A     L  +++      K +GSG FG VY G  + +G+++ + V       
Sbjct: 2   SMGEAPNQA----LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 57
Query: 442 SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL----KEHLYG 497
           + S +  +E  +E  +++ + + ++ + LG C       L+ + M  G L    +EH   
Sbjct: 58  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREH-KD 115
Query: 498 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 557
            +  +  +NW  ++      AKG+ YL       ++HRDL + N+L+      K++DFGL
Sbjct: 116 NIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGL 166
Query: 558 SKFAVDGASHVSSIVRG---TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +K    GA        G    + ++  E  + +  T +SDV+S+GV + EL++
Sbjct: 167 AKLL--GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 111/235 (47%), Gaps = 25/235 (10%)
Query: 403 SDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKR------EFTNEV 455
           S +ED  +M E+ +GSG F +V   + K  GKE A K +        R      E   EV
Sbjct: 22  SMVEDHYEMGEE-LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREV 80
Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEI 513
            +L  I H N++      + +   VL+ E +  G L + L    +LT ++   ++K++  
Sbjct: 81  NILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI-- 138
Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVS 569
                 G+ YLH+     I H DLK  NI LLDK++   R K+ DFG++   ++  +   
Sbjct: 139 ----LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFK 190
Query: 570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
           +I  GT  ++ PE    + L  ++D++S GVI   L+SG      E       NI
Sbjct: 191 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI 244

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           K IGSG  G+V        G  +AVK L+    N    KR +  E+ LL  ++H+N++  
Sbjct: 30  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 88
Query: 470 LGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           L         EE + V LV E M +  L + ++  L HE R++++    +      GI++
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHE-RMSYLLYQMLC-----GIKH 141
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH+     IIHRDLK SNI++      K+ DFGL++ A         +V  T  Y  PE 
Sbjct: 142 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEV 196
Query: 584 YISQQLTDKSDVYSFGVILLELISG 608
            +        D++S G I+ EL+ G
Sbjct: 197 ILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 85  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 136
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 137 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 191
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 111/264 (42%), Gaps = 52/264 (19%)
Query: 365 KGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVV 424
           +G K + DK+  + +  V  P     D P E ++  T            K IG+G FGVV
Sbjct: 2   RGSKVSRDKDGSKVTTVVATPGQG-PDRPQEVSYTDT------------KVIGNGSFGVV 48
Query: 425 YYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 484
           Y  KL D  E+   V      Q KR    E+ ++ ++ H N+V+            L Y 
Sbjct: 49  YQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR------------LRYF 93
Query: 485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-----------------GIEYLHTG 527
           F  +G  K+ +Y  L  +     + R+      AK                  + Y+H+ 
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 153
Query: 528 CVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY-YI 585
               I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +  Y  PE  + 
Sbjct: 154 ---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--SRYYRAPELIFG 208
Query: 586 SQQLTDKSDVYSFGVILLELISGQ 609
           +   T   DV+S G +L EL+ GQ
Sbjct: 209 ATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+     
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR----- 85
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 86  -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 138
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 139 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--S 193
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 194 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKXVNHKNIIS 87
Query: 469 FLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++           GI+
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHE-RMSYL-----LYQMLXGIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K IGSG  G+V   Y   L+  + +A+K L+    N    KR +  E+ L+  ++H+N++
Sbjct: 30  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNII 86
Query: 468 QFLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
             L         EE + V +   + +  L + +   L HE R++++    +      GI+
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHE-RMSYLLYQMLC-----GIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELISG 608
             +     +  D++S G I+ E+I G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+     
Sbjct: 45  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR----- 96
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 97  -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 149
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 150 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--S 204
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 205 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 81  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 132
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 133 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 187
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+     
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR----- 89
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 90  -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 142
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 143 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--S 197
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 198 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 82  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 133
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 134 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 188
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K IGSG  G+V   Y   L+  + +A+K L+    N    KR +  E+ L+  ++H+N++
Sbjct: 30  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNII 86
Query: 468 QFLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
             L         EE + V +   + +  L + +   L HE R++++    +      GI+
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHE-RMSYLLYQMLC-----GIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELISG 608
             +     +  D++S G I+ E+I G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 90/202 (44%), Gaps = 17/202 (8%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI--AVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLV 467
           K IG G FG V   + K  +E+  AVKVL   +   K+E     +    LL  + H  LV
Sbjct: 44  KVIGKGSFGKVLLARHK-AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHT 526
                 Q   +   V ++++ G L  HL       +R     R    A + A  + YLH+
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHL-----QRERCFLEPRARFYAAEIASALGYLHS 157
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                I++RDLK  NILLD      ++DFGL K  ++  S  S+   GT  YL PE    
Sbjct: 158 L---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEVLHK 213
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           Q      D +  G +L E++ G
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYG 235

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 40/275 (14%)
Query: 416 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNLVQFLG 471
           +G GGF   +     D KE+    +   S       + + + E+++   + H+++V F G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 472 YCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           + ++     +V E     +L E       LT  +   +++++ +      G +YLH    
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL------GCQYLHRN-- 160
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             +IHRDLK  N+ L++ +  K+ DFGL +K   DG      ++ GT  Y+ PE    + 
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKG 217
Query: 589 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD--IQGIIDPSLL 646
            + + DV+S G I+  L+ G+       F  +C   ++   L I+  +  I   I+P  +
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPP-----FETSC---LKETYLRIKKNEYSIPKHINP--V 267
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
               IQ M + +  A          RP+I+E+L D
Sbjct: 268 AASLIQKMLQTDPTA----------RPTINELLND 292

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 83  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 134
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 135 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 189
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+     
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR----- 113
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 114 -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 166
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 167 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--S 221
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 222 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 40/275 (14%)
Query: 416 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNLVQFLG 471
           +G GGF   +     D KE+    +   S       + + + E+++   + H+++V F G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 472 YCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           + ++     +V E     +L E       LT  +   +++++ +      G +YLH    
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL------GCQYLHRN-- 158
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             +IHRDLK  N+ L++ +  K+ DFGL +K   DG      ++ GT  Y+ PE    + 
Sbjct: 159 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKG 215
Query: 589 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD--IQGIIDPSLL 646
            + + DV+S G I+  L+ G+       F  +C   ++   L I+  +  I   I+P  +
Sbjct: 216 HSFEVDVWSIGCIMYTLLVGKPP-----FETSC---LKETYLRIKKNEYSIPKHINP--V 265
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
               IQ M + +  A          RP+I+E+L D
Sbjct: 266 AASLIQKMLQTDPTA----------RPTINELLND 290

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 23/205 (11%)
Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           K IGSG  G+V        G  +AVK L+    N    KR +  E+ LL  ++H+N++  
Sbjct: 28  KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISL 86
Query: 470 LGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           L         EE + V LV E M +  L + ++  L HE R++++    +      GI++
Sbjct: 87  LNVFTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHE-RMSYLLYQMLC-----GIKH 139
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH+     IIHRDLK SNI++      K+ DFGL++ A         +V  T  Y  PE 
Sbjct: 140 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVV--TRYYRAPEV 194
Query: 584 YISQQLTDKSDVYSFGVILLELISG 608
            +     +  D++S G I+ EL+ G
Sbjct: 195 ILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+     
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR----- 111
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 112 -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 165 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--S 219
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 15/211 (7%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLL 458
           L  +E+  K+  +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL
Sbjct: 2   LGSMENFQKV--EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
             ++H N+V+ L     E +  LV+EF+ +  LK+ +  +      +  IK         
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLF--QLL 116
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVG 577
           +G+ + H+     ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ 
Sbjct: 117 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 171
Query: 578 YLDPEYYI-SQQLTDKSDVYSFGVILLELIS 607
           Y  PE  +  +  +   D++S G I  E+++
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 114/236 (48%), Gaps = 30/236 (12%)
Query: 385 PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT-- 441
           P++   +AP +A     L  +++      K +GSG FG VY G  + +G+++ + V    
Sbjct: 30  PLTPSGEAPNQA----LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIME 85
Query: 442 ---SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL----KEH 494
              + S +  +E  +E  +++ + + ++ + LG C       L+ + M  G L    +EH
Sbjct: 86  LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREH 144
Query: 495 LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 554
               +  +  +NW  ++      AKG+ YL       ++HRDL + N+L+      K++D
Sbjct: 145 -KDNIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 194
Query: 555 FGLSKFAVDGASHVSSIVRG---TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           FGL+K    GA        G    + ++  E  + +  T +SDV+S+GV + EL++
Sbjct: 195 FGLAKLL--GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 113/233 (48%), Gaps = 30/233 (12%)
Query: 388 SLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT----- 441
           S+ +AP +A     L  +++      K +GSG FG VY G  + +G+++ + V       
Sbjct: 2   SMGEAPNQA----LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 57
Query: 442 SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL----KEHLYG 497
           + S +  +E  +E  +++ + + ++ + LG C       L+ + M  G L    +EH   
Sbjct: 58  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KD 115
Query: 498 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 557
            +  +  +NW  ++      AKG+ YL       ++HRDL + N+L+      K++DFGL
Sbjct: 116 NIGSQYLLNWCVQI------AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGL 166
Query: 558 SKFAVDGASHVSSIVRG---TVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           +K    GA        G    + ++  E  + +  T +SDV+S+GV + EL++
Sbjct: 167 AKLL--GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 15/211 (7%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLL 458
           L  +E+  K+  +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL
Sbjct: 1   LGSMENFQKV--EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 58
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
             ++H N+V+ L     E +  LV+EF+ +  LK+ +  +      +  IK         
Sbjct: 59  KELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLF--QLL 115
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVG 577
           +G+ + H+     ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ 
Sbjct: 116 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 170
Query: 578 YLDPEYYI-SQQLTDKSDVYSFGVILLELIS 607
           Y  PE  +  +  +   D++S G I  E+++
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+     
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR----- 115
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 116 -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 168
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 169 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--S 223
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 224 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+     
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR----- 77
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 78  -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 131 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--S 185
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+     
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR----- 105
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 106 -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 158
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 159 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--S 213
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 214 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+     
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR----- 78
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 79  -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 131
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 132 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--S 186
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 187 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+     
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR----- 77
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 78  -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 131 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--S 185
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 415 KIGSGGFGVVYYGKLKDGKEI-AVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +IG G FG VY G     KE+ A+K++    +     +   E+T+LS+     + ++ G 
Sbjct: 26  RIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
             +  +  ++ E++  G+  + L      E  I  I R     +  KG++YLH+      
Sbjct: 86  YLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR-----EILKGLDYLHS---ERK 137
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           IHRD+K++N+LL +    K++DFG++    D     +  V GT  ++ PE         K
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQSAYDFK 196
Query: 593 SDVYSFGVILLELISGQ 609
           +D++S G+  +EL  G+
Sbjct: 197 ADIWSLGITAIELAKGE 213

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 24/224 (10%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLV 467
           L K IGSG FGV    + K   E +AVK +      +   KRE  N  +L     H N+V
Sbjct: 23  LVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSL----RHPNIV 78
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +F           +V E+   G L E +   G  + ++   + ++L        G+ Y H
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCH 132
Query: 526 TGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
                 + HRDLK  N LLD     R K+ DFG SK +V  +   S++  GT  Y+ PE 
Sbjct: 133 AM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEV 187
Query: 584 YISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
            + ++   K +DV+S GV L  ++ G     + +   N R  + 
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 231

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 106/227 (46%), Gaps = 25/227 (11%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKRE-FTNE 454
           L +I  +     +++G   FG VY G L      +  + +A+K L   +    RE F +E
Sbjct: 20  LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 79
Query: 455 VTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH------------E 502
             L +R+ H N+V  LG   ++    +++ +  +G L E L     H            +
Sbjct: 80  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 139
Query: 503 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--F 560
             +     + +    A G+EYL +     ++H+DL + N+L+   +  K+SD GL +  +
Sbjct: 140 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 196
Query: 561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           A D    + + +   + ++ PE  +  + +  SD++S+GV+L E+ S
Sbjct: 197 AADYYKLLGNSLL-PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 84  RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 135
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 136 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 190
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 15/211 (7%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLL 458
           L  +E+  K+  +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL
Sbjct: 2   LGSMENFQKV--EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL 59
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
             ++H N+V+ L     E +  LV+EF+ +  LK+ +  +      +  IK         
Sbjct: 60  KELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLF--QLL 116
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVG 577
           +G+ + H+     ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ 
Sbjct: 117 QGLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLW 171
Query: 578 YLDPEYYI-SQQLTDKSDVYSFGVILLELIS 607
           Y  PE  +  +  +   D++S G I  E+++
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 82  RLLGICLTSTVQ-LIMQLMPFGXLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 133
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 134 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 188
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 189 LESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+     
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR----- 81
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 82  -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 134
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 135 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--S 189
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 190 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K IGSG  G+V   Y   L+  + +A+K L+    N    KR +  E+ L+  ++H+N++
Sbjct: 30  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNII 86
Query: 468 QFLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
             L         EE + V +   + +  L + +   L HE R++++    +      GI+
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELISG 608
             +     +  D++S G I+ E+I G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      QGK     E+ ++ ++ H N+V+     
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQGKAFKNRELQIMRKLDHCNIVR----- 77
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 78  -------LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 131 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC--S 185
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 132
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 133 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 187
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+     
Sbjct: 39  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR----- 90
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 91  -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 143
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 144 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--S 198
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 199 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 83  RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 134
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 135 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 189
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 106/227 (46%), Gaps = 25/227 (11%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSYQGKRE-FTNE 454
           L +I  +     +++G   FG VY G L      +  + +A+K L   +    RE F +E
Sbjct: 3   LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 455 VTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH------------E 502
             L +R+ H N+V  LG   ++    +++ +  +G L E L     H            +
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 503 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--F 560
             +     + +    A G+EYL +     ++H+DL + N+L+   +  K+SD GL +  +
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           A D    + + +   + ++ PE  +  + +  SD++S+GV+L E+ S
Sbjct: 180 AADYYKLLGNSLL-PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKXVNHKNIIS 87
Query: 469 FLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++    +      GI+
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHE-RMSYLLYQMLC-----GIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K IGSG  G+V   Y   L+  + +A+K L+    N    KR +  E+ L+  ++H+N++
Sbjct: 30  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNII 86
Query: 468 QFLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
             L         EE + V +   + +  L + +   L HE R++++    +      GI+
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPEVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELISG 608
             +     +  D++S G I+ E+I G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+     
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR----- 156
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 157 -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 209
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 210 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--S 264
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 265 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K IGSG  G+V   Y   L+  + +A+K L+    N    KR +  E+ L+  ++H+N++
Sbjct: 31  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNII 87
Query: 468 QFLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
             L         EE + V +   + +  L + +   L HE R++++    +      GI+
Sbjct: 88  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 141
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 142 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 196
Query: 583 YYISQQLTDKSDVYSFGVILLELISG 608
             +     +  D++S G I+ E+I G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 106 RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 157
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 158 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 212
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 213 LESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 84  RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 135
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 136 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 190
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 191 LESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 23/202 (11%)
Query: 415 KIGSGGFGVVYYGKLKDGKEIAV-KVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           ++G G FG VY  + K+   +A  KV+ + S +   ++  E+ +L+   H N+V+ L   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
             E    ++ EF   G +   +   L  E+ +   +   + +     + YLH      II
Sbjct: 104 YYENNLWILIEFCAGGAVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---KII 157
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-----GTVGYLDPEYYISQQ 588
           HRDLK+ NIL       K++DFG+S      A +   I R     GT  ++ PE  + + 
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS------AKNTRXIQRRDXFIGTPYWMAPEVVMCET 211
Query: 589 LTD-----KSDVYSFGVILLEL 605
             D     K+DV+S G+ L+E+
Sbjct: 212 SKDRPYDYKADVWSLGITLIEM 233

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+     
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVR----- 82
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 83  -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 135
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 136 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--S 190
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 191 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 87
Query: 469 FLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++           GI+
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHE-RMSYL-----LYQMLXGIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 88  RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 139
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 140 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 194
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 91  RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 142
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 143 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 197
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 198 LESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 68  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 125
Query: 469 FLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++    +      GI+
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 178
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 179 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 233
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K IGSG  G+V   Y   L+  + +A+K L+    N    KR +  E+ L+  ++H+N++
Sbjct: 30  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNII 86
Query: 468 QFLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
             L         EE + V +   + +  L + +   L HE R++++    +      GI+
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELISG 608
             +     +  D++S G I+ E+I G
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      QGK     E+ ++ ++ H N+V+     
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQGKAFKNRELQIMRKLDHCNIVR----- 77
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 78  -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 131 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--S 185
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 87  RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 138
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 139 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 193
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 194 LESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 118/227 (51%), Gaps = 24/227 (10%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKI-GSGGFGVVYYGK-LKDGKEIAVKVLTS--NSYQGK 448
           P+E A+   L+ I   T++ + K+ GSG FG V+ G  + +G+ I + V         G+
Sbjct: 16  PSEKANK-VLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR 74
Query: 449 REF---TNEVTLLSRIHHRNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLY---GTLTH 501
           + F   T+ +  +  + H ++V+ LG C   G S+ LV +++  G+L +H+    G L  
Sbjct: 75  QSFQAVTDHMLAIGSLDHAHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGP 132
Query: 502 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-F 560
           +  +NW  ++      AKG+ YL       ++HR+L + N+LL    + +V+DFG++   
Sbjct: 133 QLLLNWGVQI------AKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 183
Query: 561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
             D    + S  +  + ++  E     + T +SDV+S+GV + EL++
Sbjct: 184 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 94/215 (43%), Gaps = 39/215 (18%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      QGK     E+ ++ ++ H N+V+     
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQGKAFKNRELQIMRKLDHCNIVR----- 77
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------------- 519
                  L Y F  +G  K+ +Y  L  +     + R+      AK              
Sbjct: 78  -------LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130
Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGT 575
               + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +
Sbjct: 131 LFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--S 185
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQ 609
             Y  PE  + +   T   DV+S G +L EL+ GQ
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 14/199 (7%)
Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           ++G G +GVV   + +  G+ +AVK +  T NS + KR   +    +  +     V F G
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
               EG   +  E M + +L +     +   Q I      +IA    K +E+LH+    +
Sbjct: 118 ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--S 174
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
           +IHRD+K SN+L++   + K+ DFG+S + VD  +   +I  G   Y+ PE  I+ +L  
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVA--KTIDAGCKPYMAPE-RINPELNQ 231
Query: 592 -----KSDVYSFGVILLEL 605
                KSD++S G+ ++EL
Sbjct: 232 KGYSVKSDIWSLGITMIEL 250

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGXLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 132
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 133 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 187
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVVY  KL D  E+   V      Q KR    E+ ++ ++ H N+V+   + 
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGEL---VAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 474 QEEG-RSVLVYEFMHNGTLKEHLYGTLTH----EQRINWIKRLEIAEDAAKGIEYLHTGC 528
              G +   VY  +    + E +Y    H    +Q +  I          + + Y+H+  
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF- 141
Query: 529 VPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY-YIS 586
              I HRD+K  N+LLD      K+ DFG +K  V G  +VS I   +  Y  PE  + +
Sbjct: 142 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPELIFGA 197
Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
              T   DV+S G +L EL+ GQ
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 75  RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 126
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 181
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 80
Query: 469 FLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++           GI+
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHE-RMSYL-----LYQMLXGIK 133
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 134 HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 188
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 103/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+EF+ +  LK+ +  +      +  IK         +G+ + H+    
Sbjct: 70  DVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 123
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 124 RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 181
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 182 YSTAVDIWSLGCIFAEMVT 200

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 132
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 133 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 187
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 25/206 (12%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K IGSG  G+V   Y   L+  + +A+K L+    N    KR +  E+ L+  ++H+N++
Sbjct: 32  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNII 88
Query: 468 QFLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
             L         EE + V +   + +  L + +   L HE R++++    +      GI+
Sbjct: 89  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 142
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A      V  +V  T  Y  PE
Sbjct: 143 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV--TRYYRAPE 197
Query: 583 YYISQQLTDKSDVYSFGVILLELISG 608
             +     +  D++S G I+ E+I G
Sbjct: 198 VILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 106/238 (44%), Gaps = 22/238 (9%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKREF 451
           P E  H   L   +     + +++G+G FGVV+   +   G   A K + +     K   
Sbjct: 147 PVEIKHDHVLDHYD-----IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV 201
Query: 452 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWI 508
             E+  +S + H  LV      +++   V++YEFM  G L E +   +  ++ ++ + ++
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 261
Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGAS 566
           +++       KG+ ++H       +H DLK  NI+    +    K+ DFGL+   +D   
Sbjct: 262 RQV------CKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQ 311
Query: 567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            V  +  GT  +  PE    + +   +D++S GV+   L+SG      E      RN+
Sbjct: 312 SV-KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 368

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKR------EFT 452
           F    +ED   + E+ +GSG F +V   + K  G E A K +     +  R      E  
Sbjct: 5   FKQQKVEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKR 510
            EV++L ++ H N++      +     VL+ E +  G L + L    +L+ E+  ++IK+
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 511 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGAS 566
           +        G+ YLHT     I H DLK  NI LLDK++     K+ DFGL+    DG  
Sbjct: 124 I------LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
             +  + GT  ++ PE    + L  ++D++S GVI   L+SG
Sbjct: 175 FKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKR------EFT 452
           F    +ED   + E+ +GSG F +V   + K  G E A K +     +  R      E  
Sbjct: 5   FKQQKVEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKR 510
            EV++L ++ H N++      +     VL+ E +  G L + L    +L+ E+  ++IK+
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 511 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGAS 566
           +        G+ YLHT     I H DLK  NI LLDK++     K+ DFGL+    DG  
Sbjct: 124 I------LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
             +  + GT  ++ PE    + L  ++D++S GVI   L+SG
Sbjct: 175 FKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+E +H   LK  +  +      +  IK         +G+ + H+    
Sbjct: 68  DVIHTENKLYLVFEHVHQD-LKTFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 121
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 179
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 180 YSTAVDIWSLGCIFAEMVT 198

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 31  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 88
Query: 469 FLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++    +      GI+
Sbjct: 89  LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 141
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 142 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 196
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 24/224 (10%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLV 467
           L K IG+G FGV    + K   E +AVK +          KRE  N  +L     H N+V
Sbjct: 23  LVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSL----RHPNIV 78
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +F           +V E+   G L E +   G  + ++   + ++L        G+ Y H
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYAH 132
Query: 526 TGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
              V    HRDLK  N LLD     R K++DFG SK +V  +   S++  GT  Y+ PE 
Sbjct: 133 AMQV---AHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV--GTPAYIAPEV 187
Query: 584 YISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
            + ++   K +DV+S GV L  ++ G     + +   N R  + 
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 231

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKR------EFT 452
           F    +ED   + E+ +GSG F +V   + K  G E A K +     +  R      E  
Sbjct: 5   FKQQKVEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKR 510
            EV++L ++ H N++      +     VL+ E +  G L + L    +L+ E+  ++IK+
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 511 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGAS 566
           +        G+ YLHT     I H DLK  NI LLDK++     K+ DFGL+    DG  
Sbjct: 124 I------LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
             +  + GT  ++ PE    + L  ++D++S GVI   L+SG
Sbjct: 175 FKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKR------EFT 452
           F    +ED   + E+ +GSG F +V   + K  G E A K +     +  R      E  
Sbjct: 5   FKQQKVEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKR 510
            EV++L ++ H N++      +     VL+ E +  G L + L    +L+ E+  ++IK+
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 511 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGAS 566
           +        G+ YLHT     I H DLK  NI LLDK++     K+ DFGL+    DG  
Sbjct: 124 I------LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
             +  + GT  ++ PE    + L  ++D++S GVI   L+SG
Sbjct: 175 FKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 24  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 81
Query: 469 FLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++    +      GI+
Sbjct: 82  LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 134
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 135 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 189
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 190 VILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 124/275 (45%), Gaps = 40/275 (14%)
Query: 416 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNLVQFLG 471
           +G GGF   +     D KE+    +   S       + + + E+++   + H+++V F G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 472 YCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           + ++     +V E     +L E       LT  +   +++++ +      G +YLH    
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL------GCQYLHRN-- 134
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             +IHRDLK  N+ L++ +  K+ DFGL +K   DG      ++ GT  Y+ PE    + 
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKG 191
Query: 589 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD--IQGIIDPSLL 646
            + + DV+S G I+  L+ G+       F  +C   ++   L I+  +  I   I+P  +
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPP-----FETSC---LKETYLRIKKNEYSIPKHINP--V 241
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
               IQ M + +  A          RP+I+E+L D
Sbjct: 242 AASLIQKMLQTDPTA----------RPTINELLND 266

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 87
Query: 469 FLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++    +      GI+
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           K IG+G FGVV+  KL +  E+A+K       Q KR    E+ ++  + H N+V    + 
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIK----KVLQDKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 474 QEEGRSV------LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE----DAAKGIEY 523
              G         LV E+     + E +Y    H  ++     + + +       + + Y
Sbjct: 102 YSNGDKKDEVFLNLVLEY-----VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +H+     I HRD+K  N+LLD      K+ DFG +K  + G  +VS I   +  Y  PE
Sbjct: 157 IHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC--SRYYRAPE 211
Query: 583 Y-YISQQLTDKSDVYSFGVILLELISGQEAISNE 615
             + +   T   D++S G ++ EL+ GQ     E
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE 245

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 87
Query: 469 FLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++    +      GI+
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 24  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 81
Query: 469 FLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++    +      GI+
Sbjct: 82  LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 134
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 135 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 189
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 190 VILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 80
Query: 469 FLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++    +      GI+
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 133
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 134 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 188
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 29  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 86
Query: 469 FLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++    +      GI+
Sbjct: 87  LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 140 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 194
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 195 VILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 416 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNLVQFLG 471
           +G GGF   +     D KE+    +   S       + + + E+++   + H+++V F G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 472 YCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           + ++     +V E     +L E       LT  +   +++++ +      G +YLH    
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL------GCQYLHRN-- 140
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             +IHRDLK  N+ L++ +  K+ DFGL +K   DG       + GT  Y+ PE    + 
Sbjct: 141 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKG 197
Query: 589 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD--IQGIIDPSLL 646
            + + DV+S G I+  L+ G+       F  +C   ++   L I+  +  I   I+P  +
Sbjct: 198 HSFEVDVWSIGCIMYTLLVGKPP-----FETSC---LKETYLRIKKNEYSIPKHINP--V 247
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
               IQ M + +  A          RP+I+E+L D
Sbjct: 248 AASLIQKMLQTDPTA----------RPTINELLND 272

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKR------EFT 452
           F    +ED   + E+ +GSG F +V   + K  G E A K +     +  R      E  
Sbjct: 5   FKQQKVEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIE 63
Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKR 510
            EV++L ++ H N++      +     VL+ E +  G L + L    +L+ E+  ++IK+
Sbjct: 64  REVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 511 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGAS 566
           +        G+ YLHT     I H DLK  NI LLDK++     K+ DFGL+    DG  
Sbjct: 124 I------LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
             +  + GT  ++ PE    + L  ++D++S GVI   L+SG
Sbjct: 175 FKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 30  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKXVNHKNIIS 87
Query: 469 FLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++    +      GI+
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 31  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 88
Query: 469 FLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++    +      GI+
Sbjct: 89  LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 141
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 142 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 196
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMV 220

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 106/238 (44%), Gaps = 22/238 (9%)
Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY-YGKLKDGKEIAVKVLTSNSYQGKREF 451
           P E  H   L   +     + +++G+G FGVV+   +   G   A K + +     K   
Sbjct: 41  PVEIKHDHVLDHYD-----IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV 95
Query: 452 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWI 508
             E+  +S + H  LV      +++   V++YEFM  G L E +   +  ++ ++ + ++
Sbjct: 96  RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 155
Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGAS 566
           +++       KG+ ++H       +H DLK  NI+    +    K+ DFGL+   +D   
Sbjct: 156 RQV------CKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQ 205
Query: 567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            V  +  GT  +  PE    + +   +D++S GV+   L+SG      E      RN+
Sbjct: 206 SV-KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV 262

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV--YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           K IGSG  G+V   Y  + D + +A+K L+    N    KR +  E+ L+  ++H+N++ 
Sbjct: 68  KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIS 125
Query: 469 FLGYCQ-----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         EE + V LV E M +  L + +   L HE R++++    +      GI+
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 178
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 179 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 233
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 24/224 (10%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLV 467
           L K IGSG FGV    + K   E +AVK +          KRE  N  +L     H N+V
Sbjct: 22  LVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL----RHPNIV 77
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +F           +V E+   G L E +   G  + ++   + ++L        G+ Y H
Sbjct: 78  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCH 131
Query: 526 TGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
                 + HRDLK  N LLD     R K+ DFG SK +V  +   S++  GT  Y+ PE 
Sbjct: 132 AM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEV 186
Query: 584 YISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
            + ++   K +DV+S GV L  ++ G     + +   N R  + 
Sbjct: 187 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 230

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 107/223 (47%), Gaps = 25/223 (11%)
Query: 399 CFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKR------EF 451
            F    +ED   + E+ +GSG F +V   + K  G E A K +     +  R      E 
Sbjct: 4   TFKQQKVEDFYDIGEE-LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEI 62
Query: 452 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIK 509
             EV++L ++ H N++      +     VL+ E +  G L + L    +L+ E+  ++IK
Sbjct: 63  EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK 122
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGA 565
           ++        G+ YLHT     I H DLK  NI LLDK++     K+ DFGL+    DG 
Sbjct: 123 QI------LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173
Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
              +  + GT  ++ PE    + L  ++D++S GVI   L+SG
Sbjct: 174 EFKN--IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 416 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNLVQFLG 471
           +G GGF   +     D KE+    +   S       + + + E+++   + H+++V F G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 472 YCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           + ++     +V E     +L E       LT  +   +++++ +      G +YLH    
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL------GCQYLHRN-- 136
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             +IHRDLK  N+ L++ +  K+ DFGL +K   DG       + GT  Y+ PE    + 
Sbjct: 137 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKG 193
Query: 589 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD--IQGIIDPSLL 646
            + + DV+S G I+  L+ G+       F  +C   ++   L I+  +  I   I+P  +
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPP-----FETSC---LKETYLRIKKNEYSIPKHINP--V 243
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
               IQ M + +  A          RP+I+E+L D
Sbjct: 244 AASLIQKMLQTDPTA----------RPTINELLND 268

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 19/202 (9%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLG 471
           +KIG G +GVVY  +   G+  A+K +      +G    T  E+++L  + H N+V+   
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
               + R VLV+E + +  LK+ L    G L      +++ +L        GI Y H   
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQL------LNGIAYCHDR- 119
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-S 586
              ++HRDLK  N+L+++    K++DFGL++ F +    +   IV  T+ Y  P+  + S
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMGS 175
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           ++ +   D++S G I  E+++G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 123/275 (44%), Gaps = 40/275 (14%)
Query: 416 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSY----QGKREFTNEVTLLSRIHHRNLVQFLG 471
           +G GGF   +     D KE+    +   S       + + + E+++   + H+++V F G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 472 YCQEEGRSVLVYEFMHNGTLKE--HLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           + ++     +V E     +L E       LT  +   +++++ +      G +YLH    
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL------GCQYLHRN-- 136
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             +IHRDLK  N+ L++ +  K+ DFGL +K   DG       + GT  Y+ PE    + 
Sbjct: 137 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKTLCGTPNYIAPEVLSKKG 193
Query: 589 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD--IQGIIDPSLL 646
            + + DV+S G I+  L+ G+       F  +C   ++   L I+  +  I   I+P  +
Sbjct: 194 HSFEVDVWSIGCIMYTLLVGKPP-----FETSC---LKETYLRIKKNEYSIPKHINP--V 243
Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
               IQ M + +  A          RP+I+E+L D
Sbjct: 244 AASLIQKMLQTDPTA----------RPTINELLND 268

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +            DA +    L  G V
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-----------PDAQRFFHQLMAGVV 118
Query: 530 ----PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 584
                 I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE  
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 585 ISQQL-TDKSDVYSFGVILLELISGQ 609
             ++   +  DV+S G++L  +++G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 107/207 (51%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEI----AVKVLTSNSYQGKREF---TNEVTLLSRIHHRN 465
           K +GSG FG V+ G  + +G+ I     +KV+   S  G++ F   T+ +  +  + H +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAH 76
Query: 466 LVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGI 521
           +V+ LG C   G S+ LV +++  G+L +H+    G L  +  +NW          AKG+
Sbjct: 77  IVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGM 128
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLD 580
            YL       ++HR+L + N+LL    + +V+DFG++     D    + S  +  + ++ 
Sbjct: 129 YYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E     + T +SDV+S+GV + EL++
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +            DA +    L  G V
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-----------PDAQRFFHQLMAGVV 118
Query: 530 ----PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 584
                 I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE  
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 585 ISQQL-TDKSDVYSFGVILLELISGQ 609
             ++   +  DV+S G++L  +++G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 13/207 (6%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQ 468
           + +G G FG V   ++K+ G   AVKVL  +      +     T +  L    +H  L Q
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                Q   R   V EF++ G L  H+  +    +R +  +    A +    + +LH   
Sbjct: 89  LFCCFQTPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK- 143
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              II+RDLK  N+LLD     K++DFG+ K  +      ++   GT  Y+ PE      
Sbjct: 144 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQEML 200
Query: 589 LTDKSDVYSFGVILLELISGQEAISNE 615
                D ++ GV+L E++ G      E
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFEAE 227

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +            DA +    L  G V
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-----------PDAQRFFHQLMAGVV 118
Query: 530 ----PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 584
                 I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE  
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 585 ISQQL-TDKSDVYSFGVILLELISGQ 609
             ++   +  DV+S G++L  +++G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 106/210 (50%), Gaps = 12/210 (5%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVL-TSNSYQGKREFTNEVTLLS 459
           ++D E+    LE+ IG G FG V+ G   +  + +A+K++    +     +   E+T+LS
Sbjct: 18  IADPEELFTKLER-IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLS 76
Query: 460 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 519
           +     + ++ G   +  +  ++ E++  G+  + L      E +I       + ++  K
Sbjct: 77  QCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILK 131
Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 579
           G++YLH+      IHRD+K++N+LL +    K++DFG++    D     ++ V GT  ++
Sbjct: 132 GLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWM 187
Query: 580 DPEYYISQQLTDKSDVYSFGVILLELISGQ 609
            PE         K+D++S G+  +EL  G+
Sbjct: 188 APEVIQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF 69
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +            DA +    L  G V
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-----------PDAQRFFHQLMAGVV 118
Query: 530 ----PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 584
                 I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE  
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 585 ISQQL-TDKSDVYSFGVILLELISGQ 609
             ++   +  DV+S G++L  +++G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 469
           K +G G FG V   + K  G+  A+K+L       K E  + VT   +L    H  L   
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTGC 528
               Q   R   V E+ + G L  HL       +R+   +R      +    +EYLH+  
Sbjct: 74  KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD 128
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
           V   ++RD+K  N++LDK    K++DFGL K  +   + + +   GT  YL PE      
Sbjct: 129 V---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND 184
Query: 589 LTDKSDVYSFGVILLELISGQEAISNE 615
                D +  GV++ E++ G+    N+
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLPFYNQ 211

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 469
           K +G G FG V   + K  G+  A+K+L       K E  + VT   +L    H  L   
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTGC 528
               Q   R   V E+ + G L  HL       +R+   +R      +    +EYLH+  
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSR- 124
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              +++RD+K  N++LDK    K++DFGL K  +   + + +   GT  YL PE      
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND 181
Query: 589 LTDKSDVYSFGVILLELISGQEAISNE 615
                D +  GV++ E++ G+    N+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF 70
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +            DA +    L  G V
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-----------PDAQRFFHQLMAGVV 119
Query: 530 ----PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 584
                 I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE  
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 585 ISQQL-TDKSDVYSFGVILLELISGQ 609
             ++   +  DV+S G++L  +++G+
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 469
           K +G G FG V   + K  G+  A+K+L       K E  + VT   +L    H  L   
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTGC 528
               Q   R   V E+ + G L  HL       +R+   +R      +    +EYLH+  
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
           V   ++RD+K  N++LDK    K++DFGL K  +   + + +   GT  YL PE      
Sbjct: 126 V---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND 181
Query: 589 LTDKSDVYSFGVILLELISGQEAISNE 615
                D +  GV++ E++ G+    N+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ + + ++H N+V+F
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKF 70
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +                G+ YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFFHQLMAGVVYLHGI-- 124
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE    ++
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 589 L-TDKSDVYSFGVILLELISGQ 609
              +  DV+S G++L  +++G+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 102/207 (49%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      A+G+ Y
Sbjct: 78  RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AEGMNY 129
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 130 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 184
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 185 LESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVL----TSNSYQG--KREFTNEVTLLSRIHHRNL 466
           +++GSG F VV   + K  G + A K +    T +S +G  + +   EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +      + +   +L+ E +  G L + L    +LT E+   ++K++        G+ YL
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------LNGVYYL 130
Query: 525 HTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           H+     I H DLK  NI LLD+++   R K+ DFGL+   +D  +   +I  GT  ++ 
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIF-GTPAFVA 185
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISG 608
           PE    + L  ++D++S GVI   L+SG
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 19/202 (9%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLG 471
           +KIG G +GVVY  +   G+  A+K +      +G    T  E+++L  + H N+V+   
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
               + R VLV+E + +  LK+ L    G L      +++ +L        GI Y H   
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQL------LNGIAYCHDR- 119
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-S 586
              ++HRDLK  N+L+++    K++DFGL++ F +    +   +V  T+ Y  P+  + S
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGS 175
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           ++ +   D++S G I  E+++G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 19/202 (9%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLG 471
           +KIG G +GVVY  +   G+  A+K +      +G    T  E+++L  + H N+V+   
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
               + R VLV+E + +  LK+ L    G L      +++ +L        GI Y H   
Sbjct: 68  VIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQL------LNGIAYCHDR- 119
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-S 586
              ++HRDLK  N+L+++    K++DFGL++ F +    +   +V  T+ Y  P+  + S
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV--TLWYRAPDVLMGS 175
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           ++ +   D++S G I  E+++G
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 469
           K +G G FG V   + K  G+  A+K+L       K E  + VT   +L    H  L   
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTGC 528
               Q   R   V E+ + G L  HL       +R+   +R      +    +EYLH+  
Sbjct: 76  KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD 130
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQ 587
           V   ++RD+K  N++LDK    K++DFGL K  + DGA+       GT  YL PE     
Sbjct: 131 V---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEVLEDN 185
Query: 588 QLTDKSDVYSFGVILLELISGQEAISNE 615
                 D +  GV++ E++ G+    N+
Sbjct: 186 DYGRAVDWWGLGVVMYEMMCGRLPFYNQ 213

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +                G+ YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFFHQLMAGVVYLHGI-- 123
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE    ++
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 589 L-TDKSDVYSFGVILLELISGQ 609
              +  DV+S G++L  +++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +                G+ YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFFHQLMAGVVYLHGI-- 124
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE    ++
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 589 L-TDKSDVYSFGVILLELISGQ 609
              +  DV+S G++L  +++G+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +            DA +    L  G V
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-----------PDAQRFFHQLMAGVV 118
Query: 530 ----PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 584
                 I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE  
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 585 ISQQL-TDKSDVYSFGVILLELISGQ 609
             ++   +  DV+S G++L  +++G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 9   LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +            DA +    L  G V
Sbjct: 69  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-----------PDAQRFFHQLMAGVV 117
Query: 530 ----PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 584
                 I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE  
Sbjct: 118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 585 ISQQL-TDKSDVYSFGVILLELISGQ 609
             ++   +  DV+S G++L  +++G+
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +                G+ YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFFHQLMAGVVYLHGI-- 124
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE    ++
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 589 L-TDKSDVYSFGVILLELISGQ 609
              +  DV+S G++L  +++G+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +                G+ YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFFHQLMAGVVYLHGI-- 123
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE    ++
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 589 L-TDKSDVYSFGVILLELISGQ 609
              +  DV+S G++L  +++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +                G+ YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFFHQLMAGVVYLHGI-- 123
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE    ++
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 589 L-TDKSDVYSFGVILLELISGQ 609
              +  DV+S G++L  +++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 111/227 (48%), Gaps = 20/227 (8%)
Query: 405 IEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           + D   +LE+ +GSG FGVV+    K  G+    K + +     K    NE+++++++HH
Sbjct: 49  VYDYYDILEE-LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107
Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG---TLTHEQRINWIKRLEIAEDAAKG 520
             L+      +++   VL+ EF+  G L + +      ++  + IN++++      A +G
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ------ACEG 161
Query: 521 IEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGL-SKFAVDGASHVSSIVRGTVG 577
           ++++H     +I+H D+K  NI+ +  K    K+ DFGL +K   D    +  +   T  
Sbjct: 162 LKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAE 215
Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
           +  PE    + +   +D+++ GV+   L+SG    + E      +N+
Sbjct: 216 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 262

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 85  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 136
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFG +K    GA        G    + ++ 
Sbjct: 137 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVPIKWMA 191
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 192 LESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +                G+ YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFFHQLMAGVVYLHGI-- 124
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE    ++
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 589 L-TDKSDVYSFGVILLELISGQ 609
              +  DV+S G++L  +++G+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +                G+ YLH    
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFFHQLMAGVVYLHGI-- 123
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE    ++
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 589 L-TDKSDVYSFGVILLELISGQ 609
              +  DV+S G++L  +++G+
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +            DA +    L  G V
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-----------PDAQRFFHQLMAGVV 118
Query: 530 ----PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 584
                 I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE  
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 585 ISQQL-TDKSDVYSFGVILLELISGQ 609
             ++   +  DV+S G++L  +++G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           ++G G +GVV   + +  G+ +AVK +  T NS + KR   +    +  +     V F G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
               EG   +  E M + +L +     +   Q I      +IA    K +E+LH+    +
Sbjct: 74  ALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--S 130
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
           +IHRD+K SN+L++   + K+ DFG+S + VD  +    I  G   Y+ PE  I+ +L  
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA--KDIDAGCKPYMAPE-RINPELNQ 187
Query: 592 -----KSDVYSFGVILLEL 605
                KSD++S G+ ++EL
Sbjct: 188 KGYSVKSDIWSLGITMIEL 206

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K + SG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 88  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 139
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 140 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 194
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 44/229 (19%)
Query: 412 LEKKIGSGGFGVVYYG-KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIH-HRNL 466
           L KK+G G +G+V+     + G+ +AVK +     NS   +R F  E+ +L+ +  H N+
Sbjct: 13  LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENI 71
Query: 467 VQFLGYCQEEG-RSV-LVYEFMH---NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
           V  L   + +  R V LV+++M    +  ++ ++   + H+Q + +           K I
Sbjct: 72  VNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPV-HKQYVVY--------QLIKVI 122
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV------------------- 562
           +YLH+G    ++HRD+K SNILL+     KV+DFGLS+  V                   
Sbjct: 123 KYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 563 -DGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 609
            D    + +    T  Y  PE  + S + T   D++S G IL E++ G+
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 83  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 134
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFG +K    GA        G    + ++ 
Sbjct: 135 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVPIKWMA 189
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +                G+ YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFFHQLMAGVVYLHGI-- 124
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE    ++
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 589 L-TDKSDVYSFGVILLELISGQ 609
              +  DV+S G++L  +++G+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +                G+ YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFFHQLMAGVVYLHGI-- 124
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE    ++
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 589 L-TDKSDVYSFGVILLELISGQ 609
              +  DV+S G++L  +++G+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 11/202 (5%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 70
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +                G+ YLH    
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFFHQLMAGVVYLHGI-- 124
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE    ++
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 589 L-TDKSDVYSFGVILLELISGQ 609
              +  DV+S G++L  +++G+
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGE 205

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 10  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKF 69
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +            DA +    L  G V
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-----------PDAQRFFHQLMAGVV 118
Query: 530 ----PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 584
                 I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE  
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 585 ISQQL-TDKSDVYSFGVILLELISGQ 609
             ++   +  DV+S G++L  +++G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 469
           K +G G FG V   + K  G+  A+K+L       K E  + VT   +L    H  L   
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTGC 528
               Q   R   V E+ + G L  HL       +R+   +R      +    +EYLH+  
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQ 587
           V   ++RD+K  N++LDK    K++DFGL K  + DGA+       GT  YL PE     
Sbjct: 126 V---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEVLEDN 180
Query: 588 QLTDKSDVYSFGVILLELISGQEAISNE 615
                 D +  GV++ E++ G+    N+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 83  RLLGICLTSTVQ-LIMQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 134
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFG +K    GA        G    + ++ 
Sbjct: 135 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVPIKWMA 189
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFL 470
           +KIG G +G V+  K ++  EI    +V   +  +G       E+ LL  + H+N+V+  
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 471 GYCQEEGRSVLVYEFMHNGTLK--EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                + +  LV+EF      K  +   G L  E   +++ +L       KG+ + H+  
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------LKGLGFCHSR- 120
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQ 587
              ++HRDLK  N+L++++   K++DFGL++ F +    + + +V  T+ Y  P+     
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGA 176
Query: 588 QLTDKS-DVYSFGVILLELISGQEAI 612
           +L   S D++S G I  EL +    +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 132
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFG +K    GA        G    + ++ 
Sbjct: 133 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVPIKWMA 187
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K + SG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 81  RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 132
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 133 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 187
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 469
           K +G G FG V   + K  G+  A+K+L       K E  + VT   +L    H  L   
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q   R   V E+ + G L  HL    + E+     +      +    +EYLH+  V
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQ 588
              ++RD+K  N++LDK    K++DFGL K  + DGA+       GT  YL PE      
Sbjct: 127 ---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEVLEDND 181
Query: 589 LTDKSDVYSFGVILLELISGQEAISNE 615
                D +  GV++ E++ G+    N+
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 105/208 (50%), Gaps = 17/208 (8%)
Query: 406 EDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR 464
           E+   +LEK +G G +G VY    K+ G+ +A+K +   S    +E   E++++ +    
Sbjct: 28  EEVFDVLEK-LGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSP 84
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGI 521
           ++V++ G   +     +V E+   G++ + +     TLT ++         I +   KG+
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT------ILQSTLKGL 138
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           EYLH       IHRD+K+ NILL+    AK++DFG++    D  +  + ++ GT  ++ P
Sbjct: 139 EYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVI-GTPFWMAP 194
Query: 582 EYYISQQLTDKSDVYSFGVILLELISGQ 609
           E          +D++S G+  +E+  G+
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 16/208 (7%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 469
           K +G G FG V   + K  G+  A+K+L       K E  + VT   +L    H  L   
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI-AEDAAKGIEYLHTGC 528
               Q   R   V E+ + G L  HL       +R+   +R      +    +EYLH+  
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQ 587
           V   ++RD+K  N++LDK    K++DFGL K  + DGA+       GT  YL PE     
Sbjct: 126 V---VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEVLEDN 180
Query: 588 QLTDKSDVYSFGVILLELISGQEAISNE 615
                 D +  GV++ E++ G+    N+
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 16/226 (7%)
Query: 394 AEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT 452
           A+  H  T+++ E       K +G G FG V   K K  G+  A+K+L       K E  
Sbjct: 139 AKPKHRVTMNEFEYL-----KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA 193
Query: 453 NEVT---LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 509
           + +T   +L    H  L       Q   R   V E+ + G L  HL    + E+  +  +
Sbjct: 194 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDR 249
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
                 +    ++YLH+     +++RDLK  N++LDK    K++DFGL K  +   + + 
Sbjct: 250 ARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 307
Query: 570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
           +   GT  YL PE           D +  GV++ E++ G+    N+
Sbjct: 308 TFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 83  RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 134
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFG +K    GA        G    + ++ 
Sbjct: 135 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVPIKWMA 189
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 190 LESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K + SG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 88  RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 139
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFGL+K    GA        G    + ++ 
Sbjct: 140 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIKWMA 194
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 26/207 (12%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT-----SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K +GSG FG VY G  + +G+++ + V       + S +  +E  +E  +++ + + ++ 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + LG C       L+ + M  G L    +EH    +  +  +NW  ++      AKG+ Y
Sbjct: 88  RLLGICLTSTVQ-LITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQI------AKGMNY 139
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG---TVGYLD 580
           L       ++HRDL + N+L+      K++DFG +K    GA        G    + ++ 
Sbjct: 140 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVPIKWMA 194
Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
            E  + +  T +SDV+S+GV + EL++
Sbjct: 195 LESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 412 LEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRN 465
           L + +G G FG V   +LK  DG   ++AVK+L ++        EF  E   +    H +
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 466 LVQFLGYC---QEEGR---SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR--LEIAEDA 517
           + + +G     + +GR    +++  FM +G L   L  +   E   N   +  +    D 
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV-RGTV 576
           A G+EYL +      IHRDL + N +L + M   V+DFGLS+    G  +      +  V
Sbjct: 147 ACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            +L  E       T  SDV++FGV + E+++
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 34/210 (16%)
Query: 416 IGSGGFGVVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           IG G FG VY+G+     E+A+++  +  ++    + F  EV    +  H N+V F+G C
Sbjct: 41  IGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI-KRLEIAEDAAKGIEYLHTGCVPAI 532
                  ++       T    LY  +   + +  + K  +IA++  KG+ YLH      I
Sbjct: 99  MSPPHLAIITSLCKGRT----LYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGI 151
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS------SIVRGTVGYLDPEYYIS 586
           +H+DLKS N+  D + +  ++DFGL  F++ G            I  G + +L PE  I 
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGL--FSISGVLQAGRREDKLRIQNGWLCHLAPE--II 206
Query: 587 QQLT-----DK------SDVYSFGVILLEL 605
           +QL+     DK      SDV++ G I  EL
Sbjct: 207 RQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 416 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 469
           IG GGFG VY  +  D GK  A+K L        QG+    NE  +LS +   +   +  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 470 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + Y      +   + + M+ G L  HL  +G  +      +      A +   G+E++H 
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY------AAEIILGLEHMHN 310
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
             V   ++RDLK +NILLD+H   ++SD GL   A D +        GT GY+ PE    
Sbjct: 311 RFV---VYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASVGTHGYMAPEVLQK 364
Query: 587 QQLTDKS-DVYSFGVILLELISGQEAISNEK 616
               D S D +S G +L +L+ G       K
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 16/226 (7%)
Query: 394 AEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT 452
           A+  H  T+++ E       K +G G FG V   K K  G+  A+K+L       K E  
Sbjct: 142 AKPKHRVTMNEFEYL-----KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA 196
Query: 453 NEVT---LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 509
           + +T   +L    H  L       Q   R   V E+ + G L  HL    + E+  +  +
Sbjct: 197 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDR 252
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
                 +    ++YLH+     +++RDLK  N++LDK    K++DFGL K  +   + + 
Sbjct: 253 ARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 310
Query: 570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
           +   GT  YL PE           D +  GV++ E++ G+    N+
Sbjct: 311 TFC-GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 355

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 416 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 469
           IG GGFG VY  +  D GK  A+K L        QG+    NE  +LS +   +   +  
Sbjct: 196 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 255
Query: 470 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + Y      +   + + M+ G L  HL  +G  +      +      A +   G+E++H 
Sbjct: 256 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY------AAEIILGLEHMHN 309
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
             V   ++RDLK +NILLD+H   ++SD GL   A D +        GT GY+ PE    
Sbjct: 310 RFV---VYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASVGTHGYMAPEVLQK 363
Query: 587 QQLTDKS-DVYSFGVILLELISGQEAISNEK 616
               D S D +S G +L +L+ G       K
Sbjct: 364 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 394

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 412 LEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 468
           L + IG G F VV    KL  G E A K++ +     +  ++   E  +   + H N+V+
Sbjct: 8   LYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVR 67
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                 EEG   LV++ +  G L E +     + +            DA+  I+ +    
Sbjct: 68  LHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE-----------ADASHCIQQILEAV 116
Query: 529 VPA----IIHRDLKSSNILLDKHMRA---KVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           +      ++HRDLK  N+LL    +    K++DFGL+   V G         GT GYL P
Sbjct: 117 LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSP 175
Query: 582 EYYISQQLTDKSDVYSFGVILLELISG 608
           E    +      D+++ GVIL  L+ G
Sbjct: 176 EVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 416 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 469
           IG GGFG VY  +  D GK  A+K L        QG+    NE  +LS +   +   +  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 470 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + Y      +   + + M+ G L  HL  +G  +      +      A +   G+E++H 
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY------AAEIILGLEHMHN 310
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
             V   ++RDLK +NILLD+H   ++SD GL   A D +        GT GY+ PE    
Sbjct: 311 RFV---VYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASVGTHGYMAPEVLQK 364
Query: 587 QQLTDKS-DVYSFGVILLELISGQEAISNEK 616
               D S D +S G +L +L+ G       K
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 416 IGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRN--LVQF 469
           IG GGFG VY  +  D GK  A+K L        QG+    NE  +LS +   +   +  
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256
Query: 470 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           + Y      +   + + M+ G L  HL  +G  +      +      A +   G+E++H 
Sbjct: 257 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY------AAEIILGLEHMHN 310
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
             V   ++RDLK +NILLD+H   ++SD GL   A D +        GT GY+ PE    
Sbjct: 311 RFV---VYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASVGTHGYMAPEVLQK 364
Query: 587 QQLTDKS-DVYSFGVILLELISGQEAISNEK 616
               D S D +S G +L +L+ G       K
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVL----TSNSYQG--KREFTNEVTLLSRIHHRNL 466
           +++GSG F VV   + K  G + A K +    T +S +G  + +   EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +      + +   +L+ E +  G L + L    +LT E+   ++K++        G+ YL
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------LNGVYYL 130
Query: 525 HTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           H+     I H DLK  NI LLD+++   R K+ DFGL+   +D  +   +I  GT  ++ 
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIF-GTPEFVA 185
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISG 608
           PE    + L  ++D++S GVI   L+SG
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 416 IGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +G G +G+V   + KD G+ +A+K    + +    K+    E+ LL ++ H NLV  L  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 473 CQEEGRSVLVYEFMHNGTLK--EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
           C+++ R  LV+EF+ +  L   E     L ++    ++ ++        GI + H+    
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI------INGIGFCHSH--- 143
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
            IIHRD+K  NIL+ +    K+ DFG ++  A  G  +   +   T  Y  PE  +    
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV--ATRWYRAPELLVGDVK 201
Query: 590 TDKS-DVYSFGVILLELISGQ 609
             K+ DV++ G ++ E+  G+
Sbjct: 202 YGKAVDVWAIGCLVTEMFMGE 222

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVL----TSNSYQG--KREFTNEVTLLSRIHHRNL 466
           +++GSG F VV   + K  G + A K +    T +S +G  + +   EV++L  I H N+
Sbjct: 17  EELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +      + +   +L+ E +  G L + L    +LT E+   ++K++        G+ YL
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------LNGVYYL 130
Query: 525 HTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           H+     I H DLK  NI LLD+++   R K+ DFGL+   +D  +   +I  GT  ++ 
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIF-GTPEFVA 185
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISG 608
           PE    + L  ++D++S GVI   L+SG
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVL----TSNSYQG--KREFTNEVTLLSRIHHRNL 466
           +++GSG F VV   + K  G + A K +    T +S +G  + +   EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +      + +   +L+ E +  G L + L    +LT E+   ++K++        G+ YL
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------LNGVYYL 130
Query: 525 HTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           H+     I H DLK  NI LLD+++   R K+ DFGL+   +D  +   +I  GT  ++ 
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIF-GTPEFVA 185
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISG 608
           PE    + L  ++D++S GVI   L+SG
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 29/226 (12%)
Query: 405 IEDATKMLEKKIGSGGFGVV-YYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH 463
           I++   +  +K+G GGF  V     L DG   A+K +  +  Q + E   E  +    +H
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH 85
Query: 464 RNLVQFLGYC-QEEG---RSVLVYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIA 514
            N+++ + YC +E G    + L+  F   GTL   +      G    E +I W     + 
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW-----LL 140
Query: 515 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA---VDGASHVSSI 571
               +G+E +H        HRDLK +NILL    +  + D G    A   V+G+    ++
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 572 -----VRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQ 609
                 R T+ Y  PE +  Q    + +++DV+S G +L  ++ G+
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 412 LEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 468
           L +++G G F VV    K+  G+E A K++ +     +  ++   E  +   + H N+V+
Sbjct: 8   LFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVR 67
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                 EEG   LV++ +  G L E +           +    + +    + +E ++   
Sbjct: 68  LHDSISEEGFHYLVFDLVTGGELFEDIVAR-------EYYSEADASHCIQQILESVNHCH 120
Query: 529 VPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
           +  I+HRDLK  N+LL    K    K++DFGL+   V G         GT GYL PE   
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 586 SQQLTDKSDVYSFGVILLELISG 608
                   D+++ GVIL  L+ G
Sbjct: 180 KDPYGKPVDMWACGVILYILLVG 202

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVL----TSNSYQG--KREFTNEVTLLSRIHHRNL 466
           +++GSG F VV   + K  G + A K +    T +S +G  + +   EV++L  I H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +      + +   +L+ E +  G L + L    +LT E+   ++K++        G+ YL
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------LNGVYYL 129
Query: 525 HTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           H+     I H DLK  NI LLD+++   R K+ DFGL+   +D  +   +I  GT  ++ 
Sbjct: 130 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIF-GTPEFVA 184
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISG 608
           PE    + L  ++D++S GVI   L+SG
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 412 LEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 468
           L +++G G F VV    K+  G+E A K++ +     +  ++   E  +   + H N+V+
Sbjct: 8   LFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVR 67
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                 EEG   LV++ +  G L E +           +    + +    + +E ++   
Sbjct: 68  LHDSISEEGFHYLVFDLVTGGELFEDIVAR-------EYYSEADASHCIQQILESVNHCH 120
Query: 529 VPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
           +  I+HRDLK  N+LL    K    K++DFGL+   V G         GT GYL PE   
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLR 179
Query: 586 SQQLTDKSDVYSFGVILLELISGQEAISNE 615
                   D+++ GVIL  L+ G     +E
Sbjct: 180 KDPYGKPVDMWACGVILYILLVGYPPFWDE 209

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVL----TSNSYQG--KREFTNEVTLLSRIHHRNL 466
           +++GSG F VV   + K  G + A K +    T +S +G  + +   EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +      + +   +L+ E +  G L + L    +LT E+   ++K++        G+ YL
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------LNGVYYL 130
Query: 525 HTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           H+     I H DLK  NI LLD+++   R K+ DFGL+   +D  +   +I  GT  ++ 
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIF-GTPEFVA 185
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISG 608
           PE    + L  ++D++S GVI   L+SG
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVL----TSNSYQG--KREFTNEVTLLSRIHHRNL 466
           +++GSG F VV   + K  G + A K +    T +S +G  + +   EV++L  I H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +      + +   +L+ E +  G L + L    +LT E+   ++K++        G+ YL
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------LNGVYYL 129
Query: 525 HTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           H+     I H DLK  NI LLD+++   R K+ DFGL+   +D  +   +I  GT  ++ 
Sbjct: 130 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIF-GTPEFVA 184
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISG 608
           PE    + L  ++D++S GVI   L+SG
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVL----TSNSYQG--KREFTNEVTLLSRIHHRNL 466
           +++GSG F VV   + K  G + A K +    T +S +G  + +   EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +      + +   +L+ E +  G L + L    +LT E+   ++K++        G+ YL
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------LNGVYYL 130
Query: 525 HTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           H+     I H DLK  NI LLD+++   R K+ DFGL+   +D  +   +I  GT  ++ 
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIF-GTPEFVA 185
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISG 608
           PE    + L  ++D++S GVI   L+SG
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 108/231 (46%), Gaps = 18/231 (7%)
Query: 416 IGSGGFGVVYY-GKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ 474
           +G G FG V+   +   G ++A K++ +   + K E  NE+++++++ H NL+Q     +
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 475 EEGRSVLVYEFMHNGTLKEHLYG---TLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
            +   VLV E++  G L + +      LT    I ++K++       +GI ++H      
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI------CEGIRHMHQ---MY 207
Query: 532 IIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
           I+H DLK  NIL       + K+ DFGL++           +  GT  +L PE      +
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLAPEVVNYDFV 265
Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 640
           +  +D++S GVI   L+SG      +       NI+   +  +E  + Q I
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILA-CRWDLEDEEFQDI 315

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVL----TSNSYQG--KREFTNEVTLLSRIHHRNL 466
           +++GSG F VV   + K  G + A K +    T +S +G  + +   EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +      + +   +L+ E +  G L + L    +LT E+   ++K++        G+ YL
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------LNGVYYL 130
Query: 525 HTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           H+     I H DLK  NI LLD+++   R K+ DFGL+   +D  +   +I  GT  ++ 
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIF-GTPEFVA 185
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISG 608
           PE    + L  ++D++S GVI   L+SG
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVL----TSNSYQG--KREFTNEVTLLSRIHHRNL 466
           +++GSG F VV   + K  G + A K +    T +S +G  + +   EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +      + +   +L+ E +  G L + L    +LT E+   ++K++        G+ YL
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------LNGVYYL 130
Query: 525 HTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           H+     I H DLK  NI LLD+++   R K+ DFGL+   +D  +   +I  GT  ++ 
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIF-GTPEFVA 185
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISG 608
           PE    + L  ++D++S GVI   L+SG
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 108/228 (47%), Gaps = 31/228 (13%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K IGSG  G+V   Y   L+  + +A+K L+    N    KR +  E+ L+  ++H+N++
Sbjct: 24  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNII 80
Query: 468 QFLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
             L         EE + V +   + +  L + +   L HE R++++    +      GI+
Sbjct: 81  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 134
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 135 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 189
Query: 583 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL 630
             +     +  D++S G I+ E++  +       +      I QW K+
Sbjct: 190 VILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDY------IDQWNKV 231

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVL----TSNSYQG--KREFTNEVTLLSRIHHRNL 466
           +++GSG F VV   + K  G + A K +    T +S +G  + +   EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +      + +   +L+ E +  G L + L    +LT E+   ++K++        G+ YL
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------LNGVYYL 130
Query: 525 HTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           H+     I H DLK  NI LLD+++   R K+ DFGL+   +D  +   +I  GT  ++ 
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIF-GTPEFVA 185
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISG 608
           PE    + L  ++D++S GVI   L+SG
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 8/199 (4%)
Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           IG+G +G     + K DGK +  K L   S +   K+   +EV LL  + H N+V++   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 473 CQEEGRSVL--VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--TGC 528
             +   + L  V E+   G L   +       Q ++    L +       ++  H  +  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              ++HRDLK +N+ LD     K+ DFGL++      S   + V GT  Y+ PE      
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQMNRMS 192
Query: 589 LTDKSDVYSFGVILLELIS 607
             +KSD++S G +L EL +
Sbjct: 193 YNEKSDIWSLGCLLYELCA 211

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 8/199 (4%)
Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           IG+G +G     + K DGK +  K L   S +   K+   +EV LL  + H N+V++   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 473 CQEEGRSVL--VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--TGC 528
             +   + L  V E+   G L   +       Q ++    L +       ++  H  +  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              ++HRDLK +N+ LD     K+ DFGL++      S   + V GT  Y+ PE      
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMS 192
Query: 589 LTDKSDVYSFGVILLELIS 607
             +KSD++S G +L EL +
Sbjct: 193 YNEKSDIWSLGCLLYELCA 211

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVL----TSNSYQG--KREFTNEVTLLSRIHHRNL 466
           +++GSG F VV   + K  G + A K +    T +S +G  + +   EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +      + +   +L+ E +  G L + L    +LT E+   ++K++        G+ YL
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------LNGVYYL 130
Query: 525 HTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           H+     I H DLK  NI LLD+++   R K+ DFGL+   +D  +   +I  GT  ++ 
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIF-GTPEFVA 185
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISG 608
           PE    + L  ++D++S GVI   L+SG
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K IGSG  G+V   Y   L+  + +A+K L+    N    KR +  E+ L+  ++H+N++
Sbjct: 35  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNII 91
Query: 468 QFLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
             L         EE + V +   + +  L + +   L HE R++++    +      GI+
Sbjct: 92  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 145
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S + +    T  Y  PE
Sbjct: 146 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPE 200
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 201 VILGMGYKENVDLWSVGCIMGEMV 224

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 469
           + IG G FG V   +  D K++ A+K +       + E  N   E+ ++  + H  LV  
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q+E    +V + +  G L+ HL   +  ++      +L I E     ++YL     
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET---VKLFICE-LVMALDYLQNQ-- 134
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             IIHRD+K  NILLD+H    ++DF ++   +   + ++++  GT  Y+ PE + S++ 
Sbjct: 135 -RIIHRDMKPDNILLDEHGHVHITDFNIAAM-LPRETQITTMA-GTKPYMAPEMFSSRKG 191
Query: 590 TDKS---DVYSFGVILLELISGQ 609
              S   D +S GV   EL+ G+
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGR 214

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 411 MLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQ 468
           + ++K+GSG FG V+  + +  G E  +K +  +  Q   E    E+ +L  + H N+++
Sbjct: 25  IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                ++     +V E    G L E +       + ++     E+ +     + Y H+  
Sbjct: 85  IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 529 VPAIIHRDLKSSNILLDK---HMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 584
           V   +H+DLK  NIL      H   K+ DFGL++ F  D  S  ++   GT  Y+ PE +
Sbjct: 145 V---VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA---GTALYMAPEVF 198
Query: 585 ISQQLTDKSDVYSFGVILLELISG 608
             + +T K D++S GV++  L++G
Sbjct: 199 -KRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 102/199 (51%), Gaps = 13/199 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFT--NEVTLLSRIHHRNLVQFL 470
           +KIG G +GVVY  + K  G+ +A+K +  ++       T   E++LL  ++H N+V+ L
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 71
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                E +  LV+E + +  LK+ +  +      +  IK         +G+ + H+    
Sbjct: 72  DVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLF--QLLQGLAFCHSH--- 125
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI-SQQ 588
            ++HRDLK  N+L++     K++DFGL++ F V   ++   +V  T+ Y  PE  +  + 
Sbjct: 126 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEILLGCKY 183
Query: 589 LTDKSDVYSFGVILLELIS 607
            +   D++S G I  E+++
Sbjct: 184 YSTAVDIWSLGCIFAEMVT 202

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVL----TSNSYQG--KREFTNEVTLLSRIHHRNL 466
           +++GSG F VV   + K  G + A K +    T +S +G  + +   EV++L  I H N+
Sbjct: 17  EELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +      + +   +L+ E +  G L + L    +LT E+   ++K++        G+ YL
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI------LNGVYYL 130
Query: 525 HTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           H+     I H DLK  NI LLD+++   R K+ DFGL+   +D  +   +I  GT  ++ 
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIF-GTPEFVA 185
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISG 608
           PE    + L  ++D++S GVI   L+SG
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 469
           K +G G FG V   K K  G+  A+K+L       K E  + +T   +L    H  L   
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 75
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q   R   V E+ + G L  HL    + E+  +  +      +    ++YLH+   
Sbjct: 76  KYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSE-- 129
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQ 588
             +++RDLK  N++LDK    K++DFGL K  + DGA+       GT  YL PE      
Sbjct: 130 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPEVLEDND 187
Query: 589 LTDKSDVYSFGVILLELISGQEAISNE 615
                D +  GV++ E++ G+    N+
Sbjct: 188 YGRAVDWWGLGVVMYEMMCGRLPFYNQ 214

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 468
           +++++G G F VV     K  G E A K++ +     +  ++   E  +  ++ H N+V+
Sbjct: 10  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                QEE    LV++ +  G L E +     + +           +   + I Y H+  
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE----ADASHCIQQILESIAYCHSN- 124
Query: 529 VPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
              I+HR+LK  N+LL    K    K++DFGL+    D  S       GT GYL PE   
Sbjct: 125 --GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEVLK 180
Query: 586 SQQLTDKSDVYSFGVILLELISGQEAISNE 615
               +   D+++ GVIL  L+ G     +E
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDE 210

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 24/224 (10%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLV 467
           L K IGSG FGV    + K   E +AVK +          KRE  N  +L     H N+V
Sbjct: 23  LVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL----RHPNIV 78
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +F           +V E+   G L E +   G  + ++   + ++L        G+ Y H
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCH 132
Query: 526 TGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
                 + HRDLK  N LLD     R K+  FG SK +V  +   S++  GT  Y+ PE 
Sbjct: 133 AM---QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV--GTPAYIAPEV 187
Query: 584 YISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
            + ++   K +DV+S GV L  ++ G     + +   N R  + 
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 231

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQF 469
           +++++G+GGFG V     +D G+++A+K      S + +  +  E+ ++ +++H N+V  
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 470 ------LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA---EDAAKG 520
                 L         +L  E+   G L+++L       +    +K   I     D +  
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----NQFENCCGLKEGPIRTLLSDISSA 133
Query: 521 IEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
           + YLH      IIHRDLK  NI+L    + +  K+ D G +K  +D     +  V GT+ 
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCTEFV-GTLQ 188
Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELISG 608
           YL PE    ++ T   D +SFG +  E I+G
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQF 469
           +++++G+GGFG V     +D G+++A+K      S + +  +  E+ ++ +++H N+V  
Sbjct: 19  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 78
Query: 470 ------LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA---EDAAKG 520
                 L         +L  E+   G L+++L       +    +K   I     D +  
Sbjct: 79  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----NQFENCCGLKEGPIRTLLSDISSA 134
Query: 521 IEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
           + YLH      IIHRDLK  NI+L    + +  K+ D G +K  +D     +  V GT+ 
Sbjct: 135 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCTEFV-GTLQ 189
Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELISG 608
           YL PE    ++ T   D +SFG +  E I+G
Sbjct: 190 YLAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 468
           +++++G G F VV     K  G E A K++ +     +  ++   E  +  ++ H N+V+
Sbjct: 10  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                QEE    LV++ +  G L E +     + +           +   + I Y H+  
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE----ADASHCIQQILESIAYCHSN- 124
Query: 529 VPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
              I+HR+LK  N+LL    K    K++DFGL+    D  S       GT GYL PE   
Sbjct: 125 --GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEVLK 180
Query: 586 SQQLTDKSDVYSFGVILLELISGQEAISNE 615
               +   D+++ GVIL  L+ G     +E
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDE 210

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 19/206 (9%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G  G V     +  +E +AVK++    +         E+ +   ++H N+V+F
Sbjct: 10  LVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 69
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +   +   +            DA +    L  G V
Sbjct: 70  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE-----------PDAQRFFHQLMAGVV 118
Query: 530 ----PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 584
                 I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE  
Sbjct: 119 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 585 ISQQL-TDKSDVYSFGVILLELISGQ 609
             ++   +  DV+S G++L  +++G+
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE 204

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 15/210 (7%)
Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 468
           +++++G G F VV     K  G E A K++ +     +  ++   E  +  ++ H N+V+
Sbjct: 9   VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 68
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                QEE    LV++ +  G L E +     + +           +   + I Y H+  
Sbjct: 69  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE----ADASHCIQQILESIAYCHSN- 123
Query: 529 VPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
              I+HR+LK  N+LL    K    K++DFGL+    D  S       GT GYL PE   
Sbjct: 124 --GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEVLK 179
Query: 586 SQQLTDKSDVYSFGVILLELISGQEAISNE 615
               +   D+++ GVIL  L+ G     +E
Sbjct: 180 KDPYSKPVDIWACGVILYILLVGYPPFWDE 209

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 469
           K +G G FG V   K K  G+  A+K+L       K E  + +T   +L    H  L   
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 74
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q   R   V E+ + G L  HL    + E+  +  +      +    ++YLH+   
Sbjct: 75  KYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSE-- 128
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQ 588
             +++RDLK  N++LDK    K++DFGL K  + DGA+       GT  YL PE      
Sbjct: 129 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPEVLEDND 186
Query: 589 LTDKSDVYSFGVILLELISGQEAISNE 615
                D +  GV++ E++ G+    N+
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPFYNQ 213

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVT---LLSRIHHRNLVQF 469
           K +G G FG V   K K  G+  A+K+L       K E  + +T   +L    H  L   
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 73
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q   R   V E+ + G L  HL    + E+  +  +      +    ++YLH+   
Sbjct: 74  KYSFQTHDRLCFVMEYANGGELFFHL----SRERVFSEDRARFYGAEIVSALDYLHSE-- 127
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYYISQQ 588
             +++RDLK  N++LDK    K++DFGL K  + DGA+       GT  YL PE      
Sbjct: 128 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPEVLEDND 185
Query: 589 LTDKSDVYSFGVILLELISGQEAISNE 615
                D +  GV++ E++ G+    N+
Sbjct: 186 YGRAVDWWGLGVVMYEMMCGRLPFYNQ 212

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K IGSG  G+V   Y   L+  + +A+K L+    N    KR +  E+ L+  ++H+N++
Sbjct: 30  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNII 86
Query: 468 QFLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
             L         EE + V +   + +  L + +   L HE R++++    +      GI+
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S +      T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 196 VILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 99/233 (42%), Gaps = 21/233 (9%)
Query: 388 SLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKL--KDGK--EIAVKVLTSN 443
           S  + P ++  C     I +    L +K+G G FGVV  G+     GK   +AVK L  +
Sbjct: 2   SAGEGPLQSLTCL----IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD 57
Query: 444 SY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT 500
                +   +F  EV  +  + HRNL++  G         +V E    G+L + L     
Sbjct: 58  VLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR---K 113
Query: 501 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 560
           H+           A   A+G+ YL +      IHRDL + N+LL      K+ DFGL + 
Sbjct: 114 HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170
Query: 561 AVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQE 610
                 H  +    +    +  PE   ++  +  SD + FGV L E+ + GQE
Sbjct: 171 LPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLVQ 468
           +IG G +G VY  +    G  +A+K V   N  +G    T  EV LL R+    H N+V+
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 469 FLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
            +  C       E +  LV+E + +  L+ +L            IK  ++     +G+++
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK--DLMRQFLRGLDF 127
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH  C   I+HRDLK  NIL+      K++DFGL++      +    +V  T+ Y  PE 
Sbjct: 128 LHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVV--TLWYRAPEV 182
Query: 584 YISQQLTDKSDVYSFGVILLELI 606
            +        D++S G I  E+ 
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 468
           +++++G G F VV     K  G E A K++ +     +  ++   E  +  ++ H N+V+
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                QEE    LV++ +  G L E +     + +           +   + I Y H+  
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE----ADASHCIQQILESIAYCHSN- 147
Query: 529 VPAIIHRDLKSSNILLDKHMRA---KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
              I+HR+LK  N+LL    +    K++DFGL+    D  S       GT GYL PE   
Sbjct: 148 --GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEVLK 203
Query: 586 SQQLTDKSDVYSFGVILLELISG 608
               +   D+++ GVIL  L+ G
Sbjct: 204 KDPYSKPVDIWACGVILYILLVG 226

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 24/208 (11%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVL----TSNSYQG--KREFTNEVTLLSRIHHRNL 466
           +++GSG F VV   + K  G + A K +    T +S +G  + +   EV++L  I H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +      + +   +L+ E +  G L + L    +LT E+   ++K++        G+ YL
Sbjct: 77  ITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQI------LNGVYYL 130
Query: 525 HTGCVPAIIHRDLKSSNI-LLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           H+     I H DLK  NI LLD+++   R K+ DFGL+   +D  +   +I  GT  ++ 
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIF-GTPEFVA 185
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISG 608
           PE    + L  ++D++S GVI   L+SG
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 99/233 (42%), Gaps = 21/233 (9%)
Query: 388 SLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKL--KDGK--EIAVKVLTSN 443
           S  + P ++  C     I +    L +K+G G FGVV  G+     GK   +AVK L  +
Sbjct: 2   SAGEGPLQSLTCL----IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD 57
Query: 444 SY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLT 500
                +   +F  EV  +  + HRNL++  G         +V E    G+L + L     
Sbjct: 58  VLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR---K 113
Query: 501 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 560
           H+           A   A+G+ YL +      IHRDL + N+LL      K+ DFGL + 
Sbjct: 114 HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170
Query: 561 AVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQE 610
                 H  +    +    +  PE   ++  +  SD + FGV L E+ + GQE
Sbjct: 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 412 LEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 468
           L +++G G F VV    K+  G+E A K++ +     +  ++   E  +   + H N+V+
Sbjct: 26  LFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVR 85
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                 EEG   L+++ +  G L E +     + +            DA+  I+ +    
Sbjct: 86  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE-----------ADASHCIQQILEAV 134
Query: 529 VPA----IIHRDLKSSNILLDKHMRA---KVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           +      ++HRDLK  N+LL   ++    K++DFGL+   V+G         GT GYL P
Sbjct: 135 LHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSP 193
Query: 582 EYYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
           E           D+++ GVIL  L+ G     +E
Sbjct: 194 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE 227

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 104/240 (43%), Gaps = 31/240 (12%)
Query: 387 SSLNDAPAE-AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK----LKDGKEIAVKVLT 441
           +S+N  P +    CF L  +          +G GG+G V+  +       GK  A+KVL 
Sbjct: 5   TSVNRGPEKIRPECFELLRV----------LGKGGYGKVFQVRKVTGANTGKIFAMKVLK 54
Query: 442 S----NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY- 496
                 + +       E  +L  + H  +V  +   Q  G+  L+ E++  G L   L  
Sbjct: 55  KAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER 114
Query: 497 -GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 555
            G    +    ++  + +A      + +LH      II+RDLK  NI+L+     K++DF
Sbjct: 115 EGIFMEDTACFYLAEISMA------LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDF 165
Query: 556 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
           GL K ++   + V+    GT+ Y+ PE  +        D +S G ++ ++++G    + E
Sbjct: 166 GLCKESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 113/234 (48%), Gaps = 26/234 (11%)
Query: 405 IEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH- 462
            ED  ++ E  +G G    V     L   +E AVK++       +     EV +L +   
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG 69
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-INWIKRLEIAEDAAKGI 521
           HRN+++ + + +EE R  LV+E M  G++  H+     H++R  N ++   + +D A  +
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI-----HKRRHFNELEASVVVQDVASAL 124
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGL-SKFAVDG-ASHVSS----IV 572
           ++LH      I HRDLK  NIL +   +    K+ DFGL S   ++G  S +S+      
Sbjct: 125 DFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTP 181
Query: 573 RGTVGYLDPE----YYISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANC 621
            G+  Y+ PE    +     + DK  D++S GVIL  L+SG       + G++C
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG-RCGSDC 234

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLVQ 468
           +IG G +G VY  +    G  +A+K V   N  +G    T  EV LL R+    H N+V+
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 469 FLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
            +  C       E +  LV+E + +  L+ +L            IK  ++     +G+++
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK--DLMRQFLRGLDF 127
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH  C   I+HRDLK  NIL+      K++DFGL++      +    +V  T+ Y  PE 
Sbjct: 128 LHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV--TLWYRAPEV 182
Query: 584 YISQQLTDKSDVYSFGVILLELI 606
            +        D++S G I  E+ 
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLG 471
           +G G FG V     K  +E+ A+K+L  +      +      E  +L+ +     +  L 
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 472 YC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
            C Q   R   V E+++ G L  H+   G     Q + +   + I      G+ +LH   
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISI------GLFFLHKR- 139
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQ 587
              II+RDLK  N++LD     K++DFG+ K   +DG +  +    GT  Y+ PE    Q
Sbjct: 140 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVT--TREFCGTPDYIAPEIIAYQ 195
Query: 588 QLTDKSDVYSFGVILLELISGQEAISNE 615
                 D +++GV+L E+++GQ     E
Sbjct: 196 PYGKSVDWWAYGVLLYEMLAGQPPFDGE 223

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 104/240 (43%), Gaps = 31/240 (12%)
Query: 387 SSLNDAPAE-AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK----LKDGKEIAVKVLT 441
           +S+N  P +    CF L  +          +G GG+G V+  +       GK  A+KVL 
Sbjct: 5   TSVNRGPEKIRPECFELLRV----------LGKGGYGKVFQVRKVTGANTGKIFAMKVLK 54
Query: 442 S----NSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY- 496
                 + +       E  +L  + H  +V  +   Q  G+  L+ E++  G L   L  
Sbjct: 55  KAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER 114
Query: 497 -GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 555
            G    +    ++  + +A      + +LH      II+RDLK  NI+L+     K++DF
Sbjct: 115 EGIFMEDTACFYLAEISMA------LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDF 165
Query: 556 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
           GL K ++   + V+    GT+ Y+ PE  +        D +S G ++ ++++G    + E
Sbjct: 166 GLCKESIHDGT-VTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 406 EDATKMLEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNSY---QGKREFTNEVTLL 458
           E   ++LEK +G G FGVV  G+     GK   +AVK L  +     +   +F  EV  +
Sbjct: 11  EKDLRLLEK-LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 69
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
             + HRNL++  G         +V E    G+L + L     H+           A   A
Sbjct: 70  HSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVA 125
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTV 576
           +G+ YL +      IHRDL + N+LL      K+ DFGL +       H  +    +   
Sbjct: 126 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 182
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQE 610
            +  PE   ++  +  SD + FGV L E+ + GQE
Sbjct: 183 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 217

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 406 EDATKMLEKKIGSGGFGVVYYGKL--KDGK--EIAVKVLTSNSY---QGKREFTNEVTLL 458
           E   ++LEK +G G FGVV  G+     GK   +AVK L  +     +   +F  EV  +
Sbjct: 7   EKDLRLLEK-LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
             + HRNL++  G         +V E    G+L + L     H+           A   A
Sbjct: 66  HSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVA 121
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTV 576
           +G+ YL +      IHRDL + N+LL      K+ DFGL +       H  +    +   
Sbjct: 122 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF 178
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQE 610
            +  PE   ++  +  SD + FGV L E+ + GQE
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           K IGSG  G+V   Y   L+  + +A+K L+    N    KR +  E+ L+  ++H+N++
Sbjct: 30  KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNII 86
Query: 468 QFLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
             L         EE + V +   + +  L + +   L HE R++++    +      GI+
Sbjct: 87  GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE-RMSYLLYQMLC-----GIK 140
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++ A  G S +      T  Y  PE
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMEPEVVTRYYRAPE 195
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +     +  D++S G I+ E++
Sbjct: 196 VILGMGYKENVDLWSVGCIMGEMV 219

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFL 470
           +KIG G +G V+  K ++  EI    +V   +  +G       E+ LL  + H+N+V+  
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 471 GYCQEEGRSVLVYEFMHNGTLK--EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                + +  LV+EF      K  +   G L  E   +++ +L       KG+ + H+  
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------LKGLGFCHSR- 120
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQ 587
              ++HRDLK  N+L++++   K+++FGL++ F +    + + +V  T+ Y  P+     
Sbjct: 121 --NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGA 176
Query: 588 QLTDKS-DVYSFGVILLELISG 608
           +L   S D++S G I  EL + 
Sbjct: 177 KLYSTSIDMWSAGCIFAELANA 198

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 406 EDATKMLEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNSY---QGKREFTNEVTLL 458
           E   ++LEK +G G FGVV  G+     GK   +AVK L  +     +   +F  EV  +
Sbjct: 7   EKDLRLLEK-LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
             + HRNL++  G         +V E    G+L + L     H+           A   A
Sbjct: 66  HSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVA 121
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTV 576
           +G+ YL +      IHRDL + N+LL      K+ DFGL +       H  +    +   
Sbjct: 122 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQE 610
            +  PE   ++  +  SD + FGV L E+ + GQE
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 33/220 (15%)
Query: 416 IGSGGFGVVYYGKLKDGKEIAVKVLTS---NSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +G G +G V+ G  + G+ +AVK+ +S    S+  + E  N V L     H N++ F+  
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 99
Query: 473 CQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--- 525
                 S     L+  +   G+L ++L  T      ++ +  L I    A G+ +LH   
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEI 154
Query: 526 --TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVGYLD 580
             T   PAI HRDLKS NIL+ K+ +  ++D GL+       + +   ++   GT  Y+ 
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 581 PEYYISQQLTD------KSDVYSFGVILLELISGQEAISN 614
           PE        D      + D+++FG++L E+   +  +SN
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSN 252

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 33/220 (15%)
Query: 416 IGSGGFGVVYYGKLKDGKEIAVKVLTS---NSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +G G +G V+ G  + G+ +AVK+ +S    S+  + E  N V L     H N++ F+  
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 473 CQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--- 525
                 S     L+  +   G+L ++L  T      ++ +  L I    A G+ +LH   
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 526 --TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVGYLD 580
             T   PAI HRDLKS NIL+ K+ +  ++D GL+       + +   ++   GT  Y+ 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 581 PEYYISQQLTD------KSDVYSFGVILLELISGQEAISN 614
           PE        D      + D+++FG++L E+   +  +SN
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSN 223

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 406 EDATKMLEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNSY---QGKREFTNEVTLL 458
           E   ++LEK +G G FGVV  G+     GK   +AVK L  +     +   +F  EV  +
Sbjct: 7   EKDLRLLEK-LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
             + HRNL++  G         +V E    G+L + L     H+           A   A
Sbjct: 66  HSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVA 121
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTV 576
           +G+ YL +      IHRDL + N+LL      K+ DFGL +       H  +    +   
Sbjct: 122 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQE 610
            +  PE   ++  +  SD + FGV L E+ + GQE
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 18/215 (8%)
Query: 406 EDATKMLEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNSY---QGKREFTNEVTLL 458
           E   ++LEK +G G FGVV  G+     GK   +AVK L  +     +   +F  EV  +
Sbjct: 11  EKDLRLLEK-LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 69
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
             + HRNL++  G         +V E    G+L + L     H+           A   A
Sbjct: 70  HSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVA 125
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTV 576
           +G+ YL +      IHRDL + N+LL      K+ DFGL +       H  +    +   
Sbjct: 126 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 182
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQE 610
            +  PE   ++  +  SD + FGV L E+ + GQE
Sbjct: 183 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 217

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K IG+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E+M  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    KV+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 97/224 (43%), Gaps = 24/224 (10%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-IAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLV 467
           L K IGSG FGV    + K   E +AVK +          KRE  N  +L     H N+V
Sbjct: 23  LVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSL----RHPNIV 78
Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +F           +V E+   G L E +   G  + ++   + ++L        G+ Y H
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL------ISGVSYCH 132
Query: 526 TGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
                 + HRDLK  N LLD     R K+  FG SK +V  +    ++  GT  Y+ PE 
Sbjct: 133 AM---QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV--GTPAYIAPEV 187
Query: 584 YISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
            + ++   K +DV+S GV L  ++ G     + +   N R  + 
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 231

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 472
           ++G+G  GVV+    K    +  + L     +   + +   E+ +L   +   +V F G 
Sbjct: 75  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 134
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
              +G   +  E M  G+L + L       ++I  + ++ IA    KG+ YL       I
Sbjct: 135 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLREKH--KI 188
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           +HRD+K SNIL++     K+ DFG+S   +D  S  +S V GT  Y+ PE       + +
Sbjct: 189 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSVQ 245
Query: 593 SDVYSFGVILLELISGQEAI 612
           SD++S G+ L+E+  G+  I
Sbjct: 246 SDIWSMGLSLVEMAVGRYPI 265

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 33/220 (15%)
Query: 416 IGSGGFGVVYYGKLKDGKEIAVKVLTS---NSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +G G +G V+ G  + G+ +AVK+ +S    S+  + E  N V L     H N++ F+  
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 473 CQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--- 525
                 S     L+  +   G+L ++L  T      ++ +  L I    A G+ +LH   
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 526 --TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVGYLD 580
             T   PAI HRDLKS NIL+ K+ +  ++D GL+       + +   ++   GT  Y+ 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 581 PEYYISQQLTD------KSDVYSFGVILLELISGQEAISN 614
           PE        D      + D+++FG++L E+   +  +SN
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSN 223

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K IG+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E+M  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYMPGGDMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    KV+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLVQ 468
           +IG G +G VY  +    G  +A+K V   N  +G    T  EV LL R+    H N+V+
Sbjct: 11  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVR 70
Query: 469 FLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
            +  C       E +  LV+E + +  L+ +L            IK  ++     +G+++
Sbjct: 71  LMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK--DLMRQFLRGLDF 127
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH  C   I+HRDLK  NIL+      K++DFGL++      +    +V  T+ Y  PE 
Sbjct: 128 LHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV--TLWYRAPEV 182
Query: 584 YISQQLTDKSDVYSFGVILLELI 606
            +        D++S G I  E+ 
Sbjct: 183 LLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 37/240 (15%)
Query: 411 MLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ--GKRE------FTNEVTLLSRI 461
           ++ K +GSG  G V    + K  K++A+K+++   +     RE         E+ +L ++
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE------ 515
           +H  +++   +   E   + V E M  G L + + G           KRL+ A       
Sbjct: 73  NHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGN----------KRLKEATCKLYFY 121
Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIV 572
                ++YLH      IIHRDLK  N+LL   ++    K++DFG SK  + G + +   +
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTL 176
Query: 573 RGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 629
            GT  YL PE  +S          D +S GVIL   +SG    S  +   + ++ +   K
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 91/196 (46%), Gaps = 28/196 (14%)
Query: 430 KDGKEIAVKVLTSNSYQGKREFT-----------------NEVTLLSRIHHRNLVQFLGY 472
           KD K  A+K    +  + KR+FT                 NE+ +++ I +   +   G 
Sbjct: 52  KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI----EYLHTGC 528
                   ++YE+M N ++ +        ++       +++ +   K +     Y+H   
Sbjct: 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE- 170
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              I HRD+K SNIL+DK+ R K+SDFG S++ VD     S   RGT  ++ PE++ ++ 
Sbjct: 171 -KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---RGTYEFMPPEFFSNES 226
Query: 589 LTD--KSDVYSFGVIL 602
             +  K D++S G+ L
Sbjct: 227 SYNGAKVDIWSLGICL 242

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 466
           L + IG G FG V+ G           +A+K   + +    RE F  E   + +  H ++
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 73
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+ +G   E      V+  M   TL E        +  ++    +  A   +  + YL +
Sbjct: 74  VKLIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+ + N+L+  +   K+ DFGLS++  D   + +S  +  + ++ PE    
Sbjct: 130 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 587 QQLTDKSDVYSFGVILLELI 606
           ++ T  SDV+ FGV + E++
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 404 DIEDATKMLEKK--IGSGGFGVVYYGKLKDGKEIAV--KVLTSNSYQGK----REFTNEV 455
           D++   K  EK   +G G F  VY  + K+  +I    K+   +  + K    R    E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG---TLKEH-LYGTLTHEQRINWIKRL 511
            LL  + H N++  L     +    LV++FM       +K++ L  T +H      IK  
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSH------IKAY 117
Query: 512 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSS 570
            +     +G+EYLH      I+HRDLK +N+LLD++   K++DFGL+K F     ++   
Sbjct: 118 MLM--TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQ 172
Query: 571 IVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELI 606
           +V  T  Y  PE     ++     D+++ G IL EL+
Sbjct: 173 VV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 37/240 (15%)
Query: 411 MLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ--GKRE------FTNEVTLLSRI 461
           ++ K +GSG  G V    + K  K++A+K+++   +     RE         E+ +L ++
Sbjct: 12  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 71
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE------ 515
           +H  +++   +   E   + V E M  G L + + G           KRL+ A       
Sbjct: 72  NHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGN----------KRLKEATCKLYFY 120
Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIV 572
                ++YLH      IIHRDLK  N+LL   ++    K++DFG SK  + G + +   +
Sbjct: 121 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTL 175
Query: 573 RGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 629
            GT  YL PE  +S          D +S GVIL   +SG    S  +   + ++ +   K
Sbjct: 176 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 235

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 37/240 (15%)
Query: 411 MLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ--GKRE------FTNEVTLLSRI 461
           ++ K +GSG  G V    + K  K++A+K+++   +     RE         E+ +L ++
Sbjct: 19  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 78
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE------ 515
           +H  +++   +   E   + V E M  G L + + G           KRL+ A       
Sbjct: 79  NHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGN----------KRLKEATCKLYFY 127
Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIV 572
                ++YLH      IIHRDLK  N+LL   ++    K++DFG SK  + G + +   +
Sbjct: 128 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTL 182
Query: 573 RGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 629
            GT  YL PE  +S          D +S GVIL   +SG    S  +   + ++ +   K
Sbjct: 183 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 242

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 472
           ++G+G  GVV+    K    +  + L     +   + +   E+ +L   +   +V F G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
              +G   +  E M  G+L + L       ++I  + ++ IA    KG+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLREKH--KI 126
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           +HRD+K SNIL++     K+ DFG+S   +D  S  +S V GT  Y+ PE       + +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSVQ 183
Query: 593 SDVYSFGVILLELISGQEAI 612
           SD++S G+ L+E+  G+  I
Sbjct: 184 SDIWSMGLSLVEMAVGRYPI 203

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 37/240 (15%)
Query: 411 MLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ--GKRE------FTNEVTLLSRI 461
           ++ K +GSG  G V    + K  K++A+K+++   +     RE         E+ +L ++
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE------ 515
           +H  +++   +   E   + V E M  G L + + G           KRL+ A       
Sbjct: 73  NHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGN----------KRLKEATCKLYFY 121
Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIV 572
                ++YLH      IIHRDLK  N+LL   ++    K++DFG SK  + G + +   +
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTL 176
Query: 573 RGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 629
            GT  YL PE  +S          D +S GVIL   +SG    S  +   + ++ +   K
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 466
           L + IG G FG V+ G     +     +A+K   + +    RE F  E   + +  H ++
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 73
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+ +G   E      V+  M   TL E        +  ++    +  A   +  + YL +
Sbjct: 74  VKLIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+ + N+L+  +   K+ DFGLS++  D   + +S  +  + ++ PE    
Sbjct: 130 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 587 QQLTDKSDVYSFGVILLELI 606
           ++ T  SDV+ FGV + E++
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 466
           L + IG G FG V+ G     +     +A+K   + +    RE F  E   + +  H ++
Sbjct: 42  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 101
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+ +G   E      V+  M   TL E        +  ++    +  A   +  + YL +
Sbjct: 102 VKLIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 157
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+ + N+L+  +   K+ DFGLS++  D   + +S  +  + ++ PE    
Sbjct: 158 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 214
Query: 587 QQLTDKSDVYSFGVILLELI 606
           ++ T  SDV+ FGV + E++
Sbjct: 215 RRFTSASDVWMFGVCMWEIL 234

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 8/199 (4%)
Query: 416 IGSGGFGVVYYGKLK-DGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           IG+G +G     + K DGK +  K L   S +   K+   +EV LL  + H N+V++   
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 473 CQEEGRSVL--VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--TGC 528
             +   + L  V E+   G L   +       Q ++    L +       ++  H  +  
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              ++HRDLK +N+ LD     K+ DFGL++            V GT  Y+ PE      
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV-GTPYYMSPEQMNRMS 192
Query: 589 LTDKSDVYSFGVILLELIS 607
             +KSD++S G +L EL +
Sbjct: 193 YNEKSDIWSLGCLLYELCA 211

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 106/240 (44%), Gaps = 37/240 (15%)
Query: 411 MLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ--GKRE------FTNEVTLLSRI 461
           ++ K +GSG  G V    + K  K++A+K+++   +     RE         E+ +L ++
Sbjct: 13  IMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE------ 515
           +H  +++   +   E   + V E M  G L + + G           KRL+ A       
Sbjct: 73  NHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGN----------KRLKEATCKLYFY 121
Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIV 572
                ++YLH      IIHRDLK  N+LL   ++    K++DFG SK  + G + +   +
Sbjct: 122 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTL 176
Query: 573 RGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 629
            GT  YL PE  +S          D +S GVIL   +SG    S  +   + ++ +   K
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK 236

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSRI------HHRNLVQ 468
           +G G FG V   + K   E+ AVK+L  +      +   E T++ +           L Q
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV--ECTMVEKRVLALPGKPPFLTQ 406
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR---LEIAEDAAKGIEYLH 525
                Q   R   V E+++ G L  H+       Q++   K    +  A + A G+ +L 
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYY 584
           +     II+RDLK  N++LD     K++DFG+ K  + DG +  +    GT  Y+ PE  
Sbjct: 460 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEII 514
Query: 585 ISQQLTDKSDVYSFGVILLELISGQEAISNE 615
             Q      D ++FGV+L E+++GQ     E
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 472
           ++G+G  GVV+    K    +  + L     +   + +   E+ +L   +   +V F G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
              +G   +  E M  G+L + L       ++I  + ++ IA    KG+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLREK--HKI 126
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           +HRD+K SNIL++     K+ DFG+S   +D  S  +S V GT  Y+ PE       + +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSVQ 183
Query: 593 SDVYSFGVILLELISGQEAI 612
           SD++S G+ L+E+  G+  I
Sbjct: 184 SDIWSMGLSLVEMAVGRYPI 203

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V GA+     + GT  YL PE  +S
Sbjct: 181 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGATWT---LCGTPEYLAPEIILS 233
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAG 255

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 466
           L + IG G FG V+ G     +     +A+K   + +    RE F  E   + +  H ++
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+ +G   E      V+  M   TL E        +  ++    +  A   +  + YL +
Sbjct: 71  VKLIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+ + N+L+  +   K+ DFGLS++  D   + +S  +  + ++ PE    
Sbjct: 127 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 587 QQLTDKSDVYSFGVILLELI 606
           ++ T  SDV+ FGV + E++
Sbjct: 184 RRFTSASDVWMFGVCMWEIL 203

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 405 IEDATKMLEKKIGSGGFGVVY---------YGKLKDGKEIAVKVLTSNSYQGKREFTNEV 455
           I +   +  + +G G F  ++         YG+L +  E+ +KVL          F    
Sbjct: 5   IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHE-TEVLLKVLDKAHRNYSESFFEAA 63
Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 515
           +++S++ H++LV   G C     ++LV EF+  G+L  +L     ++  IN + +LE+A+
Sbjct: 64  SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAK 120
Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIV 572
             A  + +L       +IH ++ + NILL +    K  +    K +  G S       I+
Sbjct: 121 QLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
Query: 573 RGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISG 608
           +  + ++ PE   + + L   +D +SFG  L E+ SG
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 466
           L + IG G FG V+ G     +     +A+K   + +    RE F  E   + +  H ++
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+ +G   E      V+  M   TL E        +  ++    +  A   +  + YL +
Sbjct: 79  VKLIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+ + N+L+  +   K+ DFGLS++  D   + +S  +  + ++ PE    
Sbjct: 135 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 587 QQLTDKSDVYSFGVILLELI 606
           ++ T  SDV+ FGV + E++
Sbjct: 192 RRFTSASDVWMFGVCMWEIL 211

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 34/212 (16%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 469
           K IG G FG V   + K  +++    L S     KR     F  E  +++  +   +VQ 
Sbjct: 81  KVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 140
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GI 521
               Q++    +V E+M  G L             +N +   ++ E  AK         +
Sbjct: 141 FCAFQDDKYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWAKFYTAEVVLAL 187
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLD 580
           + +H+     +IHRD+K  N+LLDKH   K++DFG   K    G  H  + V GT  Y+ 
Sbjct: 188 DAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYIS 243
Query: 581 PEYYISQ----QLTDKSDVYSFGVILLELISG 608
           PE   SQ        + D +S GV L E++ G
Sbjct: 244 PEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 23/213 (10%)
Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           +E ++G G   +VY  K K   K  A+KVL       K+    E+ +L R+ H N+++  
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----GIEYLHT 526
              +      LV E +  G L + +     + +R         A DA K     + YLH 
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERD--------AADAVKQILEAVAYLHE 166
Query: 527 GCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
                I+HRDLK  N+L          K++DFGLSK        +   V GT GY  PE 
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEI 221
Query: 584 YISQQLTDKSDVYSFGVILLELISGQEAISNEK 616
                   + D++S G+I   L+ G E   +E+
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 466
           L + IG G FG V+ G     +     +A+K   + +    RE F  E   + +  H ++
Sbjct: 16  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 75
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+ +G   E      V+  M   TL E        +  ++    +  A   +  + YL +
Sbjct: 76  VKLIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 131
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+ + N+L+  +   K+ DFGLS++  D   + +S  +  + ++ PE    
Sbjct: 132 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 188
Query: 587 QQLTDKSDVYSFGVILLELI 606
           ++ T  SDV+ FGV + E++
Sbjct: 189 RRFTSASDVWMFGVCMWEIL 208

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 472
           ++G+G  GVV+    K    +  + L     +   + +   E+ +L   +   +V F G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
              +G   +  E M  G+L + L       ++I  + ++ IA    KG+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLREK--HKI 126
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           +HRD+K SNIL++     K+ DFG+S   +D  S  +S V GT  Y+ PE       + +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSVQ 183
Query: 593 SDVYSFGVILLELISGQEAI 612
           SD++S G+ L+E+  G+  I
Sbjct: 184 SDIWSMGLSLVEMAVGRYPI 203

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 466
           L + IG G FG V+ G     +     +A+K   + +    RE F  E   + +  H ++
Sbjct: 17  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+ +G   E      V+  M   TL E        +  ++    +  A   +  + YL +
Sbjct: 77  VKLIGVITENP----VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 132
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+ + N+L+  +   K+ DFGLS++  D   + +S  +  + ++ PE    
Sbjct: 133 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 189
Query: 587 QQLTDKSDVYSFGVILLELI 606
           ++ T  SDV+ FGV + E++
Sbjct: 190 RRFTSASDVWMFGVCMWEIL 209

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 472
           ++G+G  GVV+    K    +  + L     +   + +   E+ +L   +   +V F G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
              +G   +  E M  G+L + L       ++I  + ++ IA    KG+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLREK--HKI 126
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           +HRD+K SNIL++     K+ DFG+S   +D  S  +S V GT  Y+ PE       + +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSVQ 183
Query: 593 SDVYSFGVILLELISGQEAI 612
           SD++S G+ L+E+  G+  I
Sbjct: 184 SDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 472
           ++G+G  GVV+    K    +  + L     +   + +   E+ +L   +   +V F G 
Sbjct: 13  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 72
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
              +G   +  E M  G+L + L       ++I  + ++ IA    KG+ YL       I
Sbjct: 73  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLREK--HKI 126
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           +HRD+K SNIL++     K+ DFG+S   +D  S  +S V GT  Y+ PE       + +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSVQ 183
Query: 593 SDVYSFGVILLELISGQEAI 612
           SD++S G+ L+E+  G+  I
Sbjct: 184 SDIWSMGLSLVEMAVGRYPI 203

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 466
           L + IG G FG V+ G           +A+K   + +    RE F  E   + +  H ++
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 73
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+ +G   E      V+  M   TL E        +  ++    +  A   +  + YL +
Sbjct: 74  VKLIGVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+ + N+L+  +   K+ DFGLS++  D     +S  +  + ++ PE    
Sbjct: 130 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINF 186
Query: 587 QQLTDKSDVYSFGVILLELI 606
           ++ T  SDV+ FGV + E++
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 100/223 (44%), Gaps = 21/223 (9%)
Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVL--TSNSYQGKREFTNEVTLL 458
           ++D+E+  +M     GSG  G V+  +  K G  IAVK +  + N  + KR   +   +L
Sbjct: 24  INDLENLGEM-----GSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVL 78
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
                  +VQ  G         +  E M  GT  E L   +        + ++ +A    
Sbjct: 79  KSHDCPYIVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVA--IV 134
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           K + YL       +IHRD+K SNILLD+  + K+ DFG+S   VD  +   S   G   Y
Sbjct: 135 KALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAY 190
Query: 579 LDPEYYISQQLTD-----KSDVYSFGVILLELISGQEAISNEK 616
           + PE       T      ++DV+S G+ L+EL +GQ    N K
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK 233

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVTLLSRI------HHRNLVQ 468
           +G G FG V   + K   E+ AVK+L  +      +   E T++ +           L Q
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV--ECTMVEKRVLALPGKPPFLTQ 85
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR---LEIAEDAAKGIEYLH 525
                Q   R   V E+++ G L  H+       Q++   K    +  A + A G+ +L 
Sbjct: 86  LHSCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV-DGASHVSSIVRGTVGYLDPEYY 584
           +     II+RDLK  N++LD     K++DFG+ K  + DG +  +    GT  Y+ PE  
Sbjct: 139 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEII 193
Query: 585 ISQQLTDKSDVYSFGVILLELISGQEAISNE 615
             Q      D ++FGV+L E+++GQ     E
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 37/227 (16%)
Query: 411 MLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ--GKRE------FTNEVTLLSRI 461
           ++ K +GSG  G V    + K  K++A+++++   +     RE         E+ +L ++
Sbjct: 138 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE------ 515
           +H  +++   +   E   + V E M  G L + + G           KRL+ A       
Sbjct: 198 NHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGN----------KRLKEATCKLYFY 246
Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIV 572
                ++YLH      IIHRDLK  N+LL   ++    K++DFG SK  + G + +   +
Sbjct: 247 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTL 301
Query: 573 RGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEK 616
            GT  YL PE  +S          D +S GVIL   +SG    S  +
Sbjct: 302 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 37/227 (16%)
Query: 411 MLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ--GKRE------FTNEVTLLSRI 461
           ++ K +GSG  G V    + K  K++A+++++   +     RE         E+ +L ++
Sbjct: 152 IMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 211
Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE------ 515
           +H  +++   +   E   + V E M  G L + + G           KRL+ A       
Sbjct: 212 NHPCIIKIKNFFDAEDYYI-VLELMEGGELFDKVVGN----------KRLKEATCKLYFY 260
Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIV 572
                ++YLH      IIHRDLK  N+LL   ++    K++DFG SK  + G + +   +
Sbjct: 261 QMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTL 315
Query: 573 RGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEK 616
            GT  YL PE  +S          D +S GVIL   +SG    S  +
Sbjct: 316 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 362

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 124/300 (41%), Gaps = 55/300 (18%)
Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQF 469
           + + +  GGF  VY  + +  G+E A+K L SN  +  R    EV  + ++  H N+VQF
Sbjct: 32  VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE------------IAEDA 517
                    + +  E    G  +  L   L   Q + ++K++E            I    
Sbjct: 92  CSA------ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG----LSKF------AVDGASH 567
            + ++++H    P IIHRDLK  N+LL      K+ DFG    +S +      A   A  
Sbjct: 146 CRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 568 VSSIVRGTVG-YLDPE---YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 623
              I R T   Y  PE    Y +  + +K D+++ G IL  L   Q    +   GA  R 
Sbjct: 205 EEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED---GAKLR- 260
Query: 624 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
            +   K  I   D Q  +  SL+             +A++ V P    R SI+EV+  +Q
Sbjct: 261 -IVNGKYSIPPHDTQYTVFHSLI-------------RAMLQVNP--EERLSIAEVVHQLQ 304

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 11/200 (5%)
Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 472
           ++G+G  GVV+    K    +  + L     +   + +   E+ +L   +   +V F G 
Sbjct: 40  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
              +G   +  E M  G+L + L       ++I  + ++ IA    KG+ YL       I
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLREK--HKI 153
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           +HRD+K SNIL++     K+ DFG+S   +D  S  +S V GT  Y+ PE       + +
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSVQ 210
Query: 593 SDVYSFGVILLELISGQEAI 612
           SD++S G+ L+E+  G+  I
Sbjct: 211 SDIWSMGLSLVEMAVGRYPI 230

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 416 IGSGGFGVV--YYGKLKDGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 472
           IG G +G+V   Y  ++  + +A+K ++   +Q   + T  E+ +L R  H N++     
Sbjct: 51  IGEGAYGMVSSAYDHVRKTR-VAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDI 109
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
            +      +   ++    ++  LY  L  +Q  N            +G++Y+H+  V   
Sbjct: 110 LRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSN-DHICYFLYQILRGLKYIHSANV--- 165
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQL 589
           +HRDLK SN+L++     K+ DFGL++ A     H   +     T  Y  PE  + S+  
Sbjct: 166 LHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGY 225
Query: 590 TDKSDVYSFGVILLELISGQ 609
           T   D++S G IL E++S +
Sbjct: 226 TKSIDIWSVGCILAEMLSNR 245

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 22/206 (10%)
Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREF----TNEVTLLSRIH---HRN 465
           +IG G +G VY  +    G  +A+K V   N   G          EV LL R+    H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 466 LVQFLGYCQ-----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 520
           +V+ +  C       E +  LV+E + +  L+ +L            IK  ++     +G
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK--DLMRQFLRG 132
Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           +++LH  C   I+HRDLK  NIL+      K++DFGL++      +    +V  T+ Y  
Sbjct: 133 LDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWYRA 187
Query: 581 PEYYISQQLTDKSDVYSFGVILLELI 606
           PE  +        D++S G I  E+ 
Sbjct: 188 PEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        +E     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E+   G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+++D+    KV+DFGL+K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 405 IEDATKMLEKKIGSGGFGVVY---------YGKLKDGKEIAVKVLTSNSYQGKREFTNEV 455
           I +   +  + +G G F  ++         YG+L +  E+ +KVL          F    
Sbjct: 5   IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHE-TEVLLKVLDKAHRNYSESFFEAA 63
Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 515
           +++S++ H++LV   G C     ++LV EF+  G+L  +L     ++  IN + +LE+A+
Sbjct: 64  SMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAK 120
Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIV 572
             A  + +L       +IH ++ + NILL +    K  +    K +  G S       I+
Sbjct: 121 QLAWAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
Query: 573 RGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISG 608
           +  + ++ PE   + + L   +D +SFG  L E+ SG
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 112/234 (47%), Gaps = 26/234 (11%)
Query: 405 IEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH- 462
            ED  ++ E  +G G    V     L   +E AVK++       +     EV +L +   
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG 69
Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-INWIKRLEIAEDAAKGI 521
           HRN+++ + + +EE R  LV+E M  G++  H+     H++R  N ++   + +D A  +
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI-----HKRRHFNELEASVVVQDVASAL 124
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGL-SKFAVDG-ASHVSS----IV 572
           ++LH      I HRDLK  NIL +   +    K+ DF L S   ++G  S +S+      
Sbjct: 125 DFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 573 RGTVGYLDPE----YYISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANC 621
            G+  Y+ PE    +     + DK  D++S GVIL  L+SG       + G++C
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG-RCGSDC 234

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 101/219 (46%), Gaps = 20/219 (9%)
Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVT 456
           FT  D++D  +     IG G +G V     K  G+ +AVK +  T +  + K+   +   
Sbjct: 19  FTAEDLKDLGE-----IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV 73
Query: 457 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK--EHLYGTLTHEQRINWIKRLEIA 514
           ++       +VQF G    EG   +  E M     K  +++Y  L        + ++ +A
Sbjct: 74  VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 515 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 574
               K + +L       IIHRD+K SNILLD+    K+ DFG+S   VD  +       G
Sbjct: 134 --TVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--G 187
Query: 575 TVGYLDPEYY---ISQQLTD-KSDVYSFGVILLELISGQ 609
              Y+ PE      S+Q  D +SDV+S G+ L EL +G+
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K IG+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    KV+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 466
           L + IG G FG V+ G           +A+K   + +    RE F  E   + +  H ++
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 73
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+ +G   E      V+  M   TL E        +  ++    +  A   +  + YL +
Sbjct: 74  VKLIGVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+ + N+L+      K+ DFGLS++  D   + +S  +  + ++ PE    
Sbjct: 130 K---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 587 QQLTDKSDVYSFGVILLELI 606
           ++ T  SDV+ FGV + E++
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 472
           ++G+G  GVV   + +    I  + L     +   + +   E+ +L   +   +V F G 
Sbjct: 23  ELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 82
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIAEDAAKGIEYLHTGCVP 530
              +G   +  E M  G+L +     L   +RI    + ++ IA    +G+ YL      
Sbjct: 83  FYSDGEISICMEHMDGGSLDQ----VLKEAKRIPEEILGKVSIA--VLRGLAYLREKH-- 134
Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
            I+HRD+K SNIL++     K+ DFG+S   +D  S  +S V GT  Y+ PE       +
Sbjct: 135 QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMAPERLQGTHYS 191
Query: 591 DKSDVYSFGVILLELISGQEAI 612
            +SD++S G+ L+EL  G+  I
Sbjct: 192 VQSDIWSMGLSLVELAVGRYPI 213

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 28/194 (14%)
Query: 432 GKEIAVKV-------LTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQEEGRSVLV 482
           G E AVK+       L+    +  RE T   T + R    H +++  +   +      LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 542
           ++ M  G     L+  LT +  ++  +   I     + + +LH      I+HRDLK  NI
Sbjct: 179 FDLMRKG----ELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENI 231
Query: 543 LLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS--------D 594
           LLD +M+ ++SDFG S     G       + GT GYL PE  I +   D++        D
Sbjct: 232 LLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGTPGYLAPE--ILKCSMDETHPGYGKEVD 287
Query: 595 VYSFGVILLELISG 608
           +++ GVIL  L++G
Sbjct: 288 LWACGVILFTLLAG 301

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 94
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 95  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA----TRWYRAPE 199
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 94
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 95  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA----TRWYRAPE 199
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LXGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 466
           L + IG G FG V+ G           +A+K   + +    RE F  E   + +  H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+ +G   E      V+  M   TL E        +  ++    +  A   +  + YL +
Sbjct: 454 VKLIGVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+ + N+L+  +   K+ DFGLS++  D   + +S  +  + ++ PE    
Sbjct: 510 K---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 587 QQLTDKSDVYSFGVILLELI 606
           ++ T  SDV+ FGV + E++
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 94
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 95  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA----TRWYRAPE 199
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/228 (23%), Positives = 111/228 (48%), Gaps = 24/228 (10%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTS--NSYQGKREFTNEVTLLSR 460
           D+ D  +++E  IG+G +GVV   + +  G+++A+K + +  +     +    E+ +L  
Sbjct: 52  DVGDEYEIIET-IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH 110
Query: 461 IHHRNLVQFLGYCQE-----EGRSVLVYEFMHNGTLKEHLYGT--LTHEQRINWIKRLEI 513
             H N++      +      E +SV V   +    L + ++ +  LT E    ++ +L  
Sbjct: 111 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQL-- 168
Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIV 572
                +G++Y+H+     +IHRDLK SN+L++++   K+ DFG+++      A H   + 
Sbjct: 169 ----LRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMT 221
Query: 573 R--GTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKF 617
               T  Y  PE  +S  + T   D++S G I  E+++ ++    + +
Sbjct: 222 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY 269

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LAGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 16/170 (9%)
Query: 453 NEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYEFMHNGTLKE-HLYGTLTHEQRINWIK 509
            E+ +L ++ H N+V+ +    +  E    +V+E ++ G + E      L+ +Q   +  
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYF- 143
Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
                +D  KGIEYLH      IIHRD+K SN+L+ +    K++DFG+S     G+  + 
Sbjct: 144 -----QDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN-EFKGSDALL 194
Query: 570 SIVRGTVGYLDPEYYISQQ--LTDKS-DVYSFGVILLELISGQEAISNEK 616
           S   GT  ++ PE     +   + K+ DV++ GV L   + GQ    +E+
Sbjct: 195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 11/202 (5%)
Query: 415 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGY 472
           ++G+G  GVV+    K  G  +A K++        R +   E+ +L   +   +V F G 
Sbjct: 32  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 91
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
              +G   +  E M  G+L + L       ++I  + ++ IA    KG+ YL       I
Sbjct: 92  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLREK--HKI 145
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           +HRD+K SNIL++     K+ DFG+S   +D  S  +S V GT  Y+ PE       + +
Sbjct: 146 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGTHYSVQ 202
Query: 593 SDVYSFGVILLELISGQEAISN 614
           SD++S G+ L+E+  G+  I +
Sbjct: 203 SDIWSMGLSLVEMAVGRYPIGS 224

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF--- 469
           K +G GG G+V+     D  K +A+K +     Q  +    E+ ++ R+ H N+V+    
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 470 -----------LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
                      +G   E     +V E+M          G L  E    ++ +L       
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL------L 130
Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
           +G++Y+H+  V   +HRDLK +N+ ++ + +  K+ DFGL++      SH   +  G V 
Sbjct: 131 RGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 578 --YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 609
             Y  P   +S    T   D+++ G I  E+++G+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      + G+++A+K L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIFAKRAY-RELLLLKHMQHENVIGLL 107
Query: 471 GYCQEEGR------SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
                           LV  FM     K  + G    E++I ++          KG++Y+
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQK--IMGMEFSEEKIQYL-----VYQMLKGLKYI 160
Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 584
           H+     ++HRDLK  N+ +++    K+ DFGL++ A   A     +V  T  Y  PE  
Sbjct: 161 HSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVV--TRWYRAPEVI 213
Query: 585 ISQQLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
           +S    +++ D++S G I+ E+++G+     + +      I++
Sbjct: 214 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 256

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 412 LEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 468
           L +++G G F VV    K+  G+E A  ++ +     +  ++   E  +   + H N+V+
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                 EEG   L+++ +  G L E +     + +            DA+  I+ +    
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE-----------ADASHCIQQILEAV 123
Query: 529 VPA----IIHRDLKSSNILLDKHMRA---KVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           +      ++HR+LK  N+LL   ++    K++DFGL+   V+G         GT GYL P
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSP 182
Query: 582 EYYISQQLTDKSDVYSFGVILLELISG 608
           E           D+++ GVIL  L+ G
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      + G+++A+K L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIFAKRAY-RELLLLKHMQHENVIGLL 89
Query: 471 GYCQEEGR------SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
                           LV  FM     K  + G    E++I ++          KG++Y+
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQK--IMGLKFSEEKIQYL-----VYQMLKGLKYI 142
Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 584
           H+     ++HRDLK  N+ +++    K+ DFGL++ A   A     +V  T  Y  PE  
Sbjct: 143 HSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMTGYVV--TRWYRAPEVI 195
Query: 585 ISQQLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
           +S    +++ D++S G I+ E+++G+     + +      I++
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKXQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        +E     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E+   G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+++D+    +V+DFGL+K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D    ++  V  T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMAGFV-ATRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 27/201 (13%)
Query: 433 KEIAVKVL--------TSNSYQGKREFT-NEVTLLSRIH-HRNLVQFLGYCQEEGRSVLV 482
           KE AVK++        ++   Q  RE T  EV +L ++  H N++Q     +      LV
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 542
           ++ M  G L ++L   +T  ++    +  +I     + I  LH      I+HRDLK  NI
Sbjct: 103 FDLMKKGELFDYLTEKVTLSEK----ETRKIMRALLEVICALHK---LNIVHRDLKPENI 155
Query: 543 LLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-------KSDV 595
           LLD  M  K++DFG S   +D    + S+  GT  YL PE  I   + D       + D+
Sbjct: 156 LLDDDMNIKLTDFGFS-CQLDPGEKLRSVC-GTPSYLAPE-IIECSMNDNHPGYGKEVDM 212
Query: 596 YSFGVILLELISGQEAISNEK 616
           +S GVI+  L++G     + K
Sbjct: 213 WSTGVIMYTLLAGSPPFWHRK 233

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 416 IGSGGFGVV--YYGKLKDGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 472
           IG G +G+V   Y  L   + +A+K ++   +Q   + T  E+ +L R  H N++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDI 93
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
            +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV--- 149
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQL 589
           +HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 590 TDKSDVYSFGVILLELISGQ 609
           T   D++S G IL E++S +
Sbjct: 210 TKSIDIWSVGCILAEMLSNR 229

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 83
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 84  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCAKLTDDHVQFLIYQILRGLK 135
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 188
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 83
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 84  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVA----TRWYRAPE 188
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           IGSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 92
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 93  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 145 YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA----TRWYRAPE 197
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 416 IGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGYC 473
           IG G +G+V        K  +A+K ++   +Q   + T  E+ +L R  H N++      
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI---- 106
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGT----LTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            +  R+  + E M +  L  HL G     L   Q ++            +G++Y+H+  V
Sbjct: 107 NDIIRAPTI-EQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANV 165
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-S 586
              +HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S
Sbjct: 166 ---LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKF 617
           +  T   D++S G IL E++S +     + +
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 253

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EYSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 411 MLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK---REFTNEVTLLSRIHHRNL 466
           ++ + +G G FG V      K  +++A+K ++    +          E++ L  + H ++
Sbjct: 12  IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI 71
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++           V+V E+         L+  +  ++R+   +     +     IEY H 
Sbjct: 72  IKLYDVITTPTDIVMVIEYAGG-----ELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR 126
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                I+HRDLK  N+LLD ++  K++DFGLS    DG    +S   G+  Y  PE  I+
Sbjct: 127 H---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC--GSPNYAAPE-VIN 180
Query: 587 QQLT--DKSDVYSFGVILLELISGQEAISNE 615
            +L    + DV+S G++L  ++ G+    +E
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+++D+    +V+DFG +K  V G +     + GT  YL PE  IS
Sbjct: 160 ---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIIIS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 128 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS 180
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 181 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 233
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAG 255

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKXQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 108 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 213
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 83
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 84  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 188
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 153 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 205
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 206 KGYNKAVDWWALGVLIYEMAAG 227

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 37/211 (17%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 107
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 108 DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 159
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YL 579
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++       H    + G V    Y 
Sbjct: 160 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATRWYR 209
Query: 580 DPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
            PE  ++    +++ D++S G I+ EL++G+
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 94  EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 146
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 147 ---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 199
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 200 KGYNKAVDWWALGVLIYEMAAG 221

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG--KREFTNEVTLLSRIHHRNLVQFLGY 472
           ++G+G  GVV+    K    +  + L     +   + +   E+ +L   +   +V F G 
Sbjct: 16  ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 75
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
              +G   +  E M  G+L + L       ++I  + ++ IA    KG+ YL       I
Sbjct: 76  FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLREK--HKI 129
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDK 592
           +HRD+K SNIL++     K+ DFG+S   +D    +++   GT  Y+ PE       + +
Sbjct: 130 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID---EMANEFVGTRSYMSPERLQGTHYSVQ 186
Query: 593 SDVYSFGVILLELISGQ 609
           SD++S G+ L+E+  G+
Sbjct: 187 SDIWSMGLSLVEMAVGR 203

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 466
           L + IG G FG V+ G           +A+K   + +    RE F  E   + +  H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+ +G   E      V+  M   TL E        +  ++    +  A   +  + YL +
Sbjct: 454 VKLIGVITENP----VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+ + N+L+      K+ DFGLS++  D   + +S  +  + ++ PE    
Sbjct: 510 K---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 587 QQLTDKSDVYSFGVILLELI 606
           ++ T  SDV+ FGV + E++
Sbjct: 567 RRFTSASDVWMFGVCMWEIL 586

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 40  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 99
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 100 EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 153 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 205
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 206 KGYNKAVDWWALGVLIYEMAAG 227

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 35/219 (15%)
Query: 416 IGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH----------- 463
           +G G FG VV      D +  A+K +  ++ +      +EV LL+ ++H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 464 --RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
             RN V+ +   +++    +  E+  NGTL + ++    ++QR  + +   +     + +
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR---LFRQILEAL 129
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--------FAVD-----GASHV 568
            Y+H+     IIHRDLK  NI +D+    K+ DFGL+K          +D     G+S  
Sbjct: 130 SYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 569 SSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELI 606
            +   GT  Y+  E    +    +K D+YS G+I  E+I
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 33  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 92
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 93  EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 146 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWT---LCGTPEYLAPEIILS 198
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 199 KGYNKAVDWWALGVLIYEMAAG 220

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWT---LCGTPEYLAPEIILS 213
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 97
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 98  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 149
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 150 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 202
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 203 IMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 15/214 (7%)
Query: 401 TLSDIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGK--REFTNEVTL 457
           T +   D  ++ E+ +G G F VV    K    +E A K++ +     +  ++   E  +
Sbjct: 25  TCTRFTDDYQLFEE-LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARI 83
Query: 458 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 517
              + H N+V+      EEG   LV++ +  G L E +     + +              
Sbjct: 84  CRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE----ADASHCIHQI 139
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRG 574
            + + ++H      I+HRDLK  N+LL    K    K++DFGL+   V G         G
Sbjct: 140 LESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAG 195
Query: 575 TVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
           T GYL PE           D+++ GVIL  L+ G
Sbjct: 196 TPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFAEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 102 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS 154
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 155 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 207
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 208 KGYNKAVDWWALGVLIYEMAAG 229

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 107
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 108 DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 159
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 160 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 212
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 106
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 107 DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 158
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 159 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 211
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 213
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 213
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 68  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 128 EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 181 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 233
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 234 KGYNKAVDWWALGVLIYEMAAG 255

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 213
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 48  KTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E+   G +  HL       +RI           AA+ +   EYLH+
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+++D+    KV+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 161 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 213
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 94
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 95  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 147 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 199
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 111/228 (48%), Gaps = 24/228 (10%)
Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTS--NSYQGKREFTNEVTLLSR 460
           D+ D  +++E  IG+G +GVV   + +  G+++A+K + +  +     +    E+ +L  
Sbjct: 51  DVGDEYEIIET-IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH 109
Query: 461 IHHRNLVQFLGYCQE-----EGRSVLVYEFMHNGTLKEHLYGT--LTHEQRINWIKRLEI 513
             H N++      +      E +SV V   +    L + ++ +  LT E    ++ +L  
Sbjct: 110 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQL-- 167
Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIV 572
                +G++Y+H+  V   IHRDLK SN+L++++   K+ DFG+++      A H   + 
Sbjct: 168 ----LRGLKYMHSAQV---IHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMT 220
Query: 573 R--GTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKF 617
               T  Y  PE  +S  + T   D++S G I  E+++ ++    + +
Sbjct: 221 EYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY 268

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 92
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 93  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 145 YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA----TRWYRAPE 197
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 416 IGSGGFGVV--YYGKLKDGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 472
           IG G +G+V   Y  L   + +A+K ++   +Q   + T  E+ +L R  H N++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
            +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV--- 149
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQL 589
           +HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 590 TDKSDVYSFGVILLELISGQ 609
           T   D++S G IL E++S +
Sbjct: 210 TKSIDIWSVGCILAEMLSNR 229

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 83
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 84  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 136 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 188
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 416 IGSGGFGVV--YYGKLKDGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 472
           IG G +G+V   Y  L   + +A+K ++   +Q   + T  E+ +L R  H N++     
Sbjct: 36  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 94
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
            +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV--- 150
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQL 589
           +HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 210
Query: 590 TDKSDVYSFGVILLELISGQ 609
           T   D++S G IL E++S +
Sbjct: 211 TKSIDIWSVGCILAEMLSNR 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 416 IGSGGFGVV--YYGKLKDGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 472
           IG G +G+V   Y  L   + +A+K ++   +Q   + T  E+ +L R  H N++     
Sbjct: 29  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 87
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
            +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV--- 143
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQL 589
           +HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 203
Query: 590 TDKSDVYSFGVILLELISGQ 609
           T   D++S G IL E++S +
Sbjct: 204 TKSIDIWSVGCILAEMLSNR 223

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 416 IGSGGFGVV--YYGKLKDGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 472
           IG G +G+V   Y  L   + +A+K ++   +Q   + T  E+ +L R  H N++     
Sbjct: 37  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 95
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
            +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   
Sbjct: 96  IRAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV--- 151
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQL 589
           +HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  
Sbjct: 152 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 211
Query: 590 TDKSDVYSFGVILLELISGQ 609
           T   D++S G IL E++S +
Sbjct: 212 TKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 416 IGSGGFGVV--YYGKLKDGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 472
           IG G +G+V   Y  L   + +A+K ++   +Q   + T  E+ +L R  H N++     
Sbjct: 28  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 86
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
            +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   
Sbjct: 87  IRAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV--- 142
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQL 589
           +HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  
Sbjct: 143 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 202
Query: 590 TDKSDVYSFGVILLELISGQ 609
           T   D++S G IL E++S +
Sbjct: 203 TKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 416 IGSGGFGVV--YYGKLKDGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 472
           IG G +G+V   Y  L   + +A+K ++   +Q   + T  E+ +L R  H N++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
            +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV--- 149
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQL 589
           +HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 590 TDKSDVYSFGVILLELISGQ 609
           T   D++S G IL E++S +
Sbjct: 210 TKSIDIWSVGCILAEMLSNR 229

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 27/201 (13%)
Query: 433 KEIAVKVL--------TSNSYQGKREFT-NEVTLLSRIH-HRNLVQFLGYCQEEGRSVLV 482
           KE AVK++        ++   Q  RE T  EV +L ++  H N++Q     +      LV
Sbjct: 30  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 89
Query: 483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 542
           ++ M  G L ++L   +T  ++    +  +I     + I  LH      I+HRDLK  NI
Sbjct: 90  FDLMKKGELFDYLTEKVTLSEK----ETRKIMRALLEVICALHK---LNIVHRDLKPENI 142
Query: 543 LLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-------KSDV 595
           LLD  M  K++DFG S   +D    +  +  GT  YL PE  I   + D       + D+
Sbjct: 143 LLDDDMNIKLTDFGFS-CQLDPGEKLREVC-GTPSYLAPE-IIECSMNDNHPGYGKEVDM 199
Query: 596 YSFGVILLELISGQEAISNEK 616
           +S GVI+  L++G     + K
Sbjct: 200 WSTGVIMYTLLAGSPPFWHRK 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 89
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 90  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 142 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 194
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 84
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 85  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 136
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 137 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 189
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFLGY 472
           K+     G ++ G+ + G +I VKVL    +  +  R+F  E   L    H N++  LG 
Sbjct: 17  KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 473 CQEE--GRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYLHTG 527
           CQ        L+  +M  G+    LY  L HE     ++  + ++ A D A+G+ +LHT 
Sbjct: 76  CQSPPAPHPTLITHWMPYGS----LYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHT- 129
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVS--DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
             P I    L S ++++D+ M A++S  D   S F   G  +  + V        PE   
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFS-FQSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 586 SQQLTDKSDVYSFGVILLELISGQ 609
            +     +D++SF V+L EL++ +
Sbjct: 189 RRS----ADMWSFAVLLWELVTRE 208

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL-SKPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 99
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 100 DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 152 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 204
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 416 IGSGGFGVV--YYGKLKDGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 472
           IG G +G+V   Y  L   + +A+K ++   +Q   + T  E+ +L R  H N++     
Sbjct: 29  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 87
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
            +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV--- 143
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQL 589
           +HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 203
Query: 590 TDKSDVYSFGVILLELISGQ 609
           T   D++S G IL E++S +
Sbjct: 204 TKSIDIWSVGCILAEMLSNR 223

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 99
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 100 DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 152 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 204
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 99
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 100 DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 151
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 152 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 204
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 92
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 93  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 145 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 197
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 86
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 87  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 138
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 139 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 191
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 192 IMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 84
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 85  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 136
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 137 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 189
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 93
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 94  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 146 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 198
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 213
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 92
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 93  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 144
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 145 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 197
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 85
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 86  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 137
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 138 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 190
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 416 IGSGGFGVV--YYGKLKDGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 472
           IG G +G+V   Y  L   + +A+K ++   +Q   + T  E+ +L R  H N++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
            +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV--- 149
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQL 589
           +HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGY 209
Query: 590 TDKSDVYSFGVILLELISGQ 609
           T   D++S G IL E++S +
Sbjct: 210 TKSIDIWSVGCILAEMLSNR 229

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 107
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 108 DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 159
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 160 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 212
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 89
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 90  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 142 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 194
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 110
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 111 DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 162
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 163 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 215
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 416 IGSGGFGVV--YYGKLKDGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 472
           IG G +G+V   Y  L   + +A+K ++   +Q   + T  E+ +L R  H N++     
Sbjct: 36  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 94
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
            +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV--- 150
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQL 589
           +HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGY 210
Query: 590 TDKSDVYSFGVILLELISGQ 609
           T   D++S G IL E++S +
Sbjct: 211 TKSIDIWSVGCILAEMLSNR 230

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E+   G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+++D+    KV+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 108 EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 213
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 98
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 99  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 150
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 151 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 203
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 98
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 99  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 150
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 151 YIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA----TRWYRAPE 203
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 106
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 107 DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 158
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 159 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 211
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 93
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 94  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 146 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 198
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E+   G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+++D+    KV+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 89
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 90  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 142 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 194
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKSQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL +   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 416 IGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGYC 473
           IG G +G+V        K  +A+K ++   +Q   + T  E+ +L R  H N++      
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
           +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   +
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV---L 146
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQLT 590
           HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  T
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 591 DKSDVYSFGVILLELISGQ 609
              D++S G IL E++S +
Sbjct: 207 KSIDIWSVGCILAEMLSNR 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 416 IGSGGFGVV--YYGKLKDGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 472
           IG G +G+V   Y  L   + +A+K ++   +Q   + T  E+ +L R  H N++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 473 CQ----EEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
            +    E+ + V +V + M     K      L+++    ++ ++       +G++Y+H+ 
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQI------LRGLKYIHSA 147
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI 585
            V   +HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  +
Sbjct: 148 NV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 586 -SQQLTDKSDVYSFGVILLELISGQ 609
            S+  T   D++S G IL E++S +
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 37/211 (17%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 110
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 111 DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 162
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YL 579
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++       H    + G V    Y 
Sbjct: 163 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGYVATRWYR 212
Query: 580 DPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
            PE  ++    +++ D++S G I+ EL++G+
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 416 IGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGYC 473
           IG G +G+V        K  +A+K ++   +Q   + T  E+ +L R  H N++      
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
           +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   +
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV---L 148
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQLT 590
           HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  T
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 591 DKSDVYSFGVILLELISGQ 609
              D++S G IL E++S +
Sbjct: 209 KSIDIWSVGCILAEMLSNR 227

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 89
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 90  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 141
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 142 YIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVA----TRWYRAPE 194
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 9/207 (4%)
Query: 416 IGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGYC 473
           IG G +G+V        K  +A+K ++   +Q   + T  E+ +L R  H N++      
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
           +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   +
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV---L 166
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQLT 590
           HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  T
Sbjct: 167 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 226
Query: 591 DKSDVYSFGVILLELISGQEAISNEKF 617
              D++S G IL E++S +     + +
Sbjct: 227 KSIDIWSVGCILAEMLSNRPIFPGKHY 253

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 416 IGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGYC 473
           IG G +G+V        K  +A+K ++   +Q   + T  E+ +L R  H N++      
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
           +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   +
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV---L 146
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQLT 590
           HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  T
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 591 DKSDVYSFGVILLELISGQ 609
              D++S G IL E++S +
Sbjct: 207 KSIDIWSVGCILAEMLSNR 225

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ ++ +G
Sbjct: 213 KGYNKAVDWWALGVLIYQMAAG 234

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 416 IGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGYC 473
           IG G +G+V        K  +A+K ++   +Q   + T  E+ +L R  H N++      
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
           +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   +
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV---L 154
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQLT 590
           HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  T
Sbjct: 155 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 214
Query: 591 DKSDVYSFGVILLELISGQ 609
              D++S G IL E++S +
Sbjct: 215 KSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 416 IGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGYC 473
           IG G +G+V        K  +A+K ++   +Q   + T  E+ +L R  H N++      
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
           +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   +
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV---L 146
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQLT 590
           HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  T
Sbjct: 147 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 591 DKSDVYSFGVILLELISGQ 609
              D++S G IL E++S +
Sbjct: 207 KSIDIWSVGCILAEMLSNR 225

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 93
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 94  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 146 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 198
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 14/199 (7%)
Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           ++G G +GVV   + +  G+  AVK +  T NS + KR   +       +     V F G
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
               EG   +  E + + +L +     +   Q I      +IA    K +E+LH+    +
Sbjct: 101 ALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--S 157
Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
           +IHRD+K SN+L++   + K  DFG+S + VD  +    I  G   Y  PE  I+ +L  
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVA--KDIDAGCKPYXAPE-RINPELNQ 214
Query: 592 -----KSDVYSFGVILLEL 605
                KSD++S G+  +EL
Sbjct: 215 KGYSVKSDIWSLGITXIEL 233

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 27/201 (13%)
Query: 433 KEIAVKVL--------TSNSYQGKREFT-NEVTLLSRIH-HRNLVQFLGYCQEEGRSVLV 482
           KE AVK++        ++   Q  RE T  EV +L ++  H N++Q     +      LV
Sbjct: 43  KEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI 542
           ++ M  G L ++L   +T  ++    +  +I     + I  LH      I+HRDLK  NI
Sbjct: 103 FDLMKKGELFDYLTEKVTLSEK----ETRKIMRALLEVICALHK---LNIVHRDLKPENI 155
Query: 543 LLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-------KSDV 595
           LLD  M  K++DFG S   +D    +  +  GT  YL PE  I   + D       + D+
Sbjct: 156 LLDDDMNIKLTDFGFS-CQLDPGEKLREVC-GTPSYLAPE-IIECSMNDNHPGYGKEVDM 212
Query: 596 YSFGVILLELISGQEAISNEK 616
           +S GVI+  L++G     + K
Sbjct: 213 WSTGVIMYTLLAGSPPFWHRK 233

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 93
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 94  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 146 YIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVA----TRWYRAPE 198
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 9/199 (4%)
Query: 416 IGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGYC 473
           IG G +G+V        K  +A+K ++   +Q   + T  E+ +L R  H N++      
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
           +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   +
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV---L 146
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQLT 590
           HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  T
Sbjct: 147 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 591 DKSDVYSFGVILLELISGQ 609
              D++S G IL E++S +
Sbjct: 207 KSIDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 9/215 (4%)
Query: 416 IGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGYC 473
           IG G +G+V        K  +A+K ++   +Q   + T  E+ +L R  H N++      
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
           +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   +
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV---L 146
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQLT 590
           HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  T
Sbjct: 147 HRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 206
Query: 591 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 625
              D++S G IL E++S +     + +     +I+
Sbjct: 207 KSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 11/200 (5%)
Query: 416 IGSGGFGVV--YYGKLKDGKEIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGY 472
           IG G +G+V   Y  L   + +A++ ++   +Q   + T  E+ +L R  H N++     
Sbjct: 35  IGEGAYGMVCSAYDNLNKVR-VAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 473 CQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
            +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV--- 149
Query: 533 IHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQL 589
           +HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 209
Query: 590 TDKSDVYSFGVILLELISGQ 609
           T   D++S G IL E++S +
Sbjct: 210 TKSIDIWSVGCILAEMLSNR 229

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 120/291 (41%), Gaps = 52/291 (17%)
Query: 407 DATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLS 459
           +A   L   +G GGFG V+ G +L D  ++A+KV+  N   G    ++      EV LL 
Sbjct: 30  EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 460 RIH----HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 515
           ++     H  +++ L + + +   +LV E        + L+  +T +  +          
Sbjct: 90  KVGAGGGHPGVIRLLDWFETQEGFMLVLE---RPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRG 574
                I++ H+     ++HRD+K  NIL+D +   AK+ DFG      D      +   G
Sbjct: 147 QVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTDFDG 200
Query: 575 TVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE 633
           T  Y  PE+    Q     + V+S G++L +++ G      ++       I++ A+LH  
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILE-AELHFP 253
Query: 634 ---SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
              S D   +I                      C+ P    RPS+ E+L D
Sbjct: 254 AHVSPDCCALIR--------------------RCLAPKPSSRPSLEEILLD 284

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 30/210 (14%)
Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 471
           KIG G FG V+  +  K G+++A+K VL  N  +G       E+ +L  + H N+V  + 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 472 YCQEE--------GRSVLVYEFMHNGTLKEH-LYGTLTH---EQRINWIKRLEIAEDAAK 519
            C+ +        G   LV++F       EH L G L++   +  ++ IKR  + +    
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKR--VMQMLLN 136
Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRG--TV 576
           G+ Y+H      I+HRD+K++N+L+ +    K++DFGL++ F++   S  +       T+
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 577 GYLDPEYYISQQ-LTDKSDVYSFGVILLEL 605
            Y  PE  + ++      D++  G I+ E+
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E+   G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+++D+    +V+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ D+GL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V     +K G +IAVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 116
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                        E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 117 DVFT----PATSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 168
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DFGL++   D  +   +    T  Y  PE
Sbjct: 169 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPE 221
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    + + D++S G I+ EL++G+
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 30/210 (14%)
Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 471
           KIG G FG V+  +  K G+++A+K VL  N  +G       E+ +L  + H N+V  + 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 472 YCQEE--------GRSVLVYEFMHNGTLKEH-LYGTLTH---EQRINWIKRLEIAEDAAK 519
            C+ +        G   LV++F       EH L G L++   +  ++ IKR  + +    
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKR--VMQMLLN 136
Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRG--TV 576
           G+ Y+H      I+HRD+K++N+L+ +    K++DFGL++ F++   S  +       T+
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 577 GYLDPEYYISQQ-LTDKSDVYSFGVILLEL 605
            Y  PE  + ++      D++  G I+ E+
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   L + 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E+   G +  HL       +RI           AA+ +   EYLH+
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+++D+    KV+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 161 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 213
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   L + 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E+   G +  HL       +RI           AA+ +   EYLH+
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+++D+    KV+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 161 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 213
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 30/210 (14%)
Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 471
           KIG G FG V+  +  K G+++A+K VL  N  +G       E+ +L  + H N+V  + 
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 472 YCQEE--------GRSVLVYEFMHNGTLKEH-LYGTLTH---EQRINWIKRLEIAEDAAK 519
            C+ +        G   LV++F       EH L G L++   +  ++ IKR  + +    
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKR--VMQMLLN 135
Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRG--TV 576
           G+ Y+H      I+HRD+K++N+L+ +    K++DFGL++ F++   S  +       T+
Sbjct: 136 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 192
Query: 577 GYLDPEYYISQQ-LTDKSDVYSFGVILLEL 605
            Y  PE  + ++      D++  G I+ E+
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT  YL P   +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEYLAPAIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K ++ G   A+K+L        ++     NE  +L  ++   L + 
Sbjct: 48  KTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKL 107
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E+   G +  HL       +RI           AA+ +   EYLH+
Sbjct: 108 EFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+++D+    KV+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 161 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 213
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           +GSG +G V      + G ++A+K L     +    KR +  E+ LL  + H N++  L 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGLLD 91
Query: 472 -YCQEEGRS-----VLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
            +  +E         LV  FM    G L +H       E RI ++          KG+ Y
Sbjct: 92  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFL-----VYQMLKGLRY 143
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +H      IIHRDLK  N+ +++    K+ DFGL++ A   +     +V  T  Y  PE 
Sbjct: 144 IHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMXGXVV--TRWYRAPEV 196
Query: 584 YIS-QQLTDKSDVYSFGVILLELISGQ 609
            ++  + T   D++S G I+ E+I+G+
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 416 IGSGGFGVVYYGKLKD-GKEIAVKVL----------TSNSYQGKREFTNEVTLLSRIHHR 464
           +GSG FG V+    K+  KE+ VK +            +   GK   T E+ +LSR+ H 
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK--VTLEIAILSRVEHA 89
Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
           N+++ L   + +G   LV E   +G     L+  +    R++      I       + YL
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146
Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 584
               +  IIHRD+K  NI++ +    K+ DFG + +   G    +    GT+ Y  PE  
Sbjct: 147 R---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--GTIEYCAPEVL 201
Query: 585 ISQQLTDKS-DVYSFGVILLELI 606
           +         +++S GV L  L+
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLV 224

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 412 LEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNSYQGKREFT----NEVTLLSRIHH 463
           L K +G+G +G V+  +       GK  A+KVL   +   K + T     E  +L  I  
Sbjct: 58  LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 117
Query: 464 RNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
              +  L Y  Q E +  L+ ++++ G L  HL    +  +R    +      +    +E
Sbjct: 118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGEIVLALE 173
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH      II+RD+K  NILLD +    ++DFGLSK  V   +  +    GT+ Y+ P+
Sbjct: 174 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 583 YYI-SQQLTDKS-DVYSFGVILLELISG 608
                    DK+ D +S GV++ EL++G
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           + +G+G FG V   K K+ G   A+K+L        ++     NE  +   ++   LV+ 
Sbjct: 48  RTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKL 107
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E+   G +  HL       +RI           AA+ +   EYLH+
Sbjct: 108 EFSFKDNSNLYMVLEYAPGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    KV+DFG +K  V G +     + GT  YL PE  +S
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-RVKGRTWX---LCGTPEYLAPEIILS 213
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 214 KGYNKAVDWWALGVLIYEMAAG 235

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 99/219 (45%), Gaps = 35/219 (15%)
Query: 416 IGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH----------- 463
           +G G FG VV      D +  A+K +  ++ +      +EV LL+ ++H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 464 --RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
             RN V+ +   +++    +  E+  N TL + ++    ++QR  + +   +     + +
Sbjct: 73  ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR---LFRQILEAL 129
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--------FAVD-----GASHV 568
            Y+H+     IIHRDLK  NI +D+    K+ DFGL+K          +D     G+S  
Sbjct: 130 SYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 569 SSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELI 606
            +   GT  Y+  E    +    +K D+YS G+I  E+I
Sbjct: 187 LTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 21/202 (10%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K K+ G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI---EYLHT 526
               ++     +V E++  G +  HL       +RI           AA+ +   EYLH+
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                +I+RDLK  N+L+D+    +V+DFG +K  V G +     + GT   L PE  +S
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-RVKGRTWX---LCGTPEALAPEIILS 212
Query: 587 QQLTDKSDVYSFGVILLELISG 608
           +      D ++ GV++ E+ +G
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAG 234

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 13/203 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNL 466
           L + IG G +  V   +LK    I A+KV+         +     T +       +H  L
Sbjct: 13  LLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V      Q E R   V E+++ G L  H+      ++++        + + +  + YLH 
Sbjct: 73  VGLHSCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                II+RDLK  N+LLD     K++D+G+ K  +      S    GT  Y+ PE    
Sbjct: 129 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEILRG 184
Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
           +      D ++ GV++ E+++G+
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGR 207

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 92/214 (42%), Gaps = 21/214 (9%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 469
           K IG G FG V   KLK+  ++ A+K+L       + E   F  E  +L     + +   
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 470 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
               Q++    LV ++   G   TL       L  E    ++  + IA D+   + Y   
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY--- 196
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+K  NIL+D +   +++DFG     ++  +  SS+  GT  Y+ PE   +
Sbjct: 197 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 587 QQ-----LTDKSDVYSFGVILLELISGQEAISNE 615
            +        + D +S GV + E++ G+     E
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 284

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ DF L++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 88/203 (43%), Gaps = 13/203 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNL 466
           L + IG G +  V   +LK    I A+KV+         +     T +       +H  L
Sbjct: 9   LLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 68
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V      Q E R   V E+++ G L  H+      ++++        + + +  + YLH 
Sbjct: 69  VGLHSCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLHE 124
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                II+RDLK  N+LLD     K++D+G+ K  +      S    GT  Y+ PE    
Sbjct: 125 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEILRG 180
Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
           +      D ++ GV++ E+++G+
Sbjct: 181 EDYGFSVDWWALGVLMFEMMAGR 203

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 30/210 (14%)
Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQG-KREFTNEVTLLSRIHHRNLVQFLG 471
           KIG G FG V+  +  K G+++A+K VL  N  +G       E+ +L  + H N+V  + 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 472 YCQEEGRSV--------LVYEFMHNGTLKEH-LYGTLTH---EQRINWIKRLEIAEDAAK 519
            C+ +            LV++F       EH L G L++   +  ++ IKR  + +    
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKR--VMQMLLN 136
Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRG--TV 576
           G+ Y+H      I+HRD+K++N+L+ +    K++DFGL++ F++   S  +       T+
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 577 GYLDPEYYISQQ-LTDKSDVYSFGVILLEL 605
            Y  PE  + ++      D++  G I+ E+
Sbjct: 194 WYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+  FGL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNL 466
           L + IG G +  V   +LK    I A+KV+         +     T +       +H  L
Sbjct: 24  LLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 83
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--TLTHEQRINWIKRLEIAEDAAKGIEYL 524
           V      Q E R   V E+++ G L  H+     L  E    +   + +A      + YL
Sbjct: 84  VGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNYL 137
Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 584
           H      II+RDLK  N+LLD     K++D+G+ K  +      S    GT  Y+ PE  
Sbjct: 138 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC-GTPNYIAPEIL 193
Query: 585 ISQQLTDKSDVYSFGVILLELISGQ 609
             +      D ++ GV++ E+++G+
Sbjct: 194 RGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 13/203 (6%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF----TNEVTLLSRIHHRNL 466
           L + IG G +  V   +LK    I A++V+         +     T +       +H  L
Sbjct: 56  LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL 115
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V      Q E R   V E+++ G L  H+      ++++        + + +  + YLH 
Sbjct: 116 VGLHSCFQTESRLFFVIEYVNGGDLMFHM----QRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                II+RDLK  N+LLD     K++D+G+ K  +      S+   GT  Y+ PE    
Sbjct: 172 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRG 227
Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
           +      D ++ GV++ E+++G+
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGR 250

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 9/199 (4%)
Query: 416 IGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGYC 473
           IG G +G+V        K  +A+K ++   +Q   + T  E+ +L    H N++      
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
           +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   +
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV---L 148
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQLT 590
           HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  T
Sbjct: 149 HRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 591 DKSDVYSFGVILLELISGQ 609
              D++S G IL E++S +
Sbjct: 209 KSIDIWSVGCILAEMLSNR 227

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ D GL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 469
           K IG G FG V   + K  +++    L S     KR     F  E  +++  +   +VQ 
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++    +V E+M  G L   +      E+   W  R   AE     ++ +H+   
Sbjct: 135 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---W-ARFYTAE-VVLALDAIHSM-- 187
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYYISQ- 587
              IHRD+K  N+LLDK    K++DFG   K   +G     + V GT  Y+ PE   SQ 
Sbjct: 188 -GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 245
Query: 588 ---QLTDKSDVYSFGVILLELISG 608
                  + D +S GV L E++ G
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ D GL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 25/216 (11%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 469
           K IG G FG V   K+K+ + I A+K+L       + E   F  E  +L     + +   
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 139
Query: 470 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
               Q+E    LV ++   G   TL       L  +    +I  + +A D+   + Y   
Sbjct: 140 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY--- 196
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+K  N+LLD +   +++DFG      D  +  SS+  GT  Y+ PE  I 
Sbjct: 197 ------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPE--IL 248
Query: 587 QQLTD-------KSDVYSFGVILLELISGQEAISNE 615
           Q + D       + D +S GV + E++ G+     E
Sbjct: 249 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 284

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 469
           K IG G FG V   + K  +++    L S     KR     F  E  +++  +   +VQ 
Sbjct: 80  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++    +V E+M  G L   +      E+   W  R   AE     ++ +H+   
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---W-ARFYTAE-VVLALDAIHSM-- 192
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYYISQ- 587
              IHRD+K  N+LLDK    K++DFG   K   +G     + V GT  Y+ PE   SQ 
Sbjct: 193 -GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 250
Query: 588 ---QLTDKSDVYSFGVILLELISG 608
                  + D +S GV L E++ G
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 93/216 (43%), Gaps = 25/216 (11%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 469
           K IG G FG V   K+K+ + I A+K+L       + E   F  E  +L     + +   
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQWITAL 155
Query: 470 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
               Q+E    LV ++   G   TL       L  +    +I  + +A D+   + Y   
Sbjct: 156 HYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHY--- 212
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+K  N+LLD +   +++DFG      D  +  SS+  GT  Y+ PE  I 
Sbjct: 213 ------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPE--IL 264
Query: 587 QQLTD-------KSDVYSFGVILLELISGQEAISNE 615
           Q + D       + D +S GV + E++ G+     E
Sbjct: 265 QAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 300

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 100/203 (49%), Gaps = 21/203 (10%)
Query: 415 KIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRNLVQFLGY 472
           K+G G +  VY GK K     +A+K +     +G       EV+LL  + H N+V     
Sbjct: 9   KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 473 CQEEGRSVLVYEFMHNGTLKEHL--YGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGC 528
              E    LV+E++ +  LK++L   G +   H  ++   + L       +G+ Y H   
Sbjct: 69  IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLL-------RGLAYCHR-- 118
Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYI-S 586
              ++HRDLK  N+L+++    K++DFGL++  ++   ++ + +V  T+ Y  P+  + S
Sbjct: 119 -QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGS 175
Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
              + + D++  G I  E+ +G+
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGR 198

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 9/199 (4%)
Query: 416 IGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFT-NEVTLLSRIHHRNLVQFLGYC 473
           IG G +G+V        K  +A+K ++   +Q   + T  E+ +L    H N++      
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAII 533
           +      +   ++    ++  LY  L   Q ++            +G++Y+H+  V   +
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANV---L 148
Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--GTVGYLDPEYYI-SQQLT 590
           HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  + S+  T
Sbjct: 149 HRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYT 208
Query: 591 DKSDVYSFGVILLELISGQ 609
              D++S G IL E++S +
Sbjct: 209 KSIDIWSVGCILAEMLSNR 227

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNLVQF 469
           K IG G FG V   + K  +++    L S     KR     F  E  +++  +   +VQ 
Sbjct: 80  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 139
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               Q++    +V E+M  G L   +      E+   W  R   AE     ++ +H+   
Sbjct: 140 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---W-ARFYTAE-VVLALDAIHS--- 191
Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYYISQ- 587
              IHRD+K  N+LLDK    K++DFG   K   +G     + V GT  Y+ PE   SQ 
Sbjct: 192 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQG 250
Query: 588 ---QLTDKSDVYSFGVILLELISG 608
                  + D +S GV L E++ G
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTV 576
           AKG+E+L +      IHRDL + NILL +    K+ DFGL++       +V     R  +
Sbjct: 210 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 266
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 267 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 31/208 (14%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFL 470
           +GSG +G V      K G  +AVK L S  +Q     KR +  E+ LL  + H N++  L
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTY-RELRLLKHMKHENVIGLL 87
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KGIE 522
                  RS+   E  ++  L  HL G   +    N +K  ++ +D          +G++
Sbjct: 88  DVFTP-ARSL---EEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILRGLK 139
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           Y+H+     IIHRDLK SN+ +++    K+ D GL++   D  +   +    T  Y  PE
Sbjct: 140 YIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVA----TRWYRAPE 192
Query: 583 YYISQQLTDKS-DVYSFGVILLELISGQ 609
             ++    +++ D++S G I+ EL++G+
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTV 576
           AKG+E+L +      IHRDL + NILL +    K+ DFGL++       +V     R  +
Sbjct: 208 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 264
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 265 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTV 576
           AKG+E+L +      IHRDL + NILL +    K+ DFGL++       +V     R  +
Sbjct: 203 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 259
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 115/268 (42%), Gaps = 41/268 (15%)
Query: 405 IEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL-----TSNSYQGKREFTNEVTLL 458
            ED  ++ E  IG G F VV     ++ G++ AVK++     TS+      +   E ++ 
Sbjct: 22  FEDVYELCEV-IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 459 SRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL-----KEHLYGTLTHEQRINWIKRLEI 513
             + H ++V+ L     +G   +V+EFM    L     K    G +  E   +   R +I
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR-QI 139
Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 570
            E     + Y H      IIHRD+K  N+LL   +     K+ DFG++   +  +  V+ 
Sbjct: 140 LE----ALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVA-IQLGESGLVAG 191
Query: 571 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-----------EAISNEKFGA 619
              GT  ++ PE    +      DV+  GVIL  L+SG            E I   K+  
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKM 251
Query: 620 NCRNIVQWAKLHIESGDI---QGIIDPS 644
           N R   QW+ +   + D+     ++DP+
Sbjct: 252 NPR---QWSHISESAKDLVRRMLMLDPA 276

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTV 576
           AKG+E+L +      IHRDL + NILL +    K+ DFGL++       +V     R  +
Sbjct: 201 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 257
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            ++ PE    +  T +SDV+SFGV+L E+ S
Sbjct: 258 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLTS--NSYQGKREFTNEVTLLSRIHHRNLVQ 468
           + +GSG +G V   Y  +L+  +++AVK L+    S    R    E+ LL  + H N++ 
Sbjct: 26  RPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 83
Query: 469 FL-----GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
            L         E+   V +   +    L   +      ++ + ++          +G++Y
Sbjct: 84  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL-----VYQLLRGLKY 138
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +H+     IIHRDLK SN+ +++    ++ DFGL++ A +  +   +    T  Y  PE 
Sbjct: 139 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVA----TRWYRAPEI 191
Query: 584 YISQQLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
            ++    +++ D++S G I+ EL+ G+       +    + I++
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 235

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLTS--NSYQGKREFTNEVTLLSRIHHRNLVQ 468
           + +GSG +G V   Y  +L+  +++AVK L+    S    R    E+ LL  + H N++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 469 FL-----GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
            L         E+   V +   +    L   +      ++ + ++          +G++Y
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFL-----VYQLLRGLKY 146
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +H+     IIHRDLK SN+ +++    ++ DFGL++ A +  +   +    T  Y  PE 
Sbjct: 147 IHSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVA----TRWYRAPEI 199
Query: 584 YISQQLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
            ++    +++ D++S G I+ EL+ G+       +    + I++
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 243

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 101/263 (38%), Gaps = 78/263 (29%)
Query: 416 IGSGGFGVVYYGKLK-DGKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           +G GGFGVV+  K K D    A+K +   N    + +   EV  L+++ H  +V++    
Sbjct: 14  MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 73
Query: 474 --------QEEGRSVLVYE-------------------------FMHNGTL--------K 492
                   QEE   + + +                         F    T+        K
Sbjct: 74  LETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPK 133
Query: 493 EHLYGTLT---HEQRINWIKR------------LEIAEDAAKGIEYLHTGCVPAIIHRDL 537
            +LY  +     E   +W+ R            L I    A+ +E+LH+     ++HRDL
Sbjct: 134 VYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDL 190
Query: 538 KSSNILLDKHMRAKVSDFGLSKFAVDG--------------ASHVSSIVRGTVGYLDPEY 583
           K SNI        KV DFGL   A+D               A+H   +  GT  Y+ PE 
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVT-AMDQDEEEQTVLTPMPAYATHXGQV--GTKLYMSPEQ 247
Query: 584 YISQQLTDKSDVYSFGVILLELI 606
                 + K D++S G+IL EL+
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELL 270

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 52/91 (57%), Gaps = 4/91 (4%)
Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-SSIVRGTV 576
           A+G+E+L +      IHRDL + NILL ++   K+ DFGL++       +V     R  +
Sbjct: 209 ARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPL 265
Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
            ++ PE    +  + KSDV+S+GV+L E+ S
Sbjct: 266 KWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/230 (22%), Positives = 98/230 (42%), Gaps = 17/230 (7%)
Query: 413 EKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFL 470
           +K +G G F +       K  +  AVK+++       ++   E+T L     H N+V+  
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72
Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
               ++  + LV E ++ G     L+  +  ++  +  +   I       + ++H     
Sbjct: 73  EVFHDQLHTFLVMELLNGG----ELFERIKKKKHFSETEASYIMRKLVSAVSHMHD---V 125
Query: 531 AIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
            ++HRDLK  N+L    + ++  K+ DFG ++        + +    T+ Y  PE     
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQN 184
Query: 588 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 637
              +  D++S GVIL  ++SGQ    +      C + V+  K  I+ GD 
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK-KIKKGDF 233

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 414 KKIGSGGFGVV---YYGKLKDGKEIAVKVLTS--NSYQGKREFTNEVTLLSRIHHRNLVQ 468
           + +GSG +G V   Y  +L+  +++AVK L+    S    R    E+ LL  + H N++ 
Sbjct: 34  RPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIG 91
Query: 469 FL-----GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
            L         E+   V +   +    L   +      ++ + ++          +G++Y
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL-----VYQLLRGLKY 146
Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +H+     IIHRDLK SN+ +++    ++ DFGL++ A +  +   +    T  Y  PE 
Sbjct: 147 IHSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVA----TRWYRAPEI 199
Query: 584 YISQQLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
            ++    +++ D++S G I+ EL+ G+       +    + I++
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIME 243

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E M      + L+  +T    +             + + + H 
Sbjct: 76  IRLLDWFERPDSFVLILERMEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 132
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 133 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 186
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 242

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 416 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQ 474
           +G G  G + Y  + D +++AVK +    +        EV LL     H N++++  +C 
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA---DREVQLLRESDEHPNVIRY--FCT 86
Query: 475 EEGRSVLVYEF-MHNGTLKEHLYGTLTHEQRINW---IKRLEIAEDAAKGIEYLHTGCVP 530
           E+ R        +   TL+E++      EQ+      ++ + + +    G+ +LH+    
Sbjct: 87  EKDRQFQYIAIELCAATLQEYV------EQKDFAHLGLEPITLLQQTTSGLAHLHS---L 137
Query: 531 AIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAVDGASHVS--SIVRGTVGYLDPEY 583
            I+HRDLK  NIL+        ++A +SDFGL K    G    S  S V GT G++ PE 
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 584 Y---ISQQLTDKSDVYSFGVILLELIS 607
                 +  T   D++S G +   +IS
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 21/172 (12%)
Query: 447 GKREFTNEVTLLSRIHHRNLVQFLG--YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 504
           G+     E+ LL R+ H+N++Q +   Y +E+ +  +V E+   G ++E L      E+R
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEML--DSVPEKR 105
Query: 505 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK----F 560
               +          G+EYLH+     I+H+D+K  N+LL      K+S  G+++    F
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162
Query: 561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTD----KSDVYSFGVILLELISG 608
           A D     S   +G+  +  PE  I+  L      K D++S GV L  + +G
Sbjct: 163 AADDTCRTS---QGSPAFQPPE--IANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 415 KIGSGGFGVVYYGK-LKDG-KEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLV 467
           +IG G +G V+  + LK+G + +A+K V      +G    T  EV +L  +    H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 468 QFLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           +    C       E +  LV+E + +  L  +L            IK  ++     +G++
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLD 134
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     ++HRDLK  NIL+    + K++DFGL++      +  S +V  T+ Y  PE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 189
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +        D++S G I  E+ 
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 98/221 (44%), Gaps = 22/221 (9%)
Query: 413 EKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           + ++G G FG V+  K K  G + AVK +    ++       E+   + +    +V   G
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG 117
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
             +E     +  E +  G+L + +   G L  ++ + ++ +      A +G+EYLHT   
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ------ALEGLEYLHT--- 168
Query: 530 PAIIHRDLKSSNILLDKH-MRAKVSDFG----LSKFAVDGASHVSSIVRGTVGYLDPEYY 584
             I+H D+K+ N+LL     RA + DFG    L    +  +      + GT  ++ PE  
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 585 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 625
           + +    K D++S   ++L +++G    +    G  C  I 
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA 269

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 98/221 (44%), Gaps = 22/221 (9%)
Query: 413 EKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           + ++G G FG V+  K K  G + AVK +    ++       E+   + +    +V   G
Sbjct: 79  QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG 133
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
             +E     +  E +  G+L + +   G L  ++ + ++ +      A +G+EYLHT   
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ------ALEGLEYLHT--- 184
Query: 530 PAIIHRDLKSSNILLDKH-MRAKVSDFG----LSKFAVDGASHVSSIVRGTVGYLDPEYY 584
             I+H D+K+ N+LL     RA + DFG    L    +  +      + GT  ++ PE  
Sbjct: 185 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 244
Query: 585 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 625
           + +    K D++S   ++L +++G    +    G  C  I 
Sbjct: 245 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA 285

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 104 IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 161 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 214
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWC 270

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 105 IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 162 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 215
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWC 271

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 105 IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 162 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 215
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWC 271

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 111 IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 167
Query: 527 GCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D      K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 168 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 221
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 277

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 104 IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 161 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 214
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWC 270

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 91  IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 147
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 148 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 201
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 257

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 104 IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 161 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 214
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 270

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 101/246 (41%), Gaps = 52/246 (21%)
Query: 412 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSY-----QGKREFTNEVTLLSRIHHRN 465
           L+  IG G +GVV        + I A+K++  N       +       EV L+ ++HH N
Sbjct: 30  LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTL-------------------------------KEH 494
           + +     ++E    LV E  H G L                               +E 
Sbjct: 90  IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 495 LYGTLT-HEQRINWIKRLEIAEDAAKGI----EYLHTGCVPAIIHRDLKSSNILL--DKH 547
           + G++    + +++++R ++  +  + I     YLH      I HRD+K  N L   +K 
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKS 206
Query: 548 MRAKVSDFGLSK--FAVDGASHVSSIVR-GTVGYLDPEYY--ISQQLTDKSDVYSFGVIL 602
              K+ DFGLSK  + ++   +     + GT  ++ PE     ++    K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 603 LELISG 608
             L+ G
Sbjct: 267 HLLLMG 272

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 108/222 (48%), Gaps = 25/222 (11%)
Query: 396 AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNE 454
           A+H     + +D    L +K+G G +  V+    + + +++ VK+L       K +   E
Sbjct: 27  ASHVVEWGNQDDYQ--LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KNKIKRE 81
Query: 455 VTLLSRIHH-RNLVQFLGYCQE--EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL 511
           + +L  +    N++      ++       LV+E ++N   K+ LY TLT     ++  R 
Sbjct: 82  IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLT-----DYDIRF 135
Query: 512 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSS 570
            + E   K ++Y H+     I+HRD+K  N+++D +H + ++ D+GL++F   G  +   
Sbjct: 136 YMYE-ILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN-- 189
Query: 571 IVRGTVGYLD-PEYYISQQLTDKS-DVYSFGVILLELISGQE 610
            VR    Y   PE  +  Q+ D S D++S G +L  +I  +E
Sbjct: 190 -VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 230

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 415 KIGSGGFGVVYYGK-LKDG-KEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLV 467
           +IG G +G V+  + LK+G + +A+K V      +G    T  EV +L  +    H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 468 QFLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           +    C       E +  LV+E + +  L  +L            IK  ++     +G++
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLD 134
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     ++HRDLK  NIL+    + K++DFGL++      +  S +V  T+ Y  PE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 189
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +        D++S G I  E+ 
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/221 (23%), Positives = 98/221 (44%), Gaps = 22/221 (9%)
Query: 413 EKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           + ++G G FG V+  K K  G + AVK +    ++       E+   + +    +V   G
Sbjct: 77  QPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG 131
Query: 472 YCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
             +E     +  E +  G+L + +   G L  ++ + ++ +      A +G+EYLHT   
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQ------ALEGLEYLHT--- 182
Query: 530 PAIIHRDLKSSNILLDKH-MRAKVSDFG----LSKFAVDGASHVSSIVRGTVGYLDPEYY 584
             I+H D+K+ N+LL     RA + DFG    L    +  +      + GT  ++ PE  
Sbjct: 183 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 242
Query: 585 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV 625
           + +    K D++S   ++L +++G    +    G  C  I 
Sbjct: 243 MGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA 283

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 415 KIGSGGFGVVYYGK-LKDG-KEIAVK-VLTSNSYQGKREFT-NEVTLLSRIH---HRNLV 467
           +IG G +G V+  + LK+G + +A+K V      +G    T  EV +L  +    H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 468 QFLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           +    C       E +  LV+E + +  L  +L            IK  ++     +G++
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLD 134
Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     ++HRDLK  NIL+    + K++DFGL++      +  S +V  T+ Y  PE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 189
Query: 583 YYISQQLTDKSDVYSFGVILLELI 606
             +        D++S G I  E+ 
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 92  IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 148
Query: 527 GCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D      K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 149 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 202
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 258

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 24/216 (11%)
Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFLGY 472
           K+     G ++ G+ + G +I VKVL    +  +  R+F  E   L    H N++  LG 
Sbjct: 17  KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 473 CQEE--GRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYLHTG 527
           CQ        L+  +   G+    LY  L HE     ++  + ++ A D A+G  +LHT 
Sbjct: 76  CQSPPAPHPTLITHWXPYGS----LYNVL-HEGTNFVVDQSQAVKFALDXARGXAFLHT- 129
Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVS--DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
             P I    L S ++ +D+   A++S  D   S F   G  +  + V        PE   
Sbjct: 130 LEPLIPRHALNSRSVXIDEDXTARISXADVKFS-FQSPGRXYAPAWVAPEALQKKPEDTN 188
Query: 586 SQQLTDKSDVYSFGVILLELISGQ---EAISNEKFG 618
            +     +D +SF V+L EL++ +     +SN + G
Sbjct: 189 RRS----ADXWSFAVLLWELVTREVPFADLSNXEIG 220

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 119 IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 175
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 176 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 229
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 285

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 77  IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 133
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 134 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 187
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 243

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 90/187 (48%), Gaps = 19/187 (10%)
Query: 434 EIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV-LVYEFMHNGTL 491
           E AVKV+     + KR+ + E+ +L R   H N++  L    ++G+ V LV E M  G L
Sbjct: 54  EYAVKVID----KSKRDPSEEIEILLRYGQHPNIIT-LKDVYDDGKHVYLVTELMRGGEL 108
Query: 492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL-LDKHMRA 550
            + +       +R    +   +     K +EYLH+     ++HRDLK SNIL +D+    
Sbjct: 109 LDKILRQKFFSER----EASFVLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNP 161
Query: 551 ---KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
              ++ DFG +K  +   + +      T  ++ PE    Q   +  D++S G++L  +++
Sbjct: 162 ECLRICDFGFAK-QLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLA 220
Query: 608 GQEAISN 614
           G    +N
Sbjct: 221 GYTPFAN 227

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 35/219 (15%)
Query: 416 IGSGGFG-VVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH----------- 463
           +G G FG VV      D +  A+K +  ++ +      +EV LL+ ++H           
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVVRYYAAWL 72
Query: 464 --RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
             RN V+     +++    +  E+  N TL + ++    ++QR  + +   +     + +
Sbjct: 73  ERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR---LFRQILEAL 129
Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK--------FAVD-----GASHV 568
            Y+H+     IIHR+LK  NI +D+    K+ DFGL+K          +D     G+S  
Sbjct: 130 SYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDN 186
Query: 569 SSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELI 606
            +   GT  Y+  E    +    +K D YS G+I  E I
Sbjct: 187 LTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 19/187 (10%)
Query: 434 EIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV-LVYEFMHNGTL 491
           E AVKV+     + KR+ + E+ +L R   H N++  L    ++G+ V LV E M  G L
Sbjct: 54  EYAVKVID----KSKRDPSEEIEILLRYGQHPNIIT-LKDVYDDGKHVYLVTELMRGGEL 108
Query: 492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL-LDKHMRA 550
            + +       +R        +     K +EYLH+     ++HRDLK SNIL +D+    
Sbjct: 109 LDKILRQKFFSEREASF----VLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNP 161
Query: 551 ---KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
              ++ DFG +K  +   + +      T  ++ PE    Q   +  D++S G++L  +++
Sbjct: 162 ECLRICDFGFAK-QLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLA 220
Query: 608 GQEAISN 614
           G    +N
Sbjct: 221 GYTPFAN 227

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 76  IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 132
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 133 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 186
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 242

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 105 IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 162 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 215
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F        C+++++W 
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQHLIRWC 271

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 77  IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 133
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 134 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 187
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 243

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 77  IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 133
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 134 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 187
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 105 IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 161
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 162 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 215
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F        C+++++W 
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQHLIRWC 271

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 104 IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 160
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 161 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 214
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F        C+++++W 
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSXECQHLIRWC 270

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 91  IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 147
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 148 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 201
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F        C+++++W 
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWC 257

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 92  IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 148
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 149 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 202
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F        C+++++W 
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWC 258

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 119 IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 175
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 176 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 229
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F        C+++++W 
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWC 285

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 100/236 (42%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 92  IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 148
Query: 527 GCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D      K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 149 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 202
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F        C+++++W 
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWC 258

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 124 IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 180
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 181 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 234
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F        C+++++W 
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWC 290

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 72  IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 129 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 182
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFRQRVSSECQHLIRWC 238

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 72  IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 129 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 182
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 238

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 75  IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 131
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 132 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 185
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F      + C+++++W 
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWC 241

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 93/233 (39%), Gaps = 29/233 (12%)
Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 469
           K IG G F  V   K+K  G+  A+K++       + E   F  E  +L     R + Q 
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 470 LGYCQEEGRSVLVYEFMHNG---TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
               Q+E    LV E+   G   TL       +  E    ++  + +A D+   + Y   
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGY--- 183
Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFG-LSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
                 +HRD+K  NILLD+    +++DFG   K   DG    S +  GT  YL PE  I
Sbjct: 184 ------VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPE--I 234
Query: 586 SQQLTD---------KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 629
            Q +           + D ++ GV   E+  GQ     +        IV + +
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE 287

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 99  IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 155
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
            C   ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 156 -C--GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 209
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F        C+++++W 
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWC 265

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 469
           +++ IG G + V      K    E AVK++     + KR+ T E+ +L R   H N++  
Sbjct: 26  VKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEILLRYGQHPNIIT- 80
Query: 470 LGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
           L    ++G+ V +V E M  G L + +       +R    +   +     K +EYLH   
Sbjct: 81  LKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER----EASAVLFTITKTVEYLHA-- 134
Query: 529 VPAIIHRDLKSSNIL-LDKH---MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 584
              ++HRDLK SNIL +D+       ++ DFG +K  +   + +      T  ++ PE  
Sbjct: 135 -QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK-QLRAENGLLMTPCYTANFVAPEVL 192
Query: 585 ISQQLTDKSDVYSFGVILLELISGQEAISN 614
             Q      D++S GV+L  +++G    +N
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 100/236 (42%), Gaps = 32/236 (13%)
Query: 416 IGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH--HRNL 466
           +GSGGFG VY G ++ D   +A+K +  +      E  N      EV LL ++      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           ++ L + +     VL+ E        + L+  +T    +             + + + H 
Sbjct: 72  IRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 128
Query: 527 GCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
                ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  PE+  
Sbjct: 129 X---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIR 182
Query: 586 SQQLTDKS-DVYSFGVILLELISG-------QEAISNEKF-----GANCRNIVQWA 628
             +   +S  V+S G++L +++ G       +E I  + F        C+++++W 
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSXECQHLIRWC 238

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 110/253 (43%), Gaps = 31/253 (12%)
Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           +E+  G G FG V  GK K  G  +A+K +  +     RE    +  L+ +HH N+VQ  
Sbjct: 27  VERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLHHPNIVQLQ 85
Query: 471 GYC----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE----------D 516
            Y     + + R + +        + E++  TL H    N+ +R ++A            
Sbjct: 86  SYFYTLGERDRRDIYL------NVVMEYVPDTL-HRCCRNYYRR-QVAPPPILIKVFLFQ 137
Query: 517 AAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSIVRGT 575
             + I  LH   V  + HRD+K  N+L+++     K+ DFG +K       +V+ I   +
Sbjct: 138 LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC--S 194
Query: 576 VGYLDPEY-YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 634
             Y  PE  + +Q  T   D++S G I  E++ G+     +        IV+   L   S
Sbjct: 195 RYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV--LGCPS 252
Query: 635 GDIQGIIDPSLLD 647
            ++   ++PS  D
Sbjct: 253 REVLRKLNPSHTD 265

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 87/164 (53%), Gaps = 17/164 (10%)
Query: 481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 540
           LV+E ++N   K+ LY TLT     ++  R  + E   K ++Y H+     I+HRD+K  
Sbjct: 111 LVFEHVNNTDFKQ-LYQTLT-----DYDIRFYMYE-ILKALDYCHSM---GIMHRDVKPH 160
Query: 541 NILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSF 598
           N+L+D +H + ++ D+GL++F   G  +  ++   +  +  PE  +  Q+ D S D++S 
Sbjct: 161 NVLIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSL 218
Query: 599 GVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
           G +L  +I  +E   +     N   +V+ AK+ + + D+   ID
Sbjct: 219 GCMLASMIFRKEPFFHGH--DNYDQLVRIAKV-LGTEDLYDYID 259

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 412 LEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEV-TLLSRIHHRNLVQF 469
           L +KIGSG FG +Y G  ++  +E+A+K+    +   +  + +++  +L        V++
Sbjct: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRW 70
Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G   E   +VLV + +  G   E L+   + +  +  +  L +A+     +E++H+   
Sbjct: 71  FGV--EGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTV--LMLADQMINRVEFVHS--- 121
Query: 530 PAIIHRDLKSSNILLDKHMRAK---VSDFGLSKFAVDGASHVSSIVR------GTVGYLD 580
            + +HRD+K  N L+    RA    + DFGL+K   D ++H     R      GT  Y  
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 581 PEYYISQQLTDKSDVYSFGVILLELISG 608
              ++  + + + D+ S G +L+  + G
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRG 209

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 72/136 (52%), Gaps = 16/136 (11%)
Query: 480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 539
            LV+E ++N   K+ LY TLT     ++  R  + E   K ++Y H+     I+HRD+K 
Sbjct: 110 ALVFEHVNNTDFKQ-LYQTLT-----DYDIRFYMYE-ILKALDYCHSM---GIMHRDVKP 159
Query: 540 SNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD-PEYYISQQLTDKS-DVY 596
            N+++D +H + ++ D+GL++F   G  +    VR    Y   PE  +  Q+ D S D++
Sbjct: 160 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMW 216
Query: 597 SFGVILLELISGQEAI 612
           S G +L  +I  +E  
Sbjct: 217 SLGCMLASMIFRKEPF 232

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 86/166 (51%), Gaps = 19/166 (11%)
Query: 480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 539
            LV+E ++N   K+ LY TLT     ++  R  + E   K ++Y H+     I+HRD+K 
Sbjct: 110 ALVFEHVNNTDFKQ-LYQTLT-----DYDIRFYMYE-ILKALDYCHSM---GIMHRDVKP 159
Query: 540 SNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD-PEYYISQQLTDKS-DVY 596
            N+++D +H + ++ D+GL++F   G  +    VR    Y   PE  +  Q+ D S D++
Sbjct: 160 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMW 216
Query: 597 SFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
           S G +L  +I  +E   +     N   +V+ AK+ + + D+   ID
Sbjct: 217 SLGCMLASMIFRKEPFFHGH--DNYDQLVRIAKV-LGTEDLYDYID 259

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 86/166 (51%), Gaps = 19/166 (11%)
Query: 480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 539
            LV+E ++N   K+ LY TLT     ++  R  + E   K ++Y H+     I+HRD+K 
Sbjct: 109 ALVFEHVNNTDFKQ-LYQTLT-----DYDIRFYMYE-ILKALDYCHSM---GIMHRDVKP 158
Query: 540 SNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD-PEYYISQQLTDKS-DVY 596
            N+++D +H + ++ D+GL++F   G  +    VR    Y   PE  +  Q+ D S D++
Sbjct: 159 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMW 215
Query: 597 SFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
           S G +L  +I  +E   +     N   +V+ AK+ + + D+   ID
Sbjct: 216 SLGCMLASMIFRKEPFFHGH--DNYDQLVRIAKV-LGTEDLYDYID 258

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 86/166 (51%), Gaps = 19/166 (11%)
Query: 480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 539
            LV+E ++N   K+ LY TLT     ++  R  + E   K ++Y H+     I+HRD+K 
Sbjct: 110 ALVFEHVNNTDFKQ-LYQTLT-----DYDIRFYMYE-ILKALDYCHSM---GIMHRDVKP 159
Query: 540 SNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD-PEYYISQQLTDKS-DVY 596
            N+++D +H + ++ D+GL++F   G  +    VR    Y   PE  +  Q+ D S D++
Sbjct: 160 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMW 216
Query: 597 SFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
           S G +L  +I  +E   +     N   +V+ AK+ + + D+   ID
Sbjct: 217 SLGCMLASMIFRKEPFFHGH--DNYDQLVRIAKV-LGTEDLYDYID 259

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 86/165 (52%), Gaps = 19/165 (11%)
Query: 481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 540
           LV+E ++N   K+ LY TLT     ++  R  + E   K ++Y H+     I+HRD+K  
Sbjct: 111 LVFEHVNNTDFKQ-LYQTLT-----DYDIRFYMYE-ILKALDYCHSM---GIMHRDVKPH 160
Query: 541 NILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD-PEYYISQQLTDKS-DVYS 597
           N+++D +H + ++ D+GL++F   G  +    VR    Y   PE  +  Q+ D S D++S
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWS 217
Query: 598 FGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
            G +L  +I  +E   +     N   +V+ AK+ + + D+   ID
Sbjct: 218 LGCMLASMIFRKEPFFHGH--DNYDQLVRIAKV-LGTEDLYDYID 259

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 86/166 (51%), Gaps = 19/166 (11%)
Query: 480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 539
            LV+E ++N   K+ LY TLT     ++  R  + E   K ++Y H+     I+HRD+K 
Sbjct: 110 ALVFEHVNNTDFKQ-LYQTLT-----DYDIRFYMYE-ILKALDYCHSM---GIMHRDVKP 159
Query: 540 SNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD-PEYYISQQLTDKS-DVY 596
            N+++D +H + ++ D+GL++F   G  +    VR    Y   PE  +  Q+ D S D++
Sbjct: 160 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMW 216
Query: 597 SFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
           S G +L  +I  +E   +     N   +V+ AK+ + + D+   ID
Sbjct: 217 SLGCMLASMIFRKEPFFHGH--DNYDQLVRIAKV-LGTEDLYDYID 259

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 86/166 (51%), Gaps = 19/166 (11%)
Query: 480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 539
            LV+E ++N   K+ LY TLT     ++  R  + E   K ++Y H+     I+HRD+K 
Sbjct: 110 ALVFEHVNNTDFKQ-LYQTLT-----DYDIRFYMYE-ILKALDYCHSM---GIMHRDVKP 159
Query: 540 SNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD-PEYYISQQLTDKS-DVY 596
            N+++D +H + ++ D+GL++F   G  +    VR    Y   PE  +  Q+ D S D++
Sbjct: 160 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMW 216
Query: 597 SFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
           S G +L  +I  +E   +     N   +V+ AK+ + + D+   ID
Sbjct: 217 SLGCMLASMIFRKEPFFHGH--DNYDQLVRIAKV-LGTEDLYDYID 259

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 86/166 (51%), Gaps = 19/166 (11%)
Query: 480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 539
            LV+E ++N   K+ LY TLT     ++  R  + E   K ++Y H+     I+HRD+K 
Sbjct: 110 ALVFEHVNNTDFKQ-LYQTLT-----DYDIRFYMYE-ILKALDYCHSM---GIMHRDVKP 159
Query: 540 SNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD-PEYYISQQLTDKS-DVY 596
            N+++D +H + ++ D+GL++F   G  +    VR    Y   PE  +  Q+ D S D++
Sbjct: 160 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMW 216
Query: 597 SFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
           S G +L  +I  +E   +     N   +V+ AK+ + + D+   ID
Sbjct: 217 SLGCMLASMIFRKEPFFHGH--DNYDQLVRIAKV-LGTEDLYDYID 259

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 86/165 (52%), Gaps = 19/165 (11%)
Query: 481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 540
           LV+E ++N   K+ LY TLT     ++  R  + E   K ++Y H+     I+HRD+K  
Sbjct: 111 LVFEHVNNTDFKQ-LYQTLT-----DYDIRFYMYE-ILKALDYCHSM---GIMHRDVKPH 160
Query: 541 NILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD-PEYYISQQLTDKS-DVYS 597
           N+++D +H + ++ D+GL++F   G  +    VR    Y   PE  +  Q+ D S D++S
Sbjct: 161 NVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWS 217
Query: 598 FGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
            G +L  +I  +E   +     N   +V+ AK+ + + D+   ID
Sbjct: 218 LGCMLASMIFRKEPFFHGH--DNYDQLVRIAKV-LGTEDLYDYID 259

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 87/165 (52%), Gaps = 17/165 (10%)
Query: 480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 539
            LV+E ++N   K+ LY TLT     ++  R  + E   K ++Y H+     I+HRD+K 
Sbjct: 115 ALVFEHVNNTDFKQ-LYQTLT-----DYDIRFYMYE-ILKALDYCHSM---GIMHRDVKP 164
Query: 540 SNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYS 597
            N+++D +H + ++ D+GL++F   G  +  ++   +  +  PE  +  Q+ D S D++S
Sbjct: 165 HNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYDYSLDMWS 222
Query: 598 FGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
            G +L  +I  +E   +     N   +V+ AK+ + + D+   ID
Sbjct: 223 LGCMLASMIFRKEPFFHGH--DNYDQLVRIAKV-LGTEDLYDYID 264

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 86/166 (51%), Gaps = 19/166 (11%)
Query: 480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKS 539
            LV+E ++N   K+ LY TLT     ++  R  + E   K ++Y H+     I+HRD+K 
Sbjct: 109 ALVFEHVNNTDFKQ-LYQTLT-----DYDIRFYMYE-ILKALDYCHSM---GIMHRDVKP 158
Query: 540 SNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD-PEYYISQQLTDKS-DVY 596
            N+++D +H + ++ D+GL++F   G  +    VR    Y   PE  +  Q+ D S D++
Sbjct: 159 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMW 215
Query: 597 SFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
           S G +L  +I  +E   +     N   +V+ AK+ + + D+   ID
Sbjct: 216 SLGCMLASMIFRKEPFFHGH--DNYDQLVRIAKV-LGTEDLYDYID 258

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 86/165 (52%), Gaps = 19/165 (11%)
Query: 481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 540
           LV+E ++N   K+ LY TLT     ++  R  + E   K ++Y H+     I+HRD+K  
Sbjct: 109 LVFEHVNNTDFKQ-LYQTLT-----DYDIRFYMYE-ILKALDYCHSM---GIMHRDVKPH 158
Query: 541 NILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD-PEYYISQQLTDKS-DVYS 597
           N+++D +H + ++ D+GL++F   G  +    VR    Y   PE  +  Q+ D S D++S
Sbjct: 159 NVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGPELLVDYQMYDYSLDMWS 215
Query: 598 FGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
            G +L  +I  +E   +     N   +V+ AK+ + + D+   ID
Sbjct: 216 LGCMLASMIFRKEPFFHGH--DNYDQLVRIAKV-LGTEDLYDYID 257

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 112/238 (47%), Gaps = 44/238 (18%)
Query: 399 CFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT----N 453
            F     +DA  +L +K+G G F  V+  K + +   +A+K++     +G + +T    +
Sbjct: 10  AFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-----RGDKVYTEAAED 64
Query: 454 EVTLLSRIHH-----------RNLVQFLGYCQEEG----RSVLVYEFMHNGTLKEHLYGT 498
           E+ LL R++             ++++ L +   +G      V+V+E      L E+L   
Sbjct: 65  EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLAL 119
Query: 499 LT-HEQR-INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL------DKHMRA 550
           +  +E R I  I   +I++    G++Y+H  C   IIH D+K  N+L+      +  ++ 
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQI 177
Query: 551 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
           K++D G + +      H ++ ++ T  Y  PE  +       +D++S   ++ ELI+G
Sbjct: 178 KIADLGNACWY---DEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 112/238 (47%), Gaps = 44/238 (18%)
Query: 399 CFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFT----N 453
            F     +DA  +L +K+G G F  V+  K + +   +A+K++     +G + +T    +
Sbjct: 10  AFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-----RGDKVYTEAAED 64
Query: 454 EVTLLSRIHH-----------RNLVQFLGYCQEEG----RSVLVYEFMHNGTLKEHLYGT 498
           E+ LL R++             ++++ L +   +G      V+V+E      L E+L   
Sbjct: 65  EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLAL 119
Query: 499 LT-HEQR-INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL------DKHMRA 550
           +  +E R I  I   +I++    G++Y+H  C   IIH D+K  N+L+      +  ++ 
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQI 177
Query: 551 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
           K++D G + +      H ++ ++ T  Y  PE  +       +D++S   ++ ELI+G
Sbjct: 178 KIADLGNACWY---DEHYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 20/203 (9%)
Query: 412 LEKKIGSGGFGVVYYG-KLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           L +KIGSG FG +Y G  +  G+E+A+K+    +   +     E      +     +  +
Sbjct: 13  LGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHI--ESKFYKMMQGGVGIPSI 70
Query: 471 GYCQEEG-RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            +C  EG  +V+V E +  G   E L+   + +  +  +  L +A+     IEY+H+   
Sbjct: 71  KWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHS--- 123
Query: 530 PAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVR------GTVGYLD 580
              IHRD+K  N L+    K     + DFGL+K   D  +H     R      GT  Y  
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 581 PEYYISQQLTDKSDVYSFGVILL 603
              ++  + + + D+ S G +L+
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLM 206

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           L +KIGSG FG +Y G  +  G+E+A+K+    +   +    +++  +  +     +  +
Sbjct: 13  LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKM--MQGGVGIPTI 70
Query: 471 GYCQEEG-RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            +C  EG  +V+V E +  G   E L+   + +  +  +  L +A+     IEY+H+   
Sbjct: 71  RWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHS--- 123
Query: 530 PAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVR------GTVGYLD 580
              IHRD+K  N L+    K     + DFGL+K   D  +H     R      GT  Y  
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 581 PEYYISQQLTDKSDVYSFGVILL 603
              ++  + + + D+ S G +L+
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLM 206

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           L +KIGSG FG +Y G  +  G+E+A+K+    +   +    +++  +  +     +  +
Sbjct: 11  LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKM--MQGGVGIPTI 68
Query: 471 GYCQEEG-RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            +C  EG  +V+V E +  G   E L+   + +  +  +  L +A+     IEY+H+   
Sbjct: 69  RWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHS--- 121
Query: 530 PAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVR------GTVGYLD 580
              IHRD+K  N L+    K     + DFGL+K   D  +H     R      GT  Y  
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181
Query: 581 PEYYISQQLTDKSDVYSFGVILL 603
              ++  + + + D+ S G +L+
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLM 204
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	736
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-153
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-125
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-118
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-76
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-71
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-63
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-63
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-63
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-63
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-62
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-61
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-60
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-60
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-60
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-56
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-55
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	9e-53
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-42
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-38
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-38
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-36
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-36
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-36
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	7e-36
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-35
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-35
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-35
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-34
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-33
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-33
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-32
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-32
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-32
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-31
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-31
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-31
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-31
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-31
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-30
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-30
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-30
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-29
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-29
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-29
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-29
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-29
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-29
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-29
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-29
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-28
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-27
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-27
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-27
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-26
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-25
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-25
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-22
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-09
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-27
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-25
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-25
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-24
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-23
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-23
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-23
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-20
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-20
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-19
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-19
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-17
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-04
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-27
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-26
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-26
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-25
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-25
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-25
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	7e-25
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-25
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-25
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-24
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-24
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-24
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-24
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-22
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-22
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-21
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-21
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-21
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-21
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-20
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-20
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-19
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-16
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-14
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-05
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-19
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	7e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-18
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	4e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-14
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-08
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-18
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-18
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-18
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-18
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-17
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-17
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-17
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-15
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-14
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-07
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-16
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-16
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	9e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-13
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-12
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-12
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-06
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-14
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-12
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-07
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-06
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-15
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-15
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	6e-11
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-09
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-15
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-15
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-04
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-15
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-13
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-11
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	9e-15
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-13
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-12
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-11
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-10
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-09
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-14
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-12
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-12
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-12
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-12
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-08
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-14
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-14
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-10
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-13
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-11
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	8e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-10
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-09
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-06
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-13
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-11
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-09
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-13
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-13
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-12
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-09
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-10
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-11
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-11
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-10
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-10
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-10
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-09
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-12
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-11
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-11
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-08
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-08
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-04
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-06
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-05
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-10
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-11
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-10
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-09
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-11
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-10
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	8e-09
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	9e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-08
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-09
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-08
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-11
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-11
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-10
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-06
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-11
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-08
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-11
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	6e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-06
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-10
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-07
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-06
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-10
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-10
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-08
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-10
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-10
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-04
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-10
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-09
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-07
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-07
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-10
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-08
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-05
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-09
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	9e-09
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	8e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-09
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-05
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	9e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-06
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-08
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-07
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-07
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-06
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-07
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-06
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-07
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-07
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-07
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-04
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-05
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	7e-05
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	7e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  447 bits (1152), Expect = e-153
 Identities = 122/312 (39%), Positives = 187/312 (59%), Gaps = 7/312 (2%)

Query: 384 RPVSSLNDAPAEAAHCFTLSDIEDATKMLEKK--IGSGGFGVVYYGKLKDGKEIAVKVLT 441
               S +      ++   L D+E+AT   + K  IG G FG VY G L+DG ++A+K  T
Sbjct: 13  NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT 72

Query: 442 SNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH 501
             S QG  EF  E+  LS   H +LV  +G+C E    +L+Y++M NG LK HLYG+   
Sbjct: 73  PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132

Query: 502 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-F 560
              ++W +RLEI   AA+G+ YLHT     IIHRD+KS NILLD++   K++DFG+SK  
Sbjct: 133 TMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189

Query: 561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 620
                +H+S++V+GT+GY+DPEY+I  +LT+KSDVYSFGV+L E++  + AI  +     
Sbjct: 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPRE 248

Query: 621 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 680
             N+ +WA     +G ++ I+DP+L D+   +S+ K  + A+ C+      RPS+ +VL 
Sbjct: 249 MVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLW 308

Query: 681 DIQDAIVIEREA 692
            ++ A+ ++   
Sbjct: 309 KLEYALRLQESV 320

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  376 bits (968), Expect = e-125
 Identities = 103/288 (35%), Positives = 168/288 (58%), Gaps = 4/288 (1%)

Query: 397 AHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-KREFTN 453
              F+L +++ A+     +  +G GGFG VY G+L DG  +AVK L     QG + +F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 454 EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 513
           EV ++S   HRNL++  G+C      +LVY +M NG++   L      +  ++W KR  I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 573
           A  +A+G+ YLH  C P IIHRD+K++NILLD+   A V DFGL+K      +HV++ VR
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196

Query: 574 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-GANCRNIVQWAKLHI 632
           GT+G++ PEY  + + ++K+DV+ +GV+LLELI+GQ A    +    +   ++ W K  +
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256

Query: 633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 680
           +   ++ ++D  L   Y  + + ++ + AL+C       RP +SEV++
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVR 304

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  356 bits (916), Expect = e-118
 Identities = 97/305 (31%), Positives = 166/305 (54%), Gaps = 27/305 (8%)

Query: 398 HCFTLSDIEDATK--------MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTS----NSY 445
           H F+  ++++ T         +   K+G GGFGVVY G + +   +AVK L +     + 
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 446 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI 505
           + K++F  E+ ++++  H NLV+ LG+  +     LVY +M NG+L + L   L     +
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPL 130

Query: 506 NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDG 564
           +W  R +IA+ AA GI +LH       IHRD+KS+NILLD+   AK+SDFGL++      
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
            + ++S + GT  Y+ PE  +  ++T KSD+YSFGV+LLE+I+G  A+   +     + +
Sbjct: 188 QTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR---EPQLL 243

Query: 625 VQWAK-LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV---LK 680
           +   + +  E   I+  ID   +++ D  S+  +   A  C+    + RP I +V   L+
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

Query: 681 DIQDA 685
           ++  +
Sbjct: 303 EMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  248 bits (635), Expect = 2e-76
 Identities = 77/310 (24%), Positives = 124/310 (40%), Gaps = 33/310 (10%)

Query: 400 FTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTL 457
               ++   +  L+  +    G FG V+  +L   + +AVK+      Q   +   EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVYS 71

Query: 458 LSRIHHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEI 513
           L  + H N++QF+G  +          L+  F   G+L + L         ++W +   I
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHI 126

Query: 514 AEDAAKGIEYLHT-------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
           AE  A+G+ YLH        G  PAI HRD+KS N+LL  ++ A ++DFGL+     G S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 567 HVSSIVR-GTVGYLDPEY-----YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN 620
              +  + GT  Y+ PE         +    + D+Y+ G++L EL S   A         
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP-VDEY 245

Query: 621 CRNIVQWAKLHIESGDIQGII-----DPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPS 674
                +    H    D+Q ++      P L D +     M  + E    C       R S
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 675 ISEVLKDIQD 684
              V + I  
Sbjct: 306 AGCVGERITQ 315

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  233 bits (597), Expect = 4e-71
 Identities = 82/240 (34%), Positives = 125/240 (52%), Gaps = 6/240 (2%)

Query: 373 KEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDG 432
           K  H H       + +  +   + A      DI      +++KIG+G FG V+  +   G
Sbjct: 2   KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-G 60

Query: 433 KEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT 490
            ++AVK+L    +  +   EF  EV ++ R+ H N+V F+G   +     +V E++  G+
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120

Query: 491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA 550
           L   L+ +   EQ ++  +RL +A D AKG+ YLH    P I+HR+LKS N+L+DK    
Sbjct: 121 LYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTV 178

Query: 551 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE 610
           KV DFGLS+          S   GT  ++ PE    +   +KSDVYSFGVIL EL + Q+
Sbjct: 179 KVCDFGLSRLKASTFLSSKS-AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  212 bits (541), Expect = 2e-63
 Identities = 68/211 (32%), Positives = 100/211 (47%), Gaps = 21/211 (9%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLV 467
           LE+ IG GGFG VY      G E+AVK    +  +           E  L + + H N++
Sbjct: 11  LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
              G C +E    LV EF   G L   L       +RI     +  A   A+G+ YLH  
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDE 124

Query: 528 CVPAIIHRDLKSSNILLDK--------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 579
            +  IIHRDLKSSNIL+ +        +   K++DFGL++      +   S   G   ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAA-GAYAWM 181

Query: 580 DPEYYISQQLTDKSDVYSFGVILLELISGQE 610
            PE   +   +  SDV+S+GV+L EL++G+ 
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEV 212

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  212 bits (542), Expect = 3e-63
 Identities = 80/338 (23%), Positives = 141/338 (41%), Gaps = 59/338 (17%)

Query: 402 LSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI 461
             +IE     +E+ +G G FGVV   K +  K++A+K + S S   ++ F  E+  LSR+
Sbjct: 7   YKEIE-----VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQLSRV 58

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
           +H N+V+  G C       LV E+   G+L   L+G             +      ++G+
Sbjct: 59  NHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGV 115

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMR-AKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
            YLH+    A+IHRDLK  N+LL       K+ DFG +           +  +G+  ++ 
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMA 171

Query: 581 PEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 640
           PE +     ++K DV+S+G+IL E+I+ ++                + ++   +  I   
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKP---------------FDEIGGPAFRIMWA 216

Query: 641 ID----PSLLDEYD------IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 690
           +     P L+          +   W  +        P    RPS+ E++K +     + R
Sbjct: 217 VHNGTRPPLIKNLPKPIESLMTRCWSKD--------P--SQRPSMEEIVKIMTH---LMR 263

Query: 691 EAAAARDGNSDDMSRNSLHSSLNVGSFGGTENFLSLDE 728
                    +D+  +     SL  G  G  E ++   E
Sbjct: 264 YFP-----GADEPLQYPCQHSLPPGEDGRVEPYVDFAE 296

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  211 bits (539), Expect = 4e-63
 Identities = 85/291 (29%), Positives = 137/291 (47%), Gaps = 45/291 (15%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK-------REFTNEVTLLSRIHH 463
            EK+IG GGFG+V+ G+L  D   +A+K L     +G+       +EF  EV ++S ++H
Sbjct: 23  YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH 82

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
            N+V+  G         +V EF+  G L   L         I W  +L +  D A GIEY
Sbjct: 83  PNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEY 137

Query: 524 LHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           +     P I+HRDL+S NI L        + AKV+DFGLS+     + H  S + G   +
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQW 192

Query: 579 LDPEYYISQQL--TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG- 635
           + PE   +++   T+K+D YSF +IL  +++G+       +G      +++  +  E G 
Sbjct: 193 MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGL 247

Query: 636 --DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 684
              I     P L +   I+  W  +        P    RP  S ++K++ +
Sbjct: 248 RPTIPEDCPPRLRNV--IELCWSGD--------P--KKRPHFSYIVKELSE 286

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  210 bits (536), Expect = 7e-63
 Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 23/209 (11%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 469
              K+     G ++ G+ + G +I VKVL    +  +  R+F  E   L    H N++  
Sbjct: 14  FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 470 LGYCQE--EGRSVLVYEFMHNGTLKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYL 524
           LG CQ        L+  +M  G+L   L     HE     ++  + ++ A D A+G+ +L
Sbjct: 73  LGACQSPPAPHPTLITHWMPYGSLYNVL-----HEGTNFVVDQSQAVKFALDMARGMAFL 127

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 584
           HT   P I    L S ++++D+ M A++S   +                    ++ PE  
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPG------RMYAPAWVAPEAL 180

Query: 585 ISQQL---TDKSDVYSFGVILLELISGQE 610
             +        +D++SF V+L EL++ + 
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREV 209

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  210 bits (536), Expect = 5e-62
 Identities = 71/322 (22%), Positives = 122/322 (37%), Gaps = 46/322 (14%)

Query: 400 FTLSDIEDATKMLE--KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--V 455
              S+       L+  + IG G +G VY G L D + +AVKV +  + Q    F NE  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRINWIKR 510
             +  + H N+ +F+   +           LV E+  NG+L ++L          +W+  
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSS 113

Query: 511 LEIAEDAAKGIEYLHT------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---- 560
             +A    +G+ YLHT         PAI HRDL S N+L+       +SDFGLS      
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 561 ---AVDGASHVSSIVRGTVGYLDPEY-------YISQQLTDKSDVYSFGVILLELISGQE 610
                    + +    GT+ Y+ PE           +    + D+Y+ G+I  E+     
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 611 AISNEKFGANCRNIVQW-AKLHIESGDIQGIID-----PSLLDEYDIQSMWKIEEKALM- 663
            +   +     +   Q     H    D+Q ++      P   + +   S+     K  + 
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 664 -CVLPHGHMRPSISEVLKDIQD 684
            C       R +     + + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAE 315

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  205 bits (524), Expect = 8e-61
 Identities = 70/205 (34%), Positives = 114/205 (55%), Gaps = 15/205 (7%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 469
           + ++IGSG FG VY GK     ++AVK+L   +   +  + F NEV +L +  H N++ F
Sbjct: 28  VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           +GY      ++ V ++    +L  HL+     E +    K ++IA   A+G++YLH    
Sbjct: 86  MGYSTAPQLAI-VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA--- 138

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPE---YYI 585
            +IIHRDLKS+NI L +    K+ DFGL+   +    SH    + G++ ++ PE      
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 586 SQQLTDKSDVYSFGVILLELISGQE 610
           S   + +SDVY+FG++L EL++GQ 
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQL 223

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  205 bits (524), Expect = 2e-60
 Identities = 61/290 (21%), Positives = 111/290 (38%), Gaps = 44/290 (15%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQF 469
           + + IG G FG VY+G+     E+A++++          + F  EV    +  H N+V F
Sbjct: 37  IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           +G C       ++       TL   +      +  ++  K  +IA++  KG+ YLH    
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHA--- 148

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF----AVDGASHVSSIVRGTVGYLDPEYYI 585
             I+H+DLKS N+  D   +  ++DFGL                 I  G + +L PE   
Sbjct: 149 KGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207

Query: 586 SQQL---------TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 636
                        +  SDV++ G I  EL + +     +   A     + W    + +G 
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-----IIWQ---MGTGM 259

Query: 637 IQGIIDPSLLDEYD--IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 684
              +    +  E    +   W  E             RP+ ++++  ++ 
Sbjct: 260 KPNLSQIGMGKEISDILLFCWAFE--------Q--EERPTFTKLMDMLEK 299

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  204 bits (520), Expect = 4e-60
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 20/214 (9%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
             + +G G FG       ++ G+ + +K L     + +R F  EV ++  + H N+++F+
Sbjct: 14  HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
           G   ++ R   + E++  GTL+  +    + + +  W +R+  A+D A G+ YLH+    
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHS---M 127

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-------------VRGTVG 577
            IIHRDL S N L+ ++    V+DFGL++  VD  +    +             V G   
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187

Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEA 611
           ++ PE    +   +K DV+SFG++L E+I    A
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  193 bits (492), Expect = 7e-56
 Identities = 69/303 (22%), Positives = 126/303 (41%), Gaps = 45/303 (14%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 469
           + K+IG G +G V+ GK + G+++AVKV  +     +  +  E  +     + H N++ F
Sbjct: 41  MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGF 96

Query: 470 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +    +   S     L+ ++  NG+L ++L         ++    L++A  +  G+ +LH
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLH 151

Query: 526 T-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVG 577
           T        PAI HRDLKS NIL+ K+    ++D GL+   +   + V    +   GT  
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211

Query: 578 YLDPE------YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 631
           Y+ PE           Q    +D+YSFG+IL E+     +    +      + +  +   
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271

Query: 632 IESGDIQGIID--------PSLLDEYDIQSMWK--IEEKALMCVLPHGHMRPSISEVLKD 681
            E  D++ I+         P+     +        + E    C   +   R +   V K 
Sbjct: 272 YE--DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE----CWAHNPASRLTALRVKKT 325

Query: 682 IQD 684
           +  
Sbjct: 326 LAK 328

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  190 bits (484), Expect = 5e-55
 Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 29/217 (13%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 469
           L + +G G +G V+ G  + G+ +AVK+ +S   + ++ +  E  +     + H N++ F
Sbjct: 12  LLECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGF 67

Query: 470 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +        S     L+  +   G+L ++L         ++ +  L I    A G+ +LH
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLH 122

Query: 526 T-----GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG--- 577
                    PAI HRDLKS NIL+ K+ +  ++D GL+       + +       VG   
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 578 YLDPE------YYISQQLTDKSDVYSFGVILLELISG 608
           Y+ PE               + D+++FG++L E+   
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  185 bits (471), Expect = 9e-53
 Identities = 65/303 (21%), Positives = 128/303 (42%), Gaps = 45/303 (14%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNE--VTLLSRIHHRNLVQF 469
           L++ IG G FG V+ GK + G+E+AVK+ +S   + +R +  E  +     + H N++ F
Sbjct: 46  LQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGF 101

Query: 470 LGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +    ++  +     LV ++  +G+L ++L     +   +     +++A   A G+ +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 156

Query: 526 -----TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV---SSIVRGTVG 577
                T   PAI HRDLKS NIL+ K+    ++D GL+         +    +   GT  
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 578 YLDPE------YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH 631
           Y+ PE           +   ++D+Y+ G++  E+          +        +  +   
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276

Query: 632 IESGDIQGI---------IDPSLLDEYDIQSMWK-IEEKALMCVLPHGHMRPSISEVLKD 681
           +E  +++ +         I         ++ M K + E    C   +G  R +   + K 
Sbjct: 277 VE--EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE----CWYANGAARLTALRIKKT 330

Query: 682 IQD 684
           +  
Sbjct: 331 LSQ 333

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  153 bits (389), Expect = 5e-42
 Identities = 73/282 (25%), Positives = 124/282 (43%), Gaps = 40/282 (14%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
            + +IG G F  VY G   +   E+A         +   ++ F  E  +L  + H N+V+
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 469 FLGY----CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 522
           F        + +   VLV E M +GTLK +L  +  +  +   +W +  +I +    G++
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR--QILK----GLQ 143

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           +LHT   P IIHRDLK  NI +       K+ D GL+   +  AS   +++ GT  ++ P
Sbjct: 144 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT--LKRASFAKAVI-GTPEFMAP 199

Query: 582 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 641
           E Y  ++  +  DVY+FG+ +LE+ +       E   + C+N  Q  +  + SG      
Sbjct: 200 EMY-EEKYDESVDVYAFGMCMLEMATS------EYPYSECQNAAQIYRR-VTSGVKPASF 251

Query: 642 DPSLLDEYDIQSMWKIEEKA--LMCVLPHGHMRPSISEVLKD 681
              +            E K     C+  +   R SI ++L  
Sbjct: 252 -DKVAIP---------EVKEIIEGCIRQNKDERYSIKDLLNH 283

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  151 bits (383), Expect = 3e-40
 Identities = 65/203 (32%), Positives = 100/203 (49%), Gaps = 17/203 (8%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGK-EIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L ++IG G FG V+ G+L+     +AVK    +     K +F  E  +L +  H N+V+ 
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           +G C ++    +V E +  G     L    T   R+     L++  DAA G+EYL + C 
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-----VRGTVGYLDPEYY 584
              IHRDL + N L+ +    K+SDFG+S+   DG    S       V+ T     PE  
Sbjct: 235 ---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA----PEAL 287

Query: 585 ISQQLTDKSDVYSFGVILLELIS 607
              + + +SDV+SFG++L E  S
Sbjct: 288 NYGRYSSESDVWSFGILLWETFS 310

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  144 bits (364), Expect = 6e-38
 Identities = 66/280 (23%), Positives = 121/280 (43%), Gaps = 46/280 (16%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           +KIG G FG     K  +DG++  +K   ++  S + + E   EV +L+ + H N+VQ+ 
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 526
              +E G   +V ++   G L + +    G L  E +I +W  ++         ++++H 
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------CLALKHVHD 143

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                I+HRD+KS NI L K    ++ DFG+++          + + GT  YL PE   +
Sbjct: 144 ---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICEN 199

Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           +   +KSD+++ G +L EL + + A            I+         G       P + 
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--------GSF-----PPVS 246

Query: 647 DEYD------IQSMWKIEEKALMCVLPHGHMRPSISEVLK 680
             Y       +  ++K               RPS++ +L+
Sbjct: 247 LHYSYDLRSLVSQLFKRNP----------RDRPSVNSILE 276

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  143 bits (362), Expect = 6e-38
 Identities = 73/262 (27%), Positives = 114/262 (43%), Gaps = 52/262 (19%)

Query: 375 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSD---IEDATKMLEKKIGSGGFGVVYYGKL-- 429
            H H      P +            F   D    E+      +++G G FG V   +   
Sbjct: 5   HHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDP 64

Query: 430 ---KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV--LVYE 484
                G+ +AVK L  ++ +  R+F  E+ +L  + H N+V++ G C   GR    L+ E
Sbjct: 65  LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124

Query: 485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNIL 543
           ++  G+L+++L     H++RI+ IK L+      KG+EYL T       IHRDL + NIL
Sbjct: 125 YLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGTKRY----IHRDLATRNIL 177

Query: 544 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-------------- 589
           ++   R K+ DFGL+K                    D EYY  ++               
Sbjct: 178 VENENRVKIGDFGLTKVLPQ----------------DKEYYKVKEPGESPIFWYAPESLT 221

Query: 590 ----TDKSDVYSFGVILLELIS 607
               +  SDV+SFGV+L EL +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  142 bits (360), Expect = 9e-38
 Identities = 65/315 (20%), Positives = 118/315 (37%), Gaps = 40/315 (12%)

Query: 378 HSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIA 436
            S  +Q P                 + + +      KKIG G F  VY    L DG  +A
Sbjct: 4   QSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIE--KKIGRGQFSEVYRAACLLDGVPVA 61

Query: 437 VK---VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKE 493
           +K   +      + + +   E+ LL +++H N++++     E+    +V E    G L  
Sbjct: 62  LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSR 121

Query: 494 HL-----YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 547
            +        L  E+ +  +  +L         +E++H+     ++HRD+K +N+ +   
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQL------CSALEHMHS---RRVMHRDIKPANVFITAT 172

Query: 548 MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
              K+ D GL +F     +   S+V GT  Y+ PE         KSD++S G +L E+ +
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231

Query: 608 GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD--IQSMWKIEEKALMCV 665
            Q       F  +  N+       IE  D   +      +E    +      +       
Sbjct: 232 LQSP-----FYGDKMNLYS-LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDP------ 279

Query: 666 LPHGHMRPSISEVLK 680
                 RP ++ V  
Sbjct: 280 ----EKRPDVTYVYD 290

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  140 bits (355), Expect = 2e-37
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 49/222 (22%)

Query: 412 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 466
             +++G G FG V   +        G+ +AVK L  ++ +  R+F  E+ +L  + H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 467 VQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
           V++ G C   GR    L+ E++  G+L+++L     H++RI+ IK L+      KG+EYL
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL 130

Query: 525 HT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
            T       IHRDL + NIL++   R K+ DFGL+K                    D E+
Sbjct: 131 GTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQ----------------DKEF 170

Query: 584 YISQQ------------------LTDKSDVYSFGVILLELIS 607
           +  ++                   +  SDV+SFGV+L EL +
Sbjct: 171 FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  140 bits (354), Expect = 3e-37
 Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 47/286 (16%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
             IG+G +G     +   DGK +  K     S +   K+   +EV LL  + H N+V++ 
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 471 GYCQEEGRSVL--VYEFMHNGTLKEHL-----YGTLTHEQRINWIKRLEIAEDAAKGIEY 523
               +   + L  V E+   G L   +           E+ +     L +       ++ 
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-----LRVMTQLTLALKE 126

Query: 524 LHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
            H        ++HRDLK +N+ LD     K+ DFGL++      S   + V GT  Y+ P
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSP 185

Query: 582 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII 641
           E        +KSD++S G +L EL +         F A   +  + A   I  G      
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPP-----FTAF--SQKELAGK-IREGKF---- 233

Query: 642 DPSLLDEYD------IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
              +   Y       I  M  +++          + RPS+ E+L++
Sbjct: 234 -RRIPYRYSDELNEIITRMLNLKD----------YHRPSVEEILEN 268

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  144 bits (365), Expect = 3e-37
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H  LVQ   
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 246

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCVP 530
              EE    +V E+M  G+L + L        + +   + +++A   A G+ Y+      
Sbjct: 247 VVSEEPI-YIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVERMN-- 300

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
             +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T
Sbjct: 301 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359

Query: 591 DKSDVYSFGVILLELIS 607
            KSDV+SFG++L EL +
Sbjct: 360 IKSDVWSFGILLTELTT 376

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  139 bits (352), Expect = 3e-37
 Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 15/200 (7%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
             ++IGSG FG+V+ G   +  ++A+K +   +   + +F  E  ++ ++ H  LVQ  G
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
            C E+    LV EFM +G L ++L    T          L +  D  +G+ YL   CV  
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEEACV-- 125

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 587
            IHRDL + N L+ ++   KVSDFG+++F +D    +S  +   V+       PE +   
Sbjct: 126 -IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS----PEVFSFS 180

Query: 588 QLTDKSDVYSFGVILLELIS 607
           + + KSDV+SFGV++ E+ S
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  140 bits (355), Expect = 5e-37
 Identities = 60/293 (20%), Positives = 108/293 (36%), Gaps = 44/293 (15%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
             +K+G GGF  V   + L DG   A+K +  +  Q + E   E  +    +H N+++ +
Sbjct: 33  FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92

Query: 471 GYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
            YC  E  +     L+  F   GTL   +         +   + L +     +G+E +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR--------GTVGY 578
                  HRDLK +NILL    +  + D G    A          +          T+ Y
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 579 LDPE---YYISQQLTDKSDVYSFGVILLELISGQ-----EAISNEKFGANCRNIVQWAKL 630
             PE         + +++DV+S G +L  ++ G+          +      +N +   + 
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQS 269

Query: 631 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
              S  +  ++                   ++M V P  H RP I  +L  ++
Sbjct: 270 PRHSSALWQLL------------------NSMMTVDP--HQRPHIPLLLSQLE 302

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  138 bits (351), Expect = 7e-37
 Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 15/200 (7%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
             K++G+G FGVV YGK +   ++A+K++   S   + EF  E  ++  + H  LVQ  G
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
            C ++    ++ E+M NG L  +L        R    + LE+ +D  + +EYL +     
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESKQF-- 141

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 587
            +HRDL + N L++     KVSDFGLS++ +D    +S  S   VR +     PE  +  
Sbjct: 142 -LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP----PEVLMYS 196

Query: 588 QLTDKSDVYSFGVILLELIS 607
           + + KSD+++FGV++ E+ S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  139 bits (351), Expect = 1e-36
 Identities = 65/298 (21%), Positives = 106/298 (35%), Gaps = 58/298 (19%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           + +G GGFGVV+  K K D    A+K +   N    + +   EV  L+++ H  +V++  
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 472 YCQEEG---------RSVLVY---EFMHNGTLKEHL----YGTLTHEQRINWIKRLEIAE 515
              E+            V +Y   +      LK+ +                   L I  
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC-----LHIFL 125

Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-----------FAVDG 564
             A+ +E+LH+     ++HRDLK SNI        KV DFGL                  
Sbjct: 126 QIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
           A    +   GT  Y+ PE       + K D++S G+IL EL+          F      +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--------PFSTQMERV 234

Query: 625 VQWAKLHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
                  + +     +       EY  +Q M        +   P    RP    ++++
Sbjct: 235 RTLTD--VRNLKFPPLFTQKYPCEYVMVQDM--------LSPSP--MERPEAINIIEN 280

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  144 bits (364), Expect = 1e-36
 Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L   +      F  E  ++ ++ H  LVQ   
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYA 329

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCVP 530
              EE    +V E+M  G+L + L        + +   + +++A   A G+ Y+      
Sbjct: 330 VVSEEPI-YIVTEYMSKGSLLDFLK---GETGKYLRLPQLVDMAAQIASGMAYVERMN-- 383

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
             +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T
Sbjct: 384 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442

Query: 591 DKSDVYSFGVILLELIS 607
            KSDV+SFG++L EL +
Sbjct: 443 IKSDVWSFGILLTELTT 459

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  137 bits (348), Expect = 1e-36
 Identities = 65/200 (32%), Positives = 112/200 (56%), Gaps = 15/200 (7%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L K++GSG FGVV  GK K   ++AVK++   S   + EF  E   + ++ H  LV+F G
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
            C +E    +V E++ NG L  +L    +H + +   + LE+  D  +G+ +L +     
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQF-- 125

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 587
            IHRDL + N L+D+ +  KVSDFG++++ +D    +S  +   V+ +     PE +   
Sbjct: 126 -IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSA----PEVFHYF 180

Query: 588 QLTDKSDVYSFGVILLELIS 607
           + + KSDV++FG+++ E+ S
Sbjct: 181 KYSSKSDVWAFGILMWEVFS 200

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  139 bits (352), Expect = 1e-36
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 22/226 (9%)

Query: 391 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNS 444
           +AP +A        +++      K +GSG FG VY G      E     +A+K L  + S
Sbjct: 2   EAPNQALLRI----LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57

Query: 445 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 504
            +  +E  +E  +++ + + ++ + LG C       L+ + M  G L +++     H+  
Sbjct: 58  PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV---REHKDN 113

Query: 505 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 564
           I     L      AKG+ YL       ++HRDL + N+L+      K++DFGL+K     
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

Query: 565 ASHVSSIVRGT---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
                +   G    + ++  E  + +  T +SDV+S+GV + EL++
Sbjct: 171 EKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  138 bits (349), Expect = 2e-36
 Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 50/223 (22%)

Query: 412 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRN 465
             + +G G FG V   +        G+++AVK L   +      +   E+ +L  ++H N
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 466 LVQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           +V++ G C E+G +   L+ EF+ +G+LKE+L     ++ +IN  ++L+ A    KG++Y
Sbjct: 85  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDY 141

Query: 524 LHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           L +       +HRDL + N+L++   + K+ DFGL+K                    D E
Sbjct: 142 LGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAI----------------ETDKE 181

Query: 583 YYISQQL------------------TDKSDVYSFGVILLELIS 607
           YY  +                       SDV+SFGV L EL++
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  137 bits (348), Expect = 2e-36
 Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 13/208 (6%)

Query: 406 EDATKMLEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRI 461
            D   + + ++G G FG V  G  +  K+   +A+KVL          E   E  ++ ++
Sbjct: 8   RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 67

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            +  +V+ +G CQ E   +LV E    G L + L   +   + I      E+    + G+
Sbjct: 68  DNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGM 123

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYL 579
           +YL        +HRDL + N+LL     AK+SDFGLSK      S+ ++   G   + + 
Sbjct: 124 KYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180

Query: 580 DPEYYISQQLTDKSDVYSFGVILLELIS 607
            PE    ++ + +SDV+S+GV + E +S
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALS 208

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  142 bits (359), Expect = 3e-36
 Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 9/198 (4%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           ++ K+G G +G VY G  K     +AVK L  ++ +   EF  E  ++  I H NLVQ L
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 282

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE-QRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G C  E    ++ EFM  G L ++L        Q ++ +  L +A   +  +EYL     
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKN- 338

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
              IHR+L + N L+ ++   KV+DFGLS+          +  +  + +  PE     + 
Sbjct: 339 --FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396

Query: 590 TDKSDVYSFGVILLELIS 607
           + KSDV++FGV+L E+ +
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  138 bits (349), Expect = 3e-36
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 49/222 (22%)

Query: 412 LEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL 466
              ++G G FG V   +        G  +AVK L  +    +R+F  E+ +L  +H   +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 467 VQFLGYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
           V++ G     GR    LV E++ +G L++ L     H  R++  + L  +    KG+EYL
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYL 143

Query: 525 HT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
            +  C    +HRDL + NIL++     K++DFGL+K                    D +Y
Sbjct: 144 GSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPL----------------DKDY 183

Query: 584 YISQQL------------------TDKSDVYSFGVILLELIS 607
           Y+ ++                   + +SDV+SFGV+L EL +
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  143 bits (362), Expect = 4e-36
 Identities = 72/341 (21%), Positives = 126/341 (36%), Gaps = 24/341 (7%)

Query: 273 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG 332
            I   +  +   P  +    L  L    V+   L        L +    + A N +    
Sbjct: 212 LISQDKAGKYCIPEGTKFDTLWQL----VEYLKLKADGLIYCLKEACPNSSASNASGAAA 267

Query: 333 GRGAKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDA 392
                H + +         L                           +P+   V     +
Sbjct: 268 PTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSP-------DKPRPMPMDTSVFESPFS 320

Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGK 448
             E      L    D   + + ++G G FG V  G  +  K+   +A+KVL         
Sbjct: 321 DPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT 380

Query: 449 REFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWI 508
            E   E  ++ ++ +  +V+ +G CQ E   +LV E    G L + L   +   + I   
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFL---VGKREEIPVS 436

Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
              E+    + G++YL        +HR+L + N+LL     AK+SDFGLSK      S+ 
Sbjct: 437 NVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493

Query: 569 SSIVRGT--VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           ++   G   + +  PE    ++ + +SDV+S+GV + E +S
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  140 bits (354), Expect = 7e-36
 Identities = 63/199 (31%), Positives = 105/199 (52%), Gaps = 15/199 (7%)

Query: 411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
            L + IG G FG V  G  + G ++AVK + +++    + F  E ++++++ H NLVQ L
Sbjct: 196 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLL 252

Query: 471 GYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
           G   +E+G   +V E+M  G+L ++L         +     L+ + D  + +EYL     
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN- 309

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQ 588
              +HRDL + N+L+ +   AKVSDFGL+K           + V+ T     PE    ++
Sbjct: 310 --FVHRDLAARNVLVSEDNVAKVSDFGLTKE-ASSTQDTGKLPVKWTA----PEALREKK 362

Query: 589 LTDKSDVYSFGVILLELIS 607
            + KSDV+SFG++L E+ S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  136 bits (344), Expect = 1e-35
 Identities = 63/261 (24%), Positives = 101/261 (38%), Gaps = 58/261 (22%)

Query: 374 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK--- 430
             H H       +  L   P +       +          + +G G FG V         
Sbjct: 3   HHHHHHHHHHGALEVLFQGPGDP------TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTN 56

Query: 431 DGKEI--AVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV--LVYEF 485
           DG     AVK L      Q +  +  E+ +L  ++H +++++ G C++ G +   LV E+
Sbjct: 57  DGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116

Query: 486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILL 544
           +  G+L+++L         I   + L  A+   +G+ YLH        IHRDL + N+LL
Sbjct: 117 VPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQHY----IHRDLAARNVLL 167

Query: 545 DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL--------------- 589
           D     K+ DFGL+K                      EYY  ++                
Sbjct: 168 DNDRLVKIGDFGLAKAV----------------PEGHEYYRVREDGDSPVFWYAPECLKE 211

Query: 590 ---TDKSDVYSFGVILLELIS 607
                 SDV+SFGV L EL++
Sbjct: 212 YKFYYASDVWSFGVTLYELLT 232

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  136 bits (345), Expect = 2e-35
 Identities = 66/254 (25%), Positives = 120/254 (47%), Gaps = 29/254 (11%)

Query: 371 YDKEQHRHS-LPVQR---PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 426
           Y    H    +P         ++   P +A   FT ++I  +    +K IG+G FG VY 
Sbjct: 4   YHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFT-TEIHPSCVTRQKVIGAGEFGEVYK 62

Query: 427 GKLKDGKE-----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 480
           G LK         +A+K L +  + + + +F  E  ++ +  H N+++  G   +    +
Sbjct: 63  GMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122

Query: 481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 539
           ++ E+M NG L + L      +   + ++ + +    A G++YL         +HRDL +
Sbjct: 123 IITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANMNY----VHRDLAA 175

Query: 540 SNILLDKHMRAKVSDFGLSKFAVDG-----ASHVSSI-VRGTVGYLDPEYYISQQLTDKS 593
            NIL++ ++  KVSDFGLS+   D       +    I +R T     PE    ++ T  S
Sbjct: 176 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PEAISYRKFTSAS 231

Query: 594 DVYSFGVILLELIS 607
           DV+SFG+++ E+++
Sbjct: 232 DVWSFGIVMWEVMT 245

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  135 bits (341), Expect = 2e-35
 Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 46/221 (20%)

Query: 411 MLEKKIGSGGFGVVYYGKLK--DGKEI--AVKVL---TSNSYQGKREFTNEVTLLSRIHH 463
            L +K+G G FGVV  G+     GK +  AVK L     +  +   +F  EV  +  + H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           RNL++  G         +V E    G+L + L     H+           A   A+G+ Y
Sbjct: 81  RNLIRLYGVVLTP-PMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGY 136

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           L +      IHRDL + N+LL      K+ DFGL +                +   D  Y
Sbjct: 137 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA---------------LPQNDDHY 178

Query: 584 YISQ-----------------QLTDKSDVYSFGVILLELIS 607
            + +                   +  SD + FGV L E+ +
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  135 bits (341), Expect = 2e-35
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 15/205 (7%)

Query: 410 KMLEKKIGSGGFGVVYYGKLKDGK---EIAVKVL--TSNSYQGKREFTNEVTLLSRIHHR 464
            + +K++GSG FG V  G  +  K    +AVK+L   +N    K E   E  ++ ++ + 
Sbjct: 19  TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 78

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
            +V+ +G C+ E   +LV E    G L ++L       + +     +E+    + G++YL
Sbjct: 79  YIVRMIGICEAESW-MLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL 133

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPE 582
                   +HRDL + N+LL     AK+SDFGLSK      ++  +   G   V +  PE
Sbjct: 134 EESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 190

Query: 583 YYISQQLTDKSDVYSFGVILLELIS 607
                + + KSDV+SFGV++ E  S
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFS 215

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  135 bits (343), Expect = 2e-35
 Identities = 67/269 (24%), Positives = 122/269 (45%), Gaps = 48/269 (17%)

Query: 364 HKGKKNNYDKEQHRHSLPVQRPV--SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGF 421
           H    +  +    +  LP  +        + P  A   FT  +IE +   +EK IGSG  
Sbjct: 4   HHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFT-REIEASRIHIEKIIGSGDS 62

Query: 422 GVVYYGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE 476
           G V YG+L+    +++  A+K L +  + + +R+F +E +++ +  H N+++  G     
Sbjct: 63  GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122

Query: 477 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRD 536
             +++V E+M NG+L   L    TH+ +   ++ + +      G+ YL        +HRD
Sbjct: 123 RLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---VHRD 176

Query: 537 LKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ-------- 588
           L + N+L+D ++  KVSDFGLS+   D                DP+   +          
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRVLED----------------DPDAAYTTTGGKIPIRW 220

Query: 589 ----------LTDKSDVYSFGVILLELIS 607
                      +  SDV+SFGV++ E+++
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  134 bits (340), Expect = 2e-35
 Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 58/289 (20%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           + IGSGGFG V+  K   DGK   +K +  N      +   EV  L+++ H N+V + G 
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGC 72

Query: 473 CQEEGRSVLVYEFMHNGTLKEHLY--------GTLTHEQRINWIKR-----------LEI 513
                          + +  + L+        GTL       WI++           LE+
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ-----WIEKRRGEKLDKVLALEL 127

Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 573
            E   KG++Y+H+     +I+RDLK SNI L    + K+ DFGL     +      S   
Sbjct: 128 FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-- 182

Query: 574 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE-AISNEKFGANCRNIVQWAKLHI 632
           GT+ Y+ PE   SQ    + D+Y+ G+IL EL+   + A    KF  + R+ +       
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIF-- 240

Query: 633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
                + ++                  + L+   P    RP+ SE+L+ 
Sbjct: 241 -DKKEKTLL------------------QKLLSKKP--EDRPNTSEILRT 268

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  138 bits (349), Expect = 3e-35
 Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 7/196 (3%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LEKK+G+G FG V+        ++AVK +          F  E  ++  + H  LV+   
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHA 250

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              +E   + + EFM  G+L + L        +    K ++ +   A+G+ ++       
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN--- 304

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE       T 
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364

Query: 592 KSDVYSFGVILLELIS 607
           KSDV+SFG++L+E+++
Sbjct: 365 KSDVWSFGILLMEIVT 380

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  135 bits (343), Expect = 5e-35
 Identities = 70/250 (28%), Positives = 126/250 (50%), Gaps = 22/250 (8%)

Query: 372 DKEQHRHSLPVQRP-VSSLND-----APAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY 425
           +K  H  +  ++ P + +  D      P +  H F   +++     ++K +G+G FG V 
Sbjct: 4   EKRLHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFA-KELDATNISIDKVVGAGEFGEVC 62

Query: 426 YGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV 480
            G+LK    KEI  A+K L    + + +R+F  E +++ +  H N+++  G   +    +
Sbjct: 63  SGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122

Query: 481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKS 539
           +V E+M NG+L   L     H+ +   I+ + +    A G++YL   G V    HRDL +
Sbjct: 123 IVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV----HRDLAA 175

Query: 540 SNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT--VGYLDPEYYISQQLTDKSDVYS 597
            NIL++ ++  KVSDFGL +   D      +   G   + +  PE    ++ T  SDV+S
Sbjct: 176 RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWS 235

Query: 598 FGVILLELIS 607
           +G++L E++S
Sbjct: 236 YGIVLWEVMS 245

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  133 bits (337), Expect = 6e-35
 Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 24/207 (11%)

Query: 412 LEKKIGSGGFGVVYYGKLK--DGKEI--AVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 466
           L + +G G FG VY G      G++I  AVK    + +   K +F +E  ++  + H ++
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+ +G  +EE  + ++ E    G L  +L     ++  +  +  +  +    K + YL +
Sbjct: 76  VKLIGIIEEE-PTWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLES 131

Query: 527 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL-----D 580
             C    +HRD+   NIL+      K+ DFGLS++  D         + +V  L      
Sbjct: 132 INC----VHRDIAVRNILVASPECVKLGDFGLSRYIED-----EDYYKASVTRLPIKWMS 182

Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
           PE    ++ T  SDV+ F V + E++S
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILS 209

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  133 bits (336), Expect = 7e-35
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L +++G+G FG V+ G      ++AVK L   S      F  E  L+ ++ H+ LV+   
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              +E   + + E+M NG+L + L        ++   K L++A   A+G+ ++       
Sbjct: 76  VVTQEPIYI-ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNY-- 130

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---ASHVSSI-VRGTVGYLDPEYYISQ 587
            IHRDL+++NIL+   +  K++DFGL++   D    A   +   ++ T     PE     
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYG 185

Query: 588 QLTDKSDVYSFGVILLELIS 607
             T KSDV+SFG++L E+++
Sbjct: 186 TFTIKSDVWSFGILLTEIVT 205

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  133 bits (336), Expect = 9e-35
 Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 7/197 (3%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGK-EIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           ++ K+G G +G VY G  K     +AVK L  ++ +   EF  E  ++  I H NLVQ L
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
           G C  E    ++ EFM  G L ++L     + Q ++ +  L +A   +  +EYL      
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKNF- 132

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
             IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE     + +
Sbjct: 133 --IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190

Query: 591 DKSDVYSFGVILLELIS 607
            KSDV++FGV+L E+ +
Sbjct: 191 IKSDVWAFGVLLWEIAT 207

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  132 bits (335), Expect = 1e-34
 Identities = 47/202 (23%), Positives = 92/202 (45%), Gaps = 14/202 (6%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 466
           L + IG G FG V+ G     +     +A+K   +  S   + +F  E   + +  H ++
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+ +G   E     ++ E    G L+  L      +  ++    +  A   +  + YL +
Sbjct: 79  VKLIGVITEN-PVWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLES 134

Query: 527 -GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
                  +HRD+ + N+L+  +   K+ DFGLS++  D   + +S  +  + ++ PE   
Sbjct: 135 KRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 190

Query: 586 SQQLTDKSDVYSFGVILLELIS 607
            ++ T  SDV+ FGV + E++ 
Sbjct: 191 FRRFTSASDVWMFGVCMWEILM 212

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  133 bits (336), Expect = 2e-34
 Identities = 60/275 (21%), Positives = 105/275 (38%), Gaps = 41/275 (14%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRI-HHRNLVQF 469
            ++G G +G V+  + K DG+  AVK   S     + +     EV    ++  H   V+ 
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
               +E G   L  E     +L++H   +G    E ++          D    + +LH+ 
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQV-----WGYLRDTLLALAHLHS- 175

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               ++H D+K +NI L    R K+ DFGL    +  A        G   Y+ PE  +  
Sbjct: 176 --QGLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQE-GDPRYMAPE-LLQG 230

Query: 588 QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 647
                +DV+S G+ +LE+    E     +          W +L       QG + P    
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQL------RQGYLPPEFTA 275

Query: 648 EY--DIQSMWKIEEKALMCVLPHGHMRPSISEVLK 680
               +++S+        M + P   +R +   +L 
Sbjct: 276 GLSSELRSVLV------MMLEPDPKLRATAEALLA 304

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  131 bits (333), Expect = 2e-34
 Identities = 64/199 (32%), Positives = 106/199 (53%), Gaps = 17/199 (8%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L + IG G FG V  G  + G ++AVK + +++    + F  E ++++++ H NLVQ LG
Sbjct: 25  LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 81

Query: 472 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL-HTGCV 529
              +E+G   +V E+M  G+L ++L         +     L+ + D  + +EYL      
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNF- 138

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI-VRGTVGYLDPEYYISQQ 588
              +HRDL + N+L+ +   AKVSDFGL+K A         + V+ T     PE    ++
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASS-TQDTGKLPVKWTA----PEALREKK 190

Query: 589 LTDKSDVYSFGVILLELIS 607
            + KSDV+SFG++L E+ S
Sbjct: 191 FSTKSDVWSFGILLWEIYS 209

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  131 bits (332), Expect = 3e-34
 Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 13/203 (6%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 466
           +  K+G GG   VY  +      ++A+K +     + K E    F  EV   S++ H+N+
Sbjct: 15  IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQNI 73

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V  +   +E+    LV E++   TL E++         ++    +        GI++ H 
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYI----ESHGPLSVDTAINFTNQILDGIKHAHD 129

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                I+HRD+K  NIL+D +   K+ DFG++K   + +   ++ V GTV Y  PE    
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186

Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
           +   + +D+YS G++L E++ G+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  132 bits (334), Expect = 3e-34
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 22/226 (9%)

Query: 391 DAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNS 444
           +AP +A        +++      K +GSG FG VY G      E     +A+K L  + S
Sbjct: 2   EAPNQALLRI----LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS 57

Query: 445 YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR 504
            +  +E  +E  +++ + + ++ + LG C       L+ + M  G L +++     H+  
Sbjct: 58  PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYV---REHKDN 113

Query: 505 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 564
           I     L      AKG+ YL       ++HRDL + N+L+      K++DFGL+K     
Sbjct: 114 IGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170

Query: 565 ASHVSSIVRGT---VGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
                +   G    + ++  E  + +  T +SDV+S+GV + EL++
Sbjct: 171 EKEYHA--EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  133 bits (336), Expect = 4e-34
 Identities = 74/284 (26%), Positives = 121/284 (42%), Gaps = 26/284 (9%)

Query: 336 AKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAE 395
           A  + +  GS     +  +  + + L+   G +N Y +  +   + +    S+LN    +
Sbjct: 22  AAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDL----SALNPELVQ 77

Query: 396 AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKRE 450
           A     +           + IG G FG VY+G L D        AVK L          +
Sbjct: 78  AVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ 136

Query: 451 FTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 509
           F  E  ++    H N++  LG C + EG  ++V  +M +G L+  +              
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKD 193

Query: 510 RLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
            +      AKG+++L +   V    HRDL + N +LD+    KV+DFGL++   D     
Sbjct: 194 LIGFGLQVAKGMKFLASKKFV----HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD- 248

Query: 569 SSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
            S+   T   L       E   +Q+ T KSDV+SFGV+L EL++
Sbjct: 249 -SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  131 bits (331), Expect = 4e-34
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 18/231 (7%)

Query: 387 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTS 442
           S+LN    +A     +           + IG G FG VY+G L D        AVK L  
Sbjct: 5   SALNPELVQAVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63

Query: 443 N-SYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLT 500
                   +F  E  ++    H N++  LG C + EG  ++V  +M +G L+  +     
Sbjct: 64  ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RN 120

Query: 501 HEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 559
                     +      AKG++YL +   V    HRDL + N +LD+    KV+DFGL++
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYLASKKFV----HRDLAARNCMLDEKFTVKVADFGLAR 176

Query: 560 FAVDG---ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
              D    + H  +  +  V ++  E   +Q+ T KSDV+SFGV+L EL++
Sbjct: 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  131 bits (332), Expect = 7e-34
 Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 18/206 (8%)

Query: 411 MLEKKIGSGGFGVVYYGKLKDGKE-----IAVKVL-TSNSYQGKREFTNEVTLLSRIHHR 464
              K +GSG FG V+ G      E     + +KV+   +  Q  +  T+ +  +  + H 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
           ++V+ LG C       LV +++  G+L +H+     H   +     L      AKG+ YL
Sbjct: 76  HIVRLLGLCPGS-SLQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWGVQIAKGMYYL 131

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT---VGYLDP 581
                  ++HR+L + N+LL    + +V+DFG++         +          + ++  
Sbjct: 132 EEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMAL 186

Query: 582 EYYISQQLTDKSDVYSFGVILLELIS 607
           E     + T +SDV+S+GV + EL++
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT 212

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  130 bits (329), Expect = 8e-34
 Identities = 51/216 (23%), Positives = 97/216 (44%), Gaps = 32/216 (14%)

Query: 411 MLEKKIGSGGFGVVYYGKLKDGK--------EIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           +  + +G G F  ++ G  ++          E+ +KVL          F    +++S++ 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H++LV   G C     ++LV EF+  G+L  +L     ++  IN + +LE+A+  A  + 
Sbjct: 71  HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMH 127

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMR--------AKVSDFGLSKFAVDGASHVSSIVRG 574
           +L    +   IH ++ + NILL +            K+SD G+S   +        I++ 
Sbjct: 128 FLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-----KDILQE 179

Query: 575 TVGYLDPE---YYISQQLTDKSDVYSFGVILLELIS 607
            + ++ PE       + L   +D +SFG  L E+ S
Sbjct: 180 RIPWVPPECIENP--KNLNLATDKWSFGTTLWEICS 213

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (328), Expect = 1e-33
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 17/206 (8%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNL 466
            ++ IG G FGVVY+G+  D  +     A+K L+     Q    F  E  L+  ++H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 467 VQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +  +G     EG   ++  +M +G L + +    + ++       +      A+G+EYL 
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYLA 141

Query: 526 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT---VGYLDP 581
                   +HRDL + N +LD+    KV+DFGL++  +D   +     R     V +   
Sbjct: 142 EQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTAL 197

Query: 582 EYYISQQLTDKSDVYSFGVILLELIS 607
           E   + + T KSDV+SFGV+L EL++
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLT 223

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  130 bits (328), Expect = 3e-33
 Identities = 59/257 (22%), Positives = 110/257 (42%), Gaps = 43/257 (16%)

Query: 385 PVSSLNDAPAEAAHCFTLS-DIEDATKMLE-----KKIGSGGFGVVYYGKLKDGKEIAVK 438
           P+ S+ D  +  ++   L+  +++  K +      + +  G F  +   + KD K  A+K
Sbjct: 2   PLGSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALK 60

Query: 439 VLTSNSYQGKREFT-----------------NEVTLLSRIHHRNLVQFLGYCQEEGRSVL 481
               +  + KR+FT                 NE+ +++ I +   +   G         +
Sbjct: 61  KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYI 120

Query: 482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAII 533
           +YE+M N ++ +       +   ++      I     K           Y+H      I 
Sbjct: 121 IYEYMENDSILKFD----EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NIC 174

Query: 534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-- 591
           HRD+K SNIL+DK+ R K+SDFG S++ VD     S   RGT  ++ PE++ ++   +  
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---RGTYEFMPPEFFSNESSYNGA 231

Query: 592 KSDVYSFGVILLELISG 608
           K D++S G+ L  +   
Sbjct: 232 KVDIWSLGICLYVMFYN 248

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  128 bits (323), Expect = 7e-33
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 19/209 (9%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 466
           L + +G GG   V+  + L+D +++AVKVL ++           F  E    + ++H  +
Sbjct: 16  LGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAI 74

Query: 467 VQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           V      + E  +     +V E++   TL++ +      E  +   + +E+  DA + + 
Sbjct: 75  VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQALN 130

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLD 580
           + H      IIHRD+K +NI++      KV DFG+++   D  + V  ++ V GT  YL 
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 581 PEYYISQQLTDKSDVYSFGVILLELISGQ 609
           PE      +  +SDVYS G +L E+++G+
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  129 bits (325), Expect = 7e-33
 Identities = 63/299 (21%), Positives = 103/299 (34%), Gaps = 53/299 (17%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 469
           + + +  GGF  VY  + +  G+E A+K L SN  +  R    EV  + ++  H N+VQF
Sbjct: 32  VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91

Query: 470 LGYC-------QEEGRSVLVYEFMHNGTLKEHLYGTLTH----EQRINWIKRLEIAEDAA 518
                             L+   +  G L E L    +        +     L+I     
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV-----LKIFYQTC 146

Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI------- 571
           + ++++H    P IIHRDLK  N+LL      K+ DFG +        +  S        
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 572 ----VRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI 624
                  T  Y  PE    Y +  + +K D+++ G IL  L   Q    +          
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK 265

Query: 625 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
                   +      +I                       +  +   R SI+EV+  +Q
Sbjct: 266 YSIPPHDTQYTVFHSLIR--------------------AMLQVNPEERLSIAEVVHQLQ 304

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  127 bits (320), Expect = 2e-32
 Identities = 67/306 (21%), Positives = 113/306 (36%), Gaps = 67/306 (21%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
               +G G FG V   +   D +  A+K +  ++ +      +EV LL+ ++H+ +V++ 
Sbjct: 10  EIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYY 68

Query: 471 GYCQEEGRSV-------------LVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIA 514
               E    V             +  E+  NGTL + +                +  +I 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR--QIL 126

Query: 515 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR- 573
           E     + Y+H+     IIHRDLK  NI +D+    K+ DFGL+K        +    + 
Sbjct: 127 E----ALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 574 ------------GTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISGQEAISNE 615
                       GT  Y+  E      +Y      +K D+YS G+I  E+I         
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIYP------- 227

Query: 616 KFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI 675
                 R  +   K  + S  I+    P   D+  ++   KI    L+   P  + RP  
Sbjct: 228 FSTGMERVNI-LKK--LRSVSIE---FPPDFDDNKMKVEKKIIRL-LIDHDP--NKRPGA 278

Query: 676 SEVLKD 681
             +L  
Sbjct: 279 RTLLNS 284

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  133 bits (335), Expect = 2e-32
 Identities = 51/229 (22%), Positives = 97/229 (42%), Gaps = 19/229 (8%)

Query: 385 PVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKE----IAVKVL 440
                   P+   +      IE     L + IG G FG V+ G     +     +A+K  
Sbjct: 372 DEEDTYTMPSTRDYEIQRERIE-----LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC 426

Query: 441 TSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTL 499
            +  S   + +F  E   + +  H ++V+ +G   E     ++ E    G L+  L    
Sbjct: 427 KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL---Q 482

Query: 500 THEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 558
             +  ++    +  A   +  + YL +   V    HRD+ + N+L+  +   K+ DFGLS
Sbjct: 483 VRKFSLDLASLILYAYQLSTALAYLESKRFV----HRDIAARNVLVSSNDCVKLGDFGLS 538

Query: 559 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS 607
           ++  D   + +S  +  + ++ PE    ++ T  SDV+ FGV + E++ 
Sbjct: 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  127 bits (321), Expect = 2e-32
 Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 60/232 (25%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE---IAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNL 466
            +  IG G FG V   ++K        A+K +    S    R+F  E+ +L ++ HH N+
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLEIA 514
           +  LG C+  G   L  E+  +G L + L                +    ++  + L  A
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 515 EDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 573
            D A+G++YL         IHRDL + NIL+ ++  AK++DFGLS+              
Sbjct: 149 ADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR-------------- 190

Query: 574 GTVGYLDPEYYISQQL------------------TDKSDVYSFGVILLELIS 607
                   E Y+ + +                  T  SDV+S+GV+L E++S
Sbjct: 191 ------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  126 bits (318), Expect = 5e-32
 Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 29/218 (13%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 465
           L+ ++G G FG V+  +  +         +AVK L   S   +++F  E  LL+ + H++
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-----------YGTLTHEQRINWIKRLEIA 514
           +V+F G C E    ++V+E+M +G L   L            G       +   + L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 515 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 574
              A G+ YL        +HRDL + N L+ + +  K+ DFG+S+       +      G
Sbjct: 165 SQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY----RVG 217

Query: 575 TVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
               L      PE  + ++ T +SDV+SFGV+L E+ +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  124 bits (313), Expect = 8e-32
 Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 27/217 (12%)

Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL---TSNSYQGKREFTNEV 455
           + L D E     + + +G G FG VY  + K     +A+KVL          + +   EV
Sbjct: 6   WALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60

Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 515
            + S + H N+++  GY  +  R  L+ E+   GT+    Y  L    + +  +      
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYIT 116

Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR-- 573
           + A  + Y H+     +IHRD+K  N+LL      K++DFG S        H  S  R  
Sbjct: 117 ELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV-------HAPSSRRTD 166

Query: 574 --GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
             GT+ YL PE    +   +K D++S GV+  E + G
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 203

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  125 bits (316), Expect = 9e-32
 Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 25/214 (11%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 464
           + +++G G FG+VY G  K   +      +A+K +    S + + EF NE +++   +  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------YGTLTHEQRINWIKRLEIAEDAA 518
           ++V+ LG   +   ++++ E M  G LK +L                +  K +++A + A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
            G+ YL+       +HRDL + N ++ +    K+ DFG+++   +         +G  G 
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET----DYYRKGGKGL 201

Query: 579 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
           L      PE       T  SDV+SFGV+L E+ +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  124 bits (313), Expect = 1e-31
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 30/219 (13%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 465
           L++++G G FG V+  +  +         +AVK L   +   +++F  E  LL+ + H +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLEI 513
           +V+F G C +    ++V+E+M +G L + L                  +  +   + L I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 573
           A   A G+ YL +      +HRDL + N L+  ++  K+ DFG+S+       +      
Sbjct: 139 ASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RV 191

Query: 574 GTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
           G    L      PE  + ++ T +SDV+SFGVIL E+ +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  123 bits (312), Expect = 2e-31
 Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 19/232 (8%)

Query: 387 SSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY 445
           S  +    +        D E         +G G +G+VY G+ L +   IA+K +     
Sbjct: 1   SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60

Query: 446 QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTL-TH 501
           +  +    E+ L   + H+N+VQ+LG   E G   +  E +  G+L       +G L  +
Sbjct: 61  RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120

Query: 502 EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKF 560
           EQ I +  + +I E    G++YLH      I+HRD+K  N+L++ +    K+SDFG SK 
Sbjct: 121 EQTIGFYTK-QILE----GLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKR 172

Query: 561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 609
                    +   GT+ Y+ PE  I +        +D++S G  ++E+ +G+
Sbjct: 173 LAGINPCTET-FTGTLQYMAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  124 bits (313), Expect = 2e-31
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 25/214 (11%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVL--TSNSYQGKREFTNEVTLLSRIHHRN 465
           L K +G G FG V  G LK        +AVK +   ++S +   EF +E   +    H N
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 466 LVQFLGYCQEEG-----RSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAA 518
           +++ LG C E       + +++  FM  G L  +L      T  + I     L+   D A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
            G+EYL        +HRDL + N +L   M   V+DFGLSK    G  +     +G +  
Sbjct: 158 LGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAK 210

Query: 579 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
           +       E    +  T KSDV++FGV + E+ +
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  123 bits (312), Expect = 2e-31
 Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 26/215 (12%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN--SYQGKREFTNEVTLLSRIHHRN 465
           L + +G G FG V   +LK        +AVK+L ++  +     EF  E   +    H +
Sbjct: 27  LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86

Query: 466 LVQFLGYCQEEGRSV------LVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDA 517
           + + +G               ++  FM +G L   L       +   +     +    D 
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
           A G+EYL +      IHRDL + N +L + M   V+DFGLS+    G  +     +G   
Sbjct: 147 ACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCAS 199

Query: 578 YL-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
            L       E       T  SDV++FGV + E+++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  123 bits (312), Expect = 3e-31
 Identities = 61/214 (28%), Positives = 98/214 (45%), Gaps = 25/214 (11%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGK------EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 464
           L + +G G FG VY G++          ++AVK L    S Q + +F  E  ++S+ +H+
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGI 521
           N+V+ +G   +     ++ E M  G LK  L       +    +  +  L +A D A G 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           +YL        IHRD+ + N LL        AK+ DFG+++         S   +G    
Sbjct: 154 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAM 206

Query: 579 L-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
           L      PE ++    T K+D +SFGV+L E+ S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  122 bits (309), Expect = 3e-31
 Identities = 57/221 (25%), Positives = 90/221 (40%), Gaps = 35/221 (15%)

Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL---TSNSYQGKREFTNEV 455
           FT+ D +     + + +G G FG VY  + K     +A+KVL          + +   E+
Sbjct: 11  FTIDDFD-----IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI 65

Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 515
            + S + H N+++   Y  +  R  L+ EF   G L    Y  L    R +        E
Sbjct: 66  EIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFD--------E 113

Query: 516 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 567
             +          + Y H   V   IHRD+K  N+L+      K++DFG S  A      
Sbjct: 114 QRSATFMEELADALHYCHERKV---IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR 170

Query: 568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
                 GT+ YL PE    +   +K D++  GV+  E + G
Sbjct: 171 TMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  123 bits (311), Expect = 3e-31
 Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 29/216 (13%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL--V 467
           + K+IGSGG   V+    +  +  A+K   L     Q    + NE+  L+++   +   +
Sbjct: 32  ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +   Y   +    +V E   N  L   L    ++   +R ++ K   + E     +  +H
Sbjct: 92  RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLE----AVHTIH 144

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE-- 582
                 I+H DLK +N L+   M  K+ DFG++     D  S V     GTV Y+ PE  
Sbjct: 145 QH---GIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

Query: 583 ---------YYISQQLTDKSDVYSFGVILLELISGQ 609
                         +++ KSDV+S G IL  +  G+
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  124 bits (313), Expect = 4e-31
 Identities = 67/267 (25%), Positives = 109/267 (40%), Gaps = 28/267 (10%)

Query: 362 FMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSD---IEDATKMLEKKIGS 418
           F           E     L     ++  N     A    ++SD   +      L + +G 
Sbjct: 22  FQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGH 81

Query: 419 GGFGVVYYGKLKDGK------EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           G FG VY G++          ++AVK L    S Q + +F  E  ++S+ +H+N+V+ +G
Sbjct: 82  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIG 141

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
              +     ++ E M  G LK  L       +    +  +  L +A D A G +YL    
Sbjct: 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 201

Query: 529 VPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL-----D 580
               IHRD+ + N LL        AK+ DFG+++             +G    L      
Sbjct: 202 ---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKGGCAMLPVKWMP 254

Query: 581 PEYYISQQLTDKSDVYSFGVILLELIS 607
           PE ++    T K+D +SFGV+L E+ S
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  123 bits (311), Expect = 6e-31
 Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 31/217 (14%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRI--HHRNLV 467
           + K+IGSGG   V+    +  +  A+K   L     Q    + NE+  L+++  H   ++
Sbjct: 13  ILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +   Y   +    +V E   N  L   L    ++   +R ++ K +       + +  +H
Sbjct: 73  RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM------LEAVHTIH 125

Query: 526 T-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE- 582
             G    I+H DLK +N L+   M  K+ DFG++     D  S V     GTV Y+ PE 
Sbjct: 126 QHG----IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 583 ----------YYISQQLTDKSDVYSFGVILLELISGQ 609
                          +++ KSDV+S G IL  +  G+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  121 bits (305), Expect = 1e-30
 Identities = 51/234 (21%), Positives = 88/234 (37%), Gaps = 59/234 (25%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 464
             +++G   FG VY G L           +A+K L        + EF +E  L +R+ H 
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIKRLE 512
           N+V  LG   ++    +++ +  +G L E L                T +  +     + 
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 513 IAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 571
           +    A G+EYL +   V    H+DL + N+L+   +  K+SD GL +            
Sbjct: 133 LVAQIAAGMEYLSSHHVV----HKDLATRNVLVYDKLNVKISDLGLFREVYAA------- 181

Query: 572 VRGTVGYLDPEYYISQQL------------------TDKSDVYSFGVILLELIS 607
                     +YY                       +  SD++S+GV+L E+ S
Sbjct: 182 ----------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  120 bits (304), Expect = 2e-30
 Identities = 43/208 (20%), Positives = 86/208 (41%), Gaps = 23/208 (11%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSN-----SYQGKREFTNEVTLLSRIHHRN 465
           L + +G GG G VY  +     + +A+K+++        ++ +     E     R+   +
Sbjct: 38  LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR--MQREARTAGRLQEPH 95

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           +V    + + +G+  +    ++   L   L   G L   +       + I       ++ 
Sbjct: 96  VVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA------VAIVRQIGSALDA 149

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDP 581
            H        HRD+K  NIL+     A + DFG++  A        + + V GT+ Y+ P
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTV-GTLYYMAP 204

Query: 582 EYYISQQLTDKSDVYSFGVILLELISGQ 609
           E +     T ++D+Y+   +L E ++G 
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGS 232

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  123 bits (311), Expect = 2e-30
 Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 23/209 (11%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFL 470
            +  +G G  G + Y  + D +++AVK +    +        EV LL     H N++++ 
Sbjct: 28  PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRYF 84

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCV 529
              ++     +  E     TL+E++      +     ++ + + +    G+ +LH+    
Sbjct: 85  CTEKDRQFQYIAIELC-AATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSLN-- 138

Query: 530 PAIIHRDLKSSNILL-----DKHMRAKVSDFGLSKFAVDGAS--HVSSIVRGTVGYLDPE 582
             I+HRDLK  NIL+        ++A +SDFGL K    G       S V GT G++ PE
Sbjct: 139 --IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 583 YY---ISQQLTDKSDVYSFGVILLELISG 608
                  +  T   D++S G +   +IS 
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  122 bits (308), Expect = 3e-30
 Identities = 59/261 (22%), Positives = 104/261 (39%), Gaps = 32/261 (12%)

Query: 367 KKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYY 426
           K+    K + +H           + A + A  C +   ++     + K+IGSGG   V+ 
Sbjct: 18  KETAAAKFERQHMDSPDLGTDDDDKASSSANECIS---VKGRIYSILKQIGSGGSSKVFQ 74

Query: 427 GKLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLGYCQEEGRSVLV 482
              +  +  A+K   L     Q    + NE+  L+++   +   ++   Y   +    +V
Sbjct: 75  VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134

Query: 483 YEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS 540
            E   N  L   L    ++   +R ++ K   + E     +  +H      I+H DLK +
Sbjct: 135 MEC-GNIDLNSWLKKKKSIDPWERKSYWK--NMLE----AVHTIHQH---GIVHSDLKPA 184

Query: 541 NILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPE-----------YYISQQ 588
           N L+   M  K+ DFG++     D  S V     G V Y+ PE                +
Sbjct: 185 NFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSK 243

Query: 589 LTDKSDVYSFGVILLELISGQ 609
           ++ KSDV+S G IL  +  G+
Sbjct: 244 ISPKSDVWSLGCILYYMTYGK 264

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  122 bits (309), Expect = 4e-30
 Identities = 70/300 (23%), Positives = 117/300 (39%), Gaps = 54/300 (18%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFL 470
            EK +G G  G V +     G+ +AVK +  +          E+ LL+    H N++++ 
Sbjct: 19  SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNVIRY- 74

Query: 471 GYCQEEGRSV--LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYLH 525
            YC E       +  E   N  L++ +      ++ +   K           A G+ +LH
Sbjct: 75  -YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132

Query: 526 TGCVPAIIHRDLKSSNILLD-------------KHMRAKVSDFGLSKFAVDGASHVSSIV 572
           +     IIHRDLK  NIL+              +++R  +SDFGL K    G S   + +
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 573 R---GTVGYLDPE-------YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 622
               GT G+  PE           ++LT   D++S G +   ++S         FG    
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK----GKHPFGDKYS 245

Query: 623 NIVQWAKLHIESGDIQGIIDPSLLDE-YD-IQSMWKIEEKALMCVLPHGHMRPSISEVLK 680
                 +      +++ + D SL+ E  D I  M        +   P    RP+  +VL+
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQM--------IDHDP--LKRPTAMKVLR 295

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  120 bits (304), Expect = 4e-30
 Identities = 56/223 (25%), Positives = 105/223 (47%), Gaps = 34/223 (15%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE--------IAVKVLTSN-SYQGKREFTNEVTLLSRI- 461
           L K +G G FG V   +     +        +AVK+L  + + +   +  +E+ ++  I 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L                  E+++ +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +      A+G+EYL +      IHRDL + N+L+ ++   K++DFGL++   +      
Sbjct: 159 LVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNI----D 211

Query: 570 SIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
              + T G L      PE    +  T +SDV+SFGV++ E+ +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  125 bits (316), Expect = 5e-30
 Identities = 45/207 (21%), Positives = 84/207 (40%), Gaps = 26/207 (12%)

Query: 412 LEKKIGSGGFGVVYYGK--LKDGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           ++  I  GG G +Y       +G+ + +K L  S   + +     E   L+ + H ++VQ
Sbjct: 84  VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143

Query: 469 FLGYCQEEGRSV-----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
              + +   R       +V E++   +LK      L   + I          +    + Y
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI------AYLLEILPALSY 197

Query: 524 LHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           LH+ G    +++ DLK  NI+L +  + K+ D G     ++   ++     GT G+  PE
Sbjct: 198 LHSIG----LVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYLY----GTPGFQAPE 247

Query: 583 YYISQQLTDKSDVYSFGVILLELISGQ 609
             +    T  +D+Y+ G  L  L    
Sbjct: 248 I-VRTGPTVATDIYTVGRTLAALTLDL 273

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  120 bits (302), Expect = 5e-30
 Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 33/222 (14%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 463
           L K +G G FG V         +      +AVK+L    ++   R   +E+ +L  I HH
Sbjct: 31  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90

Query: 464 RNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHL------------YGTLTHEQRINWIKR 510
            N+V  LG C + G  ++V  EF   G L  +L                 ++  +     
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 511 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 570
           +  +   AKG+E+L +      IHRDL + NILL +    K+ DFGL++           
Sbjct: 151 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PD 203

Query: 571 IVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
            VR     L      PE    +  T +SDV+SFGV+L E+ S
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  119 bits (301), Expect = 6e-30
 Identities = 60/224 (26%), Positives = 94/224 (41%), Gaps = 36/224 (16%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 463
             K +G+G FG V         +      +AVK+L  +     +    +E+ +LS + +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------YGTLTHEQRINWIK 509
            N+V  LG C   G ++++ E+   G L   L                    E  ++   
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 510 RLEIAEDAAKGIEYLH-TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
            L  +   AKG+ +L    C    IHRDL + NILL      K+ DFGL++   +     
Sbjct: 147 LLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKND---- 198

Query: 569 SSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
           S+ V      L      PE   +   T +SDV+S+G+ L EL S
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  119 bits (300), Expect = 8e-30
 Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 45/231 (19%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 464
           L K +G G FG V        K       +AVK+L  N S    R+  +E  +L +++H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------------YGTLTHEQR 504
           ++++  G C ++G  +L+ E+   G+L+  L                          E+ 
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 505 INWIKRLEIAEDAAKGIEYL---HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 561
           +     +  A   ++G++YL          ++HRDL + NIL+ +  + K+SDFGLS+  
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMK------LVHRDLAARNILVAEGRKMKISDFGLSRDV 200

Query: 562 VDGASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
            +      S V+ + G +       E       T +SDV+SFGV+L E+++
Sbjct: 201 YEE----DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  119 bits (300), Expect = 9e-30
 Identities = 62/249 (24%), Positives = 108/249 (43%), Gaps = 13/249 (5%)

Query: 363 MHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFG 422
           MH    ++   +    +L  Q  V +     A         D         K IG G  G
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVK-IGEGSTG 59

Query: 423 VVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL 481
           +V   +    G+++AVK++     Q +    NEV ++    H N+V+            +
Sbjct: 60  IVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119

Query: 482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 541
           + EF+  G L + +     +E++I  +          + + YLH      +IHRD+KS +
Sbjct: 120 LMEFLQGGALTDIVSQVRLNEEQIATVCE-----AVLQALAYLHA---QGVIHRDIKSDS 171

Query: 542 ILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-KSDVYSFGV 600
           ILL    R K+SDFG             S+V GT  ++ PE  IS+ L   + D++S G+
Sbjct: 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPE-VISRSLYATEVDIWSLGI 229

Query: 601 ILLELISGQ 609
           +++E++ G+
Sbjct: 230 MVIEMVDGE 238

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  119 bits (299), Expect = 1e-29
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 28/217 (12%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 469
           L   +G G    V+ G+ K  G   A+KV  + S+    +    E  +L +++H+N+V+ 
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72

Query: 470 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYL 524
               +E      VL+ EF   G+L   L            +   E      D   G+ +L
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 525 HTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
                  I+HR++K  NI+     D     K++DFG ++   D    VS    GT  YL 
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLH 183

Query: 581 PEYY--------ISQQLTDKSDVYSFGVILLELISGQ 609
           P+ Y          ++     D++S GV      +G 
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  118 bits (298), Expect = 1e-29
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 20/205 (9%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLV 467
             + +G GGF   +        +  A K++  +         + + E+++   + H+++V
Sbjct: 19  RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
            F G+ ++     +V E     +L E       LT  +   +++++        G +YLH
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------VLGCQYLH 132

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYY 584
              V   IHRDLK  N+ L++ +  K+ DFGL+ K   DG         GT  Y+ PE  
Sbjct: 133 RNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE-V 186

Query: 585 ISQQLTD-KSDVYSFGVILLELISG 608
           +S++    + DV+S G I+  L+ G
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVG 211

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  120 bits (303), Expect = 1e-29
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 34/223 (15%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGK--------EIAVKVLTSN-SYQGKREFTNEVTLLSRI- 461
           L K +G G FG V   +             ++AVK+L S+ + +   +  +E+ ++  I 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L              +   E++++   
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +  A   A+G+EYL +      IHRDL + N+L+ +    K++DFGL++          
Sbjct: 193 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----D 245

Query: 570 SIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
              + T G L      PE    +  T +SDV+SFGV+L E+ +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  118 bits (299), Expect = 2e-29
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 20/205 (9%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKR---EFTNEVTLLSRIHHRNLV 467
             + +G GGF   +        +  A K++  +         + + E+++   + H+++V
Sbjct: 45  RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
            F G+ ++     +V E     +L E       LT  +   +++++        G +YLH
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI------VLGCQYLH 158

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEYY 584
              V   IHRDLK  N+ L++ +  K+ DFGL+ K   DG         GT  Y+ PE  
Sbjct: 159 RNRV---IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAPE-V 212

Query: 585 ISQQLTD-KSDVYSFGVILLELISG 608
           +S++    + DV+S G I+  L+ G
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVG 237

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  118 bits (298), Expect = 2e-29
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 32/220 (14%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 463
             K +G+G FG V         +      +AVK+L S      K    +E+ ++S +  H
Sbjct: 50  FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------YGTLTHEQRINWIKRLEI 513
            N+V  LG C   G  +++ E+   G L   L                    +    L  
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 514 AEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 572
           +   A+G+ +L +  C    IHRD+ + N+LL     AK+ DFGL++  ++     S+ +
Sbjct: 170 SSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMND----SNYI 221

Query: 573 RGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
                 L      PE       T +SDV+S+G++L E+ S
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  116 bits (294), Expect = 3e-29
 Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 19/205 (9%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLV 467
           +   +G G F  VY  + +  G E+A+K++   +       +   NEV +  ++ H +++
Sbjct: 15  VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSIL 74

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
           +   Y ++     LV E  HNG +  +L       +  +  +++ ++        G+ YL
Sbjct: 75  ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI------ITGMLYL 128

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASHVSSIVRGTVGYLDPEY 583
           H+  +   +HRDL  SN+LL ++M  K++DFGL+ +  +    H +    GT  Y+ PE 
Sbjct: 129 HSHGI---LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPEI 183

Query: 584 YISQQLTDKSDVYSFGVILLELISG 608
                   +SDV+S G +   L+ G
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIG 208

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  118 bits (299), Expect = 3e-29
 Identities = 56/226 (24%), Positives = 104/226 (46%), Gaps = 40/226 (17%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE--------IAVKVLTSN-SYQGKREFTNEVTLLSRI- 461
           L K +G G FG V   +     +        +AVK+L  + + +   +  +E+ ++  I 
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL------------YGTLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L                  E+++ +  
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 510 RLEIAEDAAKGIEYL---HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS 566
            +      A+G+EYL           IHRDL + N+L+ ++   K++DFGL++   +   
Sbjct: 205 LVSCTYQLARGMEYLASQK------CIHRDLAARNVLVTENNVMKIADFGLARDINNI-- 256

Query: 567 HVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
                 + T G L      PE    +  T +SDV+SFGV++ E+ +
Sbjct: 257 --DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  119 bits (299), Expect = 4e-29
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 28/217 (12%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 469
           L   +G G    V+ G+ K  G   A+KV  + S+    +    E  +L +++H+N+V+ 
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72

Query: 470 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKGIEYL 524
               +E      VL+ EF   G+L   L            +   E      D   G+ +L
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 525 HTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
                  I+HR++K  NI+     D     K++DFG ++   D    VS    GT  YL 
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLH 183

Query: 581 PEYY--------ISQQLTDKSDVYSFGVILLELISGQ 609
           P+ Y          ++     D++S GV      +G 
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  117 bits (296), Expect = 5e-29
 Identities = 58/228 (25%), Positives = 93/228 (40%), Gaps = 39/228 (17%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRI-HH 463
             K +GSG FG V         +      +AVK+L        +    +E+ +++++  H
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-------------YGTLTHEQRINWIKR 510
            N+V  LG C   G   L++E+   G L  +L             Y      +    +  
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 511 L------EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 564
           L        A   AKG+E+L        +HRDL + N+L+      K+ DFGL++  +  
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

Query: 565 ASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
               S+ V      L      PE       T KSDV+S+G++L E+ S
Sbjct: 226 ----SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  117 bits (295), Expect = 5e-29
 Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 22/204 (10%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
            ++G G FG V+  K  + G + AVK +    ++       E+   + +    +V   G 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGA 118

Query: 473 CQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
            +E     +  E +  G+L + +   G L  E R  +         A +G+EYLHT    
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLP-EDRALYYLG-----QALEGLEYLHTRR-- 170

Query: 531 AIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSI----VRGTVGYLDPEYYI 585
            I+H D+K+ N+LL     RA + DFG +          S +    + GT  ++ PE  +
Sbjct: 171 -ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

Query: 586 SQQLTDKSDVYSFGVILLELISGQ 609
            +    K D++S   ++L +++G 
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGC 253

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (296), Expect = 6e-29
 Identities = 27/271 (9%), Positives = 67/271 (24%), Gaps = 41/271 (15%)

Query: 373 KEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD- 431
           +E  +    +   V++            +L    +    L + +  G   VV+  +  + 
Sbjct: 27  EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVER 86

Query: 432 GKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQFLGYCQEEGRS--------- 479
            ++ A+KV T  +   + E           +R+   +  +     +    S         
Sbjct: 87  LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146

Query: 480 -----------------VLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 520
                            +L+          L   L            +    +     + 
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
              L +     ++H      N+ +    R  + D                     V Y  
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGPASSVPVTYAP 259

Query: 581 PEYYISQ--QLTDKSDVYSFGVILLELISGQ 609
            E+  +     T   + +  G+ +  +    
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  117 bits (294), Expect = 9e-29
 Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 41/229 (17%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE------IAVKVLTSN-SYQGKREFTNEVTLLSRIHHR 464
             + IG G FG V+  +            +AVK+L    S   + +F  E  L++   + 
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--------------------YGTLTHEQR 504
           N+V+ LG C       L++E+M  G L E L                      +      
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 505 INWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 563
           ++  ++L IA   A G+ YL     V    HRDL + N L+ ++M  K++DFGLS+    
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFV----HRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 564 GASHVSSIVRGTVGYL-----DPEYYISQQLTDKSDVYSFGVILLELIS 607
                          +      PE     + T +SDV+++GV+L E+ S
Sbjct: 227 A----DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  115 bits (290), Expect = 2e-28
 Identities = 63/338 (18%), Positives = 111/338 (32%), Gaps = 91/338 (26%)

Query: 413 EKKIGSGGFGVVYYGKLK-DGKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
            + +G GGFGVV+  K K D    A+K +   N    + +   EV  L+++ H  +V++ 
Sbjct: 11  IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 70

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI------------------------- 505
               E        E        E     L+    +                         
Sbjct: 71  NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130

Query: 506 -------------------NWIKR------------LEIAEDAAKGIEYLHTGCVPAIIH 534
                              +W+ R            L I    A+ +E+LH+     ++H
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMH 187

Query: 535 RDLKSSNILLDKHMRAKVSDFGLSK---FAVDGASHVSSIVR--------GTVGYLDPEY 583
           RDLK SNI        KV DFGL        +  + ++ +          GT  Y+ PE 
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247

Query: 584 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 643
                 + K D++S G+IL EL+          F      +     +             
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYS--------FSTQMERVRIITDVR------NLKFPL 293

Query: 644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
               +Y  + M  +  + ++   P    RP  ++++++
Sbjct: 294 LFTQKYPQEHMM-V--QDMLSPSP--TERPEATDIIEN 326

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  114 bits (288), Expect = 2e-28
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 12/212 (5%)

Query: 401 TLSDIEDATKMLEK--KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTL 457
           ++  + D  K   +  KIG G  G VY    +  G+E+A++ +       K    NE+ +
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70

Query: 458 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 517
           +    + N+V +L          +V E++  G+L + +  T   E +I  + R     + 
Sbjct: 71  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----EC 125

Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
            + +E+LH+     +IHRD+KS NILL      K++DFG         S  S++V GT  
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPY 181

Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
           ++ PE    +    K D++S G++ +E+I G+
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  120 bits (301), Expect = 3e-28
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 23/212 (10%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 469
           +++++G+GGFG V     +D G+++A+K          RE +  E+ ++ +++H N+V  
Sbjct: 18  MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77

Query: 470 L------GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE---DAAKG 520
                           +L  E+   G L+++L       +    +K   I     D +  
Sbjct: 78  REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL----NQFENCCGLKEGPIRTLLSDISSA 133

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
           + YLH      IIHRDLK  NI+L    + +  K+ D G +K    G    +  V GT+ 
Sbjct: 134 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQ 188

Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
           YL PE    ++ T   D +SFG +  E I+G 
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  118 bits (297), Expect = 3e-28
 Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 33/212 (15%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLV 467
            ++ +G G FG V   K K  G+E AVKV++    + K +      EV LL ++ H N++
Sbjct: 30  GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------- 519
           +   + +++G   LV E    G L +           I  I R   +E  A         
Sbjct: 90  KLYEFFEDKGYFYLVGEVYTGGELFD----------EI--ISRKRFSEVDAARIIRQVLS 137

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 576
           GI Y+H      I+HRDLK  N+LL    K    ++ DFGLS            I  GT 
Sbjct: 138 GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTA 192

Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
            Y+ PE  +     +K DV+S GVIL  L+SG
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  115 bits (290), Expect = 4e-28
 Identities = 40/217 (18%), Positives = 69/217 (31%), Gaps = 22/217 (10%)

Query: 412 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN 465
           +   +G G F  VY     D       ++  +KV    +       T  +  L       
Sbjct: 69  VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-YGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
            ++F      +  SVLV E    GTL   +     T E+ +     +  A      IE +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRA-----------KVSDFGLSKFA-VDGASHVSSIV 572
           H      IIH D+K  N +L                  + D G S    +     + +  
Sbjct: 189 HDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245

Query: 573 RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
             T G+   E   ++    + D +     +  ++ G 
Sbjct: 246 CETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  117 bits (295), Expect = 6e-28
 Identities = 68/250 (27%), Positives = 103/250 (41%), Gaps = 34/250 (13%)

Query: 375 QHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGKLK-D 431
            H H     R               F  S     ++M    KK+GSG +G V   + K  
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61

Query: 432 GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG 489
             E A+K++   S           EV +L  + H N+++   + +++    LV E    G
Sbjct: 62  HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121

Query: 490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSN 541
            L +           I  I R++  E  A         G+ YLH      I+HRDLK  N
Sbjct: 122 ELFD----------EI--IHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPEN 166

Query: 542 ILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 598
           +LL   +K    K+ DFGLS    +       +  GT  Y+ PE  + ++  +K DV+S 
Sbjct: 167 LLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPE-VLRKKYDEKCDVWSI 223

Query: 599 GVILLELISG 608
           GVIL  L++G
Sbjct: 224 GVILFILLAG 233

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  113 bits (284), Expect = 6e-28
 Identities = 61/295 (20%), Positives = 116/295 (39%), Gaps = 56/295 (18%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 469
            ++K+GSG FG V+  + +  G E  +K +  +  Q   E    E+ +L  + H N+++ 
Sbjct: 26  FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85

Query: 470 LGYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
               ++     +V E    G L       +     L+       +K++         + Y
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM------MNALAY 139

Query: 524 LHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 579
            H+      ++H+DLK  NIL      H   K+ DFGL++       H ++   GT  Y+
Sbjct: 140 FHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAA-GTALYM 193

Query: 580 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 639
            PE    + +T K D++S GV++  L++G        F                   ++ 
Sbjct: 194 APE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP-----F---------TGT------SLEE 232

Query: 640 IIDPSLLDEYDIQSMWK-IEEKA------LMCVLPHGHMRPSISEVLKD--IQDA 685
           +   +   E +     + +  +A      ++   P    RPS ++VL     + A
Sbjct: 233 VQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDP--ERRPSAAQVLHHEWFKQA 285

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  113 bits (285), Expect = 7e-28
 Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 32/210 (15%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
             + +GSG F  V+  K +  GK  A+K +  +         NE+ +L +I H N+V   
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GIE 522
              +      LV + +  G L +          RI  ++R    E DA+         ++
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFD----------RI--LERGVYTEKDASLVIQQVLSAVK 120

Query: 523 YLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           YLH  G    I+HRDLK  N+L    +++ +  ++DFGLSK   +G   +S+   GT GY
Sbjct: 121 YLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGY 173

Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELISG 608
           + PE    +  +   D +S GVI   L+ G
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  113 bits (284), Expect = 2e-27
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 27/213 (12%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 465
           L + IG G F VV     ++ G++ AVK+      TS+      +   E ++   + H +
Sbjct: 28  LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAK 519
           +V+ L     +G   +V+EFM    L      +       +     ++++++       +
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI------LE 141

Query: 520 GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 575
            + Y H       IIHRD+K   +LL   +     K+  FG++    +        V GT
Sbjct: 142 ALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196

Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
             ++ PE    +      DV+  GVIL  L+SG
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  112 bits (281), Expect = 3e-27
 Identities = 58/226 (25%), Positives = 107/226 (47%), Gaps = 20/226 (8%)

Query: 393 PAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREF 451
             E  H     D  +  +++ + +G G FG VY  K  + G   A KV+ + S +   ++
Sbjct: 5   SREYEHVRRDLDPNEVWEIVGE-LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY 63

Query: 452 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWI 508
             E+ +L+   H  +V+ LG    +G+  ++ EF   G +      L   LT E +I  +
Sbjct: 64  IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT-EPQIQVV 122

Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV 568
            R        + + +LH+     IIHRDLK+ N+L+      +++DFG+S   +      
Sbjct: 123 CR-----QMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174

Query: 569 SSIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 609
            S + GT  ++ PE  + + + D     K+D++S G+ L+E+   +
Sbjct: 175 DSFI-GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  115 bits (289), Expect = 3e-27
 Identities = 68/212 (32%), Positives = 97/212 (45%), Gaps = 34/212 (16%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 468
           +   +G G FG V   K +   +E AVKV+   S + K       EV LL ++ H N+++
Sbjct: 26  IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------G 520
                ++     +V E    G L +           I  IKR   +E DAA+       G
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFD----------EI--IKRKRFSEHDAARIIKQVFSG 133

Query: 521 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 576
           I Y+H       I+HRDLK  NILL   +K    K+ DFGLS       + +   + GT 
Sbjct: 134 ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTA 187

Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
            Y+ PE  +     +K DV+S GVIL  L+SG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  113 bits (284), Expect = 3e-27
 Identities = 43/308 (13%), Positives = 86/308 (27%), Gaps = 61/308 (19%)

Query: 374 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGK-LKDG 432
                       VS+      +     +       T +    +G             + G
Sbjct: 39  TSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETG 98

Query: 433 KEIAVKVLTSNSYQG-------KRE---------------------FTNEVTLLSRIHHR 464
           +   V V               K E                     F     L+     +
Sbjct: 99  ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK 158

Query: 465 NLVQFLGYCQEEGRS--VLVYEFMH--NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 520
            +++     ++        +Y  M     T  E L    +  + +    RL++     + 
Sbjct: 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL 218

Query: 521 IEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 579
           +  LH  G    ++H  L+  +I+LD+     ++ F       DGA  VS     + G+ 
Sbjct: 219 LASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR--DGARVVS---SVSRGFE 269

Query: 580 DPEYYISQQL-----------TDKSDVYSFGVILLELISGQ-------EAISNEKFGANC 621
            PE    +             T   D ++ G+++  +               +E    +C
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC 329

Query: 622 RNIVQWAK 629
           +NI Q  +
Sbjct: 330 KNIPQPVR 337

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  111 bits (280), Expect = 3e-27
 Identities = 56/246 (22%), Positives = 99/246 (40%), Gaps = 37/246 (15%)

Query: 379 SLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AV 437
           + P     S  +  P          D +       K +G G F  V   +        A+
Sbjct: 6   AEPRPGAGSLQHAQPPPQPRKKRPEDFK-----FGKILGEGSFSTVVLARELATSREYAI 60

Query: 438 KVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH 494
           K+L       + +      E  ++SR+ H   V+     Q++ +      +  NG L ++
Sbjct: 61  KILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120

Query: 495 LYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDK 546
           +          +        E   +         +EYLH      IIHRDLK  NILL++
Sbjct: 121 IR----KIGSFD--------ETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNE 165

Query: 547 HMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILL 603
            M  +++DFG +K     +     +S V GT  Y+ PE  ++++   KS D+++ G I+ 
Sbjct: 166 DMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVSPE-LLTEKSACKSSDLWALGCIIY 223

Query: 604 ELISGQ 609
           +L++G 
Sbjct: 224 QLVAGL 229

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  111 bits (279), Expect = 5e-27
 Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 2/94 (2%)

Query: 223 PSITVIHLSSKN-LTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-SGCPDLRIIHLEDN 280
           P +  +++   N L G IP  + KL+ L  L++   +++G IPDF S    L  +    N
Sbjct: 76  PYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN 135

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
            L+G LP S+ +LPNL  +    N +SG +P S 
Sbjct: 136 ALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  109 bits (276), Expect = 1e-26
 Identities = 29/107 (27%), Positives = 44/107 (41%), Gaps = 1/107 (0%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 283
           ++  + LS   L G+         +  ++ L  NSL   +       +L  + L +N++ 
Sbjct: 198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY 257

Query: 284 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINL 329
           G LP  L  L  L  L V  N L G +P    L +  V  YA N  L
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  106 bits (267), Expect = 2e-25
 Identities = 40/145 (27%), Positives = 64/145 (44%), Gaps = 9/145 (6%)

Query: 189 SVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP-SITVIHLSSKNLTG--NIPSDLTK 245
            + +  + + W       C    W  + C++D Q   +  + LS  NL     IPS L  
Sbjct: 17  DLGNPTTLSSWL--PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN 74

Query: 246 LSSLVELWL-DGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 303
           L  L  L++   N+L GPIP   +    L  +++    ++G +P  L  +  L  L    
Sbjct: 75  LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSY 134

Query: 304 NMLSGTVPSSL--LSKNVVLNYAGN 326
           N LSGT+P S+  L   V + + GN
Sbjct: 135 NALSGTLPPSISSLPNLVGITFDGN 159

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  106 bits (266), Expect = 3e-25
 Identities = 28/109 (25%), Positives = 55/109 (50%), Gaps = 12/109 (11%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ 281
             +  ++++  N++G IP  L+++ +LV L    N+L+G +P   S  P+L  I  + N+
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160

Query: 282 LTGPLPSSLMNLPNLRE-LYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 329
           ++G +P S  +   L   + +  N L+G +P +            N+NL
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTF----------ANLNL 199

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 96.1 bits (240), Expect = 8e-22
 Identities = 21/91 (23%), Positives = 37/91 (40%), Gaps = 1/91 (1%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVE-LWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 281
           P++  I      ++G IP      S L   + +  N LTG IP      +L  + L  N 
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM 208

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 312
           L G       +  N +++++  N L+  +  
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 59.1 bits (144), Expect = 1e-09
 Identities = 17/68 (25%), Positives = 30/68 (44%), Gaps = 2/68 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++  + L +  + G +P  LT+L  L  L +  N+L G IP         +    +N+ 
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303

Query: 283 T--GPLPS 288
               PLP+
Sbjct: 304 LCGSPLPA 311

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  115 bits (291), Expect = 8e-27
 Identities = 22/118 (18%), Positives = 50/118 (42%), Gaps = 4/118 (3%)

Query: 209 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG 268
                W+  +      +  + +S   ++G++   +++  +L  L +  N+ +  IP    
Sbjct: 166 ANVVGWVLSDGCG--ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGD 221

Query: 269 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           C  L+ + +  N+L+G    ++     L+ L + +N   G +P   L     L+ A N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAEN 279

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  111 bits (281), Expect = 1e-25
 Identities = 39/111 (35%), Positives = 54/111 (48%), Gaps = 4/111 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
             +  +HLS   L+G IPS L  LS L +L L  N L G IP        L  + L+ N 
Sbjct: 418 SELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 330
           LTG +PS L N  NL  + + NN L+G +P  +  L    +L  + N +  
Sbjct: 478 LTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN-SFS 527

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  109 bits (274), Expect = 9e-25
 Identities = 37/121 (30%), Positives = 57/121 (47%), Gaps = 6/121 (4%)

Query: 209 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFS 267
           P+  +  Q    P+ ++  ++L +   TG IP  L+  S LV L L  N L+G IP    
Sbjct: 383 PILPNLCQN---PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439

Query: 268 GCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAG 325
               LR + L  N L G +P  LM +  L  L +  N L+G +PS L   +    ++ + 
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499

Query: 326 N 326
           N
Sbjct: 500 N 500

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  107 bits (269), Expect = 4e-24
 Identities = 31/128 (24%), Positives = 58/128 (45%), Gaps = 3/128 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ 281
            ++  + L   +LTG IPS L+  ++L  + L  N LTG IP       +L I+ L +N 
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGGRGAKHL 339
            +G +P+ L +  +L  L +  N+ +GT+P+++   S  +  N+                
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK 585

Query: 340 NIIIGSSV 347
                 ++
Sbjct: 586 ECHGAGNL 593

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  104 bits (262), Expect = 2e-23
 Identities = 39/95 (41%), Positives = 54/95 (56%), Gaps = 3/95 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 279
            S+  + LSS N +G I  +L     ++L EL+L  N  TG IP   S C +L  +HL  
Sbjct: 368 ASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           N L+G +PSSL +L  LR+L +  NML G +P  L
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  103 bits (260), Expect = 4e-23
 Identities = 38/124 (30%), Positives = 57/124 (45%), Gaps = 13/124 (10%)

Query: 209 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPD-F 266
           P+P   L        S+  + L+    TG IP  L+    +L  L L GN   G +P  F
Sbjct: 262 PIPPLPL-------KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFF 314

Query: 267 SGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYVQNNMLSGTVPSSL--LSKN-VVLN 322
             C  L  + L  N  +G LP  +L+ +  L+ L +  N  SG +P SL  LS + + L+
Sbjct: 315 GSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374

Query: 323 YAGN 326
            + N
Sbjct: 375 LSSN 378

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  102 bits (257), Expect = 9e-23
 Identities = 31/97 (31%), Positives = 42/97 (43%), Gaps = 4/97 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG--CPDLRIIHLEDN 280
             + ++++SS    G IP     L SL  L L  N  TG IPDF    C  L  + L  N
Sbjct: 247 TELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
              G +P    +   L  L + +N  SG +P   L K
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLK 341

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 96.5 bits (241), Expect = 1e-20
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 5/97 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
             +  + LSS N +G +P D L K+  L  L L  N  +G +P+   +    L  + L  
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377

Query: 280 NQLTGPLPSSLMN--LPNLRELYVQNNMLSGTVPSSL 314
           N  +GP+  +L       L+ELY+QNN  +G +P +L
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 94.6 bits (236), Expect = 4e-20
 Identities = 36/128 (28%), Positives = 53/128 (41%), Gaps = 16/128 (12%)

Query: 197 ADWAQEGGDPCLPVPWSWL--QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVE 251
            DW     +PC     ++    C  D    +T I LSSK L      + S L  L+ L  
Sbjct: 31  PDW-SSNKNPC-----TFDGVTCRDD---KVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81

Query: 252 LWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS--SLMNLPNLRELYVQNNMLSGT 309
           L+L  + + G +  F     L  + L  N L+GP+ +  SL +   L+ L V +N L   
Sbjct: 82  LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFP 141

Query: 310 VPSSLLSK 317
              S   K
Sbjct: 142 GKVSGGLK 149

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 91.9 bits (229), Expect = 3e-19
 Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 7/111 (6%)

Query: 223 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTG--PIPDFSGCPDLRIIHLE 278
            S+T + LS  +L+G + +   L   S L  L +  N+L     +        L ++ L 
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159

Query: 279 DNQLTGPLPSSLM---NLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
            N ++G      +       L+ L +  N +SG V  S       L+ + N
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSN 210

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 90.4 bits (225), Expect = 8e-19
 Identities = 32/108 (29%), Positives = 50/108 (46%), Gaps = 2/108 (1%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQL 282
           S+  + +S   L+G IP ++  +  L  L L  N ++G IPD       L I+ L  N+L
Sbjct: 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSS-LLSKNVVLNYAGNINL 329
            G +P ++  L  L E+ + NN LSG +P            +  N  L
Sbjct: 693 DGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGL 740

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 83.8 bits (208), Expect = 9e-17
 Identities = 18/97 (18%), Positives = 37/97 (38%), Gaps = 1/97 (1%)

Query: 219 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHL 277
           +D          +     G     L +LS+     +      G     F     +  + +
Sbjct: 580 NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDM 639

Query: 278 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
             N L+G +P  + ++P L  L + +N +SG++P  +
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 71.9 bits (177), Expect = 4e-13
 Identities = 17/102 (16%), Positives = 33/102 (32%), Gaps = 5/102 (4%)

Query: 230 LSSKNLTGNIPSDLTKLSSLVELWLDGN--SLTGPIP-DFSGCPDLRIIHLEDNQLTGPL 286
           +++  + G     +       E    GN     G      +        ++      G  
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624

Query: 287 PSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 326
             +  N  ++  L +  NMLSG +P  +  +    +LN   N
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 43.0 bits (102), Expect = 4e-04
 Identities = 14/56 (25%), Positives = 26/56 (46%), Gaps = 4/56 (7%)

Query: 275 IHLEDNQLT---GPLPSSLMNLPNLRELYVQNNMLSGTVPS-SLLSKNVVLNYAGN 326
           I L    L      + SSL++L  L  L++ N+ ++G+V      +    L+ + N
Sbjct: 55  IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRN 110

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  114 bits (286), Expect = 9e-27
 Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 45/223 (20%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-------------TSNSYQGKREFTNEVTL 457
             +K+GSG +G V   K K    E A+KV+               N  +   E  NE++L
Sbjct: 40  KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99

Query: 458 LSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDA 517
           L  + H N+++     +++    LV EF   G L E          +I  I R +  E  
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE----------QI--INRHKFDECD 147

Query: 518 AK--------GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGA 565
           A         GI YLH       I+HRD+K  NILL   +  +  K+ DFGLS F     
Sbjct: 148 AANIMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD- 202

Query: 566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
             +   + GT  Y+ PE  + ++  +K DV+S GVI+  L+ G
Sbjct: 203 YKLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  110 bits (276), Expect = 9e-27
 Identities = 55/220 (25%), Positives = 102/220 (46%), Gaps = 23/220 (10%)

Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-FTNEVT- 456
               D+E        ++G G +GVV   +    G+ +AVK + +     +++    ++  
Sbjct: 4   VKADDLEP-----IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI 58

Query: 457 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIKRLEIA 514
            +  +     V F G    EG   +  E M + +L +     +   Q I  + + +  IA
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IA 115

Query: 515 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 574
               K +E+LH+    ++IHRD+K SN+L++   + K+ DFG+S + VD  +       G
Sbjct: 116 VSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--G 171

Query: 575 TVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 609
              Y+ PE  I+ +L       KSD++S G+ ++EL   +
Sbjct: 172 CKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  114 bits (286), Expect = 1e-26
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 26/207 (12%)

Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 471
           +G GGFG V+  ++K   ++ A K L     + ++ +     E  +L+++H R +V  L 
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LA 251

Query: 472 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 522
           Y  + +    LV   M+ G ++ H+Y                  E  A         G+E
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ--------EPRAIFYTAQIVSGLE 303

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH      II+RDLK  N+LLD     ++SD GL+     G +       GT G++ PE
Sbjct: 304 HLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359

Query: 583 YYISQQLTDKSDVYSFGVILLELISGQ 609
             + ++     D ++ GV L E+I+ +
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  108 bits (273), Expect = 1e-26
 Identities = 49/210 (23%), Positives = 78/210 (37%), Gaps = 32/210 (15%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           LE  IG G +G V     K      A K +     +    F  E+ ++  + H N+++  
Sbjct: 13  LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIE 522
              ++     LV E    G L E          R+  + +    E  A          + 
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFE----------RV--VHKRVFRESDAARIMKDVLSAVA 120

Query: 523 YLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           Y H       + HRDLK  N L          K+ DFGL+     G   + + V GT  Y
Sbjct: 121 YCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKV-GTPYY 174

Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELISG 608
           + P+  +      + D +S GV++  L+ G
Sbjct: 175 VSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  110 bits (277), Expect = 2e-26
 Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 18/230 (7%)

Query: 383 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 441
           QR          +        D E        ++G+G  GVV+    K    + A K++ 
Sbjct: 13  QRKRLEAFLTQKQKVGELKDDDFE-----KISELGAGNGGVVFKVSHKPSGLVMARKLIH 67

Query: 442 SNSYQGKREF-TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL-YGTL 499
                  R     E+ +L   +   +V F G    +G   +  E M  G+L + L     
Sbjct: 68  LEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR 127

Query: 500 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 559
             EQ +      +++    KG+ YL       I+HRD+K SNIL++     K+ DFG+S 
Sbjct: 128 IPEQILG-----KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180

Query: 560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
             +D  S  +S V GT  Y+ PE       + +SD++S G+ L+E+  G+
Sbjct: 181 QLID--SMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  110 bits (277), Expect = 3e-26
 Identities = 47/206 (22%), Positives = 100/206 (48%), Gaps = 23/206 (11%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           + +++GSG FGVV+    K  G+    K + +     K    NE+++++++HH  L+   
Sbjct: 55  ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 114

Query: 471 GYCQEEGRSVLVYEFMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
              +++   VL+ EF+  G L      +++     +  + IN+++  +  E    G++++
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDYKM---SEAEVINYMR--QACE----GLKHM 165

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           H     +I+H D+K  NI+ +    +  K+ DFGL+         +  +   T  +  PE
Sbjct: 166 HEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPE 220

Query: 583 YYISQQLTDKSDVYSFGVILLELISG 608
               + +   +D+++ GV+   L+SG
Sbjct: 221 IVDREPVGFYTDMWAIGVLGYVLLSG 246

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  108 bits (272), Expect = 3e-26
 Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 44/223 (19%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV--------LTSNSYQGKRE-FTNEVTLLSRI 461
            ++ +G G   VV     K   KE AVK+         ++   Q  RE    EV +L ++
Sbjct: 21  PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80

Query: 462 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 519
             H N++Q     +      LV++ M  G L +           +   +++ ++E   + 
Sbjct: 81  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD----------YL--TEKVTLSEKETRK 128

Query: 520 -------GIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 571
                   I  LH       I+HRDLK  NILLD  M  K++DFG S   +D    +  +
Sbjct: 129 IMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEKLREV 183

Query: 572 VRGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISG 608
             GT  YL PE               + D++S GVI+  L++G
Sbjct: 184 C-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  107 bits (270), Expect = 4e-26
 Identities = 66/212 (31%), Positives = 94/212 (44%), Gaps = 34/212 (16%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 468
           +   +G G FG V   K +   +E AVKV+   S + K       EV LL ++ H N+++
Sbjct: 26  IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 520
                ++     +V E    G L +           I  IKR   +E  A         G
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFD----------EI--IKRKRFSEHDAARIIKQVFSG 133

Query: 521 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 576
           I Y+H       I+HRDLK  NILL   +K    K+ DFGLS       + +   + GT 
Sbjct: 134 ITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTA 187

Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
            Y+ PE  +     +K DV+S GVIL  L+SG
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  108 bits (271), Expect = 5e-26
 Identities = 58/201 (28%), Positives = 106/201 (52%), Gaps = 13/201 (6%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 469
             +KIG G FG V+ G   +  K +A+K++     + + E    E+T+LS+     + ++
Sbjct: 26  KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKY 85

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G   ++ +  ++ E++  G+  + L      E +I  I R     +  KG++YLH+   
Sbjct: 86  YGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYLHSE-- 138

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
              IHRD+K++N+LL +H   K++DFG++    D     ++ V GT  ++ PE  I Q  
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPE-VIKQSA 195

Query: 590 TD-KSDVYSFGVILLELISGQ 609
            D K+D++S G+  +EL  G+
Sbjct: 196 YDSKADIWSLGITAIELARGE 216

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  108 bits (271), Expect = 6e-26
 Identities = 71/310 (22%), Positives = 114/310 (36%), Gaps = 54/310 (17%)

Query: 403 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRI 461
              ED  ++ E  +G G    V         +E AVK++       +     EV +L + 
Sbjct: 8   GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQC 67

Query: 462 -HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK 519
             HRN+++ + + +EE R  LV+E M  G++             I   KR    E +A+ 
Sbjct: 68  QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS----------HI--HKRRHFNELEASV 115

Query: 520 -------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVS 569
                   +++LH      I HRDLK  NIL    ++    K+ DF L            
Sbjct: 116 VVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172

Query: 570 SIVR------GTVGYLDPE----YYISQQLTDKS-DVYSFGVILLELISGQEAISNEKFG 618
                     G+  Y+ PE    +     + DK  D++S GVIL  L+SG        F 
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP-----FV 227

Query: 619 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQS-MWK-IEEKA------LMCVLPHGH 670
             C +   W +          + +     +Y+     W  I   A      L+       
Sbjct: 228 GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDA--K 285

Query: 671 MRPSISEVLK 680
            R S ++VL+
Sbjct: 286 QRLSAAQVLQ 295

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  112 bits (281), Expect = 6e-26
 Identities = 56/258 (21%), Positives = 112/258 (43%), Gaps = 24/258 (9%)

Query: 364 HKGKKNNYDKEQHRHSLPVQRPVSSLNDAP-AEAAHCFTLSDIEDATK------MLEKKI 416
            + ++  YD ++    +  +  VSS  D    +    +    +E           + +++
Sbjct: 106 ERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEEL 165

Query: 417 GSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE 475
           G+G FGVV+    +  G   A K + +     K     E+  +S + H  LV      ++
Sbjct: 166 GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED 225

Query: 476 EGRSVLVYEFMHNGTLKEHL---YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAI 532
           +   V++YEFM  G L E +   +  ++ ++ + +++  ++ +    G+ ++H       
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR--QVCK----GLCHMHEN---NY 276

Query: 533 IHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
           +H DLK  NI+         K+ DFGL+   +D    V     GT  +  PE    + + 
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTT-GTAEFAAPEVAEGKPVG 334

Query: 591 DKSDVYSFGVILLELISG 608
             +D++S GV+   L+SG
Sbjct: 335 YYTDMWSVGVLSYILLSG 352

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  108 bits (271), Expect = 8e-26
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 22/225 (9%)

Query: 395 EAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKV--LTSNSYQGKREF 451
           E    FT  D++        +IG G +G V     K  G+ +AVK    T +  + K+  
Sbjct: 14  EQHWDFTAEDLK-----DLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL 68

Query: 452 TNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRI--NWIK 509
            +   ++       +VQF G    EG   +  E M     K + Y     +  I    + 
Sbjct: 69  MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128

Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
           +  I     K + +L       IIHRD+K SNILLD+    K+ DFG+S   VD  +   
Sbjct: 129 K--ITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTR 184

Query: 570 SIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 609
               G   Y+ PE  I    +      +SDV+S G+ L EL +G+
Sbjct: 185 DA--GCRPYMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  107 bits (270), Expect = 1e-25
 Identities = 55/247 (22%), Positives = 83/247 (33%), Gaps = 54/247 (21%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKV-----LTSNSYQGKREFTNEVTLLSRIHHRN 465
           L+  IG G +GVV            A+K+     +   + +       EV L+ ++HH N
Sbjct: 30  LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHL----------------------------YG 497
           + +     ++E    LV E  H G L + L                              
Sbjct: 90  IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 498 TLTHEQRINWIKRLEIAEDAAK--------GIEYLHT-GCVPAIIHRDLKSSNILL--DK 546
                            E             + YLH  G    I HRD+K  N L   +K
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG----ICHRDIKPENFLFSTNK 205

Query: 547 HMRAKVSDFGLSKFAVDGASHVSSIVR---GTVGYLDPE--YYISQQLTDKSDVYSFGVI 601
               K+ DFGLSK      +     +    GT  ++ PE     ++    K D +S GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 602 LLELISG 608
           L  L+ G
Sbjct: 266 LHLLLMG 272

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  106 bits (267), Expect = 1e-25
 Identities = 50/294 (17%), Positives = 104/294 (35%), Gaps = 58/294 (19%)

Query: 414 KKIGSGGFGVVYYG-KLKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 469
           +KIGSG FG V+   K  DG   A+K           ++    EV   + +  H ++V++
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
                E+   ++  E+ + G+L + +             +  ++     +G+ Y+H+   
Sbjct: 77  FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS--- 133

Query: 530 PAIIHRDLKSSNILLDKH-------------------MRAKVSDFGLSKFAVDGASHVSS 570
            +++H D+K SNI + +                    +  K+ D G              
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191

Query: 571 IVRGTVGYLDPEYYISQQL--TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 628
              G   +L  E  + +      K+D+++  + ++     +    N           QW 
Sbjct: 192 ---GDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---------QWH 238

Query: 629 KLHIESGDIQGIIDPSLLDEY--DIQSMWKIEEKALMCVLPHGHMRPSISEVLK 680
           +  I  G +     P +      +   + K      + + P    RPS   ++K
Sbjct: 239 E--IRQGRL-----PRIPQVLSQEFTELLK------VMIHPDPERRPSAMALVK 279

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  106 bits (267), Expect = 2e-25
 Identities = 67/239 (28%), Positives = 116/239 (48%), Gaps = 30/239 (12%)

Query: 390 NDAPAEAAHCFTLSDIEDATKM--LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQ 446
           +D+PA +     LS + D   +  L + +G+G +G VY G+ +K G+  A+KV+      
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-D 62

Query: 447 GKREFTNEVTLLSRI-HHRNLVQFLG-YCQEEGRSV-----LVYEFMHNGT----LKEHL 495
            + E   E+ +L +  HHRN+  + G + ++    +     LV EF   G+    +K   
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122

Query: 496 YGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF 555
             TL  E+ I +I R     +  +G+ +LH   V   IHRD+K  N+LL ++   K+ DF
Sbjct: 123 GNTLK-EEWIAYICR-----EILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDF 173

Query: 556 GLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 609
           G+S          ++ + GT  ++ PE     +  D     KSD++S G+  +E+  G 
Sbjct: 174 GVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  110 bits (276), Expect = 2e-25
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 19/202 (9%)

Query: 416 IGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLG 471
           +G GGFG V   +++   ++ A K L     + ++      NE  +L +++ R +V  L 
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LA 250

Query: 472 YC-QEEGRSVLVYEFMHNGTLKEHLYGTLTH---EQRINWIKRLEIAEDAAKGIEYLHTG 527
           Y  + +    LV   M+ G LK H+Y        E R         AE    G+E LH  
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA----VFYAAE-ICCGLEDLHRE 305

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               I++RDLK  NILLD H   ++SD GL+    +G + +   V GTVGY+ PE   ++
Sbjct: 306 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 360

Query: 588 QLTDKSDVYSFGVILLELISGQ 609
           + T   D ++ G +L E+I+GQ
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQ 382

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  105 bits (264), Expect = 3e-25
 Identities = 63/219 (28%), Positives = 108/219 (49%), Gaps = 25/219 (11%)

Query: 403 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEV 455
           S +ED  + + +++GSG F +V   + K  GKE A K +      +S     + E   EV
Sbjct: 1   SMVEDHYE-MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59

Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEI 513
            +L  I H N++      + +   VL+ E +  G L + L    +LT ++   ++K  +I
Sbjct: 60  NILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK--QI 117

Query: 514 AEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVS 569
            +    G+ YLH+     I H DLK  NI+L      + R K+ DFG++   ++  +   
Sbjct: 118 LD----GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFK 169

Query: 570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
           +I  GT  ++ PE    + L  ++D++S GVI   L+SG
Sbjct: 170 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  108 bits (270), Expect = 3e-25
 Identities = 28/235 (11%), Positives = 59/235 (25%), Gaps = 43/235 (18%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIH--- 462
             +G             + G+   V V               K E      L    +   
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 463 ---------------HRNLVQFLGYCQEEGRSVLVYEF-------MHNGTLKEHLYGTLT 500
                               + +    +E    ++  F        +  T  E L    +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 501 HEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 559
             + +    RL++     + +  LH  G    ++H  L+  +I+LD+     ++ F    
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 560 FAVDGASHVSSIVRGTVGYLDPEYYISQQ-----LTDKSDVYSFGVILLELISGQ 609
                A                      Q     +T   D ++ G+ +  +    
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  106 bits (266), Expect = 3e-25
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 464
           + +++GSG F +V   + K  G E A K +       S     + E   EV++L ++ H 
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 522
           N++      +     VL+ E +  G L + L    +L+ E+  ++IK  +I +    G+ 
Sbjct: 76  NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--QILD----GVN 129

Query: 523 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           YLHT     I H DLK  NI+L          K+ DFGL+   ++      +I  GT  +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEF 184

Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELISG 608
           + PE    + L  ++D++S GVI   L+SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  109 bits (275), Expect = 4e-25
 Identities = 63/207 (30%), Positives = 97/207 (46%), Gaps = 24/207 (11%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEVTLLSRIH---HRNL 466
           + IG GGFG VY  +  D  ++ A+K L     + K+  T   NE  +LS +       +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254

Query: 467 VQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEY 523
           V  + Y      +   + + M+ G L  HL   G  + E  +    R   AE    G+E+
Sbjct: 255 VC-MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-EADM----RFYAAE-IILGLEH 307

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           +H      +++RDLK +NILLD+H   ++SD GL+        H  + V GT GY+ PE 
Sbjct: 308 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEV 361

Query: 584 YISQQLTDKS-DVYSFGVILLELISGQ 609
                  D S D +S G +L +L+ G 
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  105 bits (265), Expect = 5e-25
 Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 24/218 (11%)

Query: 403 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLS 459
            +  +   +  K++G G F VV     K  G+E A K L         + E  +E+ +L 
Sbjct: 24  ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLE 83

Query: 460 RI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTL----KEHLYGTLTHEQRINWIKRLEIA 514
                  ++      +     +L+ E+   G +       L   ++    I  IK  +I 
Sbjct: 84  LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK--QIL 141

Query: 515 EDAAKGIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 570
           E    G+ YLH       I+H DLK  NILL         K+ DFG+S+  +  A  +  
Sbjct: 142 E----GVYYLHQNN----IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHACELRE 192

Query: 571 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
           I+ GT  YL PE      +T  +D+++ G+I   L++ 
Sbjct: 193 IM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  106 bits (266), Expect = 5e-25
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 464
           + +++GSG F +V   + K  G E A K +       S     + E   EV++L ++ H 
Sbjct: 16  IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 522
           N++      +     VL+ E +  G L + L    +L+ E+  ++IK  +I +    G+ 
Sbjct: 76  NIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK--QILD----GVN 129

Query: 523 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           YLHT     I H DLK  NI+L          K+ DFGL+   ++      +I  GT  +
Sbjct: 130 YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEF 184

Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELISG 608
           + PE    + L  ++D++S GVI   L+SG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  106 bits (267), Expect = 5e-25
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLV 467
           + + IG G FG V   +  D K++ A+K +       + E  N   E+ ++  + H  LV
Sbjct: 19  ILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLV 78

Query: 468 QFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYL 524
             L Y  Q+E    +V + +  G L+ HL        E+ +    +L I E     ++YL
Sbjct: 79  N-LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK-EETV----KLFICE-LVMALDYL 131

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 584
                  IIHRD+K  NILLD+H    ++DF ++          +  + GT  Y+ PE +
Sbjct: 132 QNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMF 186

Query: 585 ISQQLT--DKS-DVYSFGVILLELISGQ 609
            S++      + D +S GV   EL+ G+
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGR 214

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  105 bits (263), Expect = 6e-25
 Identities = 52/203 (25%), Positives = 99/203 (48%), Gaps = 16/203 (7%)

Query: 411 MLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
            + +K+G G +G VY     + G+ +A+K +        +E   E++++ +    ++V++
Sbjct: 32  DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKY 89

Query: 470 LGYCQEEGRSVLVYEFMHNGTLK---EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
            G   +     +V E+   G++         TLT E  I  I +        KG+EYLH 
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT-EDEIATILQ-----STLKGLEYLHF 143

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 IHRD+K+ NILL+    AK++DFG++    D  +  ++++ GT  ++ PE    
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQE 199

Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
                 +D++S G+  +E+  G+
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGK 222

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  104 bits (261), Expect = 7e-25
 Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 31/211 (14%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 468
           +++++G G F VV     K  G E A K++ +     +       E  +  ++ H N+V+
Sbjct: 10  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KG 520
                QEE    LV++ +  G L E           I  + R   +E  A        + 
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFE----------DI--VAREFYSEADASHCIQQILES 117

Query: 521 IEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
           I Y H+     I+HR+LK  N+LL    K    K++DFGL+    D          GT G
Sbjct: 118 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFA-GTPG 172

Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELISG 608
           YL PE       +   D+++ GVIL  L+ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  105 bits (263), Expect = 7e-25
 Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 21/218 (9%)

Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE-FTNEV-T 456
             ++D+E        ++GSG  G V+  + +    + AVK +  +  + + +    ++  
Sbjct: 22  AEINDLE-----NLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV 76

Query: 457 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 516
           +L       +VQ  G         +  E M     K  L   +        + +  +   
Sbjct: 77  VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGK--MTVA 132

Query: 517 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 576
             K + YL       +IHRD+K SNILLD+  + K+ DFG+S   VD  +   S   G  
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCA 188

Query: 577 GYLDPEYYISQQLTD-----KSDVYSFGVILLELISGQ 609
            Y+ PE       T      ++DV+S G+ L+EL +GQ
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  106 bits (266), Expect = 7e-25
 Identities = 63/252 (25%), Positives = 111/252 (44%), Gaps = 30/252 (11%)

Query: 373 KEQHRHSLPVQRPVSSLNDAPAEAA---HCFTLS---DIEDATKMLEKK-IGSGGFGVVY 425
               R  +  +R  +   D PA  A   H    +    +     + + + +G G FG V+
Sbjct: 47  DLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVH 106

Query: 426 YGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE 484
             +    G ++A K++ +   + K E  NE+++++++ H NL+Q     + +   VLV E
Sbjct: 107 KCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166

Query: 485 FMHNGTL------KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 538
           ++  G L      + +     T    I ++K  +I E    GI ++H      I+H DLK
Sbjct: 167 YVDGGELFDRIIDESYNL---TELDTILFMK--QICE----GIRHMHQM---YILHLDLK 214

Query: 539 SSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVY 596
             NIL         K+ DFGL++        +     GT  +L PE      ++  +D++
Sbjct: 215 PENILCVNRDAKQIKIIDFGLARR-YKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMW 272

Query: 597 SFGVILLELISG 608
           S GVI   L+SG
Sbjct: 273 SVGVIAYMLLSG 284

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  104 bits (262), Expect = 8e-25
 Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 30/217 (13%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 469
           L++ IGSG   VV         +++A+K +     Q   +    E+  +S+ HH N+V +
Sbjct: 19  LQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY 78

Query: 470 LGYCQEEGRSVLVYEFMHNGTL----------KEHLYGTLTHEQRINWIKRLEIAEDAAK 519
                 +    LV + +  G++           EH  G L  E  I  I R     +  +
Sbjct: 79  YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILR-----EVLE 132

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT-VG- 577
           G+EYLH       IHRD+K+ NILL +    +++DFG+S F   G     + VR T VG 
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189

Query: 578 --YLDPEYYISQQLTD---KSDVYSFGVILLELISGQ 609
             ++ PE  + +Q+     K+D++SFG+  +EL +G 
Sbjct: 190 PCWMAPE--VMEQVRGYDFKADIWSFGITAIELATGA 224

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  105 bits (265), Expect = 8e-25
 Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 43/222 (19%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 462
            +  IG G   VV     +  G E AVK++   + +   E           E  +L ++ 
Sbjct: 98  PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157

Query: 463 -HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 519
            H +++  +   +      LV++ M  G L +           +   +++ ++E   +  
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFD----------YL--TEKVALSEKETRSI 205

Query: 520 ------GIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIV 572
                  + +LH       I+HRDLK  NILLD +M+ ++SDFG S     G   +  + 
Sbjct: 206 MRSLLEAVSFLHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELC 260

Query: 573 RGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISG 608
            GT GYL PE               + D+++ GVIL  L++G
Sbjct: 261 -GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  104 bits (261), Expect = 1e-24
 Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 40/219 (18%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIH-- 462
           L   +G GGFG V+ G  L D  ++A+KV+  N   G    ++      EV LL ++   
Sbjct: 35  LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAG 94

Query: 463 --HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 519
             H  +++ L + + +   +LV E        + L+  +T +  +         E  ++ 
Sbjct: 95  GGHPGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLG--------EGPSRC 143

Query: 520 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSI 571
                   I++ H+  V   +HRD+K  NIL+D     AK+ DFG      D        
Sbjct: 144 FFGQVVAAIQHCHSRGV---VHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199

Query: 572 VRGTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 608
             GT  Y  PE +IS+       + V+S G++L +++ G
Sbjct: 200 --GTRVYSPPE-WISRHQYHALPATVWSLGILLYDMVCG 235

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  103 bits (258), Expect = 1e-24
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 37/214 (17%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 465
           L + +G G +G V         + +AVK++            K+E    + +   ++H N
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHEN 66

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------ 519
           +V+F G+ +E     L  E+   G L + +               + + E  A+      
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQL 114

Query: 520 --GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTV 576
             G+ YLH      I HRD+K  N+LLD+    K+SDFGL+          + + + GT+
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 577 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 608
            Y+ PE  + ++       DV+S G++L  +++G
Sbjct: 172 PYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  103 bits (260), Expect = 1e-24
 Identities = 62/291 (21%), Positives = 110/291 (37%), Gaps = 55/291 (18%)

Query: 374 EQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKM-----LEKKIGSGGFGVVYYGK 428
             H H           + AP    H   L+  ++   +     +   +GSGGFG VY G 
Sbjct: 4   SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63

Query: 429 -LKDGKEIAVKVLTSNSYQGKREFTN------EVTLLSRIHHR--NLVQFLGYCQEEGRS 479
            + D   +A+K +  +      E  N      EV LL ++      +++ L + +     
Sbjct: 64  RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123

Query: 480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPA 531
           VL+ E       ++ L+  +T    +         E+ A+         + + H   V  
Sbjct: 124 VLILERPEPV--QD-LFDFITERGALQ--------EELARSFFWQVLEAVRHCHNCGV-- 170

Query: 532 IIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
            +HRD+K  NIL+D      K+ DFG      D          GT  Y  PE +I     
Sbjct: 171 -LHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPE-WIRYHRY 225

Query: 591 D--KSDVYSFGVILLELISG------QEAISNEKFG------ANCRNIVQW 627
               + V+S G++L +++ G       E I   +        + C+++++W
Sbjct: 226 HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW 276

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  104 bits (261), Expect = 2e-24
 Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 464
             +++GSG F VV   + K  G + A K +      +S     + +   EV++L  I H 
Sbjct: 15  TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIE 522
           N++      + +   +L+ E +  G L + L    +LT E+   ++K  +I      G+ 
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK--QILN----GVY 128

Query: 523 YLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           YLH+     I H DLK  NI+L        R K+ DFGL+   +D  +   +I  GT  +
Sbjct: 129 YLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEFKNIF-GTPEF 183

Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELISG 608
           + PE    + L  ++D++S GVI   L+SG
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  105 bits (264), Expect = 2e-24
 Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 43/221 (19%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 462
           + K +GSG  G V     +   K++A+++++   +                E+ +L +++
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198

Query: 463 HRNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 519
           H  +++   +   E     +V E M  G L +          ++  +    + E   K  
Sbjct: 199 HPCIIKIKNFFDAE--DYYIVLELMEGGELFD----------KV--VGNKRLKEATCKLY 244

Query: 520 ------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 570
                  ++YLH      IIHRDLK  N+LL   ++    K++DFG SK   +  S + +
Sbjct: 245 FYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRT 300

Query: 571 IVRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISG 608
           +  GT  YL PE      +       D +S GVIL   +SG
Sbjct: 301 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  103 bits (259), Expect = 2e-24
 Identities = 37/203 (18%), Positives = 88/203 (43%), Gaps = 18/203 (8%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           + + +G G FG+V+        K    K +       +     E+++L+   HRN++   
Sbjct: 9   IAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLY---GTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
              +     V+++EF+    + E +      L   + ++++   ++ E     +++LH+ 
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH--QVCE----ALQFLHSH 121

Query: 528 CVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
               I H D++  NI+    +    K+ +FG ++  +    +   +      Y  PE + 
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLF-TAPEYYAPEVHQ 176

Query: 586 SQQLTDKSDVYSFGVILLELISG 608
              ++  +D++S G ++  L+SG
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSG 199

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  103 bits (260), Expect = 3e-24
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 31/211 (14%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 468
           +++++G G F VV     K  G E A K++ +     +       E  +  ++ H N+V+
Sbjct: 33  VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA--------KG 520
                QEE    LV++ +  G L E           I  + R   +E  A        + 
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFE----------DI--VAREFYSEADASHCIQQILES 140

Query: 521 IEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
           I Y H+     I+HR+LK  N+LL    K    K++DFGL+   V+ +        GT G
Sbjct: 141 IAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGFA-GTPG 195

Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELISG 608
           YL PE       +   D+++ GVIL  L+ G
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  105 bits (263), Expect = 4e-24
 Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 32/212 (15%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--FTNEVTLLSRIHHRNLVQ 468
           L +++G G F VV        G+E A  ++ +     +       E  +   + H N+V+
Sbjct: 15  LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------G 520
                 EEG   L+++ +  G L E           I  + R   +E DA+         
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFE----------DI--VAREYYSEADASHCIQQILEA 122

Query: 521 IEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 576
           + + H  G    ++HR+LK  N+LL    K    K++DFGL+               GT 
Sbjct: 123 VLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTP 177

Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
           GYL PE           D+++ GVIL  L+ G
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  104 bits (260), Expect = 4e-24
 Identities = 45/216 (20%), Positives = 82/216 (37%), Gaps = 28/216 (12%)

Query: 412 LEKKIGSG--GFGVVYYGK-LKDGKEIAVKV--LTSNSYQGKREFTNEVTLLSRIHHRNL 466
           L   IG G      V   +    G+ + V+   L + S +       E+ +    +H N+
Sbjct: 29  LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGT----LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           V +      +    +V  FM  G+    +  H    +  E  I +I +        K ++
Sbjct: 89  VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN-ELAIAYILQ-----GVLKALD 142

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR------GTV 576
           Y+H       +HR +K+S+IL+    +  +S    +   +        +          +
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199

Query: 577 GYLDPEYYISQQL---TDKSDVYSFGVILLELISGQ 609
            +L PE  + Q L     KSD+YS G+   EL +G 
Sbjct: 200 PWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGH 234

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  102 bits (257), Expect = 6e-24
 Identities = 67/251 (26%), Positives = 108/251 (43%), Gaps = 26/251 (10%)

Query: 368 KNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYG 427
             N   +     +P      SL D   + A  F   D E     L + IG G FG VY+ 
Sbjct: 17  TENLYFQGAMDPMPAGGRAGSLKDP--DVAELFFKDDPEKLFSDLRE-IGHGSFGAVYFA 73

Query: 428 K-LKDGKEIAVKVLTSNSYQGKREFT---NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY 483
           + +++ + +A+K ++ +  Q   ++     EV  L ++ H N +Q+ G    E  + LV 
Sbjct: 74  RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133

Query: 484 EFMHNG--TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN 541
           E+       L E     L  E  I  +        A +G+ YLH+     +IHRD+K+ N
Sbjct: 134 EYCLGSASDLLEVHKKPLQ-EVEIAAVTH-----GALQGLAYLHSH---NMIHRDVKAGN 184

Query: 542 ILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSF 598
           ILL +    K+ DFG +       S V     GT  ++ PE  ++        K DV+S 
Sbjct: 185 ILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSL 239

Query: 599 GVILLELISGQ 609
           G+  +EL   +
Sbjct: 240 GITCIELAERK 250

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  102 bits (256), Expect = 6e-24
 Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 37/214 (17%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 465
           L + +G G +G V         + +AVK++            K+E    + +   ++H N
Sbjct: 11  LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHEN 66

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK------ 519
           +V+F G+ +E     L  E+   G L + +               + + E  A+      
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRI------------EPDIGMPEPDAQRFFHQL 114

Query: 520 --GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTV 576
             G+ YLH      I HRD+K  N+LLD+    K+SDFGL+          + + + GT+
Sbjct: 115 MAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171

Query: 577 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 608
            Y+ PE  + ++       DV+S G++L  +++G
Sbjct: 172 PYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  102 bits (255), Expect = 1e-23
 Identities = 69/267 (25%), Positives = 108/267 (40%), Gaps = 42/267 (15%)

Query: 363 MHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAEAAHCF--------TLSDIEDATKMLEK 414
           MH    ++   +    +L  Q   S    A    A               + D  + +E 
Sbjct: 1   MHHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFE-VES 59

Query: 415 KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC 473
           ++G G   +VY  K K   K  A+KVL       K+    E+ +L R+ H N+++     
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GIEYLH 525
           +      LV E +  G L +          RI  +++   +E DAA         + YLH
Sbjct: 118 ETPTEISLVLELVTGGELFD----------RI--VEKGYYSERDAADAVKQILEAVAYLH 165

Query: 526 T-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
             G    I+HRDLK  N+L          K++DFGLSK  V+    + ++  GT GY  P
Sbjct: 166 ENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC-GTPGYCAP 219

Query: 582 EYYISQQLTDKSDVYSFGVILLELISG 608
           E         + D++S G+I   L+ G
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCG 246

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  100 bits (251), Expect = 3e-23
 Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 38/217 (17%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--------TSNSYQGKREFTNEVTLLSRIH 462
               +GSG FG V+     +  KE+ VK +                 + T E+ +LSR+ 
Sbjct: 28  TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE 87

Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--- 519
           H N+++ L   + +G   LV E   +G     L+  +    R++        E  A    
Sbjct: 88  HANIIKVLDIFENQGFFQLVMEKHGSGL---DLFAFIDRHPRLD--------EPLASYIF 136

Query: 520 -----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVR 573
                 + YL       IIHRD+K  NI++ +    K+ DFG + +   G   +      
Sbjct: 137 RQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--- 190

Query: 574 GTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 608
           GT+ Y  PE  +        + +++S GV L  L+  
Sbjct: 191 GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFE 226

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  100 bits (250), Expect = 4e-23
 Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 43/221 (19%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE--------FTNEVTLLSRIH 462
           + K +GSG  G V     +   K++A+K+++   +                E+ +L +++
Sbjct: 14  MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73

Query: 463 HRNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 519
           H  +++   +   E     +V E M  G L +          ++  +    + E   K  
Sbjct: 74  HPCIIKIKNFFDAE--DYYIVLELMEGGELFD----------KV--VGNKRLKEATCKLY 119

Query: 520 ------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSS 570
                  ++YLH      IIHRDLK  N+LL   ++    K++DFG SK   +  S + +
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRT 175

Query: 571 IVRGTVGYLDPE---YYISQQLTDKSDVYSFGVILLELISG 608
           +  GT  YL PE      +       D +S GVIL   +SG
Sbjct: 176 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 99.3 bits (248), Expect = 7e-23
 Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 38/223 (17%)

Query: 403 SDIEDA--TKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLS 459
           S         + +K +G G F +      K   +  AVK+++       +    E+T L 
Sbjct: 4   SPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALK 60

Query: 460 RI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DA 517
               H N+V+      ++  + LV E ++ G L E          RI   K+   +E +A
Sbjct: 61  LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE----------RI--KKKKHFSETEA 108

Query: 518 AK-------GIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGAS 566
           +         + ++H  G    ++HRDLK  N+L    + ++  K+ DFG ++       
Sbjct: 109 SYIMRKLVSAVSHMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164

Query: 567 HVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISG 608
            + +    T+ Y  PE  ++Q   D+S D++S GVIL  ++SG
Sbjct: 165 PLKTPC-FTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSG 205

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 98.5 bits (246), Expect = 8e-23
 Identities = 53/222 (23%), Positives = 89/222 (40%), Gaps = 46/222 (20%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--------TSNSYQGKREFTNEVTLLSRIH 462
           +   +G G +G V      +     AVK+L         +     K+E    + LL R+ 
Sbjct: 9   MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE----IQLLRRLR 64

Query: 463 HRNLVQFLGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK- 519
           H+N++Q +     E +    +V E+   G ++E +  ++         KR       A  
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQE-MLDSVPE-------KRFP--VCQAHG 113

Query: 520 -------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS----KFAVDGASHV 568
                  G+EYLH+     I+H+D+K  N+LL      K+S  G++     FA D     
Sbjct: 114 YFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170

Query: 569 SSIVRGTVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 608
           S    G+  +  PE           K D++S GV L  + +G
Sbjct: 171 SQ---GSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 38/213 (17%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSR-IHHRNLVQF 469
           +++ IG G + V      K    E AVK++  +      E    + +L R   H N++  
Sbjct: 26  VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITL 81

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE-DAAK-------GI 521
                +     +V E M  G L +          +I  +++   +E +A+         +
Sbjct: 82  KDVYDDGKYVYVVTELMKGGELLD----------KI--LRQKFFSEREASAVLFTITKTV 129

Query: 522 EYLHT-GCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 576
           EYLH  G    ++HRDLK SNIL           ++ DFG +K        + +    T 
Sbjct: 130 EYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTA 184

Query: 577 GYLDPEYYISQQLTDKS-DVYSFGVILLELISG 608
            ++ PE  + +Q  D + D++S GV+L  +++G
Sbjct: 185 NFVAPE-VLERQGYDAACDIWSLGVLLYTMLTG 216

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 98.6 bits (246), Expect = 2e-22
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 38/213 (17%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHRNLV 467
             K IGSG FGV    +     + +AVK +    +     +RE    +     + H N+V
Sbjct: 24  FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIV 79

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-------- 519
           +F           ++ E+   G L E +                  +ED A+        
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELYERI------------CNAGRFSEDEARFFFQQLLS 127

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGASHVSSIVRGTVG 577
           G+ Y H+  +    HRDLK  N LLD     R K+ DFG SK +V  +   S++  GT  
Sbjct: 128 GVSYCHSMQI---CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPA 182

Query: 578 YLDPEYYISQQLTD--KSDVYSFGVILLELISG 608
           Y+ PE  + +Q  D   +DV+S GV L  ++ G
Sbjct: 183 YIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVG 214

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 99.4 bits (248), Expect = 2e-22
 Identities = 58/211 (27%), Positives = 85/211 (40%), Gaps = 25/211 (11%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 469
           K IG G F  V   K+K   ++ A+K++       + E   F  E  +L     R + Q 
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ- 125

Query: 470 LGYC-QEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           L +  Q+E    LV E+   G L   L  +G     +      R  +AE     I+ +H 
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMA----RFYLAE-IVMAIDSVHR 180

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 585
                 +HRD+K  NILLD+    +++DFG       DG       V GT  YL PE   
Sbjct: 181 L---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQ 236

Query: 586 SQQLTDKSDVY-------SFGVILLELISGQ 609
           +      +  Y       + GV   E+  GQ
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 95.7 bits (239), Expect = 5e-22
 Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 40/215 (18%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 463
           L   +G G FG V  G+    G ++AVK+L            + KRE    +  L    H
Sbjct: 15  LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE----IQNLKLFRH 70

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 519
            ++++            +V E++  G L +++             K   + E  A+    
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYI------------CKHGRVEEMEARRLFQ 118

Query: 520 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 575
                ++Y H      ++HRDLK  N+LLD HM AK++DFGLS    DG    +S   G+
Sbjct: 119 QILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GS 173

Query: 576 VGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 608
             Y  PE  IS +L    + D++S GVIL  L+ G
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 97.4 bits (243), Expect = 8e-22
 Identities = 66/243 (27%), Positives = 104/243 (42%), Gaps = 30/243 (12%)

Query: 381 PVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVK-V 439
               P+   N      A      +  +      K IG+G FGVV+  KL +  E+A+K V
Sbjct: 13  VKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV 72

Query: 440 LTSNSYQGKREFTN-EVTLLSRIHHRNLVQFLGYCQEEGRSV------LVYEFMHNGTLK 492
           L     Q KR F N E+ ++  + H N+V    +    G         LV E++   T+ 
Sbjct: 73  L-----QDKR-FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVY 125

Query: 493 EHLYGTLTHEQRI--NWIKRL--EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM 548
                    +Q +    IK    ++     + + Y+H+     I HRD+K  N+LLD   
Sbjct: 126 RASRHYAKLKQTMPMLLIKLYMYQL----LRSLAYIHSI---GICHRDIKPQNLLLDPPS 178

Query: 549 RA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELI 606
              K+ DFG +K  + G  +VS I   +  Y  PE    +   T   D++S G ++ EL+
Sbjct: 179 GVLKLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236

Query: 607 SGQ 609
            GQ
Sbjct: 237 QGQ 239

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 97.9 bits (244), Expect = 8e-22
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 33/214 (15%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 469
           K IG G FG V   KLK+  ++ A+K+L       + E   F  E  +L     + +   
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT- 138

Query: 470 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 520
           L Y  Q++    LV ++   G L   L      E R+         E+ A+         
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLS---KFEDRLP--------EEMARFYLAEMVIA 187

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           I+ +H       +HRD+K  NIL+D +   +++DFG     ++  +  SS+  GT  Y+ 
Sbjct: 188 IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244

Query: 581 PEYYISQQLTDKS-----DVYSFGVILLELISGQ 609
           PE   + +          D +S GV + E++ G+
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 39/214 (18%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL------TSNSYQGKREFTNEVTLLSRIHHR 464
           L K IG G F  V   + +  G+E+A+K++       ++  +  RE    V ++  ++H 
Sbjct: 19  LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE----VRIMKILNHP 74

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 519
           N+V+     + E    L+ E+   G + ++L            +    + E  A+     
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYL------------VAHGRMKEKEARSKFRQ 122

Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 576
               ++Y H      I+HRDLK+ N+LLD  M  K++DFG S     G   + +   G  
Sbjct: 123 IVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAP 177

Query: 577 GYLDPEYYISQQLTD--KSDVYSFGVILLELISG 608
            Y  PE     +  D  + DV+S GVIL  L+SG
Sbjct: 178 PYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSG 210

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 95.5 bits (238), Expect = 2e-21
 Identities = 62/307 (20%), Positives = 111/307 (36%), Gaps = 70/307 (22%)

Query: 403 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSR 460
             + D  ++ ++ +G G  G V     +  G++ A+K+L              EV    +
Sbjct: 24  YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY------DSPKARQEVDHHWQ 77

Query: 461 I-HHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA- 514
                ++V  L   +          ++ E M  G L            RI   +R + A 
Sbjct: 78  ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS----------RI--QERGDQAF 125

Query: 515 --EDAAK-------GIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAV 562
              +AA+        I++LH+     I HRD+K  N+L    +K    K++DFG +K   
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182

Query: 563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR 622
             A  + +    T  Y+ PE    ++     D++S GVI+  L+ G        F +N  
Sbjct: 183 QNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP-----FYSNTG 234

Query: 623 NIVQWAKLH-IESGDIQGIIDPSLLDEYDIQSMW-KIEEKA------LMCVLPHGHMRPS 674
             +       I  G           +       W ++ E A      L+   P    R +
Sbjct: 235 QAISPGMKRRIRLGQY------GFPNPE-----WSEVSEDAKQLIRLLLKTDP--TERLT 281

Query: 675 ISEVLKD 681
           I++ +  
Sbjct: 282 ITQFMNH 288

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 95.0 bits (237), Expect = 3e-21
 Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 38/223 (17%)

Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEV 455
             L   +       K +G+G FG V   K K+     A+K+L        ++     NE 
Sbjct: 38  AQLDQFD-----RIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92

Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 515
            +L  ++   LV+     ++     +V E++  G +  HL        R +        E
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFS--------E 140

Query: 516 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 567
             A+          EYLH+     +I+RDLK  N+L+D+    +V+DFG +K        
Sbjct: 141 PHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193

Query: 568 VSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
            +  + GT   L PE  I  +  +K+ D ++ GV++ E+ +G 
Sbjct: 194 RTWTLCGTPEALAPE-IILSKGYNKAVDWWALGVLIYEMAAGY 235

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 94.5 bits (236), Expect = 3e-21
 Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 38/223 (17%)

Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFT---NEV 455
           ++L D +     + + +G+G FG V+  + +      A+KVL        ++     +E 
Sbjct: 3   YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 57

Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 515
            +LS + H  +++  G  Q+  +  ++ +++  G L   L       QR           
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFP--------N 105

Query: 516 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH 567
             AK         +EYLH+     II+RDLK  NILLDK+   K++DFG +K+  D    
Sbjct: 106 PVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-- 160

Query: 568 VSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
               + GT  Y+ PE  +S +  +KS D +SFG+++ E+++G 
Sbjct: 161 --YTLCGTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 95.6 bits (238), Expect = 3e-21
 Identities = 58/255 (22%), Positives = 99/255 (38%), Gaps = 47/255 (18%)

Query: 376 HRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKE 434
           H  + P   P         ++      + I D  K+  + +G G  G V     K   ++
Sbjct: 30  HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89

Query: 435 IAVKVLTSNSYQGKRE-FTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV----LVYEFMHN 488
            A+K+L              EV L  R     ++V+ +   +          +V E +  
Sbjct: 90  FALKMLQ------DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143

Query: 489 GTLKEHLYGTLTHEQRINWIKRLEIA---EDAA-------KGIEYLHT-GCVPAIIHRDL 537
           G L            RI    R + A    +A+       + I+YLH+      I HRD+
Sbjct: 144 GELFS----------RI--QDRGDQAFTEREASEIMKSIGEAIQYLHSIN----IAHRDV 187

Query: 538 KSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS- 593
           K  N+L      +   K++DFG +K      + +++    T  Y+ PE  +  +  DKS 
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPC-YTPYYVAPE-VLGPEKYDKSC 244

Query: 594 DVYSFGVILLELISG 608
           D++S GVI+  L+ G
Sbjct: 245 DMWSLGVIMYILLCG 259

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 96.0 bits (239), Expect = 4e-21
 Identities = 68/251 (27%), Positives = 103/251 (41%), Gaps = 23/251 (9%)

Query: 367 KKNNYDKEQHRHSLPVQRP-VSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY 425
           KK    +   R   P        +  + A+  H  T+++ E       K +G G FG V 
Sbjct: 111 KKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFE-----YLKLLGKGTFGKVI 165

Query: 426 YGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQFLGYC-QEEGRSV 480
             K K      A+K+L       K E  +   E  +L    H  L   L Y  Q   R  
Sbjct: 166 LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA-LKYSFQTHDRLC 224

Query: 481 LVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLK 538
            V E+ + G L  HL      + E R     R   AE     ++YLH+     +++RDLK
Sbjct: 225 FVMEYANGGELFFHLSRERVFS-EDRA----RFYGAE-IVSALDYLHSEK--NVVYRDLK 276

Query: 539 SSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSF 598
             N++LDK    K++DFGL K  +   + + +   GT  YL PE           D +  
Sbjct: 277 LENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGRAVDWWGL 335

Query: 599 GVILLELISGQ 609
           GV++ E++ G+
Sbjct: 336 GVVMYEMMCGR 346

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 95.6 bits (238), Expect = 6e-21
 Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 40/215 (18%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 463
           L   +G G FG V  GK    G ++AVK+L            + +RE    +  L    H
Sbjct: 20  LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLFRH 75

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 519
            ++++            +V E++  G L +++             K   + E  ++    
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYI------------CKNGRLDEKESRRLFQ 123

Query: 520 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 575
               G++Y H   V   +HRDLK  N+LLD HM AK++DFGLS    DG    +S   G+
Sbjct: 124 QILSGVDYCHRHMV---VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GS 178

Query: 576 VGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 608
             Y  PE  IS +L    + D++S GVIL  L+ G
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCG 212

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 61/245 (24%), Positives = 100/245 (40%), Gaps = 71/245 (28%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------------------TSNSYQGKREF 451
           L+ +IG G +GVV       D    A+KVL                   T  +  G  + 
Sbjct: 17  LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76

Query: 452 TN-------EVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY-------- 496
                    E+ +L ++ H N+V+             + E + +   ++HLY        
Sbjct: 77  RGPIEQVYQEIAILKKLDHPNVVK-------------LVEVLDDPN-EDHLYMVFELVNQ 122

Query: 497 GTLTHEQRINWIKRLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHM 548
           G +     +       ++ED A+        GIEYLH      IIHRD+K SN+L+ +  
Sbjct: 123 GPV-----MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDG 174

Query: 549 RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD----KSDVYSFGVILLE 604
             K++DFG+S       + +S+ V GT  ++ PE  +S+          DV++ GV L  
Sbjct: 175 HIKIADFGVSNEFKGSDALLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYC 232

Query: 605 LISGQ 609
            + GQ
Sbjct: 233 FVFGQ 237

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 33/218 (15%)

Query: 411 MLEKKIGSGGFGVVYYGKLKD-GKEIAVK-VLTSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
            +E+  G G FG V  GK K  G  +A+K V+    ++  RE    +  L+ +HH N+VQ
Sbjct: 26  QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-NRELQ-IMQDLAVLHHPNIVQ 83

Query: 469 ----FLGYCQEEGRSV---LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 519
               F    + + R +   +V E++   TL            R  + +++       K  
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCC--------RNYYRRQVAPPPILIKVF 134

Query: 520 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIV 572
                  I  LH   V  + HRD+K  N+L+++     K+ DFG +K       +V+ I 
Sbjct: 135 LFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193

Query: 573 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 609
             +  Y  PE    +Q  T   D++S G I  E++ G+
Sbjct: 194 --SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 93.1 bits (232), Expect = 2e-20
 Identities = 73/247 (29%), Positives = 109/247 (44%), Gaps = 27/247 (10%)

Query: 372 DKEQHRHSLPVQRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKD 431
            +  + +  P   P   +N  P+   H    SD         K IG G FG V   + K 
Sbjct: 8   PELMNANPAPPPAPSQQINLGPSSNPH-AKPSDFH-----FLKVIGKGSFGKVLLARHKA 61

Query: 432 GKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQFLGYC-QEEGRSVLVYEF 485
            +   AVKVL   +   K+E  + ++    LL  + H  LV  L +  Q   +   V ++
Sbjct: 62  EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG-LHFSFQTADKLYFVLDY 120

Query: 486 MHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL 543
           ++ G L  HL        E R     R   AE  A  + YLH+     I++RDLK  NIL
Sbjct: 121 INGGELFYHLQRERCFL-EPRA----RFYAAE-IASALGYLHSL---NIVYRDLKPENIL 171

Query: 544 LDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVIL 602
           LD      ++DFGL K  ++  S  S+   GT  YL PE  + +Q  D++ D +  G +L
Sbjct: 172 LDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPE-VLHKQPYDRTVDWWCLGAVL 229

Query: 603 LELISGQ 609
            E++ G 
Sbjct: 230 YEMLYGL 236

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 93.2 bits (232), Expect = 3e-20
 Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 34/213 (15%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 469
           K IG G FG V   + K  +++ A+K+L+      + +   F  E  +++  +   +VQ 
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ- 133

Query: 470 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 520
           L Y  Q++    +V E+M  G L   +                ++ E  A+         
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM-------------SNYDVPEKWARFYTAEVVLA 180

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           ++ +H+      IHRD+K  N+LLDK    K++DFG                 GT  Y+ 
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237

Query: 581 PEYYISQQLT---DKS-DVYSFGVILLELISGQ 609
           PE   SQ       +  D +S GV L E++ G 
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 93.2 bits (232), Expect = 3e-20
 Identities = 68/218 (31%), Positives = 98/218 (44%), Gaps = 39/218 (17%)

Query: 411 MLEKKIGSGGFGVVYYGKLKD-GKEIAVK-VLTSNSYQGKREFTN-EVTLLSRIHHRNLV 467
              K IG+G FGVVY  KL D G+ +A+K VL     Q KR F N E+ ++ ++ H N+V
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-----QDKR-FKNRELQIMRKLDHCNIV 110

Query: 468 QFLGYCQEEGRSV------LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK-- 519
           +   +    G         LV +++      E +Y    H  R        +     K  
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAK----QTLPVIYVKLY 161

Query: 520 ------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIV 572
                  + Y+H+     I HRD+K  N+LLD      K+ DFG +K  V G  +VS I 
Sbjct: 162 MYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218

Query: 573 RGTVGYLDPEYYI-SQQLTDKSDVYSFGVILLELISGQ 609
             +  Y  PE    +   T   DV+S G +L EL+ GQ
Sbjct: 219 --SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 90.6 bits (225), Expect = 3e-20
 Identities = 24/203 (11%), Positives = 56/203 (27%), Gaps = 43/203 (21%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLV 467
           L    G       +        +++A+  +           +E  +    LSRI    + 
Sbjct: 35  LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-T 526
           + L         ++V E++  G+L+E    + +          +   +  A   +  H  
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA------IRAMQSLAAAADAAHRA 148

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
           G    +       S + +       ++                     T+   +P+    
Sbjct: 149 G----VALSIDHPSRVRVSIDGDVVLAYP------------------ATMPDANPQ---- 182

Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
                  D+   G  L  L+  +
Sbjct: 183 ------DDIRGIGASLYALLVNR 199

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 54/216 (25%), Positives = 97/216 (44%), Gaps = 43/216 (19%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL-------TSNSYQGKREFTNEVTLLSRIHH 463
           + + +G G FG V      K  +++A+K +       +    + +RE    ++ L  + H
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRH 68

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK---- 519
            ++++           V+V E+   G L +++            +++  + ED  +    
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYA-GGELFDYI------------VEKKRMTEDEGRRFFQ 115

Query: 520 ----GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRG 574
                IEY H      I+HRDLK  N+LLD ++  K++DFGLS    DG     S    G
Sbjct: 116 QIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---G 169

Query: 575 TVGYLDPEYYISQQLTD--KSDVYSFGVILLELISG 608
           +  Y  PE  I+ +L    + DV+S G++L  ++ G
Sbjct: 170 SPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVG 204

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 90.3 bits (225), Expect = 7e-20
 Identities = 70/232 (30%), Positives = 116/232 (50%), Gaps = 27/232 (11%)

Query: 388 SLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSN 443
           ++     E       S  E     L K +G G FG V+        D +++ A+KVL   
Sbjct: 9   AITHHVKEGHEKADPSQFE-----LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA 63

Query: 444 SYQGKREF--TNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GT 498
           + + +       E  +L  ++H  +V+ L Y  Q EG+  L+ +F+  G L   L     
Sbjct: 64  TLKVRDRVRTKMERDILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 122

Query: 499 LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS 558
            T E+ +    +  +AE  A  +++LH+     II+RDLK  NILLD+    K++DFGLS
Sbjct: 123 FT-EEDV----KFYLAE-LALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLS 173

Query: 559 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
           K ++D      S   GTV Y+ PE  ++++   +S D +SFGV++ E+++G 
Sbjct: 174 KESIDHEKKAYSFC-GTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 92.4 bits (230), Expect = 1e-19
 Identities = 24/108 (22%), Positives = 42/108 (38%), Gaps = 4/108 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
            ++  + +S  +           LSSL  L + GNS         F+   +L  + L   
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN--VVLNYAGN 326
           QL    P++  +L +L+ L + +N             N   VL+Y+ N
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 528

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 87.8 bits (218), Expect = 3e-18
 Identities = 22/109 (20%), Positives = 39/109 (35%), Gaps = 5/109 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 280
            S+ V+ ++  +   N   D  T+L +L  L L    L    P  F+    L+++++  N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS---LLSKNVVLNYAGN 326
                       L +L+ L    N +  +         S    LN   N
Sbjct: 505 NFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 87.8 bits (218), Expect = 4e-18
 Identities = 23/96 (23%), Positives = 36/96 (37%), Gaps = 1/96 (1%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
           P + V+ LS   +          LS L  L L GN +       FSG   L+ +   +  
Sbjct: 52  PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
           L       + +L  L+EL V +N++         S 
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 85.9 bits (213), Expect = 1e-17
 Identities = 20/106 (18%), Positives = 37/106 (34%), Gaps = 2/106 (1%)

Query: 212 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCP 270
            ++L        ++T + LS   L    P+    LSSL  L +  N+        +    
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518

Query: 271 DLRIIHLEDNQLTGPLPSSLMNLP-NLRELYVQNNMLSGTVPSSLL 315
            L+++    N +       L + P +L  L +  N  + T      
Sbjct: 519 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 564

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 84.3 bits (209), Expect = 4e-17
 Identities = 14/97 (14%), Positives = 29/97 (29%), Gaps = 3/97 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
            S+  + LS   +   + S+   L  L  L    ++L        F    +L  + +   
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
                       L +L  L +  N         + ++
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 80.1 bits (198), Expect = 9e-16
 Identities = 27/109 (24%), Positives = 40/109 (36%), Gaps = 5/109 (4%)

Query: 223 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 280
           PS+  + LS   L+  G         +SL  L L  N +     +F G   L  +  + +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406

Query: 281 QLTGPLPSS-LMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 326
            L      S  ++L NL  L + +             LS   VL  AGN
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGN 455

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 77.4 bits (191), Expect = 6e-15
 Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 7/111 (6%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLEDN 280
            S+  +     NL       +  L +L EL +  N +    +P+ FS   +L  + L  N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 281 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSLLSKN-VVLNYAGN 326
           ++     + L  L  +      L +  N ++   P +        L    N
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 77.0 bits (190), Expect = 1e-14
 Identities = 20/93 (21%), Positives = 34/93 (36%), Gaps = 5/93 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ 281
           P+IT       N    IP +L    S   L L  N L       F   P+L+++ L   +
Sbjct: 8   PNITY-QCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           +      +  +L +L  L +  N +      + 
Sbjct: 64  IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF 96

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 68.9 bits (169), Expect = 3e-12
 Identities = 23/107 (21%), Positives = 37/107 (34%), Gaps = 4/107 (3%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPD-FSGCPDLRIIH 276
                 ++  L+  +  G        L SL  L L  N L+  G       G   L+ + 
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379

Query: 277 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
           L  N +   + S+ + L  L  L  Q++ L      S+      L Y
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 62.4 bits (152), Expect = 3e-10
 Identities = 16/102 (15%), Positives = 31/102 (30%), Gaps = 5/102 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSL----VELWLDGNSLTGPIPDFSGCPDLRIIHLE 278
            ++  + LSS  +     +DL  L  +    + L L  N +    P       L  + L 
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208

Query: 279 DNQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPSSLLSKNV 319
           +N  +  +    +  L  L    +               K+ 
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 62.0 bits (151), Expect = 4e-10
 Identities = 15/125 (12%), Positives = 36/125 (28%), Gaps = 11/125 (8%)

Query: 213 SWLQCNSDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG----PIPDFS 267
           +++Q  +  +  +  + L +   + N+    +  L+ L    L              D S
Sbjct: 190 NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKS 249

Query: 268 GCPDLRIIHLEDNQLT------GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 321
               L  + +E+ +L         +      L N+    + +  +      S       L
Sbjct: 250 ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHL 309

Query: 322 NYAGN 326
                
Sbjct: 310 ELVNC 314

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 55.4 bits (134), Expect = 4e-08
 Identities = 22/130 (16%), Positives = 43/130 (33%), Gaps = 25/130 (19%)

Query: 221 PQPSITVIHLSSKNLTGN-IPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 279
              +I    L+  +   + I      L+++    L   ++   + DFS     + + L +
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVN 313

Query: 280 NQLT-------------------GPLPSSLMNLPNLRELYVQNNMLS--GTVPSSL--LS 316
            +                     G    S ++LP+L  L +  N LS  G    S    +
Sbjct: 314 CKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373

Query: 317 KNVVLNYAGN 326
               L+ + N
Sbjct: 374 SLKYLDLSFN 383

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 16/100 (16%), Positives = 25/100 (25%), Gaps = 28/100 (28%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPD-LRIIHLEDN 280
            S+ V+++S  N           L+SL  L    N +           P  L  ++L  N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553

Query: 281 QLTG--------------------------PLPSSLMNLP 294
                                           PS    +P
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP 593

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 89.6 bits (223), Expect = 2e-19
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 32/210 (15%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTN---EVTLLSRIHHRNLVQF 469
           K +G G FG V   + K      A+K+L       K E  +   E  +L    H  L   
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA- 69

Query: 470 LGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK--------G 520
           L Y  Q   R   V E+ + G L  HL      E+           E+ A+         
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFT--------EERARFYGAEIVSA 117

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           +EYLH+     +++RD+K  N++LDK    K++DFGL K  +   + + +   GT  YL 
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLA 173

Query: 581 PEYYISQQLTDKS-DVYSFGVILLELISGQ 609
           PE  +      ++ D +  GV++ E++ G+
Sbjct: 174 PE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 88.4 bits (220), Expect = 4e-19
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 36/214 (16%)

Query: 414 KKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSNSYQGKREFT----NEVTLLSRIHHRN 465
           + +G GG+G V+        +  +I A+KVL         + T     E  +L  + H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82

Query: 466 LVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK----- 519
           +V  L Y  Q  G+  L+ E++  G L   L      E            ED A      
Sbjct: 83  IVD-LIYAFQTGGKLYLILEYLSGGELFMQLE----REGIFM--------EDTACFYLAE 129

Query: 520 ---GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 576
               + +LH      II+RDLK  NI+L+     K++DFGL K ++   +   +   GT+
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTI 185

Query: 577 GYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
            Y+ PE  + +   +++ D +S G ++ ++++G 
Sbjct: 186 EYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 87.7 bits (218), Expect = 6e-19
 Identities = 48/205 (23%), Positives = 95/205 (46%), Gaps = 21/205 (10%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLG 471
           +K+G G +  V+    + + +++ VK+L       K++   E+ +L  +    N++    
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 98

Query: 472 --YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
                      LV+E ++N   K  LY TLT      ++  +       K ++Y H+   
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFK-QLYQTLTDYDIRFYMYEI------LKALDYCHSM-- 149

Query: 530 PAIIHRDLKSSNILLDKHMRA-KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             I+HRD+K  N+++D   R  ++ D+GL++F   G  +   +   +  +  PE  +  Q
Sbjct: 150 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVDYQ 206

Query: 589 LTDKS-DVYSFGVILLELISGQEAI 612
           + D S D++S G +L  +I  +E  
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPF 231

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 87.2 bits (217), Expect = 7e-19
 Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 23/205 (11%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 468
           +K+G G +GVVY  K   G+ +A+K +  ++   + E    T   E++LL  +HH N+V 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDA---EDEGIPSTAIREISLLKELHHPNIVS 83

Query: 469 FLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
            +     E    LV+EFM      + +     L   Q   ++ +L       +G+ + H 
Sbjct: 84  LIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL------LRGVAHCHQ 137

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 585
                I+HRDLK  N+L++     K++DFGL++ F +   S+   +V  T+ Y  P+  +
Sbjct: 138 HR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLM 192

Query: 586 -SQQLTDKSDVYSFGVILLELISGQ 609
            S++ +   D++S G I  E+I+G+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 25/212 (11%)

Query: 411 MLEK-----KIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN--EVTLLSRIH 462
           M+EK     KIG G +GVV+  + +D G+ +A+K    +      +     E+ +L ++ 
Sbjct: 1   MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK 60

Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIAEDAAK 519
           H NLV  L   + + R  LV+E+  + T+   L  Y     E  + +   +        +
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQT------LQ 113

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGY 578
            + + H       IHRD+K  NIL+ KH   K+ DFG ++        +   +   T  Y
Sbjct: 114 AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA--TRWY 168

Query: 579 LDPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
             PE  +         DV++ G +  EL+SG 
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 86.9 bits (216), Expect = 2e-18
 Identities = 63/243 (25%), Positives = 103/243 (42%), Gaps = 40/243 (16%)

Query: 383 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 441
           +      N     +++   + + E       + +G G FG V   ++K+  ++ AVKVL 
Sbjct: 3   KESSKEGNGIGVNSSNRLGIDNFE-----FIRVLGKGSFGKVMLARVKETGDLYAVKVL- 56

Query: 442 SNSYQGKREF---TNEVT--------LLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNG 489
                 K++     ++V         L    +H  L Q L  C Q   R   V EF++ G
Sbjct: 57  ------KKDVILQDDDVECTMTEKRILSLARNHPFLTQ-LFCCFQTPDRLFFVMEFVNGG 109

Query: 490 TLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH 547
            L  H+        E R     R   AE     + +LH      II+RDLK  N+LLD  
Sbjct: 110 DLMFHIQKSRRFD-EARA----RFYAAE-IISALMFLHDK---GIIYRDLKLDNVLLDHE 160

Query: 548 MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELI 606
              K++DFG+ K  +      ++   GT  Y+ PE  + + L   + D ++ GV+L E++
Sbjct: 161 GHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEML 218

Query: 607 SGQ 609
            G 
Sbjct: 219 CGH 221

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 88.6 bits (220), Expect = 2e-18
 Identities = 24/96 (25%), Positives = 41/96 (42%), Gaps = 2/96 (2%)

Query: 224 SITVIHLSSKNL-TGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            I +I++   NL T  + + L K+  L  L    N L G +P F     L  ++L  NQ+
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQI 365

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 318
           T    +       +  L   +N L   +P+   +K+
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKS 400

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 81.2 bits (201), Expect = 4e-16
 Identities = 15/111 (13%), Positives = 32/111 (28%), Gaps = 8/111 (7%)

Query: 208 LPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-F 266
            PV  S  +        + ++      L G +P+       L  L L  N +T    +  
Sbjct: 320 FPVETSLQKM-----KKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFC 373

Query: 267 SGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
                +  +    N+L   P      ++  +  +    N +      +   
Sbjct: 374 GFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 80.1 bits (198), Expect = 1e-15
 Identities = 25/119 (21%), Positives = 40/119 (33%), Gaps = 14/119 (11%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG--------PIPDFSGCPDLRI 274
            +++ I+LS+  ++       +  S L  + L GN LT            +F     L  
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492

Query: 275 IHLEDNQLTGPLPSSLM--NLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINL 329
           I L  N+LT  L        LP L  + +  N  S   P+     S           + 
Sbjct: 493 IDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDA 549

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 78.2 bits (193), Expect = 4e-15
 Identities = 25/116 (21%), Positives = 42/116 (36%), Gaps = 10/116 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED- 279
             +T I L    LT  +  D   T L  LV + L  NS +           L+   + + 
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQ 546

Query: 280 -----NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 330
                N+     P  +   P+L +L + +N +   V   +     VL+   N N+ 
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKITPNISVLDIKDNPNIS 601

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 77.4 bits (191), Expect = 7e-15
 Identities = 19/115 (16%), Positives = 39/115 (33%), Gaps = 13/115 (11%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVEL------WLDGNSLTGPIPD-FSGCPDLRII 275
           P +  I LS  + +   P+     S+L            GN      P+  + CP L  +
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571

Query: 276 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNIN 328
            +  N +   +   +   PN+  L +++N       S +    +  +     +  
Sbjct: 572 QIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 76.2 bits (188), Expect = 2e-14
 Identities = 12/104 (11%), Positives = 32/104 (30%), Gaps = 10/104 (9%)

Query: 221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 279
              +    +                L  L ++ +        +P      P++++I++  
Sbjct: 223 ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVAC 282

Query: 280 NQLT--------GPLPSSLMNLPNLRELYVQNNML-SGTVPSSL 314
           N+              +       ++ +Y+  N L +  V +SL
Sbjct: 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 74.3 bits (183), Expect = 5e-14
 Identities = 16/128 (12%), Positives = 36/128 (28%), Gaps = 22/128 (17%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP------------------- 264
             T I   S N+T  +   + +L+ L + ++  +                          
Sbjct: 184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTED 242

Query: 265 -DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
             +    DL  + + +      LP+ L  LP ++ + V  N               + + 
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADA 301

Query: 324 AGNINLHE 331
                +  
Sbjct: 302 PVGEKIQI 309

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 74.3 bits (183), Expect = 7e-14
 Identities = 21/163 (12%), Positives = 52/163 (31%), Gaps = 19/163 (11%)

Query: 183 DGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQ--CNSDPQPSITV--------IHLSS 232
           D +A+  +    +  +W+Q+G        W++ +       QP +++        + L  
Sbjct: 31  DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEG 90

Query: 233 KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF-----SGCPDLRIIHLEDNQLTGPLP 287
              +G +P  + +L+ L  L L  +        F     S                    
Sbjct: 91  FGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFV 150

Query: 288 SSLM--NLPNLRELYVQNNMLSGTVPSS--LLSKNVVLNYAGN 326
                 +  +L +  + ++    ++  S  +  K+  +    N
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSN 193

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 72.4 bits (178), Expect = 3e-13
 Identities = 13/92 (14%), Positives = 27/92 (29%), Gaps = 4/92 (4%)

Query: 228 IHLSSKNLTGNIPSDLTKL--SSLVELWLDGNSLTGPIPDFSG-CPDLRIIHLEDNQLTG 284
                 +          +   S L++  ++ +     I   S        I    N +T 
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197

Query: 285 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
            +  ++M L  LR+ Y+ N+            
Sbjct: 198 -VSKAVMRLTKLRQFYMGNSPFVAENICEAWE 228

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 72.0 bits (177), Expect = 3e-13
 Identities = 15/102 (14%), Positives = 31/102 (30%), Gaps = 11/102 (10%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 279
             +  ++L+   +T    +       +  L    N L   IP+         +  I    
Sbjct: 353 IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSY 411

Query: 280 NQLTG-------PLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           N++         PL  +     N+  + + NN +S       
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELF 453

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 70.5 bits (173), Expect = 1e-12
 Identities = 17/124 (13%), Positives = 37/124 (29%), Gaps = 21/124 (16%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 283
            +    ++S     +I           ++    N++T           LR  ++ ++   
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219

Query: 284 GP-------------------LPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLN 322
                                      NL +L ++ V N      +P+ L  L +  ++N
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279

Query: 323 YAGN 326
            A N
Sbjct: 280 VACN 283

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 70.1 bits (172), Expect = 1e-12
 Identities = 18/109 (16%), Positives = 37/109 (33%), Gaps = 11/109 (10%)

Query: 223 PSITVIHLSSKNLTGNIPS--DLTKLSSLVELWLDGNSLTGPI--------PDFSGCPDL 272
             +  +  +   L   IP+  D   +S +  +    N +            P      ++
Sbjct: 377 EQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435

Query: 273 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 321
             I+L +NQ++            L  + +  NML+    +SL  +N   
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 55.8 bits (135), Expect = 3e-08
 Identities = 14/113 (12%), Positives = 32/113 (28%), Gaps = 10/113 (8%)

Query: 223 PSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIPDFSG---CPDLRII 275
             + V+ L S     N     P  ++   S  +             D+       DL   
Sbjct: 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKD 164

Query: 276 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 326
            +  +     +  S        ++   +N ++  V  ++  L+K        +
Sbjct: 165 CINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNS 216

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 85.7 bits (213), Expect = 3e-18
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 22/205 (10%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTN--EVTLLSRIHHRNLVQF 469
             +G G +G+V   + KD   I A+K  L S+  +  +      E+ LL ++ H NLV  
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRHENLVNL 89

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRI-NWIKRLEIAEDAAKGIEYLHT 526
           L  C+++ R  LV+EF+ + T+ + L  +      Q +  ++ ++        GI + H+
Sbjct: 90  LEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQI------INGIGFCHS 142

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 585
                IIHRD+K  NIL+ +    K+ DFG ++  A  G  +   +   T  Y  PE  +
Sbjct: 143 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA--TRWYRAPELLV 197

Query: 586 -SQQLTDKSDVYSFGVILLELISGQ 609
              +     DV++ G ++ E+  G+
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGE 222

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 63/230 (27%), Positives = 101/230 (43%), Gaps = 41/230 (17%)

Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVY---YGKLKDGKEI-AVKVLTSNSYQGKREFT--- 452
             + + E     L K +G+G +G V+        D  ++ A+KVL   +   K + T   
Sbjct: 51  VGIENFE-----LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 105

Query: 453 -NEVTLLSRI-HHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK 509
             E  +L  I     LV  L Y  Q E +  L+ ++++ G L  HL       +R     
Sbjct: 106 RTERQVLEHIRQSPFLVT-LHYAFQTETKLHLILDYINGGELFTHLS----QRERFT--- 157

Query: 510 RLEIAEDAAK--------GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA 561
                E   +         +E+LH      II+RD+K  NILLD +    ++DFGLSK  
Sbjct: 158 -----EHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209

Query: 562 VDGASHVSSIVRGTVGYLDPE-YYISQQLTDKS-DVYSFGVILLELISGQ 609
           V   +  +    GT+ Y+ P+         DK+ D +S GV++ EL++G 
Sbjct: 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 85.7 bits (213), Expect = 4e-18
 Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 468
           + IG G +  V   +LK    I A+KV+         +     T         +H  LV 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74

Query: 469 FLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
            L  C Q E R   V E+++ G L  H+     L  E+      R   AE  +  + YLH
Sbjct: 75  -LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP-EEHA----RFYSAE-ISLALNYLH 127

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
                 II+RDLK  N+LLD     K++D+G+ K  +      S+   GT  Y+ PE  +
Sbjct: 128 ER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPE-IL 182

Query: 586 SQQLTDKS-DVYSFGVILLELISGQ 609
             +    S D ++ GV++ E+++G+
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGR 207

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 84.1 bits (209), Expect = 5e-18
 Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 23/204 (11%)

Query: 415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQF 469
           KIG G +GVVY  +   G+  A+K +       + E    T   E+++L  + H N+V+ 
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEK---EDEGIPSTTIREISILKELKHSNIVKL 65

Query: 470 LGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
                 + R VLV+E +      L +   G L      +++ +L        GI Y H  
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL------LNGIAYCHDR 119

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI- 585
               ++HRDLK  N+L+++    K++DFGL++ F +    +   IV  T+ Y  P+  + 
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMG 174

Query: 586 SQQLTDKSDVYSFGVILLELISGQ 609
           S++ +   D++S G I  E+++G 
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGT 198

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 84.6 bits (210), Expect = 6e-18
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 30/210 (14%)

Query: 415 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGK-----REFTNEVTLLSRIHHRNLVQ 468
           K+G+G +  VY G  K      A+K +  +S +G      RE    ++L+  + H N+V+
Sbjct: 12  KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKHENIVR 67

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEH-LYGTLTHEQRINWIKRLEIAEDAA------KGI 521
                  E +  LV+EFM      ++ L   +      N  + LE+           +G+
Sbjct: 68  LYDVIHTENKLTLVFEFM------DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLD 580
            + H      I+HRDLK  N+L++K  + K+ DFGL++ F +   +  S +V  T+ Y  
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLWYRA 176

Query: 581 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 609
           P+  + S+  +   D++S G IL E+I+G+
Sbjct: 177 PDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 87.0 bits (215), Expect = 7e-18
 Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 19/204 (9%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 468
             +G G FG V   + K   E+ AVK+L  +      +    +     L        L Q
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406

Query: 469 FLGYC-QEEGRSVLVYEFMHNGTLKEHLYGT-LTHEQRINWIKRLEIAEDAAKGIEYLHT 526
            L  C Q   R   V E+++ G L  H+       E           AE  A G+ +L +
Sbjct: 407 -LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA----VFYAAE-IAIGLFFLQS 460

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                II+RDLK  N++LD     K++DFG+ K  +       +   GT  Y+ PE  I+
Sbjct: 461 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPE-IIA 515

Query: 587 QQLTDKS-DVYSFGVILLELISGQ 609
            Q   KS D ++FGV+L E+++GQ
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQ 539

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 26/236 (11%)

Query: 383 QRPVSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEI-AVKVLT 441
           +   +       +A+    L D +     L + IG G +  V   +LK    I A++V+ 
Sbjct: 32  EEKEAMNTRESGKASSSLGLQDFD-----LLRVIGRGSYAKVLLVRLKKTDRIYAMRVVK 86

Query: 442 SNSYQGKREFTNEVT----LLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY 496
                   +     T         +H  LV  L  C Q E R   V E+++ G L  H+ 
Sbjct: 87  KELVNDDEDIDWVQTEKHVFEQASNHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQ 145

Query: 497 --GTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD 554
               L  E+      R   AE  +  + YLH      II+RDLK  N+LLD     K++D
Sbjct: 146 RQRKLP-EEHA----RFYSAE-ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196

Query: 555 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
           +G+ K  +      S+   GT  Y+ PE  +  +    S D ++ GV++ E+++G+
Sbjct: 197 YGMCKEGLRPGDTTSTFC-GTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 250

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 35/212 (16%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREF---TNEVT--------LLSRI 461
             +G G FG V   + K   E+ AVK+L       K++     ++V         L    
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKIL-------KKDVVIQDDDVECTMVEKRVLALPG 78

Query: 462 HHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAA 518
               L Q L  C Q   R   V E+++ G L  H+   G    E           AE  A
Sbjct: 79  KPPFLTQ-LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK-EPHA----VFYAAE-IA 131

Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
            G+ +L +     II+RDLK  N++LD     K++DFG+ K  +       +   GT  Y
Sbjct: 132 IGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDY 187

Query: 579 LDPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
           + PE  I+ Q   KS D ++FGV+L E+++GQ
Sbjct: 188 IAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 84.5 bits (209), Expect = 2e-17
 Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 49/235 (20%)

Query: 405 IEDATKMLEKKIGSGGFGVVYYGKLKD---GKEIAVKVLTSNSYQGKREFTN--EVTLLS 459
           +ED  +    K+G G +G VY  K KD    K+ A+K +           +   E+ LL 
Sbjct: 18  VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLR 73

Query: 460 RIHHRNLVQFLGYCQEEG-RSV-LVYEFMHNGTLKEH-LYGTL-THEQRINWIKRLEIAE 515
            + H N++           R V L++++       EH L+  +  H       K +++  
Sbjct: 74  ELKHPNVISLQKVFLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPR 127

Query: 516 DAAK--------GIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKF--- 560
              K        GI YLH      ++HRDLK +NIL+     +  R K++D G ++    
Sbjct: 128 GMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184

Query: 561 AVDGASHVSSIVRGTVGYLDPE------YYISQQLTDKSDVYSFGVILLELISGQ 609
            +   + +  +V  T  Y  PE      +Y     T   D+++ G I  EL++ +
Sbjct: 185 PLKPLADLDPVVV-TFWYRAPELLLGARHY-----TKAIDIWAIGCIFAELLTSE 233

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 83.4 bits (207), Expect = 2e-17
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 21/205 (10%)

Query: 414 KKIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKREFTNEVT----LLSRIHHRNLVQ 468
           K +G G FG V+  + K   +  A+K L  +      +    +     L     H  L  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82

Query: 469 FLGYC-QEEGRSVLVYEFMHNGTLKEHLY--GTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
            +    Q +     V E+++ G L  H+         +          AE    G+++LH
Sbjct: 83  -MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRA-----TFYAAE-IILGLQFLH 135

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI 585
           +     I++RDLK  NILLDK    K++DFG+ K  + G +  ++   GT  Y+ PE  +
Sbjct: 136 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE-IL 190

Query: 586 SQQLTDKS-DVYSFGVILLELISGQ 609
             Q  + S D +SFGV+L E++ GQ
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 24/208 (11%)

Query: 415 KIGSGGFGVVYYGKLKDGKEI-AVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 468
           KIG G +G V+  K ++  EI A+K +  +      E    +   E+ LL  + H+N+V+
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDD---DDEGVPSSALREICLLKELKHKNIVR 65

Query: 469 FLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
                  + +  LV+EF         +   G L  E   +++ +L       KG+ + H+
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL------LKGLGFCHS 119

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYI 585
                ++HRDLK  N+L++++   K+++FGL++ F +    + + +V  T+ Y  P+   
Sbjct: 120 RN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLF 174

Query: 586 -SQQLTDKSDVYSFGVILLELISGQEAI 612
            ++  +   D++S G I  EL +    +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL 202

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 82.2 bits (204), Expect = 5e-17
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 21/206 (10%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLV 467
             +G G F  VY  +     + +A+K +        ++    T   E+ LL  + H N++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75

Query: 468 QFLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
             L     +    LV++FM      + +     LT      ++          +G+EYLH
Sbjct: 76  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMT------LQGLEYLH 129

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEY- 583
                 I+HRDLK +N+LLD++   K++DFGL+K F     ++   +V  T  Y  PE  
Sbjct: 130 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TRWYRAPELL 184

Query: 584 YISQQLTDKSDVYSFGVILLELISGQ 609
           + ++      D+++ G IL EL+   
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRV 210

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 83.5 bits (207), Expect = 9e-17
 Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 5/109 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
           P + V++L    L+          ++L EL L  NS+     + F    +L  + L  N 
Sbjct: 73  PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKNVVLNYAGN 326
           L+     + + L NL+EL + NN +       L     S    L  + N
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 82.7 bits (205), Expect = 1e-16
 Identities = 25/107 (23%), Positives = 41/107 (38%), Gaps = 3/107 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
             +T + +    ++   P    KL  L  L L  N L+      F+ C +L  +HL  N 
Sbjct: 49  SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 326
           +     +  +   NL  L + +N LS T   +   L     L  + N
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 82.4 bits (204), Expect = 2e-16
 Identities = 19/97 (19%), Positives = 35/97 (36%), Gaps = 3/97 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 279
            ++  + LS   L+        +L +L EL L  N +     +         L+ + L  
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
           NQ+    P     +  L  L++ N  L  ++   L  
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCL 217

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 81.2 bits (201), Expect = 5e-16
 Identities = 20/112 (17%), Positives = 45/112 (40%), Gaps = 6/112 (5%)

Query: 221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLE 278
               + +++L+   ++       + L  L  L L  N +   +    + G  ++  I+L 
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438

Query: 279 DNQLTGPLPSSLMNLPNLRELYVQNNMLSG--TVPSSL--LSKNVVLNYAGN 326
            N+      +S   +P+L+ L ++   L    + PS    L    +L+ + N
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNN 490

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 80.4 bits (199), Expect = 9e-16
 Identities = 26/116 (22%), Positives = 40/116 (34%), Gaps = 12/116 (10%)

Query: 223 PSITVIHLSSKNLT--------GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLR 273
             + ++ L   NL         G     L  LS L  L L+ N       + F    +L+
Sbjct: 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563

Query: 274 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 326
           II L  N L     S   N  +L+ L +Q N+++                L+   N
Sbjct: 564 IIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 79.7 bits (197), Expect = 2e-15
 Identities = 25/100 (25%), Positives = 40/100 (40%), Gaps = 8/100 (8%)

Query: 216 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRI 274
           +C      S  V   S   LT  +P DL   +++  L L  N L      +F+    L  
Sbjct: 1   KCTV----SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTS 53

Query: 275 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           + +  N ++   P     LP L+ L +Q+N LS     + 
Sbjct: 54  LDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTF 93

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 78.1 bits (193), Expect = 4e-15
 Identities = 24/112 (21%), Positives = 39/112 (34%), Gaps = 4/112 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 279
            +I  I+LS         +    + SL  L L   +L         F    +L I+ L +
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 331
           N +       L  L  L  L +Q+N L+  +         +    G  +LH 
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLHI 540

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 76.2 bits (188), Expect = 2e-14
 Identities = 15/106 (14%), Positives = 36/106 (33%), Gaps = 5/106 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG---PIPDFSGCP--DLRIIHL 277
             +  +++   ++ G   +  T L +L  L L  +  +        F       L I++L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388

Query: 278 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
             N+++     +   L +L  L +  N +   +          +  
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 74.7 bits (184), Expect = 6e-14
 Identities = 27/104 (25%), Positives = 43/104 (41%), Gaps = 3/104 (2%)

Query: 217 CNSDPQPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDGNSLTGPIPD-FSGCPDLR 273
           C      SI  + LS+  L+    +     K ++L  L L  N+L     D F+  P L 
Sbjct: 216 CLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLE 275

Query: 274 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
              LE N +      SL  L N+R L ++ +    ++  + L K
Sbjct: 276 YFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPK 319

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 73.9 bits (182), Expect = 1e-13
 Identities = 20/100 (20%), Positives = 38/100 (38%), Gaps = 6/100 (6%)

Query: 221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIH 276
              S+  + LSS  +    P     +  L  L+L+   L   + +          +R + 
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228

Query: 277 LEDNQLTGPLPSSLMNL--PNLRELYVQNNMLSGTVPSSL 314
           L ++QL+    ++ + L   NL  L +  N L+     S 
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 73.5 bits (181), Expect = 1e-13
 Identities = 20/110 (18%), Positives = 38/110 (34%), Gaps = 10/110 (9%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----------FSGCPDL 272
           P +    L   N+       L  L ++  L L  +     I            F     L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331

Query: 273 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 322
             +++EDN + G   +    L NL+ L + N+  S    ++    ++  +
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.9 bits (125), Expect = 6e-07
 Identities = 15/69 (21%), Positives = 24/69 (34%), Gaps = 2/69 (2%)

Query: 248 SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS 307
           S          LT  +PD     ++ +++L  NQL     ++      L  L V  N +S
Sbjct: 5   SHEVADCSHLKLTQ-VPDDLP-TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62

Query: 308 GTVPSSLLS 316
              P     
Sbjct: 63  KLEPELCQK 71

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 81.1 bits (201), Expect = 1e-16
 Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 25/206 (12%)

Query: 414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGK-----REFTNEVTLLSRIHHRNLV 467
            K+G G +  VY GK K     +A+K +     +G      RE    V+LL  + H N+V
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKHANIV 63

Query: 468 QFLGYCQEEGRSVLVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
                   E    LV+E++        +     +       ++ +L       +G+ Y H
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL------LRGLAYCH 117

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYY 584
                 ++HRDLK  N+L+++    K++DFGL++  ++   ++ + +V  T+ Y  P+  
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDIL 172

Query: 585 I-SQQLTDKSDVYSFGVILLELISGQ 609
           + S   + + D++  G I  E+ +G+
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGR 198

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 81.5 bits (202), Expect = 1e-16
 Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 24/157 (15%)

Query: 415 KIGSGGFGVVYYGKLKDGKEI-AVK-VLTSNSYQGKREFTN--EVTLLSRIHHRNLVQFL 470
           KIG G FG V+  + +   +  A+K VL  N  +G    T   E+ +L  + H N+V  +
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLI 82

Query: 471 GYCQEEGRSV--------LVYEFMHN--GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 520
             C+ +            LV++F  +    L  ++    T  +    ++ L        G
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML------LNG 136

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL 557
           + Y+H      I+HRD+K++N+L+ +    K++DFGL
Sbjct: 137 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 80.4 bits (198), Expect = 2e-16
 Identities = 60/272 (22%), Positives = 95/272 (34%), Gaps = 83/272 (30%)

Query: 412 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQG-KREFTNEVTLLSRI-HH 463
           L K +G G FG V              + +AVK+L   +     R   +E+ +L  I HH
Sbjct: 26  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85

Query: 464 RN--------------------------LVQFL-------------GYCQEEGRSVLVYE 484
            N                          L  +L             G    +G+  +   
Sbjct: 86  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145

Query: 485 FMH----------------NGTLKEHLYGTLTHEQRINWIKR--------LEIAEDAAKG 520
            +                 +G ++E     +  E+    + +        +  +   AKG
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           +E+L +      IHRDL + NILL +    K+ DFGL++            VR     L 
Sbjct: 206 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDYVRKGDARLP 258

Query: 581 -----PEYYISQQLTDKSDVYSFGVILLELIS 607
                PE    +  T +SDV+SFGV+L E+ S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 23/206 (11%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           K IGSG  G+V         + +A+K L+    N    KR +  E+ L+  ++H+N++  
Sbjct: 31  KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 89

Query: 470 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           L         EE + V +V E M    L + +   L HE+    + ++        GI++
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQM------LCGIKH 142

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH+  +   IHRDLK SNI++      K+ DFGL++ A         +V  T  Y  PE 
Sbjct: 143 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEV 197

Query: 584 YISQQLTDKSDVYSFGVILLELISGQ 609
            +     +  D++S G I+ E+I G 
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGG 223

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 51/227 (22%), Positives = 82/227 (36%), Gaps = 66/227 (29%)

Query: 403 SDIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKRE-FTNEVTLLSR 460
           + I D  K+  + +G G  G V     K   ++ A+K+L              EV L  R
Sbjct: 13  NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ------DCPKARREVELHWR 66

Query: 461 I-HHRNLVQFLGYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA- 514
                ++V+ +   +          +V E +  G L            RI    R + A 
Sbjct: 67  ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS----------RI--QDRGDQAF 114

Query: 515 --EDAA-------KGIEYLHT-GCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFA 561
              +A+       + I+YLH+      I HRD+K  N+L      +   K++DFG +K  
Sbjct: 115 TEREASEIMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-- 168

Query: 562 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG 608
                       G   Y D             D++S GVI+  L+ G
Sbjct: 169 ---------ETTGE-KY-DKS----------CDMWSLGVIMYILLCG 194

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.2 bits (198), Expect = 4e-16
 Identities = 47/254 (18%), Positives = 94/254 (37%), Gaps = 65/254 (25%)

Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTN-EVTLLSRI 461
           +       L K +G+G FG+V      + GK  A+K +  +       + N E+ ++  +
Sbjct: 3   ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVL 57

Query: 462 HHRNLVQFLGYCQEEGRSV--------------------------------------LVY 483
            H N+++ + Y    G                                         ++ 
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE------DAAKGIEYLHTGCVPAIIHRDL 537
           E++      + L+  L    R    + + +           + + ++H+     I HRD+
Sbjct: 118 EYV-----PDTLHKVLKSFIRSG--RSIPMNLISIYIYQLFRAVGFIHSL---GICHRDI 167

Query: 538 KSSNILLDKHM-RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI-SQQLTDKSDV 595
           K  N+L++      K+ DFG +K  +     V+ I   +  Y  PE  + + + T   D+
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDL 225

Query: 596 YSFGVILLELISGQ 609
           +S G +  ELI G+
Sbjct: 226 WSIGCVFGELILGK 239

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 80.7 bits (199), Expect = 9e-16
 Identities = 22/116 (18%), Positives = 37/116 (31%), Gaps = 13/116 (11%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI----------PDFSGCPDL 272
             +T + L +      +P  L  L  L  L +  N                 D    P +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550

Query: 273 RIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPS-SLLSKNVVLNYAGN 326
           +I ++  N L   P  +SL  +  L  L   +N +   + +     K   L    N
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYN 605

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 77.2 bits (190), Expect = 1e-14
 Identities = 19/113 (16%), Positives = 34/113 (30%), Gaps = 10/113 (8%)

Query: 221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED 279
                   +        N     + L  L ++ L        +PD     P+L+ +++  
Sbjct: 465 IAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524

Query: 280 NQLTGP---------LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
           N+             L       P ++  Y+  N L     S+ L K V L  
Sbjct: 525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGL 577

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 76.5 bits (188), Expect = 2e-14
 Identities = 23/120 (19%), Positives = 38/120 (31%), Gaps = 16/120 (13%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---------FSGCPDLRI 274
           + + + LS   +           S +  + L  N +T  IP+         +     L  
Sbjct: 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS-IPENSLKPKDGNYKNTYLLTT 732

Query: 275 IHLEDNQLTGPLPSSLM--NLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLH 330
           I L  N+LT  L        LP L  + V  N  S + P+     S+          +  
Sbjct: 733 IDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAE 790

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 76.1 bits (187), Expect = 2e-14
 Identities = 24/117 (20%), Positives = 44/117 (37%), Gaps = 12/117 (10%)

Query: 223 PSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLE- 278
             +T I L    LT  +  D   T L  L  + +  N  +   P        L+   +  
Sbjct: 728 YLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH 785

Query: 279 -----DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 330
                 N++    P+ +   P+L +L + +N +   V   L  +  +L+ A N N+ 
Sbjct: 786 QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDIADNPNIS 841

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 72.6 bits (178), Expect = 3e-13
 Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 5/98 (5%)

Query: 223 PSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 281
           P I + ++   NL      + L K+  L  L    N +   +  F     L  + L+ NQ
Sbjct: 548 PKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYNQ 606

Query: 282 LTGPLPSSLM-NLPNLRELYVQNNMLSGTVPSSLLSKN 318
           +   +P         +  L   +N L   +P+   +K+
Sbjct: 607 IEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKS 642

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 70.3 bits (172), Expect = 1e-12
 Identities = 17/110 (15%), Positives = 30/110 (27%), Gaps = 20/110 (18%)

Query: 229 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--------------------FSG 268
             +  N    I   + +L+ L  ++   +  T                         +S 
Sbjct: 430 IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSN 489

Query: 269 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 318
             DL  + L +      LP  L +LP L+ L +  N              
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTR 539

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 69.1 bits (169), Expect = 3e-12
 Identities = 21/115 (18%), Positives = 39/115 (33%), Gaps = 15/115 (13%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVEL------WLDGNSLTGPIPD-FSGCPDLRII 275
           P ++ + +S    +   P+     S L           +GN +    P   + CP L  +
Sbjct: 753 PYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811

Query: 276 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS----GTVPSSLLSKNVVLNYAGN 326
            +  N +   +   L   P L  L + +N        +V   + +   VL Y   
Sbjct: 812 QIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 65.7 bits (160), Expect = 3e-11
 Identities = 13/102 (12%), Positives = 33/102 (32%), Gaps = 10/102 (9%)

Query: 223 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIPDFSGCPD------LRI 274
             +  +  S   L   IP+      +  +  +    N +     + S   D         
Sbjct: 619 DQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677

Query: 275 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
           + L  N++             +  + + NN+++ ++P + L 
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLK 718

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 61.8 bits (150), Expect = 6e-10
 Identities = 20/118 (16%), Positives = 35/118 (29%), Gaps = 21/118 (17%)

Query: 230 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP---- 285
           ++       I  D        ++    N +T           L+II+  ++  T      
Sbjct: 408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV 467

Query: 286 ---------------LPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 326
                             S  NL +L ++ + N      +P  L  L +   LN A N
Sbjct: 468 DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 61.4 bits (149), Expect = 8e-10
 Identities = 13/120 (10%), Positives = 38/120 (31%), Gaps = 4/120 (3%)

Query: 205 DPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP 264
           +  +      +  ++     +T + L+     G +P  + +L+ L  L    +S T    
Sbjct: 307 ELDMWGDQPGVDLDN--NGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGR 364

Query: 265 DFSG-CPDLRIIHLEDNQLTGPLPS-SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 322
            F        +     +++        L     L    +  + ++       + K+  ++
Sbjct: 365 LFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRIS 424

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 56.8 bits (137), Expect = 2e-08
 Identities = 17/122 (13%), Positives = 41/122 (33%), Gaps = 11/122 (9%)

Query: 219 SDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHL 277
            D + +  +       +  +     L     L    L  +++    P+         I L
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISL 425

Query: 278 ED-------NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 330
           +D       N++T  +  ++  L  L+ +Y  N+  +     ++  ++   +YA      
Sbjct: 426 KDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTY-DNIAVDWEDANSDYAKQYENE 483

Query: 331 EG 332
           E 
Sbjct: 484 EL 485

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 9/62 (14%), Positives = 22/62 (35%), Gaps = 3/62 (4%)

Query: 272 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSS---LLSKNVVLNYAGNIN 328
           +  + L      G +P ++  L  L+ L    +  + +        L+ ++       I 
Sbjct: 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIR 384

Query: 329 LH 330
           +H
Sbjct: 385 MH 386

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 50/210 (23%), Positives = 94/210 (44%), Gaps = 30/210 (14%)

Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTN--EVTLLSRIHHRNLVQ 468
           K+G G +G VY        + +A+K +     + + E    T   EV+LL  + HRN+++
Sbjct: 41  KLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNIIE 97

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHL--YGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
                    R  L++E+  N  LK+++     ++     +++ +L        G+ + H+
Sbjct: 98  LKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL------INGVNFCHS 150

Query: 527 GCVPAIIHRDLKSSNILLDKHMRA-----KVSDFGLSK-FAVDGASHVSSIVRGTVGYLD 580
                 +HRDLK  N+LL     +     K+ DFGL++ F +        I+  T+ Y  
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYRP 205

Query: 581 PEYYI-SQQLTDKSDVYSFGVILLELISGQ 609
           PE  + S+  +   D++S   I  E++   
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 79.3 bits (196), Expect = 2e-15
 Identities = 18/108 (16%), Positives = 34/108 (31%), Gaps = 4/108 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 280
            S+  + ++  +   N  S+     ++L  L L    L       F     L+++++  N
Sbjct: 448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 326
            L     S    L +L  L    N +  +              N   N
Sbjct: 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNN 555

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 76.6 bits (189), Expect = 1e-14
 Identities = 15/101 (14%), Positives = 30/101 (29%), Gaps = 3/101 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDN 280
            S+  + LS       + ++   L  L  L    ++L        F     L  + +   
Sbjct: 376 NSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 321
                     + L +L  L +  N       S++ +    L
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 75.8 bits (187), Expect = 2e-14
 Identities = 20/96 (20%), Positives = 33/96 (34%), Gaps = 1/96 (1%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
             +  + LS   +          L  L  L L GN +    P  FSG   L  +   + +
Sbjct: 56  SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
           L       +  L  L++L V +N +      +  S 
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 75.1 bits (185), Expect = 4e-14
 Identities = 18/99 (18%), Positives = 32/99 (32%), Gaps = 4/99 (4%)

Query: 217 CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRII 275
                           + L+  +P D+   SS   + L  N L       FS   +L+ +
Sbjct: 5   NPCIEVVPNITYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWL 61

Query: 276 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
            L   ++      +   L +L  L +  N +    P S 
Sbjct: 62  DLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSF 100

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 74.3 bits (183), Expect = 6e-14
 Identities = 14/86 (16%), Positives = 28/86 (32%), Gaps = 1/86 (1%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
            ++T + LS   L          L  L  L +  N+L       ++    L  +    N+
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLS 307
           +            +L    + NN ++
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 67.4 bits (165), Expect = 8e-12
 Identities = 21/116 (18%), Positives = 37/116 (31%), Gaps = 7/116 (6%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLEDN 280
            S+  +      L       + +L +L +L +  N +    +P  FS   +L  + L  N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163

Query: 281 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSL-LSKNVVLNYAGNINLHE 331
            +     + L  L         L +  N +      +    K   L   GN N   
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSN 219

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 67.4 bits (165), Expect = 9e-12
 Identities = 24/109 (22%), Positives = 40/109 (36%), Gaps = 5/109 (4%)

Query: 223 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 280
           PS++ + LS   L+  G         +SL  L L  N       +F G  +L+ +  + +
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHS 409

Query: 281 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 326
            L      S+ ++L  L  L +               L+    L  AGN
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 64.7 bits (158), Expect = 5e-11
 Identities = 20/106 (18%), Positives = 39/106 (36%), Gaps = 4/106 (3%)

Query: 221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 280
              +I    L+  N   +       L+++  + L G S+   + D       + + +   
Sbjct: 259 CDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRC 317

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           QL    P+   +LP L+ L +  N  S +     L     L+ + N
Sbjct: 318 QLKQ-FPTL--DLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRN 360

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 52.7 bits (127), Expect = 3e-07
 Identities = 20/108 (18%), Positives = 35/108 (32%), Gaps = 9/108 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
                + +    L      DL     L  L L  N  +         P L  + L  N L
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNKGSI-SFKKVALPSLSYLDLSRNAL 362

Query: 283 T--GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 326
           +  G    S +   +LR L +  N     + ++   L +   L++  +
Sbjct: 363 SFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHS 409

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 52.0 bits (125), Expect = 6e-07
 Identities = 14/114 (12%), Positives = 24/114 (21%), Gaps = 10/114 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG-------PIPDFSGCPDLRI 274
             +  + L     + NI    L  L+ L    L                    G  D+ I
Sbjct: 204 IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263

Query: 275 IHLED--NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
                               L N+  + +    +          K   L+    
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRC 317

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 50.4 bits (121), Expect = 2e-06
 Identities = 14/102 (13%), Positives = 30/102 (29%), Gaps = 5/102 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLS----SLVELWLDGNSLTGPIPDFSGCPDLRIIHLE 278
            ++  + LS   +     +DL  L       + L +  N +            L  + L 
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLR 212

Query: 279 DNQLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNV 319
            N  +   + + L NL  L    +            +   ++
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 78.3 bits (193), Expect = 2e-15
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 23/206 (11%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           K IGSG  G+V         + +A+K L+    N    KR +  E+ L+  ++H+N++  
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 126

Query: 470 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           L         EE + V LV E M    L + +   L HE+    + ++        GI++
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQM------LCGIKH 179

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           LH+  +   IHRDLK SNI++      K+ DFGL++     +  ++  V  T  Y  PE 
Sbjct: 180 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYV-VTRYYRAPEV 234

Query: 584 YISQQLTDKSDVYSFGVILLELISGQ 609
            +     +  D++S G I+ E++  +
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHK 260

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 78.2 bits (193), Expect = 3e-15
 Identities = 14/98 (14%), Positives = 31/98 (31%), Gaps = 5/98 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLED 279
            S+  + LS   +   + S+   L  L  L    ++L   + +   F    +L  + +  
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISH 430

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
                        L +L  L +  N         + ++
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 76.7 bits (189), Expect = 1e-14
 Identities = 26/110 (23%), Positives = 45/110 (40%), Gaps = 6/110 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
            ++  + +S  +           LSSL  L + GNS         F+   +L  + L   
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 480

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 330
           QL    P++  +L +L+ L + +N L  +VP  +  +   L     I LH
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQK---IWLH 526

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 68.6 bits (168), Expect = 4e-12
 Identities = 19/97 (19%), Positives = 33/97 (34%), Gaps = 5/97 (5%)

Query: 226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTG 284
                   N    IP +L    S   L L  N L       F   P+L+++ L   ++  
Sbjct: 10  ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66

Query: 285 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 321
               +  +L +L  L +  N +  ++     S    L
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSL 102

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 67.8 bits (166), Expect = 6e-12
 Identities = 21/104 (20%), Positives = 37/104 (35%), Gaps = 4/104 (3%)

Query: 223 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 280
           PS+  + LS   L+  G         +SL  L L  N +     +F G   L  +  + +
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406

Query: 281 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
            L      S  ++L NL  L + +        + + +    L  
Sbjct: 407 NLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEV 449

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 67.0 bits (164), Expect = 1e-11
 Identities = 19/89 (21%), Positives = 39/89 (43%), Gaps = 2/89 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 280
            S+ V+ ++  +   N   D  T+L +L  L L    L    P  F+    L+++++  N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGT 309
           QL          L +L+++++  N    +
Sbjct: 505 QLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 20/115 (17%), Positives = 40/115 (34%), Gaps = 8/115 (6%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLE 278
                ++ + L+   +        + LSSL +L     +L             L+ +++ 
Sbjct: 73  QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132

Query: 279 DNQLT-GPLPSSLMNLPNLRELYVQNNMLSGTVP------SSLLSKNVVLNYAGN 326
            N +    LP    NL NL  L + +N +             +   N+ L+ + N
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 64.4 bits (157), Expect = 7e-11
 Identities = 22/86 (25%), Positives = 36/86 (41%), Gaps = 1/86 (1%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 281
           P + V+ LS   +          LS L  L L GN +    +  FSG   L+ +   +  
Sbjct: 52  PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLS 307
           L       + +L  L+EL V +N++ 
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQ 137

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 60.9 bits (148), Expect = 8e-10
 Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 7/111 (6%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-GPIPD-FSGCPDLRIIHLEDN 280
            S+  +     NL       +  L +L EL +  N +    +P+ FS   +L  + L  N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159

Query: 281 QLTGPLPSSLMNLPNLR----ELYVQNNMLSGTVPSSLLSKN-VVLNYAGN 326
           ++     + L  L  +      L +  N ++   P +        L    N
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 20/73 (27%), Positives = 29/73 (39%), Gaps = 3/73 (4%)

Query: 212 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGC 269
            ++L        ++T + LS   L    P+    LSSL  L +  N L   +PD  F   
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VPDGIFDRL 517

Query: 270 PDLRIIHLEDNQL 282
             L+ I L  N  
Sbjct: 518 TSLQKIWLHTNPW 530

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 17/107 (15%), Positives = 38/107 (35%), Gaps = 5/107 (4%)

Query: 221 PQPSITVIHLSSKNLTGN-IPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 279
              +I    L+  +   + I      L+++    L   ++   + DFS     + + L +
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVN 313

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
            +     P+  + L +L+ L   +N          L     L+ + N
Sbjct: 314 CKFGQ-FPT--LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRN 357

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 48/233 (20%), Positives = 87/233 (37%), Gaps = 62/233 (26%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVK--VLTSNSYQGKREFTN---------EVTLLSR 460
           +++ I SG +G V  G   +G  +A+K    T +  +     ++         E+ LL+ 
Sbjct: 26  VQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85

Query: 461 IHHRNLVQ----FLGYCQEEGRSV-LVYEFM----------HNGTLKEH-----LYGTLT 500
            HH N++     F+ + +     + LV E M              +        +Y  L 
Sbjct: 86  FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHIL- 144

Query: 501 HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF 560
                              G+  LH   V   +HRDL   NILL  +    + DF L++ 
Sbjct: 145 ------------------LGLHVLHEAGV---VHRDLHPGNILLADNNDITICDFNLARE 183

Query: 561 AVDGAS---HVSSIVRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
               A+   +V+        Y  PE  +  +   K  D++S G ++ E+ + +
Sbjct: 184 DTADANKTHYVT-----HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 78.1 bits (193), Expect = 3e-15
 Identities = 20/96 (20%), Positives = 33/96 (34%)

Query: 221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 280
            + S+  I+L          +     S L EL L    L+       G   L+ + L  N
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSAN 311

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
           +       S  N P+L  L ++ N     + +  L 
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 78.1 bits (193), Expect = 4e-15
 Identities = 23/109 (21%), Positives = 40/109 (36%), Gaps = 5/109 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD----FSGCPDLRIIHLE 278
             + V++LS   L  +       L +L  L L GN                  L I+ L 
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484

Query: 279 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGN 326
              L+     +  +L  +  + + +N L+ +   +L   K + LN A N
Sbjct: 485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASN 533

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 77.7 bits (192), Expect = 5e-15
 Identities = 20/107 (18%), Positives = 32/107 (29%), Gaps = 3/107 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
            S   +  S   L     +  ++L +L  L L    +     D F     L  + L  N 
Sbjct: 33  NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP 92

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 326
           L     ++L     L+ L+     +S      L        L    N
Sbjct: 93  LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSN 139

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 75.4 bits (186), Expect = 3e-14
 Identities = 19/109 (17%), Positives = 37/109 (33%), Gaps = 5/109 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
             +  + L++  L     + L+   +L  L+     ++            L  ++L  N 
Sbjct: 81  HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS----KNVVLNYAGN 326
           ++            L+ L  QNN +       + S     N+ LN  GN
Sbjct: 141 ISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGN 189

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 75.4 bits (186), Expect = 3e-14
 Identities = 21/123 (17%), Positives = 45/123 (36%), Gaps = 4/123 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
            ++  +      ++      L    +L  L+L  N ++            L+++  ++N 
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164

Query: 282 LTGPLPSSLMNLPNLR--ELYVQNNMLSGTVPSSLLSKNV-VLNYAGNINLHEGGRGAKH 338
           +       + +L       L +  N ++G  P +  S     LN+ G  NL    +G K+
Sbjct: 165 IHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224

Query: 339 LNI 341
             I
Sbjct: 225 STI 227

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 75.1 bits (185), Expect = 4e-14
 Identities = 16/94 (17%), Positives = 27/94 (28%), Gaps = 2/94 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
             +  ++LS             +   L  L L    L        F     L++++L  +
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
            L          LP L+ L +Q N          
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKT 469

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 72.0 bits (177), Expect = 3e-13
 Identities = 18/99 (18%), Positives = 30/99 (30%), Gaps = 4/99 (4%)

Query: 217 CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRII 275
                +      +  +  L   IP  L   +S   L    N L       FS   +L  +
Sbjct: 6   QKCIEKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFL 62

Query: 276 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
            L   Q+      +  +   L  L +  N L     ++L
Sbjct: 63  DLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETAL 101

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 69.3 bits (170), Expect = 2e-12
 Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 4/105 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD---FSGCPDLRIIHLE 278
           PS+T + +        + +  L  L +L EL L  + +               L+ ++L 
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384

Query: 279 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
            N+       +    P L  L +    L      S      +L  
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKV 429

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 66.2 bits (162), Expect = 2e-11
 Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 2/88 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
             + ++ LS  +L+       T L  +  + L  N LT    +  S    + + +L  N 
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYL-NLASNH 534

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGT 309
           ++  LPS L  L   R + ++ N L  T
Sbjct: 535 ISIILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 59.3 bits (144), Expect = 3e-09
 Identities = 21/121 (17%), Positives = 41/121 (33%), Gaps = 8/121 (6%)

Query: 213 SWLQCNSDPQPSITVIHLSSKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPD-FSGC 269
           + ++  +        ++         I   L  + + SL     +        P  F G 
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251

Query: 270 PD--LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAG 325
            +  +  I+L+ +       ++      L+EL +    LS  +PS L  LS    L  + 
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310

Query: 326 N 326
           N
Sbjct: 311 N 311

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 76.2 bits (188), Expect = 6e-15
 Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 32/210 (15%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 469
             +GSG +G V      + G+++A+K L+    +    KR +  E+ LL  + H N++  
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGL 88

Query: 470 L-----GYCQEEGRSV-LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           L                LV  FM    L++ +    + E+    + ++       KG++Y
Sbjct: 89  LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQML------KGLKY 141

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVG---YLD 580
           +H+     ++HRDLK  N+ +++    K+ DFGL       A H  + + G V    Y  
Sbjct: 142 IHSA---GVVHRDLKPGNLAVNEDCELKILDFGL-------ARHADAEMTGYVVTRWYRA 191

Query: 581 PEYYISQQLTDKS-DVYSFGVILLELISGQ 609
           PE  +S    +++ D++S G I+ E+++G+
Sbjct: 192 PEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 76.7 bits (189), Expect = 7e-15
 Identities = 53/252 (21%), Positives = 92/252 (36%), Gaps = 68/252 (26%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           ++  IG G +G VY        K +A+K +     +    KR    E+T+L+R+    ++
Sbjct: 30  IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKSDYII 88

Query: 468 Q----FLGYCQEEGRSV-LVYEFM---------HNGTLK-EH----LYGTLTHEQRINWI 508
           +     +     +   + +V E               L  EH    LY  L         
Sbjct: 89  RLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLL--------- 139

Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS-KFAVDGASH 567
                      G  ++H      IIHRDLK +N LL++    KV DFGL+     +  ++
Sbjct: 140 ----------LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186

Query: 568 VSSIVRGTVGYLDPEYYISQQLTD--------------------KS-DVYSFGVILLELI 606
           + + +            + +QLT                     KS D++S G I  EL+
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

Query: 607 SGQEAISNEKFG 618
           +  ++  N+   
Sbjct: 247 NMLQSHINDPTN 258

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 74.9 bits (185), Expect = 8e-15
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 32/214 (14%)

Query: 415 KIGSGGFGVVYYGK-LKDGKEIAVK-VLTSNSYQGKREFTN----EVTLLSRIH---HRN 465
           +IG G +G VY  +    G  +A+K V   N   G          EV LL R+    H N
Sbjct: 16  EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75

Query: 466 LVQFL-----GYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAEDA 517
           +V+ +          E +  LV+E +       L +     L  E   + +++       
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF------ 129

Query: 518 AKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGA-SHVSSIVRGT 575
            +G+++LH  C   I+HRDLK  NIL+      K++DFGL++ ++   A + V  +V  T
Sbjct: 130 LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV--VV--T 182

Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
           + Y  PE  +        D++S G I  E+   +
Sbjct: 183 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 75.4 bits (186), Expect = 9e-15
 Identities = 55/229 (24%), Positives = 87/229 (37%), Gaps = 54/229 (23%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           L+  +G G +GVV        G+ +A+K +          R    E+ +L    H N++ 
Sbjct: 15  LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHENIIT 73

Query: 469 ----FLGYCQEEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKR 510
                     E    V ++ E M            L  +H    +Y TL           
Sbjct: 74  IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL----------- 122

Query: 511 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 570
                   + ++ LH   V   IHRDLK SN+L++ +   KV DFGL++   + A+  S 
Sbjct: 123 --------RAVKVLHGSNV---IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

Query: 571 IVRGTVG---------YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
                 G         Y  PE  ++     ++ DV+S G IL EL   +
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 14/97 (14%), Positives = 29/97 (29%), Gaps = 3/97 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDN 280
            S+  + LS   +   + S+   L  L  L    ++L        F    +L  + +   
Sbjct: 78  TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
                       L +L  L +  N         + ++
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 25/104 (24%), Positives = 38/104 (36%), Gaps = 4/104 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG---PIPDFSGCPDLRIIHLED 279
            S T + L S  L         KL+ L +L L  N L+          G   L+ + L  
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
           N +   + S+ + L  L  L  Q++ L      S+      L Y
Sbjct: 88  NGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 130

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 66.2 bits (162), Expect = 6e-12
 Identities = 19/97 (19%), Positives = 39/97 (40%), Gaps = 5/97 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
            ++  + +S  +      +     LSSL  L + GNS         F+   +L  + L  
Sbjct: 126 RNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
            QL    P++  +L +L+ L + +N    ++ +    
Sbjct: 185 CQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK 220

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 5/97 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
            S+ V+ ++  +   N   D  T+L +L  L L    L   +    F+    L+++++  
Sbjct: 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMSH 208

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
           N            L +L+ L    N +  T     L 
Sbjct: 209 NNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQ 244

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 20/97 (20%), Positives = 36/97 (37%), Gaps = 4/97 (4%)

Query: 223 PSITVIHLSSKNLT-GNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 280
             +T + LSS  L+     S      +SL  L L  N +     +F G   L  +  + +
Sbjct: 52  TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 111

Query: 281 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
            L      S  ++L NL  L + +        + + +
Sbjct: 112 NLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFN 147

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 56.6 bits (137), Expect = 8e-09
 Identities = 17/89 (19%), Positives = 33/89 (37%), Gaps = 6/89 (6%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
            ++T + LS   L   +       LSSL  L +  N+    +    +     L+++    
Sbjct: 175 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSL 232

Query: 280 NQLTGPLPSSLMNLP-NLRELYVQNNMLS 307
           N +       L + P +L  L +  N  +
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 73.3 bits (181), Expect = 4e-14
 Identities = 21/104 (20%), Positives = 44/104 (42%), Gaps = 3/104 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +T + + +  ++    + +  L+ L  L +  N ++  I   +    L  + L +NQL
Sbjct: 243 SQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQL 299

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
                  +  L NL  L++  N ++   P + LSK    ++A  
Sbjct: 300 GNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQ 343

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 68.0 bits (167), Expect = 2e-12
 Identities = 33/104 (31%), Positives = 55/104 (52%), Gaps = 5/104 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            SIT + ++ + +  +I   +  L++L  L L+GN +T  I   S    L  +++  N++
Sbjct: 44  ESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI 100

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           T    S+L NL NLRELY+  + +S   P + L+K   LN   N
Sbjct: 101 TDI--SALQNLTNLRELYLNEDNISDISPLANLTKMYSLNLGAN 142

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 67.2 bits (165), Expect = 4e-12
 Identities = 18/86 (20%), Positives = 35/86 (40%), Gaps = 5/86 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
             + ++++ S  ++    S L  LS L  L+L+ N L     +   G  +L  + L  N 
Sbjct: 265 TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLS 307
           +T      L +L  +      N ++ 
Sbjct: 323 ITDI--RPLASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 66.8 bits (164), Expect = 6e-12
 Identities = 22/104 (21%), Positives = 46/104 (44%), Gaps = 4/104 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +T +++ +  +T    S L  L++L EL+L+ ++++  I   +    +  ++L  N  
Sbjct: 88  VKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHN 144

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
                S L N+  L  L V  + +    P + L+    L+   N
Sbjct: 145 LS-DLSPLSNMTGLNYLTVTESKVKDVTPIANLTDLYSLSLNYN 187

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 66.8 bits (164), Expect = 6e-12
 Identities = 25/104 (24%), Positives = 41/104 (39%), Gaps = 5/104 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +  + L+   +    P  L  L+SL       N +T  I   +    L  + + +N++
Sbjct: 177 TDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKI 233

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           T    S L NL  L  L +  N +S       L+K  +LN   N
Sbjct: 234 TDL--SPLANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSN 275

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 63.3 bits (155), Expect = 8e-11
 Identities = 21/104 (20%), Positives = 40/104 (38%), Gaps = 5/104 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +  + ++   +    P  +  L+ L  L L+ N +   I   +    L       NQ+
Sbjct: 155 TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQI 211

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           T    + + N+  L  L + NN ++   P + LS+   L    N
Sbjct: 212 TDI--TPVANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTN 253

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 62.9 bits (154), Expect = 9e-11
 Identities = 15/86 (17%), Positives = 36/86 (41%), Gaps = 4/86 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++  ++L+  N++    S L  L+ +  L L  N     +   S    L  + + ++++
Sbjct: 110 TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV 167

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSG 308
                + + NL +L  L +  N +  
Sbjct: 168 KD--VTPIANLTDLYSLSLNYNQIED 191

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 54.5 bits (132), Expect = 5e-08
 Identities = 15/86 (17%), Positives = 28/86 (32%), Gaps = 3/86 (3%)

Query: 241 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 300
                L+  +   L   S+T  +        +  + +   ++       +  L NL  L 
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLN 72

Query: 301 VQNNMLSGTVPSSLLSKNVVLNYAGN 326
           +  N ++   P S L K   L    N
Sbjct: 73  LNGNQITDISPLSNLVKLTNLYIGTN 98

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 72.2 bits (178), Expect = 8e-14
 Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 38/216 (17%)

Query: 415 KIGSGGFGVVYYGK-LKDGKEI-AVK-VLTSNSYQGK-----REFTNEVTLL---SRIHH 463
           +IG G +G V+  + LK+G    A+K V      +G      RE    V +L       H
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE----VAVLRHLETFEH 73

Query: 464 RNLVQFL-----GYCQEEGRSVLVYEFMHN---GTLKEHLYGTLTHEQRINWIKRLEIAE 515
            N+V+            E +  LV+E +       L +     +  E   + + +L    
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL---- 129

Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGA-SHVSSIVR 573
              +G+++LH+     ++HRDLK  NIL+    + K++DFGL++ ++   A + V  +V 
Sbjct: 130 --LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VV- 181

Query: 574 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
            T+ Y  PE  +        D++S G I  E+   +
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 72.7 bits (179), Expect = 9e-14
 Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 49/221 (22%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT--SNSYQGKREFTNEVTLLSRIHHRNLVQ-- 468
             IG G +G+V       +   +A+K ++   +    +R    E+ +L R  H N++   
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGIN 91

Query: 469 --FLGYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHEQRINWIKRLE 512
                   E+ + V +V + M            L  +H    LY  L             
Sbjct: 92  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL------------- 138

Query: 513 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI- 571
                 +G++Y+H+  V   +HRDLK SN+LL+     K+ DFGL++ A     H   + 
Sbjct: 139 ------RGLKYIHSANV---LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 572 --VRGTVGYLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
             V  T  Y  PE  ++ +   KS D++S G IL E++S +
Sbjct: 190 EYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 73.1 bits (180), Expect = 9e-14
 Identities = 26/104 (25%), Positives = 40/104 (38%), Gaps = 5/104 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++  + L+   L       L  L++L +L L  N ++  +   SG   L  + L  NQ+
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI 277

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           +    S L  L  L  L +  N L    P S L     L    N
Sbjct: 278 SNI--SPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN 319

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 72.7 bits (179), Expect = 1e-13
 Identities = 31/104 (29%), Positives = 50/104 (48%), Gaps = 5/104 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++T + L++  ++   P  L+ L+ L EL L  N ++  I   +G   L  + L +NQL
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQL 299

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
                S + NL NL  L +  N +S   P S L+K   L +  N
Sbjct: 300 EDI--SPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNN 341

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 72.3 bits (178), Expect = 2e-13
 Identities = 17/106 (16%), Positives = 45/106 (42%), Gaps = 6/106 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++T + L   N++   P  ++ L+ L  L+   N ++  +   +   ++  +    NQ+
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQI 365

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 328
           +    + L NL  + +L + +   +   P +  +   + N   N+ 
Sbjct: 366 SDL--TPLANLTRITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVT 408

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 70.4 bits (173), Expect = 7e-13
 Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 5/104 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +T + L +  ++   P  L  L++L  L L+ N L   I   S   +L  + L  N +
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNI 321

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           +   P  + +L  L+ L+  NN +S     + L+    L+   N
Sbjct: 322 SDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHN 363

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 66.1 bits (162), Expect = 2e-11
 Identities = 23/104 (22%), Positives = 40/104 (38%), Gaps = 5/104 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +T +      +       +  L++L ++    N LT  I        L  I + +NQ+
Sbjct: 46  DQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQI 102

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
                + L NL NL  L + NN ++   P   L+    L  + N
Sbjct: 103 AD--ITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 144

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 66.1 bits (162), Expect = 2e-11
 Identities = 24/104 (23%), Positives = 44/104 (42%), Gaps = 6/104 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            S+  +   +  +T   P  L  L++L  L +  N ++  I   +   +L  +   +NQ+
Sbjct: 156 TSLQQLSFGN-QVTDLKP--LANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQI 211

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           +    + L  L NL EL +  N L      + L+    L+ A N
Sbjct: 212 SDI--TPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANN 253

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 64.6 bits (158), Expect = 5e-11
 Identities = 28/105 (26%), Positives = 50/105 (47%), Gaps = 5/105 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++T I+ S+  LT   P  L  L+ LV++ ++ N +   I   +   +L  + L +NQ+
Sbjct: 68  NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQI 124

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 327
           T      L NL NL  L + +N +S     S L+    L++   +
Sbjct: 125 TDI--DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV 167

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 61.5 bits (150), Expect = 4e-10
 Identities = 29/104 (27%), Positives = 48/104 (46%), Gaps = 6/104 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++  + LSS  ++    S L+ L+SL +L   GN +T   P  +    L  + +  N++
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP-LANLTTLERLDISSNKV 189

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           +    S L  L NL  L   NN +S   P  +L+    L+  GN
Sbjct: 190 SDI--SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGN 231

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 58.8 bits (143), Expect = 3e-09
 Identities = 19/101 (18%), Positives = 38/101 (37%), Gaps = 7/101 (6%)

Query: 230 LSSKNLTGNIP----SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 285
           L S  +T + P       T L+  ++  L   ++T  +   +    +  +  +   +   
Sbjct: 3   LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI 61

Query: 286 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
               +  L NL ++   NN L+   P   L+K V +    N
Sbjct: 62  --DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNN 100

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 53.8 bits (130), Expect = 1e-07
 Identities = 12/104 (11%), Positives = 30/104 (28%), Gaps = 3/104 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +  +   +  ++    S L  L+++  L    N ++  +   +    +  + L D   
Sbjct: 331 TKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQAW 387

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           T    +   N+     +      L      S        +   N
Sbjct: 388 TNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWN 431

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.4 bits (178), Expect = 1e-13
 Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 64/239 (26%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIH-HRNL 466
           L KK+G G +G+V+     + G+ +AVK +     NS   +R F  E+ +L+ +  H N+
Sbjct: 13  LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENI 71

Query: 467 VQFLGYCQ-EEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKRL 511
           V  L   + +  R V LV+++M            L+  H    +Y  +            
Sbjct: 72  VNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLI------------ 119

Query: 512 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI 571
                  K I+YLH+G +   +HRD+K SNILL+     KV+DFGLS+  V+     ++I
Sbjct: 120 -------KVIKYLHSGGL---LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169

Query: 572 VRGTVGYLDPEYYISQQLTD---------------------KSDVYSFGVILLELISGQ 609
                   +        LTD                       D++S G IL E++ G+
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.5 bits (178), Expect = 2e-13
 Identities = 48/250 (19%), Positives = 90/250 (36%), Gaps = 73/250 (29%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLV 467
           +   IG+G +G V       + + +A+K +     +    KR    E+ +L+R++H ++V
Sbjct: 57  IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDHVV 115

Query: 468 Q----FLGYCQEEGRSV-LVYEFMH---------NGTLK-EH----LYGTLTHEQRINWI 508
           +     +    E+   + +V E               L   H    LY  L         
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLL--------- 166

Query: 509 KRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS------KFAV 562
                      G++Y+H+  +   +HRDLK +N L+++    KV DFGL+      +   
Sbjct: 167 ----------VGVKYVHSAGI---LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213

Query: 563 DGASHVSSIVRGTVGYLDPEYYISQQLTD--------------------KS-DVYSFGVI 601
                        +        + +QLT                     ++ DV+S G I
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273

Query: 602 LLELISGQEA 611
             EL++  + 
Sbjct: 274 FAELLNMIKE 283

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 72.5 bits (178), Expect = 2e-13
 Identities = 19/86 (22%), Positives = 35/86 (40%), Gaps = 2/86 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 281
           PS+  + L        I       L +L  L L   ++   +P+ +    L  + +  N 
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNH 229

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLS 307
                P S   L +L++L+V N+ +S
Sbjct: 230 FPEIRPGSFHGLSSLKKLWVMNSQVS 255

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 26/96 (27%), Positives = 41/96 (42%), Gaps = 4/96 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
            +   ++L   N+          L  L  L L  NS+   I    F+G   L  + L DN
Sbjct: 75  SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDN 133

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
            LT     +   L  LREL+++NN +  ++PS   +
Sbjct: 134 WLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFN 168

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 25/95 (26%), Positives = 49/95 (51%), Gaps = 4/95 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
            ++  ++L   N+  ++P +LT L  L EL + GN      P  F G   L+ + + ++Q
Sbjct: 196 FNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQ 253

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
           ++    ++   L +L EL + +N LS ++P  L +
Sbjct: 254 VSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFT 287

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 60.9 bits (148), Expect = 8e-10
 Identities = 21/85 (24%), Positives = 33/85 (38%), Gaps = 5/85 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
             + V+ L   ++   I       L+SL  L L  N LT  IP   F     LR + L +
Sbjct: 99  HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRN 156

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNN 304
           N +      +   +P+L  L +   
Sbjct: 157 NPIESIPSYAFNRVPSLMRLDLGEL 181

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 5/87 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
             +  + +S  +    I       LSSL +LW+  + ++  I    F G   L  ++L  
Sbjct: 218 VGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAH 275

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNML 306
           N L+         L  L EL++ +N  
Sbjct: 276 NNLSSLPHDLFTPLRYLVELHLHHNPW 302

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 55/223 (24%), Positives = 92/223 (41%), Gaps = 57/223 (25%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           + +GSG +G V      + G ++A+K L     +    KR +  E+ LL  + H N++  
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGL 89

Query: 470 L-----GYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHEQRINWIKR 510
           L         ++     LV  FM         +  L ++     +Y  L           
Sbjct: 90  LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML----------- 138

Query: 511 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 570
                   KG+ Y+H      IIHRDLK  N+ +++    K+ DFGL       A    S
Sbjct: 139 --------KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL-------ARQADS 180

Query: 571 IVRGTVG---YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
            + G V    Y  PE  ++     ++ D++S G I+ E+I+G+
Sbjct: 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 57/223 (25%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLT---SNSYQGKREFTNEVTLLSRIHHRNLVQF 469
             +GSG +G V      K G  +AVK L+    +    KR +  E+ LL  + H N++  
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGL 93

Query: 470 L-----GYCQEEGRSV-LVYEFM--------HNGTLK-EH----LYGTLTHEQRINWIKR 510
           L         EE   V LV   M            L  +H    +Y  L           
Sbjct: 94  LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL----------- 142

Query: 511 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS 570
                   +G++Y+H+     IIHRDLK SN+ +++    K+ DFGL       A H + 
Sbjct: 143 --------RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL-------ARHTAD 184

Query: 571 IVRGTVG---YLDPEYYISQQLTDKS-DVYSFGVILLELISGQ 609
            + G V    Y  PE  ++    +++ D++S G I+ EL++G+
Sbjct: 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 51/271 (18%), Positives = 109/271 (40%), Gaps = 64/271 (23%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIH------- 462
           +K+G G F  V+  K + +   +A+K++  +       + E    + LL R++       
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTKE 80

Query: 463 ----HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEH-----------LYGTL--THEQRI 505
                 ++++ L +            F H G    H           L   +     + I
Sbjct: 81  DSMGANHILKLLDH------------FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 128

Query: 506 N--WIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRA------KVSDFGL 557
              ++K+  I++    G++Y+H  C   IIH D+K  N+L++           K++D G 
Sbjct: 129 PLIYVKQ--ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184

Query: 558 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF 617
           + +  +   H ++ ++ T  Y  PE  +       +D++S   ++ ELI+G      ++ 
Sbjct: 185 ACWYDE---HYTNSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240

Query: 618 GANCRNIVQWAKLHIESGDIQGIIDPSLLDE 648
            +  ++    A+  I   ++ G +   LL  
Sbjct: 241 HSYTKDDDHIAQ--II--ELLGELPSYLLRN 267

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 30/170 (17%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 469
           + KKIG G FG +  GK L   + +A+K+    S     +   E     ++     + Q 
Sbjct: 13  VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 522
             +      + +V E +  G   E L+         +   R       L IA      +E
Sbjct: 71  YYFGPCGKYNAMVLELL--GPSLEDLF---------DLCDRTFSLKTVLMIAIQLISRME 119

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVS-----DFGLSKFAVDGASH 567
           Y+H+     +I+RD+K  N L+ +            DF L+K  +D  + 
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 52/232 (22%), Positives = 96/232 (41%), Gaps = 58/232 (25%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHRNLVQF 469
             K +G GG G+V+        K +A+K +  ++    K     E+ ++ R+ H N+V+ 
Sbjct: 15  DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKV 73

Query: 470 L-------------GYCQEEGRSV-LVYEFM--------HNGTL-KEH----LYGTLTHE 502
                              E  SV +V E+M          G L +EH    +Y  L   
Sbjct: 74  FEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL--- 130

Query: 503 QRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFA 561
                           +G++Y+H+  V   +HRDLK +N+ ++ + +  K+ DFGL++  
Sbjct: 131 ----------------RGLKYIHSANV---LHRDLKPANLFINTEDLVLKIGDFGLAR-I 170

Query: 562 VDGASHVSSIVRGTVG---YLDPEYYIS-QQLTDKSDVYSFGVILLELISGQ 609
           +D        +   +    Y  P   +S    T   D+++ G I  E+++G+
Sbjct: 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 71.8 bits (176), Expect = 3e-13
 Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 3/101 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++  ++L    +  ++   +   + L  L L  N L    P+F     +  I L +N+L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
              +  +L    NL    ++ N           SKN  +  
Sbjct: 227 VL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT 266

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 19/86 (22%), Positives = 34/86 (39%), Gaps = 3/86 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
               +  ++  +L   + S      ++ EL L GN L+       +    L +++L  N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLS 307
           L       L +L  LR L + NN + 
Sbjct: 70  LYE--TLDLESLSTLRTLDLNNNYVQ 93

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 18/107 (16%), Positives = 41/107 (38%), Gaps = 7/107 (6%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
           PSI  +H ++ N++  +            ++L  N +T  + D        ++ + L+ N
Sbjct: 99  PSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLN 154

Query: 281 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           ++          +   L  L +Q N +       + +K   L+ + N
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSN 201

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 61.8 bits (150), Expect = 4e-10
 Identities = 15/82 (18%), Positives = 30/82 (36%), Gaps = 1/82 (1%)

Query: 246 LSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 304
            +      +  +SL   +        +++ + L  N L+    + L     L  L + +N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 305 MLSGTVPSSLLSKNVVLNYAGN 326
           +L  T+    LS    L+   N
Sbjct: 69  VLYETLDLESLSTLRTLDLNNN 90

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 14/84 (16%), Positives = 32/84 (38%), Gaps = 4/84 (4%)

Query: 234 NLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN 292
           +L  N   +L    S+  L    N+++        G    + I+L +N++T         
Sbjct: 86  DLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQG---KKNIYLANNKITMLRDLDEGC 142

Query: 293 LPNLRELYVQNNMLSGTVPSSLLS 316
              ++ L ++ N +     + L +
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAA 166

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 14/108 (12%), Positives = 28/108 (25%), Gaps = 2/108 (1%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +T I L +  L   I   L    +L    L GN             + R+  +    +
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 330
                 +          +         +P+    + + L    +  L 
Sbjct: 273 KKLTGQNEEECTVPTLGHYGAYCCE-DLPAPFADRLIALKRKEHALLS 319

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 12/96 (12%), Positives = 22/96 (22%), Gaps = 3/96 (3%)

Query: 229 HLSSKNLTGNIPSDLTKL--SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPL 286
               ++L       L  L       L   G+       +       R I     Q    +
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352

Query: 287 PSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 322
               +       L  +   L     S+    +  L+
Sbjct: 353 DQVTLRKQAKITLEQKKKALD-EQVSNGRRAHAELD 387

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 69.6 bits (171), Expect = 6e-13
 Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 3/96 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++  ++L    +  ++       + L  L L  N L    P+F     +  I L +N+L
Sbjct: 169 DTLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 318
              +  +L    NL    ++ N           SKN
Sbjct: 227 VL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 18/106 (16%), Positives = 40/106 (37%), Gaps = 5/106 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 281
           PSI  +H ++ N++  +            ++L  N +T     D      ++ + L+ N+
Sbjct: 99  PSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155

Query: 282 LTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           +          +   L  L +Q N +       + +K   L+ + N
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSN 201

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 20/86 (23%), Positives = 35/86 (40%), Gaps = 3/86 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 281
               +  ++  +L   + S      ++ EL L GN L+     D +    L +++L  N 
Sbjct: 10  NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLS 307
           L       L +L  LR L + NN + 
Sbjct: 70  LYE--TLDLESLSTLRTLDLNNNYVQ 93

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 16/89 (17%), Positives = 31/89 (34%), Gaps = 1/89 (1%)

Query: 239 IPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 297
           I       +      +  +SL   +        +++ + L  N L+    + L     L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 298 ELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
            L + +N+L  T+    LS    L+   N
Sbjct: 62  LLNLSSNVLYETLDLESLSTLRTLDLNNN 90

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 14/85 (16%), Positives = 32/85 (37%), Gaps = 4/85 (4%)

Query: 234 NLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN 292
           +L  N   +L    S+  L    N+++        G    + I+L +N++T         
Sbjct: 86  DLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQG---KKNIYLANNKITMLRDLDEGC 142

Query: 293 LPNLRELYVQNNMLSGTVPSSLLSK 317
              ++ L ++ N +     + L + 
Sbjct: 143 RSRVQYLDLKLNEIDTVNFAELAAS 167

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 15/77 (19%), Positives = 24/77 (31%), Gaps = 9/77 (11%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +T I L +  L   I   L    +L    L GN           C  LR    ++ ++
Sbjct: 214 AGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH--------CGTLRDFFSKNQRV 264

Query: 283 TGPLPSSLMNLPNLREL 299
                 ++  L    E 
Sbjct: 265 QTVAKQTVKKLTGQNEE 281

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.8 bits (171), Expect = 7e-13
 Identities = 25/188 (13%), Positives = 59/188 (31%), Gaps = 46/188 (24%)

Query: 412 LEKKIGSGGFGVVYYGK---------LKDGKEIAVKVLTSNS----------YQGKREFT 452
           L+        G++Y                ++ ++K+   +              K    
Sbjct: 46  LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105

Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGR-SVLVYEFMHNGTLKEHLYGT-LTHEQRINWIKR 510
           N+   L       +   +G+   + +   LV              G  L  +  ++   +
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLP----------SLGRSL--QSALDVSPK 153

Query: 511 --------LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKF 560
                   L++A      +E+LH       +H ++ + NI +D   +++V  + +G +  
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210

Query: 561 AVDGASHV 568
                 HV
Sbjct: 211 YCPSGKHV 218

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 70.2 bits (172), Expect = 8e-13
 Identities = 21/86 (24%), Positives = 36/86 (41%), Gaps = 2/86 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 281
           PS+  + L        I       LS+L  L L   +L   IP+ +    L  + L  N 
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNH 218

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLS 307
           L+   P S   L +L++L++  + + 
Sbjct: 219 LSAIRPGSFQGLMHLQKLWMIQSQIQ 244

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 68.6 bits (168), Expect = 3e-12
 Identities = 23/96 (23%), Positives = 44/96 (45%), Gaps = 4/96 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
            +  +++L    +     +    L  L  L L  N +   I    F+G  +L  + L DN
Sbjct: 64  TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDN 122

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
           +LT     + + L  L+EL+++NN +  ++PS   +
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 30/109 (27%), Positives = 52/109 (47%), Gaps = 9/109 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
            ++  ++L+  NL   IP +LT L  L EL L GN L+  I    F G   L+ + +  +
Sbjct: 185 SNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQS 241

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 326
           Q+     ++  NL +L E+ + +N L+  +P  L   L     ++   N
Sbjct: 242 QIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 22/89 (24%), Positives = 38/89 (42%), Gaps = 6/89 (6%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
             + ++ LS  ++   I       L++L  L L  N LT  IP+  F     L+ + L +
Sbjct: 88  RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRN 145

Query: 280 NQLTGPLPSSLMNLPNLRELYVQ-NNMLS 307
           N +      +   +P+LR L +     LS
Sbjct: 146 NPIESIPSYAFNRIPSLRRLDLGELKRLS 174

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 58.2 bits (141), Expect = 5e-09
 Identities = 19/87 (21%), Positives = 33/87 (37%), Gaps = 5/87 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
             +  + LS  +L+  I       L  L +LW+  + +   I    F     L  I+L  
Sbjct: 207 IKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAH 264

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNML 306
           N LT         L +L  +++ +N  
Sbjct: 265 NNLTLLPHDLFTPLHHLERIHLHHNPW 291

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 20/98 (20%), Positives = 38/98 (38%), Gaps = 6/98 (6%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
             +  +HL    L   +       L++L  L+L  N+L   +PD  F    +L  + L  
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHG 162

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
           N+++     +   L +L  L +  N ++  V       
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 29/112 (25%), Positives = 52/112 (46%), Gaps = 9/112 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
            ++  ++L    L   +P D    L +L  L+L GN ++  +P+  F G   L  + L  
Sbjct: 129 AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQ 186

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 331
           N++    P +  +L  L  LY+  N LS  +P+  L+    L Y   + L++
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQY---LRLND 234

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 23/112 (20%), Positives = 43/112 (38%), Gaps = 11/112 (9%)

Query: 206 PCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIP 264
           PC         C    +P +T      + L   +P  +   ++   ++L GN ++  P  
Sbjct: 1   PCPGA------CVCYNEPKVTT-SCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAA 50

Query: 265 DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
            F  C +L I+ L  N L     ++   L  L +L + +N    +V  +   
Sbjct: 51  SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 63.1 bits (154), Expect = 6e-11
 Identities = 23/98 (23%), Positives = 35/98 (35%), Gaps = 5/98 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
            +   I L    ++    +      +L  LWL  N L   I    F+G   L  + L DN
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-IDAAAFTGLALLEQLDLSDN 90

Query: 281 -QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
            QL    P++   L  L  L++    L   +   L   
Sbjct: 91  AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRG 127

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 59.2 bits (144), Expect = 9e-10
 Identities = 19/85 (22%), Positives = 35/85 (41%), Gaps = 5/85 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
            ++T + L    ++ ++P      L SL  L L  N +   +    F     L  ++L  
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFA 210

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNN 304
           N L+     +L  L  L+ L + +N
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDN 235

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 7/94 (7%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
             ++ I ++  N+T  IP  L    SL EL LDGN +T  +      G  +L  + L  N
Sbjct: 171 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSFN 226

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
            ++     SL N P+LREL++ NN L   VP  L
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 22/105 (20%), Positives = 43/105 (40%), Gaps = 9/105 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLT-GPIPD--FSGCPDLRIIHLE 278
            ++  + +    +T  +       L+ ++ + L  N L    I +  F G   L  I + 
Sbjct: 121 KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179

Query: 279 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
           D  +T  +P  L   P+L EL++  N ++  V ++ L     L  
Sbjct: 180 DTNITT-IPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAK 220

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 28/114 (24%), Positives = 43/114 (37%), Gaps = 8/114 (7%)

Query: 206 PCLPVPWSW-LQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP 264
           P +P        C    Q  + V+  S   L   +P DL        L L  N +T  I 
Sbjct: 13  PEVPEIEPMGPVCPFRCQCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITE-IK 68

Query: 265 --DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
             DF    +L  + L +N+++   P +   L  L  LY+  N L   +P  +  
Sbjct: 69  DGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK 121

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 14/115 (12%), Positives = 40/115 (34%), Gaps = 12/115 (10%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 281
            ++  + LS  +++  + +  L     L EL L+ N L       +    +++++L +N 
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274

Query: 282 LTG------PLPSSLMNLPNLRELYVQNNMLSGT-VPSSL---LSKNVVLNYAGN 326
           ++         P       +   + + +N +    +  S    +     +     
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 21/108 (19%), Positives = 36/108 (33%), Gaps = 24/108 (22%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
           P   ++ L +  +T     D   L +L  L L  N ++  I    F+    L  ++L  N
Sbjct: 52  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLSKN 110

Query: 281 QLT---GPLPSSLM------------------NLPNLRELYVQNNMLS 307
           QL      +P +L                    L  +  + +  N L 
Sbjct: 111 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK 158

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 42/224 (18%), Positives = 84/224 (37%), Gaps = 48/224 (21%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 469
           + ++IG G FGV++ G  L + +++A+K     S     +  +E      +     +   
Sbjct: 14  VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 522
             + QE   +VLV + +  G   E L          +   R          A+     ++
Sbjct: 72  YYFGQEGLHNVLVIDLL--GPSLEDLL---------DLCGRKFSVKTVAMAAKQMLARVQ 120

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAK-----VSDFGLSKFAVDGASHV------SSI 571
            +H      +++RD+K  N L+ +          V DFG+ KF  D  +           
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177

Query: 572 VRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQ 609
           + GT        Y+S      ++ + + D+ + G + +  + G 
Sbjct: 178 LSGTA------RYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 50/209 (23%), Positives = 90/209 (43%), Gaps = 20/209 (9%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQF 469
           L +KIGSG FG +Y G  +  G+E+A+K+    +     +   E  +   +     +   
Sbjct: 13  LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTI 70

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
                E   +V+V E +  G   E L+   + +  +  +  L +A+     IEY+H+   
Sbjct: 71  RWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTV--LLLADQMISRIEYIHSKN- 125

Query: 530 PAIIHRDLKSSNILLDKHMRAK---VSDFGLSKFAVDGASHV------SSIVRGTVGYLD 580
              IHRD+K  N L+    +     + DFGL+K   D  +H       +  + GT  Y  
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183

Query: 581 PEYYISQQLTDKSDVYSFGVILLELISGQ 609
              ++  + + + D+ S G +L+    G 
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 24/109 (22%), Positives = 43/109 (39%), Gaps = 7/109 (6%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
             + V+ +S       +  +     +L  L +   +LT  +P         LR ++L  N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYN 258

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 326
            ++    S L  L  L+E+ +    L+  V       L+   VLN +GN
Sbjct: 259 PISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGN 306

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 67.4 bits (165), Expect = 6e-12
 Identities = 20/97 (20%), Positives = 38/97 (39%), Gaps = 6/97 (6%)

Query: 223 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
            ++T + +S   +   +   +   L +L  L +  N L   I    FSG   L  + LE 
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEK 161

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
             LT     +L +L  L  L +++  ++  +      
Sbjct: 162 CNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFK 197

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 24/104 (23%), Positives = 45/104 (43%), Gaps = 6/104 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
            S+  + L   NLT +IP++ L+ L  L+ L L   ++   I D  F     L+++ +  
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEISH 209

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
                 +  + +   NL  L + +  L+  VP   +   V L +
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRF 252

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 23/97 (23%), Positives = 41/97 (42%), Gaps = 6/97 (6%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
           P +  + L+   ++  +       L +L  L L  N L   IP   F+G  +L  + + +
Sbjct: 56  PHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISE 113

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
           N++   L     +L NL+ L V +N L   +     S
Sbjct: 114 NKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFS 149

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 60.5 bits (147), Expect = 9e-10
 Identities = 20/96 (20%), Positives = 38/96 (39%), Gaps = 5/96 (5%)

Query: 222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDN 280
                 +    K     +P  +   +    L L  N +      +F+  P L  + L +N
Sbjct: 10  SAQDRAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
            ++   P +  NL NLR L +++N L   +P  + +
Sbjct: 67  IVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFT 101

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 58.2 bits (141), Expect = 5e-09
 Identities = 24/88 (27%), Positives = 41/88 (46%), Gaps = 5/88 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
             +  ++LS   ++  I    L +L  L E+ L G  L   +    F G   LR++++  
Sbjct: 248 VYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAV-VEPYAFRGLNYLRVLNVSG 305

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLS 307
           NQLT    S   ++ NL  L + +N L+
Sbjct: 306 NQLTTLEESVFHSVGNLETLILDSNPLA 333

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 32/122 (26%), Positives = 44/122 (36%), Gaps = 24/122 (19%)

Query: 217 CNSDPQPSITVIHLSSKNLT---GNIPSDLTKL------------------SSLVELWLD 255
           C      S   ++   +NLT    ++P D T L                  + L +L LD
Sbjct: 4   CEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 256 GNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL 315
              LT  +      P L  + L  NQL   LP     LP L  L V  N L+ ++P   L
Sbjct: 64  RAELTK-LQVDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120

Query: 316 SK 317
             
Sbjct: 121 RG 122

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 62.8 bits (153), Expect = 7e-11
 Identities = 28/100 (28%), Positives = 47/100 (47%), Gaps = 5/100 (5%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHL 277
              P +  + LS   L  ++P     L +L  L +  N LT  +P     G  +L+ ++L
Sbjct: 74  GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYL 131

Query: 278 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
           + N+L    P  L   P L +L + NN L+  +P+ LL+ 
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNG 170

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 32/92 (34%), Positives = 45/92 (48%), Gaps = 6/92 (6%)

Query: 223 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
           P++TV+ +S   LT ++P      L  L EL+L GN L   +P    +  P L  + L +
Sbjct: 100 PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLAN 157

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 311
           N LT      L  L NL  L +Q N L  T+P
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 69.2 bits (169), Expect = 2e-12
 Identities = 23/105 (21%), Positives = 38/105 (36%), Gaps = 4/105 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 281
           P +  + LS   L   I      K+  L  L++  N L          P L+++ L  N 
Sbjct: 254 PGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNH 312

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           L   +  +      L  LY+ +N +  T+  S       L  + N
Sbjct: 313 LLH-VERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHN 355

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 67.3 bits (164), Expect = 8e-12
 Identities = 22/107 (20%), Positives = 44/107 (41%), Gaps = 6/107 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
            +I  +++    +   +P  +   +  L  L L+ N L+  +P   F   P L  + + +
Sbjct: 99  HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 156

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           N L      +     +L+ L + +N L+  V  SL+      N + N
Sbjct: 157 NNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYN 202

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 67.3 bits (164), Expect = 1e-11
 Identities = 21/109 (19%), Positives = 39/109 (35%), Gaps = 7/109 (6%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 279
               ++  +  S  ++   +   +     L  L L  N+LT         P L  + L  
Sbjct: 208 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSY 263

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 326
           N+L   +    + +  L  LY+ NN L   +      +    VL+ + N
Sbjct: 264 NELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 311

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 65.3 bits (159), Expect = 4e-11
 Identities = 17/102 (16%), Positives = 40/102 (39%), Gaps = 6/102 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
            +  ++   +  +   +P+  L     +  L L+   +   I    F+    ++ +++  
Sbjct: 51  NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 108

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 321
           N +    P    N+P L  L ++ N LS ++P  +      L
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKL 149

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 26/88 (29%), Positives = 42/88 (47%), Gaps = 8/88 (9%)

Query: 223 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
           P +TV+ L   +L+ ++P  +      L  L +  N+L   I D  F     L+ + L  
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 180

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLS 307
           N+LT  +  SL  +P+L    V  N+LS
Sbjct: 181 NRLTH-VDLSL--IPSLFHANVSYNLLS 205

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 16/104 (15%), Positives = 33/104 (31%), Gaps = 4/104 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +  +++S+  L   +      + +L  L L  N L     +      L  ++L+ N +
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSI 336

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
              L  S      L+ L + +N        +L            
Sbjct: 337 V-TLKLS--THHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDA 377

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 7/86 (8%), Positives = 30/86 (34%), Gaps = 2/86 (2%)

Query: 239 IPSDLTKLSSLVELWLDGNSLTGP-IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLR 297
           I S+L       ++ +D  +       +     + +I+  +++ +     + L +   + 
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 78

Query: 298 ELYVQNNMLSGTVPSSLLSKNVVLNY 323
            L + +  +   + +   +    +  
Sbjct: 79  LLNLNDLQIE-EIDTYAFAYAHTIQK 103

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 22/107 (20%), Positives = 43/107 (40%), Gaps = 6/107 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
            +I  +++    +   +P      +  L  L L+ N L+  +P   F   P L  + + +
Sbjct: 93  HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 150

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           N L      +     +L+ L + +N L+  V  SL+      N + N
Sbjct: 151 NNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHANVSYN 196

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 18/88 (20%), Positives = 32/88 (36%), Gaps = 4/88 (4%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED 279
               ++  +  S  ++   +   +     L  L L  N+LT         P L  + L  
Sbjct: 202 AIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSY 257

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLS 307
           N+L   +    + +  L  LY+ NN L 
Sbjct: 258 NELEKIMYHPFVKMQRLERLYISNNRLV 285

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 66.6 bits (163), Expect = 8e-12
 Identities = 18/110 (16%), Positives = 43/110 (39%), Gaps = 9/110 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
            +  ++   +  +   +P+  L     +  L L+   +   I    F+    ++ +++  
Sbjct: 45  NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 102

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN---VVLNYAGN 326
           N +    P    N+P L  L ++ N LS ++P  +         L+ + N
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNN 151

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 23/95 (24%), Positives = 38/95 (40%), Gaps = 5/95 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 281
             +T++ L   NLT +    L     LVE+ L  N L       F     L  +++ +N+
Sbjct: 226 VELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
           L   L      +P L+ L + +N L   V  +   
Sbjct: 284 LVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ 316

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 8/88 (9%)

Query: 223 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
           P +TV+ L   +L+ ++P  +      L  L +  N+L   I D  F     L+ + L  
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 174

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLS 307
           N+LT  +  S   +P+L    V  N+LS
Sbjct: 175 NRLTH-VDLS--LIPSLFHANVSYNLLS 199

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 57.0 bits (138), Expect = 9e-09
 Identities = 11/100 (11%), Positives = 34/100 (34%), Gaps = 6/100 (6%)

Query: 222 QPSITVIHLSSKNLTGNIPSDLTK--LSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHL 277
           Q       +     T ++        L++   +    +++   +P         + +++L
Sbjct: 18  QYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNL 76

Query: 278 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
            D Q+      +      +++LY+  N +   +P  +   
Sbjct: 77  NDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN 115

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 22/97 (22%), Positives = 39/97 (40%), Gaps = 7/97 (7%)

Query: 221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 280
           P P++ V+ LS  +L  ++  +  +   L  L+LD NS+   +   S    L+ + L  N
Sbjct: 293 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHN 349

Query: 281 QLTGPLPSSLMNLP-NLRELYVQNNMLSGTVPSSLLS 316
                  +SL  L  N+    V +      +   L  
Sbjct: 350 DWD---CNSLRALFRNVARPAVDDADQHCKIDYQLEH 383

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 68.6 bits (168), Expect = 4e-12
 Identities = 23/96 (23%), Positives = 46/96 (47%), Gaps = 5/96 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 281
            +  V    S++ T +IPS L   +++  L L  N +T     D   C +L+++ L+ ++
Sbjct: 5   DASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
           +      +  +L +L  L + +N LS ++ SS    
Sbjct: 62  INTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGP 96

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 64.0 bits (156), Expect = 8e-11
 Identities = 22/97 (22%), Positives = 36/97 (37%), Gaps = 3/97 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
            ++  + LS   +T     DL   ++L  L L  + +   I    F     L  + L DN
Sbjct: 26  AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDN 84

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
            L+    S    L +L+ L +  N       +SL   
Sbjct: 85  HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 63.2 bits (154), Expect = 2e-10
 Identities = 19/111 (17%), Positives = 39/111 (35%), Gaps = 5/111 (4%)

Query: 223 PSITVIHLSSKNLTGNIP-SDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
            ++  + + +      I   D   L+SL EL +   SL             D+  + L  
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN-YQSQSLKSIRDIHHLTLHL 181

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 330
           ++    L      L ++R L +++  L+     S L  + V +    +   
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFR 231

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 62.4 bits (152), Expect = 3e-10
 Identities = 21/82 (25%), Positives = 39/82 (47%), Gaps = 5/82 (6%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++ V+ +S+ NL  +    L     L EL++  N L   +PD S  P L ++ +  NQL
Sbjct: 431 QTLEVLDVSNNNLD-SFSLFLP---RLQELYISRNKLKT-LPDASLFPVLLVMKISRNQL 485

Query: 283 TGPLPSSLMNLPNLRELYVQNN 304
                     L +L+++++  N
Sbjct: 486 KSVPDGIFDRLTSLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 61.3 bits (149), Expect = 6e-10
 Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 21/124 (16%)

Query: 223 PSITVIHLSSKNLT--GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDN 280
           PS+  + LS  +L         L  L +L  L +  N+             +R ++L   
Sbjct: 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSST 420

Query: 281 QLT---GPLPSSL--------------MNLPNLRELYVQNNMLSGTVPSSLLSKN-VVLN 322
            +      +P +L              + LP L+ELY+  N L  T+P + L    +V+ 
Sbjct: 421 GIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TLPDASLFPVLLVMK 479

Query: 323 YAGN 326
            + N
Sbjct: 480 ISRN 483

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 59.0 bits (143), Expect = 3e-09
 Identities = 18/108 (16%), Positives = 38/108 (35%), Gaps = 7/108 (6%)

Query: 210 VPWSWLQCNSDPQPSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIP--DF 266
           +  SW      P  S+  ++L         + S    L++L  L +        I   DF
Sbjct: 89  LSSSWFG----PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144

Query: 267 SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           +G   L  + ++   L      SL ++ ++  L +  +  +  +    
Sbjct: 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 58.2 bits (141), Expect = 6e-09
 Identities = 13/88 (14%), Positives = 33/88 (37%), Gaps = 4/88 (4%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQL 282
           +I  +H+    L  ++ +  + L  +  + ++ + +   P         L  + L +N +
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLM 346

Query: 283 T---GPLPSSLMNLPNLRELYVQNNMLS 307
                   +     P+L+ L +  N L 
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLR 374

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 57.8 bits (140), Expect = 7e-09
 Identities = 23/104 (22%), Positives = 37/104 (35%), Gaps = 4/104 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
            ++ V+ L S  +          L SL  L L  N L+  +    F     L+ ++L  N
Sbjct: 50  ANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGN 108

Query: 281 QLTG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
                 + S   NL NL+ L + N      +     +    LN 
Sbjct: 109 PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNE 152

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 55.9 bits (135), Expect = 3e-08
 Identities = 21/107 (19%), Positives = 43/107 (40%), Gaps = 12/107 (11%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +  ++LSS  +   + + +    +L  L +  N+L          P L+ +++  N+L
Sbjct: 410 EKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDS-FS--LFLPRLQELYISRNKL 463

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGN 326
              LP +    P L  + +  N L  +VP  +   L+    +    N
Sbjct: 464 KT-LPDA-SLFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTN 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 13/109 (11%), Positives = 38/109 (34%), Gaps = 8/109 (7%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQL 282
            +   + S  ++   +     +  ++  L +    L   +   +S    ++ I +E++++
Sbjct: 265 GLGDFNPSESDVVSELGK--VETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSG-----TVPSSLLSKNVVLNYAGN 326
                S   +L +L  L +  N++       +           L  + N
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQN 371

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 42.4 bits (100), Expect = 5e-04
 Identities = 11/89 (12%), Positives = 22/89 (24%), Gaps = 1/89 (1%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLE 278
                I  + L        +      LSS+  L L   +L                +   
Sbjct: 169 KSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228

Query: 279 DNQLTGPLPSSLMNLPNLRELYVQNNMLS 307
             + +     S   L  L    ++ + + 
Sbjct: 229 AFRGSVLTDESFNELLKLLRYILELSEVE 257

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 67.8 bits (166), Expect = 4e-12
 Identities = 25/104 (24%), Positives = 45/104 (43%), Gaps = 8/104 (7%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++T +   + ++T ++   + KL+ L +L    N++T    D S   +L  +  + N+L
Sbjct: 42  ATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITTL--DLSQNTNLTYLACDSNKL 97

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           T  L   +  L  L  L    N L+  +  S       LN A N
Sbjct: 98  TN-LD--VTPLTKLTYLNCDTNKLT-KLDVSQNPLLTYLNCARN 137

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 62.8 bits (153), Expect = 2e-10
 Identities = 23/104 (22%), Positives = 39/104 (37%), Gaps = 9/104 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +T +  S   +T     D+++   L  L  D N++T    D +    L  +    N+L
Sbjct: 170 TQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK--LDLNQNIQLTFLDCSSNKL 224

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           T  +  +   L  L       N L+  +  S LSK   L+    
Sbjct: 225 TE-IDVT--PLTQLTYFDCSVNPLT-ELDVSTLSKLTTLHCIQT 264

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 22/109 (20%), Positives = 37/109 (33%), Gaps = 9/109 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +  ++  + N+T  +  DL +   L  L    N LT    D +    L       N L
Sbjct: 191 KLLNRLNCDTNNIT-KL--DLNQNIQLTFLDCSSNKLTEI--DVTPLTQLTYFDCSVNPL 245

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 331
           T  L  S   L  L  L+     L   +  +  ++ +     G   + E
Sbjct: 246 T-ELDVS--TLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKIKE 290

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 61.6 bits (150), Expect = 4e-10
 Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 5/99 (5%)

Query: 228 IHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP 287
           I+  ++        D+T  + L  L      +T  + D S  P L  ++L + +LT  L 
Sbjct: 278 IYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELTE-LD 334

Query: 288 SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
            S  +   L+ L   N  +        +        A  
Sbjct: 335 VS--HNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEG 371

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 61.2 bits (149), Expect = 5e-10
 Identities = 16/105 (15%), Positives = 42/105 (40%), Gaps = 7/105 (6%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             + ++   +  +T  +  DL++   LV L+L+   LT  + D S    L+ +   +  +
Sbjct: 297 TQLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTELTE-L-DVSHNTKLKSLSCVNAHI 351

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI 327
                S +  +P L   +            +L + ++ +  + ++
Sbjct: 352 QD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 60.5 bits (147), Expect = 9e-10
 Identities = 20/97 (20%), Positives = 36/97 (37%), Gaps = 5/97 (5%)

Query: 230 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSS 289
            ++  +         +L++L  L    +S+T  +        L  +    N +T  L  S
Sbjct: 25  AAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNITT-LDLS 82

Query: 290 LMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
                NL  L   +N L+  +  + L+K   LN   N
Sbjct: 83  --QNTNLTYLACDSNKLT-NLDVTPLTKLTYLNCDTN 116

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 27/104 (25%), Positives = 43/104 (41%), Gaps = 8/104 (7%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++T +   S  LT N+   +T L+ L  L  D N LT    D S  P L  ++   N L
Sbjct: 85  TNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL--DVSQNPLLTYLNCARNTL 139

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           T  +  S  +   L EL    N     +  +  ++   L+ + N
Sbjct: 140 T-EIDVS--HNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFN 180

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 19/104 (18%), Positives = 38/104 (36%), Gaps = 8/104 (7%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
           P +T ++ +   LT  I  D++  + L EL    N       D +    L  +    N++
Sbjct: 127 PLLTYLNCARNTLT-EI--DVSHNTQLTELDCHLNKKI-TKLDVTPQTQLTTLDCSFNKI 182

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           T      +     L  L    N ++  +  +   +   L+ + N
Sbjct: 183 TE---LDVSQNKLLNRLNCDTNNIT-KLDLNQNIQLTFLDCSSN 222

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 25/123 (20%), Positives = 35/123 (28%), Gaps = 25/123 (20%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +T +  SS  LT  I  D+T L+ L       N LT    D S    L  +H     L
Sbjct: 212 IQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLT--ELDVSTLSKLTTLHCIQTDL 266

Query: 283 T----GPLPS---------------SLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
                                     + +   L  L  Q   ++  +  S   K V L  
Sbjct: 267 LEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELDLSQNPKLVYLYL 325

Query: 324 AGN 326
              
Sbjct: 326 NNT 328

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 44.7 bits (106), Expect = 8e-05
 Identities = 18/106 (16%), Positives = 37/106 (34%), Gaps = 8/106 (7%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
           P +  ++L++  LT  +  D++  + L  L      +          P L      + Q 
Sbjct: 318 PKLVYLYLNNTELT-EL--DVSHNTKLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQT 373

Query: 283 TGPLPSSLMNLPNLRELYVQNNML--SGTVPSSLLSKNVVLNYAGN 326
              +P   +   +L  + V  ++L   G   +       V + A N
Sbjct: 374 IT-MPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDGGVYDQATN 417

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 64.2 bits (157), Expect = 7e-12
 Identities = 19/109 (17%), Positives = 49/109 (44%), Gaps = 5/109 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            S+T I L++ N+T ++ + +    ++ +L ++    T      SG  +L  + +    +
Sbjct: 44  NSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDV 100

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINL 329
           T     +L  L +L  L + ++    ++ + +  L K   ++ + N  +
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI 149

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 15/86 (17%), Positives = 37/86 (43%), Gaps = 2/86 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            S+T++ +S      +I + +  L  +  + L  N     I      P+L+ ++++ + +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSG 308
                  + + P L +LY  +  + G
Sbjct: 172 HD--YRGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 59.2 bits (144), Expect = 3e-10
 Identities = 19/105 (18%), Positives = 40/105 (38%), Gaps = 2/105 (1%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 281
            ++  + +  K++T +   +L+ L+SL  L +  ++     +   +  P +  I L  N 
Sbjct: 88  SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
               +   L  LP L+ L +Q + +          K   L     
Sbjct: 148 AITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQ 191

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 66.2 bits (162), Expect = 9e-12
 Identities = 33/93 (35%), Positives = 43/93 (46%), Gaps = 7/93 (7%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQ 281
            +  + +S   LT  IP DL    +L EL LD N +   I          L  + L  NQ
Sbjct: 173 KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQA-IELEDLLRYSKLYRLGLGHNQ 228

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           +      SL  LP LREL++ NN LS  VP+ L
Sbjct: 229 IRMIENGSLSFLPTLRELHLDNNKLS-RVPAGL 260

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 63.9 bits (156), Expect = 5e-11
 Identities = 26/113 (23%), Positives = 46/113 (40%), Gaps = 7/113 (6%)

Query: 216 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLR 273
            C       + V+  S   L   +P +++       L L  N ++  +   DF G   L 
Sbjct: 26  MCPFGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISE-LRKDDFKGLQHLY 81

Query: 274 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
            + L +N+++     +   L  L++LY+  N L   +P +L S  V L    N
Sbjct: 82  ALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDN 133

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 60.0 bits (146), Expect = 8e-10
 Identities = 17/91 (18%), Positives = 36/91 (39%), Gaps = 10/91 (10%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-------GPIPDFSGCPDLRII 275
           P++  +HL +  L+  +P+ L  L  L  ++L  N++T        P+           I
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299

Query: 276 HLEDNQLTGPL--PSSLMNLPNLRELYVQNN 304
            L +N +      P++   + +   +   N 
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 24/110 (21%), Positives = 41/110 (37%), Gaps = 24/110 (21%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
           P  T++ L + +++     D   L  L  L L  N ++  I +  FS    L+ +++  N
Sbjct: 54  PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKN 112

Query: 281 QLT---GPLPSSL------------------MNLPNLRELYVQNNMLSGT 309
            L      LPSSL                    L N+  + +  N L  +
Sbjct: 113 HLVEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS 162

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 17/92 (18%), Positives = 33/92 (35%), Gaps = 8/92 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQ 281
             +  + L    +   I +  L+ L +L EL LD N L+           L++++L  N 
Sbjct: 217 SKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNN 275

Query: 282 LTG------PLPSSLMNLPNLRELYVQNNMLS 307
           +T             +       + + NN + 
Sbjct: 276 ITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 33/179 (18%), Positives = 64/179 (35%), Gaps = 28/179 (15%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEI------AVKVLTSNSYQGKREFTNEVTLLSRIHHRN 465
           +   IG GGFG +Y   +   + +       VKV  S++     E        ++     
Sbjct: 39  VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTEL-KFYQRAAKPEQIQ 97

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEH------LYGT-LTHEQRINWIKR-------L 511
                   +  G        +H+   K +       +G+ L  ++      +       L
Sbjct: 98  KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDL--QKIYEANAKRFSRKTVL 155

Query: 512 EIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKFAVDGASHV 568
           +++      +EY+H       +H D+K+SN+LL+     +V   D+GL+        H 
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.3 bits (158), Expect = 2e-11
 Identities = 38/268 (14%), Positives = 73/268 (27%), Gaps = 68/268 (25%)

Query: 397 AHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVL--------TSNSYQGK 448
           +HC     ++       +KIG G FG V+         +A+K++          +  +  
Sbjct: 14  SHCLPTEKLQRC-----EKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTF 67

Query: 449 REFTNEVTLLSRIH---------HRNLVQFLGYCQEEGRS-------------------- 479
            E   E+ +   +              +        +G                      
Sbjct: 68  EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127

Query: 480 ----------VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
                      +V EF   G   E +       +  +      I       +        
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTASLAVAEA--S 180

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
               HRDL   N+LL K    K+      K +   +  +       V  +D  Y +S+  
Sbjct: 181 LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGL------QVSIID--YTLSRLE 232

Query: 590 TDKSDVYSFGVILLELISGQEAISNEKF 617
            D   V+    +  +L +G      + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDGDYQFDIY 260

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 66.2 bits (161), Expect = 2e-11
 Identities = 50/216 (23%), Positives = 93/216 (43%), Gaps = 34/216 (15%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLV-QF 469
           L +KIGSG FG +Y G  ++  +E+A+K+    +     +   E  +   +     +   
Sbjct: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNV 68

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR-------LEIAEDAAKGIE 522
             +  E   +VLV + +  G   E L+         N+  R       L +A+     +E
Sbjct: 69  RWFGVEGDYNVLVMDLL--GPSLEDLF---------NFCSRKLSLKTVLMLADQMINRVE 117

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAK---VSDFGLSKFAVDGASHV------SSIVR 573
           ++H+      +HRD+K  N L+    RA    + DFGL+K   D ++H       +  + 
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174

Query: 574 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
           GT  Y     ++  + + + D+ S G +L+  + G 
Sbjct: 175 GTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 65.4 bits (160), Expect = 2e-11
 Identities = 31/111 (27%), Positives = 46/111 (41%), Gaps = 4/111 (3%)

Query: 222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDN 280
           QP    + L S  L    P    +LS L  + +D   L   +PD       L  + L  N
Sbjct: 80  QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARN 137

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 331
            L   LP+S+ +L  LREL ++       +P  L S +    + G +NL  
Sbjct: 138 PLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQS 187

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 22/112 (19%), Positives = 46/112 (41%), Gaps = 7/112 (6%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED-NQL 282
           ++  + L    +  ++P+ +  L +L  L +  + L+   P     P L  + L     L
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTAL 242

Query: 283 TGPLPSSLMNLPNLRELYVQN-NMLSGTVPSSL--LSKNVVLNYAGNINLHE 331
               P        L+ L +++ + L  T+P  +  L++   L+  G +NL  
Sbjct: 243 RN-YPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSR 292

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 18/95 (18%), Positives = 29/95 (30%), Gaps = 4/95 (4%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWL-DGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
            +  + L       N P      + L  L L D ++L   +P        L  + L    
Sbjct: 230 KLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCV 288

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
               LPS +  LP    + V  + L   +      
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPH-LQAQLDQHRPV 322

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 18/119 (15%), Positives = 40/119 (33%), Gaps = 12/119 (10%)

Query: 224 SITVIHLSSKNLTGNIPSDL---------TKLSSLVELWLDGNSLTGPIPDFSGCPDLRI 274
            +  + + +      +P  L           L +L  L L+   +       +   +L+ 
Sbjct: 151 RLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKS 210

Query: 275 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHE 331
           + + ++ L+  L  ++ +LP L EL ++        P      +    L      NL  
Sbjct: 211 LKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT 268

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 60.0 bits (146), Expect = 9e-10
 Identities = 26/124 (20%), Positives = 46/124 (37%), Gaps = 12/124 (9%)

Query: 213 SWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSS--LVELWLDGNSLTGPIPD-FSGC 269
           +W Q NS+   +  +   + + L       L   +    V L L    L    PD     
Sbjct: 49  AWRQANSN---NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRL 103

Query: 270 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI 327
             L+ + ++   L   LP ++     L  L +  N L   +P+S+  L++   L+     
Sbjct: 104 SHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161

Query: 328 NLHE 331
            L E
Sbjct: 162 ELTE 165

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 56.9 bits (138), Expect = 8e-09
 Identities = 20/115 (17%), Positives = 42/115 (36%), Gaps = 15/115 (13%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLED-NQ 281
            +  + + +  L   +P  + + + L  L L  N L   +P   +    LR + +    +
Sbjct: 105 HLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPE 162

Query: 282 LT--------GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGN 326
           LT                 L NL+ L ++   +  ++P+S+  L     L    +
Sbjct: 163 LTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 23/99 (23%), Positives = 43/99 (43%), Gaps = 6/99 (6%)

Query: 226 TVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 282
             + LS  +L   I S+    + +L  L L  N L   + +  FS    L ++ L +N +
Sbjct: 67  HSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHI 124

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 321
                ++  ++  L++LY+  N +S   P  L+     L
Sbjct: 125 VVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKL 162

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 63.3 bits (154), Expect = 9e-11
 Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 7/99 (7%)

Query: 223 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLE 278
               ++ LS  NL+  + ++   T+L++L  L L  N L   I    F   P+LR + L 
Sbjct: 39  SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLS 96

Query: 279 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
            N L         +L  L  L + NN +   V  +    
Sbjct: 97  SNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFED 134

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 28/116 (24%), Positives = 47/116 (40%), Gaps = 12/116 (10%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
           P++  + LSS +L   +     + L +L  L L  N +   +    F     L+ ++L  
Sbjct: 88  PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQ 145

Query: 280 NQLTGPLP----SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 331
           NQ++   P         LP L  L + +N L   +P + L K       G + LH 
Sbjct: 146 NQISR-FPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKNG-LYLHN 198

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 66.0 bits (161), Expect = 3e-11
 Identities = 25/112 (22%), Positives = 48/112 (42%), Gaps = 9/112 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTGPIPD------FSGCPDLRI 274
           P + ++ L+    + +   D   ++  SL +L+L  N L            F G   L++
Sbjct: 426 PHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484

Query: 275 IHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           ++L  N L    P    +L  LR L + +N L+    + L +   +L+ + N
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRN 536

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 65.2 bits (159), Expect = 4e-11
 Identities = 22/104 (21%), Positives = 34/104 (32%), Gaps = 3/104 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
            +   + LS   +     S    L  L  L L        I    F   P+LRI+ L  +
Sbjct: 24  NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLS-GTVPSSLLSKNVVLNY 323
           ++    P +   L +L EL +    LS   +          L  
Sbjct: 84  KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 61.7 bits (150), Expect = 7e-10
 Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 2/97 (2%)

Query: 221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLED 279
            + S+  + LS   +          L  L  L L  N +       F G  +L++++L  
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
           N L     S+   LP +  + +Q N ++  +      
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFK 359

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 59.8 bits (145), Expect = 3e-09
 Identities = 19/99 (19%), Positives = 34/99 (34%), Gaps = 7/99 (7%)

Query: 227 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGP 285
           +      NLT  +P  L   ++   L L  N +       F     L+++ L        
Sbjct: 8   IAFYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63

Query: 286 L-PSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
           +   +  NLPNLR L + ++ +   +          L  
Sbjct: 64  IDKEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFE 101

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 58.3 bits (141), Expect = 7e-09
 Identities = 30/110 (27%), Positives = 42/110 (38%), Gaps = 9/110 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTK-----LSSLVELWLDGNSLTG-PIPDFSGCPDLRIIH 276
           PS+  + L    L     ++L       LS L  L+L+ N L   P   FS    LR + 
Sbjct: 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLS 510

Query: 277 LEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           L  N+LT    + L    NL  L +  N L       +     VL+   N
Sbjct: 511 LNSNRLTVLSHNDL--PANLEILDISRNQLL-APNPDVFVSLSVLDITHN 557

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 23/120 (19%), Positives = 48/120 (40%), Gaps = 2/120 (1%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQ 281
             + V++L+   +          L +L  L L  N L      +F G P +  I L+ N 
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRGAKHLNI 341
           +      +   L  L+ L +++N L+ T+       ++ L+    + L +    A  +++
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNALT-TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHL 408

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 56.4 bits (136), Expect = 3e-08
 Identities = 22/115 (19%), Positives = 33/115 (28%), Gaps = 9/115 (7%)

Query: 223 PSITVIHLSSKNLTGNI--PSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLE 278
             +  + L    L+  +        L +L  L L  N +      P F     L+ I   
Sbjct: 97  FHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS 156

Query: 279 DNQLTGPLPSSLMNL--PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 331
            NQ+       L  L    L    +  N L   V          +N   N+ L  
Sbjct: 157 SNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGK---CMNPFRNMVLEI 208

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 50.6 bits (121), Expect = 2e-06
 Identities = 23/100 (23%), Positives = 43/100 (43%), Gaps = 9/100 (9%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +  + L    LT      +  + S+ +++L GN L   +P  +      +IHL +N+L
Sbjct: 362 EKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVT-LPKIN--LTANLIHLSENRL 413

Query: 283 TG-PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 321
               +   L+ +P+L+ L +  N  S        S+N  L
Sbjct: 414 ENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL 453

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 43.6 bits (103), Expect = 2e-04
 Identities = 15/116 (12%), Positives = 36/116 (31%), Gaps = 22/116 (18%)

Query: 222 QPSITVIHLSSKNLTGNIPSDLTKLS------SLVELWLDGNSLTGPIPD---------- 265
             +++   L++ +L   +  D  K         L  L + GN  T  I            
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232

Query: 266 ---FSGCPDLRIIHLEDNQLTGPLPSSLMNLP--NLRELYVQNNMLSGTVPSSLLS 316
                    +       + +  P  ++   L   ++R L + +  +  ++ S +  
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFE 287

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 36/185 (19%), Positives = 64/185 (34%), Gaps = 43/185 (23%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLL--SRIHHRNLVQ 468
           L KKIGSGGFG++Y        ++ A  V+       K E+     L    + + R    
Sbjct: 41  LGKKIGSGGFGLIYLAFPTNKPEKDARHVV-------KVEYQENGPLFSELKFYQR---- 89

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQR-----------------INWIKR- 510
            +       + +   +  + G    +  G    + R                        
Sbjct: 90  -VAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTF 148

Query: 511 -----LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV--SDFGLSKFAVD 563
                L++       +EY+H       +H D+K++N+LL      +V  +D+GLS     
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCP 205

Query: 564 GASHV 568
             +H 
Sbjct: 206 NGNHK 210

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 64.0 bits (156), Expect = 4e-11
 Identities = 27/114 (23%), Positives = 44/114 (38%), Gaps = 6/114 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
            ++  + LS+  +T    SDL +  +L  L L  N +   I +  FS    L  + L  N
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYN 110

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNINLHE 331
            L+    S    L +L  L +  N       +SL   L+K  +L         +
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTK 164

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 24/132 (18%), Positives = 40/132 (30%), Gaps = 30/132 (22%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLT------------------ 260
               S+  + LS   L+ N+ S     LSSL  L L GN                     
Sbjct: 97  SSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILR 155

Query: 261 -------GPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 311
                    I    F+G   L  + ++ + L    P SL ++ N+  L +        + 
Sbjct: 156 VGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLL 214

Query: 312 SSLLSKNVVLNY 323
              +     +  
Sbjct: 215 EIFVDVTSSVEC 226

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 60.9 bits (148), Expect = 5e-10
 Identities = 16/114 (14%), Positives = 35/114 (30%), Gaps = 3/114 (2%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHL 277
                + ++ + + +    I       L+ L EL +D + L            ++  + L
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205

Query: 278 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 331
              Q    L   +    ++  L +++  L  T   S LS     +         
Sbjct: 206 HMKQHILLLEIFVDVTSSVECLELRDTDLD-TFHFSELSTGETNSLIKKFTFRN 258

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 15/93 (16%), Positives = 31/93 (33%), Gaps = 7/93 (7%)

Query: 214 WLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLR 273
            L+        +   H S   L+    + L K  +   + +   SL   +   +    L 
Sbjct: 228 ELRDTD-----LDTFHFSE--LSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLL 280

Query: 274 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 306
            +    NQL          L +L+++++  N  
Sbjct: 281 ELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 20/107 (18%), Positives = 32/107 (29%), Gaps = 13/107 (12%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSL---------TGPIPDFSGC 269
               +++ + L  K     +        SS+  L L    L         TG        
Sbjct: 195 KSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253

Query: 270 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
              R + + D  L   +   L  +  L EL    N L  +VP  +  
Sbjct: 254 FTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFD 298

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 24/106 (22%), Positives = 49/106 (46%), Gaps = 6/106 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++  + + +  ++ ++ + L  LS L  L  D N ++  I   +  P+L  +HL++NQ+
Sbjct: 151 TNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQI 207

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 328
           +    S L N  NL  + + N  ++   P    +  VV N     +
Sbjct: 208 SDV--SPLANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPS 250

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 62.8 bits (153), Expect = 8e-11
 Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 5/104 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            SI  + L+S  +T   P  L  LS+L  L+LD N +T  I   +G  +L+ + + + Q+
Sbjct: 107 QSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQV 163

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           +    + L NL  L  L   +N +S   P + L   + ++   N
Sbjct: 164 SDL--TPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNN 205

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 25/104 (24%), Positives = 51/104 (49%), Gaps = 5/104 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++ V++L    +T NI S L  L++L  L +    ++  +   +    L  +  +DN++
Sbjct: 129 SNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKI 185

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           +    S L +LPNL E++++NN +S   P +  S   ++     
Sbjct: 186 SDI--SPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQ 227

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 22/104 (21%), Positives = 42/104 (40%), Gaps = 5/104 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             IT +      +T  I   +  L++L+ L L  N +T  +        +  + L  N L
Sbjct: 41  DGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPL 97

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
                S++  L +++ L + +  ++   P + LS   VL    N
Sbjct: 98  KNV--SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLN 139

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 14/86 (16%), Positives = 35/86 (40%), Gaps = 3/86 (3%)

Query: 241 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 300
                L++ +++    +++T  +   +    +  +      +T      +  L NL  L 
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLE 69

Query: 301 VQNNMLSGTVPSSLLSKNVVLNYAGN 326
           +++N ++   P   L+K   L  +GN
Sbjct: 70  LKDNQITDLAPLKNLTKITELELSGN 95

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 47.8 bits (114), Expect = 6e-06
 Identities = 17/100 (17%), Positives = 39/100 (39%), Gaps = 5/100 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +T +      ++ +I S L  L +L+E+ L  N ++  +   +   +L I+ L +  +
Sbjct: 173 SKLTTLKADDNKIS-DI-SPLASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTI 229

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 322
           T        NL       V+    +   P+++       +
Sbjct: 230 TNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYAS 267

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 23/117 (19%), Positives = 42/117 (35%), Gaps = 10/117 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
           PS   + L   +L   IPS   + L ++  +++  +     +    F     +  I + +
Sbjct: 31  PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89

Query: 280 NQ-LTGPLPSSLMNLPNLRELYVQNNMLSGTVPS----SLLSKNVVLNYAGNINLHE 331
            + LT   P +L  LP L+ L + N  L    P            +L    N  +  
Sbjct: 90  TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTS 145

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 52.7 bits (127), Expect = 8e-08
 Identities = 22/111 (19%), Positives = 42/111 (37%), Gaps = 13/111 (11%)

Query: 216 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLR 273
           +C+ +         ++ K++   IPS      S   L L    L   IP   FS  P++ 
Sbjct: 9   ECHQE-----EDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHLRT-IPSHAFSNLPNIS 58

Query: 274 IIHLEDN-QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
            I++  +  L      S  NL  +  + ++N      +    L +  +L +
Sbjct: 59  RIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF 109

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 21/113 (18%), Positives = 40/113 (35%), Gaps = 9/113 (7%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSS-LVELWLDGNSLTGPIPD--FSGCPDLRIIHLE 278
               ++ ++      +IP +    L +  + L L  N  T  +    F+G   L  ++L 
Sbjct: 130 DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNG-TKLDAVYLN 187

Query: 279 DNQ-LTGPLPSSLMNLPN-LRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL 329
            N+ LT     +   + +    L V    ++  +PS  L     L       L
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWTL 239

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 64.5 bits (157), Expect = 6e-11
 Identities = 19/102 (18%), Positives = 36/102 (35%), Gaps = 5/102 (4%)

Query: 226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTG 284
            ++  S   L  ++P DL+       L +  N ++     D      LRI+ +  N++  
Sbjct: 3   FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59

Query: 285 PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
              S       L  L + +N L   +          L+ + N
Sbjct: 60  LDISVFKFNQELEYLDLSHNKLV-KISCHPTVNLKHLDLSFN 100

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 22/93 (23%), Positives = 44/93 (47%), Gaps = 4/93 (4%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLE 278
               S+  + +S  +++ +      +   SL+ L +  N LT  I      P ++++ L 
Sbjct: 371 TQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR-CLPPRIKVLDLH 429

Query: 279 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 311
            N++   +P  ++ L  L+EL V +N L  +VP
Sbjct: 430 SNKIKS-IPKQVVKLEALQELNVASNQLK-SVP 460

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 20/109 (18%), Positives = 40/109 (36%), Gaps = 6/109 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD----LRIIHLE 278
                +  S+  LT  +  +   L+ L  L L  N L   +   +        L+ + + 
Sbjct: 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDIS 382

Query: 279 DNQLTGPLPSSL-MNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
            N ++            +L  L + +N+L+ T+   L  +  VL+   N
Sbjct: 383 QNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSN 431

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 19/102 (18%), Positives = 35/102 (34%), Gaps = 4/102 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
              T++++S   ++    SD+  LS L  L +  N +       F    +L  + L  N+
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
           L   +        NL+ L +  N                L +
Sbjct: 81  LVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 54.9 bits (132), Expect = 6e-08
 Identities = 12/85 (14%), Positives = 27/85 (31%), Gaps = 1/85 (1%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQL 282
           ++++  + S              S++       +      +   S       +   +N L
Sbjct: 277 ALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLL 336

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLS 307
           T  +  +  +L  L  L +Q N L 
Sbjct: 337 TDTVFENCGHLTELETLILQMNQLK 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 9/96 (9%)

Query: 209 PVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG 268
               SW         S+  +++SS  LT  I   L     +  L L  N +         
Sbjct: 392 KGDCSWT-------KSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVK 442

Query: 269 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 304
              L+ +++  NQL          L +L+++++  N
Sbjct: 443 LEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 16/105 (15%), Positives = 27/105 (25%), Gaps = 5/105 (4%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHL 277
                +  + LS   L   I        +L  L L  N+        +F     L+ + L
Sbjct: 66  KFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL 122

Query: 278 EDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 322
               L       + +L   + L V             L      +
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTES 167

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 23/88 (26%), Positives = 37/88 (42%), Gaps = 5/88 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
           P + V+ LS   +   I       LS L  L L GN +   +    FSG   L+ +   +
Sbjct: 52  PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVE 109

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLS 307
             L       + +L  L+EL V +N++ 
Sbjct: 110 TNLASLENFPIGHLKTLKELNVAHNLIQ 137

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 51.5 bits (124), Expect = 4e-07
 Identities = 18/92 (19%), Positives = 37/92 (40%), Gaps = 8/92 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTG-PIPD-FSGCPDLRIIHLED 279
            S+  +     NL  ++ +     L +L EL +  N +    +P+ FS   +L  + L  
Sbjct: 100 SSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158

Query: 280 NQLTGPLPSSLMNLPNLR----ELYVQNNMLS 307
           N++     + L  L  +      L +  N ++
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 19/115 (16%), Positives = 42/115 (36%), Gaps = 13/115 (11%)

Query: 223 PSITVIHLSSKNLTGNIPSD--LTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLE- 278
            ++  ++++   +  +       + L++L  L L  N +      D      + +++L  
Sbjct: 124 KTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182

Query: 279 ---DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 330
               N +   +         L+EL +  N L  +VP  +  +   L     I LH
Sbjct: 183 DLSLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQK---IWLH 232

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 45.3 bits (108), Expect = 3e-05
 Identities = 19/89 (21%), Positives = 37/89 (41%), Gaps = 10/89 (11%)

Query: 223 PSITVIHLSSKNLTGNIPSD----LTKLSSL-VELWLDGNSLTGPIPD--FSGCPDLRII 275
            ++  + LSS  +  +I       L ++  L + L L  N +   I    F     L+ +
Sbjct: 149 TNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKE-IRLKEL 205

Query: 276 HLEDNQLTGPLPSSLMNLPNLRELYVQNN 304
            L+ NQL          L +L+++++  N
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 14/93 (15%), Positives = 32/93 (34%), Gaps = 4/93 (4%)

Query: 226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLT 283
           + +  +      +    L    +L EL+++       +      G  +LR + +  + L 
Sbjct: 11  SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69

Query: 284 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
              P +    P L  L +  N L  ++    + 
Sbjct: 70  FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQ 101

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 58.6 bits (141), Expect = 2e-09
 Identities = 26/115 (22%), Positives = 45/115 (39%), Gaps = 15/115 (13%)

Query: 205 DPCLPVPWSWLQCNSD----------PQPSITVIHLSSKNLTGNIPS-DLTKLSSLVELW 253
           D C P   S L+C  D             ++T +++ ++    ++   DL  L  L  L 
Sbjct: 3   DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62

Query: 254 LDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML 306
           +  + L   +    F   P L  ++L  N L   L    +   +L+EL +  N L
Sbjct: 63  IVKSGLR-FVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPL 115

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 28/111 (25%), Positives = 45/111 (40%), Gaps = 9/111 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
             +  + L+   +   I  +    L+ L++L L  N L   I    F     L ++ L  
Sbjct: 299 TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSY 356

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 330
           N +      S + LPNL+EL +  N L  +VP  +  +   L     I LH
Sbjct: 357 NHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQK---IWLH 403

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 61.7 bits (150), Expect = 3e-10
 Identities = 19/104 (18%), Positives = 36/104 (34%), Gaps = 3/104 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
             +  + LS  ++     +  ++L  L  L ++  +    I +  F G   L I+ L+ N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNML-SGTVPSSLLSKNVVLNY 323
           Q       +   L NL  L +    L    +  +       L  
Sbjct: 90  QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM 133

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 54.8 bits (132), Expect = 6e-08
 Identities = 23/85 (27%), Positives = 40/85 (47%), Gaps = 5/85 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLED 279
             +  ++LS  N  G+I S +   L  L  L L  N +   + D  F G P+L+ + L+ 
Sbjct: 323 THLLKLNLSQ-NFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDT 380

Query: 280 NQLTGPLPSSLMNLPNLRELYVQNN 304
           NQL          L +L+++++  N
Sbjct: 381 NQLKSVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 48.6 bits (116), Expect = 5e-06
 Identities = 22/118 (18%), Positives = 43/118 (36%), Gaps = 7/118 (5%)

Query: 220 DPQPSITVIHLSSKNLTG-NIPSDL-TKLSSLVELWLDGNSLT--GPIPDFSGCPDLRII 275
           +   ++ V+ L+  NL G  +  +    L+SL  L L  N++    P   F       ++
Sbjct: 100 NGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVL 159

Query: 276 HLEDNQLTGPLPSSLMNLP--NLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 331
            L  N++       L+N    +   L + +  L   +    L      N   N ++  
Sbjct: 160 DLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ-DMNEYWLGWEKCGNPFKNTSITT 216

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 61.8 bits (150), Expect = 3e-10
 Identities = 51/262 (19%), Positives = 92/262 (35%), Gaps = 80/262 (30%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGY 472
           +K+G G F  V+    ++  K +A+KV+ S  +  +    +E+ LL  + + +       
Sbjct: 43  RKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDP------ 95

Query: 473 CQEEGRSVLVY---EFMHNGTLKEH-------LYGTLTHEQRINWIKRL------EIAED 516
             +  R ++V    +F  +G    H       L   L      +  + L      +I + 
Sbjct: 96  -NDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154

Query: 517 AAKGIEYLHTGCVPAIIHRDLKSSNILL-------------------------------- 544
             +G++YLHT C   IIH D+K  NILL                                
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212

Query: 545 -----------------DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
                             + ++ K++D G    A     H +  ++ T  Y   E  I  
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGN---ACWVHKHFTEDIQ-TRQYRSLEVLIGS 268

Query: 588 QLTDKSDVYSFGVILLELISGQ 609
                +D++S   +  EL +G 
Sbjct: 269 GYNTPADIWSTACMAFELATGD 290

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 62.2 bits (151), Expect = 3e-10
 Identities = 29/109 (26%), Positives = 48/109 (44%), Gaps = 8/109 (7%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +  + +S   LT ++P   +    L EL + GN LT  +P       L  + +  NQL
Sbjct: 221 SGLKELIVSGNRLT-SLPVLPS---ELKELMVSGNRLTS-LPM--LPSGLLSLSVYRNQL 273

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 331
           T  LP SL++L +   + ++ N LS     +L        Y+G I   +
Sbjct: 274 TR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFD 321

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 25/89 (28%), Positives = 38/89 (42%), Gaps = 8/89 (8%)

Query: 226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 285
            V+++    LT  +P  L   + +  L +  N+LT  +P     P+LR + +  NQLT  
Sbjct: 43  AVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLTS- 95

Query: 286 LPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           LP     L  L         L   +PS L
Sbjct: 96  LPVLPPGLLELSIFSNPLTHLP-ALPSGL 123

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 22/92 (23%), Positives = 39/92 (42%), Gaps = 12/92 (13%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +  +   +  LT ++P   +    L EL +  N L   +P      +L  +   +N+L
Sbjct: 161 SELCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQLAS-LPTLPS--ELYKLWAYNNRL 213

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           T  LP+       L+EL V  N L+ ++P   
Sbjct: 214 T-SLPALP---SGLKELIVSGNRLT-SLPVLP 240

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 30/120 (25%), Positives = 48/120 (40%), Gaps = 33/120 (27%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD 265
           P +  + +S   LT ++P     L                 S L +LW+ GN LT  +P 
Sbjct: 81  PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS-LPV 138

Query: 266 FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-------LSKN 318
                 L+ + + DNQL   LP+       L +L+  NN L+ ++P          +S N
Sbjct: 139 LPP--GLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLT-SLPMLPSGLQELSVSDN 191

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 42.6 bits (100), Expect = 5e-04
 Identities = 14/100 (14%), Positives = 27/100 (27%), Gaps = 9/100 (9%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +  + +    LT  +P  L  LSS   + L+GN L+          ++         +
Sbjct: 261 SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQA--LREITSAPGYSGPI 317

Query: 283 T------GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
                     P     L      ++         P+    
Sbjct: 318 IRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWH 357

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 61.7 bits (149), Expect = 5e-10
 Identities = 27/104 (25%), Positives = 42/104 (40%), Gaps = 5/104 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +  + L    ++ +I + L  L  L  L+L  N +T  I   S    L  + LEDNQ+
Sbjct: 109 KKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 165

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           +      L  L  L+ LY+  N +S     + L    VL     
Sbjct: 166 SDI--VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQ 207

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 59.4 bits (143), Expect = 2e-09
 Identities = 26/104 (25%), Positives = 48/104 (46%), Gaps = 5/104 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            ++  + L    +  ++ S L  L  L  L L+ N ++  I      P L  ++L +N++
Sbjct: 87  KNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKI 143

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           T    + L  L  L  L +++N +S  VP + L+K   L  + N
Sbjct: 144 TDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKN 185

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 25/106 (23%), Positives = 49/106 (46%), Gaps = 6/106 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
           P +  ++L +  +T +I + L++L+ L  L L+ N ++  I   +G   L+ ++L  N +
Sbjct: 131 PQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 187

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 328
           +     +L  L NL  L + +        +   S  VV N   N +
Sbjct: 188 SDL--RALAGLKNLDVLELFSQECLNKPINH-QSNLVVPNTVKNTD 230

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 54.0 bits (129), Expect = 1e-07
 Identities = 21/104 (20%), Positives = 42/104 (40%), Gaps = 5/104 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
                 +L  K++T  +     +L+S+ ++  + + +   +      P++  + L  N+L
Sbjct: 21  AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 77

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           T      L NL NL  L++  N +        L K   L+   N
Sbjct: 78  TDI--KPLTNLKNLGWLFLDENKIKDLSSLKDLKKLKSLSLEHN 119

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 47.8 bits (113), Expect = 9e-06
 Identities = 14/86 (16%), Positives = 30/86 (34%), Gaps = 3/86 (3%)

Query: 241 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 300
                 +  ++  L   S+T      +    +  I   ++ +       +  LPN+ +L+
Sbjct: 15  FPDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKS--VQGIQYLPNVTKLF 71

Query: 301 VQNNMLSGTVPSSLLSKNVVLNYAGN 326
           +  N L+   P + L     L    N
Sbjct: 72  LNGNKLTDIKPLTNLKNLGWLFLDEN 97

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 22/107 (20%), Positives = 39/107 (36%), Gaps = 16/107 (14%)

Query: 216 QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCP 270
           +C  +     T +  S++ L     +IP          EL L+ N  T       F   P
Sbjct: 8   KCRCEG----TTVDCSNQKLNKIPEHIPQYTA------ELRLNNNEFTVLEATGIFKKLP 57

Query: 271 DLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
            LR I+  +N++T     +      + E+ + +N L   V   +   
Sbjct: 58  QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKG 103

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 58.5 bits (142), Expect = 8e-10
 Identities = 23/91 (25%), Positives = 41/91 (45%), Gaps = 4/91 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDN 280
           P +  I+ S+  +T +I        S + E+ L  N L       F G   L+ + L  N
Sbjct: 57  PQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSN 115

Query: 281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVP 311
           ++T     S + L ++R L + +N ++ TV 
Sbjct: 116 RITCVGNDSFIGLSSVRLLSLYDNQIT-TVA 145

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 25/88 (28%), Positives = 40/88 (45%), Gaps = 5/88 (5%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 276
           +    +  I L+S  L  N+   +   L SL  L L  N +T  + +  F G   +R++ 
Sbjct: 78  EGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLS 135

Query: 277 LEDNQLTGPLPSSLMNLPNLRELYVQNN 304
           L DNQ+T   P +   L +L  L +  N
Sbjct: 136 LYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 60.8 bits (148), Expect = 8e-10
 Identities = 24/111 (21%), Positives = 41/111 (36%), Gaps = 26/111 (23%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             + +I + + +L   +P       SL  +    N L   +P+    P L  I+ ++N L
Sbjct: 153 SFLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSL 207

Query: 283 TGPLPSSLMNL-------------------PNLRELYVQNNMLSGTVPSSL 314
              LP   ++L                   P L  +Y  NN+L  T+P   
Sbjct: 208 KK-LPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLP 256

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 58.9 bits (143), Expect = 3e-09
 Identities = 28/130 (21%), Positives = 42/130 (32%), Gaps = 40/130 (30%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD 265
           P +  +  S  +LT  +P     L                   L  L +  N L   +P+
Sbjct: 91  PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LPE 148

Query: 266 FSGCPDLRIIHLEDNQLTGPLPSSLMNL-------------------PNLRELYVQNNML 306
                 L+II +++N L   LP    +L                   P L  +Y  NN L
Sbjct: 149 LQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSL 207

Query: 307 SGTVPSSLLS 316
              +P   LS
Sbjct: 208 K-KLPDLPLS 216

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 27/99 (27%), Positives = 40/99 (40%), Gaps = 11/99 (11%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 283
           S+  I   +  L      +L  L  L  ++ D N L   +PD    P L  +++ DN LT
Sbjct: 216 SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPD--LPPSLEALNVRDNYLT 270

Query: 284 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKN 318
             LP    +L  L       + LS  +P +L     S N
Sbjct: 271 D-LPELPQSLTFLDVSENIFSGLS-ELPPNLYYLNASSN 307

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 12/92 (13%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
           P++  ++ SS  +  ++        SL EL +  N L   +P  +  P L  +    N L
Sbjct: 297 PNLYYLNASSNEIR-SLCD---LPPSLEELNVSNNKLIE-LP--ALPPRLERLIASFNHL 349

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
              +P       NL++L+V+ N L    P   
Sbjct: 350 AE-VPEL---PQNLKQLHVEYNPLR-EFPDIP 376

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 24/113 (21%), Positives = 36/113 (31%), Gaps = 22/113 (19%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLS-------------SLVELWLDGNSLTGPIPDFSGC 269
            S T  + +      N P    +                  EL L+   L+  +P+    
Sbjct: 34  KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL--P 90

Query: 270 PDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL----LSKN 318
           P L  +    N LT  LP    +L +L         LS  +P  L    +S N
Sbjct: 91  PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSD-LPPLLEYLGVSNN 141

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 26/109 (23%), Positives = 46/109 (42%), Gaps = 23/109 (21%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
           PS+  +++S+  L   +P+   +L     L    N L   +P      +L+ +H+E N L
Sbjct: 317 PSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAE-VP--ELPQNLKQLHVEYNPL 369

Query: 283 TG--PLPSSLMNL-------------PNLRELYVQNNMLSGTVPSSLLS 316
                +P S+ +L              NL++L+V+ N L    P    S
Sbjct: 370 REFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPES 417

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 49.2 bits (118), Expect = 3e-06
 Identities = 19/99 (19%), Positives = 31/99 (31%), Gaps = 20/99 (20%)

Query: 230 LSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG--------------CPDLRII 275
             S NLT  +P +   + S  E +   +      P  +G                    +
Sbjct: 18  RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHEL 76

Query: 276 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
            L +  L+  LP      P+L  L    N L+  +P   
Sbjct: 77  ELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP 110

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 48.5 bits (116), Expect = 6e-06
 Identities = 10/79 (12%), Positives = 26/79 (32%), Gaps = 6/79 (7%)

Query: 229 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 288
            L   +    +P       +L +L ++ N L    PD      +  + +   ++  P   
Sbjct: 381 DLRMNSHLAEVPE---LPQNLKQLHVETNPLRE-FPDIPE--SVEDLRMNSERVVDPYEF 434

Query: 289 SLMNLPNLRELYVQNNMLS 307
           +      L +   +++   
Sbjct: 435 AHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 26/106 (24%), Positives = 38/106 (35%), Gaps = 20/106 (18%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
           P +T I+  +  L   +P       SL  L +  N LT           L +     + L
Sbjct: 237 PFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 292

Query: 283 TGPLPSSLMNL--------------PNLRELYVQNNMLSGTVPSSL 314
           +  LP +L  L              P+L EL V NN L   +P+  
Sbjct: 293 S-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP 336

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 27/104 (25%), Positives = 42/104 (40%), Gaps = 5/104 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +  + L    ++ +I + L  L  L  L+L  N +T  I   S    L  + LEDNQ+
Sbjct: 112 KKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 168

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           +      L  L  L+ LY+  N +S     + L    VL     
Sbjct: 169 SDI--VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQ 210

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 56.2 bits (136), Expect = 9e-09
 Identities = 26/106 (24%), Positives = 50/106 (47%), Gaps = 6/106 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
           P +  ++L +  +T +I + L++L+ L  L L+ N ++  I   +G   L+ ++L  N +
Sbjct: 134 PQLESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 190

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 328
           +     +L  L NL  L + +       P +  S  VV N   N +
Sbjct: 191 SDL--RALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNTD 233

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 21/104 (20%), Positives = 42/104 (40%), Gaps = 5/104 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
                 +L  K++T  +     +L+S+ ++  + + +   +      P++  + L  N+L
Sbjct: 24  AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 80

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           T      L NL NL  L++  N +        L K   L+   N
Sbjct: 81  TDI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 22/85 (25%), Positives = 47/85 (55%), Gaps = 5/85 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            SI  I  ++ ++  ++   +  L ++ +L+L+GN LT  I   +   +L  + L++N++
Sbjct: 46  NSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKV 102

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLS 307
                SSL +L  L+ L +++N +S
Sbjct: 103 KDL--SSLKDLKKLKSLSLEHNGIS 125

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 47.4 bits (113), Expect = 8e-06
 Identities = 18/101 (17%), Positives = 36/101 (35%), Gaps = 7/101 (6%)

Query: 230 LSSKNLTGNIP----SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGP 285
           L S+ +T   P          +  ++  L   S+T      +    +  I   ++ +   
Sbjct: 3   LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKS- 60

Query: 286 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
               +  LPN+ +L++  N L+   P + L     L    N
Sbjct: 61  -VQGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDEN 100

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 49/211 (23%), Positives = 89/211 (42%), Gaps = 32/211 (15%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHR----- 464
           K IG G FG V      K  + +A+K++ +      Q       E+ +L  +  +     
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDNT 158

Query: 465 -NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 520
            N++  L          + +E +       +K++ +   +    +  +++   A    + 
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFS----LPLVRK--FAHSILQC 212

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRA--KVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           ++ LH      IIH DLK  NILL +  R+  KV DFG S +       V + ++ +  Y
Sbjct: 213 LDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQ-SRFY 265

Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
             PE  +  +     D++S G IL EL++G 
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 60.2 bits (145), Expect = 2e-09
 Identities = 23/86 (26%), Positives = 36/86 (41%), Gaps = 3/86 (3%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +T + LS   L   +P  L  L  L  L    N+L   +   +  P L+ + L +N+L
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRL 520

Query: 283 TG-PLPSSLMNLPNLRELYVQNNMLS 307
                   L++ P L  L +Q N L 
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 56.3 bits (135), Expect = 2e-08
 Identities = 31/115 (26%), Positives = 48/115 (41%), Gaps = 9/115 (7%)

Query: 216 QCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRII 275
                    + V+HL+ K+LT  +   L +L  +  L L  N L    P  +    L ++
Sbjct: 434 SVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVL 491

Query: 276 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS----SLLSKNVVLNYAGN 326
              DN L   +   + NLP L+EL + NN L     +        + V+LN  GN
Sbjct: 492 QASDNALEN-VD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 21/82 (25%), Positives = 33/82 (40%), Gaps = 7/82 (8%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGP--IPDFSGCPDLRIIHLEDN 280
             + V+  S   L  N+   +  L  L EL L  N L     I     CP L +++L+ N
Sbjct: 486 RCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543

Query: 281 QLTG--PLPSSLMN-LPNLREL 299
            L     +   L   LP++  +
Sbjct: 544 SLCQEEGIQERLAEMLPSVSSI 565

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 30/129 (23%), Positives = 52/129 (40%), Gaps = 16/129 (12%)

Query: 214 WLQCNS---------DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTG-P 262
            L+ N+          P   +  I LS+  ++  +  D    L SL  L L GN +T  P
Sbjct: 38  RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELP 96

Query: 263 IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 322
              F G   L+++ L  N++      +  +L NL  L + +N L  T+     S    + 
Sbjct: 97  KSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQ 155

Query: 323 YAGNINLHE 331
               ++L +
Sbjct: 156 T---MHLAQ 161

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 27/92 (29%), Positives = 42/92 (45%), Gaps = 13/92 (14%)

Query: 231 SSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGP 285
             K LT    N+P  +T      E+ L+ N++   IP   FS    LR I L +NQ++  
Sbjct: 19  RGKGLTEIPTNLPETIT------EIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISEL 71

Query: 286 LPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
            P +   L +L  L +  N ++  +P SL   
Sbjct: 72  APDAFQGLRSLNSLVLYGNKIT-ELPKSLFEG 102

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 52.7 bits (127), Expect = 7e-08
 Identities = 22/88 (25%), Positives = 37/88 (42%), Gaps = 5/88 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
            +IT I L    +    P   +    L  + L  N ++  +    F G   L  + L  N
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGN 90

Query: 281 QLTGPLPSSLM-NLPNLRELYVQNNMLS 307
           ++T  LP SL   L +L+ L +  N ++
Sbjct: 91  KITE-LPKSLFEGLFSLQLLLLNANKIN 117

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 19/88 (21%), Positives = 36/88 (40%), Gaps = 5/88 (5%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 276
               S+  + L    +T  +P  L   L SL  L L+ N +   +    F    +L ++ 
Sbjct: 77  QGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLS 134

Query: 277 LEDNQLTGPLPSSLMNLPNLRELYVQNN 304
           L DN+L      +   L  ++ +++  N
Sbjct: 135 LYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 54.7 bits (132), Expect = 6e-09
 Identities = 18/76 (23%), Positives = 30/76 (39%), Gaps = 1/76 (1%)

Query: 232 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 291
           S++  G +     +   L  L      LT  I +      L+ + L DN+++G L     
Sbjct: 27  SRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSDNRVSGGLEVLAE 85

Query: 292 NLPNLRELYVQNNMLS 307
             PNL  L +  N + 
Sbjct: 86  KCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 23/89 (25%), Positives = 43/89 (48%), Gaps = 4/89 (4%)

Query: 218 NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFS-GCPDLRIIH 276
            +D    +  +   +  LT +I ++L KL+ L +L L  N ++G +   +  CP+L  ++
Sbjct: 37  LTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94

Query: 277 LEDNQLTGPL-PSSLMNLPNLRELYVQNN 304
           L  N++        L  L NL+ L + N 
Sbjct: 95  LSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 56.6 bits (137), Expect = 7e-09
 Identities = 17/106 (16%), Positives = 35/106 (33%), Gaps = 6/106 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             ++ + L +  L  +    L  L +L  L +  N L   I        L ++ L  N++
Sbjct: 106 ACLSRLFLDNNELR-DT-DSLIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGNEI 162

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN 328
           T      L  L  +  + +         P     +  + N   + +
Sbjct: 163 TNT--GGLTRLKKVNWIDLTGQKCV-NEPVKYQPELYITNTVKDPD 205

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 56.2 bits (136), Expect = 9e-09
 Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 5/95 (5%)

Query: 234 NLTGNIPSDLTKLS--SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 291
           ++  N   +L  +    L  L+LD N L           +L I+ + +N+L       L 
Sbjct: 91  SVNRNRLKNLNGIPSACLSRLFLDNNELRD-TDSLIHLKNLEILSIRNNKLKSI--VMLG 147

Query: 292 NLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
            L  L  L +  N ++ T   + L K   ++  G 
Sbjct: 148 FLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQ 182

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 27/123 (21%), Positives = 49/123 (39%), Gaps = 22/123 (17%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +   +  + N+  ++ + +   ++L EL L  N ++  +        L  + +  N+L
Sbjct: 41  SGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQISD-LSPLKDLTKLEELSVNRNRL 97

Query: 283 TG--PLP-----------------SSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
                +P                  SL++L NL  L ++NN L   V    LSK  VL+ 
Sbjct: 98  KNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDL 157

Query: 324 AGN 326
            GN
Sbjct: 158 HGN 160

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 16/86 (18%), Positives = 37/86 (43%), Gaps = 3/86 (3%)

Query: 241 SDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY 300
                L++ V+  L   S+T  +        ++  + +++ +     + +    NL+EL+
Sbjct: 13  FPDPGLANAVKQNLGKQSVTD-LVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELH 69

Query: 301 VQNNMLSGTVPSSLLSKNVVLNYAGN 326
           + +N +S   P   L+K   L+   N
Sbjct: 70  LSHNQISDLSPLKDLTKLEELSVNRN 95

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 17/101 (16%), Positives = 27/101 (26%), Gaps = 21/101 (20%)

Query: 229 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLT--- 283
           +   +  +G   +       L  L L  NSL              L  ++L    L    
Sbjct: 210 NAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVP 269

Query: 284 GPLPSSL----------------MNLPNLRELYVQNNMLSG 308
             LP+ L                  LP +  L ++ N    
Sbjct: 270 KGLPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 18/109 (16%), Positives = 36/109 (33%), Gaps = 8/109 (7%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPD----LRIIHL 277
           P + V+ ++  +        +    +L  L L  N   G      + CP     L+++ L
Sbjct: 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLAL 208

Query: 278 EDNQLT---GPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
            +  +    G   +       L+ L + +N L     +        LN 
Sbjct: 209 RNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 22/115 (19%), Positives = 42/115 (36%), Gaps = 4/115 (3%)

Query: 205 DPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP 264
           +PC     S     SDP+P  +            +      L  L    +D  +  G   
Sbjct: 4   EPCELDEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYL-LKRVDTEADLGQFT 62

Query: 265 DFSGCPDLRIIHLEDNQLTGPLPSS---LMNLPNLRELYVQNNMLSGTVPSSLLS 316
           D      L+ + +   ++   +      ++ +  L+EL ++N  ++GT P  LL 
Sbjct: 63  DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE 117

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 41.4 bits (97), Expect = 7e-04
 Identities = 14/63 (22%), Positives = 22/63 (34%), Gaps = 4/63 (6%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
             +  ++LS   L   +P  L   + L  L L  N L    P     P +  + L+ N  
Sbjct: 253 SQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNPF 308

Query: 283 TGP 285
              
Sbjct: 309 LDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 41.4 bits (97), Expect = 7e-04
 Identities = 20/110 (18%), Positives = 38/110 (34%), Gaps = 11/110 (10%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKL---SSLVELWLDGNSLTGPIPD---FSGCPDLRIIHL 277
           S+  + + +  +   I     ++   S L EL L+   +TG  P     +  PDL I++L
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 278 EDNQLTG--PLPSSLMNL--PNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
            +          + L     P L+ L +             +     L+ 
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL-NFSCEQVRVFPALST 177

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 30/211 (14%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHR----- 464
             IG G FG V       + + +A+K++ +      Q +     EV LL  ++       
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMK 115

Query: 465 -NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAKG 520
             +V    +        LV+E +       L+   +  ++    +N  ++   A+     
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS----LNLTRK--FAQQMCTA 169

Query: 521 IEYLHTGCVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           + +L T  + +IIH DLK  NILL   K    K+ DFG S         +   ++ +  Y
Sbjct: 170 LLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQ-SRFY 224

Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
             PE  +        D++S G IL+E+ +G+
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 24/139 (17%), Positives = 47/139 (33%), Gaps = 25/139 (17%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD- 265
            +  I+  +  LT  +P   T L                  SL  L +  N L   +P  
Sbjct: 141 LLEYINADNNQLT-MLPELPTSLEVLSVRNNQLTFLPELPESLEALDVSTNLLES-LPAV 198

Query: 266 FSGCPDLR----IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVL 321
                            +N++T  +P ++++L     + +++N LS  +  SL  +    
Sbjct: 199 PVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQP 257

Query: 322 NYAGNINLHEGGRGAKHLN 340
           +Y G         G ++  
Sbjct: 258 DYHGPRIYFSMSDGQQNTL 276

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 53.1 bits (127), Expect = 3e-07
 Identities = 30/109 (27%), Positives = 46/109 (42%), Gaps = 26/109 (23%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKL-----------------SSLVELWLDGNSLTGPIPD 265
           P ITV+ ++   L  ++P     L                 +SL  L +D N LT  +P+
Sbjct: 80  PQITVLEITQNALI-SLPELPASLEYLDACDNRLSTLPELPASLKHLDVDNNQLTM-LPE 137

Query: 266 FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
                 L  I+ ++NQLT  LP       +L  L V+NN L+  +P   
Sbjct: 138 LPA--LLEYINADNNQLTM-LPEL---PTSLEVLSVRNNQLT-FLPELP 179

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 22/91 (24%), Positives = 41/91 (45%), Gaps = 11/91 (12%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 283
             + + L+  NL+ ++P +L     +  L +  N+L   +P+      L  +   DN+L+
Sbjct: 60  QFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPA--SLEYLDACDNRLS 113

Query: 284 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
             LP       +L+ L V NN L+  +P   
Sbjct: 114 T-LPEL---PASLKHLDVDNNQLT-MLPELP 139

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 51.1 bits (122), Expect = 1e-06
 Identities = 21/87 (24%), Positives = 35/87 (40%), Gaps = 9/87 (10%)

Query: 232 SKNLTGNIPSDL--TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSS 289
                    S L    ++   EL L+  +L+  +PD +  P + ++ +  N L   LP  
Sbjct: 42  PGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPD-NLPPQITVLEITQNALI-SLPEL 98

Query: 290 LMNLPNLRELYVQNNMLSGTVPSSLLS 316
                +L  L   +N LS T+P    S
Sbjct: 99  ---PASLEYLDACDNRLS-TLPELPAS 121

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 27/85 (31%), Positives = 39/85 (45%), Gaps = 9/85 (10%)

Query: 226 TVIHLSSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
           TV+  S+K L      IP D+T      EL+LDGN  T    + S    L +I L +N++
Sbjct: 13  TVVRCSNKGLKVLPKGIPRDVT------ELYLDGNQFTLVPKELSNYKHLTLIDLSNNRI 66

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLS 307
           +     S  N+  L  L +  N L 
Sbjct: 67  STLSNQSFSNMTQLLTLILSYNRLR 91

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 52.4 bits (126), Expect = 4e-08
 Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 1/76 (1%)

Query: 232 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 291
            K+  G I     +  +L  L L    L   + +    P L+ + L +N++ G L     
Sbjct: 34  CKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSENRIFGGLDMLAE 92

Query: 292 NLPNLRELYVQNNMLS 307
            LPNL  L +  N L 
Sbjct: 93  KLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 4/89 (4%)

Query: 218 NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSG-CPDLRIIH 276
            +    ++  + L +  L  ++ S+L KL  L +L L  N + G +   +   P+L  ++
Sbjct: 44  LTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101

Query: 277 LEDNQLTGPLP-SSLMNLPNLRELYVQNN 304
           L  N+L        L  L  L+ L + N 
Sbjct: 102 LSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 34/115 (29%), Positives = 48/115 (41%), Gaps = 30/115 (26%)

Query: 217 CNSDPQPSITVIHLSSKNLT---GNIPSDLTKL------------------SSLVELWLD 255
           CN++     +V   SSK LT    NIP+D  KL                  + L  L+L+
Sbjct: 14  CNNNKN---SV-DCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLN 69

Query: 256 GNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLM-NLPNLRELYVQNNMLS 307
            N L   +P   F    +L  + + DN+L   LP  +   L NL EL +  N L 
Sbjct: 70  DNKLQT-LPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK 122

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 51.1 bits (123), Expect = 4e-07
 Identities = 25/101 (24%), Positives = 37/101 (36%), Gaps = 6/101 (5%)

Query: 226 TVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 282
             + L    L  ++P  +   L+ L  L L  N L   +P   F     L+ + L +NQL
Sbjct: 112 AELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQL 169

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
                 +   L  L+ L + NN L   VP         L  
Sbjct: 170 KRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKM 209

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 25/82 (30%), Positives = 41/82 (50%), Gaps = 5/82 (6%)

Query: 226 TVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 282
           T + L    L  ++P  +  KL+SL EL L  N L   +P+  F    +L+ + L++NQL
Sbjct: 136 TYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQL 193

Query: 283 TGPLPSSLMNLPNLRELYVQNN 304
                 +  +L  L+ L +Q N
Sbjct: 194 KRVPEGAFDSLEKLKMLQLQEN 215

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 53.3 bits (128), Expect = 1e-07
 Identities = 20/116 (17%), Positives = 36/116 (31%), Gaps = 6/116 (5%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSD-LTKLSS-LVELWLDGNSLTGPIPD--FSGCPDLRII 275
                  ++ +        I  +    LS   V LWL+ N +   I +  F+G     + 
Sbjct: 125 IHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELN 183

Query: 276 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHE 331
             ++N L                L +    +  ++PS  L     L      NL +
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLKK 238

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 17/99 (17%), Positives = 39/99 (39%), Gaps = 5/99 (5%)

Query: 223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWL-DGNSLTGPIPD--FSGCPDLRIIHLE 278
             +  I +S  ++   I +D  + L  L E+ +   N+L   I    F   P+L+ + + 
Sbjct: 54  GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQYLLIS 112

Query: 279 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
           +  +        ++      L +Q+N+   T+  +    
Sbjct: 113 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 44.0 bits (104), Expect = 1e-04
 Identities = 17/84 (20%), Positives = 26/84 (30%), Gaps = 9/84 (10%)

Query: 224 SITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
              +    + NL   +P+D     S  V L +    +   +P         LR       
Sbjct: 179 LDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--Y 234

Query: 281 QLTGPLPSSLMNLPNLRELYVQNN 304
            L   LP+ L  L  L E  +   
Sbjct: 235 NLKK-LPT-LEKLVALMEASLTYP 256

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 52.2 bits (125), Expect = 5e-07
 Identities = 23/89 (25%), Positives = 44/89 (49%), Gaps = 4/89 (4%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKL-SSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
           S+  + +S  +L  +          S++ L L  N LTG +      P ++++ L +N++
Sbjct: 404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNNRI 462

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVP 311
              +P  + +L  L+EL V +N L  +VP
Sbjct: 463 MS-IPKDVTHLQALQELNVASNQLK-SVP 489

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 24/144 (16%), Positives = 43/144 (29%), Gaps = 25/144 (17%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDN 280
           P    + LS  +++     D++ LS L  L L  N +   +    F    DL  + +  N
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHN 110

Query: 281 QLTG----------------------PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 318
           +L                        P+     NL  L  L +            +   +
Sbjct: 111 RLQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170

Query: 319 VVLNYAGNINLHEGGRGAKHLNII 342
           +       ++ H  G   + L I 
Sbjct: 171 LSCILLDLVSYHIKGGETESLQIP 194

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 38/272 (13%), Positives = 80/272 (29%), Gaps = 21/272 (7%)

Query: 61  PQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEIEDLDPDESRKFRLVLPGQPDVS 120
               + +  V  + +    L L                            + L       
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263

Query: 121 KAIVNIQENAQGKYRVYEPGYTNLSLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERND 179
           K  V + +    +  V      NL++   +  +     +++   L +  ++   +L   +
Sbjct: 264 KCSVKLFQFFWPRP-VEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKE 322

Query: 180 GSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNI 239
                 A +++  L  S         P + +      C      S T ++ +    T ++
Sbjct: 323 ALYSVFAEMNIKMLSIS-------DTPFIHMV-----C-PPSPSSFTFLNFTQNVFTDSV 369

Query: 240 PSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD-LRIIHLEDNQLT----GPLPSSLMNLP 294
               + L  L  L L  N L       +     +  +   D  L          +     
Sbjct: 370 FQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428

Query: 295 NLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           ++  L + +NML+G+V   L  K  VL+   N
Sbjct: 429 SILVLNLSSNMLTGSVFRCLPPKVKVLDLHNN 460

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 21/82 (25%), Positives = 38/82 (46%), Gaps = 2/82 (2%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL 282
            SI V++LSS  LTG++   L     +  L L  N +     D +    L+ +++  NQL
Sbjct: 428 ESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQL 485

Query: 283 TGPLPSSLMNLPNLRELYVQNN 304
                     L +L+ +++ +N
Sbjct: 486 KSVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 41.8 bits (98), Expect = 8e-04
 Identities = 21/112 (18%), Positives = 40/112 (35%), Gaps = 30/112 (26%)

Query: 212 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 271
            S    +++     +++  S++NLT ++P DL        L L  NS++           
Sbjct: 23  GSMTPFSNE---LESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSIS----------- 65

Query: 272 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNY 323
                L            +  L  LR L + +N +  ++   +   N  L Y
Sbjct: 66  ----ELR--------MPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEY 104

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.0 bits (121), Expect = 1e-06
 Identities = 99/672 (14%), Positives = 204/672 (30%), Gaps = 195/672 (29%)

Query: 131 QGKYR----VYEPGYTNLSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVA 186
           Q +Y+    V+E         FV +F      D  +  +L+  EI+  +   D ++ G  
Sbjct: 15  QYQYKDILSVFED-------AFVDNFDCKDVQDMPK-SILSKEEIDHIIMSKD-AVSGTL 65

Query: 187 IVSVISLYSSADWAQEGGDPCLPVPWSWL------QCNSDPQPS-ITVIHLSSKNLTGNI 239
            +    L    +  Q+  +  L + + +L      +     QPS +T +++  ++   N 
Sbjct: 66  RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQR---QPSMMTRMYIEQRDRLYND 122

Query: 240 PSDLTKLS------------SLVEL------WLDG------NSLTGPIPDFSGCPDLRII 275
                K +            +L+EL       +DG        +         C   ++ 
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVAL-----DVCLSYKVQ 177

Query: 276 HLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEGGRG 335
              D ++        +NL N               P ++L     L Y  + N       
Sbjct: 178 CKMDFKI------FWLNLKNCNS------------PETVLEMLQKLLYQIDPNWTSRSDH 219

Query: 336 AKHLNIIIGSSVGAAVLLLATVVSCLFMHKGKKNNYDKEQHRHSLPVQRPVSSLNDAPAE 395
           + ++ + I S        +   +  L   K          + + L V   V +     A 
Sbjct: 220 SSNIKLRIHS--------IQAELRRLLKSK---------PYENCLLVLLNVQNAKAWNAF 262

Query: 396 AAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEV 455
              C          K+L                          + T       ++ T+ +
Sbjct: 263 NLSC----------KIL--------------------------LTTRF-----KQVTDFL 281

Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLV-YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIA 514
           +  +  H       +    +E +S+L+ Y       L   +    T+ +R++ I    I 
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREV--LTTNPRRLSIIAES-IR 338

Query: 515 EDAAKGIEYLHTGCVPAIIHRDLKSS-NILLDKHMRAKVSDFGLSKFAVDGASHVSSIVR 573
           +  A    + H  C    +   ++SS N+L     R       +  F     +H+ +I+ 
Sbjct: 339 DGLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMFDRLSV--FPPS--AHIPTILL 392

Query: 574 GTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS----NEKFGANCRNIVQWAK 629
             + + D        + +K   YS    L+E    +  IS      +      N      
Sbjct: 393 SLI-WFDVIKSDVMVVVNKLHKYS----LVEKQPKESTISIPSIYLELKVKLENEYA--- 444

Query: 630 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCV-------LPHGHMRPS-------- 674
           LH            S++D Y+I   +  ++     +       + H H++          
Sbjct: 445 LHR-----------SIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-HLKNIEHPERMTL 492

Query: 675 ISEVLKD---IQDAIVIEREAAAARDGNSDD----------MSRNSLHSSLNVGSFGGTE 721
              V  D   ++  I  +  A  A     +           +  N       V +     
Sbjct: 493 FRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAI---L 549

Query: 722 NFL-SLDESIVR 732
           +FL  ++E+++ 
Sbjct: 550 DFLPKIEENLIC 561

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 19/113 (16%), Positives = 42/113 (37%), Gaps = 10/113 (8%)

Query: 214 WLQCNS-------DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF 266
            L  N+           ++ ++ L    +   I +      +L ELW+  N +   +   
Sbjct: 54  ALSTNNIEKISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGI 111

Query: 267 SGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 318
               +LR++++ +N++T       L  L  L +L +  N L      +  +  
Sbjct: 112 EKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 18/79 (22%), Positives = 34/79 (43%), Gaps = 3/79 (3%)

Query: 229 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 288
           H     +   + + L+ L +   L L  N++   I   SG  +LRI+ L  N +   + +
Sbjct: 31  HGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIKK-IEN 87

Query: 289 SLMNLPNLRELYVQNNMLS 307
                  L EL++  N ++
Sbjct: 88  LDAVADTLEELWISYNQIA 106

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 25/97 (25%), Positives = 39/97 (40%), Gaps = 16/97 (16%)

Query: 216 QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPD 271
           QC+       T +   SK        IP++   L      +L  N +T   P  F    +
Sbjct: 16  QCSCSG----TTVDCRSKRHASVPAGIPTNAQIL------YLHDNQITKLEPGVFDSLIN 65

Query: 272 LRIIHLEDNQLTGPLPSSLMN-LPNLRELYVQNNMLS 307
           L+ ++L  NQL   LP  + + L  L  L +  N L+
Sbjct: 66  LKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLT 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.3 bits (113), Expect = 2e-06
 Identities = 13/62 (20%), Positives = 24/62 (38%), Gaps = 1/62 (1%)

Query: 246 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 305
           L     +    N +   +  F     L+ + + +N++          LP+L EL + NN 
Sbjct: 41  LDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99

Query: 306 LS 307
           L 
Sbjct: 100 LV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 18/82 (21%), Positives = 30/82 (36%), Gaps = 7/82 (8%)

Query: 229 HLSSKNLTGN-IPS--DLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLT 283
              + + + N I        L  L  L ++ N +   I +      PDL  + L +N L 
Sbjct: 43  QFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICR-IGEGLDQALPDLTELILTNNSLV 101

Query: 284 GPLP-SSLMNLPNLRELYVQNN 304
                  L +L +L  L +  N
Sbjct: 102 ELGDLDPLASLKSLTYLCILRN 123

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 46.1 bits (110), Expect = 8e-06
 Identities = 25/111 (22%), Positives = 44/111 (39%), Gaps = 28/111 (25%)

Query: 226 TVIHLSSKNLT---GNIPSDLT-------------------KLSSLVELWLDGNSLTGPI 263
           T +  + + L     +IP   T                   +L  LV+L L  N LTG I
Sbjct: 11  TTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-I 69

Query: 264 PD--FSGCPDLRIIHLEDNQLTGPLPSSLMN-LPNLRELYVQNNMLSGTVP 311
               F G   ++ + L +N++   + + +   L  L+ L + +N +S  V 
Sbjct: 70  EPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQIS-CVM 118

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 5/88 (5%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 276
              P +  + L    LT  I  +     S + EL L  N +   I +  F G   L+ ++
Sbjct: 51  GRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLN 108

Query: 277 LEDNQLTGPLPSSLMNLPNLRELYVQNN 304
           L DNQ++  +P S  +L +L  L + +N
Sbjct: 109 LYDNQISCVMPGSFEHLNSLTSLNLASN 136

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.1 bits (107), Expect = 3e-05
 Identities = 24/83 (28%), Positives = 34/83 (40%), Gaps = 3/83 (3%)

Query: 226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIPDFSGCPDLRIIHLEDNQLTG 284
             + L S  L     +    L+ L  L LD N L       F    +L  + L +NQL  
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97

Query: 285 PLPSSLM-NLPNLRELYVQNNML 306
            LP  +  +L  L +LY+  N L
Sbjct: 98  -LPLGVFDHLTQLDKLYLGGNQL 119

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 25/86 (29%), Positives = 37/86 (43%), Gaps = 7/86 (8%)

Query: 226 TVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQL 282
           T ++L    L   + + +   L+ L  L L  N L   +P   F     L  ++L  NQL
Sbjct: 62  TWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLAS-LPLGVFDHLTQLDKLYLGGNQL 119

Query: 283 TGPLPSSLM-NLPNLRELYVQNNMLS 307
              LPS +   L  L+EL +  N L 
Sbjct: 120 KS-LPSGVFDRLTKLKELRLNTNQLQ 144

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 5/88 (5%)

Query: 220 DPQPSITVIHLSSKNLTGNIPSDL-TKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIH 276
           D    +  ++L    L   +PS +  +L+ L EL L+ N L   IP   F    +L+ + 
Sbjct: 104 DHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLS 161

Query: 277 LEDNQLTGPLPSSLMNLPNLRELYVQNN 304
           L  NQL      +   L  L+ + +  N
Sbjct: 162 LSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 49/229 (21%), Positives = 83/229 (36%), Gaps = 50/229 (21%)

Query: 414 KKIGSGGFGVVY--YGKLKDGKEIAVKVLTSN-SY--QGKREFTNEVTLLSRIHHR---- 464
             +G G FG V       +   ++A+K++ +   Y    + E    + +L +I  +    
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKEN 80

Query: 465 --NLVQFLGYCQEEGRSVLVYEFMHNGT---LKEHLYGTLTHEQRINWIKRLEIAEDAAK 519
               V    +    G   + +E +   T   LKE+ +           ++   +A     
Sbjct: 81  KFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPH----VRH--MAYQLCH 134

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILL-------------------DKHMRAKVSDFGLSKF 560
            + +LH      + H DLK  NIL                     K+   +V+DFG + F
Sbjct: 135 ALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191

Query: 561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
             +   H ++IV  T  Y  PE  +        DV+S G IL E   G 
Sbjct: 192 DHE---HHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 45.0 bits (107), Expect = 5e-05
 Identities = 59/238 (24%), Positives = 90/238 (37%), Gaps = 64/238 (26%)

Query: 414 KKIGSGGFG-VVYYGKLKDGKEIAVKVLTSN-SY--QGKREFTNEVTLLSRI-----HHR 464
           +K+G G FG V+    + + K  AVKV+ +   Y    K E      +L +I     ++ 
Sbjct: 41  RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNN 96

Query: 465 NLVQFLGYCQEEGRSVLV--------YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 516
           N+V++ G         L+        YE      +  + Y     E     IK      +
Sbjct: 97  NIVKYHGKFMYYDHMCLIFEPLGPSLYEI-----ITRNNYNGFHIED----IKL--YCIE 145

Query: 517 AAKGIEYLHTGCVPAIIHRDLKSSNILL-------------------------DKHMRAK 551
             K + YL      ++ H DLK  NILL                          K    K
Sbjct: 146 ILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202

Query: 552 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
           + DFG + F  D   +  SI+  T  Y  PE  ++      SD++SFG +L EL +G 
Sbjct: 203 LIDFGCATFKSD---YHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 44.2 bits (105), Expect = 7e-05
 Identities = 22/65 (33%), Positives = 35/65 (53%), Gaps = 5/65 (7%)

Query: 245 KLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQLTGPLPSSLMN-LPNLRELYV 301
           +L++L  L L GN L   +P+  F    +L+ + L +NQL   LP  + + L NL  L +
Sbjct: 83  ELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNL 140

Query: 302 QNNML 306
            +N L
Sbjct: 141 AHNQL 145

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 41.5 bits (98), Expect = 6e-04
 Identities = 17/92 (18%), Positives = 40/92 (43%), Gaps = 12/92 (13%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLT 283
                +L  K++T  +  +  +L+S+ ++  + + +   +      P++R + L  N+L 
Sbjct: 20  ETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQGIQYLPNVRYLALGGNKLH 76

Query: 284 GPLPSSLM---NLPNLRELYVQNNMLSGTVPS 312
                 +     L NL  L +  N L  ++P+
Sbjct: 77  -----DISALKELTNLTYLILTGNQLQ-SLPN 102

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 40.4 bits (95), Expect = 7e-04
 Identities = 30/114 (26%), Positives = 46/114 (40%), Gaps = 28/114 (24%)

Query: 216 QCNSDPQPSITVIHLSSKNLT---GNIPSDLTKL------------------SSLVELWL 254
           +C+       T +   S+  T     IP+  T L                  +SL +L+L
Sbjct: 4   RCSCSG----TTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYL 59

Query: 255 DGNSLTG-PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMN-LPNLRELYVQNNML 306
            GN L   P   F+    L  ++L  NQL   LP+ + + L  L+EL +  N L
Sbjct: 60  GGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQL 112

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	736
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.76
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.65
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.65
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.62
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.57
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.54
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.52
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.52
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.51
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.51
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.5
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.5
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.48
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.47
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.47
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.46
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.46
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.45
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.45
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.43
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.42
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.41
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.41
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.4
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.4
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.39
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.39
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.39
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.37
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.36
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.36
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.35
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.35
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.34
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.34
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.33
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.33
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.33
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.33
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.32
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.32
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.31
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.31
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.31
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.3
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.3
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.29
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.29
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.28
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.27
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.27
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.27
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.26
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.26
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.25
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.25
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.25
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.25
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.24
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.24
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.24
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.24
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.24
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.23
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.23
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.23
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.22
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.22
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.22
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.21
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.21
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.21
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.2
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.2
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.2
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.18
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.18
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.17
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.17
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.17
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.16
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.16
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.15
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.14
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.14
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.14
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.13
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.11
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.11
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.11
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.1
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.09
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.08
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.07
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.06
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.06
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.06
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.05
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.02
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.01
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.0
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.99
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.98
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.97
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.95
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.95
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.93
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.92
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.86
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.86
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.84
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.8
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.8
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.74
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.73
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.71
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.68
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.64
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.58
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.54
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.53
2jwp_A	174	Malectin, MGC80075; sugar binding, sugar binding p	98.52
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.46
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.45
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.41
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.38
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.37
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.26
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.19
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.19
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.18
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.15
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.11
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.1
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.88
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.87
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.77
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	97.76
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.71
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.65
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	97.58
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.57
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.44
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.4
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	97.37
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.29
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.19
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.08
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.04
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.02
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.02
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.96
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.84
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.83
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.82
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.67
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.61
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	96.61
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.52
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.51
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	96.32
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	96.07
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.54
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.54
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	94.22
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	93.96
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	93.82
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	92.44
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	91.89
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	91.66
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	90.93
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	90.05
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	88.81
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	86.2
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	80.47

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.2e-52  Score=444.00  Aligned_cols=257  Identities=26%  Similarity=0.428  Sum_probs=205.8

Q ss_pred             HhhccccccCceEEEEEEEC------CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .+.++||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++|||
T Consensus        44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E  123 (329)
T 4aoj_A           44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE  123 (329)
T ss_dssp             EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            35788999999999999874      478899999987665566789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccc-----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE
Q 004689          485 FMHNGTLKEHLYGTLT-----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS  553 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~  553 (736)
                      ||++|+|.++++....           ....++|..++.|+.|+|+||+|||+.   +|+||||||+||||++++++||+
T Consensus       124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~  200 (329)
T 4aoj_A          124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG  200 (329)
T ss_dssp             CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred             cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence            9999999999975432           124589999999999999999999998   99999999999999999999999


Q ss_pred             eecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHh
Q 004689          554 DFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH  631 (736)
Q Consensus       554 DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~  631 (736)
                      |||+|+....... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....    .+...    
T Consensus       201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~~----  272 (329)
T 4aoj_A          201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT----EAIDC----  272 (329)
T ss_dssp             CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH----HHHHH----
T ss_pred             ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH----HHHHH----
Confidence            9999986544332 23345679999999999999999999999999999999999 89999865422    22222    


Q ss_pred             hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      +..+...         ..+.....++.+++.+|++.||++||||.||+++|+.+..
T Consensus       273 i~~g~~~---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          273 ITQGREL---------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHTCCC---------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCC---------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            2222111         1112233468899999999999999999999999998753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.3e-52  Score=441.85  Aligned_cols=257  Identities=27%  Similarity=0.474  Sum_probs=211.1

Q ss_pred             HHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      +.+.+.||+|+||+||+|++.      ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..++||
T Consensus        15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~   94 (299)
T 4asz_A           15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF   94 (299)
T ss_dssp             EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence            346789999999999999874      47789999998766556678999999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhccc---------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 004689          484 EFMHNGTLKEHLYGTL---------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD  554 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~D  554 (736)
                      |||++|+|.++|+...         .....++|..++.++.|+|+||.|||++   +|+||||||+||||+.++++||+|
T Consensus        95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~D  171 (299)
T 4asz_A           95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD  171 (299)
T ss_dssp             ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECC
T ss_pred             EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECC
Confidence            9999999999997532         1234689999999999999999999998   999999999999999999999999


Q ss_pred             ecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhh
Q 004689          555 FGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       555 FGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      ||+|+........ ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....    .+...    +
T Consensus       172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~----~~~~~----i  243 (299)
T 4asz_A          172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN----EVIEC----I  243 (299)
T ss_dssp             CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHHH----H
T ss_pred             cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHHH----H
Confidence            9999865433222 2233569999999999999999999999999999999999 89999865522    22222    2


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      ..+....         .+.....++.+++.+|++.||++||||+||++.|+++.
T Consensus       244 ~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~  288 (299)
T 4asz_A          244 TQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA  288 (299)
T ss_dssp             HHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            2222111         12223346889999999999999999999999998864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.7e-53  Score=447.13  Aligned_cols=257  Identities=22%  Similarity=0.375  Sum_probs=210.8

Q ss_pred             HHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      ..+|.++||+|+||+||+|++.      +++.||||+++.... ...++|.+|+.+|++++|||||+++|+|.+++..++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3457789999999999999873      467899999975433 335679999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhccc------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc
Q 004689          482 VYEFMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR  549 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~  549 (736)
                      |||||++|+|.++|....            .....++|..++.|+.|+|+||+|||++   +||||||||+||||+++++
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence            999999999999996532            1234689999999999999999999998   9999999999999999999


Q ss_pred             EEEEeecCCccccCCC-CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHH
Q 004689          550 AKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQW  627 (736)
Q Consensus       550 ~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~  627 (736)
                      +||+|||+|+...... ........||+.|||||++.++.|+.++|||||||+||||+| |+.||.+...    ..+...
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~----~~~~~~  259 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN----QDVVEM  259 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH----HHHHHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH----HHHHHH
Confidence            9999999998654332 223345679999999999999999999999999999999998 8999986552    223322


Q ss_pred             HHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          628 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       628 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                          +..+....         .+......+.+++.+|++.||++||||.||+++|+.+
T Consensus       260 ----i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 ----IRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             ----HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ----HHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                22232211         1223345688999999999999999999999999754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.9e-51  Score=430.83  Aligned_cols=254  Identities=31%  Similarity=0.520  Sum_probs=199.5

Q ss_pred             HhhccccccCceEEEEEEECCCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.++||+|+||+||+|+++  ..||||+++...  ....+.|.+|+++|++++|||||+++|+|.+ +..++|||||++
T Consensus        39 ~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g  115 (307)
T 3omv_A           39 MLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG  115 (307)
T ss_dssp             CEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred             EEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence            46789999999999999876  369999987543  2334679999999999999999999999865 467999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC-Cc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-SH  567 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~-~~  567 (736)
                      |+|.++|+..   ...+++..++.|+.|+|+||+|||++   +||||||||+||||++++++||+|||+|+...... ..
T Consensus       116 GsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          116 SSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             CBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred             CCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence            9999999643   35699999999999999999999998   99999999999999999999999999998654322 22


Q ss_pred             ceecccccccccCcccccc---CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          568 VSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~---~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                      .....+||+.|||||++.+   +.|+.++|||||||+||||+||+.||.+....   ..+    ......+..    .+.
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~~~----~~~~~~~~~----~p~  258 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---DQI----IFMVGRGYA----SPD  258 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHH----HHHHHTTCC----CCC
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---HHH----HHHHhcCCC----CCC
Confidence            3445679999999999964   46899999999999999999999999765421   111    111222211    111


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      +. .........+.+++.+|++.||++||||.||+++|+.+
T Consensus       259 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          259 LS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             ST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             cc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11 11223345688999999999999999999999999865

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-50  Score=430.13  Aligned_cols=250  Identities=22%  Similarity=0.275  Sum_probs=204.0

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      .+.++||+|+||+||+|++. +|+.||||+++..     ....+|+.+|++++|||||++++++.+++..++|||||++|
T Consensus        61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~-----~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg  135 (336)
T 4g3f_A           61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG  135 (336)
T ss_dssp             EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT-----TCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTC
T ss_pred             EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHH-----HhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence            45678999999999999976 6899999999643     22357999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeecCCccccCCCCc-
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVDGASH-  567 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~-~~kl~DFGla~~~~~~~~~-  567 (736)
                      +|.++|..    ...+++..+..++.|++.||+|||++   +|+||||||+||||+.++ ++||+|||+|+........ 
T Consensus       136 ~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          136 SLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             BHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            99999953    45699999999999999999999998   999999999999999987 6999999999876433211 


Q ss_pred             ---ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          568 ---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       568 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                         .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+....+..        +... .  ..
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--------~~~~-~--~~  277 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS--------EPPP-I--RE  277 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH--------SCCG-G--GG
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc--------CCCC-c--hh
Confidence               22345799999999999999999999999999999999999999987653332222211        1100 0  01


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      +    +......+.+++.+|++.||++|||+.|++++|...+.
T Consensus       278 ~----~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          278 I----PPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             S----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c----CccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            1    12223458899999999999999999999999988764

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.1e-50  Score=430.68  Aligned_cols=248  Identities=24%  Similarity=0.332  Sum_probs=206.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      |.+.++||+|+||+||+|++. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|+|||||++
T Consensus        76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  155 (346)
T 4fih_A           76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  155 (346)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            344578999999999999986 6899999999766555667789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++..     ..+++..+..++.|++.||+|||++   +|+||||||+||||+.++++||+|||+|+....... .
T Consensus       156 g~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~  226 (346)
T 4fih_A          156 GALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R  226 (346)
T ss_dssp             EEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred             CcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence            999998852     4589999999999999999999998   999999999999999999999999999986644332 3


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....    .+...+.    .+..     +.+.. 
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~----~~~~-----~~~~~-  292 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIR----DNLP-----PRLKN-  292 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHH----HSSC-----CCCSC-
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHHH----cCCC-----CCCCc-
Confidence            34567999999999999999999999999999999999999999765421    1222111    1110     11110 


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       ......++.+++.+|++.||++|||+.|+++|
T Consensus       293 -~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          293 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             -GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             11123457899999999999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-49  Score=415.49  Aligned_cols=247  Identities=28%  Similarity=0.433  Sum_probs=196.4

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeee----CCeEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY  483 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lV~  483 (736)
                      .++++||+|+||+||+|.+. ++..||+|++....  ......|.+|+++|++++|||||+++++|.+    +...++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            45678999999999999876 68899999986542  2234568999999999999999999999865    35679999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeecCCcccc
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAV  562 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~-~~~~kl~DFGla~~~~  562 (736)
                      |||++|+|.+++..    ...+++..+..++.|++.||+|||++. ++|+||||||+||||+. ++.+||+|||+|+...
T Consensus       109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999953    456899999999999999999999971 13999999999999985 7999999999998543


Q ss_pred             CCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      .   ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+....   ..+.    ..+..+.....++
T Consensus       184 ~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~---~~~~----~~i~~~~~~~~~~  252 (290)
T 3fpq_A          184 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIY----RRVTSGVKPASFD  252 (290)
T ss_dssp             T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HHHH----HHHTTTCCCGGGG
T ss_pred             C---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH---HHHH----HHHHcCCCCCCCC
Confidence            2   23345679999999998864 6999999999999999999999999754311   1111    1222221111111


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          ..    ...++.+++.+|++.||++|||+.|+++|
T Consensus       253 ----~~----~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          253 ----KV----AIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ----GC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ----cc----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                11    12357889999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-49  Score=420.39  Aligned_cols=265  Identities=22%  Similarity=0.344  Sum_probs=202.1

Q ss_pred             HhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCC----eEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~~lV~e~~  486 (736)
                      .++++||+|+||+||+|++. |+.||||+++.... ....++.|+..+.+++|||||+++++|.+++    ..+||||||
T Consensus         6 ~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~   83 (303)
T 3hmm_A            6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH   83 (303)
T ss_dssp             EEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred             EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence            45789999999999999985 89999999864422 1223445677778899999999999998654    579999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCC-----CCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~-----~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ++|+|.++|+.     ..++|..+++++.|+++||+|||+++     .++|+||||||+||||+.++++||+|||+|+..
T Consensus        84 ~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           84 EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             CCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            99999999953     45899999999999999999999863     358999999999999999999999999999876


Q ss_pred             cCCCCc---ceecccccccccCccccccC------cCCCcchhHHHHHHHHHHHhCCCcCcccccccc--------cccH
Q 004689          562 VDGASH---VSSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGAN--------CRNI  624 (736)
Q Consensus       562 ~~~~~~---~~~~~~gt~~Y~aPE~~~~~------~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~--------~~~l  624 (736)
                      ......   .....+||+.|||||++.+.      .++.++|||||||+||||+||..|+......+.        ....
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            543322   22345799999999999754      477899999999999999999888754321110        0111


Q ss_pred             HHHHHHhhhcCCcceeccCccCCcC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          625 VQWAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       625 ~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ... ......+    .+++.+.... +.+....+.+++.+|++.||++||||.||++.|+++..
T Consensus       239 ~~~-~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          239 EEM-RKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHH-HHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHH-HHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            122 1111111    1223332222 34566788999999999999999999999999998754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.2e-50  Score=431.15  Aligned_cols=249  Identities=24%  Similarity=0.395  Sum_probs=199.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      |.+.+.||+|+||+||+|++. +|+.||||++.....  .....+.+|+++|++++|||||++++++.+++..++|||||
T Consensus        26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~  105 (350)
T 4b9d_A           26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC  105 (350)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            556789999999999999876 689999999975432  23457899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.++|...  ....+++..++.++.|++.||+|||++   +|+||||||+||||+.++++||+|||+|+..... .
T Consensus       106 ~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~  179 (350)
T 4b9d_A          106 EGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-V  179 (350)
T ss_dssp             TTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-H
T ss_pred             CCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-c
Confidence            999999999642  234578889999999999999999998   9999999999999999999999999999865322 1


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....    .+..   .. ..+...     .+.
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~---~i-~~~~~~-----~~~  246 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK----NLVL---KI-ISGSFP-----PVS  246 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHH---HH-HHTCCC-----CCC
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHH---HH-HcCCCC-----CCC
Confidence            2234567999999999999999999999999999999999999999865422    1111   11 122221     111


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..+    ..++.+++.+|++.||++|||+.|++++
T Consensus       247 ~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          247 LHY----SYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            222    2458899999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4e-50  Score=432.21  Aligned_cols=264  Identities=26%  Similarity=0.401  Sum_probs=212.4

Q ss_pred             HHHHHHHhhccccccCceEEEEEEECC------CcEEEEEEeccCCcc-cchhhhhHHHHHhhcCC-CceeeEeeeeeeC
Q 004689          405 IEDATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHH-RNLVQFLGYCQEE  476 (736)
Q Consensus       405 i~~~~~~~~~~IG~G~fG~Vy~~~~~~------~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~  476 (736)
                      |....+.+.+.||+|+||+||+|.+..      ++.||||++...... ..+.|.+|+++|++++| ||||+++|+|.++
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            334455678899999999999998652      367999999765433 35679999999999965 9999999999764


Q ss_pred             -CeEEEEEEecCCCCHHHHhhcccc------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEE
Q 004689          477 -GRSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL  543 (736)
Q Consensus       477 -~~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NIL  543 (736)
                       +..++|||||++|+|.++|+....            ....+++..++.++.|+|+||+|||++   +||||||||+|||
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL  217 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL  217 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence             568999999999999999975422            134589999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCccccccccc
Q 004689          544 LDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANC  621 (736)
Q Consensus       544 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~  621 (736)
                      +++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....+  
T Consensus       218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~--  295 (353)
T 4ase_A          218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--  295 (353)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--
T ss_pred             eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence            999999999999999876544333 3345679999999999999999999999999999999998 999998654221  


Q ss_pred             ccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          622 RNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       622 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                       .+..    .+.++...     .    .+.....++.+++..|++.||++|||+.||+++|++++.
T Consensus       296 -~~~~----~i~~g~~~-----~----~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          296 -EFCR----RLKEGTRM-----R----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             -HHHH----HHHHTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHH----HHHcCCCC-----C----CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence             1222    22222211     1    111223458899999999999999999999999999865

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.5e-50  Score=420.18  Aligned_cols=247  Identities=23%  Similarity=0.326  Sum_probs=206.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||+||+|+.. +++.||||++....   ......+.+|+++|++++|||||++++++.+++..++||||
T Consensus        34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy  113 (311)
T 4aw0_A           34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY  113 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence            567899999999999999876 68999999997542   22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      |++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+|+......
T Consensus       114 ~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          114 AKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             CCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            99999999995    345689999999999999999999998   99999999999999999999999999998764332


Q ss_pred             -CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          566 -SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       566 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                       .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+    +...    +..+.+      .
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~----i~~~~~------~  252 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL----IFAK----IIKLEY------D  252 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHHTCC------C
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHH----HHcCCC------C
Confidence             234456789999999999999999999999999999999999999998654222    2111    112221      1


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +....+    .++.+++.+|++.||++|||++|+..+
T Consensus       253 ~p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          253 FPEKFF----PKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             CCTTCC----HHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             CCcccC----HHHHHHHHHHccCCHhHCcChHHHcCC
Confidence            111222    357899999999999999999997544

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3e-49  Score=431.94  Aligned_cols=248  Identities=24%  Similarity=0.335  Sum_probs=206.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      |.+.++||+|+||+||+|++. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..|+|||||++
T Consensus       153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g  232 (423)
T 4fie_A          153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  232 (423)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence            445678999999999999986 6899999999876666667789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+||||+.++++||+|||+|+....... .
T Consensus       233 G~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~  303 (423)
T 4fie_A          233 GALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R  303 (423)
T ss_dssp             EEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred             CcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence            99999884     34589999999999999999999998   999999999999999999999999999986644332 3


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....    .+...+.    .+..     +.+.. 
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~----~~~~~i~----~~~~-----~~~~~-  369 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMIR----DNLP-----PRLKN-  369 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHHHH----HSCC-----CCCSC-
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HHHHHHH----cCCC-----CCCcc-
Confidence            34567999999999999999999999999999999999999999765421    1222111    1111     11110 


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       .......+.+++.+|+..||++|||+.|+++|
T Consensus       370 -~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          370 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             -TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             01122357899999999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.9e-49  Score=408.32  Aligned_cols=245  Identities=23%  Similarity=0.398  Sum_probs=190.0

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .|.+.+.||+|+||+||+|+.. +|+.||||++.....   .....+.+|+++|++++|||||++++++.+++..++|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            3567889999999999999875 689999999975432   224568999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+ +|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+|+...+.
T Consensus        94 y~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           94 YA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             CC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             CC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            99 6899998853    45699999999999999999999998   9999999999999999999999999999865432


Q ss_pred             CCcceecccccccccCccccccCcC-CCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      .  .....+||+.|||||++.+..| +.++||||+||++|||++|+.||.+....    .+.+    .+..+...     
T Consensus       166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~----~~~~----~i~~~~~~-----  230 (275)
T 3hyh_A          166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP----VLFK----NISNGVYT-----  230 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHTCCC-----
T ss_pred             C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH----HHHH----HHHcCCCC-----
Confidence            2  2345679999999999998876 57999999999999999999999865422    1211    11222211     


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       +....    ...+.+++.+|++.||++|||++|++++
T Consensus       231 -~p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          231 -LPKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             -CCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             -CCCCC----CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence             11122    2357889999999999999999999876

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.4e-49  Score=414.23  Aligned_cols=246  Identities=26%  Similarity=0.342  Sum_probs=194.7

Q ss_pred             HHhhccccccCceEEEEEEEC----CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      |.+.+.||+|+||+||+|+..    +++.||||+++....  .....+.+|+++|++++|||||++++++.+++..++||
T Consensus        26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm  105 (304)
T 3ubd_A           26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL  105 (304)
T ss_dssp             EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred             cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            567889999999999999863    478899999975432  23446888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      |||++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+|+....
T Consensus       106 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          106 DFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             CCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            99999999999953    45689999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      ... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+    +...    +..+.+      
T Consensus       179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~----~~~~----i~~~~~------  243 (304)
T 3ubd_A          179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE----TMTM----ILKAKL------  243 (304)
T ss_dssp             --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHHCCC------
T ss_pred             CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH----HHHH----HHcCCC------
Confidence            322 2345679999999999999999999999999999999999999998654221    2111    111211      


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  681 (736)
                      ......    ..++.+++.+|++.||++|||     ++|+++|
T Consensus       244 ~~p~~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          244 GMPQFL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             CCCTTS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             CCCCcC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            111122    235789999999999999998     4666654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.7e-47  Score=400.04  Aligned_cols=249  Identities=24%  Similarity=0.328  Sum_probs=186.1

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCC----------
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----------  477 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----------  477 (736)
                      |.+.+.||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+.+          
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            456789999999999999876 689999999875433 23457889999999999999999999987544          


Q ss_pred             --eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEee
Q 004689          478 --RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF  555 (736)
Q Consensus       478 --~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DF  555 (736)
                        ..++|||||++|+|.+++.... ......+..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DF  162 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF  162 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccC
Confidence              3689999999999999996542 223356667889999999999999998   9999999999999999999999999


Q ss_pred             cCCccccCCCCc-----------ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccH
Q 004689          556 GLSKFAVDGASH-----------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI  624 (736)
Q Consensus       556 Gla~~~~~~~~~-----------~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l  624 (736)
                      |+|+........           .....+||+.|||||++.+..|+.++|||||||++|||++   ||.....     ..
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-----~~  234 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-----RV  234 (299)
T ss_dssp             CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----HH
T ss_pred             ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----HH
Confidence            999865433211           1234579999999999999999999999999999999996   6753220     01


Q ss_pred             HHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          625 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       625 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       ... ...........         .......+.+++.+|++.||++|||+.|++++
T Consensus       235 -~~~-~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          235 -RTL-TDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             -HHH-HHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHH-HHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             111 11111111110         11222346789999999999999999999874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.5e-44  Score=384.50  Aligned_cols=273  Identities=42%  Similarity=0.744  Sum_probs=239.4

Q ss_pred             HhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      .+.+.||+|+||+||+|++.+++.||||++..........+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus        42 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  121 (321)
T 2qkw_B           42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN  121 (321)
T ss_dssp             SCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCB
T ss_pred             CccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCc
Confidence            34678999999999999988899999999876655556779999999999999999999999999999999999999999


Q ss_pred             HHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC-CCcce
Q 004689          491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG-ASHVS  569 (736)
Q Consensus       491 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~-~~~~~  569 (736)
                      |.+++.........+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..... .....
T Consensus       122 L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  198 (321)
T 2qkw_B          122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS  198 (321)
T ss_dssp             TGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCB
T ss_pred             HHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            9999976544445689999999999999999999998   9999999999999999999999999999754322 22223


Q ss_pred             ecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcC
Q 004689          570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY  649 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  649 (736)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.... +.....+..|.......+.+...+++.+....
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (321)
T 2qkw_B          199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSL-PREMVNLAEWAVESHNNGQLEQIVDPNLADKI  277 (321)
T ss_dssp             CCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSS-SSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred             cccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccC-cHHHHHHHHHhhhccccccHHHhcChhhcccc
Confidence            34568999999999999999999999999999999999999998655 33445677787777777888888888888888


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          650 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       650 ~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ..+....+.+++.+|++.||++|||+.||+++|+.++.
T Consensus       278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            88889999999999999999999999999999998864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-44  Score=388.01  Aligned_cols=288  Identities=35%  Similarity=0.656  Sum_probs=248.8

Q ss_pred             cccCHHHHHHHHHH--hhccccccCceEEEEEEECCCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeee
Q 004689          398 HCFTLSDIEDATKM--LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQ  474 (736)
Q Consensus       398 ~~~~~~~i~~~~~~--~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~  474 (736)
                      ..+++.++.....+  +.+.||+|+||.||+|+..+++.||||++..... .....+.+|++++++++||||+++++++.
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            34666666655444  4688999999999999988899999999876543 23447899999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 004689          475 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD  554 (736)
Q Consensus       475 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~D  554 (736)
                      ..+..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+.++|+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D  177 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD  177 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence            99999999999999999999987655566799999999999999999999998667999999999999999999999999


Q ss_pred             ecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccc-ccccccHHHHHHHhhh
Q 004689          555 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-GANCRNIVQWAKLHIE  633 (736)
Q Consensus       555 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~-~~~~~~l~~~~~~~~~  633 (736)
                      ||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+..|......
T Consensus       178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 3uim_A          178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK  257 (326)
T ss_dssp             CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred             CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence            999987655555555556799999999999988999999999999999999999999975432 2334567888888888


Q ss_pred             cCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          634 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       634 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      ...+....+..+...+..+....+.+++..|++.||.+|||+.||+++|++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            8888888998888888889999999999999999999999999999999863

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=395.67  Aligned_cols=263  Identities=20%  Similarity=0.283  Sum_probs=198.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeee------CCeEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRSV  480 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~~~~~  480 (736)
                      |.+.+.||+|+||+||+|++. +|+.||||+++....  ...+.+.+|+++|++++|||||++++++..      .+..|
T Consensus        56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~  135 (398)
T 4b99_A           56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY  135 (398)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred             eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence            556789999999999999876 799999999975432  234567899999999999999999998754      36789


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +|||||+ |+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus       136 ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          136 VVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence            9999996 679998843    45799999999999999999999998   999999999999999999999999999986


Q ss_pred             ccCCC---CcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          561 AVDGA---SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       561 ~~~~~---~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      +....   .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+....+....+........ ...
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~-~~~  286 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS-PAV  286 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC-GGG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC-hHH
Confidence            54322   2233456899999999998875 568999999999999999999999987653222222211110000 000


Q ss_pred             cceecc-------CccCC--cCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 IQGIID-------PSLLD--EYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~~~~~d-------~~l~~--~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....-.       ..+..  ..+.     .....+.+|+.+|+..||++|||+.|+++|
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000000       00000  0000     112357899999999999999999999876

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.3e-44  Score=385.73  Aligned_cols=195  Identities=25%  Similarity=0.374  Sum_probs=166.2

Q ss_pred             HHhhccccccCceEEEEEEEC----CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      |.+.++||+|+||+||+|+.+    +++.||||++....  ....+.+|+++|+.+ +||||+++++++.+.++.++|||
T Consensus        23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE  100 (361)
T 4f9c_A           23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP  100 (361)
T ss_dssp             CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred             EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence            556789999999999999763    46789999986543  345678999999998 69999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeecCCccccC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVD  563 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~-~~~kl~DFGla~~~~~  563 (736)
                      |+++|+|.+++.       .+++..+..++.|++.||+|||++   +|+||||||+|||++.+ +.+||+|||+|+...+
T Consensus       101 ~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~  170 (361)
T 4f9c_A          101 YLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD  170 (361)
T ss_dssp             CCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred             CCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence            999999999883       378889999999999999999998   99999999999999877 7999999999975433


Q ss_pred             CCC---------------------------cceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCccc
Q 004689          564 GAS---------------------------HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNE  615 (736)
Q Consensus       564 ~~~---------------------------~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~  615 (736)
                      ...                           ......+||+.|||||++.+. .|+.++||||+||++|||++|+.||...
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~  250 (361)
T 4f9c_A          171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA  250 (361)
T ss_dssp             CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence            221                           112345799999999999875 5899999999999999999999999644


Q ss_pred             c
Q 004689          616 K  616 (736)
Q Consensus       616 ~  616 (736)
                      .
T Consensus       251 ~  251 (361)
T 4f9c_A          251 S  251 (361)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.2e-44  Score=409.14  Aligned_cols=250  Identities=23%  Similarity=0.365  Sum_probs=206.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      |.+.+.||+|+||+||+|+.+ +|+.||+|++..........+.+|+.+|+.++|||||++++++.++...++|||||++
T Consensus       159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~g  238 (573)
T 3uto_A          159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG  238 (573)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence            556789999999999999876 6899999999766555567789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC--CcEEEEeecCCccccCCCC
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~--~~~kl~DFGla~~~~~~~~  566 (736)
                      |+|.++|..   ....+++..+..++.||+.||.|||++   +|+||||||+|||++.+  +.+||+|||+|+.....  
T Consensus       239 g~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~--  310 (573)
T 3uto_A          239 GELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--  310 (573)
T ss_dssp             CBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT--
T ss_pred             CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC--
Confidence            999999853   234689999999999999999999998   99999999999999864  89999999999876443  


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+    +...    +..+...  ++....
T Consensus       311 ~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~----~~~~----i~~~~~~--~~~~~~  380 (573)
T 3uto_A          311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----TLRN----VKSCDWN--MDDSAF  380 (573)
T ss_dssp             SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHH----HHTTCCC--CCSGGG
T ss_pred             CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH----HHHH----HHhCCCC--CCcccc
Confidence            23345679999999999999999999999999999999999999998655221    1111    1111110  111111


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...+    ..+.+|+.+|++.||.+|||+.|+++|
T Consensus       381 ~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          381 SGIS----EDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             TTSC----HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCCC----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1222    357889999999999999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.2e-43  Score=402.34  Aligned_cols=246  Identities=25%  Similarity=0.331  Sum_probs=196.5

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhh---HHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTN---EVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~---E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      .+.+.||+|+||+||+|+.. +|+.||||++.+...   .....+.+   ++.+++.++|||||++++++.+.+.+|+||
T Consensus       192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVm  271 (689)
T 3v5w_A          192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFIL  271 (689)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEE
Confidence            45688999999999999886 689999999965321   11222333   456677789999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      |||+||+|.++|.    ....+++..+..++.||+.||+|||++   +||||||||+||||+.+|++||+|||+|+....
T Consensus       272 Ey~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          272 DLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             CCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            9999999999995    345689999999999999999999998   999999999999999999999999999986644


Q ss_pred             CCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          564 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      ..   ....+||+.|||||++.. ..|+.++|+||+||++|||++|+.||.+...... ..+....    ....+     
T Consensus       345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-~~i~~~i----~~~~~-----  411 (689)
T 3v5w_A          345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMT----LTMAV-----  411 (689)
T ss_dssp             CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-HHHHHHH----HHCCC-----
T ss_pred             CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhh----cCCCC-----
Confidence            32   334679999999999974 5799999999999999999999999976542211 1121111    11111     


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  681 (736)
                       .+...+    ..++.+++.+|++.||.+|++     ++||.+|
T Consensus       412 -~~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          412 -ELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             -CCCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             -CCCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence             111222    235789999999999999998     6888776

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.2e-42  Score=363.46  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=209.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.+.+.||+|+||+||+|.+. +++.||+|++..........+.+|++++++++||||+++++++.+++..++||||+++
T Consensus        12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   91 (310)
T 3s95_A           12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG   91 (310)
T ss_dssp             EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence            445789999999999999886 6899999998766556677899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        92 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           92 GTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999642   35689999999999999999999998   99999999999999999999999999998654332211


Q ss_pred             -------------eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccc--cccHHHHHHHhhh
Q 004689          569 -------------SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN--CRNIVQWAKLHIE  633 (736)
Q Consensus       569 -------------~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~--~~~l~~~~~~~~~  633 (736)
                                   .....||+.|+|||++.+..++.++|||||||++|||++|..|+........  ...........  
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~--  243 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY--  243 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT--
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc--
Confidence                         1145699999999999999999999999999999999999999875432111  11222211111  


Q ss_pred             cCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          634 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       634 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                                 ....    ....+.+++.+|++.||++|||+.|+++.|+.+...
T Consensus       244 -----------~~~~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          244 -----------CPPN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             -----------CCTT----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------CCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                       1111    123478899999999999999999999999987644

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.2e-41  Score=361.85  Aligned_cols=259  Identities=31%  Similarity=0.477  Sum_probs=201.1

Q ss_pred             HHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      ..+.+.+.||+|+||+||+|+.. ++.||||++.....  .....+.+|++++++++||||+++++++...+..++||||
T Consensus        37 ~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  115 (309)
T 3p86_A           37 CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY  115 (309)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred             hHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence            34556789999999999999875 89999999875532  2235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~--iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      +++|+|.+++.... ....+++..++.++.|++.||+|||+.   +  |+||||||+|||++.++.+||+|||+++....
T Consensus       116 ~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          116 LSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             CTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             CCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            99999999996432 234589999999999999999999998   7  99999999999999999999999999975433


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+.......   ...     .
T Consensus       192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~----~~~~~~~~~---~~~-----~  258 (309)
T 3p86_A          192 TF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA----QVVAAVGFK---CKR-----L  258 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH----HHHHHHHHS---CCC-----C
T ss_pred             cc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhc---CCC-----C
Confidence            22 2233456999999999999999999999999999999999999999765421    122211111   100     0


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                      .+    +......+.+++.+|++.+|.+|||+.||++.|+.++..
T Consensus       259 ~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          259 EI----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            11    112234588999999999999999999999999988653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.9e-41  Score=358.36  Aligned_cols=248  Identities=24%  Similarity=0.350  Sum_probs=204.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      |.+.+.||+|+||+||+|... +++.||||++..........+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  101 (297)
T 3fxz_A           22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (297)
T ss_dssp             BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence            445688999999999999864 6899999999766555567789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++..     ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++........ .
T Consensus       102 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~  172 (297)
T 3fxz_A          102 GSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (297)
T ss_dssp             CBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred             CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence            999999853     3588899999999999999999998   999999999999999999999999999976544332 2


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .+    ......+... .       .
T Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~----~~~~~~~~~~-~-------~  237 (297)
T 3fxz_A          173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---AL----YLIATNGTPE-L-------Q  237 (297)
T ss_dssp             BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----HHHHHHCSCC-C-------S
T ss_pred             cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhCCCCC-C-------C
Confidence            334569999999999999999999999999999999999999997654211   11    1111111110 0       0


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .+......+.+++.+|++.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111223458899999999999999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.1e-41  Score=371.52  Aligned_cols=261  Identities=23%  Similarity=0.434  Sum_probs=210.5

Q ss_pred             HHHhhccccccCceEEEEEEEC--------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCe
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR  478 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~--------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~  478 (736)
                      .+.+.+.||+|+||.||+|++.        ++..||||+++.... .....+.+|+++++++ +||||++++++|...+.
T Consensus        82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~  161 (370)
T 2psq_A           82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP  161 (370)
T ss_dssp             GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred             HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence            3456789999999999999863        356799999975532 2345689999999999 89999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcccc------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK  546 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~  546 (736)
                      .++||||+++|+|.+++.....            ....+++..++.++.|++.||.|||++   +|+||||||+|||++.
T Consensus       162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~  238 (370)
T 2psq_A          162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE  238 (370)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred             EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECC
Confidence            9999999999999999965421            124588999999999999999999998   9999999999999999


Q ss_pred             CCcEEEEeecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccH
Q 004689          547 HMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI  624 (736)
Q Consensus       547 ~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l  624 (736)
                      ++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....    .+
T Consensus       239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~----~~  314 (370)
T 2psq_A          239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----EL  314 (370)
T ss_dssp             TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GH
T ss_pred             CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH----HH
Confidence            99999999999986543322 12233457889999999999999999999999999999999 99999765422    22


Q ss_pred             HHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          625 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       625 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                      ....    ..+...         ..+......+.+++..|++.+|.+||++.|+++.|++++...
T Consensus       315 ~~~~----~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          315 FKLL----KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             HHHH----HTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHH----hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            2221    112111         111223346889999999999999999999999999987643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=369.97  Aligned_cols=260  Identities=26%  Similarity=0.453  Sum_probs=208.2

Q ss_pred             HHHHHHHhhccccccCceEEEEEEEC----CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeE
Q 004689          405 IEDATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       405 i~~~~~~~~~~IG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  479 (736)
                      +....+.+.+.||+|+||+||+|.+.    .+..||||+++... ......+.+|+.++++++||||+++++++.+.+..
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            33445667789999999999999885    34569999997543 23356789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ++||||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       126 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccc
Confidence            9999999999999998532   34689999999999999999999998   99999999999999999999999999998


Q ss_pred             cccCCCCc--ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          560 FAVDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       560 ~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      ........  ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......    .+...+    ..+.
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~~~----~~~~  271 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR----DVISSV----EEGY  271 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HHHHHH----HTTC
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH----HHHHHH----HcCC
Confidence            66443222  2223446789999999998999999999999999999999 99999765421    121111    1111


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                               ....+......+.+++..|++.||++||++.||++.|+.++.
T Consensus       272 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          272 ---------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                     011112233468899999999999999999999999999864

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.8e-40  Score=352.01  Aligned_cols=280  Identities=35%  Similarity=0.590  Sum_probs=226.1

Q ss_pred             cccCHHHHHHHHHHhh--------ccccccCceEEEEEEECCCcEEEEEEeccCC----cccchhhhhHHHHHhhcCCCc
Q 004689          398 HCFTLSDIEDATKMLE--------KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRN  465 (736)
Q Consensus       398 ~~~~~~~i~~~~~~~~--------~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l~Hpn  465 (736)
                      +.|++.++...+.++.        +.||+|+||.||+|.. +++.||||++....    ......+.+|+.++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            5588899998888774        5699999999999987 48999999986532    122456889999999999999


Q ss_pred             eeeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc
Q 004689          466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD  545 (736)
Q Consensus       466 Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~  545 (736)
                      |+++++++...+..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+.   +|+||||||+||+++
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~  167 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD  167 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence            999999999999999999999999999998643 2234689999999999999999999998   999999999999999


Q ss_pred             CCCcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccH
Q 004689          546 KHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI  624 (736)
Q Consensus       546 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l  624 (736)
                      .++.+||+|||+++........ ......||+.|+|||.+.+ .++.++|||||||++|||++|..||...........+
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI  246 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence            9999999999999865433222 2234569999999998765 5889999999999999999999999876543333333


Q ss_pred             HHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          625 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       625 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      ......  ....+...+++.+ ..........+.+++..|++.+|.+||++.||+++|+++.
T Consensus       247 ~~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          247 KEEIED--EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHT--TSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHhhh--hhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            221111  1223344444444 2345667778999999999999999999999999999863

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-41  Score=354.50  Aligned_cols=254  Identities=28%  Similarity=0.472  Sum_probs=208.8

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.+.+.||+|+||+||+|.+.+++.||+|++.... ...+++.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (269)
T 4hcu_A           12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG   90 (269)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTC
T ss_pred             ceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCC
Confidence            45678999999999999999889999999997543 23567899999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        91 ~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (269)
T 4hcu_A           91 CLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  164 (269)
T ss_dssp             BHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             cHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence            999998542   34588999999999999999999998   999999999999999999999999999986543322223


Q ss_pred             ecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      ....||+.|+|||.+.+..++.++|||||||++|||++ |+.||......    .+...    +..+.  ...       
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~----~~~~~----~~~~~--~~~-------  227 (269)
T 4hcu_A          165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVED----ISTGF--RLY-------  227 (269)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHH----HHTTC--CCC-------
T ss_pred             cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH----HHHHH----HhcCc--cCC-------
Confidence            34457889999999998999999999999999999999 99999765421    11111    11110  001       


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      .+......+.+++..|++.+|++||++.|++++|+++..
T Consensus       228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            111123458899999999999999999999999998853

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.9e-42  Score=356.03  Aligned_cols=255  Identities=29%  Similarity=0.468  Sum_probs=209.9

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.+.+.||+|+||.||+|+..++..||+|++..... ....+.+|++++++++||||+++++++.+....++||||+++
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (268)
T 3sxs_A            9 EITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN   87 (268)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred             heeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence            4456789999999999999999888999999975433 356789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      ++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        88 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  161 (268)
T 3sxs_A           88 GCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS  161 (268)
T ss_dssp             CBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred             CcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence            9999998532   34589999999999999999999998   99999999999999999999999999998665544333


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......    ....   . ...+..  ...+    
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~---~-~~~~~~--~~~~----  227 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS----EVVL---K-VSQGHR--LYRP----  227 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHH---H-HHTTCC--CCCC----
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH----HHHH---H-HHcCCC--CCCC----
Confidence            344557788999999999899999999999999999999 99999765421    1111   1 111110  0111    


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                         ......+.+++..|++.+|++|||+.|++++|+.+..
T Consensus       228 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          228 ---HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             ---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             ---CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence               1112358899999999999999999999999988743

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.7e-42  Score=374.09  Aligned_cols=257  Identities=25%  Similarity=0.434  Sum_probs=197.3

Q ss_pred             HHHhhccccccCceEEEEEEEC----CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      .+.+.+.||+|+||.||+|++.    ++..||||+++... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  125 (373)
T 2qol_A           46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT  125 (373)
T ss_dssp             GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence            4456789999999999999875    56789999987543 233567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       126 e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          126 EYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             ECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             eCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            999999999999632   34689999999999999999999998   999999999999999999999999999986544


Q ss_pred             CCCcc--eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          564 GASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       564 ~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      .....  .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......    .+...+    ..+.    
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~----~~~~~i----~~~~----  267 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ----DVIKAV----DEGY----  267 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH----HHHHHH----HTTE----
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HcCC----
Confidence            32221  122345788999999999999999999999999999998 99999765421    122211    1110    


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                           ....+......+.+++..|++.||++||++.||++.|+.++..
T Consensus       268 -----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          268 -----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             -----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                 0111222345688999999999999999999999999998653

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.4e-40  Score=355.67  Aligned_cols=259  Identities=23%  Similarity=0.364  Sum_probs=210.8

Q ss_pred             ccCHHHHHHHHHH------------hhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCc
Q 004689          399 CFTLSDIEDATKM------------LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN  465 (736)
Q Consensus       399 ~~~~~~i~~~~~~------------~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn  465 (736)
                      .++..++..++..            ..+.||+|+||.||+|+.. +|+.||||++..........+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4677777776653            2458999999999999987 79999999997666555677899999999999999


Q ss_pred             eeeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc
Q 004689          466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD  545 (736)
Q Consensus       466 Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~  545 (736)
                      |+++++++...+..++||||+++|+|.+++..     ..+++..+..++.|++.||.|||+.   +|+||||||+|||++
T Consensus       104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~  175 (321)
T 2c30_A          104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT  175 (321)
T ss_dssp             BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEC
T ss_pred             cceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEC
Confidence            99999999999999999999999999998842     3589999999999999999999998   999999999999999


Q ss_pred             CCCcEEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHH
Q 004689          546 KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIV  625 (736)
Q Consensus       546 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~  625 (736)
                      .++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......    ...
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~----~~~  250 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----QAM  250 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHH
T ss_pred             CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHH
Confidence            999999999999976543322 223456999999999999999999999999999999999999999755421    111


Q ss_pred             HHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          626 QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       626 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...    .....     +.+..  .......+.+++.+|++.||++|||+.|++++
T Consensus       251 ~~~----~~~~~-----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          251 KRL----RDSPP-----PKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHH----HHSSC-----CCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHH----hcCCC-----CCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111    11111     11110  11122457889999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.4e-41  Score=354.29  Aligned_cols=256  Identities=29%  Similarity=0.469  Sum_probs=207.2

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.+.+.||+|+||+||+|.+.++..||||++..... ...++.+|++++++++||||+++++++.+.+..++||||+++
T Consensus        25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  103 (283)
T 3gen_A           25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN  103 (283)
T ss_dssp             GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred             HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence            4556789999999999999999888999999975432 356789999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.........
T Consensus       104 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  177 (283)
T 3gen_A          104 GCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  177 (283)
T ss_dssp             CBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred             CcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence            9999999642   35689999999999999999999998   99999999999999999999999999998654332222


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......    ....    .+..+.         ..
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~----~~~~----~~~~~~---------~~  240 (283)
T 3gen_A          178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ETAE----HIAQGL---------RL  240 (283)
T ss_dssp             TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----HHHH----HHHTTC---------CC
T ss_pred             ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh----HHHH----HHhccc---------CC
Confidence            233457889999999998899999999999999999998 99999765421    1111    111111         00


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                      ..+......+.+++..|++.+|.+|||+.|++++|++++..
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            01111124588999999999999999999999999998653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.5e-41  Score=371.48  Aligned_cols=255  Identities=29%  Similarity=0.431  Sum_probs=207.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.+.+.||+|+||.||+|++. +++.||||+++.... .....+.+|+++|++++||||+++++++...+..++||||++
T Consensus       116 ~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~  195 (377)
T 3cbl_A          116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQ  195 (377)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             eEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCC
Confidence            446789999999999999987 789999999875432 234578999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++..   ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++........
T Consensus       196 ~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~  269 (377)
T 3cbl_A          196 GGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA  269 (377)
T ss_dssp             TCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEE
T ss_pred             CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCcee
Confidence            9999999963   234689999999999999999999998   9999999999999999999999999999754332111


Q ss_pred             ce-ecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          568 VS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       568 ~~-~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      .. ....+++.|+|||.+.+..++.++|||||||++|||++ |..||......    .+..    .+..+...       
T Consensus       270 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----~~~~----~~~~~~~~-------  334 (377)
T 3cbl_A          270 ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----QTRE----FVEKGGRL-------  334 (377)
T ss_dssp             CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----HHHH----HHHTTCCC-------
T ss_pred             ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH----HHHcCCCC-------
Confidence            11 12235788999999998899999999999999999998 99999765421    1111    12222110       


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                        ..+......+.+++.+|++.||++|||+.+|++.|+++..
T Consensus       335 --~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          335 --PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence              1111223468899999999999999999999999998754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.3e-41  Score=361.41  Aligned_cols=245  Identities=24%  Similarity=0.413  Sum_probs=201.8

Q ss_pred             HHhhccccccCceEEEEEEE-CCCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      |.+.+.||+|+||.||+|++ .+|+.||||++....  ......+.+|+++|+.++||||+++++++...+..++||||+
T Consensus        17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~   96 (328)
T 3fe3_A           17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA   96 (328)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence            45678999999999999988 479999999986542  223456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus        97 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  168 (328)
T 3fe3_A           97 SGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-  168 (328)
T ss_dssp             TTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence            99999999853    35688999999999999999999998   99999999999999999999999999997654332 


Q ss_pred             cceecccccccccCccccccCcCC-CcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                       .....+||+.|+|||++.+..+. .++||||+||++|||++|+.||.+....    .+..    .+..+...      +
T Consensus       169 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~----~i~~~~~~------~  233 (328)
T 3fe3_A          169 -KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK----ELRE----RVLRGKYR------I  233 (328)
T ss_dssp             -GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCCCC------C
T ss_pred             -ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH----HHHH----HHHhCCCC------C
Confidence             23446799999999999988765 7899999999999999999999865421    1111    11112111      1


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          +......+.+++.+|++.||.+|||++|++++
T Consensus       234 ----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          234 ----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             ----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             ----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                11122357889999999999999999999876

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.4e-41  Score=359.67  Aligned_cols=267  Identities=27%  Similarity=0.357  Sum_probs=205.8

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCC----eEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~~lV~e  484 (736)
                      .+.+.++||+|+||+||+|++. ++.||||++.... .....+..|+.++++++||||+++++++....    ..++|||
T Consensus        25 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e  102 (322)
T 3soc_A           25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA  102 (322)
T ss_dssp             EEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             hchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence            3456789999999999999987 8999999986443 22345667999999999999999999998754    4699999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCC-------CCceecCCCCCCCEEEcCCCcEEEEeecC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-------VPAIIHRDLKSSNILLDKHMRAKVSDFGL  557 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~-------~~~iiHrDikp~NILl~~~~~~kl~DFGl  557 (736)
                      |+++|+|.+++..     ..+++..++.++.|++.||.|||+.+       .++|+||||||+|||++.++.+||+|||+
T Consensus       103 ~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~  177 (322)
T 3soc_A          103 FHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL  177 (322)
T ss_dssp             CCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence            9999999999953     34899999999999999999999851       23899999999999999999999999999


Q ss_pred             CccccCCCCc-ceecccccccccCcccccc-----CcCCCcchhHHHHHHHHHHHhCCCcCccccccccc---------c
Q 004689          558 SKFAVDGASH-VSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANC---------R  622 (736)
Q Consensus       558 a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~---------~  622 (736)
                      ++........ ......||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+.......         .
T Consensus       178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  257 (322)
T 3soc_A          178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP  257 (322)
T ss_dssp             CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred             ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence            9765443322 2233569999999999986     35667889999999999999999999764321111         0


Q ss_pred             cHHHHHHHhhhcCCcceeccCccCCcC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          623 NIVQWAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       623 ~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ....+...... ..    ..+.+.... .......+.+++.+|++.||++|||+.||++.|+++..
T Consensus       258 ~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          258 SLEDMQEVVVH-KK----KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             CHHHHHHHHTT-SC----CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhhhhhhhhc-cc----CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11122111111 11    111111111 23455679999999999999999999999999998754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-40  Score=348.99  Aligned_cols=272  Identities=21%  Similarity=0.289  Sum_probs=212.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCC--eEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~lV~e~  485 (736)
                      |.+.+.||+|+||+||+|... +++.||||++..... .....+.+|++++++++||||+++++++....  ..++||||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   90 (319)
T 4euu_A           11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF   90 (319)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred             EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence            456789999999999999887 589999999975432 33456789999999999999999999987655  78999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE----cCCCcEEEEeecCCccc
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl----~~~~~~kl~DFGla~~~  561 (736)
                      +++|+|.+++.... ....+++..++.++.|++.||.|||+.   +|+||||||+|||+    +.++.+||+|||+++..
T Consensus        91 ~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~  166 (319)
T 4euu_A           91 CPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (319)
T ss_dssp             CTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred             CCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence            99999999996432 223389999999999999999999998   99999999999999    78888999999999865


Q ss_pred             cCCCCcceecccccccccCccccc--------cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYI--------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE  633 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~  633 (736)
                      .....  .....||+.|+|||++.        +..++.++|||||||++|||++|+.||...........+.........
T Consensus       167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            44332  23356999999999986        467899999999999999999999999755433332233222222111


Q ss_pred             cCCcceec---------cCcc--CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          634 SGDIQGII---------DPSL--LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       634 ~~~~~~~~---------d~~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ...+..+.         .+.+  ...........+.+++..|++.||++|||++|++++..+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            11111110         0111  113345667788999999999999999999999999987643

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.4e-41  Score=358.39  Aligned_cols=265  Identities=27%  Similarity=0.396  Sum_probs=205.3

Q ss_pred             HHHHhhccccccCceEEEEEEE-----CCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeee--CCeEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSV  480 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~  480 (736)
                      ..+.+.+.||+|+||+||+|++     .+++.||||++........+.+.+|++++++++||||+++++++..  ....+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            3456778999999999999985     2688999999986655556779999999999999999999999854  45689


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        90 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            999999999999999643   34589999999999999999999998   999999999999999999999999999986


Q ss_pred             ccCCCC--cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccc--------cccccHHHHHHH
Q 004689          561 AVDGAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG--------ANCRNIVQWAKL  630 (736)
Q Consensus       561 ~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~--------~~~~~l~~~~~~  630 (736)
                      ......  .......||..|+|||.+.+..++.++|||||||++|||++|..|+......        ............
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            543322  1223345788899999999999999999999999999999999998643210        000111111122


Q ss_pred             hhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          631 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       631 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ....+..         ...+......+.+++..|++.||++|||+.||++.|+++..
T Consensus       244 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          244 LLKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HHHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhccCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence            2221111         11122233568899999999999999999999999998753

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-40  Score=361.64  Aligned_cols=249  Identities=24%  Similarity=0.363  Sum_probs=202.7

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc------cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      |.+.+.||+|+||+||+|+.. +|+.||+|++......      ....+.+|+.+|++++||||+++++++.+....++|
T Consensus        14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   93 (361)
T 2yab_A           14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI   93 (361)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence            456789999999999999886 6899999999765322      235688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC----cEEEEeecCC
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGLS  558 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~----~~kl~DFGla  558 (736)
                      |||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++    .+||+|||++
T Consensus        94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           94 LELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            999999999999843    45689999999999999999999998   999999999999998877    7999999999


Q ss_pred             ccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          559 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       559 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      +......  ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....+    +..    .+..+...
T Consensus       167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~----~~~----~i~~~~~~  236 (361)
T 2yab_A          167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLA----NITAVSYD  236 (361)
T ss_dssp             EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHH----HHHTTCCC
T ss_pred             eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH----HHH----HHHhcCCC
Confidence            8654432  2234569999999999999999999999999999999999999997654211    111    11111110


Q ss_pred             eeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       639 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        +++......    ...+.+++..|+..||.+|||+.|++++
T Consensus       237 --~~~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          237 --FDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             --CCHHHHTTS----CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --CCchhccCC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              111111111    2357899999999999999999999875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.7e-41  Score=352.28  Aligned_cols=258  Identities=24%  Similarity=0.382  Sum_probs=202.6

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .|.+.+.||+|+||.||+|+.. +++.||+|++......   ....+.+|+.++++++||||+++++++...+..++|||
T Consensus        12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   91 (294)
T 4eqm_A           12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME   91 (294)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence            4556789999999999999875 6889999998654322   23568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++|+|.+++..    ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        92 ~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           92 YIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            9999999999843    34689999999999999999999998   9999999999999999999999999999866544


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                      .........||+.|+|||.+.+..++.++|||||||++|||++|+.||.+....       .......... ... ... 
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~-~~~-~~~-  234 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQDS-VPN-VTT-  234 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSSC-CCC-HHH-
T ss_pred             cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhcc-CCC-cch-
Confidence            333344567999999999999999999999999999999999999999765421       1111111111 110 001 


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAI  686 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~~~  686 (736)
                         .........+.+++.+|++.||++|| ++.++.+.|+.++
T Consensus       235 ---~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          235 ---DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             ---HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             ---hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence               11122234688999999999999999 8999999888664

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.3e-40  Score=356.04  Aligned_cols=246  Identities=23%  Similarity=0.306  Sum_probs=201.9

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.+.||+|+||+||+|+.. +++.||+|+++...   ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~   86 (337)
T 1o6l_A            7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence            345689999999999999876 68999999997542   22345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......
T Consensus        87 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           87 ANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             CTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            999999998843    45688999999999999999999998   99999999999999999999999999997533222


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+...   . ..+.+      .+
T Consensus       160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~---i-~~~~~------~~  224 (337)
T 1o6l_A          160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFEL---I-LMEEI------RF  224 (337)
T ss_dssp             -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH---H-HHCCC------CC
T ss_pred             -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH----HHHHH---H-HcCCC------CC
Confidence             2234567999999999999999999999999999999999999999765421    11111   1 11111      11


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                          +......+.+++.+|++.||++||     +++||+++
T Consensus       225 ----p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          225 ----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                111224578999999999999999     89999876

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=354.73  Aligned_cols=251  Identities=23%  Similarity=0.325  Sum_probs=203.3

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc------cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  480 (736)
                      ..|.+.+.||+|+||.||+|... +++.||+|++......      ....+.+|+.++++++||||+++++++......+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45667889999999999999886 6899999998754322      2456889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC----cEEEEeec
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFG  556 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~----~~kl~DFG  556 (736)
                      +||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++    .+||+|||
T Consensus        91 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999843    35689999999999999999999998   999999999999999887    89999999


Q ss_pred             CCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          557 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       557 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      +++......  ......||+.|+|||++.+..++.++|||||||++|||++|..||......+    ......    ...
T Consensus       164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~~~----~~~  233 (326)
T 2y0a_A          164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLANVS----AVN  233 (326)
T ss_dssp             TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH----HHHHHH----HTC
T ss_pred             CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH----HHHHHH----hcC
Confidence            998654322  2234569999999999998999999999999999999999999997654211    111111    111


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..  +......    .....+.+++.+|++.||++|||+.|++++
T Consensus       234 ~~--~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          234 YE--FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             CC--CCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CC--cCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00  0000001    112357899999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-40  Score=354.61  Aligned_cols=259  Identities=27%  Similarity=0.434  Sum_probs=209.4

Q ss_pred             HHHhhccccccCceEEEEEEE------CCCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~------~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      .+.+.+.||+|+||.||+|..      .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  103 (314)
T 2ivs_A           24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL  103 (314)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence            355678999999999999986      245789999987543 2334678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcccc--------------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCC
Q 004689          482 VYEFMHNGTLKEHLYGTLT--------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN  541 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~N  541 (736)
                      ||||+++|+|.+++.....                    ....+++..++.++.|++.||.|||++   +|+||||||+|
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~N  180 (314)
T 2ivs_A          104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN  180 (314)
T ss_dssp             EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred             EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchhe
Confidence            9999999999999965432                    124588999999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCccccccc
Q 004689          542 ILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGA  619 (736)
Q Consensus       542 ILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~  619 (736)
                      ||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... 
T Consensus       181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-  259 (314)
T 2ivs_A          181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE-  259 (314)
T ss_dssp             EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            99999999999999999865443322 2233457889999999999899999999999999999999 99999765421 


Q ss_pred             ccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          620 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       620 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                         .+.....    .+...         ..+......+.+++.+|++.||++||++.||+++|++++.
T Consensus       260 ---~~~~~~~----~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          260 ---RLFNLLK----TGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             ---GHHHHHH----TTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---HHHHHhh----cCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               2222211    11111         1111223458899999999999999999999999999865

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.8e-40  Score=348.12  Aligned_cols=258  Identities=22%  Similarity=0.366  Sum_probs=199.2

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhh--cCCCceeeEeeeeee----CCeEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQE----EGRSVLV  482 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~----~~~~~lV  482 (736)
                      .+.+.+.||+|+||+||+|++ +++.||||++...   ....+..|.+++..  ++||||+++++++..    ....++|
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv   84 (301)
T 3q4u_A            9 DITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI   84 (301)
T ss_dssp             GCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence            345678999999999999998 4899999998643   23455667777766  799999999998754    3457999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHH--------hCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--------TGCVPAIIHRDLKSSNILLDKHMRAKVSD  554 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH--------~~~~~~iiHrDikp~NILl~~~~~~kl~D  554 (736)
                      |||+++|+|.+++.     ...+++..++.++.|++.||.|||        +.   +|+||||||+|||++.++.+||+|
T Consensus        85 ~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           85 THYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             ECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred             hhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence            99999999999994     346899999999999999999999        66   999999999999999999999999


Q ss_pred             ecCCccccCCCCcc---eecccccccccCccccccC------cCCCcchhHHHHHHHHHHHhC----------CCcCccc
Q 004689          555 FGLSKFAVDGASHV---SSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISG----------QEAISNE  615 (736)
Q Consensus       555 FGla~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~------~~~~~~DVwSlGvvl~elltG----------~~p~~~~  615 (736)
                      ||+++.........   .....||+.|+|||++.+.      .++.++|||||||++|||++|          +.||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            99997654433322   2234699999999999876      456799999999999999999          7777654


Q ss_pred             ccccccccHHHHHHHhhhcCCcceeccCccCC-cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          616 KFGANCRNIVQWAKLHIESGDIQGIIDPSLLD-EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       616 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                      .....  ..............     .+.+.. ..+......+.+++.+|++.||++|||+.||++.|+++
T Consensus       237 ~~~~~--~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          237 VPNDP--SFEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SCSSC--CHHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCc--chhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            32211  11111111111111     111111 12334667899999999999999999999999999875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=364.53  Aligned_cols=262  Identities=24%  Similarity=0.433  Sum_probs=211.3

Q ss_pred             HHHHhhccccccCceEEEEEEEC--------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCC
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG  477 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~--------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~  477 (736)
                      ..+.+.+.||+|+||+||+|+..        .+..||||+++.... .....+.+|+++++++ +||||+++++++...+
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            35567789999999999999863        235799999976532 2346788999999999 9999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcccc------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc
Q 004689          478 RSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD  545 (736)
Q Consensus       478 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~  545 (736)
                      ..++||||+++|+|.+++.....            ....+++..++.++.|++.||.|||+.   +|+||||||+|||++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT  225 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEc
Confidence            99999999999999999965431            124589999999999999999999998   999999999999999


Q ss_pred             CCCcEEEEeecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCccccccccccc
Q 004689          546 KHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN  623 (736)
Q Consensus       546 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~  623 (736)
                      .++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||......    .
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~----~  301 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----E  301 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----H
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----H
Confidence            999999999999986543322 22333457899999999999999999999999999999999 99999765421    2


Q ss_pred             HHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          624 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       624 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                      +...    +..+...         ..+......+.+++..|++.||++||++.||+++|++++...
T Consensus       302 ~~~~----~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          302 LFKL----LKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             HHHH----HHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHHH----HHcCCCC---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            2221    1122111         111122345889999999999999999999999999987543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.1e-40  Score=356.54  Aligned_cols=256  Identities=21%  Similarity=0.298  Sum_probs=204.8

Q ss_pred             HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-----cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  480 (736)
                      ...|.+.+.||+|+||+||+|... +++.||||++....     ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            446777899999999999999876 68999999986431     123567899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc---EEEEeecC
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGL  557 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~---~kl~DFGl  557 (736)
                      +||||+++|+|.+.+.........+++..+..++.|++.||.|||++   +|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            99999999999988865433344588999999999999999999998   9999999999999987654   99999999


Q ss_pred             CccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          558 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       558 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                      ++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...     .+...    +..+..
T Consensus       180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~----i~~~~~  249 (351)
T 3c0i_A          180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEG----IIKGKY  249 (351)
T ss_dssp             CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-----HHHHH----HHHTCC
T ss_pred             eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-----HHHHH----HHcCCC
Confidence            98654432 223345699999999999999999999999999999999999999976431     11111    111111


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .  .++......    ...+.+++.+|++.||++|||+.|++++
T Consensus       250 ~--~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          250 K--MNPRQWSHI----SESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             C--CCHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             C--CCccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0  011101111    2458899999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=7.4e-41  Score=375.09  Aligned_cols=254  Identities=23%  Similarity=0.395  Sum_probs=207.0

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.+.+.||+|+||+||+|.+.++..||||+++... ...+.|.+|+.+|++++||||+++++++. .+..++||||+.+
T Consensus       189 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~  266 (454)
T 1qcf_A          189 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAK  266 (454)
T ss_dssp             GEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred             HeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCC
Confidence            345678999999999999999888999999997543 34677999999999999999999999987 5678999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       267 g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~  341 (454)
T 1qcf_A          267 GSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  341 (454)
T ss_dssp             CBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred             CcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence            9999999642  234578889999999999999999998   99999999999999999999999999998654322222


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      .....+|+.|+|||++....++.++|||||||++|||++ |+.||.+....    .+...+.    .+...         
T Consensus       342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~----~~~~~i~----~~~~~---------  404 (454)
T 1qcf_A          342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIRALE----RGYRM---------  404 (454)
T ss_dssp             TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHHH----HTCCC---------
T ss_pred             cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH----cCCCC---------
Confidence            233446889999999998999999999999999999999 99999865422    1222111    11100         


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      ..+......+.+++.+|++.||++|||+++|++.|+++.
T Consensus       405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence            011122346889999999999999999999999998763

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.5e-40  Score=352.11  Aligned_cols=260  Identities=21%  Similarity=0.282  Sum_probs=198.4

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||+|+||+||+|+..+++.||+|++......  ....+.+|++++++++||||+++++++.++...++||||++
T Consensus        23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~  102 (311)
T 3niz_A           23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME  102 (311)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred             hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence            4567899999999999999988999999998754322  23568899999999999999999999999999999999998


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      + +|.+.+...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus       103 ~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  174 (311)
T 3niz_A          103 K-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-  174 (311)
T ss_dssp             E-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred             C-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence            5 788877532   34588999999999999999999998   999999999999999999999999999986543322 


Q ss_pred             ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc---e----
Q 004689          568 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ---G----  639 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~---~----  639 (736)
                      ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+..    ........   .    
T Consensus       175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS----ILGTPNPREWPQVQEL  250 (311)
T ss_dssp             ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH----HHCCCCTTTSGGGTTS
T ss_pred             cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH----HHCCCChHHhhhhhcc
Confidence            2233468999999999876 5689999999999999999999999986553322222211    11111000   0    


Q ss_pred             ---------eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 ---------IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 ---------~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                               ..+.............++.+++.+|++.||++|||++|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                     000000000001122457899999999999999999999874

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.6e-40  Score=352.90  Aligned_cols=260  Identities=18%  Similarity=0.223  Sum_probs=207.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.+.+.||+|+||+||+|+.. +++.||||++....  ....+.+|+++++++ +||||+++++++...+..++||||+ 
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-   87 (330)
T 2izr_A           11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-   87 (330)
T ss_dssp             EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence            445789999999999999874 78999999986543  245688999999999 9999999999999999999999999 


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc-----EEEEeecCCcccc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFAV  562 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~-----~kl~DFGla~~~~  562 (736)
                      +++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.     +||+|||+++...
T Consensus        88 ~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           88 GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99999998643   35689999999999999999999998   9999999999999998887     9999999998654


Q ss_pred             CCCCc------ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          563 DGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       563 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      .....      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+......... ..
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-~~  240 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-TP  240 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-SC
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-CC
Confidence            43221      123467999999999999999999999999999999999999999875422211111111111110 00


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                      . +    .+...    .. ++.+++..|++.+|.+||++.+|.+.|+++....
T Consensus       241 ~-~----~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          241 I-E----VLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             H-H----HHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             H-H----HHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            0 0    00001    12 6889999999999999999999999999876543

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.4e-40  Score=348.28  Aligned_cols=258  Identities=21%  Similarity=0.334  Sum_probs=196.2

Q ss_pred             HHHHhhccccccCceEEEEEEECC----CcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      ..+.+.+.||+|+||.||+|.+..    +..||+|++..... .....+.+|+.++++++||||+++++++. ++..++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv   93 (281)
T 1mp8_A           15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   93 (281)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence            345567899999999999998753    45699999875432 23456889999999999999999999985 4567899


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      |||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        94 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           94 MELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccC
Confidence            9999999999998532   34588999999999999999999998   99999999999999999999999999998665


Q ss_pred             CCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      ...........+|+.|+|||++.+..++.++|||||||++|||++ |..||......    .+...+.    .+...   
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~----~~~~~i~----~~~~~---  236 (281)
T 1mp8_A          168 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRIE----NGERL---  236 (281)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHH----TTCCC---
T ss_pred             cccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH----HHHHHHH----cCCCC---
Confidence            443333344457889999999998899999999999999999997 99999765422    2222211    11111   


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                            ..+......+.+++.+|++.||++||++.|++++|++++..+
T Consensus       237 ------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          237 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                  011122345889999999999999999999999999987654

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=6.9e-41  Score=363.25  Aligned_cols=261  Identities=27%  Similarity=0.425  Sum_probs=206.8

Q ss_pred             HHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCC-e
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG-R  478 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~-~  478 (736)
                      ..+.+.+.||+|+||.||+|++.      +++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+.+ .
T Consensus        22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~  101 (359)
T 3vhe_A           22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  101 (359)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence            34556889999999999999742      467899999975432 2345689999999999 7999999999998755 4


Q ss_pred             EEEEEEecCCCCHHHHhhccccc---------------------------------------------------------
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLTH---------------------------------------------------------  501 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~~---------------------------------------------------------  501 (736)
                      .++||||+++|+|.+++......                                                         
T Consensus       102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (359)
T 3vhe_A          102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  181 (359)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred             eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence            89999999999999999754321                                                         


Q ss_pred             -----ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC-cceeccccc
Q 004689          502 -----EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGT  575 (736)
Q Consensus       502 -----~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt  575 (736)
                           ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....... .......||
T Consensus       182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t  258 (359)
T 3vhe_A          182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  258 (359)
T ss_dssp             --CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred             ccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence                 11288999999999999999999998   999999999999999999999999999986543322 233445689


Q ss_pred             ccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHH
Q 004689          576 VGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSM  654 (736)
Q Consensus       576 ~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  654 (736)
                      +.|+|||++.+..++.++|||||||++|||++ |+.||......+   .+..    .+..+...     .....    ..
T Consensus       259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~----~~~~~~~~-----~~~~~----~~  322 (359)
T 3vhe_A          259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EFCR----RLKEGTRM-----RAPDY----TT  322 (359)
T ss_dssp             GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---HHHH----HHHHTCCC-----CCCTT----CC
T ss_pred             ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH---HHHH----HHHcCCCC-----CCCCC----CC
Confidence            99999999999999999999999999999998 999997654221   1111    11111111     11111    22


Q ss_pred             HHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          655 WKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       655 ~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ..+.+++..|++.||.+|||+.||+++|++++.
T Consensus       323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            358899999999999999999999999999865

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.3e-41  Score=364.63  Aligned_cols=262  Identities=26%  Similarity=0.400  Sum_probs=208.2

Q ss_pred             HHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  480 (736)
                      ..+.+.+.||+|+||+||+|++.      +++.||||+++... ......+.+|+.++++++||||+++++++......+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            34556789999999999999853      46789999986542 334557889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhccc---ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC---cEEEEe
Q 004689          481 LVYEFMHNGTLKEHLYGTL---THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSD  554 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~---~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~---~~kl~D  554 (736)
                      +||||+++|+|.+++....   .....+++..++.++.|++.||.|||++   +|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence            9999999999999996543   1224589999999999999999999998   999999999999999554   599999


Q ss_pred             ecCCccccCC-CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhh
Q 004689          555 FGLSKFAVDG-ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       555 FGla~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      ||+++..... .........||+.|+|||++.+..++.++|||||||++|||++ |..||......    .+...    +
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~----~~~~~----i  299 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEF----V  299 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHH----H
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH----H
Confidence            9999754222 1222334568999999999999999999999999999999998 99999765421    12221    1


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                      ..+...         ..+......+.+++.+|++.+|++||++.||+++|+.+....
T Consensus       300 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          300 TSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HcCCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            111110         111122345889999999999999999999999999886543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1e-40  Score=377.78  Aligned_cols=254  Identities=28%  Similarity=0.424  Sum_probs=209.5

Q ss_pred             HHhhccccccCceEEEEEEECC-CcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.+.+.||+|+||.||+|.+.. +..||||+++... .....|.+|+.+|++++||||++++++|......++||||+++
T Consensus       222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~  300 (495)
T 1opk_A          222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY  300 (495)
T ss_dssp             EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCC
Confidence            4567899999999999999874 7899999987543 3356799999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       301 g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  375 (495)
T 1opk_A          301 GNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  375 (495)
T ss_dssp             CBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEEC
T ss_pred             CCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceee
Confidence            9999999643  234588999999999999999999998   99999999999999999999999999998764433333


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      .....+|+.|+|||++....++.++|||||||++|||++ |..||.+....    .+.+.+.    .+.         ..
T Consensus       376 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----~~~~~~~----~~~---------~~  438 (495)
T 1opk_A          376 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLE----KDY---------RM  438 (495)
T ss_dssp             CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHHH----TTC---------CC
T ss_pred             cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH----HHHHHHH----cCC---------CC
Confidence            333456789999999999999999999999999999999 99999865522    2222211    111         11


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      ..+......+.+++.+|++.||++|||+.||++.|+.+.
T Consensus       439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            112223346889999999999999999999999998763

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.4e-40  Score=354.76  Aligned_cols=255  Identities=23%  Similarity=0.375  Sum_probs=199.1

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCc----EEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~----~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      .+.+.+.||+|+||+||+|++. +++    .||+|.+.... ......+.+|+.++++++||||++++++|.... .++|
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v   94 (327)
T 3poz_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI   94 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEE
T ss_pred             HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEE
Confidence            3456789999999999999865 344    35888875432 234567899999999999999999999998765 7899


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      +||+.+|+|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        95 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           95 TQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            9999999999999643   35688999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          563 DGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       563 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||......    .+.....    .+..   
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~~----~~~~---  237 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILE----KGER---  237 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHH----TTCC---
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH----HHHHHHH----cCCC---
Confidence            33322 2233457889999999999999999999999999999999 99999765422    2222211    1110   


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                            ...+......+.+++.+|++.+|.+||++.||+++|+.+..
T Consensus       238 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          238 ------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             ------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                  01112233468899999999999999999999999998754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.7e-40  Score=348.71  Aligned_cols=259  Identities=27%  Similarity=0.408  Sum_probs=213.2

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      ..+.+.+.||+|+||+||+|.+. ++..||+|++.... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   91 (288)
T 3kfa_A           13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   91 (288)
T ss_dssp             GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence            34556789999999999999987 47889999987543 33567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++...  ....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus        92 ~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           92 TYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             TTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             CCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            999999999643  234588999999999999999999998   999999999999999999999999999987655444


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......    .+.......    .         
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~----~~~~~~~~~----~---------  229 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYELLEKD----Y---------  229 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHHHTT----C---------
T ss_pred             ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHhcc----C---------
Confidence            44444567889999999998999999999999999999999 99999765422    222221111    0         


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                      ....+......+.+++..|++.||.+||++.|+++.|+.+....
T Consensus       230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            01111122346889999999999999999999999999887643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.3e-41  Score=358.56  Aligned_cols=266  Identities=24%  Similarity=0.349  Sum_probs=208.8

Q ss_pred             HHHhhccccccCceEEEEEEE-----CCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeee--eCCeEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ--EEGRSVL  481 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~l  481 (736)
                      .+.+.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++.  +....++
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l  103 (327)
T 3lxl_A           24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL  103 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred             hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence            455678999999999999984     368899999998765555677999999999999999999999886  4567899


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       104 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          104 VMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence            99999999999998532   34589999999999999999999998   9999999999999999999999999999866


Q ss_pred             cCCCCc--ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccccc-------ccccHHHHHHHhh
Q 004689          562 VDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA-------NCRNIVQWAKLHI  632 (736)
Q Consensus       562 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~-------~~~~l~~~~~~~~  632 (736)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......       .............
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL  257 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence            443322  2233458889999999999899999999999999999999999986543110       0000111111111


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                      ..+         .....+......+.+++.+|++.||++|||+.|++++|+.+....
T Consensus       258 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          258 EEG---------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             hcc---------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            111         111122233456889999999999999999999999999886543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=360.20  Aligned_cols=246  Identities=25%  Similarity=0.352  Sum_probs=197.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      +.+.+.||+|+||+||+|+.. +++.||||+++...   ......+.+|..+++.+ +||||+++++++.+.+..++|||
T Consensus        25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E  104 (353)
T 3txo_A           25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME  104 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence            456789999999999999876 58999999997542   22345577899999988 79999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+++.....
T Consensus       105 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~  177 (353)
T 3txo_A          105 FVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN  177 (353)
T ss_dssp             CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence            9999999999853    45689999999999999999999998   9999999999999999999999999999753322


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+    +...    +..+..       
T Consensus       178 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~----~~~~----i~~~~~-------  241 (353)
T 3txo_A          178 -GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD----LFEA----ILNDEV-------  241 (353)
T ss_dssp             ---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH----HHHCCC-------
T ss_pred             -CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH----HHHH----HHcCCC-------
Confidence             223345679999999999999999999999999999999999999998655221    1111    111111       


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~ev~~~  681 (736)
                         .++......+.+++..|++.||++||++      .||++|
T Consensus       242 ---~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          242 ---VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             ---CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence               1111122357889999999999999998      777765

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.6e-40  Score=346.64  Aligned_cols=264  Identities=21%  Similarity=0.290  Sum_probs=197.5

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||+|+||+||+|+..+++.||+|++.....  .....+.+|++++++++||||+++++++...+..++||||+.
T Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (288)
T 1ob3_A            4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD   83 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred             chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence            345688999999999999998899999999865432  224568899999999999999999999999999999999998


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      + +|.+++...   ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++....... 
T Consensus        84 ~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (288)
T 1ob3_A           84 Q-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (288)
T ss_dssp             E-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             C-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence            5 898888532   35688899999999999999999998   999999999999999999999999999976533221 


Q ss_pred             ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC--Ccc--eecc
Q 004689          568 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG--DIQ--GIID  642 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~--~~~--~~~d  642 (736)
                      ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...........  ...  ..++
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            2233468999999999976 4589999999999999999999999976542211111111100000000  000  0011


Q ss_pred             CccC-------CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PSLL-------DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~l~-------~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +...       ..........+.+++.+|++.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            1110       01111223457899999999999999999999865

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-40  Score=352.80  Aligned_cols=250  Identities=18%  Similarity=0.298  Sum_probs=202.7

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      |.+.+.||+|+||+||+|... +++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus         7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g   85 (321)
T 1tki_A            7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence            456788999999999999876 57899999986443 3345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC--CCcEEEEeecCCccccCCCC
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~--~~~~kl~DFGla~~~~~~~~  566 (736)
                      |+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.  ++.+||+|||+++...... 
T Consensus        86 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           86 LDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            9999998532   34689999999999999999999998   9999999999999997  7899999999998664432 


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                       ......||+.|+|||++.+..++.++|||||||++|||++|..||......    .+...+.    .+...  .+....
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~i~----~~~~~--~~~~~~  227 (321)
T 1tki_A          159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ----QIIENIM----NAEYT--FDEEAF  227 (321)
T ss_dssp             -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHHH----HTCCC--CCHHHH
T ss_pred             -ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH----HHHHHHH----cCCCC--CChhhh
Confidence             233456999999999999888999999999999999999999999765421    1111111    11110  000001


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      ..    ....+.+++.+|+..||.+|||+.|++++-
T Consensus       228 ~~----~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          228 KE----ISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             cc----CCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence            11    124588999999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.2e-39  Score=357.31  Aligned_cols=254  Identities=22%  Similarity=0.291  Sum_probs=200.4

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      +.+.++||+|+||+||+|+.. +++.||||+++....   .....+..|..++.++ +||||+++++++.+.+..++|||
T Consensus        54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E  133 (396)
T 4dc2_A           54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE  133 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence            456789999999999999987 578899999976432   2345578899999887 89999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       134 ~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          134 YVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            9999999999853    45689999999999999999999998   9999999999999999999999999999853222


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccc-cccHHHHHHHhhhcCCcceeccC
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN-CRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...........+..+.+      
T Consensus       207 -~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------  279 (396)
T 4dc2_A          207 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------  279 (396)
T ss_dssp             -TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred             -CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence             2234456799999999999999999999999999999999999999975432111 11112222222222221      


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~ev~~~  681 (736)
                      .    ++......+.+++.+|++.||++||++      .||+++
T Consensus       280 ~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          280 R----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             C----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             C----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            1    111123457899999999999999985      566655

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.3e-40  Score=354.31  Aligned_cols=250  Identities=22%  Similarity=0.356  Sum_probs=199.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||+|+||+||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++.+++..++||||++
T Consensus         9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~   88 (323)
T 3tki_A            9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   88 (323)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence            446789999999999999876 789999999865432 234678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC-C
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-S  566 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~-~  566 (736)
                      +|+|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... .
T Consensus        89 ~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           89 GGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             TEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             CCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999884    345689999999999999999999998   99999999999999999999999999997653222 2


Q ss_pred             cceecccccccccCccccccCcC-CCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......  ......|...    ...   ..   
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~~~~~~----~~~---~~---  229 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWKEK----KTY---LN---  229 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT--SHHHHHHHTT----CTT---ST---
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHHhcc----ccc---CC---
Confidence            22334579999999999987765 77899999999999999999999765421  1112222111    000   00   


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                         ........+.+++.+|++.||++|||+.|++++
T Consensus       230 ---~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence               001123457889999999999999999999876

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.7e-40  Score=352.94  Aligned_cols=254  Identities=23%  Similarity=0.398  Sum_probs=200.6

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcE----EEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKE----IAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~----vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      +.+.+.||+|+||+||+|.+. +++.    ||+|++.... ......+.+|+.++++++||||+++++++. .+..++||
T Consensus        15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~   93 (325)
T 3kex_A           15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT   93 (325)
T ss_dssp             EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred             ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence            445789999999999999875 3443    7888875443 334567889999999999999999999986 45689999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+.+|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus        94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           94 QYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             ECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            999999999998643   35688889999999999999999998   999999999999999999999999999987644


Q ss_pred             CCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          564 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       564 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      .... ......||..|+|||++.+..++.++|||||||++|||++ |+.||......    .+....    ..+....  
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~----~~~~~~~--  237 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA----EVPDLL----EKGERLA--  237 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT----HHHHHH----HTTCBCC--
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH----HHHHHH----HcCCCCC--
Confidence            3322 2344568889999999999999999999999999999999 99999865422    222211    1111100  


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                             .+......+.+++.+|++.||.+||++.|++++|+.+..
T Consensus       238 -------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          238 -------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                   011112247789999999999999999999999998754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.9e-40  Score=365.06  Aligned_cols=252  Identities=23%  Similarity=0.324  Sum_probs=202.5

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      ..|.+.+.||+|+||+||+|... +|+.||+|++.....  .....+.+|++++++++||||+++++++.+++..++|||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E   90 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD   90 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence            45667889999999999999875 689999999875432  234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc---CCCcEEEEeecCCccc
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFA  561 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~---~~~~~kl~DFGla~~~  561 (736)
                      |+.+|+|.+.+..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++   .++.+||+|||+++..
T Consensus        91 ~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~  163 (444)
T 3soa_A           91 LVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV  163 (444)
T ss_dssp             CCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred             eCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence            9999999998853    35689999999999999999999998   999999999999998   4578999999999765


Q ss_pred             cCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      ..... ......||+.|+|||++.+..++.++||||+||++|||++|..||.+....    .+...    +..+...  +
T Consensus       164 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~----~~~~~----i~~~~~~--~  232 (444)
T 3soa_A          164 EGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH----RLYQQ----IKAGAYD--F  232 (444)
T ss_dssp             CTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHH----HHHTCCC--C
T ss_pred             cCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH----HHHHH----HHhCCCC--C
Confidence            44322 223457999999999999999999999999999999999999999765421    12111    1122111  0


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .......    ....+.+++..|++.||++|||+.|++++
T Consensus       233 ~~~~~~~----~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          233 PSPEWDT----VTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CTTTTTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             Ccccccc----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            0111111    22458899999999999999999999886

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=6.4e-40  Score=366.96  Aligned_cols=249  Identities=28%  Similarity=0.428  Sum_probs=203.4

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCC-eEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG-RSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-~~~lV~e~~~~  488 (736)
                      +.+.+.||+|+||.||+|.+. ++.||||+++...  ..+.|.+|+.+|++++||||+++++++.... ..++||||+++
T Consensus       195 ~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~  271 (450)
T 1k9a_A          195 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK  271 (450)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTT
T ss_pred             eEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCC
Confidence            345789999999999999987 7899999997543  4567999999999999999999999987665 78999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.....    
T Consensus       272 g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----  342 (450)
T 1k9a_A          272 GSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  342 (450)
T ss_dssp             CBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             CcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc----
Confidence            9999999643  123478889999999999999999998   9999999999999999999999999999754221    


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||......    .+...+    ..+..         .
T Consensus       343 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~~~~i----~~~~~---------~  405 (450)
T 1k9a_A          343 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPRV----EKGYK---------M  405 (450)
T ss_dssp             ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT----THHHHH----HTTCC---------C
T ss_pred             ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHH----HcCCC---------C
Confidence            122357899999999999999999999999999999998 99999866532    222211    12211         0


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ..+......+.+++..|++.||++|||+.||++.|+.+..
T Consensus       406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            1112233468899999999999999999999999998754

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.1e-40  Score=365.21  Aligned_cols=249  Identities=22%  Similarity=0.270  Sum_probs=201.9

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+.+.||+|+||+||+|+.. +++.||+|+++...   ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus        72 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~  151 (410)
T 3v8s_A           72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM  151 (410)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            34678999999999999987 58899999986532   223456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++..     ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++++||+|||+++.......
T Consensus       152 ~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          152 PGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             TTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred             CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence            99999998853     3588889999999999999999998   999999999999999999999999999986654443


Q ss_pred             cceecccccccccCccccccCc----CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQ----LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~----~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||......+....+..+....    ...    
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~----~~p----  295 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL----TFP----  295 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC----CCC----
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc----cCC----
Confidence            3444667999999999998655    8899999999999999999999998665332222222211110    000    


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~  681 (736)
                       . ...    ....+.+++.+|+..+|.+  ||+++||++|
T Consensus       296 -~-~~~----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          296 -D-DND----ISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             -T-TCC----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             -C-ccc----ccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence             0 011    1235788999999999988  9999999887

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-40  Score=354.63  Aligned_cols=263  Identities=25%  Similarity=0.384  Sum_probs=207.0

Q ss_pred             HHHHhhccccccCceEEEEEEE------CCCcEEEEEEeccCC-cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~------~~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  479 (736)
                      ..+.+.+.||+|+||.||+|.+      .++..||||++.... ......+.+|+.+++++ +||||+++++++...+..
T Consensus        45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  124 (344)
T 1rjb_A           45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  124 (344)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCcc
Confidence            4455678999999999999986      245689999997543 23456789999999999 899999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhccccc-------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCC
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTH-------------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS  540 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~  540 (736)
                      ++||||+++|+|.+++......                   ...+++..++.++.|++.||.|||+.   +|+||||||+
T Consensus       125 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~  201 (344)
T 1rjb_A          125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR  201 (344)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred             EEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChh
Confidence            9999999999999999654211                   13478999999999999999999998   9999999999


Q ss_pred             CEEEcCCCcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccc
Q 004689          541 NILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFG  618 (736)
Q Consensus       541 NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~  618 (736)
                      |||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  281 (344)
T 1rjb_A          202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  281 (344)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH
Confidence            999999999999999999865443322 2334567899999999999999999999999999999998 99999765422


Q ss_pred             cccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          619 ANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       619 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                      .   .+...    ...+..         ...+......+.+++..|++.||.+||++.||+++|+.++...
T Consensus       282 ~---~~~~~----~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          282 A---NFYKL----IQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             H---HHHHH----HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             H---HHHHH----HhcCCC---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            1   11111    111110         0111122346889999999999999999999999999886543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-40  Score=343.88  Aligned_cols=254  Identities=28%  Similarity=0.454  Sum_probs=207.8

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.+.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus        10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   88 (267)
T 3t9t_A           10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG   88 (267)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred             eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence            446788999999999999998889999999975543 3467899999999999999999999999999999999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +|.+++...   ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++..........
T Consensus        89 ~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           89 CLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             BHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             cHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence            999998542   34588999999999999999999998   999999999999999999999999999976543222222


Q ss_pred             ecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      ....||+.|+|||++.+..++.++||||||+++|||++ |+.||......    .+...    +..+..     ..    
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~----i~~~~~-----~~----  225 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS----EVVED----ISTGFR-----LY----  225 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHH----HHTTCC-----CC----
T ss_pred             ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH----HHHHH----HhcCCc-----CC----
Confidence            33457889999999998899999999999999999999 89999765421    11111    111110     00    


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      .+......+.+++.+|++.+|++||++.|++++|+++..
T Consensus       226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            011123458899999999999999999999999998853

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=6.8e-40  Score=356.19  Aligned_cols=252  Identities=24%  Similarity=0.353  Sum_probs=203.4

Q ss_pred             HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      ...|.+.+.||+|+||.||+|... +++.||+|++.....  .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            345667889999999999999876 689999999975432  23456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC---CcEEEEeecCCcc
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKF  560 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~---~~~kl~DFGla~~  560 (736)
                      ||+.+|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.+   +.+||+|||+++.
T Consensus       108 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          108 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             CCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999998853    34688999999999999999999998   99999999999999865   4599999999986


Q ss_pred             ccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|..||......    .+...    +..+...  
T Consensus       181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----~~~~~----i~~~~~~--  248 (362)
T 2bdw_A          181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQ----IKAGAYD--  248 (362)
T ss_dssp             CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----HHHTCCC--
T ss_pred             ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHHH----HHhCCCC--
Confidence            54332  223456999999999999989999999999999999999999999765421    12221    1112111  


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +......    .....+.+++.+|++.||++||++.|++++
T Consensus       249 ~~~~~~~----~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          249 YPSPEWD----TVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CCTTGGG----GSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCccccc----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000011    123457899999999999999999999875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.9e-40  Score=365.90  Aligned_cols=252  Identities=23%  Similarity=0.301  Sum_probs=203.5

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+.++||+|+||+||+|+.. +++.||||++....   ......+.+|+.++..++||||++++++|.+.+..++||||+
T Consensus        77 ~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~  156 (437)
T 4aw2_A           77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYY  156 (437)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecC
Confidence            34688999999999999987 47889999997532   122345889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.......
T Consensus       157 ~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~  230 (437)
T 4aw2_A          157 VGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  230 (437)
T ss_dssp             TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             CCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence            999999999642   35689999999999999999999998   999999999999999999999999999986655444


Q ss_pred             cceecccccccccCccccc-----cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          567 HVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||......+....+..+....    .+    
T Consensus       231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~----~~----  302 (437)
T 4aw2_A          231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERF----QF----  302 (437)
T ss_dssp             EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC----CC----
T ss_pred             cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccc----cC----
Confidence            4445567999999999997     4678999999999999999999999998665333332332221111    11    


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHM--RPSISEVLKD  681 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~  681 (736)
                       +......    ...+.+++.+|+..+|++  ||+++|++++
T Consensus       303 -p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          303 -PTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             -CSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             -CcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence             1111112    234788999999888887  9999999876

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.3e-40  Score=344.04  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=207.9

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.+.+.||+|+||.||+|...++..||||++.... .....+.+|++++++++||||+++++++.. +..++||||+++
T Consensus        14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~   91 (279)
T 1qpc_A           14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN   91 (279)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCC
Confidence            445678999999999999999888899999987543 335678999999999999999999999874 457999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      ++|.+++...  ....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        92 ~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  166 (279)
T 1qpc_A           92 GSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (279)
T ss_dssp             CBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             CCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence            9999998532  223689999999999999999999998   99999999999999999999999999998665443333


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||......    .+...    +..+..     ..   
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~----~~~~~~-----~~---  230 (279)
T 1qpc_A          167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP----EVIQN----LERGYR-----MV---  230 (279)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHH----HHTTCC-----CC---
T ss_pred             ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH----HHHHH----HhcccC-----CC---
Confidence            334457889999999998889999999999999999999 99999765421    12111    111110     00   


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                       .+......+.+++..|++.+|++|||+.++++.|+++...
T Consensus       231 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence             1112234688999999999999999999999999998654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.5e-40  Score=344.11  Aligned_cols=250  Identities=30%  Similarity=0.431  Sum_probs=191.9

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCcc----cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.+.||+|+||.||+|.+. ++.||||+++.....    ..+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         9 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (271)
T 3dtc_A            9 LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF   87 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEEC
T ss_pred             eeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEc
Confidence            446789999999999999986 899999998754322    235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC--------CCcEEEEeecC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--------HMRAKVSDFGL  557 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~--------~~~~kl~DFGl  557 (736)
                      +++++|.+++.     ...+++..++.++.|++.||.|||+++..+|+||||||+|||++.        ++.+||+|||+
T Consensus        88 ~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~  162 (271)
T 3dtc_A           88 ARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL  162 (271)
T ss_dssp             CTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred             CCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence            99999999884     346889999999999999999999983223999999999999986        77899999999


Q ss_pred             CccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          558 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       558 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                      ++.......   ....||+.|+|||.+.+..++.++||||||+++|||++|+.||......    ....   .. .....
T Consensus       163 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~---~~-~~~~~  231 (271)
T 3dtc_A          163 AREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL----AVAY---GV-AMNKL  231 (271)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH----HHHH---HH-HTSCC
T ss_pred             ccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH---hh-hcCCC
Confidence            975533222   2346899999999999989999999999999999999999999765411    1111   11 11111


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                      .        ...+......+.+++.+|++.||.+|||+.|++++|++
T Consensus       232 ~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          232 A--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             C--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             C--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            1        11112223468899999999999999999999999975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=343.77  Aligned_cols=247  Identities=25%  Similarity=0.348  Sum_probs=193.1

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--------------------------cchhhhhHHHHHhhcC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------------------------GKREFTNEVTLLSRIH  462 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--------------------------~~~~~~~E~~il~~l~  462 (736)
                      |.+.+.||+|+||.||+|+.. +++.||||++......                          ....+.+|++++++++
T Consensus        15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   94 (298)
T 2zv2_A           15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD   94 (298)
T ss_dssp             EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred             eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence            456789999999999999875 6889999998654311                          1356889999999999


Q ss_pred             CCceeeEeeeeee--CCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCC
Q 004689          463 HRNLVQFLGYCQE--EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSS  540 (736)
Q Consensus       463 HpnIv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~  540 (736)
                      ||||+++++++.+  ....++||||+++|+|.+++.     ...+++..+..++.|++.||.|||+.   +|+||||||+
T Consensus        95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~  166 (298)
T 2zv2_A           95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPS  166 (298)
T ss_dssp             CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGG
T ss_pred             CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence            9999999999986  568899999999999987542     34689999999999999999999998   9999999999


Q ss_pred             CEEEcCCCcEEEEeecCCccccCCCCcceecccccccccCccccccCc---CCCcchhHHHHHHHHHHHhCCCcCccccc
Q 004689          541 NILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEKF  617 (736)
Q Consensus       541 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~~DVwSlGvvl~elltG~~p~~~~~~  617 (736)
                      |||++.++.+||+|||+++....... ......||+.|+|||.+.+..   ++.++|||||||++|||++|+.||.....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            99999999999999999986543322 233456999999999997654   47789999999999999999999975441


Q ss_pred             ccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          618 GANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       618 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                             ..... .+........    ....    ....+.+++.+|++.||++||++.|++++
T Consensus       246 -------~~~~~-~~~~~~~~~~----~~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          246 -------MCLHS-KIKSQALEFP----DQPD----IAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             -------HHHHH-HHHHCCCCCC----SSSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             -------HHHHH-HHhcccCCCC----Cccc----cCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence                   11111 1111111100    0111    22358899999999999999999999765

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.7e-40  Score=371.76  Aligned_cols=254  Identities=25%  Similarity=0.428  Sum_probs=201.8

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.+.+.||+|+||.||+|.+..+..||||+++... .....|.+|+++|++++||||+++++++.+ +..++||||+++
T Consensus       185 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~  262 (452)
T 1fmk_A          185 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK  262 (452)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred             HceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence            345678999999999999999888889999987543 235679999999999999999999999876 678999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       263 gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  337 (452)
T 1fmk_A          263 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  337 (452)
T ss_dssp             CBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence            9999999532  234588999999999999999999998   99999999999999999999999999998664433333


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      .....+|..|+|||.+.+..++.++|||||||++|||++ |+.||.+....    .+..    .+..+..         .
T Consensus       338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~----~~~~----~i~~~~~---------~  400 (452)
T 1fmk_A          338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLD----QVERGYR---------M  400 (452)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHH----HHHTTCC---------C
T ss_pred             ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH----HHHH----HHHcCCC---------C
Confidence            334457889999999999999999999999999999999 99999765421    1211    1112210         0


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      ..+......+.+++.+|++.||++|||+++|++.|+++.
T Consensus       401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            111223346889999999999999999999999998764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-40  Score=357.73  Aligned_cols=251  Identities=21%  Similarity=0.328  Sum_probs=204.4

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .|.+.+.||+|+||.||+|... +++.||+|++..........+.+|+.+|++++||||+++++++.+....++||||+.
T Consensus        52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~  131 (387)
T 1kob_A           52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS  131 (387)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence            3556789999999999999876 688999999976655455678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC--CCcEEEEeecCCccccCCC
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~--~~~~kl~DFGla~~~~~~~  565 (736)
                      +|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.  ++.+||+|||+++......
T Consensus       132 gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          132 GGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            99999998532   34689999999999999999999998   9999999999999974  4789999999998654332


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                        ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....    .....+.    ....  .+++..
T Consensus       206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~----~~~~~i~----~~~~--~~~~~~  273 (387)
T 1kob_A          206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVK----RCDW--EFDEDA  273 (387)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHHHH----HCCC--CCCSST
T ss_pred             --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH----HHHHHHH----hCCC--CCCccc
Confidence              233446999999999999999999999999999999999999999765421    1111111    1111  011111


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....    ...+.+++..|++.||++|||+.|++++
T Consensus       274 ~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          274 FSSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             TTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccC----CHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            1122    3458899999999999999999999876

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.7e-40  Score=352.77  Aligned_cols=245  Identities=22%  Similarity=0.352  Sum_probs=200.1

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||.||+|.+. +++.||||++....   ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus        11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~   90 (336)
T 3h4j_B           11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY   90 (336)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence            456789999999999999974 78999999986432   22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      + +|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        91 ~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           91 A-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             C-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             C-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9 6899888843    45689999999999999999999998   99999999999999999999999999998654332


Q ss_pred             CcceecccccccccCccccccCcC-CCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                        .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...........+                 ...
T Consensus       163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-----------------~~~  223 (336)
T 3h4j_B          163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV-----------------NSC  223 (336)
T ss_dssp             --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC-----------------CSS
T ss_pred             --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH-----------------HcC
Confidence              2234569999999999988776 67999999999999999999999865432221111                 000


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      . ...+......+.+++.+|++.||.+|||+.|++++-
T Consensus       224 ~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          224 V-YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             C-CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred             C-CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence            0 001111234578999999999999999999998874

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-40  Score=357.37  Aligned_cols=259  Identities=25%  Similarity=0.423  Sum_probs=207.6

Q ss_pred             HHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      .+.+.+.||+|+||.||+|+..      +++.||||+++.... .....+.+|+.++++++||||+++++++...+..++
T Consensus        48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  127 (343)
T 1luf_A           48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL  127 (343)
T ss_dssp             GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence            3456788999999999999875      347899999975432 234678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhccccc--------------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCC
Q 004689          482 VYEFMHNGTLKEHLYGTLTH--------------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN  541 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~N  541 (736)
                      ||||+++|+|.+++......                    ...+++..++.++.|++.||.|||++   +|+||||||+|
T Consensus       128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~N  204 (343)
T 1luf_A          128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRN  204 (343)
T ss_dssp             EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcce
Confidence            99999999999999653211                    25689999999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEEeecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCccccccc
Q 004689          542 ILLDKHMRAKVSDFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGA  619 (736)
Q Consensus       542 ILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~  619 (736)
                      ||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||...... 
T Consensus       205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-  283 (343)
T 1luf_A          205 CLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-  283 (343)
T ss_dssp             EEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-
T ss_pred             EEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH-
Confidence            9999999999999999975432221 22234568999999999998899999999999999999999 99999765421 


Q ss_pred             ccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          620 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       620 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                         .+..    .+..+....         .+......+.+++..|++.||++||++.||+++|+++..
T Consensus       284 ---~~~~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          284 ---EVIY----YVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             ---HHHH----HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ---HHHH----HHhCCCcCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence               1211    222222211         111223468899999999999999999999999998754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3e-40  Score=352.48  Aligned_cols=262  Identities=24%  Similarity=0.357  Sum_probs=206.5

Q ss_pred             HhhccccccCceEEEEEEEC-----CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeC--CeEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-----DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLV  482 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-----~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV  482 (736)
                      .+.+.||+|+||+||++.+.     +++.||||+++.... .....+.+|++++++++||||+++++++.+.  ...++|
T Consensus        34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv  113 (318)
T 3lxp_A           34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV  113 (318)
T ss_dssp             EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred             hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence            56789999999999998753     578999999976532 3356689999999999999999999999874  678999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      |||+++|+|.+++..     ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       114 ~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          114 MEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             ECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            999999999999853     3488999999999999999999998   99999999999999999999999999998665


Q ss_pred             CCCCc--ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccccc-----ccccH--HHHHHHhhh
Q 004689          563 DGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA-----NCRNI--VQWAKLHIE  633 (736)
Q Consensus       563 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~-----~~~~l--~~~~~~~~~  633 (736)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......     .....  .........
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            43322  2234458889999999999899999999999999999999999987543110     00000  001111111


Q ss_pred             cCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          634 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       634 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                      .         ......+......+.+++.+|++.||++|||+.|+++.|+.+....
T Consensus       266 ~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          266 R---------GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             T---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             c---------ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            1         1111122233456899999999999999999999999999886544

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.5e-40  Score=349.54  Aligned_cols=260  Identities=26%  Similarity=0.393  Sum_probs=209.3

Q ss_pred             HHHhhccccccCceEEEEEEE------CCCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~------~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~  480 (736)
                      .+.+.+.||+|+||.||+|++      .+++.||||+++.... .....+.+|+.+++++ +||||+++++++...+..+
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~  103 (313)
T 1t46_A           24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL  103 (313)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence            455678999999999999985      2467899999975533 2346788999999999 9999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccc--------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 004689          481 LVYEFMHNGTLKEHLYGTLT--------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK  546 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~  546 (736)
                      +||||+++|+|.+++.....              ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  180 (313)
T 1t46_A          104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH  180 (313)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEET
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcC
Confidence            99999999999999965421              123489999999999999999999998   9999999999999999


Q ss_pred             CCcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccH
Q 004689          547 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI  624 (736)
Q Consensus       547 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l  624 (736)
                      ++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.......   .+
T Consensus       181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~  257 (313)
T 1t46_A          181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---KF  257 (313)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---HH
T ss_pred             CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh---HH
Confidence            999999999999866544332 2234457889999999999999999999999999999999 999997654221   11


Q ss_pred             HHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          625 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       625 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      .....    .+. .    .    ..+......+.+++.+|++.||.+|||+.|++++|++++.
T Consensus       258 ~~~~~----~~~-~----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  307 (313)
T 1t46_A          258 YKMIK----EGF-R----M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (313)
T ss_dssp             HHHHH----HTC-C----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHhc----cCC-C----C----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            11111    111 0    0    0111223458899999999999999999999999998864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.2e-40  Score=356.57  Aligned_cols=247  Identities=23%  Similarity=0.361  Sum_probs=196.7

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      .+.||+|+||.||+|... +|+.||+|+++.........+.+|++++++++||||+++++++...+..++||||+++|+|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            467999999999999875 6899999999876555567899999999999999999999999999999999999999999


Q ss_pred             HHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE--cCCCcEEEEeecCCccccCCCCcce
Q 004689          492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       492 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl--~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      .+++..   ....+++..++.++.|++.||.|||+.   +|+||||||+|||+  +.++.+||+|||+++.......  .
T Consensus       174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~  245 (373)
T 2x4f_A          174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L  245 (373)
T ss_dssp             HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred             HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence            998853   234688999999999999999999998   99999999999999  5678999999999986543322  2


Q ss_pred             ecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcC
Q 004689          570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY  649 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  649 (736)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.    .   ...... ...  +.......+
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----~---~~i~~~-~~~--~~~~~~~~~  315 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET----L---NNILAC-RWD--LEDEEFQDI  315 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----H---HHHHHT-CCC--SCSGGGTTS
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH----H---HHHHhc-cCC--CChhhhccC
Confidence            334699999999999988999999999999999999999999976542211    1   111111 100  011111112


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          650 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       650 ~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          ...+.+++.+|++.||.+||++.|++++
T Consensus       316 ----~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          316 ----SEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             ----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                2458899999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.2e-40  Score=355.96  Aligned_cols=267  Identities=16%  Similarity=0.235  Sum_probs=204.7

Q ss_pred             HHHhhccccccCceEEEEEEECC------CcEEEEEEeccCCccc-----------chhhhhHHHHHhhcCCCceeeEee
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQG-----------KREFTNEVTLLSRIHHRNLVQFLG  471 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~------~~~vAvK~l~~~~~~~-----------~~~~~~E~~il~~l~HpnIv~l~~  471 (736)
                      .|.+.+.||+|+||+||+|.+..      ++.||||++.......           ...+..|+..++.++||||+++++
T Consensus        36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~  115 (364)
T 3op5_A           36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG  115 (364)
T ss_dssp             EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred             eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence            45667899999999999998864      4789999987543211           112334566677788999999999


Q ss_pred             eeeeC----CeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc--
Q 004689          472 YCQEE----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--  545 (736)
Q Consensus       472 ~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~--  545 (736)
                      ++...    ...++||||+ +++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred             eeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence            98764    4589999999 99999998642   35689999999999999999999998   999999999999999  


Q ss_pred             CCCcEEEEeecCCccccCCCCc------ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccccc
Q 004689          546 KHMRAKVSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA  619 (736)
Q Consensus       546 ~~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~  619 (736)
                      .++.+||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... 
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~-  267 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD-  267 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence            8899999999999765332211      113345999999999999999999999999999999999999999864322 


Q ss_pred             ccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          620 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       620 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                        .....+...... ..+..++++.+...   .....+.+++..|++.+|.+||++.+|++.|++++...
T Consensus       268 --~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~  331 (364)
T 3op5_A          268 --PKYVRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI  331 (364)
T ss_dssp             --HHHHHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             --HHHHHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence              122222222211 12334444443221   12245888999999999999999999999999987643

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.6e-39  Score=341.19  Aligned_cols=260  Identities=17%  Similarity=0.227  Sum_probs=207.7

Q ss_pred             HHhhccccccCceEEEEEEE-CCCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||+|+||.||+|.. .+++.||||++....  ....+.+|+.+++++ +|+|++++++++......++||||+ 
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   88 (298)
T 1csn_A           12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   88 (298)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence            45678999999999999986 478999999986432  345688999999999 7999999999999999999999999 


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc-----EEEEeecCCcccc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFAV  562 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~-----~kl~DFGla~~~~  562 (736)
                      +++|.+++...   ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.     +||+|||+++...
T Consensus        89 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           89 GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99999999643   34589999999999999999999998   9999999999999987776     9999999998654


Q ss_pred             CCCCc------ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          563 DGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       563 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      .....      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .............
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~  241 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-KYERIGEKKQSTP  241 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-HHHHHHHHHHHSC
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH-HHHHHHhhccCcc
Confidence            43221      2344569999999999999999999999999999999999999998754222111 1111111111111


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                      ...     +...    ....+.+++..|++.||++||++++|++.|++++..
T Consensus       242 ~~~-----~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          242 LRE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             HHH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHH-----HHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            110     0111    234688999999999999999999999999998653

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.2e-39  Score=343.30  Aligned_cols=261  Identities=20%  Similarity=0.238  Sum_probs=196.8

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      |.+.+.||+|+||+||+|+.. +++.||||++......  ....+.+|+.++++++||||+++++++.+++..++||||+
T Consensus         4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   83 (292)
T 3o0g_A            4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence            345688999999999999886 6889999999755332  2356889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .+ ++.+.+..   ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus        84 ~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  155 (292)
T 3o0g_A           84 DQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-  155 (292)
T ss_dssp             SE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred             CC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence            86 55555532   235689999999999999999999998   99999999999999999999999999998654322 


Q ss_pred             cceecccccccccCccccccCc-CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhc---CCcceec-
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---GDIQGII-  641 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~-  641 (736)
                      .......||+.|+|||++.+.. ++.++|||||||++|||++|..|+......   .............   ....... 
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH---HHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHHhCCCChhhhhhhcc
Confidence            2233456899999999998765 899999999999999999988886433211   1111111111111   0000000 


Q ss_pred             --c---------CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          642 --D---------PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       642 --d---------~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        +         ..............+.+++.+|++.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence              0         000001111233467899999999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-40  Score=349.20  Aligned_cols=243  Identities=23%  Similarity=0.375  Sum_probs=200.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.+.||+|+||.||+|+.. +|+.||+|+++...   ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~   87 (318)
T 1fot_A            8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   87 (318)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence            345789999999999999886 68999999987542   12345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..... 
T Consensus        88 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           88 IEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             CCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             CCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            999999999853    34688999999999999999999998   9999999999999999999999999999865332 


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                         ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.       ..... .+.+      ..
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~i~-~~~~------~~  222 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------YEKIL-NAEL------RF  222 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHH-HCCC------CC
T ss_pred             ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHH-hCCC------CC
Confidence               2345799999999999999999999999999999999999999976542111       11111 1111      11


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                      ...+    ...+.+++.+|++.||++||     +++||+++
T Consensus       223 p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          223 PPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             CTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            1122    23578999999999999999     88998876

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5e-40  Score=351.23  Aligned_cols=261  Identities=24%  Similarity=0.377  Sum_probs=194.9

Q ss_pred             HHHHhhccccccCceEEEEEEECCC----cEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeE--
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLKDG----KEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS--  479 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~~~----~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~--  479 (736)
                      ..+.+.+.||+|+||+||+|++...    ..||||+++...  ......+.+|++++++++||||+++++++......  
T Consensus        23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (323)
T 3qup_A           23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR  102 (323)
T ss_dssp             --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred             hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence            3456788999999999999987643    279999987542  23356789999999999999999999999877655  


Q ss_pred             ----EEEEEecCCCCHHHHhhcccc--cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE
Q 004689          480 ----VLVYEFMHNGTLKEHLYGTLT--HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS  553 (736)
Q Consensus       480 ----~lV~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~  553 (736)
                          ++||||+.+|+|.+++.....  ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus       103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~  179 (323)
T 3qup_A          103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVA  179 (323)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred             CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEe
Confidence                999999999999999854321  122588999999999999999999998   99999999999999999999999


Q ss_pred             eecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHh
Q 004689          554 DFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH  631 (736)
Q Consensus       554 DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~  631 (736)
                      |||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......    .+.....  
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~~~~--  253 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA----EIYNYLI--  253 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHH--
T ss_pred             eccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH----HHHHHHh--
Confidence            99999865433221 2233457889999999999999999999999999999999 99999865422    2222111  


Q ss_pred             hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                        .+..         ...+......+.+++.+|++.||++|||+.|+++.|++++..
T Consensus       254 --~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          254 --GGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             --TTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --cCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence              1110         011122234688999999999999999999999999998753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.3e-39  Score=347.39  Aligned_cols=267  Identities=22%  Similarity=0.293  Sum_probs=191.2

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .|.+.+.||+|+||+||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   85 (317)
T 2pmi_A            6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM   85 (317)
T ss_dssp             -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred             ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence            3556789999999999999876 689999999875532 23467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhccc--ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          487 HNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       487 ~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      + |+|.+++....  .....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            8 59999885432  1224588999999999999999999998   9999999999999999999999999999865432


Q ss_pred             CCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce----
Q 004689          565 ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG----  639 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~----  639 (736)
                      .. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+.+..... .......    
T Consensus       162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~  239 (317)
T 2pmi_A          162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP-NESLWPSVTKL  239 (317)
T ss_dssp             CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC-CTTTCGGGGGC
T ss_pred             cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC-ChhHhhhhhhh
Confidence            22 2234468999999999976 468999999999999999999999998655322111111110000 0000000    


Q ss_pred             -eccCccCC------------cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 -IIDPSLLD------------EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 -~~d~~l~~------------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       ...+.+..            .........+.+++.+|++.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence             00000000            0001122468899999999999999999999875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.3e-40  Score=350.15  Aligned_cols=250  Identities=23%  Similarity=0.327  Sum_probs=196.0

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCC---------
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG---------  477 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---------  477 (736)
                      .|.+.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.+|++++||||+++++++.+..         
T Consensus         7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~   86 (332)
T 3qd2_B            7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD   86 (332)
T ss_dssp             HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred             cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence            4556789999999999999987 789999999975432 33567899999999999999999999986543         


Q ss_pred             ------------------------------------------------eEEEEEEecCCCCHHHHhhcccccccccCHHH
Q 004689          478 ------------------------------------------------RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIK  509 (736)
Q Consensus       478 ------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~  509 (736)
                                                                      ..++||||+++|+|.+++.... ......+..
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~  165 (332)
T 3qd2_B           87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHGV  165 (332)
T ss_dssp             C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHHH
T ss_pred             hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhHH
Confidence                                                            3799999999999999997543 234456777


Q ss_pred             HHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC-----------cceecccccccc
Q 004689          510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS-----------HVSSIVRGTVGY  578 (736)
Q Consensus       510 ~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~Y  578 (736)
                      ++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.......           .......||+.|
T Consensus       166 ~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            899999999999999998   999999999999999999999999999986544321           122335699999


Q ss_pred             cCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHH
Q 004689          579 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIE  658 (736)
Q Consensus       579 ~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  658 (736)
                      +|||++.+..++.++|||||||++|||++|..|+....      .+..    ........         .........+.
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~------~~~~----~~~~~~~~---------~~~~~~~~~~~  303 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV------RIIT----DVRNLKFP---------LLFTQKYPQEH  303 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH------HHHH----HHHTTCCC---------HHHHHHCHHHH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH------HHHH----HhhccCCC---------cccccCChhHH
Confidence            99999999999999999999999999999977653221      1111    11111111         01122334578


Q ss_pred             HHHhhccCCCCCCCCCHHHHHHH
Q 004689          659 EKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       659 ~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +++.+|++.||++|||+.|++++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHccCCCCcCCCHHHHhhc
Confidence            89999999999999999999874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=7.9e-40  Score=342.55  Aligned_cols=258  Identities=23%  Similarity=0.369  Sum_probs=203.6

Q ss_pred             HHhhccccccCceEEEEEEECC----CcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      +.+.+.||+|+||+||+|.+..    +..||+|++.... ......+.+|+.++++++||||+++++++.++ ..++|||
T Consensus        14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e   92 (281)
T 3cc6_A           14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIME   92 (281)
T ss_dssp             EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEE
T ss_pred             eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEe
Confidence            4567899999999999998652    3469999987653 23456789999999999999999999998754 5689999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++++|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        93 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  166 (281)
T 3cc6_A           93 LYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE  166 (281)
T ss_dssp             CCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred             cCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence            99999999998532   34588999999999999999999998   9999999999999999999999999999866544


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      .........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......    .+......    +....    
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~----~~~~~~~~----~~~~~----  234 (281)
T 3cc6_A          167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK----DVIGVLEK----GDRLP----  234 (281)
T ss_dssp             ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG----GHHHHHHH----TCCCC----
T ss_pred             cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH----HHHHHHhc----CCCCC----
Confidence            3333344557889999999998899999999999999999998 99999754422    22221111    11100    


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIERE  691 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~  691 (736)
                           .+......+.+++.+|++.||++||++.|++++|+++...++.
T Consensus       235 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  277 (281)
T 3cc6_A          235 -----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD  277 (281)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             -----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhhh
Confidence                 0111224588999999999999999999999999999876654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=347.32  Aligned_cols=251  Identities=22%  Similarity=0.298  Sum_probs=195.5

Q ss_pred             HHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhc-CCCceeeEeeeeeeCC
Q 004689          402 LSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG  477 (736)
Q Consensus       402 ~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~  477 (736)
                      ..++....+.+.++||+|+||+||+|+.. +++.||||++......  ....+..|+..+.++ +||||++++++|.+.+
T Consensus        51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~  130 (311)
T 3p1a_A           51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG  130 (311)
T ss_dssp             SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence            34555667778899999999999999987 7899999998654322  233455566666555 8999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecC
Q 004689          478 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL  557 (736)
Q Consensus       478 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGl  557 (736)
                      ..++||||+ +++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~  203 (311)
T 3p1a_A          131 ILYLQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGL  203 (311)
T ss_dssp             EEEEEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred             EEEEEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEcccee
Confidence            999999999 67999888543   34689999999999999999999998   999999999999999999999999999


Q ss_pred             CccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          558 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       558 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                      ++......  ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....         |  ..+..+..
T Consensus       204 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~--~~~~~~~~  269 (311)
T 3p1a_A          204 LVELGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------W--QQLRQGYL  269 (311)
T ss_dssp             CEECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------H--HHHTTTCC
T ss_pred             eeecccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------H--HHHhccCC
Confidence            87653322  2334569999999998875 789999999999999999999776654321         1  11111111


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .    +.+.    ......+.+++.+|++.||++|||+.|++++
T Consensus       270 ~----~~~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          270 P----PEFT----AGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             C----HHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             C----cccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            1    1111    1123468899999999999999999999864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.7e-40  Score=351.20  Aligned_cols=264  Identities=25%  Similarity=0.383  Sum_probs=205.4

Q ss_pred             HHHHhhccccccCceEEEEEEE-----CCCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeC--CeE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRS  479 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~-----~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~  479 (736)
                      ..+.+.+.||+|+||.||+|++     .+++.||||++..... .....+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            3456678999999999999984     3688999999975432 3346789999999999999999999999876  678


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ++||||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence            9999999999999998532   34589999999999999999999998   99999999999999999999999999998


Q ss_pred             cccCCCC--cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccc-------ccccccHHHHHHH
Q 004689          560 FAVDGAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKF-------GANCRNIVQWAKL  630 (736)
Q Consensus       560 ~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~-------~~~~~~l~~~~~~  630 (736)
                      .......  .......||..|+|||++.+..++.++|||||||++|||++|..|+.....       +............
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            6644332  223345688999999999999999999999999999999999998653210       0000111111111


Q ss_pred             hhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          631 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       631 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      ....+..         ...+......+.+++.+|++.||.+|||+.|+++.|++++
T Consensus       255 ~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          255 TLKEGKR---------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhccCC---------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            1111111         1112223346889999999999999999999999999875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-39  Score=340.77  Aligned_cols=254  Identities=26%  Similarity=0.410  Sum_probs=205.5

Q ss_pred             hccccccCceEEEEEEEC---CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          413 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      ++.||+|+||.||+|.+.   ++..||||+++... ......+.+|++++++++||||+++++++ ..+..++||||+++
T Consensus        15 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~   93 (287)
T 1u59_A           15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGG   93 (287)
T ss_dssp             EEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTT
T ss_pred             hccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCC
Confidence            348999999999999864   57889999997643 23456788999999999999999999999 55678999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      ++|.+++..   ....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        94 ~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  167 (287)
T 1u59_A           94 GPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  167 (287)
T ss_dssp             EEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             CCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence            999999853   235689999999999999999999998   99999999999999999999999999998664333221


Q ss_pred             --eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          569 --SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       569 --~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                        .....||+.|+|||++.+..++.++|||||||++|||++ |+.||......    .+...    +..+...       
T Consensus       168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~----i~~~~~~-------  232 (287)
T 1u59_A          168 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMAF----IEQGKRM-------  232 (287)
T ss_dssp             CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHHH----HHTTCCC-------
T ss_pred             eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----HHHHH----HhcCCcC-------
Confidence              223457899999999998889999999999999999998 99999765421    12221    1122111       


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER  690 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~  690 (736)
                        ..+......+.+++..|++.+|++||++.|++++|+.+.....
T Consensus       233 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          233 --ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             --CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             --CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence              1112233468899999999999999999999999999876443

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.3e-39  Score=340.04  Aligned_cols=250  Identities=32%  Similarity=0.566  Sum_probs=199.3

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCccc-------chhhhhHHHHHhhcCCCceeeEeeeeeeCCeEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG-------KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~-------~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  480 (736)
                      .+.+.+.||+|+||+||+|++. +++.||||++.......       .+.+.+|+.++++++||||+++++++.+..  +
T Consensus        20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~   97 (287)
T 4f0f_A           20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R   97 (287)
T ss_dssp             TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred             cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence            3456789999999999999875 78999999986543322       156889999999999999999999997665  6


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCEEEcCCCc-----EEEE
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMR-----AKVS  553 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~--iiHrDikp~NILl~~~~~-----~kl~  553 (736)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +  |+||||||+|||++.++.     +||+
T Consensus        98 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           98 MVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             EEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             EEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            999999999999988542   35689999999999999999999998   7  999999999999988776     9999


Q ss_pred             eecCCccccCCCCcceecccccccccCccccc--cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHh
Q 004689          554 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYI--SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH  631 (736)
Q Consensus       554 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~  631 (736)
                      |||+++....    ......||+.|+|||++.  ...++.++|||||||++|||++|+.||.......     .......
T Consensus       172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~  242 (287)
T 4f0f_A          172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMI  242 (287)
T ss_dssp             CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-----HHHHHHH
T ss_pred             CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-----HHHHHHH
Confidence            9999974332    233456999999999984  4567889999999999999999999997654221     1111111


Q ss_pred             hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                      ...+ .    .+.+    +......+.+++..|++.||++|||+.||++.|++
T Consensus       243 ~~~~-~----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          243 REEG-L----RPTI----PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHSC-C----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             hccC-C----CCCC----CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            1111 1    1111    12223468899999999999999999999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.5e-39  Score=350.80  Aligned_cols=257  Identities=22%  Similarity=0.254  Sum_probs=197.3

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccC-----CcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN-----SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      ..|.+.+.||+|+||+||+|... +++.||+|++...     .......+.+|++++++++||||+++++++.+.+..++
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            45667889999999999999875 6889999998643     22334678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhccccc------------------------------------ccccCHHHHHHHHHHHHHHHHHHH
Q 004689          482 VYEFMHNGTLKEHLYGTLTH------------------------------------EQRINWIKRLEIAEDAAKGIEYLH  525 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~qia~~L~~LH  525 (736)
                      ||||+++|+|.+++......                                    ...+++..+..++.|++.||.|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            99999999999998532111                                    223467778889999999999999


Q ss_pred             hCCCCceecCCCCCCCEEEcCCC--cEEEEeecCCccccCCC---CcceecccccccccCcccccc--CcCCCcchhHHH
Q 004689          526 TGCVPAIIHRDLKSSNILLDKHM--RAKVSDFGLSKFAVDGA---SHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSF  598 (736)
Q Consensus       526 ~~~~~~iiHrDikp~NILl~~~~--~~kl~DFGla~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DVwSl  598 (736)
                      +.   +|+||||||+|||++.++  .+||+|||+++......   ........||+.|+|||++.+  ..++.++|||||
T Consensus       186 ~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl  262 (345)
T 3hko_A          186 NQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA  262 (345)
T ss_dssp             HT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred             HC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence            98   999999999999998776  89999999998653322   112344569999999999975  678999999999


Q ss_pred             HHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 004689          599 GVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV  678 (736)
Q Consensus       599 Gvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev  678 (736)
                      ||++|||++|+.||......+.       ........ ..  ......    ......+.+++..|++.||.+||++.|+
T Consensus       263 G~il~el~~g~~pf~~~~~~~~-------~~~~~~~~-~~--~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~  328 (345)
T 3hko_A          263 GVLLHLLLMGAVPFPGVNDADT-------ISQVLNKK-LC--FENPNY----NVLSPLARDLLSNLLNRNVDERFDAMRA  328 (345)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCC-CC--TTSGGG----GGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             HHHHHHHHHCCCCCCCCChHHH-------HHHHHhcc-cc--cCCccc----ccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence            9999999999999976542211       11111111 00  000000    1123458899999999999999999999


Q ss_pred             HHH
Q 004689          679 LKD  681 (736)
Q Consensus       679 ~~~  681 (736)
                      +++
T Consensus       329 l~h  331 (345)
T 3hko_A          329 LQH  331 (345)
T ss_dssp             HHS
T ss_pred             hcC
Confidence            875

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.6e-40  Score=355.60  Aligned_cols=246  Identities=24%  Similarity=0.366  Sum_probs=200.1

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      +.+.+.||+|+||.||+|+.+ +++.||||+++...   ......+..|..++..+ +||||+++++++.+.+..++|||
T Consensus        19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E   98 (345)
T 1xjd_A           19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   98 (345)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence            446789999999999999986 68899999997542   22345577899999887 99999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus        99 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  171 (345)
T 1xjd_A           99 YLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  171 (345)
T ss_dssp             CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence            9999999999853    35688999999999999999999998   9999999999999999999999999999754322


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                      . ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+...+    ..+..      .
T Consensus       172 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i----~~~~~------~  236 (345)
T 1xjd_A          172 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSI----RMDNP------F  236 (345)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHH----HHCCC------C
T ss_pred             C-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH----HHHHHH----HhCCC------C
Confidence            2 2234567999999999999999999999999999999999999999765421    121111    11111      1


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~~~  681 (736)
                      ....    ....+.+++.+|++.||++||++. ||.++
T Consensus       237 ~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          237 YPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             CCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             CCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence            1111    224578999999999999999997 77654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.5e-39  Score=337.73  Aligned_cols=248  Identities=21%  Similarity=0.310  Sum_probs=200.6

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeC--CeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE--GRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~--~~~~lV~e~  485 (736)
                      +.+.+.||+|+||+||+|++. ++.||||++....  ....+.+.+|+.++++++||||+++++++.+.  ...++||||
T Consensus        12 y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   90 (271)
T 3kmu_A           12 LNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHW   90 (271)
T ss_dssp             CEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred             hHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecc
Confidence            446789999999999999986 8999999997553  23345789999999999999999999999877  788999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~--iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      +++|+|.+++...  ....+++..++.++.|++.||.|||+.   +  |+||||||+||+++.++.++|+|||++.....
T Consensus        91 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           91 MPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             CTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             cCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            9999999999643  223589999999999999999999997   7  99999999999999999999999998754221


Q ss_pred             CCCcceecccccccccCccccccCcCCC---cchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTD---KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~---~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                            ....||+.|+|||.+.+..++.   ++|||||||++|||++|+.||......+       ........+.    
T Consensus       166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~----  228 (271)
T 3kmu_A          166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME-------IGMKVALEGL----  228 (271)
T ss_dssp             ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH-------HHHHHHHSCC----
T ss_pred             ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH-------HHHHHHhcCC----
Confidence                  2245899999999998766555   7999999999999999999997654211       1111111111    


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                       .+.+..    .....+.+++..|++.||++|||+.|+++.|+++
T Consensus       229 -~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          229 -RPTIPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             -CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence             111112    2234588999999999999999999999999976

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.8e-40  Score=351.30  Aligned_cols=262  Identities=23%  Similarity=0.431  Sum_probs=209.2

Q ss_pred             HHHHhhccccccCceEEEEEEEC--------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCC
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG  477 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~--------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~  477 (736)
                      ..+.+.+.||+|+||.||+|+..        ++..||||++..... .....+.+|+++++++ +||||+++++++...+
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  114 (334)
T 2pvf_A           35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  114 (334)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence            44567889999999999999863        467899999875432 2345688999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCCHHHHhhcccc------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc
Q 004689          478 RSVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD  545 (736)
Q Consensus       478 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~  545 (736)
                      ..++||||+++|+|.+++.....            ....+++..++.++.|++.||.|||+.   +|+||||||+|||++
T Consensus       115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVT  191 (334)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEc
Confidence            99999999999999999975432            123588999999999999999999998   999999999999999


Q ss_pred             CCCcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCccccccccccc
Q 004689          546 KHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN  623 (736)
Q Consensus       546 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~  623 (736)
                      .++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....    .
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~  267 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE----E  267 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----H
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH----H
Confidence            9999999999999865443221 2233457889999999998899999999999999999999 99999765421    1


Q ss_pred             HHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          624 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       624 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                      +....    ..+...         ..+......+.+++..|++.+|.+||++.||+++|++++...
T Consensus       268 ~~~~~----~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~  320 (334)
T 2pvf_A          268 LFKLL----KEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  320 (334)
T ss_dssp             HHHHH----HHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHH----hcCCCC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            22211    111111         111122345889999999999999999999999999987654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-39  Score=348.71  Aligned_cols=251  Identities=22%  Similarity=0.341  Sum_probs=180.8

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      ++.||+|+||+||+|... +++.||||++...   ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            368999999999999886 6899999998643   3456788999999997 9999999999999999999999999999


Q ss_pred             HHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC---cEEEEeecCCccccCCCCc
Q 004689          491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       491 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~---~~kl~DFGla~~~~~~~~~  567 (736)
                      |.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++   .+||+|||+++...... .
T Consensus        93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~  164 (325)
T 3kn6_A           93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-Q  164 (325)
T ss_dssp             HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-C
Confidence            9999953    35689999999999999999999998   999999999999998765   89999999998654332 2


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||................. .+..+...  +.    .
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-~i~~~~~~--~~----~  237 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK-KIKKGDFS--FE----G  237 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH-HHTTTCCC--CC----S
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH-HHHcCCCC--CC----c
Confidence            23345689999999999999999999999999999999999999986553222222222222 22222211  00    0


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .........+.+++..|++.||++|||+.|++++
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            0001123468899999999999999999998754

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-39  Score=349.58  Aligned_cols=263  Identities=24%  Similarity=0.371  Sum_probs=208.7

Q ss_pred             HHHHhhccccccCceEEEEEEECC------CcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~~------~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  479 (736)
                      ..+.+.+.||+|+||.||+|....      ...||+|++..... .....+.+|+.+++++ +||||+++++++...+..
T Consensus        46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  125 (333)
T 2i1m_A           46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV  125 (333)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence            345567899999999999998752      24799999875532 2346688999999999 899999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcccc----------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLT----------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR  549 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~  549 (736)
                      ++||||+++|+|.+++.....          ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus       126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~  202 (333)
T 2i1m_A          126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHV  202 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGE
T ss_pred             EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCe
Confidence            999999999999999864321          123578999999999999999999998   9999999999999999999


Q ss_pred             EEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHH
Q 004689          550 AKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQW  627 (736)
Q Consensus       550 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~  627 (736)
                      +||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |..||.......   .+...
T Consensus       203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~  279 (333)
T 2i1m_A          203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---KFYKL  279 (333)
T ss_dssp             EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH---HHHHH
T ss_pred             EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH---HHHHH
Confidence            999999999865433322 2234557889999999998899999999999999999999 999997654221   11111


Q ss_pred             HHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          628 AKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       628 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                      ...    +..     .    ..+......+.+++..|++.||.+|||+.||+++|+++....
T Consensus       280 ~~~----~~~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          280 VKD----GYQ-----M----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHH----TCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             Hhc----CCC-----C----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            111    110     0    011112345889999999999999999999999999886544

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.4e-39  Score=348.77  Aligned_cols=247  Identities=23%  Similarity=0.332  Sum_probs=192.2

Q ss_pred             HHHhhccccccCceEEEEEEE----CCCcEEEEEEeccCC----cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~----~~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  480 (736)
                      .+.+.+.||+|+||.||+|+.    .+++.||+|+++...    ......+.+|+.++++++||||+++++++...+..+
T Consensus        18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   97 (327)
T 3a62_A           18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY   97 (327)
T ss_dssp             GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred             HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence            355678999999999999987    478999999997542    223456788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        98 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           98 LILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            99999999999999853    34588889999999999999999998   999999999999999999999999999875


Q ss_pred             ccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+    +..   ... .+..   
T Consensus       171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~---~i~-~~~~---  238 (327)
T 3a62_A          171 SIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK----TID---KIL-KCKL---  238 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHH---HHH-HTCC---
T ss_pred             cccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH----HHH---HHH-hCCC---
Confidence            43222 22334569999999999999999999999999999999999999997654211    111   111 1111   


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                         .+    +......+.+++.+|++.||++||     ++.|++++
T Consensus       239 ---~~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          239 ---NL----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ---CC----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ---CC----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence               11    111234588999999999999999     77888776

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.6e-39  Score=349.19  Aligned_cols=254  Identities=22%  Similarity=0.297  Sum_probs=200.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      +.+.+.||+|+||.||+|+.. +++.||+|+++.....   ....+.+|..+++++ +||||+++++++.+.+..++|||
T Consensus        11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e   90 (345)
T 3a8x_A           11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE   90 (345)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence            345789999999999999986 5889999999754322   234578899999988 89999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++++||+|||+++.....
T Consensus        91 ~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           91 YVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            9999999999853    35689999999999999999999998   9999999999999999999999999999753322


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccccccc-ccHHHHHHHhhhcCCcceeccC
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANC-RNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      . ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..........+..+...     
T Consensus       164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~-----  237 (345)
T 3a8x_A          164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR-----  237 (345)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-----
T ss_pred             C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-----
Confidence            2 2234567999999999999999999999999999999999999999753221110 01112222222222211     


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCH------HHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSI------SEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~ev~~~  681 (736)
                       +    +......+.+++.+|++.||++||++      .|++++
T Consensus       238 -~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          238 -I----PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             -C----CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             -C----CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence             1    11223457889999999999999995      566654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=358.64  Aligned_cols=251  Identities=23%  Similarity=0.261  Sum_probs=201.0

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+.+.||+|+||+||+|+.+ +++.||||++++..   ......+.+|..++..++||||+++++++.+.+..++||||+
T Consensus        64 ~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~  143 (412)
T 2vd5_A           64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYY  143 (412)
T ss_dssp             EEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCC
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCC
Confidence            34678999999999999986 68999999996532   223456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++++||+|||+++.......
T Consensus       144 ~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~  217 (412)
T 2vd5_A          144 VGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT  217 (412)
T ss_dssp             CSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence            999999999532   24688999999999999999999998   999999999999999999999999999986654433


Q ss_pred             cceecccccccccCccccc-------cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          567 HVSSIVRGTVGYLDPEYYI-------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~-------~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ......+||+.|+|||++.       ...++.++|||||||++|||++|+.||......+....+..+....    .+  
T Consensus       218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~----~~--  291 (412)
T 2vd5_A          218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL----SL--  291 (412)
T ss_dssp             EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC----CC--
T ss_pred             cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc----CC--
Confidence            3344567999999999997       3578999999999999999999999998665333222332221110    00  


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCC---CCHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR---PSISEVLKD  681 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~ev~~~  681 (736)
                         +......    ..++.+++.+|+. +|.+|   |+++||++|
T Consensus       292 ---p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          292 ---PLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             ---C----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             ---CccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence               1111112    2357889999999 99988   589998765

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.4e-39  Score=351.92  Aligned_cols=243  Identities=23%  Similarity=0.307  Sum_probs=200.9

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.+.||+|+||.||+|+.. +++.||||++....   ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  122 (350)
T 1rdq_E           43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence            345688999999999999986 68999999986542   12345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..... 
T Consensus       123 ~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          123 VAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             CTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            999999999853    34688999999999999999999998   9999999999999999999999999999865332 


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                         ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+..    .+..+.+      .+
T Consensus       195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~----~i~~~~~------~~  257 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIYE----KIVSGKV------RF  257 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCCC------CC
T ss_pred             ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH----HHHH----HHHcCCC------CC
Confidence               23456999999999999999999999999999999999999999765421    1111    1111221      11


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  681 (736)
                      ...    ....+.+++.+|++.||.+||+     ++||+++
T Consensus       258 p~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          258 PSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCC----CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            112    2345889999999999999998     8888776

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-39  Score=354.04  Aligned_cols=273  Identities=21%  Similarity=0.282  Sum_probs=211.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCC--eEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~lV~e~  485 (736)
                      |.+.++||+|+||+||+|++. +++.||||++..... .....+.+|++++++++||||+++++++....  ..++||||
T Consensus        11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~   90 (396)
T 4eut_A           11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF   90 (396)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred             eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence            456789999999999999887 589999999975432 23456789999999999999999999998655  78999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE----cCCCcEEEEeecCCccc
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl----~~~~~~kl~DFGla~~~  561 (736)
                      +++|+|.+++.... ....+++..++.++.|++.||+|||+.   +|+||||||+|||+    +.++.+||+|||+++..
T Consensus        91 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~  166 (396)
T 4eut_A           91 CPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (396)
T ss_dssp             CTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred             CCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence            99999999986432 223389999999999999999999998   99999999999999    77888999999999865


Q ss_pred             cCCCCcceecccccccccCcccccc--------CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYIS--------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE  633 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~  633 (736)
                      ....  ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||...........+.........
T Consensus       167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            4322  2234569999999999865        56788999999999999999999999765433222222222111111


Q ss_pred             cCCcceec---------cCc--cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          634 SGDIQGII---------DPS--LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       634 ~~~~~~~~---------d~~--l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                      ...+....         ...  ............+.+++..|++.||++||+++|+++.+++++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            11111110         001  11223456677889999999999999999999999999888653

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=353.69  Aligned_cols=248  Identities=23%  Similarity=0.317  Sum_probs=199.9

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.+|+.++||||+++++++.+.+..++||||
T Consensus        17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~   96 (384)
T 4fr4_A           17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL   96 (384)
T ss_dssp             EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence            456789999999999999876 58899999986542   22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +.+|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..... 
T Consensus        97 ~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-  168 (384)
T 4fr4_A           97 LLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-  168 (384)
T ss_dssp             CTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence            999999999853    45689999999999999999999998   9999999999999999999999999999865432 


Q ss_pred             CcceecccccccccCcccccc---CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          566 SHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                       ......+||+.|+|||++.+   ..++.++|||||||++|||++|+.||....... ...+......    ...     
T Consensus       169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~----~~~-----  237 (384)
T 4fr4_A          169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTFET----TVV-----  237 (384)
T ss_dssp             -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHHHH----CCC-----
T ss_pred             -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhh----ccc-----
Confidence             22345679999999999974   458999999999999999999999997544211 1112221111    110     


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-ISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~ev~~~  681 (736)
                           .++......+.+++.+|++.||.+||+ +.+|.++
T Consensus       238 -----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          238 -----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             -----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             -----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence                 111122345889999999999999998 7777653

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.5e-39  Score=351.66  Aligned_cols=251  Identities=26%  Similarity=0.326  Sum_probs=192.4

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .|.+.+.||+|+||+||+|+.. +++.||||++.... .....+.+|+.++++++||||+++++++...+..++||||++
T Consensus        21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~   99 (361)
T 3uc3_A           21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS   99 (361)
T ss_dssp             TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence            3567789999999999999987 78999999987543 234668899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc--EEEEeecCCccccCCC
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLSKFAVDGA  565 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~--~kl~DFGla~~~~~~~  565 (736)
                      +|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.  +||+|||+++..... 
T Consensus       100 ~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-  171 (361)
T 3uc3_A          100 GGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  171 (361)
T ss_dssp             SCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence            9999999843    45689999999999999999999998   9999999999999987765  999999999743222 


Q ss_pred             CcceecccccccccCccccccCcCCCc-chhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDK-SDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                       .......||+.|+|||++.+..++.+ +|||||||++|||++|+.||...........+..   .... ....      
T Consensus       172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~---~~~~-~~~~------  240 (361)
T 3uc3_A          172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQ---RILS-VKYS------  240 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHH---HHHT-TCCC------
T ss_pred             -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHH---HHhc-CCCC------
Confidence             12233469999999999988877655 8999999999999999999986553322222222   1111 1110      


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...  .......+.+++.+|++.||++|||+.|++++
T Consensus       241 ~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          241 IPD--DIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            000  01112457899999999999999999999987

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.1e-39  Score=342.05  Aligned_cols=263  Identities=24%  Similarity=0.368  Sum_probs=199.5

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .|.+.+.||+|+||.||+|... +++.||||++....   ......+.+|+.++++++||||+++++++...+..++|||
T Consensus        33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  112 (310)
T 2wqm_A           33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE  112 (310)
T ss_dssp             GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence            3567889999999999999874 78999999987532   2234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++|+|.+++.........+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus       113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred             cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence            9999999999865433455688999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                      .. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+...     ........ +..+......   
T Consensus       190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~-~~~~~~~~~~---  259 (310)
T 2wqm_A          190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKK-IEQCDYPPLP---  259 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHHH-HHTTCSCCCC---
T ss_pred             Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHHH-hhcccCCCCc---
Confidence            22 22334689999999999999999999999999999999999999975431     12222221 1222211111   


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                       ...    ....+.+++.+|++.||.+||++.+|++.|+++....
T Consensus       260 -~~~----~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          260 -SDH----YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             -TTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -ccc----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence             111    2235889999999999999999999999999986543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.5e-40  Score=343.91  Aligned_cols=249  Identities=24%  Similarity=0.421  Sum_probs=200.0

Q ss_pred             HHHhhccccccCceEEEEEEECC-C-------cEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKD-G-------KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~-~-------~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  480 (736)
                      .+.+.+.||+|+||+||+|.... +       ..||+|++..........+.+|+.++++++||||+++++++..++..+
T Consensus         9 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (289)
T 4fvq_A            9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENI   88 (289)
T ss_dssp             GEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCE
T ss_pred             HeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCE
Confidence            45567899999999999998653 3       579999997665555677999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc--------EEE
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--------AKV  552 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~--------~kl  552 (736)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.        +||
T Consensus        89 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           89 LVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             EEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             EEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence            999999999999999642   34488999999999999999999998   9999999999999998887        999


Q ss_pred             EeecCCccccCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCc-CcccccccccccHHHHHHH
Q 004689          553 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEA-ISNEKFGANCRNIVQWAKL  630 (736)
Q Consensus       553 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p-~~~~~~~~~~~~l~~~~~~  630 (736)
                      +|||++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|..| +.....    ......   
T Consensus       163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~----~~~~~~---  230 (289)
T 4fvq_A          163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS----QRKLQF---  230 (289)
T ss_dssp             CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHHHH---
T ss_pred             ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch----HHHHHH---
Confidence            99999864422     123458999999999987 7789999999999999999996554 433221    111111   


Q ss_pred             hhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          631 HIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       631 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ......+.        ...    ...+.+++..|++.||++|||+.|++++|++++.
T Consensus       231 ~~~~~~~~--------~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          231 YEDRHQLP--------APK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHTTCCCC--------CCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             hhccCCCC--------CCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11111111        111    2247889999999999999999999999998864

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.5e-40  Score=352.85  Aligned_cols=249  Identities=24%  Similarity=0.325  Sum_probs=193.9

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCC--CceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||.||+|...+++.||||++.....  .....+.+|+.+|++++|  |||+++++++..++..++||| 
T Consensus        11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-   89 (343)
T 3dbq_A           11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-   89 (343)
T ss_dssp             EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred             EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence            456789999999999999998899999999875432  234668899999999976  999999999999999999999 


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +.+|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++ ++.+||+|||+++......
T Consensus        90 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           90 CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             CCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            568899999853    35688999999999999999999998   999999999999997 6789999999998654333


Q ss_pred             Cc-ceecccccccccCcccccc-----------CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh
Q 004689          566 SH-VSSIVRGTVGYLDPEYYIS-----------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE  633 (736)
Q Consensus       566 ~~-~~~~~~gt~~Y~aPE~~~~-----------~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~  633 (736)
                      .. ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....     .+ ....... 
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~-~~~~~~~-  234 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QI-SKLHAII-  234 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HH-HHHHHHH-
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HH-HHHHHHh-
Confidence            22 2334579999999999865           6788899999999999999999999975331     11 1111111 


Q ss_pred             cCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          634 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       634 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                              ++.....++......+.+++..|++.||.+|||+.|++++.
T Consensus       235 --------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          235 --------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             --------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence                    11111112222234578999999999999999999998874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=348.48  Aligned_cols=256  Identities=23%  Similarity=0.363  Sum_probs=197.8

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcE----EEEEEeccC-CcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKE----IAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~----vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      .|.+.+.||+|+||+||+|.+. +++.    ||+|.+... .......+.+|+.++++++||||+++++++.... .++|
T Consensus        16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v   94 (327)
T 3lzb_A           16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI   94 (327)
T ss_dssp             TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred             HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence            3456789999999999999875 3443    577777543 2334567899999999999999999999998765 7899


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      +||+.+|+|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        95 ~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           95 TQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             ECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            9999999999998643   34588999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          563 DGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       563 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      .... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||......    .+.....    .+..   
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~~~~~~----~~~~---  237 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILE----KGER---  237 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHHH----TTCC---
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHHHHH----cCCC---
Confidence            3322 22233457889999999999999999999999999999999 99999865422    2222111    1110   


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                            ...+......+.+++.+|++.||.+||++.|+++.|+++...
T Consensus       238 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          238 ------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                  011112233588999999999999999999999999988643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.8e-39  Score=351.19  Aligned_cols=246  Identities=24%  Similarity=0.297  Sum_probs=199.7

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      +.+.+.||+|+||.||+|+.. +++.||||+++...   ......+..|..++..+ +||||+++++++.+.+..++|||
T Consensus        22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E  101 (353)
T 2i0e_A           22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME  101 (353)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence            445789999999999999987 47889999997542   22345577899999988 89999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       102 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  174 (353)
T 2i0e_A          102 YVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  174 (353)
T ss_dssp             CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence            9999999999853    34689999999999999999999998   9999999999999999999999999999753322


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                      . ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+.+.   . ..+.+      .
T Consensus       175 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~----~~~~~---i-~~~~~------~  239 (353)
T 2i0e_A          175 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED----ELFQS---I-MEHNV------A  239 (353)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH---H-HHCCC------C
T ss_pred             C-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH----HHHHH---H-HhCCC------C
Confidence            2 2234567999999999999999999999999999999999999999765422    11111   1 11111      0


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  681 (736)
                          ++......+.+++.+|++.||.+||+     ++||+++
T Consensus       240 ----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          240 ----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             ----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                11122345889999999999999995     5777765

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-39  Score=352.22  Aligned_cols=252  Identities=25%  Similarity=0.330  Sum_probs=201.9

Q ss_pred             HHhhccccccCceEEEEEEE----CCCcEEEEEEeccCC----cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKL----KDGKEIAVKVLTSNS----YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~----~~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~  480 (736)
                      |.+.+.||+|+||.||+|+.    .+++.||||+++...    ......+.+|+++++++ +||||+++++++......+
T Consensus        56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~  135 (355)
T 1vzo_A           56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  135 (355)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence            45678999999999999987    368999999987542    22345688899999999 6999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       136 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          136 LILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             EEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999853    34688999999999999999999998   999999999999999999999999999986


Q ss_pred             ccCCCCcceecccccccccCcccccc--CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      .............||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+.   .......   
T Consensus       209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~---~~~~~~~---  282 (355)
T 1vzo_A          209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS---RRILKSE---  282 (355)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH---HHHHHCC---
T ss_pred             cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH---HHHhccC---
Confidence            54433334445679999999999985  457899999999999999999999997554222222222   2221110   


Q ss_pred             eeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHHH
Q 004689          639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKDI  682 (736)
Q Consensus       639 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~L  682 (736)
                          +.    ++......+.+++.+|++.||.+||     +++|++++.
T Consensus       283 ----~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          283 ----PP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ----CC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ----CC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                11    1122234578899999999999999     999998875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-39  Score=349.38  Aligned_cols=256  Identities=25%  Similarity=0.429  Sum_probs=199.9

Q ss_pred             HHhhccccccCceEEEEEEECC-----CcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKD-----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~-----~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      +.+.+.||+|+||+||+|....     +..||||+++.... .....+.+|+.++++++||||+++++++...+..++||
T Consensus        46 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  125 (333)
T 1mqb_A           46 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT  125 (333)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEE
Confidence            3456889999999999998653     23599999875432 23456889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       126 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          126 EYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             ECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             eCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999999998632   35688999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCc--ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          564 GASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       564 ~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      ....  ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......    .+..    .+..+...  
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----~~~~----~~~~~~~~--  269 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----EVMK----AINDGFRL--  269 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHH----HHHTTCCC--
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH----HHHH----HHHCCCcC--
Confidence            3221  1223346889999999998899999999999999999999 99999755421    1211    11111100  


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                             ..+......+.+++.+|++.+|++||++.||++.|++++..
T Consensus       270 -------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          270 -------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             -------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                   01112234688999999999999999999999999998653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=350.27  Aligned_cols=248  Identities=24%  Similarity=0.355  Sum_probs=186.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      |.+.+.||+|+||.||+|+.. +++.||||++....  ..+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus        55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  132 (349)
T 2w4o_A           55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG  132 (349)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence            456789999999999999987 57899999987543  345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeecCCccccCCC
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~---~~~~kl~DFGla~~~~~~~  565 (736)
                      |+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++..... 
T Consensus       133 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-  204 (349)
T 2w4o_A          133 GELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-  204 (349)
T ss_dssp             CBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence            999999853    34588999999999999999999998   9999999999999976   889999999999865332 


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .+..    .+..+...  .....
T Consensus       205 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~----~i~~~~~~--~~~~~  274 (349)
T 2w4o_A          205 -VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ---FMFR----RILNCEYY--FISPW  274 (349)
T ss_dssp             ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH---HHHH----HHHTTCCC--CCTTT
T ss_pred             -cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH---HHHH----HHHhCCCc--cCCch
Confidence             22234569999999999999999999999999999999999999997544211   1111    11111110  00111


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..    .....+.+++.+|++.||++|||+.|++++
T Consensus       275 ~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          275 WD----EVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hh----hCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11    223458899999999999999999999874

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.3e-39  Score=336.94  Aligned_cols=250  Identities=21%  Similarity=0.267  Sum_probs=202.6

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      ..|.+.+.||+|+||.||+|... ++..||+|++..........+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            45667889999999999999876 47789999997665555678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE---cCCCcEEEEeecCCccccC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl---~~~~~~kl~DFGla~~~~~  563 (736)
                      ++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+|||++.....
T Consensus        89 ~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           89 TGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            99999998843    45688999999999999999999998   99999999999999   7889999999999976543


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      ..  ......||+.|+|||.+.+. ++.++|||||||++|||++|+.||......+    +..    .+..+....  ..
T Consensus       162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~----~~~~~~~~~--~~  228 (277)
T 3f3z_A          162 GK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE----VML----KIREGTFTF--PE  228 (277)
T ss_dssp             TS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHHCCCCC--CH
T ss_pred             cc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH----HHH----HHHhCCCCC--Cc
Confidence            32  22345699999999988654 8999999999999999999999997654211    111    111111100  00


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....    .....+.+++.+|++.||++||++.|++++
T Consensus       229 ~~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          229 KDWL----NVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             hhhh----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000    123468899999999999999999999875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.4e-39  Score=344.78  Aligned_cols=251  Identities=25%  Similarity=0.357  Sum_probs=203.6

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc------cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  480 (736)
                      ..|.+.+.||+|+||.||+|+.. +++.||||++......      ....+.+|+.++++++||||+++++++.+....+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            45667899999999999999876 6899999998764322      2456889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC----cEEEEeec
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFG  556 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~----~~kl~DFG  556 (736)
                      +||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++    .+||+|||
T Consensus        92 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            99999999999999853    34688999999999999999999998   999999999999999887    79999999


Q ss_pred             CCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          557 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       557 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      +++.......  .....||+.|+|||++.+..++.++|||||||++|||++|..||......    ....   . +....
T Consensus       165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~---~-i~~~~  234 (321)
T 2a2a_A          165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----ETLA---N-ITSVS  234 (321)
T ss_dssp             TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHH---H-HHTTC
T ss_pred             cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH----HHHH---H-HHhcc
Confidence            9986544322  23446999999999999999999999999999999999999999765421    1111   1 11111


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .  ..++.....    ....+.+++.+|++.||++|||+.|++++
T Consensus       235 ~--~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          235 Y--DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             C--CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             c--ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0  011111111    12357899999999999999999999876

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-38  Score=340.45  Aligned_cols=269  Identities=24%  Similarity=0.365  Sum_probs=202.0

Q ss_pred             HHHHHHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhc--CCCceeeEeeeeeeC----
Q 004689          403 SDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI--HHRNLVQFLGYCQEE----  476 (736)
Q Consensus       403 ~~i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~~~~~~~----  476 (736)
                      .......+.+.+.||+|+||.||+|+.. ++.||||++....   ...+..|.+++..+  +||||+++++++...    
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            3344556777899999999999999987 8999999986432   33445555665554  999999999999877    


Q ss_pred             CeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCC-----CCceecCCCCCCCEEEcCCCcEE
Q 004689          477 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAK  551 (736)
Q Consensus       477 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~-----~~~iiHrDikp~NILl~~~~~~k  551 (736)
                      ...++||||+++|+|.+++..     ..+++..++.++.|++.||.|||+.+     .++|+||||||+|||++.++.+|
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             CceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence            788999999999999999953     35889999999999999999999852     23899999999999999999999


Q ss_pred             EEeecCCccccCCCCcc---eecccccccccCccccccCcCCCc------chhHHHHHHHHHHHhC----------CCcC
Q 004689          552 VSDFGLSKFAVDGASHV---SSIVRGTVGYLDPEYYISQQLTDK------SDVYSFGVILLELISG----------QEAI  612 (736)
Q Consensus       552 l~DFGla~~~~~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~------~DVwSlGvvl~elltG----------~~p~  612 (736)
                      |+|||+++.........   .....||+.|+|||++.+..+..+      +|||||||++|||++|          +.||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            99999997654332221   224569999999999987766665      9999999999999999          5555


Q ss_pred             cccccccccccHHHHHHHhhhcCCcceeccCccCCcC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          613 SNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       613 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ........  .... .........    ..+...... .......+.+++..|++.||++|||+.||+++|+.+..
T Consensus       263 ~~~~~~~~--~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          263 HDLVPSDP--SYED-MREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             TTTSCSSC--CHHH-HHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhhcCCCC--chhh-hHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence            44321111  1111 111111111    111111111 12566779999999999999999999999999998864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.5e-39  Score=363.75  Aligned_cols=246  Identities=23%  Similarity=0.310  Sum_probs=192.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccC---CcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN---SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.+.||+|+||.||+|+.. +++.||||++...   .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus       150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~  229 (446)
T 4ejn_A          150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY  229 (446)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred             cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence            456789999999999999875 6899999998753   223345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      +++|+|.+++..    ...+++..+..++.|++.||+|||+ .   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       230 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          230 ANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             CSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            999999998843    4568999999999999999999998 7   9999999999999999999999999999754332


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                      . ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+...+.    .+..      .
T Consensus       303 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~i~----~~~~------~  367 (446)
T 4ejn_A          303 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----KLFELIL----MEEI------R  367 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHH----HCCC------C
T ss_pred             C-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH----HHHHHHH----hCCC------C
Confidence            2 2234467999999999999999999999999999999999999999765421    1111111    1111      0


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                          ++......+.+++.+|++.||.+||     +++|++++
T Consensus       368 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          368 ----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                1111224588999999999999999     99999876

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=342.51  Aligned_cols=252  Identities=29%  Similarity=0.467  Sum_probs=195.1

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNG  489 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~g  489 (736)
                      +.+.+.||+|+||+||+|++. ++.||||++...  ...+.+.+|++++++++||||+++++++.+  ..++||||+++|
T Consensus        10 ~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~   84 (307)
T 2eva_A           10 IEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGG   84 (307)
T ss_dssp             EEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTC
T ss_pred             eeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCC
Confidence            346789999999999999986 789999998643  235678999999999999999999999874  478999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc-EEEEeecCCccccCCCCcc
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR-AKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~-~kl~DFGla~~~~~~~~~~  568 (736)
                      +|.+++.... ....+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||+++.....    
T Consensus        85 ~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----  159 (307)
T 2eva_A           85 SLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----  159 (307)
T ss_dssp             BHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred             CHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----
Confidence            9999996542 2335788889999999999999999933238999999999999998886 799999999754322    


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .. ..|..   ..+...     .....
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~-~~~~~---~~~~~~-----~~~~~  228 (307)
T 2eva_A          160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA--FR-IMWAV---HNGTRP-----PLIKN  228 (307)
T ss_dssp             -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH--HH-HHHHH---HTTCCC-----CCBTT
T ss_pred             cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH--HH-HHHHH---hcCCCC-----Ccccc
Confidence            123458999999999999999999999999999999999999997543111  01 11111   111111     11112


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      .    ...+.+++.+|++.||++|||+.|++++|+.+.
T Consensus       229 ~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          229 L----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             c----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            2    235789999999999999999999999999874

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=344.74  Aligned_cols=270  Identities=21%  Similarity=0.281  Sum_probs=199.6

Q ss_pred             HHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-----ccchhhhhHHHHHhhcC---CCceeeEeeeee
Q 004689          404 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-----QGKREFTNEVTLLSRIH---HRNLVQFLGYCQ  474 (736)
Q Consensus       404 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-----~~~~~~~~E~~il~~l~---HpnIv~l~~~~~  474 (736)
                      ++....|.+.+.||+|+||+||+|+.. +++.||||++.....     .....+.+|++++++++   ||||+++++++.
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            334455677899999999999999974 689999999864321     12346778888888775   999999999998


Q ss_pred             eCC-----eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc
Q 004689          475 EEG-----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR  549 (736)
Q Consensus       475 ~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~  549 (736)
                      ...     ..++||||+. |+|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence            765     5799999997 59999986432  23489999999999999999999998   9999999999999999999


Q ss_pred             EEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHH
Q 004689          550 AKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK  629 (736)
Q Consensus       550 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~  629 (736)
                      +||+|||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.....
T Consensus       159 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  236 (308)
T 3g33_A          159 VKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG  236 (308)
T ss_dssp             EEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             EEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999999998654322  22345689999999999999999999999999999999999999976553222112211110


Q ss_pred             HhhhcCCcceec--cCccCC-------cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          630 LHIESGDIQGII--DPSLLD-------EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       630 ~~~~~~~~~~~~--d~~l~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ............  ......       ....+....+.+++.+|++.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            000000000000  000000       0001223468899999999999999999999875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.4e-39  Score=335.74  Aligned_cols=253  Identities=22%  Similarity=0.366  Sum_probs=198.6

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      ..+.+.+.||+|+||+||+|... ++..||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            45677899999999999999875 68899999987553 23456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE---cCCCcEEEEeecCCcccc
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl---~~~~~~kl~DFGla~~~~  562 (736)
                      +++|+|.+++.........+++..++.++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            999999999865544456789999999999999999999998   99999999999999   456889999999997654


Q ss_pred             CCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      ...  ......||+.|+|||++. ..++.++|||||||++|||++|+.||......    .+......  ......  ..
T Consensus       179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~----~~~~~~~~--~~~~~~--~~  247 (285)
T 3is5_A          179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE----EVQQKATY--KEPNYA--VE  247 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHH--CCCCCC--C-
T ss_pred             Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH----HHHhhhcc--CCcccc--cc
Confidence            322  223456999999999875 56889999999999999999999999765421    11111111  010000  00


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                         ...    ....+.+++.+|++.||++|||+.||+++
T Consensus       248 ---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          248 ---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             ----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               001    12357889999999999999999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.7e-38  Score=341.89  Aligned_cols=269  Identities=23%  Similarity=0.382  Sum_probs=211.0

Q ss_pred             cCHHHHHHHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhh--cCCCceeeEeeeeeeCC
Q 004689          400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSR--IHHRNLVQFLGYCQEEG  477 (736)
Q Consensus       400 ~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~--l~HpnIv~l~~~~~~~~  477 (736)
                      +...+.....+.+.+.||+|+||.||+|+.. ++.||||++...   ....+.+|++++..  ++||||+++++++....
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            3445555667778899999999999999985 899999998643   34567788998887  78999999999998776


Q ss_pred             ----eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHH--------hCCCCceecCCCCCCCEEEc
Q 004689          478 ----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--------TGCVPAIIHRDLKSSNILLD  545 (736)
Q Consensus       478 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH--------~~~~~~iiHrDikp~NILl~  545 (736)
                          ..++||||+++|+|.+++..     ..+++..++.++.|++.||.|||        +.   +|+||||||+|||++
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~  181 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK  181 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred             CccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence                78999999999999999953     35889999999999999999999        66   999999999999999


Q ss_pred             CCCcEEEEeecCCccccCCCCc---ceecccccccccCccccccC------cCCCcchhHHHHHHHHHHHhC--------
Q 004689          546 KHMRAKVSDFGLSKFAVDGASH---VSSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISG--------  608 (736)
Q Consensus       546 ~~~~~kl~DFGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~~------~~~~~~DVwSlGvvl~elltG--------  608 (736)
                      .++++||+|||+++........   ......||+.|+|||++.+.      .++.++|||||||++|||++|        
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            9999999999999765443322   22345699999999999765      344689999999999999999        


Q ss_pred             --CCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc-CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          609 --QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE-YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       609 --~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                        ..||.......  .....+..... ...    ..+.+... ...+....+.+++.+|++.||++|||+.||+++|+++
T Consensus       262 ~~~~p~~~~~~~~--~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          262 DYQLPYYDLVPSD--PSVEEMRKVVC-EQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CCCCTTTTTSCSS--CCHHHHHHHHT-TSC----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccCccccCcCc--ccHHHHHHHHH-HHH----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence              67776543211  12222222221 111    11222211 1345667899999999999999999999999999988


Q ss_pred             HH
Q 004689          686 IV  687 (736)
Q Consensus       686 ~~  687 (736)
                      ..
T Consensus       335 ~~  336 (342)
T 1b6c_B          335 SQ  336 (342)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=346.33  Aligned_cols=259  Identities=22%  Similarity=0.303  Sum_probs=203.0

Q ss_pred             HHHhhccccccCceEEEEEEE-CCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeee----eCCeEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ----EEGRSVLVY  483 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~----~~~~~~lV~  483 (736)
                      .|.+.+.||+|+||.||+|.. .+++.||||++..........+.+|++++++++||||+++++++.    .....++||
T Consensus        30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~  109 (317)
T 2buj_A           30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL  109 (317)
T ss_dssp             EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred             EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEE
Confidence            455678999999999999987 478999999987665555677899999999999999999999986    334789999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+.+|+|.+++.........+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          110 PFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             ECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             EeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            99999999999976544456789999999999999999999998   999999999999999999999999999875422


Q ss_pred             CCCc--------ceecccccccccCccccccCc---CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh
Q 004689          564 GASH--------VSSIVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       564 ~~~~--------~~~~~~gt~~Y~aPE~~~~~~---~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      ....        ......||+.|+|||++.+..   ++.++|||||||++|||++|+.||.......  ..+....... 
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~-  263 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG--DSVALAVQNQ-  263 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT--SCHHHHHHCC-
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc--chhhHHhhcc-
Confidence            1110        012235799999999987543   7899999999999999999999996532111  1111111110 


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                        ...          .........+.+++.+|++.||.+||++.|++++|+.+
T Consensus       264 --~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  304 (317)
T 2buj_A          264 --LSI----------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL  304 (317)
T ss_dssp             ----C----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             --CCC----------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence              000          00111234588999999999999999999999999876

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3e-39  Score=339.99  Aligned_cols=259  Identities=27%  Similarity=0.395  Sum_probs=204.4

Q ss_pred             HHhhc-cccccCceEEEEEEEC---CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          410 KMLEK-KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       410 ~~~~~-~IG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      +.+.+ .||+|+||+||+|.+.   +++.||||+++.....  ....+.+|+++++.++||||+++++++ ..+..++||
T Consensus        18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~   96 (291)
T 1xbb_A           18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM   96 (291)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred             hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence            34445 8999999999999653   4688999998754322  246789999999999999999999999 567789999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+++++|.+++..    ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        97 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (291)
T 1xbb_A           97 EMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  169 (291)
T ss_dssp             ECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence            99999999999953    34588999999999999999999998   999999999999999999999999999986544


Q ss_pred             CCCcc--eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          564 GASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       564 ~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      .....  .....||+.|+|||.+.+..++.++|||||||++|||++ |+.||......    .+...    +..+...  
T Consensus       170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~----~~~~~~~--  239 (291)
T 1xbb_A          170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTAM----LEKGERM--  239 (291)
T ss_dssp             TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHHH----HHTTCCC--
T ss_pred             CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHH----HHcCCCC--
Confidence            33322  122346789999999998889999999999999999999 99999765421    12221    1122111  


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIEREAA  693 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~~~~~  693 (736)
                             ..+......+.+++..|++.||.+||++.||++.|+++........
T Consensus       240 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~  285 (291)
T 1xbb_A          240 -------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG  285 (291)
T ss_dssp             -------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhcc
Confidence                   1112223468899999999999999999999999999987654443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.6e-39  Score=345.80  Aligned_cols=262  Identities=27%  Similarity=0.426  Sum_probs=207.8

Q ss_pred             HHHHhhccccccCceEEEEEEE------CCCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCC-e
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKL------KDGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEG-R  478 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~------~~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~-~  478 (736)
                      ..+.+.+.||+|+||+||+|++      .+++.||||+++.... ...+.+.+|+.+++++ +||||+++++++...+ .
T Consensus        27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  106 (316)
T 2xir_A           27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP  106 (316)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred             hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence            3455678999999999999974      2468899999976533 2345688999999999 7999999999987654 5


Q ss_pred             EEEEEEecCCCCHHHHhhccccc------------ccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLTH------------EQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK  546 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~  546 (736)
                      .++||||+++|+|.+++......            ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~  183 (316)
T 2xir_A          107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE  183 (316)
T ss_dssp             CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred             eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECC
Confidence            89999999999999999654321            12278999999999999999999998   9999999999999999


Q ss_pred             CCcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccH
Q 004689          547 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI  624 (736)
Q Consensus       547 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l  624 (736)
                      ++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |..||.......   .+
T Consensus       184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~  260 (316)
T 2xir_A          184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EF  260 (316)
T ss_dssp             GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---HH
T ss_pred             CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH---HH
Confidence            999999999999865443322 2334568899999999999999999999999999999998 999997654221   11


Q ss_pred             HHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          625 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       625 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                      ..    .+..+...     .....    ....+.+++..|++.||.+|||+.||+++|+.++..
T Consensus       261 ~~----~~~~~~~~-----~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          261 CR----RLKEGTRM-----RAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             HH----HHHHTCCC-----CCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH----HhccCccC-----CCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            11    11111111     01111    223588899999999999999999999999998753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.6e-39  Score=353.27  Aligned_cols=268  Identities=19%  Similarity=0.259  Sum_probs=201.0

Q ss_pred             HHHhhcccccc--CceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          409 TKMLEKKIGSG--GFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       409 ~~~~~~~IG~G--~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      .|.+.+.||+|  +||+||+|+.. +++.||||++.....  .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus        26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  105 (389)
T 3gni_B           26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT  105 (389)
T ss_dssp             GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence            35567899999  99999999987 689999999975432  23456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+++|+|.+++....  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||.+.....
T Consensus       106 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          106 SFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             ECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            9999999999986432  24588999999999999999999998   999999999999999999999999999864322


Q ss_pred             CCC------cceecccccccccCcccccc--CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh-h-
Q 004689          564 GAS------HVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI-E-  633 (736)
Q Consensus       564 ~~~------~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~-~-  633 (736)
                      ...      .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.........+........ . 
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            111      11223468999999999987  6799999999999999999999999976543221111110000000 0 


Q ss_pred             ----cC-------------Ccceecc---Ccc------CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          634 ----SG-------------DIQGIID---PSL------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       634 ----~~-------------~~~~~~d---~~l------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          ..             .+...+.   +..      ...+.......+.+++.+|++.||++|||+.|++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                00             0000000   000      000111223458899999999999999999999876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-38  Score=338.99  Aligned_cols=257  Identities=17%  Similarity=0.272  Sum_probs=196.8

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||.||+|... +++.||+|++......   ....+.+|+.++++++||||+++++++..++..++||||
T Consensus        36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  115 (309)
T 2h34_A           36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL  115 (309)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence            456789999999999999876 6889999998754322   236688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++++|.+++..    ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus       116 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          116 INGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             CCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            999999999853    34688999999999999999999998   99999999999999999999999999997654433


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      ........||+.|+|||++.+..++.++||||||+++|||++|+.||......    .+    ......... .  ....
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~----~~~~~~~~~-~--~~~~  257 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VM----GAHINQAIP-R--PSTV  257 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HH----HHHHHSCCC-C--GGGT
T ss_pred             cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HH----HHHhccCCC-C--cccc
Confidence            33334456999999999999999999999999999999999999999765421    11    111111110 0  0011


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIVI  688 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~~~~~  688 (736)
                      ...    ....+.+++.+|++.||++|| +++++++.|+.++..
T Consensus       258 ~~~----~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          258 RPG----IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             STT----CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             CCC----CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            111    223588899999999999999 999999999987543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.2e-40  Score=375.37  Aligned_cols=254  Identities=25%  Similarity=0.426  Sum_probs=206.5

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.+.++||+|+||.||+|.+..+..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+.+
T Consensus       268 ~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~  345 (535)
T 2h8h_A          268 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK  345 (535)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred             hhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcC
Confidence            445678999999999999999988899999997543 335679999999999999999999999876 678999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++...  ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.........
T Consensus       346 gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  420 (535)
T 2h8h_A          346 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  420 (535)
T ss_dssp             EEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred             CcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence            9999999532  234588999999999999999999998   99999999999999999999999999998654322122


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      .....++..|+|||++....++.++|||||||+||||++ |+.||.+....    .+...    +..+...         
T Consensus       421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~----~~~~~----i~~~~~~---------  483 (535)
T 2h8h_A          421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQ----VERGYRM---------  483 (535)
T ss_dssp             TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH----HHHHH----HHTTCCC---------
T ss_pred             ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH----HHcCCCC---------
Confidence            233457889999999999999999999999999999999 99999765421    12221    1222110         


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      ..+......+.+++.+|++.||++|||+.+|++.|+++.
T Consensus       484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            111222346889999999999999999999999998764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.4e-38  Score=335.12  Aligned_cols=262  Identities=22%  Similarity=0.325  Sum_probs=204.8

Q ss_pred             HHHHhhccccccCceEEEEEEE-CCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeee-eeCCeEEEEEEe
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEF  485 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~~lV~e~  485 (736)
                      ..|.+.+.||+|+||+||+|+. .+++.||||++....  ....+.+|+.+++.++|++++..+.++ ......++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence            3456788999999999999987 478899999875443  245688999999999988877766655 667788999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE---cCCCcEEEEeecCCcccc
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl---~~~~~~kl~DFGla~~~~  562 (736)
                      + +++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||+   +.++.+||+|||+++...
T Consensus        87 ~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           87 L-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             C-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             c-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9 99999998532   34589999999999999999999998   99999999999999   788999999999998654


Q ss_pred             CCCCc------ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          563 DGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       563 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      .....      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.......... .
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~  238 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-P  238 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-C
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc-h
Confidence            43221      2234569999999999999999999999999999999999999998755333333332222222111 0


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                      ..     .+...+    ...+.+++..|++.+|++||++.+|++.|+++...
T Consensus       239 ~~-----~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          239 IE-----VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HH-----HHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hh-----hhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            00     001111    24588999999999999999999999999998754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.4e-39  Score=344.38  Aligned_cols=241  Identities=23%  Similarity=0.341  Sum_probs=199.4

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--------cchhhhhHHHHHhhcCCCceeeEeeeeeeCCe
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR  478 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  478 (736)
                      ..|.+.+.||+|+||+||+|... +++.||||++......        ....+.+|+.++++++||||+++++++.+.+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            45666789999999999999865 6889999999765321        23468889999999999999999999999999


Q ss_pred             EEEEEEecCCC-CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecC
Q 004689          479 SVLVYEFMHNG-TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL  557 (736)
Q Consensus       479 ~~lV~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGl  557 (736)
                      .++||||+.+| +|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~  176 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS  176 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence            99999999777 99998853    34689999999999999999999998   999999999999999999999999999


Q ss_pred             CccccCCCCcceecccccccccCccccccCcC-CCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          558 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       558 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      ++.......  .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......                  
T Consensus       177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------  236 (335)
T 3dls_A          177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------  236 (335)
T ss_dssp             CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------
T ss_pred             ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------
Confidence            986544322  234569999999999988776 78899999999999999999999753210                  


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          .......  +......+.+++..|++.||++|||+.|++++
T Consensus       237 ----~~~~~~~--~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 ----VEAAIHP--PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----TTTCCCC--SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----HhhccCC--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0000000  01122358899999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-39  Score=353.54  Aligned_cols=254  Identities=30%  Similarity=0.472  Sum_probs=192.4

Q ss_pred             HhhccccccCceEEEEEEEC--CC--cEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeee-eCCeEEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK--DG--KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVYE  484 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~--~~--~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~lV~e  484 (736)
                      .+.+.||+|+||+||+|++.  ++  ..||||+++... ......+.+|+.++++++||||+++++++. .++..++|||
T Consensus        92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e  171 (373)
T 3c1x_A           92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  171 (373)
T ss_dssp             EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred             ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence            35678999999999999864  22  368999986543 233567899999999999999999999875 4567899999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++|+|.+++...   ...+++..++.++.|+++||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       172 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          172 YMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             CCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             CCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence            99999999999632   34578889999999999999999998   9999999999999999999999999999865332


Q ss_pred             CCc---ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          565 ASH---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       565 ~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      ...   ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......    .+.....    .+...  
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~----~~~~~~~----~~~~~--  315 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLL----QGRRL--  315 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS----CHHHHHH----TTCCC--
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH----HHHHHHH----cCCCC--
Confidence            211   2233457889999999999999999999999999999999 67777654421    2222211    11110  


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ..       +......+.+++.+|++.+|++||++.|+++.|+++..
T Consensus       316 ~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          316 LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            00       11123458899999999999999999999999998864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-39  Score=348.80  Aligned_cols=254  Identities=25%  Similarity=0.317  Sum_probs=186.4

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcC-CCceeeEeeeee--------eCCe
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQ--------EEGR  478 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~--------~~~~  478 (736)
                      .+.+.+.||+|+||.||+|++. +++.||||++..........+.+|+.+++++. ||||+++++++.        ....
T Consensus        29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~  108 (337)
T 3ll6_A           29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE  108 (337)
T ss_dssp             EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred             eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence            4566789999999999999975 68999999987665555677899999999996 999999999983        3445


Q ss_pred             EEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCEEEcCCCcEEEEeec
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLDKHMRAKVSDFG  556 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~--iiHrDikp~NILl~~~~~~kl~DFG  556 (736)
                      .++||||+. |+|.+++.... ....+++..++.++.|++.||.|||+.   +  |+||||||+|||++.++.+||+|||
T Consensus       109 ~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          109 FLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             EEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             EEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCc
Confidence            799999996 79999885432 234689999999999999999999998   7  9999999999999999999999999


Q ss_pred             CCccccCCCCcc-----------eecccccccccCcccc---ccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccc
Q 004689          557 LSKFAVDGASHV-----------SSIVRGTVGYLDPEYY---ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR  622 (736)
Q Consensus       557 la~~~~~~~~~~-----------~~~~~gt~~Y~aPE~~---~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~  622 (736)
                      +++.........           .....||+.|+|||++   .+..++.++|||||||++|||++|+.||......    
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----  259 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----  259 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH----
Confidence            998654332211           1134589999999998   5667889999999999999999999999754311    


Q ss_pred             cHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          623 NIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       623 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      .+..        +...        ..........+.+++..|++.||.+||++.|++++|+++..
T Consensus       260 ~~~~--------~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~  308 (337)
T 3ll6_A          260 RIVN--------GKYS--------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA  308 (337)
T ss_dssp             --------------CC--------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Hhhc--------Cccc--------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1110        0000        00001111247789999999999999999999999998864

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.1e-39  Score=355.95  Aligned_cols=249  Identities=23%  Similarity=0.316  Sum_probs=194.4

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCc--ccchhhhhHHHHHhhcC--CCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||.||+|...+++.||||++.....  .....+.+|+++|++++  ||||+++++++...+..++||| 
T Consensus        58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-  136 (390)
T 2zmd_A           58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-  136 (390)
T ss_dssp             EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred             eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence            556789999999999999988899999999875432  23467899999999996  5999999999999999999999 


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +.+++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++ ++.+||+|||+++......
T Consensus       137 ~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          137 CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            678899999853    34678889999999999999999998   999999999999995 5899999999998654332


Q ss_pred             Cc-ceecccccccccCcccccc-----------CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh
Q 004689          566 SH-VSSIVRGTVGYLDPEYYIS-----------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE  633 (736)
Q Consensus       566 ~~-~~~~~~gt~~Y~aPE~~~~-----------~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~  633 (736)
                      .. ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....      ......... 
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~~~~-  281 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAII-  281 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHH-
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH------HHHHHHHHh-
Confidence            22 2344579999999999865           3688899999999999999999999975431      111111111 


Q ss_pred             cCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          634 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       634 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                              ++.....++......+.+++..|++.||.+||++.|++++-
T Consensus       282 --------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          282 --------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             --------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             --------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence                    11111111111134578999999999999999999998763

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.3e-39  Score=346.36  Aligned_cols=252  Identities=23%  Similarity=0.335  Sum_probs=200.1

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEe
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      ..|.+.+.||+|+||.||+|... +++.||||++....    ....+|++++.++ +||||+++++++.+.+..++||||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            34666789999999999999886 68899999986542    3456899999888 799999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC----CcEEEEeecCCccc
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKFA  561 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~----~~~kl~DFGla~~~  561 (736)
                      +++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||+..+    +.+||+|||+++..
T Consensus        98 ~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           98 MKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            999999999853    34689999999999999999999998   99999999999998543    35999999999865


Q ss_pred             cCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      ..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||..... .....+..    .+..+...  +
T Consensus       171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~----~i~~~~~~--~  242 (342)
T 2qr7_A          171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILA----RIGSGKFS--L  242 (342)
T ss_dssp             BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHH----HHHHCCCC--C
T ss_pred             cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHH----HHccCCcc--c
Confidence            44322 23345799999999999888899999999999999999999999975431 11112222    22222221  1


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      ..    .+.......+.+++.+|+..||++||++.|++++-
T Consensus       243 ~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          243 SG----GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             CS----TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred             Cc----cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence            11    11112234588999999999999999999998763

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-39  Score=339.11  Aligned_cols=255  Identities=24%  Similarity=0.358  Sum_probs=200.5

Q ss_pred             hhccccccCceEEEEEEECC----CcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeE-EEEEEe
Q 004689          412 LEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS-VLVYEF  485 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~-~lV~e~  485 (736)
                      +.++||+|+||+||+|.+.+    +..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. ++||||
T Consensus        25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~  104 (298)
T 3pls_A           25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY  104 (298)
T ss_dssp             EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred             cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence            35789999999999998642    23799999875432 3346788999999999999999999999876655 999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +.+|+|.+++..   ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus       105 ~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          105 MCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             CTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             ccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999964   235678899999999999999999998   99999999999999999999999999997553321


Q ss_pred             ---CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          566 ---SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       566 ---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                         ........||+.|+|||.+.+..++.++|||||||++|||++|..|+......   ..+......    +..     
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~~----~~~-----  246 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP---FDLTHFLAQ----GRR-----  246 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG---GGHHHHHHT----TCC-----
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH---HHHHHHhhc----CCC-----
Confidence               11223346889999999999999999999999999999999966554332211   122222211    110     


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                          ...+......+.+++..|++.||.+|||+.|+++.|++++..
T Consensus       247 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          247 ----LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                001111224588999999999999999999999999998653

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.4e-39  Score=339.07  Aligned_cols=255  Identities=30%  Similarity=0.467  Sum_probs=198.7

Q ss_pred             HHhhccccccCceEEEEEEECC----CcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeee-eCCeEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQ-EEGRSVLVY  483 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~-~~~~~~lV~  483 (736)
                      +.+.+.||+|+||+||+|.+.+    ...+|+|++..... .....+.+|+.++++++||||+++++++. .++..++||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  106 (298)
T 3f66_A           27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  106 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence            4456899999999999998653    23589999875432 33467889999999999999999999864 556789999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+++|+|.+++..   ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....
T Consensus       107 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          107 PYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             ECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             eCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999964   235578899999999999999999998   999999999999999999999999999976533


Q ss_pred             CCC---cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          564 GAS---HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       564 ~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ...   .......||+.|+|||.+.+..++.++|||||||++|||++ |.+||......    .+.....    .+... 
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~----~~~~~~~----~~~~~-  251 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DITVYLL----QGRRL-  251 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT----THHHHHH----TTCCC-
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH----HHHHHHh----cCCCC-
Confidence            221   12233457889999999999999999999999999999999 55566544321    2222111    11100 


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                       ..       +......+.+++..|++.+|++||++.|+++.|++++.
T Consensus       252 -~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          252 -LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             -CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CC-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             00       11122458899999999999999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.4e-39  Score=372.33  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=200.3

Q ss_pred             cccccCceEEEEEEEC---CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          415 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       415 ~IG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      .||+|+||.||+|.+.   ++..||||+++.... .....+.+|+++|++++||||++++++|.. +..++||||+.+|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999874   456799999976532 345679999999999999999999999976 56899999999999


Q ss_pred             HHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc--
Q 004689          491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV--  568 (736)
Q Consensus       491 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~--  568 (736)
                      |.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.........  
T Consensus       422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            99999542   45689999999999999999999998   99999999999999999999999999998654332221  


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......    .+..    .+..+...         
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~~~~----~i~~~~~~---------  558 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMA----FIEQGKRM---------  558 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH----HHHH----HHHTTCCC---------
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH----HHHH----HHHcCCCC---------
Confidence            122346789999999999999999999999999999998 99999865522    2222    12222211         


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                      ..+......+.+++..|++.+|++||++.+|++.|+.+...
T Consensus       559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            11222335688999999999999999999999999987643

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.2e-39  Score=340.76  Aligned_cols=262  Identities=32%  Similarity=0.546  Sum_probs=195.1

Q ss_pred             HHHHHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          404 DIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       404 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      |+....+.+.++||+|+||+||+|+..  ..||||+++....  .....+.+|++++++++||||+++++++. ....++
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~l   96 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI   96 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEE
Confidence            344455667889999999999999865  4699999875432  23456899999999999999999999764 456799


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        97 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence            99999999999998532   45689999999999999999999998   9999999999999999999999999999754


Q ss_pred             cCCC-CcceecccccccccCccccc---cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          562 VDGA-SHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       562 ~~~~-~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                      .... ........||+.|+|||++.   +..++.++|||||||++|||++|+.||......   ..+...    ...+..
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~----~~~~~~  243 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEM----VGRGSL  243 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH---HHHHHH----HHHTSC
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH---HHHHHH----hccccc
Confidence            3321 22233456999999999986   567888999999999999999999999765421   112221    122221


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      .....     .........+.+++..|++.+|.+||++.|+++.|+++.
T Consensus       244 ~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          244 SPDLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CCCTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             Ccchh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            11111     111222356889999999999999999999999998763

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.6e-39  Score=341.70  Aligned_cols=264  Identities=22%  Similarity=0.284  Sum_probs=195.7

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      |.+.+.||+|+||+||+|... +++.||||++......  ....+.+|++++++++||||+++++++...+..++||||+
T Consensus         5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (311)
T 4agu_A            5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC   84 (311)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence            345688999999999999986 5899999998654322  2456789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           85 DHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             SEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             CCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            99999988742    34588999999999999999999998   999999999999999999999999999986543322


Q ss_pred             cceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHH-------HhhhcCCc-
Q 004689          567 HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK-------LHIESGDI-  637 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~-------~~~~~~~~-  637 (736)
                       ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+.....       ........ 
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence             2234568999999999976 6789999999999999999999999976542221111111000       00000000 


Q ss_pred             c--eeccCccCCc---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 Q--GIIDPSLLDE---YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~--~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .  ..-++.-...   ........+.+++..|++.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0  0000000000   001123458899999999999999999999876

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.2e-39  Score=344.91  Aligned_cols=256  Identities=27%  Similarity=0.446  Sum_probs=202.4

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcE--EEEEEeccCC-cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKE--IAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~--vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      +.+.+.||+|+||.||+|+.. ++..  +|+|++.... ......+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus        27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e  106 (327)
T 1fvr_A           27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE  106 (327)
T ss_dssp             CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence            456789999999999999875 4554  4999887532 33456789999999999 89999999999999999999999


Q ss_pred             ecCCCCHHHHhhccc------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEE
Q 004689          485 FMHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKV  552 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl  552 (736)
                      |+++|+|.+++....            .....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL  183 (327)
T 1fvr_A          107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI  183 (327)
T ss_dssp             CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEE
Confidence            999999999996542            2234689999999999999999999998   9999999999999999999999


Q ss_pred             EeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHh
Q 004689          553 SDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH  631 (736)
Q Consensus       553 ~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~  631 (736)
                      +|||+++.....  .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......    .+.    ..
T Consensus       184 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~----~~~----~~  253 (327)
T 1fvr_A          184 ADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELY----EK  253 (327)
T ss_dssp             CCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHH----HH
T ss_pred             cccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH----HHH----HH
Confidence            999998743211  11223457889999999998889999999999999999998 99999765421    111    11


Q ss_pred             hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      +..+..     .    ..+......+.+++.+|++.+|.+||++.|++++|+.++.
T Consensus       254 ~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  300 (327)
T 1fvr_A          254 LPQGYR-----L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  300 (327)
T ss_dssp             GGGTCC-----C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhcCCC-----C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            122110     0    1111223458899999999999999999999999998864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.9e-39  Score=363.68  Aligned_cols=252  Identities=23%  Similarity=0.342  Sum_probs=203.1

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.+.||+|+||.||+|+.. +|+.||||++.....   .....+.+|+.++++++||||+++++++......++||||++
T Consensus       189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~  268 (543)
T 3c4z_A          189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN  268 (543)
T ss_dssp             EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred             EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence            3467999999999999986 689999999965422   224567889999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++.........+++..+..++.|++.||.|||++   +|+||||||+|||++.++++||+|||+++........
T Consensus       269 gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~  345 (543)
T 3c4z_A          269 GGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK  345 (543)
T ss_dssp             TCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC
T ss_pred             CCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc
Confidence            9999999976544455789999999999999999999998   9999999999999999999999999999865443322


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                       ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.+.   .. .+..          
T Consensus       346 -~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~---i~-~~~~----------  410 (543)
T 3c4z_A          346 -TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR---VL-EQAV----------  410 (543)
T ss_dssp             -BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHH---HH-HCCC----------
T ss_pred             -cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHH---Hh-hccc----------
Confidence             23457999999999999999999999999999999999999999865422111122221   11 1111          


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD  681 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~ev~~~  681 (736)
                      .++......+.+++.+|++.||++||++     .||.++
T Consensus       411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            1111223457889999999999999975     666654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.8e-39  Score=352.23  Aligned_cols=242  Identities=26%  Similarity=0.328  Sum_probs=189.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHH-HhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTL-LSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~i-l~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      +.+.+.||+|+||.||+|+.+ +++.||||+++....   .....+..|..+ ++.++||||+++++++.+.+..++|||
T Consensus        40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E  119 (373)
T 2r5t_A           40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD  119 (373)
T ss_dssp             EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence            456789999999999999986 578899999976532   223456667776 577899999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+++.....
T Consensus       120 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          120 YINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            9999999999853    35688889999999999999999998   9999999999999999999999999999854332


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                      . ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+       . .+.+      .
T Consensus       193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i-------~-~~~~------~  257 (373)
T 2r5t_A          193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI-------L-NKPL------Q  257 (373)
T ss_dssp             C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH-------H-HSCC------C
T ss_pred             C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------H-hccc------C
Confidence            2 2334567999999999999999999999999999999999999999765422211111       1 1111      1


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISE  677 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  677 (736)
                      +....    ...+.+++.+|++.||.+||++.+
T Consensus       258 ~~~~~----~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          258 LKPNI----TNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             CCSSS----CHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             CCCCC----CHHHHHHHHHHcccCHHhCCCCCC
Confidence            11122    235788999999999999999853

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.6e-38  Score=348.43  Aligned_cols=248  Identities=21%  Similarity=0.243  Sum_probs=190.6

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhh-cCCCceeeEeeeeee----CCeEEEEEEec
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSR-IHHRNLVQFLGYCQE----EGRSVLVYEFM  486 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~-l~HpnIv~l~~~~~~----~~~~~lV~e~~  486 (736)
                      .+.||+|+||+||+|... +++.||||++..     ...+.+|++++.+ .+||||+++++++..    ....++||||+
T Consensus        67 ~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~  141 (400)
T 1nxk_A           67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL  141 (400)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             cceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence            368999999999999876 688999999852     3457789988754 489999999999875    56789999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeecCCccccC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~---~~~~kl~DFGla~~~~~  563 (736)
                      ++|+|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++....
T Consensus       142 ~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          142 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             CSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             CCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            999999999643  234589999999999999999999998   9999999999999998   78999999999986533


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+.    .+....  ..
T Consensus       217 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~~~~~--~~  288 (400)
T 1nxk_A          217 HN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MGQYEF--PN  288 (400)
T ss_dssp             ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HTCCCC--CT
T ss_pred             CC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cCcccC--CC
Confidence            22  22345689999999999999999999999999999999999999976553222222222221    121110  00


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      .....    ....+.+++..|++.||++|||+.|++++-
T Consensus       289 ~~~~~----~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          289 PEWSE----VSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             TTTTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            00111    234588999999999999999999999874

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1e-39  Score=347.28  Aligned_cols=256  Identities=24%  Similarity=0.379  Sum_probs=192.6

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCccc---chhhhhHHHHHhhcCCCceeeEeeeeeeCCe----EE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---KREFTNEVTLLSRIHHRNLVQFLGYCQEEGR----SV  480 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~----~~  480 (736)
                      .|.+.+.||+|+||.||+|+.. +++.||||+++......   ...+.+|+.++++++||||+++++++.....    .+
T Consensus        13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~   92 (311)
T 3ork_A           13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY   92 (311)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence            3556789999999999999874 68899999997653322   3468899999999999999999999876543    49


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+++|+|.+++..    ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        93 lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           93 IVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            99999999999999853    34689999999999999999999998   999999999999999999999999999986


Q ss_pred             ccCCCC--cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          561 AVDGAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       561 ~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......       .............
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~  238 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIP  238 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCC
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCCCCC
Confidence            543322  1223456999999999999999999999999999999999999999765421       1111111111110


Q ss_pred             eeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHH-HHHHH
Q 004689          639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK-DIQDA  685 (736)
Q Consensus       639 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~-~L~~~  685 (736)
                      .   .....    .....+.+++.+|++.||++||++.++++ .|.+.
T Consensus       239 ~---~~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          239 P---SARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             H---HHHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             c---ccccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            0   00011    12245889999999999999997666554 34433

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.1e-38  Score=334.15  Aligned_cols=250  Identities=24%  Similarity=0.348  Sum_probs=200.8

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      |.+.+.||+|+||.||+|... +++.||+|++.....  .....+.+|+.++++++||||+++++++...+..++||||+
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   87 (284)
T 3kk8_A            8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV   87 (284)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence            456789999999999999876 588999999865432  23456889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc---EEEEeecCCccccC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGLSKFAVD  563 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~---~kl~DFGla~~~~~  563 (736)
                      ++|+|.+.+..    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.   +||+|||++.....
T Consensus        88 ~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           88 TGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            99999988843    35688999999999999999999998   9999999999999987655   99999999976543


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+...    +..+.... . .
T Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~----~~~~~~~~-~-~  228 (284)
T 3kk8_A          161 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----RLYAQ----IKAGAYDY-P-S  228 (284)
T ss_dssp             SC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----HHHTCCCC-C-T
T ss_pred             Cc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh----HHHHH----HHhccccC-C-c
Confidence            32  223356999999999999999999999999999999999999999765421    11111    11111110 0 0


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      .....    ....+.+++..|++.||++|||+.|++++-
T Consensus       229 ~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (284)
T 3kk8_A          229 PEWDT----VTPEAKSLIDSMLTVNPKKRITADQALKVP  263 (284)
T ss_dssp             TTTTT----SCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred             hhhcc----cCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence            00111    224578999999999999999999998863

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.2e-38  Score=333.45  Aligned_cols=251  Identities=28%  Similarity=0.435  Sum_probs=205.0

Q ss_pred             HHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeee-------
Q 004689          404 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-------  475 (736)
Q Consensus       404 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-------  475 (736)
                      +.....+.+.+.||+|+||.||+|... +++.||+|++...    ...+.+|++++++++||||+++++++..       
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            344456667889999999999999986 7899999998643    2467899999999999999999998854       


Q ss_pred             ---------CCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 004689          476 ---------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK  546 (736)
Q Consensus       476 ---------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~  546 (736)
                               ....++||||+++|+|.+++...  ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD  157 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence                     45579999999999999999643  234688999999999999999999998   9999999999999999


Q ss_pred             CCcEEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHH
Q 004689          547 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ  626 (736)
Q Consensus       547 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~  626 (736)
                      ++.+||+|||++.......  ......||+.|+|||++.+..++.++|||||||++|||++|..|+....         .
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~  226 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS---------K  226 (284)
T ss_dssp             TTEEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---------H
T ss_pred             CCCEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH---------H
Confidence            9999999999997654432  2233468999999999999999999999999999999999998875322         1


Q ss_pred             HHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          627 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       627 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      .. .....+.+        ...++    ..+.+++.+|++.||.+||++.|++++|+.+..
T Consensus       227 ~~-~~~~~~~~--------~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          227 FF-TDLRDGII--------SDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             HH-HHHHTTCC--------CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             HH-HHhhcccc--------cccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            11 11112211        11222    347889999999999999999999999998743

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.6e-38  Score=333.17  Aligned_cols=260  Identities=22%  Similarity=0.325  Sum_probs=204.5

Q ss_pred             HHhhccccccCceEEEEEEE-CCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeee-eeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYC-QEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||+|+||.||+|+. .+++.||||++....  ....+.+|+.+++.++|++++..+.++ ......++||||+ 
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   87 (296)
T 3uzp_A           11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-   87 (296)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence            45678999999999999987 478999999986543  345688999999999988876666655 5677889999999 


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE---cCCCcEEEEeecCCccccCC
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl---~~~~~~kl~DFGla~~~~~~  564 (736)
                      +++|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||+   +.++.+||+|||+++.....
T Consensus        88 ~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           88 GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            89999998532   34689999999999999999999998   99999999999999   48899999999999865443


Q ss_pred             CCc------ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          565 ASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       565 ~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      ...      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.......... .. 
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~-  239 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI-  239 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-CH-
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC-ch-
Confidence            321      1234569999999999999999999999999999999999999998754332222222222211111 00 


Q ss_pred             eeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       639 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                          +.+...+    ...+.+++..|++.||.+||++.+|++.|+++...
T Consensus       240 ----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          240 ----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             ----HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ----HHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence                0011112    24588999999999999999999999999988653

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9.5e-39  Score=338.39  Aligned_cols=250  Identities=24%  Similarity=0.405  Sum_probs=201.1

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      ..|.+.+.||+|+||.||+|+.. +++.||+|++..........+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV   88 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence            45667889999999999999876 68999999998655445567899999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE---cCCCcEEEEeecCCccccC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl---~~~~~~kl~DFGla~~~~~  563 (736)
                      ++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+||++   +.++.+||+|||+++....
T Consensus        89 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           89 SGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            99999998843    34688999999999999999999998   99999999999999   7789999999999875432


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .+..    .+.++...  ...
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~----~i~~~~~~--~~~  228 (304)
T 2jam_A          162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES----KLFE----KIKEGYYE--FES  228 (304)
T ss_dssp             B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHH----HHHHCCCC--CCT
T ss_pred             C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH----HHHH----HHHcCCCC--CCc
Confidence            2   223346899999999999999999999999999999999999999765421    1111    11122110  011


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .....    ....+.+++..|++.||++||++.|++++
T Consensus       229 ~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          229 PFWDD----ISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             TTTTT----SCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11112    23458899999999999999999999875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.8e-38  Score=336.42  Aligned_cols=256  Identities=23%  Similarity=0.318  Sum_probs=195.2

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      ++.||+|+||+||+|... +++.||||++..........+.+|++++.++ +||||+++++++.+.+..++||||+++|+
T Consensus        18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   97 (316)
T 2ac3_A           18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS   97 (316)
T ss_dssp             CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred             CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence            478999999999999865 6899999999766555567789999999985 79999999999999999999999999999


Q ss_pred             HHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc---EEEEeecCCccccCCC--
Q 004689          491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFGLSKFAVDGA--  565 (736)
Q Consensus       491 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~---~kl~DFGla~~~~~~~--  565 (736)
                      |.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.   +||+|||+++......  
T Consensus        98 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~  170 (316)
T 2ac3_A           98 ILSHIHK----RRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC  170 (316)
T ss_dssp             HHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred             HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence            9999853    34688999999999999999999998   9999999999999998776   9999999987543211  


Q ss_pred             ----CcceecccccccccCcccccc-----CcCCCcchhHHHHHHHHHHHhCCCcCccccccccccc-------HHHHHH
Q 004689          566 ----SHVSSIVRGTVGYLDPEYYIS-----QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN-------IVQWAK  629 (736)
Q Consensus       566 ----~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~-------l~~~~~  629 (736)
                          ........||+.|+|||++..     ..++.++|||||||++|||++|+.||......+....       ......
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  250 (316)
T 2ac3_A          171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF  250 (316)
T ss_dssp             -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred             ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence                111223459999999999975     5689999999999999999999999976542211000       001111


Q ss_pred             HhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          630 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       630 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..+..+...-  ......    .....+.+++.+|++.||++|||+.|++++
T Consensus       251 ~~i~~~~~~~--~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          251 ESIQEGKYEF--PDKDWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHCCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhccCccc--Cchhcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            1122221100  000000    112458899999999999999999999875

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=7.3e-39  Score=364.46  Aligned_cols=251  Identities=27%  Similarity=0.360  Sum_probs=203.8

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus       186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy  265 (576)
T 2acx_A          186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL  265 (576)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence            345688999999999999886 68999999986542   22345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++....  ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++++||+|||+++......
T Consensus       266 ~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          266 MNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             CCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence            99999999986432  33489999999999999999999998   99999999999999999999999999998654332


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                        .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+...+..    ..      .  
T Consensus       341 --~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----~~------~--  406 (576)
T 2acx_A          341 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----VP------E--  406 (576)
T ss_dssp             --CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH----CC------C--
T ss_pred             --cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc----cc------c--
Confidence              233457999999999999999999999999999999999999999865422222222222111    11      0  


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                        .++......+.+++.+|++.||.+||     ++.||++|
T Consensus       407 --~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          407 --EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             --cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence              11111224588999999999999999     78898876

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.7e-39  Score=374.76  Aligned_cols=249  Identities=27%  Similarity=0.412  Sum_probs=198.9

Q ss_pred             ccccccCceEEEEEEEC---CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.||+|+||+||+|.+.   .++.||||+++....  .....+.+|+++|++++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   467899999975432  234679999999999999999999999964 557899999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc-
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-  567 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~-  567 (736)
                      |+|.+++..    ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus       454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999999953    35688999999999999999999998   9999999999999999999999999999865443321 


Q ss_pred             -ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          568 -VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       568 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                       ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....    .+.    ..+..+...       
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~----~~~----~~i~~~~~~-------  591 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVT----AMLEKGERM-------  591 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHH----HHHHTTCCC-------
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHH----HHHHcCCCC-------
Confidence             2233457889999999999999999999999999999998 99999866521    111    122222211       


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                        ..+......+.+++..|++.||++||++.+|++.|+++..
T Consensus       592 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          592 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence              1122233568899999999999999999999999998753

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.5e-39  Score=335.78  Aligned_cols=245  Identities=24%  Similarity=0.397  Sum_probs=197.7

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||+||+|... +++.||||++....   ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (279)
T 3fdn_A           11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   90 (279)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence            446789999999999999876 57789999986432   22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++..    ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++...... 
T Consensus        91 ~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-  162 (279)
T 3fdn_A           91 APLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  162 (279)
T ss_dssp             CTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence            999999999843    35688999999999999999999998   9999999999999999999999999998644322 


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                        ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+    ...    .+.....      . 
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~----~~~~~~~------~-  225 (279)
T 3fdn_A          163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----TYK----RISRVEF------T-  225 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH----HHHHTCC------C-
T ss_pred             --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH----HHH----HHHhCCC------C-
Confidence              2233468999999999999999999999999999999999999997654211    111    1111110      1 


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                         .+......+.+++.+|++.||++||+++|++++-
T Consensus       226 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          226 ---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             ---CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             ---CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence               1111224578899999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=342.30  Aligned_cols=268  Identities=24%  Similarity=0.384  Sum_probs=194.4

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHH--HhhcCCCceeeEeeeee-----eCCeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTL--LSRIHHRNLVQFLGYCQ-----EEGRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~i--l~~l~HpnIv~l~~~~~-----~~~~~~lV  482 (736)
                      +.+.+.||+|+||+||+|+.. ++.||||++....   ...+..|.++  +..++||||+++++++.     .....++|
T Consensus        15 y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv   90 (336)
T 3g2f_A           15 LKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV   90 (336)
T ss_dssp             EEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred             hheeeecccCCCeEEEEEEEC-CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence            446789999999999999874 8999999986432   2334444444  55689999999998553     23367899


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCC------CCceecCCCCCCCEEEcCCCcEEEEeec
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------VPAIIHRDLKSSNILLDKHMRAKVSDFG  556 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~------~~~iiHrDikp~NILl~~~~~~kl~DFG  556 (736)
                      |||+++|+|.+++..     ...++..++.++.|++.||.|||+.+      .++|+||||||+|||++.++.+||+|||
T Consensus        91 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG  165 (336)
T 3g2f_A           91 MEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG  165 (336)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred             EecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence            999999999999953     33578889999999999999999862      2389999999999999999999999999


Q ss_pred             CCccccCCC-------CcceecccccccccCcccccc-------CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccc
Q 004689          557 LSKFAVDGA-------SHVSSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR  622 (736)
Q Consensus       557 la~~~~~~~-------~~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~  622 (736)
                      +++......       ........||+.|+|||++.+       ..++.++|||||||++|||++|..|+..........
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  245 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ  245 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence            998654321       112234569999999999976       456788999999999999999987764332211111


Q ss_pred             -cHH---------HHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          623 -NIV---------QWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       623 -~l~---------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                       .+.         ...............+.....  ........+.+++.+|++.||++|||+.|+++.|++++..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~  319 (336)
T 3g2f_A          246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI  319 (336)
T ss_dssp             CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HhhhcccCCCchHHHHHhhhcccccCCCCCcccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence             111         011111111111111111111  1233556799999999999999999999999999998753

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.8e-38  Score=343.91  Aligned_cols=252  Identities=18%  Similarity=0.162  Sum_probs=202.9

Q ss_pred             HHHhhccccccCceEEEEEE------ECCCcEEEEEEeccCCcccchhhhhHHHHHhhcC---CCceeeEeeeeeeCCeE
Q 004689          409 TKMLEKKIGSGGFGVVYYGK------LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~------~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~  479 (736)
                      .|.+.+.||+|+||+||+|.      ..+++.||||++...   ...++..|++++++++   |+||+++++++...+..
T Consensus        66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            34567899999999999994      446889999998643   3456788888888886   99999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcccc-cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-----------C
Q 004689          480 VLVYEFMHNGTLKEHLYGTLT-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-----------H  547 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~-----------~  547 (736)
                      ++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++   +|+||||||+|||++.           +
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------C
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccccc
Confidence            999999999999999964322 245699999999999999999999998   9999999999999998           8


Q ss_pred             CcEEEEeecCCccccC-CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHH
Q 004689          548 MRAKVSDFGLSKFAVD-GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ  626 (736)
Q Consensus       548 ~~~kl~DFGla~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~  626 (736)
                      +.+||+|||+|+.... .........+||+.|+|||++.+..++.++|||||||++|||++|+.||........      
T Consensus       220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------  293 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------  293 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------
T ss_pred             CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------
Confidence            9999999999975432 223334556799999999999999999999999999999999999999965432100      


Q ss_pred             HHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCC-CCHHHHHHHHHHHHHH
Q 004689          627 WAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMR-PSISEVLKDIQDAIVI  688 (736)
Q Consensus       627 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~~ev~~~L~~~~~~  688 (736)
                                   .++..+.....   ...+.+++..|++.+|.+| |++.++.+.|++++..
T Consensus       294 -------------~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          294 -------------KPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             -------------EECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -------------eechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                         01111111111   2346678889999999988 5889999999988754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.3e-39  Score=360.40  Aligned_cols=245  Identities=24%  Similarity=0.407  Sum_probs=201.6

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||.||+|++. +|+.||||++.....   .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus        18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~   97 (476)
T 2y94_A           18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY   97 (476)
T ss_dssp             EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            456789999999999999986 799999999865422   2245688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......
T Consensus        98 ~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           98 VSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             CSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            999999999853    45689999999999999999999998   99999999999999999999999999998654432


Q ss_pred             CcceecccccccccCccccccCcC-CCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                        .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+....    .+..    .+..+...      
T Consensus       171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~----~~~~----~i~~~~~~------  234 (476)
T 2y94_A          171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP----TLFK----KICDGIFY------  234 (476)
T ss_dssp             --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH----HHHH----HHHTTCCC------
T ss_pred             --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH----HHHH----HHhcCCcC------
Confidence              2334579999999999988765 67999999999999999999999865422    1111    11112110      


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .....    ...+.+++.+|++.||.+|||+.|++++
T Consensus       235 ~p~~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          235 TPQYL----NPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             CCTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CCccC----CHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            01111    2357899999999999999999999975

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.2e-39  Score=345.44  Aligned_cols=263  Identities=19%  Similarity=0.214  Sum_probs=196.1

Q ss_pred             HHHHhhccccccCceEEEEEEEC----CCcEEEEEEeccCCcc-----------cchhhhhHHHHHhhcCCCceeeEeee
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSYQ-----------GKREFTNEVTLLSRIHHRNLVQFLGY  472 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~~-----------~~~~~~~E~~il~~l~HpnIv~l~~~  472 (736)
                      ..|.+.+.||+|+||+||+|...    ++..+|||++......           ....+.+|+.+++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            44567889999999999999986    5788999998754321           12346678889999999999999999


Q ss_pred             eee----CCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC
Q 004689          473 CQE----EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM  548 (736)
Q Consensus       473 ~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~  548 (736)
                      +..    ....++||||+ +++|.+++..    ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence            987    67899999999 9999999853    33789999999999999999999998   999999999999999887


Q ss_pred             --cEEEEeecCCccccCCCC------cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccc
Q 004689          549 --RAKVSDFGLSKFAVDGAS------HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN  620 (736)
Q Consensus       549 --~~kl~DFGla~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~  620 (736)
                        .+||+|||+++.......      .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... 
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-  267 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP-  267 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence              999999999976532211      11234569999999999999999999999999999999999999996532111 


Q ss_pred             cccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          621 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       621 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                       ..+ ......... .+...+......   ......+.+++..|++.||++||++.+|++.|+..
T Consensus       268 -~~~-~~~~~~~~~-~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          268 -VAV-QTAKTNLLD-ELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             -HHH-HHHHHHHHH-TTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             -HHH-HHHHHhhcc-cccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence             111 111111111 111111110000   01234688999999999999999999999999864

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1e-38  Score=334.25  Aligned_cols=251  Identities=24%  Similarity=0.365  Sum_probs=200.2

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc------cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  480 (736)
                      ..|.+.+.||+|+||.||+|+.. +++.||+|++......      ....+.+|+.++++++||||+++++++......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            45667889999999999999987 6899999998754321      2456889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC----cEEEEeec
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFG  556 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~----~~kl~DFG  556 (736)
                      +||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++    .+||+|||
T Consensus        85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999843    35689999999999999999999998   999999999999998877    89999999


Q ss_pred             CCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          557 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       557 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      ++.......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......    ....   . +....
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~---~-~~~~~  227 (283)
T 3bhy_A          158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ----ETLT---N-ISAVN  227 (283)
T ss_dssp             TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHH---H-HHTTC
T ss_pred             cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH----HHHH---H-hHhcc
Confidence            997654322  223346899999999999899999999999999999999999999765421    1111   1 11111


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..  .++....    .....+.+++.+|++.||++||++.|++++
T Consensus       228 ~~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          228 YD--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             CC--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             cC--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            00  0000111    112458899999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=344.19  Aligned_cols=262  Identities=14%  Similarity=0.202  Sum_probs=204.4

Q ss_pred             HHHhhccccccCceEEEEEEECC---------CcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceee-----------
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKD---------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ-----------  468 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~---------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~-----------  468 (736)
                      .|.+.+.||+|+||.||+|+...         ++.||||++...     ..+.+|++++++++||||++           
T Consensus        43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  117 (352)
T 2jii_A           43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL  117 (352)
T ss_dssp             EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred             eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence            45567899999999999998763         789999998643     46889999999999999998           


Q ss_pred             ----Eeeeeee-CCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEE
Q 004689          469 ----FLGYCQE-EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNIL  543 (736)
Q Consensus       469 ----l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NIL  543 (736)
                          +++++.. ....++||||+ +++|.+++...  ....+++..++.++.|++.||.|||++   +|+||||||+|||
T Consensus       118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl  191 (352)
T 2jii_A          118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF  191 (352)
T ss_dssp             SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred             CccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence                5667765 67889999999 99999999643  235689999999999999999999998   9999999999999


Q ss_pred             EcCCC--cEEEEeecCCccccCCCCc------ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccc
Q 004689          544 LDKHM--RAKVSDFGLSKFAVDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE  615 (736)
Q Consensus       544 l~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~  615 (736)
                      ++.++  .+||+|||+++........      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  9999999999765432211      123347999999999999989999999999999999999999999865


Q ss_pred             ccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          616 KFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       616 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                      ...  ...+.........  ....+.+.....   ......+.+++..|++.||++||++.||++.|++++..
T Consensus       272 ~~~--~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          272 LPN--TEDIMKQKQKFVD--KPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             TTC--HHHHHHHHHHHHH--SCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CcC--HHHHHHHHHhccC--Chhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence            411  1122222222111  112222211111   01124588999999999999999999999999998654

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.2e-39  Score=341.16  Aligned_cols=261  Identities=27%  Similarity=0.407  Sum_probs=196.9

Q ss_pred             HHHHhhccccccCceEEEEEEEC----CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCC----
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----  477 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----  477 (736)
                      ..+.+.+.||+|+||.||+|...    ++..||||+++....  .....+.+|+.++++++||||+++++++....    
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  113 (313)
T 3brb_A           34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI  113 (313)
T ss_dssp             GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred             HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence            34556789999999999999765    345899999875432  23456889999999999999999999997655    


Q ss_pred             -eEEEEEEecCCCCHHHHhhccc--ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 004689          478 -RSVLVYEFMHNGTLKEHLYGTL--THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD  554 (736)
Q Consensus       478 -~~~lV~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~D  554 (736)
                       ..++||||+++|+|.+++....  .....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~D  190 (313)
T 3brb_A          114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVAD  190 (313)
T ss_dssp             -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECS
T ss_pred             cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEee
Confidence             3599999999999999985332  2345689999999999999999999998   999999999999999999999999


Q ss_pred             ecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhh
Q 004689          555 FGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       555 FGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      ||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......    .+.....   
T Consensus       191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~~~~---  263 (313)
T 3brb_A          191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH----EMYDYLL---  263 (313)
T ss_dssp             CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHHHHH---
T ss_pred             cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH----HHHHHHH---
Confidence            999976543322 12233457889999999999999999999999999999999 88999765422    2222111   


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                       .+...     .    .+......+.+++..|++.+|.+||++.+++++|++++..
T Consensus       264 -~~~~~-----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          264 -HGHRL-----K----QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             -TTCCC-----C----CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -cCCCC-----C----CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence             11110     0    1112234588999999999999999999999999998653

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=340.22  Aligned_cols=264  Identities=27%  Similarity=0.398  Sum_probs=206.9

Q ss_pred             HHHhhccccccCceEEEEEEE-----CCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCC--eEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKL-----KDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG--RSVL  481 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~--~~~l  481 (736)
                      .+.+.+.||+|+||.||+|++     .+++.||||++........+.+.+|++++++++||||+++++++...+  ..++
T Consensus        42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  121 (326)
T 2w1i_A           42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL  121 (326)
T ss_dssp             GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEE
T ss_pred             HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEE
Confidence            345678999999999999984     368899999998665555677999999999999999999999987544  7899


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       122 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          122 IMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            99999999999999643   34588999999999999999999998   9999999999999999999999999999866


Q ss_pred             cCCCCcc--eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccc--------cccccHHHHHHHh
Q 004689          562 VDGASHV--SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFG--------ANCRNIVQWAKLH  631 (736)
Q Consensus       562 ~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~--------~~~~~l~~~~~~~  631 (736)
                      .......  .....++..|+|||.+.+..++.++|||||||++|||++|..|+......        .............
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence            4433221  22345788899999999888999999999999999999999988643200        0000111111122


Q ss_pred             hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      +..+..         ...+......+.+++.+|++.||++||++.||++.|+.+..
T Consensus       276 ~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          276 LKNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hhcCCC---------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            221111         01112223468899999999999999999999999998854

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=8.9e-39  Score=345.50  Aligned_cols=246  Identities=24%  Similarity=0.369  Sum_probs=197.4

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .+.+.+.||+|+||+||+|+.. +++.||||++......   ....+.+|++++++++||||+++++++...+..++|||
T Consensus        55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  134 (348)
T 1u5q_A           55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME  134 (348)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence            3455688999999999999874 7899999998754322   23568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+. |+|.+++..   ....+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       135 ~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          135 YCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             CCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             cCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            997 688887743   235688999999999999999999998   9999999999999999999999999999765322


Q ss_pred             CCcceecccccccccCccccc---cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          565 ASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                           ....||+.|+|||++.   ...++.++|||||||++|||++|+.||......       .......... .....
T Consensus       208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~  274 (348)
T 1u5q_A          208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNE-SPALQ  274 (348)
T ss_dssp             -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSC-CCCCC
T ss_pred             -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcC-CCCCC
Confidence                 2346999999999985   567899999999999999999999999755421       1111111111 11111


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                          ...+    ...+.+++..|++.||++|||+.|++++.
T Consensus       275 ----~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          275 ----SGHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             ----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             ----CCCC----CHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence                1111    23578899999999999999999998763

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.4e-39  Score=335.09  Aligned_cols=250  Identities=30%  Similarity=0.449  Sum_probs=196.4

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeC-CeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-GRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~lV~e~~~  487 (736)
                      .+.+.+.||+|+||+||+|... ++.||||+++...  ..+.+.+|++++++++||||+++++++.+. +..++||||++
T Consensus        22 ~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   98 (278)
T 1byg_A           22 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   98 (278)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             hceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCC
Confidence            3456789999999999999886 8999999986443  356788999999999999999999987544 57899999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++...  ....+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.....   
T Consensus        99 ~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---  170 (278)
T 1byg_A           99 KGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  170 (278)
T ss_dssp             TEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence            99999998532  123478889999999999999999998   9999999999999999999999999998754322   


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                       .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||......    .+...    +..+..     ... 
T Consensus       171 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~~----~~~~~~-----~~~-  235 (278)
T 1byg_A          171 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK----DVVPR----VEKGYK-----MDA-  235 (278)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG----GHHHH----HTTTCC-----CCC-
T ss_pred             -ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH----HhcCCC-----CCC-
Confidence             123357899999999998899999999999999999998 99999765422    22221    111110     111 


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                         +......+.+++..|++.||++||++.|+++.|+++..
T Consensus       236 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          236 ---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence               11223468899999999999999999999999998754

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=333.05  Aligned_cols=247  Identities=23%  Similarity=0.350  Sum_probs=179.8

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.+.||+|+||.||+|+.. +++.||||++.....   .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   92 (278)
T 3cok_A           13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM   92 (278)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence            445788999999999999874 789999999864421   2235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        93 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           93 CHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             CTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             CCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999998642   34688999999999999999999998   99999999999999999999999999997653322


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      . ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........       .. ...      +...
T Consensus       167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~~-~~~------~~~~  231 (278)
T 3cok_A          167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN-------KV-VLA------DYEM  231 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------C-CSS------CCCC
T ss_pred             C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH-------HH-hhc------ccCC
Confidence            1 2233568999999999998889999999999999999999999997654221110       00 000      0011


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...    ....+.+++.+|++.||++||++.|++++
T Consensus       232 ~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          232 PSF----LSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             CTT----SCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccc----cCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            111    22457899999999999999999999874

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.1e-39  Score=344.72  Aligned_cols=263  Identities=19%  Similarity=0.233  Sum_probs=190.4

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      .|.+.+.||+|+||+||+|... +++.||||+++.....  ....+.+|+.++++++||||+++++++...+..++||||
T Consensus        35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  114 (329)
T 3gbz_A           35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY  114 (329)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence            3556789999999999999865 6889999998754322  245678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc-----CCCcEEEEeecCCcc
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-----KHMRAKVSDFGLSKF  560 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~-----~~~~~kl~DFGla~~  560 (736)
                      +++ +|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++     .++.+||+|||+++.
T Consensus       115 ~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          115 AEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             CSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             CCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            984 99998853    34588999999999999999999998   999999999999994     555699999999976


Q ss_pred             ccCCCCcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+..... .........
T Consensus       187 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~  264 (329)
T 3gbz_A          187 FGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG-LPDDTTWPG  264 (329)
T ss_dssp             HC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC-CCCTTTSTT
T ss_pred             cCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC-CCchhhhhh
Confidence            543222 22344689999999999874 589999999999999999999999976542211111111000 000000000


Q ss_pred             ec-----c---CccCCc-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 II-----D---PSLLDE-----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 ~~-----d---~~l~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..     .   +.....     ........+.+++.+|++.||++|||+.|++++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            00     0   000000     001122467899999999999999999999864

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.5e-38  Score=340.67  Aligned_cols=261  Identities=21%  Similarity=0.283  Sum_probs=202.7

Q ss_pred             cCHHHHHHHHHHhh-ccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhc-CCCceeeEeeeee
Q 004689          400 FTLSDIEDATKMLE-KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI-HHRNLVQFLGYCQ  474 (736)
Q Consensus       400 ~~~~~i~~~~~~~~-~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l-~HpnIv~l~~~~~  474 (736)
                      +...+.....|.+. +.||+|+||+||+|... +++.||||++.....  .....+.+|+.+++++ +||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            33344444555554 88999999999999876 689999999875432  2346788999999999 5699999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEE
Q 004689          475 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAK  551 (736)
Q Consensus       475 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~---~~~~k  551 (736)
                      ..+..++||||+.+|+|.+++...  ....+++..++.++.|++.||+|||+.   +|+||||||+|||++.   ++.+|
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A          100 NTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             CSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred             eCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence            999999999999999999988542  235689999999999999999999998   9999999999999998   78999


Q ss_pred             EEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHh
Q 004689          552 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH  631 (736)
Q Consensus       552 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~  631 (736)
                      |+|||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.    .....  
T Consensus       175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~----~~~i~--  246 (327)
T 3lm5_A          175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET----YLNIS--  246 (327)
T ss_dssp             ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHH--
T ss_pred             EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH----HHHHH--
Confidence            99999998654322  22335699999999999999999999999999999999999999976542111    11111  


Q ss_pred             hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        .....  ...    .........+.+++..|++.||++|||++|++++
T Consensus       247 --~~~~~--~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          247 --QVNVD--YSE----ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             --HTCCC--CCT----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             --hcccc--cCc----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence              11100  001    1111223458899999999999999999999876

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1e-38  Score=334.33  Aligned_cols=246  Identities=19%  Similarity=0.300  Sum_probs=197.7

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      ..|.+.+.||+|+||+||+|... +++.||||++....  ......+.+|+..+.++ +||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            45566789999999999999886 78999999987542  23356788899999999 9999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC----------------
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----------------  547 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~----------------  547 (736)
                      ||+++|+|.+++.........+++..++.++.|++.||.|||++   +|+||||||+|||++.+                
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            99999999999965433335689999999999999999999998   99999999999999844                


Q ss_pred             ---CcEEEEeecCCccccCCCCcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCccccccccccc
Q 004689          548 ---MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN  623 (736)
Q Consensus       548 ---~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~  623 (736)
                         ..+||+|||++.......     ...||+.|+|||++.+. .++.++|||||||++|||++|..++....      .
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------~  236 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------Q  236 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------H
T ss_pred             CCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------H
Confidence               479999999997654322     23489999999999865 56689999999999999999987764332      0


Q ss_pred             HHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          624 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       624 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .     ..+..+...     .+...+    ...+.+++.+|++.||++|||+.|++++
T Consensus       237 ~-----~~~~~~~~~-----~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 W-----HEIRQGRLP-----RIPQVL----SQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             H-----HHHHTTCCC-----CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             H-----HHHHcCCCC-----CCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            1     111222221     111222    2458899999999999999999999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1e-38  Score=358.04  Aligned_cols=261  Identities=21%  Similarity=0.290  Sum_probs=192.5

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccC--CcccchhhhhHHHHHhhcCCCceeeEeeeeeeC------CeE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSN--SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS  479 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~~  479 (736)
                      .|.+.+.||+|+||+||+|... +++.||||++...  .......+.+|+.+|+.++||||+++++++...      ...
T Consensus        63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~  142 (464)
T 3ttj_A           63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV  142 (464)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred             CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence            3556789999999999999876 6889999999754  223356688999999999999999999999654      457


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ++||||++++ |.+.+.      ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       143 ~lv~E~~~~~-l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          143 YLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             EEEEeCCCCC-HHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            9999999864 666653      2378888999999999999999998   99999999999999999999999999998


Q ss_pred             cccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHH-----------
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA-----------  628 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~-----------  628 (736)
                      .....  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....+....+.+..           
T Consensus       213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            65432  22344579999999999999999999999999999999999999998654221111111110           


Q ss_pred             ----HHhhhc-CC-----cceeccCccCCcC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          629 ----KLHIES-GD-----IQGIIDPSLLDEY---DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       629 ----~~~~~~-~~-----~~~~~d~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          ...... ..     +...+...+....   .......+.+++.+|+..||++|||++|+++|
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                000000 00     0000000000000   01124568999999999999999999999876

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-39  Score=354.39  Aligned_cols=260  Identities=24%  Similarity=0.361  Sum_probs=187.3

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcC-CCceeeEeeeeeeCC--eEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEG--RSVLV  482 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~--~~~lV  482 (736)
                      .|.+.+.||+|+||.||+|... +++.||||++....  ......+.+|+.+++++. ||||+++++++...+  ..++|
T Consensus        10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv   89 (388)
T 3oz6_A           10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV   89 (388)
T ss_dssp             TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred             ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence            4556789999999999999875 68999999986432  223456778999999997 999999999997544  78999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      ||||+ |+|.+++..     ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           90 FDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             ecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            99998 589888853     4588889999999999999999998   99999999999999999999999999997543


Q ss_pred             CC--------------------CCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCccccccccc
Q 004689          563 DG--------------------ASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANC  621 (736)
Q Consensus       563 ~~--------------------~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~  621 (736)
                      ..                    ........+||++|+|||++.+ ..++.++|||||||++|||++|+.||.+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            21                    1112234579999999999986 67899999999999999999999999865422211


Q ss_pred             ccHHHHHHHhhhcCCccee---c------------------cCccCCcC------------CHHHHHHHHHHHhhccCCC
Q 004689          622 RNIVQWAKLHIESGDIQGI---I------------------DPSLLDEY------------DIQSMWKIEEKALMCVLPH  668 (736)
Q Consensus       622 ~~l~~~~~~~~~~~~~~~~---~------------------d~~l~~~~------------~~~~~~~l~~l~~~cl~~d  668 (736)
                      ..+..    .+.......+   -                  .......+            .......+.+++.+|++.|
T Consensus       241 ~~i~~----~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          241 ERIIG----VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             HHHHH----HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             HHHHH----hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence            11111    1100000000   0                  00000000            0011245889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 004689          669 GHMRPSISEVLKD  681 (736)
Q Consensus       669 P~~RPt~~ev~~~  681 (736)
                      |++|||+.|+++|
T Consensus       317 P~~R~t~~e~l~H  329 (388)
T 3oz6_A          317 PNKRISANDALKH  329 (388)
T ss_dssp             GGGSCCHHHHTTS
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999877

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.3e-39  Score=344.65  Aligned_cols=260  Identities=23%  Similarity=0.409  Sum_probs=206.8

Q ss_pred             HHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  480 (736)
                      ..+.+.+.||+|+||.||+|.+.      +++.||||++..... .....+.+|+.++++++||||+++++++.+.+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  104 (322)
T 1p4o_A           25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL  104 (322)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence            34566789999999999999764      367899999875432 23456889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccc------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 004689          481 LVYEFMHNGTLKEHLYGTLT------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD  554 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~D  554 (736)
                      +||||+++|+|.+++.....      ....+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~D  181 (322)
T 1p4o_A          105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD  181 (322)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECc
Confidence            99999999999999864321      113468889999999999999999998   999999999999999999999999


Q ss_pred             ecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhh
Q 004689          555 FGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       555 FGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      ||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||......    .+..    .+
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~----~~  253 (322)
T 1p4o_A          182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----QVLR----FV  253 (322)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH----HHHH----HH
T ss_pred             CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH----HHHH----HH
Confidence            999975533221 12223457899999999998899999999999999999999 88998765421    1111    11


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ..+....         ........+.+++.+|++.||.+||++.|++++|++.+.
T Consensus       254 ~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          254 MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            1222111         111223458899999999999999999999999987644

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-39  Score=344.51  Aligned_cols=260  Identities=22%  Similarity=0.307  Sum_probs=193.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||+|+||+||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus         4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   83 (324)
T 3mtl_A            4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD   83 (324)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred             eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence            345688999999999999886 6899999998754322 23467789999999999999999999999999999999998


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                       |+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... .
T Consensus        84 -~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~  155 (324)
T 3mtl_A           84 -KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K  155 (324)
T ss_dssp             -EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             -cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence             5888888542   34588899999999999999999998   99999999999999999999999999997543322 2


Q ss_pred             ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC---CcceeccC
Q 004689          568 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG---DIQGIIDP  643 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~d~  643 (736)
                      ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+    ....+.......   ........
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE----QLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHhchhhhcc
Confidence            2234468999999999876 568999999999999999999999998755322    122221111110   00000000


Q ss_pred             ---------ccCCc----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 ---------SLLDE----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ---------~l~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                               .....    ........+.+++.+|++.||++|||++|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                     00000    001122457899999999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.9e-39  Score=337.63  Aligned_cols=253  Identities=24%  Similarity=0.344  Sum_probs=201.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeee--eCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQ--EEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~lV~e  484 (736)
                      |.+.+.||+|+||.||+|... +++.||+|++.....  .....+.+|+.++++++||||+++++++.  .....++|||
T Consensus         8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   87 (279)
T 2w5a_A            8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   87 (279)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred             eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence            445789999999999999886 689999999875432  23456889999999999999999999885  4678899999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCc-----eecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA-----IIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~-----iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      |+++|+|.+++.........+++..++.++.|++.||.|||+.   +     |+||||||+|||++.++.+||+|||+++
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            9999999999965433344589999999999999999999998   6     9999999999999999999999999987


Q ss_pred             cccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......    .+..    .+..+....
T Consensus       165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~----~i~~~~~~~  235 (279)
T 2w5a_A          165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----ELAG----KIREGKFRR  235 (279)
T ss_dssp             HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHTCCCC
T ss_pred             eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH----HHHH----HHhhccccc
Confidence            6543221 223346899999999999889999999999999999999999999765421    1211    122222211


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ  683 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~  683 (736)
                           +...    ....+.+++.+|++.||++||++.||++++.
T Consensus       236 -----~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          236 -----IPYR----YSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             -----CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             -----CCcc----cCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                 1112    2345889999999999999999999998764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.7e-38  Score=331.17  Aligned_cols=252  Identities=22%  Similarity=0.362  Sum_probs=201.5

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      ..|.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            34566789999999999999886 68999999986443 23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++++|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        87 ~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           87 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            99999999884    335688999999999999999999998   99999999999999999999999999997543222


Q ss_pred             -CcceecccccccccCccccccCcC-CCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          566 -SHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       566 -~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                       ........||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......  ...+..|...    ...   .. 
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~----~~~---~~-  229 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--CQEYSDWKEK----KTY---LN-  229 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT--SHHHHHHHTT----CTT---ST-
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH--HHHHHHhhhc----ccc---cC-
Confidence             122334568999999999987665 67899999999999999999999765421  1112222111    000   00 


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       ..    ......+.+++..|++.||++|||+.|++++
T Consensus       230 -~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          230 -PW----KKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -TG----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -ch----hhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence             00    1122357889999999999999999999764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.5e-39  Score=351.91  Aligned_cols=263  Identities=20%  Similarity=0.232  Sum_probs=197.3

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeee------------
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------------  475 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------------  475 (736)
                      .|.+.+.||+|+||+||+|+.. +|+.||||++...    .....+|+++|+.++||||+++++++..            
T Consensus         8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred             eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence            3556789999999999999874 7899999998643    3345689999999999999999999843            


Q ss_pred             --------------------------CCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCC
Q 004689          476 --------------------------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV  529 (736)
Q Consensus       476 --------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~  529 (736)
                                                ....++||||++ |+|.+.+.........+++..+..++.|+++||.|||+.  
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--  160 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL--  160 (383)
T ss_dssp             --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence                                      334789999998 588888866555567799999999999999999999998  


Q ss_pred             CceecCCCCCCCEEEc-CCCcEEEEeecCCccccCCCCcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHh
Q 004689          530 PAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELIS  607 (736)
Q Consensus       530 ~~iiHrDikp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~ellt  607 (736)
                       +|+||||||+|||++ .++.+||+|||+++.......  .....||+.|+|||++.+. .++.++||||+||++|||++
T Consensus       161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  237 (383)
T 3eb0_A          161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL  237 (383)
T ss_dssp             -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence             999999999999998 689999999999986543322  2334689999999998864 58999999999999999999


Q ss_pred             CCCcCcccccccccccHHHHHH--------Hhh---hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHH
Q 004689          608 GQEAISNEKFGANCRNIVQWAK--------LHI---ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS  676 (736)
Q Consensus       608 G~~p~~~~~~~~~~~~l~~~~~--------~~~---~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  676 (736)
                      |+.||.+....+....++....        ..-   .+..+...........++......+.+++.+|++.||++|||+.
T Consensus       238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  317 (383)
T 3eb0_A          238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY  317 (383)
T ss_dssp             SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence            9999986553222112211100        000   00000000000000111222334588999999999999999999


Q ss_pred             HHHHH
Q 004689          677 EVLKD  681 (736)
Q Consensus       677 ev~~~  681 (736)
                      |++++
T Consensus       318 e~l~h  322 (383)
T 3eb0_A          318 EAMAH  322 (383)
T ss_dssp             HHHTS
T ss_pred             HHhcC
Confidence            99976

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.4e-38  Score=343.61  Aligned_cols=263  Identities=23%  Similarity=0.282  Sum_probs=200.0

Q ss_pred             HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcC-----CCceeeEeeeeeeCCeEE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----HRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-----HpnIv~l~~~~~~~~~~~  480 (736)
                      ...|.+.++||+|+||+||+|+.. +++.||||+++.. ......+..|+.+++.++     ||||+++++++...+..+
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~  112 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC  112 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence            345667889999999999999885 6889999998642 233456778999999996     999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC--------------
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--------------  546 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~--------------  546 (736)
                      +||||+ +++|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.              
T Consensus       113 lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          113 LIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             EEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             EEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccc
Confidence            999999 899999986432  23588999999999999999999998   9999999999999975              


Q ss_pred             -----------CCcEEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccc
Q 004689          547 -----------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNE  615 (736)
Q Consensus       547 -----------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~  615 (736)
                                 ++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence                       789999999999864332    23456899999999999999999999999999999999999999765


Q ss_pred             ccccccccHHHH--------HHHhhhcCCcceeccC-ccC----CcC-CH---------------HHHHHHHHHHhhccC
Q 004689          616 KFGANCRNIVQW--------AKLHIESGDIQGIIDP-SLL----DEY-DI---------------QSMWKIEEKALMCVL  666 (736)
Q Consensus       616 ~~~~~~~~l~~~--------~~~~~~~~~~~~~~d~-~l~----~~~-~~---------------~~~~~l~~l~~~cl~  666 (736)
                      ...+....+...        ........ ....++. .+.    ... ..               .....+.+++..|++
T Consensus       263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          263 EHMEHLAMMESIIQPIPKNMLYEATKTN-GSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SHHHHHHHHHHHTCCCCHHHHHHHTTSG-GGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             cHHHHHHHHHHhcCCCCHHHHhhhhhcc-CccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            422111111110        00000000 0000000 000    000 00               011457799999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 004689          667 PHGHMRPSISEVLKD  681 (736)
Q Consensus       667 ~dP~~RPt~~ev~~~  681 (736)
                      .||++|||+.|++++
T Consensus       342 ~dP~~Rpta~elL~h  356 (360)
T 3llt_A          342 IDPTLRPSPAELLKH  356 (360)
T ss_dssp             SSGGGSCCHHHHTTS
T ss_pred             CChhhCCCHHHHhcC
Confidence            999999999999864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=6.2e-39  Score=344.26  Aligned_cols=264  Identities=22%  Similarity=0.338  Sum_probs=198.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      |.+.+.||+|+||.||+|+.. +++.||||++......  ....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  106 (331)
T 4aaa_A           27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV  106 (331)
T ss_dssp             EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence            456789999999999999886 5899999998654322  2455789999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++++|.+++.    ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...... 
T Consensus       107 ~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  178 (331)
T 4aaa_A          107 DHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  178 (331)
T ss_dssp             SEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             CcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence            9999988763    234589999999999999999999998   99999999999999999999999999997654322 


Q ss_pred             cceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHH-------HHhh-hcCCc
Q 004689          567 HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA-------KLHI-ESGDI  637 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~-------~~~~-~~~~~  637 (736)
                      .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+....       .... .....
T Consensus       179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence            222345689999999999875 78999999999999999999999997655322111111100       0000 00001


Q ss_pred             ceeccCccCCcCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 QGIIDPSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .....+.+.....     ......+.+++.+|++.||++|||+.|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            1111111111111     1223568899999999999999999999886

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=3.4e-38  Score=349.72  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=190.0

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--------ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCe
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR  478 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  478 (736)
                      ..|.+.+.||+|+||+||+|... +++.||||++.....        .....+.+|+.+|++++||||+++++++.. +.
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~  213 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED  213 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence            34567889999999999999876 578999999865321        123458899999999999999999999854 55


Q ss_pred             EEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC---CcEEEEee
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDF  555 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~---~~~kl~DF  555 (736)
                      .++||||+++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.+   +.+||+||
T Consensus       214 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             EEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             eEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeec
Confidence            799999999999998884    345689999999999999999999998   99999999999999754   45999999


Q ss_pred             cCCccccCCCCcceecccccccccCcccccc---CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh
Q 004689          556 GLSKFAVDGASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       556 Gla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      |+++.....  .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||......   ..+....    
T Consensus       287 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~~i----  357 (419)
T 3i6u_A          287 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ---VSLKDQI----  357 (419)
T ss_dssp             STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS---CCHHHHH----
T ss_pred             ccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch---HHHHHHH----
Confidence            999865432  22344679999999999863   56788999999999999999999999764421   1222211    


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..+....  .+....    .....+.+++.+|++.||++||++.|++++
T Consensus       358 ~~~~~~~--~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          358 TSGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HTTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hcCCCCC--Cchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            1111110  000011    123458899999999999999999999886

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.3e-38  Score=329.63  Aligned_cols=246  Identities=28%  Similarity=0.412  Sum_probs=195.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeee----CCeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lV  482 (736)
                      +.+.+.||+|+||+||+|... ++..||+|++....  ......+.+|+.++++++||||+++++++..    ....++|
T Consensus        28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv  107 (290)
T 1t4h_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence            345678999999999999875 67889999987542  2234568899999999999999999998865    3568999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCc--eecCCCCCCCEEEc-CCCcEEEEeecCCc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA--IIHRDLKSSNILLD-KHMRAKVSDFGLSK  559 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~--iiHrDikp~NILl~-~~~~~kl~DFGla~  559 (736)
                      |||+++|+|.+++..    ...+++..++.++.|++.||.|||+.   +  |+||||||+|||++ .++.+||+|||++.
T Consensus       108 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          108 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            999999999999953    35688999999999999999999998   7  99999999999998 78999999999997


Q ss_pred             cccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      .....   ......||+.|+|||++. +.++.++|||||||++|||++|+.||.....      ........ ..+....
T Consensus       181 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~-~~~~~~~  249 (290)
T 1t4h_A          181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRV-TSGVKPA  249 (290)
T ss_dssp             GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHH-TTTCCCG
T ss_pred             ccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc------HHHHHHHH-hccCCcc
Confidence            54332   223456999999999876 4589999999999999999999999975431      11111111 1111111


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..        +......+.+++..|++.||.+|||+.|++++
T Consensus       250 ~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          250 SF--------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GG--------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cc--------CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            11        11112358899999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.8e-38  Score=334.50  Aligned_cols=247  Identities=21%  Similarity=0.338  Sum_probs=201.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||.||+|... +++.||+|++.....   .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus        17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   96 (294)
T 2rku_A           17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL   96 (294)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence            445789999999999999887 578899999865422   2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        97 ~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           97 CRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             CTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            999999998742    35688999999999999999999998   99999999999999999999999999997654322


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      . ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+    .   .. .+..+..      .+
T Consensus       170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~---~~-~~~~~~~------~~  234 (294)
T 2rku_A          170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----T---YL-RIKKNEY------SI  234 (294)
T ss_dssp             C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----H---HH-HHHTTCC------CC
T ss_pred             c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----H---HH-HHhhccC------CC
Confidence            2 2234568999999999999889999999999999999999999997654211    1   11 1111111      11


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      ....    ...+.+++.+|++.||++||++.|++++-
T Consensus       235 ~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          235 PKHI----NPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             CTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             cccc----CHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            1112    23578899999999999999999998863

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.2e-38  Score=353.53  Aligned_cols=259  Identities=24%  Similarity=0.282  Sum_probs=194.6

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeC------CeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~~~lV  482 (736)
                      |.+.+.||+|+||+||+|++. +++.||||++...    .....+|+++|++++||||+++++++...      ...++|
T Consensus        56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            445788999999999999986 5899999998643    23456899999999999999999988532      236799


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeecCCccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFA  561 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~-~~~kl~DFGla~~~  561 (736)
                      |||+++ +|.+.+.........+++..+..++.|+++||.|||+.   +|+||||||+|||++.+ +.+||+|||+++..
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            999986 66666654333456789999999999999999999998   99999999999999965 67899999999865


Q ss_pred             cCCCCcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHh-------hh
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH-------IE  633 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~-------~~  633 (736)
                      .....  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+   .+...++..       +.
T Consensus       208 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          208 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             CTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHHHH
T ss_pred             ccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHH
Confidence            43322  2334689999999999764 79999999999999999999999998754222   222222110       00


Q ss_pred             --cCCcceeccCccCC-----cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          634 --SGDIQGIIDPSLLD-----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       634 --~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        .....+..-+.+..     .+.......+.+|+.+|++.||.+||++.|++++
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence              01111111111111     0111223568899999999999999999999876

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-38  Score=342.56  Aligned_cols=266  Identities=21%  Similarity=0.219  Sum_probs=196.7

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc-----cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      ..|.+.+.||+|+||.||+|+.. +|+.||||++......     ..+.+.+|++++++++||||+++++++...+..++
T Consensus        10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   89 (346)
T 1ua2_A           10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL   89 (346)
T ss_dssp             ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred             cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence            34566789999999999999876 5899999998753221     13467899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+++ +|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus        90 v~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           90 VFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             EEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             EEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999986 888887532   34578888999999999999999998   9999999999999999999999999999865


Q ss_pred             cCCCCcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc--
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ--  638 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~--  638 (736)
                      .... .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+....+....+....... ......  
T Consensus       163 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~  240 (346)
T 1ua2_A          163 GSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP-TEEQWPDM  240 (346)
T ss_dssp             TSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC-CTTTSSST
T ss_pred             cCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC-Chhhhhhh
Confidence            4332 223345689999999999764 58889999999999999999999997654221111111110000 000000  


Q ss_pred             ----eeccCccCCcCC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          639 ----GIIDPSLLDEYD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       639 ----~~~d~~l~~~~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                          +.+........+     ......+.+++.+|++.||++|||+.|++++-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence                000000000001     11235689999999999999999999998763

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.4e-38  Score=339.19  Aligned_cols=247  Identities=21%  Similarity=0.336  Sum_probs=201.7

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .|.+.+.||+|+||.||++... +++.||+|++....   ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  121 (335)
T 2owb_A           42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE  121 (335)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence            3456789999999999999886 57889999986542   2234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+.+++|.+++..    ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....
T Consensus       122 ~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          122 LCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             CCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             cCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            9999999998743    35688999999999999999999998   9999999999999999999999999999865432


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                      .. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+    ...   . +..+..      .
T Consensus       195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~---~-~~~~~~------~  259 (335)
T 2owb_A          195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE----TYL---R-IKKNEY------S  259 (335)
T ss_dssp             TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH---H-HHHTCC------C
T ss_pred             cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH----HHH---H-HhcCCC------C
Confidence            22 2234569999999999999899999999999999999999999997654211    111   1 111111      1


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +....    ...+.+++.+|++.||++||++.|++++
T Consensus       260 ~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          260 IPKHI----NPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             CCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11122    2357889999999999999999999876

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.2e-38  Score=341.24  Aligned_cols=262  Identities=26%  Similarity=0.401  Sum_probs=203.8

Q ss_pred             HHHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  479 (736)
                      ...+.+.+.||+|+||.||+|++.      +++.||||++.... ......+.+|+.++++++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            345567889999999999999842      57789999986442 23456788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcccc---cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEE
Q 004689          480 VLVYEFMHNGTLKEHLYGTLT---HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVS  553 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~---~~~~kl~  553 (736)
                      ++||||+++|+|.+++.....   ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999965432   124588999999999999999999998   9999999999999994   4569999


Q ss_pred             eecCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHh
Q 004689          554 DFGLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLH  631 (736)
Q Consensus       554 DFGla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~  631 (736)
                      |||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||......    .+...+   
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~---  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ----EVLEFV---  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HHHHHH---
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH----HHHHHH---
Confidence            9999875433222 22234458999999999998899999999999999999998 99999755421    122211   


Q ss_pred             hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                       ..+...         ..+......+.+++..|++.||.+||++.||+++|+.+...
T Consensus       259 -~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          259 -TSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             -HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -hcCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence             111111         01112234588999999999999999999999999987553

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5e-38  Score=355.99  Aligned_cols=251  Identities=26%  Similarity=0.393  Sum_probs=198.2

Q ss_pred             HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      ...|.+.+.||+|+||+||+|+.. ++..||||++....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            345677899999999999999986 68899999987653  233567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC---CcEEEEeecCCcc
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLSKF  560 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~---~~~kl~DFGla~~  560 (736)
                      ||+.+|+|.+.+..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++..   +.+||+|||+++.
T Consensus       116 e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          116 ECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999998843    35688999999999999999999998   99999999999999764   5599999999986


Q ss_pred             ccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      .....  ......||+.|+|||++. ..++.++||||+||++|||++|..||.+....    .+...    +..+...  
T Consensus       189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~----i~~~~~~--  255 (494)
T 3lij_A          189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ----EILRK----VEKGKYT--  255 (494)
T ss_dssp             CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----HHHTCCC--
T ss_pred             CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----HHhCCCC--
Confidence            54332  233456999999999876 56999999999999999999999999865421    12221    1112111  


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ++.......    ...+.+++.+|++.||.+|||+.|++++
T Consensus       256 ~~~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          256 FDSPEWKNV----SEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CCSGGGTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CCchhcccC----CHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            111111112    2357899999999999999999999987

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.2e-38  Score=329.94  Aligned_cols=244  Identities=24%  Similarity=0.367  Sum_probs=200.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      +.+.+.||+|+||.||+|+.. +++.||||++....   ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus        16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   95 (284)
T 2vgo_A           16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF   95 (284)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence            456789999999999999886 57889999986432   12245688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        96 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           96 APRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             CTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            999999999853    34688999999999999999999998   99999999999999999999999999987543321


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                         .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+    .   .. .+.....      .+
T Consensus       169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~---~~-~~~~~~~------~~  231 (284)
T 2vgo_A          169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE----T---HR-RIVNVDL------KF  231 (284)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----H---HH-HHHTTCC------CC
T ss_pred             ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH----H---HH-HHhcccc------CC
Confidence               234568999999999999999999999999999999999999997654211    1   11 1111111      11


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...    ....+.+++..|++.||.+||++.|++++
T Consensus       232 ~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          232 PPF----LSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             CTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             CCc----CCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            111    22457899999999999999999999886

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=5.2e-38  Score=355.14  Aligned_cols=251  Identities=27%  Similarity=0.371  Sum_probs=200.7

Q ss_pred             HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      ...|.+.+.||+|+||+||+|... +++.||||++....  ......+.+|++++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            356777899999999999999886 78999999986432  233567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc---CCCcEEEEeecCCcc
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKF  560 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~---~~~~~kl~DFGla~~  560 (736)
                      ||+.+|+|.+.+..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++   .++.+||+|||+++.
T Consensus       101 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999998843    35689999999999999999999998   999999999999995   456799999999986


Q ss_pred             ccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                      .....  ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.+....    .+...    +..+.... 
T Consensus       174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~----i~~~~~~~-  241 (486)
T 3mwu_A          174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DILKR----VETGKYAF-  241 (486)
T ss_dssp             BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----HHHTCCCS-
T ss_pred             CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----HHhCCCCC-
Confidence            54332  2234569999999999875 5899999999999999999999999765421    11111    11121110 


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       +....    ......+.+++.+|++.||.+|||+.|++++
T Consensus       242 -~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          242 -DLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -CSGGG----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -CCccc----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             00001    1122457899999999999999999999886

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.3e-39  Score=352.89  Aligned_cols=241  Identities=14%  Similarity=0.124  Sum_probs=185.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHH---HHhhcCCCceeeEe-------eeeee
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVT---LLSRIHHRNLVQFL-------GYCQE  475 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~---il~~l~HpnIv~l~-------~~~~~  475 (736)
                      +.+.+.||+|+||+||+|+.. +|+.||||++....   ....+.+.+|+.   ++++++||||++++       +++..
T Consensus        75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~  154 (377)
T 3byv_A           75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD  154 (377)
T ss_dssp             EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred             EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence            345688999999999999964 68999999997432   223467889994   55555899999998       55554


Q ss_pred             CC-----------------eEEEEEEecCCCCHHHHhhccc--c-cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecC
Q 004689          476 EG-----------------RSVLVYEFMHNGTLKEHLYGTL--T-HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHR  535 (736)
Q Consensus       476 ~~-----------------~~~lV~e~~~~gsL~~~l~~~~--~-~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHr  535 (736)
                      ++                 ..++||||+ +|+|.+++....  . ....+++..++.++.|++.||+|||++   +|+||
T Consensus       155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHr  230 (377)
T 3byv_A          155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHT  230 (377)
T ss_dssp             TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            43                 278999999 689999996421  1 123455688889999999999999998   99999


Q ss_pred             CCCCCCEEEcCCCcEEEEeecCCccccCCCCcceecccccccccCccccccC-----------cCCCcchhHHHHHHHHH
Q 004689          536 DLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-----------QLTDKSDVYSFGVILLE  604 (736)
Q Consensus       536 Dikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~~~~~DVwSlGvvl~e  604 (736)
                      ||||+|||++.++.+||+|||+++...    .......| +.|+|||++.+.           .++.++|||||||++||
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            999999999999999999999998532    23344567 999999999887           89999999999999999


Q ss_pred             HHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          605 LISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       605 lltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      |++|+.||...........+                .. . ....    ...+.+++.+|++.||++||++.|++++
T Consensus       306 lltg~~Pf~~~~~~~~~~~~----------------~~-~-~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          306 IWCADLPITKDAALGGSEWI----------------FR-S-CKNI----PQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHSSCCC------CCSGGG----------------GS-S-CCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHCCCCCcccccccchhhh----------------hh-h-ccCC----CHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            99999999765422111111                00 0 0112    2358899999999999999999999975

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.2e-38  Score=329.62  Aligned_cols=248  Identities=24%  Similarity=0.386  Sum_probs=195.3

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCHH
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLK  492 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~  492 (736)
                      ..||+|+||.||+|... +++.||||++..........+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            47999999999999875 68899999997665555677899999999999999999999999999999999999999999


Q ss_pred             HHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-CCcEEEEeecCCccccCCCCcceec
Q 004689          493 EHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGLSKFAVDGASHVSSI  571 (736)
Q Consensus       493 ~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~  571 (736)
                      +++.... ....+++..+..++.|++.||.|||+.   +|+||||||+||+++. ++.+||+|||+++...... .....
T Consensus       108 ~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~  182 (295)
T 2clq_A          108 ALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTET  182 (295)
T ss_dssp             HHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred             HHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Ccccc
Confidence            9986432 223467888889999999999999998   9999999999999987 8999999999997654322 12234


Q ss_pred             ccccccccCccccccCc--CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcC
Q 004689          572 VRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY  649 (736)
Q Consensus       572 ~~gt~~Y~aPE~~~~~~--~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  649 (736)
                      ..||+.|+|||++.+..  ++.++|||||||++|||++|+.||.......    ...+.....  .     ..+.+... 
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~--~-----~~~~~~~~-  250 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMFKVGMF--K-----VHPEIPES-  250 (295)
T ss_dssp             CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHHHHHHH--C-----CCCCCCTT-
T ss_pred             cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHHhhccc--c-----cccccccc-
Confidence            56899999999997643  7889999999999999999999997543111    011111110  0     11111222 


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          650 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       650 ~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                         ....+.+++.+|++.||++||++.|++++
T Consensus       251 ---~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          251 ---MSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ---SCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ---CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               23457889999999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.8e-38  Score=334.54  Aligned_cols=247  Identities=25%  Similarity=0.417  Sum_probs=203.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++++......++||||++
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~  103 (303)
T 3a7i_A           24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG  103 (303)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence            445688999999999999875 688999999875532 335678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++..     ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++....... .
T Consensus       104 ~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  174 (303)
T 3a7i_A          104 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I  174 (303)
T ss_dssp             TEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred             CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence            9999999842     4588999999999999999999998   99999999999999999999999999997654332 1


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......    .....    +..+..     +.+..
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~----~~~~~~-----~~~~~  241 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM----KVLFL----IPKNNP-----PTLEG  241 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH----HHHSCC-----CCCCS
T ss_pred             ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH----HHHHH----hhcCCC-----CCCcc
Confidence            223456899999999999999999999999999999999999999754311    11111    111111     11122


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      .++    ..+.+++..|++.||++|||+.|++++.
T Consensus       242 ~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          242 NYS----KPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             SCC----HHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             ccC----HHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            222    3588999999999999999999999874

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.4e-38  Score=348.13  Aligned_cols=263  Identities=22%  Similarity=0.272  Sum_probs=194.4

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCC------eEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSVLV  482 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------~~~lV  482 (736)
                      .|.+.+.||+|+||+||+|+...+..||+|++...    .....+|+++++.++||||+++++++...+      ..++|
T Consensus        41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecC----cchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            35567899999999999999987788999988543    233457999999999999999999996543      37899


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc-CCCcEEEEeecCCccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFA  561 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~-~~~~~kl~DFGla~~~  561 (736)
                      |||+.++.+ +.+.........+++..+..++.|+++||+|||+.   +|+||||||+|||++ .++.+||+|||+++..
T Consensus       117 ~e~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          117 LEYVPETVY-RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EECCSEEHH-HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             eeccCccHH-HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            999987544 33332223345688999999999999999999998   999999999999999 7899999999999865


Q ss_pred             cCCCCcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHH--------HHh-
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA--------KLH-  631 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~--------~~~-  631 (736)
                      .....  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+....        ... 
T Consensus       193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  270 (394)
T 4e7w_A          193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN  270 (394)
T ss_dssp             CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence            43332  2234689999999998764 58999999999999999999999998765322221222110        000 


Q ss_pred             --hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          632 --IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       632 --~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        .....+...-.......+.......+.+++.+|++.||.+|||+.|++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence              00000100000000001111233468999999999999999999999876

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.3e-38  Score=356.67  Aligned_cols=251  Identities=28%  Similarity=0.395  Sum_probs=203.4

Q ss_pred             HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      ...|.+.+.||+|+||.||+|+.. +++.||||++....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            456777899999999999999886 78999999986543   22356688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE---cCCCcEEEEeecCCc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSK  559 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl---~~~~~~kl~DFGla~  559 (736)
                      |||+.+|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||+   +.++.+||+|||+++
T Consensus       105 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          105 GEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             ECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999998853    35689999999999999999999998   99999999999999   567899999999997


Q ss_pred             cccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ......  ......||+.|+|||++.+ .++.++||||+||++|||++|..||.+....    .+...    +..+....
T Consensus       178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~----i~~~~~~~  246 (484)
T 3nyv_A          178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY----DILKK----VEKGKYTF  246 (484)
T ss_dssp             HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----HHHCCCCC
T ss_pred             Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH----HHHHH----HHcCCCCC
Confidence            654332  2234569999999999865 6899999999999999999999999865421    12221    11222110


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        .....    ......+.+++.+|++.+|.+|||+.|++++
T Consensus       247 --~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          247 --ELPQW----KKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             --CSGGG----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --CCccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence              00001    1123457899999999999999999999876

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.1e-38  Score=334.81  Aligned_cols=261  Identities=24%  Similarity=0.390  Sum_probs=183.6

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.+.+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++||||+++++++...+..++||||++
T Consensus        17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   96 (303)
T 2vwi_A           17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS   96 (303)
T ss_dssp             CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred             hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence            456789999999999999865 68899999986543 2335678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhccc----ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          488 NGTLKEHLYGTL----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       488 ~gsL~~~l~~~~----~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      +|+|.+++....    .....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  173 (303)
T 2vwi_A           97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT  173 (303)
T ss_dssp             TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred             CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence            999999985421    1234589999999999999999999998   999999999999999999999999999875533


Q ss_pred             CCC----cceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          564 GAS----HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       564 ~~~----~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      ...    .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......    ................
T Consensus       174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~  249 (303)
T 2vwi_A          174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM----KVLMLTLQNDPPSLET  249 (303)
T ss_dssp             --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG----GHHHHHHTSSCCCTTC
T ss_pred             CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh----hHHHHHhccCCCcccc
Confidence            211    12234569999999999876 56899999999999999999999999765421    1111111100000001


Q ss_pred             eeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       639 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...++.....++    ..+.+++.+|++.||.+||++.|++++
T Consensus       250 ~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          250 GVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             -----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            111122222222    357899999999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.9e-37  Score=337.35  Aligned_cols=250  Identities=24%  Similarity=0.369  Sum_probs=199.2

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--------cchhhhhHHHHHhhc-CCCceeeEeeeeeeCCe
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR  478 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--------~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~  478 (736)
                      .|.+.+.||+|+||.||+|++. +|+.||||+++.....        ....+.+|+.+++++ +||||+++++++...+.
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  174 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF  174 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred             hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence            4455689999999999999986 7999999998754321        134578899999999 79999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCC
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS  558 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla  558 (736)
                      .++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus       175 ~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~  247 (365)
T 2y7j_A          175 MFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFS  247 (365)
T ss_dssp             EEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcc
Confidence            9999999999999999853    35689999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCCcceecccccccccCcccccc------CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh
Q 004689          559 KFAVDGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       559 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      .......  ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||......    .+...    +
T Consensus       248 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~----~~~~~----i  317 (365)
T 2y7j_A          248 CHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI----LMLRM----I  317 (365)
T ss_dssp             EECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----H
T ss_pred             cccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH----HHHHH----H
Confidence            7654332  2234569999999999863      35888999999999999999999999764311    11111    1


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..+..... .+ ....    ....+.+++.+|++.||++||++.|++++
T Consensus       318 ~~~~~~~~-~~-~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          318 MEGQYQFS-SP-EWDD----RSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHTCCCCC-HH-HHSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhCCCCCC-Cc-cccc----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11111000 00 0011    12358899999999999999999999874

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.2e-37  Score=346.89  Aligned_cols=197  Identities=24%  Similarity=0.354  Sum_probs=163.5

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeC-----CeEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSV  480 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~  480 (736)
                      .|.+.+.||+|+||.||+|... +++.||||++....  ......+.+|+.+|++++||||+++++++...     ...+
T Consensus        27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~  106 (432)
T 3n9x_A           27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY  106 (432)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence            3556789999999999999876 57889999997532  22346788999999999999999999999766     5789


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+. |+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       107 lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          107 IVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            9999987 599998853    35689999999999999999999998   999999999999999999999999999986


Q ss_pred             ccCCCC---------------------cceecccccccccCcccc-ccCcCCCcchhHHHHHHHHHHHhCCCcCc
Q 004689          561 AVDGAS---------------------HVSSIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELISGQEAIS  613 (736)
Q Consensus       561 ~~~~~~---------------------~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DVwSlGvvl~elltG~~p~~  613 (736)
                      ......                     ......+||++|+|||++ ....++.++|||||||++|||++|..||.
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            543221                     122456799999999986 45679999999999999999998665554

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.4e-38  Score=334.53  Aligned_cols=256  Identities=19%  Similarity=0.300  Sum_probs=196.3

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcC-CCceeeEeeeeee--CCeEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQE--EGRSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~--~~~~~lV~e  484 (736)
                      .|.+.+.||+|+||+||+|+.. +++.||||+++..   ....+.+|++++++++ ||||+++++++..  ....++|||
T Consensus        37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             ceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            4556789999999999999874 6899999998643   3467899999999997 9999999999987  667899999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeecCCccccC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD  563 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~-~~kl~DFGla~~~~~  563 (736)
                      |+.+++|.+++.       .++...+..++.|++.||.|||+.   +|+||||||+|||++.++ .+||+|||+++....
T Consensus       114 ~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          114 HVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             CCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            999999998873       378888999999999999999998   999999999999999776 899999999986543


Q ss_pred             CCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHH--------hhhc
Q 004689          564 GASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL--------HIES  634 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~--------~~~~  634 (736)
                      ...  .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......  ...+......        .+..
T Consensus       184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHHHHHHHhcCCchhhhHHHH
Confidence            322  234468999999999987 67899999999999999999999999543211  1111111110        0000


Q ss_pred             CCc--------------ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          635 GDI--------------QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       635 ~~~--------------~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...              ...................+.+++.+|++.||++|||++|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            000              00000000111111124568999999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.8e-38  Score=333.59  Aligned_cols=256  Identities=26%  Similarity=0.371  Sum_probs=194.1

Q ss_pred             HHHhhccccccCceEEEEEEEC--CCc--EEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK--DGK--EIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~--~~~--~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      .+.+.+.||+|+||+||+|++.  +++  .||||+++...   ......+.+|++++++++||||+++++++..+. .++
T Consensus        19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   97 (291)
T 1u46_A           19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM   97 (291)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred             HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence            4556789999999999999864  233  68999987542   223467889999999999999999999998765 789


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+++|+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus        98 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           98 VTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccc
Confidence            99999999999998632   35688999999999999999999998   9999999999999999999999999999865


Q ss_pred             cCCCCc--ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          562 VDGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       562 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      ......  ......+|..|+|||++.+..++.++|||||||++|||++ |+.||......    .+..   .....+...
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~---~~~~~~~~~  244 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILH---KIDKEGERL  244 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHH---HHHTSCCCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH----HHHH---HHHccCCCC
Confidence            443322  2233457889999999998889999999999999999999 99999765421    1111   111111100


Q ss_pred             eeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       639 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                           .    ........+.+++.+|++.||++||++.++++.|+++..
T Consensus       245 -----~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          245 -----P----RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             -----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             -----C----CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                 0    111223468899999999999999999999999988743

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.9e-38  Score=338.86  Aligned_cols=265  Identities=19%  Similarity=0.271  Sum_probs=197.5

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeee--------CC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EG  477 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~--------~~  477 (736)
                      .|.+.+.||+|+||+||+|+.. +++.||||++......  ....+.+|+.++++++||||+++++++..        .+
T Consensus        18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   97 (351)
T 3mi9_A           18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   97 (351)
T ss_dssp             GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred             ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence            4556789999999999999985 7899999998654322  24567899999999999999999999976        45


Q ss_pred             eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecC
Q 004689          478 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL  557 (736)
Q Consensus       478 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGl  557 (736)
                      ..++||||+++ +|.+.+...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        98 ~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           98 SIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             EEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence            68999999985 777777533   34589999999999999999999998   999999999999999999999999999


Q ss_pred             CccccCCC---CcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh
Q 004689          558 SKFAVDGA---SHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE  633 (736)
Q Consensus       558 a~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~  633 (736)
                      ++......   ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+...... ..
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~  249 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-IT  249 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CC
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-CC
Confidence            97654221   222334568999999999876 56899999999999999999999999865522211111111100 00


Q ss_pred             cCCcceeccCcc--------CCcCCH-HH------HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          634 SGDIQGIIDPSL--------LDEYDI-QS------MWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       634 ~~~~~~~~d~~l--------~~~~~~-~~------~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .......-....        ...... +.      ...+.+++.+|++.||++|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            000000000000        000011 11      2347899999999999999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.1e-38  Score=344.22  Aligned_cols=265  Identities=22%  Similarity=0.289  Sum_probs=199.8

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .+.+.+.||+|+||+||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||+
T Consensus        34 ~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  113 (360)
T 3eqc_A           34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM  113 (360)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence            3455678999999999999886 68999999987653 233467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++..    ...+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++......  
T Consensus       114 ~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          114 DGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            99999999853    346889999999999999999999841  7999999999999999999999999998754321  


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHH--------------------
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ--------------------  626 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~--------------------  626 (736)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..                    
T Consensus       186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (360)
T 3eqc_A          186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL  264 (360)
T ss_dssp             -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred             -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence             12334689999999999999999999999999999999999999976442111000000                    


Q ss_pred             --HHHHhhhcCCcceecc----CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          627 --WAKLHIESGDIQGIID----PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       627 --~~~~~~~~~~~~~~~d----~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                        +...........+.++    ..............+.+++..|++.||++|||+.|++++-
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence              0000000000000000    0000000111234588999999999999999999999873

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.8e-38  Score=351.57  Aligned_cols=192  Identities=24%  Similarity=0.358  Sum_probs=150.4

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeee-----CCeEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-----EGRSV  480 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~  480 (736)
                      .|.+.+.||+|+||+||+|... +++.||||++....  ....+.+.+|+.+|++++||||+++++++..     ....+
T Consensus        54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~  133 (458)
T 3rp9_A           54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY  133 (458)
T ss_dssp             TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred             CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence            3566789999999999999876 68999999986532  2234568899999999999999999999943     35789


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+. |+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       134 lv~e~~~-~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          134 VVLEIAD-SDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEECCCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEeccc-cchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence            9999985 689888843    35689999999999999999999998   999999999999999999999999999986


Q ss_pred             ccCCCC--------------------------cceecccccccccCcccc-ccCcCCCcchhHHHHHHHHHHHhC
Q 004689          561 AVDGAS--------------------------HVSSIVRGTVGYLDPEYY-ISQQLTDKSDVYSFGVILLELISG  608 (736)
Q Consensus       561 ~~~~~~--------------------------~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DVwSlGvvl~elltG  608 (736)
                      ......                          ......+||++|+|||++ ....++.++|||||||++|||++|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            532211                          122345689999999986 456799999999999999999993

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.3e-37  Score=346.41  Aligned_cols=260  Identities=20%  Similarity=0.335  Sum_probs=205.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCC-CceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.++||+|+||.||+|++. +++.||||++....  ...++..|+++++.++| ++|..+..++...+..++||||+ 
T Consensus         9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            456789999999999999874 68999999876443  24568899999999977 55666667777888999999999 


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE---cCCCcEEEEeecCCccccCC
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl---~~~~~~kl~DFGla~~~~~~  564 (736)
                      +++|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+||||   +.++.+||+|||+++.....
T Consensus        86 g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           86 GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99999998532   34689999999999999999999998   99999999999999   68899999999999866543


Q ss_pred             CCc------ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          565 ASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       565 ~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      ...      ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.........+......... ..+.
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~~  238 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-TSIE  238 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-SCHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-ccHH
Confidence            322      122457999999999999999999999999999999999999999875532222222221111111 1111


Q ss_pred             eeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       639 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                      .     +...+    ..++.+++..|++.+|++||++.+|++.|++++..
T Consensus       239 ~-----l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          239 A-----LCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             H-----HHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             H-----HhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence            0     01112    24688999999999999999999999999998764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.9e-38  Score=327.12  Aligned_cols=245  Identities=24%  Similarity=0.420  Sum_probs=192.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||.||+|... +++.||||++....   ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus        13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   92 (276)
T 2h6d_A           13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY   92 (276)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence            456789999999999999986 78999999986542   22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        93 ~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           93 VSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             CCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             cCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            999999999853    34588999999999999999999998   99999999999999999999999999997654322


Q ss_pred             CcceecccccccccCccccccCcC-CCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                        ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......    .+...    +..+..      .
T Consensus       166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~----~~~~~~------~  229 (276)
T 2h6d_A          166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP----TLFKK----IRGGVF------Y  229 (276)
T ss_dssp             -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----HHHCCC------C
T ss_pred             --ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----HHHHH----hhcCcc------c
Confidence              2233468999999999987765 58999999999999999999999764421    11111    111111      0


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +...    ....+.+++.+|++.||.+|||+.|++++
T Consensus       230 ~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          230 IPEY----LNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             Cchh----cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1111    12457899999999999999999999886

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-38  Score=340.99  Aligned_cols=258  Identities=21%  Similarity=0.290  Sum_probs=190.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCC------eEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV  480 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------~~~  480 (736)
                      |.+.+.||+|+||.||+|... +|+.||||++.....  .....+.+|+++++.++||||+++++++....      ..+
T Consensus        27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~  106 (367)
T 1cm8_A           27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY  106 (367)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence            456788999999999999875 689999999864322  22456889999999999999999999997653      459


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+ +++|.+++..     ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       107 lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          107 LVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             EEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            999999 7899998853     4588899999999999999999998   999999999999999999999999999986


Q ss_pred             ccCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHH-------hh
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL-------HI  632 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~-------~~  632 (736)
                      ....    .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+....+....+......       .+
T Consensus       178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  253 (367)
T ss_dssp             CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            5332    233568999999999987 68999999999999999999999999865422111111110000       00


Q ss_pred             hcC-------CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          633 ESG-------DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       633 ~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...       .+...-...+ ..........+.+++.+|++.||++|||+.|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            000       0000000000 00111223458899999999999999999999886

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.7e-38  Score=345.32  Aligned_cols=274  Identities=22%  Similarity=0.284  Sum_probs=204.6

Q ss_pred             cccCHHHHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcC--------CCceee
Q 004689          398 HCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH--------HRNLVQ  468 (736)
Q Consensus       398 ~~~~~~~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~--------HpnIv~  468 (736)
                      +.+...++....|.+.++||+|+||+||+|+.. +++.||||++... ......+.+|+.++++++        |+||++
T Consensus        27 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~  105 (397)
T 1wak_A           27 HLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQ  105 (397)
T ss_dssp             CSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred             eEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence            344445544556778899999999999999875 6889999998643 233466889999999995        788999


Q ss_pred             Eeeeee----eCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE
Q 004689          469 FLGYCQ----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL  544 (736)
Q Consensus       469 l~~~~~----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl  544 (736)
                      +++++.    .....++||||+ +++|.+.+...  ....+++..+..++.|++.||.|||+++  +|+||||||+|||+
T Consensus       106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll  180 (397)
T 1wak_A          106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILL  180 (397)
T ss_dssp             EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEE
T ss_pred             eecceeecCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeE
Confidence            999987    556889999999 56666666432  2346899999999999999999999953  89999999999999


Q ss_pred             cCCC-------------------------------------------------cEEEEeecCCccccCCCCcceeccccc
Q 004689          545 DKHM-------------------------------------------------RAKVSDFGLSKFAVDGASHVSSIVRGT  575 (736)
Q Consensus       545 ~~~~-------------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt  575 (736)
                      +.++                                                 .+||+|||+++.....    .....||
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt  256 (397)
T 1wak_A          181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQT  256 (397)
T ss_dssp             CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSC
T ss_pred             eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCC
Confidence            9775                                                 7999999999865432    2334689


Q ss_pred             ccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccH--HHHHHHhhhc--------C----------
Q 004689          576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNI--VQWAKLHIES--------G----------  635 (736)
Q Consensus       576 ~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l--~~~~~~~~~~--------~----------  635 (736)
                      +.|+|||++.+..++.++|||||||++|||++|+.||......+.....  ..........        +          
T Consensus       257 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  336 (397)
T 1wak_A          257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKK  336 (397)
T ss_dssp             GGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTT
T ss_pred             CcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCc
Confidence            9999999999999999999999999999999999999765432211111  1111111000        0          


Q ss_pred             -CcceeccCcc---------CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          636 -DIQGIIDPSL---------LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       636 -~~~~~~d~~l---------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       .+..+.+...         ....+......+.+++.+|++.||++|||+.|++++
T Consensus       337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence             0000000000         002245566789999999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=331.02  Aligned_cols=251  Identities=21%  Similarity=0.328  Sum_probs=198.4

Q ss_pred             HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      ...+.+.+.||+|+||.||+|... +|+.||||++....  ....+.+|+.++++++||||+++++++...+..++||||
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  105 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY  105 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence            344556789999999999999886 58999999987543  356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++..   ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......
T Consensus       106 ~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          106 CGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            999999999852   235688999999999999999999998   99999999999999999999999999997654332


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|+.||......       ...... ..........   
T Consensus       180 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~-~~~~~~~~~~---  247 (314)
T 3com_A          180 A-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-------RAIFMI-PTNPPPTFRK---  247 (314)
T ss_dssp             S-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHH-HHSCCCCCSS---
T ss_pred             c-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHH-hcCCCcccCC---
Confidence            2 223446899999999999989999999999999999999999999754311       101111 1111111100   


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          +......+.+++.+|++.||.+|||+.|++++
T Consensus       248 ----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          248 ----PELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             ----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ----cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                11123458899999999999999999999875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.1e-38  Score=367.63  Aligned_cols=246  Identities=24%  Similarity=0.307  Sum_probs=200.6

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      +.+.+.||+|+||.||+|+.. +++.||||+++...   ......+..|..++..+ +||||+++++++.+.+..++|||
T Consensus       343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E  422 (674)
T 3pfq_A          343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME  422 (674)
T ss_dssp             EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred             eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence            445678999999999999876 57889999997542   22345677899999887 79999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+||||+.++++||+|||+++.....
T Consensus       423 ~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          423 YVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             CcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            9999999999953    35689999999999999999999998   9999999999999999999999999999854322


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                      . ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....+    +.+   . +..+.+       
T Consensus       496 ~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~----~~~---~-i~~~~~-------  559 (674)
T 3pfq_A          496 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQ---S-IMEHNV-------  559 (674)
T ss_dssp             T-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH---H-HHSSCC-------
T ss_pred             C-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH----HHH---H-HHhCCC-------
Confidence            2 23345679999999999999999999999999999999999999998654221    111   1 111111       


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSI-----SEVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~ev~~~  681 (736)
                         .++.....++.+++..|++.||++||++     +||.++
T Consensus       560 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          560 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             ---CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             ---CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence               1112223458899999999999999997     777654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.2e-38  Score=331.45  Aligned_cols=251  Identities=21%  Similarity=0.341  Sum_probs=195.5

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .|.+.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||++
T Consensus        20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   99 (302)
T 2j7t_A           20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP   99 (302)
T ss_dssp             TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred             ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence            3456788999999999999986 588999999876655556788999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +++|.+++...   ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++...... ..
T Consensus       100 ~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  172 (302)
T 2j7t_A          100 GGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-LQ  172 (302)
T ss_dssp             TEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-HH
T ss_pred             CCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence            99999988532   34589999999999999999999998   9999999999999999999999999987532111 11


Q ss_pred             ceecccccccccCccccc-----cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          568 VSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      ......||+.|+|||++.     ...++.++|||||||++|||++|+.||......       ........ +.......
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~~~~~~  244 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAK-SDPPTLLT  244 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHH-SCCCCCSS
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHHHHHhc-cCCcccCC
Confidence            122346899999999984     567889999999999999999999999765421       11111111 11111110


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                             +......+.+++..|++.||++|||+.|++++
T Consensus       245 -------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          245 -------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             -------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             -------ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                   11123458899999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.8e-38  Score=343.72  Aligned_cols=252  Identities=10%  Similarity=0.009  Sum_probs=178.1

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhc--CCCceeeEe-------eeeeeC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRI--HHRNLVQFL-------GYCQEE  476 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l--~HpnIv~l~-------~~~~~~  476 (736)
                      +.+.+.||+|+||+||+|++. +++.||||++.....   .....+.+|+.+++.+  +||||++++       +++..+
T Consensus        64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~  143 (371)
T 3q60_A           64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ  143 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred             eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence            345789999999999999976 789999999986543   2244577886555555  599988855       344332


Q ss_pred             -----------------CeEEEEEEecCCCCHHHHhhcccccccccCHHHH------HHHHHHHHHHHHHHHhCCCCcee
Q 004689          477 -----------------GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKR------LEIAEDAAKGIEYLHTGCVPAII  533 (736)
Q Consensus       477 -----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~qia~~L~~LH~~~~~~ii  533 (736)
                                       ...++||||++ |+|.+++...   ...+.+..+      ..++.|++.||+|||++   +|+
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv  216 (371)
T 3q60_A          144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLV  216 (371)
T ss_dssp             TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence                             33799999999 8999999643   223344445      67889999999999998   999


Q ss_pred             cCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceecccccccccCcccccc--CcCCCcchhHHHHHHHHHHHhCCCc
Q 004689          534 HRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEA  611 (736)
Q Consensus       534 HrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DVwSlGvvl~elltG~~p  611 (736)
                      ||||||+|||++.++.+||+|||+++....    ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.|
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999985532    1223457799999999987  7899999999999999999999999


Q ss_pred             CcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          612 ISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       612 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      |......... .        .........................+.+++.+|++.||++|||+.|++++
T Consensus       293 f~~~~~~~~~-~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          293 FGLVTPGIKG-S--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TTBCCTTCTT-C--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCcCccccc-c--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            9866421100 0        00000000000011001011223468899999999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.8e-38  Score=333.28  Aligned_cols=252  Identities=24%  Similarity=0.310  Sum_probs=185.9

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc--cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ--GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      +.+.+.||+|+||+||+|+.. +++.||||+++.....  ..+.+.++...++.++||||+++++++.+++..++||||+
T Consensus         9 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~   88 (290)
T 3fme_A            9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM   88 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECC
T ss_pred             hhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehh
Confidence            456789999999999999875 6899999998754322  2233445556688889999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      + |+|.+++.........+++..++.++.|++.||.|||++  .+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        89 ~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  164 (290)
T 3fme_A           89 D-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-  164 (290)
T ss_dssp             S-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred             c-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccc-
Confidence            7 588888865544556799999999999999999999985  289999999999999999999999999997654332 


Q ss_pred             cceecccccccccCcccc----ccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          567 HVSSIVRGTVGYLDPEYY----ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~----~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                       ......||+.|+|||++    .+..++.++|||||||++|||++|+.||......  ...+    ......... ..  
T Consensus       165 -~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~----~~~~~~~~~-~~--  234 (290)
T 3fme_A          165 -AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--FQQL----KQVVEEPSP-QL--  234 (290)
T ss_dssp             ------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--HHHH----HHHHHSCCC-CC--
T ss_pred             -cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--HHHH----HHHhccCCC-Cc--
Confidence             22334699999999996    4567889999999999999999999999753311  1111    111111111 00  


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                            ........+.+++.+|++.||++|||+.|++++
T Consensus       235 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          235 ------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             ------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                  011123458899999999999999999999885

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1e-37  Score=354.40  Aligned_cols=249  Identities=28%  Similarity=0.412  Sum_probs=197.5

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-------------ccchhhhhHHHHHhhcCCCceeeEeeeee
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-------------QGKREFTNEVTLLSRIHHRNLVQFLGYCQ  474 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-------------~~~~~~~~E~~il~~l~HpnIv~l~~~~~  474 (736)
                      .|.+.++||+|+||+||+|... +++.||||++.....             .....+.+|+.++++++||||+++++++.
T Consensus        37 ~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  116 (504)
T 3q5i_A           37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE  116 (504)
T ss_dssp             TEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4556789999999999999876 578999999875431             22356889999999999999999999999


Q ss_pred             eCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC---cEE
Q 004689          475 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM---RAK  551 (736)
Q Consensus       475 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~---~~k  551 (736)
                      +....++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++   .+|
T Consensus       117 ~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          117 DKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEE
T ss_pred             cCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEE
Confidence            99999999999999999998853    45689999999999999999999998   999999999999999876   699


Q ss_pred             EEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHh
Q 004689          552 VSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH  631 (736)
Q Consensus       552 l~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~  631 (736)
                      |+|||+++......  ......||+.|+|||++. +.++.++||||+||++|+|++|..||.+....    .+...    
T Consensus       190 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~~----  258 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ----DIIKK----  258 (504)
T ss_dssp             ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHH----
T ss_pred             EEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----
Confidence            99999998654332  233456999999999986 56899999999999999999999999865422    12111    


Q ss_pred             hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +..+....  +......    ....+.+++..|++.||.+|||+.|++++
T Consensus       259 i~~~~~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          259 VEKGKYYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHCCCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHcCCCCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11221110  0000011    12458899999999999999999999876

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.1e-38  Score=343.04  Aligned_cols=259  Identities=21%  Similarity=0.271  Sum_probs=190.8

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCccc-----------chhhhhHHHHHhhcCCCceeeEeeeeee---
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQG-----------KREFTNEVTLLSRIHHRNLVQFLGYCQE---  475 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~-----------~~~~~~E~~il~~l~HpnIv~l~~~~~~---  475 (736)
                      |.+.+.||+|+||.||+|...+++.||||++.......           .+.+.+|++++++++||||+++++++..   
T Consensus        24 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  103 (362)
T 3pg1_A           24 YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEE  103 (362)
T ss_dssp             CEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCT
T ss_pred             eEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccC
Confidence            34578999999999999998889999999986543221           1568899999999999999999999843   


Q ss_pred             --CCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE
Q 004689          476 --EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS  553 (736)
Q Consensus       476 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~  553 (736)
                        ....++||||+. |+|.+.+..   ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus       104 ~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A          104 PAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             TTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEE
Confidence              346899999998 588888753   234689999999999999999999998   99999999999999999999999


Q ss_pred             eecCCccccCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh
Q 004689          554 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       554 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      |||+++......  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...    .
T Consensus       177 Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~----~  250 (362)
T 3pg1_A          177 DFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEV----V  250 (362)
T ss_dssp             CTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH----H
T ss_pred             ecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH----c
Confidence            999997543322  2234568999999999886 67899999999999999999999999865532222222111    1


Q ss_pred             hcCCcc-----------eeccCccCC-------cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          633 ESGDIQ-----------GIIDPSLLD-------EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       633 ~~~~~~-----------~~~d~~l~~-------~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ......           ..+...+..       .........+.+++.+|++.||++|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            100000           000000000       0011223458899999999999999999999876

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.1e-37  Score=330.86  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=196.0

Q ss_pred             HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--------ccchhhhhHHHHHhhcCCCceeeEeeeeeeCC
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG  477 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  477 (736)
                      ...|.+.+.||+|+||.||+|... +++.||||++.....        .....+.+|++++++++||||+++++++....
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            345677899999999999999876 578999999865321        12346889999999999999999999987655


Q ss_pred             eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc---EEEEe
Q 004689          478 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSD  554 (736)
Q Consensus       478 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~---~kl~D  554 (736)
                       .++||||+++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.   +||+|
T Consensus        89 -~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence             8999999999999998843    45688999999999999999999998   9999999999999987654   99999


Q ss_pred             ecCCccccCCCCcceecccccccccCccccc---cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHh
Q 004689          555 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH  631 (736)
Q Consensus       555 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~  631 (736)
                      ||+++.....  .......||+.|+|||++.   ...++.++|||||||++|||++|..||......   ..+.....  
T Consensus       161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~--  233 (322)
T 2ycf_A          161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ---VSLKDQIT--  233 (322)
T ss_dssp             CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS---SCHHHHHH--
T ss_pred             Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH---HHHHHHHH--
Confidence            9999865332  2223456899999999974   467889999999999999999999999765422   12222211  


Q ss_pred             hhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          632 IESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       632 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        .+....  .+.....    ....+.+++.+|++.||++||++.|++++
T Consensus       234 --~~~~~~--~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          234 --SGKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             --HTCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --hCcccc--Cchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence              111110  0111111    23458899999999999999999999865

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=331.00  Aligned_cols=254  Identities=24%  Similarity=0.381  Sum_probs=196.4

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.+.+.||+|+||.||+|....  .+|+|++....  ......+.+|+.++++++||||+++++++...+..++||||++
T Consensus        35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~  112 (319)
T 2y4i_B           35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCK  112 (319)
T ss_dssp             EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred             eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeeccc
Confidence            4567899999999999998863  59999987543  2334678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC---
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG---  564 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~---  564 (736)
                      +++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++ ++.+||+|||+++.....   
T Consensus       113 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          113 GRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             SEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred             CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence            99999998542   34688899999999999999999998   999999999999998 679999999998754221   


Q ss_pred             -CCcceecccccccccCcccccc---------CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhc
Q 004689          565 -ASHVSSIVRGTVGYLDPEYYIS---------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES  634 (736)
Q Consensus       565 -~~~~~~~~~gt~~Y~aPE~~~~---------~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~  634 (736)
                       .........||+.|+|||++..         ..++.++|||||||++|||++|+.||......    .+..    ....
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~----~~~~  257 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE----AIIW----QMGT  257 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH----HHHH----HHHT
T ss_pred             ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHH----Hhcc
Confidence             1122233458999999999874         35788999999999999999999999765421    1111    1112


Q ss_pred             CCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          635 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       635 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                      +........    .+    ...+.+++..|++.||++|||+.|+++.|+++...
T Consensus       258 ~~~~~~~~~----~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          258 GMKPNLSQI----GM----GKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             TCCCCCCCS----SC----CTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             CCCCCCCcC----CC----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            211111111    11    23478999999999999999999999999987543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9e-38  Score=364.45  Aligned_cols=258  Identities=21%  Similarity=0.337  Sum_probs=203.2

Q ss_pred             HHHHhhccccccCceEEEEEEECC----CcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      ..+.+.+.||+|+||.||+|.+..    +..||||+++.... .....+.+|+.++++++||||+++++++.+ +..++|
T Consensus       390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv  468 (656)
T 2j0j_A          390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII  468 (656)
T ss_dssp             GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEE
Confidence            445567889999999999998752    45799999865432 234678899999999999999999999854 568999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      |||+++|+|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus       469 ~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          469 MELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            9999999999999632   34588999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      ...........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....    .+...+    ..+...   
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----~~~~~i----~~~~~~---  611 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRI----ENGERL---  611 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHH----HHTCCC---
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHH----HcCCCC---
Confidence            444333344557889999999998899999999999999999997 99999765422    122211    111111   


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                            ..+......+.+++.+|++.||++||++.||++.|+.++..+
T Consensus       612 ------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          612 ------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence                  011122346889999999999999999999999999987544

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.9e-37  Score=338.23  Aligned_cols=261  Identities=21%  Similarity=0.287  Sum_probs=189.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCC------eEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV  480 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------~~~  480 (736)
                      |.+.+.||+|+||.||+|... +++.||||++....  ......+.+|+.+++.++||||+++++++...+      ..+
T Consensus        27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~  106 (371)
T 2xrw_A           27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY  106 (371)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred             eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence            456789999999999999876 68899999987542  223456889999999999999999999997654      789


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+.+ +|.+.+.      ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       107 lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          107 IVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             EEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            99999975 7887773      3478888999999999999999998   999999999999999999999999999976


Q ss_pred             ccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHH--------------
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ--------------  626 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~--------------  626 (736)
                      ....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+..              
T Consensus       177 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          177 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             cccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            5332  122345699999999999999999999999999999999999999976542111101100              


Q ss_pred             -HHHHhhhcC-C-----cceeccCccCCcC---CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          627 -WAKLHIESG-D-----IQGIIDPSLLDEY---DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       627 -~~~~~~~~~-~-----~~~~~d~~l~~~~---~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                       ......... .     +...+........   .......+.+++.+|++.||++|||++|++++-
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence             000000000 0     0000000000000   112345789999999999999999999998873

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.8e-37  Score=336.01  Aligned_cols=260  Identities=21%  Similarity=0.284  Sum_probs=197.8

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeC-----CeEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVL  481 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~l  481 (736)
                      .|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|++++++++||||+++++++...     ...++
T Consensus        28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i  107 (364)
T 3qyz_A           28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI  107 (364)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred             cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence            3556789999999999999876 688899999875432 2346688999999999999999999998654     46899


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+. |+|.+++.     ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++..
T Consensus       108 v~e~~~-~~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          108 VQDLME-TDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEECCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEcccC-cCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            999998 58988884     24588999999999999999999998   9999999999999999999999999999865


Q ss_pred             cCCCCc--ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          562 VDGASH--VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       562 ~~~~~~--~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      ......  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+..    ........
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~~~~~~~~  254 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG----ILGSPSQE  254 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH----HHCSCCHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH----HhCCCCHH
Confidence            432221  1234579999999998765 4589999999999999999999999987653322222221    11000000


Q ss_pred             ---e------------eccCccC--CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          639 ---G------------IIDPSLL--DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       639 ---~------------~~d~~l~--~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                         .            ...+...  ..........+.+++.+|++.||++|||+.|++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               0            0000000  00001122458899999999999999999999876

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.4e-37  Score=345.78  Aligned_cols=197  Identities=25%  Similarity=0.335  Sum_probs=169.5

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc------CCCceeeEeeeeeeCCeEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI------HHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l------~HpnIv~l~~~~~~~~~~~l  481 (736)
                      .|.+.+.||+|+||+||+|... +++.||||+++.. ......+.+|+.+++.+      .|+||+++++++......++
T Consensus        98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            3566789999999999999876 5889999998643 22345677899988887      57799999999999999999


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc--EEEEeecCCc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR--AKVSDFGLSK  559 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~--~kl~DFGla~  559 (736)
                      ||||+. ++|.+++....  ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.  +||+|||+++
T Consensus       177 v~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            999996 68999886432  24589999999999999999999998   9999999999999999987  9999999997


Q ss_pred             cccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccc
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK  616 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~  616 (736)
                      .....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus       251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            54322    233568999999999999999999999999999999999999998665

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.9e-37  Score=327.00  Aligned_cols=249  Identities=27%  Similarity=0.298  Sum_probs=198.6

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---------ccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---------QGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR  478 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---------~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~  478 (736)
                      |.+.+.||+|+||.||+|... +++.||||++.....         .....+.+|+++++++. ||||+++++++.....
T Consensus        19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   98 (298)
T 1phk_A           19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   98 (298)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence            445789999999999999986 688999999875431         11345788999999995 9999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCC
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS  558 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla  558 (736)
                      .++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        99 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~  171 (298)
T 1phk_A           99 FFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS  171 (298)
T ss_dssp             EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccch
Confidence            9999999999999999853    35688999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCCcceecccccccccCccccc------cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh
Q 004689          559 KFAVDGASHVSSIVRGTVGYLDPEYYI------SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       559 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      .......  ......||+.|+|||++.      ...++.++|||||||++|||++|+.||......    .+..    .+
T Consensus       172 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~----~~  241 (298)
T 1phk_A          172 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM----LMLR----MI  241 (298)
T ss_dssp             EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HH
T ss_pred             hhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH----HHHH----HH
Confidence            7654332  223356899999999985      456889999999999999999999999755421    1111    11


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..+....  ....    .......+.+++.+|++.||++||++.|++++
T Consensus       242 ~~~~~~~--~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          242 MSGNYQF--GSPE----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHTCCCC--CTTT----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             hcCCccc--Cccc----ccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            1111110  0000    01223458899999999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.1e-37  Score=335.92  Aligned_cols=266  Identities=21%  Similarity=0.254  Sum_probs=187.9

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCe-------EE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR-------SV  480 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-------~~  480 (736)
                      .|.+.+.||+|+||+||+|+.. +++.||||++.... .......+|++.++.++||||+++++++...+.       .+
T Consensus        24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~  102 (360)
T 3e3p_A           24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLN  102 (360)
T ss_dssp             TEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEE
Confidence            4556789999999999999986 68999999986543 234456678888899999999999999965443       78


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHH--hCCCCceecCCCCCCCEEEcC-CCcEEEEeecC
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH--TGCVPAIIHRDLKSSNILLDK-HMRAKVSDFGL  557 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH--~~~~~~iiHrDikp~NILl~~-~~~~kl~DFGl  557 (736)
                      +||||+.+ +|.+.+.........+++..+..++.|++.||.|||  +.   +|+||||||+|||++. ++.+||+|||+
T Consensus       103 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~  178 (360)
T 3e3p_A          103 VVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGS  178 (360)
T ss_dssp             EEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred             EEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence            99999986 565555444445567888999999999999999999  76   9999999999999997 89999999999


Q ss_pred             CccccCCCCcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHH--------
Q 004689          558 SKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA--------  628 (736)
Q Consensus       558 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~--------  628 (736)
                      ++.......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.+..        
T Consensus       179 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  256 (360)
T 3e3p_A          179 AKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL  256 (360)
T ss_dssp             CBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHH
Confidence            986543322  2344689999999998764 48999999999999999999999998755322222222110        


Q ss_pred             HHhhhcCCcceeccC------ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          629 KLHIESGDIQGIIDP------SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       629 ~~~~~~~~~~~~~d~------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .............+.      .............+.+++.+|++.||.+|||+.|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            000000000000000      00011122245678999999999999999999999876

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-37  Score=342.41  Aligned_cols=263  Identities=19%  Similarity=0.260  Sum_probs=180.8

Q ss_pred             hccccccCceEEEEEEEC---CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeee--eCCeEEEEEEecC
Q 004689          413 EKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ--EEGRSVLVYEFMH  487 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~~lV~e~~~  487 (736)
                      .++||+|+||+||+|++.   +++.||||++....  ....+.+|+.+|++++||||+++++++.  .....++||||+.
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence            568999999999999976   57889999986432  2456889999999999999999999995  4678999999997


Q ss_pred             CCCHHHHhhccc-----ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE----cCCCcEEEEeecCC
Q 004689          488 NGTLKEHLYGTL-----THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL----DKHMRAKVSDFGLS  558 (736)
Q Consensus       488 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl----~~~~~~kl~DFGla  558 (736)
                      + +|.+++....     .....+++..++.++.|++.||.|||+.   +|+||||||+|||+    +.++.+||+|||++
T Consensus       104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  179 (405)
T 3rgf_A          104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  179 (405)
T ss_dssp             E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred             C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence            5 7877774221     1122489999999999999999999998   99999999999999    67789999999999


Q ss_pred             ccccCCCC--cceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCccccccc-----ccccHHHHHHH
Q 004689          559 KFAVDGAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGA-----NCRNIVQWAKL  630 (736)
Q Consensus       559 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~-----~~~~l~~~~~~  630 (736)
                      +.......  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......     ........+..
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~  259 (405)
T 3rgf_A          180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  259 (405)
T ss_dssp             C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred             eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence            86543221  22344679999999999987 458999999999999999999999997543210     00011111111


Q ss_pred             hhhcCC---cceec------------cCccCCcCC---------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          631 HIESGD---IQGII------------DPSLLDEYD---------IQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       631 ~~~~~~---~~~~~------------d~~l~~~~~---------~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .+....   ...+.            .........         ......+.+|+.+|++.||.+|||+.|++++
T Consensus       260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            111000   00000            000000000         0012357899999999999999999999886

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-37  Score=330.33  Aligned_cols=249  Identities=24%  Similarity=0.403  Sum_probs=192.4

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeee------CCeEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE------EGRSVL  481 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~------~~~~~l  481 (736)
                      |.+.+.||+|+||.||+|+.. +++.||||++.... .....+.+|+.+++++ +||||+++++++..      .+..++
T Consensus        26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l  104 (326)
T 2x7f_A           26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL  104 (326)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred             EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence            446789999999999999885 68999999986543 3456788999999999 89999999999976      468899


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+++|+|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       105 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  179 (326)
T 2x7f_A          105 VMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  179 (326)
T ss_dssp             EEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred             EEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence            99999999999998643  235688899999999999999999998   9999999999999999999999999998765


Q ss_pred             cCCCCcceecccccccccCccccc-----cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      .... .......||+.|+|||++.     +..++.++|||||||++|||++|+.||......    ....   . +....
T Consensus       180 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~---~-~~~~~  250 (326)
T 2x7f_A          180 DRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALF---L-IPRNP  250 (326)
T ss_dssp             ------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHH---H-HHHSC
T ss_pred             CcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----HHHH---H-hhcCc
Confidence            3322 1223346899999999987     567889999999999999999999999754411    1111   1 11111


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .....    ...+    ...+.+++.+|++.||.+||++.|++++
T Consensus       251 ~~~~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          251 APRLK----SKKW----SKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             CCCCS----CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cccCC----cccc----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            11111    1112    2358899999999999999999999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.4e-37  Score=324.66  Aligned_cols=248  Identities=22%  Similarity=0.321  Sum_probs=194.7

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC----cccchhhhhHHHHHhhcCCCceeeEeeee--eeCCeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHHRNLVQFLGYC--QEEGRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l~HpnIv~l~~~~--~~~~~~~lV  482 (736)
                      |.+.+.||+|+||.||+|... +++.||+|++....    ......+.+|++++++++||||+++++++  .+....++|
T Consensus         7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (305)
T 2wtk_C            7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV   86 (305)
T ss_dssp             BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred             eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence            456789999999999999875 68899999986542    23346789999999999999999999998  455688999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      |||+.++ |.+++...  ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++....
T Consensus        87 ~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           87 MEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             EECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            9999987 76766543  245689999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCC-CcceecccccccccCccccccCc--CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          563 DGA-SHVSSIVRGTVGYLDPEYYISQQ--LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       563 ~~~-~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      ... ........||+.|+|||++.+..  ++.++|||||||++|||++|+.||......    .+..    .+..+..  
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~----~i~~~~~--  230 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY----KLFE----NIGKGSY--  230 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHH----HHHHCCC--
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH----HHHH----HHhcCCC--
Confidence            322 22233456999999999997643  477999999999999999999999765421    1111    1111211  


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          .+...+    ...+.+++.+|++.||.+||++.|++++
T Consensus       231 ----~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 ----AIPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ----CCCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----CCCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                111122    2357899999999999999999999886

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.8e-37  Score=331.55  Aligned_cols=265  Identities=21%  Similarity=0.287  Sum_probs=198.2

Q ss_pred             HHHhhccccccCceEEEEEEEC--CCcEEEEEEeccCCc--ccchhhhhHHHHHhhc---CCCceeeEeeeee-----eC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQ-----EE  476 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~--~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~~~~~-----~~  476 (736)
                      .|.+.+.||+|+||.||+|+..  +++.||+|+++....  .....+.+|+.+++.+   +||||+++++++.     ..
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   91 (326)
T 1blx_A           12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   91 (326)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence            3456789999999999999983  678999999875432  2244677888888877   8999999999987     55


Q ss_pred             CeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeec
Q 004689          477 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG  556 (736)
Q Consensus       477 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFG  556 (736)
                      ...++||||+. |+|.+++....  ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        92 ~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           92 TKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             EEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCc
Confidence            67899999998 69999986432  33488999999999999999999998   99999999999999999999999999


Q ss_pred             CCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          557 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       557 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      +++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+............
T Consensus       166 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          166 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             ccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            99754322  1223456899999999999999999999999999999999999999865422111111111000000000


Q ss_pred             ccee------cc---CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 IQGI------ID---PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~~~~------~d---~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....      +.   ..............+.+++.+|++.||++||++.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0000      00   000001111223457899999999999999999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.2e-37  Score=334.22  Aligned_cols=259  Identities=23%  Similarity=0.291  Sum_probs=201.2

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccc-----------------hhhhhHHHHHhhcCCCceeeEee
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGK-----------------REFTNEVTLLSRIHHRNLVQFLG  471 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~-----------------~~~~~E~~il~~l~HpnIv~l~~  471 (736)
                      .|.+.+.||+|+||.||+|.. +++.||||++........                 ..+.+|+.++++++||||+++++
T Consensus        32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~  110 (348)
T 2pml_X           32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG  110 (348)
T ss_dssp             TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred             ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            345678999999999999999 799999999875422111                 67899999999999999999999


Q ss_pred             eeeeCCeEEEEEEecCCCCHHHHhhcc--cc--cccccCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEEcC
Q 004689          472 YCQEEGRSVLVYEFMHNGTLKEHLYGT--LT--HEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDK  546 (736)
Q Consensus       472 ~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~--~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiHrDikp~NILl~~  546 (736)
                      ++.+.+..++||||+++|+|.+++...  ..  ....+++..++.++.|++.||.|||+ .   +|+||||||+||+++.
T Consensus       111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDK  187 (348)
T ss_dssp             EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECT
T ss_pred             EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcC
Confidence            999999999999999999999983210  11  14678999999999999999999999 7   9999999999999999


Q ss_pred             CCcEEEEeecCCccccCCCCcceecccccccccCccccccC-cCCC-cchhHHHHHHHHHHHhCCCcCcccccccccccH
Q 004689          547 HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ-QLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNI  624 (736)
Q Consensus       547 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~-~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l  624 (736)
                      ++.+||+|||++......   ......||+.|+|||.+.+. .++. ++|||||||++|||++|+.||......   ..+
T Consensus       188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~  261 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---VEL  261 (348)
T ss_dssp             TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---HHH
T ss_pred             CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHH
Confidence            999999999999865433   23445699999999999877 6666 999999999999999999999865421   112


Q ss_pred             HHHHHHhhhcCCcceecc------CccC---CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          625 VQWAKLHIESGDIQGIID------PSLL---DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       625 ~~~~~~~~~~~~~~~~~d------~~l~---~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...    +..+......+      +...   ..........+.+++.+|++.||.+||++.|++++
T Consensus       262 ~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          262 FNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111    11121111000      0000   00001223468899999999999999999999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.9e-37  Score=337.48  Aligned_cols=255  Identities=22%  Similarity=0.312  Sum_probs=179.7

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeC------CeE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRS  479 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~~  479 (736)
                      .|.+.+.||+|+||.||+|... +|+.||||++....  ......+.+|+.+++.++||||+++++++...      ...
T Consensus        30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~  109 (367)
T 2fst_X           30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV  109 (367)
T ss_dssp             TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred             ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence            3456789999999999999865 68899999986532  22345678999999999999999999998654      567


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ++|+|++ +++|.+++..     ..+++..+..++.|+++||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       110 ~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          110 YLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             EEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             EEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            9999999 6899888742     4689999999999999999999998   99999999999999999999999999997


Q ss_pred             cccCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      .....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+.+    ...... .
T Consensus       181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~----~~g~p~-~  251 (367)
T 2fst_X          181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR----LVGTPG-A  251 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----HHCSCC-H
T ss_pred             ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH----HhCCCC-H
Confidence            64322    233568999999999987 6789999999999999999999999986542211111111    110000 0


Q ss_pred             eeccC-----------ccC--CcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          639 GIIDP-----------SLL--DEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       639 ~~~d~-----------~l~--~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +.+..           .+.  .....     .....+.+++.+|++.||.+|||+.|++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            00000           000  00010     112457899999999999999999999876

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2e-37  Score=329.68  Aligned_cols=250  Identities=23%  Similarity=0.309  Sum_probs=192.7

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCc--ccchhhhhHHHHHhhcC--CCceeeEeeeeeeCCeEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .|.+.+.||+|+||.||+|...+++.||||++.....  .....+.+|++++++++  ||||+++++++...+..++|||
T Consensus        29 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e  108 (313)
T 3cek_A           29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME  108 (313)
T ss_dssp             EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC
T ss_pred             eEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe
Confidence            3556789999999999999998899999999865432  23467889999999997  5999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                       +.+++|.+++..    ...+++..++.++.|++.||.|||+.   +|+||||||+|||+++ +.+||+|||+++.....
T Consensus       109 -~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~  179 (313)
T 3cek_A          109 -CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD  179 (313)
T ss_dssp             -CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred             -cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence             668899999853    34688889999999999999999998   9999999999999964 89999999999865433


Q ss_pred             CCc-ceecccccccccCcccccc-----------CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh
Q 004689          565 ASH-VSSIVRGTVGYLDPEYYIS-----------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       565 ~~~-~~~~~~gt~~Y~aPE~~~~-----------~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      ... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....     .. .......
T Consensus       180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~-~~~~~~~  253 (313)
T 3cek_A          180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QI-SKLHAII  253 (313)
T ss_dssp             ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HH-HHHHHHH
T ss_pred             cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HH-HHHHHHH
Confidence            221 2234569999999999875           4678899999999999999999999975431     11 1111111


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      ..         .....++......+.+++.+|++.||.+||++.|++++-
T Consensus       254 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          254 DP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             CT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             hc---------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            11         111111111134588999999999999999999998864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6.1e-37  Score=323.26  Aligned_cols=250  Identities=24%  Similarity=0.343  Sum_probs=189.7

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeee------------
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------------  475 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------------  475 (736)
                      .|.+.+.||+|+||.||+|+.. +++.||||++... ......+.+|+.++++++||||+++++++.+            
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            4556789999999999999975 7899999998643 2334678899999999999999999998865            


Q ss_pred             -CCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 004689          476 -EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD  554 (736)
Q Consensus       476 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~D  554 (736)
                       ....++||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred             cCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEee
Confidence             45679999999999999999642   34577888999999999999999998   999999999999999999999999


Q ss_pred             ecCCccccCCC-------------CcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccc
Q 004689          555 FGLSKFAVDGA-------------SHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGAN  620 (736)
Q Consensus       555 FGla~~~~~~~-------------~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~  620 (736)
                      ||+++......             ........||+.|+|||++.+. .++.++|||||||++|||++   ||.....   
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~---  233 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME---  233 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH---
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh---
Confidence            99997653221             1122345689999999999864 78999999999999999998   4432210   


Q ss_pred             cccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          621 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       621 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...+...    +....      ......++......+.+++.+|++.||.+|||+.|++++
T Consensus       234 ~~~~~~~----~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          234 RVNILKK----LRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHHH----HHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHh----ccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            0111111    11111      111122233334567899999999999999999999875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-37  Score=337.36  Aligned_cols=259  Identities=22%  Similarity=0.278  Sum_probs=194.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeC-----CeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEE-----GRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~lV  482 (736)
                      +.+.+.||+|+||.||+|+.. +|+.||||++..... .....+.+|+.++++++||||+++++++...     ...++|
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv   92 (353)
T 2b9h_A           13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII   92 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred             eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence            446789999999999999876 688999999864332 2345678999999999999999999988754     678999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      |||+. |+|.+++..     ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           93 QELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             ECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99997 589888853     4588999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCCCc---------ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh
Q 004689          563 DGASH---------VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       563 ~~~~~---------~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      .....         ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......    ........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~  239 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ----LLLIFGII  239 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHH
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHh
Confidence            32211         1223468999999998764 6789999999999999999999999986542111    11111111


Q ss_pred             hcCC----cceeccC-------cc--CCc-----CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          633 ESGD----IQGIIDP-------SL--LDE-----YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       633 ~~~~----~~~~~d~-------~l--~~~-----~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ....    ......+       .+  ...     ........+.+++.+|++.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000    0000000       00  000     001123457899999999999999999999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.6e-37  Score=333.43  Aligned_cols=259  Identities=20%  Similarity=0.294  Sum_probs=192.8

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeE------
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRS------  479 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~------  479 (736)
                      .|.+.+.||+|+||+||+|... +|+.||||++.....  .....+.+|+.+++.++||||+++++++...+..      
T Consensus        43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  122 (371)
T 4exu_A           43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF  122 (371)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred             cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence            3456788999999999999876 689999999975432  2245688999999999999999999999877654      


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ++||||+. ++|.+.+.      ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus       123 ~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          123 YLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             EEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             EEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence            99999998 58888773      3488999999999999999999998   99999999999999999999999999997


Q ss_pred             cccCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhc--CC
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES--GD  636 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~--~~  636 (736)
                      .....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+.........+  ..
T Consensus       193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            54322    233568999999999987 789999999999999999999999998654222111111100000000  00


Q ss_pred             cc-----e---eccCccCCc---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 IQ-----G---IIDPSLLDE---YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~~-----~---~~d~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +.     .   .+.......   ........+.+++.+|++.||++|||+.|++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            00     0   000000000   001123468899999999999999999999876

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.3e-37  Score=326.56  Aligned_cols=262  Identities=21%  Similarity=0.260  Sum_probs=190.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeee--------------
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQ--------------  474 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--------------  474 (736)
                      |.+.+.||+|+||.||+|... +++.||||++........+.+.+|++++++++||||+++++++.              
T Consensus        13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~   92 (320)
T 2i6l_A           13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT   92 (320)
T ss_dssp             EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred             eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence            455788999999999999987 48999999987665555677899999999999999999999873              


Q ss_pred             eCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc-CCCcEEEE
Q 004689          475 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVS  553 (736)
Q Consensus       475 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~-~~~~~kl~  553 (736)
                      +....++||||+. |+|.+++..     ..+++..+..++.|++.||+|||++   +|+||||||+|||++ .++.+||+
T Consensus        93 ~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           93 ELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             SCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             ccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEc
Confidence            4467899999998 699998842     4588889999999999999999998   999999999999997 56799999


Q ss_pred             eecCCccccCCCC--cceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHH--
Q 004689          554 DFGLSKFAVDGAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA--  628 (736)
Q Consensus       554 DFGla~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~--  628 (736)
                      |||+++.......  .......||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....  
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999986543221  12233457999999998875 678999999999999999999999998654221111111100  


Q ss_pred             -----HHhhhcCCcceeccCccC-C-----cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          629 -----KLHIESGDIQGIIDPSLL-D-----EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       629 -----~~~~~~~~~~~~~d~~l~-~-----~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                           ..... ..+...+..... .     .........+.+++.+|++.||++|||+.|++++
T Consensus       244 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          244 VHEEDRQELL-SVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CCHHHHHHHH-TTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             Cchhhhhhhh-hcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence                 00000 000000000000 0     0001123468899999999999999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1e-36  Score=319.96  Aligned_cols=253  Identities=26%  Similarity=0.367  Sum_probs=201.3

Q ss_pred             HHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          405 IEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       405 i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      .....|.+.+.||+|+||.||+|+.. +++.||||++.....  .....+.+|++++++++||||+++++++...+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34456777899999999999999886 689999999865432  335678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC---CcEEEEeecCC
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH---MRAKVSDFGLS  558 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~---~~~kl~DFGla  558 (736)
                      ||||+++++|.+.+..    ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.+   +.+||+|||++
T Consensus        99 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            9999999999998853    34688999999999999999999998   99999999999999764   47999999999


Q ss_pred             ccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          559 KFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       559 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      ........  .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......    .+..    .+..+...
T Consensus       172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~----~~~~~~~~  240 (287)
T 2wei_A          172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY----DILK----RVETGKYA  240 (287)
T ss_dssp             GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCCCC
T ss_pred             eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH----HHHH----HHHcCCCC
Confidence            76543322  223458999999998865 4899999999999999999999999765421    1111    11222211


Q ss_pred             eeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       639 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .  +......+    ...+.+++.+|++.||++|||+.|++++
T Consensus       241 ~--~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          241 F--DLPQWRTI----SDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             C--CSGGGTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             C--Cchhhhhc----CHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            0  00001111    2458899999999999999999999885

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.4e-36  Score=325.88  Aligned_cols=263  Identities=21%  Similarity=0.273  Sum_probs=199.7

Q ss_pred             HHHHhhccccccCceEEEEEEE-C-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCc------eeeEeeeeeeCCeE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKL-K-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN------LVQFLGYCQEEGRS  479 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~-~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~~~~~~~~~~  479 (736)
                      ..|.+.+.||+|+||+||+|.. . +++.||||+++... .....+.+|+++++.++|++      ++++++++...+..
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            3456778999999999999987 3 68899999986432 33466889999999997654      99999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-------------
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-------------  546 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~-------------  546 (736)
                      ++||||+ +++|.+++...  ....+++..+..++.|++.||+|||++   +|+||||||+|||++.             
T Consensus        93 ~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence            9999999 88999998543  123578899999999999999999998   9999999999999987             


Q ss_pred             ------CCcEEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccc
Q 004689          547 ------HMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN  620 (736)
Q Consensus       547 ------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~  620 (736)
                            ++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                  668999999999764332    2334689999999999999999999999999999999999999976542211


Q ss_pred             cccHHHHHHH----hhhcCCcceecc--------------------Ccc--CCcCCHHHHHHHHHHHhhccCCCCCCCCC
Q 004689          621 CRNIVQWAKL----HIESGDIQGIID--------------------PSL--LDEYDIQSMWKIEEKALMCVLPHGHMRPS  674 (736)
Q Consensus       621 ~~~l~~~~~~----~~~~~~~~~~~d--------------------~~l--~~~~~~~~~~~l~~l~~~cl~~dP~~RPt  674 (736)
                      ...+......    ..........+.                    ..+  ...........+.+++.+|++.||.+|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            1111110000    000000000000                    000  00112344567899999999999999999


Q ss_pred             HHHHHHH
Q 004689          675 ISEVLKD  681 (736)
Q Consensus       675 ~~ev~~~  681 (736)
                      +.|++++
T Consensus       323 ~~ell~h  329 (339)
T 1z57_A          323 LREALKH  329 (339)
T ss_dssp             HHHHTTS
T ss_pred             HHHHhcC
Confidence            9999875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.6e-36  Score=329.39  Aligned_cols=199  Identities=25%  Similarity=0.296  Sum_probs=167.1

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcC-CC-----ceeeEeeeeeeCCeEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HR-----NLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-Hp-----nIv~l~~~~~~~~~~~l  481 (736)
                      .|.+.+.||+|+||+||+|... +++.||||+++... ....++..|+.+++.++ |+     +|+++++++...+..++
T Consensus        55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  133 (382)
T 2vx3_A           55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL  133 (382)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred             eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence            4556789999999999999876 67889999986432 23456778999988885 44     49999999999999999


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc--CCCcEEEEeecCCc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSK  559 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~--~~~~~kl~DFGla~  559 (736)
                      ||||+. |+|.+++....  ...+++..+..++.|++.||.|||++ ..+|+||||||+|||++  .++.+||+|||+++
T Consensus       134 v~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~  209 (382)
T 2vx3_A          134 VFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC  209 (382)
T ss_dssp             EEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence            999996 59999986432  24588999999999999999999952 13899999999999995  47889999999998


Q ss_pred             cccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccc
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK  616 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~  616 (736)
                      .....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus       210 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          210 QLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             ETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            65332    233568999999999999999999999999999999999999998654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-37  Score=325.91  Aligned_cols=244  Identities=25%  Similarity=0.390  Sum_probs=190.9

Q ss_pred             HHHHHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc------ccchhhhhHHHHHhhc----CCCceeeEeee
Q 004689          404 DIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY------QGKREFTNEVTLLSRI----HHRNLVQFLGY  472 (736)
Q Consensus       404 ~i~~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~------~~~~~~~~E~~il~~l----~HpnIv~l~~~  472 (736)
                      +.....|.+.+.||+|+||.||+|+.. +++.||||++.....      .....+.+|+.+++++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            344556777899999999999999875 688999999865432      2345677899999999    89999999999


Q ss_pred             eeeCCeEEEEEEe-cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc-CCCcE
Q 004689          473 CQEEGRSVLVYEF-MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRA  550 (736)
Q Consensus       473 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~-~~~~~  550 (736)
                      +...+..++|+|+ +.+++|.+++..    ...+++..++.++.|++.||.|||+.   +|+||||||+||+++ .++.+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence            9999999999999 789999999853    34589999999999999999999998   999999999999999 88999


Q ss_pred             EEEeecCCccccCCCCcceecccccccccCccccccCcCC-CcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHH
Q 004689          551 KVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT-DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK  629 (736)
Q Consensus       551 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~  629 (736)
                      ||+|||+++......   .....||+.|+|||++.+..+. .++|||||||++|||++|+.||....      .+.    
T Consensus       180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~----  246 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EIL----  246 (312)
T ss_dssp             EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH----
T ss_pred             EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHh----
Confidence            999999998654332   2344689999999999876664 58999999999999999999996432      010    


Q ss_pred             HhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          630 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       630 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          ....      .+...    ....+.+++.+|++.||++||++.|++++
T Consensus       247 ----~~~~------~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          247 ----EAEL------HFPAH----VSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ----HTCC------CCCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----hhcc------CCccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0100      01111    22357889999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.3e-36  Score=338.65  Aligned_cols=250  Identities=23%  Similarity=0.304  Sum_probs=185.5

Q ss_pred             hhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      ..+.||+|+||+||.+...+|+.||||++....   ...+.+|+++++++ +||||+++++++.+.+..++||||+. |+
T Consensus        19 ~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs   94 (434)
T 2rio_A           19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN   94 (434)
T ss_dssp             EEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred             ccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence            357899999999987766779999999986432   34578899999887 89999999999999999999999996 69


Q ss_pred             HHHHhhcccccccc---cCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-------------CcEEEEe
Q 004689          491 LKEHLYGTLTHEQR---INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-------------MRAKVSD  554 (736)
Q Consensus       491 L~~~l~~~~~~~~~---l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~-------------~~~kl~D  554 (736)
                      |.+++.........   ..+..++.++.|++.||+|||+.   +|+||||||+|||++.+             +.+||+|
T Consensus        95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D  171 (434)
T 2rio_A           95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD  171 (434)
T ss_dssp             HHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred             HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence            99999654322111   12334578999999999999998   99999999999999754             4899999


Q ss_pred             ecCCccccCCCCc---ceecccccccccCcccccc-------CcCCCcchhHHHHHHHHHHHh-CCCcCccccccccccc
Q 004689          555 FGLSKFAVDGASH---VSSIVRGTVGYLDPEYYIS-------QQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN  623 (736)
Q Consensus       555 FGla~~~~~~~~~---~~~~~~gt~~Y~aPE~~~~-------~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~  623 (736)
                      ||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||......     
T Consensus       172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----  246 (434)
T 2rio_A          172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-----  246 (434)
T ss_dssp             CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-----
T ss_pred             cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-----
Confidence            9999866443322   1234569999999999975       678999999999999999999 99999654311     


Q ss_pred             HHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          624 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       624 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .........   ..     +......+.....++.+++.+|++.||.+|||+.||+++
T Consensus       247 ~~~i~~~~~---~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          247 ESNIIRGIF---SL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             HHHHHHTCC---CC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHhcCCC---Cc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            111111110   00     011111234455678999999999999999999999874

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.6e-37  Score=327.49  Aligned_cols=240  Identities=21%  Similarity=0.360  Sum_probs=196.4

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc------cchhhhhHHHHHhhcC--CCceeeEeeeeeeCCe
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGR  478 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~  478 (736)
                      ..|.+.+.||+|+||.||+|... +++.||||++......      ....+.+|+.++++++  ||||+++++++...+.
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~  122 (320)
T 3a99_A           43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS  122 (320)
T ss_dssp             TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence            34566789999999999999865 6889999998755322      2356788999999996  5999999999999999


Q ss_pred             EEEEEEecCC-CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc-CCCcEEEEeec
Q 004689          479 SVLVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFG  556 (736)
Q Consensus       479 ~~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~-~~~~~kl~DFG  556 (736)
                      .++|+|++.+ ++|.+++..    ...+++..++.++.|++.||.|||+.   +|+||||||+|||++ .++.+||+|||
T Consensus       123 ~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg  195 (320)
T 3a99_A          123 FVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  195 (320)
T ss_dssp             EEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence            9999999986 899999853    45688999999999999999999998   999999999999999 78999999999


Q ss_pred             CCccccCCCCcceecccccccccCccccccCcC-CCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC
Q 004689          557 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       557 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      +++......   .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....      +.        .+
T Consensus       196 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~--------~~  258 (320)
T 3a99_A          196 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II--------RG  258 (320)
T ss_dssp             TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH--------HC
T ss_pred             ccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hh--------cc
Confidence            998654322   233469999999999987665 6789999999999999999999975420      00        01


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..  .    ....+    ...+.+++.+|++.||++||++.||+++
T Consensus       259 ~~--~----~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          259 QV--F----FRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             CC--C----CSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cc--c----ccccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            10  0    11112    2357899999999999999999999885

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.9e-36  Score=326.45  Aligned_cols=255  Identities=21%  Similarity=0.302  Sum_probs=191.7

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCe------EE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR------SV  480 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~------~~  480 (736)
                      |.+.+.||+|+||.||+|... +|+.||||++.....  .....+.+|+.++++++||||+++++++...+.      .+
T Consensus        26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  105 (353)
T 3coi_A           26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY  105 (353)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred             EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence            445688999999999999875 689999999865432  224568899999999999999999999987654      49


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+. |+|.+++.      ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       106 lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          106 LVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             EEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             EEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence            9999997 58877763      3488899999999999999999998   999999999999999999999999999975


Q ss_pred             ccCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHH----------
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK----------  629 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~----------  629 (736)
                      ....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+.....          
T Consensus       176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred             CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence            4322    233468999999999887 6789999999999999999999999986542211111111000          


Q ss_pred             ------HhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          630 ------LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       630 ------~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                            ....  .+.....+.+ ..........+.+++.+|++.||++|||+.|++++
T Consensus       252 ~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          252 NDKAAKSYIQ--SLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             SCHHHHHHHH--TSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhHHHHHHHH--hCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                  0000  0000000000 01111234568899999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-36  Score=325.86  Aligned_cols=254  Identities=26%  Similarity=0.328  Sum_probs=175.2

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHH-HHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVT-LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.||+|+||.||+|... +++.||||++..... ....++..|+. +++.++||||+++++++...+..++||||+.
T Consensus        25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~  104 (327)
T 3aln_A           25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS  104 (327)
T ss_dssp             EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence            35678999999999999986 689999999975432 22344555655 7777899999999999999999999999998


Q ss_pred             CCCHHHHhhccc-ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          488 NGTLKEHLYGTL-THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       488 ~gsL~~~l~~~~-~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      + +|.+++.... .....+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       105 ~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~  181 (327)
T 3aln_A          105 T-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA  181 (327)
T ss_dssp             E-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC------
T ss_pred             C-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc
Confidence            5 7877764321 1245688999999999999999999995  3899999999999999999999999999976543221


Q ss_pred             cceecccccccccCcccc----ccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          567 HVSSIVRGTVGYLDPEYY----ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~----~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                        .....||+.|+|||++    .+..++.++|||||||++|||++|+.||......      ...... ...+..     
T Consensus       182 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~-~~~~~~-----  247 (327)
T 3aln_A          182 --KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV------FDQLTQ-VVKGDP-----  247 (327)
T ss_dssp             --------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CC-CCCSCC-----
T ss_pred             --cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH------HHHHHH-HhcCCC-----
Confidence              2233689999999998    4567899999999999999999999999754311      000000 001111     


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +.+...........+.+++.+|++.||++||++.||+++
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            111111111223468899999999999999999999876

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.1e-36  Score=325.34  Aligned_cols=248  Identities=20%  Similarity=0.247  Sum_probs=168.3

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeee----CCeEEEEEEecC
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVYEFMH  487 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lV~e~~~  487 (736)
                      .+.||+|+||+||+|... +++.||||++...    .....+....++.++||||+++++++..    ....++||||++
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~  109 (336)
T 3fhr_A           34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME  109 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred             ceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence            457999999999999887 6899999998642    1222223334566799999999999876    455899999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeecCCccccCC
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~---~~~~kl~DFGla~~~~~~  564 (736)
                      +|+|.+++....  ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||+++.....
T Consensus       110 gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~  184 (336)
T 3fhr_A          110 GGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN  184 (336)
T ss_dssp             TEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred             CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc
Confidence            999999996432  34689999999999999999999998   9999999999999986   455999999999754322


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............    ....+...  +...
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~~~~~~--~~~~  255 (336)
T 3fhr_A          185 ---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR----RIRLGQYG--FPNP  255 (336)
T ss_dssp             ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------C--CCTT
T ss_pred             ---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH----hhhccccc--cCch
Confidence               22345689999999999888999999999999999999999999976542211111111    11111000  0000


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      ..    ......+.+++.+|++.||.+|||+.|++++-
T Consensus       256 ~~----~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          256 EW----SEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             TS----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hh----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            01    12234588999999999999999999999863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.2e-36  Score=329.45  Aligned_cols=263  Identities=20%  Similarity=0.338  Sum_probs=196.6

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcC-----------CCceeeEeeeeee
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----------HRNLVQFLGYCQE  475 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l~~~~~~  475 (736)
                      ..|.+.+.||+|+||+||+|+.. +++.||||++.... .....+.+|+.++++++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            34667889999999999999874 68899999986432 23456889999999886           8999999999976


Q ss_pred             CC----eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc------
Q 004689          476 EG----RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD------  545 (736)
Q Consensus       476 ~~----~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~------  545 (736)
                      .+    ..++||||+ +++|.+++....  ...+++..+..++.|++.||.|||+++  +|+||||||+|||++      
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence            54    789999999 889999986432  345889999999999999999999952  899999999999995      


Q ss_pred             CCCcEEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccc---cc
Q 004689          546 KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGAN---CR  622 (736)
Q Consensus       546 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~---~~  622 (736)
                      ..+.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            3458999999999765432    2234689999999999999999999999999999999999999986542111   11


Q ss_pred             cHHHHHHHhhhc--------C-----------CcceeccCcc---------CCcCCHHHHHHHHHHHhhccCCCCCCCCC
Q 004689          623 NIVQWAKLHIES--------G-----------DIQGIIDPSL---------LDEYDIQSMWKIEEKALMCVLPHGHMRPS  674 (736)
Q Consensus       623 ~l~~~~~~~~~~--------~-----------~~~~~~d~~l---------~~~~~~~~~~~l~~l~~~cl~~dP~~RPt  674 (736)
                      .+..... ....        +           ....+.....         ...++......+.+++.+|++.||++|||
T Consensus       249 ~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          249 HIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHH-hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            1111111 0000        0           0000000000         01234556678999999999999999999


Q ss_pred             HHHHHHH
Q 004689          675 ISEVLKD  681 (736)
Q Consensus       675 ~~ev~~~  681 (736)
                      +.|++++
T Consensus       328 ~~ell~h  334 (373)
T 1q8y_A          328 AGGLVNH  334 (373)
T ss_dssp             HHHHHTC
T ss_pred             HHHHhhC
Confidence            9999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.6e-36  Score=324.94  Aligned_cols=264  Identities=19%  Similarity=0.245  Sum_probs=198.1

Q ss_pred             HHHHHhhccccccCceEEEEEEEC-CC-cEEEEEEeccCCcccchhhhhHHHHHhhcCCCc------eeeEeeeeeeCCe
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK-DG-KEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN------LVQFLGYCQEEGR  478 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~-~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~l~~~~~~~~~  478 (736)
                      ...|.+.+.||+|+||+||+|... ++ +.||+|+++.. ......+.+|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            345667889999999999999875 34 68999998643 233566888999999998766      9999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEE--------------
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILL--------------  544 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl--------------  544 (736)
                      .++||||+ +++|.+++...  ....+++..+..++.|++.||.|||++   +|+||||||+|||+              
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             EEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence            99999999 66777777432  224588999999999999999999998   99999999999999              


Q ss_pred             -----cCCCcEEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCccccccc
Q 004689          545 -----DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA  619 (736)
Q Consensus       545 -----~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~  619 (736)
                           +.++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE  246 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                 66789999999999764332    233469999999999999999999999999999999999999998654221


Q ss_pred             ccccHHHHHHH----hhhcCCc-ceeccCcc---------------------CCcCCHHHHHHHHHHHhhccCCCCCCCC
Q 004689          620 NCRNIVQWAKL----HIESGDI-QGIIDPSL---------------------LDEYDIQSMWKIEEKALMCVLPHGHMRP  673 (736)
Q Consensus       620 ~~~~l~~~~~~----~~~~~~~-~~~~d~~l---------------------~~~~~~~~~~~l~~l~~~cl~~dP~~RP  673 (736)
                      ....+......    ....... ........                     ...........+.+++.+|++.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            11111110000    0000000 00000000                     0011223345788999999999999999


Q ss_pred             CHHHHHHH
Q 004689          674 SISEVLKD  681 (736)
Q Consensus       674 t~~ev~~~  681 (736)
                      |+.|++++
T Consensus       327 t~~e~l~h  334 (355)
T 2eu9_A          327 TLAEALLH  334 (355)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-36  Score=334.79  Aligned_cols=247  Identities=24%  Similarity=0.331  Sum_probs=183.7

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      +.+.+.||+|+||+||.....+++.||||++....   ...+.+|+++|+++ +||||+++++++.+....++||||+. 
T Consensus        26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-  101 (432)
T 3p23_A           26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-  101 (432)
T ss_dssp             EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence            34467899999999766556679999999986432   34577899999999 89999999999999999999999996 


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-----CCcEEEEeecCCccccC
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~-----~~~~kl~DFGla~~~~~  563 (736)
                      |+|.+++....   ..+....++.++.|++.||.|||+.   +|+||||||+|||++.     ...+||+|||+++....
T Consensus       102 g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          102 ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            59999986432   2233345578999999999999998   9999999999999953     34688999999986543


Q ss_pred             CCC--cceecccccccccCccccc---cCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          564 GAS--HVSSIVRGTVGYLDPEYYI---SQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       564 ~~~--~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                      ...  .......||+.|+|||++.   ...++.++|||||||++|||++ |..||.....     ...   .........
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-----~~~---~~~~~~~~~  247 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-----RQA---NILLGACSL  247 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----HHH---HHHTTCCCC
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----HHH---HHHhccCCc
Confidence            321  2234456999999999997   4567889999999999999999 9999864331     111   111111111


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      . ..      .........+.+++.+|++.||.+|||+.||+++
T Consensus       248 ~-~~------~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          248 D-CL------HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             T-TS------CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             c-cc------CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            0 00      1112334457899999999999999999999965

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=314.92  Aligned_cols=249  Identities=24%  Similarity=0.299  Sum_probs=175.9

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc-c-chhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-G-KREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      +.+.+.||+|+||.||+|... +++.||||++...... . .+.+.++..+++.++||||+++++++...+..++||||+
T Consensus        27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~  106 (318)
T 2dyl_A           27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM  106 (318)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence            345688999999999999986 6899999999754322 1 233445556788889999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHh-CCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~-~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                       ++.+..+...   ....+++..+..++.|++.||.|||+ .   +|+||||||+|||++.++.+||+|||+++......
T Consensus       107 -~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          107 -GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             -SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             -CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence             4455544421   13468899999999999999999998 4   89999999999999999999999999997554322


Q ss_pred             CcceecccccccccCccccc-----cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCccee
Q 004689          566 SHVSSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI  640 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  640 (736)
                        ......||+.|+|||++.     ...++.++|||||||++|||++|+.||......      ........... ..  
T Consensus       180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~-~~--  248 (318)
T 2dyl_A          180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------FEVLTKVLQEE-PP--  248 (318)
T ss_dssp             ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHHHSC-CC--
T ss_pred             --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------HHHHHHHhccC-CC--
Confidence              223346899999999994     456889999999999999999999999753311      11111111111 10  


Q ss_pred             ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       641 ~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                         .+...  ......+.+++.+|++.||.+||++.|++++
T Consensus       249 ---~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          249 ---LLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             ---CCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ---CCCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence               00000  0122358899999999999999999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.4e-36  Score=343.07  Aligned_cols=267  Identities=22%  Similarity=0.321  Sum_probs=200.4

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeee------CCeE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRS  479 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~~~~  479 (736)
                      ..|.+.+.||+|+||+||+|... +|+.||||+++... ......+.+|++++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            45677899999999999999875 68999999987542 2335568899999999999999999998765      6778


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCc---EEEEeec
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMR---AKVSDFG  556 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~---~kl~DFG  556 (736)
                      ++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.   +||+|||
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            99999999999999996532 233588888999999999999999998   9999999999999997665   9999999


Q ss_pred             CCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          557 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       557 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      +++......  ......||+.|+|||++.+..++.++|||||||++|||++|..||......      ..|.......+.
T Consensus       170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~------~~~~~~i~~~~~  241 (676)
T 3qa8_A          170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP------VQWHGKVREKSN  241 (676)
T ss_dssp             CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH------HHSSTTCC----
T ss_pred             ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch------hhhhhhhhcccc
Confidence            998654432  223456999999999999999999999999999999999999999754211      111111100000


Q ss_pred             cceeccCc------------cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHH-----HHHHHHHH
Q 004689          637 IQGIIDPS------------LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEV-----LKDIQDAI  686 (736)
Q Consensus       637 ~~~~~d~~------------l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev-----~~~L~~~~  686 (736)
                      ........            ............+.+++..|+..||++|||+.|+     .+.++.++
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence            00000000            0112334456789999999999999999999884     44455443

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.1e-35  Score=344.81  Aligned_cols=240  Identities=19%  Similarity=0.283  Sum_probs=192.0

Q ss_pred             HHHHhhccccccCceEEEEEEEC--CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCe-----E
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGR-----S  479 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~--~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-----~  479 (736)
                      ..|.+.+.||+|+||+||+|.+.  +++.||||++.... ......+.+|++++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            35667889999999999999876  58999999986432 2334568899999999999999999999987665     7


Q ss_pred             EEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ++||||+++++|.+++.      ..+++..++.++.|++.||.|||++   +|+||||||+|||++.+ .+||+|||+++
T Consensus       160 ~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence            99999999999988763      2689999999999999999999998   99999999999999986 89999999998


Q ss_pred             cccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          560 FAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       560 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      .....     ....||+.|+|||++.+. ++.++|||||||++|||++|..|+.........                  
T Consensus       230 ~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------  285 (681)
T 2pzi_A          230 RINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------  285 (681)
T ss_dssp             ETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------------
T ss_pred             hcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc------------------
Confidence            65432     335699999999998765 488999999999999999999888653311100                  


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDAIV  687 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~~~~  687 (736)
                            ...........+.+++.+|++.||.+|| +++++.+.|...+.
T Consensus       286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence                  0000111224688999999999999999 46677777776653

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.3e-35  Score=308.68  Aligned_cols=233  Identities=14%  Similarity=0.132  Sum_probs=181.7

Q ss_pred             HHHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          407 DATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       407 ~~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      ...|.+.+.||+|+||.||+|... +++.||||++......   ....+.+|+.++++++||||+++++++...+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            345677899999999999999986 4899999999765332   236788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      |||+++++|.+++...      .....+.+++.|++.||.|||++   +|+||||||+|||++.++.+||+++|      
T Consensus       110 ~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc------
Confidence            9999999999998432      34456788999999999999998   99999999999999999999997443      


Q ss_pred             CCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                                     |++|       ++.++|||||||++|||++|+.||.+....+.......    .. .+...   .
T Consensus       175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~----~~-~~~~~---~  224 (286)
T 3uqc_A          175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER----DT-AGQPI---E  224 (286)
T ss_dssp             ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB----CT-TSCBC---C
T ss_pred             ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH----Hh-ccCCC---C
Confidence                           3332       67899999999999999999999986553211100000    00 00000   0


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVI  688 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~  688 (736)
                         ...........+.+++.+|++.||++| |+.|+++.|+++...
T Consensus       225 ---~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          225 ---PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             ---HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             ---hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence               000111223458899999999999999 999999999987543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=9.8e-35  Score=321.25  Aligned_cols=239  Identities=13%  Similarity=0.091  Sum_probs=178.8

Q ss_pred             hhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhhHHHHHhhcCC-CceeeE-----------------
Q 004689          412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTNEVTLLSRIHH-RNLVQF-----------------  469 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~H-pnIv~l-----------------  469 (736)
                      +.+.||+|+||+||+|++. +|+.||||++.....   ...+.+.+|+.+++.++| +|....                 
T Consensus        82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (413)
T 3dzo_A           82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ  161 (413)
T ss_dssp             EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred             EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence            3578999999999999965 789999999874322   235678899999999977 322111                 


Q ss_pred             ----eeeeee-----CCeEEEEEEecCCCCHHHHhhcc---cccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCC
Q 004689          470 ----LGYCQE-----EGRSVLVYEFMHNGTLKEHLYGT---LTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDL  537 (736)
Q Consensus       470 ----~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDi  537 (736)
                          +.++..     ....+++|+++ +++|.+++...   ......+++..++.++.|+++||+|||++   +|+||||
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDi  237 (413)
T 3dzo_A          162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYL  237 (413)
T ss_dssp             ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCc
Confidence                111111     12456777755 67999888421   22345688889999999999999999998   9999999


Q ss_pred             CCCCEEEcCCCcEEEEeecCCccccCCCCcceecccccccccCcccc----------ccCcCCCcchhHHHHHHHHHHHh
Q 004689          538 KSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY----------ISQQLTDKSDVYSFGVILLELIS  607 (736)
Q Consensus       538 kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~~~~~DVwSlGvvl~ellt  607 (736)
                      ||+|||++.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||||||++|||++
T Consensus       238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            999999999999999999998754322    344568 999999999          55568889999999999999999


Q ss_pred             CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          608 GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       608 G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      |+.||......+....                ++...  ...    ...+.+++.+|++.||++||++.|++++
T Consensus       313 g~~Pf~~~~~~~~~~~----------------~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEW----------------IFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             SSCCCCTTGGGSCSGG----------------GGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCCCCcchhhhHHH----------------HHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            9999976542211111                11100  112    2458899999999999999999999765

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.1e-35  Score=314.43  Aligned_cols=245  Identities=18%  Similarity=0.190  Sum_probs=182.8

Q ss_pred             HHHHHHhhccccccCceEEEEEEECCCcEEEEEEeccCCc--------ccchhhhhHHHHHhhcC---------CCceee
Q 004689          406 EDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--------QGKREFTNEVTLLSRIH---------HRNLVQ  468 (736)
Q Consensus       406 ~~~~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~E~~il~~l~---------HpnIv~  468 (736)
                      ....|.+.+.||+|+||+||+|+. +|+.||||++.....        ...+.+.+|+.+++.++         ||||++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            345677889999999999999998 589999999976532        12266889999999886         666655


Q ss_pred             Eeee-----------------eee-------------CCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHH
Q 004689          469 FLGY-----------------CQE-------------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA  518 (736)
Q Consensus       469 l~~~-----------------~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia  518 (736)
                      +.+.                 +.+             .+..++||||+++|++.+.+..     ..+++..+..++.|++
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence            5554                 433             6789999999999977666632     4578999999999999


Q ss_pred             HHHHHHH-hCCCCceecCCCCCCCEEEcCCC--------------------cEEEEeecCCccccCCCCcceeccccccc
Q 004689          519 KGIEYLH-TGCVPAIIHRDLKSSNILLDKHM--------------------RAKVSDFGLSKFAVDGASHVSSIVRGTVG  577 (736)
Q Consensus       519 ~~L~~LH-~~~~~~iiHrDikp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~  577 (736)
                      .||.||| +.   +|+||||||+|||++.++                    .+||+|||+|+.....      ...||+.
T Consensus       172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~  242 (336)
T 2vuw_A          172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred             HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence            9999999 87   999999999999999887                    8999999999865432      3469999


Q ss_pred             ccCccccccCcCCCcchhHHHHHH-HHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHH
Q 004689          578 YLDPEYYISQQLTDKSDVYSFGVI-LLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWK  656 (736)
Q Consensus       578 Y~aPE~~~~~~~~~~~DVwSlGvv-l~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~  656 (736)
                      |+|||++.+.. +.++||||+|++ .+++++|..||......   ..+.+   ........    ..............+
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~---~~~~~---~~~~~~~~----~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL---HYLTD---KMLKQMTF----KTKCNTPAMKQIKRK  311 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH---HHHHH---HHHHTCCC----SSCCCSHHHHHHHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh---hHHHH---hhhhhhcc----CcccchhhhhhcCHH
Confidence            99999998766 889999998777 77888999998542100   00111   11101000    011111112345667


Q ss_pred             HHHHHhhccCCCCCCCCCHHHHH-HH
Q 004689          657 IEEKALMCVLPHGHMRPSISEVL-KD  681 (736)
Q Consensus       657 l~~l~~~cl~~dP~~RPt~~ev~-~~  681 (736)
                      +.+++.+|++.|     |++|++ ++
T Consensus       312 ~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHHhccC-----CHHHHHhcC
Confidence            999999999976     888887 53

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.1e-33  Score=298.78  Aligned_cols=223  Identities=22%  Similarity=0.271  Sum_probs=174.6

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHH-hhcCCCceeeEeeeeee----CCeEEEEEEec
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLL-SRIHHRNLVQFLGYCQE----EGRSVLVYEFM  486 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il-~~l~HpnIv~l~~~~~~----~~~~~lV~e~~  486 (736)
                      .+.||+|+||.||+|... +++.||+|++..     ...+.+|++++ +..+||||+++++++..    ....++||||+
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~   97 (299)
T 3m2w_A           23 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL   97 (299)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred             CcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence            478999999999999875 689999999853     34577899988 55699999999999977    67889999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeecCCccccC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~---~~~~kl~DFGla~~~~~  563 (736)
                      ++|+|.+++...  ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.   ++.+||+|||++.... 
T Consensus        98 ~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-  171 (299)
T 3m2w_A           98 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-  171 (299)
T ss_dssp             CSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence            999999999653  234689999999999999999999998   9999999999999998   7899999999986432 


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                                            +..++.++|||||||++|||++|+.||..........             .....+..
T Consensus       172 ----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------------~~~~~~~~  216 (299)
T 3m2w_A          172 ----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------------GMKTRIRM  216 (299)
T ss_dssp             ----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------------CSCCSSCT
T ss_pred             ----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------------HHHHHHhh
Confidence                                  2346789999999999999999999997554211000             00000000


Q ss_pred             ccCCcCC----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 004689          644 SLLDEYD----IQSMWKIEEKALMCVLPHGHMRPSISEVLKDI  682 (736)
Q Consensus       644 ~l~~~~~----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L  682 (736)
                      .. ...+    ......+.+++.+|++.||.+|||+.|++++-
T Consensus       217 ~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          217 GQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             TC-CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             cc-ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence            00 0011    11234688999999999999999999998863

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=4.7e-29  Score=285.74  Aligned_cols=186  Identities=16%  Similarity=0.107  Sum_probs=130.3

Q ss_pred             cccccCceEEEEEEE-CCCcEEEEEEeccCCc----------ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEE
Q 004689          415 KIGSGGFGVVYYGKL-KDGKEIAVKVLTSNSY----------QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       415 ~IG~G~fG~Vy~~~~-~~~~~vAvK~l~~~~~----------~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      ..+.|++|.+..++. -.|+.+|||++.....          ...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            456777776666542 3588999999975421          1234689999999999 799999999999999999999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      |||++||+|.+.|..    ...++..   +|+.||+.||+|||++   |||||||||+|||++.++++||+|||+|+...
T Consensus       321 MEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            999999999999953    3345543   5889999999999998   99999999999999999999999999998654


Q ss_pred             CCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcC
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAI  612 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~  612 (736)
                      ... ......+||++|||||++.+ .+..++|+||+|++++++.++..++
T Consensus       391 ~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          391 QDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            432 23345679999999999875 4677899999999998887765554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=3e-26  Score=261.02  Aligned_cols=182  Identities=18%  Similarity=0.227  Sum_probs=145.6

Q ss_pred             hccccccCceEEEEEEECCCcEEEEEEeccCCcc--------cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          413 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ--------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .+.||+|+||+||+|... ++.+|+|+.......        ..+.+.+|++++++++||||+++..++...+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            578999999999999554 789999987543221        12347899999999999999977667767778899999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+++|+|.+++..            +..++.|+++||.|||++   +|+||||||+|||++.  ++||+|||+++.....
T Consensus       420 ~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          420 YINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             CCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             CCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            9999999999853            457899999999999998   9999999999999999  9999999999876443


Q ss_pred             CCcc------eecccccccccCcccccc--CcCCCcchhHHHHHHHHHHHhCCCcC
Q 004689          565 ASHV------SSIVRGTVGYLDPEYYIS--QQLTDKSDVYSFGVILLELISGQEAI  612 (736)
Q Consensus       565 ~~~~------~~~~~gt~~Y~aPE~~~~--~~~~~~~DVwSlGvvl~elltG~~p~  612 (736)
                      ....      .....||+.|||||++..  ..|+...|+||..+-..+.+.++.+|
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            2211      235679999999999987  67888899999999888888777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=1.1e-22  Score=212.57  Aligned_cols=141  Identities=17%  Similarity=0.112  Sum_probs=113.9

Q ss_pred             hccccccCceEEEEEEECCCcEEEEEEeccCCcc------------------cchhhhhHHHHHhhcCCCceeeEeeeee
Q 004689          413 EKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ------------------GKREFTNEVTLLSRIHHRNLVQFLGYCQ  474 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~------------------~~~~~~~E~~il~~l~HpnIv~l~~~~~  474 (736)
                      .+.||+|+||.||+|...+|+.||||+++.....                  ....+.+|+++|++++  | +++.+++.
T Consensus        95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~  171 (282)
T 1zar_A           95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA  171 (282)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred             cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence            4889999999999999977999999998643211                  2345889999999999  4 66666554


Q ss_pred             eCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEe
Q 004689          475 EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSD  554 (736)
Q Consensus       475 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~D  554 (736)
                      . +..++||||+++|+|.+ +..          .....++.|++.||.|||+.   +|+||||||+|||++ ++.+||+|
T Consensus       172 ~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~D  235 (282)
T 1zar_A          172 W-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIID  235 (282)
T ss_dssp             E-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECC
T ss_pred             c-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEE
Confidence            4 45699999999999988 421          12346899999999999998   999999999999999 99999999


Q ss_pred             ecCCccccCCCCcceecccccccccCcccccc
Q 004689          555 FGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS  586 (736)
Q Consensus       555 FGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~  586 (736)
                      ||+|+              .+..|+|||++..
T Consensus       236 FG~a~--------------~~~~~~a~e~l~r  253 (282)
T 1zar_A          236 FPQSV--------------EVGEEGWREILER  253 (282)
T ss_dssp             CTTCE--------------ETTSTTHHHHHHH
T ss_pred             CCCCe--------------ECCCCCHHHHHHH
Confidence            99986              3455789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.76  E-value=8.9e-19  Score=180.50  Aligned_cols=134  Identities=24%  Similarity=0.263  Sum_probs=102.8

Q ss_pred             hhccccccCceEEEEEEE-CCCcE--EEEEEeccCCccc------------------------chhhhhHHHHHhhcCCC
Q 004689          412 LEKKIGSGGFGVVYYGKL-KDGKE--IAVKVLTSNSYQG------------------------KREFTNEVTLLSRIHHR  464 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~-~~~~~--vAvK~l~~~~~~~------------------------~~~~~~E~~il~~l~Hp  464 (736)
                      +.+.||+|+||.||+|.. .+|+.  ||||+++......                        ...+.+|+.+|.+++|+
T Consensus        51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~  130 (258)
T 1zth_A           51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA  130 (258)
T ss_dssp             EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence            457899999999999998 67889  9999975431110                        12578899999999888


Q ss_pred             ce--eeEeeeeeeCCeEEEEEEecCC-C----CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHH-hCCCCceecCC
Q 004689          465 NL--VQFLGYCQEEGRSVLVYEFMHN-G----TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH-TGCVPAIIHRD  536 (736)
Q Consensus       465 nI--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH-~~~~~~iiHrD  536 (736)
                      ++  ..++++    ...++||||+.+ |    +|.+....       .++..+..++.|++.||.||| +.   +|+|||
T Consensus       131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givHrD  196 (258)
T 1zth_A          131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVHAD  196 (258)
T ss_dssp             TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred             CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence            64  334432    356899999942 4    66665421       123345788999999999999 87   999999


Q ss_pred             CCCCCEEEcCCCcEEEEeecCCccc
Q 004689          537 LKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       537 ikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      |||+|||++.  .++|+|||+|...
T Consensus       197 lkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCHHHEEEcC--cEEEEECcccccC
Confidence            9999999998  9999999999754

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.65  E-value=2.3e-17  Score=196.40  Aligned_cols=112  Identities=28%  Similarity=0.433  Sum_probs=105.0

Q ss_pred             CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceee
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY  300 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~  300 (736)
                      +++|+.|||++|+|+|.+|..|++|++|+.|+|++|+++|.+| .+++|++|+.|||++|+|+|.+|..+++|++|+.|+
T Consensus       631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~  710 (768)
T 3rgz_A          631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID  710 (768)
T ss_dssp             SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred             cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence            4689999999999999999999999999999999999999999 799999999999999999999999999999999999


Q ss_pred             cccccCcCCCCccc-ccccccccccCCcccccCC
Q 004689          301 VQNNMLSGTVPSSL-LSKNVVLNYAGNINLHEGG  333 (736)
Q Consensus       301 l~~N~l~g~~P~~~-~~~~~~l~~~~n~~~c~~~  333 (736)
                      |++|+|+|.||..- +.......|.||+.+|+.+
T Consensus       711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~  744 (768)
T 3rgz_A          711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP  744 (768)
T ss_dssp             CCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT
T ss_pred             CcCCcccccCCCchhhccCCHHHhcCCchhcCCC
Confidence            99999999999763 5566778899999999864

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.65  E-value=1.8e-16  Score=168.07  Aligned_cols=146  Identities=29%  Similarity=0.489  Sum_probs=126.6

Q ss_pred             CchHHHHHHHHHHcC----CCCcCCCCCCCCCCCCCceEEecCCC-CCceEEEEccCCCCCc--cCCccccccccccccc
Q 004689          181 SIDGVAIVSVISLYS----SADWAQEGGDPCLPVPWSWLQCNSDP-QPSITVIHLSSKNLTG--NIPSDLTKLSSLVELW  253 (736)
Q Consensus       181 ~~~~~al~~l~~~~~----~~~w~~~~~dpc~~~~~~~v~c~~~~-~~~l~~L~L~~n~l~g--~~p~~~~~l~~L~~L~  253 (736)
                      ..|..||.++|+.+.    +.+|.. +.|||. ..|.||.|+... ..+|+.|+|++|+++|  .+|..|.++++|++|+
T Consensus         5 ~~~~~aL~~~k~~~~~~~~l~~W~~-~~~~C~-~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~   82 (313)
T 1ogq_A            5 PQDKQALLQIKKDLGNPTTLSSWLP-TTDCCN-RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY   82 (313)
T ss_dssp             HHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTT-TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred             HHHHHHHHHHHHhcCCcccccCCCC-CCCCCc-CCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeee
Confidence            357899999999985    468964 478992 239999997532 2689999999999999  9999999999999999


Q ss_pred             ccc-cccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCCCCcccc--cccccccccCCcc
Q 004689          254 LDG-NSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNIN  328 (736)
Q Consensus       254 Ls~-N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~~--~~~~~l~~~~n~~  328 (736)
                      |++ |++.+.+| .|+++++|++|+|++|+|++.+|..++++++|+.|+|++|.++|.+|..+.  ..+..+.+.+|..
T Consensus        83 L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  161 (313)
T 1ogq_A           83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI  161 (313)
T ss_dssp             EEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred             CCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcc
Confidence            995 99999988 799999999999999999999999999999999999999999999998874  4556777887743

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.62  E-value=1.4e-16  Score=171.00  Aligned_cols=135  Identities=16%  Similarity=0.160  Sum_probs=94.8

Q ss_pred             HhhccccccCceEEEEEEECCCcEEEEEEeccCCcc-----cchh-----------------hhhHHHHHhhcCCCceee
Q 004689          411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ-----GKRE-----------------FTNEVTLLSRIHHRNLVQ  468 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~-----~~~~-----------------~~~E~~il~~l~HpnIv~  468 (736)
                      .+...||+|+||.||+|...+|+.||||+++.....     ..++                 ..+|...|.++.+.++..
T Consensus        98 ~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~v  177 (397)
T 4gyi_A           98 SVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPV  177 (397)
T ss_dssp             EEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSC
T ss_pred             EecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            456789999999999999999999999998643110     0111                 123455555554433321


Q ss_pred             EeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC
Q 004689          469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM  548 (736)
Q Consensus       469 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~  548 (736)
                      ..-+..  ...+|||||+++++|.+....          .....++.|++.+|.|||+.   |||||||||.|||+++++
T Consensus       178 p~p~~~--~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          178 PEPIAQ--SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             CCEEEE--ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred             Ceeeec--cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence            111111  123799999999888654311          12346789999999999998   999999999999999877


Q ss_pred             ----------cEEEEeecCCcc
Q 004689          549 ----------RAKVSDFGLSKF  560 (736)
Q Consensus       549 ----------~~kl~DFGla~~  560 (736)
                                .+.|+||+.+..
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEE
T ss_pred             CcccccccccceEEEEeCCccc
Confidence                      389999998754

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.57  E-value=1.7e-15  Score=180.56  Aligned_cols=141  Identities=19%  Similarity=0.234  Sum_probs=123.3

Q ss_pred             chHHHHHHHHHHcCCCCcCCCC----CCC--CCCCCC------------ceEEecCCCCCceEEEEccCCCCCccCCccc
Q 004689          182 IDGVAIVSVISLYSSADWAQEG----GDP--CLPVPW------------SWLQCNSDPQPSITVIHLSSKNLTGNIPSDL  243 (736)
Q Consensus       182 ~~~~al~~l~~~~~~~~w~~~~----~dp--c~~~~~------------~~v~c~~~~~~~l~~L~L~~n~l~g~~p~~~  243 (736)
                      .|..||.++|+.+..++|+..+    .+|  |   .|            .||.|+.  ..+|+.|+|++|+|+|.+|+.|
T Consensus       269 ~d~~ALl~~k~~l~~~~W~~~~~~~~~~~~~C---~W~~~~~~~~w~~~~GV~C~~--~~~V~~L~Ls~~~L~G~ip~~l  343 (876)
T 4ecn_A          269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSL---NWNFNKELDMWGDQPGVDLDN--NGRVTGLSLAGFGAKGRVPDAI  343 (876)
T ss_dssp             HHHHHHHHHHHHTTGGGCCCCCSSCSSCCCCC---SCCCSSCGGGTTCCTTEEECT--TSCEEEEECTTTCCEEEECGGG
T ss_pred             HHHHHHHHHHHHcCCCCCCcCCCcccccCCcc---ccccccccccccCcCceEecC--CCCEEEEECccCCCCCcCchHH
Confidence            4899999999999878997664    467  7   68            9999976  3699999999999999999999


Q ss_pred             ccccccccccc-cccccCCC------------------------------------------------------------
Q 004689          244 TKLSSLVELWL-DGNSLTGP------------------------------------------------------------  262 (736)
Q Consensus       244 ~~l~~L~~L~L-s~N~l~~~------------------------------------------------------------  262 (736)
                      ++|++|+.|+| ++|.++|.                                                            
T Consensus       344 ~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l  423 (876)
T 4ecn_A          344 GQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRI  423 (876)
T ss_dssp             GGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCC
T ss_pred             hccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccccc
Confidence            99999999999 88766554                                                            


Q ss_pred             ----------------CC-CCCCCCCCcEEEcCCCCCCC-----------------CCCcccc--CccccceeecccccC
Q 004689          263 ----------------IP-DFSGCPDLRIIHLEDNQLTG-----------------PLPSSLM--NLPNLRELYVQNNML  306 (736)
Q Consensus       263 ----------------~p-~~~~l~~L~~L~Ls~N~l~g-----------------~~p~~~~--~l~~L~~L~l~~N~l  306 (736)
                                      +| .+++|++|++|+|++|+|+|                 .+|..++  +|++|+.|+|++|++
T Consensus       424 ~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l  503 (876)
T 4ecn_A          424 SLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPN  503 (876)
T ss_dssp             CCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTT
T ss_pred             chhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCC
Confidence                            66 68899999999999999998                 4999988  999999999999999


Q ss_pred             cCCCCccccc--ccccccccCCc
Q 004689          307 SGTVPSSLLS--KNVVLNYAGNI  327 (736)
Q Consensus       307 ~g~~P~~~~~--~~~~l~~~~n~  327 (736)
                      .|.+|..+..  .+..+.+.+|.
T Consensus       504 ~~~iP~~l~~L~~L~~L~Ls~N~  526 (876)
T 4ecn_A          504 MTQLPDFLYDLPELQSLNIACNR  526 (876)
T ss_dssp             CCSCCGGGGGCSSCCEEECTTCT
T ss_pred             CccChHHHhCCCCCCEEECcCCC
Confidence            9999987743  55778888885

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.54  E-value=5.3e-15  Score=172.17  Aligned_cols=139  Identities=20%  Similarity=0.270  Sum_probs=120.3

Q ss_pred             chHHHHHHHHHHcCCC-------------CcCCCCCCCCCCCCC---ceEEecCCCCCceEEEEccCCCCCccCCccccc
Q 004689          182 IDGVAIVSVISLYSSA-------------DWAQEGGDPCLPVPW---SWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTK  245 (736)
Q Consensus       182 ~~~~al~~l~~~~~~~-------------~w~~~~~dpc~~~~~---~~v~c~~~~~~~l~~L~L~~n~l~g~~p~~~~~  245 (736)
                      .|..||.+++....-.             +|.. +.|||   .|   .||.|+..  .+|+.|+|++|+|+|.+|++|++
T Consensus        30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c---~w~~~~GV~C~~~--~~V~~L~L~~~~l~g~lp~~l~~  103 (636)
T 4eco_A           30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELD---MWGAQPGVSLNSN--GRVTGLSLEGFGASGRVPDAIGQ  103 (636)
T ss_dssp             HHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGG---GTTCCTTEEECTT--CCEEEEECTTSCCEEEECGGGGG
T ss_pred             HHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcc---cccCCCCeEEcCC--CCEEEEEecCcccCCcCChHHhc
Confidence            4889999999997643             4543 37788   58   99999755  69999999999999999999999


Q ss_pred             ccccccccccccc-------------------------------------------------------------------
Q 004689          246 LSSLVELWLDGNS-------------------------------------------------------------------  258 (736)
Q Consensus       246 l~~L~~L~Ls~N~-------------------------------------------------------------------  258 (736)
                      |++|+.|+|++|.                                                                   
T Consensus       104 L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l  183 (636)
T 4eco_A          104 LTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL  183 (636)
T ss_dssp             CTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCC
T ss_pred             CccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccch
Confidence            9999999999984                                                                   


Q ss_pred             -----------cCCCCC-CCCCCCCCcEEEcCCCCCCCC-----------------CCcccc--CccccceeecccccCc
Q 004689          259 -----------LTGPIP-DFSGCPDLRIIHLEDNQLTGP-----------------LPSSLM--NLPNLRELYVQNNMLS  307 (736)
Q Consensus       259 -----------l~~~~p-~~~~l~~L~~L~Ls~N~l~g~-----------------~p~~~~--~l~~L~~L~l~~N~l~  307 (736)
                                 ++| +| .+++|++|++|+|++|.|+|.                 +|..++  ++++|+.|+|++|.++
T Consensus       184 ~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~  262 (636)
T 4eco_A          184 KDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNL  262 (636)
T ss_dssp             CTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTC
T ss_pred             hhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCC
Confidence                       446 56 689999999999999999986                 999999  9999999999999999


Q ss_pred             CCCCcccc--cccccccccCCc
Q 004689          308 GTVPSSLL--SKNVVLNYAGNI  327 (736)
Q Consensus       308 g~~P~~~~--~~~~~l~~~~n~  327 (736)
                      |.+|..+.  ..+..+.+.+|.
T Consensus       263 ~~~p~~l~~l~~L~~L~Ls~n~  284 (636)
T 4eco_A          263 TKLPTFLKALPEMQLINVACNR  284 (636)
T ss_dssp             SSCCTTTTTCSSCCEEECTTCT
T ss_pred             ccChHHHhcCCCCCEEECcCCC
Confidence            99998874  455777888885

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.52  E-value=5.7e-16  Score=174.44  Aligned_cols=171  Identities=13%  Similarity=0.093  Sum_probs=86.3

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecC------
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNS------  219 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~------  219 (736)
                      ++.+..|.|+.|.++.++| +..+..++.|.++.|.+....     ....+.....   .-|   ....+.|..      
T Consensus        57 l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~-----~~~~L~~L~L---~~N---~l~~~~~~~l~~L~~  124 (487)
T 3oja_A           57 FTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELL-----VGPSIETLHA---ANN---NISRVSCSRGQGKKN  124 (487)
T ss_dssp             CTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEE-----ECTTCCEEEC---CSS---CCCCEEECCCSSCEE
T ss_pred             CCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCC-----CCCCcCEEEC---cCC---cCCCCCccccCCCCE
Confidence            4567777777777777666 666677777777776553100     0001110000   001   122233321      


Q ss_pred             ----------------CCCCceEEEEccCCCCCccCCcccc-cccccccccccccccCCCCCCCCCCCCCcEEEcCCCCC
Q 004689          220 ----------------DPQPSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQL  282 (736)
Q Consensus       220 ----------------~~~~~l~~L~L~~n~l~g~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l  282 (736)
                                      ..+++|+.|+|++|.|++..|..+. .|++|+.|+|++|.|++. |.+..+++|++|+|++|.|
T Consensus       125 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~Ls~N~l  203 (487)
T 3oja_A          125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKL  203 (487)
T ss_dssp             EECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCC
T ss_pred             EECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cccccCCCCCEEECCCCCC
Confidence                            1123445555555555544444443 445555555555555544 2233455666666666666


Q ss_pred             CCCCCccccCccccceeecccccCcCCCCcccc--cccccccccCCccccc
Q 004689          283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNINLHE  331 (736)
Q Consensus       283 ~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~~--~~~~~l~~~~n~~~c~  331 (736)
                      ++ +|+.++.+++|+.|+|++|.|+ .+|..+.  ..+..+.+.+|+..|+
T Consensus       204 ~~-~~~~~~~l~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~l~~N~l~c~  252 (487)
T 3oja_A          204 AF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG  252 (487)
T ss_dssp             CE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCBCHH
T ss_pred             CC-CCHhHcCCCCccEEEecCCcCc-ccchhhccCCCCCEEEcCCCCCcCc
Confidence            64 3334666666666666666666 3555442  2345566666666654

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.52  E-value=1.4e-15  Score=161.10  Aligned_cols=181  Identities=20%  Similarity=0.174  Sum_probs=130.4

Q ss_pred             ccceeEEEeeccCCC-CCCCccchhhhhhhhccCCCCchHHHHHHHHHHc-CCCCcCCCCCCCCCCCCCceEEe-cCCCC
Q 004689          146 LPFVLSFKFGKTYDS-SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY-SSADWAQEGGDPCLPVPWSWLQC-NSDPQ  222 (736)
Q Consensus       146 l~~l~~l~l~~~~~s-~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~-~~~~w~~~~~dpc~~~~~~~v~c-~~~~~  222 (736)
                      ++.+..|.++.|.++ .+|..+..+..++.|.++.|.+.+.....+.... .+..-...   -|   ...+... ....+
T Consensus       124 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~---~N---~l~~~~~~~~~~l  197 (313)
T 1ogq_A          124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS---RN---RLTGKIPPTFANL  197 (313)
T ss_dssp             CTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECC---SS---EEEEECCGGGGGC
T ss_pred             CCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECc---CC---eeeccCChHHhCC
Confidence            456677777777777 4555577777777777777665321111111111 01100000   00   0000000 01112


Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                       .|+.|+|++|.+++.+|..|..+++|+.|+|++|++++.+|.+..+++|++|+|++|+|+|.+|..+.++++|+.|+|+
T Consensus       198 -~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls  276 (313)
T 1ogq_A          198 -NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVS  276 (313)
T ss_dssp             -CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECC
T ss_pred             -cccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECc
Confidence             3899999999999999999999999999999999999999989999999999999999999999999999999999999


Q ss_pred             cccCcCCCCccc-ccccccccccCCcccccCC
Q 004689          303 NNMLSGTVPSSL-LSKNVVLNYAGNINLHEGG  333 (736)
Q Consensus       303 ~N~l~g~~P~~~-~~~~~~l~~~~n~~~c~~~  333 (736)
                      +|+++|.+|..- +..+..+.+.+|+.+|+.+
T Consensus       277 ~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p  308 (313)
T 1ogq_A          277 FNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             SSEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred             CCcccccCCCCccccccChHHhcCCCCccCCC
Confidence            999999999862 3455788999999999864

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.51  E-value=5.8e-14  Score=146.97  Aligned_cols=155  Identities=23%  Similarity=0.260  Sum_probs=126.1

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.+..|.|+.|.++.+++. ..+..++.|.++.|.+..           ++.                   ....+++|
T Consensus        54 l~~L~~L~L~~n~l~~~~~~-~~l~~L~~L~Ls~N~l~~-----------l~~-------------------~~~~l~~L  102 (290)
T 1p9a_G           54 YTRLTQLNLDRAELTKLQVD-GTLPVLGTLDLSHNQLQS-----------LPL-------------------LGQTLPAL  102 (290)
T ss_dssp             CTTCCEEECTTSCCCEEECC-SCCTTCCEEECCSSCCSS-----------CCC-------------------CTTTCTTC
T ss_pred             CCCCCEEECCCCccCcccCC-CCCCcCCEEECCCCcCCc-----------Cch-------------------hhccCCCC
Confidence            45677788888888877765 566667777777766541           110                   01245789


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      +.|+|++|+|++..|..|..+++|++|+|++|+|++.++ .|.++++|+.|+|++|+|++..+..+..+++|+.|+|++|
T Consensus       103 ~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N  182 (290)
T 1p9a_G          103 TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN  182 (290)
T ss_dssp             CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCC
Confidence            999999999997666789999999999999999999887 4789999999999999999666667789999999999999


Q ss_pred             cCcCCCCcccccc--cccccccCCcccccC
Q 004689          305 MLSGTVPSSLLSK--NVVLNYAGNINLHEG  332 (736)
Q Consensus       305 ~l~g~~P~~~~~~--~~~l~~~~n~~~c~~  332 (736)
                      +|+ .+|..++..  +..+.+.+|++.|.+
T Consensus       183 ~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c  211 (290)
T 1p9a_G          183 SLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (290)
T ss_dssp             CCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             cCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence            999 899988654  467889999999976

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.51  E-value=6.7e-14  Score=143.18  Aligned_cols=157  Identities=18%  Similarity=0.184  Sum_probs=129.0

Q ss_pred             cceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          147 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       147 ~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      +.+..|.|+.|.++.++|. +..+..++.|.++.|.+..                   ..+-          ....+++|
T Consensus        35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-------------------~~~~----------~~~~l~~L   85 (251)
T 3m19_A           35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-------------------LSAG----------VFDDLTEL   85 (251)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC-------------------CCTT----------TTTTCTTC
T ss_pred             CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCc-------------------cCHh----------HhccCCcC
Confidence            3567899999999999885 7888888889888887652                   1110          01235789


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCCC-CCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      +.|+|++|+|++..+..|..+++|++|+|++|+|++.++. |.++++|++|+|++|+|++..|..|+.+++|+.|+|++|
T Consensus        86 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  165 (251)
T 3m19_A           86 GTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTN  165 (251)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCC
Confidence            9999999999977777889999999999999999988884 789999999999999999777778999999999999999


Q ss_pred             cCcCCCCccc--ccccccccccCCcccccC
Q 004689          305 MLSGTVPSSL--LSKNVVLNYAGNINLHEG  332 (736)
Q Consensus       305 ~l~g~~P~~~--~~~~~~l~~~~n~~~c~~  332 (736)
                      +|++..|..+  +..+..+.+.+|+..|..
T Consensus       166 ~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~  195 (251)
T 3m19_A          166 QLQSVPHGAFDRLGKLQTITLFGNQFDCSR  195 (251)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSCCBCTTS
T ss_pred             cCCccCHHHHhCCCCCCEEEeeCCceeCCc
Confidence            9995444444  245678899999999873

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.50  E-value=3.1e-14  Score=142.70  Aligned_cols=152  Identities=17%  Similarity=0.167  Sum_probs=121.2

Q ss_pred             EEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceEEEEc
Q 004689          151 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL  230 (736)
Q Consensus       151 ~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~~L~L  230 (736)
                      .+.++.|.++.+|+.+..  .++.|.++.|.+..                   ..+-     .    ....+++|+.|+|
T Consensus        15 ~l~~s~n~l~~iP~~~~~--~~~~L~L~~N~l~~-------------------~~~~-----~----~~~~l~~L~~L~L   64 (220)
T 2v70_A           15 TVDCSNQKLNKIPEHIPQ--YTAELRLNNNEFTV-------------------LEAT-----G----IFKKLPQLRKINF   64 (220)
T ss_dssp             EEECCSSCCSSCCSCCCT--TCSEEECCSSCCCE-------------------ECCC-----C----CGGGCTTCCEEEC
T ss_pred             EeEeCCCCcccCccCCCC--CCCEEEcCCCcCCc-------------------cCch-----h----hhccCCCCCEEEC
Confidence            577888888888876533  23566666665541                   0010     0    0123578999999


Q ss_pred             cCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCC
Q 004689          231 SSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT  309 (736)
Q Consensus       231 ~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~  309 (736)
                      ++|+|++..+..|.++++|++|+|++|+|++.++ .|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.
T Consensus        65 ~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  144 (220)
T 2v70_A           65 SNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTV  144 (220)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCB
T ss_pred             CCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEE
Confidence            9999998777789999999999999999999888 589999999999999999988899999999999999999999976


Q ss_pred             CCcccc--cccccccccCCcccccC
Q 004689          310 VPSSLL--SKNVVLNYAGNINLHEG  332 (736)
Q Consensus       310 ~P~~~~--~~~~~l~~~~n~~~c~~  332 (736)
                      .|..+.  ..+..+.+.+|+..|..
T Consensus       145 ~~~~~~~l~~L~~L~L~~N~l~c~c  169 (220)
T 2v70_A          145 APGAFDTLHSLSTLNLLANPFNCNC  169 (220)
T ss_dssp             CTTTTTTCTTCCEEECCSCCEECSG
T ss_pred             CHHHhcCCCCCCEEEecCcCCcCCC
Confidence            676663  35578899999999876

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.50  E-value=5.7e-14  Score=140.76  Aligned_cols=151  Identities=21%  Similarity=0.198  Sum_probs=120.3

Q ss_pred             EEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceEEEEc
Q 004689          151 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL  230 (736)
Q Consensus       151 ~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~~L~L  230 (736)
                      .+.+..+.++.+|+.+.  +.++.|.++.|.+..                   ..+-          ....+++|+.|+|
T Consensus        15 ~v~c~~~~l~~iP~~l~--~~l~~L~l~~n~i~~-------------------i~~~----------~~~~l~~L~~L~L   63 (220)
T 2v9t_B           15 IVDCRGKGLTEIPTNLP--ETITEIRLEQNTIKV-------------------IPPG----------AFSPYKKLRRIDL   63 (220)
T ss_dssp             EEECTTSCCSSCCSSCC--TTCCEEECCSSCCCE-------------------ECTT----------SSTTCTTCCEEEC
T ss_pred             EEEcCCCCcCcCCCccC--cCCCEEECCCCcCCC-------------------cCHh----------HhhCCCCCCEEEC
Confidence            35667777888877554  455666666665541                   0000          0123578999999


Q ss_pred             cCCCCCccCCcccccccccccccccccccCCCCCC-CCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCC
Q 004689          231 SSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT  309 (736)
Q Consensus       231 ~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~  309 (736)
                      ++|+|++..|..|.+|++|++|+|++|+|++.++. |.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|++.
T Consensus        64 s~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  143 (220)
T 2v9t_B           64 SNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTI  143 (220)
T ss_dssp             CSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEE
Confidence            99999988899999999999999999999988774 78999999999999999998899999999999999999999954


Q ss_pred             CCccc--ccccccccccCCcccccC
Q 004689          310 VPSSL--LSKNVVLNYAGNINLHEG  332 (736)
Q Consensus       310 ~P~~~--~~~~~~l~~~~n~~~c~~  332 (736)
                      .|..+  +..+..+.+.+|++.|.+
T Consensus       144 ~~~~~~~l~~L~~L~L~~N~~~c~c  168 (220)
T 2v9t_B          144 AKGTFSPLRAIQTMHLAQNPFICDC  168 (220)
T ss_dssp             CTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             CHHHHhCCCCCCEEEeCCCCcCCCC
Confidence            44434  234578899999999976

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.48  E-value=2.8e-13  Score=140.16  Aligned_cols=158  Identities=19%  Similarity=0.140  Sum_probs=128.4

Q ss_pred             ccceeEEEeeccCCCCCCCcc-chhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          146 LPFVLSFKFGKTYDSSRGPLL-NAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~i-n~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      ++.+..|.++.|.++.+|+.+ ..+..++.|.++.+.+..                   -.+.          ....+++
T Consensus        60 l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~-------------------~~~~----------~~~~l~~  110 (270)
T 2o6q_A           60 LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQA-------------------LPIG----------VFDQLVN  110 (270)
T ss_dssp             CTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCC-------------------CCTT----------TTTTCSS
T ss_pred             CCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCc-------------------CCHh----------HcccccC
Confidence            457788888888888888764 667778888877776541                   0110          0123568


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN  303 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~  303 (736)
                      |+.|+|++|++++..|..|..+++|++|+|++|++++.++ .|.++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus       111 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~  190 (270)
T 2o6q_A          111 LAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN  190 (270)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCC
Confidence            9999999999998777788999999999999999999887 489999999999999999987777899999999999999


Q ss_pred             ccCcCCCCcccc---cccccccccCCcccccCC
Q 004689          304 NMLSGTVPSSLL---SKNVVLNYAGNINLHEGG  333 (736)
Q Consensus       304 N~l~g~~P~~~~---~~~~~l~~~~n~~~c~~~  333 (736)
                      |+++ .+|...+   ..+..+.+.+|++.|.+.
T Consensus       191 N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          191 NQLK-RVPEGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             SCCS-CCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             CcCC-cCCHHHhccccCCCEEEecCCCeeCCCc
Confidence            9999 5666543   345788999999999863

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.47  E-value=5.9e-14  Score=137.52  Aligned_cols=122  Identities=24%  Similarity=0.297  Sum_probs=106.4

Q ss_pred             CCceEEecCCCC--------CceEEEEccCCCCCccCCc-ccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCC
Q 004689          211 PWSWLQCNSDPQ--------PSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDN  280 (736)
Q Consensus       211 ~~~~v~c~~~~~--------~~l~~L~L~~n~l~g~~p~-~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N  280 (736)
                      .|..+.|+...+        .+|+.|+|++|+|++..+. .|..+++|++|+|++|+|++.+| .|.++++|++|+|++|
T Consensus         9 ~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N   88 (192)
T 1w8a_A            9 EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             CCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence            466788875542        4899999999999966654 48999999999999999999988 7999999999999999


Q ss_pred             CCCCCCCccccCccccceeecccccCcCCCCcccc--cccccccccCCcccccC
Q 004689          281 QLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNINLHEG  332 (736)
Q Consensus       281 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~~--~~~~~l~~~~n~~~c~~  332 (736)
                      +|++..|..|.++++|+.|+|++|+|++.+|..+.  ..+..+.+.+|+..|..
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c  142 (192)
T 1w8a_A           89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             cCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence            99998888899999999999999999988787763  45678899999999875

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.47  E-value=1e-13  Score=135.88  Aligned_cols=119  Identities=23%  Similarity=0.285  Sum_probs=104.9

Q ss_pred             CceEEecCCC--------CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCC
Q 004689          212 WSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL  282 (736)
Q Consensus       212 ~~~v~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l  282 (736)
                      +..+.|+...        .++|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+ .|.++++|++|+|++|+|
T Consensus        12 ~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l   90 (193)
T 2wfh_A           12 DTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL   90 (193)
T ss_dssp             TTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             CCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence            5567786543        257999999999999 899999999999999999999999888 699999999999999999


Q ss_pred             CCCCCccccCccccceeecccccCcCCCCcccc---cccccccccCCcccccC
Q 004689          283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEG  332 (736)
Q Consensus       283 ~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~~---~~~~~l~~~~n~~~c~~  332 (736)
                      ++..|..|.++++|+.|+|++|+|+ .+|...+   ..+..+.+.+|++.|.+
T Consensus        91 ~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~c  142 (193)
T 2wfh_A           91 RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDC  142 (193)
T ss_dssp             CBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             CEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCeecCC
Confidence            9888889999999999999999999 6666543   35578899999999976

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.46  E-value=2.7e-13  Score=140.48  Aligned_cols=158  Identities=19%  Similarity=0.133  Sum_probs=124.5

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.+..|.++.|.++.+ +.+..+..++.|.++.+.+..                   ..+-          ....+++|
T Consensus        62 l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~l~~-------------------~~~~----------~~~~l~~L  111 (272)
T 3rfs_A           62 LPNVRYLALGGNKLHDI-SALKELTNLTYLILTGNQLQS-------------------LPNG----------VFDKLTNL  111 (272)
T ss_dssp             CTTCCEEECTTSCCCCC-GGGTTCTTCCEEECTTSCCCC-------------------CCTT----------TTTTCTTC
T ss_pred             CCCCcEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCc-------------------cChh----------HhcCCcCC
Confidence            45677788888887776 356666667777777665541                   1110          01235789


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCCC-CCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      +.|+|++|++++..+..+..+++|++|+|++|++++.++. +.++++|++|+|++|+|++..|..++.+++|+.|+|++|
T Consensus       112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N  191 (272)
T 3rfs_A          112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN  191 (272)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence            9999999999977777789999999999999999988884 789999999999999999888888899999999999999


Q ss_pred             cCcCCCCccc--ccccccccccCCcccccCC
Q 004689          305 MLSGTVPSSL--LSKNVVLNYAGNINLHEGG  333 (736)
Q Consensus       305 ~l~g~~P~~~--~~~~~~l~~~~n~~~c~~~  333 (736)
                      ++++..|..+  +..+..+.+.+|+..|..+
T Consensus       192 ~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  222 (272)
T 3rfs_A          192 QLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP  222 (272)
T ss_dssp             CCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             cCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence            9996555443  3456788999999888764

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.46  E-value=2e-14  Score=171.07  Aligned_cols=83  Identities=27%  Similarity=0.419  Sum_probs=64.1

Q ss_pred             ccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCCCCccccc--cccccc
Q 004689          246 LSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS--KNVVLN  322 (736)
Q Consensus       246 l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~~~--~~~~l~  322 (736)
                      +++|+.|||++|+++|.+| .+++|+.|+.|+|++|+|+|.+|..+++|++|+.|+|++|+++|.+|..+..  .+..++
T Consensus       631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~  710 (768)
T 3rgz_A          631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID  710 (768)
T ss_dssp             SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred             cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence            4667778888888888777 6788888888888888888888888888888888888888888888877643  446677


Q ss_pred             ccCCcc
Q 004689          323 YAGNIN  328 (736)
Q Consensus       323 ~~~n~~  328 (736)
                      +++|..
T Consensus       711 ls~N~l  716 (768)
T 3rgz_A          711 LSNNNL  716 (768)
T ss_dssp             CCSSEE
T ss_pred             CcCCcc
Confidence            777743

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.45  E-value=6.5e-14  Score=137.22  Aligned_cols=153  Identities=18%  Similarity=0.160  Sum_probs=120.2

Q ss_pred             EEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceEEEEc
Q 004689          151 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL  230 (736)
Q Consensus       151 ~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~~L~L  230 (736)
                      .+.++.+.+..+|..+..  .++.|.++.|.+..                   ..+-     .    ....+++|+.|+|
T Consensus        12 ~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~-------------------~~~~-----~----~~~~l~~L~~L~L   61 (192)
T 1w8a_A           12 TVDCTGRGLKEIPRDIPL--HTTELLLNDNELGR-------------------ISSD-----G----LFGRLPHLVKLEL   61 (192)
T ss_dssp             EEECTTSCCSSCCSCCCT--TCSEEECCSCCCCS-------------------BCCS-----C----SGGGCTTCCEEEC
T ss_pred             EEEcCCCCcCcCccCCCC--CCCEEECCCCcCCc-------------------cCCc-----c----ccccCCCCCEEEC
Confidence            477788888888876543  55667776665541                   0000     0    0124578999999


Q ss_pred             cCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCC
Q 004689          231 SSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT  309 (736)
Q Consensus       231 ~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~  309 (736)
                      ++|+|++..|..|.++++|++|+|++|+|++.++ .|.++++|++|+|++|+|++.+|..+..+++|+.|+|++|.+++.
T Consensus        62 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  141 (192)
T 1w8a_A           62 KRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             CCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence            9999999889999999999999999999999988 589999999999999999999999999999999999999999988


Q ss_pred             CCcccccc-cccccccCCcccccCC
Q 004689          310 VPSSLLSK-NVVLNYAGNINLHEGG  333 (736)
Q Consensus       310 ~P~~~~~~-~~~l~~~~n~~~c~~~  333 (736)
                      .+...+.. .....+.++...|..+
T Consensus       142 c~l~~~~~~l~~~~~~~~~~~C~~P  166 (192)
T 1w8a_A          142 CHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             GGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             CcchHHHHHHHHcCCCCCCCCCCCC
Confidence            87544322 2333556666677664

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.45  E-value=3.7e-14  Score=151.26  Aligned_cols=179  Identities=15%  Similarity=0.170  Sum_probs=121.3

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCc-----CCCCCCCCCCCCCceEEe--c
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADW-----AQEGGDPCLPVPWSWLQC--N  218 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w-----~~~~~dpc~~~~~~~v~c--~  218 (736)
                      ++.+..|.|+.|.++.+|..+..+..++.|.++.|.+... -..+..+..+...     +..+.-|-   .......  .
T Consensus       103 l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~l-p~~l~~l~~L~~L~L~~n~~~~~~p~---~~~~~~~~~~  178 (328)
T 4fcg_A          103 LSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPELTELPE---PLASTDASGE  178 (328)
T ss_dssp             GTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCC-CGGGGGCTTCCEEEEEEETTCCCCCS---CSEEEC-CCC
T ss_pred             CCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccC-cHHHhcCcCCCEEECCCCCCccccCh---hHhhccchhh
Confidence            4566777777777777777777777777777666655310 0011111111110     00001111   1110000  0


Q ss_pred             CCCCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccce
Q 004689          219 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE  298 (736)
Q Consensus       219 ~~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~  298 (736)
                      ...+++|+.|+|++|+|+ .+|..+.++++|++|+|++|++++.++.+.++++|++|+|++|++.+.+|..++++++|+.
T Consensus       179 ~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~  257 (328)
T 4fcg_A          179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR  257 (328)
T ss_dssp             EEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCE
T ss_pred             hccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCE
Confidence            012568899999999998 8888899999999999999999987678888999999999999998899999999999999


Q ss_pred             eecccccCcCCCCcccc--cccccccccCCccc
Q 004689          299 LYVQNNMLSGTVPSSLL--SKNVVLNYAGNINL  329 (736)
Q Consensus       299 L~l~~N~l~g~~P~~~~--~~~~~l~~~~n~~~  329 (736)
                      |+|++|++.+.+|..+.  ..+..+.+.+|...
T Consensus       258 L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~  290 (328)
T 4fcg_A          258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL  290 (328)
T ss_dssp             EECTTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred             EECCCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence            99999988888888764  34567777777554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.43  E-value=4.1e-13  Score=135.41  Aligned_cols=149  Identities=22%  Similarity=0.174  Sum_probs=117.7

Q ss_pred             EEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceEEEEc
Q 004689          151 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL  230 (736)
Q Consensus       151 ~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~~L~L  230 (736)
                      .+..+.+.+..+|+.+.  ..++.|.++.|.+..                   ..|-          ....+++|+.|+|
T Consensus        23 ~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~-------------------~~~~----------~~~~l~~L~~L~L   71 (229)
T 3e6j_A           23 TVDCRSKRHASVPAGIP--TNAQILYLHDNQITK-------------------LEPG----------VFDSLINLKELYL   71 (229)
T ss_dssp             EEECTTSCCSSCCSCCC--TTCSEEECCSSCCCC-------------------CCTT----------TTTTCTTCCEEEC
T ss_pred             EeEccCCCcCccCCCCC--CCCCEEEcCCCccCc-------------------cCHH----------HhhCccCCcEEEC
Confidence            36677788888887554  556677777776652                   1110          0123578999999


Q ss_pred             cCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCC
Q 004689          231 SSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT  309 (736)
Q Consensus       231 ~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~  309 (736)
                      ++|+|++..+..|..+++|+.|+|++|+|++.++ .|.++++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .
T Consensus        72 ~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~  149 (229)
T 3e6j_A           72 GSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-S  149 (229)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCC-C
T ss_pred             CCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCC-c
Confidence            9999985444567899999999999999998887 4789999999999999999 88999999999999999999999 5


Q ss_pred             CCcccc---cccccccccCCcccccC
Q 004689          310 VPSSLL---SKNVVLNYAGNINLHEG  332 (736)
Q Consensus       310 ~P~~~~---~~~~~l~~~~n~~~c~~  332 (736)
                      +|...+   ..+..+.+.+|+..|.+
T Consensus       150 ~~~~~~~~l~~L~~L~l~~N~~~c~c  175 (229)
T 3e6j_A          150 IPHGAFDRLSSLTHAYLFGNPWDCEC  175 (229)
T ss_dssp             CCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred             cCHHHHhCCCCCCEEEeeCCCccCCc
Confidence            555443   35578889999999875

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.42  E-value=4.7e-14  Score=150.38  Aligned_cols=142  Identities=21%  Similarity=0.256  Sum_probs=118.9

Q ss_pred             CCchHHHHHHHHHHcC------CCCcC---CCCCCCCCCCCCceEEecC-------CCCCceEEEEccCCCCCccCCccc
Q 004689          180 GSIDGVAIVSVISLYS------SADWA---QEGGDPCLPVPWSWLQCNS-------DPQPSITVIHLSSKNLTGNIPSDL  243 (736)
Q Consensus       180 ~~~~~~al~~l~~~~~------~~~w~---~~~~dpc~~~~~~~v~c~~-------~~~~~l~~L~L~~n~l~g~~p~~~  243 (736)
                      ...+..||.+||..+.      +..|.   ...+++|   .|.|+.|..       ...++|+.|+|++|+|+ .+|+.+
T Consensus        25 ~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~---~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l  100 (328)
T 4fcg_A           25 LRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE---TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA  100 (328)
T ss_dssp             CCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC---CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCG
T ss_pred             CchHHHHHHHHHHhccCCchhhhhhhccccccccccc---ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhh
Confidence            3457899999999774      24673   3457778   599999852       23578999999999999 899999


Q ss_pred             ccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCCCCccc--------
Q 004689          244 TKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--------  314 (736)
Q Consensus       244 ~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~--------  314 (736)
                      ++|++|++|+|++|.++ .+| .++++++|++|+|++|.|+ .+|..++++++|+.|+|++|++.|.+|..+        
T Consensus       101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~  178 (328)
T 4fcg_A          101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE  178 (328)
T ss_dssp             GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred             hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence            99999999999999999 555 7999999999999999999 899999999999999999999999999887        


Q ss_pred             ---ccccccccccCCc
Q 004689          315 ---LSKNVVLNYAGNI  327 (736)
Q Consensus       315 ---~~~~~~l~~~~n~  327 (736)
                         +..+..+.+.+|.
T Consensus       179 ~~~l~~L~~L~L~~n~  194 (328)
T 4fcg_A          179 HQGLVNLQSLRLEWTG  194 (328)
T ss_dssp             EEESTTCCEEEEEEEC
T ss_pred             hccCCCCCEEECcCCC
Confidence               3344566666663

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.41  E-value=3e-13  Score=135.49  Aligned_cols=137  Identities=18%  Similarity=0.193  Sum_probs=116.8

Q ss_pred             eeEEEeeccCCCCCCCc--cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceE
Q 004689          149 VLSFKFGKTYDSSRGPL--LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT  226 (736)
Q Consensus       149 l~~l~l~~~~~s~lpP~--in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~  226 (736)
                      +..|.|+.|.++.++|.  +..+..++.|.++.|.+..                   -.+-          ....+++|+
T Consensus        34 ~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~-------------------i~~~----------~~~~l~~L~   84 (220)
T 2v70_A           34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-------------------IEEG----------AFEGASGVN   84 (220)
T ss_dssp             CSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCE-------------------ECTT----------TTTTCTTCC
T ss_pred             CCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCE-------------------ECHH----------HhCCCCCCC
Confidence            35789999999999764  7888889999998887752                   1110          012357899


Q ss_pred             EEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          227 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       227 ~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      .|+|++|.|++..|..|..+++|++|+|++|+|++.+| .|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.
T Consensus        85 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  164 (220)
T 2v70_A           85 EILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANP  164 (220)
T ss_dssp             EEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred             EEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcC
Confidence            99999999998777789999999999999999999988 68999999999999999999889999999999999999999


Q ss_pred             CcCCCCccc
Q 004689          306 LSGTVPSSL  314 (736)
Q Consensus       306 l~g~~P~~~  314 (736)
                      +++..+...
T Consensus       165 l~c~c~l~~  173 (220)
T 2v70_A          165 FNCNCYLAW  173 (220)
T ss_dssp             EECSGGGHH
T ss_pred             CcCCCchHH
Confidence            998776443

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.41  E-value=5.5e-13  Score=134.41  Aligned_cols=123  Identities=24%  Similarity=0.307  Sum_probs=106.5

Q ss_pred             CCCCCCCCCCceEEecCCC--------CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCc
Q 004689          203 GGDPCLPVPWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLR  273 (736)
Q Consensus       203 ~~dpc~~~~~~~v~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~  273 (736)
                      ..+.|   .|..|.|+...        .++|+.|+|++|+|++..|..|.++++|++|+|++|+|++.++ .|.++++|+
T Consensus        15 ~~~~C---s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~   91 (229)
T 3e6j_A           15 SQCSC---SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT   91 (229)
T ss_dssp             TTCEE---ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             CCCEE---eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcC
Confidence            36778   58999998654        3579999999999998889999999999999999999988777 479999999


Q ss_pred             EEEcCCCCCCCCCCccccCccccceeecccccCcCCCCcccc--cccccccccCCccc
Q 004689          274 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNINL  329 (736)
Q Consensus       274 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~~--~~~~~l~~~~n~~~  329 (736)
                      +|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+.  ..+..+.+.+|...
T Consensus        92 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~  148 (229)
T 3e6j_A           92 VLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK  148 (229)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCC
T ss_pred             EEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCC
Confidence            9999999999777778899999999999999999 8998874  34567788888543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.40  E-value=7.1e-13  Score=127.80  Aligned_cols=121  Identities=24%  Similarity=0.271  Sum_probs=103.7

Q ss_pred             CCceEEecCCC--------CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCC-CCCCCCCcEEEcCCCC
Q 004689          211 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ  281 (736)
Q Consensus       211 ~~~~v~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~  281 (736)
                      .|..+.|+...        .++|+.|+|++|++++..+..+..+++|++|+|++|++++.++. +.++++|++|+|++|+
T Consensus         8 ~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~   87 (177)
T 2o6r_A            8 SGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK   87 (177)
T ss_dssp             ETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCC
Confidence            57788887554        35899999999999976666789999999999999999988874 7999999999999999


Q ss_pred             CCCCCCccccCccccceeecccccCcCCCCcccc---cccccccccCCcccccC
Q 004689          282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEG  332 (736)
Q Consensus       282 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~~---~~~~~l~~~~n~~~c~~  332 (736)
                      |++..+..+.++++|+.|+|++|+++ .+|...+   ..+..+.+.+|+..|..
T Consensus        88 l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A           88 LQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             ccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccC
Confidence            99877778899999999999999999 6666553   34578889999888754

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.40  E-value=1.5e-13  Score=152.67  Aligned_cols=180  Identities=19%  Similarity=0.173  Sum_probs=133.4

Q ss_pred             ccceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEe-cCCCCC
Q 004689          146 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQP  223 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c-~~~~~~  223 (736)
                      ++.+..|.|+.|.++.+|+. +..+..|+.|.++.|.+....-..+.....+......+   |.  ....+.- ....++
T Consensus       111 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~---~~--~l~~i~~~~~~~l~  185 (440)
T 3zyj_A          111 LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGE---LK--RLSYISEGAFEGLS  185 (440)
T ss_dssp             CSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCC---CT--TCCEECTTTTTTCS
T ss_pred             CccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCC---CC--CcceeCcchhhccc
Confidence            56788899999999998884 78888888888888766421100111111111111000   00  0011110 123467


Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      +|+.|+|++|+|+ .+| .+..+++|+.|+|++|++++..| .|.++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus       186 ~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  263 (440)
T 3zyj_A          186 NLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA  263 (440)
T ss_dssp             SCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECT
T ss_pred             ccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECC
Confidence            9999999999999 677 48999999999999999999888 79999999999999999999889999999999999999


Q ss_pred             cccCcCCCCcccc---cccccccccCCcccccCC
Q 004689          303 NNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG  333 (736)
Q Consensus       303 ~N~l~g~~P~~~~---~~~~~l~~~~n~~~c~~~  333 (736)
                      +|+|+ .+|...+   ..+..+.+.+|++.|.+.
T Consensus       264 ~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~  296 (440)
T 3zyj_A          264 HNNLT-LLPHDLFTPLHHLERIHLHHNPWNCNCD  296 (440)
T ss_dssp             TSCCC-CCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred             CCCCC-ccChhHhccccCCCEEEcCCCCccCCCC
Confidence            99999 5665554   345788999999999873

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.39  E-value=5e-13  Score=139.27  Aligned_cols=158  Identities=19%  Similarity=0.231  Sum_probs=123.9

Q ss_pred             ccceeEEEeeccC-CCCCCC-ccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCC
Q 004689          146 LPFVLSFKFGKTY-DSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP  223 (736)
Q Consensus       146 l~~l~~l~l~~~~-~s~lpP-~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~  223 (736)
                      ++.+..|.++.|. +..++| .+..+..++.|.++.+.+..                   ..|-          ....++
T Consensus        79 l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~-------------------~~~~----------~~~~l~  129 (285)
T 1ozn_A           79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-------------------LGPG----------LFRGLA  129 (285)
T ss_dssp             CTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCC-------------------CCTT----------TTTTCT
T ss_pred             ccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCE-------------------ECHh----------HhhCCc
Confidence            4567777777776 777744 36666777777776665531                   1111          012357


Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      +|+.|+|++|++++..+..+..+++|++|+|++|++++.++ .+.++++|++|+|++|.+++..|..+.++++|+.|+|+
T Consensus       130 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  209 (285)
T 1ozn_A          130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF  209 (285)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCC
Confidence            89999999999997666679999999999999999998887 58999999999999999999889999999999999999


Q ss_pred             cccCcCCCCccc--ccccccccccCCcccccC
Q 004689          303 NNMLSGTVPSSL--LSKNVVLNYAGNINLHEG  332 (736)
Q Consensus       303 ~N~l~g~~P~~~--~~~~~~l~~~~n~~~c~~  332 (736)
                      +|.+++..|..+  +..+..+.+.+|+..|..
T Consensus       210 ~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~  241 (285)
T 1ozn_A          210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDC  241 (285)
T ss_dssp             SSCCSCCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred             CCcCCcCCHHHcccCcccCEEeccCCCccCCC
Confidence            999995443334  244578899999999876

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.39  E-value=3.7e-13  Score=141.72  Aligned_cols=112  Identities=19%  Similarity=0.182  Sum_probs=99.9

Q ss_pred             CCCceEEEEccCCCCCc-cCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccce
Q 004689          221 PQPSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE  298 (736)
Q Consensus       221 ~~~~l~~L~L~~n~l~g-~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~  298 (736)
                      .+++|+.|+|++|.+++ .+|..+..+++|++|+|++|++++.+| .+.++++|++|+|++|+|++..+..+..+++|+.
T Consensus       148 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  227 (306)
T 2z66_A          148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV  227 (306)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCE
T ss_pred             cCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCE
Confidence            35789999999999997 688899999999999999999999877 6899999999999999999877778999999999


Q ss_pred             eecccccCcCCCCccccc---ccccccccCCcccccC
Q 004689          299 LYVQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEG  332 (736)
Q Consensus       299 L~l~~N~l~g~~P~~~~~---~~~~l~~~~n~~~c~~  332 (736)
                      |+|++|++++..|..+..   .+..+.+.+|+..|.+
T Consensus       228 L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c  264 (306)
T 2z66_A          228 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC  264 (306)
T ss_dssp             EECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred             eECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence            999999999888877643   4578899999988875

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.39  E-value=1.2e-12  Score=133.72  Aligned_cols=137  Identities=15%  Similarity=0.131  Sum_probs=116.2

Q ss_pred             cccceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCC
Q 004689          145 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP  223 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~  223 (736)
                      .++.+..|.|+.|.++.++|. +..+..++.|.++.|.+..                   -.+.          ....++
T Consensus        57 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-------------------~~~~----------~~~~l~  107 (251)
T 3m19_A           57 GLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS-------------------LPLG----------VFDHLT  107 (251)
T ss_dssp             TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC-------------------CCTT----------TTTTCT
T ss_pred             CcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccc-------------------cChh----------HhcccC
Confidence            356888999999999999886 7888889999998887651                   1111          012357


Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      +|+.|+|++|+|++..+..|..+++|++|+|++|+|++.++ .|.++++|++|+|++|+|++..|..+..+++|+.|+|+
T Consensus       108 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  187 (251)
T 3m19_A          108 QLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLF  187 (251)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEee
Confidence            99999999999996666667899999999999999999888 68999999999999999998888899999999999999


Q ss_pred             cccCcCCC
Q 004689          303 NNMLSGTV  310 (736)
Q Consensus       303 ~N~l~g~~  310 (736)
                      +|.+++..
T Consensus       188 ~N~~~c~~  195 (251)
T 3m19_A          188 GNQFDCSR  195 (251)
T ss_dssp             SCCBCTTS
T ss_pred             CCceeCCc
Confidence            99999763

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.37  E-value=9.2e-13  Score=137.82  Aligned_cols=108  Identities=27%  Similarity=0.307  Sum_probs=95.5

Q ss_pred             CCCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccce
Q 004689          220 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE  298 (736)
Q Consensus       220 ~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~  298 (736)
                      ..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++.+| .|.++++|++|+|++|+|++..+..|..+++|+.
T Consensus        74 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  152 (290)
T 1p9a_G           74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK  152 (290)
T ss_dssp             SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred             CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCE
Confidence            34679999999999999 799999999999999999999999887 6899999999999999999877778899999999


Q ss_pred             eecccccCcCCCCccccc---ccccccccCCccc
Q 004689          299 LYVQNNMLSGTVPSSLLS---KNVVLNYAGNINL  329 (736)
Q Consensus       299 L~l~~N~l~g~~P~~~~~---~~~~l~~~~n~~~  329 (736)
                      |+|++|+|+ .+|...+.   .+..+.+.+|...
T Consensus       153 L~L~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~  185 (290)
T 1p9a_G          153 LSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY  185 (290)
T ss_dssp             EECTTSCCS-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             EECCCCcCC-ccCHHHhcCcCCCCEEECCCCcCC
Confidence            999999999 77776644   4567788888544

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.36  E-value=6.3e-13  Score=143.63  Aligned_cols=153  Identities=20%  Similarity=0.141  Sum_probs=121.3

Q ss_pred             eeEEEeeccCCCCCCCcc-c-hhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceE
Q 004689          149 VLSFKFGKTYDSSRGPLL-N-AMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT  226 (736)
Q Consensus       149 l~~l~l~~~~~s~lpP~i-n-~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~  226 (736)
                      +..|.|+.|.++.+++.+ . .+..|+.|.++.|.+..                   -.+-          ....+++|+
T Consensus        41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~-------------------i~~~----------~~~~l~~L~   91 (361)
T 2xot_A           41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-------------------ISSE----------AFVPVPNLR   91 (361)
T ss_dssp             CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCE-------------------ECTT----------TTTTCTTCC
T ss_pred             CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCc-------------------cChh----------hccCCCCCC
Confidence            566899999999998874 3 77888888888877641                   0010          012457899


Q ss_pred             EEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCcc-c---cCccccceeec
Q 004689          227 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSS-L---MNLPNLRELYV  301 (736)
Q Consensus       227 ~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~-~---~~l~~L~~L~l  301 (736)
                      .|+|++|+|++..+..|..|++|+.|+|++|+|++..| .|.++++|++|+|++|+|++ +|.. +   ..+++|+.|+|
T Consensus        92 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L  170 (361)
T 2xot_A           92 YLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDL  170 (361)
T ss_dssp             EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CCGGGTC----CTTCCEEEC
T ss_pred             EEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eCHHHhcCcccCCcCCEEEC
Confidence            99999999997777789999999999999999999887 79999999999999999995 5554 4   67999999999


Q ss_pred             ccccCcCCCCccccccc-----ccccccCCcccccC
Q 004689          302 QNNMLSGTVPSSLLSKN-----VVLNYAGNINLHEG  332 (736)
Q Consensus       302 ~~N~l~g~~P~~~~~~~-----~~l~~~~n~~~c~~  332 (736)
                      ++|+|+ .+|...+...     ..+.+.+|++.|.+
T Consensus       171 ~~N~l~-~l~~~~~~~l~~~~l~~l~l~~N~~~C~C  205 (361)
T 2xot_A          171 SSNKLK-KLPLTDLQKLPAWVKNGLYLHNNPLECDC  205 (361)
T ss_dssp             CSSCCC-CCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred             CCCCCC-ccCHHHhhhccHhhcceEEecCCCccCCc
Confidence            999999 6665443332     45889999999976

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.36  E-value=9.5e-13  Score=126.22  Aligned_cols=104  Identities=24%  Similarity=0.301  Sum_probs=81.8

Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN  303 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~  303 (736)
                      .+.|++++|+|+ .+|..+.  ++|+.|+|++|+|++.+| .|.++++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            467888888888 5887764  788888888888888877 578888888888888888876666778888888888888


Q ss_pred             ccCcCCCCcc-c--ccccccccccCCcccccC
Q 004689          304 NMLSGTVPSS-L--LSKNVVLNYAGNINLHEG  332 (736)
Q Consensus       304 N~l~g~~P~~-~--~~~~~~l~~~~n~~~c~~  332 (736)
                      |+|+ .+|.. +  +..+..+.+.+|+..|..
T Consensus        88 N~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~c  118 (170)
T 3g39_A           88 NQLK-SIPRGAFDNLKSLTHIWLLNNPWDCAC  118 (170)
T ss_dssp             SCCC-CCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred             CccC-EeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence            8888 45544 3  234567888888888765

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.35  E-value=1.4e-12  Score=130.56  Aligned_cols=135  Identities=16%  Similarity=0.155  Sum_probs=113.4

Q ss_pred             cceeEEEeeccCCCCCCC-ccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          147 PFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       147 ~~l~~l~l~~~~~s~lpP-~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      +.+..|.|+.|.++.+|| .+..+..++.|.++.|.+..                   ..|-          ....+++|
T Consensus        32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~-------------------~~~~----------~~~~l~~L   82 (220)
T 2v9t_B           32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-------------------LAPD----------AFQGLRSL   82 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCE-------------------ECTT----------TTTTCSSC
T ss_pred             cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCC-------------------cCHH----------HhhCCcCC
Confidence            467789999999999998 58888899999999887752                   1110          01235799


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      +.|+|++|+|++..+..|..+++|+.|+|++|+|++..| .|.++++|++|+|++|+|++..+..+..+++|+.|+|++|
T Consensus        83 ~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  162 (220)
T 2v9t_B           83 NSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN  162 (220)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCC
Confidence            999999999995444457899999999999999999988 6899999999999999999888888999999999999999


Q ss_pred             cCcCCC
Q 004689          305 MLSGTV  310 (736)
Q Consensus       305 ~l~g~~  310 (736)
                      .+...-
T Consensus       163 ~~~c~c  168 (220)
T 2v9t_B          163 PFICDC  168 (220)
T ss_dssp             CEECSG
T ss_pred             CcCCCC
Confidence            997543

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.35  E-value=3.8e-13  Score=149.90  Aligned_cols=180  Identities=18%  Similarity=0.190  Sum_probs=131.4

Q ss_pred             ccceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEe-cCCCCC
Q 004689          146 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQP  223 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c-~~~~~~  223 (736)
                      ++.+..|.|+.|.++.+|+. +..+..|+.|.++.|.+....-..+...-.+..-...  + |.  ....+.- ....++
T Consensus       122 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~--~-~~--~l~~i~~~~~~~l~  196 (452)
T 3zyi_A          122 LASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLG--E-LK--KLEYISEGAFEGLF  196 (452)
T ss_dssp             CTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECC--C-CT--TCCEECTTTTTTCT
T ss_pred             cccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCC--C-CC--CccccChhhccCCC
Confidence            56778888888888888876 6777788888888776642100011111111111000  0 00  0011110 123467


Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      +|+.|+|++|+|++ +| .+..+++|+.|+|++|++++..| .|.++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus       197 ~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  274 (452)
T 3zyi_A          197 NLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLA  274 (452)
T ss_dssp             TCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcccc-cc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECC
Confidence            99999999999994 55 58999999999999999999888 69999999999999999999899999999999999999


Q ss_pred             cccCcCCCCcccc---cccccccccCCcccccCC
Q 004689          303 NNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG  333 (736)
Q Consensus       303 ~N~l~g~~P~~~~---~~~~~l~~~~n~~~c~~~  333 (736)
                      +|+|+ .+|...+   ..+..+.+.+|++.|.+.
T Consensus       275 ~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC~  307 (452)
T 3zyi_A          275 HNNLS-SLPHDLFTPLRYLVELHLHHNPWNCDCD  307 (452)
T ss_dssp             SSCCS-CCCTTSSTTCTTCCEEECCSSCEECSTT
T ss_pred             CCcCC-ccChHHhccccCCCEEEccCCCcCCCCC
Confidence            99999 5665553   445788999999999874

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.34  E-value=2.9e-12  Score=132.62  Aligned_cols=139  Identities=19%  Similarity=0.159  Sum_probs=117.2

Q ss_pred             cccceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCC
Q 004689          145 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP  223 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~  223 (736)
                      .++.+..|.++.|.++.++|. +..+..++.|.++.+.+..                   -.+.          ....++
T Consensus        83 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-------------------~~~~----------~~~~l~  133 (272)
T 3rfs_A           83 ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-------------------LPDG----------VFDKLT  133 (272)
T ss_dssp             TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC-------------------CCTT----------TTTTCT
T ss_pred             CCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCc-------------------cCHH----------HhccCC
Confidence            356888999999999999987 5888888889888886641                   1110          012356


Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCCC-CCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      +|+.|+|++|++++..+..+..+++|+.|+|++|++++.++. +.++++|++|+|++|+|++..|..++++++|+.|+|+
T Consensus       134 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~  213 (272)
T 3rfs_A          134 NLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLH  213 (272)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEcc
Confidence            899999999999976666789999999999999999988884 7899999999999999998888889999999999999


Q ss_pred             cccCcCCCCc
Q 004689          303 NNMLSGTVPS  312 (736)
Q Consensus       303 ~N~l~g~~P~  312 (736)
                      +|.++|..|.
T Consensus       214 ~N~~~~~~~~  223 (272)
T 3rfs_A          214 DNPWDCTCPG  223 (272)
T ss_dssp             SSCBCCCTTT
T ss_pred             CCCccccCcH
Confidence            9999988773

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.34  E-value=7.8e-13  Score=152.91  Aligned_cols=182  Identities=13%  Similarity=0.007  Sum_probs=138.5

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHH-HHHHHHcCCCCcCCCCCCCCCCCCCceEE-ecCCCC
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAI-VSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQ  222 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al-~~l~~~~~~~~w~~~~~dpc~~~~~~~v~-c~~~~~  222 (736)
                      .++.+..|.++.|.++.+|+.+..+..++.|.++.+.+..... ..+...-.+..-...   -|   ...... -....+
T Consensus       374 ~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~---~n---~l~~~~~~~~~~l  447 (606)
T 3vq2_A          374 GTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS---YT---NTKIDFDGIFLGL  447 (606)
T ss_dssp             CCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECT---TS---CCEECCTTTTTTC
T ss_pred             cCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECc---CC---CCCccchhhhcCC
Confidence            4567889999999999999888888889999888877643110 111111111111000   00   000000 012345


Q ss_pred             CceEEEEccCCCCCcc-CCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceee
Q 004689          223 PSITVIHLSSKNLTGN-IPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY  300 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~-~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~  300 (736)
                      ++|+.|+|++|.+++. +|..+..+++|+.|+|++|++++.+| .+.++++|++|+|++|++++.+|..++++++|+.|+
T Consensus       448 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  527 (606)
T 3vq2_A          448 TSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLD  527 (606)
T ss_dssp             TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEE
T ss_pred             CCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEE
Confidence            7999999999999984 78899999999999999999999988 689999999999999999998899999999999999


Q ss_pred             cccccCcCCCCccccc---ccccccccCCcccccCC
Q 004689          301 VQNNMLSGTVPSSLLS---KNVVLNYAGNINLHEGG  333 (736)
Q Consensus       301 l~~N~l~g~~P~~~~~---~~~~l~~~~n~~~c~~~  333 (736)
                      |++|+|+ .+|..+..   .+..+.+.+|+..|.++
T Consensus       528 l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~  562 (606)
T 3vq2_A          528 CSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE  562 (606)
T ss_dssp             CTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred             CCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence            9999999 88887643   35788999999999874

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.33  E-value=3.1e-12  Score=142.36  Aligned_cols=112  Identities=21%  Similarity=0.227  Sum_probs=94.3

Q ss_pred             CCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCcccccee
Q 004689          221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL  299 (736)
Q Consensus       221 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L  299 (736)
                      .+++|+.|+|++|++++..|..|.++++|++|+|++|++++.+| .+.++++|++|+|++|+|++..|..+.++++|+.|
T Consensus       297 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  376 (455)
T 3v47_A          297 HFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKEL  376 (455)
T ss_dssp             TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred             cCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEE
Confidence            35788999999999998888888899999999999999988877 57889999999999999998888899999999999


Q ss_pred             ecccccCcCCCCcccc---cccccccccCCcccccCC
Q 004689          300 YVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG  333 (736)
Q Consensus       300 ~l~~N~l~g~~P~~~~---~~~~~l~~~~n~~~c~~~  333 (736)
                      +|++|+++ .+|...+   ..+..+.+.+|+..|..+
T Consensus       377 ~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          377 ALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             ECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             ECCCCccc-cCCHhHhccCCcccEEEccCCCcccCCC
Confidence            99999998 4665443   345778899999888764

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.33  E-value=1.1e-12  Score=128.93  Aligned_cols=150  Identities=15%  Similarity=0.096  Sum_probs=117.9

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      .++.+..|.++.|.++.+| -+..+..++.|.++.+.+..                     +.          ....+++
T Consensus        42 ~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~---------------------~~----------~l~~l~~   89 (197)
T 4ezg_A           42 QMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATN---------------------YN----------PISGLSN   89 (197)
T ss_dssp             HHHTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSC---------------------CG----------GGTTCTT
T ss_pred             hcCCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCc---------------------ch----------hhhcCCC
Confidence            4567888999999999988 56777777777777664321                     10          0123578


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN  303 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~  303 (736)
                      |+.|+|++|++++..|..+..|++|++|+|++|++++..| .++++++|++|+|++|.+.+.+| .+..+++|+.|++++
T Consensus        90 L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~  168 (197)
T 4ezg_A           90 LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQF  168 (197)
T ss_dssp             CCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-GGGGCSSCCEEECTT
T ss_pred             CCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-hhcCCCCCCEEECCC
Confidence            9999999999998889999999999999999999998666 68999999999999998444666 699999999999999


Q ss_pred             ccCcCCCCcccccccccccccCCc
Q 004689          304 NMLSGTVPSSLLSKNVVLNYAGNI  327 (736)
Q Consensus       304 N~l~g~~P~~~~~~~~~l~~~~n~  327 (736)
                      |.+++..+-.-+..+..+.+.+|.
T Consensus       169 n~i~~~~~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          169 DGVHDYRGIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             BCCCCCTTGGGCSSCCEEEECBC-
T ss_pred             CCCcChHHhccCCCCCEEEeeCcc
Confidence            999953333334556777788875

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.33  E-value=4e-12  Score=125.85  Aligned_cols=135  Identities=19%  Similarity=0.166  Sum_probs=71.6

Q ss_pred             ceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceE
Q 004689          148 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT  226 (736)
Q Consensus       148 ~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~  226 (736)
                      .+..|.++.|.++.+++. +..+..++.|.++.+.+..                   -.+.          ....+++|+
T Consensus        29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-------------------~~~~----------~~~~l~~L~   79 (208)
T 2o6s_A           29 QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-------------------LPNG----------VFNKLTSLT   79 (208)
T ss_dssp             TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC-------------------CCTT----------TTTTCTTCC
T ss_pred             CCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCc-------------------cChh----------hcCCCCCcC
Confidence            455667777776666654 4455555555555544321                   0000          001234556


Q ss_pred             EEEccCCCCCccCCcccccccccccccccccccCCCCCC-CCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          227 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       227 ~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      .|+|++|+|++..+..+..+++|++|+|++|++++.++. +.++++|++|+|++|+|++..+..+..+++|+.|+|++|.
T Consensus        80 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~  159 (208)
T 2o6s_A           80 YLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP  159 (208)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCC
T ss_pred             EEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCC
Confidence            666666666543333455566666666666666655552 4556666666666666664444445555666666666655


Q ss_pred             CcCCCC
Q 004689          306 LSGTVP  311 (736)
Q Consensus       306 l~g~~P  311 (736)
                      +.+..|
T Consensus       160 ~~~~~~  165 (208)
T 2o6s_A          160 WDCTCP  165 (208)
T ss_dssp             BCCCTT
T ss_pred             eecCCC
Confidence            554443

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.33  E-value=6.9e-12  Score=124.12  Aligned_cols=149  Identities=21%  Similarity=0.174  Sum_probs=114.2

Q ss_pred             EEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceEEEEcc
Q 004689          152 FKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLS  231 (736)
Q Consensus       152 l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~~L~L~  231 (736)
                      +....+.++.+|..+.  ..++.|.++.+.+..                   ..+-          ....+++|+.|+|+
T Consensus        12 v~c~~~~l~~~p~~~~--~~l~~L~l~~n~l~~-------------------~~~~----------~~~~l~~L~~L~l~   60 (208)
T 2o6s_A           12 VECYSQGRTSVPTGIP--AQTTYLDLETNSLKS-------------------LPNG----------VFDELTSLTQLYLG   60 (208)
T ss_dssp             EECCSSCCSSCCSCCC--TTCSEEECCSSCCCC-------------------CCTT----------TTTTCTTCSEEECC
T ss_pred             EEecCCCccCCCCCCC--CCCcEEEcCCCccCc-------------------CChh----------hhcccccCcEEECC
Confidence            4556677777776543  356667777666541                   0000          01235789999999


Q ss_pred             CCCCCccCCcccccccccccccccccccCCCCCC-CCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCCC
Q 004689          232 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTV  310 (736)
Q Consensus       232 ~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~  310 (736)
                      +|++++..+..|..+++|++|+|++|++++.++. +.++++|++|+|++|+|++..+..+.++++|+.|+|++|+++ .+
T Consensus        61 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~  139 (208)
T 2o6s_A           61 GNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SV  139 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CC
T ss_pred             CCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccc-ee
Confidence            9999965555678999999999999999988774 789999999999999999777777899999999999999999 45


Q ss_pred             Cccc---ccccccccccCCcccccC
Q 004689          311 PSSL---LSKNVVLNYAGNINLHEG  332 (736)
Q Consensus       311 P~~~---~~~~~~l~~~~n~~~c~~  332 (736)
                      |...   +..+..+.+.+|+..|..
T Consensus       140 ~~~~~~~l~~L~~L~l~~N~~~~~~  164 (208)
T 2o6s_A          140 PDGVFDRLTSLQYIWLHDNPWDCTC  164 (208)
T ss_dssp             CTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred             CHHHhccCCCccEEEecCCCeecCC
Confidence            5543   345578889999888765

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.32  E-value=2.6e-12  Score=123.17  Aligned_cols=101  Identities=25%  Similarity=0.314  Sum_probs=89.0

Q ss_pred             CCceEEecCCC--------CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCC
Q 004689          211 PWSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ  281 (736)
Q Consensus       211 ~~~~v~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~  281 (736)
                      .|..+.|+...        .++|+.|+|++|+|++..|..|.+|++|++|+|++|+|++.++ .|.++++|++|+|++|+
T Consensus        10 ~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~   89 (170)
T 3g39_A           10 SGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ   89 (170)
T ss_dssp             ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence            35667776543        2579999999999998888899999999999999999999888 47899999999999999


Q ss_pred             CCCCCCccccCccccceeecccccCcCCCC
Q 004689          282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVP  311 (736)
Q Consensus       282 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P  311 (736)
                      |++..|..|.++++|+.|+|++|.+++..+
T Consensus        90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           90 LKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             cCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            997777789999999999999999986554

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.32  E-value=1.8e-12  Score=123.70  Aligned_cols=136  Identities=19%  Similarity=0.150  Sum_probs=114.4

Q ss_pred             ccceeEEEeeccCCC--CCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCC
Q 004689          146 LPFVLSFKFGKTYDS--SRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP  223 (736)
Q Consensus       146 l~~l~~l~l~~~~~s--~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~  223 (736)
                      .+.+..|.++.|.++  .+|+.+..+..++.|.++.+.+..                   . +           ....++
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~-------------------~-~-----------~~~~l~   71 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-------------------V-S-----------NLPKLP   71 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCC-------------------C-S-----------SCCCCS
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCC-------------------h-h-----------hhccCC
Confidence            357888999999998  899888999999999888877652                   0 0           112357


Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCC--CCCCCCCCCcEEEcCCCCCCCCCC---ccccCccccce
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI--PDFSGCPDLRIIHLEDNQLTGPLP---SSLMNLPNLRE  298 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~l~~L~~L~Ls~N~l~g~~p---~~~~~l~~L~~  298 (736)
                      +|+.|+|++|++++.+|..+.++++|++|+|++|.+++..  +.+.++++|++|+|++|.+++..+   ..+..+++|+.
T Consensus        72 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~  151 (168)
T 2ell_A           72 KLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTY  151 (168)
T ss_dssp             SCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCE
T ss_pred             CCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcE
Confidence            8999999999999878888888999999999999999965  478999999999999999996555   48999999999


Q ss_pred             eecccccCcCCCCcc
Q 004689          299 LYVQNNMLSGTVPSS  313 (736)
Q Consensus       299 L~l~~N~l~g~~P~~  313 (736)
                      |++++|.+. .+|..
T Consensus       152 L~l~~n~~~-~~~~~  165 (168)
T 2ell_A          152 LDGYDREDQ-EAPDS  165 (168)
T ss_dssp             ETTEETTSC-BCCSS
T ss_pred             ecCCCCChh-hcccc
Confidence            999999998 67654

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.31  E-value=2.5e-12  Score=149.63  Aligned_cols=109  Identities=22%  Similarity=0.243  Sum_probs=99.6

Q ss_pred             CCceEEEEccCCCCCccCCcccc--cccccccccccccccCCCCCCCCCCCCCcEEEc------CCCCCCCCCCccccCc
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHL------EDNQLTGPLPSSLMNL  293 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~L------s~N~l~g~~p~~~~~l  293 (736)
                      +++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|++++.++.+.++++|++|+|      ++|++.+.+|..++++
T Consensus       487 l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l  565 (636)
T 4eco_A          487 TYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLC  565 (636)
T ss_dssp             GGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGC
T ss_pred             cCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCcccccCcccccChHHHhcC
Confidence            448999999999999 8999997  999999999999999994447899999999999      5688999999999999


Q ss_pred             cccceeecccccCcCCCCcccccccccccccCCcccccC
Q 004689          294 PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG  332 (736)
Q Consensus       294 ~~L~~L~l~~N~l~g~~P~~~~~~~~~l~~~~n~~~c~~  332 (736)
                      ++|+.|+|++|++ +.+|..+...+..+.+++|+..|-.
T Consensus       566 ~~L~~L~Ls~N~l-~~ip~~~~~~L~~L~Ls~N~l~~~~  603 (636)
T 4eco_A          566 PSLTQLQIGSNDI-RKVNEKITPNISVLDIKDNPNISID  603 (636)
T ss_dssp             SSCCEEECCSSCC-CBCCSCCCTTCCEEECCSCTTCEEE
T ss_pred             CCCCEEECCCCcC-CccCHhHhCcCCEEECcCCCCcccc
Confidence            9999999999999 6999999888899999999888744

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.31  E-value=4.2e-12  Score=132.21  Aligned_cols=154  Identities=16%  Similarity=0.201  Sum_probs=115.0

Q ss_pred             ccceeEEEeeccCCCCCCC-ccchhhhhhhhccCCCC-chHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCC
Q 004689          146 LPFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGS-IDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP  223 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP-~in~~e~~~~l~~~~~~-~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~  223 (736)
                      ++.+..|.++.|.++.++| .+..+..++.|.++.+. +..                   -.|-          ....++
T Consensus        55 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~-------------------~~~~----------~~~~l~  105 (285)
T 1ozn_A           55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRS-------------------VDPA----------TFHGLG  105 (285)
T ss_dssp             CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCC-------------------CCTT----------TTTTCT
T ss_pred             CCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccc-------------------cCHH----------HhcCCc
Confidence            3456667777777766644 36666666666666554 220                   1110          012357


Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      +|+.|+|++|++++..|..+.++++|++|+|++|++++.++ .+.++++|++|+|++|+|++..+..+..+++|+.|+|+
T Consensus       106 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  185 (285)
T 1ozn_A          106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH  185 (285)
T ss_dssp             TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECC
Confidence            89999999999998778889999999999999999998877 48889999999999999997666679999999999999


Q ss_pred             cccCcCCCCcccc--cccccccccCCcc
Q 004689          303 NNMLSGTVPSSLL--SKNVVLNYAGNIN  328 (736)
Q Consensus       303 ~N~l~g~~P~~~~--~~~~~l~~~~n~~  328 (736)
                      +|.+++..|..+.  ..+..+.+.+|..
T Consensus       186 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l  213 (285)
T 1ozn_A          186 QNRVAHVHPHAFRDLGRLMTLYLFANNL  213 (285)
T ss_dssp             SSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred             CCcccccCHhHccCcccccEeeCCCCcC
Confidence            9999977777664  3456677777743

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.31  E-value=3.8e-12  Score=122.49  Aligned_cols=104  Identities=22%  Similarity=0.329  Sum_probs=89.1

Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN  303 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~  303 (736)
                      -+.|++++|+|+ .+|..+.  ++|+.|+|++|+|++.+| .|.++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            368999999997 7898775  899999999999999988 689999999999999999976666678999999999999


Q ss_pred             ccCcCCCCccc---ccccccccccCCcccccC
Q 004689          304 NMLSGTVPSSL---LSKNVVLNYAGNINLHEG  332 (736)
Q Consensus       304 N~l~g~~P~~~---~~~~~~l~~~~n~~~c~~  332 (736)
                      |+|+ .+|...   +..+..+.+.+|+..|.+
T Consensus        91 N~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~~  121 (174)
T 2r9u_A           91 NHLK-SIPRGAFDNLKSLTHIYLYNNPWDCEC  121 (174)
T ss_dssp             SCCC-CCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred             Cccc-eeCHHHhccccCCCEEEeCCCCccccc
Confidence            9999 566653   345678889999998875

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.30  E-value=2.4e-12  Score=149.05  Aligned_cols=180  Identities=14%  Similarity=0.081  Sum_probs=131.8

Q ss_pred             ccccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchH----HHHHHHHHHcCCCCcCCCCCCCCCCCCCceE-Eec
Q 004689          144 LSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDG----VAIVSVISLYSSADWAQEGGDPCLPVPWSWL-QCN  218 (736)
Q Consensus       144 ~~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~----~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v-~c~  218 (736)
                      ..+..+..+.+..+....+++.+..+..++.+.+..+....    .++..+.....   ..   ...+   ....+ ...
T Consensus       394 ~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~---l~---ls~n---~l~~~~~~~  464 (635)
T 4g8a_A          394 FGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY---LD---ISHT---HTRVAFNGI  464 (635)
T ss_dssp             HSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCE---EE---CTTS---CCEECCTTT
T ss_pred             hhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccccccc---cc---cccc---ccccccccc
Confidence            34566778888888888888887777777777666543321    00000000000   00   0000   00000 011


Q ss_pred             CCCCCceEEEEccCCCC-CccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCcccc
Q 004689          219 SDPQPSITVIHLSSKNL-TGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNL  296 (736)
Q Consensus       219 ~~~~~~l~~L~L~~n~l-~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L  296 (736)
                      ....+.++.|+|++|++ .+.+|..|..+++|++|+|++|+|++.+| .|.+|++|++|+|++|+|++..|..|.++++|
T Consensus       465 ~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L  544 (635)
T 4g8a_A          465 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL  544 (635)
T ss_dssp             TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTC
T ss_pred             cccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCC
Confidence            23457899999999985 45678889999999999999999999988 69999999999999999999889999999999


Q ss_pred             ceeecccccCcCCCCcccc---cccccccccCCcccccC
Q 004689          297 RELYVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEG  332 (736)
Q Consensus       297 ~~L~l~~N~l~g~~P~~~~---~~~~~l~~~~n~~~c~~  332 (736)
                      +.|+|++|+|++..|..+.   ..+..+.+.+|++.|.+
T Consensus       545 ~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C  583 (635)
T 4g8a_A          545 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC  583 (635)
T ss_dssp             CEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred             CEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence            9999999999988787764   34678899999999987

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.30  E-value=8.3e-12  Score=128.97  Aligned_cols=152  Identities=20%  Similarity=0.193  Sum_probs=121.5

Q ss_pred             ceeEEEeeccCCCCCCC-ccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceE
Q 004689          148 FVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT  226 (736)
Q Consensus       148 ~l~~l~l~~~~~s~lpP-~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~  226 (736)
                      .+..|.|+.|.++.+|+ .+..+..++.|.++.+.+..           +        .+-          ....+++|+
T Consensus        38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-----------i--------~~~----------~~~~l~~L~   88 (270)
T 2o6q_A           38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-----------L--------PAG----------IFKELKNLE   88 (270)
T ss_dssp             TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSC-----------C--------CTT----------TTSSCTTCC
T ss_pred             CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCe-----------e--------Chh----------hhcCCCCCC
Confidence            56788999999999987 58888888888888876541           0        000          002357899


Q ss_pred             EEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          227 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       227 ~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      .|+|++|++++..+..+..+++|++|+|++|++++..+ .|.++++|++|+|++|.|++..+..++.+++|+.|+|++|.
T Consensus        89 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~  168 (270)
T 2o6q_A           89 TLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQ  168 (270)
T ss_dssp             EEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCc
Confidence            99999999997666678899999999999999999888 58999999999999999997766779999999999999999


Q ss_pred             CcCCCCcccc---cccccccccCCccc
Q 004689          306 LSGTVPSSLL---SKNVVLNYAGNINL  329 (736)
Q Consensus       306 l~g~~P~~~~---~~~~~l~~~~n~~~  329 (736)
                      +++ +|...+   ..+..+.+.+|...
T Consensus       169 l~~-~~~~~~~~l~~L~~L~L~~N~l~  194 (270)
T 2o6q_A          169 LKR-VPEGAFDKLTELKTLKLDNNQLK  194 (270)
T ss_dssp             CSC-CCTTTTTTCTTCCEEECCSSCCS
T ss_pred             CcE-eChhHhccCCCcCEEECCCCcCC
Confidence            994 554433   34567778887433

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.29  E-value=5.7e-12  Score=150.22  Aligned_cols=107  Identities=21%  Similarity=0.288  Sum_probs=98.0

Q ss_pred             CCceEEEEccCCCCCccCCcccc--cccccccccccccccCCCCCCCCCCCCCcEEEcCC------CCCCCCCCccccCc
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLED------NQLTGPLPSSLMNL  293 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~------N~l~g~~p~~~~~l  293 (736)
                      +++|+.|+|++|+|+ .+|..+.  .+++|+.|+|++|+|++.++.+.+|++|+.|+|++      |++.+.+|..|++|
T Consensus       727 l~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L  805 (876)
T 4ecn_A          727 TYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTC  805 (876)
T ss_dssp             GGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGC
T ss_pred             cCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCCCcccccccccChHHHhcC
Confidence            458999999999999 8999997  99999999999999999544789999999999976      88999999999999


Q ss_pred             cccceeecccccCcCCCCcccccccccccccCCcccc
Q 004689          294 PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH  330 (736)
Q Consensus       294 ~~L~~L~l~~N~l~g~~P~~~~~~~~~l~~~~n~~~c  330 (736)
                      ++|+.|+|++|+| +.+|..+...+..+.+++|+...
T Consensus       806 ~~L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~~  841 (876)
T 4ecn_A          806 PSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS  841 (876)
T ss_dssp             SSCCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTCE
T ss_pred             CCCCEEECCCCCC-CccCHhhcCCCCEEECCCCCCCc
Confidence            9999999999999 69999998888889999997653

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.29  E-value=9.8e-13  Score=151.94  Aligned_cols=107  Identities=21%  Similarity=0.240  Sum_probs=64.5

Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      ++|+.|+|++|.+++..|..|..+++|+.|+|++|.+++.++.+..+++|++|+|++|.|+ .+|..++.+++|+.|+|+
T Consensus       254 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~  332 (597)
T 3oja_B          254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD  332 (597)
T ss_dssp             TTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECC
T ss_pred             CCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECC
Confidence            4566666666666655566666666666666666666654444555666666666666666 455556666666666666


Q ss_pred             cccCcCCCCcccccccccccccCCccccc
Q 004689          303 NNMLSGTVPSSLLSKNVVLNYAGNINLHE  331 (736)
Q Consensus       303 ~N~l~g~~P~~~~~~~~~l~~~~n~~~c~  331 (736)
                      +|.|+ .+|...+..+..+.+.+|+..|.
T Consensus       333 ~N~l~-~~~~~~~~~L~~L~l~~N~~~~~  360 (597)
T 3oja_B          333 HNSIV-TLKLSTHHTLKNLTLSHNDWDCN  360 (597)
T ss_dssp             SSCCC-CCCCCTTCCCSEEECCSSCEEHH
T ss_pred             CCCCC-CcChhhcCCCCEEEeeCCCCCCh
Confidence            66665 34444445555666666666654

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.28  E-value=1.4e-12  Score=135.12  Aligned_cols=111  Identities=16%  Similarity=0.195  Sum_probs=88.8

Q ss_pred             CCCceEEEEccCCCCCc-cCCcccccccccccccccccccCCCCC-CCCCCCCCc----EEEcCCCCCCCCCCccccCcc
Q 004689          221 PQPSITVIHLSSKNLTG-NIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLR----IIHLEDNQLTGPLPSSLMNLP  294 (736)
Q Consensus       221 ~~~~l~~L~L~~n~l~g-~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~----~L~Ls~N~l~g~~p~~~~~l~  294 (736)
                      .+++|+.|+|++|.+++ .+|..+.++++|++|+|++|++++..+ .+..+++|+    .|+|++|.+++..+..+ ...
T Consensus       122 ~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~-~~~  200 (276)
T 2z62_A          122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEI  200 (276)
T ss_dssp             TCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSS-CSC
T ss_pred             cCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCcccc-CCC
Confidence            45789999999999986 368899999999999999999998776 566666665    89999999995544444 455


Q ss_pred             ccceeecccccCcCCCCcccc---cccccccccCCcccccCC
Q 004689          295 NLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEGG  333 (736)
Q Consensus       295 ~L~~L~l~~N~l~g~~P~~~~---~~~~~l~~~~n~~~c~~~  333 (736)
                      +|+.|+|++|.++ .+|...+   ..+..+.+.+|+..|..+
T Consensus       201 ~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c~  241 (276)
T 2z62_A          201 RLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP  241 (276)
T ss_dssp             CEEEEECCSSCCS-CCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred             cccEEECCCCcee-ecCHhHhcccccccEEEccCCcccccCC
Confidence            8999999999999 5666553   345788999999999864

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.27  E-value=1.3e-12  Score=142.53  Aligned_cols=107  Identities=21%  Similarity=0.240  Sum_probs=63.9

Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      ++|+.|+|++|.+++..|..+..+++|+.|+|++|++++..+.+..+++|++|+|++|+++ .+|..++.+++|+.|+|+
T Consensus       248 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~  326 (390)
T 3o6n_A          248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD  326 (390)
T ss_dssp             TTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECC
T ss_pred             CCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECC
Confidence            4556666666666655555666666666666666666654444555666666666666666 455556666666666666


Q ss_pred             cccCcCCCCcccccccccccccCCccccc
Q 004689          303 NNMLSGTVPSSLLSKNVVLNYAGNINLHE  331 (736)
Q Consensus       303 ~N~l~g~~P~~~~~~~~~l~~~~n~~~c~  331 (736)
                      +|.++ .+|...+..+..+.+.+|+..|.
T Consensus       327 ~N~i~-~~~~~~~~~L~~L~l~~N~~~~~  354 (390)
T 3o6n_A          327 HNSIV-TLKLSTHHTLKNLTLSHNDWDCN  354 (390)
T ss_dssp             SSCCC-CCCCCTTCCCSEEECCSSCEEHH
T ss_pred             CCccc-eeCchhhccCCEEEcCCCCccch
Confidence            66665 44544445555666666666653

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.27  E-value=6e-12  Score=151.30  Aligned_cols=108  Identities=29%  Similarity=0.274  Sum_probs=89.2

Q ss_pred             CCceEEEEccCCCCC-----ccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccc
Q 004689          222 QPSITVIHLSSKNLT-----GNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPN  295 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~-----g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~  295 (736)
                      .++|+.|+|++|.++     +..|..|..|++|+.|+|++|+|++.+| .|.++++|+.|+|++|+|++..|..+.  ++
T Consensus       450 ~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~  527 (844)
T 3j0a_A          450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--AN  527 (844)
T ss_dssp             CTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SC
T ss_pred             CCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--cc
Confidence            356777777777776     3445568889999999999999999988 589999999999999999977766665  89


Q ss_pred             cceeecccccCcCCCCcccccccccccccCCcccccC
Q 004689          296 LRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLHEG  332 (736)
Q Consensus       296 L~~L~l~~N~l~g~~P~~~~~~~~~l~~~~n~~~c~~  332 (736)
                      |+.|+|++|+|+|..|..+ ..+..+.+.+|++.|.+
T Consensus       528 L~~L~Ls~N~l~~~~~~~~-~~L~~l~l~~Np~~C~c  563 (844)
T 3j0a_A          528 LEILDISRNQLLAPNPDVF-VSLSVLDITHNKFICEC  563 (844)
T ss_dssp             CCEEEEEEECCCCCCSCCC-SSCCEEEEEEECCCCSS
T ss_pred             ccEEECCCCcCCCCChhHh-CCcCEEEecCCCccccc
Confidence            9999999999998777654 56778889999988843

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.27  E-value=8e-12  Score=129.43  Aligned_cols=138  Identities=15%  Similarity=0.145  Sum_probs=114.5

Q ss_pred             ceeEEEeeccCCCCCCC-ccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceE
Q 004689          148 FVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT  226 (736)
Q Consensus       148 ~l~~l~l~~~~~s~lpP-~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~  226 (736)
                      .+..|.++.|.++.+++ .+..+..++.|.++.+.+..                   ..+-          ....+++|+
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-------------------~~~~----------~~~~l~~L~   79 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-------------------IEDG----------AYQSLSHLS   79 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCE-------------------ECTT----------TTTTCTTCC
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCc-------------------cCHH----------HccCCcCCC
Confidence            57889999999999998 58888888888888876641                   0000          012356899


Q ss_pred             EEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCC-CCCccccCccccceeecccc
Q 004689          227 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       227 ~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~l~~N  304 (736)
                      .|+|++|.+++..|..|.++++|++|+|++|++++..+ .+.++++|++|+|++|.+++ .+|..++++++|+.|+|++|
T Consensus        80 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N  159 (276)
T 2z62_A           80 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN  159 (276)
T ss_dssp             EEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred             EEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCC
Confidence            99999999998888889999999999999999999887 68999999999999999986 47999999999999999999


Q ss_pred             cCcCCCCccc
Q 004689          305 MLSGTVPSSL  314 (736)
Q Consensus       305 ~l~g~~P~~~  314 (736)
                      ++++..+..+
T Consensus       160 ~l~~~~~~~~  169 (276)
T 2z62_A          160 KIQSIYCTDL  169 (276)
T ss_dssp             CCCEECGGGG
T ss_pred             CCCcCCHHHh
Confidence            9995444444

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.26  E-value=3.7e-12  Score=145.92  Aligned_cols=113  Identities=20%  Similarity=0.200  Sum_probs=100.0

Q ss_pred             CCCceEEEEccCCCCCccCCcccccccccccccccccccC-CCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccce
Q 004689          221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT-GPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE  298 (736)
Q Consensus       221 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~-~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~  298 (736)
                      .+++|+.|+|++|.+++..|..+..+++|+.|+|++|.++ +.+| .+.++++|++|+|++|++++..|..+.++++|+.
T Consensus       419 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  498 (570)
T 2z63_A          419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV  498 (570)
T ss_dssp             TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             cCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCE
Confidence            4578999999999999999999999999999999999998 5677 7899999999999999999888999999999999


Q ss_pred             eecccccCcCCCCccc--ccccccccccCCcccccCC
Q 004689          299 LYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEGG  333 (736)
Q Consensus       299 L~l~~N~l~g~~P~~~--~~~~~~l~~~~n~~~c~~~  333 (736)
                      |+|++|++++..|..+  +..+..+.+.+|+..|..+
T Consensus       499 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  535 (570)
T 2z63_A          499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  535 (570)
T ss_dssp             EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             EeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCc
Confidence            9999999996655544  3455788999999998764

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.26  E-value=4.1e-12  Score=133.64  Aligned_cols=157  Identities=17%  Similarity=0.171  Sum_probs=129.1

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      .++.+..|.++.|.++.+|+.+..+..++.|.++.+.+..           ...+      ..           ...+++
T Consensus        76 ~~~~L~~L~Ls~n~i~~l~~~~~~l~~L~~L~l~~n~l~~-----------~~~~------~~-----------~~~l~~  127 (306)
T 2z66_A           76 GTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQ-----------MSEF------SV-----------FLSLRN  127 (306)
T ss_dssp             SCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEES-----------STTT------TT-----------TTTCTT
T ss_pred             cccccCEEECCCCccccChhhcCCCCCCCEEECCCCcccc-----------cccc------hh-----------hhhccC
Confidence            3568889999999999999888888889999888876651           0000      00           123578


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCC-CCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~-~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      |+.|+|++|.+++..|..+..+++|++|+|++|.+++ .+| .+.++++|++|+|++|+|++..|..+..+++|+.|+|+
T Consensus       128 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~  207 (306)
T 2z66_A          128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS  207 (306)
T ss_dssp             CCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECT
T ss_pred             CCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECC
Confidence            9999999999999899999999999999999999998 456 68999999999999999998889999999999999999


Q ss_pred             cccCcCCCCccc--ccccccccccCCccc
Q 004689          303 NNMLSGTVPSSL--LSKNVVLNYAGNINL  329 (736)
Q Consensus       303 ~N~l~g~~P~~~--~~~~~~l~~~~n~~~  329 (736)
                      +|.+++..+..+  +..+..+.+.+|...
T Consensus       208 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  236 (306)
T 2z66_A          208 HNNFFSLDTFPYKCLNSLQVLDYSLNHIM  236 (306)
T ss_dssp             TSCCSBCCSGGGTTCTTCCEEECTTSCCC
T ss_pred             CCccCccChhhccCcccCCEeECCCCCCc
Confidence            999995444444  245577888888544

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.26  E-value=1.1e-11  Score=121.33  Aligned_cols=90  Identities=23%  Similarity=0.330  Sum_probs=82.1

Q ss_pred             CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceee
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY  300 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~  300 (736)
                      +++|+.|+|++|.|++..+..|.+|++|++|+|++|+|++.+| .|.++++|++|+|++|+|++..+..|..+++|+.|+
T Consensus        53 l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  132 (193)
T 2wfh_A           53 YKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLA  132 (193)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE
T ss_pred             ccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEE
Confidence            4689999999999998777889999999999999999999988 699999999999999999976666899999999999


Q ss_pred             cccccCcCCCC
Q 004689          301 VQNNMLSGTVP  311 (736)
Q Consensus       301 l~~N~l~g~~P  311 (736)
                      |++|.+...-.
T Consensus       133 L~~N~~~C~c~  143 (193)
T 2wfh_A          133 IGANPLYCDCN  143 (193)
T ss_dssp             CCSSCEECSGG
T ss_pred             eCCCCeecCCc
Confidence            99999975444

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.25  E-value=1.6e-11  Score=118.20  Aligned_cols=130  Identities=18%  Similarity=0.204  Sum_probs=101.3

Q ss_pred             EEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceEEEEc
Q 004689          151 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL  230 (736)
Q Consensus       151 ~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~~L~L  230 (736)
                      .+.+..+.+..+|..+.  ..++.|.++.+.+..                   ..+-          ....+++|+.|+|
T Consensus        11 ~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~-------------------~~~~----------~~~~l~~L~~L~l   59 (177)
T 2o6r_A           11 EIRCNSKGLTSVPTGIP--SSATRLELESNKLQS-------------------LPHG----------VFDKLTQLTKLSL   59 (177)
T ss_dssp             EEECCSSCCSSCCTTCC--TTCSEEECCSSCCCC-------------------CCTT----------TTTTCTTCSEEEC
T ss_pred             EEEecCCCCccCCCCCC--CCCcEEEeCCCcccE-------------------eCHH----------HhcCcccccEEEC
Confidence            46667777777775433  455566666655431                   1110          0123568999999


Q ss_pred             cCCCCCccCCcccccccccccccccccccCCCCCC-CCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCC
Q 004689          231 SSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT  309 (736)
Q Consensus       231 ~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~  309 (736)
                      ++|+|++..+..+..+++|++|+|++|+|++.++. +.++++|++|+|++|+|++..+..+..+++|+.|+|++|.+++.
T Consensus        60 ~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  139 (177)
T 2o6r_A           60 SQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  139 (177)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence            99999966666689999999999999999998884 78999999999999999976666678999999999999999987


Q ss_pred             CC
Q 004689          310 VP  311 (736)
Q Consensus       310 ~P  311 (736)
                      .|
T Consensus       140 ~~  141 (177)
T 2o6r_A          140 CP  141 (177)
T ss_dssp             HH
T ss_pred             Cc
Confidence            76

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.25  E-value=8.1e-12  Score=144.22  Aligned_cols=157  Identities=18%  Similarity=0.200  Sum_probs=127.7

Q ss_pred             cccccccceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecC
Q 004689          141 YTNLSLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNS  219 (736)
Q Consensus       141 ~~~~~l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~  219 (736)
                      ...+.++.+..+.+..+.+..+|+. +..+..++.|.++.+.+..                   ..|-          ..
T Consensus        45 ~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~-------------------~~~~----------~~   95 (597)
T 3oja_B           45 FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-------------------IDTY----------AF   95 (597)
T ss_dssp             CSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCE-------------------ECTT----------TT
T ss_pred             cccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCC-------------------CChH----------Hh
Confidence            3456677888999999999999987 5777888888888776642                   1110          01


Q ss_pred             CCCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCC-CCCCCCCcEEEcCCCCCCCCCCccccCccccce
Q 004689          220 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE  298 (736)
Q Consensus       220 ~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~  298 (736)
                      ..+++|+.|+|++|.|++..|..|++|++|++|+|++|.|++.++. |+++++|++|+|++|.|++..|..|+++++|+.
T Consensus        96 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  175 (597)
T 3oja_B           96 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN  175 (597)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCE
T ss_pred             cCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcE
Confidence            2457899999999999987777889999999999999999988775 689999999999999999988889999999999


Q ss_pred             eecccccCcCCCCcccccccccccccCCc
Q 004689          299 LYVQNNMLSGTVPSSLLSKNVVLNYAGNI  327 (736)
Q Consensus       299 L~l~~N~l~g~~P~~~~~~~~~l~~~~n~  327 (736)
                      |+|++|.+++ +|...+..+..+.+.+|.
T Consensus       176 L~L~~N~l~~-~~~~~l~~L~~L~l~~n~  203 (597)
T 3oja_B          176 LQLSSNRLTH-VDLSLIPSLFHANVSYNL  203 (597)
T ss_dssp             EECTTSCCSB-CCGGGCTTCSEEECCSSC
T ss_pred             EECcCCCCCC-cChhhhhhhhhhhcccCc
Confidence            9999999994 566666666666666663

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.25  E-value=7.4e-12  Score=144.67  Aligned_cols=177  Identities=18%  Similarity=0.115  Sum_probs=131.2

Q ss_pred             cccceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHH----HHHHHHHcC--CCCcCCCCCCCCCCCCCceEEe
Q 004689          145 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVA----IVSVISLYS--SADWAQEGGDPCLPVPWSWLQC  217 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~a----l~~l~~~~~--~~~w~~~~~dpc~~~~~~~v~c  217 (736)
                      .++.+..|.++.|.++.++|. +..+..++.|.++.+.+....    +..+.++..  +..-......|.          
T Consensus       374 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~----------  443 (606)
T 3t6q_A          374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ----------  443 (606)
T ss_dssp             TCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTT----------
T ss_pred             cCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHH----------
Confidence            456788899999998888664 777888888888887664211    111111111  111100000110          


Q ss_pred             cCCCCCceEEEEccCCCCCcc---CCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCc
Q 004689          218 NSDPQPSITVIHLSSKNLTGN---IPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNL  293 (736)
Q Consensus       218 ~~~~~~~l~~L~L~~n~l~g~---~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l  293 (736)
                      ....+++|+.|+|++|.+++.   .+..+..+++|+.|+|++|++++.+| .|.++++|++|+|++|+|++.+|..+.++
T Consensus       444 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l  523 (606)
T 3t6q_A          444 LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHL  523 (606)
T ss_dssp             TTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTC
T ss_pred             HHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCcc
Confidence            012357899999999999873   33578899999999999999999887 68999999999999999999999999999


Q ss_pred             cccceeecccccCcCCCCccc--ccccccccccCCcccccC
Q 004689          294 PNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEG  332 (736)
Q Consensus       294 ~~L~~L~l~~N~l~g~~P~~~--~~~~~~l~~~~n~~~c~~  332 (736)
                      ++| .|+|++|++++..|..+  +..+..+.+.+|+..|.+
T Consensus       524 ~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c  563 (606)
T 3t6q_A          524 KGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC  563 (606)
T ss_dssp             CSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred             ccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence            999 99999999997666654  345678999999999976

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.25  E-value=1.2e-11  Score=119.03  Aligned_cols=89  Identities=24%  Similarity=0.323  Sum_probs=81.0

Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCCC-CCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      ++|+.|+|++|+|++..|..|.+|++|++|+|++|+|++.++. |.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L  112 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL  112 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence            5799999999999988888999999999999999999998875 789999999999999999766667999999999999


Q ss_pred             ccccCcCCCCc
Q 004689          302 QNNMLSGTVPS  312 (736)
Q Consensus       302 ~~N~l~g~~P~  312 (736)
                      ++|.+. ..|.
T Consensus       113 ~~N~~~-c~~~  122 (174)
T 2r9u_A          113 YNNPWD-CECR  122 (174)
T ss_dssp             CSSCBC-TTBG
T ss_pred             CCCCcc-cccc
Confidence            999998 4444

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.24  E-value=1.2e-11  Score=133.51  Aligned_cols=147  Identities=19%  Similarity=0.239  Sum_probs=118.3

Q ss_pred             EEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceEEEEc
Q 004689          151 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL  230 (736)
Q Consensus       151 ~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~~L~L  230 (736)
                      .+.++.+.++.+|..+..  .++.|.++.|.+..          ....+            +      ...+++|+.|+|
T Consensus        22 ~l~c~~~~l~~iP~~~~~--~l~~L~Ls~N~l~~----------l~~~~------------~------~~~l~~L~~L~L   71 (361)
T 2xot_A           22 ILSCSKQQLPNVPQSLPS--YTALLDLSHNNLSR----------LRAEW------------T------PTRLTNLHSLLL   71 (361)
T ss_dssp             EEECCSSCCSSCCSSCCT--TCSEEECCSSCCCE----------ECTTS------------S------SSCCTTCCEEEC
T ss_pred             EEEeCCCCcCccCccCCC--CCCEEECCCCCCCc----------cChhh------------h------hhcccccCEEEC
Confidence            578888899999876543  35667777776642          00001            0      014579999999


Q ss_pred             cCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCC
Q 004689          231 SSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT  309 (736)
Q Consensus       231 ~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~  309 (736)
                      ++|+|++..|..|.+|++|++|+|++|+|++.++ .|.++++|++|+|++|+|++..|..|.++++|+.|+|++|+|+ .
T Consensus        72 ~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~  150 (361)
T 2xot_A           72 SHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-R  150 (361)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-S
T ss_pred             CCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-e
Confidence            9999998777889999999999999999999888 5899999999999999999888999999999999999999999 6


Q ss_pred             CCcccc------cccccccccCCcc
Q 004689          310 VPSSLL------SKNVVLNYAGNIN  328 (736)
Q Consensus       310 ~P~~~~------~~~~~l~~~~n~~  328 (736)
                      +|..++      ..+..+.+.+|..
T Consensus       151 l~~~~~~~~~~l~~L~~L~L~~N~l  175 (361)
T 2xot_A          151 FPVELIKDGNKLPKLMLLDLSSNKL  175 (361)
T ss_dssp             CCGGGTC----CTTCCEEECCSSCC
T ss_pred             eCHHHhcCcccCCcCCEEECCCCCC
Confidence            887764      3456777888743

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.24  E-value=2.5e-11  Score=124.65  Aligned_cols=138  Identities=18%  Similarity=0.107  Sum_probs=108.8

Q ss_pred             hhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      +...++.|+++.||++... ++.+++|+...........+.+|+++++.+. |..+.++++++...+..++||||++|.+
T Consensus        18 ~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   96 (263)
T 3tm0_A           18 CVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL   96 (263)
T ss_dssp             EEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred             eEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCee
Confidence            4567788888999999865 7899999986532233457899999999994 6778899999999899999999999999


Q ss_pred             HHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 004689          491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC------------------------------------------  528 (736)
Q Consensus       491 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~------------------------------------------  528 (736)
                      |.+.+..         ......++.+++++|..||+..                                          
T Consensus        97 l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T 3tm0_A           97 CSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             HHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred             hhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence            8875311         1112367889999999999810                                          


Q ss_pred             --------------CCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          529 --------------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       529 --------------~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                                    ...++|+|++|.|||++.+..+.|+||+.+.
T Consensus       168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                          1369999999999999876566799998764

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.24  E-value=3.1e-12  Score=135.24  Aligned_cols=101  Identities=25%  Similarity=0.250  Sum_probs=57.1

Q ss_pred             CCceEEEEccCCCCCc--cCCcc-cccccccccccccccccCCCCC--CCCCCCCCcEEEcCCCCCCCCCCccccCcccc
Q 004689          222 QPSITVIHLSSKNLTG--NIPSD-LTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNL  296 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g--~~p~~-~~~l~~L~~L~Ls~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L  296 (736)
                      +++|+.|+|++|+|++  .++.. +.++++|++|+|++|++++.+|  .+..+++|++|+|++|+|+ .+|..+.  ++|
T Consensus       200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L  276 (312)
T 1wwl_A          200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKL  276 (312)
T ss_dssp             CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEE
T ss_pred             CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCc
Confidence            3466666666666662  22222 2355666666666666666553  3455666666666666666 5666555  566


Q ss_pred             ceeecccccCcCCCCccc--ccccccccccCCc
Q 004689          297 RELYVQNNMLSGTVPSSL--LSKNVVLNYAGNI  327 (736)
Q Consensus       297 ~~L~l~~N~l~g~~P~~~--~~~~~~l~~~~n~  327 (736)
                      +.|+|++|+|++. |. +  +..+..+.+.+|+
T Consensus       277 ~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~  307 (312)
T 1wwl_A          277 SVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNP  307 (312)
T ss_dssp             EEEECCSSCCCSC-CC-TTTSCEEEEEECTTCT
T ss_pred             eEEECCCCCCCCC-hh-HhhCCCCCEEeccCCC
Confidence            6666666666633 44 2  2233455555554

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.24  E-value=1.1e-11  Score=138.03  Aligned_cols=140  Identities=19%  Similarity=0.136  Sum_probs=117.6

Q ss_pred             ccccceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCC
Q 004689          144 LSLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQ  222 (736)
Q Consensus       144 ~~l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~  222 (736)
                      +..+.+..+.++.|.++.++|. +..+..++.|.++.+.+..                   ..|.          ....+
T Consensus       272 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-------------------~~~~----------~~~~l  322 (455)
T 3v47_A          272 LEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINK-------------------IDDN----------AFWGL  322 (455)
T ss_dssp             GTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCE-------------------ECTT----------TTTTC
T ss_pred             ccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccc-------------------cChh----------HhcCc
Confidence            3446788899999998887665 7778888888888776642                   1111          01235


Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      ++|+.|+|++|.+++..|..+.++++|++|+|++|++++.+| .+.++++|++|+|++|+|++..+..+..+++|+.|+|
T Consensus       323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l  402 (455)
T 3v47_A          323 THLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWL  402 (455)
T ss_dssp             TTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred             ccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEc
Confidence            789999999999998888899999999999999999999988 7999999999999999999777778899999999999


Q ss_pred             ccccCcCCCCc
Q 004689          302 QNNMLSGTVPS  312 (736)
Q Consensus       302 ~~N~l~g~~P~  312 (736)
                      ++|++++..|.
T Consensus       403 ~~N~l~~~~~~  413 (455)
T 3v47_A          403 HTNPWDCSCPR  413 (455)
T ss_dssp             CSSCBCCCTTT
T ss_pred             cCCCcccCCCc
Confidence            99999999984

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.24  E-value=8.8e-12  Score=144.33  Aligned_cols=138  Identities=15%  Similarity=0.150  Sum_probs=117.4

Q ss_pred             ceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceE
Q 004689          148 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT  226 (736)
Q Consensus       148 ~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~  226 (736)
                      +++.|+|+.|.++.+||- +..+..|+.|.++.|.+..                   -+|-          ....+++|+
T Consensus        53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~-------------------i~~~----------~f~~L~~L~  103 (635)
T 4g8a_A           53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-------------------IEDG----------AYQSLSHLS  103 (635)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE-------------------ECTT----------TTTTCTTCC
T ss_pred             CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCC-------------------cChh----------HhcCCCCCC
Confidence            578899999999999985 8999999999999887652                   1110          013467999


Q ss_pred             EEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCC-CCCccccCccccceeecccc
Q 004689          227 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       227 ~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~l~~N  304 (736)
                      +|+|++|+|++..+..|.+|++|++|+|++|+|++.++ .|++|++|++|+|++|.|++ .+|..++.+++|+.|+|++|
T Consensus       104 ~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N  183 (635)
T 4g8a_A          104 TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN  183 (635)
T ss_dssp             EEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred             EEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCc
Confidence            99999999996666678999999999999999999888 69999999999999999986 47889999999999999999


Q ss_pred             cCcCCCCccc
Q 004689          305 MLSGTVPSSL  314 (736)
Q Consensus       305 ~l~g~~P~~~  314 (736)
                      +|++..|..+
T Consensus       184 ~l~~~~~~~l  193 (635)
T 4g8a_A          184 KIQSIYCTDL  193 (635)
T ss_dssp             CCCEECGGGG
T ss_pred             cccccccccc
Confidence            9997666655

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.23  E-value=1.1e-11  Score=118.31  Aligned_cols=105  Identities=22%  Similarity=0.257  Sum_probs=89.5

Q ss_pred             CCceEEEEccCCCCC-ccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceee
Q 004689          222 QPSITVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY  300 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~-g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~  300 (736)
                      +++|+.|+|++|+++ |.+|..+..+++|+.|+|++|.+++. +.+.++++|++|+|++|++++.+|..+.++++|+.|+
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  101 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN  101 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence            468999999999998 88999999999999999999999988 8889999999999999999988888888899999999


Q ss_pred             cccccCcCCCC--ccc--ccccccccccCCcc
Q 004689          301 VQNNMLSGTVP--SSL--LSKNVVLNYAGNIN  328 (736)
Q Consensus       301 l~~N~l~g~~P--~~~--~~~~~~l~~~~n~~  328 (736)
                      |++|.+++ +|  ..+  +..+..+.+.+|..
T Consensus       102 Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l  132 (168)
T 2ell_A          102 LSGNKLKD-ISTLEPLKKLECLKSLDLFNCEV  132 (168)
T ss_dssp             CBSSSCCS-SGGGGGGSSCSCCCEEECCSSGG
T ss_pred             ccCCccCc-chhHHHHhcCCCCCEEEeeCCcC
Confidence            99999984 44  344  23456777788743

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.23  E-value=7e-12  Score=134.43  Aligned_cols=103  Identities=19%  Similarity=0.221  Sum_probs=84.0

Q ss_pred             EEEccCC-CCCccCCcccccccccccccccc-cccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccc
Q 004689          227 VIHLSSK-NLTGNIPSDLTKLSSLVELWLDG-NSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN  303 (736)
Q Consensus       227 ~L~L~~n-~l~g~~p~~~~~l~~L~~L~Ls~-N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~  303 (736)
                      .++++++ +|+ .+|. |..+++|+.|+|++ |+|++.++ .|.+|++|++|+|++|+|++..|..|++|++|+.|+|++
T Consensus        12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~   89 (347)
T 2ifg_A           12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF   89 (347)
T ss_dssp             CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred             EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence            3466676 788 5888 88889999999986 89988887 688899999999999999988888889999999999999


Q ss_pred             ccCcCCCCcccccc--cccccccCCcccccC
Q 004689          304 NMLSGTVPSSLLSK--NVVLNYAGNINLHEG  332 (736)
Q Consensus       304 N~l~g~~P~~~~~~--~~~l~~~~n~~~c~~  332 (736)
                      |+|+ .+|..++..  +..+.+.+|+..|.+
T Consensus        90 N~l~-~~~~~~~~~~~L~~l~l~~N~~~c~c  119 (347)
T 2ifg_A           90 NALE-SLSWKTVQGLSLQELVLSGNPLHCSC  119 (347)
T ss_dssp             SCCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred             Cccc-eeCHHHcccCCceEEEeeCCCccCCC
Confidence            9998 566665443  567788888888865

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.23  E-value=5.8e-12  Score=117.62  Aligned_cols=105  Identities=18%  Similarity=0.188  Sum_probs=86.6

Q ss_pred             CceEEEEccCCCCC-ccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          223 PSITVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       223 ~~l~~L~L~~n~l~-g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      ++|+.|+|++|+++ |.+|..+..+++|+.|+|++|++++. +.++++++|++|+|++|.+++.+|..++.+++|+.|++
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l   95 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL   95 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence            57899999999998 88998889999999999999999987 77888999999999999999878888888999999999


Q ss_pred             ccccCcCC-CCcccc--cccccccccCCcc
Q 004689          302 QNNMLSGT-VPSSLL--SKNVVLNYAGNIN  328 (736)
Q Consensus       302 ~~N~l~g~-~P~~~~--~~~~~l~~~~n~~  328 (736)
                      ++|.+++. .|..+.  ..+..+.+.+|..
T Consensus        96 s~N~i~~~~~~~~~~~l~~L~~L~l~~N~l  125 (149)
T 2je0_A           96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEV  125 (149)
T ss_dssp             TTSCCCSHHHHGGGGGCTTCCEEECTTCGG
T ss_pred             CCCcCCChHHHHHHhhCCCCCEEeCcCCcc
Confidence            99999852 224442  3456777777743

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.22  E-value=2.4e-11  Score=139.82  Aligned_cols=147  Identities=24%  Similarity=0.329  Sum_probs=112.9

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.|..|.|+.|.++.++| +..+..|+.|.++.+.+..                    -|.           ...+++|
T Consensus        64 l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~--------------------l~~-----------l~~l~~L  111 (605)
T 1m9s_A           64 LPNVTKLFLNGNKLTDIKP-LTNLKNLGWLFLDENKIKD--------------------LSS-----------LKDLKKL  111 (605)
T ss_dssp             CTTCCEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCC--------------------CTT-----------STTCTTC
T ss_pred             CCCCCEEEeeCCCCCCChh-hccCCCCCEEECcCCCCCC--------------------Chh-----------hccCCCC
Confidence            5688889999999999988 7788888888888877642                    011           1235688


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      +.|+|++|.|++ + +.+..|++|+.|+|++|.|++. +.+.+|++|+.|+|++|+|++..|  +..|++|+.|+|++|+
T Consensus       112 ~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~  186 (605)
T 1m9s_A          112 KSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH  186 (605)
T ss_dssp             CEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             CEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCC
Confidence            899999999885 3 4588889999999999998876 678888999999999999987666  8888999999999998


Q ss_pred             CcCCCCc-ccccccccccccCCcccc
Q 004689          306 LSGTVPS-SLLSKNVVLNYAGNINLH  330 (736)
Q Consensus       306 l~g~~P~-~~~~~~~~l~~~~n~~~c  330 (736)
                      |++ +|. .-+..+..+.+.+|+...
T Consensus       187 i~~-l~~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          187 ISD-LRALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             CCB-CGGGTTCTTCSEEECCSEEEEC
T ss_pred             CCC-ChHHccCCCCCEEEccCCcCcC
Confidence            885 442 113455677777775543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.22  E-value=1.7e-11  Score=133.58  Aligned_cols=157  Identities=18%  Similarity=0.202  Sum_probs=128.5

Q ss_pred             cccccccceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecC
Q 004689          141 YTNLSLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNS  219 (736)
Q Consensus       141 ~~~~~l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~  219 (736)
                      ...+.++.+..+.+..+.+..+|+. +..+..++.|.++.+.+..                   ..+-          ..
T Consensus        39 ~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~-------------------~~~~----------~~   89 (390)
T 3o6n_A           39 FEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE-------------------IDTY----------AF   89 (390)
T ss_dssp             CSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCE-------------------ECTT----------TT
T ss_pred             ccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccc-------------------cChh----------hc
Confidence            3456677889999999999999987 5778888888888776641                   1110          01


Q ss_pred             CCCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCC-CCCCCCCcEEEcCCCCCCCCCCccccCccccce
Q 004689          220 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE  298 (736)
Q Consensus       220 ~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~  298 (736)
                      ..+++|+.|+|++|++++..|..|.++++|++|+|++|++++.++. |.++++|++|+|++|.+++..|..++++++|+.
T Consensus        90 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  169 (390)
T 3o6n_A           90 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN  169 (390)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCE
T ss_pred             cCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCE
Confidence            2457899999999999987788899999999999999999977775 689999999999999999888889999999999


Q ss_pred             eecccccCcCCCCcccccccccccccCCc
Q 004689          299 LYVQNNMLSGTVPSSLLSKNVVLNYAGNI  327 (736)
Q Consensus       299 L~l~~N~l~g~~P~~~~~~~~~l~~~~n~  327 (736)
                      |++++|.++ .++...+..+..+.+.+|.
T Consensus       170 L~l~~n~l~-~~~~~~l~~L~~L~l~~n~  197 (390)
T 3o6n_A          170 LQLSSNRLT-HVDLSLIPSLFHANVSYNL  197 (390)
T ss_dssp             EECCSSCCS-BCCGGGCTTCSEEECCSSC
T ss_pred             EECCCCcCC-ccccccccccceeeccccc
Confidence            999999999 4566666666677777663

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.22  E-value=3.1e-11  Score=128.43  Aligned_cols=174  Identities=17%  Similarity=0.201  Sum_probs=125.1

Q ss_pred             cceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchH--HHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCC
Q 004689          147 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDG--VAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP  223 (736)
Q Consensus       147 ~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~--~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~  223 (736)
                      +.+..|.++.|.++.+++. +..+..++.|.++.+.+..  .....+...-.+......   -|.   ...+.  ..-.+
T Consensus       121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~---~n~---l~~l~--~~~~~  192 (330)
T 1xku_A          121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA---DTN---ITTIP--QGLPP  192 (330)
T ss_dssp             TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECC---SSC---CCSCC--SSCCT
T ss_pred             ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECC---CCc---cccCC--ccccc
Confidence            4678888899988888875 6777778888887776531  001111111111111100   000   00000  01126


Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      +|+.|+|++|++++..|..+..+++|+.|+|++|++++.++ .+.++++|++|+|++|+|+ .+|..+..+++|+.|+|+
T Consensus       193 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~  271 (330)
T 1xku_A          193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH  271 (330)
T ss_dssp             TCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECC
T ss_pred             cCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECC
Confidence            89999999999998888999999999999999999999888 6899999999999999999 899999999999999999


Q ss_pred             cccCcCCCCccccc---------ccccccccCCcccc
Q 004689          303 NNMLSGTVPSSLLS---------KNVVLNYAGNINLH  330 (736)
Q Consensus       303 ~N~l~g~~P~~~~~---------~~~~l~~~~n~~~c  330 (736)
                      +|+++ .+|...+.         ....+.+.+|+..+
T Consensus       272 ~N~i~-~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~  307 (330)
T 1xku_A          272 NNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY  307 (330)
T ss_dssp             SSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred             CCcCC-ccChhhcCCcccccccccccceEeecCcccc
Confidence            99999 55554432         23456788887654

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.21  E-value=1.3e-11  Score=129.09  Aligned_cols=146  Identities=24%  Similarity=0.359  Sum_probs=111.9

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.+..|.++.|.++.++| +..+..++.|.++.|.+...                    |           ....+++|
T Consensus        67 l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~--------------------~-----------~l~~l~~L  114 (291)
T 1h6t_A           67 LPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDL--------------------S-----------SLKDLKKL  114 (291)
T ss_dssp             CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCG--------------------G-----------GGTTCTTC
T ss_pred             CCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCC--------------------h-----------hhccCCCC
Confidence            4678889999999999988 88888888888888776420                    0           01234688


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      +.|+|++|++++ + +.+..+++|+.|+|++|++++. +.+.++++|++|+|++|+|++..|  +..+++|+.|+|++|.
T Consensus       115 ~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~  189 (291)
T 1h6t_A          115 KSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH  189 (291)
T ss_dssp             CEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             CEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence            899999999885 3 5688889999999999998876 678888999999999999886544  8888999999999998


Q ss_pred             CcCCCCccc--ccccccccccCCcccc
Q 004689          306 LSGTVPSSL--LSKNVVLNYAGNINLH  330 (736)
Q Consensus       306 l~g~~P~~~--~~~~~~l~~~~n~~~c  330 (736)
                      +++ +|. +  +..+..+.+.+|+..+
T Consensus       190 i~~-l~~-l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          190 ISD-LRA-LAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             CCB-CGG-GTTCTTCSEEEEEEEEEEC
T ss_pred             CCC-Chh-hccCCCCCEEECcCCcccC
Confidence            884 553 3  2344667777775544

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.21  E-value=2.3e-12  Score=147.33  Aligned_cols=181  Identities=20%  Similarity=0.179  Sum_probs=109.6

Q ss_pred             ccccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCc----------------hHHHHHHHHHHcCCCCcCCCC-CCC
Q 004689          144 LSLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSI----------------DGVAIVSVISLYSSADWAQEG-GDP  206 (736)
Q Consensus       144 ~~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~----------------~~~al~~l~~~~~~~~w~~~~-~dp  206 (736)
                      ...+.+..|.|+.|.++.+|+.|..+..|+.|.++++..                ....+..+.++..+..-.... .+-
T Consensus       346 ~~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~L  425 (567)
T 1dce_A          346 ATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDL  425 (567)
T ss_dssp             STTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred             ccCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccchh
Confidence            345677788999999999999999999998888765431                112222222221111000000 000


Q ss_pred             CCCCCCceEEecCCCCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCC
Q 004689          207 CLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPL  286 (736)
Q Consensus       207 c~~~~~~~v~c~~~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~  286 (736)
                      .. .....-....-....|+.|+|++|+|++ +|. |+.|++|+.|+|++|+|+..++.+++|++|++|+|++|+|++ +
T Consensus       426 ~~-l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-l  501 (567)
T 1dce_A          426 RS-KFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-V  501 (567)
T ss_dssp             HH-HHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-C
T ss_pred             hh-hhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC-C
Confidence            00 0000000000001247778888888874 665 778888888888888888433367778888888888888885 5


Q ss_pred             CccccCccccceeecccccCcCCC-Ccccc--cccccccccCCccc
Q 004689          287 PSSLMNLPNLRELYVQNNMLSGTV-PSSLL--SKNVVLNYAGNINL  329 (736)
Q Consensus       287 p~~~~~l~~L~~L~l~~N~l~g~~-P~~~~--~~~~~l~~~~n~~~  329 (736)
                      | .+++|++|+.|+|++|+|++.. |..+.  ..+..+.+.+|+..
T Consensus       502 p-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~  546 (567)
T 1dce_A          502 D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC  546 (567)
T ss_dssp             G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred             c-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCC
Confidence            6 7778888888888888887655 66663  34566777777543

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.21  E-value=9.1e-12  Score=143.91  Aligned_cols=175  Identities=15%  Similarity=0.042  Sum_probs=131.0

Q ss_pred             cccceeEEEeeccCCCCC---CCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcC-----CCCCCCCCCCCCceEE
Q 004689          145 SLPFVLSFKFGKTYDSSR---GPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWA-----QEGGDPCLPVPWSWLQ  216 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~l---pP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~-----~~~~dpc~~~~~~~v~  216 (736)
                      .++.+..|.++.|.++.+   |..+..+..++.|.++.+.+.... ..+...-.+....     ..+..|.         
T Consensus       348 ~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~---------  417 (606)
T 3vq2_A          348 ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMS-ANFMGLEELQHLDFQHSTLKRVTEF---------  417 (606)
T ss_dssp             CCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEEC-CCCTTCTTCCEEECTTSEEESTTTT---------
T ss_pred             cCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccch-hhccCCCCCCeeECCCCccCCccCh---------
Confidence            567889999999999888   455777778888888887653210 0011111111100     0000000         


Q ss_pred             ecCCCCCceEEEEccCCCCCccCCcccccccccccccccccccCC-CCC-CCCCCCCCcEEEcCCCCCCCCCCccccCcc
Q 004689          217 CNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG-PIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLP  294 (736)
Q Consensus       217 c~~~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~-~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~  294 (736)
                      .....+++|+.|+|++|.+++..|..+..+++|++|+|++|++++ .+| .+.++++|++|+|++|++++.+|..+++++
T Consensus       418 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~  497 (606)
T 3vq2_A          418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH  497 (606)
T ss_dssp             TTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred             hhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccc
Confidence            012346799999999999999999999999999999999999998 456 689999999999999999999999999999


Q ss_pred             ccceeecccccCcCCCCcccc--cccccccccCCccc
Q 004689          295 NLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNINL  329 (736)
Q Consensus       295 ~L~~L~l~~N~l~g~~P~~~~--~~~~~l~~~~n~~~  329 (736)
                      +|+.|+|++|++++.+|..+.  ..+..+.+.+|...
T Consensus       498 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  534 (606)
T 3vq2_A          498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE  534 (606)
T ss_dssp             TCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred             cCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence            999999999999987787774  34577888888543

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.21  E-value=6.5e-12  Score=132.53  Aligned_cols=170  Identities=19%  Similarity=0.264  Sum_probs=110.8

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.+..|.++.|.++.+++ +..+..++.|.++.+.+...  ..+...-.+..-...   -|.   ...+. ....+++|
T Consensus        62 l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~---~n~---l~~~~-~l~~l~~L  131 (308)
T 1h6u_A           62 LNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLT---STQ---ITDVT-PLAGLSNL  131 (308)
T ss_dssp             CTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECT---TSC---CCCCG-GGTTCTTC
T ss_pred             cCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECC---CCC---CCCch-hhcCCCCC
Confidence            4577888999999999888 78888888888888766421  112211112111100   010   01110 12345678


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      +.|+|++|.+++ ++. +..+++|+.|+|++|++++..+ +.++++|+.|+|++|++++..+  +..+++|+.|+|++|+
T Consensus       132 ~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~  206 (308)
T 1h6u_A          132 QVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ  206 (308)
T ss_dssp             CEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSC
T ss_pred             CEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCc
Confidence            888888888874 333 7788888888888888887655 7788888888888888885433  7788888888888888


Q ss_pred             CcCCCCcccccccccccccCCcccc
Q 004689          306 LSGTVPSSLLSKNVVLNYAGNINLH  330 (736)
Q Consensus       306 l~g~~P~~~~~~~~~l~~~~n~~~c  330 (736)
                      +++..|-.-+..+..+.+.+|+..+
T Consensus       207 l~~~~~l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          207 ISDVSPLANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             CCBCGGGTTCTTCCEEEEEEEEEEC
T ss_pred             cCccccccCCCCCCEEEccCCeeec
Confidence            8855443333445667777776544

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.20  E-value=3e-12  Score=143.51  Aligned_cols=108  Identities=25%  Similarity=0.210  Sum_probs=95.7

Q ss_pred             CceEEEEccCCCCCccCC-cccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceee
Q 004689          223 PSITVIHLSSKNLTGNIP-SDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY  300 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~  300 (736)
                      .+|+.|+|++|+|++ +| ..+..+++|+.|+|++|.+++..+ .|.++++|+.|+|++|+|++..|..|.++++|+.|+
T Consensus       224 ~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  302 (477)
T 2id5_A          224 LNLTSLSITHCNLTA-VPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLN  302 (477)
T ss_dssp             CCCSEEEEESSCCCS-CCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEE
T ss_pred             ccccEEECcCCcccc-cCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEE
Confidence            489999999999994 55 578899999999999999999887 689999999999999999999999999999999999


Q ss_pred             cccccCcCCCCcccc---cccccccccCCcccccC
Q 004689          301 VQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEG  332 (736)
Q Consensus       301 l~~N~l~g~~P~~~~---~~~~~l~~~~n~~~c~~  332 (736)
                      |++|+|+ .+|...+   ..+..+.+.+|+..|.+
T Consensus       303 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~c~c  336 (477)
T 2id5_A          303 VSGNQLT-TLEESVFHSVGNLETLILDSNPLACDC  336 (477)
T ss_dssp             CCSSCCS-CCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred             CCCCcCc-eeCHhHcCCCcccCEEEccCCCccCcc
Confidence            9999999 5666554   35578899999999876

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.20  E-value=2.6e-11  Score=127.95  Aligned_cols=154  Identities=20%  Similarity=0.202  Sum_probs=114.7

Q ss_pred             cccceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHH-HHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCC
Q 004689          145 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGV-AIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQ  222 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~-al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~  222 (736)
                      .++.+..|.++.|.++.++|. +..+..++.|.++.|.+... .+.               ..-|.           ..+
T Consensus       143 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~---------------~~~~~-----------~~l  196 (310)
T 4glp_A          143 LKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLM---------------AALCP-----------HKF  196 (310)
T ss_dssp             BCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHH---------------TTSCT-----------TSS
T ss_pred             hccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhh---------------HHHhh-----------hcC
Confidence            466888999999999988864 78888899999988875321 111               01110           234


Q ss_pred             CceEEEEccCCCCCccCCcc----cccccccccccccccccCCCCC-CCCCC---CCCcEEEcCCCCCCCCCCccccCcc
Q 004689          223 PSITVIHLSSKNLTGNIPSD----LTKLSSLVELWLDGNSLTGPIP-DFSGC---PDLRIIHLEDNQLTGPLPSSLMNLP  294 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~----~~~l~~L~~L~Ls~N~l~~~~p-~~~~l---~~L~~L~Ls~N~l~g~~p~~~~~l~  294 (736)
                      ++|+.|+|++|+++ .+|..    +.++++|++|+|++|++++..| .+..+   ++|++|+|++|+|+ .+|..+.  +
T Consensus       197 ~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~  272 (310)
T 4glp_A          197 PAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--A  272 (310)
T ss_dssp             CCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--S
T ss_pred             CCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--C
Confidence            68999999999997 34432    4678999999999999999865 56665   69999999999999 7788775  7


Q ss_pred             ccceeecccccCcC-CCCcccccccccccccCCccc
Q 004689          295 NLRELYVQNNMLSG-TVPSSLLSKNVVLNYAGNINL  329 (736)
Q Consensus       295 ~L~~L~l~~N~l~g-~~P~~~~~~~~~l~~~~n~~~  329 (736)
                      +|+.|+|++|+|++ ..+. -+..+..+.+++|+..
T Consensus       273 ~L~~L~Ls~N~l~~~~~~~-~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          273 KLRVLDLSSNRLNRAPQPD-ELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             CCSCEECCSCCCCSCCCTT-SCCCCSCEECSSTTTS
T ss_pred             CCCEEECCCCcCCCCchhh-hCCCccEEECcCCCCC
Confidence            99999999999996 2322 2355677888888654

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.20  E-value=2.1e-11  Score=139.28  Aligned_cols=89  Identities=26%  Similarity=0.315  Sum_probs=83.2

Q ss_pred             CCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCC-CccccCcccccee
Q 004689          221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPL-PSSLMNLPNLREL  299 (736)
Q Consensus       221 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L  299 (736)
                      .+++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +|.+++|++|++|+|++|+|++.+ |..+++|++|+.|
T Consensus       461 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L  538 (567)
T 1dce_A          461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLL  538 (567)
T ss_dssp             GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEE
T ss_pred             ccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEE
Confidence            4578999999999999 899999999999999999999998 568999999999999999999887 9999999999999


Q ss_pred             ecccccCcCCCC
Q 004689          300 YVQNNMLSGTVP  311 (736)
Q Consensus       300 ~l~~N~l~g~~P  311 (736)
                      +|++|+|++..|
T Consensus       539 ~L~~N~l~~~~~  550 (567)
T 1dce_A          539 NLQGNSLCQEEG  550 (567)
T ss_dssp             ECTTSGGGGSSS
T ss_pred             EecCCcCCCCcc
Confidence            999999996555

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.18  E-value=2.8e-11  Score=138.68  Aligned_cols=157  Identities=18%  Similarity=0.209  Sum_probs=117.6

Q ss_pred             cccceeEEEeeccCCCC-CCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCC
Q 004689          145 SLPFVLSFKFGKTYDSS-RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP  223 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~-lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~  223 (736)
                      .++.+..|.++.|.++. +|+.+..+..++.|.++.|.+....  .+               |          -....++
T Consensus       351 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~---------------~----------~~~~~l~  403 (562)
T 3a79_B          351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFF--KV---------------A----------LMTKNMS  403 (562)
T ss_dssp             SCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTT--HH---------------H----------HTTTTCT
T ss_pred             CCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcc--cc---------------h----------hhhcCCC
Confidence            34556667777776666 3444666666666666666553100  00               0          0012357


Q ss_pred             ceEEEEccCCCCCccCCcc-cccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          224 SITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~-~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      +|+.|+|++|.+++.+|.. +..+++|+.|+|++|++++.+| .+.  ++|++|+|++|+|+ .+|..+.++++|+.|+|
T Consensus       404 ~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L  480 (562)
T 3a79_B          404 SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNV  480 (562)
T ss_dssp             TCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEEC
T ss_pred             CCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEEC
Confidence            8999999999999867774 7789999999999999998777 343  79999999999999 78988889999999999


Q ss_pred             ccccCcCCCCcccc---cccccccccCCcccccC
Q 004689          302 QNNMLSGTVPSSLL---SKNVVLNYAGNINLHEG  332 (736)
Q Consensus       302 ~~N~l~g~~P~~~~---~~~~~l~~~~n~~~c~~  332 (736)
                      ++|+|+ .+|...+   ..+..+.+.+|++.|.+
T Consensus       481 ~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c  513 (562)
T 3a79_B          481 ASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTC  513 (562)
T ss_dssp             CSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred             CCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence            999999 7888733   34567899999999875

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.18  E-value=8.5e-12  Score=116.47  Aligned_cols=82  Identities=26%  Similarity=0.379  Sum_probs=39.8

Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCCC-CCCCCCCcEEEcCCCCCCCC-CCccccCccccceeec
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGP-LPSSLMNLPNLRELYV  301 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L~l  301 (736)
                      +|+.|+|++|++++.  ..+..+++|++|+|++|.+++.+|. +.++++|++|+|++|.|++. .|..++.+++|+.|++
T Consensus        43 ~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l  120 (149)
T 2je0_A           43 ELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDL  120 (149)
T ss_dssp             TCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEEC
T ss_pred             CCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeC
Confidence            455555555555532  4444555555555555555554442 33355555555555555431 2244555555555555


Q ss_pred             ccccCc
Q 004689          302 QNNMLS  307 (736)
Q Consensus       302 ~~N~l~  307 (736)
                      ++|.++
T Consensus       121 ~~N~l~  126 (149)
T 2je0_A          121 FNCEVT  126 (149)
T ss_dssp             TTCGGG
T ss_pred             cCCccc
Confidence            555554

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.17  E-value=3e-12  Score=135.63  Aligned_cols=106  Identities=15%  Similarity=0.129  Sum_probs=66.6

Q ss_pred             CceEEEEccCCCCCccCCcccc-cccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          223 PSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      ++|+.|+|++|.+++..|..+. .+++|++|+|++|++++. +....+++|++|+|++|+|++ +|..+..+++|+.|+|
T Consensus       144 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L  221 (317)
T 3o53_A          144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISL  221 (317)
T ss_dssp             SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEEC
T ss_pred             CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCCc-chhhhcccCcccEEEC
Confidence            4566666666666655555543 566666666666666655 333346677777777777773 4555777777777777


Q ss_pred             ccccCcCCCCcccc--cccccccccCCccccc
Q 004689          302 QNNMLSGTVPSSLL--SKNVVLNYAGNINLHE  331 (736)
Q Consensus       302 ~~N~l~g~~P~~~~--~~~~~l~~~~n~~~c~  331 (736)
                      ++|.++ .+|..+.  ..+..+.+.+|+..|.
T Consensus       222 ~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~  252 (317)
T 3o53_A          222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG  252 (317)
T ss_dssp             TTSCCC-EECTTCCCCTTCCEEECTTCCCBHH
T ss_pred             cCCccc-chhhHhhcCCCCCEEEccCCCccCc
Confidence            777777 5666542  3446667777776654

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.17  E-value=9.3e-12  Score=131.35  Aligned_cols=173  Identities=17%  Similarity=0.088  Sum_probs=114.9

Q ss_pred             cceeEEEeeccCCCCCCCc-c--chhhhhhhhccCCCCchHH----HHHHHHHHcCCCCc----CCCCCCCCCCCCCceE
Q 004689          147 PFVLSFKFGKTYDSSRGPL-L--NAMEINKYLERNDGSIDGV----AIVSVISLYSSADW----AQEGGDPCLPVPWSWL  215 (736)
Q Consensus       147 ~~l~~l~l~~~~~s~lpP~-i--n~~e~~~~l~~~~~~~~~~----al~~l~~~~~~~~w----~~~~~dpc~~~~~~~v  215 (736)
                      +.+..|.++.|.++..+|. +  ..+..++.|.++.|.+...    ....+...-.+..-    +.-.+-+|.       
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~-------  163 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCE-------  163 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTT-------
T ss_pred             CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHH-------
Confidence            4466677777776655444 3  5666667776666665420    00111111111110    000122221       


Q ss_pred             EecCCCCCceEEEEccCCCCCcc--C--CcccccccccccccccccccCCCCC---C-CCCCCCCcEEEcCCCCCCCCCC
Q 004689          216 QCNSDPQPSITVIHLSSKNLTGN--I--PSDLTKLSSLVELWLDGNSLTGPIP---D-FSGCPDLRIIHLEDNQLTGPLP  287 (736)
Q Consensus       216 ~c~~~~~~~l~~L~L~~n~l~g~--~--p~~~~~l~~L~~L~Ls~N~l~~~~p---~-~~~l~~L~~L~Ls~N~l~g~~p  287 (736)
                        ....+++|+.|+|++|++.+.  +  +..+..+++|++|+|++|+++...+   . +.++++|++|+|++|+|++.+|
T Consensus       164 --~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p  241 (310)
T 4glp_A          164 --QVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVN  241 (310)
T ss_dssp             --SCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCC
T ss_pred             --HhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccch
Confidence              112467899999999998753  2  2334788999999999999975433   2 4678999999999999998888


Q ss_pred             ccccCc---cccceeecccccCcCCCCcccccccccccccCCccc
Q 004689          288 SSLMNL---PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINL  329 (736)
Q Consensus       288 ~~~~~l---~~L~~L~l~~N~l~g~~P~~~~~~~~~l~~~~n~~~  329 (736)
                      ..++.+   ++|+.|+|++|+|+ .+|..+...+..+.+++|...
T Consensus       242 ~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~  285 (310)
T 4glp_A          242 PSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLN  285 (310)
T ss_dssp             SCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCC
T ss_pred             hhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCC
Confidence            888887   69999999999999 889988877788888888543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.17  E-value=8.2e-12  Score=147.11  Aligned_cols=91  Identities=32%  Similarity=0.375  Sum_probs=60.6

Q ss_pred             CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      +++|+.|+|++|.|+ .+|..|.+|++|++|+|++|+|+..+..|++|++|++|+|++|.|+ .+|..|++|++|+.|+|
T Consensus       246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L  323 (727)
T 4b8c_D          246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV  323 (727)
T ss_dssp             CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred             CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence            346666777777776 6666677777777777777777633235666777777777777665 56666777777777777


Q ss_pred             ccccCcCCCCccc
Q 004689          302 QNNMLSGTVPSSL  314 (736)
Q Consensus       302 ~~N~l~g~~P~~~  314 (736)
                      ++|.|+|.+|..+
T Consensus       324 ~~N~l~~~~p~~~  336 (727)
T 4b8c_D          324 EGNPLEKQFLKIL  336 (727)
T ss_dssp             TTSCCCSHHHHHH
T ss_pred             CCCccCCCChHHH
Confidence            7777766666555

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.16  E-value=5.5e-11  Score=134.72  Aligned_cols=156  Identities=17%  Similarity=0.230  Sum_probs=120.6

Q ss_pred             cccceeEEEeeccCCCC-CCCccchhhhhhhhccCCCCchHH-HHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCC
Q 004689          145 SLPFVLSFKFGKTYDSS-RGPLLNAMEINKYLERNDGSIDGV-AIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQ  222 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~-lpP~in~~e~~~~l~~~~~~~~~~-al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~  222 (736)
                      .++.+..|.++.|.++. +|+.+..+..++.|.++.|.+... .+.   ..                         ...+
T Consensus       322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~---~~-------------------------~~~l  373 (520)
T 2z7x_B          322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIA---EM-------------------------TTQM  373 (520)
T ss_dssp             SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHH---HH-------------------------HTTC
T ss_pred             hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccch---HH-------------------------HhhC
Confidence            45566777777777777 455577777777777777666421 110   00                         1234


Q ss_pred             CceEEEEccCCCCCccCCcc-cccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceee
Q 004689          223 PSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY  300 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~-~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~  300 (736)
                      ++|+.|+|++|.+++.+|.. +..+++|++|+|++|++++.+| .+.  ++|++|+|++|+|+ .+|..+..+++|+.|+
T Consensus       374 ~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~  450 (520)
T 2z7x_B          374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELN  450 (520)
T ss_dssp             TTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEE
T ss_pred             CCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEE
Confidence            68999999999999868875 7889999999999999998777 443  78999999999999 8999888999999999


Q ss_pred             cccccCcCCCCcccc---cccccccccCCcccccC
Q 004689          301 VQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEG  332 (736)
Q Consensus       301 l~~N~l~g~~P~~~~---~~~~~l~~~~n~~~c~~  332 (736)
                      |++|+|+ .+|...+   ..+..+.+.+|+..|.+
T Consensus       451 L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c  484 (520)
T 2z7x_B          451 VASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC  484 (520)
T ss_dssp             CCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             CCCCcCC-ccCHHHhccCCcccEEECcCCCCcccC
Confidence            9999999 7888733   34578889999999875

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.16  E-value=7.2e-11  Score=138.38  Aligned_cols=179  Identities=16%  Similarity=0.077  Sum_probs=122.1

Q ss_pred             cccceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchH-----HHHHHHHHHcC--CCCcCCCCCCCCCCCCCceEE
Q 004689          145 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDG-----VAIVSVISLYS--SADWAQEGGDPCLPVPWSWLQ  216 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~-----~al~~l~~~~~--~~~w~~~~~dpc~~~~~~~v~  216 (736)
                      .++.+..|.++.|.++.++|. +..+..++.|.+..+....     .++..+.++..  +..-....-.+.         
T Consensus       428 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~---------  498 (680)
T 1ziw_A          428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD---------  498 (680)
T ss_dssp             TCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTT---------
T ss_pred             CcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChh---------
Confidence            356778888888887777654 5556666677666655421     00100110000  111000000000         


Q ss_pred             ecCCCCCceEEEEccCCCCCccC----C----cccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCC
Q 004689          217 CNSDPQPSITVIHLSSKNLTGNI----P----SDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLP  287 (736)
Q Consensus       217 c~~~~~~~l~~L~L~~n~l~g~~----p----~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p  287 (736)
                       ....+++|+.|+|++|.+++..    |    ..+.++++|+.|+|++|+++..++ .|.++++|++|+|++|+|++..+
T Consensus       499 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~  577 (680)
T 1ziw_A          499 -MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA  577 (680)
T ss_dssp             -TTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred             -hhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCH
Confidence             0123568999999999998532    1    237889999999999999996666 58999999999999999997666


Q ss_pred             ccccCccccceeecccccCcCCCCccc---ccccccccccCCcccccCC
Q 004689          288 SSLMNLPNLRELYVQNNMLSGTVPSSL---LSKNVVLNYAGNINLHEGG  333 (736)
Q Consensus       288 ~~~~~l~~L~~L~l~~N~l~g~~P~~~---~~~~~~l~~~~n~~~c~~~  333 (736)
                      ..|.++++|+.|+|++|+|++..|..+   +..+..+.+.+|++.|.+.
T Consensus       578 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE  626 (680)
T ss_dssp             TTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred             hHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence            678899999999999999996555443   3566789999999999874

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.16  E-value=2.3e-11  Score=129.45  Aligned_cols=175  Identities=24%  Similarity=0.220  Sum_probs=116.6

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.+..|.++.|.++.+|+.+.  ..++.|.++.+.+.......+.....+...... .....  ...........+++|
T Consensus        99 l~~L~~L~Ls~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~-~n~l~--~~~~~~~~~~~l~~L  173 (330)
T 1xku_A           99 LVKLERLYLSKNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELG-TNPLK--SSGIENGAFQGMKKL  173 (330)
T ss_dssp             CTTCCEEECCSSCCSBCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECC-SSCCC--GGGBCTTGGGGCTTC
T ss_pred             CCCCCEEECCCCcCCccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECC-CCcCC--ccCcChhhccCCCCc
Confidence            4577788888888888877654  456667777665532222222222222211110 00000  000000011235688


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      +.|+|++|+++ .+|..+.  ++|++|+|++|++++..| .+.++++|++|+|++|.+++..|..+..+++|+.|+|++|
T Consensus       174 ~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N  250 (330)
T 1xku_A          174 SYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN  250 (330)
T ss_dssp             CEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSS
T ss_pred             CEEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCC
Confidence            89999999988 5777665  789999999999998877 6888999999999999999877778999999999999999


Q ss_pred             cCcCCCCccccc--ccccccccCCccc
Q 004689          305 MLSGTVPSSLLS--KNVVLNYAGNINL  329 (736)
Q Consensus       305 ~l~g~~P~~~~~--~~~~l~~~~n~~~  329 (736)
                      .++ .+|..+..  .+..+.+.+|...
T Consensus       251 ~l~-~lp~~l~~l~~L~~L~l~~N~i~  276 (330)
T 1xku_A          251 KLV-KVPGGLADHKYIQVVYLHNNNIS  276 (330)
T ss_dssp             CCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred             cCc-cCChhhccCCCcCEEECCCCcCC
Confidence            998 88887643  4466777777544

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.15  E-value=2.5e-11  Score=135.19  Aligned_cols=178  Identities=18%  Similarity=0.144  Sum_probs=118.1

Q ss_pred             cccceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEe-cCCCC
Q 004689          145 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQ  222 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c-~~~~~  222 (736)
                      .++.+..|.|+.|.++.++|. +..+..|+.|.++.|.+....-..+...-.+..-... .  |   ....+.. ....+
T Consensus        97 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~-~--N---~l~~~~~~~~~~l  170 (452)
T 3zyi_A           97 HLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR-N--N---PIESIPSYAFNRV  170 (452)
T ss_dssp             TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC-S--C---CCCEECTTTTTTC
T ss_pred             CCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC-C--C---CcceeCHhHHhcC
Confidence            356888999999999998865 7888888999888887642100001111111111000 0  0   0111110 12345


Q ss_pred             CceEEEEccCCCCCccCCc-ccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          223 PSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      ++|+.|+|++|+..+.+|. .|.++++|++|+|++|++++. |.+..+++|++|+|++|.|++..|..|.++++|+.|+|
T Consensus       171 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  249 (452)
T 3zyi_A          171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWV  249 (452)
T ss_dssp             TTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEEC
T ss_pred             CcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCcccCcccccCccCCCEEEe
Confidence            6788888887444335554 577888888888888888864 67888888999999999998888888889999999999


Q ss_pred             ccccCcCCCCcccc--cccccccccCCccc
Q 004689          302 QNNMLSGTVPSSLL--SKNVVLNYAGNINL  329 (736)
Q Consensus       302 ~~N~l~g~~P~~~~--~~~~~l~~~~n~~~  329 (736)
                      ++|++++..|..+.  ..+..+.+.+|...
T Consensus       250 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  279 (452)
T 3zyi_A          250 MNSQVSLIERNAFDGLASLVELNLAHNNLS  279 (452)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             CCCcCceECHHHhcCCCCCCEEECCCCcCC
Confidence            99998866665553  34567777777443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.15  E-value=5.7e-11  Score=133.06  Aligned_cols=137  Identities=18%  Similarity=0.156  Sum_probs=83.2

Q ss_pred             ccceeEEEeeccCCCCCCC-ccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          146 LPFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP-~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      ++.+..|.|+.|.++.++| .+..+..|+.|.++.+.+..                    -|..         ....+++
T Consensus        55 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~--------------------~~~~---------~~~~l~~  105 (477)
T 2id5_A           55 FPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKL--------------------IPLG---------VFTGLSN  105 (477)
T ss_dssp             CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCS--------------------CCTT---------SSTTCTT
T ss_pred             CCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCc--------------------cCcc---------cccCCCC
Confidence            3456666666666666644 35666666666666554431                    0000         0012356


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN  303 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~  303 (736)
                      |+.|+|++|.+++..|..|.++++|++|+|++|.+++..+ .|.++++|++|+|++|++++..+..+.++++|+.|+|++
T Consensus       106 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~  185 (477)
T 2id5_A          106 LTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRH  185 (477)
T ss_dssp             CCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEES
T ss_pred             CCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCC
Confidence            6777777777776666666677777777777777766655 566677777777777777655445566667777777777


Q ss_pred             ccCcCCCC
Q 004689          304 NMLSGTVP  311 (736)
Q Consensus       304 N~l~g~~P  311 (736)
                      |.+++..+
T Consensus       186 n~i~~~~~  193 (477)
T 2id5_A          186 LNINAIRD  193 (477)
T ss_dssp             CCCCEECT
T ss_pred             CcCcEeCh
Confidence            76664333

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.14  E-value=6.7e-11  Score=142.15  Aligned_cols=152  Identities=18%  Similarity=0.144  Sum_probs=109.4

Q ss_pred             cceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          147 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       147 ~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      +.+..|+|+.|.++.++|. +..+..|+.|.++.+..-.          .        -+|-          ....+++|
T Consensus        24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~----------~--------i~~~----------~f~~L~~L   75 (844)
T 3j0a_A           24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL----------T--------IDKE----------AFRNLPNL   75 (844)
T ss_dssp             TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCC----------E--------ECTT----------TTSSCTTC
T ss_pred             CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCcc----------c--------cCHH----------HhcCCCCC
Confidence            5678899999999988654 8888888888888763210          0        0010          01235678


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCC-C--CCCCCCCcEEEcCCCCCCCCCC-ccccCccccceeec
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-D--FSGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELYV  301 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~--~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~l  301 (736)
                      +.|+|++|++++..|..|.+|++|++|+|++|.+++.+| .  +.+|++|++|+|++|.+++..| ..|++|++|+.|+|
T Consensus        76 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~L  155 (844)
T 3j0a_A           76 RILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDF  155 (844)
T ss_dssp             CEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEE
T ss_pred             CEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEEC
Confidence            888888888887778888888888888888888888655 3  7888888888888888887654 47888888888888


Q ss_pred             ccccCcCCCCcccc----cccccccccCC
Q 004689          302 QNNMLSGTVPSSLL----SKNVVLNYAGN  326 (736)
Q Consensus       302 ~~N~l~g~~P~~~~----~~~~~l~~~~n  326 (736)
                      ++|.+++..|..+.    ..+..+.+.+|
T Consensus       156 s~N~i~~~~~~~l~~l~~~~L~~L~L~~n  184 (844)
T 3j0a_A          156 SSNQIFLVCEHELEPLQGKTLSFFSLAAN  184 (844)
T ss_dssp             ESSCCCCCCSGGGHHHHHCSSCCCEECCS
T ss_pred             CCCcCCeeCHHHcccccCCccceEECCCC
Confidence            88888877776653    23344444444

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.14  E-value=9.7e-12  Score=146.49  Aligned_cols=139  Identities=17%  Similarity=0.165  Sum_probs=116.0

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      .++.+..|.|+.|.+..+|+.+..+..|..|.++.|.+..           +         |.          ....+++
T Consensus       222 ~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~~-----------l---------p~----------~~~~l~~  271 (727)
T 4b8c_D          222 DDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLTE-----------L---------PA----------EIKNLSN  271 (727)
T ss_dssp             CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCSC-----------C---------CG----------GGGGGTT
T ss_pred             cCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCcc-----------c---------Ch----------hhhCCCC
Confidence            4567888999999999999988888888888888876641           1         10          0123578


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccc-cceeeccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPN-LRELYVQN  303 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~-L~~L~l~~  303 (736)
                      |+.|+|++|.|+ .+|..|++|++|++|+|++|.|+..++.|++|++|++|+|++|.|+|.+|..+..+.. +..|+|++
T Consensus       272 L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~  350 (727)
T 4b8c_D          272 LRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRD  350 (727)
T ss_dssp             CCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhcc
Confidence            999999999999 8999999999999999999999865558999999999999999999999998877643 34589999


Q ss_pred             ccCcCCCCccc
Q 004689          304 NMLSGTVPSSL  314 (736)
Q Consensus       304 N~l~g~~P~~~  314 (736)
                      |.++|.+|..+
T Consensus       351 N~l~~~~p~~l  361 (727)
T 4b8c_D          351 NRPEIPLPHER  361 (727)
T ss_dssp             CCCCCCCCCC-
T ss_pred             CcccCcCcccc
Confidence            99999999876

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.14  E-value=2.3e-11  Score=123.19  Aligned_cols=149  Identities=18%  Similarity=0.127  Sum_probs=114.2

Q ss_pred             ceeEEEeeccCCCCCCC-ccchhhhhhhhccCCCC-chHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          148 FVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGS-IDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       148 ~l~~l~l~~~~~s~lpP-~in~~e~~~~l~~~~~~-~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      .+..|.++.|.++.+|+ .+..+..++.|.++.+. +..                   -.+     ...     ..+++|
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~-------------------i~~-----~~f-----~~l~~L   82 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ-------------------LES-----HSF-----YNLSKV   82 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCE-------------------ECT-----TTE-----ESCTTC
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcce-------------------eCH-----hHc-----CCCcCC
Confidence            56789999999999998 57788888888888775 431                   000     011     124689


Q ss_pred             EEEEccC-CCCCccCCcccccccccccccccccccCCCCCCCCCCCCCc---EEEcCCC-CCCCCCCccccCccccc-ee
Q 004689          226 TVIHLSS-KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLR---IIHLEDN-QLTGPLPSSLMNLPNLR-EL  299 (736)
Q Consensus       226 ~~L~L~~-n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~---~L~Ls~N-~l~g~~p~~~~~l~~L~-~L  299 (736)
                      +.|+|++ |+|++..+..|.++++|++|+|++|++++ +|.+.++++|+   +|+|++| ++++..+..|.++++|+ .|
T Consensus        83 ~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L  161 (239)
T 2xwt_C           83 THIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL  161 (239)
T ss_dssp             CEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCCCTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEE
T ss_pred             cEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccccccccccccccEEECCCCcchhhcCcccccchhcceeEE
Confidence            9999998 89986666678889999999999999988 55588888887   9999999 88866666788899999 99


Q ss_pred             ecccccCcCCCCcccccc--cccccccCCc
Q 004689          300 YVQNNMLSGTVPSSLLSK--NVVLNYAGNI  327 (736)
Q Consensus       300 ~l~~N~l~g~~P~~~~~~--~~~l~~~~n~  327 (736)
                      ++++|.++ .+|...+..  +..+.+.+|.
T Consensus       162 ~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~  190 (239)
T 2xwt_C          162 KLYNNGFT-SVQGYAFNGTKLDAVYLNKNK  190 (239)
T ss_dssp             ECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred             EcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence            99999998 788766543  4566677774

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.14  E-value=6.2e-12  Score=135.21  Aligned_cols=181  Identities=13%  Similarity=0.094  Sum_probs=118.6

Q ss_pred             ccceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHH-HHHHHHcCCCCcCCCCCCCCCCCCCceEE-ecCCCC
Q 004689          146 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAI-VSVISLYSSADWAQEGGDPCLPVPWSWLQ-CNSDPQ  222 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al-~~l~~~~~~~~w~~~~~dpc~~~~~~~v~-c~~~~~  222 (736)
                      ++.+..|+++.|.++.+|+. +..+..++.|.++.|.+..... ..+.....+......+.+     ....+. -....+
T Consensus        99 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~-----~~~~~~~~~~~~l  173 (353)
T 2z80_A           99 LGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMD-----TFTKIQRKDFAGL  173 (353)
T ss_dssp             CTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS-----SCCEECTTTTTTC
T ss_pred             CCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCc-----cccccCHHHccCC
Confidence            34566677777777777665 5666666666666655431000 000000000000000000     000000 011235


Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCCC-CCCCCCCcEEEcCCCCCCCC----------------
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGP----------------  285 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~----------------  285 (736)
                      ++|+.|+|++|++++..|..+.++++|++|+|++|+++..++. +..+++|++|+|++|.+++.                
T Consensus       174 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~  253 (353)
T 2z80_A          174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK  253 (353)
T ss_dssp             CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCE
T ss_pred             CCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhc
Confidence            7899999999999988888999999999999999998765543 45688999999999999864                


Q ss_pred             ---------------CCccccCccccceeecccccCcCCCCcccc---cccccccccCCcccccC
Q 004689          286 ---------------LPSSLMNLPNLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEG  332 (736)
Q Consensus       286 ---------------~p~~~~~l~~L~~L~l~~N~l~g~~P~~~~---~~~~~l~~~~n~~~c~~  332 (736)
                                     +|..+.++++|+.|+|++|+++ .+|..++   ..+..+.+.+|+..|..
T Consensus       254 l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~  317 (353)
T 2z80_A          254 FTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC  317 (353)
T ss_dssp             EEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred             cccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence                           3445678899999999999999 8898764   34578899999998865

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.14  E-value=8.2e-11  Score=125.28  Aligned_cols=173  Identities=16%  Similarity=0.168  Sum_probs=125.3

Q ss_pred             cceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHH--HHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCC
Q 004689          147 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGV--AIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP  223 (736)
Q Consensus       147 ~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~--al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~  223 (736)
                      +.+..|.++.|.++.+|+. +..+..++.|.+..+.+...  ....+... .+..-...   -|   ....+.  ..-.+
T Consensus       123 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~---~n---~l~~l~--~~~~~  193 (332)
T 2ft3_A          123 SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRIS---EA---KLTGIP--KDLPE  193 (332)
T ss_dssp             TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCC---SS---BCSSCC--SSSCS
T ss_pred             ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECc---CC---CCCccC--ccccC
Confidence            5788899999999999885 78888888888888776420  00000000 11100000   00   000000  01125


Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      +|+.|+|++|.+++..|..+..+++|+.|+|++|++++.++ .+..+++|++|+|++|+|+ .+|..+..+++|+.|+++
T Consensus       194 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~  272 (332)
T 2ft3_A          194 TLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLH  272 (332)
T ss_dssp             SCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECC
T ss_pred             CCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECC
Confidence            89999999999998888899999999999999999999888 6899999999999999999 899999999999999999


Q ss_pred             cccCcCCCCccccc---------ccccccccCCcccc
Q 004689          303 NNMLSGTVPSSLLS---------KNVVLNYAGNINLH  330 (736)
Q Consensus       303 ~N~l~g~~P~~~~~---------~~~~l~~~~n~~~c  330 (736)
                      +|+++ .+|...+.         ....+.+.+|+..+
T Consensus       273 ~N~l~-~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~  308 (332)
T 2ft3_A          273 TNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPY  308 (332)
T ss_dssp             SSCCC-BCCTTSSSCSSCCSSSCCBSEEECCSSSSCG
T ss_pred             CCCCC-ccChhHccccccccccccccceEeecCcccc
Confidence            99999 45543322         23467788887663

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.13  E-value=5.1e-11  Score=127.68  Aligned_cols=122  Identities=22%  Similarity=0.206  Sum_probs=94.0

Q ss_pred             CCceEEecCC-C---------CCceEEEEccC-CCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcC
Q 004689          211 PWSWLQCNSD-P---------QPSITVIHLSS-KNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLE  278 (736)
Q Consensus       211 ~~~~v~c~~~-~---------~~~l~~L~L~~-n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls  278 (736)
                      .|..|.|+.. .         +++|+.|+|++ |.|++..|..|.+|++|+.|+|++|+|++.+| .|.+|++|++|+|+
T Consensus         9 ~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A            9 GSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             cCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            4677888765 2         35699999996 99998777889999999999999999999998 58999999999999


Q ss_pred             CCCCCCCCCccccCccccceeecccccCcCCCCcccccc---cccccccCCcccccCC
Q 004689          279 DNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK---NVVLNYAGNINLHEGG  333 (736)
Q Consensus       279 ~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~~~~---~~~l~~~~n~~~c~~~  333 (736)
                      +|+|++..|..+..++ |+.|+|++|.|...-....+..   .....+..+...|..+
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~  145 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQ  145 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSS
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCC
Confidence            9999966666666665 9999999999985433222211   1223334555666554

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.13  E-value=3.6e-11  Score=118.00  Aligned_cols=131  Identities=13%  Similarity=0.209  Sum_probs=103.8

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.+..|.++.|.++.++ .+..+..++.|.++.+.+..                   ..|.          ....+++|
T Consensus        65 l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~n~l~~-------------------~~~~----------~l~~l~~L  114 (197)
T 4ezg_A           65 AHNIKDLTINNIHATNYN-PISGLSNLERLRIMGKDVTS-------------------DKIP----------NLSGLTSL  114 (197)
T ss_dssp             CTTCSEEEEESCCCSCCG-GGTTCTTCCEEEEECTTCBG-------------------GGSC----------CCTTCTTC
T ss_pred             CCCCCEEEccCCCCCcch-hhhcCCCCCEEEeECCccCc-------------------ccCh----------hhcCCCCC
Confidence            357888999999877664 56677888888888776642                   0111          01235789


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      +.|+|++|++++..|..+..+++|++|+|++|.+.+.+|.+.++++|++|+|++|.+++ ++ .+..+++|+.|++++|+
T Consensus       115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred             CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence            99999999999888999999999999999999944455689999999999999999995 55 79999999999999999


Q ss_pred             CcC
Q 004689          306 LSG  308 (736)
Q Consensus       306 l~g  308 (736)
                      +.+
T Consensus       193 i~~  195 (197)
T 4ezg_A          193 IGG  195 (197)
T ss_dssp             ---
T ss_pred             cCC
Confidence            864

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.13  E-value=3.3e-11  Score=133.71  Aligned_cols=178  Identities=18%  Similarity=0.168  Sum_probs=119.2

Q ss_pred             cccceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEe-cCCCC
Q 004689          145 SLPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC-NSDPQ  222 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c-~~~~~  222 (736)
                      .++.+..|.|+.|.++.++|. +..+..|+.|.++.|.+....-..+...-.+..-... ++     ....+.. ....+
T Consensus        86 ~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~-~N-----~i~~~~~~~~~~l  159 (440)
T 3zyj_A           86 HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR-NN-----PIESIPSYAFNRI  159 (440)
T ss_dssp             SCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECC-SC-----CCCEECTTTTTTC
T ss_pred             CCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCC-CC-----cccccCHHHhhhC
Confidence            356788999999999999865 7888888899988887642100001111111111000 00     0111110 12345


Q ss_pred             CceEEEEccCCCCCccCCc-ccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          223 PSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      ++|+.|+|++|+..+.++. .|.++++|++|+|++|+++. +|.+.++++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus       160 ~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  238 (440)
T 3zyj_A          160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM  238 (440)
T ss_dssp             TTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-ccccCCCcccCEEECCCCccCccChhhhccCccCCEEEC
Confidence            7888888888544445554 67888899999999998884 467888899999999999999888888999999999999


Q ss_pred             ccccCcCCCCcccc--cccccccccCCccc
Q 004689          302 QNNMLSGTVPSSLL--SKNVVLNYAGNINL  329 (736)
Q Consensus       302 ~~N~l~g~~P~~~~--~~~~~l~~~~n~~~  329 (736)
                      ++|++++..|..+.  ..+..+.+.+|...
T Consensus       239 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  268 (440)
T 3zyj_A          239 IQSQIQVIERNAFDNLQSLVEINLAHNNLT  268 (440)
T ss_dssp             TTCCCCEECTTSSTTCTTCCEEECTTSCCC
T ss_pred             CCCceeEEChhhhcCCCCCCEEECCCCCCC
Confidence            99999855555442  34567777777443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.13  E-value=2.9e-11  Score=130.00  Aligned_cols=149  Identities=22%  Similarity=0.120  Sum_probs=107.7

Q ss_pred             ceeEEEeeccCCCCCCC-ccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceE
Q 004689          148 FVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT  226 (736)
Q Consensus       148 ~l~~l~l~~~~~s~lpP-~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~  226 (736)
                      .+..|+++.|.++.+|+ .+..+..++.|.++.+.+..                   ..|-          ....+++|+
T Consensus        53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~-------------------~~~~----------~~~~l~~L~  103 (353)
T 2z80_A           53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-------------------IEED----------SFSSLGSLE  103 (353)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCE-------------------ECTT----------TTTTCTTCC
T ss_pred             cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCc-------------------cCHh----------hcCCCCCCC
Confidence            56778888888888887 57778888888887776541                   0000          012346788


Q ss_pred             EEEccCCCCCccCCc-ccccccccccccccccccCCCCC--CCCCCCCCcEEEcCCC-CCCCCCCccccCccccceeecc
Q 004689          227 VIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDN-QLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       227 ~L~L~~n~l~g~~p~-~~~~l~~L~~L~Ls~N~l~~~~p--~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      .|+|++|++++ +|. .+.++++|++|+|++|++++..+  .+.++++|++|+|++| .+++..|..++++++|+.|+++
T Consensus       104 ~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~  182 (353)
T 2z80_A          104 HLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID  182 (353)
T ss_dssp             EEECCSSCCSS-CCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred             EEECCCCcCCc-CCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECC
Confidence            88888888884 454 47888888888888888887665  4778888888888888 4665556778888888888888


Q ss_pred             cccCcCCCCccccc--ccccccccCC
Q 004689          303 NNMLSGTVPSSLLS--KNVVLNYAGN  326 (736)
Q Consensus       303 ~N~l~g~~P~~~~~--~~~~l~~~~n  326 (736)
                      +|.+++..|..+..  .+..+.+.+|
T Consensus       183 ~n~l~~~~~~~l~~l~~L~~L~l~~n  208 (353)
T 2z80_A          183 ASDLQSYEPKSLKSIQNVSHLILHMK  208 (353)
T ss_dssp             ETTCCEECTTTTTTCSEEEEEEEECS
T ss_pred             CCCcCccCHHHHhccccCCeecCCCC
Confidence            88888766766633  3345556655

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.12  E-value=6.9e-11  Score=134.76  Aligned_cols=177  Identities=12%  Similarity=0.013  Sum_probs=118.5

Q ss_pred             cceeEEEeeccCCCCCCCcc-chhhhhhhhccCCCCchHHHHHH---HHHHcCCCCcCCCCCCCCCCCCCceEE---ecC
Q 004689          147 PFVLSFKFGKTYDSSRGPLL-NAMEINKYLERNDGSIDGVAIVS---VISLYSSADWAQEGGDPCLPVPWSWLQ---CNS  219 (736)
Q Consensus       147 ~~l~~l~l~~~~~s~lpP~i-n~~e~~~~l~~~~~~~~~~al~~---l~~~~~~~~w~~~~~dpc~~~~~~~v~---c~~  219 (736)
                      ..+..+.++.|.+..+|+.+ ..+..++.|.++.|.+.......   +...-.+..-...   -|   ....+.   -..
T Consensus       310 ~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls---~N---~l~~~~~~~~~~  383 (549)
T 2z81_A          310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS---QN---HLRSMQKTGEIL  383 (549)
T ss_dssp             TTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECT---TS---CCCCHHHHHHHG
T ss_pred             ccceEEEeccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEcc---CC---cccccccchhhh
Confidence            45778888888888888776 46778888888888876543322   1111111111100   01   011100   001


Q ss_pred             CCCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCC------------------CCCCCCcEEEcCCCC
Q 004689          220 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF------------------SGCPDLRIIHLEDNQ  281 (736)
Q Consensus       220 ~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~------------------~~l~~L~~L~Ls~N~  281 (736)
                      ..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|++++....+                  .++++|++|+|++|+
T Consensus       384 ~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~  462 (549)
T 2z81_A          384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNK  462 (549)
T ss_dssp             GGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSC
T ss_pred             hcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCChhcEEECCCCc
Confidence            23567888888888888 67777777777777777777776533221                  368889999999999


Q ss_pred             CCCCCCccccCccccceeecccccCcCCCCccc--ccccccccccCCcccccC
Q 004689          282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL--LSKNVVLNYAGNINLHEG  332 (736)
Q Consensus       282 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~--~~~~~~l~~~~n~~~c~~  332 (736)
                      |+ .+|. .+.+++|+.|+|++|+|++..|..+  +..+..+.+++|+..|..
T Consensus       463 l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  513 (549)
T 2z81_A          463 LK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC  513 (549)
T ss_dssp             CS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred             cC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence            98 7776 5778999999999999997666655  345578899999988865

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.12  E-value=8e-11  Score=124.30  Aligned_cols=152  Identities=21%  Similarity=0.172  Sum_probs=90.3

Q ss_pred             ccceeEEEeeccCCCCCCCccchh-----hhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCC
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAM-----EINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSD  220 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~-----e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~  220 (736)
                      ++.+..|.++.|.++.+|+.+..+     ..++.|.++.|.+.                    +-++.         ...
T Consensus       120 l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~--------------------~~~~~---------~~~  170 (312)
T 1wwl_A          120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL--------------------NFSCE---------QVR  170 (312)
T ss_dssp             SCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCC--------------------CCCTT---------TCC
T ss_pred             CCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCc--------------------cchHH---------Hhc
Confidence            445666777777777666556655     55666666665543                    11110         001


Q ss_pred             CCCceEEEEccCCCCCcc--CCccc--ccccccccccccccccCCCC--C-C-CCCCCCCcEEEcCCCCCCCCCC-cccc
Q 004689          221 PQPSITVIHLSSKNLTGN--IPSDL--TKLSSLVELWLDGNSLTGPI--P-D-FSGCPDLRIIHLEDNQLTGPLP-SSLM  291 (736)
Q Consensus       221 ~~~~l~~L~L~~n~l~g~--~p~~~--~~l~~L~~L~Ls~N~l~~~~--p-~-~~~l~~L~~L~Ls~N~l~g~~p-~~~~  291 (736)
                      .+++|+.|+|++|++.|.  +|..+  ..+++|++|+|++|++++..  + . +.++++|++|+|++|+|++.+| ..+.
T Consensus       171 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  250 (312)
T 1wwl_A          171 VFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD  250 (312)
T ss_dssp             CCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCC
T ss_pred             cCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhh
Confidence            245677777777776654  23333  56677777777777776422  2 2 3456677777777777776554 3455


Q ss_pred             CccccceeecccccCcCCCCcccccccccccccCCc
Q 004689          292 NLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNI  327 (736)
Q Consensus       292 ~l~~L~~L~l~~N~l~g~~P~~~~~~~~~l~~~~n~  327 (736)
                      .+++|+.|+|++|.|+ .+|..+...+..+.+++|.
T Consensus       251 ~l~~L~~L~Ls~N~l~-~ip~~~~~~L~~L~Ls~N~  285 (312)
T 1wwl_A          251 WPSQLNSLNLSFTGLK-QVPKGLPAKLSVLDLSYNR  285 (312)
T ss_dssp             CCTTCCEEECTTSCCS-SCCSSCCSEEEEEECCSSC
T ss_pred             hcCCCCEEECCCCccC-hhhhhccCCceEEECCCCC
Confidence            5667777777777776 6666666555566666664

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.12  E-value=9e-11  Score=120.76  Aligned_cols=148  Identities=20%  Similarity=0.218  Sum_probs=87.7

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.+..|.++.|.++.+| .+..+..++.|.++.|.+..                   -.+            ...+++|
T Consensus        40 l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~L~~N~i~~-------------------~~~------------l~~l~~L   87 (263)
T 1xeu_A           40 LSGVQNFNGDNSNIQSLA-GMQFFTNLKELHLSHNQISD-------------------LSP------------LKDLTKL   87 (263)
T ss_dssp             HTTCSEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCC-------------------CGG------------GTTCSSC
T ss_pred             cCcCcEEECcCCCcccch-HHhhCCCCCEEECCCCccCC-------------------Chh------------hccCCCC
Confidence            456667777777777776 45556666666666665541                   000            1234567


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      +.|+|++|++++ +|. +.. ++|+.|+|++|++++. +.+.++++|++|+|++|+|++. | .++.+++|+.|+|++|+
T Consensus        88 ~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~~-~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~  161 (263)
T 1xeu_A           88 EELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRDT-DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNE  161 (263)
T ss_dssp             CEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSBS-GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSC
T ss_pred             CEEECCCCccCC-cCc-ccc-CcccEEEccCCccCCC-hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCc
Confidence            777777777764 443 222 6677777777777663 4566677777777777777643 3 56667777777777777


Q ss_pred             CcCCCCcccccccccccccCCccccc
Q 004689          306 LSGTVPSSLLSKNVVLNYAGNINLHE  331 (736)
Q Consensus       306 l~g~~P~~~~~~~~~l~~~~n~~~c~  331 (736)
                      +++.-.-.-+..+..+.+.+|+..+.
T Consensus       162 i~~~~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          162 ITNTGGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             CCBCTTSTTCCCCCEEEEEEEEEECC
T ss_pred             CcchHHhccCCCCCEEeCCCCcccCC
Confidence            76441111123345556666655443

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.11  E-value=7.9e-11  Score=123.12  Aligned_cols=147  Identities=20%  Similarity=0.198  Sum_probs=117.8

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      .++.+..|.+..+.+..++. +..+..++.|.++.+.+..                   -.+            ...+++
T Consensus        44 ~l~~L~~L~l~~~~i~~~~~-~~~l~~L~~L~L~~n~l~~-------------------~~~------------l~~l~~   91 (291)
T 1h6t_A           44 ELNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTD-------------------IKP------------LANLKN   91 (291)
T ss_dssp             HHHTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCC-------------------CGG------------GTTCTT
T ss_pred             hcCcccEEEccCCCcccChh-HhcCCCCCEEEccCCccCC-------------------Ccc------------cccCCC
Confidence            45678889999999998865 6777788888888776641                   111            134579


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      |+.|+|++|.+++ +| .+..+++|++|+|++|++++. +.+.++++|++|+|++|++++.  ..++.+++|+.|+|++|
T Consensus        92 L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N  166 (291)
T 1h6t_A           92 LGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDN  166 (291)
T ss_dssp             CCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSS
T ss_pred             CCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCC
Confidence            9999999999995 44 499999999999999999985 6789999999999999999965  67999999999999999


Q ss_pred             cCcCCCCcccccccccccccCCcc
Q 004689          305 MLSGTVPSSLLSKNVVLNYAGNIN  328 (736)
Q Consensus       305 ~l~g~~P~~~~~~~~~l~~~~n~~  328 (736)
                      .+++..|-.-+..+..+.+.+|..
T Consensus       167 ~l~~~~~l~~l~~L~~L~L~~N~i  190 (291)
T 1h6t_A          167 QISDIVPLAGLTKLQNLYLSKNHI  190 (291)
T ss_dssp             CCCCCGGGTTCTTCCEEECCSSCC
T ss_pred             ccccchhhcCCCccCEEECCCCcC
Confidence            999655533344556777888743

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.11  E-value=4.5e-11  Score=136.27  Aligned_cols=116  Identities=22%  Similarity=0.193  Sum_probs=95.1

Q ss_pred             CCceEEecCCC----------CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCC
Q 004689          211 PWSWLQCNSDP----------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLED  279 (736)
Q Consensus       211 ~~~~v~c~~~~----------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~  279 (736)
                      +|.++ |++..          .++|+.|+|++|++++..|..|.++++|++|+|++|++++.+| .|+++++|++|+|++
T Consensus         5 ~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~   83 (549)
T 2z81_A            5 DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSD   83 (549)
T ss_dssp             CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTT
T ss_pred             CCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCC
Confidence            57777 76442          2589999999999998888899999999999999999999887 689999999999999


Q ss_pred             CCCCCCCCccccCccccceeecccccCcC-CCCccc--ccccccccccCCc
Q 004689          280 NQLTGPLPSSLMNLPNLRELYVQNNMLSG-TVPSSL--LSKNVVLNYAGNI  327 (736)
Q Consensus       280 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~P~~~--~~~~~~l~~~~n~  327 (736)
                      |+|++..|..|+++++|+.|+|++|.+++ .+|..+  +..+..+.+.+|.
T Consensus        84 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~  134 (549)
T 2z81_A           84 NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE  134 (549)
T ss_dssp             SCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS
T ss_pred             CccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCc
Confidence            99998777789999999999999999985 345544  2344556666664

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.11  E-value=2.9e-11  Score=135.87  Aligned_cols=176  Identities=13%  Similarity=-0.001  Sum_probs=115.1

Q ss_pred             ccceeEEEeeccCCCCCCC-ccchhhhhhhhccCCCCchH-HHHHHHHHHcCCCCcCCC-----CCCCCCCCCCceEEec
Q 004689          146 LPFVLSFKFGKTYDSSRGP-LLNAMEINKYLERNDGSIDG-VAIVSVISLYSSADWAQE-----GGDPCLPVPWSWLQCN  218 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP-~in~~e~~~~l~~~~~~~~~-~al~~l~~~~~~~~w~~~-----~~dpc~~~~~~~v~c~  218 (736)
                      .+.+..|.|+.|.++.++| .+..+..++.|.++.|.+.. ..   +.....+...+.+     +-.++  .....+..+
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---l~~l~~L~~L~Ls~N~l~~l~~~--~~L~~L~L~  107 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELLVG--PSIETLHAA  107 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE---CTTCTTCCEEECCSSEEEEEEEC--TTCCEEECC
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc---cccCCCCCEEEecCCcCCCCCCC--CCcCEEECc
Confidence            3478899999999999987 58889999999999987642 11   1111112111100     00000  112223333


Q ss_pred             CCCC--------CceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCC-CCCCCcEEEcCCCCCCCCCCc
Q 004689          219 SDPQ--------PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFS-GCPDLRIIHLEDNQLTGPLPS  288 (736)
Q Consensus       219 ~~~~--------~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~-~l~~L~~L~Ls~N~l~g~~p~  288 (736)
                      ...+        ++|+.|+|++|.|++..|..++.+++|+.|+|++|.+++.+| .+. ++++|++|+|++|.|++. | 
T Consensus       108 ~N~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~-  185 (487)
T 3oja_A          108 NNNISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K-  185 (487)
T ss_dssp             SSCCCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E-
T ss_pred             CCcCCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-c-
Confidence            2222        356778888888887777788888888888888888888766 554 688888888888888865 2 


Q ss_pred             cccCccccceeecccccCcCCCCcccc--cccccccccCCccc
Q 004689          289 SLMNLPNLRELYVQNNMLSGTVPSSLL--SKNVVLNYAGNINL  329 (736)
Q Consensus       289 ~~~~l~~L~~L~l~~N~l~g~~P~~~~--~~~~~l~~~~n~~~  329 (736)
                      .+..+++|+.|+|++|.|++ +|..+.  ..+..+++++|...
T Consensus       186 ~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~  227 (487)
T 3oja_A          186 GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV  227 (487)
T ss_dssp             CCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC
T ss_pred             ccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCc
Confidence            24458888888888888885 544443  34466777777533

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.11  E-value=6.1e-11  Score=135.73  Aligned_cols=164  Identities=14%  Similarity=0.139  Sum_probs=123.3

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHH-HHHHHHcCCCCcCCCCCCCCCCCCCceE-EecCCCC
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAI-VSVISLYSSADWAQEGGDPCLPVPWSWL-QCNSDPQ  222 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al-~~l~~~~~~~~w~~~~~dpc~~~~~~~v-~c~~~~~  222 (736)
                      .++.+..|.++.|.++.+|+.+..+..++.|.++.+.+..... ..+...-.+..-..   .-|   ..... .-....+
T Consensus       371 ~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l---~~n---~l~~~~~~~~~~l  444 (570)
T 2z63_A          371 GTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI---SHT---HTRVAFNGIFNGL  444 (570)
T ss_dssp             TCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEEC---TTS---CCEECCTTTTTTC
T ss_pred             ccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhhhhcCCCCCEEeC---cCC---cccccchhhhhcC
Confidence            4578889999999999998888888888888888876532100 00111111110000   000   00000 0011346


Q ss_pred             CceEEEEccCCCCC-ccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceee
Q 004689          223 PSITVIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY  300 (736)
Q Consensus       223 ~~l~~L~L~~n~l~-g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~  300 (736)
                      ++|+.|+|++|.++ +.+|..+..+++|+.|+|++|++++.+| .+.++++|++|+|++|+|++.+|..+.++++|+.|+
T Consensus       445 ~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  524 (570)
T 2z63_A          445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIW  524 (570)
T ss_dssp             TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred             CcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEE
Confidence            79999999999998 6899999999999999999999999987 789999999999999999998888999999999999


Q ss_pred             cccccCcCCCCccc
Q 004689          301 VQNNMLSGTVPSSL  314 (736)
Q Consensus       301 l~~N~l~g~~P~~~  314 (736)
                      +++|+++|..|...
T Consensus       525 l~~N~~~~~~~~~~  538 (570)
T 2z63_A          525 LHTNPWDCSCPRID  538 (570)
T ss_dssp             CCSSCBCCCTTTTH
T ss_pred             ecCCcccCCCcchH
Confidence            99999999988643

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.11  E-value=6.7e-11  Score=126.60  Aligned_cols=170  Identities=17%  Similarity=0.216  Sum_probs=122.0

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      .++.+..|.++.|.+..+++ +..+..++.|.+..+.+.....  +...-.+..-... +  |.   ...+.. ...+++
T Consensus       175 ~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~-~--n~---l~~~~~-~~~l~~  244 (347)
T 4fmz_A          175 NLTDLYSLSLNYNQIEDISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIG-N--NK---ITDLSP-LANLSQ  244 (347)
T ss_dssp             GCTTCSEEECTTSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECC-S--SC---CCCCGG-GTTCTT
T ss_pred             cCCCCCEEEccCCccccccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEcc-C--Cc---cCCCcc-hhcCCC
Confidence            45678899999999999988 7777778888877776532111  1111122111100 0  10   011111 234678


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      |+.|+|++|.+++ + +.+..+++|+.|+|++|++++. +.+..+++|+.|+|++|.+++..|..++.+++|+.|++++|
T Consensus       245 L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n  321 (347)
T 4fmz_A          245 LTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN  321 (347)
T ss_dssp             CCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSS
T ss_pred             CCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCC
Confidence            9999999999985 3 5688899999999999999875 66888999999999999999888888999999999999999


Q ss_pred             cCcCCCCcccccccccccccCCc
Q 004689          305 MLSGTVPSSLLSKNVVLNYAGNI  327 (736)
Q Consensus       305 ~l~g~~P~~~~~~~~~l~~~~n~  327 (736)
                      ++++..|..-+..+..+.+.+|+
T Consensus       322 ~l~~~~~~~~l~~L~~L~l~~N~  344 (347)
T 4fmz_A          322 HITDIRPLASLSKMDSADFANQV  344 (347)
T ss_dssp             SCCCCGGGGGCTTCSEESSSCC-
T ss_pred             ccccccChhhhhccceeehhhhc
Confidence            99977674555666778888875

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.11  E-value=8.3e-11  Score=137.83  Aligned_cols=151  Identities=19%  Similarity=0.186  Sum_probs=100.6

Q ss_pred             cceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          147 PFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       147 ~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      +.+..|+|+.|.++.+||. +..+..++.|.++.+.+..                   ..|-     .     ...+++|
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-------------------~~~~-----~-----~~~l~~L   75 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK-------------------LEPE-----L-----CQKLPML   75 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCC-------------------CCTT-----H-----HHHCTTC
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCc-------------------cCHH-----H-----HhcccCc
Confidence            4677889999999998875 7888888888888776542                   1110     0     0123567


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      +.|+|++|++++..+..|.++++|++|+|++|++++.+| .|++|++|++|+|++|.+++..|..++++++|+.|++++|
T Consensus        76 ~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  155 (680)
T 1ziw_A           76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN  155 (680)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSS
T ss_pred             CEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCC
Confidence            777777777774333357777777777777777776665 5677777777777777777777777777777777777777


Q ss_pred             cCcCCCCcccc----cccccccccCC
Q 004689          305 MLSGTVPSSLL----SKNVVLNYAGN  326 (736)
Q Consensus       305 ~l~g~~P~~~~----~~~~~l~~~~n  326 (736)
                      .+++..|..+.    ..+..+.+.+|
T Consensus       156 ~l~~~~~~~~~~~~~~~L~~L~L~~n  181 (680)
T 1ziw_A          156 KIQALKSEELDIFANSSLKKLELSSN  181 (680)
T ss_dssp             CCCCBCHHHHGGGTTCEESEEECTTC
T ss_pred             cccccCHHHhhccccccccEEECCCC
Confidence            77754444331    23455555555

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.11  E-value=2.3e-10  Score=116.88  Aligned_cols=128  Identities=20%  Similarity=0.116  Sum_probs=97.3

Q ss_pred             cccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCc--eeeEeeeeeeCCeEEEEEEecCCCCHHHH
Q 004689          417 GSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGYCQEEGRSVLVYEFMHNGTLKEH  494 (736)
Q Consensus       417 G~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~e~~~~gsL~~~  494 (736)
                      +.|..+.||++...+|..+++|+....   ....+..|+++++.+.+.+  +.+++++...++..++||||++|.+|.  
T Consensus        29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--  103 (264)
T 1nd4_A           29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--  103 (264)
T ss_dssp             CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred             cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence            455669999998777888999997543   2356889999999996545  456888888888899999999998884  


Q ss_pred             hhcccccccccCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 004689          495 LYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC----------------------------------------------  528 (736)
Q Consensus       495 l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~----------------------------------------------  528 (736)
                      .. .      ..   ...++.++++.|..||+..                                              
T Consensus       104 ~~-~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (264)
T 1nd4_A          104 SS-H------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  173 (264)
T ss_dssp             TS-C------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cC-c------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence            21 1      11   1246677788888888742                                              


Q ss_pred             ---------CCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          529 ---------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       529 ---------~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                               ...++|+|++|.|||++.++.+.|+|||.+.
T Consensus       174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                     1239999999999999877667799999874

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.10  E-value=2.6e-10  Score=121.39  Aligned_cols=174  Identities=28%  Similarity=0.236  Sum_probs=110.6

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceE-EecCCCCCc
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWL-QCNSDPQPS  224 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v-~c~~~~~~~  224 (736)
                      ++.+..|.++.|.++.+|+.+.  ..++.|.++.+.+.......+...-.+..-... ++.-   ...++ ......+ +
T Consensus       101 l~~L~~L~L~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~-~n~l---~~~~~~~~~~~~l-~  173 (332)
T 2ft3_A          101 LRKLQKLYISKNHLVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMG-GNPL---ENSGFEPGAFDGL-K  173 (332)
T ss_dssp             CTTCCEEECCSSCCCSCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECC-SCCC---BGGGSCTTSSCSC-C
T ss_pred             cCCCCEEECCCCcCCccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECC-CCcc---ccCCCCcccccCC-c
Confidence            4567778888888888877655  556666666665431100001111111100000 0000   00000 0000112 6


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN  303 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~  303 (736)
                      |+.|+|++|++++ +|..+.  ++|++|+|++|++++..+ .+.++++|++|+|++|+|++..|..++.+++|+.|+|++
T Consensus       174 L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  250 (332)
T 2ft3_A          174 LNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDN  250 (332)
T ss_dssp             CSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCS
T ss_pred             cCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCC
Confidence            7777777777773 666554  688889999999998876 688899999999999999988778899999999999999


Q ss_pred             ccCcCCCCccccc--ccccccccCCcccc
Q 004689          304 NMLSGTVPSSLLS--KNVVLNYAGNINLH  330 (736)
Q Consensus       304 N~l~g~~P~~~~~--~~~~l~~~~n~~~c  330 (736)
                      |+++ .+|..+..  .+..+.+.+|....
T Consensus       251 N~l~-~lp~~l~~l~~L~~L~l~~N~l~~  278 (332)
T 2ft3_A          251 NKLS-RVPAGLPDLKLLQVVYLHTNNITK  278 (332)
T ss_dssp             SCCC-BCCTTGGGCTTCCEEECCSSCCCB
T ss_pred             CcCe-ecChhhhcCccCCEEECCCCCCCc
Confidence            9998 88887643  45677778875443

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.09  E-value=6.5e-11  Score=136.71  Aligned_cols=177  Identities=20%  Similarity=0.184  Sum_probs=85.6

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.+..|.++.|.++.+|+.+..+..++.|.++.+.+.......+...-.+......+..--...+..    ....+++|
T Consensus       277 l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~----~~~~l~~L  352 (606)
T 3t6q_A          277 FSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG----CLENLENL  352 (606)
T ss_dssp             CTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSS----TTTTCTTC
T ss_pred             ccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchh----hhhccCcC
Confidence            34566667777777777666666666666666666543211111111111111000000000000000    01223455


Q ss_pred             EEEEccCCCCCccC--CcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCcc-ccCccccceeec
Q 004689          226 TVIHLSSKNLTGNI--PSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSS-LMNLPNLRELYV  301 (736)
Q Consensus       226 ~~L~L~~n~l~g~~--p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~l  301 (736)
                      +.|+|++|.+++..  |..+..+++|++|+|++|++++.+| .+.++++|++|+|++|.+++..|.. +.++++|+.|++
T Consensus       353 ~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l  432 (606)
T 3t6q_A          353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL  432 (606)
T ss_dssp             CEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEEC
T ss_pred             CEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEEC
Confidence            66666666655443  4455556666666666666655555 4555666666666666665554432 555566666666


Q ss_pred             ccccCcCCCCccc--ccccccccccCC
Q 004689          302 QNNMLSGTVPSSL--LSKNVVLNYAGN  326 (736)
Q Consensus       302 ~~N~l~g~~P~~~--~~~~~~l~~~~n  326 (736)
                      ++|.+++..|..+  +..+..+.+.+|
T Consensus       433 ~~n~l~~~~~~~~~~l~~L~~L~L~~n  459 (606)
T 3t6q_A          433 SHSLLDISSEQLFDGLPALQHLNLQGN  459 (606)
T ss_dssp             TTCCCBTTCTTTTTTCTTCCEEECTTC
T ss_pred             CCCccCCcCHHHHhCCCCCCEEECCCC
Confidence            6666654444443  223344455555

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.09  E-value=7.8e-11  Score=135.49  Aligned_cols=147  Identities=20%  Similarity=0.201  Sum_probs=116.9

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      .+..+..|.+..+.++.+++ +..+..|+.|.++.+.+..                   -.|            ...+++
T Consensus        41 ~L~~L~~L~l~~n~i~~l~~-l~~l~~L~~L~Ls~N~l~~-------------------~~~------------l~~l~~   88 (605)
T 1m9s_A           41 ELNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTD-------------------IKP------------LTNLKN   88 (605)
T ss_dssp             HHTTCCCCBCTTCCCCCCTT-GGGCTTCCEEECTTSCCCC-------------------CGG------------GGGCTT
T ss_pred             cCCCCCEEECcCCCCCCChH-HccCCCCCEEEeeCCCCCC-------------------Chh------------hccCCC
Confidence            35567778888888888864 6667777778777776541                   111            123578


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      |+.|+|++|.|++ +| .|..|++|+.|+|++|+|++. +.+.+|++|+.|+|++|.|++.  ..++.|++|+.|+|++|
T Consensus        89 L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N  163 (605)
T 1m9s_A           89 LGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDN  163 (605)
T ss_dssp             CCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSS
T ss_pred             CCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCC
Confidence            9999999999995 44 799999999999999999974 6799999999999999999965  67999999999999999


Q ss_pred             cCcCCCCcccccccccccccCCcc
Q 004689          305 MLSGTVPSSLLSKNVVLNYAGNIN  328 (736)
Q Consensus       305 ~l~g~~P~~~~~~~~~l~~~~n~~  328 (736)
                      .|++..|-.-+..+..+.+.+|..
T Consensus       164 ~l~~~~~l~~l~~L~~L~Ls~N~i  187 (605)
T 1m9s_A          164 QISDIVPLAGLTKLQNLYLSKNHI  187 (605)
T ss_dssp             CCCCCGGGTTCTTCCEEECCSSCC
T ss_pred             cCCCchhhccCCCCCEEECcCCCC
Confidence            999777744455667788888743

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.08  E-value=1.2e-10  Score=119.79  Aligned_cols=131  Identities=15%  Similarity=0.190  Sum_probs=110.4

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.+..|.++.|.++.+|| +..+..++.|.++.|.+..                   -.+.            .. ++|
T Consensus        62 l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~~-------------------l~~~------------~~-~~L  108 (263)
T 1xeu_A           62 FTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLKN-------------------LNGI------------PS-ACL  108 (263)
T ss_dssp             CTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCSC-------------------CTTC------------CC-SSC
T ss_pred             CCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccCC-------------------cCcc------------cc-Ccc
Confidence            4688999999999999999 8888888999998887651                   1111            01 589


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      +.|+|++|++++ ++ .+..+++|+.|+|++|++++. +.+.++++|++|+|++|+|++.  ..+..+++|+.|++++|.
T Consensus       109 ~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~  183 (263)
T 1xeu_A          109 SRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQK  183 (263)
T ss_dssp             CEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEE
T ss_pred             cEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCc
Confidence            999999999996 44 699999999999999999986 5789999999999999999976  779999999999999999


Q ss_pred             CcCCCCcccc
Q 004689          306 LSGTVPSSLL  315 (736)
Q Consensus       306 l~g~~P~~~~  315 (736)
                      +++ .|....
T Consensus       184 ~~~-~~~~~~  192 (263)
T 1xeu_A          184 CVN-EPVKYQ  192 (263)
T ss_dssp             EEC-CCEECC
T ss_pred             ccC-Cccccc
Confidence            984 465543

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.07  E-value=1.2e-10  Score=117.74  Aligned_cols=152  Identities=17%  Similarity=0.140  Sum_probs=108.7

Q ss_pred             ccceeEEEeec-cCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCC
Q 004689          146 LPFVLSFKFGK-TYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP  223 (736)
Q Consensus       146 l~~l~~l~l~~-~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~  223 (736)
                      ++.+..|.++. |.++.+|+. +..+..++.|.++.+.+..           ++.+             .    ....+.
T Consensus        79 l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-----------lp~~-------------~----~l~~L~  130 (239)
T 2xwt_C           79 LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-----------FPDL-------------T----KVYSTD  130 (239)
T ss_dssp             CTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-----------CCCC-------------T----TCCBCC
T ss_pred             CcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-----------cccc-------------c----cccccc
Confidence            45777888887 888888764 6677777777777665531           1111             0    001122


Q ss_pred             ceEEEEccCC-CCCccCCcccccccccc-cccccccccCCCCCC-CCCCCCCcEEEcCCCC-CCCCCCccccCc-cccce
Q 004689          224 SITVIHLSSK-NLTGNIPSDLTKLSSLV-ELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ-LTGPLPSSLMNL-PNLRE  298 (736)
Q Consensus       224 ~l~~L~L~~n-~l~g~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l-~~L~~  298 (736)
                      .|+.|+|++| ++++..+..|..+++|+ .|+|++|+++...+. +.. ++|+.|+|++|. |++..+..+.++ ++|+.
T Consensus       131 ~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~  209 (239)
T 2xwt_C          131 IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL  209 (239)
T ss_dssp             SEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSE
T ss_pred             cccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcE
Confidence            3459999999 88866666788999999 999999999855554 444 889999999994 886666788888 99999


Q ss_pred             eecccccCcCCCCcccccccccccccCCc
Q 004689          299 LYVQNNMLSGTVPSSLLSKNVVLNYAGNI  327 (736)
Q Consensus       299 L~l~~N~l~g~~P~~~~~~~~~l~~~~n~  327 (736)
                      |++++|+++ .+|...+.....+.+.++.
T Consensus       210 L~l~~N~l~-~l~~~~~~~L~~L~l~~~~  237 (239)
T 2xwt_C          210 LDVSQTSVT-ALPSKGLEHLKELIARNTW  237 (239)
T ss_dssp             EECTTCCCC-CCCCTTCTTCSEEECTTC-
T ss_pred             EECCCCccc-cCChhHhccCceeeccCcc
Confidence            999999998 6777766666666665553

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.07  E-value=1.1e-10  Score=132.33  Aligned_cols=176  Identities=15%  Similarity=0.122  Sum_probs=127.3

Q ss_pred             ccceeEEEeeccCCC-CCCCcc-----chhhhhhhhccCCCCc--hHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEe
Q 004689          146 LPFVLSFKFGKTYDS-SRGPLL-----NAMEINKYLERNDGSI--DGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQC  217 (736)
Q Consensus       146 l~~l~~l~l~~~~~s-~lpP~i-----n~~e~~~~l~~~~~~~--~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c  217 (736)
                      .+.+..|.++.|.++ .+|..+     ..++.++.+.+..+.+  ....+..+-....+..-... +  |.   ...+.|
T Consensus       246 ~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~-~--n~---l~~~~~  319 (520)
T 2z7x_B          246 HTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVS-G--TR---MVHMLC  319 (520)
T ss_dssp             TSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEE-S--SC---CCCCCC
T ss_pred             hCcccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcC-C--Cc---cccccc
Confidence            347888999999988 788777     7777777777666654  11223222111111111000 0  00   000111


Q ss_pred             cCCCCCceEEEEccCCCCCccCCcccccccccccccccccccCC--CCC-CCCCCCCCcEEEcCCCCCCCCCCcc-ccCc
Q 004689          218 NSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG--PIP-DFSGCPDLRIIHLEDNQLTGPLPSS-LMNL  293 (736)
Q Consensus       218 ~~~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~--~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l  293 (736)
                       ...+++|+.|+|++|++++.+|..+..+++|++|+|++|++++  .+| .+.++++|++|+|++|.+++.+|.. +..+
T Consensus       320 -~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l  398 (520)
T 2z7x_B          320 -PSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWT  398 (520)
T ss_dssp             -CSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCC
T ss_pred             -hhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccC
Confidence             0346789999999999999899999999999999999999997  445 5889999999999999999867764 8889


Q ss_pred             cccceeecccccCcCCCCcccccccccccccCCcc
Q 004689          294 PNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN  328 (736)
Q Consensus       294 ~~L~~L~l~~N~l~g~~P~~~~~~~~~l~~~~n~~  328 (736)
                      ++|+.|+|++|.+++.+|..+...+..+.+++|..
T Consensus       399 ~~L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l  433 (520)
T 2z7x_B          399 KSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKI  433 (520)
T ss_dssp             TTCCEEECCSSCCCGGGGGSCCTTCCEEECCSSCC
T ss_pred             ccCCEEECcCCCCCcchhhhhcccCCEEECCCCcc
Confidence            99999999999999888888776777788888743

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.07  E-value=9.7e-11  Score=123.47  Aligned_cols=170  Identities=23%  Similarity=0.276  Sum_probs=115.5

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      .++.+..|.+..+.++.+| .+..+..++.|.++.+.+....  .+.....+..-... ++.     ...+. ....+++
T Consensus        39 ~l~~L~~L~l~~~~i~~l~-~~~~l~~L~~L~L~~n~i~~~~--~~~~l~~L~~L~L~-~n~-----l~~~~-~~~~l~~  108 (308)
T 1h6u_A           39 DLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELS-GNP-----LKNVS-AIAGLQS  108 (308)
T ss_dssp             HHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECC-SCC-----CSCCG-GGTTCTT
T ss_pred             HcCCcCEEEeeCCCccCch-hhhccCCCCEEEccCCcCCCCh--hHccCCCCCEEEcc-CCc-----CCCch-hhcCCCC
Confidence            3567889999999999986 5777888888999888764211  12222222211110 000     01111 1234678


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      |+.|+|++|++++ +|. +..+++|++|+|++|++++..+ +.++++|++|+|++|++++ +|. +..+++|+.|+|++|
T Consensus       109 L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n  183 (308)
T 1h6u_A          109 IKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDN  183 (308)
T ss_dssp             CCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSS
T ss_pred             CCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCC
Confidence            8889999888885 443 8888889999999998887655 8888889999999998885 444 888889999999999


Q ss_pred             cCcCCCCcccccccccccccCCccc
Q 004689          305 MLSGTVPSSLLSKNVVLNYAGNINL  329 (736)
Q Consensus       305 ~l~g~~P~~~~~~~~~l~~~~n~~~  329 (736)
                      .+++..|-.-+..+..+.+.+|...
T Consensus       184 ~l~~~~~l~~l~~L~~L~L~~N~l~  208 (308)
T 1h6u_A          184 KISDISPLASLPNLIEVHLKNNQIS  208 (308)
T ss_dssp             CCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred             ccCcChhhcCCCCCCEEEccCCccC
Confidence            8885444333445566777777443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.06  E-value=2.2e-10  Score=110.16  Aligned_cols=104  Identities=17%  Similarity=0.138  Sum_probs=85.7

Q ss_pred             CceEEEEccCCCCCccCCccccccc-ccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLS-SLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      .+|+.|+|++|+++ .+|. +..+. +|++|+|++|.|++. +.+.++++|++|+|++|+|++..|..++.+++|+.|+|
T Consensus        19 ~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L   95 (176)
T 1a9n_A           19 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL   95 (176)
T ss_dssp             TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred             CCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence            58999999999999 5654 66665 999999999999987 88999999999999999999654455599999999999


Q ss_pred             ccccCcCCCCc--ccc--cccccccccCCcccc
Q 004689          302 QNNMLSGTVPS--SLL--SKNVVLNYAGNINLH  330 (736)
Q Consensus       302 ~~N~l~g~~P~--~~~--~~~~~l~~~~n~~~c  330 (736)
                      ++|.++ .+|.  .+.  ..+..+.+.+|+...
T Consensus        96 ~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~  127 (176)
T 1a9n_A           96 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN  127 (176)
T ss_dssp             CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred             CCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC
Confidence            999996 7776  442  345678888886543

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.06  E-value=1.1e-10  Score=112.38  Aligned_cols=37  Identities=5%  Similarity=-0.115  Sum_probs=20.6

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCC
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGS  181 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~  181 (736)
                      ....+..|.++.|.++.+|.+......++.|.++.|.
T Consensus        17 ~~~~L~~L~l~~n~l~~i~~~~~~~~~L~~L~Ls~N~   53 (176)
T 1a9n_A           17 NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNE   53 (176)
T ss_dssp             CTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSC
T ss_pred             CcCCceEEEeeCCCCchhHHhhhcCCCCCEEECCCCC
Confidence            3456778888888877774432222234444444443

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.06  E-value=2.3e-10  Score=130.32  Aligned_cols=145  Identities=18%  Similarity=0.148  Sum_probs=81.1

Q ss_pred             cceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceE
Q 004689          147 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT  226 (736)
Q Consensus       147 ~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~  226 (736)
                      +.+..|.++.|.++.+|+ +..  .++.|.++.|.+..  +..  ..-.+...+.. +  |   ...++..   .+++|+
T Consensus       100 ~~L~~L~Ls~N~l~~ip~-l~~--~L~~L~Ls~N~l~~--lp~--~l~~L~~L~Ls-~--N---~l~~lp~---~l~~L~  163 (571)
T 3cvr_A          100 ASLEYLDACDNRLSTLPE-LPA--SLKHLDVDNNQLTM--LPE--LPALLEYINAD-N--N---QLTMLPE---LPTSLE  163 (571)
T ss_dssp             TTCCEEECCSSCCSCCCC-CCT--TCCEEECCSSCCSC--CCC--CCTTCCEEECC-S--S---CCSCCCC---CCTTCC
T ss_pred             CCCCEEEccCCCCCCcch-hhc--CCCEEECCCCcCCC--CCC--cCccccEEeCC-C--C---ccCcCCC---cCCCcC
Confidence            567788888888888888 443  66677777776542  000  00000000000 0  0   0011110   234667


Q ss_pred             EEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCC-------cEEEcCCCCCCCCCCccccCcccccee
Q 004689          227 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDL-------RIIHLEDNQLTGPLPSSLMNLPNLREL  299 (736)
Q Consensus       227 ~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L-------~~L~Ls~N~l~g~~p~~~~~l~~L~~L  299 (736)
                      .|+|++|+|++ +|. |.  ++|+.|+|++|+|+..++ +.+  +|       +.|+|++|+|+ .+|..+.++++|+.|
T Consensus       164 ~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L  235 (571)
T 3cvr_A          164 VLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTI  235 (571)
T ss_dssp             EEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEE
T ss_pred             EEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEE
Confidence            77777777764 665 54  667777777777764333 433  45       67777777776 566666667777777


Q ss_pred             ecccccCcCCCCcccc
Q 004689          300 YVQNNMLSGTVPSSLL  315 (736)
Q Consensus       300 ~l~~N~l~g~~P~~~~  315 (736)
                      +|++|+|+|.+|..+.
T Consensus       236 ~L~~N~l~~~~p~~l~  251 (571)
T 3cvr_A          236 ILEDNPLSSRIRESLS  251 (571)
T ss_dssp             ECCSSSCCHHHHHHHH
T ss_pred             EeeCCcCCCcCHHHHH
Confidence            7777777766666553

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.05  E-value=6.9e-10  Score=126.37  Aligned_cols=94  Identities=22%  Similarity=0.292  Sum_probs=46.2

Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCcccc------
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNL------  296 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L------  296 (736)
                      ++|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++. |.|.  ++|++|+|++|+|+ .+|. +..  +|      
T Consensus       140 ~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~l-p~l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~  208 (571)
T 3cvr_A          140 ALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFL-PELP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEET  208 (571)
T ss_dssp             TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC-CCCC--TTCCEEECCSSCCS-SCCC-CC----------C
T ss_pred             ccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCc-chhh--CCCCEEECcCCCCC-chhh-HHH--hhhccccc
Confidence            345555555555553 444   345555555555555552 2233  55555555555555 4444 333  44      


Q ss_pred             -ceeecccccCcCCCCccccc--ccccccccCCcc
Q 004689          297 -RELYVQNNMLSGTVPSSLLS--KNVVLNYAGNIN  328 (736)
Q Consensus       297 -~~L~l~~N~l~g~~P~~~~~--~~~~l~~~~n~~  328 (736)
                       +.|+|++|+|+ .+|..++.  .+..+.+.+|+.
T Consensus       209 L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l  242 (571)
T 3cvr_A          209 EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL  242 (571)
T ss_dssp             CEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSC
T ss_pred             ceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcC
Confidence             55555555555 45554433  224445555543

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.05  E-value=2.5e-10  Score=127.62  Aligned_cols=170  Identities=19%  Similarity=0.186  Sum_probs=118.5

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.+..|.++.|.++.++ .+..+..++.|.++.+.+....-  +...-.+......   -|.   ...+.. ...+++|
T Consensus       220 l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~---~n~---l~~~~~-~~~l~~L  289 (466)
T 1o6v_A          220 LTNLDELSLNGNQLKDIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG---ANQ---ISNISP-LAGLTAL  289 (466)
T ss_dssp             CTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC---SSC---CCCCGG-GTTCTTC
T ss_pred             cCCCCEEECCCCCcccch-hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECC---CCc---cCcccc-ccCCCcc
Confidence            567888899999888874 46667777788887776532110  1111111111100   000   001000 2345789


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      +.|+|++|++++..|  +..+++|+.|+|++|++++.+| +..+++|+.|+|++|.+++.  ..+.++++|+.|++++|+
T Consensus       290 ~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~  364 (466)
T 1o6v_A          290 TNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQ  364 (466)
T ss_dssp             SEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSC
T ss_pred             CeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCc
Confidence            999999999986433  8889999999999999998877 78899999999999999965  478899999999999999


Q ss_pred             CcCCCCcccccccccccccCCcccc
Q 004689          306 LSGTVPSSLLSKNVVLNYAGNINLH  330 (736)
Q Consensus       306 l~g~~P~~~~~~~~~l~~~~n~~~c  330 (736)
                      +++..|..-+..+..+.+.+|....
T Consensus       365 l~~~~~~~~l~~L~~L~l~~n~~~~  389 (466)
T 1o6v_A          365 ISDLTPLANLTRITQLGLNDQAWTN  389 (466)
T ss_dssp             CCBCGGGTTCTTCCEEECCCEEEEC
T ss_pred             cCccchhhcCCCCCEEeccCCcccC
Confidence            9988875445566777888886654

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.02  E-value=3.6e-10  Score=129.36  Aligned_cols=175  Identities=17%  Similarity=0.111  Sum_probs=126.0

Q ss_pred             cceeEEEeeccCCC-CCCCcc-----chhhhhhhhccCCCCc--hHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEec
Q 004689          147 PFVLSFKFGKTYDS-SRGPLL-----NAMEINKYLERNDGSI--DGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCN  218 (736)
Q Consensus       147 ~~l~~l~l~~~~~s-~lpP~i-----n~~e~~~~l~~~~~~~--~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~  218 (736)
                      +.+..|.++.|.++ .+|+.+     ..++.+..+....+..  ....+..+-....+......   -|.   ...+.|.
T Consensus       276 ~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~---~n~---~~~~~~~  349 (562)
T 3a79_B          276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS---DTP---FIHMVCP  349 (562)
T ss_dssp             SSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEE---SSC---CCCCCCC
T ss_pred             ccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEcc---CCC---cccccCc
Confidence            37888999999988 777766     6677666655544433  22333333222222211100   000   0001111


Q ss_pred             CCCCCceEEEEccCCCCCccCCcccccccccccccccccccCCCC--C-CCCCCCCCcEEEcCCCCCCCCCCc-cccCcc
Q 004689          219 SDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPI--P-DFSGCPDLRIIHLEDNQLTGPLPS-SLMNLP  294 (736)
Q Consensus       219 ~~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~--p-~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~  294 (736)
                       ..+++|+.|+|++|++++.+|..+.++++|+.|+|++|++++..  | .+.++++|++|+|++|++++.+|. .+..++
T Consensus       350 -~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~  428 (562)
T 3a79_B          350 -PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE  428 (562)
T ss_dssp             -SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCT
T ss_pred             -cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcc
Confidence             34678999999999999989999999999999999999999854  4 589999999999999999986775 588899


Q ss_pred             ccceeecccccCcCCCCcccccccccccccCCcc
Q 004689          295 NLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNIN  328 (736)
Q Consensus       295 ~L~~L~l~~N~l~g~~P~~~~~~~~~l~~~~n~~  328 (736)
                      +|+.|+|++|.+++.+|..+...+..+.+++|..
T Consensus       429 ~L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l  462 (562)
T 3a79_B          429 SILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRI  462 (562)
T ss_dssp             TCCEEECCSSCCCGGGGSSCCTTCSEEECCSSCC
T ss_pred             cCCEEECCCCCCCcchhhhhcCcCCEEECCCCcC
Confidence            9999999999999888887766677788888743

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.01  E-value=1.2e-09  Score=121.60  Aligned_cols=153  Identities=18%  Similarity=0.174  Sum_probs=93.5

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.+..|.++.|.++.+|  +..+..++.|.++.+.+....   +.....+...... .+..    ...+  ....+++|
T Consensus       105 l~~L~~L~L~~N~l~~l~--~~~l~~L~~L~l~~N~l~~l~---l~~l~~L~~L~l~-~n~~----~~~~--~~~~l~~L  172 (457)
T 3bz5_A          105 LTKLTYLNCDTNKLTKLD--VSQNPLLTYLNCARNTLTEID---VSHNTQLTELDCH-LNKK----ITKL--DVTPQTQL  172 (457)
T ss_dssp             CTTCCEEECCSSCCSCCC--CTTCTTCCEEECTTSCCSCCC---CTTCTTCCEEECT-TCSC----CCCC--CCTTCTTC
T ss_pred             CCcCCEEECCCCcCCeec--CCCCCcCCEEECCCCccceec---cccCCcCCEEECC-CCCc----cccc--ccccCCcC
Confidence            456677777777777764  666666666766666554311   1111011100000 0000    0000  12345678


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      +.|+|++|++++ +|  +..+++|+.|+|++|++++.  .++++++|++|+|++|+|++ +|  ++.+++|+.|++++|+
T Consensus       173 ~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~  244 (457)
T 3bz5_A          173 TTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNP  244 (457)
T ss_dssp             CEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSC
T ss_pred             CEEECCCCccce-ec--cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCc
Confidence            888888888885 55  77788888888888888875  47778888888888888886 56  7788888888888888


Q ss_pred             CcCCCCcccccccc
Q 004689          306 LSGTVPSSLLSKNV  319 (736)
Q Consensus       306 l~g~~P~~~~~~~~  319 (736)
                      ++| +|...+..+.
T Consensus       245 l~~-~~~~~l~~L~  257 (457)
T 3bz5_A          245 LTE-LDVSTLSKLT  257 (457)
T ss_dssp             CSC-CCCTTCTTCC
T ss_pred             CCC-cCHHHCCCCC
Confidence            885 4443334333

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.00  E-value=4.6e-10  Score=125.38  Aligned_cols=168  Identities=23%  Similarity=0.253  Sum_probs=101.3

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      .++.+..|.++.|.++.+++ +..+..++.|.++.+.+....-  +...-.+...... +  |.   ...+. ....+++
T Consensus       175 ~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~-~--n~---l~~~~-~l~~l~~  244 (466)
T 1o6v_A          175 NLTTLERLDISSNKVSDISV-LAKLTNLESLIATNNQISDITP--LGILTNLDELSLN-G--NQ---LKDIG-TLASLTN  244 (466)
T ss_dssp             TCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECC-S--SC---CCCCG-GGGGCTT
T ss_pred             cCCCCCEEECcCCcCCCChh-hccCCCCCEEEecCCccccccc--ccccCCCCEEECC-C--CC---cccch-hhhcCCC
Confidence            35667778888887777644 5666667777776665532100  1111111111100 0  00   00000 1123467


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      |+.|+|++|.+++..|  +..+++|+.|+|++|.+++..+ +.++++|+.|+|++|++++..|  ++.+++|+.|+|++|
T Consensus       245 L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n  319 (466)
T 1o6v_A          245 LTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFN  319 (466)
T ss_dssp             CSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSS
T ss_pred             CCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCC
Confidence            7888888888775433  7777788888888888777655 7777788888888888775443  777778888888888


Q ss_pred             cCcCCCCcccccccccccccCCc
Q 004689          305 MLSGTVPSSLLSKNVVLNYAGNI  327 (736)
Q Consensus       305 ~l~g~~P~~~~~~~~~l~~~~n~  327 (736)
                      ++++..|..-+..+..+.+.+|.
T Consensus       320 ~l~~~~~~~~l~~L~~L~l~~n~  342 (466)
T 1o6v_A          320 NISDISPVSSLTKLQRLFFYNNK  342 (466)
T ss_dssp             CCSCCGGGGGCTTCCEEECCSSC
T ss_pred             cCCCchhhccCccCCEeECCCCc
Confidence            88766664445555666666664

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.99  E-value=1.3e-09  Score=117.28  Aligned_cols=140  Identities=16%  Similarity=0.304  Sum_probs=105.5

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEec--cCC-cccchhhhhHHHHHhhcC--CCceeeEeeeeeeC---CeEEEEEEe
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLT--SNS-YQGKREFTNEVTLLSRIH--HRNLVQFLGYCQEE---GRSVLVYEF  485 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~--~~~-~~~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~---~~~~lV~e~  485 (736)
                      +.|+.|.++.||+.... +..+++|+..  ... ......+.+|+++++.+.  +..+.+++.++.+.   +..++||||
T Consensus        44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~  122 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF  122 (359)
T ss_dssp             EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred             EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence            46899999999999876 5788899865  322 123457889999999996  45678899988776   457999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-------------------------------------  528 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~-------------------------------------  528 (736)
                      ++|..+.+..      ...++...+..++.++++.|..||+..                                     
T Consensus       123 v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          123 VSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             cCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            9998774422      123567777889999999999999831                                     


Q ss_pred             ------------------CCceecCCCCCCCEEEcCCCc--EEEEeecCCcc
Q 004689          529 ------------------VPAIIHRDLKSSNILLDKHMR--AKVSDFGLSKF  560 (736)
Q Consensus       529 ------------------~~~iiHrDikp~NILl~~~~~--~kl~DFGla~~  560 (736)
                                        ...++|||+++.|||++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              247999999999999997753  68999998864

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.98  E-value=1.2e-10  Score=123.35  Aligned_cols=138  Identities=17%  Similarity=0.141  Sum_probs=107.7

Q ss_pred             ccceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          146 LPFVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      ++.+..|.++.|.++.++|. +..+..++.|.++.|.+..                   ..+-     ..    ...+++
T Consensus       119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-------------------~~~~-----~~----~~~l~~  170 (317)
T 3o53_A          119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-------------------VNFA-----EL----AASSDT  170 (317)
T ss_dssp             CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCE-------------------EEGG-----GG----GGGTTT
T ss_pred             cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCc-------------------ccHH-----HH----hhccCc
Confidence            35678888888888888774 6677777777777766541                   0000     00    012468


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      |+.|+|++|++++. |. ...+++|++|+|++|++++.++.+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|
T Consensus       171 L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N  247 (317)
T 3o53_A          171 LEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN  247 (317)
T ss_dssp             CCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTC
T ss_pred             CCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCC
Confidence            99999999999954 43 44699999999999999998888999999999999999999 68888999999999999999


Q ss_pred             cCc-CCCCccc
Q 004689          305 MLS-GTVPSSL  314 (736)
Q Consensus       305 ~l~-g~~P~~~  314 (736)
                      .++ +.+|..+
T Consensus       248 ~~~~~~~~~~~  258 (317)
T 3o53_A          248 GFHCGTLRDFF  258 (317)
T ss_dssp             CCBHHHHHHHH
T ss_pred             CccCcCHHHHH
Confidence            998 6666555

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.97  E-value=1e-09  Score=126.35  Aligned_cols=84  Identities=31%  Similarity=0.353  Sum_probs=47.5

Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      ++|+.|+|++|+|++ +|   ..+++|+.|+|++|+|++.++   .+++|+.|+|++|+|+ .+|..+.++++|+.|+|+
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~  292 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  292 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence            345555566555553 44   234555666666666654322   4455666666666666 556666666666666666


Q ss_pred             cccCcCCCCccc
Q 004689          303 NNMLSGTVPSSL  314 (736)
Q Consensus       303 ~N~l~g~~P~~~  314 (736)
                      +|.++|.+|..+
T Consensus       293 ~N~l~~~~~~~l  304 (622)
T 3g06_A          293 GNPLSERTLQAL  304 (622)
T ss_dssp             SCCCCHHHHHHH
T ss_pred             CCCCCCcCHHHH
Confidence            666665555544

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.95  E-value=3.5e-09  Score=122.00  Aligned_cols=94  Identities=31%  Similarity=0.392  Sum_probs=60.4

Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN  303 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~  303 (736)
                      +|+.|+|++|.|+ .+|..   +++|+.|+|++|+|++. |  ..+++|+.|+|++|+|+ .+|.   .+++|+.|+|++
T Consensus       202 ~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~l-p--~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~  270 (622)
T 3g06_A          202 ELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTSL-P--VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYR  270 (622)
T ss_dssp             TCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCC-C--CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCS
T ss_pred             hhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCcC-C--CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCC
Confidence            3444444444444 23321   26677778888877763 3  45677888888888888 5665   567788888888


Q ss_pred             ccCcCCCCccccc--ccccccccCCccc
Q 004689          304 NMLSGTVPSSLLS--KNVVLNYAGNINL  329 (736)
Q Consensus       304 N~l~g~~P~~~~~--~~~~l~~~~n~~~  329 (736)
                      |+|+ .+|..+..  .+..+.+.+|+..
T Consensus       271 N~L~-~lp~~l~~l~~L~~L~L~~N~l~  297 (622)
T 3g06_A          271 NQLT-RLPESLIHLSSETTVNLEGNPLS  297 (622)
T ss_dssp             SCCC-SCCGGGGGSCTTCEEECCSCCCC
T ss_pred             CCCC-cCCHHHhhccccCEEEecCCCCC
Confidence            8888 77776633  3456677777543

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.95  E-value=2.2e-09  Score=119.57  Aligned_cols=163  Identities=17%  Similarity=0.078  Sum_probs=100.1

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      .++.+..|+++.|.++.+| .+..+..++.|.++.+.+....   +.....+..-...   -|   ...++  ....+++
T Consensus        40 ~l~~L~~L~Ls~n~l~~~~-~l~~l~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls---~N---~l~~~--~~~~l~~  107 (457)
T 3bz5_A           40 QLATLTSLDCHNSSITDMT-GIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACD---SN---KLTNL--DVTPLTK  107 (457)
T ss_dssp             HHTTCCEEECCSSCCCCCT-TGGGCTTCSEEECCSSCCSCCC---CTTCTTCSEEECC---SS---CCSCC--CCTTCTT
T ss_pred             HcCCCCEEEccCCCcccCh-hhcccCCCCEEEccCCcCCeEc---cccCCCCCEEECc---CC---CCcee--ecCCCCc
Confidence            4667888999999988885 5777788888888887765321   1111111111000   00   01111  1234567


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      |+.|+|++|++++ +|  +..+++|++|+|++|++++.  .++++++|++|+|++|...+.+  .++.+++|+.|++++|
T Consensus       108 L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l--~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n  180 (457)
T 3bz5_A          108 LTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI--DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFN  180 (457)
T ss_dssp             CCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC--CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSS
T ss_pred             CCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee--ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCC
Confidence            7777777777775 44  67777777777777777774  2667777777777777665565  3677777777777777


Q ss_pred             cCcCCCCcccccccccccccCCc
Q 004689          305 MLSGTVPSSLLSKNVVLNYAGNI  327 (736)
Q Consensus       305 ~l~g~~P~~~~~~~~~l~~~~n~  327 (736)
                      ++++ +|-.-+..+..+.+.+|.
T Consensus       181 ~l~~-l~l~~l~~L~~L~l~~N~  202 (457)
T 3bz5_A          181 KITE-LDVSQNKLLNRLNCDTNN  202 (457)
T ss_dssp             CCCC-CCCTTCTTCCEEECCSSC
T ss_pred             ccce-eccccCCCCCEEECcCCc
Confidence            7774 553333444555555553

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.93  E-value=6.1e-11  Score=129.09  Aligned_cols=181  Identities=14%  Similarity=0.137  Sum_probs=118.8

Q ss_pred             cccceeEEEeeccCCCC-----CCCccchhhhhhhhccCCCCchHHHHHHHHHH-------------cCCCCcCCCCCCC
Q 004689          145 SLPFVLSFKFGKTYDSS-----RGPLLNAMEINKYLERNDGSIDGVAIVSVISL-------------YSSADWAQEGGDP  206 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~-----lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~-------------~~~~~w~~~~~dp  206 (736)
                      .++.+..|.|+.|.++.     +|..+..+..++.|.++.+.+.......+...             ..+...... .+.
T Consensus        92 ~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~-~n~  170 (386)
T 2ca6_A           92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG-RNR  170 (386)
T ss_dssp             TCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECC-SSC
T ss_pred             hCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECC-CCC
Confidence            45688899999999888     66677888889999999999875544444433             233222111 000


Q ss_pred             CCCCCCceEE---ecCCCCCceEEEEccCCCCC--c---cCCcccccccccccccccccccC----CCCC-CCCCCCCCc
Q 004689          207 CLPVPWSWLQ---CNSDPQPSITVIHLSSKNLT--G---NIPSDLTKLSSLVELWLDGNSLT----GPIP-DFSGCPDLR  273 (736)
Q Consensus       207 c~~~~~~~v~---c~~~~~~~l~~L~L~~n~l~--g---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p-~~~~l~~L~  273 (736)
                      -   ...++.   -.....++|+.|+|++|+++  |   .+|..+..+++|+.|+|++|.++    +.+| .+..+++|+
T Consensus       171 l---~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~  247 (386)
T 2ca6_A          171 L---ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR  247 (386)
T ss_dssp             C---TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCC
T ss_pred             C---CcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcC
Confidence            0   000000   00012357888888888887  3   34447778888888888888885    4455 577788888


Q ss_pred             EEEcCCCCCCCC----CCccc--cCccccceeecccccCcC----CCCccc---ccccccccccCCccc
Q 004689          274 IIHLEDNQLTGP----LPSSL--MNLPNLRELYVQNNMLSG----TVPSSL---LSKNVVLNYAGNINL  329 (736)
Q Consensus       274 ~L~Ls~N~l~g~----~p~~~--~~l~~L~~L~l~~N~l~g----~~P~~~---~~~~~~l~~~~n~~~  329 (736)
                      +|+|++|.|++.    +|..+  +.+++|+.|+|++|.+++    .+|..+   +..+..+.+.+|...
T Consensus       248 ~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~  316 (386)
T 2ca6_A          248 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  316 (386)
T ss_dssp             EEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             EEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCC
Confidence            888888888755    56666  347888888888888886    477766   345567777777544

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.92  E-value=1.9e-09  Score=119.91  Aligned_cols=36  Identities=17%  Similarity=0.161  Sum_probs=24.3

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCch
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSID  183 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~  183 (736)
                      .++.+..|.++.|.++.+|+.+   ..++.|.++.|.+.
T Consensus       235 ~l~~L~~L~l~~N~l~~l~~~~---~~L~~L~l~~N~l~  270 (454)
T 1jl5_A          235 NLPFLTTIYADNNLLKTLPDLP---PSLEALNVRDNYLT  270 (454)
T ss_dssp             TCTTCCEEECCSSCCSSCCSCC---TTCCEEECCSSCCS
T ss_pred             CCCCCCEEECCCCcCCcccccc---cccCEEECCCCccc
Confidence            4567788888888888887754   34455666665543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.86  E-value=1.3e-09  Score=114.39  Aligned_cols=186  Identities=22%  Similarity=0.261  Sum_probs=120.3

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcC-CCc--eeeEeeeeeeCC---eEEEEEEecC
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRN--LVQFLGYCQEEG---RSVLVYEFMH  487 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~e~~~  487 (736)
                      +.++.|....||+..    ..+++|+....  .....+.+|+++|+.+. +..  +.+++......+   ..++||++++
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            458899999999863    56899985422  23467889999998883 332  345555544333   3478999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG----------------------------------------  527 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~----------------------------------------  527 (736)
                      |.+|.+...      ..++...+..++.++++.|..||+.                                        
T Consensus       100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A          100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            988765432      2355666677788888888888861                                        


Q ss_pred             ---------------CCCceecCCCCCCCEEEcC--CCcEEEEeecCCccccCCCCcceeccc-----c---------cc
Q 004689          528 ---------------CVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGASHVSSIVR-----G---------TV  576 (736)
Q Consensus       528 ---------------~~~~iiHrDikp~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~~~-----g---------t~  576 (736)
                                     ..+.++|+|++|.||+++.  ...+.|+||+.+.... ..........     +         ..
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~-~~~Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD-PDNDFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC-TTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC-hHHHHHHHHhhccccCHHHHHHHHHHc
Confidence                           1146899999999999998  5568899999886431 1111100000     0         00


Q ss_pred             cccC-ccccccCcCCCcchhHHHHHHHHHHHhCCCcCcc
Q 004689          577 GYLD-PEYYISQQLTDKSDVYSFGVILLELISGQEAISN  614 (736)
Q Consensus       577 ~Y~a-PE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~  614 (736)
                      ++.. |+....  .....+.|++|.++|++.+|+.+|..
T Consensus       253 ~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~~  289 (304)
T 3sg8_A          253 KHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWYE  289 (304)
T ss_dssp             TCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred             CCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence            1111 221111  11225899999999999999988753

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.86  E-value=4e-09  Score=112.68  Aligned_cols=145  Identities=17%  Similarity=0.222  Sum_probs=90.6

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.+..|.++.|.++.+++ +..+..++.|.++.+.+...  ..                             ...+++|
T Consensus        65 ~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~~~--~~-----------------------------~~~l~~L  112 (347)
T 4fmz_A           65 LTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKITDI--SA-----------------------------LQNLTNL  112 (347)
T ss_dssp             CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCC--GG-----------------------------GTTCTTC
T ss_pred             cCCccEEEccCCccccchh-hhcCCcCCEEEccCCcccCc--hH-----------------------------HcCCCcC
Confidence            4577888999999998888 77777888888877765410  00                             1223567


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      +.|+|++|.+++ +|. +..+++|+.|+|++|...+.++.+.++++|++|++++|.+++..+  +..+++|+.|++++|.
T Consensus       113 ~~L~l~~n~i~~-~~~-~~~l~~L~~L~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~  188 (347)
T 4fmz_A          113 RELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ  188 (347)
T ss_dssp             SEEECTTSCCCC-CGG-GTTCTTCCEEECTTCTTCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred             CEEECcCCcccC-chh-hccCCceeEEECCCCCCcccccchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence            777777777663 333 666777777777777655555566667777777777777664332  6666777777777776


Q ss_pred             CcCCCCcccccccccccccCC
Q 004689          306 LSGTVPSSLLSKNVVLNYAGN  326 (736)
Q Consensus       306 l~g~~P~~~~~~~~~l~~~~n  326 (736)
                      +++..+-.-+..+..+.+.+|
T Consensus       189 l~~~~~~~~l~~L~~L~l~~n  209 (347)
T 4fmz_A          189 IEDISPLASLTSLHYFTAYVN  209 (347)
T ss_dssp             CCCCGGGGGCTTCCEEECCSS
T ss_pred             ccccccccCCCccceeecccC
Confidence            663222222233344444444

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.84  E-value=9.6e-09  Score=114.22  Aligned_cols=138  Identities=29%  Similarity=0.413  Sum_probs=91.3

Q ss_pred             cceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceE
Q 004689          147 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT  226 (736)
Q Consensus       147 ~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~  226 (736)
                      +.+..|.++.|.++.+| .+..+..++.|.++.|.+..                    -|             ...++|+
T Consensus       131 ~~L~~L~L~~n~l~~lp-~~~~l~~L~~L~l~~N~l~~--------------------lp-------------~~~~~L~  176 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEKLP-ELQNSSFLKIIDVDNNSLKK--------------------LP-------------DLPPSLE  176 (454)
T ss_dssp             TTCCEEECCSSCCSSCC-CCTTCTTCCEEECCSSCCSC--------------------CC-------------CCCTTCC
T ss_pred             CCCCEEECcCCCCCCCc-ccCCCCCCCEEECCCCcCcc--------------------cC-------------CCccccc
Confidence            35556666666666655 35555556666655554431                    00             0123788


Q ss_pred             EEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccC
Q 004689          227 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML  306 (736)
Q Consensus       227 ~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l  306 (736)
                      .|+|++|++++ +| .+.++++|+.|+|++|++++. |.+  .++|++|+|++|.++ .+|. ++.+++|+.|++++|++
T Consensus       177 ~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l-~~~--~~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l  249 (454)
T 1jl5_A          177 FIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKL-PDL--PLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLL  249 (454)
T ss_dssp             EEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-CCC--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCC
T ss_pred             EEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcC-CCC--cCcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcC
Confidence            88888888885 66 588888888888888888873 322  247888888888888 6774 78888888888888888


Q ss_pred             cCCCCcccccccccccccCCc
Q 004689          307 SGTVPSSLLSKNVVLNYAGNI  327 (736)
Q Consensus       307 ~g~~P~~~~~~~~~l~~~~n~  327 (736)
                      + .+|.. ......+.+.+|.
T Consensus       250 ~-~l~~~-~~~L~~L~l~~N~  268 (454)
T 1jl5_A          250 K-TLPDL-PPSLEALNVRDNY  268 (454)
T ss_dssp             S-SCCSC-CTTCCEEECCSSC
T ss_pred             C-ccccc-ccccCEEECCCCc
Confidence            7 46653 2455566666663

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.80  E-value=2.1e-10  Score=124.83  Aligned_cols=162  Identities=14%  Similarity=0.060  Sum_probs=112.9

Q ss_pred             ccceeEEEeeccCCCCCCCc-----cchh---------hhhhhhccCCCCchHHHHHH----HHHHcCCCCcCCCCCCCC
Q 004689          146 LPFVLSFKFGKTYDSSRGPL-----LNAM---------EINKYLERNDGSIDGVAIVS----VISLYSSADWAQEGGDPC  207 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~-----in~~---------e~~~~l~~~~~~~~~~al~~----l~~~~~~~~w~~~~~dpc  207 (736)
                      .+.+..|.|+.|.++..++.     +..+         ..++.|.++.|.+....+..    ++..-.+......   -|
T Consensus       121 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~---~n  197 (386)
T 2ca6_A          121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMV---QN  197 (386)
T ss_dssp             CTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECC---SS
T ss_pred             CCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECc---CC
Confidence            46778889999887654432     2222         56777888888775333333    3333233322211   11


Q ss_pred             CCCCCce----EEecCCCCCceEEEEccCCCCC----ccCCcccccccccccccccccccCCC----CC-CC--CCCCCC
Q 004689          208 LPVPWSW----LQCNSDPQPSITVIHLSSKNLT----GNIPSDLTKLSSLVELWLDGNSLTGP----IP-DF--SGCPDL  272 (736)
Q Consensus       208 ~~~~~~~----v~c~~~~~~~l~~L~L~~n~l~----g~~p~~~~~l~~L~~L~Ls~N~l~~~----~p-~~--~~l~~L  272 (736)
                      .. ...+    ..-....+++|+.|+|++|.++    +.+|..+..+++|+.|+|++|.+++.    ++ .+  +++++|
T Consensus       198 ~l-~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L  276 (386)
T 2ca6_A          198 GI-RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGL  276 (386)
T ss_dssp             CC-CHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCC
T ss_pred             CC-CHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCe
Confidence            00 0001    0001123578999999999996    67899999999999999999999986    44 45  559999


Q ss_pred             cEEEcCCCCCCC----CCCccc-cCccccceeecccccCcCCCC
Q 004689          273 RIIHLEDNQLTG----PLPSSL-MNLPNLRELYVQNNMLSGTVP  311 (736)
Q Consensus       273 ~~L~Ls~N~l~g----~~p~~~-~~l~~L~~L~l~~N~l~g~~P  311 (736)
                      ++|+|++|.|++    .+|..+ .++++|+.|+|++|.+++..|
T Consensus       277 ~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~  320 (386)
T 2ca6_A          277 QTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD  320 (386)
T ss_dssp             CEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred             EEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence            999999999997    488888 678999999999999997664

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.80  E-value=5.4e-11  Score=116.79  Aligned_cols=89  Identities=19%  Similarity=0.300  Sum_probs=76.1

Q ss_pred             CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCC-ccccCccccceee
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP-SSLMNLPNLRELY  300 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~  300 (736)
                      +++|+.|+|++|.++ .+|..+..+++|++|+|++|++++. |.+.++++|++|+|++|+|++..+ ..+..+++|+.|+
T Consensus        69 l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~l-~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~  146 (198)
T 1ds9_A           69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLL  146 (198)
T ss_dssp             HTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCCH-HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEE
T ss_pred             CCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCcC-CccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEE
Confidence            358999999999999 7888888889999999999999984 578889999999999999984322 4788999999999


Q ss_pred             cccccCcCCCCc
Q 004689          301 VQNNMLSGTVPS  312 (736)
Q Consensus       301 l~~N~l~g~~P~  312 (736)
                      +++|.+++.+|.
T Consensus       147 l~~N~l~~~~~~  158 (198)
T 1ds9_A          147 LAGNPLYNDYKE  158 (198)
T ss_dssp             ECSCHHHHHHHT
T ss_pred             ecCCcccccccc
Confidence            999999877665

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.74  E-value=6.9e-09  Score=111.27  Aligned_cols=102  Identities=20%  Similarity=0.217  Sum_probs=84.7

Q ss_pred             CceEEecCCCC--------CceEEEEccCCCCCccCCc-ccccccccccccccccccCCCCC--CCCCCCCCcE-EEcCC
Q 004689          212 WSWLQCNSDPQ--------PSITVIHLSSKNLTGNIPS-DLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRI-IHLED  279 (736)
Q Consensus       212 ~~~v~c~~~~~--------~~l~~L~L~~n~l~g~~p~-~~~~l~~L~~L~Ls~N~l~~~~p--~~~~l~~L~~-L~Ls~  279 (736)
                      +.-|.|+...+        ++++.|+|++|+|+ .+|+ .|.+|++|++|+|++|++.+.+|  .|.+|++|.. +.+++
T Consensus        11 ~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~   89 (350)
T 4ay9_X           11 NRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   89 (350)
T ss_dssp             TTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEE
T ss_pred             CCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccC
Confidence            56689975542        47899999999999 5554 78999999999999999988777  5889998865 67788


Q ss_pred             CCCCCCCCccccCccccceeecccccCcCCCCccc
Q 004689          280 NQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL  314 (736)
Q Consensus       280 N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~  314 (736)
                      |+|++..|..|.++++|+.|++++|.+++..+...
T Consensus        90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~  124 (350)
T 4ay9_X           90 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHK  124 (350)
T ss_dssp             TTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTT
T ss_pred             CcccccCchhhhhccccccccccccccccCCchhh
Confidence            99998778899999999999999999994433333

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.73  E-value=5e-10  Score=119.08  Aligned_cols=175  Identities=14%  Similarity=0.111  Sum_probs=104.1

Q ss_pred             cceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHc-CCCCcCCCCCCCCCCCCCceEE-ecCCCCCc
Q 004689          147 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLY-SSADWAQEGGDPCLPVPWSWLQ-CNSDPQPS  224 (736)
Q Consensus       147 ~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~-~~~~w~~~~~dpc~~~~~~~v~-c~~~~~~~  224 (736)
                      +.+..+.+..|.++..+|.+..+..++.|.++.+.+...++..+-... .+..-...   -|.   ..... -....+++
T Consensus        70 ~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~---~~~---l~~~~~~~l~~~~~  143 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE---GLR---LSDPIVNTLAKNSN  143 (336)
T ss_dssp             TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT---TCB---CCHHHHHHHTTCTT
T ss_pred             ccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCc---Ccc---cCHHHHHHHhcCCC
Confidence            456677888888888887777788888888888877655444332221 12211110   010   00000 00112457


Q ss_pred             eEEEEccCC-CCCcc-CCccccccccccccccccc-ccCCC-CC-CCCCCC-CCcEEEcCCC--CCC-CCCCccccCccc
Q 004689          225 ITVIHLSSK-NLTGN-IPSDLTKLSSLVELWLDGN-SLTGP-IP-DFSGCP-DLRIIHLEDN--QLT-GPLPSSLMNLPN  295 (736)
Q Consensus       225 l~~L~L~~n-~l~g~-~p~~~~~l~~L~~L~Ls~N-~l~~~-~p-~~~~l~-~L~~L~Ls~N--~l~-g~~p~~~~~l~~  295 (736)
                      |+.|+|++| .+++. ++..+.++++|++|+|++| .+++. ++ .+.+++ +|++|+|++|  .++ +.+|..+.++++
T Consensus       144 L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~  223 (336)
T 2ast_B          144 LVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN  223 (336)
T ss_dssp             CSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTT
T ss_pred             CCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCC
Confidence            777777777 56652 5555667777777777777 77653 34 356677 7777777777  444 455666667777


Q ss_pred             cceeeccccc-CcCCCCcccc--cccccccccCCc
Q 004689          296 LRELYVQNNM-LSGTVPSSLL--SKNVVLNYAGNI  327 (736)
Q Consensus       296 L~~L~l~~N~-l~g~~P~~~~--~~~~~l~~~~n~  327 (736)
                      |+.|+|++|. +++..+..+.  ..+..+.+.+|.
T Consensus       224 L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~  258 (336)
T 2ast_B          224 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY  258 (336)
T ss_dssp             CSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred             CCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence            7777777777 5655555543  234555566654

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.71  E-value=4.1e-10  Score=119.75  Aligned_cols=177  Identities=16%  Similarity=0.165  Sum_probs=122.1

Q ss_pred             cccceeEEEeeccCCCC--CCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCC
Q 004689          145 SLPFVLSFKFGKTYDSS--RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQ  222 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~--lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~  222 (736)
                      .++.+..|.++.|.++.  +|..+..+..++.|.++.+.+.......+.....+......   -|......++.-....+
T Consensus        91 ~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~---~~~~l~~~~l~~~~~~~  167 (336)
T 2ast_B           91 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS---GCSGFSEFALQTLLSSC  167 (336)
T ss_dssp             CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT---TCBSCCHHHHHHHHHHC
T ss_pred             cCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECC---CCCCCCHHHHHHHHhcC
Confidence            45678888998888764  66778888888888888888876666666554344333211   11000000111001224


Q ss_pred             CceEEEEccCC-CCCcc-CCccccccc-cccccccccc--ccC-CCCC-CCCCCCCCcEEEcCCCC-CCCCCCccccCcc
Q 004689          223 PSITVIHLSSK-NLTGN-IPSDLTKLS-SLVELWLDGN--SLT-GPIP-DFSGCPDLRIIHLEDNQ-LTGPLPSSLMNLP  294 (736)
Q Consensus       223 ~~l~~L~L~~n-~l~g~-~p~~~~~l~-~L~~L~Ls~N--~l~-~~~p-~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l~  294 (736)
                      ++|+.|+|++| ++++. ++..+..++ +|++|+|++|  .++ +.+| .+.++++|++|+|++|. +++..+..+++++
T Consensus       168 ~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~  247 (336)
T 2ast_B          168 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN  247 (336)
T ss_dssp             TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred             CCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCC
Confidence            68999999999 99865 677788899 9999999999  555 4455 46779999999999999 7777888899999


Q ss_pred             ccceeecccccCcCCCCcc---c--ccccccccccCC
Q 004689          295 NLRELYVQNNMLSGTVPSS---L--LSKNVVLNYAGN  326 (736)
Q Consensus       295 ~L~~L~l~~N~l~g~~P~~---~--~~~~~~l~~~~n  326 (736)
                      +|+.|+|++|.  +..|..   +  +..+..+.+.||
T Consensus       248 ~L~~L~l~~~~--~~~~~~~~~l~~~~~L~~L~l~~~  282 (336)
T 2ast_B          248 YLQHLSLSRCY--DIIPETLLELGEIPTLKTLQVFGI  282 (336)
T ss_dssp             TCCEEECTTCT--TCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             CCCEeeCCCCC--CCCHHHHHHHhcCCCCCEEeccCc
Confidence            99999999996  233332   2  234456666666

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.68  E-value=3.5e-10  Score=110.97  Aligned_cols=104  Identities=27%  Similarity=0.264  Sum_probs=79.9

Q ss_pred             CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      +++|+.|+|++|++++ +| .+..+++|++|+|++|+++..++.+..+++|++|+|++|+|++ +| .++.+++|+.|+|
T Consensus        47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l  122 (198)
T 1ds9_A           47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM  122 (198)
T ss_dssp             TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred             CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence            5688999999999985 77 8888999999999999988543345667889999999999985 55 6888889999999


Q ss_pred             ccccCcCCCCc--cc--ccccccccccCCcccc
Q 004689          302 QNNMLSGTVPS--SL--LSKNVVLNYAGNINLH  330 (736)
Q Consensus       302 ~~N~l~g~~P~--~~--~~~~~~l~~~~n~~~c  330 (736)
                      ++|+++ .+|.  .+  +..+..+.+.+|+..+
T Consensus       123 ~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~~  154 (198)
T 1ds9_A          123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYN  154 (198)
T ss_dssp             SEEECC-CHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred             CCCcCC-chhHHHHHhcCCCCCEEEecCCcccc
Confidence            999988 4443  22  2345667777775543

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.64  E-value=2.6e-09  Score=115.10  Aligned_cols=141  Identities=18%  Similarity=0.161  Sum_probs=72.8

Q ss_pred             cceeEEEeeccCCCCCCCc-----cchhh-hhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCC
Q 004689          147 PFVLSFKFGKTYDSSRGPL-----LNAME-INKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSD  220 (736)
Q Consensus       147 ~~l~~l~l~~~~~s~lpP~-----in~~e-~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~  220 (736)
                      +.+..|+|+.|.++..++.     +..+. .++.|.++.|.+.......+...+..                        
T Consensus        22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~------------------------   77 (362)
T 3goz_A           22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA------------------------   77 (362)
T ss_dssp             TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHT------------------------
T ss_pred             CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhc------------------------
Confidence            3478899999998888862     33333 67778888887764434444333110                        


Q ss_pred             CCCceEEEEccCCCCCccCCcccccc-----cccccccccccccCCCCC-C----CCC-CCCCcEEEcCCCCCCCCC---
Q 004689          221 PQPSITVIHLSSKNLTGNIPSDLTKL-----SSLVELWLDGNSLTGPIP-D----FSG-CPDLRIIHLEDNQLTGPL---  286 (736)
Q Consensus       221 ~~~~l~~L~L~~n~l~g~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p-~----~~~-l~~L~~L~Ls~N~l~g~~---  286 (736)
                      ..++|+.|+|++|++++..+..+...     ++|++|+|++|++++..+ .    +.. .++|++|+|++|.|++..   
T Consensus        78 ~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~  157 (362)
T 3goz_A           78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDE  157 (362)
T ss_dssp             SCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHH
T ss_pred             cCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHH
Confidence            01245555555555554444433332     455555555555554433 1    222 245555555555555322   


Q ss_pred             -CccccCcc-ccceeecccccCcCCCC
Q 004689          287 -PSSLMNLP-NLRELYVQNNMLSGTVP  311 (736)
Q Consensus       287 -p~~~~~l~-~L~~L~l~~N~l~g~~P  311 (736)
                       +..+..++ +|+.|+|++|++++..+
T Consensus       158 l~~~l~~~~~~L~~L~Ls~n~l~~~~~  184 (362)
T 3goz_A          158 LIQILAAIPANVNSLNLRGNNLASKNC  184 (362)
T ss_dssp             HHHHHHTSCTTCCEEECTTSCGGGSCH
T ss_pred             HHHHHhcCCccccEeeecCCCCchhhH
Confidence             22223333 55555555555554433

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.58  E-value=6.2e-09  Score=112.15  Aligned_cols=152  Identities=19%  Similarity=0.239  Sum_probs=109.6

Q ss_pred             EEeeccCCCCCCCccchh-hhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCC-ceEEEE
Q 004689          152 FKFGKTYDSSRGPLLNAM-EINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQP-SITVIH  229 (736)
Q Consensus       152 l~l~~~~~s~lpP~in~~-e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~-~l~~L~  229 (736)
                      +.++.|.++.+.|.+-.. ..++.|.++.+.+.......+...+.                         ..+ +|+.|+
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~-------------------------~~~~~L~~L~   57 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFA-------------------------NTPASVTSLN   57 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH-------------------------TCCTTCCEEE
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHH-------------------------hCCCceeEEE
Confidence            456777777766664433 34788888888776433322222211                         123 799999


Q ss_pred             ccCCCCCccCCcccccc-----cccccccccccccCCCCCC-----CCCC-CCCcEEEcCCCCCCCCCCccccC-----c
Q 004689          230 LSSKNLTGNIPSDLTKL-----SSLVELWLDGNSLTGPIPD-----FSGC-PDLRIIHLEDNQLTGPLPSSLMN-----L  293 (736)
Q Consensus       230 L~~n~l~g~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~-----~~~l-~~L~~L~Ls~N~l~g~~p~~~~~-----l  293 (736)
                      |++|++++..+..+..+     ++|++|+|++|++++..+.     +..+ ++|++|+|++|.|++..+..++.     .
T Consensus        58 Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~  137 (362)
T 3goz_A           58 LSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP  137 (362)
T ss_dssp             CCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSC
T ss_pred             CcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCC
Confidence            99999998888888876     9999999999999987773     4455 89999999999999776655443     3


Q ss_pred             cccceeecccccCcCCCCccc----c---cccccccccCCcc
Q 004689          294 PNLRELYVQNNMLSGTVPSSL----L---SKNVVLNYAGNIN  328 (736)
Q Consensus       294 ~~L~~L~l~~N~l~g~~P~~~----~---~~~~~l~~~~n~~  328 (736)
                      ++|+.|+|++|.+++.-+..+    .   ..+..+.+.+|..
T Consensus       138 ~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l  179 (362)
T 3goz_A          138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL  179 (362)
T ss_dssp             TTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCG
T ss_pred             CceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCC
Confidence            699999999999985444333    1   2456777777743

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.54  E-value=3e-09  Score=118.27  Aligned_cols=105  Identities=23%  Similarity=0.162  Sum_probs=77.3

Q ss_pred             CCceEEEEccCCCCCcc----CCcccccccccccccccccccCCCCC-CC-----CCCCCCcEEEcCCCCCCCC----CC
Q 004689          222 QPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIP-DF-----SGCPDLRIIHLEDNQLTGP----LP  287 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~-----~~l~~L~~L~Ls~N~l~g~----~p  287 (736)
                      .++|+.|+|++|++++.    ++..+..+++|++|+|++|.+++..+ .+     ...++|++|+|++|.+++.    +|
T Consensus       255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~  334 (461)
T 1z7x_W          255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS  334 (461)
T ss_dssp             TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHH
Confidence            45888999999988854    67777788899999999998876433 22     2346888999999988865    56


Q ss_pred             ccccCccccceeecccccCcCCCCccccc-------ccccccccCC
Q 004689          288 SSLMNLPNLRELYVQNNMLSGTVPSSLLS-------KNVVLNYAGN  326 (736)
Q Consensus       288 ~~~~~l~~L~~L~l~~N~l~g~~P~~~~~-------~~~~l~~~~n  326 (736)
                      ..+..+++|+.|+|++|.+++..+..+..       .+..+.+.+|
T Consensus       335 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n  380 (461)
T 1z7x_W          335 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC  380 (461)
T ss_dssp             HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred             HHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCC
Confidence            67777888999999999887654544432       4456666666

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.53  E-value=5.4e-09  Score=116.16  Aligned_cols=162  Identities=19%  Similarity=0.199  Sum_probs=87.2

Q ss_pred             ccceeEEEeeccCCCCCC-----C-ccchhhhhhhhccCCCCchHHHHHHHHHHcC----CCCcCCCCCCCCCCCC-Cce
Q 004689          146 LPFVLSFKFGKTYDSSRG-----P-LLNAMEINKYLERNDGSIDGVAIVSVISLYS----SADWAQEGGDPCLPVP-WSW  214 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lp-----P-~in~~e~~~~l~~~~~~~~~~al~~l~~~~~----~~~w~~~~~dpc~~~~-~~~  214 (736)
                      .+.+..|.++.|.++..+     + +......++.|.++.+.+....+..+...+.    +..-+.. ++.-.... ...
T Consensus       226 ~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls-~n~i~~~~~~~l  304 (461)
T 1z7x_W          226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLA-GNELGDEGARLL  304 (461)
T ss_dssp             CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECT-TCCCHHHHHHHH
T ss_pred             CCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECC-CCCCchHHHHHH
Confidence            456777777777765542     1 2223455666777777766555444433321    1111100 00000000 000


Q ss_pred             EEecCCCCCceEEEEccCCCCCcc----CCcccccccccccccccccccCCCCC-CCC----C-CCCCcEEEcCCCCCCC
Q 004689          215 LQCNSDPQPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIP-DFS----G-CPDLRIIHLEDNQLTG  284 (736)
Q Consensus       215 v~c~~~~~~~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~----~-l~~L~~L~Ls~N~l~g  284 (736)
                      ...-....++|+.|+|++|.+++.    ++..+..+++|++|+|++|.+++..+ .+.    . +++|++|+|++|.+++
T Consensus       305 ~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~  384 (461)
T 1z7x_W          305 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD  384 (461)
T ss_dssp             HHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred             HHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCCh
Confidence            000001124677777777777754    45555666777777777777766433 222    1 5677777777777775


Q ss_pred             ----CCCccccCccccceeecccccCcC
Q 004689          285 ----PLPSSLMNLPNLRELYVQNNMLSG  308 (736)
Q Consensus       285 ----~~p~~~~~l~~L~~L~l~~N~l~g  308 (736)
                          .+|..+..+++|+.|+|++|++++
T Consensus       385 ~~~~~l~~~l~~~~~L~~L~l~~N~i~~  412 (461)
T 1z7x_W          385 SSCSSLAATLLANHSLRELDLSNNCLGD  412 (461)
T ss_dssp             HHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             hhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence                566667777777777777777763

>2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A*

Probab=98.52  E-value=7.3e-08  Score=92.20  Aligned_cols=140  Identities=18%  Similarity=0.162  Sum_probs=78.5

Q ss_pred             CCCCcccccCccccccccccccCceeeeccccccCCCCCCCCcHHHHhhceeccCCceEEEEcCCCCCCcceEEEEEeec
Q 004689           19 DPFDRIWESDSLKKANYLVDVAAGTEKVSTKLPIDLRSDELPPQKVMQTAVVGTNGSLTYRLNLDGFPGFGWAVTYFAEI   98 (736)
Q Consensus        19 D~~dR~W~~~~~~~~~~~~~~~~~~~~~st~~~i~~~~~~~pP~~v~~ta~t~~~~~~~~~~~~~~~~~~~~~~~~Fae~   98 (736)
                      |..+|.|.++.....    ....  ....  ..+.....+..|..|+|||=.. ..+++|..+.+. +..+.+-+||+|+
T Consensus        19 d~~gr~w~~D~~~~~----~g~~--~~~~--~~~~~~~~~~~~~~lY~TaR~~-~~~~tY~f~v~~-~G~Y~VrLhF~ei   88 (174)
T 2jwp_A           19 DVHGIHYRKDPLEGR----VGRA--SDYG--MKLPILRSNPEDQVLYQTERYN-EDSFGYDIPIKE-EGEYVLVLKFAEV   88 (174)
T ss_dssp             ETTTEEECSSCSSTT----CCCC--CCCC--TTSCCSSSCHHHHHTTTCCCCC-CSCEEEEEECCS-CEEEEEEEEEECC
T ss_pred             CCCCCEEcCCcCccc----CCcc--cccc--cceEecccCCCCchhhhhhccC-CCCeEEEEEeCC-CeEEEEEEEEecc
Confidence            678999999753110    0111  0001  1111112345688999999775 356778777642 3456677899999


Q ss_pred             cCCCCCCceEEEEEeCCCcCCccccccccccccC---cceeccCccccc---------cccceeEEEeeccCCCCCCCcc
Q 004689           99 EDLDPDESRKFRLVLPGQPDVSKAIVNIQENAQG---KYRVYEPGYTNL---------SLPFVLSFKFGKTYDSSRGPLL  166 (736)
Q Consensus        99 ~~~~~~~~R~F~i~~n~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~---------~l~~l~~l~l~~~~~s~lpP~i  166 (736)
                      .. ...+.|+|||++||+.+.+.  .++...+..   -++......++-         .....+.+.|.  +.+.-.|+|
T Consensus        89 ~~-~~~~~rvFdV~ing~~~l~~--fdi~~~ag~~~~~~~~~~~~v~~~~l~i~~~~~~~~g~L~I~f~--p~~~~~a~i  163 (174)
T 2jwp_A           89 YF-AQSQQKVFDVRVNGHTVVKD--LDIFDRVGHSTAHDEIIPISIKKGKLSVQGEVSTFTGKLSVEFV--KGYYDNPKV  163 (174)
T ss_dssp             SC-CCSSSSCEEEEETTEEEEEE--ECHHHHHSSSSCEEEEEEEEEETTEEEETTEEEECCSEEEEEEE--CSSSCSSSE
T ss_pred             cc-CCCCCeEeEEEECCEEeecC--cCHHHhhCCCeeEEEEEEEEEecCceeeeeeecccCCeEEEEEe--ccCCCCcEE
Confidence            74 46789999999999977554  233332221   011010000000         11233445554  334567999


Q ss_pred             chhhhhh
Q 004689          167 NAMEINK  173 (736)
Q Consensus       167 n~~e~~~  173 (736)
                      ||+|+++
T Consensus       164 naIEI~~  170 (174)
T 2jwp_A          164 CALFIMK  170 (174)
T ss_dssp             EEEEEES
T ss_pred             EEEEEEe
Confidence            9999864

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.46  E-value=2.1e-07  Score=99.54  Aligned_cols=137  Identities=18%  Similarity=0.132  Sum_probs=64.1

Q ss_pred             EEeeccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceEEEEc
Q 004689          152 FKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL  230 (736)
Q Consensus       152 l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~~L~L  230 (736)
                      +.+..|.++.++|. +..+..++.|.+..|.+..           ....       .      .     ....++..|++
T Consensus        85 l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~-----------~~~~-------~------~-----~~~~~l~~l~l  135 (350)
T 4ay9_X           85 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH-----------LPDV-------H------K-----IHSLQKVLLDI  135 (350)
T ss_dssp             EEEEETTCCEECTTSBCCCTTCCEEEEEEECCSS-----------CCCC-------T------T-----CCBSSCEEEEE
T ss_pred             hcccCCcccccCchhhhhcccccccccccccccc-----------CCch-------h------h-----cccchhhhhhh
Confidence            45556777777664 5666667776666655431           0000       0      0     01123444554


Q ss_pred             cC-CCCCccCCccccccc-ccccccccccccCCCCCCCCCCCCCcEEEcCC-CCCCCCCC-ccccCccccceeecccccC
Q 004689          231 SS-KNLTGNIPSDLTKLS-SLVELWLDGNSLTGPIPDFSGCPDLRIIHLED-NQLTGPLP-SSLMNLPNLRELYVQNNML  306 (736)
Q Consensus       231 ~~-n~l~g~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~-N~l~g~~p-~~~~~l~~L~~L~l~~N~l  306 (736)
                      .+ +++....+..+..+. .|+.|+|++|+|+...+......+|+.|+|++ |.++ .+| ..|..+++|+.|+|++|+|
T Consensus       136 ~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l  214 (350)
T 4ay9_X          136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRI  214 (350)
T ss_dssp             ESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCC
T ss_pred             ccccccccccccchhhcchhhhhhccccccccCCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCc
Confidence            33 334322222333332 35555555555554444333444555555543 3333 333 2445555555555555555


Q ss_pred             cCCCCcccccccc
Q 004689          307 SGTVPSSLLSKNV  319 (736)
Q Consensus       307 ~g~~P~~~~~~~~  319 (736)
                      + .+|...+..+.
T Consensus       215 ~-~lp~~~~~~L~  226 (350)
T 4ay9_X          215 H-SLPSYGLENLK  226 (350)
T ss_dssp             C-CCCSSSCTTCC
T ss_pred             C-ccChhhhccch
Confidence            5 45544444433

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.38  E-value=2.3e-08  Score=107.97  Aligned_cols=138  Identities=20%  Similarity=0.140  Sum_probs=90.5

Q ss_pred             cceeEEEeeccCCCCCC--CccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          147 PFVLSFKFGKTYDSSRG--PLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       147 ~~l~~l~l~~~~~s~lp--P~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      ..+..|+|+.|.++...  .+..++..++.|.++.|.+.......+...+.         .               ..++
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~---------~---------------~~~~  156 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL---------H---------------DQCQ  156 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH---------S---------------TTCC
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH---------h---------------cCCc
Confidence            35666777777655422  33445555666667766665555555443321         0               1136


Q ss_pred             eEEEEccCCCCCc----cCCcccccccccccccccccccCCCC----C-CCCCCCCCcEEEcCCCCCCC----CCCcccc
Q 004689          225 ITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGPI----P-DFSGCPDLRIIHLEDNQLTG----PLPSSLM  291 (736)
Q Consensus       225 l~~L~L~~n~l~g----~~p~~~~~l~~L~~L~Ls~N~l~~~~----p-~~~~l~~L~~L~Ls~N~l~g----~~p~~~~  291 (736)
                      |+.|+|++|.|+.    .++..+..+++|++|+|++|.|++.-    + .+..+++|++|+|++|.|+.    .++..+.
T Consensus       157 L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~  236 (372)
T 3un9_A          157 ITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAR  236 (372)
T ss_dssp             CCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHH
T ss_pred             cceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHH
Confidence            8888888888874    24445567888888889888887532    2 46667788888998888874    2444555


Q ss_pred             CccccceeecccccCcC
Q 004689          292 NLPNLRELYVQNNMLSG  308 (736)
Q Consensus       292 ~l~~L~~L~l~~N~l~g  308 (736)
                      .+++|+.|+|++|.|+.
T Consensus       237 ~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          237 EHPSLELLHLYFNELSS  253 (372)
T ss_dssp             HCSSCCEEECTTSSCCH
T ss_pred             hCCCCCEEeccCCCCCH
Confidence            66888888888888874

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.37  E-value=1.1e-07  Score=97.17  Aligned_cols=64  Identities=27%  Similarity=0.381  Sum_probs=28.8

Q ss_pred             CceEEEEccCCCCCc--cCCcccccccccccccccccccCCCCC--CCCCCCCCcEEEcCCCCCCCCCC
Q 004689          223 PSITVIHLSSKNLTG--NIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLEDNQLTGPLP  287 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g--~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~g~~p  287 (736)
                      ++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.-.  .+.++ +|++|+|++|.|++.+|
T Consensus       170 ~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          170 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             TTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTGGGCS
T ss_pred             CCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCccccC
Confidence            345555555555554  233344445555555555555544311  12222 44555555555444443

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.26  E-value=3.6e-06  Score=88.16  Aligned_cols=135  Identities=20%  Similarity=0.245  Sum_probs=89.6

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCC---ceeeEeeeee-eCCeEEEEEEecCCC
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR---NLVQFLGYCQ-EEGRSVLVYEFMHNG  489 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~~~~~-~~~~~~lV~e~~~~g  489 (736)
                      +.++.|....||+.    +..+++|+-.  .......+..|+++|+.+.+.   .+.+.+.++. ..+..++|||+++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            45788888899988    5778999843  222345788999999999652   3556666664 455678999999998


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG------------------------------------------  527 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~------------------------------------------  527 (736)
                      ++.+....      .++......++.++++.|..||+.                                          
T Consensus        99 ~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           99 ILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             ECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             ECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            87653211      112222333333344433333331                                          


Q ss_pred             ---------------CCCceecCCCCCCCEEEcC---CCc-EEEEeecCCcc
Q 004689          528 ---------------CVPAIIHRDLKSSNILLDK---HMR-AKVSDFGLSKF  560 (736)
Q Consensus       528 ---------------~~~~iiHrDikp~NILl~~---~~~-~kl~DFGla~~  560 (736)
                                     ..+.++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2246799999999999997   455 48999998753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.19  E-value=3.5e-06  Score=90.13  Aligned_cols=79  Identities=4%  Similarity=0.037  Sum_probs=56.5

Q ss_pred             ccc-cccCceEEEEEEEC-------CCcEEEEEEeccCC---cccchhhhhHHHHHhhcC-C--CceeeEeeeeeeC---
Q 004689          414 KKI-GSGGFGVVYYGKLK-------DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIH-H--RNLVQFLGYCQEE---  476 (736)
Q Consensus       414 ~~I-G~G~fG~Vy~~~~~-------~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~-H--pnIv~l~~~~~~~---  476 (736)
                      +.| +.|....+|+....       +++.+++|+.....   ......+..|+.+++.+. +  -.+.+++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 78888999998764       26788999865332   112356889999999884 3  3567788877655   


Q ss_pred             CeEEEEEEecCCCCHH
Q 004689          477 GRSVLVYEFMHNGTLK  492 (736)
Q Consensus       477 ~~~~lV~e~~~~gsL~  492 (736)
                      +..++||||++|..+.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999986654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.19  E-value=7.4e-06  Score=83.85  Aligned_cols=134  Identities=17%  Similarity=0.127  Sum_probs=94.4

Q ss_pred             cccccCce-EEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          415 KIGSGGFG-VVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       415 ~IG~G~fG-~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      .+..|..| .||+.... ++..+++|+-...   ....+.+|..+|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34556555 68988765 4667999986432   3456888999998884 33367888999999999999999999887


Q ss_pred             HHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 004689          492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-------------------------------------------  528 (736)
Q Consensus       492 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~-------------------------------------------  528 (736)
                      .+......        .....++.+++..|..||+..                                           
T Consensus       108 ~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          108 FQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            76542111        112234555555666665421                                           


Q ss_pred             ------------CCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          529 ------------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       529 ------------~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                                  .+.++|+|+.+.|||++.++.+-|+||+.+.
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                        1248999999999999987777799999874

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.18  E-value=6.8e-08  Score=104.32  Aligned_cols=154  Identities=17%  Similarity=0.146  Sum_probs=103.4

Q ss_pred             ccceeEEEeeccCCCCCCCc-cchh-----hhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecC
Q 004689          146 LPFVLSFKFGKTYDSSRGPL-LNAM-----EINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNS  219 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~-in~~-----e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~  219 (736)
                      .+.+..|.|+.|.++..... +..+     ..++.|.++.+.+....+..+...                          
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~--------------------------  124 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPV--------------------------  124 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHH--------------------------
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHH--------------------------
Confidence            34567788888776654322 2111     345566777776655444433322                          


Q ss_pred             CCCCceEEEEccCCCCCccCCcccc-----cccccccccccccccCCC----CC-CCCCCCCCcEEEcCCCCCCCC----
Q 004689          220 DPQPSITVIHLSSKNLTGNIPSDLT-----KLSSLVELWLDGNSLTGP----IP-DFSGCPDLRIIHLEDNQLTGP----  285 (736)
Q Consensus       220 ~~~~~l~~L~L~~n~l~g~~p~~~~-----~l~~L~~L~Ls~N~l~~~----~p-~~~~l~~L~~L~Ls~N~l~g~----  285 (736)
                        +.+|+.|+|++|+|+..-...|.     ..++|++|+|++|.|+..    ++ .+..+++|++|+|++|.|+..    
T Consensus       125 --L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~  202 (372)
T 3un9_A          125 --FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLEL  202 (372)
T ss_dssp             --HHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHH
T ss_pred             --HHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHH
Confidence              13689999999999865444443     357899999999999762    22 356788999999999999742    


Q ss_pred             CCccccCccccceeecccccCcCCCCccc------ccccccccccCCc
Q 004689          286 LPSSLMNLPNLRELYVQNNMLSGTVPSSL------LSKNVVLNYAGNI  327 (736)
Q Consensus       286 ~p~~~~~l~~L~~L~l~~N~l~g~~P~~~------~~~~~~l~~~~n~  327 (736)
                      ++..+..+++|+.|+|++|.|+..-...+      ...+..+++++|.
T Consensus       203 L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~  250 (372)
T 3un9_A          203 LAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNE  250 (372)
T ss_dssp             HHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSS
T ss_pred             HHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCC
Confidence            45667788899999999999974322222      1345677788884

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.15  E-value=3.4e-06  Score=89.29  Aligned_cols=92  Identities=22%  Similarity=0.273  Sum_probs=77.2

Q ss_pred             CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCc-EEEcCCCCCCCCCCccccCcccccee
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLR-IIHLEDNQLTGPLPSSLMNLPNLREL  299 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~-~L~Ls~N~l~g~~p~~~~~l~~L~~L  299 (736)
                      .++|+.|+|++|+++..-+..|.++++|+.|+|++| ++...+ +|.+|++|+ .|+|.+ +++..-+.+|.+|++|+.|
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            368999999999999444447889999999999998 776555 699999999 999998 7774556799999999999


Q ss_pred             ecccccCcCCCCccccc
Q 004689          300 YVQNNMLSGTVPSSLLS  316 (736)
Q Consensus       300 ~l~~N~l~g~~P~~~~~  316 (736)
                      +++.|+++ .|+...|.
T Consensus       303 ~l~~n~i~-~I~~~aF~  318 (329)
T 3sb4_A          303 LATGDKIT-TLGDELFG  318 (329)
T ss_dssp             EECSSCCC-EECTTTTC
T ss_pred             EeCCCccC-ccchhhhc
Confidence            99999998 77776554

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.11  E-value=2.8e-07  Score=94.07  Aligned_cols=82  Identities=23%  Similarity=0.371  Sum_probs=63.1

Q ss_pred             EEccCCCCCccCCc----ccccccccccccccccccCCC--CCC-CCCCCCCcEEEcCCCCCCCCCCccccCcc--ccce
Q 004689          228 IHLSSKNLTGNIPS----DLTKLSSLVELWLDGNSLTGP--IPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLP--NLRE  298 (736)
Q Consensus       228 L~L~~n~l~g~~p~----~~~~l~~L~~L~Ls~N~l~~~--~p~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~--~L~~  298 (736)
                      ++++.|... .++.    ...++++|+.|+|++|+|++.  +|. +..+++|+.|+|++|+|++.  ..+..+.  +|++
T Consensus       148 l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~  224 (267)
T 3rw6_A          148 IDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEE  224 (267)
T ss_dssp             CCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSE
T ss_pred             ccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcce
Confidence            555666433 2332    224689999999999999994  454 56899999999999999965  4455555  9999


Q ss_pred             eecccccCcCCCCc
Q 004689          299 LYVQNNMLSGTVPS  312 (736)
Q Consensus       299 L~l~~N~l~g~~P~  312 (736)
                      |+|++|.+++.+|.
T Consensus       225 L~L~~Npl~~~~~~  238 (267)
T 3rw6_A          225 LWLDGNSLCDTFRD  238 (267)
T ss_dssp             EECTTSTTGGGCSS
T ss_pred             EEccCCcCccccCc
Confidence            99999999988873

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.88  E-value=5e-05  Score=82.42  Aligned_cols=74  Identities=15%  Similarity=0.119  Sum_probs=49.1

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCc-------ccchhhhhHHHHHhhcCC--Cc-eeeEeeeeeeCCeEEEE
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-------QGKREFTNEVTLLSRIHH--RN-LVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-------~~~~~~~~E~~il~~l~H--pn-Iv~l~~~~~~~~~~~lV  482 (736)
                      +.||.|.++.||++... +++.++||.......       .....+..|.++|+.+..  +. +.+++.+  +.+..++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            46899999999999764 468899998653211       123446789999988742  33 3455543  34456899


Q ss_pred             EEecCCC
Q 004689          483 YEFMHNG  489 (736)
Q Consensus       483 ~e~~~~g  489 (736)
                      ||++++.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.87  E-value=5.1e-05  Score=80.21  Aligned_cols=140  Identities=14%  Similarity=0.202  Sum_probs=80.5

Q ss_pred             cccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCC--CceeeEee------eeeeCCeEEEEEEec
Q 004689          415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--RNLVQFLG------YCQEEGRSVLVYEFM  486 (736)
Q Consensus       415 ~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~------~~~~~~~~~lV~e~~  486 (736)
                      .|+.|..+.||+....+ ..+++|+....    ...+..|+.+++.+..  -.+.+++.      +....+..+++|+|+
T Consensus        39 ~l~gG~~n~~~~v~~~~-~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDS-GAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             ECC----CEEEEEEETT-EEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eccccccCcEEEEEeCC-CCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            45667789999998764 45899988642    2345566777766632  12333333      123466789999999


Q ss_pred             CCCCHH--------------HHhhcccc----c-c-----cccCHHHH-------------------------------H
Q 004689          487 HNGTLK--------------EHLYGTLT----H-E-----QRINWIKR-------------------------------L  511 (736)
Q Consensus       487 ~~gsL~--------------~~l~~~~~----~-~-----~~l~~~~~-------------------------------~  511 (736)
                      +|..+.              ..+|....    . .     ..-.|...                               .
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            986542              11121100    0 0     00112110                               0


Q ss_pred             HHHHHHHHHHHHHHh----------CCCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          512 EIAEDAAKGIEYLHT----------GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       512 ~i~~qia~~L~~LH~----------~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      .+...+..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            111223445666653          012489999999999999888899999999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.77  E-value=0.00012  Score=75.73  Aligned_cols=74  Identities=20%  Similarity=0.212  Sum_probs=54.8

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCC---ceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR---NLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      +.+|.|..+.||+.+..+|+.|++|+-..........|..|++.|+.+.-.   -+.+++++.    ..++||||++++.
T Consensus        21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~   96 (288)
T 3f7w_A           21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCC
T ss_pred             EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccC
Confidence            468999999999999999999999987655444455688999999988421   234455432    2378999998764


Q ss_pred             H
Q 004689          491 L  491 (736)
Q Consensus       491 L  491 (736)
                      .
T Consensus        97 ~   97 (288)
T 3f7w_A           97 P   97 (288)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=97.76  E-value=6.7e-07  Score=102.54  Aligned_cols=65  Identities=20%  Similarity=0.092  Sum_probs=29.6

Q ss_pred             ccccccccccccccc--ccCCCCC-CCC-CCCCCcEEEcCCCCCCC-CCCccccCccccceeecccccCc
Q 004689          243 LTKLSSLVELWLDGN--SLTGPIP-DFS-GCPDLRIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLS  307 (736)
Q Consensus       243 ~~~l~~L~~L~Ls~N--~l~~~~p-~~~-~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~l~~N~l~  307 (736)
                      +.++++|+.|+|++|  .+++..+ .+. .+++|++|+|++|.+++ .++..+..+++|+.|+|++|.++
T Consensus       432 ~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~  501 (592)
T 3ogk_B          432 LIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS  501 (592)
T ss_dssp             HHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred             HHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence            344555555555422  2333222 222 24555555555555543 23333444555555555555554

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.71  E-value=0.00018  Score=75.23  Aligned_cols=138  Identities=20%  Similarity=0.217  Sum_probs=91.1

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcC---CCceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH---HRNLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      +.|+.|....+|+.... +..+++|+....   ....+..|++.|+.+.   ...+.+++.++...+..++||||+++..
T Consensus        42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~  117 (312)
T 3jr1_A           42 EKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK  117 (312)
T ss_dssp             EEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred             EEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence            45889999999999864 778999986532   2456889999999884   3568888888888888999999999876


Q ss_pred             HH--------H---Hhhcccc-c-----------------ccccCHHHHH---HHHH----------------HHHHH-H
Q 004689          491 LK--------E---HLYGTLT-H-----------------EQRINWIKRL---EIAE----------------DAAKG-I  521 (736)
Q Consensus       491 L~--------~---~l~~~~~-~-----------------~~~l~~~~~~---~i~~----------------qia~~-L  521 (736)
                      +.        .   .||.... .                 ...-+|....   ++..                .+... .
T Consensus       118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~  197 (312)
T 3jr1_A          118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA  197 (312)
T ss_dssp             CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred             CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence            42        1   1222111 0                 0011343221   1111                11111 2


Q ss_pred             HHHHh-CCCCceecCCCCCCCEEEcCCCcEEEEeec
Q 004689          522 EYLHT-GCVPAIIHRDLKSSNILLDKHMRAKVSDFG  556 (736)
Q Consensus       522 ~~LH~-~~~~~iiHrDikp~NILl~~~~~~kl~DFG  556 (736)
                      ..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus       198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            23421 2246899999999999999887 8898974

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.65  E-value=9.3e-05  Score=81.02  Aligned_cols=79  Identities=15%  Similarity=0.147  Sum_probs=47.9

Q ss_pred             CceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceecccccccccCccccccCc---CCCcchhHHHHHHHHHHH
Q 004689          530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ---LTDKSDVYSFGVILLELI  606 (736)
Q Consensus       530 ~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~~DVwSlGvvl~ell  606 (736)
                      ..++|+|+++.|||++.++ ++|+||+.+..-............-...|++|+......   -....++......+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            4899999999999999876 999999988643211110000000123466666553211   112345567888888877


Q ss_pred             hCC
Q 004689          607 SGQ  609 (736)
Q Consensus       607 tG~  609 (736)
                      ++.
T Consensus       311 ~~~  313 (420)
T 2pyw_A          311 NKR  313 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            663

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=97.58  E-value=5.5e-05  Score=79.85  Aligned_cols=15  Identities=7%  Similarity=0.100  Sum_probs=12.5

Q ss_pred             ccceeEEEeeccCCC
Q 004689          146 LPFVLSFKFGKTYDS  160 (736)
Q Consensus       146 l~~l~~l~l~~~~~s  160 (736)
                      ++.+..|+|+.|.++
T Consensus        48 l~~L~~LdLs~n~i~   62 (329)
T 3sb4_A           48 FPSLKVLDISNAEIK   62 (329)
T ss_dssp             CTTCCEEEEEEEEEC
T ss_pred             hccCeEEecCcceeE
Confidence            567888999998887

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.57  E-value=7.4e-06  Score=79.01  Aligned_cols=84  Identities=11%  Similarity=0.144  Sum_probs=53.7

Q ss_pred             ceEEEEccCCCCCcc----CCcccccccccccccccccccCCC----C-CCCCCCCCCcEEEc--CCCCCCCC----CCc
Q 004689          224 SITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGP----I-PDFSGCPDLRIIHL--EDNQLTGP----LPS  288 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~----~-p~~~~l~~L~~L~L--s~N~l~g~----~p~  288 (736)
                      +|+.|+|++|+|+..    +...+...+.|++|+|++|.|+..    + ..+...++|++|+|  ++|.|...    +..
T Consensus        66 ~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~  145 (185)
T 1io0_A           66 YVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIAN  145 (185)
T ss_dssp             SCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHH
T ss_pred             CcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHH
Confidence            577777777777642    333444556777777777777653    1 24566677777777  66777632    233


Q ss_pred             cccCccccceeecccccCc
Q 004689          289 SLMNLPNLRELYVQNNMLS  307 (736)
Q Consensus       289 ~~~~l~~L~~L~l~~N~l~  307 (736)
                      .+...++|+.|+|++|.+.
T Consensus       146 ~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          146 MLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHCSSCCEEECCCSSHH
T ss_pred             HHHhCCCcCEEeccCCCCC
Confidence            4445567777777777764

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.44  E-value=2.9e-05  Score=83.12  Aligned_cols=104  Identities=18%  Similarity=0.311  Sum_probs=66.7

Q ss_pred             CceEEEEccCCCCCccCCcccc--cccccccccccc--cccCCC--C----CCC--CCCCCCcEEEcCCCCCCCCCCccc
Q 004689          223 PSITVIHLSSKNLTGNIPSDLT--KLSSLVELWLDG--NSLTGP--I----PDF--SGCPDLRIIHLEDNQLTGPLPSSL  290 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~--~l~~L~~L~Ls~--N~l~~~--~----p~~--~~l~~L~~L~Ls~N~l~g~~p~~~  290 (736)
                      ++|+.|+|..++++......+.  .+++|+.|+|+.  |...|.  +    +.+  ..+++|++|+|.+|.+.+..+..+
T Consensus       193 ~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~l  272 (362)
T 2ra8_A          193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF  272 (362)
T ss_dssp             TTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHH
T ss_pred             CCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHH
Confidence            5788899988887754444454  688888888863  222221  1    222  347889999999888875433333


Q ss_pred             c---CccccceeecccccCcCC----CCccc--ccccccccccCC
Q 004689          291 M---NLPNLRELYVQNNMLSGT----VPSSL--LSKNVVLNYAGN  326 (736)
Q Consensus       291 ~---~l~~L~~L~l~~N~l~g~----~P~~~--~~~~~~l~~~~n  326 (736)
                      .   .+++|+.|+|+.|.|++.    ++..+  +..+..+.+..|
T Consensus       273 a~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n  317 (362)
T 2ra8_A          273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN  317 (362)
T ss_dssp             HHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSB
T ss_pred             HhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCC
Confidence            3   578899999999988753    23222  234455666655

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.40  E-value=1.2e-05  Score=77.44  Aligned_cols=86  Identities=20%  Similarity=0.306  Sum_probs=68.9

Q ss_pred             CceEEEEccCC-CCCcc----CCcccccccccccccccccccCCCC----C-CCCCCCCCcEEEcCCCCCCCC----CCc
Q 004689          223 PSITVIHLSSK-NLTGN----IPSDLTKLSSLVELWLDGNSLTGPI----P-DFSGCPDLRIIHLEDNQLTGP----LPS  288 (736)
Q Consensus       223 ~~l~~L~L~~n-~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p-~~~~l~~L~~L~Ls~N~l~g~----~p~  288 (736)
                      ++|+.|+|++| .++..    +...+...++|++|+|++|.|...-    . .+...++|++|+|++|.|...    +..
T Consensus        36 ~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~  115 (185)
T 1io0_A           36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE  115 (185)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHH
Confidence            58999999999 88743    4445666789999999999997532    1 355678999999999999843    456


Q ss_pred             cccCccccceeec--ccccCcC
Q 004689          289 SLMNLPNLRELYV--QNNMLSG  308 (736)
Q Consensus       289 ~~~~l~~L~~L~l--~~N~l~g  308 (736)
                      .+...+.|+.|+|  ++|.++.
T Consensus       116 ~L~~n~~L~~L~L~~~~N~i~~  137 (185)
T 1io0_A          116 ALQSNTSLIELRIDNQSQPLGN  137 (185)
T ss_dssp             GGGGCSSCCEEECCCCSSCCCH
T ss_pred             HHHhCCCceEEEecCCCCCCCH
Confidence            7788889999999  8899874

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=97.37  E-value=0.00011  Score=84.08  Aligned_cols=87  Identities=10%  Similarity=0.010  Sum_probs=62.1

Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccC---CCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccce
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLT---GPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE  298 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~---~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~  298 (736)
                      ++|+.|+|++|.+.+ +|..+.++++|+.|+++++...   +..+ .+..+++|+.|+++++.. +.+|..+..+++|+.
T Consensus       220 ~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~  297 (592)
T 3ogk_B          220 RSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRK  297 (592)
T ss_dssp             TTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCE
T ss_pred             CCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcE
Confidence            578888888888875 6777778888888888753332   1122 467778888888887643 367777888888888


Q ss_pred             eecccccCcCCCC
Q 004689          299 LYVQNNMLSGTVP  311 (736)
Q Consensus       299 L~l~~N~l~g~~P  311 (736)
                      |+|++|.+++...
T Consensus       298 L~Ls~~~l~~~~~  310 (592)
T 3ogk_B          298 LDLLYALLETEDH  310 (592)
T ss_dssp             EEETTCCCCHHHH
T ss_pred             EecCCCcCCHHHH
Confidence            8888888764443

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.29  E-value=0.0015  Score=68.67  Aligned_cols=141  Identities=13%  Similarity=0.102  Sum_probs=74.9

Q ss_pred             cccccCceE-EEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCC--ceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          415 KIGSGGFGV-VYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHR--NLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       415 ~IG~G~fG~-Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      .|+.|+... +|+....+++.+++|......   ...+..|+.+++.+...  .+.+++.+..+.+  +++||++.+..+
T Consensus        25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l   99 (333)
T 3csv_A           25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALF   99 (333)
T ss_dssp             C--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBH
T ss_pred             ECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcch
Confidence            455555444 667765446778787643221   14567788888887432  3456666644333  789999987666


Q ss_pred             HHHhhcccc---------------------c-ccccCHHHHH--------------------HHHHHHHHHHHHHH---h
Q 004689          492 KEHLYGTLT---------------------H-EQRINWIKRL--------------------EIAEDAAKGIEYLH---T  526 (736)
Q Consensus       492 ~~~l~~~~~---------------------~-~~~l~~~~~~--------------------~i~~qia~~L~~LH---~  526 (736)
                      .+.+.....                     . ...+......                    .....+...+..+.   .
T Consensus       100 ~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~  179 (333)
T 3csv_A          100 TEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQL  179 (333)
T ss_dssp             HHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHC
T ss_pred             HHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcc
Confidence            544321100                     0 0011110000                    00011122222221   1


Q ss_pred             CCCCceecCCCCCCCEEEcCC----CcEEEEeecCCcc
Q 004689          527 GCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKF  560 (736)
Q Consensus       527 ~~~~~iiHrDikp~NILl~~~----~~~kl~DFGla~~  560 (736)
                      .....++|||+.+.|||++.+    +.+.|+||+.+..
T Consensus       180 ~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          180 EGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            123489999999999999875    6899999998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.19  E-value=0.00097  Score=69.77  Aligned_cols=143  Identities=15%  Similarity=0.189  Sum_probs=81.1

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCc--eeeEeee------eeeCCeEEEEEEe
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGY------CQEEGRSVLVYEF  485 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~~------~~~~~~~~lV~e~  485 (736)
                      +.|+.|....+|+....++ .+++|+....  .....+..|+.+++.+....  +.+++..      ....+..+++++|
T Consensus        28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~  104 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF  104 (322)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred             eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence            3466788889999987655 6889987642  23456778888888874322  2333321      1234567899999


Q ss_pred             cCCCCHHH--------------Hhhccc---ccc-----cccCHHHHHH------------HHHHHHHHHHHHHhC----
Q 004689          486 MHNGTLKE--------------HLYGTL---THE-----QRINWIKRLE------------IAEDAAKGIEYLHTG----  527 (736)
Q Consensus       486 ~~~gsL~~--------------~l~~~~---~~~-----~~l~~~~~~~------------i~~qia~~L~~LH~~----  527 (736)
                      ++|..+..              .+|...   ...     ....|...+.            +...+...+++++..    
T Consensus       105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~  184 (322)
T 2ppq_A          105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD  184 (322)
T ss_dssp             CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred             CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence            98865311              112110   000     0011222110            011234455555532    


Q ss_pred             CCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       528 ~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      ...+++|+|+++.|||++.+..+.|+||+.+.
T Consensus       185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            12479999999999999987666899998764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.08  E-value=4.6e-05  Score=72.23  Aligned_cols=83  Identities=12%  Similarity=0.087  Sum_probs=65.2

Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccc-cCCC-CCCCCCC----CCCcEEEcCCCC-CCCCCCccccCccc
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNS-LTGP-IPDFSGC----PDLRIIHLEDNQ-LTGPLPSSLMNLPN  295 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~-l~~~-~p~~~~l----~~L~~L~Ls~N~-l~g~~p~~~~~l~~  295 (736)
                      .+|+.|||+++.++..--..+..+++|+.|+|+++. ++.. +..++.+    ++|++|+|+++. ++..--..+.++++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            479999999999886655667899999999999985 6652 2245553    479999999974 77433346788999


Q ss_pred             cceeeccccc
Q 004689          296 LRELYVQNNM  305 (736)
Q Consensus       296 L~~L~l~~N~  305 (736)
                      |+.|+|+++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            9999999986

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.04  E-value=0.002  Score=66.80  Aligned_cols=70  Identities=11%  Similarity=0.148  Sum_probs=44.9

Q ss_pred             ccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCce-eeEeeeeeeCCeEEEEEEec-CCCCH
Q 004689          414 KKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYEFM-HNGTL  491 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lV~e~~-~~gsL  491 (736)
                      +.|+.|....+|+.     +.+++|+..... ........|+.+++.+...++ .++++++  .+.-++|+||+ ++.++
T Consensus        24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           24 LERLGGLTNLVFRA-----GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             EEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred             eEcCCcccccccee-----eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence            56888999999998     568889875432 112334678888888753333 4555544  33346899999 55444

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.02  E-value=3.7e-05  Score=87.93  Aligned_cols=105  Identities=15%  Similarity=0.100  Sum_probs=76.3

Q ss_pred             CCceEEEEcc--C----CCCCccCC------cccccccccccccccccccCCCCC-CCCC-CCCCcEEEcCCCCCCCCCC
Q 004689          222 QPSITVIHLS--S----KNLTGNIP------SDLTKLSSLVELWLDGNSLTGPIP-DFSG-CPDLRIIHLEDNQLTGPLP  287 (736)
Q Consensus       222 ~~~l~~L~L~--~----n~l~g~~p------~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~-l~~L~~L~Ls~N~l~g~~p  287 (736)
                      .++|+.|+|+  +    +++++ .|      .-+..+++|+.|+|++ .+++... .+.. +++|+.|+|++|.+++..+
T Consensus       396 ~~~L~~L~L~~~~~~~~~~l~~-~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~  473 (594)
T 2p1m_B          396 RPNMTRFRLCIIEPKAPDYLTL-EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGM  473 (594)
T ss_dssp             CTTCCEEEEEESSTTCCCTTTC-CCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHH
T ss_pred             CCCcceeEeecccCCCcccccC-CchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHH
Confidence            6899999999  4    56662 22      2256789999999977 6665433 5555 8999999999999986555


Q ss_pred             ccc-cCccccceeecccccCcCCCCcccc---cccccccccCCcc
Q 004689          288 SSL-MNLPNLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNIN  328 (736)
Q Consensus       288 ~~~-~~l~~L~~L~l~~N~l~g~~P~~~~---~~~~~l~~~~n~~  328 (736)
                      ..+ ..+++|+.|+|++|.+++..+..+.   ..+..+.+.+|+.
T Consensus       474 ~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~  518 (594)
T 2p1m_B          474 HHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV  518 (594)
T ss_dssp             HHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred             HHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence            555 6789999999999999654444332   3456677777744

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.02  E-value=7.2e-05  Score=85.46  Aligned_cols=83  Identities=13%  Similarity=0.185  Sum_probs=52.8

Q ss_pred             CceEEEEccCCCCCccCCcccc-ccccccccccccc-ccCCC-CCCC-CCCCCCcEEEcCCCCCCCCCCcccc----Ccc
Q 004689          223 PSITVIHLSSKNLTGNIPSDLT-KLSSLVELWLDGN-SLTGP-IPDF-SGCPDLRIIHLEDNQLTGPLPSSLM----NLP  294 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~-~l~~L~~L~Ls~N-~l~~~-~p~~-~~l~~L~~L~Ls~N~l~g~~p~~~~----~l~  294 (736)
                      ++|+.|+|++|.+++..+..+. .+++|++|+|++| .++.. ++.+ .+|++|++|+|++|.+++..+..+.    .++
T Consensus       105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~  184 (594)
T 2p1m_B          105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT  184 (594)
T ss_dssp             TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred             CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence            4677777777777766666665 5677777777777 44432 3333 3577777777777776655444333    455


Q ss_pred             ccceeeccccc
Q 004689          295 NLRELYVQNNM  305 (736)
Q Consensus       295 ~L~~L~l~~N~  305 (736)
                      +|+.|++++|.
T Consensus       185 ~L~~L~l~~~~  195 (594)
T 2p1m_B          185 SLVSLNISCLA  195 (594)
T ss_dssp             CCCEEECTTCC
T ss_pred             cCcEEEecccC
Confidence            77777777775

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.96  E-value=0.0018  Score=70.89  Aligned_cols=72  Identities=14%  Similarity=0.316  Sum_probs=49.4

Q ss_pred             ccccccCceEEEEEEECC--------CcEEEEEEeccCCcccchhhhhHHHHHhhcCCCce-eeEeeeeeeCCeEEEEEE
Q 004689          414 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lV~e  484 (736)
                      +.|+.|....+|+....+        ++.+++|+....  .....+..|..+++.+...++ .++++.+.+    .+|+|
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            457888889999998753        578999987431  111456689999998853333 566766543    28999


Q ss_pred             ecCCCCH
Q 004689          485 FMHNGTL  491 (736)
Q Consensus       485 ~~~~gsL  491 (736)
                      |++|.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9986443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.84  E-value=0.009  Score=62.44  Aligned_cols=141  Identities=13%  Similarity=0.133  Sum_probs=81.2

Q ss_pred             cccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCc--eeeEeee-----eeeCCeEEEEEEecC
Q 004689          415 KIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN--LVQFLGY-----CQEEGRSVLVYEFMH  487 (736)
Q Consensus       415 ~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~~~-----~~~~~~~~lV~e~~~  487 (736)
                      .++ |....||+....+|+.+++|+..... .....+..|..+++.+....  +.+++..     ....+..+++|++++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            355 77789999887777789999986332 23456778888888884222  3444443     123456688999998


Q ss_pred             CCCHH-----H------H---hhcccc-----cccccCHHHH----HHH---------------HHHHHHHHHHHHhC--
Q 004689          488 NGTLK-----E------H---LYGTLT-----HEQRINWIKR----LEI---------------AEDAAKGIEYLHTG--  527 (736)
Q Consensus       488 ~gsL~-----~------~---l~~~~~-----~~~~l~~~~~----~~i---------------~~qia~~L~~LH~~--  527 (736)
                      |..+.     .      .   +|....     ....+++...    ..+               ...+...++.+...  
T Consensus       111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  190 (328)
T 1zyl_A          111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR  190 (328)
T ss_dssp             CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence            75432     0      0   111100     0111121110    000               11111223333221  


Q ss_pred             --CCCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          528 --CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       528 --~~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                        ....++|+|+++.|||++ + .+.|+||+.+.
T Consensus       191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence              234789999999999999 4 89999998765

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.83  E-value=0.006  Score=67.17  Aligned_cols=73  Identities=12%  Similarity=0.126  Sum_probs=48.1

Q ss_pred             ccccccCceEEEEEEECC-CcEEEEEEeccCCcccchhhhhHHHHHhhcCCCce-eeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL-VQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      +.|+.|-...+|+....+ +..+++|+..... ...-+...|..+++.+...++ .++++++.  +  .+||||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            467888889999998874 4788999864321 112223689999999965444 46777663  2  259999987544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.82  E-value=0.0033  Score=67.39  Aligned_cols=141  Identities=16%  Similarity=0.198  Sum_probs=80.3

Q ss_pred             ccccccCceEEEEEEEC--------CCcEEEEEEeccCCcccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEE
Q 004689          414 KKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~--------~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      +.|..|-...+|+....        +++.+++|+... .......+.+|.++++.+. +.-..++++++.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            35667778889998874        247899998532 2223455678999998884 3223566666654    28999


Q ss_pred             ecCCCCHHHH-----------------hhccc-cccccc--CHHHHHHHHHHHH-------------------HHHHH--
Q 004689          485 FMHNGTLKEH-----------------LYGTL-THEQRI--NWIKRLEIAEDAA-------------------KGIEY--  523 (736)
Q Consensus       485 ~~~~gsL~~~-----------------l~~~~-~~~~~l--~~~~~~~i~~qia-------------------~~L~~--  523 (736)
                      |++|..|...                 ||... ......  -+.+..++..++.                   ..+..  
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998654311                 11110 001111  1233333332221                   12233  


Q ss_pred             --HHhC-CCCceecCCCCCCCEEEcCC----CcEEEEeecCCc
Q 004689          524 --LHTG-CVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSK  559 (736)
Q Consensus       524 --LH~~-~~~~iiHrDikp~NILl~~~----~~~kl~DFGla~  559 (736)
                        |... ....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence              3221 22478999999999999876    789999998774

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.67  E-value=0.0018  Score=58.22  Aligned_cols=55  Identities=31%  Similarity=0.489  Sum_probs=32.6

Q ss_pred             EEEccCCCCC-ccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCC
Q 004689          227 VIHLSSKNLT-GNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLT  283 (736)
Q Consensus       227 ~L~L~~n~l~-g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~  283 (736)
                      .++.++++|+ ..+|..|.  ++|+.|+|++|+|+...+ .|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            6777777776 34665443  246666666666665555 3555666666666666553

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.61  E-value=0.0023  Score=57.56  Aligned_cols=54  Identities=28%  Similarity=0.224  Sum_probs=37.0

Q ss_pred             cccccccccC--CCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccC
Q 004689          251 ELWLDGNSLT--GPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML  306 (736)
Q Consensus       251 ~L~Ls~N~l~--~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l  306 (736)
                      .++.++++|+  ..+..+.  .+|++|+|++|+|+...+..|..+++|+.|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            6788888887  4333332  3578888888888855555677777787776666654

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=96.61  E-value=0.00023  Score=76.09  Aligned_cols=84  Identities=19%  Similarity=0.221  Sum_probs=41.1

Q ss_pred             CCceEEEEccCCC-CCccCCcccccccccccccccccccCCCCC-CC--CCCCCCcEEEcCC--CCCCCC-----CCccc
Q 004689          222 QPSITVIHLSSKN-LTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DF--SGCPDLRIIHLED--NQLTGP-----LPSSL  290 (736)
Q Consensus       222 ~~~l~~L~L~~n~-l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~--~~l~~L~~L~Ls~--N~l~g~-----~p~~~  290 (736)
                      +|+|+.|+|++|. +.  ++. + .+++|+.|+|..|.++...- .+  ..+++|+.|+|+.  |...|.     +-..+
T Consensus       171 ~P~L~~L~L~g~~~l~--l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l  246 (362)
T 2ra8_A          171 MPLLNNLKIKGTNNLS--IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF  246 (362)
T ss_dssp             CTTCCEEEEECCBTCB--CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred             CCCCcEEEEeCCCCce--ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence            3566666666652 22  333 3 25666666666665543221 22  2566666666642  221111     00111


Q ss_pred             --cCccccceeecccccCcCC
Q 004689          291 --MNLPNLRELYVQNNMLSGT  309 (736)
Q Consensus       291 --~~l~~L~~L~l~~N~l~g~  309 (736)
                        ..+++|+.|+|.+|.+++.
T Consensus       247 ~~~~~p~Lr~L~L~~~~i~~~  267 (362)
T 2ra8_A          247 SKDRFPNLKWLGIVDAEEQNV  267 (362)
T ss_dssp             CTTTCTTCCEEEEESCTTHHH
T ss_pred             hcCCCCCcCEEeCCCCCCchH
Confidence              2356666666666666543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.52  E-value=0.0057  Score=65.30  Aligned_cols=73  Identities=15%  Similarity=0.166  Sum_probs=44.8

Q ss_pred             ccccccCceEEEEEEECC---------CcEEEEEEeccCCcccchhhhhHHHHHhhcCCCc-eeeEeeeeeeCCeEEEEE
Q 004689          414 KKIGSGGFGVVYYGKLKD---------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~---------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~  483 (736)
                      +.|+.|....+|+....+         ++.+++|+..... ....+...|.++++.+...+ +.++++..  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            457788888999998763         2688899865321 11223468899998885334 34666544  2  26899


Q ss_pred             EecCCCCH
Q 004689          484 EFMHNGTL  491 (736)
Q Consensus       484 e~~~~gsL  491 (736)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.51  E-value=0.01  Score=62.61  Aligned_cols=68  Identities=12%  Similarity=0.193  Sum_probs=45.6

Q ss_pred             cccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCC---CceeeEeee------eeeCCeEEEEEEecC
Q 004689          417 GSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH---RNLVQFLGY------CQEEGRSVLVYEFMH  487 (736)
Q Consensus       417 G~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H---pnIv~l~~~------~~~~~~~~lV~e~~~  487 (736)
                      |.|....||+....+| .+++|+.....      ...|+.+++.+..   |.+.+.+..      ....+..+++|+|++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~------~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYH------DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSS------CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCcc------chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            3344679999987766 99999875432      2567777777732   224455432      233567899999999


Q ss_pred             CCCH
Q 004689          488 NGTL  491 (736)
Q Consensus       488 ~gsL  491 (736)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8765

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=96.32  E-value=0.0042  Score=67.32  Aligned_cols=59  Identities=17%  Similarity=0.207  Sum_probs=25.1

Q ss_pred             ccccccccccccccccccC-----CCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          242 DLTKLSSLVELWLDGNSLT-----GPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       242 ~~~~l~~L~~L~Ls~N~l~-----~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      .|.++++|+.|+|.+|.+.     ...+ .|.+|++|+.++|. |.++..-..+|.+|++|+.|.|
T Consensus       266 aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~l  330 (401)
T 4fdw_A          266 AFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTI  330 (401)
T ss_dssp             TTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEE
T ss_pred             HhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEE
Confidence            4444444555544444443     1111 34444455555444 2233222234444445555544

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=96.07  E-value=0.0068  Score=65.64  Aligned_cols=89  Identities=15%  Similarity=0.111  Sum_probs=70.0

Q ss_pred             CCceEEEEccCCCCC-----ccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccc
Q 004689          222 QPSITVIHLSSKNLT-----GNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPN  295 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~-----g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~  295 (736)
                      .++|+.|+|.+|.+.     ..-+..|.++++|+.|+|. |+++.... .|.+|++|+.|+|..| ++..-+.+|.++ +
T Consensus       270 c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~  346 (401)
T 4fdw_A          270 CPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-G  346 (401)
T ss_dssp             CTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-C
T ss_pred             CCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-C
Confidence            368999999888765     2334578899999999999 55776555 7999999999999665 664556689999 9


Q ss_pred             cceeecccccCcCCCCccc
Q 004689          296 LRELYVQNNMLSGTVPSSL  314 (736)
Q Consensus       296 L~~L~l~~N~l~g~~P~~~  314 (736)
                      |+.|++++|.+. .++...
T Consensus       347 L~~l~l~~n~~~-~l~~~~  364 (401)
T 4fdw_A          347 IKEVKVEGTTPP-QVFEKV  364 (401)
T ss_dssp             CCEEEECCSSCC-BCCCSS
T ss_pred             CCEEEEcCCCCc-cccccc
Confidence            999999999887 454433

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.54  E-value=0.15  Score=55.20  Aligned_cols=73  Identities=14%  Similarity=0.140  Sum_probs=48.5

Q ss_pred             ccccccCceEEEEEEECC--------CcEEEEEEeccCCcccchhhhhHHHHHhhcCCCc-eeeEeeeeeeCCeEEEEEE
Q 004689          414 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~e  484 (736)
                      +.+..|-...+|+....+        ++.+++|+.... ....-+..+|..+++.+...+ ..++++.+.    -++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence            456778888999998763        578999985432 222334568999998885323 345555332    268999


Q ss_pred             ecCCCCH
Q 004689          485 FMHNGTL  491 (736)
Q Consensus       485 ~~~~gsL  491 (736)
                      |++|..|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=94.22  E-value=0.0051  Score=59.26  Aligned_cols=83  Identities=14%  Similarity=0.261  Sum_probs=59.0

Q ss_pred             CceEEEEccCC-CCCc----cCCcccccccccccccccccccCCCCC-C----CCCCCCCcEEEcCCCCCCCC----CCc
Q 004689          223 PSITVIHLSSK-NLTG----NIPSDLTKLSSLVELWLDGNSLTGPIP-D----FSGCPDLRIIHLEDNQLTGP----LPS  288 (736)
Q Consensus       223 ~~l~~L~L~~n-~l~g----~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~----~~~l~~L~~L~Ls~N~l~g~----~p~  288 (736)
                      +.|+.|+|++| +|..    .+...+..-+.|+.|+|++|+|...-- .    +..-+.|+.|+|+.|.|...    +-+
T Consensus        41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~  120 (197)
T 1pgv_A           41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR  120 (197)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred             CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence            36889999985 7753    244556667889999999999985321 2    44457899999999999832    223


Q ss_pred             cccCccccceeeccccc
Q 004689          289 SLMNLPNLRELYVQNNM  305 (736)
Q Consensus       289 ~~~~l~~L~~L~l~~N~  305 (736)
                      .+..-+.|+.|+|++|.
T Consensus       121 aL~~N~tL~~L~L~n~~  137 (197)
T 1pgv_A          121 STLVTQSIVEFKADNQR  137 (197)
T ss_dssp             HTTTTCCCSEEECCCCS
T ss_pred             HHhhCCceeEEECCCCc
Confidence            45555679999998653

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=93.96  E-value=0.011  Score=55.83  Aligned_cols=69  Identities=10%  Similarity=0.115  Sum_probs=50.6

Q ss_pred             CCcccccccccccccccccccCCC-CCCCCCCCCCcEEEcCCCC-CCCCCCccccCc----cccceeeccccc-Cc
Q 004689          239 IPSDLTKLSSLVELWLDGNSLTGP-IPDFSGCPDLRIIHLEDNQ-LTGPLPSSLMNL----PNLRELYVQNNM-LS  307 (736)
Q Consensus       239 ~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~  307 (736)
                      +|.....--+|+.|||+++.++.. +..+.+|++|+.|+|+++. |+..--..++.+    ++|+.|+|++|. +|
T Consensus        53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~IT  128 (176)
T 3e4g_A           53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVT  128 (176)
T ss_dssp             SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCC
T ss_pred             CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCC
Confidence            454333334799999999998763 3467899999999999995 764333345554    479999999985 66

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=93.82  E-value=0.34  Score=47.01  Aligned_cols=100  Identities=14%  Similarity=0.080  Sum_probs=64.0

Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      -+|.+.|...   +..+++.++|.++.|.+.+|.-+-.+.. . ..+=+-|..|++..+|.+...+ +.+.         
T Consensus        33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence            3788888533   5679999999999999999877622110 1 1223346899999999888753 1110         


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhC
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG  608 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG  608 (736)
                          .....+.+||... ...+.+.=|||+|+++|.-+-=
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy  132 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY  132 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence                1123456888763 3456788999999999998863

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=92.44  E-value=0.12  Score=55.51  Aligned_cols=79  Identities=19%  Similarity=0.168  Sum_probs=41.2

Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      .+|+.+.+.++ ++..-...|.++++|+.++|..+ ++..-. +|.+|++|+.++|..| ++..-..+|.+|++|+.+++
T Consensus       297 ~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~l  373 (394)
T 4fs7_A          297 SSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVEL  373 (394)
T ss_dssp             TTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEE
T ss_pred             ccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEE
Confidence            34555555433 43222234556666666666533 443333 4666666666666555 44222345666666666666


Q ss_pred             ccc
Q 004689          302 QNN  304 (736)
Q Consensus       302 ~~N  304 (736)
                      ..+
T Consensus       374 p~~  376 (394)
T 4fs7_A          374 PKR  376 (394)
T ss_dssp             EGG
T ss_pred             CCC
Confidence            433

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=91.89  E-value=0.031  Score=53.76  Aligned_cols=83  Identities=12%  Similarity=0.095  Sum_probs=58.6

Q ss_pred             ceEEEEccCCCCCccCCccc----ccccccccccccccccCCCCC-----CCCCCCCCcEEEcCCCCC---CC----CCC
Q 004689          224 SITVIHLSSKNLTGNIPSDL----TKLSSLVELWLDGNSLTGPIP-----DFSGCPDLRIIHLEDNQL---TG----PLP  287 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~----~~l~~L~~L~Ls~N~l~~~~p-----~~~~l~~L~~L~Ls~N~l---~g----~~p  287 (736)
                      .|+.|+|++|+|...-...|    ..-+.|++|+|+.|.|...--     .+..-+.|++|+|++|..   ..    .+-
T Consensus        71 ~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia  150 (197)
T 1pgv_A           71 HIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMM  150 (197)
T ss_dssp             CCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHH
T ss_pred             CcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHH
Confidence            68999999999985433334    456889999999999986321     355567799999997643   21    122


Q ss_pred             ccccCccccceeecccccC
Q 004689          288 SSLMNLPNLRELYVQNNML  306 (736)
Q Consensus       288 ~~~~~l~~L~~L~l~~N~l  306 (736)
                      ..+..-+.|+.|+++.|.+
T Consensus       151 ~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          151 MAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHHHCSSCCEEECCCCCH
T ss_pred             HHHHhCCCcCeEeccCCCc
Confidence            3444556788888877754

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=91.66  E-value=0.2  Score=53.24  Aligned_cols=77  Identities=16%  Similarity=0.202  Sum_probs=34.5

Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      .|+.+.+..+ ++..-...+.++.+|+.+.+..+ +..... .|.+|++|+.+.|.+|.++..-..+|.++.+|+.+.|.
T Consensus       241 ~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp  318 (379)
T 4h09_A          241 ALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLP  318 (379)
T ss_dssp             SCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECC
T ss_pred             cceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcC
Confidence            4555555443 33122223444555555555332 322222 34555555555555555542223345555555555554

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=90.93  E-value=0.28  Score=52.43  Aligned_cols=99  Identities=15%  Similarity=0.322  Sum_probs=56.4

Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      ..|+.+.+.++-.+ .-...+.++++|+.+.+. +.++.... .|.+|.+|+.++|..| ++..-..+|.+|++|+.+.|
T Consensus       265 ~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~i  341 (394)
T 4gt6_A          265 AYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAI  341 (394)
T ss_dssp             SSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred             ccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEE
Confidence            45667777655433 233355667777777775 34444333 5777777777777654 44222346777777777777


Q ss_pred             ccccCcCCCCccccc---ccccccccCC
Q 004689          302 QNNMLSGTVPSSLLS---KNVVLNYAGN  326 (736)
Q Consensus       302 ~~N~l~g~~P~~~~~---~~~~l~~~~n  326 (736)
                      ..+ ++ .|+...|.   .+..+.+.++
T Consensus       342 p~s-v~-~I~~~aF~~C~~L~~i~~~~~  367 (394)
T 4gt6_A          342 PSS-VT-KIPESAFSNCTALNNIEYSGS  367 (394)
T ss_dssp             CTT-CC-BCCGGGGTTCTTCCEEEESSC
T ss_pred             Ccc-cC-EEhHhHhhCCCCCCEEEECCc
Confidence            543 55 55554442   2344455554

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=90.05  E-value=0.51  Score=50.43  Aligned_cols=78  Identities=21%  Similarity=0.251  Sum_probs=35.3

Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      .|+.+.+. ++++..-...|.++++|+.++|..| ++..-. +|.+|++|+.+.|..+ ++..-..+|.+|++|+.+++.
T Consensus       289 ~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~  365 (394)
T 4gt6_A          289 ALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYS  365 (394)
T ss_dssp             TCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEES
T ss_pred             ccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEEC
Confidence            45555553 2333112224445555555555433 332222 4555555555555433 331222355555555555555


Q ss_pred             cc
Q 004689          303 NN  304 (736)
Q Consensus       303 ~N  304 (736)
                      +|
T Consensus       366 ~~  367 (394)
T 4gt6_A          366 GS  367 (394)
T ss_dssp             SC
T ss_pred             Cc
Confidence            44

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=88.81  E-value=0.52  Score=49.91  Aligned_cols=77  Identities=16%  Similarity=0.178  Sum_probs=39.1

Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQ  302 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~  302 (736)
                      +|+.+.+..+ ++..-...|.++++|+.+.|.++.++.... .|.+|.+|+.+.|..+ ++..-..+|.+|++|+.+.+.
T Consensus       264 ~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip  341 (379)
T 4h09_A          264 ALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP  341 (379)
T ss_dssp             TCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred             hhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence            4555555432 331222244556666666666655554443 4666666666666543 331222355566666666554

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=86.20  E-value=0.42  Score=51.08  Aligned_cols=73  Identities=16%  Similarity=0.209  Sum_probs=56.1

Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCcccccee
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL  299 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L  299 (736)
                      .+|+.++|.++ ++-.-...|.++++|+.+.|..| ++..-. +|.+|++|+.++|..| ++ .+...|.++++|+.+
T Consensus       320 ~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          320 TSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             TTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             CCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            57999999754 66333457889999999999877 665444 7999999999999865 33 345678888888865

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=80.47  E-value=3.7  Score=39.57  Aligned_cols=116  Identities=9%  Similarity=0.113  Sum_probs=78.3

Q ss_pred             CCCceeeEeeeeeeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCC
Q 004689          462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN  541 (736)
Q Consensus       462 ~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~N  541 (736)
                      .||+.+.. .+-.+++...+.|+.-..  ...+     ..-..++...+++++.+++....+++..     +|--+.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f-----~~ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPF-----DNIKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTT--SEEG-----GGGGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcc--cCCH-----HHHHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence            68888866 455566666665554332  2222     1234577888999999999988777665     788899999


Q ss_pred             EEEcCCCcEEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCc
Q 004689          542 ILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAIS  613 (736)
Q Consensus       542 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~  613 (736)
                      ++++.++.+++.-.|+....                  +|.-     .++..=.-.+=|++..+++++..|+
T Consensus       110 L~f~~~~~p~i~~RGik~~l------------------~P~~-----~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVV------------------DPLP-----VSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EEECTTSCEEESCCEETTTB------------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EEEcCCCCEEEEEccCccCC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999877764321                  2221     1112223356688889999988875

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	736
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-66
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-62
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-62
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-56
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-54
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-54
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-54
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-52
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-48
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-48
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-47
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	4e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-45
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-45
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-40
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-38
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-37
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-36
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-30
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-14
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-05
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-11
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-08
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.001
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-10
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.002
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	5e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.003
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.004
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	3e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	5e-04
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  217 bits (554), Expect = 6e-66
 Identities = 80/276 (28%), Positives = 134/276 (48%), Gaps = 23/276 (8%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           + ++IGSG FG VY GK      + +  +T+ + Q  + F NEV +L +  H N++ F+G
Sbjct: 12  VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
           Y        +V ++    +L  HL+     E +   IK ++IA   A+G++YLH     +
Sbjct: 72  YSTAPQL-AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHA---KS 124

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYISQQ-- 588
           IIHRDLKS+NI L + +  K+ DFGL+   +    SH    + G++ ++ PE    Q   
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184

Query: 589 -LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 647
             + +SDVY+FG++L EL++GQ   SN        N        +     +G + P  L 
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNI-------NNRDQIIFMVG----RGYLSPD-LS 232

Query: 648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
           +        ++     C+      RP   ++L  I+
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (536), Expect = 1e-63
 Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 25/274 (9%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
             K++G+G FGVV YGK +   ++A+K++       + EF  E  ++  + H  LVQ  G
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
            C ++    ++ E+M NG L  +L        R    + LE+ +D  + +EYL +     
Sbjct: 67  VCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESKQ--- 120

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL + N L++     KVSDFGLS++ +D     S   +  V +  PE  +  + + 
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 592 KSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 650
           KSD+++FGV++ E+ S G+             +I Q  +L+           P L  E  
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------RPHLASE-- 228

Query: 651 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 684
                K+      C       RP+   +L +I D
Sbjct: 229 -----KVYTIMYSCWHEKADERPTFKILLSNILD 257

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 2e-62
 Identities = 69/273 (25%), Positives = 123/273 (45%), Gaps = 23/273 (8%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
             ++IGSG FG+V+ G   +  ++A+K +       + +F  E  ++ ++ H  LVQ  G
Sbjct: 9   FVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
            C E+    LV+EFM +G L ++     T          L +  D  +G+ YL   C   
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVCEGMAYLEEAC--- 121

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
           +IHRDL + N L+ ++   KVSDFG+++F +D     S+  +  V +  PE +   + + 
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 592 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 651
           KSDV+SFGV++ E+ S  +     +  +     +              +  P L      
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------LYKPRLAST--- 229

Query: 652 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 684
                + +    C       RP+ S +L+ + +
Sbjct: 230 ----HVYQIMNHCWKERPEDRPAFSRLLRQLAE 258

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 6e-62
 Identities = 65/273 (23%), Positives = 123/273 (45%), Gaps = 23/273 (8%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           L +++G+G FG V+ G      ++AVK L          F  E  L+ ++ H+ LV+   
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              +E    ++ E+M NG+L + L        ++   K L++A   A+G+ ++       
Sbjct: 76  VVTQEPI-YIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN--- 129

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            IHRDL+++NIL+   +  K++DFGL++   D         +  + +  PE       T 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 592 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 651
           KSDV+SFG++L E+++          G     ++Q    ++E G    ++ P    E   
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYP---GMTNPEVIQ----NLERG--YRMVRPDNCPE--- 237

Query: 652 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 684
               ++ +   +C       RP+   +   ++D
Sbjct: 238 ----ELYQLMRLCWKERPEDRPTFDYLRSVLED 266

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 1e-60
 Identities = 62/295 (21%), Positives = 126/295 (42%), Gaps = 29/295 (9%)

Query: 411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           +L++ IG G FG V+ GK + G+E+AVK+ +S   +       E+     + H N++ F+
Sbjct: 6   VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFI 63

Query: 471 GYCQEEGRSV----LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
               ++  +     LV ++  +G+L ++L     +   +     +++A   A G+ +LH 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHM 118

Query: 527 GCV-----PAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---AVDGASHVSSIVRGTVGY 578
             V     PAI HRDLKS NIL+ K+    ++D GL+     A D      +   GT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 579 LDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGANC---RNIVQWAK 629
           + PE           +   ++D+Y+ G++  E+          +              + 
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 630 LHIESGDIQGIIDPSLLDEYD-IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
             +     +  + P++ + +   +++  + +    C   +G  R +   + K + 
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 3e-57
 Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 11/200 (5%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 469
              ++G+G  GVV+    K  G  +A K++        R     E+ +L   +   +V F
Sbjct: 10  KISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF 69

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G    +G   +  E M  G+L + L        RI      +++    KG+ YL     
Sbjct: 70  YGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH- 124

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             I+HRD+K SNIL++     K+ DFG+S   +D    +++   GT  Y+ PE       
Sbjct: 125 -KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHY 180

Query: 590 TDKSDVYSFGVILLELISGQ 609
           + +SD++S G+ L+E+  G+
Sbjct: 181 SVQSDIWSMGLSLVEMAVGR 200

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 5e-57
 Identities = 62/273 (22%), Positives = 114/273 (41%), Gaps = 23/273 (8%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLG 471
           LE K+G G FG V+ G       +A+K L          F  E  ++ ++ H  LVQ   
Sbjct: 21  LEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 79

Query: 472 YCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPA 531
              EE    +V E+M  G+L + L G     + +   + +++A   A G+ Y+       
Sbjct: 80  VVSEEPI-YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN--- 133

Query: 532 IIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTD 591
            +HRDL+++NIL+ +++  KV+DFGL++   D         +  + +  PE  +  + T 
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193

Query: 592 KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDI 651
           KSDV+SFG++L EL +                          + ++   ++         
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGM----------------VNREVLDQVERGYRMPCPP 237

Query: 652 QSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 684
           +    + +    C       RP+   +   ++D
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-56
 Identities = 63/277 (22%), Positives = 109/277 (39%), Gaps = 25/277 (9%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
           +   IG+G +G     + K DGK +  K L   S +   K+   +EV LL  + H N+V+
Sbjct: 8   VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67

Query: 469 FLGYCQEE--GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH- 525
           +     +       +V E+   G L   +       Q ++    L +       ++  H 
Sbjct: 68  YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127

Query: 526 -TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 584
            +     ++HRDLK +N+ LD     K+ DFGL++      S   +   GT  Y+ PE  
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQM 186

Query: 585 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 644
                 +KSD++S G +L EL +     +          I +     I            
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR-----YSDE 241

Query: 645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
           L +   I  M  +++            RPS+ E+L++
Sbjct: 242 LNE--IITRMLNLKDY----------HRPSVEEILEN 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 2e-56
 Identities = 67/278 (24%), Positives = 115/278 (41%), Gaps = 32/278 (11%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
            + +IG G F  VY G   +   E+A   L     +   ++ F  E  +L  + H N+V+
Sbjct: 13  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72

Query: 469 FLGYCQEEGRS----VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
           F    +   +     VLV E M +GTLK +L       + +             KG+++L
Sbjct: 73  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 128

Query: 525 HTGCVPAIIHRDLKSSNILL-DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           HT   P IIHRDLK  NI +       K+ D GL+       +  +  V GT  ++ PE 
Sbjct: 129 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM 184

Query: 584 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 643
              ++  +  DVY+FG+ +LE+ + +   S  +   N   I +     ++      +  P
Sbjct: 185 -YEEKYDESVDVYAFGMCMLEMATSEYPYSECQ---NAAQIYRRVTSGVKPASFDKVAIP 240

Query: 644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
            + +   I+   +  +            R SI ++L  
Sbjct: 241 EVKEI--IEGCIRQNKDE----------RYSIKDLLNH 266

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  192 bits (489), Expect = 2e-56
 Identities = 72/307 (23%), Positives = 137/307 (44%), Gaps = 42/307 (13%)

Query: 400 FTLSDIEDATK-----------MLEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSN- 443
           FT  D  +A +            +E+ IG+G FG V  G LK   +    +A+K L S  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 444 SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQ 503
           + + +R+F +E +++ +  H N++   G   +    +++ EFM NG+L   L     ++ 
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QNDG 123

Query: 504 RINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD 563
           +   I+ + +    A G++YL        +HRDL + NIL++ ++  KVSDFGLS+F  D
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 564 GASHVSSI----VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGA 619
             S  +       +  + +  PE    ++ T  SDV+S+G+++ E++S  E    +    
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD---- 236

Query: 620 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVL 679
                       + + D+   I+        +     + +  L C     + RP   +++
Sbjct: 237 ------------MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 680 KDIQDAI 686
             +   I
Sbjct: 285 NTLDKMI 291

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  191 bits (486), Expect = 4e-56
 Identities = 70/274 (25%), Positives = 120/274 (43%), Gaps = 23/274 (8%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           ++ K+G G +G VY G  K     +AVK L  ++ +   EF  E  ++  I H NLVQ L
Sbjct: 21  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 79

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
           G C  E    ++ EFM  G L ++L     + Q ++ +  L +A   +  +EYL      
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK---K 134

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
             IHRDL + N L+ ++   KV+DFGLS+          +  +  + +  PE     + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194

Query: 591 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 650
            KSDV++FGV+L E+ +   +                     +   +  +++     E  
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGI----------------DLSQVYELLEKDYRMERP 238

Query: 651 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 684
                K+ E    C   +   RPS +E+ +  + 
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (487), Expect = 7e-56
 Identities = 66/285 (23%), Positives = 123/285 (43%), Gaps = 37/285 (12%)

Query: 406 EDATKMLE--KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK---REFTNEVTLLS 459
           +D  K+    ++IG G FG VY+ + +++ + +A+K ++ +  Q     ++   EV  L 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 460 RIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 519
           ++ H N +Q+ G    E  + LV E+               H++ +  ++   +   A +
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQ 126

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 579
           G+ YLH+     +IHRD+K+ NILL +    K+ DFG +       S V     GT  ++
Sbjct: 127 GLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWM 178

Query: 580 DPEYYISQ---QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 636
            PE  ++    Q   K DV+S G+  +EL   +  + N    +   +I Q     ++SG 
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 238

Query: 637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
                     +   + S  +   +           RP+   +LK 
Sbjct: 239 ----WSEYFRNF--VDSCLQKIPQD----------RPTSEVLLKH 267

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 2e-55
 Identities = 61/284 (21%), Positives = 114/284 (40%), Gaps = 29/284 (10%)

Query: 404 DIEDATKMLEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIH 462
           + ED  +++  ++G G FG VY  + K+     A KV+ + S +   ++  E+ +L+   
Sbjct: 9   NPEDFWEII-GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67

Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
           H N+V+ L     E    ++ EF   G +   +      E+ +   +   + +     + 
Sbjct: 68  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALN 124

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           YLH      IIHRDLK+ NIL       K++DFG+S           S + GT  ++ PE
Sbjct: 125 YLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPE 180

Query: 583 YYISQQLTD-----KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 637
             + +   D     K+DV+S G+ L+E+   +              I +     +     
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPS- 239

Query: 638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
                 +  D   ++   +    A          R + S++L+ 
Sbjct: 240 --RWSSNFKDF--LKKCLEKNVDA----------RWTTSQLLQH 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 3e-55
 Identities = 60/271 (22%), Positives = 115/271 (42%), Gaps = 25/271 (9%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
             +KIG G  G VY    +  G+E+A++ +       K    NE+ ++    + N+V +L
Sbjct: 24  RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
                     +V E++  G+L + +      E  ++  +   +  +  + +E+LH+    
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSNQ-- 136

Query: 531 AIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLT 590
            +IHRD+KS NILL      K++DFG         S  S++V GT  ++ PE    +   
Sbjct: 137 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194

Query: 591 DKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD 650
            K D++S G++ +E+I G+    NE        I       +++ +    +     D   
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE---KLSAIFRDF-- 249

Query: 651 IQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
           +     ++ +           R S  E+L+ 
Sbjct: 250 LNRCLDMDVE----------KRGSAKELLQH 270

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 1e-54
 Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 37/286 (12%)

Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGK---REFTNEV 455
           + L D E     + + +G G FG VY  + K     +A+KVL     +      +   EV
Sbjct: 3   WALEDFE-----IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57

Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 515
            + S + H N+++  GY  +  R  L+ E+   GT+   L        + +  +      
Sbjct: 58  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 113

Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 575
           + A  + Y H+     +IHRD+K  N+LL      K++DFG S  A          + GT
Sbjct: 114 ELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGT 167

Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 635
           + YL PE    +   +K D++S GV+  E + G+       +    + I +         
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR------VEF 221

Query: 636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
                +     D   I  + K               RP + EVL+ 
Sbjct: 222 TFPDFVTEGARDL--ISRLLKHNPSQ----------RPMLREVLEH 255

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 3e-54
 Identities = 74/286 (25%), Positives = 131/286 (45%), Gaps = 34/286 (11%)

Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLS 459
             + +++     L + IG G FG V  G  + G ++AVK + +++    + F  E ++++
Sbjct: 4   LNMKELK-----LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMT 55

Query: 460 RIHHRNLVQFLGYC-QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAA 518
           ++ H NLVQ LG   +E+G   +V E+M  G+L ++L         +     L+ + D  
Sbjct: 56  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVC 113

Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           + +EYL        +HRDL + N+L+ +   AKVSDFGL+K A    S      +  V +
Sbjct: 114 EAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKW 166

Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 638
             PE    ++ + KSDV+SFG++L E+ S              +++V      +E G   
Sbjct: 167 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP---YPRIPLKDVVP----RVEKGYKM 219

Query: 639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 684
              D      Y++            C      MRPS  ++ + ++ 
Sbjct: 220 DAPDGCPPAVYEV---------MKNCWHLDAAMRPSFLQLREQLEH 256

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 4e-54
 Identities = 79/308 (25%), Positives = 127/308 (41%), Gaps = 32/308 (10%)

Query: 386 VSSLNDAPAEAAHCFTLSDIEDATKMLEKKIGSGGFGVVYYGKLKDGK----EIAVKVLT 441
           +S+LN    +A     +           + IG G FG VY+G L D        AVK L 
Sbjct: 6   LSALNPELVQAVQHVVI-GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 64

Query: 442 SNSYQGK-REFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEFMHNGTLKEHLYGTL 499
             +  G+  +F  E  ++    H N++  LG C   EG  ++V  +M +G L+  +    
Sbjct: 65  RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--- 121

Query: 500 THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 559
                      +      AKG   +        +HRDL + N +LD+    KV+DFGL++
Sbjct: 122 NETHNPTVKDLIGFGLQVAKG---MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

Query: 560 FAVDG---ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEK 616
              D    + H  +  +  V ++  E   +Q+ T KSDV+SFGV+L EL++       + 
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238

Query: 617 FGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS 676
                 N        ++           L  EY    ++++    L C  P   MRPS S
Sbjct: 239 ------NTFDITVYLLQG-------RRLLQPEYCPDPLYEV---MLKCWHPKAEMRPSFS 282

Query: 677 EVLKDIQD 684
           E++  I  
Sbjct: 283 ELVSRISA 290

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 4e-54
 Identities = 69/280 (24%), Positives = 123/280 (43%), Gaps = 33/280 (11%)

Query: 413 EKKIGSGGFGVVYYGKLKD---GKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLV 467
           +K++GSG FG V  G  +     K +AVK+L   +N    K E   E  ++ ++ +  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           + +G C+ E   +LV E    G L ++L       + +     +E+    + G++YL   
Sbjct: 72  RMIGICEAESW-MLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES 126

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS--IVRGTVGYLDPEYYI 585
                +HRDL + N+LL     AK+SDFGLSK      ++  +    +  V +  PE   
Sbjct: 127 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 586 SQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 644
             + + KSDV+SFGV++ E  S GQ+     K       + +  ++   +G         
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG-----CPRE 238

Query: 645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 684
           + D   +   W  + +           RP  + V   +++
Sbjct: 239 MYDL--MNLCWTYDVE----------NRPGFAAVELRLRN 266

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (471), Expect = 6e-54
 Identities = 67/300 (22%), Positives = 120/300 (40%), Gaps = 47/300 (15%)

Query: 412 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRIHHR 464
             + IG G FG V+  +            +AVK+L   +    + +F  E  L++   + 
Sbjct: 17  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH--------------------EQR 504
           N+V+ LG C       L++E+M  G L E L     H                       
Sbjct: 77  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136

Query: 505 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 564
           ++  ++L IA   A G+ YL        +HRDL + N L+ ++M  K++DFGLS+     
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193

Query: 565 -ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 623
                       + ++ PE     + T +SDV+++GV+L E+ S         +G     
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY---YGMAHEE 250

Query: 624 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
           ++ +    +  G+I    +   L+ Y++           +C       RPS   + + +Q
Sbjct: 251 VIYY----VRDGNILACPENCPLELYNL---------MRLCWSKLPADRPSFCSIHRILQ 297

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 9e-54
 Identities = 59/274 (21%), Positives = 113/274 (41%), Gaps = 26/274 (9%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
           L + +G G +G V     +   + +AVK++    +         E+ +   ++H N+V+F
Sbjct: 9   LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            G+ +E     L  E+   G L + +      +  +              G+ YLH    
Sbjct: 69  YGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG--- 121

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK-FAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             I HRD+K  N+LLD+    K+SDFGL+  F  +    + + + GT+ Y+ PE    ++
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 589 L-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 647
              +  DV+S G++L  +++G+             +  +  K ++        ID + L 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK---KIDSAPLA 238

Query: 648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
              +  +      A          R +I ++ KD
Sbjct: 239 --LLHKILVENPSA----------RITIPDIKKD 260

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-53
 Identities = 66/283 (23%), Positives = 129/283 (45%), Gaps = 30/283 (10%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE-----IAVKVLTSNSYQGKR-EFTNEVTLLSRIHHRN 465
            +K IG+G FG VY G LK         +A+K L +   + +R +F  E  ++ +  H N
Sbjct: 11  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +++  G   +    +++ E+M NG L + L      +   + ++ + +    A G++YL 
Sbjct: 71  IIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA 127

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG--ASHVSSIVRGTVGYLDPEY 583
                  +HRDL + NIL++ ++  KVSDFGLS+   D   A++ +S  +  + +  PE 
Sbjct: 128 N---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 584 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 643
              ++ T  SDV+SFG+++ E+++  E    E                + + ++   I+ 
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----------------LSNHEVMKAIND 228

Query: 644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 686
                  +     I +  + C       RP  ++++  +   I
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-53
 Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 31/282 (10%)

Query: 410 KMLEKKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRN 465
            + + ++G G FG V  G  +      ++A+KVL   + +   E    E  ++ ++ +  
Sbjct: 11  LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 70

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           +V+ +G CQ E   +LV E    G L + L G     + I      E+    + G++YL 
Sbjct: 71  IVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE 126

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF--AVDGASHVSSIVRGTVGYLDPEY 583
                  +HRDL + N+LL     AK+SDFGLSK   A D      S  +  + +  PE 
Sbjct: 127 E---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183

Query: 584 YISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
              ++ + +SDV+S+GV + E +S GQ+     K       I Q  ++            
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPE-----CP 238

Query: 643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD 684
           P L   Y +            C +     RP    V + ++ 
Sbjct: 239 PEL---YAL---------MSDCWIYKWEDRPDFLTVEQRMRA 268

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 4e-52
 Identities = 67/298 (22%), Positives = 119/298 (39%), Gaps = 41/298 (13%)

Query: 412 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 463
             K +G+G FG V                +AVK+L  +++  +RE   +E+ +LS + +H
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG--------------TLTHEQRINWIK 509
            N+V  LG C   G ++++ E+   G L   L                    E  ++   
Sbjct: 87  MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146

Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH-V 568
            L  +   AKG+ +L +      IHRDL + NILL      K+ DFGL++   + +++ V
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203

Query: 569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 628
               R  V ++ PE   +   T +SDV+S+G+ L EL S   +                 
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS---------------PY 248

Query: 629 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 686
                      +I           +  ++ +    C       RP+  ++++ I+  I
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-51
 Identities = 65/297 (21%), Positives = 117/297 (39%), Gaps = 46/297 (15%)

Query: 412 LEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI-HH 463
             K +GSG FG V               ++AVK+L   +   +RE   +E+ +++++  H
Sbjct: 41  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100

Query: 464 RNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTH-------------------EQR 504
            N+V  LG C   G   L++E+   G L  +L                            
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160

Query: 505 INWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG 564
           + +   L  A   AKG+E+L      + +HRDL + N+L+      K+ DFGL++  +  
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217

Query: 565 ASHVS-SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRN 623
           +++V     R  V ++ PE       T KSDV+S+G++L E+ S                
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP----------- 266

Query: 624 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 680
              +  + +++ +   +I      +    +  +I      C       RPS   +  
Sbjct: 267 ---YPGIPVDA-NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-50
 Identities = 59/285 (20%), Positives = 114/285 (40%), Gaps = 30/285 (10%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKE----IAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNL 466
           L + IG G FG V+ G     +     +A+K   + +    RE F  E   + +  H ++
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
           V+ +G    E    ++ E    G L+  L      +  ++    +  A   +  + YL +
Sbjct: 71  VKLIGVI-TENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 126

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                 +HRD+ + N+L+  +   K+ DFGLS++  D   + +S  +  + ++ PE    
Sbjct: 127 ---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 587 QQLTDKSDVYSFGVILLELI-SGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 645
           ++ T  SDV+ FGV + E++  G +     K       I    +L +          P+L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN-----CPPTL 238

Query: 646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIER 690
                +   W  +             RP  +E+   +   +  E+
Sbjct: 239 YSL--MTKCWAYDPS----------RRPRFTELKAQLSTILEEEK 271

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  177 bits (450), Expect = 2e-50
 Identities = 60/273 (21%), Positives = 108/273 (39%), Gaps = 25/273 (9%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           + +++G+G FGVV+       G   A K + +     K     E+  +S + H  LV   
Sbjct: 30  IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
              +++   V++YEFM  G L E +        +++  + +E      KG+ ++H     
Sbjct: 90  DAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHENN-- 144

Query: 531 AIIHRDLKSSNILL--DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
             +H DLK  NI+    +    K+ DFGL+       S       GT  +  PE    + 
Sbjct: 145 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKP 201

Query: 589 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 648
           +   +D++S GV+   L+SG      E      RN+      +++     G I     D 
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-DWNMDDSAFSG-ISEDGKDF 259

Query: 649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
             I+ +   +             R +I + L+ 
Sbjct: 260 --IRKLLLADPNT----------RMTIHQALEH 280

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 6e-50
 Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 38/292 (13%)

Query: 412 LEKKIGSGGFGVVYYGKLKDG---KEIAVKVL-TSNSYQGKREFTNEVTLLSRI-HHRNL 466
            +  IG G FG V   ++K      + A+K +    S    R+F  E+ +L ++ HH N+
Sbjct: 14  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHE------------QRINWIKRLEIA 514
           +  LG C+  G   L  E+  +G L + L  +   E              ++  + L  A
Sbjct: 74  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133

Query: 515 EDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRG 574
            D A+G++YL        IHRDL + NIL+ ++  AK++DFGLS+             R 
Sbjct: 134 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM--GRL 188

Query: 575 TVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 634
            V ++  E       T  SDV+S+GV+L E++S          G  C  + +        
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC---GMTCAELYEK------- 238

Query: 635 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 686
                 +      E  +    ++ +    C     + RPS +++L  +   +
Sbjct: 239 ------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  173 bits (439), Expect = 1e-48
 Identities = 55/273 (20%), Positives = 121/273 (44%), Gaps = 25/273 (9%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           + +++GSG FGVV+       G+    K + +     K    NE+++++++HH  L+   
Sbjct: 33  ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLH 92

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
              +++   VL+ EF+  G L + +      + +++  + +     A +G++++H     
Sbjct: 93  DAFEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMHE---H 146

Query: 531 AIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
           +I+H D+K  NI+ +  K    K+ DFGL+         +  +   T  +  PE    + 
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREP 204

Query: 589 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 648
           +   +D+++ GV+   L+SG    + E      +N+ +      E  D    + P   D 
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE--DAFSSVSPEAKDF 262

Query: 649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
             I+++ + E +           R ++ + L+ 
Sbjct: 263 --IKNLLQKEPRK----------RLTVHDALEH 283

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 1e-48
 Identities = 64/283 (22%), Positives = 106/283 (37%), Gaps = 31/283 (10%)

Query: 412 LEKKIGSGGFGVVYYGKLK----DGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHR 464
           L +K+G G FGVV  G+          +AVK L     +  +   +F  EV  +  + HR
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
           NL++  G         +V E    G+L + L     H+           A   A+G+ YL
Sbjct: 72  NLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--VSSIVRGTVGYLDPE 582
            +      IHRDL + N+LL      K+ DFGL +       H  +    +    +  PE
Sbjct: 128 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 583 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID 642
              ++  +  SD + FGV L E+ +  +            N  Q      + G+     +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG------LNGSQILHKIDKEGERLPRPE 238

Query: 643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA 685
               D Y++          + C       RP+   +   + +A
Sbjct: 239 DCPQDIYNV---------MVQCWAHKPEDRPTFVALRDFLLEA 272

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 2e-48
 Identities = 57/279 (20%), Positives = 116/279 (41%), Gaps = 30/279 (10%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL-----TSNSYQGKREFTNEVTLLSRIHHRN 465
             K +GSG FG VY G    +G+++ + V       + S +  +E  +E  +++ + + +
Sbjct: 13  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72

Query: 466 LVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLH 525
           + + LG C       L+ + M  G L +++     H+  I     L      AKG+ YL 
Sbjct: 73  VCRLLGICLTSTV-QLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYL- 127

Query: 526 TGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYY 584
                 ++HRDL + N+L+      K++DFGL+K    +   + +   +  + ++  E  
Sbjct: 128 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 585 ISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS 644
           + +  T +SDV+S+GV + EL++      +                   + +I  I++  
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI----------------PASEISSILEKG 229

Query: 645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQ 683
                       +    + C +     RP   E++ +  
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 9e-48
 Identities = 57/274 (20%), Positives = 104/274 (37%), Gaps = 30/274 (10%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---TSNSYQGKREFTNEVTLLSRIHHRNLV 467
             K +G G F  V   + L   +E A+K+L              T E  ++SR+ H   V
Sbjct: 12  FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
           +     Q++ +      +  NG L +++          +         +    +EYLH  
Sbjct: 72  KLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHG- 126

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF-AVDGASHVSSIVRGTVGYLDPEYYIS 586
               IIHRDLK  NILL++ M  +++DFG +K  + +     ++   GT  Y+ PE    
Sbjct: 127 --KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 587 QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           +     SD+++ G I+ +L++G             + I++         D      P   
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK------LEYDFPEKFFPKAR 238

Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 680
           D   ++ +  ++             R    E+  
Sbjct: 239 DL--VEKLLVLDATK----------RLGCEEMEG 260

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 3e-47
 Identities = 63/289 (21%), Positives = 122/289 (42%), Gaps = 33/289 (11%)

Query: 412 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLT-SNSYQGKREFTNEVTLLSRIHHR 464
           + +++G G FG+VY G  K          +A+K +  + S + + EF NE +++   +  
Sbjct: 24  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------GTLTHEQRINWIKRLEIAEDAA 518
           ++V+ LG   +   ++++ E M  G LK +L                +  K +++A + A
Sbjct: 84  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143

Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG-ASHVSSIVRGTVG 577
            G+ YL+       +HRDL + N ++ +    K+ DFG+++   +             V 
Sbjct: 144 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200

Query: 578 YLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI 637
           ++ PE       T  SDV+SFGV+L E+ +  E               +     +  G +
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVLRFVMEGGL 253

Query: 638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 686
               D      +++           MC   +  MRPS  E++  I++ +
Sbjct: 254 LDKPDNCPDMLFEL---------MRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 4e-47
 Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 40/297 (13%)

Query: 412 LEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQG-KREFTNEVTLLSRI-HH 463
           L K +G G FG V              + +AVK+L   +     R   +E+ +L  I HH
Sbjct: 17  LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76

Query: 464 RNLVQFLGYCQEEGRSV-LVYEFMHNGTLKEHLYG------------TLTHEQRINWIKR 510
            N+V  LG C + G  + ++ EF   G L  +L                 ++  +     
Sbjct: 77  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136

Query: 511 LEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV-S 569
           +  +   AKG+E+L +      IHRDL + NILL +    K+ DFGL++       +V  
Sbjct: 137 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193

Query: 570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAK 629
              R  + ++ PE    +  T +SDV+SFGV+L E+ S   +            I +   
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV------KIDEEFC 247

Query: 630 LHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 686
             ++ G      D +  + Y            L C       RP+ SE+++ + + +
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQT---------MLDCWHGEPSQRPTFSELVEHLGNLL 295

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 2e-45
 Identities = 50/273 (18%), Positives = 107/273 (39%), Gaps = 26/273 (9%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           + + +G G FG+V+        K    K +       +     E+++L+   HRN++   
Sbjct: 9   IAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
              +     V+++EF+    + E +    T    +N  + +       + +++LH+    
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---H 121

Query: 531 AIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
            I H D++  NI+    +    K+ +FG ++    G +    ++     Y  PE +    
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPEVHQHDV 179

Query: 589 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE 648
           ++  +D++S G ++  L+SG      E       NI+  A+   +    +  I    +D 
Sbjct: 180 VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN-AEYTFDEEAFKE-ISIEAMDF 237

Query: 649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
             +  +   E K           R + SE L+ 
Sbjct: 238 --VDRLLVKERK----------SRMTASEALQH 258

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  162 bits (411), Expect = 2e-45
 Identities = 68/283 (24%), Positives = 114/283 (40%), Gaps = 29/283 (10%)

Query: 404 DIEDATKMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRI 461
           DI D        +G+G F  V   +  +  K +A+K +   + +GK     NE+ +L +I
Sbjct: 6   DIRDIYD-FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI 64

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
            H N+V      +  G   L+ + +  G L + +      +          +       +
Sbjct: 65  KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAV 120

Query: 522 EYLHTGCVPAIIHRDLKSSNILL---DKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGY 578
           +YLH      I+HRDLK  N+L    D+  +  +SDFGLSK    G   V S   GT GY
Sbjct: 121 KYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGY 175

Query: 579 LDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ 638
           + PE    +  +   D +S GVI   L+ G     +E        I++ A+   +S    
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK-AEYEFDSPYWD 234

Query: 639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
             I  S  D   I+ + + + +           R +  + L+ 
Sbjct: 235 D-ISDSAKDF--IRHLMEKDPEK----------RFTCEQALQH 264

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 7e-45
 Identities = 62/298 (20%), Positives = 127/298 (42%), Gaps = 42/298 (14%)

Query: 412 LEKKIGSGGFGVVYYGKLK--------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRI- 461
           L K +G G FG V   +             ++AVK+L S++ +    +  +E+ ++  I 
Sbjct: 17  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLY------------GTLTHEQRINWIK 509
            H+N++  LG C ++G   ++ E+   G L+E+L              +   E++++   
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136

Query: 510 RLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS 569
            +  A   A+G+EYL +      IHRDL + N+L+ +    K++DFGL++       +  
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193

Query: 570 SIV-RGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 628
           +   R  V ++ PE    +  T +SDV+SFGV+L E+ +   +                 
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------------ 241

Query: 629 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 686
                  ++  ++      +       ++      C       RP+  ++++D+   +
Sbjct: 242 ----PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  160 bits (405), Expect = 2e-44
 Identities = 58/285 (20%), Positives = 118/285 (41%), Gaps = 33/285 (11%)

Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVL---TSNSYQGKREFTNEV 455
           ++L D +     + + +G+G FG V+  + + +G+  A+KVL        +      +E 
Sbjct: 1   YSLQDFQ-----ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER 55

Query: 456 TLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAE 515
            +LS + H  +++  G  Q+  +  ++ +++  G L   L  +      +      E+  
Sbjct: 56  LMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 115

Query: 516 DAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGT 575
                   L       II+RDLK  NILLDK+   K++DFG +K+  D        + GT
Sbjct: 116 -------ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGT 164

Query: 576 VGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG 635
             Y+ PE   ++      D +SFG+++ E+++G     +         I+  A+L     
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-AELRFPPF 223

Query: 636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 680
                 +  + D   +  +   +    +     G+++    +V  
Sbjct: 224 -----FNEDVKDL--LSRLITRDLSQRL-----GNLQNGTEDVKN 256

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  156 bits (394), Expect = 2e-43
 Identities = 57/225 (25%), Positives = 108/225 (48%), Gaps = 17/225 (7%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK---REFTNEVTLLSRIHHRNLV 467
           L + +G GG   V+  + L+  +++AVKVL ++  +       F  E    + ++H  +V
Sbjct: 11  LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70

Query: 468 QFLGYCQEE----GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
                 + E        +V E++   TL++ ++     E  +   + +E+  DA + + +
Sbjct: 71  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNF 126

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV--SSIVRGTVGYLDP 581
            H      IIHRD+K +NI++      KV DFG+++   D  + V  ++ V GT  YL P
Sbjct: 127 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 582 EYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ 626
           E      +  +SDVYS G +L E+++G+   + +   +     V+
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  154 bits (390), Expect = 9e-43
 Identities = 66/287 (22%), Positives = 108/287 (37%), Gaps = 40/287 (13%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL---------TSNSYQGKREFTNEVTLLSRI 461
            ++ +G G   VV         KE AVK++              + +     EV +L ++
Sbjct: 7   PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66

Query: 462 H-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 520
             H N++Q     +      LV++ M  G L ++L    T +  ++  +  +I     + 
Sbjct: 67  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEV 122

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           I  LH      I+HRDLK  NILLD  M  K++DFG S     G       V GT  YL 
Sbjct: 123 ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLA 177

Query: 581 PEYYISQQL------TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES 634
           PE               + D++S GVI+  L++G     + K     R I+        S
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG-NYQFGS 236

Query: 635 GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
            +       ++ D   +     ++ +           R +  E L  
Sbjct: 237 PEWDD-YSDTVKDL--VSRFLVVQPQK----------RYTAEEALAH 270

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 1e-41
 Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 13/203 (6%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE----FTNEVTLLSRIHHRNL 466
           L K +G G FG V+  + K   +  A+K L  +      +       +  L     H  L
Sbjct: 6   LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65

Query: 467 VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHT 526
                  Q +     V E+++ G L  H+        + +  +    A +   G+++LH+
Sbjct: 66  THMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 527 GCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
                I++RDLK  NILLDK    K++DFG+ K  + G +  ++   GT  Y+ PE  + 
Sbjct: 122 KG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLG 177

Query: 587 QQLTDKSDVYSFGVILLELISGQ 609
           Q+     D +SFGV+L E++ GQ
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQ 200

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  153 bits (387), Expect = 2e-41
 Identities = 65/277 (23%), Positives = 108/277 (38%), Gaps = 28/277 (10%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSY---QGKREFTNEV---TLLSRIHHR 464
           + + IG GGFG VY  +  D GK  A+K L        QG+    NE    +L+S     
Sbjct: 8   VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67

Query: 465 NLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
            +V          +   + + M+ G L  HL    +     +       A +   G+E++
Sbjct: 68  FIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGLEHM 123

Query: 525 HTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYY 584
           H      +++RDLK +NILLD+H   ++SD GL+        H      GT GY+ PE  
Sbjct: 124 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVL 177

Query: 585 ISQQLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP 643
                 D  +D +S G +L +L+ G       K             + +E   +     P
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE---LPDSFSP 234

Query: 644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLK 680
            L     ++ + + +    +     G +     EV +
Sbjct: 235 ELRSL--LEGLLQRDVNRRL-----GCLGRGAQEVKE 264

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 1e-40
 Identities = 58/276 (21%), Positives = 104/276 (37%), Gaps = 27/276 (9%)

Query: 414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE-----FTNEVTLLSRIHHRNLV 467
             +G G F  VY  + K   + +A+K +        ++        E+ LL  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 468 QFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
             L     +    LV++FM              +   +             +G+EYLH  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 528 CVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQ 587
               I+HRDLK +N+LLD++   K++DFGL+K         +  V  T  Y  PE     
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175

Query: 588 QLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           ++     D+++ G IL EL+     +  +        I             + +  P+  
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI------------FETLGTPTEE 223

Query: 647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
              D+ S+           +P  H+  +  + L D+
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 1e-40
 Identities = 65/293 (22%), Positives = 115/293 (39%), Gaps = 35/293 (11%)

Query: 400 FTLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVL------TSNSYQGKREFT 452
           F   +++D      +++GSG F VV   + K  G + A K +      +S     + +  
Sbjct: 3   FRQENVDDYYDTG-EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61

Query: 453 NEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLE 512
            EV++L  I H N++      + +   +L+ E +  G L + L      ++ +   +  E
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATE 117

Query: 513 IAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH----MRAKVSDFGLSKFAVDGASHV 568
             +    G+ YLH+     I H DLK  NI+L        R K+ DFGL+     G    
Sbjct: 118 FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 173

Query: 569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA 628
              + GT  ++ PE    + L  ++D++S GVI   L+SG      +       N+    
Sbjct: 174 -KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV- 231

Query: 629 KLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
               E  +          D   I+ +   + K           R +I + L+ 
Sbjct: 232 NYEFED-EYFSNTSALAKDF--IRRLLVKDPK----------KRMTIQDSLQH 271

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (375), Expect = 1e-40
 Identities = 54/288 (18%), Positives = 104/288 (36%), Gaps = 34/288 (11%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           L +KIGSG FG +Y G  +  G+E+A+K+    +     +   E  +   +     +  +
Sbjct: 11  LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTI 68

Query: 471 GYCQEEGRS-VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
            +C  EG   V+V E +         +      ++ +    L +A+     IEY+H+   
Sbjct: 69  RWCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN- 123

Query: 530 PAIIHRDLKSSNIL---LDKHMRAKVSDFGLSKFAVDGASHV------SSIVRGTVGYLD 580
              IHRD+K  N L     K     + DFGL+K   D  +H       +  + GT  Y  
Sbjct: 124 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 181

Query: 581 PEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWA--KLHIESGDIQ 638
              ++  + + + D+ S G +L+    G       K     +   + +  K+      + 
Sbjct: 182 INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241

Query: 639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 686
                       +     +              +P  S + +  ++  
Sbjct: 242 KGYPSEFATY--LNFCRSLRFDD----------KPDYSYLRQLFRNLF 277

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  148 bits (373), Expect = 2e-40
 Identities = 52/283 (18%), Positives = 97/283 (34%), Gaps = 20/283 (7%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQF 469
             +KIG G +GVVY  +   G+  A+K +               E+++L  + H N+V+ 
Sbjct: 6   GLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
                 + R VLV+E +     K         E  +  +           GI Y H    
Sbjct: 66  YDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR- 120

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             ++HRDLK  N+L+++    K++DFGL++         +  +             S++ 
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQGI 640
           +   D++S G I  E+++G               I +         W  +          
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 641 IDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 681
                L               L+   +    + R +  + L+ 
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 5e-40
 Identities = 55/288 (19%), Positives = 107/288 (37%), Gaps = 22/288 (7%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE-FTNEVTLLSRIHHRNLVQF 469
               IG G +G+V       +   +A+K ++   +Q   +    E+ +L R  H N++  
Sbjct: 12  NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI 71

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               +      +   ++    L       L   Q ++            +G++Y+H+   
Sbjct: 72  NDIIRAPTIEQMKDVYLVTH-LMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN- 129

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI--VRGTVGYLDPEYYISQ 587
             ++HRDLK SN+LL+     K+ DFGL++ A     H   +     T  Y  PE  ++ 
Sbjct: 130 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187

Query: 588 QLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL 646
           +   KS D++S G IL E++S +     + +     +I+       +      I   +  
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 247

Query: 647 DEYDIQSMWKIEEKALM-------------CVLPHGHMRPSISEVLKD 681
               +    K+    L               +  + H R  + + L  
Sbjct: 248 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 5e-40
 Identities = 54/284 (19%), Positives = 106/284 (37%), Gaps = 20/284 (7%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
             +KIG G +GVVY  + K  G+ +A+K +   + +         E++LL  ++H N+V+
Sbjct: 6   KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 65

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
            L     E +  LV+EF+H    K       +    I             +G+ + H+  
Sbjct: 66  LLDVIHTENKLYLVFEFLHQDLKKFMD---ASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              ++HRDLK  N+L++     K++DFGL++         +  V              + 
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 589 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQG 639
            +   D++S G I  E+++ +     +        I +         W  +         
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 640 IIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 681
               +  D   +      + ++L+   +    + R S    L  
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 6e-40
 Identities = 57/291 (19%), Positives = 104/291 (35%), Gaps = 29/291 (9%)

Query: 412 LEKKIGSGGFGVVYYGKLK--DGKEIAVKVLTSNSYQGK--REFTNEVTLLSRI---HHR 464
              +IG G +G V+  +     G+ +A+K +   + +         EV +L  +    H 
Sbjct: 11  CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 70

Query: 465 NLVQFLGYC-----QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAK 519
           N+V+    C       E +  LV+E +               E  +      ++     +
Sbjct: 71  NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLR 127

Query: 520 GIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYL 579
           G+++LH+     ++HRDLK  NIL+    + K++DFGL++      +  S  V  T+ Y 
Sbjct: 128 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTLWYR 182

Query: 580 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 639
            PE  +        D++S G I  E+   +              I+    L  E    + 
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 640 IIDPSLLDEYDIQSMWKI-------EEKALM--CVLPHGHMRPSISEVLKD 681
           +  P            +          K L+  C+  +   R S    L  
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 7e-39
 Identities = 62/289 (21%), Positives = 108/289 (37%), Gaps = 28/289 (9%)

Query: 412 LEKKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
             K IG+G FGVVY  KL D G+ +A+K +     Q KR    E+ ++ ++ H N+V+  
Sbjct: 24  DTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLR 79

Query: 471 GYCQEEGRS------VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYL 524
            +    G         LV +++     +   +     +Q +  I          + + Y+
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSLAYI 138

Query: 525 HTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEY 583
           H+     I HRD+K  N+LLD      K+ DFG +K  V G     S +           
Sbjct: 139 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELI 194

Query: 584 YISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIES 634
           + +   T   DV+S G +L EL+ GQ     +        I++           +++   
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254

Query: 635 GDIQGIIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 681
            + +     +       +     E  AL    +      R +  E    
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 8e-39
 Identities = 55/284 (19%), Positives = 107/284 (37%), Gaps = 37/284 (13%)

Query: 410 KMLEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLV 467
           K+  + +G G  G V      +  ++ A+K+L     Q   +   EV L  R     ++V
Sbjct: 14  KVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIV 68

Query: 468 QFLGYCQ----EEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEY 523
           + +   +         ++V E +  G L   +      +Q     +  EI +   + I+Y
Sbjct: 69  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQY 126

Query: 524 LHTGCVPAIIHRDLKSSNILLDKHM---RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLD 580
           LH+     I HRD+K  N+L          K++DFG +K      S  +     T  Y+ 
Sbjct: 127 LHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVA 181

Query: 581 PEYYISQQLTDKSDVYSFGVILLELISGQ---EAISNEKFGANCRNIVQWAKLHIESGDI 637
           PE    ++     D++S GVI+  L+ G     +          +  ++  +    + + 
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241

Query: 638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
              +   +     I+++ K E             R +I+E +  
Sbjct: 242 SE-VSEEVKML--IRNLLKTEPT----------QRMTITEFMNH 272

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  143 bits (360), Expect = 1e-38
 Identities = 44/289 (15%), Positives = 105/289 (36%), Gaps = 34/289 (11%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFL 470
           + ++IG G FGV++ G  L + +++A+K     S     +  +E      +     +  +
Sbjct: 9   VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 471 GYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVP 530
            Y  +EG   ++   +   +L++ L       ++ +       A+     ++ +H     
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 121

Query: 531 AIIHRDLKSSNILLDKHMR-----AKVSDFGLSKFAVDGASHVSSI------VRGTVGYL 579
            +++RD+K  N L+ +          V DFG+ KF  D  +           + GT  Y+
Sbjct: 122 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 580 DPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG 639
               ++ ++ + + D+ + G + +  + G       K  A  +   +      +S  ++ 
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK-AATNKQKYERIGEKKQSTPLRE 239

Query: 640 IID--PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI 686
           +    P    +Y +     +   A           P    +       +
Sbjct: 240 LCAGFPEEFYKY-MHYARNLAFDA----------TPDYDYLQGLFSKVL 277

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-38
 Identities = 52/281 (18%), Positives = 98/281 (34%), Gaps = 44/281 (15%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE------FTNEVTLLSRIH-- 462
           +   +GSGGFG VY G  + D   +A+K +  +      E         EV LL ++   
Sbjct: 8   VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67

Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
              +++ L + +     VL+ E              +T    +             + + 
Sbjct: 68  FSGVIRLLDWFERPDSFVLILERPEPVQDLFDF---ITERGALQEELARSFFWQVLEAVR 124

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDP 581
           + H      ++HRD+K  NIL+D +    K+ DFG      D    V +   GT  Y  P
Sbjct: 125 HCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPP 178

Query: 582 EYYISQQLTDKS-DVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGI 640
           E+    +   +S  V+S G++L +++ G     ++         +   ++          
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-------EEIIRGQVFFRQR----- 226

Query: 641 IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD 681
           +         I+    +              RP+  E+   
Sbjct: 227 VSSECQHL--IRWCLALRPSD----------RPTFEEIQNH 255

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 2e-38
 Identities = 50/285 (17%), Positives = 104/285 (36%), Gaps = 22/285 (7%)

Query: 412 LEKKIGSGGFGVVYYGKLK-DGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
             +KIG G +G V+  K +   + +A+K +    +          E+ LL  + H+N+V+
Sbjct: 6   KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR 65

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
                  + +  LV+EF      K            ++            KG+ + H+  
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              ++HRDLK  N+L++++   K+++FGL++         S+ V           + ++ 
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 589 LTDKSDVYSFGVILLELISG----------QEAISNEKFGANCRNIVQWAKLHIESGDIQ 638
            +   D++S G I  EL +            + +             QW  +        
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 639 GIIDPSLLDEYDIQSMWKIEEKALM--CVLPHGHMRPSISEVLKD 681
             + P+     ++        + L+   +  +   R S  E L+ 
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 2e-37
 Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 17/213 (7%)

Query: 401 TLSDIEDATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKRE---FTNEVT 456
           T++D +       K +G G FG V   + K  G+  A+K+L       K E      E  
Sbjct: 3   TMNDFD-----YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR 57

Query: 457 LLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAED 516
           +L    H  L       Q   R   V E+ + G L  HL        R            
Sbjct: 58  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-------SRERVFTEERARFY 110

Query: 517 AAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTV 576
            A+ +  L       +++RD+K  N++LDK    K++DFGL K  +   + + +   GT 
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTP 169

Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQ 609
            YL PE           D +  GV++ E++ G+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 4e-36
 Identities = 55/286 (19%), Positives = 103/286 (36%), Gaps = 22/286 (7%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
             + +GSG +G V      + G ++A+K L     S    +    E+ LL  + H N++ 
Sbjct: 22  DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 81

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
            L     +       +F           G L   +++   +   +     KG+ Y+H   
Sbjct: 82  LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 141

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              IIHRDLK  N+ +++    K+ DFGL++ A    S ++  V               +
Sbjct: 142 ---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMR 195

Query: 589 LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ---------WAKLHIESGDIQG 639
            T   D++S G I+ E+I+G+            + I++           +L  +      
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255

Query: 640 IIDPSLLDEYDIQSMWKIEEKAL----MCVLPHGHMRPSISEVLKD 681
              P L  +     +      A+      ++     R +  E L  
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 7e-36
 Identities = 53/300 (17%), Positives = 110/300 (36%), Gaps = 38/300 (12%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGK--REFTNEVTLLSRIHHRNLVQ 468
              KIG G FG V+  +  K G+++A+K +   + +         E+ +L  + H N+V 
Sbjct: 14  KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 73

Query: 469 FLGYCQE--------EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKG 520
            +  C+         +G   LV++F  +                +      EI       
Sbjct: 74  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-------NVLVKFTLSEIKRVMQML 126

Query: 521 IEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF---AVDGASHVSSIVRGTVG 577
           +  L+      I+HRD+K++N+L+ +    K++DFGL++    A +   +  +    T+ 
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 578 YLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 636
           Y  PE  + ++      D++  G I+ E+ +    +           I Q     I    
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ-LCGSITPEV 245

Query: 637 IQGIIDPSLLDEYDIQSMWKIEEKALM---------------CVLPHGHMRPSISEVLKD 681
              + +  L ++ ++    K + K  +                ++     R    + L  
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  135 bits (340), Expect = 3e-35
 Identities = 58/290 (20%), Positives = 113/290 (38%), Gaps = 33/290 (11%)

Query: 414 KKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKRE---FTNEVTLLSRIHHRNLVQF 469
           K +G+G FG V   K  + G   A+K+L        ++     NE  +L  ++   LV+ 
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 470 LGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCV 529
               ++     +V E++  G +  HL        R +       A       EYLH+   
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSLD- 161

Query: 530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQL 589
             +I+RDLK  N+L+D+    +V+DFG +K            + GT   L PE  +S+  
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LCGTPEALAPEIILSKGY 215

Query: 590 TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY 649
               D ++ GV++ E+ +G      ++       IV                   L D  
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------KVRFPSHFSSDLKD-- 267

Query: 650 DIQSMWKIEEKALMCVLPHGHMRPSISEVL-----KDIQDAIVIEREAAA 694
            ++++ +++          G+++  ++++             + +R+  A
Sbjct: 268 LLRNLLQVDLTKRF-----GNLKNGVNDIKNHKWFATTDWIAIYQRKVEA 312

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  129 bits (325), Expect = 1e-33
 Identities = 52/277 (18%), Positives = 114/277 (41%), Gaps = 23/277 (8%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQF 469
           L +K+G G +  V+    + + +++ VK+L       K++   E+ +L  +    N++  
Sbjct: 39  LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITL 95

Query: 470 LGYCQEEGRS--VLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTG 527
               ++       LV+E ++N   K+         Q +          +  K ++Y H+ 
Sbjct: 96  ADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM 148

Query: 528 CVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYIS 586
               I+HRD+K  N+++D +H + ++ D+GL++F   G  +   +   +  +  PE  + 
Sbjct: 149 G---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVD 203

Query: 587 QQLTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL 645
            Q+ D   D++S G +L  +I  +E   +     N   +V+ AK+         I   ++
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGH--DNYDQLVRIAKVLGTEDLYDYIDKYNI 261

Query: 646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDI 682
             +     +     +       H   +  +S    D 
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 1e-31
 Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 18/209 (8%)

Query: 412 LEKKIGSGGFGVVYYGKL----KDGKEIAVKVL----TSNSYQGKREFTNEVTLLSRI-H 462
           L K +G+G +G V+  +       GK  A+KVL         +       E  +L  I  
Sbjct: 28  LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87

Query: 463 HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
              LV      Q E +  L+ ++++ G L  HL       +    I   EI         
Sbjct: 88  SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL------- 140

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
            L       II+RD+K  NILLD +    ++DFGLSK  V   +  +    GT+ Y+ P+
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 583 YYISQQ--LTDKSDVYSFGVILLELISGQ 609
                        D +S GV++ EL++G 
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 3e-30
 Identities = 56/276 (20%), Positives = 104/276 (37%), Gaps = 22/276 (7%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
               +GSG +G V      K G  +AVK L     S    +    E+ LL  + H N++ 
Sbjct: 22  NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81

Query: 469 FLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC 528
            L             +      L       +   Q++       +     +G++Y+H+  
Sbjct: 82  LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141

Query: 529 VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQ 588
              IIHRDLK SN+ +++    K+ DFGL++          +    T  Y  PE  ++  
Sbjct: 142 ---IIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEIMLNWM 194

Query: 589 LTD-KSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD 647
             +   D++S G I+ EL++G+            + I++          + G     LL 
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR----------LVGTPGAELLK 244

Query: 648 EYDIQSMWK-IEEKALMCVLPHGHMRPSISEVLKDI 682
           +   +S    I+    M  +   ++    + +  D+
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 280

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 6e-30
 Identities = 50/225 (22%), Positives = 92/225 (40%), Gaps = 21/225 (9%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVL--TSNSYQGKREFTNEVTLLSRIHHRNLVQ 468
             K IGSG  G+V         + +A+K L     +    +    E+ L+  ++H+N++ 
Sbjct: 21  NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIS 80

Query: 469 FLGYC------QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIE 522
            L         +E     LV E M     +         +  ++  +   +      GI+
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDANLCQ-------VIQMELDHERMSYLLYQMLCGIK 133

Query: 523 YLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPE 582
           +LH+     IIHRDLK SNI++      K+ DFGL++    G S + +    T  Y  PE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 188

Query: 583 YYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQW 627
             +     +  D++S G I+ E++  +       +      +++ 
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  115 bits (287), Expect = 2e-28
 Identities = 42/241 (17%), Positives = 97/241 (40%), Gaps = 18/241 (7%)

Query: 412 LEKKIGSGGFGVVYYGK-LKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL---- 466
           L +K+G G F  V+  K + +   +A+K++            +E+ LL R++  +     
Sbjct: 17  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKED 75

Query: 467 -------VQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRL-EIAEDAA 518
                  ++ L +   +G + +    +     +  L     +E R   +  + +I++   
Sbjct: 76  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135

Query: 519 KGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGLSKFAVDGASHVS-SIVRGTV 576
            G++Y+H  C   IIH D+K  N+L++       +    ++            +    T 
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 577 GYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD 636
            Y  PE  +       +D++S   ++ ELI+G      ++  +  ++    A++    G+
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253

Query: 637 I 637
           +
Sbjct: 254 L 254

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 92.9 bits (230), Expect = 3e-22
 Identities = 29/158 (18%), Positives = 48/158 (30%), Gaps = 21/158 (13%)

Query: 412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVL----------TSNSYQGKREFTNEVTLLSRI 461
           + K +G G    V+    +   E  VK                  G   F+      +R 
Sbjct: 4   IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 462 HHRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGI 521
             R L +  G          VY +  N  L E          R+      E+ +   + +
Sbjct: 64  EFRALQKLQGLAV-----PKVYAWEGNAVLME--LIDAKELYRVRVENPDEVLDMILEEV 116

Query: 522 EYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSK 559
              +      I+H DL   N+L+ +     + DF  S 
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQSV 150

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 72.7 bits (177), Expect = 3e-14
 Identities = 15/93 (16%), Positives = 36/93 (38%), Gaps = 5/93 (5%)

Query: 212 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 271
                       ++T + L   N++   P  ++ L+ L  L+   N ++      +   +
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLANLTN 352

Query: 272 LRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 304
           +  +    NQ++   P  L NL  + +L + + 
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 66.6 bits (161), Expect = 3e-12
 Identities = 21/81 (25%), Positives = 37/81 (45%), Gaps = 3/81 (3%)

Query: 246 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 305
           L +L  L L  N+++   P  S    L+ +   +N+++    SSL NL N+  L   +N 
Sbjct: 306 LKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQ 362

Query: 306 LSGTVPSSLLSKNVVLNYAGN 326
           +S   P + L++   L     
Sbjct: 363 ISDLTPLANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 50.0 bits (118), Expect = 6e-07
 Identities = 36/131 (27%), Positives = 52/131 (39%), Gaps = 24/131 (18%)

Query: 219 SDPQPSITVIHLSSKNLTGNI---PSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRII 275
           SD  P   + +L   +L GN       L  L++L +L L  N ++   P  SG   L  +
Sbjct: 210 SDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTEL 268

Query: 276 HLEDNQLTGPLP--------------------SSLMNLPNLRELYVQNNMLSGTVPSSLL 315
            L  NQ++   P                    S + NL NL  L +  N +S   P S L
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSL 328

Query: 316 SKNVVLNYAGN 326
           +K   L +A N
Sbjct: 329 TKLQRLFFANN 339

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 46.5 bits (109), Expect = 8e-06
 Identities = 13/78 (16%), Positives = 30/78 (38%), Gaps = 3/78 (3%)

Query: 246 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 305
           L+  ++  L   ++T  +   +    +  +  +   +       +  L NL ++   NN 
Sbjct: 21  LAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ 77

Query: 306 LSGTVPSSLLSKNVVLNY 323
           L+   P   L+K V +  
Sbjct: 78  LTDITPLKNLTKLVDILM 95

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 1e-05
 Identities = 24/78 (30%), Positives = 36/78 (46%), Gaps = 3/78 (3%)

Query: 245 KLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 304
           KL++L  L    N ++   P      +L  + L  NQL      +L +L NL +L + NN
Sbjct: 195 KLTNLESLIATNNQISDITPLGI-LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANN 251

Query: 305 MLSGTVPSSLLSKNVVLN 322
            +S   P S L+K   L 
Sbjct: 252 QISNLAPLSGLTKLTELK 269

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 69.4 bits (168), Expect = 3e-13
 Identities = 19/79 (24%), Positives = 34/79 (43%), Gaps = 2/79 (2%)

Query: 212 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 271
            ++         ++  + L +  + G +P  LT+L  L  L +  N+L G IP       
Sbjct: 233 LAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR 292

Query: 272 LRIIHLEDNQ-LTG-PLPS 288
             +    +N+ L G PLP+
Sbjct: 293 FDVSAYANNKCLCGSPLPA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 60.1 bits (144), Expect = 3e-10
 Identities = 21/62 (33%), Positives = 28/62 (45%), Gaps = 1/62 (1%)

Query: 269 CPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL-LSKNVVLNYAGNI 327
             +L  + L +N++ G LP  L  L  L  L V  N L G +P    L +  V  YA N 
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302

Query: 328 NL 329
            L
Sbjct: 303 CL 304

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 55.9 bits (133), Expect = 5e-09
 Identities = 15/58 (25%), Positives = 22/58 (37%), Gaps = 3/58 (5%)

Query: 253 WLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN-MLSG 308
            L  N + G +P   +    L  +++  N L G +P    NL         NN  L G
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCG 306

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 63.1 bits (152), Expect = 3e-11
 Identities = 25/104 (24%), Positives = 39/104 (37%), Gaps = 5/104 (4%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQL 282
            + V+  S   L   +P DL        L L  N +T     DF    +L  + L +N++
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 283 TGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGN 326
           +   P +   L  L  LY+  N L   +P  +      L    N
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHEN 110

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 54.3 bits (129), Expect = 2e-08
 Identities = 24/93 (25%), Positives = 38/93 (40%), Gaps = 4/93 (4%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQ 281
           P   ++ L +  +T     D   L +L  L L  N ++   P  F+    L  ++L  NQ
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
           L   LP  +     L+EL V  N ++    S  
Sbjct: 91  LKE-LPEKMPK--TLQELRVHENEITKVRKSVF 120

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 46.6 bits (109), Expect = 5e-06
 Identities = 16/128 (12%), Positives = 38/128 (29%), Gaps = 25/128 (19%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTG--------------------- 261
            ++  + L +  ++   P     L  L  L+L  N L                       
Sbjct: 55  KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114

Query: 262 ---PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKN 318
               + +      +  +     + +G    +   +  L  + + +  ++ T+P  L    
Sbjct: 115 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSL 173

Query: 319 VVLNYAGN 326
             L+  GN
Sbjct: 174 TELHLDGN 181

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 40.0 bits (92), Expect = 7e-04
 Identities = 17/115 (14%), Positives = 38/115 (33%), Gaps = 30/115 (26%)

Query: 223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLD------------------------GNS 258
           PS+T +HL    +T    + L  L++L +L L                          N 
Sbjct: 171 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 230

Query: 259 LTGPIPDFSGCPDLRIIHLEDNQLTG------PLPSSLMNLPNLRELYVQNNMLS 307
           L       +    +++++L +N ++         P       +   + + +N + 
Sbjct: 231 LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 39.6 bits (91), Expect = 0.001
 Identities = 19/71 (26%), Positives = 31/71 (43%), Gaps = 4/71 (5%)

Query: 245 KLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 303
               +VEL  +    +G     F G   L  I + D  +T  +P  L   P+L EL++  
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDG 180

Query: 304 NMLSGTVPSSL 314
           N ++    +SL
Sbjct: 181 NKITKVDAASL 191

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 55.9 bits (134), Expect = 4e-10
 Identities = 24/105 (22%), Positives = 38/105 (36%), Gaps = 25/105 (23%)

Query: 227 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDL-------------- 272
           V+HL+ K+LT  +   L +L  +  L L  N L    P  +    L              
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59

Query: 273 --------RIIHLEDNQLTG-PLPSSLMNLPNLRELYVQNNMLSG 308
                   + + L +N+L        L++ P L  L +Q N L  
Sbjct: 60  GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.2 bits (88), Expect = 6e-04
 Identities = 11/40 (27%), Positives = 17/40 (42%), Gaps = 2/40 (5%)

Query: 273 RIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS 312
           R++HL    LT      L  L  +  L + +N L    P+
Sbjct: 1   RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA 38

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 52.3 bits (124), Expect = 5e-08
 Identities = 25/97 (25%), Positives = 43/97 (44%), Gaps = 3/97 (3%)

Query: 207 CLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDF 266
            L +  + +   S       + +LS  N   +  + L  LS L  L  D N ++  I   
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPL 191

Query: 267 SGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 303
           +  P+L  +HL++NQ++   P  L N  NL  + + N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 2e-05
 Identities = 15/59 (25%), Positives = 30/59 (50%), Gaps = 2/59 (3%)

Query: 264 PDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLN 322
              +    L  +  +DN+++   P  L +LPNL E++++NN +S   P +  S   ++ 
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVT 223

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 5e-04
 Identities = 8/61 (13%), Positives = 26/61 (42%), Gaps = 3/61 (4%)

Query: 246 LSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM 305
           L++ +++    +++T  +   +    +  +      +T      +  L NL  L +++N 
Sbjct: 18  LANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74

Query: 306 L 306
           +
Sbjct: 75  I 75

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.4 bits (121), Expect = 2e-07
 Identities = 23/118 (19%), Positives = 37/118 (31%), Gaps = 9/118 (7%)

Query: 199 WAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNS 258
                  P         +        +          +  I S      SL EL +  N 
Sbjct: 236 LTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNK 295

Query: 259 LTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSG--TVPSSL 314
           L   +P  +  P L  +    N L   +P       NL++L+V+ N L     +P S+
Sbjct: 296 LIE-LP--ALPPRLERLIASFNHLAE-VPEL---PQNLKQLHVEYNPLREFPDIPESV 346

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 2e-06
 Identities = 15/75 (20%), Positives = 28/75 (37%), Gaps = 6/75 (8%)

Query: 248 SLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDNQLTG----PLPSSLMNLPNLRELYV 301
            +  L +    L+              +++ L+D  LT      + S+L   P L EL +
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 302 QNNMLSGTVPSSLLS 316
           ++N L       +L 
Sbjct: 63  RSNELGDVGVHCVLQ 77

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 9e-06
 Identities = 20/103 (19%), Positives = 34/103 (33%), Gaps = 14/103 (13%)

Query: 211 PWSWLQCNSDPQPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIPD- 265
                Q    P   + V+ L+  +++ +    + + L    SL EL L  N L       
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416

Query: 266 -----FSGCPDLRIIHLEDNQLTGPLPSSLMNL----PNLREL 299
                      L  + L D   +  +   L  L    P+LR +
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 7e-04
 Identities = 14/55 (25%), Positives = 24/55 (43%), Gaps = 4/55 (7%)

Query: 266 FSGCPDLRIIHLEDNQLTG----PLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS 316
                 LR++ L D  ++      L ++L+   +LREL + NN L       L+ 
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE 419

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (107), Expect = 7e-06
 Identities = 18/64 (28%), Positives = 32/64 (50%), Gaps = 2/64 (3%)

Query: 242 DLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV 301
           +++K++S +E+  D  +LT   PD     D  I+HL +N L     ++LM    L +L +
Sbjct: 5   EVSKVASHLEVNCDKRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 302 QNNM 305
               
Sbjct: 63  DRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 16/100 (16%), Positives = 30/100 (30%), Gaps = 3/100 (3%)

Query: 207 CLPVPWSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDG-NSLTGPIPD 265
                 + L   +              N    +P  L   +  +E      N+LT     
Sbjct: 107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAG 166

Query: 266 -FSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 304
             +G  +L  + L++N L   +P        L   ++  N
Sbjct: 167 LLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.4 bits (103), Expect = 2e-05
 Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 1/91 (1%)

Query: 225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLT 283
           +  +HL    L    P     L++L  L+L  N+L     D F    +L  + L  N+++
Sbjct: 107 LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166

Query: 284 GPLPSSLMNLPNLRELYVQNNMLSGTVPSSL 314
                +   L +L  L +  N ++   P + 
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAF 197

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.9 bits (102), Expect = 3e-05
 Identities = 12/76 (15%), Positives = 28/76 (36%), Gaps = 2/76 (2%)

Query: 232 SKNLTGNIPSDLTKLSSLVELWLDGNSLT--GPIPDFSGCPDLRIIHLEDNQLTGPLPSS 289
            ++      ++      +  + L  + +         S C  L+ + LE  +L+ P+ ++
Sbjct: 31  PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 90

Query: 290 LMNLPNLRELYVQNNM 305
           L    NL  L +    
Sbjct: 91  LAKNSNLVRLNLSGCS 106

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 4e-05
 Identities = 12/73 (16%), Positives = 29/73 (39%), Gaps = 3/73 (4%)

Query: 244 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 303
              +  ++  L   S+T  +   +    +  I   ++ +       +  LPN+ +L++  
Sbjct: 21  DAFAETIKDNLKKKSVTDAVTQ-NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 304 NMLSGTVPSSLLS 316
           N L+   P + L 
Sbjct: 78  NKLTDIKPLANLK 90

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 5e-04
 Identities = 10/41 (24%), Positives = 19/41 (46%), Gaps = 2/41 (4%)

Query: 263 IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 303
           I   +G   L+ ++L  N ++     +L  L NL  L + +
Sbjct: 171 IVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 11/66 (16%), Positives = 25/66 (37%), Gaps = 3/66 (4%)

Query: 212 WSWLQCNSDPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPD 271
                        +  + L    ++  +P  L  L+ L  L+L  N ++  +   +G  +
Sbjct: 145 KITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKN 201

Query: 272 LRIIHL 277
           L ++ L
Sbjct: 202 LDVLEL 207

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (93), Expect = 2e-04
 Identities = 16/72 (22%), Positives = 27/72 (37%), Gaps = 2/72 (2%)

Query: 238 NIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTG--PLPSSLMNLPN 295
               DL   +  V L    +            P+L  ++L +N+L     + S +   PN
Sbjct: 33  RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPN 92

Query: 296 LRELYVQNNMLS 307
           L+ L +  N L 
Sbjct: 93  LKILNLSGNELK 104

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 0.002
 Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 3/90 (3%)

Query: 229 HLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS 288
            L  + +   +   ++K     +  LD   L    PD        +++   +     L  
Sbjct: 3   ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLRS-DPDLVAQNIDVVLNRRSSMAAT-LRI 59

Query: 289 SLMNLPNLRELYVQNNMLSGTVPSSLLSKN 318
              N+P L  L + NN L      S + + 
Sbjct: 60  IEENIPELLSLNLSNNRLYRLDDMSSIVQK 89

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (94), Expect = 3e-04
 Identities = 10/43 (23%), Positives = 14/43 (32%)

Query: 262 PIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN 304
           P   F G     I+ +   ++       L NL  LR     N 
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (84), Expect = 0.004
 Identities = 14/88 (15%), Positives = 24/88 (27%), Gaps = 12/88 (13%)

Query: 211 PWSWLQCNSDPQPSITVIHLSSKNLTGNIPSD-LTKLSSLVELWLDGNSLTGPIPD-FSG 268
               +   +     +  ++LS  N    +P+D     S  V L +    +          
Sbjct: 164 GIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223

Query: 269 CPDLRIIHLEDNQLTGPLPSSLMNLPNL 296
              LR               +L  LP L
Sbjct: 224 LKKLRARST----------YNLKKLPTL 241

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (90), Expect = 3e-04
 Identities = 16/109 (14%), Positives = 35/109 (32%), Gaps = 3/109 (2%)

Query: 224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD--FSGCPDLRIIHLEDNQ 281
             + +  +      +    L    +L EL+++       +      G  +LR + +  + 
Sbjct: 9   GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSKNVVLNYAGNINLH 330
           L    P +    P L  L +  N L      ++   ++         LH
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 5e-04
 Identities = 10/65 (15%), Positives = 25/65 (38%), Gaps = 3/65 (4%)

Query: 244 TKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN 303
           T L+  ++  L   ++T  +   +    +  +  +   +       +  L NL ++   N
Sbjct: 15  TALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 71

Query: 304 NMLSG 308
           N L+ 
Sbjct: 72  NQLTD 76

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 11/47 (23%), Positives = 18/47 (38%), Gaps = 3/47 (6%)

Query: 253 WLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL 299
               N +T   P  +    L  + +  N+++    S L  L NL  L
Sbjct: 156 NFSSNQVTDLKP-LANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (88), Expect = 0.001
 Identities = 6/55 (10%), Positives = 17/55 (30%), Gaps = 1/55 (1%)

Query: 263 IPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLSK 317
              ++     R + L   ++   + +    L     +   +N +       LL +
Sbjct: 11  AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKLDGFPLLRR 64

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.5 bits (83), Expect = 0.004
 Identities = 15/80 (18%), Positives = 22/80 (27%), Gaps = 3/80 (3%)

Query: 232 SKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLM 291
           +  L        T      EL L G  +       +       I   DN++         
Sbjct: 4   TAELIEQAAQ-YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFP-- 60

Query: 292 NLPNLRELYVQNNMLSGTVP 311
            L  L+ L V NN +     
Sbjct: 61  LLRRLKTLLVNNNRICRIGE 80

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	736
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.86
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.68
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.43
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.42
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.41
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.3
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.24
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.23
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.22
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.21
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.16
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.15
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.13
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.09
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.97
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.9
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.87
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.86
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.84
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.82
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.82
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.8
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.78
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.76
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.57
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.53
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.38
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.37
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.27
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.02
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.97
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.95
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.91
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.62
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.51
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	97.34
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.26
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.21
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.13
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.02
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.69
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.67
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	96.57
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	96.12
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.86
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	95.42
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.99
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	92.91
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	90.53

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=416.84  Aligned_cols=252  Identities=28%  Similarity=0.476  Sum_probs=197.7

Q ss_pred             HhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      .+.+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|..++..++||||+++|+
T Consensus         8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~   86 (263)
T d1sm2a_           8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC   86 (263)
T ss_dssp             EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence            3568899999999999999988999999987543 345679999999999999999999999999999999999999999


Q ss_pred             HHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCccee
Q 004689          491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSS  570 (736)
Q Consensus       491 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~  570 (736)
                      |.+++...   ...+++..++.++.|+|+||.|||++   +|+||||||+|||++.++++||+|||+++...........
T Consensus        87 L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  160 (263)
T d1sm2a_          87 LSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST  160 (263)
T ss_dssp             HHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             HHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence            99998643   35688999999999999999999998   9999999999999999999999999999876554444444


Q ss_pred             cccccccccCccccccCcCCCcchhHHHHHHHHHHHhC-CCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcC
Q 004689          571 IVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISG-QEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEY  649 (736)
Q Consensus       571 ~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG-~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  649 (736)
                      ...||+.|+|||++.+..++.++|||||||++|||+|+ .+|+.....    ..+.+.+.    .+..  ...+      
T Consensus       161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~----~~~~~~i~----~~~~--~~~p------  224 (263)
T d1sm2a_         161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----SEVVEDIS----TGFR--LYKP------  224 (263)
T ss_dssp             ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH----HHHHHHHH----HTCC--CCCC------
T ss_pred             ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH----HHHHHHHH----hcCC--CCCc------
Confidence            56799999999999999999999999999999999995 555543331    12222222    1111  1111      


Q ss_pred             CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          650 DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       650 ~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                       .....++.+++.+|++.||++||||+||+++|+++.
T Consensus       225 -~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         225 -RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence             122346889999999999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-50  Score=415.53  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=208.0

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.+.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+++|++++|||||++++++.+ +..++||||+++
T Consensus        14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~   91 (272)
T d1qpca_          14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN   91 (272)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred             HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence            345678899999999999999988999999997543 345679999999999999999999998865 456899999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++...  ....+++..++.++.|+++||.|||++   +|+||||||+||||+.++.+||+|||+|+.........
T Consensus        92 g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~  166 (272)
T d1qpca_          92 GSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (272)
T ss_dssp             CBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             CcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence            9999987542  344689999999999999999999998   99999999999999999999999999998776554444


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||+||..|+.....   ...+.+.    +..+..     +..   
T Consensus       167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~---~~~~~~~----i~~~~~-----~~~---  231 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NPEVIQN----LERGYR-----MVR---  231 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHH----HHTTCC-----CCC---
T ss_pred             ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC---HHHHHHH----HHhcCC-----CCC---
Confidence            4556799999999999999999999999999999999996655543221   1122222    122211     111   


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                       +.....++.+++.+|++.||++||||+||++.|+++..
T Consensus       232 -p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence             11223458899999999999999999999999998753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-49  Score=418.11  Aligned_cols=253  Identities=26%  Similarity=0.454  Sum_probs=196.5

Q ss_pred             hhccccccCceEEEEEEECC-C---cEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          412 LEKKIGSGGFGVVYYGKLKD-G---KEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~-~---~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      +.++||+|+||+||+|+++. +   ..||||++.... ....+.|.+|+++|++++|||||+++|+|..++..++|||||
T Consensus        30 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~  109 (299)
T d1jpaa_          30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM  109 (299)
T ss_dssp             EEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             EeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEec
Confidence            45789999999999998752 2   258999886543 233567999999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      ++|+|.+++...   ...+++..++.++.|+++||.|||++   +|+||||||+||||+.++++||+|||+|+.......
T Consensus       110 ~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         110 ENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             TTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             CCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence            999999988632   34689999999999999999999998   999999999999999999999999999987644322


Q ss_pred             cc----eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          567 HV----SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       567 ~~----~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      ..    .....||+.|||||++.++.++.++|||||||++|||+| |+.||.+....    .+...+.    .+.     
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~----~~~~~i~----~~~-----  250 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ----DVINAIE----QDY-----  250 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHHH----TTC-----
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH----HHHHHHH----cCC-----
Confidence            21    122458999999999999999999999999999999998 89999765421    2222221    111     


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                          ....+......+.+++.+|++.||++||||.||++.|++++.
T Consensus       251 ----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         251 ----RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                111122334568899999999999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.4e-50  Score=417.78  Aligned_cols=256  Identities=28%  Similarity=0.393  Sum_probs=210.7

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.+.||+|+||+||+|++. +++.||||+++... ...++|.+|+++|++++|||||+++++|.+++..++|||||+
T Consensus        18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~   96 (287)
T d1opja_          18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT   96 (287)
T ss_dssp             GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence            4456789999999999999986 58899999987543 345679999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++...  ....+++..++.++.|+++||+|||++   +|+||||||+||||+.++++||+|||+|+........
T Consensus        97 ~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~  171 (287)
T d1opja_          97 YGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  171 (287)
T ss_dssp             TCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred             CcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence            99999998643  245689999999999999999999998   9999999999999999999999999999876655544


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      ......||+.|+|||++.+..|+.++|||||||++|||++|..|+.....   ...+.+.    +..+.         ..
T Consensus       172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~---~~~~~~~----i~~~~---------~~  235 (287)
T d1opja_         172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQVYEL----LEKDY---------RM  235 (287)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHH----HHTTC---------CC
T ss_pred             eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch---HHHHHHH----HhcCC---------CC
Confidence            45556689999999999999999999999999999999997776643321   1122221    11111         11


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      ..+.....++.+++.+|++.||++||||.||++.|+.+.
T Consensus       236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            112223346889999999999999999999999998763

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-49  Score=404.58  Aligned_cols=249  Identities=29%  Similarity=0.502  Sum_probs=209.8

Q ss_pred             hhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      +.++||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++||||++++|+|.+++..++||||+++|+|
T Consensus         8 ~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l   86 (258)
T d1k2pa_           8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL   86 (258)
T ss_dssp             CCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred             EeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence            568899999999999999988899999997644 3457899999999999999999999999999999999999999999


Q ss_pred             HHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcceec
Q 004689          492 KEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVSSI  571 (736)
Q Consensus       492 ~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~  571 (736)
                      .+++..   ....+++..+++++.|+++||+|||+.   +|+||||||+|||++.++.+||+|||+++............
T Consensus        87 ~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (258)
T d1k2pa_          87 LNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG  160 (258)
T ss_dssp             HHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred             HHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence            999753   345688999999999999999999998   99999999999999999999999999998765544444445


Q ss_pred             ccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCcCC
Q 004689          572 VRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDEYD  650 (736)
Q Consensus       572 ~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  650 (736)
                      ..||+.|+|||++.+..++.++|||||||++|||+| |+.||......    .+..    .+.++..  ...       +
T Consensus       161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~----~~~~----~i~~~~~--~~~-------p  223 (258)
T d1k2pa_         161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS----ETAE----HIAQGLR--LYR-------P  223 (258)
T ss_dssp             SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH----HHHH----HHHTTCC--CCC-------C
T ss_pred             cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH----HHHH----HHHhCCC--CCC-------c
Confidence            679999999999999999999999999999999998 89999866522    1221    1222211  111       1


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          651 IQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       651 ~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                      .....++.+++.+|++.||++|||++||+++|.+
T Consensus       224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            1223468899999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-49  Score=408.04  Aligned_cols=256  Identities=32%  Similarity=0.538  Sum_probs=199.2

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      +.+.+.||+|+||+||+|+++  ..||||+++...  ....+.|.+|+++|++++|||||++++++.+ +..++|||||+
T Consensus        10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~   86 (276)
T d1uwha_          10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE   86 (276)
T ss_dssp             CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred             EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence            345688999999999999875  469999987543  3335678999999999999999999999865 46799999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC-C
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-S  566 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~-~  566 (736)
                      +|+|.+++...   ...+++..++.++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+|+...... .
T Consensus        87 ~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~  160 (276)
T d1uwha_          87 GSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS  160 (276)
T ss_dssp             EEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred             CCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence            99999999643   34689999999999999999999998   99999999999999999999999999998664432 2


Q ss_pred             cceecccccccccCcccccc---CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          567 HVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      .......||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+.....   .+..    ....+...    +
T Consensus       161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~---~~~~----~~~~~~~~----p  229 (276)
T d1uwha_         161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIF----MVGRGYLS----P  229 (276)
T ss_dssp             -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHH----HHHHTSCC----C
T ss_pred             ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH---HHHH----HHhcCCCC----C
Confidence            23345679999999999864   358889999999999999999999998654211   1111    11112111    1


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      .+ ..........+.+++.+|++.||++|||++||+++|+.+.
T Consensus       230 ~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         230 DL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             CG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            11 1112223346889999999999999999999999998764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-49  Score=407.48  Aligned_cols=250  Identities=22%  Similarity=0.339  Sum_probs=199.7

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..++||||++
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~   86 (271)
T d1nvra_           7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS   86 (271)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence            446789999999999999986 68999999987543 2345678999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC-C
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA-S  566 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~-~  566 (736)
                      +|+|.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+|||++.++++||+|||+|+...... .
T Consensus        87 gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          87 GGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             TEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             CCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999884    345789999999999999999999998   99999999999999999999999999998654332 2


Q ss_pred             cceecccccccccCccccccCcC-CCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                      ......+||+.|||||++.+..+ +.++||||+||++|||++|+.||.......  ..+..+    .......       
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~----~~~~~~~-------  226 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDW----KEKKTYL-------  226 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHH----HTTCTTS-------
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHHHH----hcCCCCC-------
Confidence            23345679999999999988776 578999999999999999999997654211  111111    1111100       


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        ........++.+++.+|++.||++|||++|++++
T Consensus       227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         227 --NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             --TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              0001122457789999999999999999998764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-48  Score=405.22  Aligned_cols=248  Identities=24%  Similarity=0.347  Sum_probs=204.8

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      |.+.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..++|||||++
T Consensus        22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g  101 (293)
T d1yhwa1          22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG  101 (293)
T ss_dssp             BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence            455678999999999999875 6999999999765555566799999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++.     ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++++||+|||+|+....... .
T Consensus       102 g~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~  172 (293)
T d1yhwa1         102 GSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (293)
T ss_dssp             CBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred             CcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence            99998874     24589999999999999999999998   999999999999999999999999999987644332 2


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....       +........+... .       .
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~~~~~~~~~-~-------~  237 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTPE-L-------Q  237 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCSCC-C-------S
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCCCCC-C-------C
Confidence            34457999999999999999999999999999999999999999765421       1111111111111 0       0


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .+......+.+++.+|++.||++|||+.|+++|
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111223458899999999999999999999765

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=401.86  Aligned_cols=244  Identities=25%  Similarity=0.415  Sum_probs=203.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||+||+|+.+ +++.||+|++....   ......+.+|++++++++|||||++++++.+++..++||||
T Consensus         8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy   87 (263)
T d2j4za1           8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY   87 (263)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence            456789999999999999986 68899999986432   22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      |++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++++||+|||+|+......
T Consensus        88 ~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          88 APLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             CTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             cCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            99999999985    345689999999999999999999998   99999999999999999999999999997654322


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                         .....||+.|||||++.+..++.++|||||||++|||++|+.||.+....    .+..    .+..+..      .+
T Consensus       161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~----~~~~----~i~~~~~------~~  223 (263)
T d2j4za1         161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ----ETYK----RISRVEF------TF  223 (263)
T ss_dssp             ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHH----HHHTTCC------CC
T ss_pred             ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH----HHHH----HHHcCCC------CC
Confidence               23457999999999999999999999999999999999999999765421    1111    1112211      11


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...    ...++.+++.+|++.||++|||++|++++
T Consensus       224 p~~----~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         224 PDF----VTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             Ccc----CCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            111    22457889999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=407.58  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=194.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeee--CCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE--EGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lV~e  484 (736)
                      |.+.+.||+|+||+||+|+.. +|+.||||++.....  ...+.+.+|+++|++++|||||++++++.+  .+..++|||
T Consensus         6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE   85 (269)
T d2java1           6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME   85 (269)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred             CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence            446789999999999999875 689999999875532  234568899999999999999999999864  456899999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCC--CCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC--VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~--~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      ||++|+|.+++.........+++..++.++.|++.||.|||+++  ..+|+||||||+|||++.++.+||+|||+|+...
T Consensus        86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  165 (269)
T d2java1          86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN  165 (269)
T ss_dssp             CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred             cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence            99999999999765445567999999999999999999999862  1249999999999999999999999999998764


Q ss_pred             CCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      .... ......||+.|||||++.+..|+.++|||||||++|||++|+.||......    .+..    .+.++....   
T Consensus       166 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~----~~~~----~i~~~~~~~---  233 (269)
T d2java1         166 HDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK----ELAG----KIREGKFRR---  233 (269)
T ss_dssp             -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHH----HHHHTCCCC---
T ss_pred             cCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH----HHHH----HHHcCCCCC---
Confidence            4322 234467999999999999999999999999999999999999999765421    1221    222233221   


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        +...++    .++.+++.+|++.||++|||+.|++++
T Consensus       234 --~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         234 --IPYRYS----DELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             --CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --CCcccC----HHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence              112222    358899999999999999999999764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=404.00  Aligned_cols=248  Identities=27%  Similarity=0.415  Sum_probs=199.3

Q ss_pred             ccccccCceEEEEEEEC---CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          414 KKIGSGGFGVVYYGKLK---DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      ++||+|+||+||+|.++   .++.||||+++....  ...+.|.+|+++|++++|||||+++++|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            57999999999999865   346899999965432  234579999999999999999999999965 457899999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++..    ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.........
T Consensus        92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            999999853    45689999999999999999999998   99999999999999999999999999998664443322


Q ss_pred             --eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          569 --SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       569 --~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                        .....||+.|+|||.+.+..++.++|||||||++|||++ |+.||.+....    .+..    .+..+...       
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~----~~~~----~i~~~~~~-------  229 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS----EVTA----MLEKGERM-------  229 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH----HHHH----HHHTTCCC-------
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH----HHHH----HHHcCCCC-------
Confidence              234568999999999999999999999999999999998 89999865421    2222    22222211       


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                        ..+.....++.+++.+|++.||++|||+.||.+.|+...
T Consensus       230 --~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         230 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             --CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence              111222346889999999999999999999999998764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=405.51  Aligned_cols=250  Identities=22%  Similarity=0.316  Sum_probs=203.8

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      |.+.+.||+|+||+||+|++. +++.||||+++.......+.+.+|+++|++++|||||++++++.+++..++|||||++
T Consensus        14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~   93 (288)
T d2jfla1          14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence            455688999999999999876 6889999999876666677899999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|.+++...   ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++++||+|||+|+...... ..
T Consensus        94 g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~  166 (288)
T d2jfla1          94 GAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR  166 (288)
T ss_dssp             EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred             CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence            9999987532   34589999999999999999999998   99999999999999999999999999997543221 12


Q ss_pred             eecccccccccCccccc-----cCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          569 SSIVRGTVGYLDPEYYI-----SQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~-----~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      .....||+.|+|||++.     ...|+.++|||||||++|||++|+.||.+....    .+...+    ..+......  
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~----~~~~~i----~~~~~~~~~--  236 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM----RVLLKI----AKSEPPTLA--  236 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG----GHHHHH----HHSCCCCCS--
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH----HHHHHH----HcCCCCCCC--
Confidence            23457999999999984     456889999999999999999999999765422    121111    111111110  


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                           .+.....++.+++.+|++.||++|||+.|++++
T Consensus       237 -----~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         237 -----QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -----SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -----ccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 111223458899999999999999999999774

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-48  Score=402.28  Aligned_cols=249  Identities=27%  Similarity=0.416  Sum_probs=203.5

Q ss_pred             cccccCceEEEEEEEC---CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCCCC
Q 004689          415 KIGSGGFGVVYYGKLK---DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       415 ~IG~G~fG~Vy~~~~~---~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~gs  490 (736)
                      +||+|+||+||+|.++   ++..||||+++... ....+.|.+|+++|++++|||||+++|+|.. +..++|||||++|+
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~   94 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP   94 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence            4999999999999764   35579999997543 2335679999999999999999999999865 46799999999999


Q ss_pred             HHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc--c
Q 004689          491 LKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH--V  568 (736)
Q Consensus       491 L~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~--~  568 (736)
                      |.+++..   ....+++..++.++.|+++||+|||++   +|+||||||+|||++.++.+||+|||+|+........  .
T Consensus        95 L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~  168 (285)
T d1u59a_          95 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  168 (285)
T ss_dssp             HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred             HHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence            9998753   245689999999999999999999998   9999999999999999999999999999876543322  2


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCC
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLD  647 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  647 (736)
                      .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....    .+..    .+..+...+        
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~----~~~~----~i~~~~~~~--------  232 (285)
T d1u59a_         169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVMA----FIEQGKRME--------  232 (285)
T ss_dssp             CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHHH----HHHTTCCCC--------
T ss_pred             ccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH----HHHH----HHHcCCCCC--------
Confidence            234568999999999999999999999999999999998 99999865522    2222    222232111        


Q ss_pred             cCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          648 EYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       648 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                       .+.....++.+++.+|++.+|++||||.+|++.|+.+..
T Consensus       233 -~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         233 -CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             -CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence             112233468899999999999999999999999987754

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=407.10  Aligned_cols=255  Identities=25%  Similarity=0.406  Sum_probs=198.6

Q ss_pred             HhhccccccCceEEEEEEECCC-----cEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLKDG-----KEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~~-----~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .++++||+|+||+||+|.++..     ..||||+++.... ....+|.+|+++|++++|||||+++|++.+.+..++|||
T Consensus        10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e   89 (283)
T d1mqba_          10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE   89 (283)
T ss_dssp             EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence            3568899999999999987632     3699999865433 234568999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      |+.+|++.+.+...   ...+++..++.++.|++.||.|||+.   +|+||||||+||||+.++.+||+|||+|+.....
T Consensus        90 ~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          90 YMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             CCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             ecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999887532   35689999999999999999999998   9999999999999999999999999999876443


Q ss_pred             CC--cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          565 AS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       565 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||++|..|+.....   ...+.+.+    ..+.      
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~---~~~~~~~i----~~~~------  230 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHEVMKAI----NDGF------  230 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHH----HTTC------
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC---HHHHHHHH----hccC------
Confidence            22  223345689999999999999999999999999999999997666543321   11222221    2221      


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                         ....+.....++.+++.+|++.||++||||.||++.|++++.
T Consensus       231 ---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~  272 (283)
T d1mqba_         231 ---RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  272 (283)
T ss_dssp             ---CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence               111222334568899999999999999999999999998764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-47  Score=394.66  Aligned_cols=247  Identities=28%  Similarity=0.440  Sum_probs=195.4

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeee----CCeEEEEE
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE----EGRSVLVY  483 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~----~~~~~lV~  483 (736)
                      +++++||+|+||+||+|++. +++.||+|++....  ....+.+.+|+++|++++|||||++++++.+    ....++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            46678999999999999876 68899999986543  2234568999999999999999999999865    34679999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc-CCCcEEEEeecCCcccc
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD-KHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~-~~~~~kl~DFGla~~~~  562 (736)
                      ||+++|+|.+++..    ...+++..+..++.|+++||+|||++. ++|+||||||+|||++ .++.+||+|||+|+...
T Consensus        92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999853    456899999999999999999999971 1399999999999997 47899999999998543


Q ss_pred             CCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      ..   .....+||+.|||||++.+ .++.++|||||||++|||++|+.||.+....   ..+.+    .+..+.....++
T Consensus       167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~---~~~~~----~i~~~~~~~~~~  235 (270)
T d1t4ha_         167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQIYR----RVTSGVKPASFD  235 (270)
T ss_dssp             TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HHHHH----HHTTTCCCGGGG
T ss_pred             CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH---HHHHH----HHHcCCCCcccC
Confidence            22   2345679999999998865 6999999999999999999999999754311   11111    222221111111


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          ..    ...++.+++.+|++.||++|||++|+++|
T Consensus       236 ----~~----~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         236 ----KV----AIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             ----GC----CCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ----cc----CCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence                11    12347889999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=413.33  Aligned_cols=263  Identities=22%  Similarity=0.307  Sum_probs=200.1

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC-cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS-YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|+.+|++++|||||+++++|.++++.++|||||+
T Consensus         8 y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~   87 (322)
T d1s9ja_           8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD   87 (322)
T ss_dssp             EEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             CEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            455688999999999999975 68999999987543 2334678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      +|+|.+++..    ...+++..+..++.|++.||.|||+++  +|+||||||+|||++.++++||+|||+|+...+.   
T Consensus        88 gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~---  158 (322)
T d1s9ja_          88 GGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  158 (322)
T ss_dssp             TEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred             CCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC---
Confidence            9999999853    456899999999999999999999731  7999999999999999999999999999865332   


Q ss_pred             ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh--------cC----
Q 004689          568 VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE--------SG----  635 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~--------~~----  635 (736)
                      .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.....................        .+    
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLS  238 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------
T ss_pred             ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccc
Confidence            223457999999999999999999999999999999999999999764421110000000000000        00    


Q ss_pred             ----------CcceeccC---ccCCcC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          636 ----------DIQGIIDP---SLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       636 ----------~~~~~~d~---~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                                ...+..+.   ...... ......++.+++.+|++.||++|||++|+++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         239 SYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                      00000000   000000 00112457889999999999999999999987

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-48  Score=410.17  Aligned_cols=257  Identities=26%  Similarity=0.397  Sum_probs=204.6

Q ss_pred             HHHhhccccccCceEEEEEEECC------CcEEEEEEeccCC-cccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKD------GKEIAVKVLTSNS-YQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~------~~~vAvK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~  480 (736)
                      .+.+.+.||+|+||+||+|++..      ...||||++.... ......+.+|+.+|.++ +|||||++++++.+.+..+
T Consensus        38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~  117 (325)
T d1rjba_          38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY  117 (325)
T ss_dssp             GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence            34567899999999999998752      2369999986543 33456789999999998 8999999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccc-------------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCC
Q 004689          481 LVYEFMHNGTLKEHLYGTLT-------------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSN  541 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~N  541 (736)
                      +|||||++|+|.++|+....                   ....+++..++.++.|+++||+|||++   +|+||||||+|
T Consensus       118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~N  194 (325)
T d1rjba_         118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN  194 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred             EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhc
Confidence            99999999999999965421                   123588999999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCccccccc
Q 004689          542 ILLDKHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGA  619 (736)
Q Consensus       542 ILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~  619 (736)
                      ||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+.....
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~  274 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  274 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999999866544333 2344568999999999999999999999999999999998 899998654221


Q ss_pred             ccccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 004689          620 NCRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQD  684 (736)
Q Consensus       620 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~  684 (736)
                         .+.+.    +..+.         ....+.....++.+++.+|++.||++|||++||+++|..
T Consensus       275 ---~~~~~----~~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         275 ---NFYKL----IQNGF---------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             ---HHHHH----HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HHHHH----HhcCC---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence               12221    11111         111122223468899999999999999999999999964

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=403.74  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=200.9

Q ss_pred             HHHhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      .+.+.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.+|++++|||||+++++|.+ +..++||||+++
T Consensus        18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~   95 (285)
T d1fmka3          18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK   95 (285)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred             HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence            356788999999999999999988899999997543 345679999999999999999999999965 457899999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcc
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHV  568 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~  568 (736)
                      |+|..++...  ....+++..++.++.|++.||+|||+.   +|+||||||+||||+.++++||+|||+|+.........
T Consensus        96 g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          96 GSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             CBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             Cchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            9999988643  234689999999999999999999998   99999999999999999999999999998765544444


Q ss_pred             eecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          569 SSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       569 ~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      .....||+.|+|||++..+.++.++|||||||++|||++|..|+.....   ...+...+.    .+..         ..
T Consensus       171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~---~~~~~~~i~----~~~~---------~~  234 (285)
T d1fmka3         171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVE----RGYR---------MP  234 (285)
T ss_dssp             -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHHHHH----TTCC---------CC
T ss_pred             eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC---HHHHHHHHH----hcCC---------CC
Confidence            4556799999999999999999999999999999999997666544331   112222222    1111         11


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      .+.....++.+++.+|++.||++||+|++|++.|++..
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            12223346889999999999999999999999888754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-47  Score=402.72  Aligned_cols=249  Identities=24%  Similarity=0.365  Sum_probs=188.6

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||+|+||+||+|+.. +++.||||++..... .....+.+|+.+|++++|||||++++++.+++..++|||||+
T Consensus        11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~   90 (307)
T d1a06a_          11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS   90 (307)
T ss_dssp             EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            567789999999999999876 689999999975532 234568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc---CCCcEEEEeecCCccccCC
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD---KHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~---~~~~~kl~DFGla~~~~~~  564 (736)
                      +|+|.+++..    ...+++..+..++.|++.||+|||++   +|+||||||+|||+.   .++.+||+|||+|+.....
T Consensus        91 gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          91 GGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             SCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             CCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            9999999953    45689999999999999999999998   999999999999995   4789999999999865433


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                      .  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....    .+...    +..+...  ....
T Consensus       164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~~----i~~~~~~--~~~~  231 (307)
T d1a06a_         164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA----KLFEQ----ILKAEYE--FDSP  231 (307)
T ss_dssp             -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHH----HHTTCCC--CCTT
T ss_pred             C--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH----HHHHH----HhccCCC--CCCc
Confidence            2  233457999999999999999999999999999999999999999765422    12111    1111110  1111


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .....    ...+.+++.+|++.||++|||+.|++++
T Consensus       232 ~~~~~----s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         232 YWDDI----SDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TTTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cccCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            11122    2458899999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-48  Score=402.10  Aligned_cols=247  Identities=23%  Similarity=0.327  Sum_probs=201.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||+||+|+.. +++.||||++....   ......+.+|+++|++++||||+++++++.+++..++||||
T Consensus        10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy   89 (288)
T d1uu3a_          10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY   89 (288)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred             CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence            557889999999999999885 68999999986532   22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+......
T Consensus        90 ~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          90 AKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            99999999884    345689999999999999999999998   99999999999999999999999999998764332


Q ss_pred             -CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          566 -SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       566 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                       .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||......    .+..    .+..+.+      .
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~~~----~i~~~~~------~  228 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY----LIFQ----KIIKLEY------D  228 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHTTCC------C
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH----HHHH----HHHcCCC------C
Confidence             22334567999999999999999999999999999999999999999865421    1111    1112221      1


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      +....    ..++.+++.+|++.||++|||++|++++
T Consensus       229 ~p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         229 FPEKF----FPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             CCTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             CCccC----CHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            11122    2357899999999999999999998664

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6e-47  Score=405.61  Aligned_cols=251  Identities=23%  Similarity=0.352  Sum_probs=205.9

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .|.+.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..++|||||+
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~  106 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS  106 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence            3567789999999999999875 689999999976655556778999999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC--CCcEEEEeecCCccccCCC
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK--HMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~--~~~~kl~DFGla~~~~~~~  565 (736)
                      +|+|.+++...   ...+++..+..++.|++.||.|||++   +|+||||||+|||++.  ++.+||+|||+|+......
T Consensus       107 gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         107 GGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             SCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            99999998532   34689999999999999999999998   9999999999999964  5789999999998664432


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                        ......||+.|||||++.+..++.++|||||||++|||++|+.||.+....+    +..-+    ..+...  .+...
T Consensus       181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i----~~~~~~--~~~~~  248 (350)
T d1koaa2         181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----TLRNV----KSCDWN--MDDSA  248 (350)
T ss_dssp             --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH----HHTCCC--SCCGG
T ss_pred             --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH----HHHHH----HhCCCC--CCccc
Confidence              3344679999999999999999999999999999999999999997654221    11111    111110  01111


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...    ....+.+++.+|++.||++|||++|+++|
T Consensus       249 ~~~----~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         249 FSG----ISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGG----CCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111    22357899999999999999999999886

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=397.00  Aligned_cols=257  Identities=21%  Similarity=0.337  Sum_probs=197.2

Q ss_pred             HHHhhccccccCceEEEEEEECC----CcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKD----GKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~----~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      .+.+.+.||+|+||+||+|++..    +..||||+++.... .....|.+|+.+|++++|||||++++++.+ +..++||
T Consensus         8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~   86 (273)
T d1mp8a_           8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIM   86 (273)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEE
Confidence            35567899999999999998753    35688998865432 234568999999999999999999999964 6789999


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+++|+|.+++...   ...+++..++.++.|+++||.|||++   +|+||||||+||+++.++.+||+|||+|+....
T Consensus        87 E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          87 ELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             ECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccC
Confidence            999999999987532   35689999999999999999999998   999999999999999999999999999987655


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      ..........||+.|+|||++.+..++.++|||||||++|||++ |..||......    .+...+    ..+....   
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~----~~~~~i----~~~~~~~---  229 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN----DVIGRI----ENGERLP---  229 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GHHHHH----HTTCCCC---
T ss_pred             CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH----HHHHHH----HcCCCCC---
Confidence            44444555678999999999999999999999999999999998 89999866532    232222    2222111   


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIVIE  689 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~~~  689 (736)
                            .+......+.+++.+|++.||++|||+.||+++|+.++..+
T Consensus       230 ------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         230 ------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence                  11222346889999999999999999999999999987544

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.7e-47  Score=398.97  Aligned_cols=245  Identities=24%  Similarity=0.366  Sum_probs=198.9

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      .|...+.||+|+||+||+|+.. +++.||||++......   ..+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            4555788999999999999875 6889999999765432   23468899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      ||.+|+|..++.    ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        96 ~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          96 YCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             CCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            999999976653    345689999999999999999999998   9999999999999999999999999999864332


Q ss_pred             CCcceecccccccccCcccccc---CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          565 ASHVSSIVRGTVGYLDPEYYIS---QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                           ....||+.|||||++.+   ..|+.++|||||||++|||++|+.||.+....+    .   ..... .+......
T Consensus       169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~----~---~~~i~-~~~~~~~~  235 (309)
T d1u5ra_         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----A---LYHIA-QNESPALQ  235 (309)
T ss_dssp             -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----H---HHHHH-HSCCCCCS
T ss_pred             -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH----H---HHHHH-hCCCCCCC
Confidence                 23569999999999864   468999999999999999999999997654211    1   11111 11111111


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .    ..+    ...+.+++.+|++.||++|||+.|+++|
T Consensus       236 ~----~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         236 S----GHW----SEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             C----TTS----CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             C----CCC----CHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            1    112    2358899999999999999999999874

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.2e-46  Score=403.49  Aligned_cols=250  Identities=21%  Similarity=0.345  Sum_probs=206.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      |.+.+.||+|+||+||+|+.. +|+.||||+++.........+.+|+++|++++|||||++++++.+++..++|||||++
T Consensus        31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g  110 (352)
T d1koba_          31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG  110 (352)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence            567789999999999999875 6999999999766555566788999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc--CCCcEEEEeecCCccccCCCC
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD--KHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~--~~~~~kl~DFGla~~~~~~~~  566 (736)
                      |+|.+++..   ....+++..+..++.|++.||.|||++   +|+||||||+|||++  .++.+||+|||+|+.....  
T Consensus       111 g~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~--  182 (352)
T d1koba_         111 GELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--  182 (352)
T ss_dssp             CBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred             ChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence            999988743   244689999999999999999999998   999999999999998  5789999999999876443  


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....    .+...    +..+...  +.....
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~----i~~~~~~--~~~~~~  252 (352)
T d1koba_         183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQN----VKRCDWE--FDEDAF  252 (352)
T ss_dssp             SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HHHHH----HHHCCCC--CCSSTT
T ss_pred             CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHH----HHhCCCC--CCcccc
Confidence            2334567999999999999999999999999999999999999999765421    11111    1111110  111111


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...    ...+.+++.+|++.||.+|||+.|+++|
T Consensus       253 ~~~----s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         253 SSV----SPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            122    2357899999999999999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=393.69  Aligned_cols=250  Identities=23%  Similarity=0.334  Sum_probs=202.7

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc------cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      .|.+.+.||+|+||+||+|+.. +|+.||||++......      ....+.+|+++|++++|||||++++++.+++..++
T Consensus        11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   90 (293)
T d1jksa_          11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL   90 (293)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4567789999999999999985 6899999998754221      23568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC----cEEEEeecC
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM----RAKVSDFGL  557 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~----~~kl~DFGl  557 (736)
                      |||||++|+|.+++..    ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++    .+|++|||+
T Consensus        91 v~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          91 ILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999853    45699999999999999999999998   999999999999998776    599999999


Q ss_pred             CccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCc
Q 004689          558 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDI  637 (736)
Q Consensus       558 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~  637 (736)
                      |+......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+    ...    .+..+..
T Consensus       164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~----~~~----~i~~~~~  233 (293)
T d1jksa_         164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----TLA----NVSAVNY  233 (293)
T ss_dssp             CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHH----HHHTTCC
T ss_pred             hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH----HHH----HHHhcCC
Confidence            98654332  2334569999999999999999999999999999999999999998654221    111    1111111


Q ss_pred             ceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          638 QGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       638 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .  ..+...    ......+.+++.+|++.||++|||++|++++
T Consensus       234 ~--~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         234 E--FEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             C--CCHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             C--CCchhc----CCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0  000000    1122357899999999999999999999764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=386.91  Aligned_cols=247  Identities=29%  Similarity=0.451  Sum_probs=196.5

Q ss_pred             HhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeee-CCeEEEEEEecCCC
Q 004689          411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEFMHNG  489 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lV~e~~~~g  489 (736)
                      .+.+.||+|+||.||+|+++ |+.||||+++..  ...+.+.+|++++++++||||++++|+|.+ .+..++||||+++|
T Consensus        10 ~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g   86 (262)
T d1byga_          10 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG   86 (262)
T ss_dssp             EEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred             EEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence            46788999999999999986 889999999643  335679999999999999999999999865 45689999999999


Q ss_pred             CHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCcce
Q 004689          490 TLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASHVS  569 (736)
Q Consensus       490 sL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~~~  569 (736)
                      +|.+++...  ....+++..+++++.|++.||.|||+.   +|+||||||+|||++.++.+|++|||+++.....    .
T Consensus        87 ~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~  157 (262)
T d1byga_          87 SLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q  157 (262)
T ss_dssp             EHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             CHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----C
Confidence            999999642  234589999999999999999999998   9999999999999999999999999999865332    2


Q ss_pred             ecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceeccCccCCc
Q 004689          570 SIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLLDE  648 (736)
Q Consensus       570 ~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  648 (736)
                      ....+|+.|+|||++.+..++.++|||||||++|||+| |+.||.....    ..+..++.    .+..         ..
T Consensus       158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~----~~~~~~i~----~~~~---------~~  220 (262)
T d1byga_         158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDVVPRVE----KGYK---------MD  220 (262)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GGHHHHHT----TTCC---------CC
T ss_pred             ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH----HHHHHHHH----cCCC---------CC
Confidence            23458999999999999999999999999999999998 6777765542    23333322    2211         11


Q ss_pred             CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          649 YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       649 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      .+.....++.+++.+|++.||++||||.||+++|+++.
T Consensus       221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            12222346889999999999999999999999999874

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-46  Score=391.33  Aligned_cols=254  Identities=29%  Similarity=0.446  Sum_probs=201.9

Q ss_pred             hhccccccCceEEEEEEECCC----cEEEEEEeccC-CcccchhhhhHHHHHhhcCCCceeeEeeeeee-CCeEEEEEEe
Q 004689          412 LEKKIGSGGFGVVYYGKLKDG----KEIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQE-EGRSVLVYEF  485 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~~----~~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lV~e~  485 (736)
                      +.++||+|+||+||+|++.++    ..||||+++.. ......+|.+|+++|++++||||++++|++.+ ++..++||||
T Consensus        31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence            467899999999999987532    35899998743 33345679999999999999999999999876 4688999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      |++|+|.+++...   ...+++..++.++.|+++||.|||+.   +|+||||||+|||+++++.+||+|||+++......
T Consensus       111 ~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         111 MKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             eecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            9999999998643   34577888999999999999999998   99999999999999999999999999998654432


Q ss_pred             Cc---ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc
Q 004689          566 SH---VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID  642 (736)
Q Consensus       566 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  642 (736)
                      ..   ......||+.|+|||.+.++.++.++|||||||++|||++|..||......   ..+..++    ..+...  ..
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~---~~~~~~i----~~g~~~--~~  255 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL----LQGRRL--LQ  255 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHHH----HTTCCC--CC
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH---HHHHHHH----HcCCCC--CC
Confidence            22   223356899999999999999999999999999999999988887654311   1222222    122211  11


Q ss_pred             CccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          643 PSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       643 ~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                             +.....++.+++.+|++.||++||+|.||+++|+.+..
T Consensus       256 -------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         256 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                   11123468899999999999999999999999998853

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-46  Score=395.94  Aligned_cols=254  Identities=23%  Similarity=0.379  Sum_probs=200.1

Q ss_pred             HHhhccccccCceEEEEEEEC-CCc----EEEEEEeccC-CcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGK----EIAVKVLTSN-SYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVY  483 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~----~vAvK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~  483 (736)
                      |.+.++||+|+||+||+|.+. +|+    .||+|+++.. .....+.|.+|+.+|++++|||||+++|+|.++ ..++++
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            456789999999999999875 343    5899988644 334466799999999999999999999999865 567888


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      ||+.+|+|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++++||+|||+|+....
T Consensus        90 e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          90 QLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             ECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            999999999987643   45689999999999999999999998   999999999999999999999999999987644


Q ss_pred             CCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          564 GASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       564 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      .... ......||+.|+|||++.++.++.++|||||||++|||+| |..||.+....    .+...+.    .+..    
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~----~~~~~i~----~~~~----  231 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----EISSILE----KGER----  231 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG----GHHHHHH----HTCC----
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH----HHHHHHH----cCCC----
Confidence            3332 2334568999999999999999999999999999999998 78888765522    2222221    1211    


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                           ...+......+.+++.+|++.||++|||+.||+++|+.+..
T Consensus       232 -----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         232 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             -----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                 11112223468899999999999999999999999988753

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=394.02  Aligned_cols=261  Identities=26%  Similarity=0.398  Sum_probs=197.0

Q ss_pred             HHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeC-Ce
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEE-GR  478 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~-~~  478 (736)
                      ..+.+.+.||+|+||.||+|++.      +++.||||+++.... ...+.+.+|+.++.++ +|+||+.+++++... ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            34567789999999999999864      346899999875432 3345677888888777 689999999988654 46


Q ss_pred             EEEEEEecCCCCHHHHhhcccc------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK  546 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~  546 (736)
                      .++|||||++|+|.++++....            ....+++..++.++.|+++||.|||++   +|+||||||+||||+.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence            8999999999999999965421            134588999999999999999999998   9999999999999999


Q ss_pred             CCcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCC-CcCcccccccccccH
Q 004689          547 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRNI  624 (736)
Q Consensus       547 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~-~p~~~~~~~~~~~~l  624 (736)
                      ++++||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|. .||......+   .+
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~---~~  246 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---EF  246 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---HH
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH---HH
Confidence            999999999999865443332 334467999999999999999999999999999999999975 5776544221   11


Q ss_pred             HHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          625 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       625 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ..    .+..+....     .    +.....++.+++.+|++.||++|||+.||+++|++++.
T Consensus       247 ~~----~~~~~~~~~-----~----~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         247 CR----RLKEGTRMR-----A----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             HH----HHHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH----HHhcCCCCC-----C----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            11    222222111     1    11123458899999999999999999999999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=392.37  Aligned_cols=246  Identities=24%  Similarity=0.321  Sum_probs=203.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||+||+|+.+ +|+.||||+++...   ......+.+|+.+|++++||||+++++++.+++..++||||
T Consensus         7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey   86 (337)
T d1o6la_           7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY   86 (337)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence            446789999999999999875 78999999997542   22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      |++|+|.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.+|.+||+|||+|+......
T Consensus        87 ~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          87 ANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             CTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             cCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999884    345688889999999999999999998   99999999999999999999999999998654322


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                       ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....    .+..    .+..+.+      .+
T Consensus       160 -~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~----~~~~----~i~~~~~------~~  224 (337)
T d1o6la_         160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFE----LILMEEI------RF  224 (337)
T ss_dssp             -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCCC------CC
T ss_pred             -cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH----HHHH----HHhcCCC------CC
Confidence             2334567999999999999999999999999999999999999999876522    1221    1111221      11


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  681 (736)
                      ....+    .++.+++.+|++.||++||+     +.|+++|
T Consensus       225 p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         225 PRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CccCC----HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            11222    35788999999999999995     8888875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-46  Score=393.59  Aligned_cols=257  Identities=25%  Similarity=0.412  Sum_probs=205.8

Q ss_pred             HHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCcc-cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSYQ-GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      +.+.+.||+|+||+||+|+++      +++.||||+++..... ...+|.+|+++|++++||||++++++|...+..++|
T Consensus        15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v   94 (301)
T d1lufa_          15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL   94 (301)
T ss_dssp             CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence            345788999999999999864      3578999998754332 356799999999999999999999999999999999


Q ss_pred             EEecCCCCHHHHhhccc--------------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCE
Q 004689          483 YEFMHNGTLKEHLYGTL--------------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNI  542 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NI  542 (736)
                      |||+++|+|.++++...                    .....+++..++.++.|++.||+|||++   +|+||||||+||
T Consensus        95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI  171 (301)
T d1lufa_          95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC  171 (301)
T ss_dssp             EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence            99999999999996431                    1123488999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEEeecCCccccCCC-CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCC-CcCcccccccc
Q 004689          543 LLDKHMRAKVSDFGLSKFAVDGA-SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGAN  620 (736)
Q Consensus       543 Ll~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~-~p~~~~~~~~~  620 (736)
                      |++.++++||+|||+|+...... ........||+.|+|||++.+..|+.++|||||||++|||++|. +||.+....  
T Consensus       172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~--  249 (301)
T d1lufa_         172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE--  249 (301)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--
T ss_pred             EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH--
Confidence            99999999999999998553322 22334566899999999999999999999999999999999986 567654421  


Q ss_pred             cccHHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          621 CRNIVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       621 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                        .+...    +.++.....         +.....++.+++..|++.+|++||||.||++.|+++.
T Consensus       250 --e~~~~----v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         250 --EVIYY----VRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             --HHHHH----HHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             --HHHHH----HHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence              22222    223332111         1122346889999999999999999999999999863

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-45  Score=390.67  Aligned_cols=243  Identities=24%  Similarity=0.379  Sum_probs=201.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||+||+|+.+ +|+.||||+++...   ....+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus         6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~   85 (316)
T d1fota_           6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY   85 (316)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred             eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence            456789999999999999975 68999999986532   22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      |++|+|..++.    ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++++||+|||+|+..... 
T Consensus        86 ~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          86 IEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             CCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             cCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            99999999884    345577888889999999999999998   9999999999999999999999999999875432 


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                         ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+....+    +..   . +..+..      ..
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~---~-i~~~~~------~~  220 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK----TYE---K-ILNAEL------RF  220 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHH---H-HHHCCC------CC
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH----HHH---H-HHcCCC------CC
Confidence               234679999999999999999999999999999999999999998654221    111   1 111211      11


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                      ....    ...+.+++.+|+..||.+||     |++|+++|
T Consensus       221 p~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         221 PPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             CTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            1112    23578999999999999996     89999876

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-45  Score=383.82  Aligned_cols=266  Identities=23%  Similarity=0.344  Sum_probs=200.7

Q ss_pred             HhhccccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCC----eEEEEEEec
Q 004689          411 MLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVYEFM  486 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~~lV~e~~  486 (736)
                      .+.+.||+|+||+||+|++. |+.||||+++.... .....+.|+..+.+++||||++++++|.+.+    ..++|||||
T Consensus         6 ~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~   83 (303)
T d1vjya_           6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH   83 (303)
T ss_dssp             EEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred             EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence            45788999999999999975 89999999864322 1222344556667789999999999998654    579999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCC-----CCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-----VPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~-----~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ++|+|.++++.     ..++|..++.++.|+|.||.|||+.+     .++|+||||||+||||+.++++||+|||+++..
T Consensus        84 ~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          84 EHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             TTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             cCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            99999999953     35899999999999999999999732     249999999999999999999999999999876


Q ss_pred             cCCCCc---ceecccccccccCccccccC------cCCCcchhHHHHHHHHHHHhCCCcCcccccccc-c------ccHH
Q 004689          562 VDGASH---VSSIVRGTVGYLDPEYYISQ------QLTDKSDVYSFGVILLELISGQEAISNEKFGAN-C------RNIV  625 (736)
Q Consensus       562 ~~~~~~---~~~~~~gt~~Y~aPE~~~~~------~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~-~------~~l~  625 (736)
                      ......   ......||+.|+|||++...      .++.++|||||||+||||+||..|+......+. .      ....
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            543322   23346799999999998754      367789999999999999999988754331110 0      0111


Q ss_pred             HHHHHhhhcCCcceeccCccCCcC-CHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          626 QWAKLHIESGDIQGIIDPSLLDEY-DIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       626 ~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      .........+.    +++.+.... +.+....+.+++.+|++.||++|||+.||++.|+++..
T Consensus       239 ~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         239 EEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            22222222111    223322222 33456779999999999999999999999999998864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-46  Score=383.90  Aligned_cols=253  Identities=26%  Similarity=0.385  Sum_probs=193.4

Q ss_pred             HHhhccccccCceEEEEEEECC--C--cEEEEEEeccCCc---ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKD--G--KEIAVKVLTSNSY---QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~--~--~~vAvK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      +.+.+.||+|+||+||+|++..  +  .+||||++.....   ...++|.+|+.+|++++||||++++|+|.++ ..++|
T Consensus        10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv   88 (273)
T d1u46a_          10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMV   88 (273)
T ss_dssp             EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEE
T ss_pred             eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chhee
Confidence            3466889999999999998642  2  3789999865422   2345789999999999999999999999764 66899


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      |||+++|++.+++..   ....+++..++.++.|+++||.|||++   +|+||||||+|||++.++++||+|||+++...
T Consensus        89 ~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          89 TELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            999999999998753   245689999999999999999999998   99999999999999999999999999998764


Q ss_pred             CCCCc--ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          563 DGASH--VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       563 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      .....  ......||..|+|||++.+..++.++|||||||++|||+| |+.||.+....    .+..++   ...+... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~----~~~~~i---~~~~~~~-  234 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS----QILHKI---DKEGERL-  234 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHHHH---HTSCCCC-
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH----HHHHHH---HhCCCCC-
Confidence            44332  2233458899999999999999999999999999999998 89999765522    222222   1222111 


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDA  685 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~  685 (736)
                              ..+......+.+++.+|++.||++|||+.||.+.|++.
T Consensus       235 --------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         235 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                    11112234588999999999999999999999988864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=2e-45  Score=382.22  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=198.4

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc---cchhhhhHHHHHhhcCCCceeeEeeeeeeCC----eEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ---GKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVL  481 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~~l  481 (736)
                      |.+.+.||+|+||+||+|+.. +|+.||||+++.....   ....+.+|+++|++++||||+++++++...+    ..++
T Consensus         9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l   88 (277)
T d1o6ya_           9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI   88 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence            557789999999999999875 7899999999765332   2346889999999999999999999987654    3789


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      ||||+++|+|.+++.    ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++..+++|||.++..
T Consensus        89 vmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          89 VMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence            999999999999874    345689999999999999999999998   9999999999999999999999999998754


Q ss_pred             cCCCC--cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce
Q 004689          562 VDGAS--HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG  639 (736)
Q Consensus       562 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~  639 (736)
                      .....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....       +.....+..+....
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~~~~~~~~~~  234 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIPP  234 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCCG
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-------HHHHHHHhcCCCCC
Confidence            33222  2334567999999999999999999999999999999999999999765421       11222222221110


Q ss_pred             eccCccCCcCCHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHH
Q 004689          640 IIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-SISEVLKDIQDA  685 (736)
Q Consensus       640 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~~  685 (736)
                         ......    ....+.+++.+|++.||.+|| |++++.+.|.++
T Consensus       235 ---~~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         235 ---SARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             ---GGTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ---chhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence               011112    224588999999999999999 899999988875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-46  Score=391.81  Aligned_cols=261  Identities=26%  Similarity=0.383  Sum_probs=209.2

Q ss_pred             HHHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeE
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~  479 (736)
                      ..+.+.++||+|+||.||+|++.      +++.||||+++.... .....+.+|+.+++++ +|||||+++++|.++...
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            34557789999999999999863      457899999976543 3345688999999999 699999999999999999


Q ss_pred             EEEEEecCCCCHHHHhhcccc--------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEc
Q 004689          480 VLVYEFMHNGTLKEHLYGTLT--------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLD  545 (736)
Q Consensus       480 ~lV~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~  545 (736)
                      ++|||||++|+|.++++....              ....+++..+..++.|+++||+|||++   +++||||||+|||++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~  179 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT  179 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence            999999999999999965421              233588999999999999999999998   999999999999999


Q ss_pred             CCCcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCccccccccccc
Q 004689          546 KHMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRN  623 (736)
Q Consensus       546 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~  623 (736)
                      .++.+|++|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+| |.+|+......+.   
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~---  256 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---  256 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            9999999999999876544333 3344679999999999999999999999999999999999 5555554432211   


Q ss_pred             HHHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          624 IVQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       624 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      +.+.+.    .+.         ....+......+.+|+.+|++.||++||||.||+++|++.+.
T Consensus       257 ~~~~i~----~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         257 FYKMIK----EGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             HHHHHH----HTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHh----cCC---------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            112211    111         111112223468899999999999999999999999998754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=388.14  Aligned_cols=255  Identities=27%  Similarity=0.443  Sum_probs=202.0

Q ss_pred             HhhccccccCceEEEEEEECC-Cc--EEEEEEeccC-CcccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCeEEEEEEe
Q 004689          411 MLEKKIGSGGFGVVYYGKLKD-GK--EIAVKVLTSN-SYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~~-~~--~vAvK~l~~~-~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      .+.+.||+|+||+||+|++++ +.  .||||+++.. .....+.|.+|+++|+++ +|||||+++++|.+.+..++||||
T Consensus        13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey   92 (309)
T d1fvra_          13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   92 (309)
T ss_dssp             EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEe
Confidence            467899999999999998863 44  4778887644 333456799999999998 799999999999999999999999


Q ss_pred             cCCCCHHHHhhccc------------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE
Q 004689          486 MHNGTLKEHLYGTL------------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS  553 (736)
Q Consensus       486 ~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~  553 (736)
                      +++|+|.++|+...            .....+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        93 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          93 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             CTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEEC
T ss_pred             cCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEc
Confidence            99999999996542            2345789999999999999999999998   99999999999999999999999


Q ss_pred             eecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCC-cCcccccccccccHHHHHHHhh
Q 004689          554 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQE-AISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       554 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~-p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      |||+++......  ......||..|+|||.+....++.++|||||||++|||++|.. ||.+....    .+.+    .+
T Consensus       170 DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~----~~~~----~i  239 (309)
T d1fvra_         170 DFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYE----KL  239 (309)
T ss_dssp             CTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----HHHH----HG
T ss_pred             cccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH----HHHH----HH
Confidence            999997543222  2233468999999999999999999999999999999999764 66554421    2222    12


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      .++..     +    ..+.....++.+++.+|++.||++||||+||+++|++++.
T Consensus       240 ~~~~~-----~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         240 PQGYR-----L----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             GGTCC-----C----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcCC-----C----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            22211     1    1112223468899999999999999999999999999863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-45  Score=386.07  Aligned_cols=259  Identities=25%  Similarity=0.430  Sum_probs=205.0

Q ss_pred             HHHhhccccccCceEEEEEEECC--------CcEEEEEEeccCCc-ccchhhhhHHHHHhhc-CCCceeeEeeeeeeCCe
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSY-QGKREFTNEVTLLSRI-HHRNLVQFLGYCQEEGR  478 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~~--------~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~  478 (736)
                      .+.+.+.||+|+||.||+|+...        +..||||+++.... ....++.+|+..+.++ +|||||+++++|.+++.
T Consensus        14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~   93 (299)
T d1fgka_          14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP   93 (299)
T ss_dssp             GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence            44567899999999999998642        34799999976543 2346788899999888 89999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcccc------------cccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLT------------HEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK  546 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~  546 (736)
                      .++||||+++|+|.+++.....            ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.
T Consensus        94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE  170 (299)
T ss_dssp             CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred             EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence            9999999999999999965431            234689999999999999999999998   9999999999999999


Q ss_pred             CCcEEEEeecCCccccCCCCc-ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHh-CCCcCcccccccccccH
Q 004689          547 HMRAKVSDFGLSKFAVDGASH-VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELIS-GQEAISNEKFGANCRNI  624 (736)
Q Consensus       547 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~ellt-G~~p~~~~~~~~~~~~l  624 (736)
                      ++.+||+|||+++........ ......||+.|+|||++.++.|+.++|||||||++|||++ |..||.+....    .+
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~----~~  246 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----EL  246 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----HH
T ss_pred             CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----HH
Confidence            999999999999866543322 3344568999999999999999999999999999999998 78888755421    22


Q ss_pred             HHHHHHhhhcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          625 VQWAKLHIESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       625 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      .+    .+..+...         ..+.....++.+++.+|++.||.+|||+.||++.|++++.
T Consensus       247 ~~----~i~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         247 FK----LLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HH----HHHTTCCC---------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HH----HHHcCCCC---------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            22    22222111         1111223458899999999999999999999999999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.5e-45  Score=377.35  Aligned_cols=249  Identities=27%  Similarity=0.309  Sum_probs=201.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCccc---------chhhhhHHHHHhhcC-CCceeeEeeeeeeCCe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQG---------KREFTNEVTLLSRIH-HRNLVQFLGYCQEEGR  478 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~---------~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~  478 (736)
                      |.+.+.||+|+||+||+|+.. +++.||||+++......         ...+.+|+.+|++++ ||||+++++++.+++.
T Consensus         5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~   84 (277)
T d1phka_           5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF   84 (277)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence            446789999999999999875 68999999987653221         235788999999997 9999999999999999


Q ss_pred             EEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCC
Q 004689          479 SVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLS  558 (736)
Q Consensus       479 ~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla  558 (736)
                      .++|||||++|+|.+++.    ....+++..+..++.|+++||+|||++   +|+||||||+|||++.++.+||+|||++
T Consensus        85 ~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          85 FFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             EEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence            999999999999999995    345789999999999999999999998   9999999999999999999999999999


Q ss_pred             ccccCCCCcceecccccccccCcccccc------CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhh
Q 004689          559 KFAVDGASHVSSIVRGTVGYLDPEYYIS------QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHI  632 (736)
Q Consensus       559 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~  632 (736)
                      +......  ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||.+.....    +    ...+
T Consensus       158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~----~----~~~i  227 (277)
T d1phka_         158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML----M----LRMI  227 (277)
T ss_dssp             EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----H----HHHH
T ss_pred             eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH----H----HHHH
Confidence            8765432  2234579999999999863      346889999999999999999999998654211    1    1111


Q ss_pred             hcCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          633 ESGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       633 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..+...  ......    .....++.+++.+|++.||++|||++||+++
T Consensus       228 ~~~~~~--~~~~~~----~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         228 MSGNYQ--FGSPEW----DDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHTCCC--CCTTTG----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HhCCCC--CCCccc----ccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            122211  000011    1223468899999999999999999999765

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.8e-45  Score=389.32  Aligned_cols=243  Identities=23%  Similarity=0.307  Sum_probs=201.1

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEe
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEF  485 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~  485 (736)
                      |.+.+.||+|+||+||+|+++ +|+.||||++....   ......+.+|+.+|+.++|||||++++++.+....++||||
T Consensus        43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~  122 (350)
T d1rdqe_          43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY  122 (350)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence            455689999999999999885 79999999986432   22345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCC
Q 004689          486 MHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGA  565 (736)
Q Consensus       486 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~  565 (736)
                      +.+|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++++||+|||+|+..... 
T Consensus       123 ~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         123 VAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             CTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             ccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            999999999853    35689999999999999999999998   9999999999999999999999999999866432 


Q ss_pred             CcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCcc
Q 004689          566 SHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSL  645 (736)
Q Consensus       566 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  645 (736)
                         .....||+.|||||++.+..++.++|||||||++|||++|+.||.+....    .+..    .+..+..      ..
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~----~i~~~~~------~~  257 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI----QIYE----KIVSGKV------RF  257 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCCC------CC
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH----HHHH----HHhcCCC------CC
Confidence               23457999999999999999999999999999999999999999765421    1111    1111211      11


Q ss_pred             CCcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          646 LDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       646 ~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                      ...    ....+.+++..|++.||.+|+     |++|+++|
T Consensus       258 p~~----~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         258 PSH----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CTT----CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             Ccc----CCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            111    223578999999999999994     89999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=380.20  Aligned_cols=256  Identities=22%  Similarity=0.227  Sum_probs=194.1

Q ss_pred             ccccccCceEEEEEEEC-CCcEEEEEEeccCCcc-----cchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          414 KKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ-----GKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      ++||+|+||+||+|+.. +|+.||||+++.....     ..+.+.+|+.+|++++|||||++++++..++..++||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            57999999999999975 6899999998654321     13568899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      ++++.....    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+........
T Consensus        84 ~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~  156 (299)
T d1ua2a_          84 TDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA  156 (299)
T ss_dssp             EEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred             chHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence            987776552    345678888999999999999999998   9999999999999999999999999999865443322


Q ss_pred             ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceecc----
Q 004689          568 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIID----  642 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d----  642 (736)
                       ....+||+.|+|||++.. ..|+.++|||||||++|||++|+.||.+....+....+    .............+    
T Consensus       157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i----~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI----FETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHHHCCCCTTTSSSTTSS
T ss_pred             -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH----HHhcCCCChhhccchhcc
Confidence             234569999999999875 46789999999999999999999999765422211111    11111100000000    


Q ss_pred             --C---ccCCcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          643 --P---SLLDEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       643 --~---~l~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                        .   ......+.     .....+.+++.+|++.||++|||++|+++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence              0   00000111     112468899999999999999999999765

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=383.92  Aligned_cols=249  Identities=19%  Similarity=0.308  Sum_probs=201.9

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecCC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMHN  488 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~~  488 (736)
                      |.+.+.||+|+||+||+|... +++.||||+++.... ....+.+|+++|++++|||||++++++.+++..++|||||++
T Consensus         7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g   85 (321)
T d1tkia_           7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG   85 (321)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence            456789999999999999886 688999999975532 345688999999999999999999999999999999999999


Q ss_pred             CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC--CcEEEEeecCCccccCCCC
Q 004689          489 GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH--MRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       489 gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~--~~~kl~DFGla~~~~~~~~  566 (736)
                      |+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.+  ..+||+|||+++.....  
T Consensus        86 g~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--  157 (321)
T d1tkia_          86 LDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             CBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence            9999998532   34689999999999999999999998   99999999999999854  58999999999865432  


Q ss_pred             cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCccC
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPSLL  646 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  646 (736)
                      .......||+.|+|||.+.+..|+.++||||+||++|||++|+.||......+    +...    +..+...  ++....
T Consensus       158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~----~~~~----i~~~~~~--~~~~~~  227 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ----IIEN----IMNAEYT--FDEEAF  227 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHH----HHHTCCC--CCHHHH
T ss_pred             CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH----HHHH----HHhCCCC--CChhhc
Confidence            23344568999999999999999999999999999999999999998655221    1111    1111110  011111


Q ss_pred             CcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          647 DEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       647 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ...    ..++.+++.+|+..||.+|||++|+++|
T Consensus       228 ~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         228 KEI----SIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             TTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cCC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111    2357899999999999999999999885

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-45  Score=385.25  Aligned_cols=246  Identities=24%  Similarity=0.377  Sum_probs=199.3

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC---cccchhhhhHHHHHh-hcCCCceeeEeeeeeeCCeEEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS---YQGKREFTNEVTLLS-RIHHRNLVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~---~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~~lV~e  484 (736)
                      |.+.+.||+|+||+||+|+.. +++.||||+++...   ......+..|+.++. .++|||||++++++.+++..++|||
T Consensus         4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE   83 (320)
T d1xjda_           4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME   83 (320)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred             eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence            456789999999999999886 68999999997532   222345666777665 6899999999999999999999999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~  564 (736)
                      ||++|+|.+++.    ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++++||+|||+++.....
T Consensus        84 y~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          84 YLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             CCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             ecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            999999999985    345688899999999999999999998   9999999999999999999999999999865433


Q ss_pred             CCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccCc
Q 004689          565 ASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDPS  644 (736)
Q Consensus       565 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  644 (736)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....    .+..    .+..+..      .
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~----~~~~----~i~~~~~------~  221 (320)
T d1xjda_         157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE----ELFH----SIRMDNP------F  221 (320)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHH----HHHHCCC------C
T ss_pred             c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH----HHHH----HHHcCCC------C
Confidence            2 2334457999999999999999999999999999999999999999865421    1221    1112211      1


Q ss_pred             cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHH-HHHHH
Q 004689          645 LLDEYDIQSMWKIEEKALMCVLPHGHMRPSIS-EVLKD  681 (736)
Q Consensus       645 l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~~~  681 (736)
                      ....    ...++.+++.+|++.||++||++. |+++|
T Consensus       222 ~p~~----~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         222 YPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             CCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             CCcc----CCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence            1111    224588999999999999999995 77653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3e-44  Score=386.84  Aligned_cols=247  Identities=24%  Similarity=0.316  Sum_probs=195.8

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc---ccchhhhh---HHHHHhhcCCCceeeEeeeeeeCCeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY---QGKREFTN---EVTLLSRIHHRNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~~---E~~il~~l~HpnIv~l~~~~~~~~~~~lV  482 (736)
                      |.+.+.||+|+||.||+|+.. +|+.||||++.....   .....+.+   |+.+++.++|||||++++++.+++..++|
T Consensus         6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv   85 (364)
T d1omwa3           6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI   85 (364)
T ss_dssp             EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred             CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence            446789999999999999876 689999999864321   12233444   46677778899999999999999999999


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAV  562 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~  562 (736)
                      ||||++|+|.+++..    ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+...
T Consensus        86 mE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          86 LDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             ECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            999999999999853    45678899999999999999999998   99999999999999999999999999998664


Q ss_pred             CCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceec
Q 004689          563 DGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGII  641 (736)
Q Consensus       563 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  641 (736)
                      ...   .....||+.|+|||++.. ..|+.++|||||||++|||++|+.||......    ......+.. ....     
T Consensus       159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~~~~~-~~~~-----  225 (364)
T d1omwa3         159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK----DKHEIDRMT-LTMA-----  225 (364)
T ss_dssp             SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS----CHHHHHHHS-SSCC-----
T ss_pred             CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhc-ccCC-----
Confidence            432   234579999999999975 56899999999999999999999999865422    111111111 1111     


Q ss_pred             cCccCCcCCHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 004689          642 DPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPS-----ISEVLKD  681 (736)
Q Consensus       642 d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~  681 (736)
                       ......++    .++.+++.+|++.||++|||     ++|+++|
T Consensus       226 -~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         226 -VELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             -CCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             -CCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence             11111222    35789999999999999999     6888765

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-44  Score=381.25  Aligned_cols=247  Identities=22%  Similarity=0.254  Sum_probs=194.1

Q ss_pred             hccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhc-CCCceeeEeeeeee----CCeEEEEEEec
Q 004689          413 EKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRI-HHRNLVQFLGYCQE----EGRSVLVYEFM  486 (736)
Q Consensus       413 ~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~----~~~~~lV~e~~  486 (736)
                      .+.||+|+||+||+|++. +++.||||+++.     ...+.+|++++.++ +|||||++++++.+    ....++|||||
T Consensus        17 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~   91 (335)
T d2ozaa1          17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL   91 (335)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             eEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence            457999999999999874 689999999853     34577899987655 89999999999865    46789999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeecCCccccC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~---~~~~kl~DFGla~~~~~  563 (736)
                      ++|+|.+++...  ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.   .+.+||+|||+|+....
T Consensus        92 ~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~  166 (335)
T d2ozaa1          92 DGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  166 (335)
T ss_dssp             CSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred             CCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccC
Confidence            999999999643  234699999999999999999999998   9999999999999986   46799999999986544


Q ss_pred             CCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcceeccC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQGIIDP  643 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  643 (736)
                      ...  .....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.......    ......+..+...     
T Consensus       167 ~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~----~~~~~~i~~~~~~-----  235 (335)
T d2ozaa1         167 HNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIRMGQYE-----  235 (335)
T ss_dssp             CCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSSS-----
T ss_pred             CCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH----HHHHHHHhcCCCC-----
Confidence            332  33457999999999999999999999999999999999999999765422111    1111111111110     


Q ss_pred             ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       ...........++.+++.+|++.||++|||+.|++++
T Consensus       236 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         236 -FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             -CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence             0000011223468899999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-45  Score=385.43  Aligned_cols=258  Identities=24%  Similarity=0.401  Sum_probs=206.1

Q ss_pred             HHHhhccccccCceEEEEEEEC------CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK------DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVL  481 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~------~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l  481 (736)
                      .+.+.+.||+|+||+||+|.+.      +++.||||+++.... .....|.+|+.++++++||||++++++|..++..++
T Consensus        21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  100 (308)
T d1p4oa_          21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV  100 (308)
T ss_dssp             GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred             HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence            3446789999999999999864      357899999975432 334568999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHHhhccc------ccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEee
Q 004689          482 VYEFMHNGTLKEHLYGTL------THEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDF  555 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DF  555 (736)
                      ||||+++|+|.+++....      .....+++..+..++.|+|+||.|||++   +|+||||||+|||++.++++||+||
T Consensus       101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DF  177 (308)
T d1p4oa_         101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF  177 (308)
T ss_dssp             EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred             EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeec
Confidence            999999999999986431      1113468889999999999999999998   9999999999999999999999999


Q ss_pred             cCCccccCCCC-cceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCC-CcCcccccccccccHHHHHHHhhh
Q 004689          556 GLSKFAVDGAS-HVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQ-EAISNEKFGANCRNIVQWAKLHIE  633 (736)
Q Consensus       556 Gla~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~-~p~~~~~~~~~~~~l~~~~~~~~~  633 (736)
                      |+|+....... .......||+.|+|||.+.+..++.++|||||||++|||+||. .||.+....       ++... +.
T Consensus       178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~-------~~~~~-i~  249 (308)
T d1p4oa_         178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------QVLRF-VM  249 (308)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-------HHHHH-HH
T ss_pred             ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH-------HHHHH-HH
Confidence            99986544322 2233446899999999999999999999999999999999985 667654421       22221 22


Q ss_pred             cCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 004689          634 SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAI  686 (736)
Q Consensus       634 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~  686 (736)
                      ++.....         +......+.+++.+|++.+|.+||||.||+++|++.+
T Consensus       250 ~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         250 EGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             TTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             hCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            2222111         1122346899999999999999999999999998764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-44  Score=373.49  Aligned_cols=261  Identities=21%  Similarity=0.278  Sum_probs=195.2

Q ss_pred             HhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          411 MLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       411 ~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      .+.+.||+|+||+||+|++. +|+.||||+++....  .....+.+|+++|++++|||||++++++.++...++||||+.
T Consensus         5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~   84 (298)
T d1gz8a_           5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH   84 (298)
T ss_dssp             EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC
Confidence            44678999999999999875 689999999965432  235678899999999999999999999999999999999997


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      ++.+ +++..  .....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+...... .
T Consensus        85 ~~~~-~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~  157 (298)
T d1gz8a_          85 QDLK-KFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R  157 (298)
T ss_dssp             EEHH-HHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-B
T ss_pred             Cchh-hhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-c
Confidence            6544 44422  2345689999999999999999999998   99999999999999999999999999998654332 2


Q ss_pred             ceecccccccccCccccccCc-CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh--cCCccee-ccC
Q 004689          568 VSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE--SGDIQGI-IDP  643 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~~~-~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~--~~~~~~~-~d~  643 (736)
                      ......||+.|+|||++.... ++.++||||+||++|||++|+.||.+....+   .+.........  +...... ..+
T Consensus       158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhcCCCchhhcccccccc
Confidence            233456999999999987655 5789999999999999999999997654211   11111111000  0000000 000


Q ss_pred             ccCCc------CC-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          644 SLLDE------YD-----IQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       644 ~l~~~------~~-----~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .....      .+     ......+.+++.+|+..||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00000      00     1112467889999999999999999999876

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=367.66  Aligned_cols=239  Identities=22%  Similarity=0.371  Sum_probs=195.0

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcc------cchhhhhHHHHHhhcC--CCceeeEeeeeeeCCeE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQ------GKREFTNEVTLLSRIH--HRNLVQFLGYCQEEGRS  479 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~------~~~~~~~E~~il~~l~--HpnIv~l~~~~~~~~~~  479 (736)
                      .|.+.+.||+|+||+||+|+.. +|+.||||++......      ....+.+|+.+|++++  |||||++++++.+++..
T Consensus         5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~   84 (273)
T d1xwsa_           5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF   84 (273)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred             eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence            3567789999999999999875 6899999998754221      2345789999999996  89999999999999999


Q ss_pred             EEEEEecCC-CCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCC-CcEEEEeecC
Q 004689          480 VLVYEFMHN-GTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKH-MRAKVSDFGL  557 (736)
Q Consensus       480 ~lV~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~-~~~kl~DFGl  557 (736)
                      ++||||+.+ +++.+++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.+ +.+||+|||+
T Consensus        85 ~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          85 VLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence            999999976 67777774    345689999999999999999999998   99999999999999854 7999999999


Q ss_pred             CccccCCCCcceecccccccccCccccccCcC-CCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCC
Q 004689          558 SKFAVDGASHVSSIVRGTVGYLDPEYYISQQL-TDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGD  636 (736)
Q Consensus       558 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~  636 (736)
                      |+.....   ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....      .+.        .+.
T Consensus       158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~--------~~~  220 (273)
T d1xwsa_         158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EII--------RGQ  220 (273)
T ss_dssp             CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHH--------HCC
T ss_pred             ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHh--------hcc
Confidence            9865332   2334679999999999987765 567899999999999999999997542      111        111


Q ss_pred             cceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 IQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .  .+    ....+    .++.+++.+|++.||++|||++|++++
T Consensus       221 ~--~~----~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         221 V--FF----RQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             C--CC----SSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             c--CC----CCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            1  01    11222    357899999999999999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.3e-43  Score=370.35  Aligned_cols=263  Identities=20%  Similarity=0.263  Sum_probs=197.8

Q ss_pred             HHhhccccccCceEEEEEEECCCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.++||+|+||+||+|++++|+.||||+++....  .....+.+|+.+|++++||||+++++++..++..++++||+.
T Consensus         4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~   83 (286)
T d1ob3a_           4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD   83 (286)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred             ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence            345678999999999999999999999999975532  235678899999999999999999999999999999999999


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCCc
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGASH  567 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~~  567 (736)
                      ++.+..+..    ....++...+..++.|++.||+|||+.   +|+||||||+|||++.++.+|++|||+|....... .
T Consensus        84 ~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~  155 (286)
T d1ob3a_          84 QDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R  155 (286)
T ss_dssp             EEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             hhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc-c
Confidence            877766653    346799999999999999999999998   99999999999999999999999999998654332 2


Q ss_pred             ceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc---ee---
Q 004689          568 VSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ---GI---  640 (736)
Q Consensus       568 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~---~~---  640 (736)
                      ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+....+...++..-. .........   ..   
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL-GTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH-CCCCTTTSTTGGGSTTC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhh-CCCChhhccchhhhhhc
Confidence            2334458999999999976 456899999999999999999999997654222111111100 000000000   00   


Q ss_pred             ------ccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          641 ------IDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       641 ------~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                            ..+.-...........+.+++.+|++.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  00000001111123467899999999999999999999864

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-43  Score=370.81  Aligned_cols=265  Identities=21%  Similarity=0.269  Sum_probs=195.9

Q ss_pred             HHHhhccccccCceEEEEEEEC-C-CcEEEEEEeccCCc--ccchhhhhHHHHHhhc---CCCceeeEeeeeee-----C
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-D-GKEIAVKVLTSNSY--QGKREFTNEVTLLSRI---HHRNLVQFLGYCQE-----E  476 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~-~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l---~HpnIv~l~~~~~~-----~  476 (736)
                      .|.+.+.||+|+||+||+|++. + ++.||||+++....  .....+.+|+.+|+.+   +||||++++++|..     .
T Consensus         8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~   87 (305)
T d1blxa_           8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   87 (305)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred             CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence            3556789999999999999874 4 56799999865432  2344677888888776   79999999999853     3


Q ss_pred             CeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeec
Q 004689          477 GRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFG  556 (736)
Q Consensus       477 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFG  556 (736)
                      ...+++|||+.++.+.....   .....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||
T Consensus        88 ~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          88 TKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             EEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             ceEEEEEEeccCCchhhhhh---ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence            46799999999887755443   2345688999999999999999999998   99999999999999999999999999


Q ss_pred             CCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC-
Q 004689          557 LSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG-  635 (736)
Q Consensus       557 la~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~-  635 (736)
                      +++....  ........||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....+....+........... 
T Consensus       162 ~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         162 LARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             SCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            9875432  2233456799999999999999999999999999999999999999986553222112211110000000 


Q ss_pred             ----CcceeccCcc----CCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          636 ----DIQGIIDPSL----LDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       636 ----~~~~~~d~~l----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                          ..........    ...+.......+.+|+.+|++.||++|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                0000000000    001111223457889999999999999999999875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-42  Score=367.95  Aligned_cols=262  Identities=22%  Similarity=0.245  Sum_probs=193.2

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceeeEeeeeeeC------CeEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQFLGYCQEE------GRSVLV  482 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~------~~~~lV  482 (736)
                      |...++||+|+||+||+|++. +|+.||||++....    ..+.+|+++|++++||||++++++|...      .+.++|
T Consensus        22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence            344678999999999999986 68999999986542    3456899999999999999999998542      357899


Q ss_pred             EEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeecCCccc
Q 004689          483 YEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFA  561 (736)
Q Consensus       483 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~-~~kl~DFGla~~~  561 (736)
                      ||||+++.+. .+.........+++..+..++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||+++..
T Consensus        98 ~Ey~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          98 LDYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EECCSEEHHH-HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EeccCCccHH-HHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999876443 3433323455789999999999999999999998   999999999999999775 8999999999865


Q ss_pred             cCCCCcceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHH--------HHHHhh
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ--------WAKLHI  632 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~--------~~~~~~  632 (736)
                      .....  .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+..        +.....
T Consensus       174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            44322  234569999999998875 5789999999999999999999999976543221111111        000000


Q ss_pred             h---cCCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          633 E---SGDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       633 ~---~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .   ...+...................+.+|+.+|+..||++|||+.|+++|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0   000110000000011111223457899999999999999999999876

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-41  Score=355.64  Aligned_cols=259  Identities=21%  Similarity=0.288  Sum_probs=198.1

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCceee-EeeeeeeCCeEEEEEEecC
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNLVQ-FLGYCQEEGRSVLVYEFMH  487 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~-l~~~~~~~~~~~lV~e~~~  487 (736)
                      |.+.+.||+|+||+||+|++. +|+.||||++....  ...++..|++++++++|+|++. +.+++.+.+..++||||+.
T Consensus         9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~   86 (299)
T d1ckia_           9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG   86 (299)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred             EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence            567789999999999999875 68999999987543  3456889999999998776554 5555677888899999995


Q ss_pred             CCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC---CCcEEEEeecCCccccCC
Q 004689          488 NGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK---HMRAKVSDFGLSKFAVDG  564 (736)
Q Consensus       488 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~---~~~~kl~DFGla~~~~~~  564 (736)
                       |+|.+.+..   ....+++..+..++.|++.||+|||++   +|+||||||+|||++.   +..+||+|||+|+.....
T Consensus        87 -~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          87 -PSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             -CBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             -Cchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence             566665532   245689999999999999999999998   9999999999999864   557999999999876543


Q ss_pred             CCc------ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          565 ASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       565 ~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      ...      ......||+.|||||.+.+..++.++|||||||++|||++|+.||...........+..+....... .. 
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~-  237 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-PI-  237 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-CH-
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-Ch-
Confidence            322      2334579999999999999999999999999999999999999998765333333333332221111 00 


Q ss_pred             eeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       639 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                          +.+...+    ..++.+++..|++.+|++||++.++.+.|+.+..
T Consensus       238 ----~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         238 ----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             ----HHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ----hHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence                0111122    2458899999999999999999999999988754

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-42  Score=361.63  Aligned_cols=251  Identities=24%  Similarity=0.309  Sum_probs=201.6

Q ss_pred             HHhhccccccCceEEEEEEEC----CCcEEEEEEeccCC----cccchhhhhHHHHHhhcCC-CceeeEeeeeeeCCeEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK----DGKEIAVKVLTSNS----YQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSV  480 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~----~~~~vAvK~l~~~~----~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~  480 (736)
                      |.+.+.||+|+||+||+|+..    +|+.||||+++...    ......+.+|+++|++++| |||+++++++.+....+
T Consensus        26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~  105 (322)
T d1vzoa_          26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH  105 (322)
T ss_dssp             EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred             eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence            567789999999999999763    47899999986542    1234568899999999976 89999999999999999


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+.+|+|.+++.    ....++......++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         106 LILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence            9999999999999984    344567888889999999999999998   999999999999999999999999999986


Q ss_pred             ccCCCCcceecccccccccCccccccC--cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcc
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYISQ--QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQ  638 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~  638 (736)
                      .............|++.|+|||.+.+.  .++.++|||||||+||||++|+.||......+....+......    ..  
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~----~~--  252 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK----SE--  252 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH----CC--
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc----CC--
Confidence            655444445566799999999999764  4678999999999999999999999876543333333221111    11  


Q ss_pred             eeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 004689          639 GIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRP-----SISEVLKD  681 (736)
Q Consensus       639 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~  681 (736)
                          +.+    +.....++.+++.+|++.||++||     |++|+++|
T Consensus       253 ----~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         253 ----PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             ----CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ----CCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                111    112234688899999999999999     47888765

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=360.13  Aligned_cols=265  Identities=18%  Similarity=0.251  Sum_probs=192.7

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCC--cccchhhhhHHHHHhhcCCCceeeEeeeeee--------CC
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNS--YQGKREFTNEVTLLSRIHHRNLVQFLGYCQE--------EG  477 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--------~~  477 (736)
                      .|.+.+.||+|+||+||+|++. +|+.||||++....  ......+.+|+.+|++++||||+++++++..        ..
T Consensus        11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~   90 (318)
T d3blha1          11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG   90 (318)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred             CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence            3456789999999999999975 78999999986542  2335668899999999999999999998854        34


Q ss_pred             eEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecC
Q 004689          478 RSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGL  557 (736)
Q Consensus       478 ~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGl  557 (736)
                      ..++||||+.++.+....    .....++...+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        91 ~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          91 SIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             eEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence            679999999988776554    2345678888999999999999999998   999999999999999999999999999


Q ss_pred             CccccCCCC---cceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhh
Q 004689          558 SKFAVDGAS---HVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIE  633 (736)
Q Consensus       558 a~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~  633 (736)
                      ++.......   .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.........+.+.... ..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~-~~  242 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-IT  242 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC-CC
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC-CC
Confidence            976543221   122335699999999998764 6899999999999999999999999765422111111111100 00


Q ss_pred             cCCccee--------ccCccCCcCCHH-------HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          634 SGDIQGI--------IDPSLLDEYDIQ-------SMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       634 ~~~~~~~--------~d~~l~~~~~~~-------~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .......        +...........       ....+.+|+.+|++.||++|||++|+++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            0000000        000000011111       12346789999999999999999999865

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.7e-41  Score=351.09  Aligned_cols=260  Identities=17%  Similarity=0.243  Sum_probs=205.3

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcCC-CceeeEeeeeeeCCeEEEEEEec
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH-RNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      .|.+.+.||+|+||+||+|++. +|+.||||++....  ....+.+|+++++.++| +|++.+++++......++||||+
T Consensus         6 ~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~   83 (293)
T d1csna_           6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL   83 (293)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence            3567889999999999999976 68899999986442  34568899999999965 89999999999999999999998


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcC-----CCcEEEEeecCCccc
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDK-----HMRAKVSDFGLSKFA  561 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~-----~~~~kl~DFGla~~~  561 (736)
                       +|+|.+++...   ...++...+..++.|++.||+|||++   +|+||||||+|||++.     ++.+||+|||+|+..
T Consensus        84 -~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          84 -GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             -CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             -CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence             68999887532   34689999999999999999999998   9999999999999974     578999999999875


Q ss_pred             cCCCCc------ceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcC
Q 004689          562 VDGASH------VSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESG  635 (736)
Q Consensus       562 ~~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~  635 (736)
                      ......      ......||+.|||||.+.+..++.++|||||||++|||++|+.||.+............ +.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~-i~~~~~~~  235 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-IGEKKQST  235 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-HHHHHHHS
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH-HHhccCCC
Confidence            433221      23345799999999999999999999999999999999999999986553222211111 11111111


Q ss_pred             CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 004689          636 DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKDIQDAIV  687 (736)
Q Consensus       636 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~~~~  687 (736)
                      ...+     +....    +.++.+++..|+..+|++||+++.+.+.|++++.
T Consensus       236 ~~~~-----l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         236 PLRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             CHHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ChHH-----hcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            1111     11122    2458889999999999999999999999988764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-41  Score=358.55  Aligned_cols=259  Identities=20%  Similarity=0.269  Sum_probs=191.0

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc-ccchhhhhHHHHHhhcCCCceeeEeeeeeeCC----eEEEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY-QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG----RSVLVY  483 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~----~~~lV~  483 (736)
                      |.+.++||+|+||+||+|... +|+.||||+++.... ...+.+.+|+++|++++||||+++++++....    ..++++
T Consensus        10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~   89 (345)
T d1pmea_          10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV   89 (345)
T ss_dssp             EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred             eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence            456689999999999999874 799999999975432 23456889999999999999999999987643    234555


Q ss_pred             EecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccC
Q 004689          484 EFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVD  563 (736)
Q Consensus       484 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~  563 (736)
                      +|+.+|+|.+++.     ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          90 THLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            6677999999984     24689999999999999999999998   999999999999999999999999999976533


Q ss_pred             CCC--cceecccccccccCcccccc-CcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhcCCcce-
Q 004689          564 GAS--HVSSIVRGTVGYLDPEYYIS-QQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIESGDIQG-  639 (736)
Q Consensus       564 ~~~--~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~~~~~~-  639 (736)
                      ...  .......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+..    .............. 
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~----~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL----NHILGILGSPSQEDL  237 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHHHCSCCHHHH
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH----HHHhhhccCCChhhh
Confidence            222  22344569999999999854 56789999999999999999999999765421111    10000000000000 


Q ss_pred             ----------e-c-cCccCCcCCH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 ----------I-I-DPSLLDEYDI-----QSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 ----------~-~-d~~l~~~~~~-----~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                                . . .+. ....+.     ....++.+++.+|++.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         238 NCIINLKARNYLLSLPH-KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HTCCCHHHHHHHHTSCC-CCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhcccccCCc-cCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      0 0 000 000000     111357899999999999999999999876

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-40  Score=357.99  Aligned_cols=262  Identities=21%  Similarity=0.278  Sum_probs=189.7

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCC------eEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEG------RSV  480 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~------~~~  480 (736)
                      |.+.+.||+|+||+||+|... +|+.||||+++....  ...+.+.+|+++|++++|||||+++++|...+      ..+
T Consensus        20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~   99 (346)
T d1cm8a_          20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY   99 (346)
T ss_dssp             EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence            455688999999999999875 699999999975422  22456889999999999999999999997654      569


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+ +++|...+.     ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+|++|||+|+.
T Consensus       100 lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_         100 LVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             EEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceec
Confidence            999999 557776653     35689999999999999999999998   999999999999999999999999999986


Q ss_pred             ccCCCCcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHH----hhhcC
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKL----HIESG  635 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~----~~~~~  635 (736)
                      ....    .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.........+......    .....
T Consensus       171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            5432    2345699999999999764 5689999999999999999999999765421111111100000    00000


Q ss_pred             ----------CcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHH
Q 004689          636 ----------DIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD--IQDA  685 (736)
Q Consensus       636 ----------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~~  685 (736)
                                .+.+.-...+. .........+.+|+.+|+..||.+|||++|+++|  ++.+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             cchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                      00000000000 0011112357789999999999999999999987  5443

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-41  Score=350.77  Aligned_cols=261  Identities=19%  Similarity=0.208  Sum_probs=198.8

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeeeCCeEEEEEEec
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQEEGRSVLVYEFM  486 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lV~e~~  486 (736)
                      |++.+.||+|+||+||+|++. +++.||||+++....  .....+.+|+.+|+.++||||+++++++.+....++|+|++
T Consensus         4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~   83 (292)
T d1unla_           4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_dssp             EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence            445689999999999999975 788999999965432  23467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccccCCCC
Q 004689          487 HNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFAVDGAS  566 (736)
Q Consensus       487 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~~~~~~  566 (736)
                      .+++|..++.    ....+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||.++.......
T Consensus        84 ~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          84 DQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             SEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             cccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            9999888774    345678889999999999999999998   999999999999999999999999999986544332


Q ss_pred             cceecccccccccCccccccCc-CCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHhhhc---CCcc---e
Q 004689          567 HVSSIVRGTVGYLDPEYYISQQ-LTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLHIES---GDIQ---G  639 (736)
Q Consensus       567 ~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~~~~---~~~~---~  639 (736)
                       ......+++.|+|||++.... ++.++||||+||++|||++|+.||......   .....-+......   ....   .
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH---HHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH---HHHHHHHHhhcCCCChhhhhhhhh
Confidence             223345788999999987654 689999999999999999999997543311   1111111111110   0000   0


Q ss_pred             eccC--------c-cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          640 IIDP--------S-LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       640 ~~d~--------~-l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      ..+.        . -...........+.+++.+|++.||.+|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000        0 0000111222457889999999999999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.2e-40  Score=351.39  Aligned_cols=258  Identities=19%  Similarity=0.278  Sum_probs=193.3

Q ss_pred             HHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcC-CCceeeEeeeeee--CCeEEEEEE
Q 004689          409 TKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQE--EGRSVLVYE  484 (736)
Q Consensus       409 ~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~--~~~~~lV~e  484 (736)
                      .|.+.++||+|+||+||+|+.. +|+.||||+++..   ..+.+.+|+++|++++ ||||+++++++..  ....++|||
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e  112 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  112 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence            4567789999999999999875 6899999998643   2457889999999995 9999999999874  456899999


Q ss_pred             ecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-cEEEEeecCCccccC
Q 004689          485 FMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-RAKVSDFGLSKFAVD  563 (736)
Q Consensus       485 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~-~~kl~DFGla~~~~~  563 (736)
                      |+.+|+|....       +.++...+..++.|++.||+|||++   +|+||||||+|||++.++ .+||+|||+|+....
T Consensus       113 ~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             CCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             ecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence            99999987653       3588889999999999999999998   999999999999998655 699999999986544


Q ss_pred             CCCcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCccccccccc-ccHHHHH-----HHhhhcCC
Q 004689          564 GASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANC-RNIVQWA-----KLHIESGD  636 (736)
Q Consensus       564 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~-~~l~~~~-----~~~~~~~~  636 (736)
                      ..  ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ..+....     ........
T Consensus       183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            32  23345689999999998765 5799999999999999999999999754321110 0111100     00000000


Q ss_pred             c------ceeccC--------ccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          637 I------QGIIDP--------SLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       637 ~------~~~~d~--------~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                      .      ......        ............++.+|+.+|+..||++|||++|+++|
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0      000000        00000011122457899999999999999999999874

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-40  Score=354.98  Aligned_cols=260  Identities=21%  Similarity=0.274  Sum_probs=187.5

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeee------CCeEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE------EGRSV  480 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~------~~~~~  480 (736)
                      |.+.++||+|+||+||+|.+. +|+.||||+++....  .....+.+|+.+|++++||||+++++++..      ....+
T Consensus        19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~   98 (355)
T d2b1pa1          19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY   98 (355)
T ss_dssp             EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred             eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence            455689999999999999876 699999999975432  234568899999999999999999999853      36889


Q ss_pred             EEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCcc
Q 004689          481 LVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKF  560 (736)
Q Consensus       481 lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~  560 (736)
                      +||||+.++.+ +.+.      ..+++..+..++.|++.||.|||+.   ||+||||||+|||++.++.+|++|||+++.
T Consensus        99 iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          99 LVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence            99999976554 4442      3478889999999999999999998   999999999999999999999999999875


Q ss_pred             ccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHH--------------
Q 004689          561 AVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQ--------------  626 (736)
Q Consensus       561 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~--------------  626 (736)
                      ....  .......||+.|+|||++.+..++.++||||+||+++||++|+.||.+.........+..              
T Consensus       169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            4332  233445689999999999999999999999999999999999999975542111111110              


Q ss_pred             -HHHHhhhcC-Cc-----ceeccCccCCc---CCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          627 -WAKLHIESG-DI-----QGIIDPSLLDE---YDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       627 -~~~~~~~~~-~~-----~~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                       ......... ..     ...........   ........+.+|+.+|+..||++|||++|+++|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence             000000100 00     00010011111   112344578899999999999999999999987

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-39  Score=348.67  Aligned_cols=259  Identities=20%  Similarity=0.270  Sum_probs=190.1

Q ss_pred             HHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCc--ccchhhhhHHHHHhhcCCCceeeEeeeeee-----CCeEEE
Q 004689          410 KMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSY--QGKREFTNEVTLLSRIHHRNLVQFLGYCQE-----EGRSVL  481 (736)
Q Consensus       410 ~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~l  481 (736)
                      |.+.++||+|+||+||+|+.. +|+.||||+++....  .....+.+|+++|++++|||||++++++..     ....++
T Consensus        20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~   99 (348)
T d2gfsa1          20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY   99 (348)
T ss_dssp             EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred             eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence            556789999999999999875 799999999975432  234568899999999999999999999853     234466


Q ss_pred             EEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEEeecCCccc
Q 004689          482 VYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVSDFGLSKFA  561 (736)
Q Consensus       482 V~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~DFGla~~~  561 (736)
                      +++|+.+|+|.+++.     .+.+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||++...
T Consensus       100 i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1         100 LVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             EEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             EEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhccc
Confidence            778888999999884     24589999999999999999999998   9999999999999999999999999998754


Q ss_pred             cCCCCcceecccccccccCccccccC-cCCCcchhHHHHHHHHHHHhCCCcCcccccccccccHHHHHHHh----hhc--
Q 004689          562 VDGASHVSSIVRGTVGYLDPEYYISQ-QLTDKSDVYSFGVILLELISGQEAISNEKFGANCRNIVQWAKLH----IES--  634 (736)
Q Consensus       562 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~~l~~~~~~~----~~~--  634 (736)
                      .    .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.+.........+.......    ...  
T Consensus       172 ~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         172 D----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             T----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             C----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            2    223345699999999987765 46889999999999999999999997654221111111110000    000  


Q ss_pred             --------CCcceeccCccCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 004689          635 --------GDIQGIIDPSLLDEYDIQSMWKIEEKALMCVLPHGHMRPSISEVLKD  681 (736)
Q Consensus       635 --------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~  681 (736)
                              ..+...-...+.. ........+.+++.+|+..||++|||++|+++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             chhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence                    0000000000000 000112357889999999999999999999875

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-36  Score=325.41  Aligned_cols=266  Identities=19%  Similarity=0.280  Sum_probs=189.4

Q ss_pred             HHHHhhccccccCceEEEEEEEC-CCcEEEEEEeccCCcccchhhhhHHHHHhhcC-----------CCceeeEeeeeee
Q 004689          408 ATKMLEKKIGSGGFGVVYYGKLK-DGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-----------HRNLVQFLGYCQE  475 (736)
Q Consensus       408 ~~~~~~~~IG~G~fG~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l~~~~~~  475 (736)
                      .+|.+.++||+|+||+||+|+.. +|+.||||+++.... ....+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            34778899999999999999875 789999999975432 2456788999988875           5789999988754


Q ss_pred             --CCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCC-----
Q 004689          476 --EGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHM-----  548 (736)
Q Consensus       476 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~-----  548 (736)
                        ....+++++++..+........ ......++...+..++.|++.||+|||+.  .+|+||||||+|||++.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCccccc
Confidence              4566777777665543332221 13345678889999999999999999983  2899999999999998765     


Q ss_pred             -cEEEEeecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHHHHHHHhCCCcCcccccccccc---cH
Q 004689          549 -RAKVSDFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVILLELISGQEAISNEKFGANCR---NI  624 (736)
Q Consensus       549 -~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvvl~elltG~~p~~~~~~~~~~~---~l  624 (736)
                       .++++|||.+......    .....||+.|+|||++....++.++||||+||+++||++|+.||..........   .+
T Consensus       169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~  244 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI  244 (362)
T ss_dssp             EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred             ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence             3999999999754322    234569999999999999999999999999999999999999997544221111   11


Q ss_pred             HHHHHHh-------hhcCC-cceecc---------Cc----------cCCcCCHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 004689          625 VQWAKLH-------IESGD-IQGIID---------PS----------LLDEYDIQSMWKIEEKALMCVLPHGHMRPSISE  677 (736)
Q Consensus       625 ~~~~~~~-------~~~~~-~~~~~d---------~~----------l~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  677 (736)
                      ...+...       ...+. .....+         ..          ...........++.+++.+|+..||.+|||++|
T Consensus       245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e  324 (362)
T d1q8ya_         245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG  324 (362)
T ss_dssp             HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred             HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence            1111110       00000 000000         00          011223456678999999999999999999999


Q ss_pred             HHHH
Q 004689          678 VLKD  681 (736)
Q Consensus       678 v~~~  681 (736)
                      +++|
T Consensus       325 ~L~H  328 (362)
T d1q8ya_         325 LVNH  328 (362)
T ss_dssp             HHTC
T ss_pred             HhcC
Confidence            9876

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.86  E-value=1.6e-22  Score=196.43  Aligned_cols=167  Identities=17%  Similarity=0.156  Sum_probs=118.5

Q ss_pred             hhccccccCceEEEEEEECCCcEEEEEEeccCCcc------------------cchhhhhHHHHHhhcCCCceeeEeeee
Q 004689          412 LEKKIGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQ------------------GKREFTNEVTLLSRIHHRNLVQFLGYC  473 (736)
Q Consensus       412 ~~~~IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~------------------~~~~~~~E~~il~~l~HpnIv~l~~~~  473 (736)
                      +.++||+|+||+||+|...+|++||||+++.....                  .......|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            46889999999999999988999999987632110                  012245688899999999999887653


Q ss_pred             eeCCeEEEEEEecCCCCHHHHhhcccccccccCHHHHHHHHHHHHHHHHHHHhCCCCceecCCCCCCCEEEcCCCcEEEE
Q 004689          474 QEEGRSVLVYEFMHNGTLKEHLYGTLTHEQRINWIKRLEIAEDAAKGIEYLHTGCVPAIIHRDLKSSNILLDKHMRAKVS  553 (736)
Q Consensus       474 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~~~~iiHrDikp~NILl~~~~~~kl~  553 (736)
                      .    .+++|||++++.+.+           ++......++.|++.+|.|||++   +|+||||||+|||++++ .++|+
T Consensus        84 ~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          84 G----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             T----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred             C----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence            2    379999998865433           22333467899999999999998   99999999999999965 58999


Q ss_pred             eecCCccccCCCCcceecccccccccCccccccCcCCCcchhHHHHHH
Q 004689          554 DFGLSKFAVDGASHVSSIVRGTVGYLDPEYYISQQLTDKSDVYSFGVI  601 (736)
Q Consensus       554 DFGla~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DVwSlGvv  601 (736)
                      |||+|....+......  ....... -.|. ..+.|+.++|+||..--
T Consensus       145 DFG~a~~~~~~~~~~~--l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         145 DFPQSVEVGEEGWREI--LERDVRN-IITY-FSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CCTTCEETTSTTHHHH--HHHHHHH-HHHH-HHHHHCCCCCHHHHHHH
T ss_pred             ECCCcccCCCCCcHHH--HHHHHHH-HHHH-HcCCCCCcccHHHHHHH
Confidence            9999975533221110  0000000 0111 24678899999997543

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.68  E-value=3e-17  Score=171.44  Aligned_cols=146  Identities=29%  Similarity=0.493  Sum_probs=126.0

Q ss_pred             CchHHHHHHHHHHcC----CCCcCCCCCCCCCCCCCceEEecCCC-CCceEEEEccCCCCCc--cCCccccccccccccc
Q 004689          181 SIDGVAIVSVISLYS----SADWAQEGGDPCLPVPWSWLQCNSDP-QPSITVIHLSSKNLTG--NIPSDLTKLSSLVELW  253 (736)
Q Consensus       181 ~~~~~al~~l~~~~~----~~~w~~~~~dpc~~~~~~~v~c~~~~-~~~l~~L~L~~n~l~g--~~p~~~~~l~~L~~L~  253 (736)
                      ..|..||.++|+.+.    +.+|.. ++|||. ..|.||.|+... ..+|+.|+|++|+++|  .+|++|++|++|++|+
T Consensus         5 ~~e~~aLl~~k~~~~~~~~l~sW~~-~~d~C~-~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~   82 (313)
T d1ogqa_           5 PQDKQALLQIKKDLGNPTTLSSWLP-TTDCCN-RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLY   82 (313)
T ss_dssp             HHHHHHHHHHHHHTTCCGGGTTCCT-TSCTTT-TCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEE
T ss_pred             HHHHHHHHHHHHHCCCCCcCCCCCC-CCCCCC-CcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccc
Confidence            457899999999886    578964 589992 349999998543 4589999999999998  5899999999999999


Q ss_pred             ccc-cccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCCCCccccc--ccccccccCCcc
Q 004689          254 LDG-NSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLLS--KNVVLNYAGNIN  328 (736)
Q Consensus       254 Ls~-N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~~~--~~~~l~~~~n~~  328 (736)
                      |++ |+++|.+| .|++|++|++|+|++|+|++..|..+.++.+|+.+++++|.+.+.+|..+..  ....+.+.+|..
T Consensus        83 Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l  161 (313)
T d1ogqa_          83 IGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI  161 (313)
T ss_dssp             EEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred             cccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccc
Confidence            997 89999988 7999999999999999999999999999999999999999999999988854  345666677643

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.43  E-value=8e-14  Score=134.23  Aligned_cols=120  Identities=23%  Similarity=0.285  Sum_probs=103.0

Q ss_pred             CceEEecCCC--------CCceEEEEccCCCCCccCC-cccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCC
Q 004689          212 WSWLQCNSDP--------QPSITVIHLSSKNLTGNIP-SDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQ  281 (736)
Q Consensus       212 ~~~v~c~~~~--------~~~l~~L~L~~n~l~g~~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~  281 (736)
                      +..|.|+...        +++++.|+|++|.|++.++ ..|.++++|+.|+|++|++++.++ .+.++++|++|+|++|+
T Consensus        10 ~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~   89 (192)
T d1w8aa_          10 GTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK   89 (192)
T ss_dssp             TTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred             CCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence            6678897554        2478999999999987664 467899999999999999999988 68999999999999999


Q ss_pred             CCCCCCccccCccccceeecccccCcCCCCcccc---cccccccccCCcccccC
Q 004689          282 LTGPLPSSLMNLPNLRELYVQNNMLSGTVPSSLL---SKNVVLNYAGNINLHEG  332 (736)
Q Consensus       282 l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~~~~---~~~~~l~~~~n~~~c~~  332 (736)
                      |++..|..|.++++|+.|+|++|+|+ .+|...+   ..+..+.+.+|+..|..
T Consensus        90 l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~  142 (192)
T d1w8aa_          90 IKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             CCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             ccccCHHHHhCCCcccccccCCcccc-ccCHHHhcCCccccccccccccccccc
Confidence            99878889999999999999999999 5665544   34578889999998875

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.42  E-value=1.8e-14  Score=149.96  Aligned_cols=110  Identities=26%  Similarity=0.317  Sum_probs=100.9

Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN  303 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~  303 (736)
                      ....++++++.+.|.+|..+..+++|+.|++++|.+++.+|.++.+++|++|+|++|+|+|.+|++|++|++|+.|+|++
T Consensus       198 ~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~  277 (313)
T d1ogqa_         198 NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF  277 (313)
T ss_dssp             CCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence            44579999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccCcCCCCccc-ccccccccccCCcccccCC
Q 004689          304 NMLSGTVPSSL-LSKNVVLNYAGNINLHEGG  333 (736)
Q Consensus       304 N~l~g~~P~~~-~~~~~~l~~~~n~~~c~~~  333 (736)
                      |+|+|.+|..- +..+..+.+.+|+.+|+.+
T Consensus       278 N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~p  308 (313)
T d1ogqa_         278 NNLCGEIPQGGNLQRFDVSAYANNKCLCGSP  308 (313)
T ss_dssp             SEEEEECCCSTTGGGSCGGGTCSSSEEESTT
T ss_pred             CcccccCCCcccCCCCCHHHhCCCccccCCC
Confidence            99999999742 4566788999999999875

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=3.2e-13  Score=136.97  Aligned_cols=112  Identities=31%  Similarity=0.369  Sum_probs=100.7

Q ss_pred             CCCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccce
Q 004689          220 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRE  298 (736)
Q Consensus       220 ~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~  298 (736)
                      ..+++|+.|+|++|.+.+..+..+..+.+|+.|++++|.+++..+ .+..+++|+.|++++|+|++..|..|..+++|+.
T Consensus        97 ~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~  176 (266)
T d1p9ag_          97 QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT  176 (266)
T ss_dssp             TTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCE
T ss_pred             ccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccce
Confidence            346789999999999997777788899999999999999998887 4788999999999999999888888999999999


Q ss_pred             eecccccCcCCCCccccc--ccccccccCCcccccC
Q 004689          299 LYVQNNMLSGTVPSSLLS--KNVVLNYAGNINLHEG  332 (736)
Q Consensus       299 L~l~~N~l~g~~P~~~~~--~~~~l~~~~n~~~c~~  332 (736)
                      |+|++|+|+ .+|.+++.  .+..+.+.||++.|.+
T Consensus       177 L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC  211 (266)
T d1p9ag_         177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC  211 (266)
T ss_dssp             EECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred             eecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence            999999999 99998865  4578899999999986

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.30  E-value=1.4e-12  Score=125.40  Aligned_cols=153  Identities=20%  Similarity=0.167  Sum_probs=115.9

Q ss_pred             EEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceEEEEc
Q 004689          151 SFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHL  230 (736)
Q Consensus       151 ~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~~L~L  230 (736)
                      .++.+.+.++.+|+-|-  ..++.|.++.|.+..          ....+             .     ...+++|+.|+|
T Consensus        12 ~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~----------~~~~~-------------~-----f~~l~~L~~L~L   61 (192)
T d1w8aa_          12 TVDCTGRGLKEIPRDIP--LHTTELLLNDNELGR----------ISSDG-------------L-----FGRLPHLVKLEL   61 (192)
T ss_dssp             EEECTTSCCSSCCSCCC--TTCSEEECCSCCCCS----------BCCSC-------------S-----GGGCTTCCEEEC
T ss_pred             EEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcc----------ccccc-------------c-----cCCCceEeeeec
Confidence            35667788888887553  345667777776641          00000             0     123579999999


Q ss_pred             cCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCC
Q 004689          231 SSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGT  309 (736)
Q Consensus       231 ~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~  309 (736)
                      ++|++.+..+..+..+++|++|+|++|+|++.+| .|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.+.+.
T Consensus        62 ~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~  141 (192)
T d1w8aa_          62 KRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             cccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence            9999998888899999999999999999999888 689999999999999999988888999999999999999999865


Q ss_pred             CCccccc-ccccccccCCcccccCC
Q 004689          310 VPSSLLS-KNVVLNYAGNINLHEGG  333 (736)
Q Consensus       310 ~P~~~~~-~~~~l~~~~n~~~c~~~  333 (736)
                      .+...+. ......+.+|...|..+
T Consensus       142 ~~~~~~~~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_         142 CHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             GGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             cchHHHhhhhhhhcccCCCeEeCCC
Confidence            5443322 23344555665566543

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.24  E-value=7.1e-12  Score=111.12  Aligned_cols=99  Identities=32%  Similarity=0.445  Sum_probs=71.3

Q ss_pred             EEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccC
Q 004689          227 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML  306 (736)
Q Consensus       227 ~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l  306 (736)
                      .|+|++|+|+ .++ .+..|++|++|+|++|+|+..++.++++++|++|+|++|.|+ .+| .++++++|+.|++++|++
T Consensus         2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i   77 (124)
T d1dcea3           2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL   77 (124)
T ss_dssp             EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCC
T ss_pred             EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCcc
Confidence            6788888887 555 478888888888888888865556778888888888888888 344 478888888888888888


Q ss_pred             cCCCCc--ccc--cccccccccCCcccc
Q 004689          307 SGTVPS--SLL--SKNVVLNYAGNINLH  330 (736)
Q Consensus       307 ~g~~P~--~~~--~~~~~l~~~~n~~~c  330 (736)
                      + .+|.  .+.  ..+..+.+.||+...
T Consensus        78 ~-~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          78 Q-QSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             C-SSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             C-CCCCchhhcCCCCCCEEECCCCcCCc
Confidence            7 4442  222  234567777776543

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.23  E-value=1.5e-11  Score=125.52  Aligned_cols=149  Identities=19%  Similarity=0.212  Sum_probs=117.3

Q ss_pred             eccCCCCCCCc-cchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceEEEEccCC
Q 004689          155 GKTYDSSRGPL-LNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSITVIHLSSK  233 (736)
Q Consensus       155 ~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~~L~L~~n  233 (736)
                      ..+.++.++|. +..+..++.|.++.+....                   ..+.          ......+|+.+++++|
T Consensus        89 ~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~-------------------~~~~----------~~~~~~~L~~l~l~~N  139 (284)
T d1ozna_          89 DNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-------------------LGPG----------LFRGLAALQYLYLQDN  139 (284)
T ss_dssp             SCTTCCCCCTTTTTTCTTCCEEECTTSCCCC-------------------CCTT----------TTTTCTTCCEEECCSS
T ss_pred             cccccccccchhhcccccCCEEecCCccccc-------------------cccc----------ccchhcccchhhhccc
Confidence            45666677655 6666777777666655431                   0010          0123468999999999


Q ss_pred             CCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccCcCCCCc
Q 004689          234 NLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLSGTVPS  312 (736)
Q Consensus       234 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~P~  312 (736)
                      +|++..+..|..+++|+.|+|++|+|++.++ .|.++++|++|+|++|++++..|..|.++++|+.|++++|.+++..|.
T Consensus       140 ~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~  219 (284)
T d1ozna_         140 ALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE  219 (284)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHH
T ss_pred             cccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccc
Confidence            9996666778899999999999999999887 689999999999999999999999999999999999999999965555


Q ss_pred             ccc--cccccccccCCcccccC
Q 004689          313 SLL--SKNVVLNYAGNINLHEG  332 (736)
Q Consensus       313 ~~~--~~~~~l~~~~n~~~c~~  332 (736)
                      .+.  ..+..+.+.+|+..|..
T Consensus       220 ~~~~~~~L~~L~l~~N~l~C~C  241 (284)
T d1ozna_         220 ALAPLRALQYLRLNDNPWVCDC  241 (284)
T ss_dssp             HHTTCTTCCEEECCSSCEECSG
T ss_pred             ccccccccCEEEecCCCCCCCc
Confidence            542  33578889999999976

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.22  E-value=1.2e-11  Score=109.59  Aligned_cols=84  Identities=27%  Similarity=0.333  Sum_probs=76.1

Q ss_pred             CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCC-CccccCccccceee
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPL-PSSLMNLPNLRELY  300 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~  300 (736)
                      +++|+.|+|++|+|+ .+|+.+..+++|+.|+|++|.|++. |++.++++|++|++++|+|+... +..++.+++|+.|+
T Consensus        19 l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~   96 (124)
T d1dcea3          19 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN   96 (124)
T ss_dssp             GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred             CCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCCccCCCCCchhhcCCCCCCEEE
Confidence            458999999999999 7899999999999999999999975 67999999999999999999543 25789999999999


Q ss_pred             cccccCc
Q 004689          301 VQNNMLS  307 (736)
Q Consensus       301 l~~N~l~  307 (736)
                      +++|+++
T Consensus        97 l~~N~i~  103 (124)
T d1dcea3          97 LQGNSLC  103 (124)
T ss_dssp             CTTSGGG
T ss_pred             CCCCcCC
Confidence            9999998

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.21  E-value=9.8e-12  Score=114.98  Aligned_cols=104  Identities=18%  Similarity=0.188  Sum_probs=88.8

Q ss_pred             EEEccCCCCCccCCcccccccccccccccccc-cCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          227 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNS-LTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       227 ~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~-l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      .+++++++++ .+|..+..+++|++|+|++|+ |+...+ .|.++++|+.|+|++|+|+...|..|..+++|+.|+|++|
T Consensus        12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N   90 (156)
T d2ifga3          12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (156)
T ss_dssp             CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence            4556677777 678889999999999998764 887665 6999999999999999999777888999999999999999


Q ss_pred             cCcCCCCcccccc--cccccccCCcccccC
Q 004689          305 MLSGTVPSSLLSK--NVVLNYAGNINLHEG  332 (736)
Q Consensus       305 ~l~g~~P~~~~~~--~~~l~~~~n~~~c~~  332 (736)
                      +|+ .+|...+..  +..+.+.+|++.|..
T Consensus        91 ~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C  119 (156)
T d2ifga3          91 ALE-SLSWKTVQGLSLQELVLSGNPLHCSC  119 (156)
T ss_dssp             CCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred             CCc-ccChhhhccccccccccCCCcccCCc
Confidence            999 888887654  467889999999876

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.16  E-value=4e-11  Score=121.09  Aligned_cols=133  Identities=18%  Similarity=0.146  Sum_probs=108.7

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.+..|.++.|.++..++.+..+..++.|.++.+....                   ..++          ....+.++
T Consensus        76 l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~-------------------~~~~----------~~~~l~~l  126 (266)
T d1p9ag_          76 LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS-------------------LPLG----------ALRGLGEL  126 (266)
T ss_dssp             CTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCC-------------------CCSS----------TTTTCTTC
T ss_pred             cccccccccccccccccccccccccccccccccccccce-------------------eecc----------cccccccc
Confidence            456777888888888888877777777777776655431                   1111          11335689


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      ..|++++|.+++..+..+..+++|+.|++++|+|++.++ .|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|
T Consensus       127 ~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~N  205 (266)
T d1p9ag_         127 QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN  205 (266)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSC
T ss_pred             ccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCC
Confidence            999999999996666677889999999999999999888 5899999999999999999 89999999999999999999


Q ss_pred             cCcC
Q 004689          305 MLSG  308 (736)
Q Consensus       305 ~l~g  308 (736)
                      .+..
T Consensus       206 p~~C  209 (266)
T d1p9ag_         206 PWLC  209 (266)
T ss_dssp             CBCC
T ss_pred             CCCC
Confidence            9864

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.15  E-value=9.1e-11  Score=120.77  Aligned_cols=108  Identities=26%  Similarity=0.356  Sum_probs=94.8

Q ss_pred             CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceee
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY  300 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~  300 (736)
                      .++|+.|+|++|.+++..+..+.+++.++.|++++|.+++..+ .+.++++|++|+|++|.|+ .+|.+|.++++|+.|+
T Consensus       170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~  248 (305)
T d1xkua_         170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY  248 (305)
T ss_dssp             CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred             CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEE
Confidence            4689999999999999999999999999999999999999888 6889999999999999999 7899999999999999


Q ss_pred             cccccCcCCCCccccc---------ccccccccCCccccc
Q 004689          301 VQNNMLSGTVPSSLLS---------KNVVLNYAGNINLHE  331 (736)
Q Consensus       301 l~~N~l~g~~P~~~~~---------~~~~l~~~~n~~~c~  331 (736)
                      |++|+|+ .++...+.         .+..+.+.||++.+.
T Consensus       249 Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~  287 (305)
T d1xkua_         249 LHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW  287 (305)
T ss_dssp             CCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred             CCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence            9999999 77665432         235678899987653

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.13  E-value=2.8e-11  Score=112.55  Aligned_cols=105  Identities=18%  Similarity=0.141  Sum_probs=87.7

Q ss_pred             CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      ..+++.|+|++|+|+ .+|..+..+++|+.|+|++|+|+.. +.+..|++|++|+|++|+|+...+..+..+++|+.|++
T Consensus        17 ~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L   94 (162)
T d1a9na_          17 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL   94 (162)
T ss_dssp             TTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred             cCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCcccccccccccccee
Confidence            357999999999999 6787678899999999999999965 77999999999999999999655555678999999999


Q ss_pred             ccccCcCCCCc--cc--ccccccccccCCccc
Q 004689          302 QNNMLSGTVPS--SL--LSKNVVLNYAGNINL  329 (736)
Q Consensus       302 ~~N~l~g~~P~--~~--~~~~~~l~~~~n~~~  329 (736)
                      ++|+++ .++.  .+  +..+..+.+.+|+..
T Consensus        95 ~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          95 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             cccccc-ccccccccccccccchhhcCCCccc
Confidence            999998 5554  22  345577888998654

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.09  E-value=4.6e-11  Score=121.84  Aligned_cols=172  Identities=16%  Similarity=0.122  Sum_probs=126.9

Q ss_pred             ceeEEEeeccCCCCCCCc-cchhhhhhhhccCCCCchHH---HHHHHHHHcCCCC-c--CCCCCCCCCCCCCceEEecCC
Q 004689          148 FVLSFKFGKTYDSSRGPL-LNAMEINKYLERNDGSIDGV---AIVSVISLYSSAD-W--AQEGGDPCLPVPWSWLQCNSD  220 (736)
Q Consensus       148 ~l~~l~l~~~~~s~lpP~-in~~e~~~~l~~~~~~~~~~---al~~l~~~~~~~~-w--~~~~~dpc~~~~~~~v~c~~~  220 (736)
                      .+..|.|+.|.++.+|+. +..+..++.|..+.+.+...   +...+.....+.. .  ....-++.          ...
T Consensus        33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~----------~~~  102 (284)
T d1ozna_          33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPA----------TFH  102 (284)
T ss_dssp             TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTT----------TTT
T ss_pred             CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccch----------hhc
Confidence            456799999999999985 88888888888888765311   1100000000000 0  00001111          123


Q ss_pred             CCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCcccccee
Q 004689          221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLREL  299 (736)
Q Consensus       221 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L  299 (736)
                      .+++|+.|+|++|++.+..+..+..+++|+.+++++|+|++.++ .|.++++|+.|+|++|+|++..|..+.++++|+.|
T Consensus       103 ~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l  182 (284)
T d1ozna_         103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL  182 (284)
T ss_dssp             TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred             ccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchh
Confidence            45799999999999997777788899999999999999998877 58899999999999999998888899999999999


Q ss_pred             ecccccCcCCCCcccc--cccccccccCCccc
Q 004689          300 YVQNNMLSGTVPSSLL--SKNVVLNYAGNINL  329 (736)
Q Consensus       300 ~l~~N~l~g~~P~~~~--~~~~~l~~~~n~~~  329 (736)
                      ++++|++++..|..+.  .....+.+.+|...
T Consensus       183 ~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~  214 (284)
T d1ozna_         183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS  214 (284)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             hhhhccccccChhHhhhhhhcccccccccccc
Confidence            9999999977777664  34466777777543

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.97  E-value=1.8e-10  Score=106.91  Aligned_cols=85  Identities=21%  Similarity=0.281  Sum_probs=58.5

Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCCC-CCCCCCCcEEEcCCCCCCCCCC--ccccCcccccee
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPD-FSGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLREL  299 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L  299 (736)
                      ++|+.|+|++|+|+ .++ .|..|++|++|+|++|++++..+. +.++++|++|+|++|+|+ .++  ..+..+++|+.|
T Consensus        41 ~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L  117 (162)
T d1a9na_          41 DQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL  117 (162)
T ss_dssp             TCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred             ccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccchh
Confidence            35777777777777 443 467777777777777777776664 355777777777777776 333  356677777777


Q ss_pred             ecccccCcCCCC
Q 004689          300 YVQNNMLSGTVP  311 (736)
Q Consensus       300 ~l~~N~l~g~~P  311 (736)
                      ++++|.++ ..|
T Consensus       118 ~l~~N~i~-~~~  128 (162)
T d1a9na_         118 CILRNPVT-NKK  128 (162)
T ss_dssp             ECCSSGGG-GST
T ss_pred             hcCCCccc-ccc
Confidence            77777776 444

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.90  E-value=6.1e-10  Score=102.60  Aligned_cols=101  Identities=27%  Similarity=0.300  Sum_probs=83.3

Q ss_pred             CCCCCCCceEEecCCC----------CCceEEEEccCCC-CCccCCcccccccccccccccccccCCCCC-CCCCCCCCc
Q 004689          206 PCLPVPWSWLQCNSDP----------QPSITVIHLSSKN-LTGNIPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLR  273 (736)
Q Consensus       206 pc~~~~~~~v~c~~~~----------~~~l~~L~L~~n~-l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~  273 (736)
                      .|.+..++.+.|+...          +++|+.|+|++|+ |+..-+..|.+|++|+.|+|++|+|+...| .|.++++|+
T Consensus         4 ~C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~   83 (156)
T d2ifga3           4 ACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS   83 (156)
T ss_dssp             SSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred             CCCcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence            4555567788887543          3689999998764 885455679999999999999999999888 589999999


Q ss_pred             EEEcCCCCCCCCCCccccCccccceeecccccCc
Q 004689          274 IIHLEDNQLTGPLPSSLMNLPNLRELYVQNNMLS  307 (736)
Q Consensus       274 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  307 (736)
                      +|+|++|+|+ .+|.......+|+.|+|++|.+.
T Consensus        84 ~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~  116 (156)
T d2ifga3          84 RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH  116 (156)
T ss_dssp             EEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred             ceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence            9999999999 66665555558999999999985

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.87  E-value=5.2e-10  Score=108.53  Aligned_cols=128  Identities=23%  Similarity=0.368  Sum_probs=86.6

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.+..|.++.|.++.++|+ ..+..++.|.++.+.+..     +             ..             ...+++|
T Consensus        67 l~~L~~L~L~~n~i~~l~~~-~~l~~L~~L~l~~n~i~~-----l-------------~~-------------l~~l~~L  114 (210)
T d1h6ta2          67 LPNVTKLFLNGNKLTDIKPL-ANLKNLGWLFLDENKVKD-----L-------------SS-------------LKDLKKL  114 (210)
T ss_dssp             CTTCCEEECCSSCCCCCGGG-TTCTTCCEEECCSSCCCC-----G-------------GG-------------GTTCTTC
T ss_pred             CCCCCEEeCCCccccCcccc-ccCccccccccccccccc-----c-------------cc-------------ccccccc
Confidence            45788899999999998874 567778888887776541     0             00             0124567


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      +.|++++|.+. .+ +.+..+++|+.+++++|.+++. +.+.++++|++|++++|++++ ++ .++++++|+.|+|++|+
T Consensus       115 ~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~~-~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~  189 (210)
T d1h6ta2         115 KSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNH  189 (210)
T ss_dssp             CEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSC
T ss_pred             ccccccccccc-cc-cccccccccccccccccccccc-ccccccccccccccccccccc-cc-cccCCCCCCEEECCCCC
Confidence            77777777766 23 3567777777777777777653 345667777777777777774 33 26777777777777777


Q ss_pred             CcCCCC
Q 004689          306 LSGTVP  311 (736)
Q Consensus       306 l~g~~P  311 (736)
                      ++ .+|
T Consensus       190 i~-~l~  194 (210)
T d1h6ta2         190 IS-DLR  194 (210)
T ss_dssp             CC-BCG
T ss_pred             CC-CCh
Confidence            76 454

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.86  E-value=1.9e-09  Score=103.40  Aligned_cols=128  Identities=23%  Similarity=0.296  Sum_probs=97.4

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      ++.+..|.++.|.++.++| +..+..++.|.++.+....                   -        .    ....+++|
T Consensus        61 l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~-------------------~--------~----~l~~l~~L  108 (199)
T d2omxa2          61 LNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIAD-------------------I--------T----PLANLTNL  108 (199)
T ss_dssp             CTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-------------------C--------G----GGTTCTTC
T ss_pred             CCCcCcCccccccccCccc-ccCCccccccccccccccc-------------------c--------c----cccccccc
Confidence            4577788888888888876 6666666666666554421                   0        0    01235689


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      +.|++++|.+..  .+.+..+++|+.|++++|++.. ++.+.++++|+.|++++|++++. + .++++++|+.|++++|+
T Consensus       109 ~~L~l~~~~~~~--~~~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~  183 (199)
T d2omxa2         109 TGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNK  183 (199)
T ss_dssp             SEEECCSSCCCC--CGGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSC
T ss_pred             cccccccccccc--ccccchhhhhHHhhhhhhhhcc-cccccccccccccccccccccCC-c-cccCCCCCCEEECCCCC
Confidence            999999998884  3358889999999999999875 45688899999999999999853 3 48899999999999999


Q ss_pred             CcCCCC
Q 004689          306 LSGTVP  311 (736)
Q Consensus       306 l~g~~P  311 (736)
                      ++ .+|
T Consensus       184 i~-~i~  188 (199)
T d2omxa2         184 VS-DIS  188 (199)
T ss_dssp             CC-CCG
T ss_pred             CC-CCc
Confidence            98 454

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.84  E-value=4.1e-09  Score=108.03  Aligned_cols=98  Identities=14%  Similarity=0.154  Sum_probs=83.1

Q ss_pred             CCCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCc-------cccC
Q 004689          220 DPQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPS-------SLMN  292 (736)
Q Consensus       220 ~~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~-------~~~~  292 (736)
                      ...+.++.|++++|.+++..+..+.++++|++|+|++|+|+..++++.++++|++|+|++|+|+. ++.       .+..
T Consensus       192 ~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~-i~~~~f~~~~~~~~  270 (305)
T d1xkua_         192 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA-IGSNDFCPPGYNTK  270 (305)
T ss_dssp             TTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCC-CCTTSSSCSSCCTT
T ss_pred             hccccccccccccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccCc-cChhhccCcchhcc
Confidence            34568999999999999888889999999999999999999776689999999999999999994 432       3456


Q ss_pred             ccccceeecccccCc-CCCCccccccc
Q 004689          293 LPNLRELYVQNNMLS-GTVPSSLLSKN  318 (736)
Q Consensus       293 l~~L~~L~l~~N~l~-g~~P~~~~~~~  318 (736)
                      +.+|+.|+|++|.++ +.+|+..++..
T Consensus       271 ~~~L~~L~L~~N~~~~~~~~~~~f~~~  297 (305)
T d1xkua_         271 KASYSGVSLFSNPVQYWEIQPSTFRCV  297 (305)
T ss_dssp             SCCCSEEECCSSSSCGGGSCGGGGTTC
T ss_pred             cCCCCEEECCCCcCccCcCCHhHhccc
Confidence            788999999999985 56777776653

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.82  E-value=2.2e-09  Score=113.30  Aligned_cols=165  Identities=19%  Similarity=0.219  Sum_probs=91.4

Q ss_pred             cceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCceE
Q 004689          147 PFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSIT  226 (736)
Q Consensus       147 ~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l~  226 (736)
                      +.+..+.+..|.++.+|. +..+..++.|.+..+.+....  .+...-.+...... ....     ..+. .....+.++
T Consensus       219 ~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~-~~~l-----~~~~-~~~~~~~l~  288 (384)
T d2omza2         219 TNLDELSLNGNQLKDIGT-LASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLG-ANQI-----SNIS-PLAGLTALT  288 (384)
T ss_dssp             TTCCEEECCSSCCCCCGG-GGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECC-SSCC-----CCCG-GGTTCTTCS
T ss_pred             CCCCEEECCCCCCCCcch-hhcccccchhccccCccCCCC--cccccccCCEeecc-Cccc-----CCCC-ccccccccc
Confidence            455677777777777643 445555666666665543100  01100011100000 0000     0000 012235566


Q ss_pred             EEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccccC
Q 004689          227 VIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNML  306 (736)
Q Consensus       227 ~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~l  306 (736)
                      .+++..|.+++  +..+..+++|+.|+|++|++++..+ +..+++|++|+|++|+|++ +| .+++|++|+.|++++|+|
T Consensus       289 ~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~-l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l  363 (384)
T d2omza2         289 NLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQI  363 (384)
T ss_dssp             EEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCC
T ss_pred             ccccccccccc--ccccchhcccCeEECCCCCCCCCcc-cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcC
Confidence            77777777764  3346777777777888777776543 6777777888888887773 44 577777788888888877


Q ss_pred             cCCCCcccccccccccccCC
Q 004689          307 SGTVPSSLLSKNVVLNYAGN  326 (736)
Q Consensus       307 ~g~~P~~~~~~~~~l~~~~n  326 (736)
                      ++..|-.-+..+..+.++.|
T Consensus       364 ~~l~~l~~l~~L~~L~L~~N  383 (384)
T d2omza2         364 SDLTPLANLTRITQLGLNDQ  383 (384)
T ss_dssp             CBCGGGTTCTTCSEEECCCE
T ss_pred             CCChhhccCCCCCEeeCCCC
Confidence            75444322344455555544

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.82  E-value=1.3e-09  Score=115.25  Aligned_cols=145  Identities=16%  Similarity=0.242  Sum_probs=102.3

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      .++.+..+.+..|.++.++| +..+..++.|.++.+.+..  +..+.....+....   ..-|   ...++.+ ....++
T Consensus       239 ~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~~~l~~--~~~~~~~~~l~~l~---~~~n---~l~~~~~-~~~~~~  308 (384)
T d2omza2         239 SLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISN--ISPLAGLTALTNLE---LNEN---QLEDISP-ISNLKN  308 (384)
T ss_dssp             GCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCC--CGGGTTCTTCSEEE---CCSS---CCSCCGG-GGGCTT
T ss_pred             cccccchhccccCccCCCCc-ccccccCCEeeccCcccCC--CCcccccccccccc---cccc---ccccccc-cchhcc
Confidence            45678889999999999887 5556667777777665421  00111111111000   0001   0111110 123468


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      ++.|+|++|++++. + .+..+++|+.|+|++|+|++ ++.+++|++|++|+|++|+|++..|  +.+|++|+.|+|++|
T Consensus       309 l~~L~ls~n~l~~l-~-~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         309 LTYLTLYFNNISDI-S-PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CSEEECCSSCCSCC-G-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             cCeEECCCCCCCCC-c-ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            99999999999964 3 38999999999999999997 4579999999999999999997655  899999999999998

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.80  E-value=3.2e-09  Score=102.78  Aligned_cols=145  Identities=21%  Similarity=0.223  Sum_probs=111.7

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      +.++..|.+..+.+..+++ |..+..++.|.++.+.+..                   -+++            ..+++|
T Consensus        45 L~~L~~L~l~~~~i~~l~~-l~~l~~L~~L~L~~n~i~~-------------------l~~~------------~~l~~L   92 (210)
T d1h6ta2          45 LNSIDQIIANNSDIKSVQG-IQYLPNVTKLFLNGNKLTD-------------------IKPL------------ANLKNL   92 (210)
T ss_dssp             HHTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCC-------------------CGGG------------TTCTTC
T ss_pred             hcCccEEECcCCCCCCchh-HhhCCCCCEEeCCCccccC-------------------cccc------------ccCccc
Confidence            4577888999999888865 5667777778777775541                   1111            235789


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      +.|+|++|++++ +| .+..+++|+.|++++|.+.. ++.+.+++.|+.+++++|.+++  +..++.+++|+.+++++|+
T Consensus        93 ~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~  167 (210)
T d1h6ta2          93 GWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ  167 (210)
T ss_dssp             CEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSC
T ss_pred             cccccccccccc-cc-cccccccccccccccccccc-cccccccccccccccccccccc--ccccccccccccccccccc
Confidence            999999999994 55 58899999999999999875 4568899999999999999985  3457889999999999999


Q ss_pred             CcCCCCcccccccccccccCCc
Q 004689          306 LSGTVPSSLLSKNVVLNYAGNI  327 (736)
Q Consensus       306 l~g~~P~~~~~~~~~l~~~~n~  327 (736)
                      +++..|-.-+..+..+.+++|.
T Consensus       168 l~~i~~l~~l~~L~~L~Ls~N~  189 (210)
T d1h6ta2         168 ISDIVPLAGLTKLQNLYLSKNH  189 (210)
T ss_dssp             CCCCGGGTTCTTCCEEECCSSC
T ss_pred             ccccccccCCCCCCEEECCCCC
Confidence            9953332334556777888874

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.78  E-value=5.8e-09  Score=100.00  Aligned_cols=145  Identities=17%  Similarity=0.230  Sum_probs=109.7

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCce
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPSI  225 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~l  225 (736)
                      +..+..|.+..+.+..+.. |..+..++.|.++.+.+..              +     +|            ...+++|
T Consensus        39 l~~l~~L~l~~~~i~~l~~-l~~l~nL~~L~Ls~N~l~~--------------~-----~~------------l~~l~~L   86 (199)
T d2omxa2          39 LDQVTTLQADRLGIKSIDG-VEYLNNLTQINFSNNQLTD--------------I-----TP------------LKNLTKL   86 (199)
T ss_dssp             HTTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCC--------------C-----GG------------GTTCTTC
T ss_pred             hcCCCEEECCCCCCCCccc-cccCCCcCcCccccccccC--------------c-----cc------------ccCCccc
Confidence            4577788888888888753 5666777777777776541              1     11            1245789


Q ss_pred             EEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccccc
Q 004689          226 TVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNNM  305 (736)
Q Consensus       226 ~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N~  305 (736)
                      +.|++++|.+. .++ .+.++++|+.|++++|.+... +.+.++++|+.|++++|++. .+| .+..+++|+.|++++|+
T Consensus        87 ~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~~-~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~  161 (199)
T d2omxa2          87 VDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITDI-DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQ  161 (199)
T ss_dssp             CEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSC
T ss_pred             ccccccccccc-ccc-ccccccccccccccccccccc-cccchhhhhHHhhhhhhhhc-ccc-ccccccccccccccccc
Confidence            99999999988 455 488999999999999998864 44788999999999999998 344 58899999999999999


Q ss_pred             CcCCCCcccccccccccccCCc
Q 004689          306 LSGTVPSSLLSKNVVLNYAGNI  327 (736)
Q Consensus       306 l~g~~P~~~~~~~~~l~~~~n~  327 (736)
                      +++.-|-.-+..+..+.+.+|.
T Consensus       162 l~~l~~l~~l~~L~~L~ls~N~  183 (199)
T d2omxa2         162 VTDLKPLANLTTLERLDISSNK  183 (199)
T ss_dssp             CCCCGGGTTCTTCCEEECCSSC
T ss_pred             ccCCccccCCCCCCEEECCCCC
Confidence            9853333334556777888874

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.76  E-value=2.8e-09  Score=104.47  Aligned_cols=149  Identities=21%  Similarity=0.281  Sum_probs=92.5

Q ss_pred             ccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCc-hHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          146 LPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSI-DGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~-~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      ++.+..|.++.|.++.++| +..++.+..+....+.. +..++.   ....+.....   ..|.   ..+.. .....+.
T Consensus        62 l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~~i~~l~---~l~~L~~l~l---~~~~---~~~~~-~~~~~~~  130 (227)
T d1h6ua2          62 LNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVSAIA---GLQSIKTLDL---TSTQ---ITDVT-PLAGLSN  130 (227)
T ss_dssp             CTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCGGGT---TCTTCCEEEC---TTSC---CCCCG-GGTTCTT
T ss_pred             CCCCcEeecCCceeecccc-cccccccccccccccccccccccc---cccccccccc---cccc---ccccc-hhccccc
Confidence            5677888888888888776 55555666666655443 211111   1111111110   0110   01110 0122456


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      +..|.++++.+...  ..+.++++|+.|++++|.+++..+ ++++++|+.|+|++|++++ +|. ++++++|+.|+|++|
T Consensus       131 ~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~-l~~-l~~l~~L~~L~Ls~N  205 (227)
T d1h6ua2         131 LQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD-ISP-LASLPNLIEVHLKNN  205 (227)
T ss_dssp             CCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECTTS
T ss_pred             hhhhhchhhhhchh--hhhccccccccccccccccccchh-hcccccceecccCCCccCC-Chh-hcCCCCCCEEECcCC
Confidence            77788888777732  347778888888888888875443 7788888888888888885 443 788888888888888


Q ss_pred             cCcCCCC
Q 004689          305 MLSGTVP  311 (736)
Q Consensus       305 ~l~g~~P  311 (736)
                      +++ .+|
T Consensus       206 ~lt-~i~  211 (227)
T d1h6ua2         206 QIS-DVS  211 (227)
T ss_dssp             CCC-BCG
T ss_pred             cCC-CCc
Confidence            888 454

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.57  E-value=8.2e-10  Score=106.01  Aligned_cols=105  Identities=28%  Similarity=0.274  Sum_probs=84.0

Q ss_pred             CCCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceee
Q 004689          221 PQPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELY  300 (736)
Q Consensus       221 ~~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~  300 (736)
                      .+++|+.|+|++|+|+ .++ .|..|++|+.|+|++|.|+...+.+..+++|++|+|++|+|+. + +.+.++++|+.|+
T Consensus        46 ~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L~  121 (198)
T d1m9la_          46 TLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVLY  121 (198)
T ss_dssp             HTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEEE
T ss_pred             cccccceeECcccCCC-Ccc-cccCCccccChhhcccccccccccccccccccccccccccccc-c-ccccccccccccc
Confidence            3678999999999999 565 5999999999999999998654333446789999999999994 4 3588999999999


Q ss_pred             cccccCcCCCCc--cc--ccccccccccCCcccc
Q 004689          301 VQNNMLSGTVPS--SL--LSKNVVLNYAGNINLH  330 (736)
Q Consensus       301 l~~N~l~g~~P~--~~--~~~~~~l~~~~n~~~c  330 (736)
                      |++|+++ .++.  .+  +..+..+.+.||+..+
T Consensus       122 L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~  154 (198)
T d1m9la_         122 MSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYN  154 (198)
T ss_dssp             ESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred             cccchhc-cccccccccCCCccceeecCCCcccc
Confidence            9999998 5553  22  3456788899997543

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.53  E-value=7.7e-10  Score=106.22  Aligned_cols=84  Identities=20%  Similarity=0.352  Sum_probs=69.9

Q ss_pred             CceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCC--ccccCccccceee
Q 004689          223 PSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLP--SSLMNLPNLRELY  300 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~  300 (736)
                      ++|+.|+|++|.|+ .+|..+..+++|++|+|++|+++.. +.+.++++|++|+|++|+|+ .++  ..+..|++|+.|+
T Consensus        70 ~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~  146 (198)
T d1m9la_          70 ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLL  146 (198)
T ss_dssp             TTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEE
T ss_pred             ccccChhhcccccc-ccccccccccccccccccccccccc-ccccccccccccccccchhc-cccccccccCCCccceee
Confidence            57999999999998 6776666778899999999999864 55788899999999999998 444  4688999999999


Q ss_pred             cccccCcCC
Q 004689          301 VQNNMLSGT  309 (736)
Q Consensus       301 l~~N~l~g~  309 (736)
                      |++|.++..
T Consensus       147 L~~N~l~~~  155 (198)
T d1m9la_         147 LAGNPLYND  155 (198)
T ss_dssp             ECSSHHHHH
T ss_pred             cCCCccccC
Confidence            999988743

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.38  E-value=1.5e-07  Score=92.49  Aligned_cols=97  Identities=22%  Similarity=0.281  Sum_probs=75.6

Q ss_pred             CceEEecCCC--------CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCC--CCCCCCCCcEEEcC-CC
Q 004689          212 WSWLQCNSDP--------QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIP--DFSGCPDLRIIHLE-DN  280 (736)
Q Consensus       212 ~~~v~c~~~~--------~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~l~~L~~L~Ls-~N  280 (736)
                      ...+.|+..+        ++++++|+|++|+|+...+..|.++++|++|+|++|.+.+.++  .|.+++.+++|.+. .|
T Consensus        10 ~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n   89 (242)
T d1xwdc1          10 NRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN   89 (242)
T ss_dssp             SSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCT
T ss_pred             CCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccc
Confidence            4557776433        2378899999999984334468889999999999999888665  47888999888875 46


Q ss_pred             CCCCCCCccccCccccceeecccccCcC
Q 004689          281 QLTGPLPSSLMNLPNLRELYVQNNMLSG  308 (736)
Q Consensus       281 ~l~g~~p~~~~~l~~L~~L~l~~N~l~g  308 (736)
                      ++....+..|.++++|+.|++++|.+..
T Consensus        90 ~l~~~~~~~~~~l~~L~~l~l~~~~l~~  117 (242)
T d1xwdc1          90 NLLYINPEAFQNLPNLQYLLISNTGIKH  117 (242)
T ss_dssp             TCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred             cccccccccccccccccccccchhhhcc
Confidence            7877777788899999999999998873

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.37  E-value=3.8e-07  Score=88.77  Aligned_cols=167  Identities=20%  Similarity=0.220  Sum_probs=114.6

Q ss_pred             cccceeEEEeeccCCCCCCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          145 SLPFVLSFKFGKTYDSSRGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       145 ~l~~l~~l~l~~~~~s~lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      .+.++..|.+..+.++.+++ +..++.++.|.++.+.+..  +..+.....+....   ..-|.   .+-+. ....+++
T Consensus        39 ~l~~L~~L~l~~~~i~~l~~-l~~l~~L~~L~ls~n~i~~--~~~l~~l~~l~~l~---~~~n~---~~~i~-~l~~l~~  108 (227)
T d1h6ua2          39 DLDGITTLSAFGTGVTTIEG-VQYLNNLIGLELKDNQITD--LAPLKNLTKITELE---LSGNP---LKNVS-AIAGLQS  108 (227)
T ss_dssp             HHHTCCEEECTTSCCCCCTT-GGGCTTCCEEECCSSCCCC--CGGGTTCCSCCEEE---CCSCC---CSCCG-GGTTCTT
T ss_pred             HcCCcCEEECCCCCCCcchh-HhcCCCCcEeecCCceeec--cccccccccccccc---ccccc---ccccc-ccccccc
Confidence            35678899999999999964 7888999999998887642  11111111111111   11111   01111 1234578


Q ss_pred             eEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeecccc
Q 004689          225 ITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQNN  304 (736)
Q Consensus       225 l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~N  304 (736)
                      |+.|+++++...+.  ..+...+.+..|.++++.+....+ +.++++|++|++++|.+++..  .++++++|+.|+|++|
T Consensus       109 L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n  183 (227)
T d1h6ua2         109 IKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDN  183 (227)
T ss_dssp             CCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSS
T ss_pred             cccccccccccccc--chhccccchhhhhchhhhhchhhh-hccccccccccccccccccch--hhcccccceecccCCC
Confidence            88999988887743  336777888888888888876544 778899999999999998543  3899999999999999


Q ss_pred             cCcCCCCc-ccccccccccccCCc
Q 004689          305 MLSGTVPS-SLLSKNVVLNYAGNI  327 (736)
Q Consensus       305 ~l~g~~P~-~~~~~~~~l~~~~n~  327 (736)
                      ++++ +|. .-+..+..+.+.+|.
T Consensus       184 ~l~~-l~~l~~l~~L~~L~Ls~N~  206 (227)
T d1h6ua2         184 KISD-ISPLASLPNLIEVHLKNNQ  206 (227)
T ss_dssp             CCCC-CGGGGGCTTCCEEECTTSC
T ss_pred             ccCC-ChhhcCCCCCCEEECcCCc
Confidence            9984 553 224556777888874

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.27  E-value=2.1e-06  Score=85.12  Aligned_cols=131  Identities=18%  Similarity=0.126  Sum_probs=91.5

Q ss_pred             cCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcC-CCceeeEeeeeeeCCeEEEEEEecCCCCHHHHhhc
Q 004689          419 GGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIH-HRNLVQFLGYCQEEGRSVLVYEFMHNGTLKEHLYG  497 (736)
Q Consensus       419 G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~  497 (736)
                      ++.+.||+.... ++.+++|+...........+.+|...++.+. +--+.+++.++..++..++||++++|.++.+....
T Consensus        25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~  103 (263)
T d1j7la_          25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED  103 (263)
T ss_dssp             CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred             CCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence            334689998654 6778899876555455567888999988774 33367788888888999999999999887654321


Q ss_pred             ccccccccCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------------
Q 004689          498 TLTHEQRINWIKRLEIAEDAAKGIEYLHTGC-------------------------------------------------  528 (736)
Q Consensus       498 ~~~~~~~l~~~~~~~i~~qia~~L~~LH~~~-------------------------------------------------  528 (736)
                      ..         ....++.++++.+..||+..                                                 
T Consensus       104 ~~---------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (263)
T d1j7la_         104 EQ---------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL  174 (263)
T ss_dssp             CS---------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred             cc---------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence            10         01223444555555555321                                                 


Q ss_pred             -------CCceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          529 -------VPAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       529 -------~~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                             ...++|+|+.|.|||+++++..-|+||+.+.
T Consensus       175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                   1248999999999999987666799999764

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.02  E-value=9.2e-06  Score=79.18  Aligned_cols=77  Identities=21%  Similarity=0.229  Sum_probs=37.0

Q ss_pred             ceEEEEccCCCCCccCCcccccccccccc-cccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVEL-WLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L-~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      .++.|++++|+++ .++..+.+.++++.+ ++++|+++...+ .|.++++|++|+|++|+|+...+..|.+|++|+.|++
T Consensus       154 ~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~  232 (242)
T d1xwdc1         154 ESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST  232 (242)
T ss_dssp             SCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred             cceeeeccccccc-ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence            4555555555555 333333333343333 345555554433 3455555555555555555322334555555555444

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.97  E-value=6.4e-06  Score=84.57  Aligned_cols=76  Identities=30%  Similarity=0.411  Sum_probs=40.1

Q ss_pred             ceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeeccc
Q 004689          224 SITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYVQN  303 (736)
Q Consensus       224 ~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l~~  303 (736)
                      +++.|||++++|+ .+|+.   +++|++|+|++|+|+.. |..  +.+|+.|++++|+++ .++. +  .+.|+.|++++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~l-p~~--~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~  107 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTEL-PEL--PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSN  107 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSC-CCC--CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCS
T ss_pred             CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCccc-ccc--hhhhhhhhhhhcccc-hhhh-h--ccccccccccc
Confidence            4556666666666 45543   34556666666666633 321  235556666666655 3332 1  12356666666


Q ss_pred             ccCcCCCC
Q 004689          304 NMLSGTVP  311 (736)
Q Consensus       304 N~l~g~~P  311 (736)
                      |.++ .+|
T Consensus       108 n~l~-~lp  114 (353)
T d1jl5a_         108 NQLE-KLP  114 (353)
T ss_dssp             SCCS-SCC
T ss_pred             cccc-ccc
Confidence            6665 444

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.95  E-value=1.4e-05  Score=78.36  Aligned_cols=75  Identities=20%  Similarity=0.144  Sum_probs=55.4

Q ss_pred             cccccCc-eEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCC--CceeeEeeeeeeCCeEEEEEEecCCCCH
Q 004689          415 KIGSGGF-GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHH--RNLVQFLGYCQEEGRSVLVYEFMHNGTL  491 (736)
Q Consensus       415 ~IG~G~f-G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~~~~~~~~~~~lV~e~~~~gsL  491 (736)
                      .+..|.. +.||+....++..+++|.-...   ....+..|+..++.+..  -.+.+++.++.+++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            3455554 6899999887888899986533   24467889999988743  3356778888888889999999988665


Q ss_pred             H
Q 004689          492 K  492 (736)
Q Consensus       492 ~  492 (736)
                      .
T Consensus        94 ~   94 (255)
T d1nd4a_          94 L   94 (255)
T ss_dssp             T
T ss_pred             c
Confidence            3

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.91  E-value=7e-07  Score=82.06  Aligned_cols=62  Identities=27%  Similarity=0.368  Sum_probs=26.9

Q ss_pred             cccccccccccccccCCCCC---CCCCCCCCcEEEcCCCCCCCCCCc-cccCccccceeecccccCc
Q 004689          245 KLSSLVELWLDGNSLTGPIP---DFSGCPDLRIIHLEDNQLTGPLPS-SLMNLPNLRELYVQNNMLS  307 (736)
Q Consensus       245 ~l~~L~~L~Ls~N~l~~~~p---~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~  307 (736)
                      .+++|++|+|++|+|+...+   .+..|++|+.|+|++|.|+ .+++ ......+|+.|++++|.++
T Consensus        63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcC
Confidence            34455555555555544321   1233455555555555554 2222 1222234455555555554

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.62  E-value=3.7e-05  Score=78.65  Aligned_cols=81  Identities=33%  Similarity=0.490  Sum_probs=65.7

Q ss_pred             CCceEEEEccCCCCCccCCcccccccccccccccccccCCCCCCCCCCCCCcEEEcCCCCCCCCCCccccCccccceeec
Q 004689          222 QPSITVIHLSSKNLTGNIPSDLTKLSSLVELWLDGNSLTGPIPDFSGCPDLRIIHLEDNQLTGPLPSSLMNLPNLRELYV  301 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~l  301 (736)
                      +++|++|+|++|+|+ .+|..+   .+|+.|++++|+++.. +.+.  +.|++|+|++|.|+ .+|. ++.+++|+.|++
T Consensus        57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l-~~lp--~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l  127 (353)
T d1jl5a_          57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKAL-SDLP--PLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV  127 (353)
T ss_dssp             CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCC-CSCC--TTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred             CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchh-hhhc--cccccccccccccc-cccc-hhhhccceeecc
Confidence            358999999999999 888765   4788889999998843 3222  46999999999999 6775 688999999999


Q ss_pred             ccccCcCCCCc
Q 004689          302 QNNMLSGTVPS  312 (736)
Q Consensus       302 ~~N~l~g~~P~  312 (736)
                      ++|.++ ..|.
T Consensus       128 ~~~~~~-~~~~  137 (353)
T d1jl5a_         128 DNNSLK-KLPD  137 (353)
T ss_dssp             CSSCCS-CCCC
T ss_pred             cccccc-cccc
Confidence            999998 4444

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.51  E-value=6.3e-06  Score=75.41  Aligned_cols=83  Identities=25%  Similarity=0.281  Sum_probs=51.3

Q ss_pred             CCceEEEEccCCCCCcc--CCcccccccccccccccccccCCCCC-CCCCCCCCcEEEcCCCCCCCCCCcc-------cc
Q 004689          222 QPSITVIHLSSKNLTGN--IPSDLTKLSSLVELWLDGNSLTGPIP-DFSGCPDLRIIHLEDNQLTGPLPSS-------LM  291 (736)
Q Consensus       222 ~~~l~~L~L~~n~l~g~--~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~g~~p~~-------~~  291 (736)
                      +++|+.|+|++|+|+..  ++..+..+++|+.|+|++|.++...+ .+.+..+|+.|+|++|.+++.....       +.
T Consensus        64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~  143 (162)
T d1koha1          64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRE  143 (162)
T ss_dssp             CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHT
T ss_pred             CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHH
Confidence            35677777777777732  22345567777777777777776554 3333446777777777777554422       45


Q ss_pred             CccccceeecccccC
Q 004689          292 NLPNLRELYVQNNML  306 (736)
Q Consensus       292 ~l~~L~~L~l~~N~l  306 (736)
                      .+|+|+.||  ++.+
T Consensus       144 ~~P~L~~LD--g~~v  156 (162)
T d1koha1         144 RFPKLLRLD--GHEL  156 (162)
T ss_dssp             TSTTCCEET--TEEC
T ss_pred             HCCCCCEEC--cCCC
Confidence            567777654  4444

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.34  E-value=7.7e-06  Score=82.15  Aligned_cols=165  Identities=14%  Similarity=0.131  Sum_probs=79.4

Q ss_pred             cceeEEEeeccCCCC--CCCccchhhhhhhhccCCCCchHHHHHHHHHHcCCCCcCCCCCCCCCCCCCceEEecCCCCCc
Q 004689          147 PFVLSFKFGKTYDSS--RGPLLNAMEINKYLERNDGSIDGVAIVSVISLYSSADWAQEGGDPCLPVPWSWLQCNSDPQPS  224 (736)
Q Consensus       147 ~~l~~l~l~~~~~s~--lpP~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~~~w~~~~~dpc~~~~~~~v~c~~~~~~~  224 (736)
                      ..+..|+++.+.++.  +..++.....++.|.+....++...+..+.+.-.+..-+.   .-|....-.++.--....++
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L---s~c~~itd~~l~~l~~~~~~  122 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL---SGCSGFSEFALQTLLSSCSR  122 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC---TTCBSCCHHHHHHHHHHCTT
T ss_pred             CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccc---cccccccccccchhhHHHHh
Confidence            345556666554332  3333445555666666666665555555543322222211   11210000110000011356


Q ss_pred             eEEEEccCC-CCCcc-CCccccc-cccccccccccc--ccCCC-CCCC-CCCCCCcEEEcCCC-CCCCCCCccccCcccc
Q 004689          225 ITVIHLSSK-NLTGN-IPSDLTK-LSSLVELWLDGN--SLTGP-IPDF-SGCPDLRIIHLEDN-QLTGPLPSSLMNLPNL  296 (736)
Q Consensus       225 l~~L~L~~n-~l~g~-~p~~~~~-l~~L~~L~Ls~N--~l~~~-~p~~-~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L  296 (736)
                      |+.|+|+++ +++.. +...+.. .++|+.|+|++.  .++.. +..+ .++++|++|+|++| .+++..+..++++++|
T Consensus       123 L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L  202 (284)
T d2astb2         123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL  202 (284)
T ss_dssp             CCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred             ccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcC
Confidence            777777764 34321 1222333 256777777653  23321 2222 45677777777764 4666666667777777


Q ss_pred             ceeecccc-cCcCCCCccc
Q 004689          297 RELYVQNN-MLSGTVPSSL  314 (736)
Q Consensus       297 ~~L~l~~N-~l~g~~P~~~  314 (736)
                      +.|+|++| .+++.....+
T Consensus       203 ~~L~L~~C~~i~~~~l~~L  221 (284)
T d2astb2         203 QHLSLSRCYDIIPETLLEL  221 (284)
T ss_dssp             CEEECTTCTTCCGGGGGGG
T ss_pred             CEEECCCCCCCChHHHHHH
Confidence            77777773 4554433333

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.26  E-value=0.00051  Score=71.73  Aligned_cols=75  Identities=16%  Similarity=0.137  Sum_probs=47.7

Q ss_pred             ccccccCceEEEEEEECC-CcEEEEEEeccCC-------cccchhhhhHHHHHhhcC-C--CceeeEeeeeeeCCeEEEE
Q 004689          414 KKIGSGGFGVVYYGKLKD-GKEIAVKVLTSNS-------YQGKREFTNEVTLLSRIH-H--RNLVQFLGYCQEEGRSVLV  482 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~-~~~vAvK~l~~~~-------~~~~~~~~~E~~il~~l~-H--pnIv~l~~~~~~~~~~~lV  482 (736)
                      +.||.|....||+....+ ++.|+||.-....       .........|++.|+.+. +  ..+.+++.+  +++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            468999999999998754 6789999643211       112233556888887763 3  335555554  44456899


Q ss_pred             EEecCCCC
Q 004689          483 YEFMHNGT  490 (736)
Q Consensus       483 ~e~~~~gs  490 (736)
                      ||++.+..
T Consensus       110 mE~L~~~~  117 (392)
T d2pula1         110 MEDLSHLK  117 (392)
T ss_dssp             ECCCTTSE
T ss_pred             EeccCCcc
Confidence            99997654

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.21  E-value=7.6e-06  Score=84.49  Aligned_cols=144  Identities=17%  Similarity=0.246  Sum_probs=74.8

Q ss_pred             ccceeEEEeeccCCCCCC-----CccchhhhhhhhccCCCCchHHHHHHHHHHcCC--CCcCCCCCCCCCCCCCceEEec
Q 004689          146 LPFVLSFKFGKTYDSSRG-----PLLNAMEINKYLERNDGSIDGVAIVSVISLYSS--ADWAQEGGDPCLPVPWSWLQCN  218 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lp-----P~in~~e~~~~l~~~~~~~~~~al~~l~~~~~~--~~w~~~~~dpc~~~~~~~v~c~  218 (736)
                      .+.+..|+|+.|.++...     ..+.....++.|.++.+.+.......+...+..  ..+.                  
T Consensus        92 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~------------------  153 (344)
T d2ca6a1          92 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKK------------------  153 (344)
T ss_dssp             CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHH------------------
T ss_pred             CCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccc------------------
Confidence            356788899988876632     122233345667787777755444444332210  0000                  


Q ss_pred             CCCCCceEEEEccCCCCCcc----CCcccccccccccccccccccCCC-----C-CCCCCCCCCcEEEcCCCCCCCC---
Q 004689          219 SDPQPSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGP-----I-PDFSGCPDLRIIHLEDNQLTGP---  285 (736)
Q Consensus       219 ~~~~~~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~-----~-p~~~~l~~L~~L~Ls~N~l~g~---  285 (736)
                      ....+.|+.|++++|.++..    +...+...+.|+.|+|++|+++..     + ..+..+++|+.|+|++|.|+..   
T Consensus       154 ~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~  233 (344)
T d2ca6a1         154 AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSS  233 (344)
T ss_dssp             HHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHH
T ss_pred             cccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccc
Confidence            00123456666666655421    222334455666666666665531     1 1345566666666666665421   


Q ss_pred             -CCccccCccccceeecccccCc
Q 004689          286 -LPSSLMNLPNLRELYVQNNMLS  307 (736)
Q Consensus       286 -~p~~~~~l~~L~~L~l~~N~l~  307 (736)
                       +...+..+++|+.|+|++|.|+
T Consensus       234 ~L~~~l~~~~~L~~L~Ls~n~i~  256 (344)
T d2ca6a1         234 ALAIALKSWPNLRELGLNDCLLS  256 (344)
T ss_dssp             HHHHHGGGCTTCCEEECTTCCCC
T ss_pred             cccccccccccchhhhhhcCccC
Confidence             3334555666666666666665

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.13  E-value=2.6e-05  Score=82.78  Aligned_cols=85  Identities=32%  Similarity=0.436  Sum_probs=56.8

Q ss_pred             CceEEEEccCCCCCc----cCCcccccccccccccccccccCCC----CC-CCC-CCCCCcEEEcCCCCCCCC----CCc
Q 004689          223 PSITVIHLSSKNLTG----NIPSDLTKLSSLVELWLDGNSLTGP----IP-DFS-GCPDLRIIHLEDNQLTGP----LPS  288 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p-~~~-~l~~L~~L~Ls~N~l~g~----~p~  288 (736)
                      ++++.|+|++|+++-    .++..+..+++|++|||++|.|+..    +. .+. ...+|++|+|++|+++..    ++.
T Consensus        27 ~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~  106 (460)
T d1z7xw1          27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS  106 (460)
T ss_dssp             TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred             CCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccc
Confidence            356778888887762    3344556777888888888877531    11 232 235688888888887643    455


Q ss_pred             cccCccccceeecccccCc
Q 004689          289 SLMNLPNLRELYVQNNMLS  307 (736)
Q Consensus       289 ~~~~l~~L~~L~l~~N~l~  307 (736)
                      .+..+++|+.|+|++|.++
T Consensus       107 ~l~~~~~L~~L~L~~N~i~  125 (460)
T d1z7xw1         107 TLRTLPTLQELHLSDNLLG  125 (460)
T ss_dssp             HTTSCTTCCEEECCSSBCH
T ss_pred             hhhccccccccccccccch
Confidence            6677788888888888776

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.02  E-value=3.1e-05  Score=82.17  Aligned_cols=86  Identities=24%  Similarity=0.330  Sum_probs=62.3

Q ss_pred             CceEEEEccCCCCCccCCccc----ccccccccccccccccCCC----CC-CCC-CCCCCcEEEcCCCCCCC----CCCc
Q 004689          223 PSITVIHLSSKNLTGNIPSDL----TKLSSLVELWLDGNSLTGP----IP-DFS-GCPDLRIIHLEDNQLTG----PLPS  288 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p~~~----~~l~~L~~L~Ls~N~l~~~----~p-~~~-~l~~L~~L~Ls~N~l~g----~~p~  288 (736)
                      ..|+.++++++.++......|    ...++|++|+|++|++++.    +. .+. ..+.|++|+|++|.|+.    .++.
T Consensus       312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~  391 (460)
T d1z7xw1         312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA  391 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence            468889999988875543333    3456799999999988652    22 233 46778999999999873    2455


Q ss_pred             cccCccccceeecccccCcC
Q 004689          289 SLMNLPNLRELYVQNNMLSG  308 (736)
Q Consensus       289 ~~~~l~~L~~L~l~~N~l~g  308 (736)
                      .+..+++|++|+|++|+|+.
T Consensus       392 ~l~~~~~L~~L~Ls~N~i~~  411 (460)
T d1z7xw1         392 TLLANHSLRELDLSNNCLGD  411 (460)
T ss_dssp             HHHHCCCCCEEECCSSSCCH
T ss_pred             HHhcCCCCCEEECCCCcCCH
Confidence            66777889999999998874

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.69  E-value=0.00036  Score=69.47  Aligned_cols=156  Identities=17%  Similarity=0.126  Sum_probs=92.5

Q ss_pred             ccceeEEEeeccCCCCCC-CccchhhhhhhhccCC-CCchHHHHHHHHHHc-CCCCcCCCCCCCCCCCCCceEE-ecCCC
Q 004689          146 LPFVLSFKFGKTYDSSRG-PLLNAMEINKYLERND-GSIDGVAIVSVISLY-SSADWAQEGGDPCLPVPWSWLQ-CNSDP  221 (736)
Q Consensus       146 l~~l~~l~l~~~~~s~lp-P~in~~e~~~~l~~~~-~~~~~~al~~l~~~~-~~~~w~~~~~dpc~~~~~~~v~-c~~~~  221 (736)
                      .+++..|.|..+.++... ..+.....++.|.++. ..+...++..+.... .+..-+.   .-|.-..-.++. .-...
T Consensus        70 c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~l---s~c~~~~~~~~~~~~~~~  146 (284)
T d2astb2          70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL---SWCFDFTEKHVQVAVAHV  146 (284)
T ss_dssp             BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEEC---CCCTTCCHHHHHHHHHHS
T ss_pred             CCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccccc---ccccccccccchhhhccc
Confidence            356777777777654322 2244455666777765 445445555554432 2332221   112100001100 00011


Q ss_pred             CCceEEEEccCC--CCCcc-CCccccccccccccccccc-ccCCCCC-CCCCCCCCcEEEcCC-CCCCCCCCccccCccc
Q 004689          222 QPSITVIHLSSK--NLTGN-IPSDLTKLSSLVELWLDGN-SLTGPIP-DFSGCPDLRIIHLED-NQLTGPLPSSLMNLPN  295 (736)
Q Consensus       222 ~~~l~~L~L~~n--~l~g~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p-~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~  295 (736)
                      .++|+.|+|+++  .++.. +..-+.++++|++|+|++| .+++... .+.++++|++|+|++ +.+++.....++++++
T Consensus       147 ~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~  226 (284)
T d2astb2         147 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT  226 (284)
T ss_dssp             CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTT
T ss_pred             ccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCC
Confidence            257899999865  34432 2222346789999999885 5775444 688899999999998 4687666677888999


Q ss_pred             cceeecccc
Q 004689          296 LRELYVQNN  304 (736)
Q Consensus       296 L~~L~l~~N  304 (736)
                      |+.|+++++
T Consensus       227 L~~L~l~~~  235 (284)
T d2astb2         227 LKTLQVFGI  235 (284)
T ss_dssp             CCEEECTTS
T ss_pred             CCEEeeeCC
Confidence            999999877

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.67  E-value=0.0021  Score=65.02  Aligned_cols=68  Identities=12%  Similarity=0.121  Sum_probs=47.1

Q ss_pred             eEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCce--eeEee-----eeeeCCeEEEEEEecCCCC
Q 004689          422 GVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLG-----YCQEEGRSVLVYEFMHNGT  490 (736)
Q Consensus       422 G~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI--v~l~~-----~~~~~~~~~lV~e~~~~gs  490 (736)
                      -.||+++..+|..+++|+.+.. ..+..++..|...+..+....+  +..+.     .+...+..+.+++++.|..
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            4799999999999999998644 2346678889999888853222  11111     2244567788999987643

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=96.57  E-value=0.00013  Score=74.95  Aligned_cols=85  Identities=19%  Similarity=0.237  Sum_probs=58.1

Q ss_pred             CceEEEEccCCCCCcc-----CCcccccccccccccccccccCCC----C-CCCCCCCCCcEEEcCCCCCCCCCC----c
Q 004689          223 PSITVIHLSSKNLTGN-----IPSDLTKLSSLVELWLDGNSLTGP----I-PDFSGCPDLRIIHLEDNQLTGPLP----S  288 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~-p~~~~l~~L~~L~Ls~N~l~g~~p----~  288 (736)
                      +.|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    + ..+..+++|++|+|++|.|++.-.    .
T Consensus       186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~  265 (344)
T d2ca6a1         186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD  265 (344)
T ss_dssp             TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred             hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence            3678888888887632     344566778888888888887642    2 246778888888888888874311    2


Q ss_pred             cccC--ccccceeecccccCc
Q 004689          289 SLMN--LPNLRELYVQNNMLS  307 (736)
Q Consensus       289 ~~~~--l~~L~~L~l~~N~l~  307 (736)
                      .+..  .+.|+.|++++|+++
T Consensus       266 ~l~~~~~~~L~~L~ls~N~i~  286 (344)
T d2ca6a1         266 AFSKLENIGLQTLRLQYNEIE  286 (344)
T ss_dssp             HHHTCSSCCCCEEECCSSCCB
T ss_pred             HhhhccCCCCCEEECCCCcCC
Confidence            2222  256888888888876

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=96.12  E-value=0.00022  Score=65.07  Aligned_cols=85  Identities=15%  Similarity=0.237  Sum_probs=62.4

Q ss_pred             CceEEEEccCC-CCCcc----CCcccccccccccccccccccCCCC-C----CCCCCCCCcEEEcCCCCCCCC----CCc
Q 004689          223 PSITVIHLSSK-NLTGN----IPSDLTKLSSLVELWLDGNSLTGPI-P----DFSGCPDLRIIHLEDNQLTGP----LPS  288 (736)
Q Consensus       223 ~~l~~L~L~~n-~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~-p----~~~~l~~L~~L~Ls~N~l~g~----~p~  288 (736)
                      ++|+.|+|+++ .++..    +...+...+.|+.|+|++|.+...- .    .+...+.|++|+|++|.|+..    +-.
T Consensus        15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~   94 (167)
T d1pgva_          15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR   94 (167)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred             CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence            57999999974 46532    3334566788999999999987522 2    245578899999999998832    223


Q ss_pred             cccCccccceeecccccCc
Q 004689          289 SLMNLPNLRELYVQNNMLS  307 (736)
Q Consensus       289 ~~~~l~~L~~L~l~~N~l~  307 (736)
                      .+...+.|+.|+|++|.+.
T Consensus        95 aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          95 STLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HTTTTCCCSEEECCCCSSC
T ss_pred             HHHhCCcCCEEECCCCcCC
Confidence            5667788999999998765

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.86  E-value=0.013  Score=60.72  Aligned_cols=72  Identities=14%  Similarity=0.281  Sum_probs=49.1

Q ss_pred             ccccccCceEEEEEEECC--------CcEEEEEEeccCCcccchhhhhHHHHHhhcCCCc-eeeEeeeeeeCCeEEEEEE
Q 004689          414 KKIGSGGFGVVYYGKLKD--------GKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRN-LVQFLGYCQEEGRSVLVYE  484 (736)
Q Consensus       414 ~~IG~G~fG~Vy~~~~~~--------~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~e  484 (736)
                      +.|+.|-.-.+|+....+        .+.|.+++.- . ........+|..+++.+.-.+ ..++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            467888888999998754        3457777654 2 223345678999999885334 4477777653    57999


Q ss_pred             ecCCCCH
Q 004689          485 FMHNGTL  491 (736)
Q Consensus       485 ~~~~gsL  491 (736)
                      |+++..+
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=95.42  E-value=0.0012  Score=59.99  Aligned_cols=84  Identities=11%  Similarity=0.071  Sum_probs=62.0

Q ss_pred             CceEEEEccCCCCCccCC----cccccccccccccccccccCCCC-C----CCCCCCCCcEEEcCCCCCCCC-------C
Q 004689          223 PSITVIHLSSKNLTGNIP----SDLTKLSSLVELWLDGNSLTGPI-P----DFSGCPDLRIIHLEDNQLTGP-------L  286 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~~p----~~~~~l~~L~~L~Ls~N~l~~~~-p----~~~~l~~L~~L~Ls~N~l~g~-------~  286 (736)
                      +.|+.|+|++|.++..-.    ..+...+.|+.|+|++|.++..- .    .+...++|++|+|++|.+...       +
T Consensus        44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l  123 (167)
T d1pgva_          44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM  123 (167)
T ss_dssp             SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred             CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHH
Confidence            368999999999984333    34456788999999999998632 1    477789999999999987632       2


Q ss_pred             CccccCccccceeecccccC
Q 004689          287 PSSLMNLPNLRELYVQNNML  306 (736)
Q Consensus       287 p~~~~~l~~L~~L~l~~N~l  306 (736)
                      ...+...+.|+.|+++.+..
T Consensus       124 ~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_         124 MMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             HHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHhCCCccEeeCcCCCc
Confidence            34455567888888876644

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.99  E-value=0.05  Score=53.87  Aligned_cols=141  Identities=13%  Similarity=0.086  Sum_probs=72.8

Q ss_pred             ccccCceEEEEEEECCCcEEEEEEeccCCcccchhhhhHHHHHhhcCCCce--eeEee------eeeeCCeEEEEEEecC
Q 004689          416 IGSGGFGVVYYGKLKDGKEIAVKVLTSNSYQGKREFTNEVTLLSRIHHRNL--VQFLG------YCQEEGRSVLVYEFMH  487 (736)
Q Consensus       416 IG~G~fG~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~~E~~il~~l~HpnI--v~l~~------~~~~~~~~~lV~e~~~  487 (736)
                      |..|---+.|+.+..+| .+++|+....  ....++..|++++..+...++  ...+.      +.........++.+..
T Consensus        26 i~~G~~N~ny~v~t~~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~  102 (316)
T d2ppqa1          26 IAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE  102 (316)
T ss_dssp             ECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred             CCCCcccCeEEEEECCC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence            45566678899887754 5899987543  234566778888888743222  11111      1122345566677665


Q ss_pred             CCCHHH--------------Hhhc---ccc---cccc-----------------cCHHHHHHHHHHHHHHHHHHHh-CCC
Q 004689          488 NGTLKE--------------HLYG---TLT---HEQR-----------------INWIKRLEIAEDAAKGIEYLHT-GCV  529 (736)
Q Consensus       488 ~gsL~~--------------~l~~---~~~---~~~~-----------------l~~~~~~~i~~qia~~L~~LH~-~~~  529 (736)
                      +.....              .++.   ...   ....                 .........+......+...+. ...
T Consensus       103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~  182 (316)
T d2ppqa1         103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP  182 (316)
T ss_dssp             CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred             cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence            542210              0000   000   0000                 0000111122222222222222 223


Q ss_pred             CceecCCCCCCCEEEcCCCcEEEEeecCCc
Q 004689          530 PAIIHRDLKSSNILLDKHMRAKVSDFGLSK  559 (736)
Q Consensus       530 ~~iiHrDikp~NILl~~~~~~kl~DFGla~  559 (736)
                      .++||+|+.+.||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            489999999999999998777899999874

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=92.91  E-value=0.0041  Score=55.97  Aligned_cols=85  Identities=20%  Similarity=0.311  Sum_probs=55.9

Q ss_pred             CceEEEEccC-CCCCcc----CCcccccccccccccccccccCCCCC-----CCCCCCCCcEEEcCCCCCCCC----CCc
Q 004689          223 PSITVIHLSS-KNLTGN----IPSDLTKLSSLVELWLDGNSLTGPIP-----DFSGCPDLRIIHLEDNQLTGP----LPS  288 (736)
Q Consensus       223 ~~l~~L~L~~-n~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~p-----~~~~l~~L~~L~Ls~N~l~g~----~p~  288 (736)
                      +.|+.|+|++ +.++..    +...+...++|++|+|++|.++...-     .+...+.|+.|++++|.++..    +-.
T Consensus        17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~   96 (166)
T d1io0a_          17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE   96 (166)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred             CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence            5788888887 456532    33344567888888888888765321     245578888888888887632    234


Q ss_pred             cccCccccceeec--ccccCc
Q 004689          289 SLMNLPNLRELYV--QNNMLS  307 (736)
Q Consensus       289 ~~~~l~~L~~L~l--~~N~l~  307 (736)
                      .+...++|+.++|  ++|.+.
T Consensus        97 ~l~~~~~L~~l~L~l~~n~i~  117 (166)
T d1io0a_          97 ALQSNTSLIELRIDNQSQPLG  117 (166)
T ss_dssp             GGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHhCccccEEeeccCCCcCc
Confidence            5666777876555  455554

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=90.53  E-value=0.0076  Score=54.11  Aligned_cols=85  Identities=11%  Similarity=0.115  Sum_probs=62.7

Q ss_pred             CceEEEEccCCCCCcc----CCcccccccccccccccccccCCCC-----CCCCCCCCCcEEEc--CCCCCCC----CCC
Q 004689          223 PSITVIHLSSKNLTGN----IPSDLTKLSSLVELWLDGNSLTGPI-----PDFSGCPDLRIIHL--EDNQLTG----PLP  287 (736)
Q Consensus       223 ~~l~~L~L~~n~l~g~----~p~~~~~l~~L~~L~Ls~N~l~~~~-----p~~~~l~~L~~L~L--s~N~l~g----~~p  287 (736)
                      ++|+.|+|++|+++..    +...+...+.|+.|++++|.++...     ..+...++|+.++|  ++|.+..    .+.
T Consensus        46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La  125 (166)
T d1io0a_          46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA  125 (166)
T ss_dssp             CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred             CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence            4789999999998754    3334556789999999999987532     25777889987665  5677752    244


Q ss_pred             ccccCccccceeecccccCc
Q 004689          288 SSLMNLPNLRELYVQNNMLS  307 (736)
Q Consensus       288 ~~~~~l~~L~~L~l~~N~l~  307 (736)
                      ..+...++|+.|+++.|+..
T Consensus       126 ~~L~~n~~L~~L~l~~~~~~  145 (166)
T d1io0a_         126 NMLEKNTTLLKFGYHFTQQG  145 (166)
T ss_dssp             HHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHhCCCcCEEeCcCCCCc
Confidence            56677889999999877653